<<<<<<< HEAD
2025-01-28 16:24:52 [INFO] Bot is started. Polling begins.
2025-01-28 16:24:52 [INFO] Start polling
2025-01-28 16:24:52 [INFO] Run polling for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-28 16:24:56 [ERROR] Failed to fetch updates - TelegramConflictError: Telegram server says - Conflict: terminated by other getUpdates request; make sure that only one bot instance is running
2025-01-28 16:24:56 [WARNING] Sleep for 1.000000 seconds and try again... (tryings = 0, bot id = 8108339380)
2025-01-28 16:25:01 [ERROR] Failed to fetch updates - TelegramConflictError: Telegram server says - Conflict: terminated by other getUpdates request; make sure that only one bot instance is running
2025-01-28 16:25:01 [WARNING] Sleep for 1.346202 seconds and try again... (tryings = 1, bot id = 8108339380)
2025-01-28 16:25:07 [ERROR] Failed to fetch updates - TelegramConflictError: Telegram server says - Conflict: terminated by other getUpdates request; make sure that only one bot instance is running
2025-01-28 16:25:07 [WARNING] Sleep for 1.728928 seconds and try again... (tryings = 2, bot id = 8108339380)
2025-01-28 16:25:14 [ERROR] Failed to fetch updates - TelegramConflictError: Telegram server says - Conflict: terminated by other getUpdates request; make sure that only one bot instance is running
2025-01-28 16:25:14 [WARNING] Sleep for 2.376162 seconds and try again... (tryings = 3, bot id = 8108339380)
2025-01-28 16:25:20 [INFO] Polling stopped
2025-01-28 16:25:20 [INFO] Polling stopped for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-28 16:25:20 [WARNING] Bot is stopped manually.
2025-01-28 16:25:25 [INFO] Bot is started. Polling begins.
2025-01-28 16:25:25 [INFO] Start polling
2025-01-28 16:25:25 [INFO] Run polling for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-28 16:25:25 [INFO] The user 711983855 called the command /start.
2025-01-28 16:25:26 [INFO] Update id=273477807 is handled. Duration 250 ms by bot id=8108339380
2025-01-28 16:25:27 [INFO] The user 711983855's state has been set to Survey.age.
2025-01-28 16:25:27 [INFO] Update id=273477808 is handled. Duration 125 ms by bot id=8108339380
2025-01-28 16:25:34 [INFO] The user 711983855's state has been set to Survey.weight.
2025-01-28 16:25:34 [INFO] Update id=273477809 is handled. Duration 125 ms by bot id=8108339380
2025-01-28 16:25:40 [INFO] The user 711983855's state has been set to Survey.height.
2025-01-28 16:25:40 [INFO] Update id=273477810 is handled. Duration 265 ms by bot id=8108339380
2025-01-28 16:25:44 [INFO] The user 711983855's state has been set to Survey.feet.
2025-01-28 16:25:44 [INFO] Update id=273477811 is handled. Duration 108 ms by bot id=8108339380
2025-01-28 16:25:48 [INFO] The user 711983855's state has been set to Survey.gender.
2025-01-28 16:25:48 [INFO] Update id=273477812 is handled. Duration 140 ms by bot id=8108339380
2025-01-28 16:25:53 [INFO] The user 711983855's state has been set to Survey.pregnant.
2025-01-28 16:25:53 [INFO] Update id=273477813 is handled. Duration 156 ms by bot id=8108339380
2025-01-28 16:25:55 [INFO] The user 711983855's state has been set to Survey.smoking.
2025-01-28 16:25:56 [INFO] Update id=273477814 is handled. Duration 125 ms by bot id=8108339380
2025-01-28 16:25:57 [INFO] The user 711983855's state has been set to Survey.sex.
2025-01-28 16:25:57 [INFO] Update id=273477815 is handled. Duration 108 ms by bot id=8108339380
2025-01-28 16:25:59 [INFO] The user 711983855's state has been clean.
2025-01-28 16:25:59 [INFO] Update id=273477816 is handled. Duration 391 ms by bot id=8108339380
2025-01-28 16:26:03 [INFO] Update id=273477817 is handled. Duration 375 ms by bot id=8108339380
2025-01-28 16:26:06 [INFO] Update id=273477818 is handled. Duration 250 ms by bot id=8108339380
2025-01-28 16:26:09 [INFO] Update id=273477819 is handled. Duration 202 ms by bot id=8108339380
2025-01-28 16:26:11 [INFO] Update id=273477820 is handled. Duration 407 ms by bot id=8108339380
2025-01-28 16:26:12 [INFO] Update id=273477821 is handled. Duration 187 ms by bot id=8108339380
2025-01-28 16:26:13 [INFO] Update id=273477822 is handled. Duration 202 ms by bot id=8108339380
2025-01-28 16:26:14 [INFO] Update id=273477823 is handled. Duration 171 ms by bot id=8108339380
2025-01-28 16:26:15 [INFO] Update id=273477824 is handled. Duration 358 ms by bot id=8108339380
2025-01-28 16:26:52 [INFO] Polling stopped
2025-01-28 16:26:53 [INFO] Polling stopped for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-28 16:26:53 [WARNING] Bot is stopped manually.
2025-01-28 11:40:43 [INFO] Bot is started. Polling begins.
2025-01-28 11:40:43 [INFO] Start polling
2025-01-28 11:40:44 [INFO] Run polling for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-28 11:44:28 [ERROR] Failed to fetch updates - TelegramConflictError: Telegram server says - Conflict: terminated by other getUpdates request; make sure that only one bot instance is running
2025-01-28 11:44:28 [WARNING] Sleep for 1.000000 seconds and try again... (tryings = 0, bot id = 8108339380)
2025-01-28 11:44:34 [ERROR] Failed to fetch updates - TelegramConflictError: Telegram server says - Conflict: terminated by other getUpdates request; make sure that only one bot instance is running
2025-01-28 11:44:34 [WARNING] Sleep for 1.348710 seconds and try again... (tryings = 1, bot id = 8108339380)
2025-01-28 11:44:36 [INFO] Connection established (tryings = 2, bot id = 8108339380)
2025-01-28 11:44:36 [INFO] The user 5407850682's state has been set to Survey.age.
2025-01-28 11:44:37 [INFO] Update id=273477826 is handled. Duration 1397 ms by bot id=8108339380
2025-01-28 11:44:39 [INFO] The user 5407850682's state has been set to Survey.weight.
2025-01-28 11:44:39 [INFO] Update id=273477827 is handled. Duration 384 ms by bot id=8108339380
2025-01-28 11:44:39 [ERROR] Failed to fetch updates - TelegramConflictError: Telegram server says - Conflict: terminated by other getUpdates request; make sure that only one bot instance is running
2025-01-28 11:44:39 [WARNING] Sleep for 1.000000 seconds and try again... (tryings = 0, bot id = 8108339380)
2025-01-28 11:44:45 [ERROR] Failed to fetch updates - TelegramConflictError: Telegram server says - Conflict: terminated by other getUpdates request; make sure that only one bot instance is running
2025-01-28 11:44:45 [WARNING] Sleep for 1.377565 seconds and try again... (tryings = 1, bot id = 8108339380)
2025-01-28 11:44:51 [ERROR] Failed to fetch updates - TelegramConflictError: Telegram server says - Conflict: terminated by other getUpdates request; make sure that only one bot instance is running
2025-01-28 11:44:51 [WARNING] Sleep for 1.940926 seconds and try again... (tryings = 2, bot id = 8108339380)
2025-01-28 11:44:55 [INFO] Connection established (tryings = 3, bot id = 8108339380)
2025-01-28 11:44:55 [INFO] The user 5407850682's state has been set to Survey.height.
2025-01-28 11:44:55 [INFO] Update id=273477829 is handled. Duration 466 ms by bot id=8108339380
2025-01-28 11:44:58 [ERROR] Failed to fetch updates - TelegramConflictError: Telegram server says - Conflict: terminated by other getUpdates request; make sure that only one bot instance is running
2025-01-28 11:44:58 [WARNING] Sleep for 1.000000 seconds and try again... (tryings = 0, bot id = 8108339380)
2025-01-28 11:45:00 [INFO] Connection established (tryings = 1, bot id = 8108339380)
2025-01-28 11:45:00 [INFO] The user 5407850682's state has been set to Survey.feet.
2025-01-28 11:45:00 [INFO] Update id=273477831 is handled. Duration 441 ms by bot id=8108339380
2025-01-28 11:45:03 [ERROR] Failed to fetch updates - TelegramConflictError: Telegram server says - Conflict: terminated by other getUpdates request; make sure that only one bot instance is running
2025-01-28 11:45:03 [WARNING] Sleep for 1.000000 seconds and try again... (tryings = 0, bot id = 8108339380)
2025-01-28 11:45:14 [INFO] Bot is started. Polling begins.
2025-01-28 11:45:14 [INFO] Start polling
2025-01-28 11:45:15 [INFO] Run polling for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-28 11:45:19 [ERROR] Failed to fetch updates - TelegramConflictError: Telegram server says - Conflict: terminated by other getUpdates request; make sure that only one bot instance is running
2025-01-28 11:45:19 [WARNING] Sleep for 1.000000 seconds and try again... (tryings = 0, bot id = 8108339380)
2025-01-28 11:45:25 [ERROR] Failed to fetch updates - TelegramConflictError: Telegram server says - Conflict: terminated by other getUpdates request; make sure that only one bot instance is running
2025-01-28 11:45:25 [WARNING] Sleep for 1.121459 seconds and try again... (tryings = 1, bot id = 8108339380)
2025-01-28 11:45:31 [ERROR] Failed to fetch updates - TelegramConflictError: Telegram server says - Conflict: terminated by other getUpdates request; make sure that only one bot instance is running
2025-01-28 11:45:31 [WARNING] Sleep for 1.472470 seconds and try again... (tryings = 2, bot id = 8108339380)
2025-01-28 12:18:28 [INFO] Bot is started. Polling begins.
2025-01-28 12:18:28 [INFO] Start polling
2025-01-28 12:18:29 [INFO] Run polling for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-28 12:18:34 [ERROR] Failed to fetch updates - TelegramConflictError: Telegram server says - Conflict: terminated by other getUpdates request; make sure that only one bot instance is running
2025-01-28 12:18:34 [WARNING] Sleep for 1.000000 seconds and try again... (tryings = 0, bot id = 8108339380)
2025-01-28 12:18:40 [ERROR] Failed to fetch updates - TelegramConflictError: Telegram server says - Conflict: terminated by other getUpdates request; make sure that only one bot instance is running
2025-01-28 12:18:40 [WARNING] Sleep for 1.310261 seconds and try again... (tryings = 1, bot id = 8108339380)
2025-01-28 12:18:46 [ERROR] Failed to fetch updates - TelegramConflictError: Telegram server says - Conflict: terminated by other getUpdates request; make sure that only one bot instance is running
2025-01-28 12:18:46 [WARNING] Sleep for 1.816602 seconds and try again... (tryings = 2, bot id = 8108339380)
2025-01-28 12:18:52 [ERROR] Failed to fetch updates - TelegramConflictError: Telegram server says - Conflict: terminated by other getUpdates request; make sure that only one bot instance is running
2025-01-28 12:18:52 [WARNING] Sleep for 2.495054 seconds and try again... (tryings = 3, bot id = 8108339380)
2025-01-28 12:18:59 [ERROR] Failed to fetch updates - TelegramConflictError: Telegram server says - Conflict: terminated by other getUpdates request; make sure that only one bot instance is running
2025-01-28 12:18:59 [WARNING] Sleep for 3.221564 seconds and try again... (tryings = 4, bot id = 8108339380)
2025-01-28 12:19:07 [ERROR] Failed to fetch updates - TelegramConflictError: Telegram server says - Conflict: terminated by other getUpdates request; make sure that only one bot instance is running
2025-01-28 12:19:07 [WARNING] Sleep for 4.025329 seconds and try again... (tryings = 5, bot id = 8108339380)
2025-01-28 12:19:15 [ERROR] Failed to fetch updates - TelegramConflictError: Telegram server says - Conflict: terminated by other getUpdates request; make sure that only one bot instance is running
2025-01-28 12:19:15 [WARNING] Sleep for 4.977467 seconds and try again... (tryings = 6, bot id = 8108339380)
2025-01-28 12:19:21 [INFO] Connection established (tryings = 7, bot id = 8108339380)
2025-01-28 12:19:21 [INFO] Update id=273477886 is not handled. Duration 2 ms by bot id=8108339380
2025-01-28 12:19:22 [INFO] Update id=273477887 is not handled. Duration 1 ms by bot id=8108339380
2025-01-28 12:19:25 [ERROR] Failed to fetch updates - TelegramConflictError: Telegram server says - Conflict: terminated by other getUpdates request; make sure that only one bot instance is running
2025-01-28 12:19:25 [WARNING] Sleep for 1.000000 seconds and try again... (tryings = 0, bot id = 8108339380)
2025-01-28 12:19:27 [INFO] Connection established (tryings = 1, bot id = 8108339380)
2025-01-28 12:19:27 [INFO] The user 711983855's state has been clean.
2025-01-28 12:19:27 [INFO] Update id=273477890 is not handled. Duration 1 ms by bot id=8108339380
2025-01-28 12:19:27 [ERROR] Cause exception while process update id=273477890 by bot id=8108339380
IndexError: list index out of range
Traceback (most recent call last):
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/dispatcher.py", line 309, in _process_update
    response = await self.feed_update(bot, update, **kwargs)
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/dispatcher.py", line 158, in feed_update
    response = await self.update.wrap_outer_middleware(
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/middlewares/error.py", line 25, in __call__
    return await handler(event, data)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/middlewares/user_context.py", line 56, in __call__
    return await handler(event, data)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/fsm/middleware.py", line 42, in __call__
    return await handler(event, data)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/event/telegram.py", line 121, in trigger
    return await wrapped_inner(event, kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/event/handler.py", line 43, in call
    return await wrapped()
           ^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/dispatcher.py", line 276, in _listen_update
    return await self.propagate_event(update_type=update_type, event=event, **kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 146, in propagate_event
    return await observer.wrap_outer_middleware(_wrapped, event=event, data=kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 141, in _wrapped
    return await self._propagate_event(
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 174, in _propagate_event
    response = await router.propagate_event(update_type=update_type, event=event, **kwargs)
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 146, in propagate_event
    return await observer.wrap_outer_middleware(_wrapped, event=event, data=kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 141, in _wrapped
    return await self._propagate_event(
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 166, in _propagate_event
    response = await observer.trigger(event, **kwargs)
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/event/telegram.py", line 121, in trigger
    return await wrapped_inner(event, kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/event/handler.py", line 43, in call
    return await wrapped()
           ^^^^^^^^^^^^^^^
  File "/app/bot/handlers.py", line 157, in pagination_query
    await query.message.edit_text(f"{recommendations[page][0]}"
                                     ~~~~~~~~~~~~~~~^^^^^^
IndexError: list index out of range
2025-01-28 12:19:30 [ERROR] Failed to fetch updates - TelegramConflictError: Telegram server says - Conflict: terminated by other getUpdates request; make sure that only one bot instance is running
2025-01-28 12:19:30 [WARNING] Sleep for 1.000000 seconds and try again... (tryings = 0, bot id = 8108339380)
2025-01-28 12:19:36 [ERROR] Failed to fetch updates - TelegramConflictError: Telegram server says - Conflict: terminated by other getUpdates request; make sure that only one bot instance is running
2025-01-28 12:19:36 [WARNING] Sleep for 1.365792 seconds and try again... (tryings = 1, bot id = 8108339380)
2025-01-28 12:19:42 [ERROR] Failed to fetch updates - TelegramConflictError: Telegram server says - Conflict: terminated by other getUpdates request; make sure that only one bot instance is running
2025-01-28 12:19:42 [WARNING] Sleep for 1.694455 seconds and try again... (tryings = 2, bot id = 8108339380)
2025-01-28 12:19:48 [ERROR] Failed to fetch updates - TelegramConflictError: Telegram server says - Conflict: terminated by other getUpdates request; make sure that only one bot instance is running
2025-01-28 12:19:48 [WARNING] Sleep for 2.218992 seconds and try again... (tryings = 3, bot id = 8108339380)
2025-01-28 12:19:56 [ERROR] Failed to fetch updates - TelegramConflictError: Telegram server says - Conflict: terminated by other getUpdates request; make sure that only one bot instance is running
2025-01-28 12:19:56 [WARNING] Sleep for 2.988893 seconds and try again... (tryings = 4, bot id = 8108339380)
2025-01-28 12:20:05 [ERROR] Failed to fetch updates - TelegramConflictError: Telegram server says - Conflict: terminated by other getUpdates request; make sure that only one bot instance is running
2025-01-28 12:20:05 [WARNING] Sleep for 4.045941 seconds and try again... (tryings = 5, bot id = 8108339380)
2025-01-28 12:20:12 [ERROR] Failed to fetch updates - TelegramConflictError: Telegram server says - Conflict: terminated by other getUpdates request; make sure that only one bot instance is running
2025-01-28 12:20:12 [WARNING] Sleep for 4.923046 seconds and try again... (tryings = 6, bot id = 8108339380)
2025-01-28 12:20:29 [INFO] Bot is started. Polling begins.
2025-01-28 12:20:29 [INFO] Start polling
2025-01-28 12:20:30 [INFO] Run polling for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-28 12:20:34 [INFO] The user 711983855 called the command /start.
2025-01-28 12:20:36 [ERROR] Failed to fetch updates - TelegramConflictError: Telegram server says - Conflict: terminated by other getUpdates request; make sure that only one bot instance is running
2025-01-28 12:20:36 [WARNING] Sleep for 1.000000 seconds and try again... (tryings = 0, bot id = 8108339380)
2025-01-28 12:20:36 [INFO] Update id=273477894 is handled. Duration 1398 ms by bot id=8108339380
2025-01-28 12:20:38 [INFO] Connection established (tryings = 1, bot id = 8108339380)
2025-01-28 12:20:38 [INFO] The user 711983855's state has been set to Survey.age.
2025-01-28 12:20:38 [INFO] Update id=273477895 is handled. Duration 350 ms by bot id=8108339380
2025-01-28 12:20:41 [INFO] The user 711983855's state has been set to Survey.weight.
2025-01-28 12:20:41 [INFO] Update id=273477896 is handled. Duration 346 ms by bot id=8108339380
2025-01-28 12:20:42 [INFO] The user 711983855's state has been set to Survey.height.
2025-01-28 12:20:42 [INFO] Update id=273477897 is handled. Duration 347 ms by bot id=8108339380
2025-01-28 12:20:43 [INFO] The user 711983855's state has been set to Survey.feet.
2025-01-28 12:20:43 [INFO] Update id=273477898 is handled. Duration 356 ms by bot id=8108339380
2025-01-28 12:20:43 [INFO] Update id=273477899 is not handled. Duration 19 ms by bot id=8108339380
2025-01-28 12:20:43 [ERROR] Cause exception while process update id=273477899 by bot id=8108339380
ValueError: invalid literal for int() with base 10: '90-'
Traceback (most recent call last):
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/dispatcher.py", line 309, in _process_update
    response = await self.feed_update(bot, update, **kwargs)
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/dispatcher.py", line 158, in feed_update
    response = await self.update.wrap_outer_middleware(
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/middlewares/error.py", line 25, in __call__
    return await handler(event, data)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/middlewares/user_context.py", line 56, in __call__
    return await handler(event, data)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/fsm/middleware.py", line 42, in __call__
    return await handler(event, data)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/event/telegram.py", line 121, in trigger
    return await wrapped_inner(event, kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/event/handler.py", line 43, in call
    return await wrapped()
           ^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/dispatcher.py", line 276, in _listen_update
    return await self.propagate_event(update_type=update_type, event=event, **kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 146, in propagate_event
    return await observer.wrap_outer_middleware(_wrapped, event=event, data=kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 141, in _wrapped
    return await self._propagate_event(
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 174, in _propagate_event
    response = await router.propagate_event(update_type=update_type, event=event, **kwargs)
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 146, in propagate_event
    return await observer.wrap_outer_middleware(_wrapped, event=event, data=kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 141, in _wrapped
    return await self._propagate_event(
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 166, in _propagate_event
    response = await observer.trigger(event, **kwargs)
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/event/telegram.py", line 121, in trigger
    return await wrapped_inner(event, kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/event/handler.py", line 43, in call
    return await wrapped()
           ^^^^^^^^^^^^^^^
  File "/app/bot/handlers.py", line 91, in set_gender
    if 15 < int(user_message) < 80:
            ^^^^^^^^^^^^^^^^^
ValueError: invalid literal for int() with base 10: '90-'
2025-01-28 12:20:45 [INFO] Update id=273477900 is handled. Duration 364 ms by bot id=8108339380
2025-01-28 12:20:49 [ERROR] Failed to fetch updates - TelegramConflictError: Telegram server says - Conflict: terminated by other getUpdates request; make sure that only one bot instance is running
2025-01-28 12:20:49 [WARNING] Sleep for 1.000000 seconds and try again... (tryings = 0, bot id = 8108339380)
2025-01-28 12:20:55 [ERROR] Failed to fetch updates - TelegramConflictError: Telegram server says - Conflict: terminated by other getUpdates request; make sure that only one bot instance is running
2025-01-28 12:20:55 [WARNING] Sleep for 1.231951 seconds and try again... (tryings = 1, bot id = 8108339380)
2025-01-28 12:21:00 [ERROR] Failed to fetch updates - TelegramConflictError: Telegram server says - Conflict: terminated by other getUpdates request; make sure that only one bot instance is running
2025-01-28 12:21:00 [WARNING] Sleep for 1.724004 seconds and try again... (tryings = 2, bot id = 8108339380)
2025-01-28 12:21:07 [ERROR] Failed to fetch updates - TelegramConflictError: Telegram server says - Conflict: terminated by other getUpdates request; make sure that only one bot instance is running
2025-01-28 12:21:07 [WARNING] Sleep for 2.284215 seconds and try again... (tryings = 3, bot id = 8108339380)
2025-01-28 12:21:13 [ERROR] Failed to fetch updates - TelegramConflictError: Telegram server says - Conflict: terminated by other getUpdates request; make sure that only one bot instance is running
2025-01-28 12:21:13 [WARNING] Sleep for 3.091703 seconds and try again... (tryings = 4, bot id = 8108339380)
2025-01-28 12:21:17 [INFO] Connection established (tryings = 5, bot id = 8108339380)
2025-01-28 12:21:17 [INFO] The user 711983855's state has been set to Survey.age.
2025-01-28 12:21:18 [INFO] Update id=273477907 is handled. Duration 364 ms by bot id=8108339380
2025-01-28 12:21:21 [ERROR] Failed to fetch updates - TelegramConflictError: Telegram server says - Conflict: terminated by other getUpdates request; make sure that only one bot instance is running
2025-01-28 12:21:21 [WARNING] Sleep for 1.000000 seconds and try again... (tryings = 0, bot id = 8108339380)
2025-01-28 12:21:26 [ERROR] Failed to fetch updates - TelegramConflictError: Telegram server says - Conflict: terminated by other getUpdates request; make sure that only one bot instance is running
2025-01-28 12:21:26 [WARNING] Sleep for 1.230625 seconds and try again... (tryings = 1, bot id = 8108339380)
2025-01-28 12:21:28 [INFO] Connection established (tryings = 2, bot id = 8108339380)
2025-01-28 12:21:28 [INFO] The user 711983855's state has been set to Survey.weight.
2025-01-28 12:21:29 [INFO] Update id=273477910 is handled. Duration 335 ms by bot id=8108339380
2025-01-28 12:21:32 [ERROR] Failed to fetch updates - TelegramConflictError: Telegram server says - Conflict: terminated by other getUpdates request; make sure that only one bot instance is running
2025-01-28 12:21:32 [WARNING] Sleep for 1.000000 seconds and try again... (tryings = 0, bot id = 8108339380)
2025-01-28 12:21:34 [INFO] Connection established (tryings = 1, bot id = 8108339380)
2025-01-28 12:21:34 [INFO] The user 711983855's state has been set to Survey.height.
2025-01-28 12:21:34 [INFO] Update id=273477911 is handled. Duration 340 ms by bot id=8108339380
2025-01-28 12:21:37 [ERROR] Failed to fetch updates - TelegramConflictError: Telegram server says - Conflict: terminated by other getUpdates request; make sure that only one bot instance is running
2025-01-28 12:21:37 [WARNING] Sleep for 1.000000 seconds and try again... (tryings = 0, bot id = 8108339380)
2025-01-28 12:21:43 [ERROR] Failed to fetch updates - TelegramConflictError: Telegram server says - Conflict: terminated by other getUpdates request; make sure that only one bot instance is running
2025-01-28 12:21:43 [WARNING] Sleep for 1.224361 seconds and try again... (tryings = 1, bot id = 8108339380)
2025-01-28 12:21:50 [ERROR] Failed to fetch updates - TelegramConflictError: Telegram server says - Conflict: terminated by other getUpdates request; make sure that only one bot instance is running
2025-01-28 12:21:50 [WARNING] Sleep for 1.804898 seconds and try again... (tryings = 2, bot id = 8108339380)
2025-01-28 12:22:02 [INFO] Connection established (tryings = 3, bot id = 8108339380)
2025-01-28 12:22:08 [INFO] The user 711983855's state has been set to Survey.feet.
2025-01-28 12:22:09 [INFO] Update id=273477912 is handled. Duration 357 ms by bot id=8108339380
2025-01-28 12:22:12 [INFO] The user 711983855's state has been set to Survey.gender.
2025-01-28 12:22:12 [INFO] Update id=273477913 is handled. Duration 358 ms by bot id=8108339380
2025-01-28 12:22:14 [INFO] The user 711983855's state has been set to Survey.smoking.
2025-01-28 12:22:15 [INFO] Update id=273477914 is handled. Duration 346 ms by bot id=8108339380
2025-01-28 12:22:16 [INFO] The user 711983855's state has been set to Survey.sex.
2025-01-28 12:22:16 [INFO] Update id=273477915 is handled. Duration 364 ms by bot id=8108339380
2025-01-28 12:22:17 [WARNING] An error occurred: relation "specific_recommendations" does not exist
LINE 3:             FROM specific_recommendations
                         ^

2025-01-28 12:22:17 [INFO] Update id=273477916 is not handled. Duration 275 ms by bot id=8108339380
2025-01-28 12:22:17 [ERROR] Cause exception while process update id=273477916 by bot id=8108339380
TypeError: AbstractConnectionPool._putconn() missing 1 required positional argument: 'conn'
Traceback (most recent call last):
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/dispatcher.py", line 309, in _process_update
    response = await self.feed_update(bot, update, **kwargs)
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/dispatcher.py", line 158, in feed_update
    response = await self.update.wrap_outer_middleware(
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/middlewares/error.py", line 25, in __call__
    return await handler(event, data)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/middlewares/user_context.py", line 56, in __call__
    return await handler(event, data)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/fsm/middleware.py", line 42, in __call__
    return await handler(event, data)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/event/telegram.py", line 121, in trigger
    return await wrapped_inner(event, kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/event/handler.py", line 43, in call
    return await wrapped()
           ^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/dispatcher.py", line 276, in _listen_update
    return await self.propagate_event(update_type=update_type, event=event, **kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 146, in propagate_event
    return await observer.wrap_outer_middleware(_wrapped, event=event, data=kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 141, in _wrapped
    return await self._propagate_event(
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 174, in _propagate_event
    response = await router.propagate_event(update_type=update_type, event=event, **kwargs)
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 146, in propagate_event
    return await observer.wrap_outer_middleware(_wrapped, event=event, data=kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 141, in _wrapped
    return await self._propagate_event(
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 166, in _propagate_event
    response = await observer.trigger(event, **kwargs)
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/event/telegram.py", line 121, in trigger
    return await wrapped_inner(event, kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/event/handler.py", line 43, in call
    return await wrapped()
           ^^^^^^^^^^^^^^^
  File "/app/bot/handlers.py", line 167, in set_sex
    recommendations = db.get_recommendation(data)
                      ^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/app/bot/scripts/algoritm.py", line 66, in get_recommendation
    results = self.execute_read_many_query(query, params)
              ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/app/bot/scripts/algoritm.py", line 37, in execute_read_many_query
    self.release_connection(conn)
  File "/app/bot/scripts/algoritm.py", line 21, in release_connection
    self.connection_pool.putconn()
TypeError: AbstractConnectionPool._putconn() missing 1 required positional argument: 'conn'
2025-01-28 12:49:00 [INFO] Bot is started. Polling begins.
2025-01-28 12:49:00 [INFO] Start polling
2025-01-28 12:49:02 [INFO] Run polling for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-28 12:49:37 [INFO] The user 711983855 called the command /start.
2025-01-28 12:49:38 [INFO] Update id=273477917 is handled. Duration 1298 ms by bot id=8108339380
2025-01-28 12:49:40 [INFO] The user 711983855's state has been set to Survey.age.
2025-01-28 12:49:40 [INFO] Update id=273477918 is handled. Duration 415 ms by bot id=8108339380
2025-01-28 12:50:11 [INFO] Bot is started. Polling begins.
2025-01-28 12:50:11 [INFO] Start polling
2025-01-28 12:50:12 [INFO] Run polling for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-28 12:52:31 [INFO] Bot is started. Polling begins.
2025-01-28 12:52:31 [INFO] Start polling
2025-01-28 12:52:32 [INFO] Run polling for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-28 13:12:48 [INFO] Bot is started. Polling begins.
2025-01-28 13:12:48 [INFO] Start polling
2025-01-28 13:12:49 [INFO] Run polling for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-28 13:25:05 [INFO] Bot is started. Polling begins.
2025-01-28 13:25:05 [INFO] Start polling
2025-01-28 13:25:07 [INFO] Run polling for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-28 13:25:45 [INFO] Bot is started. Polling begins.
2025-01-28 13:25:45 [INFO] Start polling
2025-01-28 13:25:46 [INFO] Run polling for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-28 13:26:27 [INFO] Bot is started. Polling begins.
2025-01-28 13:26:27 [INFO] Start polling
2025-01-28 13:26:29 [INFO] Run polling for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-29 20:15:30 [INFO] ๐ ะะพั ะทะฐะฟััะบะฐะตััั...
2025-01-29 20:15:31 [INFO] โ ะัะป ะฟะพะดะบะปััะตะฝะธะน ะบ ะะ ัะพะทะดะฐะฝ.
2025-01-29 20:15:31 [INFO] โ ะขะฐะฑะปะธัั ะฒ ะฑะฐะทะต ะดะฐะฝะฝัั ััะฟะตัะฝะพ ัะพะทะดะฐะฝั.
2025-01-29 20:16:15 [INFO] ๐ ะะพั ะทะฐะฟััะบะฐะตััั...
2025-01-29 20:16:15 [INFO] โ ะัะป ะฟะพะดะบะปััะตะฝะธะน ะบ ะะ ัะพะทะดะฐะฝ.
2025-01-29 20:16:15 [INFO] โ ะขะฐะฑะปะธัั ะฒ ะฑะฐะทะต ะดะฐะฝะฝัั ััะฟะตัะฝะพ ัะพะทะดะฐะฝั.
2025-01-29 20:16:15 [INFO] Start polling
2025-01-29 20:16:17 [INFO] Run polling for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-29 20:31:45 [INFO] The user 711983855 called the command /start.
2025-01-29 20:31:46 [INFO] Update id=273477919 is handled. Duration 1386 ms by bot id=8108339380
2025-01-29 20:31:47 [INFO] The user 711983855's state has been set to Survey.age.
2025-01-29 20:31:47 [INFO] Update id=273477920 is handled. Duration 429 ms by bot id=8108339380
2025-01-29 20:31:52 [INFO] The user 711983855's state has been set to Survey.weight.
2025-01-29 20:31:52 [INFO] Update id=273477921 is handled. Duration 342 ms by bot id=8108339380
2025-01-29 20:31:58 [INFO] The user 711983855's state has been set to Survey.height.
2025-01-29 20:31:59 [INFO] Update id=273477922 is handled. Duration 338 ms by bot id=8108339380
2025-01-29 20:32:05 [INFO] The user 711983855's state has been set to Survey.feet.
2025-01-29 20:32:05 [INFO] Update id=273477923 is handled. Duration 409 ms by bot id=8108339380
2025-01-29 20:32:08 [INFO] The user 711983855's state has been set to Survey.gender.
2025-01-29 20:32:08 [INFO] Update id=273477924 is handled. Duration 339 ms by bot id=8108339380
2025-01-29 20:32:12 [INFO] The user 711983855's state has been set to Survey.smoking.
2025-01-29 20:32:13 [INFO] Update id=273477925 is handled. Duration 895 ms by bot id=8108339380
2025-01-29 20:32:14 [INFO] The user 711983855's state has been set to Survey.sex.
2025-01-29 20:32:14 [INFO] Update id=273477926 is handled. Duration 337 ms by bot id=8108339380
2025-01-29 20:32:15 [INFO] Update id=273477927 is not handled. Duration 2 ms by bot id=8108339380
2025-01-29 20:32:15 [ERROR] Cause exception while process update id=273477927 by bot id=8108339380
NameError: name 'db' is not defined
Traceback (most recent call last):
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/dispatcher.py", line 309, in _process_update
    response = await self.feed_update(bot, update, **kwargs)
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/dispatcher.py", line 158, in feed_update
    response = await self.update.wrap_outer_middleware(
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/middlewares/error.py", line 25, in __call__
    return await handler(event, data)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/middlewares/user_context.py", line 56, in __call__
    return await handler(event, data)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/fsm/middleware.py", line 42, in __call__
    return await handler(event, data)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/event/telegram.py", line 121, in trigger
    return await wrapped_inner(event, kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/app/bot/middleware.py", line 12, in __call__
    return await handler(event, data)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/event/handler.py", line 43, in call
    return await wrapped()
           ^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/dispatcher.py", line 276, in _listen_update
    return await self.propagate_event(update_type=update_type, event=event, **kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 146, in propagate_event
    return await observer.wrap_outer_middleware(_wrapped, event=event, data=kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 141, in _wrapped
    return await self._propagate_event(
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 174, in _propagate_event
    response = await router.propagate_event(update_type=update_type, event=event, **kwargs)
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 146, in propagate_event
    return await observer.wrap_outer_middleware(_wrapped, event=event, data=kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 141, in _wrapped
    return await self._propagate_event(
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 166, in _propagate_event
    response = await observer.trigger(event, **kwargs)
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/event/telegram.py", line 121, in trigger
    return await wrapped_inner(event, kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/event/handler.py", line 43, in call
    return await wrapped()
           ^^^^^^^^^^^^^^^
  File "/app/bot/handlers.py", line 161, in set_sex
    recommendations = db.get_recommendation(data)
                      ^^
NameError: name 'db' is not defined
2025-01-29 20:34:56 [INFO] Update id=273477928 is not handled. Duration 1 ms by bot id=8108339380
2025-01-29 20:34:56 [ERROR] Cause exception while process update id=273477928 by bot id=8108339380
NameError: name 'db' is not defined
Traceback (most recent call last):
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/dispatcher.py", line 309, in _process_update
    response = await self.feed_update(bot, update, **kwargs)
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/dispatcher.py", line 158, in feed_update
    response = await self.update.wrap_outer_middleware(
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/middlewares/error.py", line 25, in __call__
    return await handler(event, data)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/middlewares/user_context.py", line 56, in __call__
    return await handler(event, data)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/fsm/middleware.py", line 42, in __call__
    return await handler(event, data)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/event/telegram.py", line 121, in trigger
    return await wrapped_inner(event, kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/app/bot/middleware.py", line 12, in __call__
    return await handler(event, data)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/event/handler.py", line 43, in call
    return await wrapped()
           ^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/dispatcher.py", line 276, in _listen_update
    return await self.propagate_event(update_type=update_type, event=event, **kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 146, in propagate_event
    return await observer.wrap_outer_middleware(_wrapped, event=event, data=kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 141, in _wrapped
    return await self._propagate_event(
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 174, in _propagate_event
    response = await router.propagate_event(update_type=update_type, event=event, **kwargs)
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 146, in propagate_event
    return await observer.wrap_outer_middleware(_wrapped, event=event, data=kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 141, in _wrapped
    return await self._propagate_event(
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 166, in _propagate_event
    response = await observer.trigger(event, **kwargs)
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/event/telegram.py", line 121, in trigger
    return await wrapped_inner(event, kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/event/handler.py", line 43, in call
    return await wrapped()
           ^^^^^^^^^^^^^^^
  File "/app/bot/handlers.py", line 161, in set_sex
    f"\n{recommendations[page][3]}"
              ^^
NameError: name 'db' is not defined
2025-01-29 20:35:16 [INFO] The user 711983855 called the command /start.
2025-01-29 20:35:18 [INFO] Update id=273477929 is handled. Duration 1256 ms by bot id=8108339380
2025-01-29 20:35:19 [INFO] The user 711983855's state has been set to Survey.age.
2025-01-29 20:35:19 [INFO] Update id=273477930 is handled. Duration 347 ms by bot id=8108339380
2025-01-29 20:35:25 [INFO] The user 711983855's state has been set to Survey.weight.
2025-01-29 20:35:25 [INFO] Update id=273477931 is handled. Duration 322 ms by bot id=8108339380
2025-01-29 20:35:26 [INFO] The user 711983855's state has been set to Survey.height.
2025-01-29 20:35:27 [INFO] Update id=273477932 is handled. Duration 385 ms by bot id=8108339380
2025-01-29 20:35:28 [INFO] The user 711983855's state has been set to Survey.feet.
2025-01-29 20:35:29 [INFO] Update id=273477933 is handled. Duration 365 ms by bot id=8108339380
2025-01-29 20:35:32 [INFO] The user 711983855's state has been set to Survey.gender.
2025-01-29 20:35:33 [INFO] Update id=273477934 is handled. Duration 362 ms by bot id=8108339380
2025-01-29 20:35:36 [INFO] The user 711983855's state has been set to Survey.smoking.
2025-01-29 20:35:37 [INFO] Update id=273477935 is handled. Duration 320 ms by bot id=8108339380
2025-01-29 20:35:38 [INFO] The user 711983855's state has been set to Survey.sex.
2025-01-29 20:35:38 [INFO] Update id=273477936 is handled. Duration 349 ms by bot id=8108339380
2025-01-29 20:35:39 [INFO] Update id=273477937 is not handled. Duration 1 ms by bot id=8108339380
2025-01-29 20:35:39 [ERROR] Cause exception while process update id=273477937 by bot id=8108339380
NameError: name 'db' is not defined
Traceback (most recent call last):
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/dispatcher.py", line 309, in _process_update
    response = await self.feed_update(bot, update, **kwargs)
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/dispatcher.py", line 158, in feed_update
    response = await self.update.wrap_outer_middleware(
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/middlewares/error.py", line 25, in __call__
    return await handler(event, data)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/middlewares/user_context.py", line 56, in __call__
    return await handler(event, data)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/fsm/middleware.py", line 42, in __call__
    return await handler(event, data)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/event/telegram.py", line 121, in trigger
    return await wrapped_inner(event, kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/app/bot/middleware.py", line 12, in __call__
    return await handler(event, data)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/event/handler.py", line 43, in call
    return await wrapped()
           ^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/dispatcher.py", line 276, in _listen_update
    return await self.propagate_event(update_type=update_type, event=event, **kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 146, in propagate_event
    return await observer.wrap_outer_middleware(_wrapped, event=event, data=kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 141, in _wrapped
    return await self._propagate_event(
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 174, in _propagate_event
    response = await router.propagate_event(update_type=update_type, event=event, **kwargs)
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 146, in propagate_event
    return await observer.wrap_outer_middleware(_wrapped, event=event, data=kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 141, in _wrapped
    return await self._propagate_event(
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 166, in _propagate_event
    response = await observer.trigger(event, **kwargs)
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/event/telegram.py", line 121, in trigger
    return await wrapped_inner(event, kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/event/handler.py", line 43, in call
    return await wrapped()
           ^^^^^^^^^^^^^^^
  File "/app/bot/handlers.py", line 161, in set_sex
    f"\n{recommendations[page][3]}"
              ^^
NameError: name 'db' is not defined
2025-01-29 20:40:58 [WARNING] Received SIGTERM signal
2025-01-29 20:40:58 [INFO] Polling stopped for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-29 20:40:58 [INFO] Polling stopped
2025-01-29 20:40:58 [INFO] โ ะัะป ะฟะพะดะบะปััะตะฝะธะน ะบ ะะ ะทะฐะบััั.
2025-01-29 20:40:58 [INFO] โ ะะพะดะบะปััะตะฝะธะต ะบ ะะ ะทะฐะบัััะพ.
2025-01-29 20:43:39 [INFO] ๐ ะะพั ะทะฐะฟััะบะฐะตััั...
2025-01-29 20:43:40 [INFO] โ ะัะป ะฟะพะดะบะปััะตะฝะธะน ะบ ะะ ัะพะทะดะฐะฝ.
2025-01-29 20:43:40 [INFO] โ ะขะฐะฑะปะธัั ะฒ ะฑะฐะทะต ะดะฐะฝะฝัั ััะฟะตัะฝะพ ัะพะทะดะฐะฝั.
2025-01-29 20:44:27 [INFO] ๐ ะะพั ะทะฐะฟััะบะฐะตััั...
2025-01-29 20:44:28 [INFO] โ ะัะป ะฟะพะดะบะปััะตะฝะธะน ะบ ะะ ัะพะทะดะฐะฝ.
2025-01-29 20:44:28 [INFO] โ ะขะฐะฑะปะธัั ะฒ ะฑะฐะทะต ะดะฐะฝะฝัั ััะฟะตัะฝะพ ัะพะทะดะฐะฝั.
2025-01-29 20:44:28 [INFO] Start polling
2025-01-29 20:44:29 [INFO] Run polling for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-29 20:44:33 [INFO] The user 711983855 called the command /start.
2025-01-29 20:44:36 [INFO] Update id=273477938 is handled. Duration 2988 ms by bot id=8108339380
2025-01-29 20:44:37 [INFO] The user 711983855's state has been set to Survey.age.
2025-01-29 20:44:37 [INFO] Update id=273477939 is handled. Duration 346 ms by bot id=8108339380
2025-01-29 20:44:45 [INFO] The user 711983855's state has been set to Survey.weight.
2025-01-29 20:44:45 [INFO] Update id=273477940 is handled. Duration 330 ms by bot id=8108339380
2025-01-29 20:44:48 [INFO] The user 711983855's state has been set to Survey.height.
2025-01-29 20:44:49 [INFO] Update id=273477941 is handled. Duration 339 ms by bot id=8108339380
2025-01-29 20:44:50 [INFO] The user 711983855's state has been set to Survey.feet.
2025-01-29 20:44:51 [INFO] Update id=273477942 is handled. Duration 337 ms by bot id=8108339380
2025-01-29 20:44:55 [INFO] Update id=273477943 is handled. Duration 345 ms by bot id=8108339380
2025-01-29 20:44:58 [INFO] The user 711983855's state has been set to Survey.gender.
2025-01-29 20:44:59 [INFO] Update id=273477944 is handled. Duration 336 ms by bot id=8108339380
2025-01-29 20:45:01 [INFO] The user 711983855's state has been set to Survey.pregnant.
2025-01-29 20:45:01 [INFO] Update id=273477945 is handled. Duration 339 ms by bot id=8108339380
2025-01-29 20:45:03 [INFO] The user 711983855's state has been set to Survey.smoking.
2025-01-29 20:45:03 [INFO] Update id=273477946 is handled. Duration 332 ms by bot id=8108339380
2025-01-29 20:45:05 [INFO] The user 711983855's state has been set to Survey.sex.
2025-01-29 20:45:05 [INFO] Update id=273477947 is handled. Duration 343 ms by bot id=8108339380
2025-01-29 20:45:06 [INFO] Update id=273477948 is not handled. Duration 1 ms by bot id=8108339380
2025-01-29 20:45:06 [ERROR] Cause exception while process update id=273477948 by bot id=8108339380
AttributeError: 'FSMContext' object has no attribute 'get'
Traceback (most recent call last):
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/dispatcher.py", line 309, in _process_update
    response = await self.feed_update(bot, update, **kwargs)
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/dispatcher.py", line 158, in feed_update
    response = await self.update.wrap_outer_middleware(
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/middlewares/error.py", line 25, in __call__
    return await handler(event, data)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/middlewares/user_context.py", line 56, in __call__
    return await handler(event, data)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/fsm/middleware.py", line 42, in __call__
    return await handler(event, data)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/event/telegram.py", line 121, in trigger
    return await wrapped_inner(event, kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/app/bot/middleware.py", line 12, in __call__
    return await handler(event, data)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/event/handler.py", line 43, in call
    return await wrapped()
           ^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/dispatcher.py", line 276, in _listen_update
    return await self.propagate_event(update_type=update_type, event=event, **kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 146, in propagate_event
    return await observer.wrap_outer_middleware(_wrapped, event=event, data=kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 141, in _wrapped
    return await self._propagate_event(
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 174, in _propagate_event
    response = await router.propagate_event(update_type=update_type, event=event, **kwargs)
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 146, in propagate_event
    return await observer.wrap_outer_middleware(_wrapped, event=event, data=kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 141, in _wrapped
    return await self._propagate_event(
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 166, in _propagate_event
    response = await observer.trigger(event, **kwargs)
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/event/telegram.py", line 121, in trigger
    return await wrapped_inner(event, kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/event/handler.py", line 43, in call
    return await wrapped()
           ^^^^^^^^^^^^^^^
  File "/app/bot/handlers.py", line 174, in set_sex
    db = state.get('db')  # ะะตัะตะผ db ะธะท state (middleware ะฟะตัะตะดะฐะป)
         ^^^^^^^^^
AttributeError: 'FSMContext' object has no attribute 'get'
2025-01-29 20:47:12 [WARNING] Received SIGTERM signal
2025-01-29 20:47:12 [INFO] Polling stopped for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-29 20:47:12 [INFO] Polling stopped
2025-01-29 20:47:13 [INFO] โ ะัะป ะฟะพะดะบะปััะตะฝะธะน ะบ ะะ ะทะฐะบััั.
2025-01-29 20:47:13 [INFO] โ ะะพะดะบะปััะตะฝะธะต ะบ ะะ ะทะฐะบัััะพ.
2025-01-29 20:47:22 [INFO] ๐ ะะพั ะทะฐะฟััะบะฐะตััั...
2025-01-29 20:47:22 [INFO] โ ะัะป ะฟะพะดะบะปััะตะฝะธะน ะบ ะะ ัะพะทะดะฐะฝ.
2025-01-29 20:47:22 [INFO] โ ะขะฐะฑะปะธัั ะฒ ะฑะฐะทะต ะดะฐะฝะฝัั ััะฟะตัะฝะพ ัะพะทะดะฐะฝั.
2025-01-29 20:47:22 [INFO] Start polling
2025-01-29 20:47:23 [INFO] Run polling for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-29 20:47:24 [INFO] The user 711983855 called the command /start.
2025-01-29 20:47:26 [INFO] Update id=273477949 is handled. Duration 1888 ms by bot id=8108339380
2025-01-29 20:47:27 [INFO] The user 711983855's state has been set to Survey.age.
2025-01-29 20:47:28 [INFO] Update id=273477950 is handled. Duration 345 ms by bot id=8108339380
2025-01-29 20:47:31 [INFO] The user 711983855's state has been set to Survey.weight.
2025-01-29 20:47:32 [INFO] Update id=273477951 is handled. Duration 333 ms by bot id=8108339380
2025-01-29 20:47:33 [INFO] The user 711983855's state has been set to Survey.height.
2025-01-29 20:47:33 [INFO] Update id=273477952 is handled. Duration 340 ms by bot id=8108339380
2025-01-29 20:47:34 [INFO] The user 711983855's state has been set to Survey.feet.
2025-01-29 20:47:34 [INFO] Update id=273477953 is handled. Duration 335 ms by bot id=8108339380
2025-01-29 20:47:36 [INFO] Update id=273477954 is handled. Duration 335 ms by bot id=8108339380
2025-01-29 20:47:39 [INFO] The user 711983855's state has been set to Survey.gender.
2025-01-29 20:47:39 [INFO] Update id=273477955 is handled. Duration 345 ms by bot id=8108339380
2025-01-29 20:47:41 [INFO] The user 711983855's state has been set to Survey.pregnant.
2025-01-29 20:47:42 [INFO] Update id=273477956 is handled. Duration 329 ms by bot id=8108339380
2025-01-29 20:47:43 [INFO] The user 711983855's state has been set to Survey.smoking.
2025-01-29 20:47:43 [INFO] Update id=273477957 is handled. Duration 326 ms by bot id=8108339380
2025-01-29 20:47:44 [INFO] The user 711983855's state has been set to Survey.sex.
2025-01-29 20:47:45 [INFO] Update id=273477958 is handled. Duration 337 ms by bot id=8108339380
2025-01-29 20:47:46 [INFO] Update id=273477959 is not handled. Duration 1 ms by bot id=8108339380
2025-01-29 20:47:46 [ERROR] Cause exception while process update id=273477959 by bot id=8108339380
TypeError: set_sex() missing 1 required positional argument: 'data'
Traceback (most recent call last):
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/dispatcher.py", line 309, in _process_update
    response = await self.feed_update(bot, update, **kwargs)
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/dispatcher.py", line 158, in feed_update
    response = await self.update.wrap_outer_middleware(
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/middlewares/error.py", line 25, in __call__
    return await handler(event, data)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/middlewares/user_context.py", line 56, in __call__
    return await handler(event, data)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/fsm/middleware.py", line 42, in __call__
    return await handler(event, data)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/event/telegram.py", line 121, in trigger
    return await wrapped_inner(event, kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/app/bot/middleware.py", line 12, in __call__
    return await handler(event, data)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/event/handler.py", line 43, in call
    return await wrapped()
           ^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/dispatcher.py", line 276, in _listen_update
    return await self.propagate_event(update_type=update_type, event=event, **kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 146, in propagate_event
    return await observer.wrap_outer_middleware(_wrapped, event=event, data=kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 141, in _wrapped
    return await self._propagate_event(
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 174, in _propagate_event
    response = await router.propagate_event(update_type=update_type, event=event, **kwargs)
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 146, in propagate_event
    return await observer.wrap_outer_middleware(_wrapped, event=event, data=kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 141, in _wrapped
    return await self._propagate_event(
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 166, in _propagate_event
    response = await observer.trigger(event, **kwargs)
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/event/telegram.py", line 121, in trigger
    return await wrapped_inner(event, kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/event/handler.py", line 43, in call
    return await wrapped()
                 ^^^^^^^^^
TypeError: set_sex() missing 1 required positional argument: 'data'
2025-01-29 20:48:52 [WARNING] Received SIGTERM signal
2025-01-29 20:48:52 [INFO] Polling stopped for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-29 20:48:52 [INFO] Polling stopped
2025-01-29 20:48:53 [INFO] โ ะัะป ะฟะพะดะบะปััะตะฝะธะน ะบ ะะ ะทะฐะบััั.
2025-01-29 20:48:53 [INFO] โ ะะพะดะบะปััะตะฝะธะต ะบ ะะ ะทะฐะบัััะพ.
2025-01-29 20:49:01 [INFO] ๐ ะะพั ะทะฐะฟััะบะฐะตััั...
2025-01-29 20:49:02 [INFO] โ ะัะป ะฟะพะดะบะปััะตะฝะธะน ะบ ะะ ัะพะทะดะฐะฝ.
2025-01-29 20:49:02 [INFO] โ ะขะฐะฑะปะธัั ะฒ ะฑะฐะทะต ะดะฐะฝะฝัั ััะฟะตัะฝะพ ัะพะทะดะฐะฝั.
2025-01-29 20:49:02 [INFO] Start polling
2025-01-29 20:49:03 [INFO] Run polling for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-29 20:49:04 [INFO] The user 711983855 called the command /start.
2025-01-29 20:49:05 [INFO] Update id=273477960 is handled. Duration 1280 ms by bot id=8108339380
2025-01-29 20:49:07 [INFO] Update id=273477961 is not handled. Duration 1 ms by bot id=8108339380
2025-01-29 20:49:09 [INFO] The user 711983855's state has been set to Survey.age.
2025-01-29 20:49:09 [INFO] Update id=273477962 is handled. Duration 367 ms by bot id=8108339380
2025-01-29 20:49:11 [INFO] The user 711983855's state has been set to Survey.weight.
2025-01-29 20:49:12 [INFO] Update id=273477963 is handled. Duration 415 ms by bot id=8108339380
2025-01-29 20:49:13 [INFO] The user 711983855's state has been set to Survey.height.
2025-01-29 20:49:14 [INFO] Update id=273477964 is handled. Duration 336 ms by bot id=8108339380
2025-01-29 20:49:16 [INFO] The user 711983855's state has been set to Survey.feet.
2025-01-29 20:49:16 [INFO] Update id=273477965 is handled. Duration 346 ms by bot id=8108339380
2025-01-29 20:49:18 [INFO] The user 711983855's state has been set to Survey.gender.
2025-01-29 20:49:20 [INFO] Update id=273477966 is handled. Duration 1317 ms by bot id=8108339380
2025-01-29 20:49:22 [INFO] The user 711983855's state has been set to Survey.smoking.
2025-01-29 20:49:23 [INFO] Update id=273477967 is handled. Duration 337 ms by bot id=8108339380
2025-01-29 20:49:24 [INFO] The user 711983855's state has been set to Survey.sex.
2025-01-29 20:49:24 [INFO] Update id=273477968 is handled. Duration 591 ms by bot id=8108339380
2025-01-29 20:49:25 [INFO] Update id=273477969 is not handled. Duration 1 ms by bot id=8108339380
2025-01-29 20:49:25 [ERROR] Cause exception while process update id=273477969 by bot id=8108339380
AttributeError: 'NoneType' object has no attribute 'get_recommendation'
Traceback (most recent call last):
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/dispatcher.py", line 309, in _process_update
    response = await self.feed_update(bot, update, **kwargs)
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/dispatcher.py", line 158, in feed_update
    response = await self.update.wrap_outer_middleware(
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/middlewares/error.py", line 25, in __call__
    return await handler(event, data)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/middlewares/user_context.py", line 56, in __call__
    return await handler(event, data)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/fsm/middleware.py", line 42, in __call__
    return await handler(event, data)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/event/telegram.py", line 121, in trigger
    return await wrapped_inner(event, kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/app/bot/middleware.py", line 12, in __call__
    return await handler(event, data)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/event/handler.py", line 43, in call
    return await wrapped()
           ^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/dispatcher.py", line 276, in _listen_update
    return await self.propagate_event(update_type=update_type, event=event, **kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 146, in propagate_event
    return await observer.wrap_outer_middleware(_wrapped, event=event, data=kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 141, in _wrapped
    return await self._propagate_event(
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 174, in _propagate_event
    response = await router.propagate_event(update_type=update_type, event=event, **kwargs)
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 146, in propagate_event
    return await observer.wrap_outer_middleware(_wrapped, event=event, data=kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 141, in _wrapped
    return await self._propagate_event(
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 166, in _propagate_event
    response = await observer.trigger(event, **kwargs)
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/event/telegram.py", line 121, in trigger
    return await wrapped_inner(event, kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/event/handler.py", line 43, in call
    return await wrapped()
           ^^^^^^^^^^^^^^^
  File "/app/bot/handlers.py", line 199, in set_sex
    recommendations = db.get_recommendation(data_from_state)  # ะัะฟะพะปัะทัะตะผ db ะดะปั ะฟะพะปััะตะฝะธั ัะตะบะพะผะตะฝะดะฐัะธะน
                      ^^^^^^^^^^^^^^^^^^^^^
AttributeError: 'NoneType' object has no attribute 'get_recommendation'
2025-01-29 20:51:08 [WARNING] Received SIGTERM signal
2025-01-29 20:51:08 [INFO] Polling stopped for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-29 20:51:08 [INFO] Polling stopped
2025-01-29 20:51:08 [INFO] โ ะัะป ะฟะพะดะบะปััะตะฝะธะน ะบ ะะ ะทะฐะบััั.
2025-01-29 20:51:08 [INFO] โ ะะพะดะบะปััะตะฝะธะต ะบ ะะ ะทะฐะบัััะพ.
2025-01-29 20:51:16 [INFO] ๐ ะะพั ะทะฐะฟััะบะฐะตััั...
2025-01-29 20:51:16 [INFO] โ ะัะป ะฟะพะดะบะปััะตะฝะธะน ะบ ะะ ัะพะทะดะฐะฝ.
2025-01-29 20:51:16 [INFO] โ ะขะฐะฑะปะธัั ะฒ ะฑะฐะทะต ะดะฐะฝะฝัั ััะฟะตัะฝะพ ัะพะทะดะฐะฝั.
2025-01-29 20:51:16 [INFO] Start polling
2025-01-29 20:51:18 [INFO] Run polling for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-29 20:51:18 [INFO] The user 711983855 called the command /start.
2025-01-29 20:51:19 [INFO] Update id=273477970 is handled. Duration 1209 ms by bot id=8108339380
2025-01-29 20:51:21 [INFO] The user 711983855's state has been set to Survey.age.
2025-01-29 20:51:21 [INFO] Update id=273477971 is handled. Duration 338 ms by bot id=8108339380
2025-01-29 20:51:25 [INFO] The user 711983855's state has been set to Survey.weight.
2025-01-29 20:51:25 [INFO] Update id=273477972 is handled. Duration 338 ms by bot id=8108339380
2025-01-29 20:51:26 [INFO] The user 711983855's state has been set to Survey.height.
2025-01-29 20:51:27 [INFO] Update id=273477973 is handled. Duration 350 ms by bot id=8108339380
2025-01-29 20:51:28 [INFO] The user 711983855's state has been set to Survey.feet.
2025-01-29 20:51:28 [INFO] Update id=273477974 is handled. Duration 327 ms by bot id=8108339380
2025-01-29 20:51:30 [INFO] The user 711983855's state has been set to Survey.gender.
2025-01-29 20:51:30 [INFO] Update id=273477975 is handled. Duration 336 ms by bot id=8108339380
2025-01-29 20:51:32 [INFO] The user 711983855's state has been set to Survey.smoking.
2025-01-29 20:51:32 [INFO] Update id=273477976 is handled. Duration 327 ms by bot id=8108339380
2025-01-29 20:51:33 [INFO] The user 711983855's state has been set to Survey.sex.
2025-01-29 20:51:34 [INFO] Update id=273477977 is handled. Duration 324 ms by bot id=8108339380
2025-01-29 20:51:35 [INFO] Update id=273477978 is not handled. Duration 1 ms by bot id=8108339380
2025-01-29 20:51:35 [ERROR] Cause exception while process update id=273477978 by bot id=8108339380
AttributeError: 'NoneType' object has no attribute 'get_recommendation'
Traceback (most recent call last):
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/dispatcher.py", line 309, in _process_update
    response = await self.feed_update(bot, update, **kwargs)
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/dispatcher.py", line 158, in feed_update
    response = await self.update.wrap_outer_middleware(
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/middlewares/error.py", line 25, in __call__
    return await handler(event, data)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/middlewares/user_context.py", line 56, in __call__
    return await handler(event, data)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/fsm/middleware.py", line 42, in __call__
    return await handler(event, data)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/event/telegram.py", line 121, in trigger
    return await wrapped_inner(event, kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/app/bot/middleware.py", line 12, in __call__
    return await handler(event, data)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/event/handler.py", line 43, in call
    return await wrapped()
           ^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/dispatcher.py", line 276, in _listen_update
    return await self.propagate_event(update_type=update_type, event=event, **kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 146, in propagate_event
    return await observer.wrap_outer_middleware(_wrapped, event=event, data=kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 141, in _wrapped
    return await self._propagate_event(
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 174, in _propagate_event
    response = await router.propagate_event(update_type=update_type, event=event, **kwargs)
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 146, in propagate_event
    return await observer.wrap_outer_middleware(_wrapped, event=event, data=kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 141, in _wrapped
    return await self._propagate_event(
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 166, in _propagate_event
    response = await observer.trigger(event, **kwargs)
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/event/telegram.py", line 121, in trigger
    return await wrapped_inner(event, kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/event/handler.py", line 43, in call
    return await wrapped()
           ^^^^^^^^^^^^^^^
  File "/app/bot/handlers.py", line 199, in set_sex
    recommendations = db.get_recommendation(data_from_state)  # ะัะฟะพะปัะทัะตะผ db ะดะปั ะฟะพะปััะตะฝะธั ัะตะบะพะผะตะฝะดะฐัะธะน
                      ^^^^^^^^^^^^^^^^^^^^^
AttributeError: 'NoneType' object has no attribute 'get_recommendation'
2025-01-29 20:52:38 [WARNING] Received SIGTERM signal
2025-01-29 20:52:38 [INFO] Polling stopped for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-29 20:52:38 [INFO] Polling stopped
2025-01-29 20:52:38 [INFO] โ ะัะป ะฟะพะดะบะปััะตะฝะธะน ะบ ะะ ะทะฐะบััั.
2025-01-29 20:52:38 [INFO] โ ะะพะดะบะปััะตะฝะธะต ะบ ะะ ะทะฐะบัััะพ.
2025-01-29 20:52:46 [INFO] ๐ ะะพั ะทะฐะฟััะบะฐะตััั...
2025-01-29 20:52:46 [INFO] โ ะัะป ะฟะพะดะบะปััะตะฝะธะน ะบ ะะ ัะพะทะดะฐะฝ.
2025-01-29 20:52:46 [INFO] โ ะขะฐะฑะปะธัั ะฒ ะฑะฐะทะต ะดะฐะฝะฝัั ััะฟะตัะฝะพ ัะพะทะดะฐะฝั.
2025-01-29 20:52:46 [INFO] Start polling
2025-01-29 20:52:48 [INFO] Run polling for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-29 20:52:48 [INFO] The user 711983855 called the command /start.
2025-01-29 20:52:49 [INFO] Update id=273477979 is handled. Duration 1213 ms by bot id=8108339380
2025-01-29 20:52:52 [INFO] The user 711983855's state has been set to Survey.age.
2025-01-29 20:52:52 [INFO] Update id=273477980 is handled. Duration 344 ms by bot id=8108339380
2025-01-29 20:52:54 [INFO] The user 711983855's state has been set to Survey.weight.
2025-01-29 20:52:54 [INFO] Update id=273477981 is handled. Duration 330 ms by bot id=8108339380
2025-01-29 20:52:55 [INFO] The user 711983855's state has been set to Survey.height.
2025-01-29 20:52:56 [INFO] Update id=273477982 is handled. Duration 332 ms by bot id=8108339380
2025-01-29 20:52:57 [INFO] The user 711983855's state has been set to Survey.feet.
2025-01-29 20:52:57 [INFO] Update id=273477983 is handled. Duration 330 ms by bot id=8108339380
2025-01-29 20:52:59 [INFO] The user 711983855's state has been set to Survey.gender.
2025-01-29 20:52:59 [INFO] Update id=273477984 is handled. Duration 331 ms by bot id=8108339380
2025-01-29 20:53:01 [INFO] The user 711983855's state has been set to Survey.smoking.
2025-01-29 20:53:01 [INFO] Update id=273477985 is handled. Duration 325 ms by bot id=8108339380
2025-01-29 20:53:02 [INFO] The user 711983855's state has been set to Survey.sex.
2025-01-29 20:53:03 [INFO] Update id=273477986 is handled. Duration 334 ms by bot id=8108339380
2025-01-29 20:53:03 [INFO] Update id=273477987 is not handled. Duration 1 ms by bot id=8108339380
2025-01-29 20:53:03 [ERROR] Cause exception while process update id=273477987 by bot id=8108339380
AttributeError: 'NoneType' object has no attribute 'get_recommendation'
Traceback (most recent call last):
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/dispatcher.py", line 309, in _process_update
    response = await self.feed_update(bot, update, **kwargs)
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/dispatcher.py", line 158, in feed_update
    response = await self.update.wrap_outer_middleware(
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/middlewares/error.py", line 25, in __call__
    return await handler(event, data)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/middlewares/user_context.py", line 56, in __call__
    return await handler(event, data)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/fsm/middleware.py", line 42, in __call__
    return await handler(event, data)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/event/telegram.py", line 121, in trigger
    return await wrapped_inner(event, kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/app/bot/middleware.py", line 12, in __call__
    return await handler(event, data)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/event/handler.py", line 43, in call
    return await wrapped()
           ^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/dispatcher.py", line 276, in _listen_update
    return await self.propagate_event(update_type=update_type, event=event, **kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 146, in propagate_event
    return await observer.wrap_outer_middleware(_wrapped, event=event, data=kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 141, in _wrapped
    return await self._propagate_event(
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 174, in _propagate_event
    response = await router.propagate_event(update_type=update_type, event=event, **kwargs)
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 146, in propagate_event
    return await observer.wrap_outer_middleware(_wrapped, event=event, data=kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 141, in _wrapped
    return await self._propagate_event(
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 166, in _propagate_event
    response = await observer.trigger(event, **kwargs)
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/event/telegram.py", line 121, in trigger
    return await wrapped_inner(event, kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/event/handler.py", line 43, in call
    return await wrapped()
           ^^^^^^^^^^^^^^^
  File "/app/bot/handlers.py", line 199, in set_sex
    recommendations = db.get_recommendation(data_from_state)  # ะัะฟะพะปัะทัะตะผ db ะดะปั ะฟะพะปััะตะฝะธั ัะตะบะพะผะตะฝะดะฐัะธะน
                      ^^^^^^^^^^^^^^^^^^^^^
AttributeError: 'NoneType' object has no attribute 'get_recommendation'
2025-01-29 20:57:40 [WARNING] Received SIGTERM signal
2025-01-29 20:57:40 [INFO] Polling stopped for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-29 20:57:40 [INFO] Polling stopped
2025-01-29 20:57:41 [INFO] โ ะัะป ะฟะพะดะบะปััะตะฝะธะน ะบ ะะ ะทะฐะบััั.
2025-01-29 20:57:41 [INFO] โ ะะพะดะบะปััะตะฝะธะต ะบ ะะ ะทะฐะบัััะพ.
2025-01-29 20:57:49 [INFO] ๐ ะะพั ะทะฐะฟััะบะฐะตััั...
2025-01-29 20:57:49 [INFO] โ ะัะป ะฟะพะดะบะปััะตะฝะธะน ะบ ะะ ัะพะทะดะฐะฝ.
2025-01-29 20:57:49 [INFO] โ ะขะฐะฑะปะธัั ะฒ ะฑะฐะทะต ะดะฐะฝะฝัั ััะฟะตัะฝะพ ัะพะทะดะฐะฝั.
2025-01-29 20:57:49 [INFO] Start polling
2025-01-29 20:57:50 [INFO] Run polling for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-29 20:57:51 [INFO] The user 711983855 called the command /start.
2025-01-29 20:57:52 [INFO] Update id=273477988 is handled. Duration 1545 ms by bot id=8108339380
2025-01-29 20:57:53 [INFO] The user 711983855's state has been set to Survey.age.
2025-01-29 20:57:54 [INFO] Update id=273477989 is handled. Duration 340 ms by bot id=8108339380
2025-01-29 20:57:57 [INFO] The user 711983855's state has been set to Survey.weight.
2025-01-29 20:57:58 [INFO] Update id=273477990 is handled. Duration 338 ms by bot id=8108339380
2025-01-29 20:57:59 [INFO] The user 711983855's state has been set to Survey.height.
2025-01-29 20:57:59 [INFO] Update id=273477991 is handled. Duration 346 ms by bot id=8108339380
2025-01-29 20:58:00 [INFO] The user 711983855's state has been set to Survey.feet.
2025-01-29 20:58:01 [INFO] Update id=273477992 is handled. Duration 337 ms by bot id=8108339380
2025-01-29 20:58:02 [INFO] The user 711983855's state has been set to Survey.gender.
2025-01-29 20:58:02 [INFO] Update id=273477993 is handled. Duration 325 ms by bot id=8108339380
2025-01-29 20:58:04 [INFO] The user 711983855's state has been set to Survey.smoking.
2025-01-29 20:58:04 [INFO] Update id=273477994 is handled. Duration 329 ms by bot id=8108339380
2025-01-29 20:58:05 [INFO] The user 711983855's state has been set to Survey.sex.
2025-01-29 20:58:05 [INFO] Update id=273477995 is handled. Duration 322 ms by bot id=8108339380
2025-01-29 20:58:06 [ERROR] Database connection is None!
2025-01-29 20:58:06 [INFO] Update id=273477996 is handled. Duration 333 ms by bot id=8108339380
2025-01-29 21:04:11 [WARNING] Received SIGTERM signal
2025-01-29 21:04:11 [INFO] Polling stopped for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-29 21:04:11 [INFO] Polling stopped
2025-01-29 21:04:11 [INFO] โ ะัะป ะฟะพะดะบะปััะตะฝะธะน ะบ ะะ ะทะฐะบััั.
2025-01-29 21:04:11 [INFO] โ ะะพะดะบะปััะตะฝะธะต ะบ ะะ ะทะฐะบัััะพ.
2025-01-29 21:04:19 [INFO] ๐ ะะพั ะทะฐะฟััะบะฐะตััั...
2025-01-29 21:04:19 [INFO] โ ะัะป ะฟะพะดะบะปััะตะฝะธะน ะบ ะะ ัะพะทะดะฐะฝ.
2025-01-29 21:04:19 [INFO] โ ะขะฐะฑะปะธัั ะฒ ะฑะฐะทะต ะดะฐะฝะฝัั ััะฟะตัะฝะพ ัะพะทะดะฐะฝั.
2025-01-29 21:04:19 [INFO] Start polling
2025-01-29 21:04:20 [INFO] Run polling for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-29 21:04:20 [INFO] The user 711983855 called the command /start.
2025-01-29 21:04:22 [INFO] Update id=273477997 is handled. Duration 1273 ms by bot id=8108339380
2025-01-29 21:04:23 [INFO] The user 711983855's state has been set to Survey.age.
2025-01-29 21:04:23 [INFO] Update id=273477998 is handled. Duration 341 ms by bot id=8108339380
2025-01-29 21:04:27 [INFO] The user 711983855's state has been set to Survey.weight.
2025-01-29 21:04:27 [INFO] Update id=273477999 is handled. Duration 334 ms by bot id=8108339380
2025-01-29 21:04:29 [INFO] The user 711983855's state has been set to Survey.height.
2025-01-29 21:04:30 [INFO] Update id=273478000 is handled. Duration 1405 ms by bot id=8108339380
2025-01-29 21:04:31 [INFO] The user 711983855's state has been set to Survey.feet.
2025-01-29 21:04:32 [INFO] Update id=273478001 is handled. Duration 953 ms by bot id=8108339380
2025-01-29 21:04:33 [INFO] The user 711983855's state has been set to Survey.gender.
2025-01-29 21:04:34 [INFO] Update id=273478002 is handled. Duration 498 ms by bot id=8108339380
2025-01-29 21:04:36 [INFO] The user 711983855's state has been set to Survey.smoking.
2025-01-29 21:04:37 [INFO] Update id=273478003 is handled. Duration 336 ms by bot id=8108339380
2025-01-29 21:04:37 [INFO] The user 711983855's state has been set to Survey.sex.
2025-01-29 21:04:38 [INFO] Update id=273478004 is handled. Duration 752 ms by bot id=8108339380
2025-01-29 21:04:39 [ERROR] Error getting recommendations: 'coroutine' object is not subscriptable
2025-01-29 21:04:40 [INFO] Update id=273478005 is handled. Duration 666 ms by bot id=8108339380
2025-01-29 21:07:22 [WARNING] Received SIGTERM signal
2025-01-29 21:07:22 [INFO] Polling stopped for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-29 21:07:22 [INFO] Polling stopped
2025-01-29 21:07:22 [INFO] โ ะัะป ะฟะพะดะบะปััะตะฝะธะน ะบ ะะ ะทะฐะบััั.
2025-01-29 21:07:22 [INFO] โ ะะพะดะบะปััะตะฝะธะต ะบ ะะ ะทะฐะบัััะพ.
2025-01-29 21:07:30 [INFO] ๐ ะะพั ะทะฐะฟััะบะฐะตััั...
2025-01-29 21:07:31 [INFO] โ ะัะป ะฟะพะดะบะปััะตะฝะธะน ะบ ะะ ัะพะทะดะฐะฝ.
2025-01-29 21:07:31 [INFO] โ ะขะฐะฑะปะธัั ะฒ ะฑะฐะทะต ะดะฐะฝะฝัั ััะฟะตัะฝะพ ัะพะทะดะฐะฝั.
2025-01-29 21:07:31 [INFO] Start polling
2025-01-29 21:07:32 [INFO] Run polling for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-29 21:07:32 [INFO] The user 711983855 called the command /start.
2025-01-29 21:07:34 [INFO] Update id=273478006 is handled. Duration 1219 ms by bot id=8108339380
2025-01-29 21:07:35 [INFO] The user 711983855's state has been set to Survey.age.
2025-01-29 21:07:35 [INFO] Update id=273478007 is handled. Duration 342 ms by bot id=8108339380
2025-01-29 21:07:38 [INFO] The user 711983855's state has been set to Survey.weight.
2025-01-29 21:07:38 [INFO] Update id=273478008 is handled. Duration 329 ms by bot id=8108339380
2025-01-29 21:07:39 [INFO] The user 711983855's state has been set to Survey.height.
2025-01-29 21:07:40 [INFO] Update id=273478009 is handled. Duration 336 ms by bot id=8108339380
2025-01-29 21:07:41 [INFO] The user 711983855's state has been set to Survey.feet.
2025-01-29 21:07:41 [INFO] Update id=273478010 is handled. Duration 334 ms by bot id=8108339380
2025-01-29 21:07:42 [INFO] The user 711983855's state has been set to Survey.gender.
2025-01-29 21:07:42 [INFO] Update id=273478011 is handled. Duration 335 ms by bot id=8108339380
2025-01-29 21:07:45 [INFO] The user 711983855's state has been set to Survey.smoking.
2025-01-29 21:07:45 [INFO] Update id=273478012 is handled. Duration 331 ms by bot id=8108339380
2025-01-29 21:07:46 [INFO] The user 711983855's state has been set to Survey.sex.
2025-01-29 21:07:46 [INFO] Update id=273478013 is handled. Duration 339 ms by bot id=8108339380
2025-01-29 21:07:47 [ERROR] Error getting recommendations: 'coroutine' object is not subscriptable
2025-01-29 21:07:48 [INFO] Update id=273478014 is handled. Duration 658 ms by bot id=8108339380
2025-01-29 21:10:36 [WARNING] Received SIGTERM signal
2025-01-29 21:10:36 [INFO] Polling stopped for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-29 21:10:36 [INFO] Polling stopped
2025-01-29 21:10:36 [INFO] โ ะัะป ะฟะพะดะบะปััะตะฝะธะน ะบ ะะ ะทะฐะบััั.
2025-01-29 21:10:36 [INFO] โ ะะพะดะบะปััะตะฝะธะต ะบ ะะ ะทะฐะบัััะพ.
2025-01-29 21:10:44 [INFO] ๐ ะะพั ะทะฐะฟััะบะฐะตััั...
2025-01-29 21:10:44 [INFO] โ ะัะป ะฟะพะดะบะปััะตะฝะธะน ะบ ะะ ัะพะทะดะฐะฝ.
2025-01-29 21:10:44 [INFO] โ ะขะฐะฑะปะธัั ะฒ ะฑะฐะทะต ะดะฐะฝะฝัั ััะฟะตัะฝะพ ัะพะทะดะฐะฝั.
2025-01-29 21:10:44 [INFO] Start polling
2025-01-29 21:10:45 [INFO] Run polling for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-29 21:10:46 [INFO] The user 711983855 called the command /start.
2025-01-29 21:10:47 [INFO] Update id=273478015 is handled. Duration 1231 ms by bot id=8108339380
2025-01-29 21:10:48 [INFO] The user 711983855's state has been set to Survey.age.
2025-01-29 21:10:48 [INFO] Update id=273478016 is handled. Duration 347 ms by bot id=8108339380
2025-01-29 21:10:52 [INFO] The user 711983855's state has been set to Survey.weight.
2025-01-29 21:10:52 [INFO] Update id=273478017 is handled. Duration 327 ms by bot id=8108339380
2025-01-29 21:10:54 [INFO] The user 711983855's state has been set to Survey.height.
2025-01-29 21:10:54 [INFO] Update id=273478018 is handled. Duration 333 ms by bot id=8108339380
2025-01-29 21:10:55 [INFO] The user 711983855's state has been set to Survey.feet.
2025-01-29 21:10:56 [INFO] Update id=273478019 is handled. Duration 333 ms by bot id=8108339380
2025-01-29 21:10:58 [INFO] The user 711983855's state has been set to Survey.gender.
2025-01-29 21:10:58 [INFO] Update id=273478020 is handled. Duration 338 ms by bot id=8108339380
2025-01-29 21:11:00 [INFO] The user 711983855's state has been set to Survey.smoking.
2025-01-29 21:11:01 [INFO] Update id=273478021 is handled. Duration 328 ms by bot id=8108339380
2025-01-29 21:11:02 [INFO] The user 711983855's state has been set to Survey.sex.
2025-01-29 21:11:02 [INFO] Update id=273478022 is handled. Duration 331 ms by bot id=8108339380
2025-01-29 21:11:03 [ERROR] Error getting recommendations: 0
2025-01-29 21:11:03 [INFO] Update id=273478023 is handled. Duration 681 ms by bot id=8108339380
2025-01-29 21:11:23 [INFO] The user 711983855 called the command /start.
2025-01-29 21:11:24 [INFO] Update id=273478024 is handled. Duration 416 ms by bot id=8108339380
2025-01-29 21:11:26 [INFO] The user 711983855's state has been set to Survey.age.
2025-01-29 21:11:26 [INFO] Update id=273478025 is handled. Duration 425 ms by bot id=8108339380
2025-01-29 21:11:29 [INFO] The user 711983855's state has been set to Survey.weight.
2025-01-29 21:11:30 [INFO] Update id=273478026 is handled. Duration 362 ms by bot id=8108339380
2025-01-29 21:11:35 [INFO] The user 711983855's state has been set to Survey.height.
2025-01-29 21:11:35 [INFO] Update id=273478027 is handled. Duration 337 ms by bot id=8108339380
2025-01-29 21:11:38 [INFO] The user 711983855's state has been set to Survey.feet.
2025-01-29 21:11:38 [INFO] Update id=273478028 is handled. Duration 349 ms by bot id=8108339380
2025-01-29 21:11:43 [INFO] The user 711983855's state has been set to Survey.gender.
2025-01-29 21:11:43 [INFO] Update id=273478029 is handled. Duration 330 ms by bot id=8108339380
2025-01-29 21:11:50 [INFO] The user 711983855's state has been set to Survey.smoking.
2025-01-29 21:11:50 [INFO] Update id=273478030 is handled. Duration 334 ms by bot id=8108339380
2025-01-29 21:11:51 [INFO] The user 711983855's state has been set to Survey.sex.
2025-01-29 21:11:52 [INFO] Update id=273478031 is handled. Duration 379 ms by bot id=8108339380
2025-01-29 21:11:53 [ERROR] Error getting recommendations: 0
2025-01-29 21:11:53 [INFO] Update id=273478032 is handled. Duration 693 ms by bot id=8108339380
2025-01-29 21:15:07 [WARNING] Received SIGTERM signal
2025-01-29 21:15:07 [INFO] Polling stopped for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-29 21:15:07 [INFO] Polling stopped
2025-01-29 21:15:08 [INFO] โ ะัะป ะฟะพะดะบะปััะตะฝะธะน ะบ ะะ ะทะฐะบััั.
2025-01-29 21:15:08 [INFO] โ ะะพะดะบะปััะตะฝะธะต ะบ ะะ ะทะฐะบัััะพ.
2025-01-29 21:15:15 [INFO] ๐ ะะพั ะทะฐะฟััะบะฐะตััั...
2025-01-29 21:15:15 [INFO] โ ะัะป ะฟะพะดะบะปััะตะฝะธะน ะบ ะะ ัะพะทะดะฐะฝ.
2025-01-29 21:15:15 [INFO] โ ะขะฐะฑะปะธัั ะฒ ะฑะฐะทะต ะดะฐะฝะฝัั ััะฟะตัะฝะพ ัะพะทะดะฐะฝั.
2025-01-29 21:15:15 [INFO] Start polling
2025-01-29 21:15:16 [INFO] Run polling for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-29 21:15:17 [INFO] The user 711983855 called the command /start.
2025-01-29 21:15:18 [INFO] Update id=273478033 is handled. Duration 1321 ms by bot id=8108339380
2025-01-29 21:15:19 [INFO] The user 711983855's state has been set to Survey.age.
2025-01-29 21:15:19 [INFO] Update id=273478034 is handled. Duration 339 ms by bot id=8108339380
2025-01-29 21:15:29 [INFO] The user 711983855's state has been set to Survey.weight.
2025-01-29 21:15:30 [INFO] Update id=273478035 is handled. Duration 337 ms by bot id=8108339380
2025-01-29 21:15:32 [INFO] The user 711983855's state has been set to Survey.height.
2025-01-29 21:15:33 [INFO] Update id=273478036 is handled. Duration 343 ms by bot id=8108339380
2025-01-29 21:15:35 [INFO] The user 711983855's state has been set to Survey.feet.
2025-01-29 21:15:35 [INFO] Update id=273478037 is handled. Duration 341 ms by bot id=8108339380
2025-01-29 21:15:38 [INFO] The user 711983855's state has been set to Survey.gender.
2025-01-29 21:15:38 [INFO] Update id=273478038 is handled. Duration 368 ms by bot id=8108339380
2025-01-29 21:15:40 [INFO] The user 711983855's state has been set to Survey.smoking.
2025-01-29 21:15:40 [INFO] Update id=273478039 is handled. Duration 421 ms by bot id=8108339380
2025-01-29 21:15:41 [INFO] The user 711983855's state has been set to Survey.sex.
2025-01-29 21:15:42 [INFO] Update id=273478040 is handled. Duration 391 ms by bot id=8108339380
2025-01-29 21:15:43 [ERROR] Error getting recommendations: 0
2025-01-29 21:15:43 [INFO] Update id=273478041 is handled. Duration 793 ms by bot id=8108339380
2025-01-29 21:16:58 [WARNING] Received SIGTERM signal
2025-01-29 21:16:58 [INFO] Polling stopped for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-29 21:16:58 [INFO] Polling stopped
2025-01-29 21:16:58 [INFO] โ ะัะป ะฟะพะดะบะปััะตะฝะธะน ะบ ะะ ะทะฐะบััั.
2025-01-29 21:16:58 [INFO] โ ะะพะดะบะปััะตะฝะธะต ะบ ะะ ะทะฐะบัััะพ.
2025-01-29 21:17:05 [INFO] ๐ ะะพั ะทะฐะฟััะบะฐะตััั...
2025-01-29 21:17:05 [INFO] โ ะัะป ะฟะพะดะบะปััะตะฝะธะน ะบ ะะ ัะพะทะดะฐะฝ.
2025-01-29 21:17:05 [INFO] โ ะขะฐะฑะปะธัั ะฒ ะฑะฐะทะต ะดะฐะฝะฝัั ััะฟะตัะฝะพ ัะพะทะดะฐะฝั.
2025-01-29 21:17:05 [INFO] Start polling
2025-01-29 21:17:06 [INFO] Run polling for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-29 21:17:07 [INFO] The user 711983855 called the command /start.
2025-01-29 21:17:08 [INFO] Update id=273478042 is handled. Duration 1273 ms by bot id=8108339380
2025-01-29 21:17:11 [INFO] The user 711983855's state has been set to Survey.age.
2025-01-29 21:17:11 [INFO] Update id=273478043 is handled. Duration 355 ms by bot id=8108339380
2025-01-29 21:17:12 [INFO] The user 711983855's state has been set to Survey.weight.
2025-01-29 21:17:12 [INFO] Update id=273478044 is handled. Duration 332 ms by bot id=8108339380
2025-01-29 21:17:17 [INFO] The user 711983855's state has been set to Survey.height.
2025-01-29 21:17:18 [INFO] Update id=273478045 is handled. Duration 356 ms by bot id=8108339380
2025-01-29 21:17:20 [INFO] The user 711983855's state has been set to Survey.feet.
2025-01-29 21:17:20 [INFO] Update id=273478046 is handled. Duration 331 ms by bot id=8108339380
2025-01-29 21:17:23 [INFO] The user 711983855's state has been set to Survey.gender.
2025-01-29 21:17:23 [INFO] Update id=273478047 is handled. Duration 349 ms by bot id=8108339380
2025-01-29 21:17:24 [INFO] The user 711983855's state has been set to Survey.smoking.
2025-01-29 21:17:25 [INFO] Update id=273478048 is handled. Duration 327 ms by bot id=8108339380
2025-01-29 21:17:26 [INFO] The user 711983855's state has been set to Survey.sex.
2025-01-29 21:17:26 [INFO] Update id=273478049 is handled. Duration 346 ms by bot id=8108339380
2025-01-29 21:17:27 [INFO] State data: {'db': <bot.database.Database object at 0x7fdd3852b1d0>, 'age': 20, 'weight': 89, 'height': 189, 'feet': 45, 'gender': 'male', 'pregnant': 'no', 'smoking': 'yes', 'sex': 'yes'}
2025-01-29 21:17:27 [INFO] Recommendations: [{'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in adolescents and adults aged 15 to 65 years. Younger adolescents and older adults who are at increased risk of infection should also be screened.\rSee the Clinical Considerations section for more information about assessment of risk, screening intervals, and rescreening in pregnancy.', 'servfreq': 'The USPSTF found insufficient evidence to determine appropriate or optimal time intervals or strategies for repeat HIV screening. However, repeat screening is reasonable for persons known to be at increased risk of HIV infection, such as sexually active men who have sex with men; persons with a sex partner who is living with HIV; or persons who engage in behaviors that may convey an increased risk of HIV infection, such as injection drug use, transactional sex or commercial sex work, having 1 or more new sex partners whose HIV status is unknown, or having other factors that can place a person at increased risk of HIV infection (see &ldquo;Risk Assessment&rdquo;). Repeat screening is also reasonable for persons who live or receive medical care in a high-prevalence setting, such as a sexually transmitted disease clinic, tuberculosis clinic, correctional facility, or homeless shelter.', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'title': 'Hypertension in Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hypertension in adults 18 years or older with office blood pressure measurement (OBPM). The USPSTF recommends obtaining blood pressure measurements outside of the clinical setting for diagnostic confirmation before starting treatment.', 'servfreq': ' \r\nAlthough evidence on optimal screening intervals is limited, reasonable options include:\r\n \r\n \r\n\r\n\r\nScreening for hypertension every year in adults 40 years or older and in adults at increased risk for hypertension (such as Black persons, persons with high-normal blood pressure, or persons who are overweight or obese)\r\n\r\n\r\n \r\n \r\n\r\n\r\nScreening less frequently (ie, every 3 to 5 years) as appropriate for adults aged 18 to 39 years not at increased risk for hypertension and with a prior normal blood pressure reading.\r\n\r\n\r\n ', 'risktext': ' \r\nAlthough all adults should be screened for hypertension, risk factors that increase a person&rsquo;s risk for the condition include older age, Black race, family history, excess weight and obesity, lifestyle habits (lack of physical activity, stress, and tobacco use), and dietary factors (diet high in fat or sodium, diet low in potassium, or excessive alcohol intake)\r\n '}, {'title': 'Prevention of Acquisition of HIV: Preexposure Prophylaxis ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians prescribe preexposure prophylaxis using effective antiretroviral therapy to persons who are at increased risk of HIV acquisition to decrease the risk of acquiring HIV. \r\rSee the Practice Considerations section for more information about identification of persons at increased risk and about effective antiretroviral therapy.', 'servfreq': '', 'risktext': 'HIV is primarily acquired via sexual activity or injection drug use. It is important that clinicians routinely take a sexual and injection drug use history for all their patients in an open and nonjudgmental manner. All adolescents and adults who are sexually active or who inject drugs should be informed that acquisition of HIV can be prevented, to facilitate subsequent risk assessment and discussions about preexposure prophylaxis (PrEP) and other ways to prevent acquisition of HIV. Importantly, risk of HIV acquisition exists on a continuum, and currently available risk assessment tools all have limitations. However, certain risk factors or behaviors are known to place persons at increased risk of HIV.\r\nRisk of HIV acquisition depends on the likelihood that a specific act or activity will transmit HIV and the likelihood that a sex partner or drug injection partner has HIV. Likelihood of HIV transmission is highest with needle-sharing injection drug use and condomless receptive anal intercourse. Condomless receptive anal intercourse has an approximately 10- to 15-fold higher risk of transmission than condomless insertive anal sex and condomless receptive and insertive penile-vaginal sex. A 2018 study estimated the prevalence of HIV (ie, an estimate of the likelihood that a partner whose HIV status is unknown has HIV at a population level) as 12.4% among men who have sex with men and 1.9% among persons who inject drugs. The overall prevalence of HIV in the US is estimated at 0.3%.&nbsp;Of note, both the frequency of specific sexual activities and a person&rsquo;s number of sexual partners will also affect their risk of HIV.\r\n&nbsp;The USPSTF recommends that the following persons be considered for PrEP:\r\n1.&nbsp;&nbsp;&nbsp;&nbsp; Sexually active adults and adolescents weighing at least 35 kg (77 lb) who have engaged in anal or vaginal sex in the past 6 months and have any of the following:\r\n&nbsp;\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A sexual partner who has HIV (especially if the partner has an unknown or detectable viral load).\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A bacterial sexually transmitted infection (STI) (syphilis, gonorrhea, or chlamydia for men who have sex with men and transgender women; gonorrhea and syphilis for heterosexual women and men) in the past 6 months.\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A history of inconsistent or no condom use with sex partner(s) whose HIV status is not known; assessing risk in conversation with the patient and considering factors such as number of partners, the specific sexual activities a person engages in, and whether their sex partner or partners are in a group with a higher prevalence of HIV (eg, men who have sex with men or with men and women, transgender women, persons who inject drugs, and persons who engage in transactional sex).\r\n&nbsp;\r\n2. &nbsp; Persons who inject drugs and have a drug-injecting partner who has HIV or who shares injection equipment.\r\nPersons who engage in transactional sex, such as sex for money, drugs, or housing, including commercial sex workers or persons trafficked for sex work, constitute a group at increased risk of HIV acquisition and should be considered for PrEP based on the criteria outlined above. Persons who request PrEP may have undisclosed behaviors that put them at risk. Transgender women and men who are sexually active should be considered for PrEP based on the criteria outlined above. Transgender women are at especially high risk of HIV acquisition. A Centers for Disease Control and and Prevention (CDC) survey in 7 cities found an HIV prevalence of 42% among transgender women. Prevalence was highest among Black transgender women (62%) and Native American/Alaska Native transgender women (65%).\r\nIn addition, studies have found that transmission of HIV to a seronegative partner from a partner with HIV has not been observed when the partner with HIV was being treated with antiretroviral therapy and had a suppressed viral load.&nbsp;It is not known whether PrEP use further decreases the risk of HIV transmission when a partner with HIV has a documented undetectable viral load. Factors such as the consistency or inconsistency of a partner&rsquo;s viral load being suppressed, a partner&rsquo;s adherence to antiretroviral therapy, and the degree of certainty that a partner&rsquo;s viral load is suppressed (eg, self-report vs availability of laboratory test results) may help inform decisions about the use of PrEP in this situation.\r\nAll persons being considered for PrEP must have a recently documented negative HIV antigen-antibody test result, and if they have taken oral PrEP or postexposure prophylaxis in the past 3 months, or injectable cabotegravir in the past 12 months, the CDC recommends testing with both an HIV antigen-antibody assay and an HIV-1 RNA assay.'}, {'title': 'Syphilis Infection in Nonpregnant Adolescents and Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for syphilis infection in persons who are at increased risk for infection.', 'servfreq': 'Optimal screening frequency for persons who are at increased risk for syphilis infection is not well established. Men who have sex with men or persons with HIV infection may benefit from screening at least annually or more frequently (eg, every 3 to 6 months) if they continue to be at high risk.', 'risktext': 'The USPSTF recommends screening for syphilis in persons who are at increased risk for infection. When deciding which persons to screen for syphilis, clinicians should consider the prevalence of infection in the communities they serve, as well as other sociodemographic and behavioral factors that may be associated with increased risk of syphilis infection. For example, prevalence of syphilis is higher in men, men who have sex with men, persons with HIV infection, young adults, and persons with a history of incarceration, sex work, or military service. A substantial percentage of heterosexual syphilis transmission occurs among persons who use illicit drugs, particularly methamphetamine. Diagnosis of another STI may signal that a person is having condomless sex, which increases their risk of syphilis infection. Higher infection rates in persons of some racial and ethnic groups have been reported and are primarily a reflection of a combination of factors, including social determinants of health (eg, disparities of income, low educational achievement, and unstable housing), differential health insurance coverage or access to quality health care, and differences in sexual network characteristics (eg, individuals living in communities with a high prevalence of STIs have an increased chance of encountering an infected partner). Local prevalence rates may change over time, so clinicians should be aware of the latest data and trends for their specific population and geographic area, which are available through their state and local health departments and Centers for Disease Control and Prevention (CDC) surveillance.\r\n&nbsp;\r\nAlthough direct evidence on screening in nonpregnant persons who are not at increased risk for syphilis infection is lacking, based on the established test performance characteristics of current screening tests and the low prevalence rate of syphilis in this population, the yield of screening is likely low.9,10 Therefore, screening in this population may result in high false-positive rates and overtreatment.'}, {'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and US Food and Drug Administration (FDA)--approved pharmacotherapy for cessation to nonpregnant adults who use tobacco.', 'servfreq': '', 'risktext': ''}, {'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all pregnant persons about tobacco use, advise them to stop using tobacco, and provide behavioral interventions for cessation to pregnant persons who use tobacco.', 'servfreq': '', 'risktext': ''}, {'title': 'Anxiety Disorders in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for anxiety disorders in adults, including pregnant and postpartum persons.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding optimal timing for screening, or screening interval, for both the perinatal and general adult populations; more evidence on both timing and screening interval is needed for all adult populations. A pragmatic approach in the absence of evidence might include screening all adults who have not been screened previously and using clinical judgment in considering risk factors, comorbid conditions, and life events to determine if additional screening of high-risk patients is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nRisk factors for anxiety disorders include sociodemographic factors, psychosocial factors, and physical and mental health factors such as marital status (widowed or divorced), stressful life events, smoking and alcohol use, other mental health conditions, or a parental history of mental disorders. Demographic factors such as low socioeconomic status and female sex are associated with higher rates of anxiety disorders.&nbsp;Black persons and individuals of non-Hispanic ethnicity are at increased risk of anxiety disorders due to social, rather than biological, factors. Anxiety and depressive disorders often overlap. One cohort study found that 67% of individuals with a depressive disorder also had a current anxiety disorder, and 75% had a lifetime comorbid anxiety disorder.'}, {'title': 'Latent Tuberculosis Infection in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for LTBI in populations at increased risk.\r\rSee the "Assessment of Risk" section for additional information on adults at increased risk.', 'servfreq': 'The USPSTF found no evidence on the optimal frequency of screening for LTBI. In the absence of evidence, a reasonable approach is to repeat screening based on specific risk factors; screening frequency could range from 1-time only screening among persons at low risk for future tuberculosis exposure to annual screening among those at continued risk of exposure.', 'risktext': 'Populations at increased risk for LTBI, based on increased prevalence of active disease and increased risk of exposure, include persons who were born in, or are former residents of, countries with high tuberculosis prevalence and persons who live in, or have lived in, high-risk congregate settings (eg, homeless shelters or correctional facilities). Clinicians can consult their local or state health departments for more information about populations at increased risk in their community, since local demographic patterns may vary across the US.\r\nIn 2020, 71.5% of all cases of active tuberculosis in the US occurred among persons born outside the US. According to the CDC, tuberculosis disease is common in most countries in Latin America, the Caribbean, Africa, Asia, Eastern Europe, and Russia. In 2020, among persons with new tuberculosis living in the US who were born outside the US, the most common countries of birth were Mexico (18.0%), the Philippines (12.5%), India (10.4%), Vietnam (8.2%), and China (5.1%), accounting for 54.2% of total cases. Most of these cases are believed to be due to progression of latent infection to active tuberculosis disease rather than new transmission within communities.\r\nPersons who live, or have lived, in high-risk congregate settings also have a higher prevalence rate of active tuberculosis and an increased risk for exposure. In 2020, 4.3% of tuberculosis disease cases diagnosed in persons 15 years or older occurred in persons experiencing homelessness and 2.6% occurred in residents of correctional facilities. It is estimated that persons experiencing homelessness have an 11 times higher incidence of tuberculosis disease compared with persons who are not experiencing homelessness (36 cases per 100,000 population vs 2.9 cases per 100,000 population, respectively, during 2011 to 2016).\r\nOther populations at increased risk for LTBI or progression to active disease include persons who have immunosuppression (eg, persons living with HIV, patients receiving immunosuppressive medications such as chemotherapy or tumor necrosis factor inhibitors, and patients who have received an organ transplant) and patients with silicosis (a lung disease). However, given that screening in these populations may be considered standard care as part of disease management or indicated prior to the use of certain medications, the USPSTF did not review evidence on screening in these populations. Information on testing in these populations is provided by other groups, such as the Office of AIDS Research at the National Institutes of Health, and in a guideline issued jointly by the American Thoracic Society, Infectious Diseases Society of America, and CDC. Some evidence from observational studies has explored the association between poorly controlled diabetes and progression of LTBI to active disease. However, there is insufficient evidence on screening for and treatment of LTBI in persons with diabetes for the USPSTF to make a separate recommendation for this important population.\r\nPersons who are contacts of individuals with active tuberculosis, health care workers, and workers in high-risk congregate settings may also be at increased risk of exposure. Because screening in these populations is conducted as part of public health or employee health surveillance, the USPSTF did not review the evidence in these populations. Clinicians seeking further information about testing for tuberculosis in these populations can refer to the Additional Tools and Resources and Recommendations of Others sections.'}, {'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic bacteriuria in nonpregnant adults.', 'servfreq': '', 'risktext': 'The risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6 Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5 Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7, 11, 12 In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12 Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4, 6'}, {'title': 'Asymptomatic Carotid Artery Stenosis: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic carotid artery stenosis in the general adult population.\r\rSee the Practice Considerations section for a description of adults at increased risk.', 'servfreq': '', 'risktext': ''}, {'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for suicide risk in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': '', 'risktext': ''}, {'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for depression in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding the optimal timing for screening for depression; more evidence is needed in both perinatal and general adult populations. In the absence of evidence, a pragmatic approach might include screening adults who have not been screened previously and using clinical judgment while considering risk factors, comorbid conditions, and life events to determine if additional screening of patients at increased risk is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nThe USPSTF recommends screening for depression in all adults regardless of risk factors. Risk factors for depression include a combination of genetic, biological, and environmental factors, such as a family history of depression, prior episode of depression or other mental health condition, a history of trauma or adverse life events, or a history of disease or illness (eg, cardiovascular disease).\r\nPrevalence rates vary by sex, age, race, ethnicity, education, marital status, geographic location, poverty level, and employment status. Women have twice the risk of depression compared with men. Young adults, multiracial individuals, and Native American/Alaska Native individuals have higher rates of depression.\r\nRisk factors for perinatal depression include life stress, low social support, history of depression, marital or partner dissatisfaction, and a history of abuse.'}, {'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends offering or referring adults with cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity.', 'servfreq': '', 'risktext': 'Adults 18 years or older at increased risk of CVD, defined as those with 1 or more of the following:\r\n1.Hypertension or elevated blood pressure2.Dyslipidemia3.Mixed or multiple risk factors such as the metabolic syndrome or an estimated 10-year CVD risk of &ge;7.5%\r\nThis recommendation does not apply to adults with other known modifiable cardiovascular risk factors such as abnormal blood glucose levels, obesity, and smoking; these populations are incorporated in other USPSTF recommendations.'}, {'title': 'Hepatitis B Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in adolescents and adults at increased risk for infection.\r\rSee the Practice Considerations section for a description of adolescents and adults at increased risk for infection.', 'servfreq': 'For patients with negative HBsAg results who have not received the HBV vaccine series, periodic screening may be useful for those who report continued risk for acquiring HBV transmission, such as persons who continue to inject drugs and men who have sex with men. Clinical judgment should be used to determine screening frequency. The USPSTF found no evidence to determine optimal screening intervals.', 'risktext': 'Persons from such risk groups include persons who have injected drugs in the past or currently; men who have sex with men; persons with HIV; and sex partners, needle-sharing contacts, and household contacts of persons known to be HBsAg positive. Some persons with combinations of risk factors who are not members of risk factor groups listed above may also be at increased risk for HBV infection.'}, {'title': 'Hepatitis C Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis C virus (HCV) infection in adults aged 18 to 79 years.', 'servfreq': 'One-time screening for most adults.\r\nPeriodically screen persons with continued risk for HCV infection (eg, persons with past or current injection drug use). There is limited evidence to determine how often to screen persons at increased risk.&nbsp;', 'risktext': 'Asymptomatic adults aged 18 to 79 years (including pregnant persons) without known liver disease.&nbsp;\r\nThe USPSTF also suggests that clinicians consider screening persons younger than 18 years and older than 79 years who are at high risk for infection (eg, those with past or current injection drug use).&nbsp;'}, {'title': 'Lung Cancer: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery.', 'servfreq': ' \r\nThe USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. ', 'risktext': ' \r\nSmoking and older age are the 2 most important risk factors for lung cancer.&nbsp;The risk of lung cancer in persons who smoke increases with cumulative quantity and duration of smoking and with age but decreases with increasing time since quitting for persons who formerly smoked.3 The USPSTF considers adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years to be at high risk and recommends screening for lung cancer with annual LDCT in this population. \r\n \r\n&nbsp;\r\n \r\nAfrican American/Black (Black) men have a higher incidence of lung cancer than White men, and Black women have a lower incidence than White women.1 These differences are likely related to differences in smoking exposure (ie, prevalence of smoking) and related exposure to carcinogens in cigarettes.7,8 The differences may also be related to other social risk factors.\r\n \r\n&nbsp;\r\n \r\nOther risk factors for lung cancer include environmental exposures, prior radiation therapy, other (noncancer) lung diseases, and family history. Lower level of education is also associated with a higher risk of lung cancer.7 The task force recommends using age and smoking history to determine screening eligibility rather than more elaborate risk prediction models because there is insufficient evidence to assess whether risk prediction model&ndash;based screening would improve outcomes relative to using the risk factors of age and smoking history for broad implementation in primary care.\r\n '}, {'title': 'Sexually Transmitted Infections: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends behavioral counseling for all sexually active adolescents and for adults who are at increased risk for sexually transmitted infections (STIs).\r\rSee the Practice Considerations section for more information on populations at increased risk for acquiring STIs.', 'servfreq': '', 'risktext': 'All sexually active adolescents are at increased risk for STIs because of the high rates of STIs in this age group and should receive behavioral counseling interventions. Adults at increased risk for STIs include those who currently have an STI or were diagnosed with one within the past year, do not consistently use condoms, have multiple sex partners, or have sex partners within populations with a high prevalence of STIs. Populations with a high prevalence of STIs include persons who seek STI testing or attend STI clinics; sexual and gender minorities; persons who are living with HIV, inject drugs, have exchanged sex for money or drugs, or have entered correctional facilities; and some racial/ethnic minority groups.1-4'}, {'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends counseling young adults, adolescents, children, and parents of young children about minimizing exposure to ultraviolet (UV) radiation for persons aged 6 months to 24 years with fair skin types to reduce their risk of skin cancer.', 'servfreq': '', 'risktext': 'Fair skin types'}, {'title': 'Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for unhealthy alcohol use in primary care settings in adults 18 years or older, including pregnant women, and providing persons engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce unhealthy alcohol use.', 'servfreq': 'The USPSTF did not find adequate evidence to recommend an optimal screening interval for unhealthy alcohol use in adults.&nbsp;Brief behavioral counseling interventions were found to reduce unhealthy alcohol use in adults 18 years or older, including pregnant women. Effective behavioral counseling interventions vary in their specific components, administration, length, and number of interactions. The USPSTF was unable to identify specific intervention characteristics or components that were clearly associated with improved outcomes.', 'risktext': 'engaged in risky or hazardous drinking'}, {'title': 'Unhealthy Drug Use: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening by asking questions about unhealthy drug use in adults age 18 years or older. Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. \r(Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'servfreq': 'Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. (Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'risktext': 'These include being aged 18 to 25 years; male sex; having a mental health condition, personality or mood disorder, or nicotine or alcohol dependence; a history of physical or sexual abuse, parental neglect, or other adversity in childhood; or drug or alcohol addiction in a first-degree relative.1,9&nbsp;Factors associated with misuse of prescription drugs include history of other drug use, mental illness, pain, and greater access to prescription drugs.10&nbsp;Factors associated with prenatal use of drugs include a mental health disorder, interpersonal violence, and family history of substance use.11'}, {'title': 'Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer or refer adults with a body mass index (BMI) of 30 or higher (calculated as weight in kilograms divided by height in meters squared) to intensive, multicomponent behavioral interventions.', 'servfreq': '', 'risktext': 'Adults with a BMI &ge;30'}, {'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: Behavioral Counseling Interventions ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians individualize the decision to offer or refer adults without cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity. \r\rSee the "Practice Considerations" section for information on determining which patients may benefit most from this service.', 'servfreq': '', 'risktext': ''}, {'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for chlamydia and gonorrhea in men.', 'servfreq': '', 'risktext': ''}, {'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening with resting or exercise electrocardiography (ECG) to prevent cardiovascular disease (CVD) events in asymptomatic adults at low risk of CVD events.', 'servfreq': '', 'risktext': ''}, {'title': 'Chronic Obstructive Pulmonary Disease: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for chronic obstructive pulmonary disease in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'title': 'Genital Herpes Infection: Serologic Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine serologic screening for genital herpes simplex virus infection in asymptomatic adolescents and adults, including pregnant persons.', 'servfreq': '', 'risktext': 'The USPSTF found no evidence of externally validated, reliable risk stratification tools to identify individuals more or less likely to have genital herpes.'}, {'title': 'Pancreatic Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for pancreatic cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'title': 'Testicular Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for testicular cancer in adolescent or adult men.', 'servfreq': '', 'risktext': ''}, {'title': 'Thyroid Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for thyroid cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'D', 'text': 'The DoctorAI recommends against the use of beta carotene or vitamin E supplements for the prevention of cardiovascular disease or cancer.', 'servfreq': '', 'risktext': ''}, {'title': 'Autism Spectrum Disorder in Young Children: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for autism spectrum disorder (ASD) in young children for whom no concerns of ASD have been raised by their parents or a clinician.', 'servfreq': '', 'risktext': 'Although a number of potential risk factors for ASD have been identified, there is insufficient evidence to determine if certain risk factors modify the performance characteristics of ASD screening tests, such as the age at which screening is performed or other characteristics of the child or family.'}, {'title': 'Bladder Cancer in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults.\r\rLiterature scans conducted in July 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'This evidence update focused on the benefits and harms of screening for bladder cancer among people without symptoms, the accuracy of screening tests done in primary care settings, and the benefits and harms of treatment. The updated evidence review did not find any new high quality evidence to adequately determine the balance of benefits and harms of screening for bladder cancer. However, bladder cancer is a common cancer and can cause considerable health problems including death. Therefore, the USPSTF determined that the evidence was insufficient to provide a recommendation for or against bladder cancer screening.  The USPSTF emphasizes the need for additional research in this area. '}, {'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening with resting or exercise ECG to prevent CVD events in asymptomatic adults at intermediate or high risk of CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of adding the ankle-brachial index (ABI), high-sensitivity C-reactive protein (hsCRP) level, or coronary artery calcium (CAC) score to traditional risk assessment for cardiovascular disease (CVD) in asymptomatic adults to prevent CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Celiac Disease: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'persons with family history or other risk factors'}, {'title': 'Eating Disorders in Adolescents and Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for eating disorders in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Illicit Drug Use in Children, Adolescents, and Young Adults: Primary Care-Based Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--based behavioral counseling interventions to prevent illicit drug use, including nonmedical use of prescription drugs, in children, adolescents, and young adults.\r\rSee the Practice Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for abuse and neglect in all older or vulnerable adults. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': 'Risk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health.14&nbsp;For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.15'}, {'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for iron deficiency and iron deficiency anemia in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine iron supplementation in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'title': 'Lipid Disorders in Children and Adolescents: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Obstructive Sleep Apnea in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for obstructive sleep apnea in the general adult population.\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Risk Factors\r\nRisk factors associated with OSA include male sex, older age (40-70 years), postmenopausal status, higher body mass index (BMI), and craniofacial and upper airway abnormalities (eg, enlarged tonsils or long upper airway). Black, Hispanic/Latino, and Native American/Alaska Native persons have a higher prevalence of OSA compared with White persons; some evidence suggests that these differences are partially explained by higher rates of obesity, asthma, and tobacco use among these groups.8'}, {'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of multivitamin supplements for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of single or paired nutrient supplements (other than beta carotene and vitamin E) for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Oral Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for oral cancer in asymptomatic adults.\r\rGo to the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in July 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Tobacco and alcohol use are major risk factors for oral cancer. A total of 20% to 30% of cases of oral cancer worldwide are attributable to cigarette smoking. In the United States, up to 75% of cases of oral cancer may be attributable to tobacco and alcohol use. Additional risk factors include male sex, older age, use of betel quid, ultraviolet light exposure, infection with Candida or bacterial flora, and a compromised immune system. Sexually transmitted oral HPV infection (HPV-16) has recently been recognized as an increasingly important risk factor for oropharyngeal cancer. In the United States, the prevalence of oropharyngeal cancer due to oral HPV infection is probably as high as 80% to 95%. The prevalence of oral HPV infection is associated with age, sex, number of sexual partners, and number of cigarettes smoked per day. The effect of multifactorial risk assessment and screening for risk factors on oral cancer morbidity and mortality is unknown.'}, {'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine screening performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of preventive interventions performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'title': 'Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for peripheral artery disease (PAD) and cardiovascular disease (CVD) risk with the ankle-brachial index (ABI) in asymptomatic adults.\r\rLiterature scans conducted in August 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Risk factors associated with OSA include male sex, older age (40 to 70 years), postmenopausal status, higher BMI, and craniofacial and upper airway abnormalities.'}, {'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of counseling adults about skin self-examination to prevent skin cancer.See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Skin Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Exposure to UV radiation from sun exposure, indoor tanning beds, and other UV radiation&ndash;emitting devices is the major environmental risk factor for skin cancer. History of frequent sunburns, older age, and male sex are associated with increased risk for skin cancer. Exposure to UV radiation from the use of indoor tanning beds is an important risk factor in adolescents. Incidence of melanoma is higher among White persons compared with persons of other races and ethnicities. This difference likely reflects traits associated with increased melanoma risk, such as fair skin (which is more susceptible to sunburning), light-colored eyes, and red or blond hair being more common among White persons compared with persons of other races and ethnicities. Acral lentiginous melanoma, which occurs mostly on skin not frequently exposed to direct sunlight (eg, palms of hands, soles of feet, or under fingernails or toenails), is the most common type of melanoma among Black populations. Other melanoma risk factors include higher numbers of moles on the skin, atypical moles, as well as a personal and family history of skin cancer.'}, {'title': 'Thyroid Dysfunction: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults.\r\rSee the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': 'The optimal screening interval for thyroid dysfunction (if one exists) is unknown.', 'risktext': 'The most common cause of hypothyroidism in the United States is chronic autoimmune (Hashimoto) thyroiditis. Risk factors for an elevated TSH level include female sex, advancing age, white race, type 1 diabetes, Down syndrome, family history of thyroid disease, goiter, previous hyperthyroidism (possibly due in part to ablation therapy leading to iatrogenic thyroid dysfunction), and external-beam radiation in the head and neck area. Common causes of hyperthyroidism include Graves disease, Hashimoto thyroiditis, and functional thyroid nodules. Risk factors for a low TSH level include female sex; advancing age; black race; low iodine intake; personal or family history of thyroid disease; and ingestion of iodine-containing drugs, such as amiodarone. The USPSTF found no direct evidence that treatment of thyroid dysfunction based on risk level alters final health outcomes.'}, {'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of electronic cigarettes (e-cigarettes) for tobacco cessation in adults, including pregnant persons. The USPSTF recommends that clinicians direct patients who use tobacco to other tobacco cessation interventions with proven effectiveness and established safety.\rSee the Practice Considerations section for more information on recommended behavioral interventions and pharmacotherapy and for suggestions for practice regarding the I statements.', 'servfreq': '', 'risktext': ''}, {'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of pharmacotherapy interventions for tobacco cessation in pregnant persons.', 'servfreq': '', 'risktext': ''}, {'title': 'Tobacco Use in Children and Adolescents: Primary Care Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--feasible interventions for the cessation of tobacco use among school-aged children and adolescents.\r\rSee the Practice Considerations section for more information on effective interventions to prevent initiation of tobacco use and for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Vitamin D Deficiency in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of the benefits and harms of vitamin D and calcium supplementation, alone or combined, for the primary prevention of fractures in men and premenopausal women.', 'servfreq': '', 'risktext': ''}]
2025-01-29 21:17:27 [ERROR] Error getting recommendations: 0
2025-01-29 21:17:27 [INFO] Update id=273478050 is handled. Duration 678 ms by bot id=8108339380
2025-01-29 21:19:18 [WARNING] Received SIGTERM signal
2025-01-29 21:19:18 [INFO] Polling stopped for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-29 21:19:18 [INFO] Polling stopped
2025-01-29 21:19:19 [INFO] โ ะัะป ะฟะพะดะบะปััะตะฝะธะน ะบ ะะ ะทะฐะบััั.
2025-01-29 21:19:19 [INFO] โ ะะพะดะบะปััะตะฝะธะต ะบ ะะ ะทะฐะบัััะพ.
2025-01-29 21:19:45 [INFO] ๐ ะะพั ะทะฐะฟััะบะฐะตััั...
2025-01-29 21:19:45 [INFO] โ ะัะป ะฟะพะดะบะปััะตะฝะธะน ะบ ะะ ัะพะทะดะฐะฝ.
2025-01-29 21:19:45 [INFO] โ ะขะฐะฑะปะธัั ะฒ ะฑะฐะทะต ะดะฐะฝะฝัั ััะฟะตัะฝะพ ัะพะทะดะฐะฝั.
2025-01-29 21:19:45 [INFO] Start polling
2025-01-29 21:19:47 [INFO] Run polling for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-29 21:19:47 [INFO] The user 711983855 called the command /start.
2025-01-29 21:19:48 [INFO] Update id=273478051 is handled. Duration 1257 ms by bot id=8108339380
2025-01-29 21:19:50 [INFO] The user 711983855's state has been set to Survey.age.
2025-01-29 21:19:50 [INFO] Update id=273478052 is handled. Duration 335 ms by bot id=8108339380
2025-01-29 21:19:57 [INFO] The user 711983855's state has been set to Survey.weight.
2025-01-29 21:19:57 [INFO] Update id=273478053 is handled. Duration 341 ms by bot id=8108339380
2025-01-29 21:20:01 [INFO] The user 711983855's state has been set to Survey.height.
2025-01-29 21:20:02 [INFO] Update id=273478054 is handled. Duration 1624 ms by bot id=8108339380
2025-01-29 21:20:09 [INFO] The user 711983855's state has been set to Survey.feet.
2025-01-29 21:20:10 [INFO] Update id=273478055 is handled. Duration 351 ms by bot id=8108339380
2025-01-29 21:20:11 [INFO] The user 711983855's state has been set to Survey.gender.
2025-01-29 21:20:12 [INFO] Update id=273478056 is handled. Duration 344 ms by bot id=8108339380
2025-01-29 21:20:14 [INFO] The user 711983855's state has been set to Survey.smoking.
2025-01-29 21:20:14 [INFO] Update id=273478057 is handled. Duration 355 ms by bot id=8108339380
2025-01-29 21:20:16 [INFO] The user 711983855's state has been set to Survey.sex.
2025-01-29 21:20:16 [INFO] Update id=273478058 is handled. Duration 331 ms by bot id=8108339380
2025-01-29 21:20:17 [INFO] State data: {'db': <bot.database.Database object at 0x7f14b3543050>, 'age': 20, 'weight': 90, 'height': 190, 'feet': 45, 'gender': 'male', 'pregnant': 'no', 'smoking': 'yes', 'sex': 'yes'}
2025-01-29 21:20:17 [INFO] Recommendations: [{'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in adolescents and adults aged 15 to 65 years. Younger adolescents and older adults who are at increased risk of infection should also be screened.\rSee the Clinical Considerations section for more information about assessment of risk, screening intervals, and rescreening in pregnancy.', 'servfreq': 'The USPSTF found insufficient evidence to determine appropriate or optimal time intervals or strategies for repeat HIV screening. However, repeat screening is reasonable for persons known to be at increased risk of HIV infection, such as sexually active men who have sex with men; persons with a sex partner who is living with HIV; or persons who engage in behaviors that may convey an increased risk of HIV infection, such as injection drug use, transactional sex or commercial sex work, having 1 or more new sex partners whose HIV status is unknown, or having other factors that can place a person at increased risk of HIV infection (see &ldquo;Risk Assessment&rdquo;). Repeat screening is also reasonable for persons who live or receive medical care in a high-prevalence setting, such as a sexually transmitted disease clinic, tuberculosis clinic, correctional facility, or homeless shelter.', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'title': 'Hypertension in Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hypertension in adults 18 years or older with office blood pressure measurement (OBPM). The USPSTF recommends obtaining blood pressure measurements outside of the clinical setting for diagnostic confirmation before starting treatment.', 'servfreq': ' \r\nAlthough evidence on optimal screening intervals is limited, reasonable options include:\r\n \r\n \r\n\r\n\r\nScreening for hypertension every year in adults 40 years or older and in adults at increased risk for hypertension (such as Black persons, persons with high-normal blood pressure, or persons who are overweight or obese)\r\n\r\n\r\n \r\n \r\n\r\n\r\nScreening less frequently (ie, every 3 to 5 years) as appropriate for adults aged 18 to 39 years not at increased risk for hypertension and with a prior normal blood pressure reading.\r\n\r\n\r\n ', 'risktext': ' \r\nAlthough all adults should be screened for hypertension, risk factors that increase a person&rsquo;s risk for the condition include older age, Black race, family history, excess weight and obesity, lifestyle habits (lack of physical activity, stress, and tobacco use), and dietary factors (diet high in fat or sodium, diet low in potassium, or excessive alcohol intake)\r\n '}, {'title': 'Prevention of Acquisition of HIV: Preexposure Prophylaxis ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians prescribe preexposure prophylaxis using effective antiretroviral therapy to persons who are at increased risk of HIV acquisition to decrease the risk of acquiring HIV. \r\rSee the Practice Considerations section for more information about identification of persons at increased risk and about effective antiretroviral therapy.', 'servfreq': '', 'risktext': 'HIV is primarily acquired via sexual activity or injection drug use. It is important that clinicians routinely take a sexual and injection drug use history for all their patients in an open and nonjudgmental manner. All adolescents and adults who are sexually active or who inject drugs should be informed that acquisition of HIV can be prevented, to facilitate subsequent risk assessment and discussions about preexposure prophylaxis (PrEP) and other ways to prevent acquisition of HIV. Importantly, risk of HIV acquisition exists on a continuum, and currently available risk assessment tools all have limitations. However, certain risk factors or behaviors are known to place persons at increased risk of HIV.\r\nRisk of HIV acquisition depends on the likelihood that a specific act or activity will transmit HIV and the likelihood that a sex partner or drug injection partner has HIV. Likelihood of HIV transmission is highest with needle-sharing injection drug use and condomless receptive anal intercourse. Condomless receptive anal intercourse has an approximately 10- to 15-fold higher risk of transmission than condomless insertive anal sex and condomless receptive and insertive penile-vaginal sex. A 2018 study estimated the prevalence of HIV (ie, an estimate of the likelihood that a partner whose HIV status is unknown has HIV at a population level) as 12.4% among men who have sex with men and 1.9% among persons who inject drugs. The overall prevalence of HIV in the US is estimated at 0.3%.&nbsp;Of note, both the frequency of specific sexual activities and a person&rsquo;s number of sexual partners will also affect their risk of HIV.\r\n&nbsp;The USPSTF recommends that the following persons be considered for PrEP:\r\n1.&nbsp;&nbsp;&nbsp;&nbsp; Sexually active adults and adolescents weighing at least 35 kg (77 lb) who have engaged in anal or vaginal sex in the past 6 months and have any of the following:\r\n&nbsp;\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A sexual partner who has HIV (especially if the partner has an unknown or detectable viral load).\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A bacterial sexually transmitted infection (STI) (syphilis, gonorrhea, or chlamydia for men who have sex with men and transgender women; gonorrhea and syphilis for heterosexual women and men) in the past 6 months.\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A history of inconsistent or no condom use with sex partner(s) whose HIV status is not known; assessing risk in conversation with the patient and considering factors such as number of partners, the specific sexual activities a person engages in, and whether their sex partner or partners are in a group with a higher prevalence of HIV (eg, men who have sex with men or with men and women, transgender women, persons who inject drugs, and persons who engage in transactional sex).\r\n&nbsp;\r\n2. &nbsp; Persons who inject drugs and have a drug-injecting partner who has HIV or who shares injection equipment.\r\nPersons who engage in transactional sex, such as sex for money, drugs, or housing, including commercial sex workers or persons trafficked for sex work, constitute a group at increased risk of HIV acquisition and should be considered for PrEP based on the criteria outlined above. Persons who request PrEP may have undisclosed behaviors that put them at risk. Transgender women and men who are sexually active should be considered for PrEP based on the criteria outlined above. Transgender women are at especially high risk of HIV acquisition. A Centers for Disease Control and and Prevention (CDC) survey in 7 cities found an HIV prevalence of 42% among transgender women. Prevalence was highest among Black transgender women (62%) and Native American/Alaska Native transgender women (65%).\r\nIn addition, studies have found that transmission of HIV to a seronegative partner from a partner with HIV has not been observed when the partner with HIV was being treated with antiretroviral therapy and had a suppressed viral load.&nbsp;It is not known whether PrEP use further decreases the risk of HIV transmission when a partner with HIV has a documented undetectable viral load. Factors such as the consistency or inconsistency of a partner&rsquo;s viral load being suppressed, a partner&rsquo;s adherence to antiretroviral therapy, and the degree of certainty that a partner&rsquo;s viral load is suppressed (eg, self-report vs availability of laboratory test results) may help inform decisions about the use of PrEP in this situation.\r\nAll persons being considered for PrEP must have a recently documented negative HIV antigen-antibody test result, and if they have taken oral PrEP or postexposure prophylaxis in the past 3 months, or injectable cabotegravir in the past 12 months, the CDC recommends testing with both an HIV antigen-antibody assay and an HIV-1 RNA assay.'}, {'title': 'Syphilis Infection in Nonpregnant Adolescents and Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for syphilis infection in persons who are at increased risk for infection.', 'servfreq': 'Optimal screening frequency for persons who are at increased risk for syphilis infection is not well established. Men who have sex with men or persons with HIV infection may benefit from screening at least annually or more frequently (eg, every 3 to 6 months) if they continue to be at high risk.', 'risktext': 'The USPSTF recommends screening for syphilis in persons who are at increased risk for infection. When deciding which persons to screen for syphilis, clinicians should consider the prevalence of infection in the communities they serve, as well as other sociodemographic and behavioral factors that may be associated with increased risk of syphilis infection. For example, prevalence of syphilis is higher in men, men who have sex with men, persons with HIV infection, young adults, and persons with a history of incarceration, sex work, or military service. A substantial percentage of heterosexual syphilis transmission occurs among persons who use illicit drugs, particularly methamphetamine. Diagnosis of another STI may signal that a person is having condomless sex, which increases their risk of syphilis infection. Higher infection rates in persons of some racial and ethnic groups have been reported and are primarily a reflection of a combination of factors, including social determinants of health (eg, disparities of income, low educational achievement, and unstable housing), differential health insurance coverage or access to quality health care, and differences in sexual network characteristics (eg, individuals living in communities with a high prevalence of STIs have an increased chance of encountering an infected partner). Local prevalence rates may change over time, so clinicians should be aware of the latest data and trends for their specific population and geographic area, which are available through their state and local health departments and Centers for Disease Control and Prevention (CDC) surveillance.\r\n&nbsp;\r\nAlthough direct evidence on screening in nonpregnant persons who are not at increased risk for syphilis infection is lacking, based on the established test performance characteristics of current screening tests and the low prevalence rate of syphilis in this population, the yield of screening is likely low.9,10 Therefore, screening in this population may result in high false-positive rates and overtreatment.'}, {'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and US Food and Drug Administration (FDA)--approved pharmacotherapy for cessation to nonpregnant adults who use tobacco.', 'servfreq': '', 'risktext': ''}, {'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all pregnant persons about tobacco use, advise them to stop using tobacco, and provide behavioral interventions for cessation to pregnant persons who use tobacco.', 'servfreq': '', 'risktext': ''}, {'title': 'Anxiety Disorders in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for anxiety disorders in adults, including pregnant and postpartum persons.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding optimal timing for screening, or screening interval, for both the perinatal and general adult populations; more evidence on both timing and screening interval is needed for all adult populations. A pragmatic approach in the absence of evidence might include screening all adults who have not been screened previously and using clinical judgment in considering risk factors, comorbid conditions, and life events to determine if additional screening of high-risk patients is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nRisk factors for anxiety disorders include sociodemographic factors, psychosocial factors, and physical and mental health factors such as marital status (widowed or divorced), stressful life events, smoking and alcohol use, other mental health conditions, or a parental history of mental disorders. Demographic factors such as low socioeconomic status and female sex are associated with higher rates of anxiety disorders.&nbsp;Black persons and individuals of non-Hispanic ethnicity are at increased risk of anxiety disorders due to social, rather than biological, factors. Anxiety and depressive disorders often overlap. One cohort study found that 67% of individuals with a depressive disorder also had a current anxiety disorder, and 75% had a lifetime comorbid anxiety disorder.'}, {'title': 'Latent Tuberculosis Infection in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for LTBI in populations at increased risk.\r\rSee the "Assessment of Risk" section for additional information on adults at increased risk.', 'servfreq': 'The USPSTF found no evidence on the optimal frequency of screening for LTBI. In the absence of evidence, a reasonable approach is to repeat screening based on specific risk factors; screening frequency could range from 1-time only screening among persons at low risk for future tuberculosis exposure to annual screening among those at continued risk of exposure.', 'risktext': 'Populations at increased risk for LTBI, based on increased prevalence of active disease and increased risk of exposure, include persons who were born in, or are former residents of, countries with high tuberculosis prevalence and persons who live in, or have lived in, high-risk congregate settings (eg, homeless shelters or correctional facilities). Clinicians can consult their local or state health departments for more information about populations at increased risk in their community, since local demographic patterns may vary across the US.\r\nIn 2020, 71.5% of all cases of active tuberculosis in the US occurred among persons born outside the US. According to the CDC, tuberculosis disease is common in most countries in Latin America, the Caribbean, Africa, Asia, Eastern Europe, and Russia. In 2020, among persons with new tuberculosis living in the US who were born outside the US, the most common countries of birth were Mexico (18.0%), the Philippines (12.5%), India (10.4%), Vietnam (8.2%), and China (5.1%), accounting for 54.2% of total cases. Most of these cases are believed to be due to progression of latent infection to active tuberculosis disease rather than new transmission within communities.\r\nPersons who live, or have lived, in high-risk congregate settings also have a higher prevalence rate of active tuberculosis and an increased risk for exposure. In 2020, 4.3% of tuberculosis disease cases diagnosed in persons 15 years or older occurred in persons experiencing homelessness and 2.6% occurred in residents of correctional facilities. It is estimated that persons experiencing homelessness have an 11 times higher incidence of tuberculosis disease compared with persons who are not experiencing homelessness (36 cases per 100,000 population vs 2.9 cases per 100,000 population, respectively, during 2011 to 2016).\r\nOther populations at increased risk for LTBI or progression to active disease include persons who have immunosuppression (eg, persons living with HIV, patients receiving immunosuppressive medications such as chemotherapy or tumor necrosis factor inhibitors, and patients who have received an organ transplant) and patients with silicosis (a lung disease). However, given that screening in these populations may be considered standard care as part of disease management or indicated prior to the use of certain medications, the USPSTF did not review evidence on screening in these populations. Information on testing in these populations is provided by other groups, such as the Office of AIDS Research at the National Institutes of Health, and in a guideline issued jointly by the American Thoracic Society, Infectious Diseases Society of America, and CDC. Some evidence from observational studies has explored the association between poorly controlled diabetes and progression of LTBI to active disease. However, there is insufficient evidence on screening for and treatment of LTBI in persons with diabetes for the USPSTF to make a separate recommendation for this important population.\r\nPersons who are contacts of individuals with active tuberculosis, health care workers, and workers in high-risk congregate settings may also be at increased risk of exposure. Because screening in these populations is conducted as part of public health or employee health surveillance, the USPSTF did not review the evidence in these populations. Clinicians seeking further information about testing for tuberculosis in these populations can refer to the Additional Tools and Resources and Recommendations of Others sections.'}, {'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic bacteriuria in nonpregnant adults.', 'servfreq': '', 'risktext': 'The risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6 Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5 Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7, 11, 12 In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12 Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4, 6'}, {'title': 'Asymptomatic Carotid Artery Stenosis: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic carotid artery stenosis in the general adult population.\r\rSee the Practice Considerations section for a description of adults at increased risk.', 'servfreq': '', 'risktext': ''}, {'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for suicide risk in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': '', 'risktext': ''}, {'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for depression in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding the optimal timing for screening for depression; more evidence is needed in both perinatal and general adult populations. In the absence of evidence, a pragmatic approach might include screening adults who have not been screened previously and using clinical judgment while considering risk factors, comorbid conditions, and life events to determine if additional screening of patients at increased risk is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nThe USPSTF recommends screening for depression in all adults regardless of risk factors. Risk factors for depression include a combination of genetic, biological, and environmental factors, such as a family history of depression, prior episode of depression or other mental health condition, a history of trauma or adverse life events, or a history of disease or illness (eg, cardiovascular disease).\r\nPrevalence rates vary by sex, age, race, ethnicity, education, marital status, geographic location, poverty level, and employment status. Women have twice the risk of depression compared with men. Young adults, multiracial individuals, and Native American/Alaska Native individuals have higher rates of depression.\r\nRisk factors for perinatal depression include life stress, low social support, history of depression, marital or partner dissatisfaction, and a history of abuse.'}, {'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends offering or referring adults with cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity.', 'servfreq': '', 'risktext': 'Adults 18 years or older at increased risk of CVD, defined as those with 1 or more of the following:\r\n1.Hypertension or elevated blood pressure2.Dyslipidemia3.Mixed or multiple risk factors such as the metabolic syndrome or an estimated 10-year CVD risk of &ge;7.5%\r\nThis recommendation does not apply to adults with other known modifiable cardiovascular risk factors such as abnormal blood glucose levels, obesity, and smoking; these populations are incorporated in other USPSTF recommendations.'}, {'title': 'Hepatitis B Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in adolescents and adults at increased risk for infection.\r\rSee the Practice Considerations section for a description of adolescents and adults at increased risk for infection.', 'servfreq': 'For patients with negative HBsAg results who have not received the HBV vaccine series, periodic screening may be useful for those who report continued risk for acquiring HBV transmission, such as persons who continue to inject drugs and men who have sex with men. Clinical judgment should be used to determine screening frequency. The USPSTF found no evidence to determine optimal screening intervals.', 'risktext': 'Persons from such risk groups include persons who have injected drugs in the past or currently; men who have sex with men; persons with HIV; and sex partners, needle-sharing contacts, and household contacts of persons known to be HBsAg positive. Some persons with combinations of risk factors who are not members of risk factor groups listed above may also be at increased risk for HBV infection.'}, {'title': 'Hepatitis C Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis C virus (HCV) infection in adults aged 18 to 79 years.', 'servfreq': 'One-time screening for most adults.\r\nPeriodically screen persons with continued risk for HCV infection (eg, persons with past or current injection drug use). There is limited evidence to determine how often to screen persons at increased risk.&nbsp;', 'risktext': 'Asymptomatic adults aged 18 to 79 years (including pregnant persons) without known liver disease.&nbsp;\r\nThe USPSTF also suggests that clinicians consider screening persons younger than 18 years and older than 79 years who are at high risk for infection (eg, those with past or current injection drug use).&nbsp;'}, {'title': 'Lung Cancer: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery.', 'servfreq': ' \r\nThe USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. ', 'risktext': ' \r\nSmoking and older age are the 2 most important risk factors for lung cancer.&nbsp;The risk of lung cancer in persons who smoke increases with cumulative quantity and duration of smoking and with age but decreases with increasing time since quitting for persons who formerly smoked.3 The USPSTF considers adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years to be at high risk and recommends screening for lung cancer with annual LDCT in this population. \r\n \r\n&nbsp;\r\n \r\nAfrican American/Black (Black) men have a higher incidence of lung cancer than White men, and Black women have a lower incidence than White women.1 These differences are likely related to differences in smoking exposure (ie, prevalence of smoking) and related exposure to carcinogens in cigarettes.7,8 The differences may also be related to other social risk factors.\r\n \r\n&nbsp;\r\n \r\nOther risk factors for lung cancer include environmental exposures, prior radiation therapy, other (noncancer) lung diseases, and family history. Lower level of education is also associated with a higher risk of lung cancer.7 The task force recommends using age and smoking history to determine screening eligibility rather than more elaborate risk prediction models because there is insufficient evidence to assess whether risk prediction model&ndash;based screening would improve outcomes relative to using the risk factors of age and smoking history for broad implementation in primary care.\r\n '}, {'title': 'Sexually Transmitted Infections: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends behavioral counseling for all sexually active adolescents and for adults who are at increased risk for sexually transmitted infections (STIs).\r\rSee the Practice Considerations section for more information on populations at increased risk for acquiring STIs.', 'servfreq': '', 'risktext': 'All sexually active adolescents are at increased risk for STIs because of the high rates of STIs in this age group and should receive behavioral counseling interventions. Adults at increased risk for STIs include those who currently have an STI or were diagnosed with one within the past year, do not consistently use condoms, have multiple sex partners, or have sex partners within populations with a high prevalence of STIs. Populations with a high prevalence of STIs include persons who seek STI testing or attend STI clinics; sexual and gender minorities; persons who are living with HIV, inject drugs, have exchanged sex for money or drugs, or have entered correctional facilities; and some racial/ethnic minority groups.1-4'}, {'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends counseling young adults, adolescents, children, and parents of young children about minimizing exposure to ultraviolet (UV) radiation for persons aged 6 months to 24 years with fair skin types to reduce their risk of skin cancer.', 'servfreq': '', 'risktext': 'Fair skin types'}, {'title': 'Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for unhealthy alcohol use in primary care settings in adults 18 years or older, including pregnant women, and providing persons engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce unhealthy alcohol use.', 'servfreq': 'The USPSTF did not find adequate evidence to recommend an optimal screening interval for unhealthy alcohol use in adults.&nbsp;Brief behavioral counseling interventions were found to reduce unhealthy alcohol use in adults 18 years or older, including pregnant women. Effective behavioral counseling interventions vary in their specific components, administration, length, and number of interactions. The USPSTF was unable to identify specific intervention characteristics or components that were clearly associated with improved outcomes.', 'risktext': 'engaged in risky or hazardous drinking'}, {'title': 'Unhealthy Drug Use: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening by asking questions about unhealthy drug use in adults age 18 years or older. Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. \r(Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'servfreq': 'Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. (Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'risktext': 'These include being aged 18 to 25 years; male sex; having a mental health condition, personality or mood disorder, or nicotine or alcohol dependence; a history of physical or sexual abuse, parental neglect, or other adversity in childhood; or drug or alcohol addiction in a first-degree relative.1,9&nbsp;Factors associated with misuse of prescription drugs include history of other drug use, mental illness, pain, and greater access to prescription drugs.10&nbsp;Factors associated with prenatal use of drugs include a mental health disorder, interpersonal violence, and family history of substance use.11'}, {'title': 'Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer or refer adults with a body mass index (BMI) of 30 or higher (calculated as weight in kilograms divided by height in meters squared) to intensive, multicomponent behavioral interventions.', 'servfreq': '', 'risktext': 'Adults with a BMI &ge;30'}, {'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: Behavioral Counseling Interventions ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians individualize the decision to offer or refer adults without cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity. \r\rSee the "Practice Considerations" section for information on determining which patients may benefit most from this service.', 'servfreq': '', 'risktext': ''}, {'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for chlamydia and gonorrhea in men.', 'servfreq': '', 'risktext': ''}, {'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening with resting or exercise electrocardiography (ECG) to prevent cardiovascular disease (CVD) events in asymptomatic adults at low risk of CVD events.', 'servfreq': '', 'risktext': ''}, {'title': 'Chronic Obstructive Pulmonary Disease: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for chronic obstructive pulmonary disease in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'title': 'Genital Herpes Infection: Serologic Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine serologic screening for genital herpes simplex virus infection in asymptomatic adolescents and adults, including pregnant persons.', 'servfreq': '', 'risktext': 'The USPSTF found no evidence of externally validated, reliable risk stratification tools to identify individuals more or less likely to have genital herpes.'}, {'title': 'Pancreatic Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for pancreatic cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'title': 'Testicular Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for testicular cancer in adolescent or adult men.', 'servfreq': '', 'risktext': ''}, {'title': 'Thyroid Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for thyroid cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'D', 'text': 'The DoctorAI recommends against the use of beta carotene or vitamin E supplements for the prevention of cardiovascular disease or cancer.', 'servfreq': '', 'risktext': ''}, {'title': 'Autism Spectrum Disorder in Young Children: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for autism spectrum disorder (ASD) in young children for whom no concerns of ASD have been raised by their parents or a clinician.', 'servfreq': '', 'risktext': 'Although a number of potential risk factors for ASD have been identified, there is insufficient evidence to determine if certain risk factors modify the performance characteristics of ASD screening tests, such as the age at which screening is performed or other characteristics of the child or family.'}, {'title': 'Bladder Cancer in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults.\r\rLiterature scans conducted in July 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'This evidence update focused on the benefits and harms of screening for bladder cancer among people without symptoms, the accuracy of screening tests done in primary care settings, and the benefits and harms of treatment. The updated evidence review did not find any new high quality evidence to adequately determine the balance of benefits and harms of screening for bladder cancer. However, bladder cancer is a common cancer and can cause considerable health problems including death. Therefore, the USPSTF determined that the evidence was insufficient to provide a recommendation for or against bladder cancer screening.  The USPSTF emphasizes the need for additional research in this area. '}, {'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening with resting or exercise ECG to prevent CVD events in asymptomatic adults at intermediate or high risk of CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of adding the ankle-brachial index (ABI), high-sensitivity C-reactive protein (hsCRP) level, or coronary artery calcium (CAC) score to traditional risk assessment for cardiovascular disease (CVD) in asymptomatic adults to prevent CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Celiac Disease: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'persons with family history or other risk factors'}, {'title': 'Eating Disorders in Adolescents and Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for eating disorders in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Illicit Drug Use in Children, Adolescents, and Young Adults: Primary Care-Based Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--based behavioral counseling interventions to prevent illicit drug use, including nonmedical use of prescription drugs, in children, adolescents, and young adults.\r\rSee the Practice Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for abuse and neglect in all older or vulnerable adults. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': 'Risk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health.14&nbsp;For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.15'}, {'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for iron deficiency and iron deficiency anemia in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine iron supplementation in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'title': 'Lipid Disorders in Children and Adolescents: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Obstructive Sleep Apnea in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for obstructive sleep apnea in the general adult population.\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Risk Factors\r\nRisk factors associated with OSA include male sex, older age (40-70 years), postmenopausal status, higher body mass index (BMI), and craniofacial and upper airway abnormalities (eg, enlarged tonsils or long upper airway). Black, Hispanic/Latino, and Native American/Alaska Native persons have a higher prevalence of OSA compared with White persons; some evidence suggests that these differences are partially explained by higher rates of obesity, asthma, and tobacco use among these groups.8'}, {'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of multivitamin supplements for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of single or paired nutrient supplements (other than beta carotene and vitamin E) for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Oral Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for oral cancer in asymptomatic adults.\r\rGo to the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in July 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Tobacco and alcohol use are major risk factors for oral cancer. A total of 20% to 30% of cases of oral cancer worldwide are attributable to cigarette smoking. In the United States, up to 75% of cases of oral cancer may be attributable to tobacco and alcohol use. Additional risk factors include male sex, older age, use of betel quid, ultraviolet light exposure, infection with Candida or bacterial flora, and a compromised immune system. Sexually transmitted oral HPV infection (HPV-16) has recently been recognized as an increasingly important risk factor for oropharyngeal cancer. In the United States, the prevalence of oropharyngeal cancer due to oral HPV infection is probably as high as 80% to 95%. The prevalence of oral HPV infection is associated with age, sex, number of sexual partners, and number of cigarettes smoked per day. The effect of multifactorial risk assessment and screening for risk factors on oral cancer morbidity and mortality is unknown.'}, {'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine screening performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of preventive interventions performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'title': 'Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for peripheral artery disease (PAD) and cardiovascular disease (CVD) risk with the ankle-brachial index (ABI) in asymptomatic adults.\r\rLiterature scans conducted in August 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Risk factors associated with OSA include male sex, older age (40 to 70 years), postmenopausal status, higher BMI, and craniofacial and upper airway abnormalities.'}, {'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of counseling adults about skin self-examination to prevent skin cancer.See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Skin Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Exposure to UV radiation from sun exposure, indoor tanning beds, and other UV radiation&ndash;emitting devices is the major environmental risk factor for skin cancer. History of frequent sunburns, older age, and male sex are associated with increased risk for skin cancer. Exposure to UV radiation from the use of indoor tanning beds is an important risk factor in adolescents. Incidence of melanoma is higher among White persons compared with persons of other races and ethnicities. This difference likely reflects traits associated with increased melanoma risk, such as fair skin (which is more susceptible to sunburning), light-colored eyes, and red or blond hair being more common among White persons compared with persons of other races and ethnicities. Acral lentiginous melanoma, which occurs mostly on skin not frequently exposed to direct sunlight (eg, palms of hands, soles of feet, or under fingernails or toenails), is the most common type of melanoma among Black populations. Other melanoma risk factors include higher numbers of moles on the skin, atypical moles, as well as a personal and family history of skin cancer.'}, {'title': 'Thyroid Dysfunction: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults.\r\rSee the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': 'The optimal screening interval for thyroid dysfunction (if one exists) is unknown.', 'risktext': 'The most common cause of hypothyroidism in the United States is chronic autoimmune (Hashimoto) thyroiditis. Risk factors for an elevated TSH level include female sex, advancing age, white race, type 1 diabetes, Down syndrome, family history of thyroid disease, goiter, previous hyperthyroidism (possibly due in part to ablation therapy leading to iatrogenic thyroid dysfunction), and external-beam radiation in the head and neck area. Common causes of hyperthyroidism include Graves disease, Hashimoto thyroiditis, and functional thyroid nodules. Risk factors for a low TSH level include female sex; advancing age; black race; low iodine intake; personal or family history of thyroid disease; and ingestion of iodine-containing drugs, such as amiodarone. The USPSTF found no direct evidence that treatment of thyroid dysfunction based on risk level alters final health outcomes.'}, {'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of electronic cigarettes (e-cigarettes) for tobacco cessation in adults, including pregnant persons. The USPSTF recommends that clinicians direct patients who use tobacco to other tobacco cessation interventions with proven effectiveness and established safety.\rSee the Practice Considerations section for more information on recommended behavioral interventions and pharmacotherapy and for suggestions for practice regarding the I statements.', 'servfreq': '', 'risktext': ''}, {'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of pharmacotherapy interventions for tobacco cessation in pregnant persons.', 'servfreq': '', 'risktext': ''}, {'title': 'Tobacco Use in Children and Adolescents: Primary Care Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--feasible interventions for the cessation of tobacco use among school-aged children and adolescents.\r\rSee the Practice Considerations section for more information on effective interventions to prevent initiation of tobacco use and for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Vitamin D Deficiency in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of the benefits and harms of vitamin D and calcium supplementation, alone or combined, for the primary prevention of fractures in men and premenopausal women.', 'servfreq': '', 'risktext': ''}]
2025-01-29 21:20:17 [INFO] Update id=273478059 is handled. Duration 693 ms by bot id=8108339380
2025-01-29 21:20:24 [INFO] Update id=273478060 is not handled. Duration 1 ms by bot id=8108339380
2025-01-29 21:20:24 [ERROR] Cause exception while process update id=273478060 by bot id=8108339380
KeyError: 0
Traceback (most recent call last):
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/dispatcher.py", line 309, in _process_update
    response = await self.feed_update(bot, update, **kwargs)
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/dispatcher.py", line 158, in feed_update
    response = await self.update.wrap_outer_middleware(
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/middlewares/error.py", line 25, in __call__
    return await handler(event, data)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/middlewares/user_context.py", line 56, in __call__
    return await handler(event, data)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/fsm/middleware.py", line 42, in __call__
    return await handler(event, data)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/event/telegram.py", line 121, in trigger
    return await wrapped_inner(event, kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/app/bot/middleware.py", line 14, in __call__
    return await handler(event, data)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/event/handler.py", line 43, in call
    return await wrapped()
           ^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/dispatcher.py", line 276, in _listen_update
    return await self.propagate_event(update_type=update_type, event=event, **kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 146, in propagate_event
    return await observer.wrap_outer_middleware(_wrapped, event=event, data=kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 141, in _wrapped
    return await self._propagate_event(
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 174, in _propagate_event
    response = await router.propagate_event(update_type=update_type, event=event, **kwargs)
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 146, in propagate_event
    return await observer.wrap_outer_middleware(_wrapped, event=event, data=kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 141, in _wrapped
    return await self._propagate_event(
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/router.py", line 166, in _propagate_event
    response = await observer.trigger(event, **kwargs)
               ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/event/telegram.py", line 121, in trigger
    return await wrapped_inner(event, kwargs)
           ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "/usr/local/lib/python3.12/site-packages/aiogram/dispatcher/event/handler.py", line 43, in call
    return await wrapped()
           ^^^^^^^^^^^^^^^
  File "/app/bot/handlers.py", line 159, in pagination_query
    f"{recommendations[page][0]}"
       ~~~~~~~~~~~~~~~~~~~~~^^^
KeyError: 0
2025-01-29 21:22:21 [WARNING] Received SIGTERM signal
2025-01-29 21:22:21 [INFO] Polling stopped for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-29 21:22:21 [INFO] Polling stopped
2025-01-29 21:22:21 [INFO] โ ะัะป ะฟะพะดะบะปััะตะฝะธะน ะบ ะะ ะทะฐะบััั.
2025-01-29 21:22:21 [INFO] โ ะะพะดะบะปััะตะฝะธะต ะบ ะะ ะทะฐะบัััะพ.
2025-01-29 21:22:28 [INFO] ๐ ะะพั ะทะฐะฟััะบะฐะตััั...
2025-01-29 21:22:29 [INFO] โ ะัะป ะฟะพะดะบะปััะตะฝะธะน ะบ ะะ ัะพะทะดะฐะฝ.
2025-01-29 21:22:29 [INFO] โ ะขะฐะฑะปะธัั ะฒ ะฑะฐะทะต ะดะฐะฝะฝัั ััะฟะตัะฝะพ ัะพะทะดะฐะฝั.
2025-01-29 21:22:29 [INFO] Start polling
2025-01-29 21:22:30 [INFO] Run polling for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-29 21:22:30 [INFO] The user 711983855 called the command /start.
2025-01-29 21:22:31 [INFO] Update id=273478061 is handled. Duration 1246 ms by bot id=8108339380
2025-01-29 21:22:33 [INFO] The user 711983855's state has been set to Survey.age.
2025-01-29 21:22:33 [INFO] Update id=273478062 is handled. Duration 824 ms by bot id=8108339380
2025-01-29 21:22:36 [INFO] The user 711983855's state has been set to Survey.weight.
2025-01-29 21:22:37 [INFO] Update id=273478063 is handled. Duration 812 ms by bot id=8108339380
2025-01-29 21:22:39 [INFO] The user 711983855's state has been set to Survey.height.
2025-01-29 21:22:40 [INFO] Update id=273478064 is handled. Duration 1241 ms by bot id=8108339380
2025-01-29 21:22:42 [INFO] The user 711983855's state has been set to Survey.feet.
2025-01-29 21:22:42 [INFO] Update id=273478065 is handled. Duration 400 ms by bot id=8108339380
2025-01-29 21:22:45 [INFO] The user 711983855's state has been set to Survey.gender.
2025-01-29 21:22:45 [INFO] Update id=273478066 is handled. Duration 331 ms by bot id=8108339380
2025-01-29 21:22:48 [INFO] The user 711983855's state has been set to Survey.pregnant.
2025-01-29 21:22:48 [INFO] Update id=273478067 is handled. Duration 323 ms by bot id=8108339380
2025-01-29 21:22:49 [INFO] The user 711983855's state has been set to Survey.smoking.
2025-01-29 21:22:49 [INFO] Update id=273478068 is handled. Duration 323 ms by bot id=8108339380
2025-01-29 21:22:50 [INFO] The user 711983855's state has been set to Survey.sex.
2025-01-29 21:22:50 [INFO] Update id=273478069 is handled. Duration 375 ms by bot id=8108339380
2025-01-29 21:22:51 [INFO] State data: {'db': <bot.database.Database object at 0x7f853d097260>, 'age': 20, 'weight': 190, 'height': 190, 'feet': 23, 'gender': 'female', 'pregnant': 'yes', 'smoking': 'yes', 'sex': 'yes'}
2025-01-29 21:22:51 [INFO] Recommendations: [{'title': 'Folic Acid Supplementation to Prevent Neural Tube Defects: Preventive Medication ', 'grade': 'A', 'text': 'The DoctorAI recommends that all persons planning to or who could become pregnant take a daily supplement containing 0.4 to 0.8 mg (400 to 800 mcg) of folic acid.', 'servfreq': 'The neural plate completes its formation and closure early in pregnancy (usually 26 to 28 days after fertilization). This means the critical period for folic acid supplementation starts at least 1 month before conception and continues through the first 2 to 3 months of pregnancy. Nearly half of all pregnancies in the US are unplanned; to gain the full benefits of supplementation, clinicians should advise all persons who plan to or who could become pregnant to take daily folic acid.', 'risktext': 'All pregnancies are at risk for neural tube defects, and persons who are planning to or could become pregnant should take folic acid supplements. Certain risk factors convey a higher risk, and individuals with these risk factors should talk to their health care professional. These factors include personal, partner, or family history of neural tube defects, malabsorption caused by bariatric procedures, the use of certain antiseizure medicines, and genetic mutations in folate-related enzymes. Pregestational diabetes and obesity have been associated with an increased risk of neural tube defects. Ethnic groups such as First Nation persons in Canada and Hispanic persons in California are thought to be at higher risk of neural tube defects. It is unclear, however, whether this is related to a higher risk of genetic variations among these groups or due to differential intake of folic acid&ndash;fortified foods.'}, {'title': 'Hepatitis B Virus Infection in Pregnant Women: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in pregnant women at their first prenatal visit', 'servfreq': 'A test for HBsAg should be ordered at the first prenatal visit. Women with unknown HBsAg status or with new or continuing risk factors for HBV infection (eg, injection drug use or a sexually transmitted infection) should be screened at the time of admission to a hospital or other delivery setting.', 'risktext': 'In the United States, new cases of HBV among adults are largely transmitted through injection drug use or sexual intercourse, but most prevalent cases of HBV infection are chronic infections from exposure occurring in infancy or childhood. Another major risk factor for HBV infection is country of origin. In the United States, adults with HBV born in high-prevalence countries were commonly infected during childhood. In children, the primary source of infection is perinatal transmission at birth.'}, {'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in adolescents and adults aged 15 to 65 years. Younger adolescents and older adults who are at increased risk of infection should also be screened.\rSee the Clinical Considerations section for more information about assessment of risk, screening intervals, and rescreening in pregnancy.', 'servfreq': 'The USPSTF found insufficient evidence to determine appropriate or optimal time intervals or strategies for repeat HIV screening. However, repeat screening is reasonable for persons known to be at increased risk of HIV infection, such as sexually active men who have sex with men; persons with a sex partner who is living with HIV; or persons who engage in behaviors that may convey an increased risk of HIV infection, such as injection drug use, transactional sex or commercial sex work, having 1 or more new sex partners whose HIV status is unknown, or having other factors that can place a person at increased risk of HIV infection (see &ldquo;Risk Assessment&rdquo;). Repeat screening is also reasonable for persons who live or receive medical care in a high-prevalence setting, such as a sexually transmitted disease clinic, tuberculosis clinic, correctional facility, or homeless shelter.', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in all pregnant persons, including those who present in labor or at delivery whose HIV status is unknown.', 'servfreq': 'The CDC and ACOG recommend repeat prenatal screening for HIV during the third trimester of pregnancy in women with risk factors for HIV acquisition and in women living or receiving care in high-incidence settings, and the CDC notes that repeat screening for HIV during the third trimester may be considered in all women.&nbsp;', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'title': 'Hypertension in Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hypertension in adults 18 years or older with office blood pressure measurement (OBPM). The USPSTF recommends obtaining blood pressure measurements outside of the clinical setting for diagnostic confirmation before starting treatment.', 'servfreq': ' \r\nAlthough evidence on optimal screening intervals is limited, reasonable options include:\r\n \r\n \r\n\r\n\r\nScreening for hypertension every year in adults 40 years or older and in adults at increased risk for hypertension (such as Black persons, persons with high-normal blood pressure, or persons who are overweight or obese)\r\n\r\n\r\n \r\n \r\n\r\n\r\nScreening less frequently (ie, every 3 to 5 years) as appropriate for adults aged 18 to 39 years not at increased risk for hypertension and with a prior normal blood pressure reading.\r\n\r\n\r\n ', 'risktext': ' \r\nAlthough all adults should be screened for hypertension, risk factors that increase a person&rsquo;s risk for the condition include older age, Black race, family history, excess weight and obesity, lifestyle habits (lack of physical activity, stress, and tobacco use), and dietary factors (diet high in fat or sodium, diet low in potassium, or excessive alcohol intake)\r\n '}, {'title': 'Prevention of Acquisition of HIV: Preexposure Prophylaxis ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians prescribe preexposure prophylaxis using effective antiretroviral therapy to persons who are at increased risk of HIV acquisition to decrease the risk of acquiring HIV. \r\rSee the Practice Considerations section for more information about identification of persons at increased risk and about effective antiretroviral therapy.', 'servfreq': '', 'risktext': 'HIV is primarily acquired via sexual activity or injection drug use. It is important that clinicians routinely take a sexual and injection drug use history for all their patients in an open and nonjudgmental manner. All adolescents and adults who are sexually active or who inject drugs should be informed that acquisition of HIV can be prevented, to facilitate subsequent risk assessment and discussions about preexposure prophylaxis (PrEP) and other ways to prevent acquisition of HIV. Importantly, risk of HIV acquisition exists on a continuum, and currently available risk assessment tools all have limitations. However, certain risk factors or behaviors are known to place persons at increased risk of HIV.\r\nRisk of HIV acquisition depends on the likelihood that a specific act or activity will transmit HIV and the likelihood that a sex partner or drug injection partner has HIV. Likelihood of HIV transmission is highest with needle-sharing injection drug use and condomless receptive anal intercourse. Condomless receptive anal intercourse has an approximately 10- to 15-fold higher risk of transmission than condomless insertive anal sex and condomless receptive and insertive penile-vaginal sex. A 2018 study estimated the prevalence of HIV (ie, an estimate of the likelihood that a partner whose HIV status is unknown has HIV at a population level) as 12.4% among men who have sex with men and 1.9% among persons who inject drugs. The overall prevalence of HIV in the US is estimated at 0.3%.&nbsp;Of note, both the frequency of specific sexual activities and a person&rsquo;s number of sexual partners will also affect their risk of HIV.\r\n&nbsp;The USPSTF recommends that the following persons be considered for PrEP:\r\n1.&nbsp;&nbsp;&nbsp;&nbsp; Sexually active adults and adolescents weighing at least 35 kg (77 lb) who have engaged in anal or vaginal sex in the past 6 months and have any of the following:\r\n&nbsp;\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A sexual partner who has HIV (especially if the partner has an unknown or detectable viral load).\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A bacterial sexually transmitted infection (STI) (syphilis, gonorrhea, or chlamydia for men who have sex with men and transgender women; gonorrhea and syphilis for heterosexual women and men) in the past 6 months.\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A history of inconsistent or no condom use with sex partner(s) whose HIV status is not known; assessing risk in conversation with the patient and considering factors such as number of partners, the specific sexual activities a person engages in, and whether their sex partner or partners are in a group with a higher prevalence of HIV (eg, men who have sex with men or with men and women, transgender women, persons who inject drugs, and persons who engage in transactional sex).\r\n&nbsp;\r\n2. &nbsp; Persons who inject drugs and have a drug-injecting partner who has HIV or who shares injection equipment.\r\nPersons who engage in transactional sex, such as sex for money, drugs, or housing, including commercial sex workers or persons trafficked for sex work, constitute a group at increased risk of HIV acquisition and should be considered for PrEP based on the criteria outlined above. Persons who request PrEP may have undisclosed behaviors that put them at risk. Transgender women and men who are sexually active should be considered for PrEP based on the criteria outlined above. Transgender women are at especially high risk of HIV acquisition. A Centers for Disease Control and and Prevention (CDC) survey in 7 cities found an HIV prevalence of 42% among transgender women. Prevalence was highest among Black transgender women (62%) and Native American/Alaska Native transgender women (65%).\r\nIn addition, studies have found that transmission of HIV to a seronegative partner from a partner with HIV has not been observed when the partner with HIV was being treated with antiretroviral therapy and had a suppressed viral load.&nbsp;It is not known whether PrEP use further decreases the risk of HIV transmission when a partner with HIV has a documented undetectable viral load. Factors such as the consistency or inconsistency of a partner&rsquo;s viral load being suppressed, a partner&rsquo;s adherence to antiretroviral therapy, and the degree of certainty that a partner&rsquo;s viral load is suppressed (eg, self-report vs availability of laboratory test results) may help inform decisions about the use of PrEP in this situation.\r\nAll persons being considered for PrEP must have a recently documented negative HIV antigen-antibody test result, and if they have taken oral PrEP or postexposure prophylaxis in the past 3 months, or injectable cabotegravir in the past 12 months, the CDC recommends testing with both an HIV antigen-antibody assay and an HIV-1 RNA assay.'}, {'title': 'Rh(D) Incompatibility: Screening ', 'grade': 'A', 'text': 'The DoctorAI strongly recommends Rh(D) blood typing and antibody testing for all pregnant women during their first visit for pregnancy-related care.', 'servfreq': 'First prenatal visit.', 'risktext': ''}, {'title': 'Syphilis Infection in Nonpregnant Adolescents and Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for syphilis infection in persons who are at increased risk for infection.', 'servfreq': 'Optimal screening frequency for persons who are at increased risk for syphilis infection is not well established. Men who have sex with men or persons with HIV infection may benefit from screening at least annually or more frequently (eg, every 3 to 6 months) if they continue to be at high risk.', 'risktext': 'The USPSTF recommends screening for syphilis in persons who are at increased risk for infection. When deciding which persons to screen for syphilis, clinicians should consider the prevalence of infection in the communities they serve, as well as other sociodemographic and behavioral factors that may be associated with increased risk of syphilis infection. For example, prevalence of syphilis is higher in men, men who have sex with men, persons with HIV infection, young adults, and persons with a history of incarceration, sex work, or military service. A substantial percentage of heterosexual syphilis transmission occurs among persons who use illicit drugs, particularly methamphetamine. Diagnosis of another STI may signal that a person is having condomless sex, which increases their risk of syphilis infection. Higher infection rates in persons of some racial and ethnic groups have been reported and are primarily a reflection of a combination of factors, including social determinants of health (eg, disparities of income, low educational achievement, and unstable housing), differential health insurance coverage or access to quality health care, and differences in sexual network characteristics (eg, individuals living in communities with a high prevalence of STIs have an increased chance of encountering an infected partner). Local prevalence rates may change over time, so clinicians should be aware of the latest data and trends for their specific population and geographic area, which are available through their state and local health departments and Centers for Disease Control and Prevention (CDC) surveillance.\r\n&nbsp;\r\nAlthough direct evidence on screening in nonpregnant persons who are not at increased risk for syphilis infection is lacking, based on the established test performance characteristics of current screening tests and the low prevalence rate of syphilis in this population, the yield of screening is likely low.9,10 Therefore, screening in this population may result in high false-positive rates and overtreatment.'}, {'title': 'Syphilis Infection in Pregnant Women: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends early screening for syphilis infection in all pregnant women.', 'servfreq': 'All pregnant women should be tested for syphilis as early as possible when they first present to care. If a woman has not received prenatal care prior to delivery, she should be tested at the time she presents for delivery. In most cases of congenital syphilis, pregnant women received prenatal care but were not screened and treated for syphilis early enough during the pregnancy to prevent transmission to the fetus.', 'risktext': ''}, {'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and US Food and Drug Administration (FDA)--approved pharmacotherapy for cessation to nonpregnant adults who use tobacco.', 'servfreq': '', 'risktext': ''}, {'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all pregnant persons about tobacco use, advise them to stop using tobacco, and provide behavioral interventions for cessation to pregnant persons who use tobacco.', 'servfreq': '', 'risktext': ''}, {'title': 'Anxiety Disorders in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for anxiety disorders in adults, including pregnant and postpartum persons.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding optimal timing for screening, or screening interval, for both the perinatal and general adult populations; more evidence on both timing and screening interval is needed for all adult populations. A pragmatic approach in the absence of evidence might include screening all adults who have not been screened previously and using clinical judgment in considering risk factors, comorbid conditions, and life events to determine if additional screening of high-risk patients is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nRisk factors for anxiety disorders include sociodemographic factors, psychosocial factors, and physical and mental health factors such as marital status (widowed or divorced), stressful life events, smoking and alcohol use, other mental health conditions, or a parental history of mental disorders. Demographic factors such as low socioeconomic status and female sex are associated with higher rates of anxiety disorders.&nbsp;Black persons and individuals of non-Hispanic ethnicity are at increased risk of anxiety disorders due to social, rather than biological, factors. Anxiety and depressive disorders often overlap. One cohort study found that 67% of individuals with a depressive disorder also had a current anxiety disorder, and 75% had a lifetime comorbid anxiety disorder.'}, {'title': 'Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication ', 'grade': 'B', 'text': 'The DoctorAI recommends the use of low-dose aspirin (81 mg/day) as preventive medication after 12 weeks of gestation in persons who are at high risk for preeclampsia.\r\rSee the Practice Considerations section for information on high risk and aspirin dose.', 'servfreq': 'Once daily after 12 weeks of gestation', 'risktext': ' \r\nPersons with a history of preeclampsia in a previous pregnancy, type 1 or type 2 diabetes, and chronic hypertension are at highest risk for preeclampsia. Additional conditions that place a person at high risk for preeclampsia include multifetal gestation, conception using assisted reproductive technology, autoimmune disease, and kidney disease. Other factors associated with increased preeclampsia risk include nulliparity, high prepregnancy body mass index, family history of preeclampsia, and advanced maternal age (35 years or older). In addition, Black persons have higher rates of preeclampsia and are at increased risk for serious complications due to various societal and health inequities.\r\n '}, {'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for asymptomatic bacteriuria using urine culture in pregnant persons.', 'servfreq': 'In general, screening is performed once at the first prenatal visit per clinical guidelines. However, there is little evidence on the optimal timing and frequency of screening for asymptomatic bacteriuria in pregnancy.2&nbsp; .&nbsp;Screen pregnant persons for asymptomatic bacteriuria using a midstream, clean-catch urine culture at the first prenatal visit or at 12 to 16 weeks of gestation, whichever is earlier. A urine culture showing &gt;100,000 CFU/mL of a single uropathogen or &gt;10,000 CFU/mL if the pathogen is group B streptococcus indicates treatment.', 'risktext': 'This recommendation applies to adults 18 years and older and pregnant persons of any age without signs and symptoms of a urinary tract infection. It does not apply to persons who have chronic medical or urinary tract conditions, such as end-stage renal disease; have indwelling urinary catheters, urinary stents, or spinal cord injuries; are hospitalized; reside in an institution (eg, a nursing home); or who are transplant recipients.\r\n&nbsp;\r\nThe risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6&nbsp;Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5&nbsp;Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7,&nbsp;11,&nbsp;12&nbsp;In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12&nbsp;Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4,&nbsp;6'}, {'title': 'Latent Tuberculosis Infection in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for LTBI in populations at increased risk.\r\rSee the "Assessment of Risk" section for additional information on adults at increased risk.', 'servfreq': 'The USPSTF found no evidence on the optimal frequency of screening for LTBI. In the absence of evidence, a reasonable approach is to repeat screening based on specific risk factors; screening frequency could range from 1-time only screening among persons at low risk for future tuberculosis exposure to annual screening among those at continued risk of exposure.', 'risktext': 'Populations at increased risk for LTBI, based on increased prevalence of active disease and increased risk of exposure, include persons who were born in, or are former residents of, countries with high tuberculosis prevalence and persons who live in, or have lived in, high-risk congregate settings (eg, homeless shelters or correctional facilities). Clinicians can consult their local or state health departments for more information about populations at increased risk in their community, since local demographic patterns may vary across the US.\r\nIn 2020, 71.5% of all cases of active tuberculosis in the US occurred among persons born outside the US. According to the CDC, tuberculosis disease is common in most countries in Latin America, the Caribbean, Africa, Asia, Eastern Europe, and Russia. In 2020, among persons with new tuberculosis living in the US who were born outside the US, the most common countries of birth were Mexico (18.0%), the Philippines (12.5%), India (10.4%), Vietnam (8.2%), and China (5.1%), accounting for 54.2% of total cases. Most of these cases are believed to be due to progression of latent infection to active tuberculosis disease rather than new transmission within communities.\r\nPersons who live, or have lived, in high-risk congregate settings also have a higher prevalence rate of active tuberculosis and an increased risk for exposure. In 2020, 4.3% of tuberculosis disease cases diagnosed in persons 15 years or older occurred in persons experiencing homelessness and 2.6% occurred in residents of correctional facilities. It is estimated that persons experiencing homelessness have an 11 times higher incidence of tuberculosis disease compared with persons who are not experiencing homelessness (36 cases per 100,000 population vs 2.9 cases per 100,000 population, respectively, during 2011 to 2016).\r\nOther populations at increased risk for LTBI or progression to active disease include persons who have immunosuppression (eg, persons living with HIV, patients receiving immunosuppressive medications such as chemotherapy or tumor necrosis factor inhibitors, and patients who have received an organ transplant) and patients with silicosis (a lung disease). However, given that screening in these populations may be considered standard care as part of disease management or indicated prior to the use of certain medications, the USPSTF did not review evidence on screening in these populations. Information on testing in these populations is provided by other groups, such as the Office of AIDS Research at the National Institutes of Health, and in a guideline issued jointly by the American Thoracic Society, Infectious Diseases Society of America, and CDC. Some evidence from observational studies has explored the association between poorly controlled diabetes and progression of LTBI to active disease. However, there is insufficient evidence on screening for and treatment of LTBI in persons with diabetes for the USPSTF to make a separate recommendation for this important population.\r\nPersons who are contacts of individuals with active tuberculosis, health care workers, and workers in high-risk congregate settings may also be at increased risk of exposure. Because screening in these populations is conducted as part of public health or employee health surveillance, the USPSTF did not review the evidence in these populations. Clinicians seeking further information about testing for tuberculosis in these populations can refer to the Additional Tools and Resources and Recommendations of Others sections.'}, {'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic bacteriuria in nonpregnant adults.', 'servfreq': '', 'risktext': 'The risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6 Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5 Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7, 11, 12 In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12 Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4, 6'}, {'title': 'BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing ', 'grade': 'B', 'text': 'The DoctorAI recommends that primary care clinicians assess women with a personal or family history of breast, ovarian, tubal, or peritoneal cancer or who have an ancestry associated with breast cancer susceptibility 1 and 2 (BRCA1/2) gene mutations with an appropriate brief familial risk assessment tool. Women with a positive result on the risk assessment tool should receive genetic counseling and, if indicated after counseling, genetic testing.', 'servfreq': 'Consideration of screening for potentially harmful BRCA mutations should begin once women have reached the age of consent (18 years). Primary care providers should periodically assess all patients for changes in family history (for example, comprehensive review at least every 5 to 10 years)', 'risktext': 'Patients with family or personal histories of breast, ovarian, tubal, or peritoneal cancer or ancestry associated with harmful&nbsp;&lt; i&gt;BRCA1/2&nbsp;mutations should be assessed using a familial risk assessment tool. The USPSTF found adequate evidence that these tools are accurate in identifying women with increased likelihood of&nbsp;&lt; i&gt;BRCA1/2mutations. Tools evaluated by the USPSTF include the Ontario Family History Assessment Tool, Manchester Scoring System, Referral Screening Tool, Pedigree Assessment Tool, 7-Question Family History Screening Tool, International Breast Cancer Intervention Study instrument (Tyrer-Cuzick), and brief versions of BRCAPRO. These tools should be used to guide referrals to genetic counseling.&nbsp;Persons should consider their sex at birth to determine which recommendation best applies to them.'}, {'title': 'Breastfeeding: Primary Care Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends providing interventions during pregnancy and after birth to support breastfeeding.', 'servfreq': 'During pregnancy and after birth', 'risktext': "This recommendation applies to pregnant women, new mothers, and their infants and children. Interventions to support breastfeeding may also involve a woman's partner, other family members, and friends. This recommendation does not apply in circumstances where there are contraindications to breastfeeding (e.g., certain maternal medical conditions or infant metabolic disorders, such as galactosemia). The USPSTF did not review evidence on interventions directed at breastfeeding of preterm infants."}, {'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for chlamydia in all sexually active women 24 years or younger and in women 25 years or older who are at increased risk for infection.', 'servfreq': ' \r\nIn the absence of studies on screening intervals, a reasonable approach would be to screen patients whose sexual history reveals new or persistent risk factors since the last negative test result.\r\n ', 'risktext': ' \r\nAge is a strong predictor of risk for chlamydial and gonococcal infections, with the highest infection rates in women occurring during ages 15 to 24 years. Women 25 years or older are at increased risk if they have a new sex partner, more than 1 sex partner, a sex partner with concurrent partners, or a sex partner who has an STI; practice inconsistent condom use when not in a mutually monogamous relationship; or have a previous or coexisting STI. Exchanging sex for money or drugs and history of incarceration also are associated with increased risk.&nbsp;Clinicians should consider the communities they serve and may want to consult local public health authorities for information about local epidemiology and guidance on determining who is at increased risk.\r\n '}, {'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for gonorrhea in all sexually active women 24 years or younger and in women 25 years or older who are at increased risk for infection.', 'servfreq': ' \r\nIn the absence of studies on screening intervals, a reasonable approach would be to screen patients whose sexual history reveals new or persistent risk factors since the last negative test result.\r\n ', 'risktext': ' \r\nAge is a strong predictor of risk for chlamydial and gonococcal infections, with the highest infection rates in women occurring during ages 15 to 24 years. Women 25 years or older are at increased risk if they have a new sex partner, more than 1 sex partner, a sex partner with concurrent partners, or a sex partner who has an STI; practice inconsistent condom use when not in a mutually monogamous relationship; or have a previous or coexisting STI. Exchanging sex for money or drugs and history of incarceration also are associated with increased risk.&nbsp;Clinicians should consider the communities they serve and may want to consult local public health authorities for information about local epidemiology and guidance on determining who is at increased risk.\r\n '}, {'title': 'Asymptomatic Carotid Artery Stenosis: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic carotid artery stenosis in the general adult population.\r\rSee the Practice Considerations section for a description of adults at increased risk.', 'servfreq': '', 'risktext': ''}, {'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for suicide risk in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': '', 'risktext': ''}, {'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for depression in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding the optimal timing for screening for depression; more evidence is needed in both perinatal and general adult populations. In the absence of evidence, a pragmatic approach might include screening adults who have not been screened previously and using clinical judgment while considering risk factors, comorbid conditions, and life events to determine if additional screening of patients at increased risk is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nThe USPSTF recommends screening for depression in all adults regardless of risk factors. Risk factors for depression include a combination of genetic, biological, and environmental factors, such as a family history of depression, prior episode of depression or other mental health condition, a history of trauma or adverse life events, or a history of disease or illness (eg, cardiovascular disease).\r\nPrevalence rates vary by sex, age, race, ethnicity, education, marital status, geographic location, poverty level, and employment status. Women have twice the risk of depression compared with men. Young adults, multiracial individuals, and Native American/Alaska Native individuals have higher rates of depression.\r\nRisk factors for perinatal depression include life stress, low social support, history of depression, marital or partner dissatisfaction, and a history of abuse.'}, {'title': 'Gestational Diabetes: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for gestational diabetes in asymptomatic pregnant persons at 24 weeks of gestation or after.', 'servfreq': 'At 24 weeks of gestation or after to improve maternal and fetal outcomes', 'risktext': ' \r\nSeveral factors increase a person&rsquo;s risk for developing gestational diabetes, including obesity, increased maternal age, history of gestational diabetes, family history of diabetes, and belonging to a racial/ethnic group that is at increased risk for developing type 2 diabetes (Hispanic, Native American, South or East Asian, or Pacific Islander descent).4,19,20 Factors associated with a lower risk for developing gestational diabetes include age younger than 25 to 30 years, White race, a body mass index (BMI) of 25 or less (calculated as weight in kilograms divided by height in meters squared), no family history (in a first-degree relative) of diabetes, and no history of glucose intolerance or adverse pregnancy outcomes related to gestational diabetes.21-23 The risk in different racial/ethnic groups may be due in part to social risk factors such as low socioeconomic status or structural racism, although these associations are not examined in the current evidence. Although a higher BMI increases the risk of gestational diabetes across racial/ethnic groups, the association varies. In Asian American persons, the prevalence of gestational diabetes at a BMI of 22 to less than 25 is similar to the prevalence in Hispanic persons, non-Hispanic White persons, and Black persons with a higher (&gt;28) BMI.24,25\r\n '}, {'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends offering or referring adults with cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity.', 'servfreq': '', 'risktext': 'Adults 18 years or older at increased risk of CVD, defined as those with 1 or more of the following:\r\n1.Hypertension or elevated blood pressure2.Dyslipidemia3.Mixed or multiple risk factors such as the metabolic syndrome or an estimated 10-year CVD risk of &ge;7.5%\r\nThis recommendation does not apply to adults with other known modifiable cardiovascular risk factors such as abnormal blood glucose levels, obesity, and smoking; these populations are incorporated in other USPSTF recommendations.'}, {'title': 'Healthy Weight and Weight Gain In Pregnancy: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer pregnant persons effective behavioral counseling interventions aimed at promoting healthy weight gain and preventing excess gestational weight gain in pregnancy.', 'servfreq': 'Throughout pregnancy', 'risktext': 'Pregnancy'}, {'title': 'Hepatitis B Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in adolescents and adults at increased risk for infection.\r\rSee the Practice Considerations section for a description of adolescents and adults at increased risk for infection.', 'servfreq': 'For patients with negative HBsAg results who have not received the HBV vaccine series, periodic screening may be useful for those who report continued risk for acquiring HBV transmission, such as persons who continue to inject drugs and men who have sex with men. Clinical judgment should be used to determine screening frequency. The USPSTF found no evidence to determine optimal screening intervals.', 'risktext': 'Persons from such risk groups include persons who have injected drugs in the past or currently; men who have sex with men; persons with HIV; and sex partners, needle-sharing contacts, and household contacts of persons known to be HBsAg positive. Some persons with combinations of risk factors who are not members of risk factor groups listed above may also be at increased risk for HBV infection.'}, {'title': 'Hepatitis C Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis C virus (HCV) infection in adults aged 18 to 79 years.', 'servfreq': 'One-time screening for most adults.\r\nPeriodically screen persons with continued risk for HCV infection (eg, persons with past or current injection drug use). There is limited evidence to determine how often to screen persons at increased risk.&nbsp;', 'risktext': 'Asymptomatic adults aged 18 to 79 years (including pregnant persons) without known liver disease.&nbsp;\r\nThe USPSTF also suggests that clinicians consider screening persons younger than 18 years and older than 79 years who are at high risk for infection (eg, those with past or current injection drug use).&nbsp;'}, {'title': 'Hypertensive Disorders of Pregnancy: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hypertensive disorders in pregnant persons with blood pressure measurements throughout pregnancy.', 'servfreq': 'Screening Interval\r\nBlood pressure measurements should be obtained during each prenatal care visit throughout pregnancy. Hypertensive disorders of pregnancy can quickly evolve into severe disease that can result in serious, even fatal, maternal and infant health outcomes. The ability to screen for hypertensive disorders of pregnancy using blood pressure measurements is important to identify and effectively treat a potentially unpredictable and fatal condition. While it is known that risk continues into the immediate postpartum period, there is little evidence regarding screening during this period. A pragmatic approach would be for patients to be counseled regarding signs and symptoms of preeclampsia at hospital discharge and for patients with hypertensive disorders to have subsequent blood pressure checks.\r\nScreening for hypertensive disorders of pregnancy alone is not sufficient to improve inequities in health outcomes. Identifying hypertensive disorders of pregnancy requires adequate prenatal visits, surveillance, and evidence-based care in response to evolving patient signs and symptoms during pregnancy and the postpartum period to improve health outcomes. Black and Native American/Alaska Native persons have lower rates of prenatal visits and are at greater risk of serious postpartum morbidity and hospital readmission after delivery. Screening and monitoring of Black and Hispanic/Latina individuals during the postpartum period could be an important step for reducing health inequities by preventing serious adverse events. In addition, screening and monitoring by various health care providers (eg, nurse midwives, nurses, pediatricians, doulas, and lactation consultants) could also help avert serious complications in the postpartum period.', 'risktext': 'Assessment of Risk\r\nImportant clinical conditions associated with increased risk for preeclampsia include a history of eclampsia or preeclampsia in a prior pregnancy, a previous adverse pregnancy outcome, and maternal comorbid conditions (including type 1 or type 2 diabetes prior to pregnancy, gestational diabetes, chronic hypertension, kidney disease, and autoimmune diseases).\r\n&nbsp;Other factors associated with increased risk of preeclampsia and gestational hypertension include nulliparity, high prepregnancy body mass index, family history of preeclampsia, multifetal gestation, and the pregnant individual being 35 years or older.\r\nThe higher prevalence of hypertensive disorders of pregnancy and the increased risk for severe complications seen in Black persons may be due to their disproportionate burden of social and clinical risk factors. These social and clinical determinants largely result from historical and current manifestations of structural racism that influence environmental exposures, access to health resources, and overall health status.'}, {'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians screen for intimate partner violence (IPV) in women of reproductive age and provide or refer women who screen positive to ongoing support services. See the Clinical Considerations section for more information on effective ongoing support services for IPV and for information on IPV in men.', 'servfreq': 'The USPSTF found no evidence on appropriate intervals for screening. Randomized clinical trials (RCTs) of screening and interventions for IPV often screen for current IPV or IPV in the past year.\r\n&nbsp;', 'risktext': 'All women of reproductive age are at potential risk for IPV and should be screened. There are a variety of factors that increase risk of IPV, such as exposure to violence as a child, young age, unemployment, substance abuse, marital difficulties, and economic hardships.\r\nRisk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health. For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.'}, {'title': 'Rh(D) Incompatibility: Screening ', 'grade': 'B', 'text': "The DoctorAI recommends repeated Rh(D) antibody testing for all unsensitized Rh(D)-negative women at 24 to 28 weeks' gestation, unless the biological father is known to be Rh(D)-negative.", 'servfreq': 'Repeat testing at 24-28 weeks gestation.', 'risktext': ''}, {'title': 'Lung Cancer: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery.', 'servfreq': ' \r\nThe USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. ', 'risktext': ' \r\nSmoking and older age are the 2 most important risk factors for lung cancer.&nbsp;The risk of lung cancer in persons who smoke increases with cumulative quantity and duration of smoking and with age but decreases with increasing time since quitting for persons who formerly smoked.3 The USPSTF considers adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years to be at high risk and recommends screening for lung cancer with annual LDCT in this population. \r\n \r\n&nbsp;\r\n \r\nAfrican American/Black (Black) men have a higher incidence of lung cancer than White men, and Black women have a lower incidence than White women.1 These differences are likely related to differences in smoking exposure (ie, prevalence of smoking) and related exposure to carcinogens in cigarettes.7,8 The differences may also be related to other social risk factors.\r\n \r\n&nbsp;\r\n \r\nOther risk factors for lung cancer include environmental exposures, prior radiation therapy, other (noncancer) lung diseases, and family history. Lower level of education is also associated with a higher risk of lung cancer.7 The task force recommends using age and smoking history to determine screening eligibility rather than more elaborate risk prediction models because there is insufficient evidence to assess whether risk prediction model&ndash;based screening would improve outcomes relative to using the risk factors of age and smoking history for broad implementation in primary care.\r\n '}, {'title': 'Perinatal Depression: Preventive Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians provide or refer pregnant and postpartum persons who are at increased risk of perinatal depression to counseling interventions.', 'servfreq': '', 'risktext': 'Include&nbsp;a past history of depression. Current depressive symptoms (that do not reach a diagnostic threshold),&nbsp;history of physical or sexual abuse,&nbsp;unplanned or unwanted pregnancy,&nbsp;stressful life events,&nbsp;lack of social and financial support,&nbsp;intimate partner violence,pregestational or gestational diabetes,and complications during pregnancy. Additional risk factors include adolescent parenthood, low socioeconomic status, and lack of social support.&nbsp;Genetic factors are also suspected to contribute to women&rsquo;s risk of developing perinatal depression.'}, {'title': 'Sexually Transmitted Infections: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends behavioral counseling for all sexually active adolescents and for adults who are at increased risk for sexually transmitted infections (STIs).\r\rSee the Practice Considerations section for more information on populations at increased risk for acquiring STIs.', 'servfreq': '', 'risktext': 'All sexually active adolescents are at increased risk for STIs because of the high rates of STIs in this age group and should receive behavioral counseling interventions. Adults at increased risk for STIs include those who currently have an STI or were diagnosed with one within the past year, do not consistently use condoms, have multiple sex partners, or have sex partners within populations with a high prevalence of STIs. Populations with a high prevalence of STIs include persons who seek STI testing or attend STI clinics; sexual and gender minorities; persons who are living with HIV, inject drugs, have exchanged sex for money or drugs, or have entered correctional facilities; and some racial/ethnic minority groups.1-4'}, {'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends counseling young adults, adolescents, children, and parents of young children about minimizing exposure to ultraviolet (UV) radiation for persons aged 6 months to 24 years with fair skin types to reduce their risk of skin cancer.', 'servfreq': '', 'risktext': 'Fair skin types'}, {'title': 'Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for unhealthy alcohol use in primary care settings in adults 18 years or older, including pregnant women, and providing persons engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce unhealthy alcohol use.', 'servfreq': 'The USPSTF did not find adequate evidence to recommend an optimal screening interval for unhealthy alcohol use in adults.&nbsp;Brief behavioral counseling interventions were found to reduce unhealthy alcohol use in adults 18 years or older, including pregnant women. Effective behavioral counseling interventions vary in their specific components, administration, length, and number of interactions. The USPSTF was unable to identify specific intervention characteristics or components that were clearly associated with improved outcomes.', 'risktext': 'engaged in risky or hazardous drinking'}, {'title': 'Unhealthy Drug Use: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening by asking questions about unhealthy drug use in adults age 18 years or older. Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. \r(Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'servfreq': 'Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. (Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'risktext': 'These include being aged 18 to 25 years; male sex; having a mental health condition, personality or mood disorder, or nicotine or alcohol dependence; a history of physical or sexual abuse, parental neglect, or other adversity in childhood; or drug or alcohol addiction in a first-degree relative.1,9&nbsp;Factors associated with misuse of prescription drugs include history of other drug use, mental illness, pain, and greater access to prescription drugs.10&nbsp;Factors associated with prenatal use of drugs include a mental health disorder, interpersonal violence, and family history of substance use.11'}, {'title': 'Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer or refer adults with a body mass index (BMI) of 30 or higher (calculated as weight in kilograms divided by height in meters squared) to intensive, multicomponent behavioral interventions.', 'servfreq': '', 'risktext': 'Adults with a BMI &ge;30'}, {'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: Behavioral Counseling Interventions ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians individualize the decision to offer or refer adults without cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity. \r\rSee the "Practice Considerations" section for information on determining which patients may benefit most from this service.', 'servfreq': '', 'risktext': ''}, {'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for chlamydia and gonorrhea in men.', 'servfreq': '', 'risktext': ''}, {'title': 'BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine risk assessment, genetic counseling, or genetic testing for women whose personal or family history or ancestry is not associated with potentially harmful BRCA1/2 gene mutations.', 'servfreq': '', 'risktext': 'Patients with family or personal histories of breast, ovarian, tubal, or peritoneal cancer or ancestry associated with harmful&nbsp;BRCA1/2&nbsp;mutations should be assessed using a familial risk assessment tool. The USPSTF found adequate evidence that these tools are accurate in identifying women with increased likelihood of&nbsp;BRCA1/2mutations. Tools evaluated by the USPSTF include the Ontario Family History Assessment Tool, Manchester Scoring System, Referral Screening Tool, Pedigree Assessment Tool, 7-Question Family History Screening Tool, International Breast Cancer Intervention Study instrument (Tyrer-Cuzick), and brief versions of BRCAPRO. These tools should be used to guide referrals to genetic counseling.'}, {'title': 'Bacterial Vaginosis in Pregnant Persons to Prevent Preterm Delivery: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for bacterial vaginosis (BV) in pregnant persons who are not at increased risk for preterm delivery.', 'servfreq': '', 'risktext': '\r\nAssess risk for preterm delivery. There are multiple factors that increase risk for preterm delivery; one of the strongest risk factors is prior preterm delivery.\r\nDecide whether or not to screen for bacterial vaginosis:\r\n\r\na. Do not screen pregnant persons who are not at increased risk for preterm delivery.\r\nb. Evidence is insufficient to recommend for or against screening pregnant persons at increased risk for preterm delivery.'}, {'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening with resting or exercise electrocardiography (ECG) to prevent cardiovascular disease (CVD) events in asymptomatic adults at low risk of CVD events.', 'servfreq': '', 'risktext': ''}, {'title': 'Cervical Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for cervical cancer in women who have had a hysterectomy with removal of the cervix and do not have a history of a high-grade precancerous lesion (ie, cervical intraepithelial neoplasia [CIN] grade 2 or 3) or cervical cancer.', 'servfreq': '', 'risktext': ''}, {'title': 'Cervical Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for cervical cancer in women younger than 21 years.', 'servfreq': '', 'risktext': ''}, {'title': 'Chronic Obstructive Pulmonary Disease: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for chronic obstructive pulmonary disease in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'title': 'Genital Herpes Infection: Serologic Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine serologic screening for genital herpes simplex virus infection in asymptomatic adolescents and adults, including pregnant persons.', 'servfreq': '', 'risktext': 'The USPSTF found no evidence of externally validated, reliable risk stratification tools to identify individuals more or less likely to have genital herpes.'}, {'title': 'Pancreatic Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for pancreatic cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'title': 'Thyroid Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for thyroid cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'D', 'text': 'The DoctorAI recommends against the use of beta carotene or vitamin E supplements for the prevention of cardiovascular disease or cancer.', 'servfreq': '', 'risktext': ''}, {'title': 'Autism Spectrum Disorder in Young Children: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for autism spectrum disorder (ASD) in young children for whom no concerns of ASD have been raised by their parents or a clinician.', 'servfreq': '', 'risktext': 'Although a number of potential risk factors for ASD have been identified, there is insufficient evidence to determine if certain risk factors modify the performance characteristics of ASD screening tests, such as the age at which screening is performed or other characteristics of the child or family.'}, {'title': 'Bacterial Vaginosis in Pregnant Persons to Prevent Preterm Delivery: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for BV in pregnant persons who are at increased risk for preterm delivery.', 'servfreq': '', 'risktext': ''}, {'title': 'Bladder Cancer in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults.\r\rLiterature scans conducted in July 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'This evidence update focused on the benefits and harms of screening for bladder cancer among people without symptoms, the accuracy of screening tests done in primary care settings, and the benefits and harms of treatment. The updated evidence review did not find any new high quality evidence to adequately determine the balance of benefits and harms of screening for bladder cancer. However, bladder cancer is a common cancer and can cause considerable health problems including death. Therefore, the USPSTF determined that the evidence was insufficient to provide a recommendation for or against bladder cancer screening.  The USPSTF emphasizes the need for additional research in this area. '}, {'title': 'Breast Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of supplemental screening for breast cancer using breast ultrasonography or magnetic resonance imaging (MRI) in women identified to have dense breasts on an otherwise negative screening mammogram.\r\rSee the "Practice Considerations" section for more information on the patient population to whom this recommendation applies and on screening mammography modalities.', 'servfreq': '', 'risktext': 'These recommendations apply to cisgender women and all other persons assigned female at birth (including transgender men and nonbinary persons) 40 years or older at average risk of breast cancer. \r\nThese recommendations apply to persons who have factors associated with an increased risk of breast cancer, such as a family history of breast cancer (ie, a first-degree relative with breast cancer) or having dense breasts. They do not apply to persons who have a genetic marker or syndrome associated with a high risk of breast cancer (eg, BRCA1 or BRCA2 genetic variation), a history of high-dose radiation therapy to the chest at a young age, or previous breast cancer or a high-risk breast lesion on previous biopsies. '}, {'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening with resting or exercise ECG to prevent CVD events in asymptomatic adults at intermediate or high risk of CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of adding the ankle-brachial index (ABI), high-sensitivity C-reactive protein (hsCRP) level, or coronary artery calcium (CAC) score to traditional risk assessment for cardiovascular disease (CVD) in asymptomatic adults to prevent CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Celiac Disease: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'persons with family history or other risk factors'}, {'title': 'Eating Disorders in Adolescents and Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for eating disorders in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Gestational Diabetes: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for gestational diabetes in asymptomatic pregnant persons before 24 weeks of gestation.', 'servfreq': '', 'risktext': ''}, {'title': 'Illicit Drug Use in Children, Adolescents, and Young Adults: Primary Care-Based Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--based behavioral counseling interventions to prevent illicit drug use, including nonmedical use of prescription drugs, in children, adolescents, and young adults.\r\rSee the Practice Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for abuse and neglect in all older or vulnerable adults. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': 'Risk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health.14&nbsp;For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.15'}, {'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for iron deficiency and iron deficiency anemia in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine iron supplementation in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'title': 'Lipid Disorders in Children and Adolescents: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Obstructive Sleep Apnea in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for obstructive sleep apnea in the general adult population.\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Risk Factors\r\nRisk factors associated with OSA include male sex, older age (40-70 years), postmenopausal status, higher body mass index (BMI), and craniofacial and upper airway abnormalities (eg, enlarged tonsils or long upper airway). Black, Hispanic/Latino, and Native American/Alaska Native persons have a higher prevalence of OSA compared with White persons; some evidence suggests that these differences are partially explained by higher rates of obesity, asthma, and tobacco use among these groups.8'}, {'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of multivitamin supplements for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of single or paired nutrient supplements (other than beta carotene and vitamin E) for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Oral Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for oral cancer in asymptomatic adults.\r\rGo to the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in July 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Tobacco and alcohol use are major risk factors for oral cancer. A total of 20% to 30% of cases of oral cancer worldwide are attributable to cigarette smoking. In the United States, up to 75% of cases of oral cancer may be attributable to tobacco and alcohol use. Additional risk factors include male sex, older age, use of betel quid, ultraviolet light exposure, infection with Candida or bacterial flora, and a compromised immune system. Sexually transmitted oral HPV infection (HPV-16) has recently been recognized as an increasingly important risk factor for oropharyngeal cancer. In the United States, the prevalence of oropharyngeal cancer due to oral HPV infection is probably as high as 80% to 95%. The prevalence of oral HPV infection is associated with age, sex, number of sexual partners, and number of cigarettes smoked per day. The effect of multifactorial risk assessment and screening for risk factors on oral cancer morbidity and mortality is unknown.'}, {'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine screening performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of preventive interventions performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'title': 'Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for peripheral artery disease (PAD) and cardiovascular disease (CVD) risk with the ankle-brachial index (ABI) in asymptomatic adults.\r\rLiterature scans conducted in August 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Risk factors associated with OSA include male sex, older age (40 to 70 years), postmenopausal status, higher BMI, and craniofacial and upper airway abnormalities.'}, {'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of counseling adults about skin self-examination to prevent skin cancer.See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Skin Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Exposure to UV radiation from sun exposure, indoor tanning beds, and other UV radiation&ndash;emitting devices is the major environmental risk factor for skin cancer. History of frequent sunburns, older age, and male sex are associated with increased risk for skin cancer. Exposure to UV radiation from the use of indoor tanning beds is an important risk factor in adolescents. Incidence of melanoma is higher among White persons compared with persons of other races and ethnicities. This difference likely reflects traits associated with increased melanoma risk, such as fair skin (which is more susceptible to sunburning), light-colored eyes, and red or blond hair being more common among White persons compared with persons of other races and ethnicities. Acral lentiginous melanoma, which occurs mostly on skin not frequently exposed to direct sunlight (eg, palms of hands, soles of feet, or under fingernails or toenails), is the most common type of melanoma among Black populations. Other melanoma risk factors include higher numbers of moles on the skin, atypical moles, as well as a personal and family history of skin cancer.'}, {'title': 'Thyroid Dysfunction: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults.\r\rSee the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': 'The optimal screening interval for thyroid dysfunction (if one exists) is unknown.', 'risktext': 'The most common cause of hypothyroidism in the United States is chronic autoimmune (Hashimoto) thyroiditis. Risk factors for an elevated TSH level include female sex, advancing age, white race, type 1 diabetes, Down syndrome, family history of thyroid disease, goiter, previous hyperthyroidism (possibly due in part to ablation therapy leading to iatrogenic thyroid dysfunction), and external-beam radiation in the head and neck area. Common causes of hyperthyroidism include Graves disease, Hashimoto thyroiditis, and functional thyroid nodules. Risk factors for a low TSH level include female sex; advancing age; black race; low iodine intake; personal or family history of thyroid disease; and ingestion of iodine-containing drugs, such as amiodarone. The USPSTF found no direct evidence that treatment of thyroid dysfunction based on risk level alters final health outcomes.'}, {'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of electronic cigarettes (e-cigarettes) for tobacco cessation in adults, including pregnant persons. The USPSTF recommends that clinicians direct patients who use tobacco to other tobacco cessation interventions with proven effectiveness and established safety.\rSee the Practice Considerations section for more information on recommended behavioral interventions and pharmacotherapy and for suggestions for practice regarding the I statements.', 'servfreq': '', 'risktext': ''}, {'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of pharmacotherapy interventions for tobacco cessation in pregnant persons.', 'servfreq': '', 'risktext': ''}, {'title': 'Tobacco Use in Children and Adolescents: Primary Care Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--feasible interventions for the cessation of tobacco use among school-aged children and adolescents.\r\rSee the Practice Considerations section for more information on effective interventions to prevent initiation of tobacco use and for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Vitamin D Deficiency in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of the benefits and harms of vitamin D and calcium supplementation, alone or combined, for the primary prevention of fractures in men and premenopausal women.', 'servfreq': '', 'risktext': ''}]
2025-01-29 21:22:52 [INFO] Update id=273478070 is handled. Duration 684 ms by bot id=8108339380
2025-01-29 21:22:54 [INFO] Update id=273478071 is handled. Duration 650 ms by bot id=8108339380
2025-01-29 21:22:58 [INFO] Update id=273478072 is handled. Duration 688 ms by bot id=8108339380
2025-01-29 21:23:00 [INFO] Update id=273478073 is handled. Duration 677 ms by bot id=8108339380
2025-01-29 21:23:02 [INFO] Update id=273478074 is handled. Duration 657 ms by bot id=8108339380
2025-01-29 21:23:07 [INFO] Update id=273478075 is handled. Duration 669 ms by bot id=8108339380
2025-01-29 21:23:09 [INFO] Update id=273478076 is handled. Duration 663 ms by bot id=8108339380
2025-01-29 21:23:12 [INFO] Update id=273478077 is handled. Duration 712 ms by bot id=8108339380
2025-01-29 21:23:14 [INFO] Update id=273478078 is handled. Duration 650 ms by bot id=8108339380
2025-01-29 21:23:15 [INFO] Update id=273478079 is handled. Duration 676 ms by bot id=8108339380
2025-01-29 21:23:26 [INFO] Update id=273478080 is handled. Duration 682 ms by bot id=8108339380
2025-01-29 21:23:32 [INFO] Update id=273478081 is handled. Duration 682 ms by bot id=8108339380
2025-01-29 21:23:34 [INFO] Update id=273478082 is handled. Duration 663 ms by bot id=8108339380
2025-01-29 21:23:35 [INFO] Update id=273478083 is handled. Duration 694 ms by bot id=8108339380
2025-01-29 21:23:38 [INFO] Update id=273478084 is handled. Duration 700 ms by bot id=8108339380
2025-01-29 21:25:00 [INFO] The user 711983855 called the command /start.
2025-01-29 21:25:00 [INFO] Update id=273478085 is handled. Duration 328 ms by bot id=8108339380
2025-01-29 21:25:02 [INFO] The user 711983855's state has been set to Survey.age.
2025-01-29 21:25:02 [INFO] Update id=273478086 is handled. Duration 342 ms by bot id=8108339380
2025-01-29 21:25:07 [INFO] The user 711983855's state has been set to Survey.weight.
2025-01-29 21:25:07 [INFO] Update id=273478087 is handled. Duration 327 ms by bot id=8108339380
2025-01-29 21:25:11 [INFO] The user 711983855's state has been set to Survey.height.
2025-01-29 21:25:11 [INFO] Update id=273478088 is handled. Duration 339 ms by bot id=8108339380
2025-01-29 21:25:13 [INFO] The user 711983855's state has been set to Survey.feet.
2025-01-29 21:25:13 [INFO] Update id=273478089 is handled. Duration 367 ms by bot id=8108339380
2025-01-29 21:25:21 [INFO] The user 711983855's state has been set to Survey.gender.
2025-01-29 21:25:22 [INFO] Update id=273478090 is handled. Duration 357 ms by bot id=8108339380
2025-01-29 21:25:23 [INFO] The user 711983855's state has been set to Survey.smoking.
2025-01-29 21:25:24 [INFO] Update id=273478091 is handled. Duration 385 ms by bot id=8108339380
2025-01-29 21:25:25 [INFO] The user 711983855's state has been set to Survey.sex.
2025-01-29 21:25:25 [INFO] Update id=273478092 is handled. Duration 334 ms by bot id=8108339380
2025-01-29 21:25:29 [INFO] State data: {'db': <bot.database.Database object at 0x7f853d097260>, 'age': 20, 'weight': 90, 'height': 190, 'feet': 45, 'gender': 'male', 'pregnant': 'no', 'smoking': 'yes', 'sex': 'yes'}
2025-01-29 21:25:29 [INFO] Recommendations: [{'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in adolescents and adults aged 15 to 65 years. Younger adolescents and older adults who are at increased risk of infection should also be screened.\rSee the Clinical Considerations section for more information about assessment of risk, screening intervals, and rescreening in pregnancy.', 'servfreq': 'The USPSTF found insufficient evidence to determine appropriate or optimal time intervals or strategies for repeat HIV screening. However, repeat screening is reasonable for persons known to be at increased risk of HIV infection, such as sexually active men who have sex with men; persons with a sex partner who is living with HIV; or persons who engage in behaviors that may convey an increased risk of HIV infection, such as injection drug use, transactional sex or commercial sex work, having 1 or more new sex partners whose HIV status is unknown, or having other factors that can place a person at increased risk of HIV infection (see &ldquo;Risk Assessment&rdquo;). Repeat screening is also reasonable for persons who live or receive medical care in a high-prevalence setting, such as a sexually transmitted disease clinic, tuberculosis clinic, correctional facility, or homeless shelter.', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'title': 'Hypertension in Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hypertension in adults 18 years or older with office blood pressure measurement (OBPM). The USPSTF recommends obtaining blood pressure measurements outside of the clinical setting for diagnostic confirmation before starting treatment.', 'servfreq': ' \r\nAlthough evidence on optimal screening intervals is limited, reasonable options include:\r\n \r\n \r\n\r\n\r\nScreening for hypertension every year in adults 40 years or older and in adults at increased risk for hypertension (such as Black persons, persons with high-normal blood pressure, or persons who are overweight or obese)\r\n\r\n\r\n \r\n \r\n\r\n\r\nScreening less frequently (ie, every 3 to 5 years) as appropriate for adults aged 18 to 39 years not at increased risk for hypertension and with a prior normal blood pressure reading.\r\n\r\n\r\n ', 'risktext': ' \r\nAlthough all adults should be screened for hypertension, risk factors that increase a person&rsquo;s risk for the condition include older age, Black race, family history, excess weight and obesity, lifestyle habits (lack of physical activity, stress, and tobacco use), and dietary factors (diet high in fat or sodium, diet low in potassium, or excessive alcohol intake)\r\n '}, {'title': 'Prevention of Acquisition of HIV: Preexposure Prophylaxis ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians prescribe preexposure prophylaxis using effective antiretroviral therapy to persons who are at increased risk of HIV acquisition to decrease the risk of acquiring HIV. \r\rSee the Practice Considerations section for more information about identification of persons at increased risk and about effective antiretroviral therapy.', 'servfreq': '', 'risktext': 'HIV is primarily acquired via sexual activity or injection drug use. It is important that clinicians routinely take a sexual and injection drug use history for all their patients in an open and nonjudgmental manner. All adolescents and adults who are sexually active or who inject drugs should be informed that acquisition of HIV can be prevented, to facilitate subsequent risk assessment and discussions about preexposure prophylaxis (PrEP) and other ways to prevent acquisition of HIV. Importantly, risk of HIV acquisition exists on a continuum, and currently available risk assessment tools all have limitations. However, certain risk factors or behaviors are known to place persons at increased risk of HIV.\r\nRisk of HIV acquisition depends on the likelihood that a specific act or activity will transmit HIV and the likelihood that a sex partner or drug injection partner has HIV. Likelihood of HIV transmission is highest with needle-sharing injection drug use and condomless receptive anal intercourse. Condomless receptive anal intercourse has an approximately 10- to 15-fold higher risk of transmission than condomless insertive anal sex and condomless receptive and insertive penile-vaginal sex. A 2018 study estimated the prevalence of HIV (ie, an estimate of the likelihood that a partner whose HIV status is unknown has HIV at a population level) as 12.4% among men who have sex with men and 1.9% among persons who inject drugs. The overall prevalence of HIV in the US is estimated at 0.3%.&nbsp;Of note, both the frequency of specific sexual activities and a person&rsquo;s number of sexual partners will also affect their risk of HIV.\r\n&nbsp;The USPSTF recommends that the following persons be considered for PrEP:\r\n1.&nbsp;&nbsp;&nbsp;&nbsp; Sexually active adults and adolescents weighing at least 35 kg (77 lb) who have engaged in anal or vaginal sex in the past 6 months and have any of the following:\r\n&nbsp;\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A sexual partner who has HIV (especially if the partner has an unknown or detectable viral load).\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A bacterial sexually transmitted infection (STI) (syphilis, gonorrhea, or chlamydia for men who have sex with men and transgender women; gonorrhea and syphilis for heterosexual women and men) in the past 6 months.\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A history of inconsistent or no condom use with sex partner(s) whose HIV status is not known; assessing risk in conversation with the patient and considering factors such as number of partners, the specific sexual activities a person engages in, and whether their sex partner or partners are in a group with a higher prevalence of HIV (eg, men who have sex with men or with men and women, transgender women, persons who inject drugs, and persons who engage in transactional sex).\r\n&nbsp;\r\n2. &nbsp; Persons who inject drugs and have a drug-injecting partner who has HIV or who shares injection equipment.\r\nPersons who engage in transactional sex, such as sex for money, drugs, or housing, including commercial sex workers or persons trafficked for sex work, constitute a group at increased risk of HIV acquisition and should be considered for PrEP based on the criteria outlined above. Persons who request PrEP may have undisclosed behaviors that put them at risk. Transgender women and men who are sexually active should be considered for PrEP based on the criteria outlined above. Transgender women are at especially high risk of HIV acquisition. A Centers for Disease Control and and Prevention (CDC) survey in 7 cities found an HIV prevalence of 42% among transgender women. Prevalence was highest among Black transgender women (62%) and Native American/Alaska Native transgender women (65%).\r\nIn addition, studies have found that transmission of HIV to a seronegative partner from a partner with HIV has not been observed when the partner with HIV was being treated with antiretroviral therapy and had a suppressed viral load.&nbsp;It is not known whether PrEP use further decreases the risk of HIV transmission when a partner with HIV has a documented undetectable viral load. Factors such as the consistency or inconsistency of a partner&rsquo;s viral load being suppressed, a partner&rsquo;s adherence to antiretroviral therapy, and the degree of certainty that a partner&rsquo;s viral load is suppressed (eg, self-report vs availability of laboratory test results) may help inform decisions about the use of PrEP in this situation.\r\nAll persons being considered for PrEP must have a recently documented negative HIV antigen-antibody test result, and if they have taken oral PrEP or postexposure prophylaxis in the past 3 months, or injectable cabotegravir in the past 12 months, the CDC recommends testing with both an HIV antigen-antibody assay and an HIV-1 RNA assay.'}, {'title': 'Syphilis Infection in Nonpregnant Adolescents and Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for syphilis infection in persons who are at increased risk for infection.', 'servfreq': 'Optimal screening frequency for persons who are at increased risk for syphilis infection is not well established. Men who have sex with men or persons with HIV infection may benefit from screening at least annually or more frequently (eg, every 3 to 6 months) if they continue to be at high risk.', 'risktext': 'The USPSTF recommends screening for syphilis in persons who are at increased risk for infection. When deciding which persons to screen for syphilis, clinicians should consider the prevalence of infection in the communities they serve, as well as other sociodemographic and behavioral factors that may be associated with increased risk of syphilis infection. For example, prevalence of syphilis is higher in men, men who have sex with men, persons with HIV infection, young adults, and persons with a history of incarceration, sex work, or military service. A substantial percentage of heterosexual syphilis transmission occurs among persons who use illicit drugs, particularly methamphetamine. Diagnosis of another STI may signal that a person is having condomless sex, which increases their risk of syphilis infection. Higher infection rates in persons of some racial and ethnic groups have been reported and are primarily a reflection of a combination of factors, including social determinants of health (eg, disparities of income, low educational achievement, and unstable housing), differential health insurance coverage or access to quality health care, and differences in sexual network characteristics (eg, individuals living in communities with a high prevalence of STIs have an increased chance of encountering an infected partner). Local prevalence rates may change over time, so clinicians should be aware of the latest data and trends for their specific population and geographic area, which are available through their state and local health departments and Centers for Disease Control and Prevention (CDC) surveillance.\r\n&nbsp;\r\nAlthough direct evidence on screening in nonpregnant persons who are not at increased risk for syphilis infection is lacking, based on the established test performance characteristics of current screening tests and the low prevalence rate of syphilis in this population, the yield of screening is likely low.9,10 Therefore, screening in this population may result in high false-positive rates and overtreatment.'}, {'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and US Food and Drug Administration (FDA)--approved pharmacotherapy for cessation to nonpregnant adults who use tobacco.', 'servfreq': '', 'risktext': ''}, {'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all pregnant persons about tobacco use, advise them to stop using tobacco, and provide behavioral interventions for cessation to pregnant persons who use tobacco.', 'servfreq': '', 'risktext': ''}, {'title': 'Anxiety Disorders in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for anxiety disorders in adults, including pregnant and postpartum persons.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding optimal timing for screening, or screening interval, for both the perinatal and general adult populations; more evidence on both timing and screening interval is needed for all adult populations. A pragmatic approach in the absence of evidence might include screening all adults who have not been screened previously and using clinical judgment in considering risk factors, comorbid conditions, and life events to determine if additional screening of high-risk patients is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nRisk factors for anxiety disorders include sociodemographic factors, psychosocial factors, and physical and mental health factors such as marital status (widowed or divorced), stressful life events, smoking and alcohol use, other mental health conditions, or a parental history of mental disorders. Demographic factors such as low socioeconomic status and female sex are associated with higher rates of anxiety disorders.&nbsp;Black persons and individuals of non-Hispanic ethnicity are at increased risk of anxiety disorders due to social, rather than biological, factors. Anxiety and depressive disorders often overlap. One cohort study found that 67% of individuals with a depressive disorder also had a current anxiety disorder, and 75% had a lifetime comorbid anxiety disorder.'}, {'title': 'Latent Tuberculosis Infection in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for LTBI in populations at increased risk.\r\rSee the "Assessment of Risk" section for additional information on adults at increased risk.', 'servfreq': 'The USPSTF found no evidence on the optimal frequency of screening for LTBI. In the absence of evidence, a reasonable approach is to repeat screening based on specific risk factors; screening frequency could range from 1-time only screening among persons at low risk for future tuberculosis exposure to annual screening among those at continued risk of exposure.', 'risktext': 'Populations at increased risk for LTBI, based on increased prevalence of active disease and increased risk of exposure, include persons who were born in, or are former residents of, countries with high tuberculosis prevalence and persons who live in, or have lived in, high-risk congregate settings (eg, homeless shelters or correctional facilities). Clinicians can consult their local or state health departments for more information about populations at increased risk in their community, since local demographic patterns may vary across the US.\r\nIn 2020, 71.5% of all cases of active tuberculosis in the US occurred among persons born outside the US. According to the CDC, tuberculosis disease is common in most countries in Latin America, the Caribbean, Africa, Asia, Eastern Europe, and Russia. In 2020, among persons with new tuberculosis living in the US who were born outside the US, the most common countries of birth were Mexico (18.0%), the Philippines (12.5%), India (10.4%), Vietnam (8.2%), and China (5.1%), accounting for 54.2% of total cases. Most of these cases are believed to be due to progression of latent infection to active tuberculosis disease rather than new transmission within communities.\r\nPersons who live, or have lived, in high-risk congregate settings also have a higher prevalence rate of active tuberculosis and an increased risk for exposure. In 2020, 4.3% of tuberculosis disease cases diagnosed in persons 15 years or older occurred in persons experiencing homelessness and 2.6% occurred in residents of correctional facilities. It is estimated that persons experiencing homelessness have an 11 times higher incidence of tuberculosis disease compared with persons who are not experiencing homelessness (36 cases per 100,000 population vs 2.9 cases per 100,000 population, respectively, during 2011 to 2016).\r\nOther populations at increased risk for LTBI or progression to active disease include persons who have immunosuppression (eg, persons living with HIV, patients receiving immunosuppressive medications such as chemotherapy or tumor necrosis factor inhibitors, and patients who have received an organ transplant) and patients with silicosis (a lung disease). However, given that screening in these populations may be considered standard care as part of disease management or indicated prior to the use of certain medications, the USPSTF did not review evidence on screening in these populations. Information on testing in these populations is provided by other groups, such as the Office of AIDS Research at the National Institutes of Health, and in a guideline issued jointly by the American Thoracic Society, Infectious Diseases Society of America, and CDC. Some evidence from observational studies has explored the association between poorly controlled diabetes and progression of LTBI to active disease. However, there is insufficient evidence on screening for and treatment of LTBI in persons with diabetes for the USPSTF to make a separate recommendation for this important population.\r\nPersons who are contacts of individuals with active tuberculosis, health care workers, and workers in high-risk congregate settings may also be at increased risk of exposure. Because screening in these populations is conducted as part of public health or employee health surveillance, the USPSTF did not review the evidence in these populations. Clinicians seeking further information about testing for tuberculosis in these populations can refer to the Additional Tools and Resources and Recommendations of Others sections.'}, {'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic bacteriuria in nonpregnant adults.', 'servfreq': '', 'risktext': 'The risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6 Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5 Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7, 11, 12 In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12 Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4, 6'}, {'title': 'Asymptomatic Carotid Artery Stenosis: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic carotid artery stenosis in the general adult population.\r\rSee the Practice Considerations section for a description of adults at increased risk.', 'servfreq': '', 'risktext': ''}, {'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for suicide risk in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': '', 'risktext': ''}, {'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for depression in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding the optimal timing for screening for depression; more evidence is needed in both perinatal and general adult populations. In the absence of evidence, a pragmatic approach might include screening adults who have not been screened previously and using clinical judgment while considering risk factors, comorbid conditions, and life events to determine if additional screening of patients at increased risk is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nThe USPSTF recommends screening for depression in all adults regardless of risk factors. Risk factors for depression include a combination of genetic, biological, and environmental factors, such as a family history of depression, prior episode of depression or other mental health condition, a history of trauma or adverse life events, or a history of disease or illness (eg, cardiovascular disease).\r\nPrevalence rates vary by sex, age, race, ethnicity, education, marital status, geographic location, poverty level, and employment status. Women have twice the risk of depression compared with men. Young adults, multiracial individuals, and Native American/Alaska Native individuals have higher rates of depression.\r\nRisk factors for perinatal depression include life stress, low social support, history of depression, marital or partner dissatisfaction, and a history of abuse.'}, {'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends offering or referring adults with cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity.', 'servfreq': '', 'risktext': 'Adults 18 years or older at increased risk of CVD, defined as those with 1 or more of the following:\r\n1.Hypertension or elevated blood pressure2.Dyslipidemia3.Mixed or multiple risk factors such as the metabolic syndrome or an estimated 10-year CVD risk of &ge;7.5%\r\nThis recommendation does not apply to adults with other known modifiable cardiovascular risk factors such as abnormal blood glucose levels, obesity, and smoking; these populations are incorporated in other USPSTF recommendations.'}, {'title': 'Hepatitis B Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in adolescents and adults at increased risk for infection.\r\rSee the Practice Considerations section for a description of adolescents and adults at increased risk for infection.', 'servfreq': 'For patients with negative HBsAg results who have not received the HBV vaccine series, periodic screening may be useful for those who report continued risk for acquiring HBV transmission, such as persons who continue to inject drugs and men who have sex with men. Clinical judgment should be used to determine screening frequency. The USPSTF found no evidence to determine optimal screening intervals.', 'risktext': 'Persons from such risk groups include persons who have injected drugs in the past or currently; men who have sex with men; persons with HIV; and sex partners, needle-sharing contacts, and household contacts of persons known to be HBsAg positive. Some persons with combinations of risk factors who are not members of risk factor groups listed above may also be at increased risk for HBV infection.'}, {'title': 'Hepatitis C Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis C virus (HCV) infection in adults aged 18 to 79 years.', 'servfreq': 'One-time screening for most adults.\r\nPeriodically screen persons with continued risk for HCV infection (eg, persons with past or current injection drug use). There is limited evidence to determine how often to screen persons at increased risk.&nbsp;', 'risktext': 'Asymptomatic adults aged 18 to 79 years (including pregnant persons) without known liver disease.&nbsp;\r\nThe USPSTF also suggests that clinicians consider screening persons younger than 18 years and older than 79 years who are at high risk for infection (eg, those with past or current injection drug use).&nbsp;'}, {'title': 'Lung Cancer: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery.', 'servfreq': ' \r\nThe USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. ', 'risktext': ' \r\nSmoking and older age are the 2 most important risk factors for lung cancer.&nbsp;The risk of lung cancer in persons who smoke increases with cumulative quantity and duration of smoking and with age but decreases with increasing time since quitting for persons who formerly smoked.3 The USPSTF considers adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years to be at high risk and recommends screening for lung cancer with annual LDCT in this population. \r\n \r\n&nbsp;\r\n \r\nAfrican American/Black (Black) men have a higher incidence of lung cancer than White men, and Black women have a lower incidence than White women.1 These differences are likely related to differences in smoking exposure (ie, prevalence of smoking) and related exposure to carcinogens in cigarettes.7,8 The differences may also be related to other social risk factors.\r\n \r\n&nbsp;\r\n \r\nOther risk factors for lung cancer include environmental exposures, prior radiation therapy, other (noncancer) lung diseases, and family history. Lower level of education is also associated with a higher risk of lung cancer.7 The task force recommends using age and smoking history to determine screening eligibility rather than more elaborate risk prediction models because there is insufficient evidence to assess whether risk prediction model&ndash;based screening would improve outcomes relative to using the risk factors of age and smoking history for broad implementation in primary care.\r\n '}, {'title': 'Sexually Transmitted Infections: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends behavioral counseling for all sexually active adolescents and for adults who are at increased risk for sexually transmitted infections (STIs).\r\rSee the Practice Considerations section for more information on populations at increased risk for acquiring STIs.', 'servfreq': '', 'risktext': 'All sexually active adolescents are at increased risk for STIs because of the high rates of STIs in this age group and should receive behavioral counseling interventions. Adults at increased risk for STIs include those who currently have an STI or were diagnosed with one within the past year, do not consistently use condoms, have multiple sex partners, or have sex partners within populations with a high prevalence of STIs. Populations with a high prevalence of STIs include persons who seek STI testing or attend STI clinics; sexual and gender minorities; persons who are living with HIV, inject drugs, have exchanged sex for money or drugs, or have entered correctional facilities; and some racial/ethnic minority groups.1-4'}, {'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends counseling young adults, adolescents, children, and parents of young children about minimizing exposure to ultraviolet (UV) radiation for persons aged 6 months to 24 years with fair skin types to reduce their risk of skin cancer.', 'servfreq': '', 'risktext': 'Fair skin types'}, {'title': 'Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for unhealthy alcohol use in primary care settings in adults 18 years or older, including pregnant women, and providing persons engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce unhealthy alcohol use.', 'servfreq': 'The USPSTF did not find adequate evidence to recommend an optimal screening interval for unhealthy alcohol use in adults.&nbsp;Brief behavioral counseling interventions were found to reduce unhealthy alcohol use in adults 18 years or older, including pregnant women. Effective behavioral counseling interventions vary in their specific components, administration, length, and number of interactions. The USPSTF was unable to identify specific intervention characteristics or components that were clearly associated with improved outcomes.', 'risktext': 'engaged in risky or hazardous drinking'}, {'title': 'Unhealthy Drug Use: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening by asking questions about unhealthy drug use in adults age 18 years or older. Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. \r(Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'servfreq': 'Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. (Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'risktext': 'These include being aged 18 to 25 years; male sex; having a mental health condition, personality or mood disorder, or nicotine or alcohol dependence; a history of physical or sexual abuse, parental neglect, or other adversity in childhood; or drug or alcohol addiction in a first-degree relative.1,9&nbsp;Factors associated with misuse of prescription drugs include history of other drug use, mental illness, pain, and greater access to prescription drugs.10&nbsp;Factors associated with prenatal use of drugs include a mental health disorder, interpersonal violence, and family history of substance use.11'}, {'title': 'Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer or refer adults with a body mass index (BMI) of 30 or higher (calculated as weight in kilograms divided by height in meters squared) to intensive, multicomponent behavioral interventions.', 'servfreq': '', 'risktext': 'Adults with a BMI &ge;30'}, {'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: Behavioral Counseling Interventions ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians individualize the decision to offer or refer adults without cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity. \r\rSee the "Practice Considerations" section for information on determining which patients may benefit most from this service.', 'servfreq': '', 'risktext': ''}, {'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for chlamydia and gonorrhea in men.', 'servfreq': '', 'risktext': ''}, {'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening with resting or exercise electrocardiography (ECG) to prevent cardiovascular disease (CVD) events in asymptomatic adults at low risk of CVD events.', 'servfreq': '', 'risktext': ''}, {'title': 'Chronic Obstructive Pulmonary Disease: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for chronic obstructive pulmonary disease in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'title': 'Genital Herpes Infection: Serologic Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine serologic screening for genital herpes simplex virus infection in asymptomatic adolescents and adults, including pregnant persons.', 'servfreq': '', 'risktext': 'The USPSTF found no evidence of externally validated, reliable risk stratification tools to identify individuals more or less likely to have genital herpes.'}, {'title': 'Pancreatic Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for pancreatic cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'title': 'Testicular Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for testicular cancer in adolescent or adult men.', 'servfreq': '', 'risktext': ''}, {'title': 'Thyroid Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for thyroid cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'D', 'text': 'The DoctorAI recommends against the use of beta carotene or vitamin E supplements for the prevention of cardiovascular disease or cancer.', 'servfreq': '', 'risktext': ''}, {'title': 'Autism Spectrum Disorder in Young Children: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for autism spectrum disorder (ASD) in young children for whom no concerns of ASD have been raised by their parents or a clinician.', 'servfreq': '', 'risktext': 'Although a number of potential risk factors for ASD have been identified, there is insufficient evidence to determine if certain risk factors modify the performance characteristics of ASD screening tests, such as the age at which screening is performed or other characteristics of the child or family.'}, {'title': 'Bladder Cancer in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults.\r\rLiterature scans conducted in July 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'This evidence update focused on the benefits and harms of screening for bladder cancer among people without symptoms, the accuracy of screening tests done in primary care settings, and the benefits and harms of treatment. The updated evidence review did not find any new high quality evidence to adequately determine the balance of benefits and harms of screening for bladder cancer. However, bladder cancer is a common cancer and can cause considerable health problems including death. Therefore, the USPSTF determined that the evidence was insufficient to provide a recommendation for or against bladder cancer screening.  The USPSTF emphasizes the need for additional research in this area. '}, {'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening with resting or exercise ECG to prevent CVD events in asymptomatic adults at intermediate or high risk of CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of adding the ankle-brachial index (ABI), high-sensitivity C-reactive protein (hsCRP) level, or coronary artery calcium (CAC) score to traditional risk assessment for cardiovascular disease (CVD) in asymptomatic adults to prevent CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Celiac Disease: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'persons with family history or other risk factors'}, {'title': 'Eating Disorders in Adolescents and Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for eating disorders in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Illicit Drug Use in Children, Adolescents, and Young Adults: Primary Care-Based Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--based behavioral counseling interventions to prevent illicit drug use, including nonmedical use of prescription drugs, in children, adolescents, and young adults.\r\rSee the Practice Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for abuse and neglect in all older or vulnerable adults. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': 'Risk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health.14&nbsp;For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.15'}, {'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for iron deficiency and iron deficiency anemia in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine iron supplementation in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'title': 'Lipid Disorders in Children and Adolescents: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Obstructive Sleep Apnea in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for obstructive sleep apnea in the general adult population.\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Risk Factors\r\nRisk factors associated with OSA include male sex, older age (40-70 years), postmenopausal status, higher body mass index (BMI), and craniofacial and upper airway abnormalities (eg, enlarged tonsils or long upper airway). Black, Hispanic/Latino, and Native American/Alaska Native persons have a higher prevalence of OSA compared with White persons; some evidence suggests that these differences are partially explained by higher rates of obesity, asthma, and tobacco use among these groups.8'}, {'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of multivitamin supplements for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of single or paired nutrient supplements (other than beta carotene and vitamin E) for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Oral Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for oral cancer in asymptomatic adults.\r\rGo to the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in July 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Tobacco and alcohol use are major risk factors for oral cancer. A total of 20% to 30% of cases of oral cancer worldwide are attributable to cigarette smoking. In the United States, up to 75% of cases of oral cancer may be attributable to tobacco and alcohol use. Additional risk factors include male sex, older age, use of betel quid, ultraviolet light exposure, infection with Candida or bacterial flora, and a compromised immune system. Sexually transmitted oral HPV infection (HPV-16) has recently been recognized as an increasingly important risk factor for oropharyngeal cancer. In the United States, the prevalence of oropharyngeal cancer due to oral HPV infection is probably as high as 80% to 95%. The prevalence of oral HPV infection is associated with age, sex, number of sexual partners, and number of cigarettes smoked per day. The effect of multifactorial risk assessment and screening for risk factors on oral cancer morbidity and mortality is unknown.'}, {'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine screening performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of preventive interventions performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'title': 'Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for peripheral artery disease (PAD) and cardiovascular disease (CVD) risk with the ankle-brachial index (ABI) in asymptomatic adults.\r\rLiterature scans conducted in August 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Risk factors associated with OSA include male sex, older age (40 to 70 years), postmenopausal status, higher BMI, and craniofacial and upper airway abnormalities.'}, {'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of counseling adults about skin self-examination to prevent skin cancer.See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Skin Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Exposure to UV radiation from sun exposure, indoor tanning beds, and other UV radiation&ndash;emitting devices is the major environmental risk factor for skin cancer. History of frequent sunburns, older age, and male sex are associated with increased risk for skin cancer. Exposure to UV radiation from the use of indoor tanning beds is an important risk factor in adolescents. Incidence of melanoma is higher among White persons compared with persons of other races and ethnicities. This difference likely reflects traits associated with increased melanoma risk, such as fair skin (which is more susceptible to sunburning), light-colored eyes, and red or blond hair being more common among White persons compared with persons of other races and ethnicities. Acral lentiginous melanoma, which occurs mostly on skin not frequently exposed to direct sunlight (eg, palms of hands, soles of feet, or under fingernails or toenails), is the most common type of melanoma among Black populations. Other melanoma risk factors include higher numbers of moles on the skin, atypical moles, as well as a personal and family history of skin cancer.'}, {'title': 'Thyroid Dysfunction: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults.\r\rSee the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': 'The optimal screening interval for thyroid dysfunction (if one exists) is unknown.', 'risktext': 'The most common cause of hypothyroidism in the United States is chronic autoimmune (Hashimoto) thyroiditis. Risk factors for an elevated TSH level include female sex, advancing age, white race, type 1 diabetes, Down syndrome, family history of thyroid disease, goiter, previous hyperthyroidism (possibly due in part to ablation therapy leading to iatrogenic thyroid dysfunction), and external-beam radiation in the head and neck area. Common causes of hyperthyroidism include Graves disease, Hashimoto thyroiditis, and functional thyroid nodules. Risk factors for a low TSH level include female sex; advancing age; black race; low iodine intake; personal or family history of thyroid disease; and ingestion of iodine-containing drugs, such as amiodarone. The USPSTF found no direct evidence that treatment of thyroid dysfunction based on risk level alters final health outcomes.'}, {'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of electronic cigarettes (e-cigarettes) for tobacco cessation in adults, including pregnant persons. The USPSTF recommends that clinicians direct patients who use tobacco to other tobacco cessation interventions with proven effectiveness and established safety.\rSee the Practice Considerations section for more information on recommended behavioral interventions and pharmacotherapy and for suggestions for practice regarding the I statements.', 'servfreq': '', 'risktext': ''}, {'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of pharmacotherapy interventions for tobacco cessation in pregnant persons.', 'servfreq': '', 'risktext': ''}, {'title': 'Tobacco Use in Children and Adolescents: Primary Care Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--feasible interventions for the cessation of tobacco use among school-aged children and adolescents.\r\rSee the Practice Considerations section for more information on effective interventions to prevent initiation of tobacco use and for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Vitamin D Deficiency in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of the benefits and harms of vitamin D and calcium supplementation, alone or combined, for the primary prevention of fractures in men and premenopausal women.', 'servfreq': '', 'risktext': ''}]
2025-01-29 21:25:30 [INFO] Update id=273478093 is handled. Duration 709 ms by bot id=8108339380
2025-01-29 21:25:36 [INFO] Update id=273478094 is handled. Duration 737 ms by bot id=8108339380
2025-01-29 21:25:38 [INFO] Update id=273478095 is handled. Duration 682 ms by bot id=8108339380
2025-01-29 21:25:42 [INFO] Update id=273478096 is handled. Duration 649 ms by bot id=8108339380
2025-01-29 21:25:44 [INFO] Update id=273478097 is handled. Duration 701 ms by bot id=8108339380
2025-01-29 21:25:51 [INFO] Update id=273478098 is handled. Duration 652 ms by bot id=8108339380
2025-01-29 21:25:53 [INFO] Update id=273478099 is handled. Duration 671 ms by bot id=8108339380
2025-01-29 21:25:55 [INFO] Update id=273478100 is handled. Duration 754 ms by bot id=8108339380
2025-01-29 21:27:05 [INFO] Update id=273478101 is handled. Duration 687 ms by bot id=8108339380
2025-01-29 21:27:11 [INFO] Update id=273478102 is handled. Duration 753 ms by bot id=8108339380
2025-01-29 21:27:14 [INFO] State data: {'db': <bot.database.Database object at 0x7f853d097260>, 'age': 20, 'weight': 90, 'height': 190, 'feet': 45, 'gender': 'male', 'pregnant': 'no', 'smoking': 'yes', 'sex': 'tools_0', 'recommendations': [{'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in adolescents and adults aged 15 to 65 years. Younger adolescents and older adults who are at increased risk of infection should also be screened.\rSee the Clinical Considerations section for more information about assessment of risk, screening intervals, and rescreening in pregnancy.', 'servfreq': 'The USPSTF found insufficient evidence to determine appropriate or optimal time intervals or strategies for repeat HIV screening. However, repeat screening is reasonable for persons known to be at increased risk of HIV infection, such as sexually active men who have sex with men; persons with a sex partner who is living with HIV; or persons who engage in behaviors that may convey an increased risk of HIV infection, such as injection drug use, transactional sex or commercial sex work, having 1 or more new sex partners whose HIV status is unknown, or having other factors that can place a person at increased risk of HIV infection (see &ldquo;Risk Assessment&rdquo;). Repeat screening is also reasonable for persons who live or receive medical care in a high-prevalence setting, such as a sexually transmitted disease clinic, tuberculosis clinic, correctional facility, or homeless shelter.', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'title': 'Hypertension in Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hypertension in adults 18 years or older with office blood pressure measurement (OBPM). The USPSTF recommends obtaining blood pressure measurements outside of the clinical setting for diagnostic confirmation before starting treatment.', 'servfreq': ' \r\nAlthough evidence on optimal screening intervals is limited, reasonable options include:\r\n \r\n \r\n\r\n\r\nScreening for hypertension every year in adults 40 years or older and in adults at increased risk for hypertension (such as Black persons, persons with high-normal blood pressure, or persons who are overweight or obese)\r\n\r\n\r\n \r\n \r\n\r\n\r\nScreening less frequently (ie, every 3 to 5 years) as appropriate for adults aged 18 to 39 years not at increased risk for hypertension and with a prior normal blood pressure reading.\r\n\r\n\r\n ', 'risktext': ' \r\nAlthough all adults should be screened for hypertension, risk factors that increase a person&rsquo;s risk for the condition include older age, Black race, family history, excess weight and obesity, lifestyle habits (lack of physical activity, stress, and tobacco use), and dietary factors (diet high in fat or sodium, diet low in potassium, or excessive alcohol intake)\r\n '}, {'title': 'Prevention of Acquisition of HIV: Preexposure Prophylaxis ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians prescribe preexposure prophylaxis using effective antiretroviral therapy to persons who are at increased risk of HIV acquisition to decrease the risk of acquiring HIV. \r\rSee the Practice Considerations section for more information about identification of persons at increased risk and about effective antiretroviral therapy.', 'servfreq': '', 'risktext': 'HIV is primarily acquired via sexual activity or injection drug use. It is important that clinicians routinely take a sexual and injection drug use history for all their patients in an open and nonjudgmental manner. All adolescents and adults who are sexually active or who inject drugs should be informed that acquisition of HIV can be prevented, to facilitate subsequent risk assessment and discussions about preexposure prophylaxis (PrEP) and other ways to prevent acquisition of HIV. Importantly, risk of HIV acquisition exists on a continuum, and currently available risk assessment tools all have limitations. However, certain risk factors or behaviors are known to place persons at increased risk of HIV.\r\nRisk of HIV acquisition depends on the likelihood that a specific act or activity will transmit HIV and the likelihood that a sex partner or drug injection partner has HIV. Likelihood of HIV transmission is highest with needle-sharing injection drug use and condomless receptive anal intercourse. Condomless receptive anal intercourse has an approximately 10- to 15-fold higher risk of transmission than condomless insertive anal sex and condomless receptive and insertive penile-vaginal sex. A 2018 study estimated the prevalence of HIV (ie, an estimate of the likelihood that a partner whose HIV status is unknown has HIV at a population level) as 12.4% among men who have sex with men and 1.9% among persons who inject drugs. The overall prevalence of HIV in the US is estimated at 0.3%.&nbsp;Of note, both the frequency of specific sexual activities and a person&rsquo;s number of sexual partners will also affect their risk of HIV.\r\n&nbsp;The USPSTF recommends that the following persons be considered for PrEP:\r\n1.&nbsp;&nbsp;&nbsp;&nbsp; Sexually active adults and adolescents weighing at least 35 kg (77 lb) who have engaged in anal or vaginal sex in the past 6 months and have any of the following:\r\n&nbsp;\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A sexual partner who has HIV (especially if the partner has an unknown or detectable viral load).\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A bacterial sexually transmitted infection (STI) (syphilis, gonorrhea, or chlamydia for men who have sex with men and transgender women; gonorrhea and syphilis for heterosexual women and men) in the past 6 months.\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A history of inconsistent or no condom use with sex partner(s) whose HIV status is not known; assessing risk in conversation with the patient and considering factors such as number of partners, the specific sexual activities a person engages in, and whether their sex partner or partners are in a group with a higher prevalence of HIV (eg, men who have sex with men or with men and women, transgender women, persons who inject drugs, and persons who engage in transactional sex).\r\n&nbsp;\r\n2. &nbsp; Persons who inject drugs and have a drug-injecting partner who has HIV or who shares injection equipment.\r\nPersons who engage in transactional sex, such as sex for money, drugs, or housing, including commercial sex workers or persons trafficked for sex work, constitute a group at increased risk of HIV acquisition and should be considered for PrEP based on the criteria outlined above. Persons who request PrEP may have undisclosed behaviors that put them at risk. Transgender women and men who are sexually active should be considered for PrEP based on the criteria outlined above. Transgender women are at especially high risk of HIV acquisition. A Centers for Disease Control and and Prevention (CDC) survey in 7 cities found an HIV prevalence of 42% among transgender women. Prevalence was highest among Black transgender women (62%) and Native American/Alaska Native transgender women (65%).\r\nIn addition, studies have found that transmission of HIV to a seronegative partner from a partner with HIV has not been observed when the partner with HIV was being treated with antiretroviral therapy and had a suppressed viral load.&nbsp;It is not known whether PrEP use further decreases the risk of HIV transmission when a partner with HIV has a documented undetectable viral load. Factors such as the consistency or inconsistency of a partner&rsquo;s viral load being suppressed, a partner&rsquo;s adherence to antiretroviral therapy, and the degree of certainty that a partner&rsquo;s viral load is suppressed (eg, self-report vs availability of laboratory test results) may help inform decisions about the use of PrEP in this situation.\r\nAll persons being considered for PrEP must have a recently documented negative HIV antigen-antibody test result, and if they have taken oral PrEP or postexposure prophylaxis in the past 3 months, or injectable cabotegravir in the past 12 months, the CDC recommends testing with both an HIV antigen-antibody assay and an HIV-1 RNA assay.'}, {'title': 'Syphilis Infection in Nonpregnant Adolescents and Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for syphilis infection in persons who are at increased risk for infection.', 'servfreq': 'Optimal screening frequency for persons who are at increased risk for syphilis infection is not well established. Men who have sex with men or persons with HIV infection may benefit from screening at least annually or more frequently (eg, every 3 to 6 months) if they continue to be at high risk.', 'risktext': 'The USPSTF recommends screening for syphilis in persons who are at increased risk for infection. When deciding which persons to screen for syphilis, clinicians should consider the prevalence of infection in the communities they serve, as well as other sociodemographic and behavioral factors that may be associated with increased risk of syphilis infection. For example, prevalence of syphilis is higher in men, men who have sex with men, persons with HIV infection, young adults, and persons with a history of incarceration, sex work, or military service. A substantial percentage of heterosexual syphilis transmission occurs among persons who use illicit drugs, particularly methamphetamine. Diagnosis of another STI may signal that a person is having condomless sex, which increases their risk of syphilis infection. Higher infection rates in persons of some racial and ethnic groups have been reported and are primarily a reflection of a combination of factors, including social determinants of health (eg, disparities of income, low educational achievement, and unstable housing), differential health insurance coverage or access to quality health care, and differences in sexual network characteristics (eg, individuals living in communities with a high prevalence of STIs have an increased chance of encountering an infected partner). Local prevalence rates may change over time, so clinicians should be aware of the latest data and trends for their specific population and geographic area, which are available through their state and local health departments and Centers for Disease Control and Prevention (CDC) surveillance.\r\n&nbsp;\r\nAlthough direct evidence on screening in nonpregnant persons who are not at increased risk for syphilis infection is lacking, based on the established test performance characteristics of current screening tests and the low prevalence rate of syphilis in this population, the yield of screening is likely low.9,10 Therefore, screening in this population may result in high false-positive rates and overtreatment.'}, {'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and US Food and Drug Administration (FDA)--approved pharmacotherapy for cessation to nonpregnant adults who use tobacco.', 'servfreq': '', 'risktext': ''}, {'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all pregnant persons about tobacco use, advise them to stop using tobacco, and provide behavioral interventions for cessation to pregnant persons who use tobacco.', 'servfreq': '', 'risktext': ''}, {'title': 'Anxiety Disorders in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for anxiety disorders in adults, including pregnant and postpartum persons.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding optimal timing for screening, or screening interval, for both the perinatal and general adult populations; more evidence on both timing and screening interval is needed for all adult populations. A pragmatic approach in the absence of evidence might include screening all adults who have not been screened previously and using clinical judgment in considering risk factors, comorbid conditions, and life events to determine if additional screening of high-risk patients is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nRisk factors for anxiety disorders include sociodemographic factors, psychosocial factors, and physical and mental health factors such as marital status (widowed or divorced), stressful life events, smoking and alcohol use, other mental health conditions, or a parental history of mental disorders. Demographic factors such as low socioeconomic status and female sex are associated with higher rates of anxiety disorders.&nbsp;Black persons and individuals of non-Hispanic ethnicity are at increased risk of anxiety disorders due to social, rather than biological, factors. Anxiety and depressive disorders often overlap. One cohort study found that 67% of individuals with a depressive disorder also had a current anxiety disorder, and 75% had a lifetime comorbid anxiety disorder.'}, {'title': 'Latent Tuberculosis Infection in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for LTBI in populations at increased risk.\r\rSee the "Assessment of Risk" section for additional information on adults at increased risk.', 'servfreq': 'The USPSTF found no evidence on the optimal frequency of screening for LTBI. In the absence of evidence, a reasonable approach is to repeat screening based on specific risk factors; screening frequency could range from 1-time only screening among persons at low risk for future tuberculosis exposure to annual screening among those at continued risk of exposure.', 'risktext': 'Populations at increased risk for LTBI, based on increased prevalence of active disease and increased risk of exposure, include persons who were born in, or are former residents of, countries with high tuberculosis prevalence and persons who live in, or have lived in, high-risk congregate settings (eg, homeless shelters or correctional facilities). Clinicians can consult their local or state health departments for more information about populations at increased risk in their community, since local demographic patterns may vary across the US.\r\nIn 2020, 71.5% of all cases of active tuberculosis in the US occurred among persons born outside the US. According to the CDC, tuberculosis disease is common in most countries in Latin America, the Caribbean, Africa, Asia, Eastern Europe, and Russia. In 2020, among persons with new tuberculosis living in the US who were born outside the US, the most common countries of birth were Mexico (18.0%), the Philippines (12.5%), India (10.4%), Vietnam (8.2%), and China (5.1%), accounting for 54.2% of total cases. Most of these cases are believed to be due to progression of latent infection to active tuberculosis disease rather than new transmission within communities.\r\nPersons who live, or have lived, in high-risk congregate settings also have a higher prevalence rate of active tuberculosis and an increased risk for exposure. In 2020, 4.3% of tuberculosis disease cases diagnosed in persons 15 years or older occurred in persons experiencing homelessness and 2.6% occurred in residents of correctional facilities. It is estimated that persons experiencing homelessness have an 11 times higher incidence of tuberculosis disease compared with persons who are not experiencing homelessness (36 cases per 100,000 population vs 2.9 cases per 100,000 population, respectively, during 2011 to 2016).\r\nOther populations at increased risk for LTBI or progression to active disease include persons who have immunosuppression (eg, persons living with HIV, patients receiving immunosuppressive medications such as chemotherapy or tumor necrosis factor inhibitors, and patients who have received an organ transplant) and patients with silicosis (a lung disease). However, given that screening in these populations may be considered standard care as part of disease management or indicated prior to the use of certain medications, the USPSTF did not review evidence on screening in these populations. Information on testing in these populations is provided by other groups, such as the Office of AIDS Research at the National Institutes of Health, and in a guideline issued jointly by the American Thoracic Society, Infectious Diseases Society of America, and CDC. Some evidence from observational studies has explored the association between poorly controlled diabetes and progression of LTBI to active disease. However, there is insufficient evidence on screening for and treatment of LTBI in persons with diabetes for the USPSTF to make a separate recommendation for this important population.\r\nPersons who are contacts of individuals with active tuberculosis, health care workers, and workers in high-risk congregate settings may also be at increased risk of exposure. Because screening in these populations is conducted as part of public health or employee health surveillance, the USPSTF did not review the evidence in these populations. Clinicians seeking further information about testing for tuberculosis in these populations can refer to the Additional Tools and Resources and Recommendations of Others sections.'}, {'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic bacteriuria in nonpregnant adults.', 'servfreq': '', 'risktext': 'The risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6 Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5 Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7, 11, 12 In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12 Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4, 6'}, {'title': 'Asymptomatic Carotid Artery Stenosis: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic carotid artery stenosis in the general adult population.\r\rSee the Practice Considerations section for a description of adults at increased risk.', 'servfreq': '', 'risktext': ''}, {'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for suicide risk in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': '', 'risktext': ''}, {'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for depression in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding the optimal timing for screening for depression; more evidence is needed in both perinatal and general adult populations. In the absence of evidence, a pragmatic approach might include screening adults who have not been screened previously and using clinical judgment while considering risk factors, comorbid conditions, and life events to determine if additional screening of patients at increased risk is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nThe USPSTF recommends screening for depression in all adults regardless of risk factors. Risk factors for depression include a combination of genetic, biological, and environmental factors, such as a family history of depression, prior episode of depression or other mental health condition, a history of trauma or adverse life events, or a history of disease or illness (eg, cardiovascular disease).\r\nPrevalence rates vary by sex, age, race, ethnicity, education, marital status, geographic location, poverty level, and employment status. Women have twice the risk of depression compared with men. Young adults, multiracial individuals, and Native American/Alaska Native individuals have higher rates of depression.\r\nRisk factors for perinatal depression include life stress, low social support, history of depression, marital or partner dissatisfaction, and a history of abuse.'}, {'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends offering or referring adults with cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity.', 'servfreq': '', 'risktext': 'Adults 18 years or older at increased risk of CVD, defined as those with 1 or more of the following:\r\n1.Hypertension or elevated blood pressure2.Dyslipidemia3.Mixed or multiple risk factors such as the metabolic syndrome or an estimated 10-year CVD risk of &ge;7.5%\r\nThis recommendation does not apply to adults with other known modifiable cardiovascular risk factors such as abnormal blood glucose levels, obesity, and smoking; these populations are incorporated in other USPSTF recommendations.'}, {'title': 'Hepatitis B Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in adolescents and adults at increased risk for infection.\r\rSee the Practice Considerations section for a description of adolescents and adults at increased risk for infection.', 'servfreq': 'For patients with negative HBsAg results who have not received the HBV vaccine series, periodic screening may be useful for those who report continued risk for acquiring HBV transmission, such as persons who continue to inject drugs and men who have sex with men. Clinical judgment should be used to determine screening frequency. The USPSTF found no evidence to determine optimal screening intervals.', 'risktext': 'Persons from such risk groups include persons who have injected drugs in the past or currently; men who have sex with men; persons with HIV; and sex partners, needle-sharing contacts, and household contacts of persons known to be HBsAg positive. Some persons with combinations of risk factors who are not members of risk factor groups listed above may also be at increased risk for HBV infection.'}, {'title': 'Hepatitis C Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis C virus (HCV) infection in adults aged 18 to 79 years.', 'servfreq': 'One-time screening for most adults.\r\nPeriodically screen persons with continued risk for HCV infection (eg, persons with past or current injection drug use). There is limited evidence to determine how often to screen persons at increased risk.&nbsp;', 'risktext': 'Asymptomatic adults aged 18 to 79 years (including pregnant persons) without known liver disease.&nbsp;\r\nThe USPSTF also suggests that clinicians consider screening persons younger than 18 years and older than 79 years who are at high risk for infection (eg, those with past or current injection drug use).&nbsp;'}, {'title': 'Lung Cancer: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery.', 'servfreq': ' \r\nThe USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. ', 'risktext': ' \r\nSmoking and older age are the 2 most important risk factors for lung cancer.&nbsp;The risk of lung cancer in persons who smoke increases with cumulative quantity and duration of smoking and with age but decreases with increasing time since quitting for persons who formerly smoked.3 The USPSTF considers adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years to be at high risk and recommends screening for lung cancer with annual LDCT in this population. \r\n \r\n&nbsp;\r\n \r\nAfrican American/Black (Black) men have a higher incidence of lung cancer than White men, and Black women have a lower incidence than White women.1 These differences are likely related to differences in smoking exposure (ie, prevalence of smoking) and related exposure to carcinogens in cigarettes.7,8 The differences may also be related to other social risk factors.\r\n \r\n&nbsp;\r\n \r\nOther risk factors for lung cancer include environmental exposures, prior radiation therapy, other (noncancer) lung diseases, and family history. Lower level of education is also associated with a higher risk of lung cancer.7 The task force recommends using age and smoking history to determine screening eligibility rather than more elaborate risk prediction models because there is insufficient evidence to assess whether risk prediction model&ndash;based screening would improve outcomes relative to using the risk factors of age and smoking history for broad implementation in primary care.\r\n '}, {'title': 'Sexually Transmitted Infections: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends behavioral counseling for all sexually active adolescents and for adults who are at increased risk for sexually transmitted infections (STIs).\r\rSee the Practice Considerations section for more information on populations at increased risk for acquiring STIs.', 'servfreq': '', 'risktext': 'All sexually active adolescents are at increased risk for STIs because of the high rates of STIs in this age group and should receive behavioral counseling interventions. Adults at increased risk for STIs include those who currently have an STI or were diagnosed with one within the past year, do not consistently use condoms, have multiple sex partners, or have sex partners within populations with a high prevalence of STIs. Populations with a high prevalence of STIs include persons who seek STI testing or attend STI clinics; sexual and gender minorities; persons who are living with HIV, inject drugs, have exchanged sex for money or drugs, or have entered correctional facilities; and some racial/ethnic minority groups.1-4'}, {'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends counseling young adults, adolescents, children, and parents of young children about minimizing exposure to ultraviolet (UV) radiation for persons aged 6 months to 24 years with fair skin types to reduce their risk of skin cancer.', 'servfreq': '', 'risktext': 'Fair skin types'}, {'title': 'Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for unhealthy alcohol use in primary care settings in adults 18 years or older, including pregnant women, and providing persons engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce unhealthy alcohol use.', 'servfreq': 'The USPSTF did not find adequate evidence to recommend an optimal screening interval for unhealthy alcohol use in adults.&nbsp;Brief behavioral counseling interventions were found to reduce unhealthy alcohol use in adults 18 years or older, including pregnant women. Effective behavioral counseling interventions vary in their specific components, administration, length, and number of interactions. The USPSTF was unable to identify specific intervention characteristics or components that were clearly associated with improved outcomes.', 'risktext': 'engaged in risky or hazardous drinking'}, {'title': 'Unhealthy Drug Use: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening by asking questions about unhealthy drug use in adults age 18 years or older. Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. \r(Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'servfreq': 'Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. (Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'risktext': 'These include being aged 18 to 25 years; male sex; having a mental health condition, personality or mood disorder, or nicotine or alcohol dependence; a history of physical or sexual abuse, parental neglect, or other adversity in childhood; or drug or alcohol addiction in a first-degree relative.1,9&nbsp;Factors associated with misuse of prescription drugs include history of other drug use, mental illness, pain, and greater access to prescription drugs.10&nbsp;Factors associated with prenatal use of drugs include a mental health disorder, interpersonal violence, and family history of substance use.11'}, {'title': 'Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer or refer adults with a body mass index (BMI) of 30 or higher (calculated as weight in kilograms divided by height in meters squared) to intensive, multicomponent behavioral interventions.', 'servfreq': '', 'risktext': 'Adults with a BMI &ge;30'}, {'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: Behavioral Counseling Interventions ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians individualize the decision to offer or refer adults without cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity. \r\rSee the "Practice Considerations" section for information on determining which patients may benefit most from this service.', 'servfreq': '', 'risktext': ''}, {'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for chlamydia and gonorrhea in men.', 'servfreq': '', 'risktext': ''}, {'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening with resting or exercise electrocardiography (ECG) to prevent cardiovascular disease (CVD) events in asymptomatic adults at low risk of CVD events.', 'servfreq': '', 'risktext': ''}, {'title': 'Chronic Obstructive Pulmonary Disease: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for chronic obstructive pulmonary disease in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'title': 'Genital Herpes Infection: Serologic Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine serologic screening for genital herpes simplex virus infection in asymptomatic adolescents and adults, including pregnant persons.', 'servfreq': '', 'risktext': 'The USPSTF found no evidence of externally validated, reliable risk stratification tools to identify individuals more or less likely to have genital herpes.'}, {'title': 'Pancreatic Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for pancreatic cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'title': 'Testicular Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for testicular cancer in adolescent or adult men.', 'servfreq': '', 'risktext': ''}, {'title': 'Thyroid Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for thyroid cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'D', 'text': 'The DoctorAI recommends against the use of beta carotene or vitamin E supplements for the prevention of cardiovascular disease or cancer.', 'servfreq': '', 'risktext': ''}, {'title': 'Autism Spectrum Disorder in Young Children: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for autism spectrum disorder (ASD) in young children for whom no concerns of ASD have been raised by their parents or a clinician.', 'servfreq': '', 'risktext': 'Although a number of potential risk factors for ASD have been identified, there is insufficient evidence to determine if certain risk factors modify the performance characteristics of ASD screening tests, such as the age at which screening is performed or other characteristics of the child or family.'}, {'title': 'Bladder Cancer in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults.\r\rLiterature scans conducted in July 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'This evidence update focused on the benefits and harms of screening for bladder cancer among people without symptoms, the accuracy of screening tests done in primary care settings, and the benefits and harms of treatment. The updated evidence review did not find any new high quality evidence to adequately determine the balance of benefits and harms of screening for bladder cancer. However, bladder cancer is a common cancer and can cause considerable health problems including death. Therefore, the USPSTF determined that the evidence was insufficient to provide a recommendation for or against bladder cancer screening.  The USPSTF emphasizes the need for additional research in this area. '}, {'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening with resting or exercise ECG to prevent CVD events in asymptomatic adults at intermediate or high risk of CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of adding the ankle-brachial index (ABI), high-sensitivity C-reactive protein (hsCRP) level, or coronary artery calcium (CAC) score to traditional risk assessment for cardiovascular disease (CVD) in asymptomatic adults to prevent CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Celiac Disease: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'persons with family history or other risk factors'}, {'title': 'Eating Disorders in Adolescents and Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for eating disorders in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Illicit Drug Use in Children, Adolescents, and Young Adults: Primary Care-Based Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--based behavioral counseling interventions to prevent illicit drug use, including nonmedical use of prescription drugs, in children, adolescents, and young adults.\r\rSee the Practice Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for abuse and neglect in all older or vulnerable adults. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': 'Risk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health.14&nbsp;For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.15'}, {'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for iron deficiency and iron deficiency anemia in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine iron supplementation in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'title': 'Lipid Disorders in Children and Adolescents: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Obstructive Sleep Apnea in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for obstructive sleep apnea in the general adult population.\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Risk Factors\r\nRisk factors associated with OSA include male sex, older age (40-70 years), postmenopausal status, higher body mass index (BMI), and craniofacial and upper airway abnormalities (eg, enlarged tonsils or long upper airway). Black, Hispanic/Latino, and Native American/Alaska Native persons have a higher prevalence of OSA compared with White persons; some evidence suggests that these differences are partially explained by higher rates of obesity, asthma, and tobacco use among these groups.8'}, {'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of multivitamin supplements for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of single or paired nutrient supplements (other than beta carotene and vitamin E) for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Oral Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for oral cancer in asymptomatic adults.\r\rGo to the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in July 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Tobacco and alcohol use are major risk factors for oral cancer. A total of 20% to 30% of cases of oral cancer worldwide are attributable to cigarette smoking. In the United States, up to 75% of cases of oral cancer may be attributable to tobacco and alcohol use. Additional risk factors include male sex, older age, use of betel quid, ultraviolet light exposure, infection with Candida or bacterial flora, and a compromised immune system. Sexually transmitted oral HPV infection (HPV-16) has recently been recognized as an increasingly important risk factor for oropharyngeal cancer. In the United States, the prevalence of oropharyngeal cancer due to oral HPV infection is probably as high as 80% to 95%. The prevalence of oral HPV infection is associated with age, sex, number of sexual partners, and number of cigarettes smoked per day. The effect of multifactorial risk assessment and screening for risk factors on oral cancer morbidity and mortality is unknown.'}, {'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine screening performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of preventive interventions performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'title': 'Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for peripheral artery disease (PAD) and cardiovascular disease (CVD) risk with the ankle-brachial index (ABI) in asymptomatic adults.\r\rLiterature scans conducted in August 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Risk factors associated with OSA include male sex, older age (40 to 70 years), postmenopausal status, higher BMI, and craniofacial and upper airway abnormalities.'}, {'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of counseling adults about skin self-examination to prevent skin cancer.See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Skin Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Exposure to UV radiation from sun exposure, indoor tanning beds, and other UV radiation&ndash;emitting devices is the major environmental risk factor for skin cancer. History of frequent sunburns, older age, and male sex are associated with increased risk for skin cancer. Exposure to UV radiation from the use of indoor tanning beds is an important risk factor in adolescents. Incidence of melanoma is higher among White persons compared with persons of other races and ethnicities. This difference likely reflects traits associated with increased melanoma risk, such as fair skin (which is more susceptible to sunburning), light-colored eyes, and red or blond hair being more common among White persons compared with persons of other races and ethnicities. Acral lentiginous melanoma, which occurs mostly on skin not frequently exposed to direct sunlight (eg, palms of hands, soles of feet, or under fingernails or toenails), is the most common type of melanoma among Black populations. Other melanoma risk factors include higher numbers of moles on the skin, atypical moles, as well as a personal and family history of skin cancer.'}, {'title': 'Thyroid Dysfunction: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults.\r\rSee the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': 'The optimal screening interval for thyroid dysfunction (if one exists) is unknown.', 'risktext': 'The most common cause of hypothyroidism in the United States is chronic autoimmune (Hashimoto) thyroiditis. Risk factors for an elevated TSH level include female sex, advancing age, white race, type 1 diabetes, Down syndrome, family history of thyroid disease, goiter, previous hyperthyroidism (possibly due in part to ablation therapy leading to iatrogenic thyroid dysfunction), and external-beam radiation in the head and neck area. Common causes of hyperthyroidism include Graves disease, Hashimoto thyroiditis, and functional thyroid nodules. Risk factors for a low TSH level include female sex; advancing age; black race; low iodine intake; personal or family history of thyroid disease; and ingestion of iodine-containing drugs, such as amiodarone. The USPSTF found no direct evidence that treatment of thyroid dysfunction based on risk level alters final health outcomes.'}, {'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of electronic cigarettes (e-cigarettes) for tobacco cessation in adults, including pregnant persons. The USPSTF recommends that clinicians direct patients who use tobacco to other tobacco cessation interventions with proven effectiveness and established safety.\rSee the Practice Considerations section for more information on recommended behavioral interventions and pharmacotherapy and for suggestions for practice regarding the I statements.', 'servfreq': '', 'risktext': ''}, {'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of pharmacotherapy interventions for tobacco cessation in pregnant persons.', 'servfreq': '', 'risktext': ''}, {'title': 'Tobacco Use in Children and Adolescents: Primary Care Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--feasible interventions for the cessation of tobacco use among school-aged children and adolescents.\r\rSee the Practice Considerations section for more information on effective interventions to prevent initiation of tobacco use and for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Vitamin D Deficiency in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of the benefits and harms of vitamin D and calcium supplementation, alone or combined, for the primary prevention of fractures in men and premenopausal women.', 'servfreq': '', 'risktext': ''}]}
2025-01-29 21:27:14 [INFO] Recommendations: [{'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in adolescents and adults aged 15 to 65 years. Younger adolescents and older adults who are at increased risk of infection should also be screened.\rSee the Clinical Considerations section for more information about assessment of risk, screening intervals, and rescreening in pregnancy.', 'servfreq': 'The USPSTF found insufficient evidence to determine appropriate or optimal time intervals or strategies for repeat HIV screening. However, repeat screening is reasonable for persons known to be at increased risk of HIV infection, such as sexually active men who have sex with men; persons with a sex partner who is living with HIV; or persons who engage in behaviors that may convey an increased risk of HIV infection, such as injection drug use, transactional sex or commercial sex work, having 1 or more new sex partners whose HIV status is unknown, or having other factors that can place a person at increased risk of HIV infection (see &ldquo;Risk Assessment&rdquo;). Repeat screening is also reasonable for persons who live or receive medical care in a high-prevalence setting, such as a sexually transmitted disease clinic, tuberculosis clinic, correctional facility, or homeless shelter.', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'title': 'Hypertension in Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hypertension in adults 18 years or older with office blood pressure measurement (OBPM). The USPSTF recommends obtaining blood pressure measurements outside of the clinical setting for diagnostic confirmation before starting treatment.', 'servfreq': ' \r\nAlthough evidence on optimal screening intervals is limited, reasonable options include:\r\n \r\n \r\n\r\n\r\nScreening for hypertension every year in adults 40 years or older and in adults at increased risk for hypertension (such as Black persons, persons with high-normal blood pressure, or persons who are overweight or obese)\r\n\r\n\r\n \r\n \r\n\r\n\r\nScreening less frequently (ie, every 3 to 5 years) as appropriate for adults aged 18 to 39 years not at increased risk for hypertension and with a prior normal blood pressure reading.\r\n\r\n\r\n ', 'risktext': ' \r\nAlthough all adults should be screened for hypertension, risk factors that increase a person&rsquo;s risk for the condition include older age, Black race, family history, excess weight and obesity, lifestyle habits (lack of physical activity, stress, and tobacco use), and dietary factors (diet high in fat or sodium, diet low in potassium, or excessive alcohol intake)\r\n '}, {'title': 'Prevention of Acquisition of HIV: Preexposure Prophylaxis ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians prescribe preexposure prophylaxis using effective antiretroviral therapy to persons who are at increased risk of HIV acquisition to decrease the risk of acquiring HIV. \r\rSee the Practice Considerations section for more information about identification of persons at increased risk and about effective antiretroviral therapy.', 'servfreq': '', 'risktext': 'HIV is primarily acquired via sexual activity or injection drug use. It is important that clinicians routinely take a sexual and injection drug use history for all their patients in an open and nonjudgmental manner. All adolescents and adults who are sexually active or who inject drugs should be informed that acquisition of HIV can be prevented, to facilitate subsequent risk assessment and discussions about preexposure prophylaxis (PrEP) and other ways to prevent acquisition of HIV. Importantly, risk of HIV acquisition exists on a continuum, and currently available risk assessment tools all have limitations. However, certain risk factors or behaviors are known to place persons at increased risk of HIV.\r\nRisk of HIV acquisition depends on the likelihood that a specific act or activity will transmit HIV and the likelihood that a sex partner or drug injection partner has HIV. Likelihood of HIV transmission is highest with needle-sharing injection drug use and condomless receptive anal intercourse. Condomless receptive anal intercourse has an approximately 10- to 15-fold higher risk of transmission than condomless insertive anal sex and condomless receptive and insertive penile-vaginal sex. A 2018 study estimated the prevalence of HIV (ie, an estimate of the likelihood that a partner whose HIV status is unknown has HIV at a population level) as 12.4% among men who have sex with men and 1.9% among persons who inject drugs. The overall prevalence of HIV in the US is estimated at 0.3%.&nbsp;Of note, both the frequency of specific sexual activities and a person&rsquo;s number of sexual partners will also affect their risk of HIV.\r\n&nbsp;The USPSTF recommends that the following persons be considered for PrEP:\r\n1.&nbsp;&nbsp;&nbsp;&nbsp; Sexually active adults and adolescents weighing at least 35 kg (77 lb) who have engaged in anal or vaginal sex in the past 6 months and have any of the following:\r\n&nbsp;\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A sexual partner who has HIV (especially if the partner has an unknown or detectable viral load).\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A bacterial sexually transmitted infection (STI) (syphilis, gonorrhea, or chlamydia for men who have sex with men and transgender women; gonorrhea and syphilis for heterosexual women and men) in the past 6 months.\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A history of inconsistent or no condom use with sex partner(s) whose HIV status is not known; assessing risk in conversation with the patient and considering factors such as number of partners, the specific sexual activities a person engages in, and whether their sex partner or partners are in a group with a higher prevalence of HIV (eg, men who have sex with men or with men and women, transgender women, persons who inject drugs, and persons who engage in transactional sex).\r\n&nbsp;\r\n2. &nbsp; Persons who inject drugs and have a drug-injecting partner who has HIV or who shares injection equipment.\r\nPersons who engage in transactional sex, such as sex for money, drugs, or housing, including commercial sex workers or persons trafficked for sex work, constitute a group at increased risk of HIV acquisition and should be considered for PrEP based on the criteria outlined above. Persons who request PrEP may have undisclosed behaviors that put them at risk. Transgender women and men who are sexually active should be considered for PrEP based on the criteria outlined above. Transgender women are at especially high risk of HIV acquisition. A Centers for Disease Control and and Prevention (CDC) survey in 7 cities found an HIV prevalence of 42% among transgender women. Prevalence was highest among Black transgender women (62%) and Native American/Alaska Native transgender women (65%).\r\nIn addition, studies have found that transmission of HIV to a seronegative partner from a partner with HIV has not been observed when the partner with HIV was being treated with antiretroviral therapy and had a suppressed viral load.&nbsp;It is not known whether PrEP use further decreases the risk of HIV transmission when a partner with HIV has a documented undetectable viral load. Factors such as the consistency or inconsistency of a partner&rsquo;s viral load being suppressed, a partner&rsquo;s adherence to antiretroviral therapy, and the degree of certainty that a partner&rsquo;s viral load is suppressed (eg, self-report vs availability of laboratory test results) may help inform decisions about the use of PrEP in this situation.\r\nAll persons being considered for PrEP must have a recently documented negative HIV antigen-antibody test result, and if they have taken oral PrEP or postexposure prophylaxis in the past 3 months, or injectable cabotegravir in the past 12 months, the CDC recommends testing with both an HIV antigen-antibody assay and an HIV-1 RNA assay.'}, {'title': 'Syphilis Infection in Nonpregnant Adolescents and Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for syphilis infection in persons who are at increased risk for infection.', 'servfreq': 'Optimal screening frequency for persons who are at increased risk for syphilis infection is not well established. Men who have sex with men or persons with HIV infection may benefit from screening at least annually or more frequently (eg, every 3 to 6 months) if they continue to be at high risk.', 'risktext': 'The USPSTF recommends screening for syphilis in persons who are at increased risk for infection. When deciding which persons to screen for syphilis, clinicians should consider the prevalence of infection in the communities they serve, as well as other sociodemographic and behavioral factors that may be associated with increased risk of syphilis infection. For example, prevalence of syphilis is higher in men, men who have sex with men, persons with HIV infection, young adults, and persons with a history of incarceration, sex work, or military service. A substantial percentage of heterosexual syphilis transmission occurs among persons who use illicit drugs, particularly methamphetamine. Diagnosis of another STI may signal that a person is having condomless sex, which increases their risk of syphilis infection. Higher infection rates in persons of some racial and ethnic groups have been reported and are primarily a reflection of a combination of factors, including social determinants of health (eg, disparities of income, low educational achievement, and unstable housing), differential health insurance coverage or access to quality health care, and differences in sexual network characteristics (eg, individuals living in communities with a high prevalence of STIs have an increased chance of encountering an infected partner). Local prevalence rates may change over time, so clinicians should be aware of the latest data and trends for their specific population and geographic area, which are available through their state and local health departments and Centers for Disease Control and Prevention (CDC) surveillance.\r\n&nbsp;\r\nAlthough direct evidence on screening in nonpregnant persons who are not at increased risk for syphilis infection is lacking, based on the established test performance characteristics of current screening tests and the low prevalence rate of syphilis in this population, the yield of screening is likely low.9,10 Therefore, screening in this population may result in high false-positive rates and overtreatment.'}, {'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and US Food and Drug Administration (FDA)--approved pharmacotherapy for cessation to nonpregnant adults who use tobacco.', 'servfreq': '', 'risktext': ''}, {'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all pregnant persons about tobacco use, advise them to stop using tobacco, and provide behavioral interventions for cessation to pregnant persons who use tobacco.', 'servfreq': '', 'risktext': ''}, {'title': 'Anxiety Disorders in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for anxiety disorders in adults, including pregnant and postpartum persons.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding optimal timing for screening, or screening interval, for both the perinatal and general adult populations; more evidence on both timing and screening interval is needed for all adult populations. A pragmatic approach in the absence of evidence might include screening all adults who have not been screened previously and using clinical judgment in considering risk factors, comorbid conditions, and life events to determine if additional screening of high-risk patients is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nRisk factors for anxiety disorders include sociodemographic factors, psychosocial factors, and physical and mental health factors such as marital status (widowed or divorced), stressful life events, smoking and alcohol use, other mental health conditions, or a parental history of mental disorders. Demographic factors such as low socioeconomic status and female sex are associated with higher rates of anxiety disorders.&nbsp;Black persons and individuals of non-Hispanic ethnicity are at increased risk of anxiety disorders due to social, rather than biological, factors. Anxiety and depressive disorders often overlap. One cohort study found that 67% of individuals with a depressive disorder also had a current anxiety disorder, and 75% had a lifetime comorbid anxiety disorder.'}, {'title': 'Latent Tuberculosis Infection in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for LTBI in populations at increased risk.\r\rSee the "Assessment of Risk" section for additional information on adults at increased risk.', 'servfreq': 'The USPSTF found no evidence on the optimal frequency of screening for LTBI. In the absence of evidence, a reasonable approach is to repeat screening based on specific risk factors; screening frequency could range from 1-time only screening among persons at low risk for future tuberculosis exposure to annual screening among those at continued risk of exposure.', 'risktext': 'Populations at increased risk for LTBI, based on increased prevalence of active disease and increased risk of exposure, include persons who were born in, or are former residents of, countries with high tuberculosis prevalence and persons who live in, or have lived in, high-risk congregate settings (eg, homeless shelters or correctional facilities). Clinicians can consult their local or state health departments for more information about populations at increased risk in their community, since local demographic patterns may vary across the US.\r\nIn 2020, 71.5% of all cases of active tuberculosis in the US occurred among persons born outside the US. According to the CDC, tuberculosis disease is common in most countries in Latin America, the Caribbean, Africa, Asia, Eastern Europe, and Russia. In 2020, among persons with new tuberculosis living in the US who were born outside the US, the most common countries of birth were Mexico (18.0%), the Philippines (12.5%), India (10.4%), Vietnam (8.2%), and China (5.1%), accounting for 54.2% of total cases. Most of these cases are believed to be due to progression of latent infection to active tuberculosis disease rather than new transmission within communities.\r\nPersons who live, or have lived, in high-risk congregate settings also have a higher prevalence rate of active tuberculosis and an increased risk for exposure. In 2020, 4.3% of tuberculosis disease cases diagnosed in persons 15 years or older occurred in persons experiencing homelessness and 2.6% occurred in residents of correctional facilities. It is estimated that persons experiencing homelessness have an 11 times higher incidence of tuberculosis disease compared with persons who are not experiencing homelessness (36 cases per 100,000 population vs 2.9 cases per 100,000 population, respectively, during 2011 to 2016).\r\nOther populations at increased risk for LTBI or progression to active disease include persons who have immunosuppression (eg, persons living with HIV, patients receiving immunosuppressive medications such as chemotherapy or tumor necrosis factor inhibitors, and patients who have received an organ transplant) and patients with silicosis (a lung disease). However, given that screening in these populations may be considered standard care as part of disease management or indicated prior to the use of certain medications, the USPSTF did not review evidence on screening in these populations. Information on testing in these populations is provided by other groups, such as the Office of AIDS Research at the National Institutes of Health, and in a guideline issued jointly by the American Thoracic Society, Infectious Diseases Society of America, and CDC. Some evidence from observational studies has explored the association between poorly controlled diabetes and progression of LTBI to active disease. However, there is insufficient evidence on screening for and treatment of LTBI in persons with diabetes for the USPSTF to make a separate recommendation for this important population.\r\nPersons who are contacts of individuals with active tuberculosis, health care workers, and workers in high-risk congregate settings may also be at increased risk of exposure. Because screening in these populations is conducted as part of public health or employee health surveillance, the USPSTF did not review the evidence in these populations. Clinicians seeking further information about testing for tuberculosis in these populations can refer to the Additional Tools and Resources and Recommendations of Others sections.'}, {'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic bacteriuria in nonpregnant adults.', 'servfreq': '', 'risktext': 'The risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6 Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5 Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7, 11, 12 In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12 Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4, 6'}, {'title': 'Asymptomatic Carotid Artery Stenosis: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic carotid artery stenosis in the general adult population.\r\rSee the Practice Considerations section for a description of adults at increased risk.', 'servfreq': '', 'risktext': ''}, {'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for suicide risk in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': '', 'risktext': ''}, {'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for depression in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding the optimal timing for screening for depression; more evidence is needed in both perinatal and general adult populations. In the absence of evidence, a pragmatic approach might include screening adults who have not been screened previously and using clinical judgment while considering risk factors, comorbid conditions, and life events to determine if additional screening of patients at increased risk is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nThe USPSTF recommends screening for depression in all adults regardless of risk factors. Risk factors for depression include a combination of genetic, biological, and environmental factors, such as a family history of depression, prior episode of depression or other mental health condition, a history of trauma or adverse life events, or a history of disease or illness (eg, cardiovascular disease).\r\nPrevalence rates vary by sex, age, race, ethnicity, education, marital status, geographic location, poverty level, and employment status. Women have twice the risk of depression compared with men. Young adults, multiracial individuals, and Native American/Alaska Native individuals have higher rates of depression.\r\nRisk factors for perinatal depression include life stress, low social support, history of depression, marital or partner dissatisfaction, and a history of abuse.'}, {'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends offering or referring adults with cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity.', 'servfreq': '', 'risktext': 'Adults 18 years or older at increased risk of CVD, defined as those with 1 or more of the following:\r\n1.Hypertension or elevated blood pressure2.Dyslipidemia3.Mixed or multiple risk factors such as the metabolic syndrome or an estimated 10-year CVD risk of &ge;7.5%\r\nThis recommendation does not apply to adults with other known modifiable cardiovascular risk factors such as abnormal blood glucose levels, obesity, and smoking; these populations are incorporated in other USPSTF recommendations.'}, {'title': 'Hepatitis B Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in adolescents and adults at increased risk for infection.\r\rSee the Practice Considerations section for a description of adolescents and adults at increased risk for infection.', 'servfreq': 'For patients with negative HBsAg results who have not received the HBV vaccine series, periodic screening may be useful for those who report continued risk for acquiring HBV transmission, such as persons who continue to inject drugs and men who have sex with men. Clinical judgment should be used to determine screening frequency. The USPSTF found no evidence to determine optimal screening intervals.', 'risktext': 'Persons from such risk groups include persons who have injected drugs in the past or currently; men who have sex with men; persons with HIV; and sex partners, needle-sharing contacts, and household contacts of persons known to be HBsAg positive. Some persons with combinations of risk factors who are not members of risk factor groups listed above may also be at increased risk for HBV infection.'}, {'title': 'Hepatitis C Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis C virus (HCV) infection in adults aged 18 to 79 years.', 'servfreq': 'One-time screening for most adults.\r\nPeriodically screen persons with continued risk for HCV infection (eg, persons with past or current injection drug use). There is limited evidence to determine how often to screen persons at increased risk.&nbsp;', 'risktext': 'Asymptomatic adults aged 18 to 79 years (including pregnant persons) without known liver disease.&nbsp;\r\nThe USPSTF also suggests that clinicians consider screening persons younger than 18 years and older than 79 years who are at high risk for infection (eg, those with past or current injection drug use).&nbsp;'}, {'title': 'Lung Cancer: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery.', 'servfreq': ' \r\nThe USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. ', 'risktext': ' \r\nSmoking and older age are the 2 most important risk factors for lung cancer.&nbsp;The risk of lung cancer in persons who smoke increases with cumulative quantity and duration of smoking and with age but decreases with increasing time since quitting for persons who formerly smoked.3 The USPSTF considers adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years to be at high risk and recommends screening for lung cancer with annual LDCT in this population. \r\n \r\n&nbsp;\r\n \r\nAfrican American/Black (Black) men have a higher incidence of lung cancer than White men, and Black women have a lower incidence than White women.1 These differences are likely related to differences in smoking exposure (ie, prevalence of smoking) and related exposure to carcinogens in cigarettes.7,8 The differences may also be related to other social risk factors.\r\n \r\n&nbsp;\r\n \r\nOther risk factors for lung cancer include environmental exposures, prior radiation therapy, other (noncancer) lung diseases, and family history. Lower level of education is also associated with a higher risk of lung cancer.7 The task force recommends using age and smoking history to determine screening eligibility rather than more elaborate risk prediction models because there is insufficient evidence to assess whether risk prediction model&ndash;based screening would improve outcomes relative to using the risk factors of age and smoking history for broad implementation in primary care.\r\n '}, {'title': 'Sexually Transmitted Infections: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends behavioral counseling for all sexually active adolescents and for adults who are at increased risk for sexually transmitted infections (STIs).\r\rSee the Practice Considerations section for more information on populations at increased risk for acquiring STIs.', 'servfreq': '', 'risktext': 'All sexually active adolescents are at increased risk for STIs because of the high rates of STIs in this age group and should receive behavioral counseling interventions. Adults at increased risk for STIs include those who currently have an STI or were diagnosed with one within the past year, do not consistently use condoms, have multiple sex partners, or have sex partners within populations with a high prevalence of STIs. Populations with a high prevalence of STIs include persons who seek STI testing or attend STI clinics; sexual and gender minorities; persons who are living with HIV, inject drugs, have exchanged sex for money or drugs, or have entered correctional facilities; and some racial/ethnic minority groups.1-4'}, {'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends counseling young adults, adolescents, children, and parents of young children about minimizing exposure to ultraviolet (UV) radiation for persons aged 6 months to 24 years with fair skin types to reduce their risk of skin cancer.', 'servfreq': '', 'risktext': 'Fair skin types'}, {'title': 'Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for unhealthy alcohol use in primary care settings in adults 18 years or older, including pregnant women, and providing persons engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce unhealthy alcohol use.', 'servfreq': 'The USPSTF did not find adequate evidence to recommend an optimal screening interval for unhealthy alcohol use in adults.&nbsp;Brief behavioral counseling interventions were found to reduce unhealthy alcohol use in adults 18 years or older, including pregnant women. Effective behavioral counseling interventions vary in their specific components, administration, length, and number of interactions. The USPSTF was unable to identify specific intervention characteristics or components that were clearly associated with improved outcomes.', 'risktext': 'engaged in risky or hazardous drinking'}, {'title': 'Unhealthy Drug Use: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening by asking questions about unhealthy drug use in adults age 18 years or older. Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. \r(Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'servfreq': 'Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. (Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'risktext': 'These include being aged 18 to 25 years; male sex; having a mental health condition, personality or mood disorder, or nicotine or alcohol dependence; a history of physical or sexual abuse, parental neglect, or other adversity in childhood; or drug or alcohol addiction in a first-degree relative.1,9&nbsp;Factors associated with misuse of prescription drugs include history of other drug use, mental illness, pain, and greater access to prescription drugs.10&nbsp;Factors associated with prenatal use of drugs include a mental health disorder, interpersonal violence, and family history of substance use.11'}, {'title': 'Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer or refer adults with a body mass index (BMI) of 30 or higher (calculated as weight in kilograms divided by height in meters squared) to intensive, multicomponent behavioral interventions.', 'servfreq': '', 'risktext': 'Adults with a BMI &ge;30'}, {'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: Behavioral Counseling Interventions ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians individualize the decision to offer or refer adults without cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity. \r\rSee the "Practice Considerations" section for information on determining which patients may benefit most from this service.', 'servfreq': '', 'risktext': ''}, {'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for chlamydia and gonorrhea in men.', 'servfreq': '', 'risktext': ''}, {'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening with resting or exercise electrocardiography (ECG) to prevent cardiovascular disease (CVD) events in asymptomatic adults at low risk of CVD events.', 'servfreq': '', 'risktext': ''}, {'title': 'Chronic Obstructive Pulmonary Disease: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for chronic obstructive pulmonary disease in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'title': 'Genital Herpes Infection: Serologic Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine serologic screening for genital herpes simplex virus infection in asymptomatic adolescents and adults, including pregnant persons.', 'servfreq': '', 'risktext': 'The USPSTF found no evidence of externally validated, reliable risk stratification tools to identify individuals more or less likely to have genital herpes.'}, {'title': 'Pancreatic Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for pancreatic cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'title': 'Testicular Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for testicular cancer in adolescent or adult men.', 'servfreq': '', 'risktext': ''}, {'title': 'Thyroid Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for thyroid cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'D', 'text': 'The DoctorAI recommends against the use of beta carotene or vitamin E supplements for the prevention of cardiovascular disease or cancer.', 'servfreq': '', 'risktext': ''}, {'title': 'Autism Spectrum Disorder in Young Children: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for autism spectrum disorder (ASD) in young children for whom no concerns of ASD have been raised by their parents or a clinician.', 'servfreq': '', 'risktext': 'Although a number of potential risk factors for ASD have been identified, there is insufficient evidence to determine if certain risk factors modify the performance characteristics of ASD screening tests, such as the age at which screening is performed or other characteristics of the child or family.'}, {'title': 'Bladder Cancer in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults.\r\rLiterature scans conducted in July 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'This evidence update focused on the benefits and harms of screening for bladder cancer among people without symptoms, the accuracy of screening tests done in primary care settings, and the benefits and harms of treatment. The updated evidence review did not find any new high quality evidence to adequately determine the balance of benefits and harms of screening for bladder cancer. However, bladder cancer is a common cancer and can cause considerable health problems including death. Therefore, the USPSTF determined that the evidence was insufficient to provide a recommendation for or against bladder cancer screening.  The USPSTF emphasizes the need for additional research in this area. '}, {'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening with resting or exercise ECG to prevent CVD events in asymptomatic adults at intermediate or high risk of CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of adding the ankle-brachial index (ABI), high-sensitivity C-reactive protein (hsCRP) level, or coronary artery calcium (CAC) score to traditional risk assessment for cardiovascular disease (CVD) in asymptomatic adults to prevent CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Celiac Disease: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'persons with family history or other risk factors'}, {'title': 'Eating Disorders in Adolescents and Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for eating disorders in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Illicit Drug Use in Children, Adolescents, and Young Adults: Primary Care-Based Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--based behavioral counseling interventions to prevent illicit drug use, including nonmedical use of prescription drugs, in children, adolescents, and young adults.\r\rSee the Practice Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for abuse and neglect in all older or vulnerable adults. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': 'Risk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health.14&nbsp;For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.15'}, {'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for iron deficiency and iron deficiency anemia in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine iron supplementation in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'title': 'Lipid Disorders in Children and Adolescents: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Obstructive Sleep Apnea in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for obstructive sleep apnea in the general adult population.\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Risk Factors\r\nRisk factors associated with OSA include male sex, older age (40-70 years), postmenopausal status, higher body mass index (BMI), and craniofacial and upper airway abnormalities (eg, enlarged tonsils or long upper airway). Black, Hispanic/Latino, and Native American/Alaska Native persons have a higher prevalence of OSA compared with White persons; some evidence suggests that these differences are partially explained by higher rates of obesity, asthma, and tobacco use among these groups.8'}, {'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of multivitamin supplements for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of single or paired nutrient supplements (other than beta carotene and vitamin E) for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Oral Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for oral cancer in asymptomatic adults.\r\rGo to the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in July 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Tobacco and alcohol use are major risk factors for oral cancer. A total of 20% to 30% of cases of oral cancer worldwide are attributable to cigarette smoking. In the United States, up to 75% of cases of oral cancer may be attributable to tobacco and alcohol use. Additional risk factors include male sex, older age, use of betel quid, ultraviolet light exposure, infection with Candida or bacterial flora, and a compromised immune system. Sexually transmitted oral HPV infection (HPV-16) has recently been recognized as an increasingly important risk factor for oropharyngeal cancer. In the United States, the prevalence of oropharyngeal cancer due to oral HPV infection is probably as high as 80% to 95%. The prevalence of oral HPV infection is associated with age, sex, number of sexual partners, and number of cigarettes smoked per day. The effect of multifactorial risk assessment and screening for risk factors on oral cancer morbidity and mortality is unknown.'}, {'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine screening performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of preventive interventions performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'title': 'Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for peripheral artery disease (PAD) and cardiovascular disease (CVD) risk with the ankle-brachial index (ABI) in asymptomatic adults.\r\rLiterature scans conducted in August 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Risk factors associated with OSA include male sex, older age (40 to 70 years), postmenopausal status, higher BMI, and craniofacial and upper airway abnormalities.'}, {'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of counseling adults about skin self-examination to prevent skin cancer.See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Skin Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Exposure to UV radiation from sun exposure, indoor tanning beds, and other UV radiation&ndash;emitting devices is the major environmental risk factor for skin cancer. History of frequent sunburns, older age, and male sex are associated with increased risk for skin cancer. Exposure to UV radiation from the use of indoor tanning beds is an important risk factor in adolescents. Incidence of melanoma is higher among White persons compared with persons of other races and ethnicities. This difference likely reflects traits associated with increased melanoma risk, such as fair skin (which is more susceptible to sunburning), light-colored eyes, and red or blond hair being more common among White persons compared with persons of other races and ethnicities. Acral lentiginous melanoma, which occurs mostly on skin not frequently exposed to direct sunlight (eg, palms of hands, soles of feet, or under fingernails or toenails), is the most common type of melanoma among Black populations. Other melanoma risk factors include higher numbers of moles on the skin, atypical moles, as well as a personal and family history of skin cancer.'}, {'title': 'Thyroid Dysfunction: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults.\r\rSee the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': 'The optimal screening interval for thyroid dysfunction (if one exists) is unknown.', 'risktext': 'The most common cause of hypothyroidism in the United States is chronic autoimmune (Hashimoto) thyroiditis. Risk factors for an elevated TSH level include female sex, advancing age, white race, type 1 diabetes, Down syndrome, family history of thyroid disease, goiter, previous hyperthyroidism (possibly due in part to ablation therapy leading to iatrogenic thyroid dysfunction), and external-beam radiation in the head and neck area. Common causes of hyperthyroidism include Graves disease, Hashimoto thyroiditis, and functional thyroid nodules. Risk factors for a low TSH level include female sex; advancing age; black race; low iodine intake; personal or family history of thyroid disease; and ingestion of iodine-containing drugs, such as amiodarone. The USPSTF found no direct evidence that treatment of thyroid dysfunction based on risk level alters final health outcomes.'}, {'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of electronic cigarettes (e-cigarettes) for tobacco cessation in adults, including pregnant persons. The USPSTF recommends that clinicians direct patients who use tobacco to other tobacco cessation interventions with proven effectiveness and established safety.\rSee the Practice Considerations section for more information on recommended behavioral interventions and pharmacotherapy and for suggestions for practice regarding the I statements.', 'servfreq': '', 'risktext': ''}, {'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of pharmacotherapy interventions for tobacco cessation in pregnant persons.', 'servfreq': '', 'risktext': ''}, {'title': 'Tobacco Use in Children and Adolescents: Primary Care Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--feasible interventions for the cessation of tobacco use among school-aged children and adolescents.\r\rSee the Practice Considerations section for more information on effective interventions to prevent initiation of tobacco use and for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Vitamin D Deficiency in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of the benefits and harms of vitamin D and calcium supplementation, alone or combined, for the primary prevention of fractures in men and premenopausal women.', 'servfreq': '', 'risktext': ''}]
2025-01-29 21:27:15 [INFO] Update id=273478103 is handled. Duration 828 ms by bot id=8108339380
2025-01-29 21:41:54 [INFO] Update id=273478104 is handled. Duration 1647 ms by bot id=8108339380
2025-01-29 21:41:57 [INFO] Update id=273478105 is handled. Duration 721 ms by bot id=8108339380
2025-01-29 21:41:59 [INFO] Update id=273478106 is handled. Duration 748 ms by bot id=8108339380
2025-01-29 21:47:10 [WARNING] Received SIGTERM signal
2025-01-29 21:47:10 [INFO] Polling stopped for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-29 21:47:10 [INFO] Polling stopped
2025-01-29 21:47:10 [INFO] โ ะัะป ะฟะพะดะบะปััะตะฝะธะน ะบ ะะ ะทะฐะบััั.
2025-01-29 21:47:10 [INFO] โ ะะพะดะบะปััะตะฝะธะต ะบ ะะ ะทะฐะบัััะพ.
2025-01-29 21:47:19 [INFO] ๐ ะะพั ะทะฐะฟััะบะฐะตััั...
2025-01-29 21:47:19 [INFO] โ ะัะป ะฟะพะดะบะปััะตะฝะธะน ะบ ะะ ัะพะทะดะฐะฝ.
2025-01-29 21:47:19 [INFO] โ ะขะฐะฑะปะธัั ะฒ ะฑะฐะทะต ะดะฐะฝะฝัั ััะฟะตัะฝะพ ัะพะทะดะฐะฝั.
2025-01-29 21:47:19 [INFO] Start polling
2025-01-29 21:47:21 [INFO] Run polling for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-29 21:47:21 [INFO] The user 711983855 called the command /start.
2025-01-29 21:47:22 [INFO] Update id=273478107 is handled. Duration 1448 ms by bot id=8108339380
2025-01-29 21:47:24 [INFO] The user 711983855's state has been set to Survey.age.
2025-01-29 21:47:24 [INFO] Update id=273478108 is handled. Duration 356 ms by bot id=8108339380
2025-01-29 21:47:26 [INFO] The user 711983855's state has been set to Survey.weight.
2025-01-29 21:47:27 [INFO] Update id=273478109 is handled. Duration 339 ms by bot id=8108339380
2025-01-29 21:47:28 [INFO] The user 711983855's state has been set to Survey.height.
2025-01-29 21:47:28 [INFO] Update id=273478110 is handled. Duration 348 ms by bot id=8108339380
2025-01-29 21:47:30 [INFO] The user 711983855's state has been set to Survey.feet.
2025-01-29 21:47:30 [INFO] Update id=273478111 is handled. Duration 337 ms by bot id=8108339380
2025-01-29 21:47:32 [INFO] The user 711983855's state has been set to Survey.gender.
2025-01-29 21:47:33 [INFO] Update id=273478112 is handled. Duration 343 ms by bot id=8108339380
2025-01-29 21:47:35 [INFO] The user 711983855's state has been set to Survey.smoking.
2025-01-29 21:47:35 [INFO] Update id=273478113 is handled. Duration 338 ms by bot id=8108339380
2025-01-29 21:47:36 [INFO] The user 711983855's state has been set to Survey.sex.
2025-01-29 21:47:37 [INFO] Update id=273478114 is handled. Duration 333 ms by bot id=8108339380
2025-01-29 21:47:37 [INFO] State data: {'db': <bot.database.Database object at 0x7f4e54c2f3b0>, 'age': 20, 'weight': 90, 'height': 190, 'feet': 45, 'gender': 'male', 'pregnant': 'no', 'smoking': 'yes', 'sex': 'yes'}
2025-01-29 21:47:37 [INFO] Recommendations: [{'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in adolescents and adults aged 15 to 65 years. Younger adolescents and older adults who are at increased risk of infection should also be screened.\rSee the Clinical Considerations section for more information about assessment of risk, screening intervals, and rescreening in pregnancy.', 'servfreq': 'The USPSTF found insufficient evidence to determine appropriate or optimal time intervals or strategies for repeat HIV screening. However, repeat screening is reasonable for persons known to be at increased risk of HIV infection, such as sexually active men who have sex with men; persons with a sex partner who is living with HIV; or persons who engage in behaviors that may convey an increased risk of HIV infection, such as injection drug use, transactional sex or commercial sex work, having 1 or more new sex partners whose HIV status is unknown, or having other factors that can place a person at increased risk of HIV infection (see &ldquo;Risk Assessment&rdquo;). Repeat screening is also reasonable for persons who live or receive medical care in a high-prevalence setting, such as a sexually transmitted disease clinic, tuberculosis clinic, correctional facility, or homeless shelter.', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'title': 'Hypertension in Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hypertension in adults 18 years or older with office blood pressure measurement (OBPM). The USPSTF recommends obtaining blood pressure measurements outside of the clinical setting for diagnostic confirmation before starting treatment.', 'servfreq': ' \r\nAlthough evidence on optimal screening intervals is limited, reasonable options include:\r\n \r\n \r\n\r\n\r\nScreening for hypertension every year in adults 40 years or older and in adults at increased risk for hypertension (such as Black persons, persons with high-normal blood pressure, or persons who are overweight or obese)\r\n\r\n\r\n \r\n \r\n\r\n\r\nScreening less frequently (ie, every 3 to 5 years) as appropriate for adults aged 18 to 39 years not at increased risk for hypertension and with a prior normal blood pressure reading.\r\n\r\n\r\n ', 'risktext': ' \r\nAlthough all adults should be screened for hypertension, risk factors that increase a person&rsquo;s risk for the condition include older age, Black race, family history, excess weight and obesity, lifestyle habits (lack of physical activity, stress, and tobacco use), and dietary factors (diet high in fat or sodium, diet low in potassium, or excessive alcohol intake)\r\n '}, {'title': 'Prevention of Acquisition of HIV: Preexposure Prophylaxis ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians prescribe preexposure prophylaxis using effective antiretroviral therapy to persons who are at increased risk of HIV acquisition to decrease the risk of acquiring HIV. \r\rSee the Practice Considerations section for more information about identification of persons at increased risk and about effective antiretroviral therapy.', 'servfreq': '', 'risktext': 'HIV is primarily acquired via sexual activity or injection drug use. It is important that clinicians routinely take a sexual and injection drug use history for all their patients in an open and nonjudgmental manner. All adolescents and adults who are sexually active or who inject drugs should be informed that acquisition of HIV can be prevented, to facilitate subsequent risk assessment and discussions about preexposure prophylaxis (PrEP) and other ways to prevent acquisition of HIV. Importantly, risk of HIV acquisition exists on a continuum, and currently available risk assessment tools all have limitations. However, certain risk factors or behaviors are known to place persons at increased risk of HIV.\r\nRisk of HIV acquisition depends on the likelihood that a specific act or activity will transmit HIV and the likelihood that a sex partner or drug injection partner has HIV. Likelihood of HIV transmission is highest with needle-sharing injection drug use and condomless receptive anal intercourse. Condomless receptive anal intercourse has an approximately 10- to 15-fold higher risk of transmission than condomless insertive anal sex and condomless receptive and insertive penile-vaginal sex. A 2018 study estimated the prevalence of HIV (ie, an estimate of the likelihood that a partner whose HIV status is unknown has HIV at a population level) as 12.4% among men who have sex with men and 1.9% among persons who inject drugs. The overall prevalence of HIV in the US is estimated at 0.3%.&nbsp;Of note, both the frequency of specific sexual activities and a person&rsquo;s number of sexual partners will also affect their risk of HIV.\r\n&nbsp;The USPSTF recommends that the following persons be considered for PrEP:\r\n1.&nbsp;&nbsp;&nbsp;&nbsp; Sexually active adults and adolescents weighing at least 35 kg (77 lb) who have engaged in anal or vaginal sex in the past 6 months and have any of the following:\r\n&nbsp;\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A sexual partner who has HIV (especially if the partner has an unknown or detectable viral load).\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A bacterial sexually transmitted infection (STI) (syphilis, gonorrhea, or chlamydia for men who have sex with men and transgender women; gonorrhea and syphilis for heterosexual women and men) in the past 6 months.\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A history of inconsistent or no condom use with sex partner(s) whose HIV status is not known; assessing risk in conversation with the patient and considering factors such as number of partners, the specific sexual activities a person engages in, and whether their sex partner or partners are in a group with a higher prevalence of HIV (eg, men who have sex with men or with men and women, transgender women, persons who inject drugs, and persons who engage in transactional sex).\r\n&nbsp;\r\n2. &nbsp; Persons who inject drugs and have a drug-injecting partner who has HIV or who shares injection equipment.\r\nPersons who engage in transactional sex, such as sex for money, drugs, or housing, including commercial sex workers or persons trafficked for sex work, constitute a group at increased risk of HIV acquisition and should be considered for PrEP based on the criteria outlined above. Persons who request PrEP may have undisclosed behaviors that put them at risk. Transgender women and men who are sexually active should be considered for PrEP based on the criteria outlined above. Transgender women are at especially high risk of HIV acquisition. A Centers for Disease Control and and Prevention (CDC) survey in 7 cities found an HIV prevalence of 42% among transgender women. Prevalence was highest among Black transgender women (62%) and Native American/Alaska Native transgender women (65%).\r\nIn addition, studies have found that transmission of HIV to a seronegative partner from a partner with HIV has not been observed when the partner with HIV was being treated with antiretroviral therapy and had a suppressed viral load.&nbsp;It is not known whether PrEP use further decreases the risk of HIV transmission when a partner with HIV has a documented undetectable viral load. Factors such as the consistency or inconsistency of a partner&rsquo;s viral load being suppressed, a partner&rsquo;s adherence to antiretroviral therapy, and the degree of certainty that a partner&rsquo;s viral load is suppressed (eg, self-report vs availability of laboratory test results) may help inform decisions about the use of PrEP in this situation.\r\nAll persons being considered for PrEP must have a recently documented negative HIV antigen-antibody test result, and if they have taken oral PrEP or postexposure prophylaxis in the past 3 months, or injectable cabotegravir in the past 12 months, the CDC recommends testing with both an HIV antigen-antibody assay and an HIV-1 RNA assay.'}, {'title': 'Syphilis Infection in Nonpregnant Adolescents and Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for syphilis infection in persons who are at increased risk for infection.', 'servfreq': 'Optimal screening frequency for persons who are at increased risk for syphilis infection is not well established. Men who have sex with men or persons with HIV infection may benefit from screening at least annually or more frequently (eg, every 3 to 6 months) if they continue to be at high risk.', 'risktext': 'The USPSTF recommends screening for syphilis in persons who are at increased risk for infection. When deciding which persons to screen for syphilis, clinicians should consider the prevalence of infection in the communities they serve, as well as other sociodemographic and behavioral factors that may be associated with increased risk of syphilis infection. For example, prevalence of syphilis is higher in men, men who have sex with men, persons with HIV infection, young adults, and persons with a history of incarceration, sex work, or military service. A substantial percentage of heterosexual syphilis transmission occurs among persons who use illicit drugs, particularly methamphetamine. Diagnosis of another STI may signal that a person is having condomless sex, which increases their risk of syphilis infection. Higher infection rates in persons of some racial and ethnic groups have been reported and are primarily a reflection of a combination of factors, including social determinants of health (eg, disparities of income, low educational achievement, and unstable housing), differential health insurance coverage or access to quality health care, and differences in sexual network characteristics (eg, individuals living in communities with a high prevalence of STIs have an increased chance of encountering an infected partner). Local prevalence rates may change over time, so clinicians should be aware of the latest data and trends for their specific population and geographic area, which are available through their state and local health departments and Centers for Disease Control and Prevention (CDC) surveillance.\r\n&nbsp;\r\nAlthough direct evidence on screening in nonpregnant persons who are not at increased risk for syphilis infection is lacking, based on the established test performance characteristics of current screening tests and the low prevalence rate of syphilis in this population, the yield of screening is likely low.9,10 Therefore, screening in this population may result in high false-positive rates and overtreatment.'}, {'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and US Food and Drug Administration (FDA)--approved pharmacotherapy for cessation to nonpregnant adults who use tobacco.', 'servfreq': '', 'risktext': ''}, {'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all pregnant persons about tobacco use, advise them to stop using tobacco, and provide behavioral interventions for cessation to pregnant persons who use tobacco.', 'servfreq': '', 'risktext': ''}, {'title': 'Anxiety Disorders in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for anxiety disorders in adults, including pregnant and postpartum persons.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding optimal timing for screening, or screening interval, for both the perinatal and general adult populations; more evidence on both timing and screening interval is needed for all adult populations. A pragmatic approach in the absence of evidence might include screening all adults who have not been screened previously and using clinical judgment in considering risk factors, comorbid conditions, and life events to determine if additional screening of high-risk patients is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nRisk factors for anxiety disorders include sociodemographic factors, psychosocial factors, and physical and mental health factors such as marital status (widowed or divorced), stressful life events, smoking and alcohol use, other mental health conditions, or a parental history of mental disorders. Demographic factors such as low socioeconomic status and female sex are associated with higher rates of anxiety disorders.&nbsp;Black persons and individuals of non-Hispanic ethnicity are at increased risk of anxiety disorders due to social, rather than biological, factors. Anxiety and depressive disorders often overlap. One cohort study found that 67% of individuals with a depressive disorder also had a current anxiety disorder, and 75% had a lifetime comorbid anxiety disorder.'}, {'title': 'Latent Tuberculosis Infection in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for LTBI in populations at increased risk.\r\rSee the "Assessment of Risk" section for additional information on adults at increased risk.', 'servfreq': 'The USPSTF found no evidence on the optimal frequency of screening for LTBI. In the absence of evidence, a reasonable approach is to repeat screening based on specific risk factors; screening frequency could range from 1-time only screening among persons at low risk for future tuberculosis exposure to annual screening among those at continued risk of exposure.', 'risktext': 'Populations at increased risk for LTBI, based on increased prevalence of active disease and increased risk of exposure, include persons who were born in, or are former residents of, countries with high tuberculosis prevalence and persons who live in, or have lived in, high-risk congregate settings (eg, homeless shelters or correctional facilities). Clinicians can consult their local or state health departments for more information about populations at increased risk in their community, since local demographic patterns may vary across the US.\r\nIn 2020, 71.5% of all cases of active tuberculosis in the US occurred among persons born outside the US. According to the CDC, tuberculosis disease is common in most countries in Latin America, the Caribbean, Africa, Asia, Eastern Europe, and Russia. In 2020, among persons with new tuberculosis living in the US who were born outside the US, the most common countries of birth were Mexico (18.0%), the Philippines (12.5%), India (10.4%), Vietnam (8.2%), and China (5.1%), accounting for 54.2% of total cases. Most of these cases are believed to be due to progression of latent infection to active tuberculosis disease rather than new transmission within communities.\r\nPersons who live, or have lived, in high-risk congregate settings also have a higher prevalence rate of active tuberculosis and an increased risk for exposure. In 2020, 4.3% of tuberculosis disease cases diagnosed in persons 15 years or older occurred in persons experiencing homelessness and 2.6% occurred in residents of correctional facilities. It is estimated that persons experiencing homelessness have an 11 times higher incidence of tuberculosis disease compared with persons who are not experiencing homelessness (36 cases per 100,000 population vs 2.9 cases per 100,000 population, respectively, during 2011 to 2016).\r\nOther populations at increased risk for LTBI or progression to active disease include persons who have immunosuppression (eg, persons living with HIV, patients receiving immunosuppressive medications such as chemotherapy or tumor necrosis factor inhibitors, and patients who have received an organ transplant) and patients with silicosis (a lung disease). However, given that screening in these populations may be considered standard care as part of disease management or indicated prior to the use of certain medications, the USPSTF did not review evidence on screening in these populations. Information on testing in these populations is provided by other groups, such as the Office of AIDS Research at the National Institutes of Health, and in a guideline issued jointly by the American Thoracic Society, Infectious Diseases Society of America, and CDC. Some evidence from observational studies has explored the association between poorly controlled diabetes and progression of LTBI to active disease. However, there is insufficient evidence on screening for and treatment of LTBI in persons with diabetes for the USPSTF to make a separate recommendation for this important population.\r\nPersons who are contacts of individuals with active tuberculosis, health care workers, and workers in high-risk congregate settings may also be at increased risk of exposure. Because screening in these populations is conducted as part of public health or employee health surveillance, the USPSTF did not review the evidence in these populations. Clinicians seeking further information about testing for tuberculosis in these populations can refer to the Additional Tools and Resources and Recommendations of Others sections.'}, {'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic bacteriuria in nonpregnant adults.', 'servfreq': '', 'risktext': 'The risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6 Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5 Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7, 11, 12 In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12 Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4, 6'}, {'title': 'Asymptomatic Carotid Artery Stenosis: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic carotid artery stenosis in the general adult population.\r\rSee the Practice Considerations section for a description of adults at increased risk.', 'servfreq': '', 'risktext': ''}, {'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for suicide risk in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': '', 'risktext': ''}, {'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for depression in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding the optimal timing for screening for depression; more evidence is needed in both perinatal and general adult populations. In the absence of evidence, a pragmatic approach might include screening adults who have not been screened previously and using clinical judgment while considering risk factors, comorbid conditions, and life events to determine if additional screening of patients at increased risk is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nThe USPSTF recommends screening for depression in all adults regardless of risk factors. Risk factors for depression include a combination of genetic, biological, and environmental factors, such as a family history of depression, prior episode of depression or other mental health condition, a history of trauma or adverse life events, or a history of disease or illness (eg, cardiovascular disease).\r\nPrevalence rates vary by sex, age, race, ethnicity, education, marital status, geographic location, poverty level, and employment status. Women have twice the risk of depression compared with men. Young adults, multiracial individuals, and Native American/Alaska Native individuals have higher rates of depression.\r\nRisk factors for perinatal depression include life stress, low social support, history of depression, marital or partner dissatisfaction, and a history of abuse.'}, {'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends offering or referring adults with cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity.', 'servfreq': '', 'risktext': 'Adults 18 years or older at increased risk of CVD, defined as those with 1 or more of the following:\r\n1.Hypertension or elevated blood pressure2.Dyslipidemia3.Mixed or multiple risk factors such as the metabolic syndrome or an estimated 10-year CVD risk of &ge;7.5%\r\nThis recommendation does not apply to adults with other known modifiable cardiovascular risk factors such as abnormal blood glucose levels, obesity, and smoking; these populations are incorporated in other USPSTF recommendations.'}, {'title': 'Hepatitis B Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in adolescents and adults at increased risk for infection.\r\rSee the Practice Considerations section for a description of adolescents and adults at increased risk for infection.', 'servfreq': 'For patients with negative HBsAg results who have not received the HBV vaccine series, periodic screening may be useful for those who report continued risk for acquiring HBV transmission, such as persons who continue to inject drugs and men who have sex with men. Clinical judgment should be used to determine screening frequency. The USPSTF found no evidence to determine optimal screening intervals.', 'risktext': 'Persons from such risk groups include persons who have injected drugs in the past or currently; men who have sex with men; persons with HIV; and sex partners, needle-sharing contacts, and household contacts of persons known to be HBsAg positive. Some persons with combinations of risk factors who are not members of risk factor groups listed above may also be at increased risk for HBV infection.'}, {'title': 'Hepatitis C Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis C virus (HCV) infection in adults aged 18 to 79 years.', 'servfreq': 'One-time screening for most adults.\r\nPeriodically screen persons with continued risk for HCV infection (eg, persons with past or current injection drug use). There is limited evidence to determine how often to screen persons at increased risk.&nbsp;', 'risktext': 'Asymptomatic adults aged 18 to 79 years (including pregnant persons) without known liver disease.&nbsp;\r\nThe USPSTF also suggests that clinicians consider screening persons younger than 18 years and older than 79 years who are at high risk for infection (eg, those with past or current injection drug use).&nbsp;'}, {'title': 'Lung Cancer: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery.', 'servfreq': ' \r\nThe USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. ', 'risktext': ' \r\nSmoking and older age are the 2 most important risk factors for lung cancer.&nbsp;The risk of lung cancer in persons who smoke increases with cumulative quantity and duration of smoking and with age but decreases with increasing time since quitting for persons who formerly smoked.3 The USPSTF considers adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years to be at high risk and recommends screening for lung cancer with annual LDCT in this population. \r\n \r\n&nbsp;\r\n \r\nAfrican American/Black (Black) men have a higher incidence of lung cancer than White men, and Black women have a lower incidence than White women.1 These differences are likely related to differences in smoking exposure (ie, prevalence of smoking) and related exposure to carcinogens in cigarettes.7,8 The differences may also be related to other social risk factors.\r\n \r\n&nbsp;\r\n \r\nOther risk factors for lung cancer include environmental exposures, prior radiation therapy, other (noncancer) lung diseases, and family history. Lower level of education is also associated with a higher risk of lung cancer.7 The task force recommends using age and smoking history to determine screening eligibility rather than more elaborate risk prediction models because there is insufficient evidence to assess whether risk prediction model&ndash;based screening would improve outcomes relative to using the risk factors of age and smoking history for broad implementation in primary care.\r\n '}, {'title': 'Sexually Transmitted Infections: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends behavioral counseling for all sexually active adolescents and for adults who are at increased risk for sexually transmitted infections (STIs).\r\rSee the Practice Considerations section for more information on populations at increased risk for acquiring STIs.', 'servfreq': '', 'risktext': 'All sexually active adolescents are at increased risk for STIs because of the high rates of STIs in this age group and should receive behavioral counseling interventions. Adults at increased risk for STIs include those who currently have an STI or were diagnosed with one within the past year, do not consistently use condoms, have multiple sex partners, or have sex partners within populations with a high prevalence of STIs. Populations with a high prevalence of STIs include persons who seek STI testing or attend STI clinics; sexual and gender minorities; persons who are living with HIV, inject drugs, have exchanged sex for money or drugs, or have entered correctional facilities; and some racial/ethnic minority groups.1-4'}, {'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends counseling young adults, adolescents, children, and parents of young children about minimizing exposure to ultraviolet (UV) radiation for persons aged 6 months to 24 years with fair skin types to reduce their risk of skin cancer.', 'servfreq': '', 'risktext': 'Fair skin types'}, {'title': 'Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for unhealthy alcohol use in primary care settings in adults 18 years or older, including pregnant women, and providing persons engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce unhealthy alcohol use.', 'servfreq': 'The USPSTF did not find adequate evidence to recommend an optimal screening interval for unhealthy alcohol use in adults.&nbsp;Brief behavioral counseling interventions were found to reduce unhealthy alcohol use in adults 18 years or older, including pregnant women. Effective behavioral counseling interventions vary in their specific components, administration, length, and number of interactions. The USPSTF was unable to identify specific intervention characteristics or components that were clearly associated with improved outcomes.', 'risktext': 'engaged in risky or hazardous drinking'}, {'title': 'Unhealthy Drug Use: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening by asking questions about unhealthy drug use in adults age 18 years or older. Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. \r(Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'servfreq': 'Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. (Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'risktext': 'These include being aged 18 to 25 years; male sex; having a mental health condition, personality or mood disorder, or nicotine or alcohol dependence; a history of physical or sexual abuse, parental neglect, or other adversity in childhood; or drug or alcohol addiction in a first-degree relative.1,9&nbsp;Factors associated with misuse of prescription drugs include history of other drug use, mental illness, pain, and greater access to prescription drugs.10&nbsp;Factors associated with prenatal use of drugs include a mental health disorder, interpersonal violence, and family history of substance use.11'}, {'title': 'Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer or refer adults with a body mass index (BMI) of 30 or higher (calculated as weight in kilograms divided by height in meters squared) to intensive, multicomponent behavioral interventions.', 'servfreq': '', 'risktext': 'Adults with a BMI &ge;30'}, {'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: Behavioral Counseling Interventions ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians individualize the decision to offer or refer adults without cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity. \r\rSee the "Practice Considerations" section for information on determining which patients may benefit most from this service.', 'servfreq': '', 'risktext': ''}, {'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for chlamydia and gonorrhea in men.', 'servfreq': '', 'risktext': ''}, {'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening with resting or exercise electrocardiography (ECG) to prevent cardiovascular disease (CVD) events in asymptomatic adults at low risk of CVD events.', 'servfreq': '', 'risktext': ''}, {'title': 'Chronic Obstructive Pulmonary Disease: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for chronic obstructive pulmonary disease in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'title': 'Genital Herpes Infection: Serologic Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine serologic screening for genital herpes simplex virus infection in asymptomatic adolescents and adults, including pregnant persons.', 'servfreq': '', 'risktext': 'The USPSTF found no evidence of externally validated, reliable risk stratification tools to identify individuals more or less likely to have genital herpes.'}, {'title': 'Pancreatic Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for pancreatic cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'title': 'Testicular Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for testicular cancer in adolescent or adult men.', 'servfreq': '', 'risktext': ''}, {'title': 'Thyroid Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for thyroid cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'D', 'text': 'The DoctorAI recommends against the use of beta carotene or vitamin E supplements for the prevention of cardiovascular disease or cancer.', 'servfreq': '', 'risktext': ''}, {'title': 'Autism Spectrum Disorder in Young Children: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for autism spectrum disorder (ASD) in young children for whom no concerns of ASD have been raised by their parents or a clinician.', 'servfreq': '', 'risktext': 'Although a number of potential risk factors for ASD have been identified, there is insufficient evidence to determine if certain risk factors modify the performance characteristics of ASD screening tests, such as the age at which screening is performed or other characteristics of the child or family.'}, {'title': 'Bladder Cancer in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults.\r\rLiterature scans conducted in July 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'This evidence update focused on the benefits and harms of screening for bladder cancer among people without symptoms, the accuracy of screening tests done in primary care settings, and the benefits and harms of treatment. The updated evidence review did not find any new high quality evidence to adequately determine the balance of benefits and harms of screening for bladder cancer. However, bladder cancer is a common cancer and can cause considerable health problems including death. Therefore, the USPSTF determined that the evidence was insufficient to provide a recommendation for or against bladder cancer screening.  The USPSTF emphasizes the need for additional research in this area. '}, {'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening with resting or exercise ECG to prevent CVD events in asymptomatic adults at intermediate or high risk of CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of adding the ankle-brachial index (ABI), high-sensitivity C-reactive protein (hsCRP) level, or coronary artery calcium (CAC) score to traditional risk assessment for cardiovascular disease (CVD) in asymptomatic adults to prevent CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Celiac Disease: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'persons with family history or other risk factors'}, {'title': 'Eating Disorders in Adolescents and Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for eating disorders in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Illicit Drug Use in Children, Adolescents, and Young Adults: Primary Care-Based Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--based behavioral counseling interventions to prevent illicit drug use, including nonmedical use of prescription drugs, in children, adolescents, and young adults.\r\rSee the Practice Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for abuse and neglect in all older or vulnerable adults. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': 'Risk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health.14&nbsp;For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.15'}, {'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for iron deficiency and iron deficiency anemia in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine iron supplementation in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'title': 'Lipid Disorders in Children and Adolescents: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Obstructive Sleep Apnea in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for obstructive sleep apnea in the general adult population.\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Risk Factors\r\nRisk factors associated with OSA include male sex, older age (40-70 years), postmenopausal status, higher body mass index (BMI), and craniofacial and upper airway abnormalities (eg, enlarged tonsils or long upper airway). Black, Hispanic/Latino, and Native American/Alaska Native persons have a higher prevalence of OSA compared with White persons; some evidence suggests that these differences are partially explained by higher rates of obesity, asthma, and tobacco use among these groups.8'}, {'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of multivitamin supplements for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of single or paired nutrient supplements (other than beta carotene and vitamin E) for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Oral Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for oral cancer in asymptomatic adults.\r\rGo to the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in July 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Tobacco and alcohol use are major risk factors for oral cancer. A total of 20% to 30% of cases of oral cancer worldwide are attributable to cigarette smoking. In the United States, up to 75% of cases of oral cancer may be attributable to tobacco and alcohol use. Additional risk factors include male sex, older age, use of betel quid, ultraviolet light exposure, infection with Candida or bacterial flora, and a compromised immune system. Sexually transmitted oral HPV infection (HPV-16) has recently been recognized as an increasingly important risk factor for oropharyngeal cancer. In the United States, the prevalence of oropharyngeal cancer due to oral HPV infection is probably as high as 80% to 95%. The prevalence of oral HPV infection is associated with age, sex, number of sexual partners, and number of cigarettes smoked per day. The effect of multifactorial risk assessment and screening for risk factors on oral cancer morbidity and mortality is unknown.'}, {'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine screening performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of preventive interventions performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'title': 'Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for peripheral artery disease (PAD) and cardiovascular disease (CVD) risk with the ankle-brachial index (ABI) in asymptomatic adults.\r\rLiterature scans conducted in August 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Risk factors associated with OSA include male sex, older age (40 to 70 years), postmenopausal status, higher BMI, and craniofacial and upper airway abnormalities.'}, {'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of counseling adults about skin self-examination to prevent skin cancer.See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Skin Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Exposure to UV radiation from sun exposure, indoor tanning beds, and other UV radiation&ndash;emitting devices is the major environmental risk factor for skin cancer. History of frequent sunburns, older age, and male sex are associated with increased risk for skin cancer. Exposure to UV radiation from the use of indoor tanning beds is an important risk factor in adolescents. Incidence of melanoma is higher among White persons compared with persons of other races and ethnicities. This difference likely reflects traits associated with increased melanoma risk, such as fair skin (which is more susceptible to sunburning), light-colored eyes, and red or blond hair being more common among White persons compared with persons of other races and ethnicities. Acral lentiginous melanoma, which occurs mostly on skin not frequently exposed to direct sunlight (eg, palms of hands, soles of feet, or under fingernails or toenails), is the most common type of melanoma among Black populations. Other melanoma risk factors include higher numbers of moles on the skin, atypical moles, as well as a personal and family history of skin cancer.'}, {'title': 'Thyroid Dysfunction: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults.\r\rSee the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': 'The optimal screening interval for thyroid dysfunction (if one exists) is unknown.', 'risktext': 'The most common cause of hypothyroidism in the United States is chronic autoimmune (Hashimoto) thyroiditis. Risk factors for an elevated TSH level include female sex, advancing age, white race, type 1 diabetes, Down syndrome, family history of thyroid disease, goiter, previous hyperthyroidism (possibly due in part to ablation therapy leading to iatrogenic thyroid dysfunction), and external-beam radiation in the head and neck area. Common causes of hyperthyroidism include Graves disease, Hashimoto thyroiditis, and functional thyroid nodules. Risk factors for a low TSH level include female sex; advancing age; black race; low iodine intake; personal or family history of thyroid disease; and ingestion of iodine-containing drugs, such as amiodarone. The USPSTF found no direct evidence that treatment of thyroid dysfunction based on risk level alters final health outcomes.'}, {'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of electronic cigarettes (e-cigarettes) for tobacco cessation in adults, including pregnant persons. The USPSTF recommends that clinicians direct patients who use tobacco to other tobacco cessation interventions with proven effectiveness and established safety.\rSee the Practice Considerations section for more information on recommended behavioral interventions and pharmacotherapy and for suggestions for practice regarding the I statements.', 'servfreq': '', 'risktext': ''}, {'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of pharmacotherapy interventions for tobacco cessation in pregnant persons.', 'servfreq': '', 'risktext': ''}, {'title': 'Tobacco Use in Children and Adolescents: Primary Care Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--feasible interventions for the cessation of tobacco use among school-aged children and adolescents.\r\rSee the Practice Considerations section for more information on effective interventions to prevent initiation of tobacco use and for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Vitamin D Deficiency in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'title': 'Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of the benefits and harms of vitamin D and calcium supplementation, alone or combined, for the primary prevention of fractures in men and premenopausal women.', 'servfreq': '', 'risktext': ''}]
2025-01-29 21:47:37 [ERROR] Error getting recommendations: 'id'
2025-01-29 21:47:38 [INFO] Update id=273478115 is handled. Duration 346 ms by bot id=8108339380
2025-01-29 21:48:46 [WARNING] Received SIGTERM signal
2025-01-29 21:48:46 [INFO] Polling stopped for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-29 21:48:46 [INFO] Polling stopped
2025-01-29 21:48:46 [INFO] โ ะัะป ะฟะพะดะบะปััะตะฝะธะน ะบ ะะ ะทะฐะบััั.
2025-01-29 21:48:46 [INFO] โ ะะพะดะบะปััะตะฝะธะต ะบ ะะ ะทะฐะบัััะพ.
2025-01-29 21:48:54 [INFO] ๐ ะะพั ะทะฐะฟััะบะฐะตััั...
2025-01-29 21:48:55 [INFO] โ ะัะป ะฟะพะดะบะปััะตะฝะธะน ะบ ะะ ัะพะทะดะฐะฝ.
2025-01-29 21:48:55 [INFO] โ ะขะฐะฑะปะธัั ะฒ ะฑะฐะทะต ะดะฐะฝะฝัั ััะฟะตัะฝะพ ัะพะทะดะฐะฝั.
2025-01-29 21:48:55 [INFO] Start polling
2025-01-29 21:48:56 [INFO] Run polling for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-29 21:48:58 [INFO] The user 711983855 called the command /start.
2025-01-29 21:49:00 [INFO] Update id=273478116 is handled. Duration 1303 ms by bot id=8108339380
2025-01-29 21:49:01 [INFO] The user 711983855's state has been set to Survey.age.
2025-01-29 21:49:02 [INFO] Update id=273478117 is handled. Duration 356 ms by bot id=8108339380
2025-01-29 21:49:07 [INFO] The user 711983855's state has been set to Survey.weight.
2025-01-29 21:49:07 [INFO] Update id=273478118 is handled. Duration 347 ms by bot id=8108339380
2025-01-29 21:49:09 [INFO] The user 711983855's state has been set to Survey.height.
2025-01-29 21:49:09 [INFO] Update id=273478119 is handled. Duration 349 ms by bot id=8108339380
2025-01-29 21:49:10 [INFO] The user 711983855's state has been set to Survey.feet.
2025-01-29 21:49:11 [INFO] Update id=273478120 is handled. Duration 376 ms by bot id=8108339380
2025-01-29 21:49:13 [INFO] The user 711983855's state has been set to Survey.gender.
2025-01-29 21:49:13 [INFO] Update id=273478121 is handled. Duration 418 ms by bot id=8108339380
2025-01-29 21:49:15 [INFO] The user 711983855's state has been set to Survey.smoking.
2025-01-29 21:49:15 [INFO] Update id=273478122 is handled. Duration 368 ms by bot id=8108339380
2025-01-29 21:49:16 [INFO] The user 711983855's state has been set to Survey.sex.
2025-01-29 21:49:17 [INFO] Update id=273478123 is handled. Duration 332 ms by bot id=8108339380
2025-01-29 21:49:18 [INFO] State data: {'db': <bot.database.Database object at 0x7f2400e2f230>, 'age': 20, 'weight': 90, 'height': 190, 'feet': 45, 'gender': 'male', 'pregnant': 'no', 'smoking': 'yes', 'sex': 'yes'}
2025-01-29 21:49:18 [INFO] Recommendations: [{'id': 485, 'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in adolescents and adults aged 15 to 65 years. Younger adolescents and older adults who are at increased risk of infection should also be screened.\rSee the Clinical Considerations section for more information about assessment of risk, screening intervals, and rescreening in pregnancy.', 'servfreq': 'The USPSTF found insufficient evidence to determine appropriate or optimal time intervals or strategies for repeat HIV screening. However, repeat screening is reasonable for persons known to be at increased risk of HIV infection, such as sexually active men who have sex with men; persons with a sex partner who is living with HIV; or persons who engage in behaviors that may convey an increased risk of HIV infection, such as injection drug use, transactional sex or commercial sex work, having 1 or more new sex partners whose HIV status is unknown, or having other factors that can place a person at increased risk of HIV infection (see &ldquo;Risk Assessment&rdquo;). Repeat screening is also reasonable for persons who live or receive medical care in a high-prevalence setting, such as a sexually transmitted disease clinic, tuberculosis clinic, correctional facility, or homeless shelter.', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'id': 1921, 'title': 'Hypertension in Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hypertension in adults 18 years or older with office blood pressure measurement (OBPM). The USPSTF recommends obtaining blood pressure measurements outside of the clinical setting for diagnostic confirmation before starting treatment.', 'servfreq': ' \r\nAlthough evidence on optimal screening intervals is limited, reasonable options include:\r\n \r\n \r\n\r\n\r\nScreening for hypertension every year in adults 40 years or older and in adults at increased risk for hypertension (such as Black persons, persons with high-normal blood pressure, or persons who are overweight or obese)\r\n\r\n\r\n \r\n \r\n\r\n\r\nScreening less frequently (ie, every 3 to 5 years) as appropriate for adults aged 18 to 39 years not at increased risk for hypertension and with a prior normal blood pressure reading.\r\n\r\n\r\n ', 'risktext': ' \r\nAlthough all adults should be screened for hypertension, risk factors that increase a person&rsquo;s risk for the condition include older age, Black race, family history, excess weight and obesity, lifestyle habits (lack of physical activity, stress, and tobacco use), and dietary factors (diet high in fat or sodium, diet low in potassium, or excessive alcohol intake)\r\n '}, {'id': 2021, 'title': 'Prevention of Acquisition of HIV: Preexposure Prophylaxis ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians prescribe preexposure prophylaxis using effective antiretroviral therapy to persons who are at increased risk of HIV acquisition to decrease the risk of acquiring HIV. \r\rSee the Practice Considerations section for more information about identification of persons at increased risk and about effective antiretroviral therapy.', 'servfreq': '', 'risktext': 'HIV is primarily acquired via sexual activity or injection drug use. It is important that clinicians routinely take a sexual and injection drug use history for all their patients in an open and nonjudgmental manner. All adolescents and adults who are sexually active or who inject drugs should be informed that acquisition of HIV can be prevented, to facilitate subsequent risk assessment and discussions about preexposure prophylaxis (PrEP) and other ways to prevent acquisition of HIV. Importantly, risk of HIV acquisition exists on a continuum, and currently available risk assessment tools all have limitations. However, certain risk factors or behaviors are known to place persons at increased risk of HIV.\r\nRisk of HIV acquisition depends on the likelihood that a specific act or activity will transmit HIV and the likelihood that a sex partner or drug injection partner has HIV. Likelihood of HIV transmission is highest with needle-sharing injection drug use and condomless receptive anal intercourse. Condomless receptive anal intercourse has an approximately 10- to 15-fold higher risk of transmission than condomless insertive anal sex and condomless receptive and insertive penile-vaginal sex. A 2018 study estimated the prevalence of HIV (ie, an estimate of the likelihood that a partner whose HIV status is unknown has HIV at a population level) as 12.4% among men who have sex with men and 1.9% among persons who inject drugs. The overall prevalence of HIV in the US is estimated at 0.3%.&nbsp;Of note, both the frequency of specific sexual activities and a person&rsquo;s number of sexual partners will also affect their risk of HIV.\r\n&nbsp;The USPSTF recommends that the following persons be considered for PrEP:\r\n1.&nbsp;&nbsp;&nbsp;&nbsp; Sexually active adults and adolescents weighing at least 35 kg (77 lb) who have engaged in anal or vaginal sex in the past 6 months and have any of the following:\r\n&nbsp;\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A sexual partner who has HIV (especially if the partner has an unknown or detectable viral load).\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A bacterial sexually transmitted infection (STI) (syphilis, gonorrhea, or chlamydia for men who have sex with men and transgender women; gonorrhea and syphilis for heterosexual women and men) in the past 6 months.\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A history of inconsistent or no condom use with sex partner(s) whose HIV status is not known; assessing risk in conversation with the patient and considering factors such as number of partners, the specific sexual activities a person engages in, and whether their sex partner or partners are in a group with a higher prevalence of HIV (eg, men who have sex with men or with men and women, transgender women, persons who inject drugs, and persons who engage in transactional sex).\r\n&nbsp;\r\n2. &nbsp; Persons who inject drugs and have a drug-injecting partner who has HIV or who shares injection equipment.\r\nPersons who engage in transactional sex, such as sex for money, drugs, or housing, including commercial sex workers or persons trafficked for sex work, constitute a group at increased risk of HIV acquisition and should be considered for PrEP based on the criteria outlined above. Persons who request PrEP may have undisclosed behaviors that put them at risk. Transgender women and men who are sexually active should be considered for PrEP based on the criteria outlined above. Transgender women are at especially high risk of HIV acquisition. A Centers for Disease Control and and Prevention (CDC) survey in 7 cities found an HIV prevalence of 42% among transgender women. Prevalence was highest among Black transgender women (62%) and Native American/Alaska Native transgender women (65%).\r\nIn addition, studies have found that transmission of HIV to a seronegative partner from a partner with HIV has not been observed when the partner with HIV was being treated with antiretroviral therapy and had a suppressed viral load.&nbsp;It is not known whether PrEP use further decreases the risk of HIV transmission when a partner with HIV has a documented undetectable viral load. Factors such as the consistency or inconsistency of a partner&rsquo;s viral load being suppressed, a partner&rsquo;s adherence to antiretroviral therapy, and the degree of certainty that a partner&rsquo;s viral load is suppressed (eg, self-report vs availability of laboratory test results) may help inform decisions about the use of PrEP in this situation.\r\nAll persons being considered for PrEP must have a recently documented negative HIV antigen-antibody test result, and if they have taken oral PrEP or postexposure prophylaxis in the past 3 months, or injectable cabotegravir in the past 12 months, the CDC recommends testing with both an HIV antigen-antibody assay and an HIV-1 RNA assay.'}, {'id': 1989, 'title': 'Syphilis Infection in Nonpregnant Adolescents and Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for syphilis infection in persons who are at increased risk for infection.', 'servfreq': 'Optimal screening frequency for persons who are at increased risk for syphilis infection is not well established. Men who have sex with men or persons with HIV infection may benefit from screening at least annually or more frequently (eg, every 3 to 6 months) if they continue to be at high risk.', 'risktext': 'The USPSTF recommends screening for syphilis in persons who are at increased risk for infection. When deciding which persons to screen for syphilis, clinicians should consider the prevalence of infection in the communities they serve, as well as other sociodemographic and behavioral factors that may be associated with increased risk of syphilis infection. For example, prevalence of syphilis is higher in men, men who have sex with men, persons with HIV infection, young adults, and persons with a history of incarceration, sex work, or military service. A substantial percentage of heterosexual syphilis transmission occurs among persons who use illicit drugs, particularly methamphetamine. Diagnosis of another STI may signal that a person is having condomless sex, which increases their risk of syphilis infection. Higher infection rates in persons of some racial and ethnic groups have been reported and are primarily a reflection of a combination of factors, including social determinants of health (eg, disparities of income, low educational achievement, and unstable housing), differential health insurance coverage or access to quality health care, and differences in sexual network characteristics (eg, individuals living in communities with a high prevalence of STIs have an increased chance of encountering an infected partner). Local prevalence rates may change over time, so clinicians should be aware of the latest data and trends for their specific population and geographic area, which are available through their state and local health departments and Centers for Disease Control and Prevention (CDC) surveillance.\r\n&nbsp;\r\nAlthough direct evidence on screening in nonpregnant persons who are not at increased risk for syphilis infection is lacking, based on the established test performance characteristics of current screening tests and the low prevalence rate of syphilis in this population, the yield of screening is likely low.9,10 Therefore, screening in this population may result in high false-positive rates and overtreatment.'}, {'id': 1905, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and US Food and Drug Administration (FDA)--approved pharmacotherapy for cessation to nonpregnant adults who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 1906, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all pregnant persons about tobacco use, advise them to stop using tobacco, and provide behavioral interventions for cessation to pregnant persons who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 2014, 'title': 'Anxiety Disorders in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for anxiety disorders in adults, including pregnant and postpartum persons.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding optimal timing for screening, or screening interval, for both the perinatal and general adult populations; more evidence on both timing and screening interval is needed for all adult populations. A pragmatic approach in the absence of evidence might include screening all adults who have not been screened previously and using clinical judgment in considering risk factors, comorbid conditions, and life events to determine if additional screening of high-risk patients is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nRisk factors for anxiety disorders include sociodemographic factors, psychosocial factors, and physical and mental health factors such as marital status (widowed or divorced), stressful life events, smoking and alcohol use, other mental health conditions, or a parental history of mental disorders. Demographic factors such as low socioeconomic status and female sex are associated with higher rates of anxiety disorders.&nbsp;Black persons and individuals of non-Hispanic ethnicity are at increased risk of anxiety disorders due to social, rather than biological, factors. Anxiety and depressive disorders often overlap. One cohort study found that 67% of individuals with a depressive disorder also had a current anxiety disorder, and 75% had a lifetime comorbid anxiety disorder.'}, {'id': 2009, 'title': 'Latent Tuberculosis Infection in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for LTBI in populations at increased risk.\r\rSee the "Assessment of Risk" section for additional information on adults at increased risk.', 'servfreq': 'The USPSTF found no evidence on the optimal frequency of screening for LTBI. In the absence of evidence, a reasonable approach is to repeat screening based on specific risk factors; screening frequency could range from 1-time only screening among persons at low risk for future tuberculosis exposure to annual screening among those at continued risk of exposure.', 'risktext': 'Populations at increased risk for LTBI, based on increased prevalence of active disease and increased risk of exposure, include persons who were born in, or are former residents of, countries with high tuberculosis prevalence and persons who live in, or have lived in, high-risk congregate settings (eg, homeless shelters or correctional facilities). Clinicians can consult their local or state health departments for more information about populations at increased risk in their community, since local demographic patterns may vary across the US.\r\nIn 2020, 71.5% of all cases of active tuberculosis in the US occurred among persons born outside the US. According to the CDC, tuberculosis disease is common in most countries in Latin America, the Caribbean, Africa, Asia, Eastern Europe, and Russia. In 2020, among persons with new tuberculosis living in the US who were born outside the US, the most common countries of birth were Mexico (18.0%), the Philippines (12.5%), India (10.4%), Vietnam (8.2%), and China (5.1%), accounting for 54.2% of total cases. Most of these cases are believed to be due to progression of latent infection to active tuberculosis disease rather than new transmission within communities.\r\nPersons who live, or have lived, in high-risk congregate settings also have a higher prevalence rate of active tuberculosis and an increased risk for exposure. In 2020, 4.3% of tuberculosis disease cases diagnosed in persons 15 years or older occurred in persons experiencing homelessness and 2.6% occurred in residents of correctional facilities. It is estimated that persons experiencing homelessness have an 11 times higher incidence of tuberculosis disease compared with persons who are not experiencing homelessness (36 cases per 100,000 population vs 2.9 cases per 100,000 population, respectively, during 2011 to 2016).\r\nOther populations at increased risk for LTBI or progression to active disease include persons who have immunosuppression (eg, persons living with HIV, patients receiving immunosuppressive medications such as chemotherapy or tumor necrosis factor inhibitors, and patients who have received an organ transplant) and patients with silicosis (a lung disease). However, given that screening in these populations may be considered standard care as part of disease management or indicated prior to the use of certain medications, the USPSTF did not review evidence on screening in these populations. Information on testing in these populations is provided by other groups, such as the Office of AIDS Research at the National Institutes of Health, and in a guideline issued jointly by the American Thoracic Society, Infectious Diseases Society of America, and CDC. Some evidence from observational studies has explored the association between poorly controlled diabetes and progression of LTBI to active disease. However, there is insufficient evidence on screening for and treatment of LTBI in persons with diabetes for the USPSTF to make a separate recommendation for this important population.\r\nPersons who are contacts of individuals with active tuberculosis, health care workers, and workers in high-risk congregate settings may also be at increased risk of exposure. Because screening in these populations is conducted as part of public health or employee health surveillance, the USPSTF did not review the evidence in these populations. Clinicians seeking further information about testing for tuberculosis in these populations can refer to the Additional Tools and Resources and Recommendations of Others sections.'}, {'id': 514, 'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic bacteriuria in nonpregnant adults.', 'servfreq': '', 'risktext': 'The risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6 Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5 Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7, 11, 12 In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12 Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4, 6'}, {'id': 1909, 'title': 'Asymptomatic Carotid Artery Stenosis: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic carotid artery stenosis in the general adult population.\r\rSee the Practice Considerations section for a description of adults at increased risk.', 'servfreq': '', 'risktext': ''}, {'id': 2017, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for suicide risk in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': '', 'risktext': ''}, {'id': 2016, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for depression in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding the optimal timing for screening for depression; more evidence is needed in both perinatal and general adult populations. In the absence of evidence, a pragmatic approach might include screening adults who have not been screened previously and using clinical judgment while considering risk factors, comorbid conditions, and life events to determine if additional screening of patients at increased risk is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nThe USPSTF recommends screening for depression in all adults regardless of risk factors. Risk factors for depression include a combination of genetic, biological, and environmental factors, such as a family history of depression, prior episode of depression or other mental health condition, a history of trauma or adverse life events, or a history of disease or illness (eg, cardiovascular disease).\r\nPrevalence rates vary by sex, age, race, ethnicity, education, marital status, geographic location, poverty level, and employment status. Women have twice the risk of depression compared with men. Young adults, multiracial individuals, and Native American/Alaska Native individuals have higher rates of depression.\r\nRisk factors for perinatal depression include life stress, low social support, history of depression, marital or partner dissatisfaction, and a history of abuse.'}, {'id': 1845, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends offering or referring adults with cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity.', 'servfreq': '', 'risktext': 'Adults 18 years or older at increased risk of CVD, defined as those with 1 or more of the following:\r\n1.Hypertension or elevated blood pressure2.Dyslipidemia3.Mixed or multiple risk factors such as the metabolic syndrome or an estimated 10-year CVD risk of &ge;7.5%\r\nThis recommendation does not apply to adults with other known modifiable cardiovascular risk factors such as abnormal blood glucose levels, obesity, and smoking; these populations are incorporated in other USPSTF recommendations.'}, {'id': 1885, 'title': 'Hepatitis B Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in adolescents and adults at increased risk for infection.\r\rSee the Practice Considerations section for a description of adolescents and adults at increased risk for infection.', 'servfreq': 'For patients with negative HBsAg results who have not received the HBV vaccine series, periodic screening may be useful for those who report continued risk for acquiring HBV transmission, such as persons who continue to inject drugs and men who have sex with men. Clinical judgment should be used to determine screening frequency. The USPSTF found no evidence to determine optimal screening intervals.', 'risktext': 'Persons from such risk groups include persons who have injected drugs in the past or currently; men who have sex with men; persons with HIV; and sex partners, needle-sharing contacts, and household contacts of persons known to be HBsAg positive. Some persons with combinations of risk factors who are not members of risk factor groups listed above may also be at increased risk for HBV infection.'}, {'id': 524, 'title': 'Hepatitis C Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis C virus (HCV) infection in adults aged 18 to 79 years.', 'servfreq': 'One-time screening for most adults.\r\nPeriodically screen persons with continued risk for HCV infection (eg, persons with past or current injection drug use). There is limited evidence to determine how often to screen persons at increased risk.&nbsp;', 'risktext': 'Asymptomatic adults aged 18 to 79 years (including pregnant persons) without known liver disease.&nbsp;\r\nThe USPSTF also suggests that clinicians consider screening persons younger than 18 years and older than 79 years who are at high risk for infection (eg, those with past or current injection drug use).&nbsp;'}, {'id': 1916, 'title': 'Lung Cancer: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery.', 'servfreq': ' \r\nThe USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. ', 'risktext': ' \r\nSmoking and older age are the 2 most important risk factors for lung cancer.&nbsp;The risk of lung cancer in persons who smoke increases with cumulative quantity and duration of smoking and with age but decreases with increasing time since quitting for persons who formerly smoked.3 The USPSTF considers adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years to be at high risk and recommends screening for lung cancer with annual LDCT in this population. \r\n \r\n&nbsp;\r\n \r\nAfrican American/Black (Black) men have a higher incidence of lung cancer than White men, and Black women have a lower incidence than White women.1 These differences are likely related to differences in smoking exposure (ie, prevalence of smoking) and related exposure to carcinogens in cigarettes.7,8 The differences may also be related to other social risk factors.\r\n \r\n&nbsp;\r\n \r\nOther risk factors for lung cancer include environmental exposures, prior radiation therapy, other (noncancer) lung diseases, and family history. Lower level of education is also associated with a higher risk of lung cancer.7 The task force recommends using age and smoking history to determine screening eligibility rather than more elaborate risk prediction models because there is insufficient evidence to assess whether risk prediction model&ndash;based screening would improve outcomes relative to using the risk factors of age and smoking history for broad implementation in primary care.\r\n '}, {'id': 1445, 'title': 'Sexually Transmitted Infections: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends behavioral counseling for all sexually active adolescents and for adults who are at increased risk for sexually transmitted infections (STIs).\r\rSee the Practice Considerations section for more information on populations at increased risk for acquiring STIs.', 'servfreq': '', 'risktext': 'All sexually active adolescents are at increased risk for STIs because of the high rates of STIs in this age group and should receive behavioral counseling interventions. Adults at increased risk for STIs include those who currently have an STI or were diagnosed with one within the past year, do not consistently use condoms, have multiple sex partners, or have sex partners within populations with a high prevalence of STIs. Populations with a high prevalence of STIs include persons who seek STI testing or attend STI clinics; sexual and gender minorities; persons who are living with HIV, inject drugs, have exchanged sex for money or drugs, or have entered correctional facilities; and some racial/ethnic minority groups.1-4'}, {'id': 402, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends counseling young adults, adolescents, children, and parents of young children about minimizing exposure to ultraviolet (UV) radiation for persons aged 6 months to 24 years with fair skin types to reduce their risk of skin cancer.', 'servfreq': '', 'risktext': 'Fair skin types'}, {'id': 438, 'title': 'Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for unhealthy alcohol use in primary care settings in adults 18 years or older, including pregnant women, and providing persons engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce unhealthy alcohol use.', 'servfreq': 'The USPSTF did not find adequate evidence to recommend an optimal screening interval for unhealthy alcohol use in adults.&nbsp;Brief behavioral counseling interventions were found to reduce unhealthy alcohol use in adults 18 years or older, including pregnant women. Effective behavioral counseling interventions vary in their specific components, administration, length, and number of interactions. The USPSTF was unable to identify specific intervention characteristics or components that were clearly associated with improved outcomes.', 'risktext': 'engaged in risky or hazardous drinking'}, {'id': 767, 'title': 'Unhealthy Drug Use: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening by asking questions about unhealthy drug use in adults age 18 years or older. Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. \r(Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'servfreq': 'Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. (Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'risktext': 'These include being aged 18 to 25 years; male sex; having a mental health condition, personality or mood disorder, or nicotine or alcohol dependence; a history of physical or sexual abuse, parental neglect, or other adversity in childhood; or drug or alcohol addiction in a first-degree relative.1,9&nbsp;Factors associated with misuse of prescription drugs include history of other drug use, mental illness, pain, and greater access to prescription drugs.10&nbsp;Factors associated with prenatal use of drugs include a mental health disorder, interpersonal violence, and family history of substance use.11'}, {'id': 433, 'title': 'Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer or refer adults with a body mass index (BMI) of 30 or higher (calculated as weight in kilograms divided by height in meters squared) to intensive, multicomponent behavioral interventions.', 'servfreq': '', 'risktext': 'Adults with a BMI &ge;30'}, {'id': 1979, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: Behavioral Counseling Interventions ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians individualize the decision to offer or refer adults without cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity. \r\rSee the "Practice Considerations" section for information on determining which patients may benefit most from this service.', 'servfreq': '', 'risktext': ''}, {'id': 1937, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for chlamydia and gonorrhea in men.', 'servfreq': '', 'risktext': ''}, {'id': 418, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening with resting or exercise electrocardiography (ECG) to prevent cardiovascular disease (CVD) events in asymptomatic adults at low risk of CVD events.', 'servfreq': '', 'risktext': ''}, {'id': 1973, 'title': 'Chronic Obstructive Pulmonary Disease: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for chronic obstructive pulmonary disease in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 2003, 'title': 'Genital Herpes Infection: Serologic Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine serologic screening for genital herpes simplex virus infection in asymptomatic adolescents and adults, including pregnant persons.', 'servfreq': '', 'risktext': 'The USPSTF found no evidence of externally validated, reliable risk stratification tools to identify individuals more or less likely to have genital herpes.'}, {'id': 504, 'title': 'Pancreatic Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for pancreatic cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 203, 'title': 'Testicular Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for testicular cancer in adolescent or adult men.', 'servfreq': '', 'risktext': ''}, {'id': 365, 'title': 'Thyroid Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for thyroid cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 1976, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'D', 'text': 'The DoctorAI recommends against the use of beta carotene or vitamin E supplements for the prevention of cardiovascular disease or cancer.', 'servfreq': '', 'risktext': ''}, {'id': 318, 'title': 'Autism Spectrum Disorder in Young Children: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for autism spectrum disorder (ASD) in young children for whom no concerns of ASD have been raised by their parents or a clinician.', 'servfreq': '', 'risktext': 'Although a number of potential risk factors for ASD have been identified, there is insufficient evidence to determine if certain risk factors modify the performance characteristics of ASD screening tests, such as the age at which screening is performed or other characteristics of the child or family.'}, {'id': 65, 'title': 'Bladder Cancer in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults.\r\rLiterature scans conducted in July 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'This evidence update focused on the benefits and harms of screening for bladder cancer among people without symptoms, the accuracy of screening tests done in primary care settings, and the benefits and harms of treatment. The updated evidence review did not find any new high quality evidence to adequately determine the balance of benefits and harms of screening for bladder cancer. However, bladder cancer is a common cancer and can cause considerable health problems including death. Therefore, the USPSTF determined that the evidence was insufficient to provide a recommendation for or against bladder cancer screening.  The USPSTF emphasizes the need for additional research in this area. '}, {'id': 419, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening with resting or exercise ECG to prevent CVD events in asymptomatic adults at intermediate or high risk of CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 423, 'title': 'Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of adding the ankle-brachial index (ABI), high-sensitivity C-reactive protein (hsCRP) level, or coronary artery calcium (CAC) score to traditional risk assessment for cardiovascular disease (CVD) in asymptomatic adults to prevent CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 352, 'title': 'Celiac Disease: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'persons with family history or other risk factors'}, {'id': 1955, 'title': 'Eating Disorders in Adolescents and Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for eating disorders in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 665, 'title': 'Illicit Drug Use in Children, Adolescents, and Young Adults: Primary Care-Based Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--based behavioral counseling interventions to prevent illicit drug use, including nonmedical use of prescription drugs, in children, adolescents, and young adults.\r\rSee the Practice Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 435, 'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for abuse and neglect in all older or vulnerable adults. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': 'Risk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health.14&nbsp;For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.15'}, {'id': 2045, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for iron deficiency and iron deficiency anemia in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2046, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine iron supplementation in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2018, 'title': 'Lipid Disorders in Children and Adolescents: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1998, 'title': 'Obstructive Sleep Apnea in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for obstructive sleep apnea in the general adult population.\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Risk Factors\r\nRisk factors associated with OSA include male sex, older age (40-70 years), postmenopausal status, higher body mass index (BMI), and craniofacial and upper airway abnormalities (eg, enlarged tonsils or long upper airway). Black, Hispanic/Latino, and Native American/Alaska Native persons have a higher prevalence of OSA compared with White persons; some evidence suggests that these differences are partially explained by higher rates of obesity, asthma, and tobacco use among these groups.8'}, {'id': 1977, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of multivitamin supplements for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1978, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of single or paired nutrient supplements (other than beta carotene and vitamin E) for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 176, 'title': 'Oral Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for oral cancer in asymptomatic adults.\r\rGo to the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in July 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Tobacco and alcohol use are major risk factors for oral cancer. A total of 20% to 30% of cases of oral cancer worldwide are attributable to cigarette smoking. In the United States, up to 75% of cases of oral cancer may be attributable to tobacco and alcohol use. Additional risk factors include male sex, older age, use of betel quid, ultraviolet light exposure, infection with Candida or bacterial flora, and a compromised immune system. Sexually transmitted oral HPV infection (HPV-16) has recently been recognized as an increasingly important risk factor for oropharyngeal cancer. In the United States, the prevalence of oropharyngeal cancer due to oral HPV infection is probably as high as 80% to 95%. The prevalence of oral HPV infection is associated with age, sex, number of sexual partners, and number of cigarettes smoked per day. The effect of multifactorial risk assessment and screening for risk factors on oral cancer morbidity and mortality is unknown.'}, {'id': 2026, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine screening performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 2027, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of preventive interventions performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 424, 'title': 'Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for peripheral artery disease (PAD) and cardiovascular disease (CVD) risk with the ankle-brachial index (ABI) in asymptomatic adults.\r\rLiterature scans conducted in August 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Risk factors associated with OSA include male sex, older age (40 to 70 years), postmenopausal status, higher BMI, and craniofacial and upper airway abnormalities.'}, {'id': 404, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of counseling adults about skin self-examination to prevent skin cancer.See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 2005, 'title': 'Skin Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Exposure to UV radiation from sun exposure, indoor tanning beds, and other UV radiation&ndash;emitting devices is the major environmental risk factor for skin cancer. History of frequent sunburns, older age, and male sex are associated with increased risk for skin cancer. Exposure to UV radiation from the use of indoor tanning beds is an important risk factor in adolescents. Incidence of melanoma is higher among White persons compared with persons of other races and ethnicities. This difference likely reflects traits associated with increased melanoma risk, such as fair skin (which is more susceptible to sunburning), light-colored eyes, and red or blond hair being more common among White persons compared with persons of other races and ethnicities. Acral lentiginous melanoma, which occurs mostly on skin not frequently exposed to direct sunlight (eg, palms of hands, soles of feet, or under fingernails or toenails), is the most common type of melanoma among Black populations. Other melanoma risk factors include higher numbers of moles on the skin, atypical moles, as well as a personal and family history of skin cancer.'}, {'id': 269, 'title': 'Thyroid Dysfunction: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults.\r\rSee the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': 'The optimal screening interval for thyroid dysfunction (if one exists) is unknown.', 'risktext': 'The most common cause of hypothyroidism in the United States is chronic autoimmune (Hashimoto) thyroiditis. Risk factors for an elevated TSH level include female sex, advancing age, white race, type 1 diabetes, Down syndrome, family history of thyroid disease, goiter, previous hyperthyroidism (possibly due in part to ablation therapy leading to iatrogenic thyroid dysfunction), and external-beam radiation in the head and neck area. Common causes of hyperthyroidism include Graves disease, Hashimoto thyroiditis, and functional thyroid nodules. Risk factors for a low TSH level include female sex; advancing age; black race; low iodine intake; personal or family history of thyroid disease; and ingestion of iodine-containing drugs, such as amiodarone. The USPSTF found no direct evidence that treatment of thyroid dysfunction based on risk level alters final health outcomes.'}, {'id': 1908, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of electronic cigarettes (e-cigarettes) for tobacco cessation in adults, including pregnant persons. The USPSTF recommends that clinicians direct patients who use tobacco to other tobacco cessation interventions with proven effectiveness and established safety.\rSee the Practice Considerations section for more information on recommended behavioral interventions and pharmacotherapy and for suggestions for practice regarding the I statements.', 'servfreq': '', 'risktext': ''}, {'id': 1907, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of pharmacotherapy interventions for tobacco cessation in pregnant persons.', 'servfreq': '', 'risktext': ''}, {'id': 586, 'title': 'Tobacco Use in Children and Adolescents: Primary Care Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--feasible interventions for the cessation of tobacco use among school-aged children and adolescents.\r\rSee the Practice Considerations section for more information on effective interventions to prevent initiation of tobacco use and for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1919, 'title': 'Vitamin D Deficiency in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 408, 'title': 'Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of the benefits and harms of vitamin D and calcium supplementation, alone or combined, for the primary prevention of fractures in men and premenopausal women.', 'servfreq': '', 'risktext': ''}]
2025-01-29 21:49:18 [INFO] Tools: [{'tool_id': 321, 'url': 'https://jamanetwork.com/journals/jama/fullarticle/2735342', 'title': 'JAMA Patient Page: Who Should Be Screened for HIV Infection? ', 'text': '', 'keywords': ''}, {'tool_id': 322, 'url': 'https://sites.jamanetwork.com/spanish-patient-pages/2019/hoja-para-el-paciente-de-jama-190618.pdf', 'title': 'ยฟQuiรฉnes deben someterse a una prueba de detecciรณn de infecciรณn por VIH?', 'text': '', 'keywords': 'HIV|Human immunodeficiency syndrome|AIDS'}, {'tool_id': 210, 'url': 'https://www.aafp.org/afp/2019/1115/p637.html', 'title': "Screening for HIV Infection and Preexposure Prophylaxis for the Prevention of HIV Infection: AFP's Putting Into Practice", 'text': 'The journal American Family Physician (AFP) provides a series of short case studies and quizzes based on recommendations issued by the U.S. Preventive Services Task Force.', 'keywords': ''}]
2025-01-29 21:49:19 [INFO] Update id=273478124 is handled. Duration 1225 ms by bot id=8108339380
2025-01-29 21:49:26 [INFO] Update id=273478125 is handled. Duration 776 ms by bot id=8108339380
2025-01-29 21:49:30 [INFO] State data: {'db': <bot.database.Database object at 0x7f2400e2f230>, 'age': 20, 'weight': 90, 'height': 190, 'feet': 45, 'gender': 'male', 'pregnant': 'no', 'smoking': 'yes', 'sex': 'tools_1', 'recommendations': [{'id': 485, 'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in adolescents and adults aged 15 to 65 years. Younger adolescents and older adults who are at increased risk of infection should also be screened.\rSee the Clinical Considerations section for more information about assessment of risk, screening intervals, and rescreening in pregnancy.', 'servfreq': 'The USPSTF found insufficient evidence to determine appropriate or optimal time intervals or strategies for repeat HIV screening. However, repeat screening is reasonable for persons known to be at increased risk of HIV infection, such as sexually active men who have sex with men; persons with a sex partner who is living with HIV; or persons who engage in behaviors that may convey an increased risk of HIV infection, such as injection drug use, transactional sex or commercial sex work, having 1 or more new sex partners whose HIV status is unknown, or having other factors that can place a person at increased risk of HIV infection (see &ldquo;Risk Assessment&rdquo;). Repeat screening is also reasonable for persons who live or receive medical care in a high-prevalence setting, such as a sexually transmitted disease clinic, tuberculosis clinic, correctional facility, or homeless shelter.', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'id': 1921, 'title': 'Hypertension in Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hypertension in adults 18 years or older with office blood pressure measurement (OBPM). The USPSTF recommends obtaining blood pressure measurements outside of the clinical setting for diagnostic confirmation before starting treatment.', 'servfreq': ' \r\nAlthough evidence on optimal screening intervals is limited, reasonable options include:\r\n \r\n \r\n\r\n\r\nScreening for hypertension every year in adults 40 years or older and in adults at increased risk for hypertension (such as Black persons, persons with high-normal blood pressure, or persons who are overweight or obese)\r\n\r\n\r\n \r\n \r\n\r\n\r\nScreening less frequently (ie, every 3 to 5 years) as appropriate for adults aged 18 to 39 years not at increased risk for hypertension and with a prior normal blood pressure reading.\r\n\r\n\r\n ', 'risktext': ' \r\nAlthough all adults should be screened for hypertension, risk factors that increase a person&rsquo;s risk for the condition include older age, Black race, family history, excess weight and obesity, lifestyle habits (lack of physical activity, stress, and tobacco use), and dietary factors (diet high in fat or sodium, diet low in potassium, or excessive alcohol intake)\r\n '}, {'id': 2021, 'title': 'Prevention of Acquisition of HIV: Preexposure Prophylaxis ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians prescribe preexposure prophylaxis using effective antiretroviral therapy to persons who are at increased risk of HIV acquisition to decrease the risk of acquiring HIV. \r\rSee the Practice Considerations section for more information about identification of persons at increased risk and about effective antiretroviral therapy.', 'servfreq': '', 'risktext': 'HIV is primarily acquired via sexual activity or injection drug use. It is important that clinicians routinely take a sexual and injection drug use history for all their patients in an open and nonjudgmental manner. All adolescents and adults who are sexually active or who inject drugs should be informed that acquisition of HIV can be prevented, to facilitate subsequent risk assessment and discussions about preexposure prophylaxis (PrEP) and other ways to prevent acquisition of HIV. Importantly, risk of HIV acquisition exists on a continuum, and currently available risk assessment tools all have limitations. However, certain risk factors or behaviors are known to place persons at increased risk of HIV.\r\nRisk of HIV acquisition depends on the likelihood that a specific act or activity will transmit HIV and the likelihood that a sex partner or drug injection partner has HIV. Likelihood of HIV transmission is highest with needle-sharing injection drug use and condomless receptive anal intercourse. Condomless receptive anal intercourse has an approximately 10- to 15-fold higher risk of transmission than condomless insertive anal sex and condomless receptive and insertive penile-vaginal sex. A 2018 study estimated the prevalence of HIV (ie, an estimate of the likelihood that a partner whose HIV status is unknown has HIV at a population level) as 12.4% among men who have sex with men and 1.9% among persons who inject drugs. The overall prevalence of HIV in the US is estimated at 0.3%.&nbsp;Of note, both the frequency of specific sexual activities and a person&rsquo;s number of sexual partners will also affect their risk of HIV.\r\n&nbsp;The USPSTF recommends that the following persons be considered for PrEP:\r\n1.&nbsp;&nbsp;&nbsp;&nbsp; Sexually active adults and adolescents weighing at least 35 kg (77 lb) who have engaged in anal or vaginal sex in the past 6 months and have any of the following:\r\n&nbsp;\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A sexual partner who has HIV (especially if the partner has an unknown or detectable viral load).\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A bacterial sexually transmitted infection (STI) (syphilis, gonorrhea, or chlamydia for men who have sex with men and transgender women; gonorrhea and syphilis for heterosexual women and men) in the past 6 months.\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A history of inconsistent or no condom use with sex partner(s) whose HIV status is not known; assessing risk in conversation with the patient and considering factors such as number of partners, the specific sexual activities a person engages in, and whether their sex partner or partners are in a group with a higher prevalence of HIV (eg, men who have sex with men or with men and women, transgender women, persons who inject drugs, and persons who engage in transactional sex).\r\n&nbsp;\r\n2. &nbsp; Persons who inject drugs and have a drug-injecting partner who has HIV or who shares injection equipment.\r\nPersons who engage in transactional sex, such as sex for money, drugs, or housing, including commercial sex workers or persons trafficked for sex work, constitute a group at increased risk of HIV acquisition and should be considered for PrEP based on the criteria outlined above. Persons who request PrEP may have undisclosed behaviors that put them at risk. Transgender women and men who are sexually active should be considered for PrEP based on the criteria outlined above. Transgender women are at especially high risk of HIV acquisition. A Centers for Disease Control and and Prevention (CDC) survey in 7 cities found an HIV prevalence of 42% among transgender women. Prevalence was highest among Black transgender women (62%) and Native American/Alaska Native transgender women (65%).\r\nIn addition, studies have found that transmission of HIV to a seronegative partner from a partner with HIV has not been observed when the partner with HIV was being treated with antiretroviral therapy and had a suppressed viral load.&nbsp;It is not known whether PrEP use further decreases the risk of HIV transmission when a partner with HIV has a documented undetectable viral load. Factors such as the consistency or inconsistency of a partner&rsquo;s viral load being suppressed, a partner&rsquo;s adherence to antiretroviral therapy, and the degree of certainty that a partner&rsquo;s viral load is suppressed (eg, self-report vs availability of laboratory test results) may help inform decisions about the use of PrEP in this situation.\r\nAll persons being considered for PrEP must have a recently documented negative HIV antigen-antibody test result, and if they have taken oral PrEP or postexposure prophylaxis in the past 3 months, or injectable cabotegravir in the past 12 months, the CDC recommends testing with both an HIV antigen-antibody assay and an HIV-1 RNA assay.'}, {'id': 1989, 'title': 'Syphilis Infection in Nonpregnant Adolescents and Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for syphilis infection in persons who are at increased risk for infection.', 'servfreq': 'Optimal screening frequency for persons who are at increased risk for syphilis infection is not well established. Men who have sex with men or persons with HIV infection may benefit from screening at least annually or more frequently (eg, every 3 to 6 months) if they continue to be at high risk.', 'risktext': 'The USPSTF recommends screening for syphilis in persons who are at increased risk for infection. When deciding which persons to screen for syphilis, clinicians should consider the prevalence of infection in the communities they serve, as well as other sociodemographic and behavioral factors that may be associated with increased risk of syphilis infection. For example, prevalence of syphilis is higher in men, men who have sex with men, persons with HIV infection, young adults, and persons with a history of incarceration, sex work, or military service. A substantial percentage of heterosexual syphilis transmission occurs among persons who use illicit drugs, particularly methamphetamine. Diagnosis of another STI may signal that a person is having condomless sex, which increases their risk of syphilis infection. Higher infection rates in persons of some racial and ethnic groups have been reported and are primarily a reflection of a combination of factors, including social determinants of health (eg, disparities of income, low educational achievement, and unstable housing), differential health insurance coverage or access to quality health care, and differences in sexual network characteristics (eg, individuals living in communities with a high prevalence of STIs have an increased chance of encountering an infected partner). Local prevalence rates may change over time, so clinicians should be aware of the latest data and trends for their specific population and geographic area, which are available through their state and local health departments and Centers for Disease Control and Prevention (CDC) surveillance.\r\n&nbsp;\r\nAlthough direct evidence on screening in nonpregnant persons who are not at increased risk for syphilis infection is lacking, based on the established test performance characteristics of current screening tests and the low prevalence rate of syphilis in this population, the yield of screening is likely low.9,10 Therefore, screening in this population may result in high false-positive rates and overtreatment.'}, {'id': 1905, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and US Food and Drug Administration (FDA)--approved pharmacotherapy for cessation to nonpregnant adults who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 1906, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all pregnant persons about tobacco use, advise them to stop using tobacco, and provide behavioral interventions for cessation to pregnant persons who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 2014, 'title': 'Anxiety Disorders in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for anxiety disorders in adults, including pregnant and postpartum persons.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding optimal timing for screening, or screening interval, for both the perinatal and general adult populations; more evidence on both timing and screening interval is needed for all adult populations. A pragmatic approach in the absence of evidence might include screening all adults who have not been screened previously and using clinical judgment in considering risk factors, comorbid conditions, and life events to determine if additional screening of high-risk patients is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nRisk factors for anxiety disorders include sociodemographic factors, psychosocial factors, and physical and mental health factors such as marital status (widowed or divorced), stressful life events, smoking and alcohol use, other mental health conditions, or a parental history of mental disorders. Demographic factors such as low socioeconomic status and female sex are associated with higher rates of anxiety disorders.&nbsp;Black persons and individuals of non-Hispanic ethnicity are at increased risk of anxiety disorders due to social, rather than biological, factors. Anxiety and depressive disorders often overlap. One cohort study found that 67% of individuals with a depressive disorder also had a current anxiety disorder, and 75% had a lifetime comorbid anxiety disorder.'}, {'id': 2009, 'title': 'Latent Tuberculosis Infection in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for LTBI in populations at increased risk.\r\rSee the "Assessment of Risk" section for additional information on adults at increased risk.', 'servfreq': 'The USPSTF found no evidence on the optimal frequency of screening for LTBI. In the absence of evidence, a reasonable approach is to repeat screening based on specific risk factors; screening frequency could range from 1-time only screening among persons at low risk for future tuberculosis exposure to annual screening among those at continued risk of exposure.', 'risktext': 'Populations at increased risk for LTBI, based on increased prevalence of active disease and increased risk of exposure, include persons who were born in, or are former residents of, countries with high tuberculosis prevalence and persons who live in, or have lived in, high-risk congregate settings (eg, homeless shelters or correctional facilities). Clinicians can consult their local or state health departments for more information about populations at increased risk in their community, since local demographic patterns may vary across the US.\r\nIn 2020, 71.5% of all cases of active tuberculosis in the US occurred among persons born outside the US. According to the CDC, tuberculosis disease is common in most countries in Latin America, the Caribbean, Africa, Asia, Eastern Europe, and Russia. In 2020, among persons with new tuberculosis living in the US who were born outside the US, the most common countries of birth were Mexico (18.0%), the Philippines (12.5%), India (10.4%), Vietnam (8.2%), and China (5.1%), accounting for 54.2% of total cases. Most of these cases are believed to be due to progression of latent infection to active tuberculosis disease rather than new transmission within communities.\r\nPersons who live, or have lived, in high-risk congregate settings also have a higher prevalence rate of active tuberculosis and an increased risk for exposure. In 2020, 4.3% of tuberculosis disease cases diagnosed in persons 15 years or older occurred in persons experiencing homelessness and 2.6% occurred in residents of correctional facilities. It is estimated that persons experiencing homelessness have an 11 times higher incidence of tuberculosis disease compared with persons who are not experiencing homelessness (36 cases per 100,000 population vs 2.9 cases per 100,000 population, respectively, during 2011 to 2016).\r\nOther populations at increased risk for LTBI or progression to active disease include persons who have immunosuppression (eg, persons living with HIV, patients receiving immunosuppressive medications such as chemotherapy or tumor necrosis factor inhibitors, and patients who have received an organ transplant) and patients with silicosis (a lung disease). However, given that screening in these populations may be considered standard care as part of disease management or indicated prior to the use of certain medications, the USPSTF did not review evidence on screening in these populations. Information on testing in these populations is provided by other groups, such as the Office of AIDS Research at the National Institutes of Health, and in a guideline issued jointly by the American Thoracic Society, Infectious Diseases Society of America, and CDC. Some evidence from observational studies has explored the association between poorly controlled diabetes and progression of LTBI to active disease. However, there is insufficient evidence on screening for and treatment of LTBI in persons with diabetes for the USPSTF to make a separate recommendation for this important population.\r\nPersons who are contacts of individuals with active tuberculosis, health care workers, and workers in high-risk congregate settings may also be at increased risk of exposure. Because screening in these populations is conducted as part of public health or employee health surveillance, the USPSTF did not review the evidence in these populations. Clinicians seeking further information about testing for tuberculosis in these populations can refer to the Additional Tools and Resources and Recommendations of Others sections.'}, {'id': 514, 'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic bacteriuria in nonpregnant adults.', 'servfreq': '', 'risktext': 'The risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6 Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5 Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7, 11, 12 In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12 Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4, 6'}, {'id': 1909, 'title': 'Asymptomatic Carotid Artery Stenosis: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic carotid artery stenosis in the general adult population.\r\rSee the Practice Considerations section for a description of adults at increased risk.', 'servfreq': '', 'risktext': ''}, {'id': 2017, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for suicide risk in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': '', 'risktext': ''}, {'id': 2016, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for depression in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding the optimal timing for screening for depression; more evidence is needed in both perinatal and general adult populations. In the absence of evidence, a pragmatic approach might include screening adults who have not been screened previously and using clinical judgment while considering risk factors, comorbid conditions, and life events to determine if additional screening of patients at increased risk is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nThe USPSTF recommends screening for depression in all adults regardless of risk factors. Risk factors for depression include a combination of genetic, biological, and environmental factors, such as a family history of depression, prior episode of depression or other mental health condition, a history of trauma or adverse life events, or a history of disease or illness (eg, cardiovascular disease).\r\nPrevalence rates vary by sex, age, race, ethnicity, education, marital status, geographic location, poverty level, and employment status. Women have twice the risk of depression compared with men. Young adults, multiracial individuals, and Native American/Alaska Native individuals have higher rates of depression.\r\nRisk factors for perinatal depression include life stress, low social support, history of depression, marital or partner dissatisfaction, and a history of abuse.'}, {'id': 1845, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends offering or referring adults with cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity.', 'servfreq': '', 'risktext': 'Adults 18 years or older at increased risk of CVD, defined as those with 1 or more of the following:\r\n1.Hypertension or elevated blood pressure2.Dyslipidemia3.Mixed or multiple risk factors such as the metabolic syndrome or an estimated 10-year CVD risk of &ge;7.5%\r\nThis recommendation does not apply to adults with other known modifiable cardiovascular risk factors such as abnormal blood glucose levels, obesity, and smoking; these populations are incorporated in other USPSTF recommendations.'}, {'id': 1885, 'title': 'Hepatitis B Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in adolescents and adults at increased risk for infection.\r\rSee the Practice Considerations section for a description of adolescents and adults at increased risk for infection.', 'servfreq': 'For patients with negative HBsAg results who have not received the HBV vaccine series, periodic screening may be useful for those who report continued risk for acquiring HBV transmission, such as persons who continue to inject drugs and men who have sex with men. Clinical judgment should be used to determine screening frequency. The USPSTF found no evidence to determine optimal screening intervals.', 'risktext': 'Persons from such risk groups include persons who have injected drugs in the past or currently; men who have sex with men; persons with HIV; and sex partners, needle-sharing contacts, and household contacts of persons known to be HBsAg positive. Some persons with combinations of risk factors who are not members of risk factor groups listed above may also be at increased risk for HBV infection.'}, {'id': 524, 'title': 'Hepatitis C Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis C virus (HCV) infection in adults aged 18 to 79 years.', 'servfreq': 'One-time screening for most adults.\r\nPeriodically screen persons with continued risk for HCV infection (eg, persons with past or current injection drug use). There is limited evidence to determine how often to screen persons at increased risk.&nbsp;', 'risktext': 'Asymptomatic adults aged 18 to 79 years (including pregnant persons) without known liver disease.&nbsp;\r\nThe USPSTF also suggests that clinicians consider screening persons younger than 18 years and older than 79 years who are at high risk for infection (eg, those with past or current injection drug use).&nbsp;'}, {'id': 1916, 'title': 'Lung Cancer: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery.', 'servfreq': ' \r\nThe USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. ', 'risktext': ' \r\nSmoking and older age are the 2 most important risk factors for lung cancer.&nbsp;The risk of lung cancer in persons who smoke increases with cumulative quantity and duration of smoking and with age but decreases with increasing time since quitting for persons who formerly smoked.3 The USPSTF considers adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years to be at high risk and recommends screening for lung cancer with annual LDCT in this population. \r\n \r\n&nbsp;\r\n \r\nAfrican American/Black (Black) men have a higher incidence of lung cancer than White men, and Black women have a lower incidence than White women.1 These differences are likely related to differences in smoking exposure (ie, prevalence of smoking) and related exposure to carcinogens in cigarettes.7,8 The differences may also be related to other social risk factors.\r\n \r\n&nbsp;\r\n \r\nOther risk factors for lung cancer include environmental exposures, prior radiation therapy, other (noncancer) lung diseases, and family history. Lower level of education is also associated with a higher risk of lung cancer.7 The task force recommends using age and smoking history to determine screening eligibility rather than more elaborate risk prediction models because there is insufficient evidence to assess whether risk prediction model&ndash;based screening would improve outcomes relative to using the risk factors of age and smoking history for broad implementation in primary care.\r\n '}, {'id': 1445, 'title': 'Sexually Transmitted Infections: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends behavioral counseling for all sexually active adolescents and for adults who are at increased risk for sexually transmitted infections (STIs).\r\rSee the Practice Considerations section for more information on populations at increased risk for acquiring STIs.', 'servfreq': '', 'risktext': 'All sexually active adolescents are at increased risk for STIs because of the high rates of STIs in this age group and should receive behavioral counseling interventions. Adults at increased risk for STIs include those who currently have an STI or were diagnosed with one within the past year, do not consistently use condoms, have multiple sex partners, or have sex partners within populations with a high prevalence of STIs. Populations with a high prevalence of STIs include persons who seek STI testing or attend STI clinics; sexual and gender minorities; persons who are living with HIV, inject drugs, have exchanged sex for money or drugs, or have entered correctional facilities; and some racial/ethnic minority groups.1-4'}, {'id': 402, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends counseling young adults, adolescents, children, and parents of young children about minimizing exposure to ultraviolet (UV) radiation for persons aged 6 months to 24 years with fair skin types to reduce their risk of skin cancer.', 'servfreq': '', 'risktext': 'Fair skin types'}, {'id': 438, 'title': 'Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for unhealthy alcohol use in primary care settings in adults 18 years or older, including pregnant women, and providing persons engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce unhealthy alcohol use.', 'servfreq': 'The USPSTF did not find adequate evidence to recommend an optimal screening interval for unhealthy alcohol use in adults.&nbsp;Brief behavioral counseling interventions were found to reduce unhealthy alcohol use in adults 18 years or older, including pregnant women. Effective behavioral counseling interventions vary in their specific components, administration, length, and number of interactions. The USPSTF was unable to identify specific intervention characteristics or components that were clearly associated with improved outcomes.', 'risktext': 'engaged in risky or hazardous drinking'}, {'id': 767, 'title': 'Unhealthy Drug Use: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening by asking questions about unhealthy drug use in adults age 18 years or older. Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. \r(Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'servfreq': 'Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. (Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'risktext': 'These include being aged 18 to 25 years; male sex; having a mental health condition, personality or mood disorder, or nicotine or alcohol dependence; a history of physical or sexual abuse, parental neglect, or other adversity in childhood; or drug or alcohol addiction in a first-degree relative.1,9&nbsp;Factors associated with misuse of prescription drugs include history of other drug use, mental illness, pain, and greater access to prescription drugs.10&nbsp;Factors associated with prenatal use of drugs include a mental health disorder, interpersonal violence, and family history of substance use.11'}, {'id': 433, 'title': 'Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer or refer adults with a body mass index (BMI) of 30 or higher (calculated as weight in kilograms divided by height in meters squared) to intensive, multicomponent behavioral interventions.', 'servfreq': '', 'risktext': 'Adults with a BMI &ge;30'}, {'id': 1979, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: Behavioral Counseling Interventions ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians individualize the decision to offer or refer adults without cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity. \r\rSee the "Practice Considerations" section for information on determining which patients may benefit most from this service.', 'servfreq': '', 'risktext': ''}, {'id': 1937, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for chlamydia and gonorrhea in men.', 'servfreq': '', 'risktext': ''}, {'id': 418, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening with resting or exercise electrocardiography (ECG) to prevent cardiovascular disease (CVD) events in asymptomatic adults at low risk of CVD events.', 'servfreq': '', 'risktext': ''}, {'id': 1973, 'title': 'Chronic Obstructive Pulmonary Disease: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for chronic obstructive pulmonary disease in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 2003, 'title': 'Genital Herpes Infection: Serologic Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine serologic screening for genital herpes simplex virus infection in asymptomatic adolescents and adults, including pregnant persons.', 'servfreq': '', 'risktext': 'The USPSTF found no evidence of externally validated, reliable risk stratification tools to identify individuals more or less likely to have genital herpes.'}, {'id': 504, 'title': 'Pancreatic Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for pancreatic cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 203, 'title': 'Testicular Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for testicular cancer in adolescent or adult men.', 'servfreq': '', 'risktext': ''}, {'id': 365, 'title': 'Thyroid Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for thyroid cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 1976, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'D', 'text': 'The DoctorAI recommends against the use of beta carotene or vitamin E supplements for the prevention of cardiovascular disease or cancer.', 'servfreq': '', 'risktext': ''}, {'id': 318, 'title': 'Autism Spectrum Disorder in Young Children: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for autism spectrum disorder (ASD) in young children for whom no concerns of ASD have been raised by their parents or a clinician.', 'servfreq': '', 'risktext': 'Although a number of potential risk factors for ASD have been identified, there is insufficient evidence to determine if certain risk factors modify the performance characteristics of ASD screening tests, such as the age at which screening is performed or other characteristics of the child or family.'}, {'id': 65, 'title': 'Bladder Cancer in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults.\r\rLiterature scans conducted in July 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'This evidence update focused on the benefits and harms of screening for bladder cancer among people without symptoms, the accuracy of screening tests done in primary care settings, and the benefits and harms of treatment. The updated evidence review did not find any new high quality evidence to adequately determine the balance of benefits and harms of screening for bladder cancer. However, bladder cancer is a common cancer and can cause considerable health problems including death. Therefore, the USPSTF determined that the evidence was insufficient to provide a recommendation for or against bladder cancer screening.  The USPSTF emphasizes the need for additional research in this area. '}, {'id': 419, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening with resting or exercise ECG to prevent CVD events in asymptomatic adults at intermediate or high risk of CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 423, 'title': 'Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of adding the ankle-brachial index (ABI), high-sensitivity C-reactive protein (hsCRP) level, or coronary artery calcium (CAC) score to traditional risk assessment for cardiovascular disease (CVD) in asymptomatic adults to prevent CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 352, 'title': 'Celiac Disease: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'persons with family history or other risk factors'}, {'id': 1955, 'title': 'Eating Disorders in Adolescents and Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for eating disorders in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 665, 'title': 'Illicit Drug Use in Children, Adolescents, and Young Adults: Primary Care-Based Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--based behavioral counseling interventions to prevent illicit drug use, including nonmedical use of prescription drugs, in children, adolescents, and young adults.\r\rSee the Practice Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 435, 'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for abuse and neglect in all older or vulnerable adults. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': 'Risk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health.14&nbsp;For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.15'}, {'id': 2045, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for iron deficiency and iron deficiency anemia in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2046, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine iron supplementation in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2018, 'title': 'Lipid Disorders in Children and Adolescents: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1998, 'title': 'Obstructive Sleep Apnea in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for obstructive sleep apnea in the general adult population.\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Risk Factors\r\nRisk factors associated with OSA include male sex, older age (40-70 years), postmenopausal status, higher body mass index (BMI), and craniofacial and upper airway abnormalities (eg, enlarged tonsils or long upper airway). Black, Hispanic/Latino, and Native American/Alaska Native persons have a higher prevalence of OSA compared with White persons; some evidence suggests that these differences are partially explained by higher rates of obesity, asthma, and tobacco use among these groups.8'}, {'id': 1977, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of multivitamin supplements for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1978, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of single or paired nutrient supplements (other than beta carotene and vitamin E) for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 176, 'title': 'Oral Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for oral cancer in asymptomatic adults.\r\rGo to the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in July 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Tobacco and alcohol use are major risk factors for oral cancer. A total of 20% to 30% of cases of oral cancer worldwide are attributable to cigarette smoking. In the United States, up to 75% of cases of oral cancer may be attributable to tobacco and alcohol use. Additional risk factors include male sex, older age, use of betel quid, ultraviolet light exposure, infection with Candida or bacterial flora, and a compromised immune system. Sexually transmitted oral HPV infection (HPV-16) has recently been recognized as an increasingly important risk factor for oropharyngeal cancer. In the United States, the prevalence of oropharyngeal cancer due to oral HPV infection is probably as high as 80% to 95%. The prevalence of oral HPV infection is associated with age, sex, number of sexual partners, and number of cigarettes smoked per day. The effect of multifactorial risk assessment and screening for risk factors on oral cancer morbidity and mortality is unknown.'}, {'id': 2026, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine screening performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 2027, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of preventive interventions performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 424, 'title': 'Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for peripheral artery disease (PAD) and cardiovascular disease (CVD) risk with the ankle-brachial index (ABI) in asymptomatic adults.\r\rLiterature scans conducted in August 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Risk factors associated with OSA include male sex, older age (40 to 70 years), postmenopausal status, higher BMI, and craniofacial and upper airway abnormalities.'}, {'id': 404, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of counseling adults about skin self-examination to prevent skin cancer.See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 2005, 'title': 'Skin Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Exposure to UV radiation from sun exposure, indoor tanning beds, and other UV radiation&ndash;emitting devices is the major environmental risk factor for skin cancer. History of frequent sunburns, older age, and male sex are associated with increased risk for skin cancer. Exposure to UV radiation from the use of indoor tanning beds is an important risk factor in adolescents. Incidence of melanoma is higher among White persons compared with persons of other races and ethnicities. This difference likely reflects traits associated with increased melanoma risk, such as fair skin (which is more susceptible to sunburning), light-colored eyes, and red or blond hair being more common among White persons compared with persons of other races and ethnicities. Acral lentiginous melanoma, which occurs mostly on skin not frequently exposed to direct sunlight (eg, palms of hands, soles of feet, or under fingernails or toenails), is the most common type of melanoma among Black populations. Other melanoma risk factors include higher numbers of moles on the skin, atypical moles, as well as a personal and family history of skin cancer.'}, {'id': 269, 'title': 'Thyroid Dysfunction: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults.\r\rSee the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': 'The optimal screening interval for thyroid dysfunction (if one exists) is unknown.', 'risktext': 'The most common cause of hypothyroidism in the United States is chronic autoimmune (Hashimoto) thyroiditis. Risk factors for an elevated TSH level include female sex, advancing age, white race, type 1 diabetes, Down syndrome, family history of thyroid disease, goiter, previous hyperthyroidism (possibly due in part to ablation therapy leading to iatrogenic thyroid dysfunction), and external-beam radiation in the head and neck area. Common causes of hyperthyroidism include Graves disease, Hashimoto thyroiditis, and functional thyroid nodules. Risk factors for a low TSH level include female sex; advancing age; black race; low iodine intake; personal or family history of thyroid disease; and ingestion of iodine-containing drugs, such as amiodarone. The USPSTF found no direct evidence that treatment of thyroid dysfunction based on risk level alters final health outcomes.'}, {'id': 1908, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of electronic cigarettes (e-cigarettes) for tobacco cessation in adults, including pregnant persons. The USPSTF recommends that clinicians direct patients who use tobacco to other tobacco cessation interventions with proven effectiveness and established safety.\rSee the Practice Considerations section for more information on recommended behavioral interventions and pharmacotherapy and for suggestions for practice regarding the I statements.', 'servfreq': '', 'risktext': ''}, {'id': 1907, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of pharmacotherapy interventions for tobacco cessation in pregnant persons.', 'servfreq': '', 'risktext': ''}, {'id': 586, 'title': 'Tobacco Use in Children and Adolescents: Primary Care Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--feasible interventions for the cessation of tobacco use among school-aged children and adolescents.\r\rSee the Practice Considerations section for more information on effective interventions to prevent initiation of tobacco use and for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1919, 'title': 'Vitamin D Deficiency in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 408, 'title': 'Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of the benefits and harms of vitamin D and calcium supplementation, alone or combined, for the primary prevention of fractures in men and premenopausal women.', 'servfreq': '', 'risktext': ''}], 'tools': [{'tool_id': 321, 'url': 'https://jamanetwork.com/journals/jama/fullarticle/2735342', 'title': 'JAMA Patient Page: Who Should Be Screened for HIV Infection? ', 'text': '', 'keywords': ''}, {'tool_id': 322, 'url': 'https://sites.jamanetwork.com/spanish-patient-pages/2019/hoja-para-el-paciente-de-jama-190618.pdf', 'title': 'ยฟQuiรฉnes deben someterse a una prueba de detecciรณn de infecciรณn por VIH?', 'text': '', 'keywords': 'HIV|Human immunodeficiency syndrome|AIDS'}, {'tool_id': 210, 'url': 'https://www.aafp.org/afp/2019/1115/p637.html', 'title': "Screening for HIV Infection and Preexposure Prophylaxis for the Prevention of HIV Infection: AFP's Putting Into Practice", 'text': 'The journal American Family Physician (AFP) provides a series of short case studies and quizzes based on recommendations issued by the U.S. Preventive Services Task Force.', 'keywords': ''}]}
2025-01-29 21:49:30 [INFO] Recommendations: [{'id': 485, 'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in adolescents and adults aged 15 to 65 years. Younger adolescents and older adults who are at increased risk of infection should also be screened.\rSee the Clinical Considerations section for more information about assessment of risk, screening intervals, and rescreening in pregnancy.', 'servfreq': 'The USPSTF found insufficient evidence to determine appropriate or optimal time intervals or strategies for repeat HIV screening. However, repeat screening is reasonable for persons known to be at increased risk of HIV infection, such as sexually active men who have sex with men; persons with a sex partner who is living with HIV; or persons who engage in behaviors that may convey an increased risk of HIV infection, such as injection drug use, transactional sex or commercial sex work, having 1 or more new sex partners whose HIV status is unknown, or having other factors that can place a person at increased risk of HIV infection (see &ldquo;Risk Assessment&rdquo;). Repeat screening is also reasonable for persons who live or receive medical care in a high-prevalence setting, such as a sexually transmitted disease clinic, tuberculosis clinic, correctional facility, or homeless shelter.', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'id': 1921, 'title': 'Hypertension in Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hypertension in adults 18 years or older with office blood pressure measurement (OBPM). The USPSTF recommends obtaining blood pressure measurements outside of the clinical setting for diagnostic confirmation before starting treatment.', 'servfreq': ' \r\nAlthough evidence on optimal screening intervals is limited, reasonable options include:\r\n \r\n \r\n\r\n\r\nScreening for hypertension every year in adults 40 years or older and in adults at increased risk for hypertension (such as Black persons, persons with high-normal blood pressure, or persons who are overweight or obese)\r\n\r\n\r\n \r\n \r\n\r\n\r\nScreening less frequently (ie, every 3 to 5 years) as appropriate for adults aged 18 to 39 years not at increased risk for hypertension and with a prior normal blood pressure reading.\r\n\r\n\r\n ', 'risktext': ' \r\nAlthough all adults should be screened for hypertension, risk factors that increase a person&rsquo;s risk for the condition include older age, Black race, family history, excess weight and obesity, lifestyle habits (lack of physical activity, stress, and tobacco use), and dietary factors (diet high in fat or sodium, diet low in potassium, or excessive alcohol intake)\r\n '}, {'id': 2021, 'title': 'Prevention of Acquisition of HIV: Preexposure Prophylaxis ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians prescribe preexposure prophylaxis using effective antiretroviral therapy to persons who are at increased risk of HIV acquisition to decrease the risk of acquiring HIV. \r\rSee the Practice Considerations section for more information about identification of persons at increased risk and about effective antiretroviral therapy.', 'servfreq': '', 'risktext': 'HIV is primarily acquired via sexual activity or injection drug use. It is important that clinicians routinely take a sexual and injection drug use history for all their patients in an open and nonjudgmental manner. All adolescents and adults who are sexually active or who inject drugs should be informed that acquisition of HIV can be prevented, to facilitate subsequent risk assessment and discussions about preexposure prophylaxis (PrEP) and other ways to prevent acquisition of HIV. Importantly, risk of HIV acquisition exists on a continuum, and currently available risk assessment tools all have limitations. However, certain risk factors or behaviors are known to place persons at increased risk of HIV.\r\nRisk of HIV acquisition depends on the likelihood that a specific act or activity will transmit HIV and the likelihood that a sex partner or drug injection partner has HIV. Likelihood of HIV transmission is highest with needle-sharing injection drug use and condomless receptive anal intercourse. Condomless receptive anal intercourse has an approximately 10- to 15-fold higher risk of transmission than condomless insertive anal sex and condomless receptive and insertive penile-vaginal sex. A 2018 study estimated the prevalence of HIV (ie, an estimate of the likelihood that a partner whose HIV status is unknown has HIV at a population level) as 12.4% among men who have sex with men and 1.9% among persons who inject drugs. The overall prevalence of HIV in the US is estimated at 0.3%.&nbsp;Of note, both the frequency of specific sexual activities and a person&rsquo;s number of sexual partners will also affect their risk of HIV.\r\n&nbsp;The USPSTF recommends that the following persons be considered for PrEP:\r\n1.&nbsp;&nbsp;&nbsp;&nbsp; Sexually active adults and adolescents weighing at least 35 kg (77 lb) who have engaged in anal or vaginal sex in the past 6 months and have any of the following:\r\n&nbsp;\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A sexual partner who has HIV (especially if the partner has an unknown or detectable viral load).\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A bacterial sexually transmitted infection (STI) (syphilis, gonorrhea, or chlamydia for men who have sex with men and transgender women; gonorrhea and syphilis for heterosexual women and men) in the past 6 months.\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A history of inconsistent or no condom use with sex partner(s) whose HIV status is not known; assessing risk in conversation with the patient and considering factors such as number of partners, the specific sexual activities a person engages in, and whether their sex partner or partners are in a group with a higher prevalence of HIV (eg, men who have sex with men or with men and women, transgender women, persons who inject drugs, and persons who engage in transactional sex).\r\n&nbsp;\r\n2. &nbsp; Persons who inject drugs and have a drug-injecting partner who has HIV or who shares injection equipment.\r\nPersons who engage in transactional sex, such as sex for money, drugs, or housing, including commercial sex workers or persons trafficked for sex work, constitute a group at increased risk of HIV acquisition and should be considered for PrEP based on the criteria outlined above. Persons who request PrEP may have undisclosed behaviors that put them at risk. Transgender women and men who are sexually active should be considered for PrEP based on the criteria outlined above. Transgender women are at especially high risk of HIV acquisition. A Centers for Disease Control and and Prevention (CDC) survey in 7 cities found an HIV prevalence of 42% among transgender women. Prevalence was highest among Black transgender women (62%) and Native American/Alaska Native transgender women (65%).\r\nIn addition, studies have found that transmission of HIV to a seronegative partner from a partner with HIV has not been observed when the partner with HIV was being treated with antiretroviral therapy and had a suppressed viral load.&nbsp;It is not known whether PrEP use further decreases the risk of HIV transmission when a partner with HIV has a documented undetectable viral load. Factors such as the consistency or inconsistency of a partner&rsquo;s viral load being suppressed, a partner&rsquo;s adherence to antiretroviral therapy, and the degree of certainty that a partner&rsquo;s viral load is suppressed (eg, self-report vs availability of laboratory test results) may help inform decisions about the use of PrEP in this situation.\r\nAll persons being considered for PrEP must have a recently documented negative HIV antigen-antibody test result, and if they have taken oral PrEP or postexposure prophylaxis in the past 3 months, or injectable cabotegravir in the past 12 months, the CDC recommends testing with both an HIV antigen-antibody assay and an HIV-1 RNA assay.'}, {'id': 1989, 'title': 'Syphilis Infection in Nonpregnant Adolescents and Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for syphilis infection in persons who are at increased risk for infection.', 'servfreq': 'Optimal screening frequency for persons who are at increased risk for syphilis infection is not well established. Men who have sex with men or persons with HIV infection may benefit from screening at least annually or more frequently (eg, every 3 to 6 months) if they continue to be at high risk.', 'risktext': 'The USPSTF recommends screening for syphilis in persons who are at increased risk for infection. When deciding which persons to screen for syphilis, clinicians should consider the prevalence of infection in the communities they serve, as well as other sociodemographic and behavioral factors that may be associated with increased risk of syphilis infection. For example, prevalence of syphilis is higher in men, men who have sex with men, persons with HIV infection, young adults, and persons with a history of incarceration, sex work, or military service. A substantial percentage of heterosexual syphilis transmission occurs among persons who use illicit drugs, particularly methamphetamine. Diagnosis of another STI may signal that a person is having condomless sex, which increases their risk of syphilis infection. Higher infection rates in persons of some racial and ethnic groups have been reported and are primarily a reflection of a combination of factors, including social determinants of health (eg, disparities of income, low educational achievement, and unstable housing), differential health insurance coverage or access to quality health care, and differences in sexual network characteristics (eg, individuals living in communities with a high prevalence of STIs have an increased chance of encountering an infected partner). Local prevalence rates may change over time, so clinicians should be aware of the latest data and trends for their specific population and geographic area, which are available through their state and local health departments and Centers for Disease Control and Prevention (CDC) surveillance.\r\n&nbsp;\r\nAlthough direct evidence on screening in nonpregnant persons who are not at increased risk for syphilis infection is lacking, based on the established test performance characteristics of current screening tests and the low prevalence rate of syphilis in this population, the yield of screening is likely low.9,10 Therefore, screening in this population may result in high false-positive rates and overtreatment.'}, {'id': 1905, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and US Food and Drug Administration (FDA)--approved pharmacotherapy for cessation to nonpregnant adults who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 1906, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all pregnant persons about tobacco use, advise them to stop using tobacco, and provide behavioral interventions for cessation to pregnant persons who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 2014, 'title': 'Anxiety Disorders in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for anxiety disorders in adults, including pregnant and postpartum persons.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding optimal timing for screening, or screening interval, for both the perinatal and general adult populations; more evidence on both timing and screening interval is needed for all adult populations. A pragmatic approach in the absence of evidence might include screening all adults who have not been screened previously and using clinical judgment in considering risk factors, comorbid conditions, and life events to determine if additional screening of high-risk patients is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nRisk factors for anxiety disorders include sociodemographic factors, psychosocial factors, and physical and mental health factors such as marital status (widowed or divorced), stressful life events, smoking and alcohol use, other mental health conditions, or a parental history of mental disorders. Demographic factors such as low socioeconomic status and female sex are associated with higher rates of anxiety disorders.&nbsp;Black persons and individuals of non-Hispanic ethnicity are at increased risk of anxiety disorders due to social, rather than biological, factors. Anxiety and depressive disorders often overlap. One cohort study found that 67% of individuals with a depressive disorder also had a current anxiety disorder, and 75% had a lifetime comorbid anxiety disorder.'}, {'id': 2009, 'title': 'Latent Tuberculosis Infection in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for LTBI in populations at increased risk.\r\rSee the "Assessment of Risk" section for additional information on adults at increased risk.', 'servfreq': 'The USPSTF found no evidence on the optimal frequency of screening for LTBI. In the absence of evidence, a reasonable approach is to repeat screening based on specific risk factors; screening frequency could range from 1-time only screening among persons at low risk for future tuberculosis exposure to annual screening among those at continued risk of exposure.', 'risktext': 'Populations at increased risk for LTBI, based on increased prevalence of active disease and increased risk of exposure, include persons who were born in, or are former residents of, countries with high tuberculosis prevalence and persons who live in, or have lived in, high-risk congregate settings (eg, homeless shelters or correctional facilities). Clinicians can consult their local or state health departments for more information about populations at increased risk in their community, since local demographic patterns may vary across the US.\r\nIn 2020, 71.5% of all cases of active tuberculosis in the US occurred among persons born outside the US. According to the CDC, tuberculosis disease is common in most countries in Latin America, the Caribbean, Africa, Asia, Eastern Europe, and Russia. In 2020, among persons with new tuberculosis living in the US who were born outside the US, the most common countries of birth were Mexico (18.0%), the Philippines (12.5%), India (10.4%), Vietnam (8.2%), and China (5.1%), accounting for 54.2% of total cases. Most of these cases are believed to be due to progression of latent infection to active tuberculosis disease rather than new transmission within communities.\r\nPersons who live, or have lived, in high-risk congregate settings also have a higher prevalence rate of active tuberculosis and an increased risk for exposure. In 2020, 4.3% of tuberculosis disease cases diagnosed in persons 15 years or older occurred in persons experiencing homelessness and 2.6% occurred in residents of correctional facilities. It is estimated that persons experiencing homelessness have an 11 times higher incidence of tuberculosis disease compared with persons who are not experiencing homelessness (36 cases per 100,000 population vs 2.9 cases per 100,000 population, respectively, during 2011 to 2016).\r\nOther populations at increased risk for LTBI or progression to active disease include persons who have immunosuppression (eg, persons living with HIV, patients receiving immunosuppressive medications such as chemotherapy or tumor necrosis factor inhibitors, and patients who have received an organ transplant) and patients with silicosis (a lung disease). However, given that screening in these populations may be considered standard care as part of disease management or indicated prior to the use of certain medications, the USPSTF did not review evidence on screening in these populations. Information on testing in these populations is provided by other groups, such as the Office of AIDS Research at the National Institutes of Health, and in a guideline issued jointly by the American Thoracic Society, Infectious Diseases Society of America, and CDC. Some evidence from observational studies has explored the association between poorly controlled diabetes and progression of LTBI to active disease. However, there is insufficient evidence on screening for and treatment of LTBI in persons with diabetes for the USPSTF to make a separate recommendation for this important population.\r\nPersons who are contacts of individuals with active tuberculosis, health care workers, and workers in high-risk congregate settings may also be at increased risk of exposure. Because screening in these populations is conducted as part of public health or employee health surveillance, the USPSTF did not review the evidence in these populations. Clinicians seeking further information about testing for tuberculosis in these populations can refer to the Additional Tools and Resources and Recommendations of Others sections.'}, {'id': 514, 'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic bacteriuria in nonpregnant adults.', 'servfreq': '', 'risktext': 'The risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6 Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5 Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7, 11, 12 In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12 Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4, 6'}, {'id': 1909, 'title': 'Asymptomatic Carotid Artery Stenosis: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic carotid artery stenosis in the general adult population.\r\rSee the Practice Considerations section for a description of adults at increased risk.', 'servfreq': '', 'risktext': ''}, {'id': 2017, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for suicide risk in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': '', 'risktext': ''}, {'id': 2016, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for depression in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding the optimal timing for screening for depression; more evidence is needed in both perinatal and general adult populations. In the absence of evidence, a pragmatic approach might include screening adults who have not been screened previously and using clinical judgment while considering risk factors, comorbid conditions, and life events to determine if additional screening of patients at increased risk is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nThe USPSTF recommends screening for depression in all adults regardless of risk factors. Risk factors for depression include a combination of genetic, biological, and environmental factors, such as a family history of depression, prior episode of depression or other mental health condition, a history of trauma or adverse life events, or a history of disease or illness (eg, cardiovascular disease).\r\nPrevalence rates vary by sex, age, race, ethnicity, education, marital status, geographic location, poverty level, and employment status. Women have twice the risk of depression compared with men. Young adults, multiracial individuals, and Native American/Alaska Native individuals have higher rates of depression.\r\nRisk factors for perinatal depression include life stress, low social support, history of depression, marital or partner dissatisfaction, and a history of abuse.'}, {'id': 1845, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends offering or referring adults with cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity.', 'servfreq': '', 'risktext': 'Adults 18 years or older at increased risk of CVD, defined as those with 1 or more of the following:\r\n1.Hypertension or elevated blood pressure2.Dyslipidemia3.Mixed or multiple risk factors such as the metabolic syndrome or an estimated 10-year CVD risk of &ge;7.5%\r\nThis recommendation does not apply to adults with other known modifiable cardiovascular risk factors such as abnormal blood glucose levels, obesity, and smoking; these populations are incorporated in other USPSTF recommendations.'}, {'id': 1885, 'title': 'Hepatitis B Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in adolescents and adults at increased risk for infection.\r\rSee the Practice Considerations section for a description of adolescents and adults at increased risk for infection.', 'servfreq': 'For patients with negative HBsAg results who have not received the HBV vaccine series, periodic screening may be useful for those who report continued risk for acquiring HBV transmission, such as persons who continue to inject drugs and men who have sex with men. Clinical judgment should be used to determine screening frequency. The USPSTF found no evidence to determine optimal screening intervals.', 'risktext': 'Persons from such risk groups include persons who have injected drugs in the past or currently; men who have sex with men; persons with HIV; and sex partners, needle-sharing contacts, and household contacts of persons known to be HBsAg positive. Some persons with combinations of risk factors who are not members of risk factor groups listed above may also be at increased risk for HBV infection.'}, {'id': 524, 'title': 'Hepatitis C Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis C virus (HCV) infection in adults aged 18 to 79 years.', 'servfreq': 'One-time screening for most adults.\r\nPeriodically screen persons with continued risk for HCV infection (eg, persons with past or current injection drug use). There is limited evidence to determine how often to screen persons at increased risk.&nbsp;', 'risktext': 'Asymptomatic adults aged 18 to 79 years (including pregnant persons) without known liver disease.&nbsp;\r\nThe USPSTF also suggests that clinicians consider screening persons younger than 18 years and older than 79 years who are at high risk for infection (eg, those with past or current injection drug use).&nbsp;'}, {'id': 1916, 'title': 'Lung Cancer: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery.', 'servfreq': ' \r\nThe USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. ', 'risktext': ' \r\nSmoking and older age are the 2 most important risk factors for lung cancer.&nbsp;The risk of lung cancer in persons who smoke increases with cumulative quantity and duration of smoking and with age but decreases with increasing time since quitting for persons who formerly smoked.3 The USPSTF considers adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years to be at high risk and recommends screening for lung cancer with annual LDCT in this population. \r\n \r\n&nbsp;\r\n \r\nAfrican American/Black (Black) men have a higher incidence of lung cancer than White men, and Black women have a lower incidence than White women.1 These differences are likely related to differences in smoking exposure (ie, prevalence of smoking) and related exposure to carcinogens in cigarettes.7,8 The differences may also be related to other social risk factors.\r\n \r\n&nbsp;\r\n \r\nOther risk factors for lung cancer include environmental exposures, prior radiation therapy, other (noncancer) lung diseases, and family history. Lower level of education is also associated with a higher risk of lung cancer.7 The task force recommends using age and smoking history to determine screening eligibility rather than more elaborate risk prediction models because there is insufficient evidence to assess whether risk prediction model&ndash;based screening would improve outcomes relative to using the risk factors of age and smoking history for broad implementation in primary care.\r\n '}, {'id': 1445, 'title': 'Sexually Transmitted Infections: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends behavioral counseling for all sexually active adolescents and for adults who are at increased risk for sexually transmitted infections (STIs).\r\rSee the Practice Considerations section for more information on populations at increased risk for acquiring STIs.', 'servfreq': '', 'risktext': 'All sexually active adolescents are at increased risk for STIs because of the high rates of STIs in this age group and should receive behavioral counseling interventions. Adults at increased risk for STIs include those who currently have an STI or were diagnosed with one within the past year, do not consistently use condoms, have multiple sex partners, or have sex partners within populations with a high prevalence of STIs. Populations with a high prevalence of STIs include persons who seek STI testing or attend STI clinics; sexual and gender minorities; persons who are living with HIV, inject drugs, have exchanged sex for money or drugs, or have entered correctional facilities; and some racial/ethnic minority groups.1-4'}, {'id': 402, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends counseling young adults, adolescents, children, and parents of young children about minimizing exposure to ultraviolet (UV) radiation for persons aged 6 months to 24 years with fair skin types to reduce their risk of skin cancer.', 'servfreq': '', 'risktext': 'Fair skin types'}, {'id': 438, 'title': 'Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for unhealthy alcohol use in primary care settings in adults 18 years or older, including pregnant women, and providing persons engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce unhealthy alcohol use.', 'servfreq': 'The USPSTF did not find adequate evidence to recommend an optimal screening interval for unhealthy alcohol use in adults.&nbsp;Brief behavioral counseling interventions were found to reduce unhealthy alcohol use in adults 18 years or older, including pregnant women. Effective behavioral counseling interventions vary in their specific components, administration, length, and number of interactions. The USPSTF was unable to identify specific intervention characteristics or components that were clearly associated with improved outcomes.', 'risktext': 'engaged in risky or hazardous drinking'}, {'id': 767, 'title': 'Unhealthy Drug Use: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening by asking questions about unhealthy drug use in adults age 18 years or older. Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. \r(Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'servfreq': 'Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. (Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'risktext': 'These include being aged 18 to 25 years; male sex; having a mental health condition, personality or mood disorder, or nicotine or alcohol dependence; a history of physical or sexual abuse, parental neglect, or other adversity in childhood; or drug or alcohol addiction in a first-degree relative.1,9&nbsp;Factors associated with misuse of prescription drugs include history of other drug use, mental illness, pain, and greater access to prescription drugs.10&nbsp;Factors associated with prenatal use of drugs include a mental health disorder, interpersonal violence, and family history of substance use.11'}, {'id': 433, 'title': 'Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer or refer adults with a body mass index (BMI) of 30 or higher (calculated as weight in kilograms divided by height in meters squared) to intensive, multicomponent behavioral interventions.', 'servfreq': '', 'risktext': 'Adults with a BMI &ge;30'}, {'id': 1979, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: Behavioral Counseling Interventions ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians individualize the decision to offer or refer adults without cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity. \r\rSee the "Practice Considerations" section for information on determining which patients may benefit most from this service.', 'servfreq': '', 'risktext': ''}, {'id': 1937, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for chlamydia and gonorrhea in men.', 'servfreq': '', 'risktext': ''}, {'id': 418, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening with resting or exercise electrocardiography (ECG) to prevent cardiovascular disease (CVD) events in asymptomatic adults at low risk of CVD events.', 'servfreq': '', 'risktext': ''}, {'id': 1973, 'title': 'Chronic Obstructive Pulmonary Disease: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for chronic obstructive pulmonary disease in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 2003, 'title': 'Genital Herpes Infection: Serologic Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine serologic screening for genital herpes simplex virus infection in asymptomatic adolescents and adults, including pregnant persons.', 'servfreq': '', 'risktext': 'The USPSTF found no evidence of externally validated, reliable risk stratification tools to identify individuals more or less likely to have genital herpes.'}, {'id': 504, 'title': 'Pancreatic Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for pancreatic cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 203, 'title': 'Testicular Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for testicular cancer in adolescent or adult men.', 'servfreq': '', 'risktext': ''}, {'id': 365, 'title': 'Thyroid Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for thyroid cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 1976, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'D', 'text': 'The DoctorAI recommends against the use of beta carotene or vitamin E supplements for the prevention of cardiovascular disease or cancer.', 'servfreq': '', 'risktext': ''}, {'id': 318, 'title': 'Autism Spectrum Disorder in Young Children: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for autism spectrum disorder (ASD) in young children for whom no concerns of ASD have been raised by their parents or a clinician.', 'servfreq': '', 'risktext': 'Although a number of potential risk factors for ASD have been identified, there is insufficient evidence to determine if certain risk factors modify the performance characteristics of ASD screening tests, such as the age at which screening is performed or other characteristics of the child or family.'}, {'id': 65, 'title': 'Bladder Cancer in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults.\r\rLiterature scans conducted in July 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'This evidence update focused on the benefits and harms of screening for bladder cancer among people without symptoms, the accuracy of screening tests done in primary care settings, and the benefits and harms of treatment. The updated evidence review did not find any new high quality evidence to adequately determine the balance of benefits and harms of screening for bladder cancer. However, bladder cancer is a common cancer and can cause considerable health problems including death. Therefore, the USPSTF determined that the evidence was insufficient to provide a recommendation for or against bladder cancer screening.  The USPSTF emphasizes the need for additional research in this area. '}, {'id': 419, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening with resting or exercise ECG to prevent CVD events in asymptomatic adults at intermediate or high risk of CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 423, 'title': 'Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of adding the ankle-brachial index (ABI), high-sensitivity C-reactive protein (hsCRP) level, or coronary artery calcium (CAC) score to traditional risk assessment for cardiovascular disease (CVD) in asymptomatic adults to prevent CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 352, 'title': 'Celiac Disease: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'persons with family history or other risk factors'}, {'id': 1955, 'title': 'Eating Disorders in Adolescents and Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for eating disorders in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 665, 'title': 'Illicit Drug Use in Children, Adolescents, and Young Adults: Primary Care-Based Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--based behavioral counseling interventions to prevent illicit drug use, including nonmedical use of prescription drugs, in children, adolescents, and young adults.\r\rSee the Practice Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 435, 'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for abuse and neglect in all older or vulnerable adults. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': 'Risk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health.14&nbsp;For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.15'}, {'id': 2045, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for iron deficiency and iron deficiency anemia in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2046, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine iron supplementation in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2018, 'title': 'Lipid Disorders in Children and Adolescents: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1998, 'title': 'Obstructive Sleep Apnea in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for obstructive sleep apnea in the general adult population.\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Risk Factors\r\nRisk factors associated with OSA include male sex, older age (40-70 years), postmenopausal status, higher body mass index (BMI), and craniofacial and upper airway abnormalities (eg, enlarged tonsils or long upper airway). Black, Hispanic/Latino, and Native American/Alaska Native persons have a higher prevalence of OSA compared with White persons; some evidence suggests that these differences are partially explained by higher rates of obesity, asthma, and tobacco use among these groups.8'}, {'id': 1977, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of multivitamin supplements for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1978, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of single or paired nutrient supplements (other than beta carotene and vitamin E) for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 176, 'title': 'Oral Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for oral cancer in asymptomatic adults.\r\rGo to the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in July 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Tobacco and alcohol use are major risk factors for oral cancer. A total of 20% to 30% of cases of oral cancer worldwide are attributable to cigarette smoking. In the United States, up to 75% of cases of oral cancer may be attributable to tobacco and alcohol use. Additional risk factors include male sex, older age, use of betel quid, ultraviolet light exposure, infection with Candida or bacterial flora, and a compromised immune system. Sexually transmitted oral HPV infection (HPV-16) has recently been recognized as an increasingly important risk factor for oropharyngeal cancer. In the United States, the prevalence of oropharyngeal cancer due to oral HPV infection is probably as high as 80% to 95%. The prevalence of oral HPV infection is associated with age, sex, number of sexual partners, and number of cigarettes smoked per day. The effect of multifactorial risk assessment and screening for risk factors on oral cancer morbidity and mortality is unknown.'}, {'id': 2026, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine screening performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 2027, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of preventive interventions performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 424, 'title': 'Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for peripheral artery disease (PAD) and cardiovascular disease (CVD) risk with the ankle-brachial index (ABI) in asymptomatic adults.\r\rLiterature scans conducted in August 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Risk factors associated with OSA include male sex, older age (40 to 70 years), postmenopausal status, higher BMI, and craniofacial and upper airway abnormalities.'}, {'id': 404, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of counseling adults about skin self-examination to prevent skin cancer.See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 2005, 'title': 'Skin Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Exposure to UV radiation from sun exposure, indoor tanning beds, and other UV radiation&ndash;emitting devices is the major environmental risk factor for skin cancer. History of frequent sunburns, older age, and male sex are associated with increased risk for skin cancer. Exposure to UV radiation from the use of indoor tanning beds is an important risk factor in adolescents. Incidence of melanoma is higher among White persons compared with persons of other races and ethnicities. This difference likely reflects traits associated with increased melanoma risk, such as fair skin (which is more susceptible to sunburning), light-colored eyes, and red or blond hair being more common among White persons compared with persons of other races and ethnicities. Acral lentiginous melanoma, which occurs mostly on skin not frequently exposed to direct sunlight (eg, palms of hands, soles of feet, or under fingernails or toenails), is the most common type of melanoma among Black populations. Other melanoma risk factors include higher numbers of moles on the skin, atypical moles, as well as a personal and family history of skin cancer.'}, {'id': 269, 'title': 'Thyroid Dysfunction: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults.\r\rSee the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': 'The optimal screening interval for thyroid dysfunction (if one exists) is unknown.', 'risktext': 'The most common cause of hypothyroidism in the United States is chronic autoimmune (Hashimoto) thyroiditis. Risk factors for an elevated TSH level include female sex, advancing age, white race, type 1 diabetes, Down syndrome, family history of thyroid disease, goiter, previous hyperthyroidism (possibly due in part to ablation therapy leading to iatrogenic thyroid dysfunction), and external-beam radiation in the head and neck area. Common causes of hyperthyroidism include Graves disease, Hashimoto thyroiditis, and functional thyroid nodules. Risk factors for a low TSH level include female sex; advancing age; black race; low iodine intake; personal or family history of thyroid disease; and ingestion of iodine-containing drugs, such as amiodarone. The USPSTF found no direct evidence that treatment of thyroid dysfunction based on risk level alters final health outcomes.'}, {'id': 1908, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of electronic cigarettes (e-cigarettes) for tobacco cessation in adults, including pregnant persons. The USPSTF recommends that clinicians direct patients who use tobacco to other tobacco cessation interventions with proven effectiveness and established safety.\rSee the Practice Considerations section for more information on recommended behavioral interventions and pharmacotherapy and for suggestions for practice regarding the I statements.', 'servfreq': '', 'risktext': ''}, {'id': 1907, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of pharmacotherapy interventions for tobacco cessation in pregnant persons.', 'servfreq': '', 'risktext': ''}, {'id': 586, 'title': 'Tobacco Use in Children and Adolescents: Primary Care Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--feasible interventions for the cessation of tobacco use among school-aged children and adolescents.\r\rSee the Practice Considerations section for more information on effective interventions to prevent initiation of tobacco use and for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1919, 'title': 'Vitamin D Deficiency in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 408, 'title': 'Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of the benefits and harms of vitamin D and calcium supplementation, alone or combined, for the primary prevention of fractures in men and premenopausal women.', 'servfreq': '', 'risktext': ''}]
2025-01-29 21:49:30 [INFO] Tools: [{'tool_id': 321, 'url': 'https://jamanetwork.com/journals/jama/fullarticle/2735342', 'title': 'JAMA Patient Page: Who Should Be Screened for HIV Infection? ', 'text': '', 'keywords': ''}, {'tool_id': 322, 'url': 'https://sites.jamanetwork.com/spanish-patient-pages/2019/hoja-para-el-paciente-de-jama-190618.pdf', 'title': 'ยฟQuiรฉnes deben someterse a una prueba de detecciรณn de infecciรณn por VIH?', 'text': '', 'keywords': 'HIV|Human immunodeficiency syndrome|AIDS'}, {'tool_id': 210, 'url': 'https://www.aafp.org/afp/2019/1115/p637.html', 'title': "Screening for HIV Infection and Preexposure Prophylaxis for the Prevention of HIV Infection: AFP's Putting Into Practice", 'text': 'The journal American Family Physician (AFP) provides a series of short case studies and quizzes based on recommendations issued by the U.S. Preventive Services Task Force.', 'keywords': ''}]
2025-01-29 21:49:31 [INFO] Update id=273478126 is handled. Duration 1108 ms by bot id=8108339380
2025-01-29 21:49:40 [INFO] Update id=273478127 is handled. Duration 687 ms by bot id=8108339380
2025-01-29 21:49:44 [INFO] Update id=273478128 is handled. Duration 730 ms by bot id=8108339380
2025-01-29 21:50:29 [INFO] Update id=273478129 is handled. Duration 675 ms by bot id=8108339380
2025-01-29 21:50:33 [INFO] State data: {'db': <bot.database.Database object at 0x7f2400e2f230>, 'age': 20, 'weight': 90, 'height': 190, 'feet': 45, 'gender': 'male', 'pregnant': 'no', 'smoking': 'yes', 'sex': 'tools_0', 'recommendations': [{'id': 485, 'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in adolescents and adults aged 15 to 65 years. Younger adolescents and older adults who are at increased risk of infection should also be screened.\rSee the Clinical Considerations section for more information about assessment of risk, screening intervals, and rescreening in pregnancy.', 'servfreq': 'The USPSTF found insufficient evidence to determine appropriate or optimal time intervals or strategies for repeat HIV screening. However, repeat screening is reasonable for persons known to be at increased risk of HIV infection, such as sexually active men who have sex with men; persons with a sex partner who is living with HIV; or persons who engage in behaviors that may convey an increased risk of HIV infection, such as injection drug use, transactional sex or commercial sex work, having 1 or more new sex partners whose HIV status is unknown, or having other factors that can place a person at increased risk of HIV infection (see &ldquo;Risk Assessment&rdquo;). Repeat screening is also reasonable for persons who live or receive medical care in a high-prevalence setting, such as a sexually transmitted disease clinic, tuberculosis clinic, correctional facility, or homeless shelter.', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'id': 1921, 'title': 'Hypertension in Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hypertension in adults 18 years or older with office blood pressure measurement (OBPM). The USPSTF recommends obtaining blood pressure measurements outside of the clinical setting for diagnostic confirmation before starting treatment.', 'servfreq': ' \r\nAlthough evidence on optimal screening intervals is limited, reasonable options include:\r\n \r\n \r\n\r\n\r\nScreening for hypertension every year in adults 40 years or older and in adults at increased risk for hypertension (such as Black persons, persons with high-normal blood pressure, or persons who are overweight or obese)\r\n\r\n\r\n \r\n \r\n\r\n\r\nScreening less frequently (ie, every 3 to 5 years) as appropriate for adults aged 18 to 39 years not at increased risk for hypertension and with a prior normal blood pressure reading.\r\n\r\n\r\n ', 'risktext': ' \r\nAlthough all adults should be screened for hypertension, risk factors that increase a person&rsquo;s risk for the condition include older age, Black race, family history, excess weight and obesity, lifestyle habits (lack of physical activity, stress, and tobacco use), and dietary factors (diet high in fat or sodium, diet low in potassium, or excessive alcohol intake)\r\n '}, {'id': 2021, 'title': 'Prevention of Acquisition of HIV: Preexposure Prophylaxis ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians prescribe preexposure prophylaxis using effective antiretroviral therapy to persons who are at increased risk of HIV acquisition to decrease the risk of acquiring HIV. \r\rSee the Practice Considerations section for more information about identification of persons at increased risk and about effective antiretroviral therapy.', 'servfreq': '', 'risktext': 'HIV is primarily acquired via sexual activity or injection drug use. It is important that clinicians routinely take a sexual and injection drug use history for all their patients in an open and nonjudgmental manner. All adolescents and adults who are sexually active or who inject drugs should be informed that acquisition of HIV can be prevented, to facilitate subsequent risk assessment and discussions about preexposure prophylaxis (PrEP) and other ways to prevent acquisition of HIV. Importantly, risk of HIV acquisition exists on a continuum, and currently available risk assessment tools all have limitations. However, certain risk factors or behaviors are known to place persons at increased risk of HIV.\r\nRisk of HIV acquisition depends on the likelihood that a specific act or activity will transmit HIV and the likelihood that a sex partner or drug injection partner has HIV. Likelihood of HIV transmission is highest with needle-sharing injection drug use and condomless receptive anal intercourse. Condomless receptive anal intercourse has an approximately 10- to 15-fold higher risk of transmission than condomless insertive anal sex and condomless receptive and insertive penile-vaginal sex. A 2018 study estimated the prevalence of HIV (ie, an estimate of the likelihood that a partner whose HIV status is unknown has HIV at a population level) as 12.4% among men who have sex with men and 1.9% among persons who inject drugs. The overall prevalence of HIV in the US is estimated at 0.3%.&nbsp;Of note, both the frequency of specific sexual activities and a person&rsquo;s number of sexual partners will also affect their risk of HIV.\r\n&nbsp;The USPSTF recommends that the following persons be considered for PrEP:\r\n1.&nbsp;&nbsp;&nbsp;&nbsp; Sexually active adults and adolescents weighing at least 35 kg (77 lb) who have engaged in anal or vaginal sex in the past 6 months and have any of the following:\r\n&nbsp;\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A sexual partner who has HIV (especially if the partner has an unknown or detectable viral load).\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A bacterial sexually transmitted infection (STI) (syphilis, gonorrhea, or chlamydia for men who have sex with men and transgender women; gonorrhea and syphilis for heterosexual women and men) in the past 6 months.\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A history of inconsistent or no condom use with sex partner(s) whose HIV status is not known; assessing risk in conversation with the patient and considering factors such as number of partners, the specific sexual activities a person engages in, and whether their sex partner or partners are in a group with a higher prevalence of HIV (eg, men who have sex with men or with men and women, transgender women, persons who inject drugs, and persons who engage in transactional sex).\r\n&nbsp;\r\n2. &nbsp; Persons who inject drugs and have a drug-injecting partner who has HIV or who shares injection equipment.\r\nPersons who engage in transactional sex, such as sex for money, drugs, or housing, including commercial sex workers or persons trafficked for sex work, constitute a group at increased risk of HIV acquisition and should be considered for PrEP based on the criteria outlined above. Persons who request PrEP may have undisclosed behaviors that put them at risk. Transgender women and men who are sexually active should be considered for PrEP based on the criteria outlined above. Transgender women are at especially high risk of HIV acquisition. A Centers for Disease Control and and Prevention (CDC) survey in 7 cities found an HIV prevalence of 42% among transgender women. Prevalence was highest among Black transgender women (62%) and Native American/Alaska Native transgender women (65%).\r\nIn addition, studies have found that transmission of HIV to a seronegative partner from a partner with HIV has not been observed when the partner with HIV was being treated with antiretroviral therapy and had a suppressed viral load.&nbsp;It is not known whether PrEP use further decreases the risk of HIV transmission when a partner with HIV has a documented undetectable viral load. Factors such as the consistency or inconsistency of a partner&rsquo;s viral load being suppressed, a partner&rsquo;s adherence to antiretroviral therapy, and the degree of certainty that a partner&rsquo;s viral load is suppressed (eg, self-report vs availability of laboratory test results) may help inform decisions about the use of PrEP in this situation.\r\nAll persons being considered for PrEP must have a recently documented negative HIV antigen-antibody test result, and if they have taken oral PrEP or postexposure prophylaxis in the past 3 months, or injectable cabotegravir in the past 12 months, the CDC recommends testing with both an HIV antigen-antibody assay and an HIV-1 RNA assay.'}, {'id': 1989, 'title': 'Syphilis Infection in Nonpregnant Adolescents and Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for syphilis infection in persons who are at increased risk for infection.', 'servfreq': 'Optimal screening frequency for persons who are at increased risk for syphilis infection is not well established. Men who have sex with men or persons with HIV infection may benefit from screening at least annually or more frequently (eg, every 3 to 6 months) if they continue to be at high risk.', 'risktext': 'The USPSTF recommends screening for syphilis in persons who are at increased risk for infection. When deciding which persons to screen for syphilis, clinicians should consider the prevalence of infection in the communities they serve, as well as other sociodemographic and behavioral factors that may be associated with increased risk of syphilis infection. For example, prevalence of syphilis is higher in men, men who have sex with men, persons with HIV infection, young adults, and persons with a history of incarceration, sex work, or military service. A substantial percentage of heterosexual syphilis transmission occurs among persons who use illicit drugs, particularly methamphetamine. Diagnosis of another STI may signal that a person is having condomless sex, which increases their risk of syphilis infection. Higher infection rates in persons of some racial and ethnic groups have been reported and are primarily a reflection of a combination of factors, including social determinants of health (eg, disparities of income, low educational achievement, and unstable housing), differential health insurance coverage or access to quality health care, and differences in sexual network characteristics (eg, individuals living in communities with a high prevalence of STIs have an increased chance of encountering an infected partner). Local prevalence rates may change over time, so clinicians should be aware of the latest data and trends for their specific population and geographic area, which are available through their state and local health departments and Centers for Disease Control and Prevention (CDC) surveillance.\r\n&nbsp;\r\nAlthough direct evidence on screening in nonpregnant persons who are not at increased risk for syphilis infection is lacking, based on the established test performance characteristics of current screening tests and the low prevalence rate of syphilis in this population, the yield of screening is likely low.9,10 Therefore, screening in this population may result in high false-positive rates and overtreatment.'}, {'id': 1905, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and US Food and Drug Administration (FDA)--approved pharmacotherapy for cessation to nonpregnant adults who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 1906, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all pregnant persons about tobacco use, advise them to stop using tobacco, and provide behavioral interventions for cessation to pregnant persons who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 2014, 'title': 'Anxiety Disorders in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for anxiety disorders in adults, including pregnant and postpartum persons.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding optimal timing for screening, or screening interval, for both the perinatal and general adult populations; more evidence on both timing and screening interval is needed for all adult populations. A pragmatic approach in the absence of evidence might include screening all adults who have not been screened previously and using clinical judgment in considering risk factors, comorbid conditions, and life events to determine if additional screening of high-risk patients is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nRisk factors for anxiety disorders include sociodemographic factors, psychosocial factors, and physical and mental health factors such as marital status (widowed or divorced), stressful life events, smoking and alcohol use, other mental health conditions, or a parental history of mental disorders. Demographic factors such as low socioeconomic status and female sex are associated with higher rates of anxiety disorders.&nbsp;Black persons and individuals of non-Hispanic ethnicity are at increased risk of anxiety disorders due to social, rather than biological, factors. Anxiety and depressive disorders often overlap. One cohort study found that 67% of individuals with a depressive disorder also had a current anxiety disorder, and 75% had a lifetime comorbid anxiety disorder.'}, {'id': 2009, 'title': 'Latent Tuberculosis Infection in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for LTBI in populations at increased risk.\r\rSee the "Assessment of Risk" section for additional information on adults at increased risk.', 'servfreq': 'The USPSTF found no evidence on the optimal frequency of screening for LTBI. In the absence of evidence, a reasonable approach is to repeat screening based on specific risk factors; screening frequency could range from 1-time only screening among persons at low risk for future tuberculosis exposure to annual screening among those at continued risk of exposure.', 'risktext': 'Populations at increased risk for LTBI, based on increased prevalence of active disease and increased risk of exposure, include persons who were born in, or are former residents of, countries with high tuberculosis prevalence and persons who live in, or have lived in, high-risk congregate settings (eg, homeless shelters or correctional facilities). Clinicians can consult their local or state health departments for more information about populations at increased risk in their community, since local demographic patterns may vary across the US.\r\nIn 2020, 71.5% of all cases of active tuberculosis in the US occurred among persons born outside the US. According to the CDC, tuberculosis disease is common in most countries in Latin America, the Caribbean, Africa, Asia, Eastern Europe, and Russia. In 2020, among persons with new tuberculosis living in the US who were born outside the US, the most common countries of birth were Mexico (18.0%), the Philippines (12.5%), India (10.4%), Vietnam (8.2%), and China (5.1%), accounting for 54.2% of total cases. Most of these cases are believed to be due to progression of latent infection to active tuberculosis disease rather than new transmission within communities.\r\nPersons who live, or have lived, in high-risk congregate settings also have a higher prevalence rate of active tuberculosis and an increased risk for exposure. In 2020, 4.3% of tuberculosis disease cases diagnosed in persons 15 years or older occurred in persons experiencing homelessness and 2.6% occurred in residents of correctional facilities. It is estimated that persons experiencing homelessness have an 11 times higher incidence of tuberculosis disease compared with persons who are not experiencing homelessness (36 cases per 100,000 population vs 2.9 cases per 100,000 population, respectively, during 2011 to 2016).\r\nOther populations at increased risk for LTBI or progression to active disease include persons who have immunosuppression (eg, persons living with HIV, patients receiving immunosuppressive medications such as chemotherapy or tumor necrosis factor inhibitors, and patients who have received an organ transplant) and patients with silicosis (a lung disease). However, given that screening in these populations may be considered standard care as part of disease management or indicated prior to the use of certain medications, the USPSTF did not review evidence on screening in these populations. Information on testing in these populations is provided by other groups, such as the Office of AIDS Research at the National Institutes of Health, and in a guideline issued jointly by the American Thoracic Society, Infectious Diseases Society of America, and CDC. Some evidence from observational studies has explored the association between poorly controlled diabetes and progression of LTBI to active disease. However, there is insufficient evidence on screening for and treatment of LTBI in persons with diabetes for the USPSTF to make a separate recommendation for this important population.\r\nPersons who are contacts of individuals with active tuberculosis, health care workers, and workers in high-risk congregate settings may also be at increased risk of exposure. Because screening in these populations is conducted as part of public health or employee health surveillance, the USPSTF did not review the evidence in these populations. Clinicians seeking further information about testing for tuberculosis in these populations can refer to the Additional Tools and Resources and Recommendations of Others sections.'}, {'id': 514, 'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic bacteriuria in nonpregnant adults.', 'servfreq': '', 'risktext': 'The risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6 Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5 Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7, 11, 12 In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12 Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4, 6'}, {'id': 1909, 'title': 'Asymptomatic Carotid Artery Stenosis: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic carotid artery stenosis in the general adult population.\r\rSee the Practice Considerations section for a description of adults at increased risk.', 'servfreq': '', 'risktext': ''}, {'id': 2017, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for suicide risk in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': '', 'risktext': ''}, {'id': 2016, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for depression in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding the optimal timing for screening for depression; more evidence is needed in both perinatal and general adult populations. In the absence of evidence, a pragmatic approach might include screening adults who have not been screened previously and using clinical judgment while considering risk factors, comorbid conditions, and life events to determine if additional screening of patients at increased risk is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nThe USPSTF recommends screening for depression in all adults regardless of risk factors. Risk factors for depression include a combination of genetic, biological, and environmental factors, such as a family history of depression, prior episode of depression or other mental health condition, a history of trauma or adverse life events, or a history of disease or illness (eg, cardiovascular disease).\r\nPrevalence rates vary by sex, age, race, ethnicity, education, marital status, geographic location, poverty level, and employment status. Women have twice the risk of depression compared with men. Young adults, multiracial individuals, and Native American/Alaska Native individuals have higher rates of depression.\r\nRisk factors for perinatal depression include life stress, low social support, history of depression, marital or partner dissatisfaction, and a history of abuse.'}, {'id': 1845, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends offering or referring adults with cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity.', 'servfreq': '', 'risktext': 'Adults 18 years or older at increased risk of CVD, defined as those with 1 or more of the following:\r\n1.Hypertension or elevated blood pressure2.Dyslipidemia3.Mixed or multiple risk factors such as the metabolic syndrome or an estimated 10-year CVD risk of &ge;7.5%\r\nThis recommendation does not apply to adults with other known modifiable cardiovascular risk factors such as abnormal blood glucose levels, obesity, and smoking; these populations are incorporated in other USPSTF recommendations.'}, {'id': 1885, 'title': 'Hepatitis B Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in adolescents and adults at increased risk for infection.\r\rSee the Practice Considerations section for a description of adolescents and adults at increased risk for infection.', 'servfreq': 'For patients with negative HBsAg results who have not received the HBV vaccine series, periodic screening may be useful for those who report continued risk for acquiring HBV transmission, such as persons who continue to inject drugs and men who have sex with men. Clinical judgment should be used to determine screening frequency. The USPSTF found no evidence to determine optimal screening intervals.', 'risktext': 'Persons from such risk groups include persons who have injected drugs in the past or currently; men who have sex with men; persons with HIV; and sex partners, needle-sharing contacts, and household contacts of persons known to be HBsAg positive. Some persons with combinations of risk factors who are not members of risk factor groups listed above may also be at increased risk for HBV infection.'}, {'id': 524, 'title': 'Hepatitis C Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis C virus (HCV) infection in adults aged 18 to 79 years.', 'servfreq': 'One-time screening for most adults.\r\nPeriodically screen persons with continued risk for HCV infection (eg, persons with past or current injection drug use). There is limited evidence to determine how often to screen persons at increased risk.&nbsp;', 'risktext': 'Asymptomatic adults aged 18 to 79 years (including pregnant persons) without known liver disease.&nbsp;\r\nThe USPSTF also suggests that clinicians consider screening persons younger than 18 years and older than 79 years who are at high risk for infection (eg, those with past or current injection drug use).&nbsp;'}, {'id': 1916, 'title': 'Lung Cancer: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery.', 'servfreq': ' \r\nThe USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. ', 'risktext': ' \r\nSmoking and older age are the 2 most important risk factors for lung cancer.&nbsp;The risk of lung cancer in persons who smoke increases with cumulative quantity and duration of smoking and with age but decreases with increasing time since quitting for persons who formerly smoked.3 The USPSTF considers adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years to be at high risk and recommends screening for lung cancer with annual LDCT in this population. \r\n \r\n&nbsp;\r\n \r\nAfrican American/Black (Black) men have a higher incidence of lung cancer than White men, and Black women have a lower incidence than White women.1 These differences are likely related to differences in smoking exposure (ie, prevalence of smoking) and related exposure to carcinogens in cigarettes.7,8 The differences may also be related to other social risk factors.\r\n \r\n&nbsp;\r\n \r\nOther risk factors for lung cancer include environmental exposures, prior radiation therapy, other (noncancer) lung diseases, and family history. Lower level of education is also associated with a higher risk of lung cancer.7 The task force recommends using age and smoking history to determine screening eligibility rather than more elaborate risk prediction models because there is insufficient evidence to assess whether risk prediction model&ndash;based screening would improve outcomes relative to using the risk factors of age and smoking history for broad implementation in primary care.\r\n '}, {'id': 1445, 'title': 'Sexually Transmitted Infections: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends behavioral counseling for all sexually active adolescents and for adults who are at increased risk for sexually transmitted infections (STIs).\r\rSee the Practice Considerations section for more information on populations at increased risk for acquiring STIs.', 'servfreq': '', 'risktext': 'All sexually active adolescents are at increased risk for STIs because of the high rates of STIs in this age group and should receive behavioral counseling interventions. Adults at increased risk for STIs include those who currently have an STI or were diagnosed with one within the past year, do not consistently use condoms, have multiple sex partners, or have sex partners within populations with a high prevalence of STIs. Populations with a high prevalence of STIs include persons who seek STI testing or attend STI clinics; sexual and gender minorities; persons who are living with HIV, inject drugs, have exchanged sex for money or drugs, or have entered correctional facilities; and some racial/ethnic minority groups.1-4'}, {'id': 402, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends counseling young adults, adolescents, children, and parents of young children about minimizing exposure to ultraviolet (UV) radiation for persons aged 6 months to 24 years with fair skin types to reduce their risk of skin cancer.', 'servfreq': '', 'risktext': 'Fair skin types'}, {'id': 438, 'title': 'Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for unhealthy alcohol use in primary care settings in adults 18 years or older, including pregnant women, and providing persons engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce unhealthy alcohol use.', 'servfreq': 'The USPSTF did not find adequate evidence to recommend an optimal screening interval for unhealthy alcohol use in adults.&nbsp;Brief behavioral counseling interventions were found to reduce unhealthy alcohol use in adults 18 years or older, including pregnant women. Effective behavioral counseling interventions vary in their specific components, administration, length, and number of interactions. The USPSTF was unable to identify specific intervention characteristics or components that were clearly associated with improved outcomes.', 'risktext': 'engaged in risky or hazardous drinking'}, {'id': 767, 'title': 'Unhealthy Drug Use: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening by asking questions about unhealthy drug use in adults age 18 years or older. Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. \r(Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'servfreq': 'Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. (Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'risktext': 'These include being aged 18 to 25 years; male sex; having a mental health condition, personality or mood disorder, or nicotine or alcohol dependence; a history of physical or sexual abuse, parental neglect, or other adversity in childhood; or drug or alcohol addiction in a first-degree relative.1,9&nbsp;Factors associated with misuse of prescription drugs include history of other drug use, mental illness, pain, and greater access to prescription drugs.10&nbsp;Factors associated with prenatal use of drugs include a mental health disorder, interpersonal violence, and family history of substance use.11'}, {'id': 433, 'title': 'Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer or refer adults with a body mass index (BMI) of 30 or higher (calculated as weight in kilograms divided by height in meters squared) to intensive, multicomponent behavioral interventions.', 'servfreq': '', 'risktext': 'Adults with a BMI &ge;30'}, {'id': 1979, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: Behavioral Counseling Interventions ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians individualize the decision to offer or refer adults without cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity. \r\rSee the "Practice Considerations" section for information on determining which patients may benefit most from this service.', 'servfreq': '', 'risktext': ''}, {'id': 1937, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for chlamydia and gonorrhea in men.', 'servfreq': '', 'risktext': ''}, {'id': 418, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening with resting or exercise electrocardiography (ECG) to prevent cardiovascular disease (CVD) events in asymptomatic adults at low risk of CVD events.', 'servfreq': '', 'risktext': ''}, {'id': 1973, 'title': 'Chronic Obstructive Pulmonary Disease: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for chronic obstructive pulmonary disease in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 2003, 'title': 'Genital Herpes Infection: Serologic Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine serologic screening for genital herpes simplex virus infection in asymptomatic adolescents and adults, including pregnant persons.', 'servfreq': '', 'risktext': 'The USPSTF found no evidence of externally validated, reliable risk stratification tools to identify individuals more or less likely to have genital herpes.'}, {'id': 504, 'title': 'Pancreatic Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for pancreatic cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 203, 'title': 'Testicular Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for testicular cancer in adolescent or adult men.', 'servfreq': '', 'risktext': ''}, {'id': 365, 'title': 'Thyroid Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for thyroid cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 1976, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'D', 'text': 'The DoctorAI recommends against the use of beta carotene or vitamin E supplements for the prevention of cardiovascular disease or cancer.', 'servfreq': '', 'risktext': ''}, {'id': 318, 'title': 'Autism Spectrum Disorder in Young Children: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for autism spectrum disorder (ASD) in young children for whom no concerns of ASD have been raised by their parents or a clinician.', 'servfreq': '', 'risktext': 'Although a number of potential risk factors for ASD have been identified, there is insufficient evidence to determine if certain risk factors modify the performance characteristics of ASD screening tests, such as the age at which screening is performed or other characteristics of the child or family.'}, {'id': 65, 'title': 'Bladder Cancer in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults.\r\rLiterature scans conducted in July 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'This evidence update focused on the benefits and harms of screening for bladder cancer among people without symptoms, the accuracy of screening tests done in primary care settings, and the benefits and harms of treatment. The updated evidence review did not find any new high quality evidence to adequately determine the balance of benefits and harms of screening for bladder cancer. However, bladder cancer is a common cancer and can cause considerable health problems including death. Therefore, the USPSTF determined that the evidence was insufficient to provide a recommendation for or against bladder cancer screening.  The USPSTF emphasizes the need for additional research in this area. '}, {'id': 419, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening with resting or exercise ECG to prevent CVD events in asymptomatic adults at intermediate or high risk of CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 423, 'title': 'Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of adding the ankle-brachial index (ABI), high-sensitivity C-reactive protein (hsCRP) level, or coronary artery calcium (CAC) score to traditional risk assessment for cardiovascular disease (CVD) in asymptomatic adults to prevent CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 352, 'title': 'Celiac Disease: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'persons with family history or other risk factors'}, {'id': 1955, 'title': 'Eating Disorders in Adolescents and Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for eating disorders in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 665, 'title': 'Illicit Drug Use in Children, Adolescents, and Young Adults: Primary Care-Based Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--based behavioral counseling interventions to prevent illicit drug use, including nonmedical use of prescription drugs, in children, adolescents, and young adults.\r\rSee the Practice Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 435, 'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for abuse and neglect in all older or vulnerable adults. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': 'Risk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health.14&nbsp;For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.15'}, {'id': 2045, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for iron deficiency and iron deficiency anemia in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2046, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine iron supplementation in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2018, 'title': 'Lipid Disorders in Children and Adolescents: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1998, 'title': 'Obstructive Sleep Apnea in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for obstructive sleep apnea in the general adult population.\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Risk Factors\r\nRisk factors associated with OSA include male sex, older age (40-70 years), postmenopausal status, higher body mass index (BMI), and craniofacial and upper airway abnormalities (eg, enlarged tonsils or long upper airway). Black, Hispanic/Latino, and Native American/Alaska Native persons have a higher prevalence of OSA compared with White persons; some evidence suggests that these differences are partially explained by higher rates of obesity, asthma, and tobacco use among these groups.8'}, {'id': 1977, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of multivitamin supplements for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1978, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of single or paired nutrient supplements (other than beta carotene and vitamin E) for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 176, 'title': 'Oral Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for oral cancer in asymptomatic adults.\r\rGo to the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in July 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Tobacco and alcohol use are major risk factors for oral cancer. A total of 20% to 30% of cases of oral cancer worldwide are attributable to cigarette smoking. In the United States, up to 75% of cases of oral cancer may be attributable to tobacco and alcohol use. Additional risk factors include male sex, older age, use of betel quid, ultraviolet light exposure, infection with Candida or bacterial flora, and a compromised immune system. Sexually transmitted oral HPV infection (HPV-16) has recently been recognized as an increasingly important risk factor for oropharyngeal cancer. In the United States, the prevalence of oropharyngeal cancer due to oral HPV infection is probably as high as 80% to 95%. The prevalence of oral HPV infection is associated with age, sex, number of sexual partners, and number of cigarettes smoked per day. The effect of multifactorial risk assessment and screening for risk factors on oral cancer morbidity and mortality is unknown.'}, {'id': 2026, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine screening performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 2027, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of preventive interventions performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 424, 'title': 'Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for peripheral artery disease (PAD) and cardiovascular disease (CVD) risk with the ankle-brachial index (ABI) in asymptomatic adults.\r\rLiterature scans conducted in August 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Risk factors associated with OSA include male sex, older age (40 to 70 years), postmenopausal status, higher BMI, and craniofacial and upper airway abnormalities.'}, {'id': 404, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of counseling adults about skin self-examination to prevent skin cancer.See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 2005, 'title': 'Skin Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Exposure to UV radiation from sun exposure, indoor tanning beds, and other UV radiation&ndash;emitting devices is the major environmental risk factor for skin cancer. History of frequent sunburns, older age, and male sex are associated with increased risk for skin cancer. Exposure to UV radiation from the use of indoor tanning beds is an important risk factor in adolescents. Incidence of melanoma is higher among White persons compared with persons of other races and ethnicities. This difference likely reflects traits associated with increased melanoma risk, such as fair skin (which is more susceptible to sunburning), light-colored eyes, and red or blond hair being more common among White persons compared with persons of other races and ethnicities. Acral lentiginous melanoma, which occurs mostly on skin not frequently exposed to direct sunlight (eg, palms of hands, soles of feet, or under fingernails or toenails), is the most common type of melanoma among Black populations. Other melanoma risk factors include higher numbers of moles on the skin, atypical moles, as well as a personal and family history of skin cancer.'}, {'id': 269, 'title': 'Thyroid Dysfunction: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults.\r\rSee the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': 'The optimal screening interval for thyroid dysfunction (if one exists) is unknown.', 'risktext': 'The most common cause of hypothyroidism in the United States is chronic autoimmune (Hashimoto) thyroiditis. Risk factors for an elevated TSH level include female sex, advancing age, white race, type 1 diabetes, Down syndrome, family history of thyroid disease, goiter, previous hyperthyroidism (possibly due in part to ablation therapy leading to iatrogenic thyroid dysfunction), and external-beam radiation in the head and neck area. Common causes of hyperthyroidism include Graves disease, Hashimoto thyroiditis, and functional thyroid nodules. Risk factors for a low TSH level include female sex; advancing age; black race; low iodine intake; personal or family history of thyroid disease; and ingestion of iodine-containing drugs, such as amiodarone. The USPSTF found no direct evidence that treatment of thyroid dysfunction based on risk level alters final health outcomes.'}, {'id': 1908, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of electronic cigarettes (e-cigarettes) for tobacco cessation in adults, including pregnant persons. The USPSTF recommends that clinicians direct patients who use tobacco to other tobacco cessation interventions with proven effectiveness and established safety.\rSee the Practice Considerations section for more information on recommended behavioral interventions and pharmacotherapy and for suggestions for practice regarding the I statements.', 'servfreq': '', 'risktext': ''}, {'id': 1907, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of pharmacotherapy interventions for tobacco cessation in pregnant persons.', 'servfreq': '', 'risktext': ''}, {'id': 586, 'title': 'Tobacco Use in Children and Adolescents: Primary Care Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--feasible interventions for the cessation of tobacco use among school-aged children and adolescents.\r\rSee the Practice Considerations section for more information on effective interventions to prevent initiation of tobacco use and for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1919, 'title': 'Vitamin D Deficiency in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 408, 'title': 'Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of the benefits and harms of vitamin D and calcium supplementation, alone or combined, for the primary prevention of fractures in men and premenopausal women.', 'servfreq': '', 'risktext': ''}], 'tools': [{'tool_id': 321, 'url': 'https://jamanetwork.com/journals/jama/fullarticle/2735342', 'title': 'JAMA Patient Page: Who Should Be Screened for HIV Infection? ', 'text': '', 'keywords': ''}, {'tool_id': 322, 'url': 'https://sites.jamanetwork.com/spanish-patient-pages/2019/hoja-para-el-paciente-de-jama-190618.pdf', 'title': 'ยฟQuiรฉnes deben someterse a una prueba de detecciรณn de infecciรณn por VIH?', 'text': '', 'keywords': 'HIV|Human immunodeficiency syndrome|AIDS'}, {'tool_id': 210, 'url': 'https://www.aafp.org/afp/2019/1115/p637.html', 'title': "Screening for HIV Infection and Preexposure Prophylaxis for the Prevention of HIV Infection: AFP's Putting Into Practice", 'text': 'The journal American Family Physician (AFP) provides a series of short case studies and quizzes based on recommendations issued by the U.S. Preventive Services Task Force.', 'keywords': ''}]}
2025-01-29 21:50:33 [INFO] Recommendations: [{'id': 485, 'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in adolescents and adults aged 15 to 65 years. Younger adolescents and older adults who are at increased risk of infection should also be screened.\rSee the Clinical Considerations section for more information about assessment of risk, screening intervals, and rescreening in pregnancy.', 'servfreq': 'The USPSTF found insufficient evidence to determine appropriate or optimal time intervals or strategies for repeat HIV screening. However, repeat screening is reasonable for persons known to be at increased risk of HIV infection, such as sexually active men who have sex with men; persons with a sex partner who is living with HIV; or persons who engage in behaviors that may convey an increased risk of HIV infection, such as injection drug use, transactional sex or commercial sex work, having 1 or more new sex partners whose HIV status is unknown, or having other factors that can place a person at increased risk of HIV infection (see &ldquo;Risk Assessment&rdquo;). Repeat screening is also reasonable for persons who live or receive medical care in a high-prevalence setting, such as a sexually transmitted disease clinic, tuberculosis clinic, correctional facility, or homeless shelter.', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'id': 1921, 'title': 'Hypertension in Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hypertension in adults 18 years or older with office blood pressure measurement (OBPM). The USPSTF recommends obtaining blood pressure measurements outside of the clinical setting for diagnostic confirmation before starting treatment.', 'servfreq': ' \r\nAlthough evidence on optimal screening intervals is limited, reasonable options include:\r\n \r\n \r\n\r\n\r\nScreening for hypertension every year in adults 40 years or older and in adults at increased risk for hypertension (such as Black persons, persons with high-normal blood pressure, or persons who are overweight or obese)\r\n\r\n\r\n \r\n \r\n\r\n\r\nScreening less frequently (ie, every 3 to 5 years) as appropriate for adults aged 18 to 39 years not at increased risk for hypertension and with a prior normal blood pressure reading.\r\n\r\n\r\n ', 'risktext': ' \r\nAlthough all adults should be screened for hypertension, risk factors that increase a person&rsquo;s risk for the condition include older age, Black race, family history, excess weight and obesity, lifestyle habits (lack of physical activity, stress, and tobacco use), and dietary factors (diet high in fat or sodium, diet low in potassium, or excessive alcohol intake)\r\n '}, {'id': 2021, 'title': 'Prevention of Acquisition of HIV: Preexposure Prophylaxis ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians prescribe preexposure prophylaxis using effective antiretroviral therapy to persons who are at increased risk of HIV acquisition to decrease the risk of acquiring HIV. \r\rSee the Practice Considerations section for more information about identification of persons at increased risk and about effective antiretroviral therapy.', 'servfreq': '', 'risktext': 'HIV is primarily acquired via sexual activity or injection drug use. It is important that clinicians routinely take a sexual and injection drug use history for all their patients in an open and nonjudgmental manner. All adolescents and adults who are sexually active or who inject drugs should be informed that acquisition of HIV can be prevented, to facilitate subsequent risk assessment and discussions about preexposure prophylaxis (PrEP) and other ways to prevent acquisition of HIV. Importantly, risk of HIV acquisition exists on a continuum, and currently available risk assessment tools all have limitations. However, certain risk factors or behaviors are known to place persons at increased risk of HIV.\r\nRisk of HIV acquisition depends on the likelihood that a specific act or activity will transmit HIV and the likelihood that a sex partner or drug injection partner has HIV. Likelihood of HIV transmission is highest with needle-sharing injection drug use and condomless receptive anal intercourse. Condomless receptive anal intercourse has an approximately 10- to 15-fold higher risk of transmission than condomless insertive anal sex and condomless receptive and insertive penile-vaginal sex. A 2018 study estimated the prevalence of HIV (ie, an estimate of the likelihood that a partner whose HIV status is unknown has HIV at a population level) as 12.4% among men who have sex with men and 1.9% among persons who inject drugs. The overall prevalence of HIV in the US is estimated at 0.3%.&nbsp;Of note, both the frequency of specific sexual activities and a person&rsquo;s number of sexual partners will also affect their risk of HIV.\r\n&nbsp;The USPSTF recommends that the following persons be considered for PrEP:\r\n1.&nbsp;&nbsp;&nbsp;&nbsp; Sexually active adults and adolescents weighing at least 35 kg (77 lb) who have engaged in anal or vaginal sex in the past 6 months and have any of the following:\r\n&nbsp;\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A sexual partner who has HIV (especially if the partner has an unknown or detectable viral load).\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A bacterial sexually transmitted infection (STI) (syphilis, gonorrhea, or chlamydia for men who have sex with men and transgender women; gonorrhea and syphilis for heterosexual women and men) in the past 6 months.\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A history of inconsistent or no condom use with sex partner(s) whose HIV status is not known; assessing risk in conversation with the patient and considering factors such as number of partners, the specific sexual activities a person engages in, and whether their sex partner or partners are in a group with a higher prevalence of HIV (eg, men who have sex with men or with men and women, transgender women, persons who inject drugs, and persons who engage in transactional sex).\r\n&nbsp;\r\n2. &nbsp; Persons who inject drugs and have a drug-injecting partner who has HIV or who shares injection equipment.\r\nPersons who engage in transactional sex, such as sex for money, drugs, or housing, including commercial sex workers or persons trafficked for sex work, constitute a group at increased risk of HIV acquisition and should be considered for PrEP based on the criteria outlined above. Persons who request PrEP may have undisclosed behaviors that put them at risk. Transgender women and men who are sexually active should be considered for PrEP based on the criteria outlined above. Transgender women are at especially high risk of HIV acquisition. A Centers for Disease Control and and Prevention (CDC) survey in 7 cities found an HIV prevalence of 42% among transgender women. Prevalence was highest among Black transgender women (62%) and Native American/Alaska Native transgender women (65%).\r\nIn addition, studies have found that transmission of HIV to a seronegative partner from a partner with HIV has not been observed when the partner with HIV was being treated with antiretroviral therapy and had a suppressed viral load.&nbsp;It is not known whether PrEP use further decreases the risk of HIV transmission when a partner with HIV has a documented undetectable viral load. Factors such as the consistency or inconsistency of a partner&rsquo;s viral load being suppressed, a partner&rsquo;s adherence to antiretroviral therapy, and the degree of certainty that a partner&rsquo;s viral load is suppressed (eg, self-report vs availability of laboratory test results) may help inform decisions about the use of PrEP in this situation.\r\nAll persons being considered for PrEP must have a recently documented negative HIV antigen-antibody test result, and if they have taken oral PrEP or postexposure prophylaxis in the past 3 months, or injectable cabotegravir in the past 12 months, the CDC recommends testing with both an HIV antigen-antibody assay and an HIV-1 RNA assay.'}, {'id': 1989, 'title': 'Syphilis Infection in Nonpregnant Adolescents and Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for syphilis infection in persons who are at increased risk for infection.', 'servfreq': 'Optimal screening frequency for persons who are at increased risk for syphilis infection is not well established. Men who have sex with men or persons with HIV infection may benefit from screening at least annually or more frequently (eg, every 3 to 6 months) if they continue to be at high risk.', 'risktext': 'The USPSTF recommends screening for syphilis in persons who are at increased risk for infection. When deciding which persons to screen for syphilis, clinicians should consider the prevalence of infection in the communities they serve, as well as other sociodemographic and behavioral factors that may be associated with increased risk of syphilis infection. For example, prevalence of syphilis is higher in men, men who have sex with men, persons with HIV infection, young adults, and persons with a history of incarceration, sex work, or military service. A substantial percentage of heterosexual syphilis transmission occurs among persons who use illicit drugs, particularly methamphetamine. Diagnosis of another STI may signal that a person is having condomless sex, which increases their risk of syphilis infection. Higher infection rates in persons of some racial and ethnic groups have been reported and are primarily a reflection of a combination of factors, including social determinants of health (eg, disparities of income, low educational achievement, and unstable housing), differential health insurance coverage or access to quality health care, and differences in sexual network characteristics (eg, individuals living in communities with a high prevalence of STIs have an increased chance of encountering an infected partner). Local prevalence rates may change over time, so clinicians should be aware of the latest data and trends for their specific population and geographic area, which are available through their state and local health departments and Centers for Disease Control and Prevention (CDC) surveillance.\r\n&nbsp;\r\nAlthough direct evidence on screening in nonpregnant persons who are not at increased risk for syphilis infection is lacking, based on the established test performance characteristics of current screening tests and the low prevalence rate of syphilis in this population, the yield of screening is likely low.9,10 Therefore, screening in this population may result in high false-positive rates and overtreatment.'}, {'id': 1905, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and US Food and Drug Administration (FDA)--approved pharmacotherapy for cessation to nonpregnant adults who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 1906, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all pregnant persons about tobacco use, advise them to stop using tobacco, and provide behavioral interventions for cessation to pregnant persons who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 2014, 'title': 'Anxiety Disorders in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for anxiety disorders in adults, including pregnant and postpartum persons.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding optimal timing for screening, or screening interval, for both the perinatal and general adult populations; more evidence on both timing and screening interval is needed for all adult populations. A pragmatic approach in the absence of evidence might include screening all adults who have not been screened previously and using clinical judgment in considering risk factors, comorbid conditions, and life events to determine if additional screening of high-risk patients is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nRisk factors for anxiety disorders include sociodemographic factors, psychosocial factors, and physical and mental health factors such as marital status (widowed or divorced), stressful life events, smoking and alcohol use, other mental health conditions, or a parental history of mental disorders. Demographic factors such as low socioeconomic status and female sex are associated with higher rates of anxiety disorders.&nbsp;Black persons and individuals of non-Hispanic ethnicity are at increased risk of anxiety disorders due to social, rather than biological, factors. Anxiety and depressive disorders often overlap. One cohort study found that 67% of individuals with a depressive disorder also had a current anxiety disorder, and 75% had a lifetime comorbid anxiety disorder.'}, {'id': 2009, 'title': 'Latent Tuberculosis Infection in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for LTBI in populations at increased risk.\r\rSee the "Assessment of Risk" section for additional information on adults at increased risk.', 'servfreq': 'The USPSTF found no evidence on the optimal frequency of screening for LTBI. In the absence of evidence, a reasonable approach is to repeat screening based on specific risk factors; screening frequency could range from 1-time only screening among persons at low risk for future tuberculosis exposure to annual screening among those at continued risk of exposure.', 'risktext': 'Populations at increased risk for LTBI, based on increased prevalence of active disease and increased risk of exposure, include persons who were born in, or are former residents of, countries with high tuberculosis prevalence and persons who live in, or have lived in, high-risk congregate settings (eg, homeless shelters or correctional facilities). Clinicians can consult their local or state health departments for more information about populations at increased risk in their community, since local demographic patterns may vary across the US.\r\nIn 2020, 71.5% of all cases of active tuberculosis in the US occurred among persons born outside the US. According to the CDC, tuberculosis disease is common in most countries in Latin America, the Caribbean, Africa, Asia, Eastern Europe, and Russia. In 2020, among persons with new tuberculosis living in the US who were born outside the US, the most common countries of birth were Mexico (18.0%), the Philippines (12.5%), India (10.4%), Vietnam (8.2%), and China (5.1%), accounting for 54.2% of total cases. Most of these cases are believed to be due to progression of latent infection to active tuberculosis disease rather than new transmission within communities.\r\nPersons who live, or have lived, in high-risk congregate settings also have a higher prevalence rate of active tuberculosis and an increased risk for exposure. In 2020, 4.3% of tuberculosis disease cases diagnosed in persons 15 years or older occurred in persons experiencing homelessness and 2.6% occurred in residents of correctional facilities. It is estimated that persons experiencing homelessness have an 11 times higher incidence of tuberculosis disease compared with persons who are not experiencing homelessness (36 cases per 100,000 population vs 2.9 cases per 100,000 population, respectively, during 2011 to 2016).\r\nOther populations at increased risk for LTBI or progression to active disease include persons who have immunosuppression (eg, persons living with HIV, patients receiving immunosuppressive medications such as chemotherapy or tumor necrosis factor inhibitors, and patients who have received an organ transplant) and patients with silicosis (a lung disease). However, given that screening in these populations may be considered standard care as part of disease management or indicated prior to the use of certain medications, the USPSTF did not review evidence on screening in these populations. Information on testing in these populations is provided by other groups, such as the Office of AIDS Research at the National Institutes of Health, and in a guideline issued jointly by the American Thoracic Society, Infectious Diseases Society of America, and CDC. Some evidence from observational studies has explored the association between poorly controlled diabetes and progression of LTBI to active disease. However, there is insufficient evidence on screening for and treatment of LTBI in persons with diabetes for the USPSTF to make a separate recommendation for this important population.\r\nPersons who are contacts of individuals with active tuberculosis, health care workers, and workers in high-risk congregate settings may also be at increased risk of exposure. Because screening in these populations is conducted as part of public health or employee health surveillance, the USPSTF did not review the evidence in these populations. Clinicians seeking further information about testing for tuberculosis in these populations can refer to the Additional Tools and Resources and Recommendations of Others sections.'}, {'id': 514, 'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic bacteriuria in nonpregnant adults.', 'servfreq': '', 'risktext': 'The risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6 Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5 Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7, 11, 12 In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12 Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4, 6'}, {'id': 1909, 'title': 'Asymptomatic Carotid Artery Stenosis: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic carotid artery stenosis in the general adult population.\r\rSee the Practice Considerations section for a description of adults at increased risk.', 'servfreq': '', 'risktext': ''}, {'id': 2017, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for suicide risk in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': '', 'risktext': ''}, {'id': 2016, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for depression in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding the optimal timing for screening for depression; more evidence is needed in both perinatal and general adult populations. In the absence of evidence, a pragmatic approach might include screening adults who have not been screened previously and using clinical judgment while considering risk factors, comorbid conditions, and life events to determine if additional screening of patients at increased risk is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nThe USPSTF recommends screening for depression in all adults regardless of risk factors. Risk factors for depression include a combination of genetic, biological, and environmental factors, such as a family history of depression, prior episode of depression or other mental health condition, a history of trauma or adverse life events, or a history of disease or illness (eg, cardiovascular disease).\r\nPrevalence rates vary by sex, age, race, ethnicity, education, marital status, geographic location, poverty level, and employment status. Women have twice the risk of depression compared with men. Young adults, multiracial individuals, and Native American/Alaska Native individuals have higher rates of depression.\r\nRisk factors for perinatal depression include life stress, low social support, history of depression, marital or partner dissatisfaction, and a history of abuse.'}, {'id': 1845, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends offering or referring adults with cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity.', 'servfreq': '', 'risktext': 'Adults 18 years or older at increased risk of CVD, defined as those with 1 or more of the following:\r\n1.Hypertension or elevated blood pressure2.Dyslipidemia3.Mixed or multiple risk factors such as the metabolic syndrome or an estimated 10-year CVD risk of &ge;7.5%\r\nThis recommendation does not apply to adults with other known modifiable cardiovascular risk factors such as abnormal blood glucose levels, obesity, and smoking; these populations are incorporated in other USPSTF recommendations.'}, {'id': 1885, 'title': 'Hepatitis B Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in adolescents and adults at increased risk for infection.\r\rSee the Practice Considerations section for a description of adolescents and adults at increased risk for infection.', 'servfreq': 'For patients with negative HBsAg results who have not received the HBV vaccine series, periodic screening may be useful for those who report continued risk for acquiring HBV transmission, such as persons who continue to inject drugs and men who have sex with men. Clinical judgment should be used to determine screening frequency. The USPSTF found no evidence to determine optimal screening intervals.', 'risktext': 'Persons from such risk groups include persons who have injected drugs in the past or currently; men who have sex with men; persons with HIV; and sex partners, needle-sharing contacts, and household contacts of persons known to be HBsAg positive. Some persons with combinations of risk factors who are not members of risk factor groups listed above may also be at increased risk for HBV infection.'}, {'id': 524, 'title': 'Hepatitis C Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis C virus (HCV) infection in adults aged 18 to 79 years.', 'servfreq': 'One-time screening for most adults.\r\nPeriodically screen persons with continued risk for HCV infection (eg, persons with past or current injection drug use). There is limited evidence to determine how often to screen persons at increased risk.&nbsp;', 'risktext': 'Asymptomatic adults aged 18 to 79 years (including pregnant persons) without known liver disease.&nbsp;\r\nThe USPSTF also suggests that clinicians consider screening persons younger than 18 years and older than 79 years who are at high risk for infection (eg, those with past or current injection drug use).&nbsp;'}, {'id': 1916, 'title': 'Lung Cancer: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery.', 'servfreq': ' \r\nThe USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. ', 'risktext': ' \r\nSmoking and older age are the 2 most important risk factors for lung cancer.&nbsp;The risk of lung cancer in persons who smoke increases with cumulative quantity and duration of smoking and with age but decreases with increasing time since quitting for persons who formerly smoked.3 The USPSTF considers adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years to be at high risk and recommends screening for lung cancer with annual LDCT in this population. \r\n \r\n&nbsp;\r\n \r\nAfrican American/Black (Black) men have a higher incidence of lung cancer than White men, and Black women have a lower incidence than White women.1 These differences are likely related to differences in smoking exposure (ie, prevalence of smoking) and related exposure to carcinogens in cigarettes.7,8 The differences may also be related to other social risk factors.\r\n \r\n&nbsp;\r\n \r\nOther risk factors for lung cancer include environmental exposures, prior radiation therapy, other (noncancer) lung diseases, and family history. Lower level of education is also associated with a higher risk of lung cancer.7 The task force recommends using age and smoking history to determine screening eligibility rather than more elaborate risk prediction models because there is insufficient evidence to assess whether risk prediction model&ndash;based screening would improve outcomes relative to using the risk factors of age and smoking history for broad implementation in primary care.\r\n '}, {'id': 1445, 'title': 'Sexually Transmitted Infections: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends behavioral counseling for all sexually active adolescents and for adults who are at increased risk for sexually transmitted infections (STIs).\r\rSee the Practice Considerations section for more information on populations at increased risk for acquiring STIs.', 'servfreq': '', 'risktext': 'All sexually active adolescents are at increased risk for STIs because of the high rates of STIs in this age group and should receive behavioral counseling interventions. Adults at increased risk for STIs include those who currently have an STI or were diagnosed with one within the past year, do not consistently use condoms, have multiple sex partners, or have sex partners within populations with a high prevalence of STIs. Populations with a high prevalence of STIs include persons who seek STI testing or attend STI clinics; sexual and gender minorities; persons who are living with HIV, inject drugs, have exchanged sex for money or drugs, or have entered correctional facilities; and some racial/ethnic minority groups.1-4'}, {'id': 402, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends counseling young adults, adolescents, children, and parents of young children about minimizing exposure to ultraviolet (UV) radiation for persons aged 6 months to 24 years with fair skin types to reduce their risk of skin cancer.', 'servfreq': '', 'risktext': 'Fair skin types'}, {'id': 438, 'title': 'Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for unhealthy alcohol use in primary care settings in adults 18 years or older, including pregnant women, and providing persons engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce unhealthy alcohol use.', 'servfreq': 'The USPSTF did not find adequate evidence to recommend an optimal screening interval for unhealthy alcohol use in adults.&nbsp;Brief behavioral counseling interventions were found to reduce unhealthy alcohol use in adults 18 years or older, including pregnant women. Effective behavioral counseling interventions vary in their specific components, administration, length, and number of interactions. The USPSTF was unable to identify specific intervention characteristics or components that were clearly associated with improved outcomes.', 'risktext': 'engaged in risky or hazardous drinking'}, {'id': 767, 'title': 'Unhealthy Drug Use: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening by asking questions about unhealthy drug use in adults age 18 years or older. Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. \r(Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'servfreq': 'Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. (Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'risktext': 'These include being aged 18 to 25 years; male sex; having a mental health condition, personality or mood disorder, or nicotine or alcohol dependence; a history of physical or sexual abuse, parental neglect, or other adversity in childhood; or drug or alcohol addiction in a first-degree relative.1,9&nbsp;Factors associated with misuse of prescription drugs include history of other drug use, mental illness, pain, and greater access to prescription drugs.10&nbsp;Factors associated with prenatal use of drugs include a mental health disorder, interpersonal violence, and family history of substance use.11'}, {'id': 433, 'title': 'Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer or refer adults with a body mass index (BMI) of 30 or higher (calculated as weight in kilograms divided by height in meters squared) to intensive, multicomponent behavioral interventions.', 'servfreq': '', 'risktext': 'Adults with a BMI &ge;30'}, {'id': 1979, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: Behavioral Counseling Interventions ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians individualize the decision to offer or refer adults without cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity. \r\rSee the "Practice Considerations" section for information on determining which patients may benefit most from this service.', 'servfreq': '', 'risktext': ''}, {'id': 1937, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for chlamydia and gonorrhea in men.', 'servfreq': '', 'risktext': ''}, {'id': 418, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening with resting or exercise electrocardiography (ECG) to prevent cardiovascular disease (CVD) events in asymptomatic adults at low risk of CVD events.', 'servfreq': '', 'risktext': ''}, {'id': 1973, 'title': 'Chronic Obstructive Pulmonary Disease: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for chronic obstructive pulmonary disease in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 2003, 'title': 'Genital Herpes Infection: Serologic Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine serologic screening for genital herpes simplex virus infection in asymptomatic adolescents and adults, including pregnant persons.', 'servfreq': '', 'risktext': 'The USPSTF found no evidence of externally validated, reliable risk stratification tools to identify individuals more or less likely to have genital herpes.'}, {'id': 504, 'title': 'Pancreatic Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for pancreatic cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 203, 'title': 'Testicular Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for testicular cancer in adolescent or adult men.', 'servfreq': '', 'risktext': ''}, {'id': 365, 'title': 'Thyroid Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for thyroid cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 1976, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'D', 'text': 'The DoctorAI recommends against the use of beta carotene or vitamin E supplements for the prevention of cardiovascular disease or cancer.', 'servfreq': '', 'risktext': ''}, {'id': 318, 'title': 'Autism Spectrum Disorder in Young Children: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for autism spectrum disorder (ASD) in young children for whom no concerns of ASD have been raised by their parents or a clinician.', 'servfreq': '', 'risktext': 'Although a number of potential risk factors for ASD have been identified, there is insufficient evidence to determine if certain risk factors modify the performance characteristics of ASD screening tests, such as the age at which screening is performed or other characteristics of the child or family.'}, {'id': 65, 'title': 'Bladder Cancer in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults.\r\rLiterature scans conducted in July 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'This evidence update focused on the benefits and harms of screening for bladder cancer among people without symptoms, the accuracy of screening tests done in primary care settings, and the benefits and harms of treatment. The updated evidence review did not find any new high quality evidence to adequately determine the balance of benefits and harms of screening for bladder cancer. However, bladder cancer is a common cancer and can cause considerable health problems including death. Therefore, the USPSTF determined that the evidence was insufficient to provide a recommendation for or against bladder cancer screening.  The USPSTF emphasizes the need for additional research in this area. '}, {'id': 419, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening with resting or exercise ECG to prevent CVD events in asymptomatic adults at intermediate or high risk of CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 423, 'title': 'Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of adding the ankle-brachial index (ABI), high-sensitivity C-reactive protein (hsCRP) level, or coronary artery calcium (CAC) score to traditional risk assessment for cardiovascular disease (CVD) in asymptomatic adults to prevent CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 352, 'title': 'Celiac Disease: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'persons with family history or other risk factors'}, {'id': 1955, 'title': 'Eating Disorders in Adolescents and Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for eating disorders in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 665, 'title': 'Illicit Drug Use in Children, Adolescents, and Young Adults: Primary Care-Based Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--based behavioral counseling interventions to prevent illicit drug use, including nonmedical use of prescription drugs, in children, adolescents, and young adults.\r\rSee the Practice Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 435, 'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for abuse and neglect in all older or vulnerable adults. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': 'Risk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health.14&nbsp;For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.15'}, {'id': 2045, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for iron deficiency and iron deficiency anemia in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2046, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine iron supplementation in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2018, 'title': 'Lipid Disorders in Children and Adolescents: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1998, 'title': 'Obstructive Sleep Apnea in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for obstructive sleep apnea in the general adult population.\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Risk Factors\r\nRisk factors associated with OSA include male sex, older age (40-70 years), postmenopausal status, higher body mass index (BMI), and craniofacial and upper airway abnormalities (eg, enlarged tonsils or long upper airway). Black, Hispanic/Latino, and Native American/Alaska Native persons have a higher prevalence of OSA compared with White persons; some evidence suggests that these differences are partially explained by higher rates of obesity, asthma, and tobacco use among these groups.8'}, {'id': 1977, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of multivitamin supplements for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1978, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of single or paired nutrient supplements (other than beta carotene and vitamin E) for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 176, 'title': 'Oral Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for oral cancer in asymptomatic adults.\r\rGo to the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in July 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Tobacco and alcohol use are major risk factors for oral cancer. A total of 20% to 30% of cases of oral cancer worldwide are attributable to cigarette smoking. In the United States, up to 75% of cases of oral cancer may be attributable to tobacco and alcohol use. Additional risk factors include male sex, older age, use of betel quid, ultraviolet light exposure, infection with Candida or bacterial flora, and a compromised immune system. Sexually transmitted oral HPV infection (HPV-16) has recently been recognized as an increasingly important risk factor for oropharyngeal cancer. In the United States, the prevalence of oropharyngeal cancer due to oral HPV infection is probably as high as 80% to 95%. The prevalence of oral HPV infection is associated with age, sex, number of sexual partners, and number of cigarettes smoked per day. The effect of multifactorial risk assessment and screening for risk factors on oral cancer morbidity and mortality is unknown.'}, {'id': 2026, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine screening performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 2027, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of preventive interventions performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 424, 'title': 'Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for peripheral artery disease (PAD) and cardiovascular disease (CVD) risk with the ankle-brachial index (ABI) in asymptomatic adults.\r\rLiterature scans conducted in August 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Risk factors associated with OSA include male sex, older age (40 to 70 years), postmenopausal status, higher BMI, and craniofacial and upper airway abnormalities.'}, {'id': 404, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of counseling adults about skin self-examination to prevent skin cancer.See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 2005, 'title': 'Skin Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Exposure to UV radiation from sun exposure, indoor tanning beds, and other UV radiation&ndash;emitting devices is the major environmental risk factor for skin cancer. History of frequent sunburns, older age, and male sex are associated with increased risk for skin cancer. Exposure to UV radiation from the use of indoor tanning beds is an important risk factor in adolescents. Incidence of melanoma is higher among White persons compared with persons of other races and ethnicities. This difference likely reflects traits associated with increased melanoma risk, such as fair skin (which is more susceptible to sunburning), light-colored eyes, and red or blond hair being more common among White persons compared with persons of other races and ethnicities. Acral lentiginous melanoma, which occurs mostly on skin not frequently exposed to direct sunlight (eg, palms of hands, soles of feet, or under fingernails or toenails), is the most common type of melanoma among Black populations. Other melanoma risk factors include higher numbers of moles on the skin, atypical moles, as well as a personal and family history of skin cancer.'}, {'id': 269, 'title': 'Thyroid Dysfunction: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults.\r\rSee the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': 'The optimal screening interval for thyroid dysfunction (if one exists) is unknown.', 'risktext': 'The most common cause of hypothyroidism in the United States is chronic autoimmune (Hashimoto) thyroiditis. Risk factors for an elevated TSH level include female sex, advancing age, white race, type 1 diabetes, Down syndrome, family history of thyroid disease, goiter, previous hyperthyroidism (possibly due in part to ablation therapy leading to iatrogenic thyroid dysfunction), and external-beam radiation in the head and neck area. Common causes of hyperthyroidism include Graves disease, Hashimoto thyroiditis, and functional thyroid nodules. Risk factors for a low TSH level include female sex; advancing age; black race; low iodine intake; personal or family history of thyroid disease; and ingestion of iodine-containing drugs, such as amiodarone. The USPSTF found no direct evidence that treatment of thyroid dysfunction based on risk level alters final health outcomes.'}, {'id': 1908, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of electronic cigarettes (e-cigarettes) for tobacco cessation in adults, including pregnant persons. The USPSTF recommends that clinicians direct patients who use tobacco to other tobacco cessation interventions with proven effectiveness and established safety.\rSee the Practice Considerations section for more information on recommended behavioral interventions and pharmacotherapy and for suggestions for practice regarding the I statements.', 'servfreq': '', 'risktext': ''}, {'id': 1907, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of pharmacotherapy interventions for tobacco cessation in pregnant persons.', 'servfreq': '', 'risktext': ''}, {'id': 586, 'title': 'Tobacco Use in Children and Adolescents: Primary Care Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--feasible interventions for the cessation of tobacco use among school-aged children and adolescents.\r\rSee the Practice Considerations section for more information on effective interventions to prevent initiation of tobacco use and for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1919, 'title': 'Vitamin D Deficiency in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 408, 'title': 'Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of the benefits and harms of vitamin D and calcium supplementation, alone or combined, for the primary prevention of fractures in men and premenopausal women.', 'servfreq': '', 'risktext': ''}]
2025-01-29 21:50:33 [INFO] Tools: [{'tool_id': 321, 'url': 'https://jamanetwork.com/journals/jama/fullarticle/2735342', 'title': 'JAMA Patient Page: Who Should Be Screened for HIV Infection? ', 'text': '', 'keywords': ''}, {'tool_id': 322, 'url': 'https://sites.jamanetwork.com/spanish-patient-pages/2019/hoja-para-el-paciente-de-jama-190618.pdf', 'title': 'ยฟQuiรฉnes deben someterse a una prueba de detecciรณn de infecciรณn por VIH?', 'text': '', 'keywords': 'HIV|Human immunodeficiency syndrome|AIDS'}, {'tool_id': 210, 'url': 'https://www.aafp.org/afp/2019/1115/p637.html', 'title': "Screening for HIV Infection and Preexposure Prophylaxis for the Prevention of HIV Infection: AFP's Putting Into Practice", 'text': 'The journal American Family Physician (AFP) provides a series of short case studies and quizzes based on recommendations issued by the U.S. Preventive Services Task Force.', 'keywords': ''}]
2025-01-29 21:50:34 [INFO] Update id=273478130 is handled. Duration 1072 ms by bot id=8108339380
2025-01-29 21:50:44 [INFO] Update id=273478131 is handled. Duration 701 ms by bot id=8108339380
2025-01-29 21:50:46 [INFO] State data: {'db': <bot.database.Database object at 0x7f2400e2f230>, 'age': 20, 'weight': 90, 'height': 190, 'feet': 45, 'gender': 'male', 'pregnant': 'no', 'smoking': 'yes', 'sex': 'tools_1', 'recommendations': [{'id': 485, 'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in adolescents and adults aged 15 to 65 years. Younger adolescents and older adults who are at increased risk of infection should also be screened.\rSee the Clinical Considerations section for more information about assessment of risk, screening intervals, and rescreening in pregnancy.', 'servfreq': 'The USPSTF found insufficient evidence to determine appropriate or optimal time intervals or strategies for repeat HIV screening. However, repeat screening is reasonable for persons known to be at increased risk of HIV infection, such as sexually active men who have sex with men; persons with a sex partner who is living with HIV; or persons who engage in behaviors that may convey an increased risk of HIV infection, such as injection drug use, transactional sex or commercial sex work, having 1 or more new sex partners whose HIV status is unknown, or having other factors that can place a person at increased risk of HIV infection (see &ldquo;Risk Assessment&rdquo;). Repeat screening is also reasonable for persons who live or receive medical care in a high-prevalence setting, such as a sexually transmitted disease clinic, tuberculosis clinic, correctional facility, or homeless shelter.', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'id': 1921, 'title': 'Hypertension in Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hypertension in adults 18 years or older with office blood pressure measurement (OBPM). The USPSTF recommends obtaining blood pressure measurements outside of the clinical setting for diagnostic confirmation before starting treatment.', 'servfreq': ' \r\nAlthough evidence on optimal screening intervals is limited, reasonable options include:\r\n \r\n \r\n\r\n\r\nScreening for hypertension every year in adults 40 years or older and in adults at increased risk for hypertension (such as Black persons, persons with high-normal blood pressure, or persons who are overweight or obese)\r\n\r\n\r\n \r\n \r\n\r\n\r\nScreening less frequently (ie, every 3 to 5 years) as appropriate for adults aged 18 to 39 years not at increased risk for hypertension and with a prior normal blood pressure reading.\r\n\r\n\r\n ', 'risktext': ' \r\nAlthough all adults should be screened for hypertension, risk factors that increase a person&rsquo;s risk for the condition include older age, Black race, family history, excess weight and obesity, lifestyle habits (lack of physical activity, stress, and tobacco use), and dietary factors (diet high in fat or sodium, diet low in potassium, or excessive alcohol intake)\r\n '}, {'id': 2021, 'title': 'Prevention of Acquisition of HIV: Preexposure Prophylaxis ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians prescribe preexposure prophylaxis using effective antiretroviral therapy to persons who are at increased risk of HIV acquisition to decrease the risk of acquiring HIV. \r\rSee the Practice Considerations section for more information about identification of persons at increased risk and about effective antiretroviral therapy.', 'servfreq': '', 'risktext': 'HIV is primarily acquired via sexual activity or injection drug use. It is important that clinicians routinely take a sexual and injection drug use history for all their patients in an open and nonjudgmental manner. All adolescents and adults who are sexually active or who inject drugs should be informed that acquisition of HIV can be prevented, to facilitate subsequent risk assessment and discussions about preexposure prophylaxis (PrEP) and other ways to prevent acquisition of HIV. Importantly, risk of HIV acquisition exists on a continuum, and currently available risk assessment tools all have limitations. However, certain risk factors or behaviors are known to place persons at increased risk of HIV.\r\nRisk of HIV acquisition depends on the likelihood that a specific act or activity will transmit HIV and the likelihood that a sex partner or drug injection partner has HIV. Likelihood of HIV transmission is highest with needle-sharing injection drug use and condomless receptive anal intercourse. Condomless receptive anal intercourse has an approximately 10- to 15-fold higher risk of transmission than condomless insertive anal sex and condomless receptive and insertive penile-vaginal sex. A 2018 study estimated the prevalence of HIV (ie, an estimate of the likelihood that a partner whose HIV status is unknown has HIV at a population level) as 12.4% among men who have sex with men and 1.9% among persons who inject drugs. The overall prevalence of HIV in the US is estimated at 0.3%.&nbsp;Of note, both the frequency of specific sexual activities and a person&rsquo;s number of sexual partners will also affect their risk of HIV.\r\n&nbsp;The USPSTF recommends that the following persons be considered for PrEP:\r\n1.&nbsp;&nbsp;&nbsp;&nbsp; Sexually active adults and adolescents weighing at least 35 kg (77 lb) who have engaged in anal or vaginal sex in the past 6 months and have any of the following:\r\n&nbsp;\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A sexual partner who has HIV (especially if the partner has an unknown or detectable viral load).\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A bacterial sexually transmitted infection (STI) (syphilis, gonorrhea, or chlamydia for men who have sex with men and transgender women; gonorrhea and syphilis for heterosexual women and men) in the past 6 months.\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A history of inconsistent or no condom use with sex partner(s) whose HIV status is not known; assessing risk in conversation with the patient and considering factors such as number of partners, the specific sexual activities a person engages in, and whether their sex partner or partners are in a group with a higher prevalence of HIV (eg, men who have sex with men or with men and women, transgender women, persons who inject drugs, and persons who engage in transactional sex).\r\n&nbsp;\r\n2. &nbsp; Persons who inject drugs and have a drug-injecting partner who has HIV or who shares injection equipment.\r\nPersons who engage in transactional sex, such as sex for money, drugs, or housing, including commercial sex workers or persons trafficked for sex work, constitute a group at increased risk of HIV acquisition and should be considered for PrEP based on the criteria outlined above. Persons who request PrEP may have undisclosed behaviors that put them at risk. Transgender women and men who are sexually active should be considered for PrEP based on the criteria outlined above. Transgender women are at especially high risk of HIV acquisition. A Centers for Disease Control and and Prevention (CDC) survey in 7 cities found an HIV prevalence of 42% among transgender women. Prevalence was highest among Black transgender women (62%) and Native American/Alaska Native transgender women (65%).\r\nIn addition, studies have found that transmission of HIV to a seronegative partner from a partner with HIV has not been observed when the partner with HIV was being treated with antiretroviral therapy and had a suppressed viral load.&nbsp;It is not known whether PrEP use further decreases the risk of HIV transmission when a partner with HIV has a documented undetectable viral load. Factors such as the consistency or inconsistency of a partner&rsquo;s viral load being suppressed, a partner&rsquo;s adherence to antiretroviral therapy, and the degree of certainty that a partner&rsquo;s viral load is suppressed (eg, self-report vs availability of laboratory test results) may help inform decisions about the use of PrEP in this situation.\r\nAll persons being considered for PrEP must have a recently documented negative HIV antigen-antibody test result, and if they have taken oral PrEP or postexposure prophylaxis in the past 3 months, or injectable cabotegravir in the past 12 months, the CDC recommends testing with both an HIV antigen-antibody assay and an HIV-1 RNA assay.'}, {'id': 1989, 'title': 'Syphilis Infection in Nonpregnant Adolescents and Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for syphilis infection in persons who are at increased risk for infection.', 'servfreq': 'Optimal screening frequency for persons who are at increased risk for syphilis infection is not well established. Men who have sex with men or persons with HIV infection may benefit from screening at least annually or more frequently (eg, every 3 to 6 months) if they continue to be at high risk.', 'risktext': 'The USPSTF recommends screening for syphilis in persons who are at increased risk for infection. When deciding which persons to screen for syphilis, clinicians should consider the prevalence of infection in the communities they serve, as well as other sociodemographic and behavioral factors that may be associated with increased risk of syphilis infection. For example, prevalence of syphilis is higher in men, men who have sex with men, persons with HIV infection, young adults, and persons with a history of incarceration, sex work, or military service. A substantial percentage of heterosexual syphilis transmission occurs among persons who use illicit drugs, particularly methamphetamine. Diagnosis of another STI may signal that a person is having condomless sex, which increases their risk of syphilis infection. Higher infection rates in persons of some racial and ethnic groups have been reported and are primarily a reflection of a combination of factors, including social determinants of health (eg, disparities of income, low educational achievement, and unstable housing), differential health insurance coverage or access to quality health care, and differences in sexual network characteristics (eg, individuals living in communities with a high prevalence of STIs have an increased chance of encountering an infected partner). Local prevalence rates may change over time, so clinicians should be aware of the latest data and trends for their specific population and geographic area, which are available through their state and local health departments and Centers for Disease Control and Prevention (CDC) surveillance.\r\n&nbsp;\r\nAlthough direct evidence on screening in nonpregnant persons who are not at increased risk for syphilis infection is lacking, based on the established test performance characteristics of current screening tests and the low prevalence rate of syphilis in this population, the yield of screening is likely low.9,10 Therefore, screening in this population may result in high false-positive rates and overtreatment.'}, {'id': 1905, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and US Food and Drug Administration (FDA)--approved pharmacotherapy for cessation to nonpregnant adults who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 1906, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all pregnant persons about tobacco use, advise them to stop using tobacco, and provide behavioral interventions for cessation to pregnant persons who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 2014, 'title': 'Anxiety Disorders in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for anxiety disorders in adults, including pregnant and postpartum persons.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding optimal timing for screening, or screening interval, for both the perinatal and general adult populations; more evidence on both timing and screening interval is needed for all adult populations. A pragmatic approach in the absence of evidence might include screening all adults who have not been screened previously and using clinical judgment in considering risk factors, comorbid conditions, and life events to determine if additional screening of high-risk patients is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nRisk factors for anxiety disorders include sociodemographic factors, psychosocial factors, and physical and mental health factors such as marital status (widowed or divorced), stressful life events, smoking and alcohol use, other mental health conditions, or a parental history of mental disorders. Demographic factors such as low socioeconomic status and female sex are associated with higher rates of anxiety disorders.&nbsp;Black persons and individuals of non-Hispanic ethnicity are at increased risk of anxiety disorders due to social, rather than biological, factors. Anxiety and depressive disorders often overlap. One cohort study found that 67% of individuals with a depressive disorder also had a current anxiety disorder, and 75% had a lifetime comorbid anxiety disorder.'}, {'id': 2009, 'title': 'Latent Tuberculosis Infection in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for LTBI in populations at increased risk.\r\rSee the "Assessment of Risk" section for additional information on adults at increased risk.', 'servfreq': 'The USPSTF found no evidence on the optimal frequency of screening for LTBI. In the absence of evidence, a reasonable approach is to repeat screening based on specific risk factors; screening frequency could range from 1-time only screening among persons at low risk for future tuberculosis exposure to annual screening among those at continued risk of exposure.', 'risktext': 'Populations at increased risk for LTBI, based on increased prevalence of active disease and increased risk of exposure, include persons who were born in, or are former residents of, countries with high tuberculosis prevalence and persons who live in, or have lived in, high-risk congregate settings (eg, homeless shelters or correctional facilities). Clinicians can consult their local or state health departments for more information about populations at increased risk in their community, since local demographic patterns may vary across the US.\r\nIn 2020, 71.5% of all cases of active tuberculosis in the US occurred among persons born outside the US. According to the CDC, tuberculosis disease is common in most countries in Latin America, the Caribbean, Africa, Asia, Eastern Europe, and Russia. In 2020, among persons with new tuberculosis living in the US who were born outside the US, the most common countries of birth were Mexico (18.0%), the Philippines (12.5%), India (10.4%), Vietnam (8.2%), and China (5.1%), accounting for 54.2% of total cases. Most of these cases are believed to be due to progression of latent infection to active tuberculosis disease rather than new transmission within communities.\r\nPersons who live, or have lived, in high-risk congregate settings also have a higher prevalence rate of active tuberculosis and an increased risk for exposure. In 2020, 4.3% of tuberculosis disease cases diagnosed in persons 15 years or older occurred in persons experiencing homelessness and 2.6% occurred in residents of correctional facilities. It is estimated that persons experiencing homelessness have an 11 times higher incidence of tuberculosis disease compared with persons who are not experiencing homelessness (36 cases per 100,000 population vs 2.9 cases per 100,000 population, respectively, during 2011 to 2016).\r\nOther populations at increased risk for LTBI or progression to active disease include persons who have immunosuppression (eg, persons living with HIV, patients receiving immunosuppressive medications such as chemotherapy or tumor necrosis factor inhibitors, and patients who have received an organ transplant) and patients with silicosis (a lung disease). However, given that screening in these populations may be considered standard care as part of disease management or indicated prior to the use of certain medications, the USPSTF did not review evidence on screening in these populations. Information on testing in these populations is provided by other groups, such as the Office of AIDS Research at the National Institutes of Health, and in a guideline issued jointly by the American Thoracic Society, Infectious Diseases Society of America, and CDC. Some evidence from observational studies has explored the association between poorly controlled diabetes and progression of LTBI to active disease. However, there is insufficient evidence on screening for and treatment of LTBI in persons with diabetes for the USPSTF to make a separate recommendation for this important population.\r\nPersons who are contacts of individuals with active tuberculosis, health care workers, and workers in high-risk congregate settings may also be at increased risk of exposure. Because screening in these populations is conducted as part of public health or employee health surveillance, the USPSTF did not review the evidence in these populations. Clinicians seeking further information about testing for tuberculosis in these populations can refer to the Additional Tools and Resources and Recommendations of Others sections.'}, {'id': 514, 'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic bacteriuria in nonpregnant adults.', 'servfreq': '', 'risktext': 'The risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6 Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5 Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7, 11, 12 In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12 Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4, 6'}, {'id': 1909, 'title': 'Asymptomatic Carotid Artery Stenosis: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic carotid artery stenosis in the general adult population.\r\rSee the Practice Considerations section for a description of adults at increased risk.', 'servfreq': '', 'risktext': ''}, {'id': 2017, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for suicide risk in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': '', 'risktext': ''}, {'id': 2016, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for depression in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding the optimal timing for screening for depression; more evidence is needed in both perinatal and general adult populations. In the absence of evidence, a pragmatic approach might include screening adults who have not been screened previously and using clinical judgment while considering risk factors, comorbid conditions, and life events to determine if additional screening of patients at increased risk is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nThe USPSTF recommends screening for depression in all adults regardless of risk factors. Risk factors for depression include a combination of genetic, biological, and environmental factors, such as a family history of depression, prior episode of depression or other mental health condition, a history of trauma or adverse life events, or a history of disease or illness (eg, cardiovascular disease).\r\nPrevalence rates vary by sex, age, race, ethnicity, education, marital status, geographic location, poverty level, and employment status. Women have twice the risk of depression compared with men. Young adults, multiracial individuals, and Native American/Alaska Native individuals have higher rates of depression.\r\nRisk factors for perinatal depression include life stress, low social support, history of depression, marital or partner dissatisfaction, and a history of abuse.'}, {'id': 1845, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends offering or referring adults with cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity.', 'servfreq': '', 'risktext': 'Adults 18 years or older at increased risk of CVD, defined as those with 1 or more of the following:\r\n1.Hypertension or elevated blood pressure2.Dyslipidemia3.Mixed or multiple risk factors such as the metabolic syndrome or an estimated 10-year CVD risk of &ge;7.5%\r\nThis recommendation does not apply to adults with other known modifiable cardiovascular risk factors such as abnormal blood glucose levels, obesity, and smoking; these populations are incorporated in other USPSTF recommendations.'}, {'id': 1885, 'title': 'Hepatitis B Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in adolescents and adults at increased risk for infection.\r\rSee the Practice Considerations section for a description of adolescents and adults at increased risk for infection.', 'servfreq': 'For patients with negative HBsAg results who have not received the HBV vaccine series, periodic screening may be useful for those who report continued risk for acquiring HBV transmission, such as persons who continue to inject drugs and men who have sex with men. Clinical judgment should be used to determine screening frequency. The USPSTF found no evidence to determine optimal screening intervals.', 'risktext': 'Persons from such risk groups include persons who have injected drugs in the past or currently; men who have sex with men; persons with HIV; and sex partners, needle-sharing contacts, and household contacts of persons known to be HBsAg positive. Some persons with combinations of risk factors who are not members of risk factor groups listed above may also be at increased risk for HBV infection.'}, {'id': 524, 'title': 'Hepatitis C Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis C virus (HCV) infection in adults aged 18 to 79 years.', 'servfreq': 'One-time screening for most adults.\r\nPeriodically screen persons with continued risk for HCV infection (eg, persons with past or current injection drug use). There is limited evidence to determine how often to screen persons at increased risk.&nbsp;', 'risktext': 'Asymptomatic adults aged 18 to 79 years (including pregnant persons) without known liver disease.&nbsp;\r\nThe USPSTF also suggests that clinicians consider screening persons younger than 18 years and older than 79 years who are at high risk for infection (eg, those with past or current injection drug use).&nbsp;'}, {'id': 1916, 'title': 'Lung Cancer: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery.', 'servfreq': ' \r\nThe USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. ', 'risktext': ' \r\nSmoking and older age are the 2 most important risk factors for lung cancer.&nbsp;The risk of lung cancer in persons who smoke increases with cumulative quantity and duration of smoking and with age but decreases with increasing time since quitting for persons who formerly smoked.3 The USPSTF considers adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years to be at high risk and recommends screening for lung cancer with annual LDCT in this population. \r\n \r\n&nbsp;\r\n \r\nAfrican American/Black (Black) men have a higher incidence of lung cancer than White men, and Black women have a lower incidence than White women.1 These differences are likely related to differences in smoking exposure (ie, prevalence of smoking) and related exposure to carcinogens in cigarettes.7,8 The differences may also be related to other social risk factors.\r\n \r\n&nbsp;\r\n \r\nOther risk factors for lung cancer include environmental exposures, prior radiation therapy, other (noncancer) lung diseases, and family history. Lower level of education is also associated with a higher risk of lung cancer.7 The task force recommends using age and smoking history to determine screening eligibility rather than more elaborate risk prediction models because there is insufficient evidence to assess whether risk prediction model&ndash;based screening would improve outcomes relative to using the risk factors of age and smoking history for broad implementation in primary care.\r\n '}, {'id': 1445, 'title': 'Sexually Transmitted Infections: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends behavioral counseling for all sexually active adolescents and for adults who are at increased risk for sexually transmitted infections (STIs).\r\rSee the Practice Considerations section for more information on populations at increased risk for acquiring STIs.', 'servfreq': '', 'risktext': 'All sexually active adolescents are at increased risk for STIs because of the high rates of STIs in this age group and should receive behavioral counseling interventions. Adults at increased risk for STIs include those who currently have an STI or were diagnosed with one within the past year, do not consistently use condoms, have multiple sex partners, or have sex partners within populations with a high prevalence of STIs. Populations with a high prevalence of STIs include persons who seek STI testing or attend STI clinics; sexual and gender minorities; persons who are living with HIV, inject drugs, have exchanged sex for money or drugs, or have entered correctional facilities; and some racial/ethnic minority groups.1-4'}, {'id': 402, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends counseling young adults, adolescents, children, and parents of young children about minimizing exposure to ultraviolet (UV) radiation for persons aged 6 months to 24 years with fair skin types to reduce their risk of skin cancer.', 'servfreq': '', 'risktext': 'Fair skin types'}, {'id': 438, 'title': 'Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for unhealthy alcohol use in primary care settings in adults 18 years or older, including pregnant women, and providing persons engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce unhealthy alcohol use.', 'servfreq': 'The USPSTF did not find adequate evidence to recommend an optimal screening interval for unhealthy alcohol use in adults.&nbsp;Brief behavioral counseling interventions were found to reduce unhealthy alcohol use in adults 18 years or older, including pregnant women. Effective behavioral counseling interventions vary in their specific components, administration, length, and number of interactions. The USPSTF was unable to identify specific intervention characteristics or components that were clearly associated with improved outcomes.', 'risktext': 'engaged in risky or hazardous drinking'}, {'id': 767, 'title': 'Unhealthy Drug Use: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening by asking questions about unhealthy drug use in adults age 18 years or older. Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. \r(Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'servfreq': 'Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. (Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'risktext': 'These include being aged 18 to 25 years; male sex; having a mental health condition, personality or mood disorder, or nicotine or alcohol dependence; a history of physical or sexual abuse, parental neglect, or other adversity in childhood; or drug or alcohol addiction in a first-degree relative.1,9&nbsp;Factors associated with misuse of prescription drugs include history of other drug use, mental illness, pain, and greater access to prescription drugs.10&nbsp;Factors associated with prenatal use of drugs include a mental health disorder, interpersonal violence, and family history of substance use.11'}, {'id': 433, 'title': 'Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer or refer adults with a body mass index (BMI) of 30 or higher (calculated as weight in kilograms divided by height in meters squared) to intensive, multicomponent behavioral interventions.', 'servfreq': '', 'risktext': 'Adults with a BMI &ge;30'}, {'id': 1979, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: Behavioral Counseling Interventions ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians individualize the decision to offer or refer adults without cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity. \r\rSee the "Practice Considerations" section for information on determining which patients may benefit most from this service.', 'servfreq': '', 'risktext': ''}, {'id': 1937, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for chlamydia and gonorrhea in men.', 'servfreq': '', 'risktext': ''}, {'id': 418, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening with resting or exercise electrocardiography (ECG) to prevent cardiovascular disease (CVD) events in asymptomatic adults at low risk of CVD events.', 'servfreq': '', 'risktext': ''}, {'id': 1973, 'title': 'Chronic Obstructive Pulmonary Disease: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for chronic obstructive pulmonary disease in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 2003, 'title': 'Genital Herpes Infection: Serologic Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine serologic screening for genital herpes simplex virus infection in asymptomatic adolescents and adults, including pregnant persons.', 'servfreq': '', 'risktext': 'The USPSTF found no evidence of externally validated, reliable risk stratification tools to identify individuals more or less likely to have genital herpes.'}, {'id': 504, 'title': 'Pancreatic Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for pancreatic cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 203, 'title': 'Testicular Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for testicular cancer in adolescent or adult men.', 'servfreq': '', 'risktext': ''}, {'id': 365, 'title': 'Thyroid Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for thyroid cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 1976, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'D', 'text': 'The DoctorAI recommends against the use of beta carotene or vitamin E supplements for the prevention of cardiovascular disease or cancer.', 'servfreq': '', 'risktext': ''}, {'id': 318, 'title': 'Autism Spectrum Disorder in Young Children: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for autism spectrum disorder (ASD) in young children for whom no concerns of ASD have been raised by their parents or a clinician.', 'servfreq': '', 'risktext': 'Although a number of potential risk factors for ASD have been identified, there is insufficient evidence to determine if certain risk factors modify the performance characteristics of ASD screening tests, such as the age at which screening is performed or other characteristics of the child or family.'}, {'id': 65, 'title': 'Bladder Cancer in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults.\r\rLiterature scans conducted in July 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'This evidence update focused on the benefits and harms of screening for bladder cancer among people without symptoms, the accuracy of screening tests done in primary care settings, and the benefits and harms of treatment. The updated evidence review did not find any new high quality evidence to adequately determine the balance of benefits and harms of screening for bladder cancer. However, bladder cancer is a common cancer and can cause considerable health problems including death. Therefore, the USPSTF determined that the evidence was insufficient to provide a recommendation for or against bladder cancer screening.  The USPSTF emphasizes the need for additional research in this area. '}, {'id': 419, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening with resting or exercise ECG to prevent CVD events in asymptomatic adults at intermediate or high risk of CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 423, 'title': 'Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of adding the ankle-brachial index (ABI), high-sensitivity C-reactive protein (hsCRP) level, or coronary artery calcium (CAC) score to traditional risk assessment for cardiovascular disease (CVD) in asymptomatic adults to prevent CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 352, 'title': 'Celiac Disease: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'persons with family history or other risk factors'}, {'id': 1955, 'title': 'Eating Disorders in Adolescents and Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for eating disorders in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 665, 'title': 'Illicit Drug Use in Children, Adolescents, and Young Adults: Primary Care-Based Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--based behavioral counseling interventions to prevent illicit drug use, including nonmedical use of prescription drugs, in children, adolescents, and young adults.\r\rSee the Practice Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 435, 'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for abuse and neglect in all older or vulnerable adults. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': 'Risk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health.14&nbsp;For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.15'}, {'id': 2045, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for iron deficiency and iron deficiency anemia in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2046, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine iron supplementation in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2018, 'title': 'Lipid Disorders in Children and Adolescents: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1998, 'title': 'Obstructive Sleep Apnea in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for obstructive sleep apnea in the general adult population.\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Risk Factors\r\nRisk factors associated with OSA include male sex, older age (40-70 years), postmenopausal status, higher body mass index (BMI), and craniofacial and upper airway abnormalities (eg, enlarged tonsils or long upper airway). Black, Hispanic/Latino, and Native American/Alaska Native persons have a higher prevalence of OSA compared with White persons; some evidence suggests that these differences are partially explained by higher rates of obesity, asthma, and tobacco use among these groups.8'}, {'id': 1977, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of multivitamin supplements for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1978, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of single or paired nutrient supplements (other than beta carotene and vitamin E) for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 176, 'title': 'Oral Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for oral cancer in asymptomatic adults.\r\rGo to the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in July 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Tobacco and alcohol use are major risk factors for oral cancer. A total of 20% to 30% of cases of oral cancer worldwide are attributable to cigarette smoking. In the United States, up to 75% of cases of oral cancer may be attributable to tobacco and alcohol use. Additional risk factors include male sex, older age, use of betel quid, ultraviolet light exposure, infection with Candida or bacterial flora, and a compromised immune system. Sexually transmitted oral HPV infection (HPV-16) has recently been recognized as an increasingly important risk factor for oropharyngeal cancer. In the United States, the prevalence of oropharyngeal cancer due to oral HPV infection is probably as high as 80% to 95%. The prevalence of oral HPV infection is associated with age, sex, number of sexual partners, and number of cigarettes smoked per day. The effect of multifactorial risk assessment and screening for risk factors on oral cancer morbidity and mortality is unknown.'}, {'id': 2026, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine screening performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 2027, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of preventive interventions performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 424, 'title': 'Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for peripheral artery disease (PAD) and cardiovascular disease (CVD) risk with the ankle-brachial index (ABI) in asymptomatic adults.\r\rLiterature scans conducted in August 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Risk factors associated with OSA include male sex, older age (40 to 70 years), postmenopausal status, higher BMI, and craniofacial and upper airway abnormalities.'}, {'id': 404, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of counseling adults about skin self-examination to prevent skin cancer.See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 2005, 'title': 'Skin Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Exposure to UV radiation from sun exposure, indoor tanning beds, and other UV radiation&ndash;emitting devices is the major environmental risk factor for skin cancer. History of frequent sunburns, older age, and male sex are associated with increased risk for skin cancer. Exposure to UV radiation from the use of indoor tanning beds is an important risk factor in adolescents. Incidence of melanoma is higher among White persons compared with persons of other races and ethnicities. This difference likely reflects traits associated with increased melanoma risk, such as fair skin (which is more susceptible to sunburning), light-colored eyes, and red or blond hair being more common among White persons compared with persons of other races and ethnicities. Acral lentiginous melanoma, which occurs mostly on skin not frequently exposed to direct sunlight (eg, palms of hands, soles of feet, or under fingernails or toenails), is the most common type of melanoma among Black populations. Other melanoma risk factors include higher numbers of moles on the skin, atypical moles, as well as a personal and family history of skin cancer.'}, {'id': 269, 'title': 'Thyroid Dysfunction: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults.\r\rSee the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': 'The optimal screening interval for thyroid dysfunction (if one exists) is unknown.', 'risktext': 'The most common cause of hypothyroidism in the United States is chronic autoimmune (Hashimoto) thyroiditis. Risk factors for an elevated TSH level include female sex, advancing age, white race, type 1 diabetes, Down syndrome, family history of thyroid disease, goiter, previous hyperthyroidism (possibly due in part to ablation therapy leading to iatrogenic thyroid dysfunction), and external-beam radiation in the head and neck area. Common causes of hyperthyroidism include Graves disease, Hashimoto thyroiditis, and functional thyroid nodules. Risk factors for a low TSH level include female sex; advancing age; black race; low iodine intake; personal or family history of thyroid disease; and ingestion of iodine-containing drugs, such as amiodarone. The USPSTF found no direct evidence that treatment of thyroid dysfunction based on risk level alters final health outcomes.'}, {'id': 1908, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of electronic cigarettes (e-cigarettes) for tobacco cessation in adults, including pregnant persons. The USPSTF recommends that clinicians direct patients who use tobacco to other tobacco cessation interventions with proven effectiveness and established safety.\rSee the Practice Considerations section for more information on recommended behavioral interventions and pharmacotherapy and for suggestions for practice regarding the I statements.', 'servfreq': '', 'risktext': ''}, {'id': 1907, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of pharmacotherapy interventions for tobacco cessation in pregnant persons.', 'servfreq': '', 'risktext': ''}, {'id': 586, 'title': 'Tobacco Use in Children and Adolescents: Primary Care Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--feasible interventions for the cessation of tobacco use among school-aged children and adolescents.\r\rSee the Practice Considerations section for more information on effective interventions to prevent initiation of tobacco use and for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1919, 'title': 'Vitamin D Deficiency in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 408, 'title': 'Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of the benefits and harms of vitamin D and calcium supplementation, alone or combined, for the primary prevention of fractures in men and premenopausal women.', 'servfreq': '', 'risktext': ''}], 'tools': [{'tool_id': 321, 'url': 'https://jamanetwork.com/journals/jama/fullarticle/2735342', 'title': 'JAMA Patient Page: Who Should Be Screened for HIV Infection? ', 'text': '', 'keywords': ''}, {'tool_id': 322, 'url': 'https://sites.jamanetwork.com/spanish-patient-pages/2019/hoja-para-el-paciente-de-jama-190618.pdf', 'title': 'ยฟQuiรฉnes deben someterse a una prueba de detecciรณn de infecciรณn por VIH?', 'text': '', 'keywords': 'HIV|Human immunodeficiency syndrome|AIDS'}, {'tool_id': 210, 'url': 'https://www.aafp.org/afp/2019/1115/p637.html', 'title': "Screening for HIV Infection and Preexposure Prophylaxis for the Prevention of HIV Infection: AFP's Putting Into Practice", 'text': 'The journal American Family Physician (AFP) provides a series of short case studies and quizzes based on recommendations issued by the U.S. Preventive Services Task Force.', 'keywords': ''}]}
2025-01-29 21:50:46 [INFO] Recommendations: [{'id': 485, 'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in adolescents and adults aged 15 to 65 years. Younger adolescents and older adults who are at increased risk of infection should also be screened.\rSee the Clinical Considerations section for more information about assessment of risk, screening intervals, and rescreening in pregnancy.', 'servfreq': 'The USPSTF found insufficient evidence to determine appropriate or optimal time intervals or strategies for repeat HIV screening. However, repeat screening is reasonable for persons known to be at increased risk of HIV infection, such as sexually active men who have sex with men; persons with a sex partner who is living with HIV; or persons who engage in behaviors that may convey an increased risk of HIV infection, such as injection drug use, transactional sex or commercial sex work, having 1 or more new sex partners whose HIV status is unknown, or having other factors that can place a person at increased risk of HIV infection (see &ldquo;Risk Assessment&rdquo;). Repeat screening is also reasonable for persons who live or receive medical care in a high-prevalence setting, such as a sexually transmitted disease clinic, tuberculosis clinic, correctional facility, or homeless shelter.', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'id': 1921, 'title': 'Hypertension in Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hypertension in adults 18 years or older with office blood pressure measurement (OBPM). The USPSTF recommends obtaining blood pressure measurements outside of the clinical setting for diagnostic confirmation before starting treatment.', 'servfreq': ' \r\nAlthough evidence on optimal screening intervals is limited, reasonable options include:\r\n \r\n \r\n\r\n\r\nScreening for hypertension every year in adults 40 years or older and in adults at increased risk for hypertension (such as Black persons, persons with high-normal blood pressure, or persons who are overweight or obese)\r\n\r\n\r\n \r\n \r\n\r\n\r\nScreening less frequently (ie, every 3 to 5 years) as appropriate for adults aged 18 to 39 years not at increased risk for hypertension and with a prior normal blood pressure reading.\r\n\r\n\r\n ', 'risktext': ' \r\nAlthough all adults should be screened for hypertension, risk factors that increase a person&rsquo;s risk for the condition include older age, Black race, family history, excess weight and obesity, lifestyle habits (lack of physical activity, stress, and tobacco use), and dietary factors (diet high in fat or sodium, diet low in potassium, or excessive alcohol intake)\r\n '}, {'id': 2021, 'title': 'Prevention of Acquisition of HIV: Preexposure Prophylaxis ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians prescribe preexposure prophylaxis using effective antiretroviral therapy to persons who are at increased risk of HIV acquisition to decrease the risk of acquiring HIV. \r\rSee the Practice Considerations section for more information about identification of persons at increased risk and about effective antiretroviral therapy.', 'servfreq': '', 'risktext': 'HIV is primarily acquired via sexual activity or injection drug use. It is important that clinicians routinely take a sexual and injection drug use history for all their patients in an open and nonjudgmental manner. All adolescents and adults who are sexually active or who inject drugs should be informed that acquisition of HIV can be prevented, to facilitate subsequent risk assessment and discussions about preexposure prophylaxis (PrEP) and other ways to prevent acquisition of HIV. Importantly, risk of HIV acquisition exists on a continuum, and currently available risk assessment tools all have limitations. However, certain risk factors or behaviors are known to place persons at increased risk of HIV.\r\nRisk of HIV acquisition depends on the likelihood that a specific act or activity will transmit HIV and the likelihood that a sex partner or drug injection partner has HIV. Likelihood of HIV transmission is highest with needle-sharing injection drug use and condomless receptive anal intercourse. Condomless receptive anal intercourse has an approximately 10- to 15-fold higher risk of transmission than condomless insertive anal sex and condomless receptive and insertive penile-vaginal sex. A 2018 study estimated the prevalence of HIV (ie, an estimate of the likelihood that a partner whose HIV status is unknown has HIV at a population level) as 12.4% among men who have sex with men and 1.9% among persons who inject drugs. The overall prevalence of HIV in the US is estimated at 0.3%.&nbsp;Of note, both the frequency of specific sexual activities and a person&rsquo;s number of sexual partners will also affect their risk of HIV.\r\n&nbsp;The USPSTF recommends that the following persons be considered for PrEP:\r\n1.&nbsp;&nbsp;&nbsp;&nbsp; Sexually active adults and adolescents weighing at least 35 kg (77 lb) who have engaged in anal or vaginal sex in the past 6 months and have any of the following:\r\n&nbsp;\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A sexual partner who has HIV (especially if the partner has an unknown or detectable viral load).\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A bacterial sexually transmitted infection (STI) (syphilis, gonorrhea, or chlamydia for men who have sex with men and transgender women; gonorrhea and syphilis for heterosexual women and men) in the past 6 months.\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A history of inconsistent or no condom use with sex partner(s) whose HIV status is not known; assessing risk in conversation with the patient and considering factors such as number of partners, the specific sexual activities a person engages in, and whether their sex partner or partners are in a group with a higher prevalence of HIV (eg, men who have sex with men or with men and women, transgender women, persons who inject drugs, and persons who engage in transactional sex).\r\n&nbsp;\r\n2. &nbsp; Persons who inject drugs and have a drug-injecting partner who has HIV or who shares injection equipment.\r\nPersons who engage in transactional sex, such as sex for money, drugs, or housing, including commercial sex workers or persons trafficked for sex work, constitute a group at increased risk of HIV acquisition and should be considered for PrEP based on the criteria outlined above. Persons who request PrEP may have undisclosed behaviors that put them at risk. Transgender women and men who are sexually active should be considered for PrEP based on the criteria outlined above. Transgender women are at especially high risk of HIV acquisition. A Centers for Disease Control and and Prevention (CDC) survey in 7 cities found an HIV prevalence of 42% among transgender women. Prevalence was highest among Black transgender women (62%) and Native American/Alaska Native transgender women (65%).\r\nIn addition, studies have found that transmission of HIV to a seronegative partner from a partner with HIV has not been observed when the partner with HIV was being treated with antiretroviral therapy and had a suppressed viral load.&nbsp;It is not known whether PrEP use further decreases the risk of HIV transmission when a partner with HIV has a documented undetectable viral load. Factors such as the consistency or inconsistency of a partner&rsquo;s viral load being suppressed, a partner&rsquo;s adherence to antiretroviral therapy, and the degree of certainty that a partner&rsquo;s viral load is suppressed (eg, self-report vs availability of laboratory test results) may help inform decisions about the use of PrEP in this situation.\r\nAll persons being considered for PrEP must have a recently documented negative HIV antigen-antibody test result, and if they have taken oral PrEP or postexposure prophylaxis in the past 3 months, or injectable cabotegravir in the past 12 months, the CDC recommends testing with both an HIV antigen-antibody assay and an HIV-1 RNA assay.'}, {'id': 1989, 'title': 'Syphilis Infection in Nonpregnant Adolescents and Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for syphilis infection in persons who are at increased risk for infection.', 'servfreq': 'Optimal screening frequency for persons who are at increased risk for syphilis infection is not well established. Men who have sex with men or persons with HIV infection may benefit from screening at least annually or more frequently (eg, every 3 to 6 months) if they continue to be at high risk.', 'risktext': 'The USPSTF recommends screening for syphilis in persons who are at increased risk for infection. When deciding which persons to screen for syphilis, clinicians should consider the prevalence of infection in the communities they serve, as well as other sociodemographic and behavioral factors that may be associated with increased risk of syphilis infection. For example, prevalence of syphilis is higher in men, men who have sex with men, persons with HIV infection, young adults, and persons with a history of incarceration, sex work, or military service. A substantial percentage of heterosexual syphilis transmission occurs among persons who use illicit drugs, particularly methamphetamine. Diagnosis of another STI may signal that a person is having condomless sex, which increases their risk of syphilis infection. Higher infection rates in persons of some racial and ethnic groups have been reported and are primarily a reflection of a combination of factors, including social determinants of health (eg, disparities of income, low educational achievement, and unstable housing), differential health insurance coverage or access to quality health care, and differences in sexual network characteristics (eg, individuals living in communities with a high prevalence of STIs have an increased chance of encountering an infected partner). Local prevalence rates may change over time, so clinicians should be aware of the latest data and trends for their specific population and geographic area, which are available through their state and local health departments and Centers for Disease Control and Prevention (CDC) surveillance.\r\n&nbsp;\r\nAlthough direct evidence on screening in nonpregnant persons who are not at increased risk for syphilis infection is lacking, based on the established test performance characteristics of current screening tests and the low prevalence rate of syphilis in this population, the yield of screening is likely low.9,10 Therefore, screening in this population may result in high false-positive rates and overtreatment.'}, {'id': 1905, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and US Food and Drug Administration (FDA)--approved pharmacotherapy for cessation to nonpregnant adults who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 1906, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all pregnant persons about tobacco use, advise them to stop using tobacco, and provide behavioral interventions for cessation to pregnant persons who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 2014, 'title': 'Anxiety Disorders in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for anxiety disorders in adults, including pregnant and postpartum persons.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding optimal timing for screening, or screening interval, for both the perinatal and general adult populations; more evidence on both timing and screening interval is needed for all adult populations. A pragmatic approach in the absence of evidence might include screening all adults who have not been screened previously and using clinical judgment in considering risk factors, comorbid conditions, and life events to determine if additional screening of high-risk patients is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nRisk factors for anxiety disorders include sociodemographic factors, psychosocial factors, and physical and mental health factors such as marital status (widowed or divorced), stressful life events, smoking and alcohol use, other mental health conditions, or a parental history of mental disorders. Demographic factors such as low socioeconomic status and female sex are associated with higher rates of anxiety disorders.&nbsp;Black persons and individuals of non-Hispanic ethnicity are at increased risk of anxiety disorders due to social, rather than biological, factors. Anxiety and depressive disorders often overlap. One cohort study found that 67% of individuals with a depressive disorder also had a current anxiety disorder, and 75% had a lifetime comorbid anxiety disorder.'}, {'id': 2009, 'title': 'Latent Tuberculosis Infection in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for LTBI in populations at increased risk.\r\rSee the "Assessment of Risk" section for additional information on adults at increased risk.', 'servfreq': 'The USPSTF found no evidence on the optimal frequency of screening for LTBI. In the absence of evidence, a reasonable approach is to repeat screening based on specific risk factors; screening frequency could range from 1-time only screening among persons at low risk for future tuberculosis exposure to annual screening among those at continued risk of exposure.', 'risktext': 'Populations at increased risk for LTBI, based on increased prevalence of active disease and increased risk of exposure, include persons who were born in, or are former residents of, countries with high tuberculosis prevalence and persons who live in, or have lived in, high-risk congregate settings (eg, homeless shelters or correctional facilities). Clinicians can consult their local or state health departments for more information about populations at increased risk in their community, since local demographic patterns may vary across the US.\r\nIn 2020, 71.5% of all cases of active tuberculosis in the US occurred among persons born outside the US. According to the CDC, tuberculosis disease is common in most countries in Latin America, the Caribbean, Africa, Asia, Eastern Europe, and Russia. In 2020, among persons with new tuberculosis living in the US who were born outside the US, the most common countries of birth were Mexico (18.0%), the Philippines (12.5%), India (10.4%), Vietnam (8.2%), and China (5.1%), accounting for 54.2% of total cases. Most of these cases are believed to be due to progression of latent infection to active tuberculosis disease rather than new transmission within communities.\r\nPersons who live, or have lived, in high-risk congregate settings also have a higher prevalence rate of active tuberculosis and an increased risk for exposure. In 2020, 4.3% of tuberculosis disease cases diagnosed in persons 15 years or older occurred in persons experiencing homelessness and 2.6% occurred in residents of correctional facilities. It is estimated that persons experiencing homelessness have an 11 times higher incidence of tuberculosis disease compared with persons who are not experiencing homelessness (36 cases per 100,000 population vs 2.9 cases per 100,000 population, respectively, during 2011 to 2016).\r\nOther populations at increased risk for LTBI or progression to active disease include persons who have immunosuppression (eg, persons living with HIV, patients receiving immunosuppressive medications such as chemotherapy or tumor necrosis factor inhibitors, and patients who have received an organ transplant) and patients with silicosis (a lung disease). However, given that screening in these populations may be considered standard care as part of disease management or indicated prior to the use of certain medications, the USPSTF did not review evidence on screening in these populations. Information on testing in these populations is provided by other groups, such as the Office of AIDS Research at the National Institutes of Health, and in a guideline issued jointly by the American Thoracic Society, Infectious Diseases Society of America, and CDC. Some evidence from observational studies has explored the association between poorly controlled diabetes and progression of LTBI to active disease. However, there is insufficient evidence on screening for and treatment of LTBI in persons with diabetes for the USPSTF to make a separate recommendation for this important population.\r\nPersons who are contacts of individuals with active tuberculosis, health care workers, and workers in high-risk congregate settings may also be at increased risk of exposure. Because screening in these populations is conducted as part of public health or employee health surveillance, the USPSTF did not review the evidence in these populations. Clinicians seeking further information about testing for tuberculosis in these populations can refer to the Additional Tools and Resources and Recommendations of Others sections.'}, {'id': 514, 'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic bacteriuria in nonpregnant adults.', 'servfreq': '', 'risktext': 'The risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6 Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5 Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7, 11, 12 In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12 Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4, 6'}, {'id': 1909, 'title': 'Asymptomatic Carotid Artery Stenosis: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic carotid artery stenosis in the general adult population.\r\rSee the Practice Considerations section for a description of adults at increased risk.', 'servfreq': '', 'risktext': ''}, {'id': 2017, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for suicide risk in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': '', 'risktext': ''}, {'id': 2016, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for depression in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding the optimal timing for screening for depression; more evidence is needed in both perinatal and general adult populations. In the absence of evidence, a pragmatic approach might include screening adults who have not been screened previously and using clinical judgment while considering risk factors, comorbid conditions, and life events to determine if additional screening of patients at increased risk is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nThe USPSTF recommends screening for depression in all adults regardless of risk factors. Risk factors for depression include a combination of genetic, biological, and environmental factors, such as a family history of depression, prior episode of depression or other mental health condition, a history of trauma or adverse life events, or a history of disease or illness (eg, cardiovascular disease).\r\nPrevalence rates vary by sex, age, race, ethnicity, education, marital status, geographic location, poverty level, and employment status. Women have twice the risk of depression compared with men. Young adults, multiracial individuals, and Native American/Alaska Native individuals have higher rates of depression.\r\nRisk factors for perinatal depression include life stress, low social support, history of depression, marital or partner dissatisfaction, and a history of abuse.'}, {'id': 1845, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends offering or referring adults with cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity.', 'servfreq': '', 'risktext': 'Adults 18 years or older at increased risk of CVD, defined as those with 1 or more of the following:\r\n1.Hypertension or elevated blood pressure2.Dyslipidemia3.Mixed or multiple risk factors such as the metabolic syndrome or an estimated 10-year CVD risk of &ge;7.5%\r\nThis recommendation does not apply to adults with other known modifiable cardiovascular risk factors such as abnormal blood glucose levels, obesity, and smoking; these populations are incorporated in other USPSTF recommendations.'}, {'id': 1885, 'title': 'Hepatitis B Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in adolescents and adults at increased risk for infection.\r\rSee the Practice Considerations section for a description of adolescents and adults at increased risk for infection.', 'servfreq': 'For patients with negative HBsAg results who have not received the HBV vaccine series, periodic screening may be useful for those who report continued risk for acquiring HBV transmission, such as persons who continue to inject drugs and men who have sex with men. Clinical judgment should be used to determine screening frequency. The USPSTF found no evidence to determine optimal screening intervals.', 'risktext': 'Persons from such risk groups include persons who have injected drugs in the past or currently; men who have sex with men; persons with HIV; and sex partners, needle-sharing contacts, and household contacts of persons known to be HBsAg positive. Some persons with combinations of risk factors who are not members of risk factor groups listed above may also be at increased risk for HBV infection.'}, {'id': 524, 'title': 'Hepatitis C Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis C virus (HCV) infection in adults aged 18 to 79 years.', 'servfreq': 'One-time screening for most adults.\r\nPeriodically screen persons with continued risk for HCV infection (eg, persons with past or current injection drug use). There is limited evidence to determine how often to screen persons at increased risk.&nbsp;', 'risktext': 'Asymptomatic adults aged 18 to 79 years (including pregnant persons) without known liver disease.&nbsp;\r\nThe USPSTF also suggests that clinicians consider screening persons younger than 18 years and older than 79 years who are at high risk for infection (eg, those with past or current injection drug use).&nbsp;'}, {'id': 1916, 'title': 'Lung Cancer: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery.', 'servfreq': ' \r\nThe USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. ', 'risktext': ' \r\nSmoking and older age are the 2 most important risk factors for lung cancer.&nbsp;The risk of lung cancer in persons who smoke increases with cumulative quantity and duration of smoking and with age but decreases with increasing time since quitting for persons who formerly smoked.3 The USPSTF considers adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years to be at high risk and recommends screening for lung cancer with annual LDCT in this population. \r\n \r\n&nbsp;\r\n \r\nAfrican American/Black (Black) men have a higher incidence of lung cancer than White men, and Black women have a lower incidence than White women.1 These differences are likely related to differences in smoking exposure (ie, prevalence of smoking) and related exposure to carcinogens in cigarettes.7,8 The differences may also be related to other social risk factors.\r\n \r\n&nbsp;\r\n \r\nOther risk factors for lung cancer include environmental exposures, prior radiation therapy, other (noncancer) lung diseases, and family history. Lower level of education is also associated with a higher risk of lung cancer.7 The task force recommends using age and smoking history to determine screening eligibility rather than more elaborate risk prediction models because there is insufficient evidence to assess whether risk prediction model&ndash;based screening would improve outcomes relative to using the risk factors of age and smoking history for broad implementation in primary care.\r\n '}, {'id': 1445, 'title': 'Sexually Transmitted Infections: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends behavioral counseling for all sexually active adolescents and for adults who are at increased risk for sexually transmitted infections (STIs).\r\rSee the Practice Considerations section for more information on populations at increased risk for acquiring STIs.', 'servfreq': '', 'risktext': 'All sexually active adolescents are at increased risk for STIs because of the high rates of STIs in this age group and should receive behavioral counseling interventions. Adults at increased risk for STIs include those who currently have an STI or were diagnosed with one within the past year, do not consistently use condoms, have multiple sex partners, or have sex partners within populations with a high prevalence of STIs. Populations with a high prevalence of STIs include persons who seek STI testing or attend STI clinics; sexual and gender minorities; persons who are living with HIV, inject drugs, have exchanged sex for money or drugs, or have entered correctional facilities; and some racial/ethnic minority groups.1-4'}, {'id': 402, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends counseling young adults, adolescents, children, and parents of young children about minimizing exposure to ultraviolet (UV) radiation for persons aged 6 months to 24 years with fair skin types to reduce their risk of skin cancer.', 'servfreq': '', 'risktext': 'Fair skin types'}, {'id': 438, 'title': 'Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for unhealthy alcohol use in primary care settings in adults 18 years or older, including pregnant women, and providing persons engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce unhealthy alcohol use.', 'servfreq': 'The USPSTF did not find adequate evidence to recommend an optimal screening interval for unhealthy alcohol use in adults.&nbsp;Brief behavioral counseling interventions were found to reduce unhealthy alcohol use in adults 18 years or older, including pregnant women. Effective behavioral counseling interventions vary in their specific components, administration, length, and number of interactions. The USPSTF was unable to identify specific intervention characteristics or components that were clearly associated with improved outcomes.', 'risktext': 'engaged in risky or hazardous drinking'}, {'id': 767, 'title': 'Unhealthy Drug Use: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening by asking questions about unhealthy drug use in adults age 18 years or older. Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. \r(Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'servfreq': 'Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. (Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'risktext': 'These include being aged 18 to 25 years; male sex; having a mental health condition, personality or mood disorder, or nicotine or alcohol dependence; a history of physical or sexual abuse, parental neglect, or other adversity in childhood; or drug or alcohol addiction in a first-degree relative.1,9&nbsp;Factors associated with misuse of prescription drugs include history of other drug use, mental illness, pain, and greater access to prescription drugs.10&nbsp;Factors associated with prenatal use of drugs include a mental health disorder, interpersonal violence, and family history of substance use.11'}, {'id': 433, 'title': 'Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer or refer adults with a body mass index (BMI) of 30 or higher (calculated as weight in kilograms divided by height in meters squared) to intensive, multicomponent behavioral interventions.', 'servfreq': '', 'risktext': 'Adults with a BMI &ge;30'}, {'id': 1979, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: Behavioral Counseling Interventions ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians individualize the decision to offer or refer adults without cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity. \r\rSee the "Practice Considerations" section for information on determining which patients may benefit most from this service.', 'servfreq': '', 'risktext': ''}, {'id': 1937, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for chlamydia and gonorrhea in men.', 'servfreq': '', 'risktext': ''}, {'id': 418, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening with resting or exercise electrocardiography (ECG) to prevent cardiovascular disease (CVD) events in asymptomatic adults at low risk of CVD events.', 'servfreq': '', 'risktext': ''}, {'id': 1973, 'title': 'Chronic Obstructive Pulmonary Disease: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for chronic obstructive pulmonary disease in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 2003, 'title': 'Genital Herpes Infection: Serologic Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine serologic screening for genital herpes simplex virus infection in asymptomatic adolescents and adults, including pregnant persons.', 'servfreq': '', 'risktext': 'The USPSTF found no evidence of externally validated, reliable risk stratification tools to identify individuals more or less likely to have genital herpes.'}, {'id': 504, 'title': 'Pancreatic Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for pancreatic cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 203, 'title': 'Testicular Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for testicular cancer in adolescent or adult men.', 'servfreq': '', 'risktext': ''}, {'id': 365, 'title': 'Thyroid Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for thyroid cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 1976, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'D', 'text': 'The DoctorAI recommends against the use of beta carotene or vitamin E supplements for the prevention of cardiovascular disease or cancer.', 'servfreq': '', 'risktext': ''}, {'id': 318, 'title': 'Autism Spectrum Disorder in Young Children: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for autism spectrum disorder (ASD) in young children for whom no concerns of ASD have been raised by their parents or a clinician.', 'servfreq': '', 'risktext': 'Although a number of potential risk factors for ASD have been identified, there is insufficient evidence to determine if certain risk factors modify the performance characteristics of ASD screening tests, such as the age at which screening is performed or other characteristics of the child or family.'}, {'id': 65, 'title': 'Bladder Cancer in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults.\r\rLiterature scans conducted in July 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'This evidence update focused on the benefits and harms of screening for bladder cancer among people without symptoms, the accuracy of screening tests done in primary care settings, and the benefits and harms of treatment. The updated evidence review did not find any new high quality evidence to adequately determine the balance of benefits and harms of screening for bladder cancer. However, bladder cancer is a common cancer and can cause considerable health problems including death. Therefore, the USPSTF determined that the evidence was insufficient to provide a recommendation for or against bladder cancer screening.  The USPSTF emphasizes the need for additional research in this area. '}, {'id': 419, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening with resting or exercise ECG to prevent CVD events in asymptomatic adults at intermediate or high risk of CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 423, 'title': 'Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of adding the ankle-brachial index (ABI), high-sensitivity C-reactive protein (hsCRP) level, or coronary artery calcium (CAC) score to traditional risk assessment for cardiovascular disease (CVD) in asymptomatic adults to prevent CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 352, 'title': 'Celiac Disease: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'persons with family history or other risk factors'}, {'id': 1955, 'title': 'Eating Disorders in Adolescents and Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for eating disorders in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 665, 'title': 'Illicit Drug Use in Children, Adolescents, and Young Adults: Primary Care-Based Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--based behavioral counseling interventions to prevent illicit drug use, including nonmedical use of prescription drugs, in children, adolescents, and young adults.\r\rSee the Practice Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 435, 'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for abuse and neglect in all older or vulnerable adults. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': 'Risk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health.14&nbsp;For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.15'}, {'id': 2045, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for iron deficiency and iron deficiency anemia in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2046, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine iron supplementation in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2018, 'title': 'Lipid Disorders in Children and Adolescents: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1998, 'title': 'Obstructive Sleep Apnea in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for obstructive sleep apnea in the general adult population.\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Risk Factors\r\nRisk factors associated with OSA include male sex, older age (40-70 years), postmenopausal status, higher body mass index (BMI), and craniofacial and upper airway abnormalities (eg, enlarged tonsils or long upper airway). Black, Hispanic/Latino, and Native American/Alaska Native persons have a higher prevalence of OSA compared with White persons; some evidence suggests that these differences are partially explained by higher rates of obesity, asthma, and tobacco use among these groups.8'}, {'id': 1977, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of multivitamin supplements for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1978, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of single or paired nutrient supplements (other than beta carotene and vitamin E) for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 176, 'title': 'Oral Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for oral cancer in asymptomatic adults.\r\rGo to the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in July 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Tobacco and alcohol use are major risk factors for oral cancer. A total of 20% to 30% of cases of oral cancer worldwide are attributable to cigarette smoking. In the United States, up to 75% of cases of oral cancer may be attributable to tobacco and alcohol use. Additional risk factors include male sex, older age, use of betel quid, ultraviolet light exposure, infection with Candida or bacterial flora, and a compromised immune system. Sexually transmitted oral HPV infection (HPV-16) has recently been recognized as an increasingly important risk factor for oropharyngeal cancer. In the United States, the prevalence of oropharyngeal cancer due to oral HPV infection is probably as high as 80% to 95%. The prevalence of oral HPV infection is associated with age, sex, number of sexual partners, and number of cigarettes smoked per day. The effect of multifactorial risk assessment and screening for risk factors on oral cancer morbidity and mortality is unknown.'}, {'id': 2026, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine screening performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 2027, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of preventive interventions performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 424, 'title': 'Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for peripheral artery disease (PAD) and cardiovascular disease (CVD) risk with the ankle-brachial index (ABI) in asymptomatic adults.\r\rLiterature scans conducted in August 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Risk factors associated with OSA include male sex, older age (40 to 70 years), postmenopausal status, higher BMI, and craniofacial and upper airway abnormalities.'}, {'id': 404, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of counseling adults about skin self-examination to prevent skin cancer.See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 2005, 'title': 'Skin Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Exposure to UV radiation from sun exposure, indoor tanning beds, and other UV radiation&ndash;emitting devices is the major environmental risk factor for skin cancer. History of frequent sunburns, older age, and male sex are associated with increased risk for skin cancer. Exposure to UV radiation from the use of indoor tanning beds is an important risk factor in adolescents. Incidence of melanoma is higher among White persons compared with persons of other races and ethnicities. This difference likely reflects traits associated with increased melanoma risk, such as fair skin (which is more susceptible to sunburning), light-colored eyes, and red or blond hair being more common among White persons compared with persons of other races and ethnicities. Acral lentiginous melanoma, which occurs mostly on skin not frequently exposed to direct sunlight (eg, palms of hands, soles of feet, or under fingernails or toenails), is the most common type of melanoma among Black populations. Other melanoma risk factors include higher numbers of moles on the skin, atypical moles, as well as a personal and family history of skin cancer.'}, {'id': 269, 'title': 'Thyroid Dysfunction: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults.\r\rSee the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': 'The optimal screening interval for thyroid dysfunction (if one exists) is unknown.', 'risktext': 'The most common cause of hypothyroidism in the United States is chronic autoimmune (Hashimoto) thyroiditis. Risk factors for an elevated TSH level include female sex, advancing age, white race, type 1 diabetes, Down syndrome, family history of thyroid disease, goiter, previous hyperthyroidism (possibly due in part to ablation therapy leading to iatrogenic thyroid dysfunction), and external-beam radiation in the head and neck area. Common causes of hyperthyroidism include Graves disease, Hashimoto thyroiditis, and functional thyroid nodules. Risk factors for a low TSH level include female sex; advancing age; black race; low iodine intake; personal or family history of thyroid disease; and ingestion of iodine-containing drugs, such as amiodarone. The USPSTF found no direct evidence that treatment of thyroid dysfunction based on risk level alters final health outcomes.'}, {'id': 1908, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of electronic cigarettes (e-cigarettes) for tobacco cessation in adults, including pregnant persons. The USPSTF recommends that clinicians direct patients who use tobacco to other tobacco cessation interventions with proven effectiveness and established safety.\rSee the Practice Considerations section for more information on recommended behavioral interventions and pharmacotherapy and for suggestions for practice regarding the I statements.', 'servfreq': '', 'risktext': ''}, {'id': 1907, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of pharmacotherapy interventions for tobacco cessation in pregnant persons.', 'servfreq': '', 'risktext': ''}, {'id': 586, 'title': 'Tobacco Use in Children and Adolescents: Primary Care Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--feasible interventions for the cessation of tobacco use among school-aged children and adolescents.\r\rSee the Practice Considerations section for more information on effective interventions to prevent initiation of tobacco use and for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1919, 'title': 'Vitamin D Deficiency in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 408, 'title': 'Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of the benefits and harms of vitamin D and calcium supplementation, alone or combined, for the primary prevention of fractures in men and premenopausal women.', 'servfreq': '', 'risktext': ''}]
2025-01-29 21:50:46 [INFO] Tools: [{'tool_id': 321, 'url': 'https://jamanetwork.com/journals/jama/fullarticle/2735342', 'title': 'JAMA Patient Page: Who Should Be Screened for HIV Infection? ', 'text': '', 'keywords': ''}, {'tool_id': 322, 'url': 'https://sites.jamanetwork.com/spanish-patient-pages/2019/hoja-para-el-paciente-de-jama-190618.pdf', 'title': 'ยฟQuiรฉnes deben someterse a una prueba de detecciรณn de infecciรณn por VIH?', 'text': '', 'keywords': 'HIV|Human immunodeficiency syndrome|AIDS'}, {'tool_id': 210, 'url': 'https://www.aafp.org/afp/2019/1115/p637.html', 'title': "Screening for HIV Infection and Preexposure Prophylaxis for the Prevention of HIV Infection: AFP's Putting Into Practice", 'text': 'The journal American Family Physician (AFP) provides a series of short case studies and quizzes based on recommendations issued by the U.S. Preventive Services Task Force.', 'keywords': ''}]
2025-01-29 21:50:47 [INFO] Update id=273478132 is handled. Duration 1133 ms by bot id=8108339380
2025-01-29 21:50:59 [INFO] Update id=273478133 is handled. Duration 654 ms by bot id=8108339380
2025-01-29 21:51:02 [INFO] Update id=273478134 is handled. Duration 901 ms by bot id=8108339380
2025-01-29 21:51:03 [INFO] State data: {'db': <bot.database.Database object at 0x7f2400e2f230>, 'age': 20, 'weight': 90, 'height': 190, 'feet': 45, 'gender': 'male', 'pregnant': 'no', 'smoking': 'yes', 'sex': 'tools_1', 'recommendations': [{'id': 485, 'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in adolescents and adults aged 15 to 65 years. Younger adolescents and older adults who are at increased risk of infection should also be screened.\rSee the Clinical Considerations section for more information about assessment of risk, screening intervals, and rescreening in pregnancy.', 'servfreq': 'The USPSTF found insufficient evidence to determine appropriate or optimal time intervals or strategies for repeat HIV screening. However, repeat screening is reasonable for persons known to be at increased risk of HIV infection, such as sexually active men who have sex with men; persons with a sex partner who is living with HIV; or persons who engage in behaviors that may convey an increased risk of HIV infection, such as injection drug use, transactional sex or commercial sex work, having 1 or more new sex partners whose HIV status is unknown, or having other factors that can place a person at increased risk of HIV infection (see &ldquo;Risk Assessment&rdquo;). Repeat screening is also reasonable for persons who live or receive medical care in a high-prevalence setting, such as a sexually transmitted disease clinic, tuberculosis clinic, correctional facility, or homeless shelter.', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'id': 1921, 'title': 'Hypertension in Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hypertension in adults 18 years or older with office blood pressure measurement (OBPM). The USPSTF recommends obtaining blood pressure measurements outside of the clinical setting for diagnostic confirmation before starting treatment.', 'servfreq': ' \r\nAlthough evidence on optimal screening intervals is limited, reasonable options include:\r\n \r\n \r\n\r\n\r\nScreening for hypertension every year in adults 40 years or older and in adults at increased risk for hypertension (such as Black persons, persons with high-normal blood pressure, or persons who are overweight or obese)\r\n\r\n\r\n \r\n \r\n\r\n\r\nScreening less frequently (ie, every 3 to 5 years) as appropriate for adults aged 18 to 39 years not at increased risk for hypertension and with a prior normal blood pressure reading.\r\n\r\n\r\n ', 'risktext': ' \r\nAlthough all adults should be screened for hypertension, risk factors that increase a person&rsquo;s risk for the condition include older age, Black race, family history, excess weight and obesity, lifestyle habits (lack of physical activity, stress, and tobacco use), and dietary factors (diet high in fat or sodium, diet low in potassium, or excessive alcohol intake)\r\n '}, {'id': 2021, 'title': 'Prevention of Acquisition of HIV: Preexposure Prophylaxis ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians prescribe preexposure prophylaxis using effective antiretroviral therapy to persons who are at increased risk of HIV acquisition to decrease the risk of acquiring HIV. \r\rSee the Practice Considerations section for more information about identification of persons at increased risk and about effective antiretroviral therapy.', 'servfreq': '', 'risktext': 'HIV is primarily acquired via sexual activity or injection drug use. It is important that clinicians routinely take a sexual and injection drug use history for all their patients in an open and nonjudgmental manner. All adolescents and adults who are sexually active or who inject drugs should be informed that acquisition of HIV can be prevented, to facilitate subsequent risk assessment and discussions about preexposure prophylaxis (PrEP) and other ways to prevent acquisition of HIV. Importantly, risk of HIV acquisition exists on a continuum, and currently available risk assessment tools all have limitations. However, certain risk factors or behaviors are known to place persons at increased risk of HIV.\r\nRisk of HIV acquisition depends on the likelihood that a specific act or activity will transmit HIV and the likelihood that a sex partner or drug injection partner has HIV. Likelihood of HIV transmission is highest with needle-sharing injection drug use and condomless receptive anal intercourse. Condomless receptive anal intercourse has an approximately 10- to 15-fold higher risk of transmission than condomless insertive anal sex and condomless receptive and insertive penile-vaginal sex. A 2018 study estimated the prevalence of HIV (ie, an estimate of the likelihood that a partner whose HIV status is unknown has HIV at a population level) as 12.4% among men who have sex with men and 1.9% among persons who inject drugs. The overall prevalence of HIV in the US is estimated at 0.3%.&nbsp;Of note, both the frequency of specific sexual activities and a person&rsquo;s number of sexual partners will also affect their risk of HIV.\r\n&nbsp;The USPSTF recommends that the following persons be considered for PrEP:\r\n1.&nbsp;&nbsp;&nbsp;&nbsp; Sexually active adults and adolescents weighing at least 35 kg (77 lb) who have engaged in anal or vaginal sex in the past 6 months and have any of the following:\r\n&nbsp;\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A sexual partner who has HIV (especially if the partner has an unknown or detectable viral load).\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A bacterial sexually transmitted infection (STI) (syphilis, gonorrhea, or chlamydia for men who have sex with men and transgender women; gonorrhea and syphilis for heterosexual women and men) in the past 6 months.\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A history of inconsistent or no condom use with sex partner(s) whose HIV status is not known; assessing risk in conversation with the patient and considering factors such as number of partners, the specific sexual activities a person engages in, and whether their sex partner or partners are in a group with a higher prevalence of HIV (eg, men who have sex with men or with men and women, transgender women, persons who inject drugs, and persons who engage in transactional sex).\r\n&nbsp;\r\n2. &nbsp; Persons who inject drugs and have a drug-injecting partner who has HIV or who shares injection equipment.\r\nPersons who engage in transactional sex, such as sex for money, drugs, or housing, including commercial sex workers or persons trafficked for sex work, constitute a group at increased risk of HIV acquisition and should be considered for PrEP based on the criteria outlined above. Persons who request PrEP may have undisclosed behaviors that put them at risk. Transgender women and men who are sexually active should be considered for PrEP based on the criteria outlined above. Transgender women are at especially high risk of HIV acquisition. A Centers for Disease Control and and Prevention (CDC) survey in 7 cities found an HIV prevalence of 42% among transgender women. Prevalence was highest among Black transgender women (62%) and Native American/Alaska Native transgender women (65%).\r\nIn addition, studies have found that transmission of HIV to a seronegative partner from a partner with HIV has not been observed when the partner with HIV was being treated with antiretroviral therapy and had a suppressed viral load.&nbsp;It is not known whether PrEP use further decreases the risk of HIV transmission when a partner with HIV has a documented undetectable viral load. Factors such as the consistency or inconsistency of a partner&rsquo;s viral load being suppressed, a partner&rsquo;s adherence to antiretroviral therapy, and the degree of certainty that a partner&rsquo;s viral load is suppressed (eg, self-report vs availability of laboratory test results) may help inform decisions about the use of PrEP in this situation.\r\nAll persons being considered for PrEP must have a recently documented negative HIV antigen-antibody test result, and if they have taken oral PrEP or postexposure prophylaxis in the past 3 months, or injectable cabotegravir in the past 12 months, the CDC recommends testing with both an HIV antigen-antibody assay and an HIV-1 RNA assay.'}, {'id': 1989, 'title': 'Syphilis Infection in Nonpregnant Adolescents and Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for syphilis infection in persons who are at increased risk for infection.', 'servfreq': 'Optimal screening frequency for persons who are at increased risk for syphilis infection is not well established. Men who have sex with men or persons with HIV infection may benefit from screening at least annually or more frequently (eg, every 3 to 6 months) if they continue to be at high risk.', 'risktext': 'The USPSTF recommends screening for syphilis in persons who are at increased risk for infection. When deciding which persons to screen for syphilis, clinicians should consider the prevalence of infection in the communities they serve, as well as other sociodemographic and behavioral factors that may be associated with increased risk of syphilis infection. For example, prevalence of syphilis is higher in men, men who have sex with men, persons with HIV infection, young adults, and persons with a history of incarceration, sex work, or military service. A substantial percentage of heterosexual syphilis transmission occurs among persons who use illicit drugs, particularly methamphetamine. Diagnosis of another STI may signal that a person is having condomless sex, which increases their risk of syphilis infection. Higher infection rates in persons of some racial and ethnic groups have been reported and are primarily a reflection of a combination of factors, including social determinants of health (eg, disparities of income, low educational achievement, and unstable housing), differential health insurance coverage or access to quality health care, and differences in sexual network characteristics (eg, individuals living in communities with a high prevalence of STIs have an increased chance of encountering an infected partner). Local prevalence rates may change over time, so clinicians should be aware of the latest data and trends for their specific population and geographic area, which are available through their state and local health departments and Centers for Disease Control and Prevention (CDC) surveillance.\r\n&nbsp;\r\nAlthough direct evidence on screening in nonpregnant persons who are not at increased risk for syphilis infection is lacking, based on the established test performance characteristics of current screening tests and the low prevalence rate of syphilis in this population, the yield of screening is likely low.9,10 Therefore, screening in this population may result in high false-positive rates and overtreatment.'}, {'id': 1905, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and US Food and Drug Administration (FDA)--approved pharmacotherapy for cessation to nonpregnant adults who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 1906, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all pregnant persons about tobacco use, advise them to stop using tobacco, and provide behavioral interventions for cessation to pregnant persons who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 2014, 'title': 'Anxiety Disorders in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for anxiety disorders in adults, including pregnant and postpartum persons.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding optimal timing for screening, or screening interval, for both the perinatal and general adult populations; more evidence on both timing and screening interval is needed for all adult populations. A pragmatic approach in the absence of evidence might include screening all adults who have not been screened previously and using clinical judgment in considering risk factors, comorbid conditions, and life events to determine if additional screening of high-risk patients is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nRisk factors for anxiety disorders include sociodemographic factors, psychosocial factors, and physical and mental health factors such as marital status (widowed or divorced), stressful life events, smoking and alcohol use, other mental health conditions, or a parental history of mental disorders. Demographic factors such as low socioeconomic status and female sex are associated with higher rates of anxiety disorders.&nbsp;Black persons and individuals of non-Hispanic ethnicity are at increased risk of anxiety disorders due to social, rather than biological, factors. Anxiety and depressive disorders often overlap. One cohort study found that 67% of individuals with a depressive disorder also had a current anxiety disorder, and 75% had a lifetime comorbid anxiety disorder.'}, {'id': 2009, 'title': 'Latent Tuberculosis Infection in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for LTBI in populations at increased risk.\r\rSee the "Assessment of Risk" section for additional information on adults at increased risk.', 'servfreq': 'The USPSTF found no evidence on the optimal frequency of screening for LTBI. In the absence of evidence, a reasonable approach is to repeat screening based on specific risk factors; screening frequency could range from 1-time only screening among persons at low risk for future tuberculosis exposure to annual screening among those at continued risk of exposure.', 'risktext': 'Populations at increased risk for LTBI, based on increased prevalence of active disease and increased risk of exposure, include persons who were born in, or are former residents of, countries with high tuberculosis prevalence and persons who live in, or have lived in, high-risk congregate settings (eg, homeless shelters or correctional facilities). Clinicians can consult their local or state health departments for more information about populations at increased risk in their community, since local demographic patterns may vary across the US.\r\nIn 2020, 71.5% of all cases of active tuberculosis in the US occurred among persons born outside the US. According to the CDC, tuberculosis disease is common in most countries in Latin America, the Caribbean, Africa, Asia, Eastern Europe, and Russia. In 2020, among persons with new tuberculosis living in the US who were born outside the US, the most common countries of birth were Mexico (18.0%), the Philippines (12.5%), India (10.4%), Vietnam (8.2%), and China (5.1%), accounting for 54.2% of total cases. Most of these cases are believed to be due to progression of latent infection to active tuberculosis disease rather than new transmission within communities.\r\nPersons who live, or have lived, in high-risk congregate settings also have a higher prevalence rate of active tuberculosis and an increased risk for exposure. In 2020, 4.3% of tuberculosis disease cases diagnosed in persons 15 years or older occurred in persons experiencing homelessness and 2.6% occurred in residents of correctional facilities. It is estimated that persons experiencing homelessness have an 11 times higher incidence of tuberculosis disease compared with persons who are not experiencing homelessness (36 cases per 100,000 population vs 2.9 cases per 100,000 population, respectively, during 2011 to 2016).\r\nOther populations at increased risk for LTBI or progression to active disease include persons who have immunosuppression (eg, persons living with HIV, patients receiving immunosuppressive medications such as chemotherapy or tumor necrosis factor inhibitors, and patients who have received an organ transplant) and patients with silicosis (a lung disease). However, given that screening in these populations may be considered standard care as part of disease management or indicated prior to the use of certain medications, the USPSTF did not review evidence on screening in these populations. Information on testing in these populations is provided by other groups, such as the Office of AIDS Research at the National Institutes of Health, and in a guideline issued jointly by the American Thoracic Society, Infectious Diseases Society of America, and CDC. Some evidence from observational studies has explored the association between poorly controlled diabetes and progression of LTBI to active disease. However, there is insufficient evidence on screening for and treatment of LTBI in persons with diabetes for the USPSTF to make a separate recommendation for this important population.\r\nPersons who are contacts of individuals with active tuberculosis, health care workers, and workers in high-risk congregate settings may also be at increased risk of exposure. Because screening in these populations is conducted as part of public health or employee health surveillance, the USPSTF did not review the evidence in these populations. Clinicians seeking further information about testing for tuberculosis in these populations can refer to the Additional Tools and Resources and Recommendations of Others sections.'}, {'id': 514, 'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic bacteriuria in nonpregnant adults.', 'servfreq': '', 'risktext': 'The risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6 Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5 Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7, 11, 12 In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12 Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4, 6'}, {'id': 1909, 'title': 'Asymptomatic Carotid Artery Stenosis: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic carotid artery stenosis in the general adult population.\r\rSee the Practice Considerations section for a description of adults at increased risk.', 'servfreq': '', 'risktext': ''}, {'id': 2017, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for suicide risk in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': '', 'risktext': ''}, {'id': 2016, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for depression in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding the optimal timing for screening for depression; more evidence is needed in both perinatal and general adult populations. In the absence of evidence, a pragmatic approach might include screening adults who have not been screened previously and using clinical judgment while considering risk factors, comorbid conditions, and life events to determine if additional screening of patients at increased risk is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nThe USPSTF recommends screening for depression in all adults regardless of risk factors. Risk factors for depression include a combination of genetic, biological, and environmental factors, such as a family history of depression, prior episode of depression or other mental health condition, a history of trauma or adverse life events, or a history of disease or illness (eg, cardiovascular disease).\r\nPrevalence rates vary by sex, age, race, ethnicity, education, marital status, geographic location, poverty level, and employment status. Women have twice the risk of depression compared with men. Young adults, multiracial individuals, and Native American/Alaska Native individuals have higher rates of depression.\r\nRisk factors for perinatal depression include life stress, low social support, history of depression, marital or partner dissatisfaction, and a history of abuse.'}, {'id': 1845, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends offering or referring adults with cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity.', 'servfreq': '', 'risktext': 'Adults 18 years or older at increased risk of CVD, defined as those with 1 or more of the following:\r\n1.Hypertension or elevated blood pressure2.Dyslipidemia3.Mixed or multiple risk factors such as the metabolic syndrome or an estimated 10-year CVD risk of &ge;7.5%\r\nThis recommendation does not apply to adults with other known modifiable cardiovascular risk factors such as abnormal blood glucose levels, obesity, and smoking; these populations are incorporated in other USPSTF recommendations.'}, {'id': 1885, 'title': 'Hepatitis B Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in adolescents and adults at increased risk for infection.\r\rSee the Practice Considerations section for a description of adolescents and adults at increased risk for infection.', 'servfreq': 'For patients with negative HBsAg results who have not received the HBV vaccine series, periodic screening may be useful for those who report continued risk for acquiring HBV transmission, such as persons who continue to inject drugs and men who have sex with men. Clinical judgment should be used to determine screening frequency. The USPSTF found no evidence to determine optimal screening intervals.', 'risktext': 'Persons from such risk groups include persons who have injected drugs in the past or currently; men who have sex with men; persons with HIV; and sex partners, needle-sharing contacts, and household contacts of persons known to be HBsAg positive. Some persons with combinations of risk factors who are not members of risk factor groups listed above may also be at increased risk for HBV infection.'}, {'id': 524, 'title': 'Hepatitis C Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis C virus (HCV) infection in adults aged 18 to 79 years.', 'servfreq': 'One-time screening for most adults.\r\nPeriodically screen persons with continued risk for HCV infection (eg, persons with past or current injection drug use). There is limited evidence to determine how often to screen persons at increased risk.&nbsp;', 'risktext': 'Asymptomatic adults aged 18 to 79 years (including pregnant persons) without known liver disease.&nbsp;\r\nThe USPSTF also suggests that clinicians consider screening persons younger than 18 years and older than 79 years who are at high risk for infection (eg, those with past or current injection drug use).&nbsp;'}, {'id': 1916, 'title': 'Lung Cancer: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery.', 'servfreq': ' \r\nThe USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. ', 'risktext': ' \r\nSmoking and older age are the 2 most important risk factors for lung cancer.&nbsp;The risk of lung cancer in persons who smoke increases with cumulative quantity and duration of smoking and with age but decreases with increasing time since quitting for persons who formerly smoked.3 The USPSTF considers adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years to be at high risk and recommends screening for lung cancer with annual LDCT in this population. \r\n \r\n&nbsp;\r\n \r\nAfrican American/Black (Black) men have a higher incidence of lung cancer than White men, and Black women have a lower incidence than White women.1 These differences are likely related to differences in smoking exposure (ie, prevalence of smoking) and related exposure to carcinogens in cigarettes.7,8 The differences may also be related to other social risk factors.\r\n \r\n&nbsp;\r\n \r\nOther risk factors for lung cancer include environmental exposures, prior radiation therapy, other (noncancer) lung diseases, and family history. Lower level of education is also associated with a higher risk of lung cancer.7 The task force recommends using age and smoking history to determine screening eligibility rather than more elaborate risk prediction models because there is insufficient evidence to assess whether risk prediction model&ndash;based screening would improve outcomes relative to using the risk factors of age and smoking history for broad implementation in primary care.\r\n '}, {'id': 1445, 'title': 'Sexually Transmitted Infections: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends behavioral counseling for all sexually active adolescents and for adults who are at increased risk for sexually transmitted infections (STIs).\r\rSee the Practice Considerations section for more information on populations at increased risk for acquiring STIs.', 'servfreq': '', 'risktext': 'All sexually active adolescents are at increased risk for STIs because of the high rates of STIs in this age group and should receive behavioral counseling interventions. Adults at increased risk for STIs include those who currently have an STI or were diagnosed with one within the past year, do not consistently use condoms, have multiple sex partners, or have sex partners within populations with a high prevalence of STIs. Populations with a high prevalence of STIs include persons who seek STI testing or attend STI clinics; sexual and gender minorities; persons who are living with HIV, inject drugs, have exchanged sex for money or drugs, or have entered correctional facilities; and some racial/ethnic minority groups.1-4'}, {'id': 402, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends counseling young adults, adolescents, children, and parents of young children about minimizing exposure to ultraviolet (UV) radiation for persons aged 6 months to 24 years with fair skin types to reduce their risk of skin cancer.', 'servfreq': '', 'risktext': 'Fair skin types'}, {'id': 438, 'title': 'Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for unhealthy alcohol use in primary care settings in adults 18 years or older, including pregnant women, and providing persons engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce unhealthy alcohol use.', 'servfreq': 'The USPSTF did not find adequate evidence to recommend an optimal screening interval for unhealthy alcohol use in adults.&nbsp;Brief behavioral counseling interventions were found to reduce unhealthy alcohol use in adults 18 years or older, including pregnant women. Effective behavioral counseling interventions vary in their specific components, administration, length, and number of interactions. The USPSTF was unable to identify specific intervention characteristics or components that were clearly associated with improved outcomes.', 'risktext': 'engaged in risky or hazardous drinking'}, {'id': 767, 'title': 'Unhealthy Drug Use: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening by asking questions about unhealthy drug use in adults age 18 years or older. Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. \r(Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'servfreq': 'Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. (Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'risktext': 'These include being aged 18 to 25 years; male sex; having a mental health condition, personality or mood disorder, or nicotine or alcohol dependence; a history of physical or sexual abuse, parental neglect, or other adversity in childhood; or drug or alcohol addiction in a first-degree relative.1,9&nbsp;Factors associated with misuse of prescription drugs include history of other drug use, mental illness, pain, and greater access to prescription drugs.10&nbsp;Factors associated with prenatal use of drugs include a mental health disorder, interpersonal violence, and family history of substance use.11'}, {'id': 433, 'title': 'Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer or refer adults with a body mass index (BMI) of 30 or higher (calculated as weight in kilograms divided by height in meters squared) to intensive, multicomponent behavioral interventions.', 'servfreq': '', 'risktext': 'Adults with a BMI &ge;30'}, {'id': 1979, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: Behavioral Counseling Interventions ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians individualize the decision to offer or refer adults without cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity. \r\rSee the "Practice Considerations" section for information on determining which patients may benefit most from this service.', 'servfreq': '', 'risktext': ''}, {'id': 1937, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for chlamydia and gonorrhea in men.', 'servfreq': '', 'risktext': ''}, {'id': 418, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening with resting or exercise electrocardiography (ECG) to prevent cardiovascular disease (CVD) events in asymptomatic adults at low risk of CVD events.', 'servfreq': '', 'risktext': ''}, {'id': 1973, 'title': 'Chronic Obstructive Pulmonary Disease: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for chronic obstructive pulmonary disease in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 2003, 'title': 'Genital Herpes Infection: Serologic Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine serologic screening for genital herpes simplex virus infection in asymptomatic adolescents and adults, including pregnant persons.', 'servfreq': '', 'risktext': 'The USPSTF found no evidence of externally validated, reliable risk stratification tools to identify individuals more or less likely to have genital herpes.'}, {'id': 504, 'title': 'Pancreatic Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for pancreatic cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 203, 'title': 'Testicular Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for testicular cancer in adolescent or adult men.', 'servfreq': '', 'risktext': ''}, {'id': 365, 'title': 'Thyroid Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for thyroid cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 1976, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'D', 'text': 'The DoctorAI recommends against the use of beta carotene or vitamin E supplements for the prevention of cardiovascular disease or cancer.', 'servfreq': '', 'risktext': ''}, {'id': 318, 'title': 'Autism Spectrum Disorder in Young Children: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for autism spectrum disorder (ASD) in young children for whom no concerns of ASD have been raised by their parents or a clinician.', 'servfreq': '', 'risktext': 'Although a number of potential risk factors for ASD have been identified, there is insufficient evidence to determine if certain risk factors modify the performance characteristics of ASD screening tests, such as the age at which screening is performed or other characteristics of the child or family.'}, {'id': 65, 'title': 'Bladder Cancer in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults.\r\rLiterature scans conducted in July 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'This evidence update focused on the benefits and harms of screening for bladder cancer among people without symptoms, the accuracy of screening tests done in primary care settings, and the benefits and harms of treatment. The updated evidence review did not find any new high quality evidence to adequately determine the balance of benefits and harms of screening for bladder cancer. However, bladder cancer is a common cancer and can cause considerable health problems including death. Therefore, the USPSTF determined that the evidence was insufficient to provide a recommendation for or against bladder cancer screening.  The USPSTF emphasizes the need for additional research in this area. '}, {'id': 419, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening with resting or exercise ECG to prevent CVD events in asymptomatic adults at intermediate or high risk of CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 423, 'title': 'Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of adding the ankle-brachial index (ABI), high-sensitivity C-reactive protein (hsCRP) level, or coronary artery calcium (CAC) score to traditional risk assessment for cardiovascular disease (CVD) in asymptomatic adults to prevent CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 352, 'title': 'Celiac Disease: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'persons with family history or other risk factors'}, {'id': 1955, 'title': 'Eating Disorders in Adolescents and Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for eating disorders in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 665, 'title': 'Illicit Drug Use in Children, Adolescents, and Young Adults: Primary Care-Based Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--based behavioral counseling interventions to prevent illicit drug use, including nonmedical use of prescription drugs, in children, adolescents, and young adults.\r\rSee the Practice Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 435, 'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for abuse and neglect in all older or vulnerable adults. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': 'Risk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health.14&nbsp;For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.15'}, {'id': 2045, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for iron deficiency and iron deficiency anemia in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2046, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine iron supplementation in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2018, 'title': 'Lipid Disorders in Children and Adolescents: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1998, 'title': 'Obstructive Sleep Apnea in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for obstructive sleep apnea in the general adult population.\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Risk Factors\r\nRisk factors associated with OSA include male sex, older age (40-70 years), postmenopausal status, higher body mass index (BMI), and craniofacial and upper airway abnormalities (eg, enlarged tonsils or long upper airway). Black, Hispanic/Latino, and Native American/Alaska Native persons have a higher prevalence of OSA compared with White persons; some evidence suggests that these differences are partially explained by higher rates of obesity, asthma, and tobacco use among these groups.8'}, {'id': 1977, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of multivitamin supplements for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1978, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of single or paired nutrient supplements (other than beta carotene and vitamin E) for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 176, 'title': 'Oral Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for oral cancer in asymptomatic adults.\r\rGo to the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in July 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Tobacco and alcohol use are major risk factors for oral cancer. A total of 20% to 30% of cases of oral cancer worldwide are attributable to cigarette smoking. In the United States, up to 75% of cases of oral cancer may be attributable to tobacco and alcohol use. Additional risk factors include male sex, older age, use of betel quid, ultraviolet light exposure, infection with Candida or bacterial flora, and a compromised immune system. Sexually transmitted oral HPV infection (HPV-16) has recently been recognized as an increasingly important risk factor for oropharyngeal cancer. In the United States, the prevalence of oropharyngeal cancer due to oral HPV infection is probably as high as 80% to 95%. The prevalence of oral HPV infection is associated with age, sex, number of sexual partners, and number of cigarettes smoked per day. The effect of multifactorial risk assessment and screening for risk factors on oral cancer morbidity and mortality is unknown.'}, {'id': 2026, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine screening performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 2027, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of preventive interventions performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 424, 'title': 'Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for peripheral artery disease (PAD) and cardiovascular disease (CVD) risk with the ankle-brachial index (ABI) in asymptomatic adults.\r\rLiterature scans conducted in August 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Risk factors associated with OSA include male sex, older age (40 to 70 years), postmenopausal status, higher BMI, and craniofacial and upper airway abnormalities.'}, {'id': 404, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of counseling adults about skin self-examination to prevent skin cancer.See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 2005, 'title': 'Skin Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Exposure to UV radiation from sun exposure, indoor tanning beds, and other UV radiation&ndash;emitting devices is the major environmental risk factor for skin cancer. History of frequent sunburns, older age, and male sex are associated with increased risk for skin cancer. Exposure to UV radiation from the use of indoor tanning beds is an important risk factor in adolescents. Incidence of melanoma is higher among White persons compared with persons of other races and ethnicities. This difference likely reflects traits associated with increased melanoma risk, such as fair skin (which is more susceptible to sunburning), light-colored eyes, and red or blond hair being more common among White persons compared with persons of other races and ethnicities. Acral lentiginous melanoma, which occurs mostly on skin not frequently exposed to direct sunlight (eg, palms of hands, soles of feet, or under fingernails or toenails), is the most common type of melanoma among Black populations. Other melanoma risk factors include higher numbers of moles on the skin, atypical moles, as well as a personal and family history of skin cancer.'}, {'id': 269, 'title': 'Thyroid Dysfunction: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults.\r\rSee the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': 'The optimal screening interval for thyroid dysfunction (if one exists) is unknown.', 'risktext': 'The most common cause of hypothyroidism in the United States is chronic autoimmune (Hashimoto) thyroiditis. Risk factors for an elevated TSH level include female sex, advancing age, white race, type 1 diabetes, Down syndrome, family history of thyroid disease, goiter, previous hyperthyroidism (possibly due in part to ablation therapy leading to iatrogenic thyroid dysfunction), and external-beam radiation in the head and neck area. Common causes of hyperthyroidism include Graves disease, Hashimoto thyroiditis, and functional thyroid nodules. Risk factors for a low TSH level include female sex; advancing age; black race; low iodine intake; personal or family history of thyroid disease; and ingestion of iodine-containing drugs, such as amiodarone. The USPSTF found no direct evidence that treatment of thyroid dysfunction based on risk level alters final health outcomes.'}, {'id': 1908, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of electronic cigarettes (e-cigarettes) for tobacco cessation in adults, including pregnant persons. The USPSTF recommends that clinicians direct patients who use tobacco to other tobacco cessation interventions with proven effectiveness and established safety.\rSee the Practice Considerations section for more information on recommended behavioral interventions and pharmacotherapy and for suggestions for practice regarding the I statements.', 'servfreq': '', 'risktext': ''}, {'id': 1907, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of pharmacotherapy interventions for tobacco cessation in pregnant persons.', 'servfreq': '', 'risktext': ''}, {'id': 586, 'title': 'Tobacco Use in Children and Adolescents: Primary Care Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--feasible interventions for the cessation of tobacco use among school-aged children and adolescents.\r\rSee the Practice Considerations section for more information on effective interventions to prevent initiation of tobacco use and for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1919, 'title': 'Vitamin D Deficiency in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 408, 'title': 'Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of the benefits and harms of vitamin D and calcium supplementation, alone or combined, for the primary prevention of fractures in men and premenopausal women.', 'servfreq': '', 'risktext': ''}], 'tools': [{'tool_id': 321, 'url': 'https://jamanetwork.com/journals/jama/fullarticle/2735342', 'title': 'JAMA Patient Page: Who Should Be Screened for HIV Infection? ', 'text': '', 'keywords': ''}, {'tool_id': 322, 'url': 'https://sites.jamanetwork.com/spanish-patient-pages/2019/hoja-para-el-paciente-de-jama-190618.pdf', 'title': 'ยฟQuiรฉnes deben someterse a una prueba de detecciรณn de infecciรณn por VIH?', 'text': '', 'keywords': 'HIV|Human immunodeficiency syndrome|AIDS'}, {'tool_id': 210, 'url': 'https://www.aafp.org/afp/2019/1115/p637.html', 'title': "Screening for HIV Infection and Preexposure Prophylaxis for the Prevention of HIV Infection: AFP's Putting Into Practice", 'text': 'The journal American Family Physician (AFP) provides a series of short case studies and quizzes based on recommendations issued by the U.S. Preventive Services Task Force.', 'keywords': ''}]}
2025-01-29 21:51:04 [INFO] Recommendations: [{'id': 485, 'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in adolescents and adults aged 15 to 65 years. Younger adolescents and older adults who are at increased risk of infection should also be screened.\rSee the Clinical Considerations section for more information about assessment of risk, screening intervals, and rescreening in pregnancy.', 'servfreq': 'The USPSTF found insufficient evidence to determine appropriate or optimal time intervals or strategies for repeat HIV screening. However, repeat screening is reasonable for persons known to be at increased risk of HIV infection, such as sexually active men who have sex with men; persons with a sex partner who is living with HIV; or persons who engage in behaviors that may convey an increased risk of HIV infection, such as injection drug use, transactional sex or commercial sex work, having 1 or more new sex partners whose HIV status is unknown, or having other factors that can place a person at increased risk of HIV infection (see &ldquo;Risk Assessment&rdquo;). Repeat screening is also reasonable for persons who live or receive medical care in a high-prevalence setting, such as a sexually transmitted disease clinic, tuberculosis clinic, correctional facility, or homeless shelter.', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'id': 1921, 'title': 'Hypertension in Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hypertension in adults 18 years or older with office blood pressure measurement (OBPM). The USPSTF recommends obtaining blood pressure measurements outside of the clinical setting for diagnostic confirmation before starting treatment.', 'servfreq': ' \r\nAlthough evidence on optimal screening intervals is limited, reasonable options include:\r\n \r\n \r\n\r\n\r\nScreening for hypertension every year in adults 40 years or older and in adults at increased risk for hypertension (such as Black persons, persons with high-normal blood pressure, or persons who are overweight or obese)\r\n\r\n\r\n \r\n \r\n\r\n\r\nScreening less frequently (ie, every 3 to 5 years) as appropriate for adults aged 18 to 39 years not at increased risk for hypertension and with a prior normal blood pressure reading.\r\n\r\n\r\n ', 'risktext': ' \r\nAlthough all adults should be screened for hypertension, risk factors that increase a person&rsquo;s risk for the condition include older age, Black race, family history, excess weight and obesity, lifestyle habits (lack of physical activity, stress, and tobacco use), and dietary factors (diet high in fat or sodium, diet low in potassium, or excessive alcohol intake)\r\n '}, {'id': 2021, 'title': 'Prevention of Acquisition of HIV: Preexposure Prophylaxis ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians prescribe preexposure prophylaxis using effective antiretroviral therapy to persons who are at increased risk of HIV acquisition to decrease the risk of acquiring HIV. \r\rSee the Practice Considerations section for more information about identification of persons at increased risk and about effective antiretroviral therapy.', 'servfreq': '', 'risktext': 'HIV is primarily acquired via sexual activity or injection drug use. It is important that clinicians routinely take a sexual and injection drug use history for all their patients in an open and nonjudgmental manner. All adolescents and adults who are sexually active or who inject drugs should be informed that acquisition of HIV can be prevented, to facilitate subsequent risk assessment and discussions about preexposure prophylaxis (PrEP) and other ways to prevent acquisition of HIV. Importantly, risk of HIV acquisition exists on a continuum, and currently available risk assessment tools all have limitations. However, certain risk factors or behaviors are known to place persons at increased risk of HIV.\r\nRisk of HIV acquisition depends on the likelihood that a specific act or activity will transmit HIV and the likelihood that a sex partner or drug injection partner has HIV. Likelihood of HIV transmission is highest with needle-sharing injection drug use and condomless receptive anal intercourse. Condomless receptive anal intercourse has an approximately 10- to 15-fold higher risk of transmission than condomless insertive anal sex and condomless receptive and insertive penile-vaginal sex. A 2018 study estimated the prevalence of HIV (ie, an estimate of the likelihood that a partner whose HIV status is unknown has HIV at a population level) as 12.4% among men who have sex with men and 1.9% among persons who inject drugs. The overall prevalence of HIV in the US is estimated at 0.3%.&nbsp;Of note, both the frequency of specific sexual activities and a person&rsquo;s number of sexual partners will also affect their risk of HIV.\r\n&nbsp;The USPSTF recommends that the following persons be considered for PrEP:\r\n1.&nbsp;&nbsp;&nbsp;&nbsp; Sexually active adults and adolescents weighing at least 35 kg (77 lb) who have engaged in anal or vaginal sex in the past 6 months and have any of the following:\r\n&nbsp;\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A sexual partner who has HIV (especially if the partner has an unknown or detectable viral load).\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A bacterial sexually transmitted infection (STI) (syphilis, gonorrhea, or chlamydia for men who have sex with men and transgender women; gonorrhea and syphilis for heterosexual women and men) in the past 6 months.\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A history of inconsistent or no condom use with sex partner(s) whose HIV status is not known; assessing risk in conversation with the patient and considering factors such as number of partners, the specific sexual activities a person engages in, and whether their sex partner or partners are in a group with a higher prevalence of HIV (eg, men who have sex with men or with men and women, transgender women, persons who inject drugs, and persons who engage in transactional sex).\r\n&nbsp;\r\n2. &nbsp; Persons who inject drugs and have a drug-injecting partner who has HIV or who shares injection equipment.\r\nPersons who engage in transactional sex, such as sex for money, drugs, or housing, including commercial sex workers or persons trafficked for sex work, constitute a group at increased risk of HIV acquisition and should be considered for PrEP based on the criteria outlined above. Persons who request PrEP may have undisclosed behaviors that put them at risk. Transgender women and men who are sexually active should be considered for PrEP based on the criteria outlined above. Transgender women are at especially high risk of HIV acquisition. A Centers for Disease Control and and Prevention (CDC) survey in 7 cities found an HIV prevalence of 42% among transgender women. Prevalence was highest among Black transgender women (62%) and Native American/Alaska Native transgender women (65%).\r\nIn addition, studies have found that transmission of HIV to a seronegative partner from a partner with HIV has not been observed when the partner with HIV was being treated with antiretroviral therapy and had a suppressed viral load.&nbsp;It is not known whether PrEP use further decreases the risk of HIV transmission when a partner with HIV has a documented undetectable viral load. Factors such as the consistency or inconsistency of a partner&rsquo;s viral load being suppressed, a partner&rsquo;s adherence to antiretroviral therapy, and the degree of certainty that a partner&rsquo;s viral load is suppressed (eg, self-report vs availability of laboratory test results) may help inform decisions about the use of PrEP in this situation.\r\nAll persons being considered for PrEP must have a recently documented negative HIV antigen-antibody test result, and if they have taken oral PrEP or postexposure prophylaxis in the past 3 months, or injectable cabotegravir in the past 12 months, the CDC recommends testing with both an HIV antigen-antibody assay and an HIV-1 RNA assay.'}, {'id': 1989, 'title': 'Syphilis Infection in Nonpregnant Adolescents and Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for syphilis infection in persons who are at increased risk for infection.', 'servfreq': 'Optimal screening frequency for persons who are at increased risk for syphilis infection is not well established. Men who have sex with men or persons with HIV infection may benefit from screening at least annually or more frequently (eg, every 3 to 6 months) if they continue to be at high risk.', 'risktext': 'The USPSTF recommends screening for syphilis in persons who are at increased risk for infection. When deciding which persons to screen for syphilis, clinicians should consider the prevalence of infection in the communities they serve, as well as other sociodemographic and behavioral factors that may be associated with increased risk of syphilis infection. For example, prevalence of syphilis is higher in men, men who have sex with men, persons with HIV infection, young adults, and persons with a history of incarceration, sex work, or military service. A substantial percentage of heterosexual syphilis transmission occurs among persons who use illicit drugs, particularly methamphetamine. Diagnosis of another STI may signal that a person is having condomless sex, which increases their risk of syphilis infection. Higher infection rates in persons of some racial and ethnic groups have been reported and are primarily a reflection of a combination of factors, including social determinants of health (eg, disparities of income, low educational achievement, and unstable housing), differential health insurance coverage or access to quality health care, and differences in sexual network characteristics (eg, individuals living in communities with a high prevalence of STIs have an increased chance of encountering an infected partner). Local prevalence rates may change over time, so clinicians should be aware of the latest data and trends for their specific population and geographic area, which are available through their state and local health departments and Centers for Disease Control and Prevention (CDC) surveillance.\r\n&nbsp;\r\nAlthough direct evidence on screening in nonpregnant persons who are not at increased risk for syphilis infection is lacking, based on the established test performance characteristics of current screening tests and the low prevalence rate of syphilis in this population, the yield of screening is likely low.9,10 Therefore, screening in this population may result in high false-positive rates and overtreatment.'}, {'id': 1905, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and US Food and Drug Administration (FDA)--approved pharmacotherapy for cessation to nonpregnant adults who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 1906, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all pregnant persons about tobacco use, advise them to stop using tobacco, and provide behavioral interventions for cessation to pregnant persons who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 2014, 'title': 'Anxiety Disorders in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for anxiety disorders in adults, including pregnant and postpartum persons.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding optimal timing for screening, or screening interval, for both the perinatal and general adult populations; more evidence on both timing and screening interval is needed for all adult populations. A pragmatic approach in the absence of evidence might include screening all adults who have not been screened previously and using clinical judgment in considering risk factors, comorbid conditions, and life events to determine if additional screening of high-risk patients is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nRisk factors for anxiety disorders include sociodemographic factors, psychosocial factors, and physical and mental health factors such as marital status (widowed or divorced), stressful life events, smoking and alcohol use, other mental health conditions, or a parental history of mental disorders. Demographic factors such as low socioeconomic status and female sex are associated with higher rates of anxiety disorders.&nbsp;Black persons and individuals of non-Hispanic ethnicity are at increased risk of anxiety disorders due to social, rather than biological, factors. Anxiety and depressive disorders often overlap. One cohort study found that 67% of individuals with a depressive disorder also had a current anxiety disorder, and 75% had a lifetime comorbid anxiety disorder.'}, {'id': 2009, 'title': 'Latent Tuberculosis Infection in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for LTBI in populations at increased risk.\r\rSee the "Assessment of Risk" section for additional information on adults at increased risk.', 'servfreq': 'The USPSTF found no evidence on the optimal frequency of screening for LTBI. In the absence of evidence, a reasonable approach is to repeat screening based on specific risk factors; screening frequency could range from 1-time only screening among persons at low risk for future tuberculosis exposure to annual screening among those at continued risk of exposure.', 'risktext': 'Populations at increased risk for LTBI, based on increased prevalence of active disease and increased risk of exposure, include persons who were born in, or are former residents of, countries with high tuberculosis prevalence and persons who live in, or have lived in, high-risk congregate settings (eg, homeless shelters or correctional facilities). Clinicians can consult their local or state health departments for more information about populations at increased risk in their community, since local demographic patterns may vary across the US.\r\nIn 2020, 71.5% of all cases of active tuberculosis in the US occurred among persons born outside the US. According to the CDC, tuberculosis disease is common in most countries in Latin America, the Caribbean, Africa, Asia, Eastern Europe, and Russia. In 2020, among persons with new tuberculosis living in the US who were born outside the US, the most common countries of birth were Mexico (18.0%), the Philippines (12.5%), India (10.4%), Vietnam (8.2%), and China (5.1%), accounting for 54.2% of total cases. Most of these cases are believed to be due to progression of latent infection to active tuberculosis disease rather than new transmission within communities.\r\nPersons who live, or have lived, in high-risk congregate settings also have a higher prevalence rate of active tuberculosis and an increased risk for exposure. In 2020, 4.3% of tuberculosis disease cases diagnosed in persons 15 years or older occurred in persons experiencing homelessness and 2.6% occurred in residents of correctional facilities. It is estimated that persons experiencing homelessness have an 11 times higher incidence of tuberculosis disease compared with persons who are not experiencing homelessness (36 cases per 100,000 population vs 2.9 cases per 100,000 population, respectively, during 2011 to 2016).\r\nOther populations at increased risk for LTBI or progression to active disease include persons who have immunosuppression (eg, persons living with HIV, patients receiving immunosuppressive medications such as chemotherapy or tumor necrosis factor inhibitors, and patients who have received an organ transplant) and patients with silicosis (a lung disease). However, given that screening in these populations may be considered standard care as part of disease management or indicated prior to the use of certain medications, the USPSTF did not review evidence on screening in these populations. Information on testing in these populations is provided by other groups, such as the Office of AIDS Research at the National Institutes of Health, and in a guideline issued jointly by the American Thoracic Society, Infectious Diseases Society of America, and CDC. Some evidence from observational studies has explored the association between poorly controlled diabetes and progression of LTBI to active disease. However, there is insufficient evidence on screening for and treatment of LTBI in persons with diabetes for the USPSTF to make a separate recommendation for this important population.\r\nPersons who are contacts of individuals with active tuberculosis, health care workers, and workers in high-risk congregate settings may also be at increased risk of exposure. Because screening in these populations is conducted as part of public health or employee health surveillance, the USPSTF did not review the evidence in these populations. Clinicians seeking further information about testing for tuberculosis in these populations can refer to the Additional Tools and Resources and Recommendations of Others sections.'}, {'id': 514, 'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic bacteriuria in nonpregnant adults.', 'servfreq': '', 'risktext': 'The risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6 Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5 Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7, 11, 12 In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12 Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4, 6'}, {'id': 1909, 'title': 'Asymptomatic Carotid Artery Stenosis: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic carotid artery stenosis in the general adult population.\r\rSee the Practice Considerations section for a description of adults at increased risk.', 'servfreq': '', 'risktext': ''}, {'id': 2017, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for suicide risk in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': '', 'risktext': ''}, {'id': 2016, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for depression in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding the optimal timing for screening for depression; more evidence is needed in both perinatal and general adult populations. In the absence of evidence, a pragmatic approach might include screening adults who have not been screened previously and using clinical judgment while considering risk factors, comorbid conditions, and life events to determine if additional screening of patients at increased risk is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nThe USPSTF recommends screening for depression in all adults regardless of risk factors. Risk factors for depression include a combination of genetic, biological, and environmental factors, such as a family history of depression, prior episode of depression or other mental health condition, a history of trauma or adverse life events, or a history of disease or illness (eg, cardiovascular disease).\r\nPrevalence rates vary by sex, age, race, ethnicity, education, marital status, geographic location, poverty level, and employment status. Women have twice the risk of depression compared with men. Young adults, multiracial individuals, and Native American/Alaska Native individuals have higher rates of depression.\r\nRisk factors for perinatal depression include life stress, low social support, history of depression, marital or partner dissatisfaction, and a history of abuse.'}, {'id': 1845, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends offering or referring adults with cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity.', 'servfreq': '', 'risktext': 'Adults 18 years or older at increased risk of CVD, defined as those with 1 or more of the following:\r\n1.Hypertension or elevated blood pressure2.Dyslipidemia3.Mixed or multiple risk factors such as the metabolic syndrome or an estimated 10-year CVD risk of &ge;7.5%\r\nThis recommendation does not apply to adults with other known modifiable cardiovascular risk factors such as abnormal blood glucose levels, obesity, and smoking; these populations are incorporated in other USPSTF recommendations.'}, {'id': 1885, 'title': 'Hepatitis B Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in adolescents and adults at increased risk for infection.\r\rSee the Practice Considerations section for a description of adolescents and adults at increased risk for infection.', 'servfreq': 'For patients with negative HBsAg results who have not received the HBV vaccine series, periodic screening may be useful for those who report continued risk for acquiring HBV transmission, such as persons who continue to inject drugs and men who have sex with men. Clinical judgment should be used to determine screening frequency. The USPSTF found no evidence to determine optimal screening intervals.', 'risktext': 'Persons from such risk groups include persons who have injected drugs in the past or currently; men who have sex with men; persons with HIV; and sex partners, needle-sharing contacts, and household contacts of persons known to be HBsAg positive. Some persons with combinations of risk factors who are not members of risk factor groups listed above may also be at increased risk for HBV infection.'}, {'id': 524, 'title': 'Hepatitis C Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis C virus (HCV) infection in adults aged 18 to 79 years.', 'servfreq': 'One-time screening for most adults.\r\nPeriodically screen persons with continued risk for HCV infection (eg, persons with past or current injection drug use). There is limited evidence to determine how often to screen persons at increased risk.&nbsp;', 'risktext': 'Asymptomatic adults aged 18 to 79 years (including pregnant persons) without known liver disease.&nbsp;\r\nThe USPSTF also suggests that clinicians consider screening persons younger than 18 years and older than 79 years who are at high risk for infection (eg, those with past or current injection drug use).&nbsp;'}, {'id': 1916, 'title': 'Lung Cancer: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery.', 'servfreq': ' \r\nThe USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. ', 'risktext': ' \r\nSmoking and older age are the 2 most important risk factors for lung cancer.&nbsp;The risk of lung cancer in persons who smoke increases with cumulative quantity and duration of smoking and with age but decreases with increasing time since quitting for persons who formerly smoked.3 The USPSTF considers adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years to be at high risk and recommends screening for lung cancer with annual LDCT in this population. \r\n \r\n&nbsp;\r\n \r\nAfrican American/Black (Black) men have a higher incidence of lung cancer than White men, and Black women have a lower incidence than White women.1 These differences are likely related to differences in smoking exposure (ie, prevalence of smoking) and related exposure to carcinogens in cigarettes.7,8 The differences may also be related to other social risk factors.\r\n \r\n&nbsp;\r\n \r\nOther risk factors for lung cancer include environmental exposures, prior radiation therapy, other (noncancer) lung diseases, and family history. Lower level of education is also associated with a higher risk of lung cancer.7 The task force recommends using age and smoking history to determine screening eligibility rather than more elaborate risk prediction models because there is insufficient evidence to assess whether risk prediction model&ndash;based screening would improve outcomes relative to using the risk factors of age and smoking history for broad implementation in primary care.\r\n '}, {'id': 1445, 'title': 'Sexually Transmitted Infections: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends behavioral counseling for all sexually active adolescents and for adults who are at increased risk for sexually transmitted infections (STIs).\r\rSee the Practice Considerations section for more information on populations at increased risk for acquiring STIs.', 'servfreq': '', 'risktext': 'All sexually active adolescents are at increased risk for STIs because of the high rates of STIs in this age group and should receive behavioral counseling interventions. Adults at increased risk for STIs include those who currently have an STI or were diagnosed with one within the past year, do not consistently use condoms, have multiple sex partners, or have sex partners within populations with a high prevalence of STIs. Populations with a high prevalence of STIs include persons who seek STI testing or attend STI clinics; sexual and gender minorities; persons who are living with HIV, inject drugs, have exchanged sex for money or drugs, or have entered correctional facilities; and some racial/ethnic minority groups.1-4'}, {'id': 402, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends counseling young adults, adolescents, children, and parents of young children about minimizing exposure to ultraviolet (UV) radiation for persons aged 6 months to 24 years with fair skin types to reduce their risk of skin cancer.', 'servfreq': '', 'risktext': 'Fair skin types'}, {'id': 438, 'title': 'Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for unhealthy alcohol use in primary care settings in adults 18 years or older, including pregnant women, and providing persons engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce unhealthy alcohol use.', 'servfreq': 'The USPSTF did not find adequate evidence to recommend an optimal screening interval for unhealthy alcohol use in adults.&nbsp;Brief behavioral counseling interventions were found to reduce unhealthy alcohol use in adults 18 years or older, including pregnant women. Effective behavioral counseling interventions vary in their specific components, administration, length, and number of interactions. The USPSTF was unable to identify specific intervention characteristics or components that were clearly associated with improved outcomes.', 'risktext': 'engaged in risky or hazardous drinking'}, {'id': 767, 'title': 'Unhealthy Drug Use: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening by asking questions about unhealthy drug use in adults age 18 years or older. Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. \r(Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'servfreq': 'Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. (Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'risktext': 'These include being aged 18 to 25 years; male sex; having a mental health condition, personality or mood disorder, or nicotine or alcohol dependence; a history of physical or sexual abuse, parental neglect, or other adversity in childhood; or drug or alcohol addiction in a first-degree relative.1,9&nbsp;Factors associated with misuse of prescription drugs include history of other drug use, mental illness, pain, and greater access to prescription drugs.10&nbsp;Factors associated with prenatal use of drugs include a mental health disorder, interpersonal violence, and family history of substance use.11'}, {'id': 433, 'title': 'Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer or refer adults with a body mass index (BMI) of 30 or higher (calculated as weight in kilograms divided by height in meters squared) to intensive, multicomponent behavioral interventions.', 'servfreq': '', 'risktext': 'Adults with a BMI &ge;30'}, {'id': 1979, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: Behavioral Counseling Interventions ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians individualize the decision to offer or refer adults without cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity. \r\rSee the "Practice Considerations" section for information on determining which patients may benefit most from this service.', 'servfreq': '', 'risktext': ''}, {'id': 1937, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for chlamydia and gonorrhea in men.', 'servfreq': '', 'risktext': ''}, {'id': 418, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening with resting or exercise electrocardiography (ECG) to prevent cardiovascular disease (CVD) events in asymptomatic adults at low risk of CVD events.', 'servfreq': '', 'risktext': ''}, {'id': 1973, 'title': 'Chronic Obstructive Pulmonary Disease: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for chronic obstructive pulmonary disease in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 2003, 'title': 'Genital Herpes Infection: Serologic Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine serologic screening for genital herpes simplex virus infection in asymptomatic adolescents and adults, including pregnant persons.', 'servfreq': '', 'risktext': 'The USPSTF found no evidence of externally validated, reliable risk stratification tools to identify individuals more or less likely to have genital herpes.'}, {'id': 504, 'title': 'Pancreatic Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for pancreatic cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 203, 'title': 'Testicular Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for testicular cancer in adolescent or adult men.', 'servfreq': '', 'risktext': ''}, {'id': 365, 'title': 'Thyroid Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for thyroid cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 1976, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'D', 'text': 'The DoctorAI recommends against the use of beta carotene or vitamin E supplements for the prevention of cardiovascular disease or cancer.', 'servfreq': '', 'risktext': ''}, {'id': 318, 'title': 'Autism Spectrum Disorder in Young Children: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for autism spectrum disorder (ASD) in young children for whom no concerns of ASD have been raised by their parents or a clinician.', 'servfreq': '', 'risktext': 'Although a number of potential risk factors for ASD have been identified, there is insufficient evidence to determine if certain risk factors modify the performance characteristics of ASD screening tests, such as the age at which screening is performed or other characteristics of the child or family.'}, {'id': 65, 'title': 'Bladder Cancer in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults.\r\rLiterature scans conducted in July 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'This evidence update focused on the benefits and harms of screening for bladder cancer among people without symptoms, the accuracy of screening tests done in primary care settings, and the benefits and harms of treatment. The updated evidence review did not find any new high quality evidence to adequately determine the balance of benefits and harms of screening for bladder cancer. However, bladder cancer is a common cancer and can cause considerable health problems including death. Therefore, the USPSTF determined that the evidence was insufficient to provide a recommendation for or against bladder cancer screening.  The USPSTF emphasizes the need for additional research in this area. '}, {'id': 419, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening with resting or exercise ECG to prevent CVD events in asymptomatic adults at intermediate or high risk of CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 423, 'title': 'Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of adding the ankle-brachial index (ABI), high-sensitivity C-reactive protein (hsCRP) level, or coronary artery calcium (CAC) score to traditional risk assessment for cardiovascular disease (CVD) in asymptomatic adults to prevent CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 352, 'title': 'Celiac Disease: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'persons with family history or other risk factors'}, {'id': 1955, 'title': 'Eating Disorders in Adolescents and Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for eating disorders in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 665, 'title': 'Illicit Drug Use in Children, Adolescents, and Young Adults: Primary Care-Based Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--based behavioral counseling interventions to prevent illicit drug use, including nonmedical use of prescription drugs, in children, adolescents, and young adults.\r\rSee the Practice Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 435, 'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for abuse and neglect in all older or vulnerable adults. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': 'Risk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health.14&nbsp;For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.15'}, {'id': 2045, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for iron deficiency and iron deficiency anemia in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2046, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine iron supplementation in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2018, 'title': 'Lipid Disorders in Children and Adolescents: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1998, 'title': 'Obstructive Sleep Apnea in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for obstructive sleep apnea in the general adult population.\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Risk Factors\r\nRisk factors associated with OSA include male sex, older age (40-70 years), postmenopausal status, higher body mass index (BMI), and craniofacial and upper airway abnormalities (eg, enlarged tonsils or long upper airway). Black, Hispanic/Latino, and Native American/Alaska Native persons have a higher prevalence of OSA compared with White persons; some evidence suggests that these differences are partially explained by higher rates of obesity, asthma, and tobacco use among these groups.8'}, {'id': 1977, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of multivitamin supplements for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1978, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of single or paired nutrient supplements (other than beta carotene and vitamin E) for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 176, 'title': 'Oral Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for oral cancer in asymptomatic adults.\r\rGo to the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in July 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Tobacco and alcohol use are major risk factors for oral cancer. A total of 20% to 30% of cases of oral cancer worldwide are attributable to cigarette smoking. In the United States, up to 75% of cases of oral cancer may be attributable to tobacco and alcohol use. Additional risk factors include male sex, older age, use of betel quid, ultraviolet light exposure, infection with Candida or bacterial flora, and a compromised immune system. Sexually transmitted oral HPV infection (HPV-16) has recently been recognized as an increasingly important risk factor for oropharyngeal cancer. In the United States, the prevalence of oropharyngeal cancer due to oral HPV infection is probably as high as 80% to 95%. The prevalence of oral HPV infection is associated with age, sex, number of sexual partners, and number of cigarettes smoked per day. The effect of multifactorial risk assessment and screening for risk factors on oral cancer morbidity and mortality is unknown.'}, {'id': 2026, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine screening performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 2027, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of preventive interventions performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 424, 'title': 'Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for peripheral artery disease (PAD) and cardiovascular disease (CVD) risk with the ankle-brachial index (ABI) in asymptomatic adults.\r\rLiterature scans conducted in August 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Risk factors associated with OSA include male sex, older age (40 to 70 years), postmenopausal status, higher BMI, and craniofacial and upper airway abnormalities.'}, {'id': 404, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of counseling adults about skin self-examination to prevent skin cancer.See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 2005, 'title': 'Skin Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Exposure to UV radiation from sun exposure, indoor tanning beds, and other UV radiation&ndash;emitting devices is the major environmental risk factor for skin cancer. History of frequent sunburns, older age, and male sex are associated with increased risk for skin cancer. Exposure to UV radiation from the use of indoor tanning beds is an important risk factor in adolescents. Incidence of melanoma is higher among White persons compared with persons of other races and ethnicities. This difference likely reflects traits associated with increased melanoma risk, such as fair skin (which is more susceptible to sunburning), light-colored eyes, and red or blond hair being more common among White persons compared with persons of other races and ethnicities. Acral lentiginous melanoma, which occurs mostly on skin not frequently exposed to direct sunlight (eg, palms of hands, soles of feet, or under fingernails or toenails), is the most common type of melanoma among Black populations. Other melanoma risk factors include higher numbers of moles on the skin, atypical moles, as well as a personal and family history of skin cancer.'}, {'id': 269, 'title': 'Thyroid Dysfunction: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults.\r\rSee the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': 'The optimal screening interval for thyroid dysfunction (if one exists) is unknown.', 'risktext': 'The most common cause of hypothyroidism in the United States is chronic autoimmune (Hashimoto) thyroiditis. Risk factors for an elevated TSH level include female sex, advancing age, white race, type 1 diabetes, Down syndrome, family history of thyroid disease, goiter, previous hyperthyroidism (possibly due in part to ablation therapy leading to iatrogenic thyroid dysfunction), and external-beam radiation in the head and neck area. Common causes of hyperthyroidism include Graves disease, Hashimoto thyroiditis, and functional thyroid nodules. Risk factors for a low TSH level include female sex; advancing age; black race; low iodine intake; personal or family history of thyroid disease; and ingestion of iodine-containing drugs, such as amiodarone. The USPSTF found no direct evidence that treatment of thyroid dysfunction based on risk level alters final health outcomes.'}, {'id': 1908, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of electronic cigarettes (e-cigarettes) for tobacco cessation in adults, including pregnant persons. The USPSTF recommends that clinicians direct patients who use tobacco to other tobacco cessation interventions with proven effectiveness and established safety.\rSee the Practice Considerations section for more information on recommended behavioral interventions and pharmacotherapy and for suggestions for practice regarding the I statements.', 'servfreq': '', 'risktext': ''}, {'id': 1907, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of pharmacotherapy interventions for tobacco cessation in pregnant persons.', 'servfreq': '', 'risktext': ''}, {'id': 586, 'title': 'Tobacco Use in Children and Adolescents: Primary Care Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--feasible interventions for the cessation of tobacco use among school-aged children and adolescents.\r\rSee the Practice Considerations section for more information on effective interventions to prevent initiation of tobacco use and for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1919, 'title': 'Vitamin D Deficiency in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 408, 'title': 'Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of the benefits and harms of vitamin D and calcium supplementation, alone or combined, for the primary prevention of fractures in men and premenopausal women.', 'servfreq': '', 'risktext': ''}]
2025-01-29 21:51:04 [INFO] Tools: [{'tool_id': 321, 'url': 'https://jamanetwork.com/journals/jama/fullarticle/2735342', 'title': 'JAMA Patient Page: Who Should Be Screened for HIV Infection? ', 'text': '', 'keywords': ''}, {'tool_id': 322, 'url': 'https://sites.jamanetwork.com/spanish-patient-pages/2019/hoja-para-el-paciente-de-jama-190618.pdf', 'title': 'ยฟQuiรฉnes deben someterse a una prueba de detecciรณn de infecciรณn por VIH?', 'text': '', 'keywords': 'HIV|Human immunodeficiency syndrome|AIDS'}, {'tool_id': 210, 'url': 'https://www.aafp.org/afp/2019/1115/p637.html', 'title': "Screening for HIV Infection and Preexposure Prophylaxis for the Prevention of HIV Infection: AFP's Putting Into Practice", 'text': 'The journal American Family Physician (AFP) provides a series of short case studies and quizzes based on recommendations issued by the U.S. Preventive Services Task Force.', 'keywords': ''}]
2025-01-29 21:51:05 [INFO] Update id=273478135 is handled. Duration 1046 ms by bot id=8108339380
2025-01-29 21:51:08 [INFO] State data: {'db': <bot.database.Database object at 0x7f2400e2f230>, 'age': 20, 'weight': 90, 'height': 190, 'feet': 45, 'gender': 'male', 'pregnant': 'no', 'smoking': 'yes', 'sex': 'tools_0', 'recommendations': [{'id': 485, 'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in adolescents and adults aged 15 to 65 years. Younger adolescents and older adults who are at increased risk of infection should also be screened.\rSee the Clinical Considerations section for more information about assessment of risk, screening intervals, and rescreening in pregnancy.', 'servfreq': 'The USPSTF found insufficient evidence to determine appropriate or optimal time intervals or strategies for repeat HIV screening. However, repeat screening is reasonable for persons known to be at increased risk of HIV infection, such as sexually active men who have sex with men; persons with a sex partner who is living with HIV; or persons who engage in behaviors that may convey an increased risk of HIV infection, such as injection drug use, transactional sex or commercial sex work, having 1 or more new sex partners whose HIV status is unknown, or having other factors that can place a person at increased risk of HIV infection (see &ldquo;Risk Assessment&rdquo;). Repeat screening is also reasonable for persons who live or receive medical care in a high-prevalence setting, such as a sexually transmitted disease clinic, tuberculosis clinic, correctional facility, or homeless shelter.', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'id': 1921, 'title': 'Hypertension in Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hypertension in adults 18 years or older with office blood pressure measurement (OBPM). The USPSTF recommends obtaining blood pressure measurements outside of the clinical setting for diagnostic confirmation before starting treatment.', 'servfreq': ' \r\nAlthough evidence on optimal screening intervals is limited, reasonable options include:\r\n \r\n \r\n\r\n\r\nScreening for hypertension every year in adults 40 years or older and in adults at increased risk for hypertension (such as Black persons, persons with high-normal blood pressure, or persons who are overweight or obese)\r\n\r\n\r\n \r\n \r\n\r\n\r\nScreening less frequently (ie, every 3 to 5 years) as appropriate for adults aged 18 to 39 years not at increased risk for hypertension and with a prior normal blood pressure reading.\r\n\r\n\r\n ', 'risktext': ' \r\nAlthough all adults should be screened for hypertension, risk factors that increase a person&rsquo;s risk for the condition include older age, Black race, family history, excess weight and obesity, lifestyle habits (lack of physical activity, stress, and tobacco use), and dietary factors (diet high in fat or sodium, diet low in potassium, or excessive alcohol intake)\r\n '}, {'id': 2021, 'title': 'Prevention of Acquisition of HIV: Preexposure Prophylaxis ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians prescribe preexposure prophylaxis using effective antiretroviral therapy to persons who are at increased risk of HIV acquisition to decrease the risk of acquiring HIV. \r\rSee the Practice Considerations section for more information about identification of persons at increased risk and about effective antiretroviral therapy.', 'servfreq': '', 'risktext': 'HIV is primarily acquired via sexual activity or injection drug use. It is important that clinicians routinely take a sexual and injection drug use history for all their patients in an open and nonjudgmental manner. All adolescents and adults who are sexually active or who inject drugs should be informed that acquisition of HIV can be prevented, to facilitate subsequent risk assessment and discussions about preexposure prophylaxis (PrEP) and other ways to prevent acquisition of HIV. Importantly, risk of HIV acquisition exists on a continuum, and currently available risk assessment tools all have limitations. However, certain risk factors or behaviors are known to place persons at increased risk of HIV.\r\nRisk of HIV acquisition depends on the likelihood that a specific act or activity will transmit HIV and the likelihood that a sex partner or drug injection partner has HIV. Likelihood of HIV transmission is highest with needle-sharing injection drug use and condomless receptive anal intercourse. Condomless receptive anal intercourse has an approximately 10- to 15-fold higher risk of transmission than condomless insertive anal sex and condomless receptive and insertive penile-vaginal sex. A 2018 study estimated the prevalence of HIV (ie, an estimate of the likelihood that a partner whose HIV status is unknown has HIV at a population level) as 12.4% among men who have sex with men and 1.9% among persons who inject drugs. The overall prevalence of HIV in the US is estimated at 0.3%.&nbsp;Of note, both the frequency of specific sexual activities and a person&rsquo;s number of sexual partners will also affect their risk of HIV.\r\n&nbsp;The USPSTF recommends that the following persons be considered for PrEP:\r\n1.&nbsp;&nbsp;&nbsp;&nbsp; Sexually active adults and adolescents weighing at least 35 kg (77 lb) who have engaged in anal or vaginal sex in the past 6 months and have any of the following:\r\n&nbsp;\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A sexual partner who has HIV (especially if the partner has an unknown or detectable viral load).\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A bacterial sexually transmitted infection (STI) (syphilis, gonorrhea, or chlamydia for men who have sex with men and transgender women; gonorrhea and syphilis for heterosexual women and men) in the past 6 months.\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A history of inconsistent or no condom use with sex partner(s) whose HIV status is not known; assessing risk in conversation with the patient and considering factors such as number of partners, the specific sexual activities a person engages in, and whether their sex partner or partners are in a group with a higher prevalence of HIV (eg, men who have sex with men or with men and women, transgender women, persons who inject drugs, and persons who engage in transactional sex).\r\n&nbsp;\r\n2. &nbsp; Persons who inject drugs and have a drug-injecting partner who has HIV or who shares injection equipment.\r\nPersons who engage in transactional sex, such as sex for money, drugs, or housing, including commercial sex workers or persons trafficked for sex work, constitute a group at increased risk of HIV acquisition and should be considered for PrEP based on the criteria outlined above. Persons who request PrEP may have undisclosed behaviors that put them at risk. Transgender women and men who are sexually active should be considered for PrEP based on the criteria outlined above. Transgender women are at especially high risk of HIV acquisition. A Centers for Disease Control and and Prevention (CDC) survey in 7 cities found an HIV prevalence of 42% among transgender women. Prevalence was highest among Black transgender women (62%) and Native American/Alaska Native transgender women (65%).\r\nIn addition, studies have found that transmission of HIV to a seronegative partner from a partner with HIV has not been observed when the partner with HIV was being treated with antiretroviral therapy and had a suppressed viral load.&nbsp;It is not known whether PrEP use further decreases the risk of HIV transmission when a partner with HIV has a documented undetectable viral load. Factors such as the consistency or inconsistency of a partner&rsquo;s viral load being suppressed, a partner&rsquo;s adherence to antiretroviral therapy, and the degree of certainty that a partner&rsquo;s viral load is suppressed (eg, self-report vs availability of laboratory test results) may help inform decisions about the use of PrEP in this situation.\r\nAll persons being considered for PrEP must have a recently documented negative HIV antigen-antibody test result, and if they have taken oral PrEP or postexposure prophylaxis in the past 3 months, or injectable cabotegravir in the past 12 months, the CDC recommends testing with both an HIV antigen-antibody assay and an HIV-1 RNA assay.'}, {'id': 1989, 'title': 'Syphilis Infection in Nonpregnant Adolescents and Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for syphilis infection in persons who are at increased risk for infection.', 'servfreq': 'Optimal screening frequency for persons who are at increased risk for syphilis infection is not well established. Men who have sex with men or persons with HIV infection may benefit from screening at least annually or more frequently (eg, every 3 to 6 months) if they continue to be at high risk.', 'risktext': 'The USPSTF recommends screening for syphilis in persons who are at increased risk for infection. When deciding which persons to screen for syphilis, clinicians should consider the prevalence of infection in the communities they serve, as well as other sociodemographic and behavioral factors that may be associated with increased risk of syphilis infection. For example, prevalence of syphilis is higher in men, men who have sex with men, persons with HIV infection, young adults, and persons with a history of incarceration, sex work, or military service. A substantial percentage of heterosexual syphilis transmission occurs among persons who use illicit drugs, particularly methamphetamine. Diagnosis of another STI may signal that a person is having condomless sex, which increases their risk of syphilis infection. Higher infection rates in persons of some racial and ethnic groups have been reported and are primarily a reflection of a combination of factors, including social determinants of health (eg, disparities of income, low educational achievement, and unstable housing), differential health insurance coverage or access to quality health care, and differences in sexual network characteristics (eg, individuals living in communities with a high prevalence of STIs have an increased chance of encountering an infected partner). Local prevalence rates may change over time, so clinicians should be aware of the latest data and trends for their specific population and geographic area, which are available through their state and local health departments and Centers for Disease Control and Prevention (CDC) surveillance.\r\n&nbsp;\r\nAlthough direct evidence on screening in nonpregnant persons who are not at increased risk for syphilis infection is lacking, based on the established test performance characteristics of current screening tests and the low prevalence rate of syphilis in this population, the yield of screening is likely low.9,10 Therefore, screening in this population may result in high false-positive rates and overtreatment.'}, {'id': 1905, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and US Food and Drug Administration (FDA)--approved pharmacotherapy for cessation to nonpregnant adults who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 1906, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all pregnant persons about tobacco use, advise them to stop using tobacco, and provide behavioral interventions for cessation to pregnant persons who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 2014, 'title': 'Anxiety Disorders in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for anxiety disorders in adults, including pregnant and postpartum persons.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding optimal timing for screening, or screening interval, for both the perinatal and general adult populations; more evidence on both timing and screening interval is needed for all adult populations. A pragmatic approach in the absence of evidence might include screening all adults who have not been screened previously and using clinical judgment in considering risk factors, comorbid conditions, and life events to determine if additional screening of high-risk patients is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nRisk factors for anxiety disorders include sociodemographic factors, psychosocial factors, and physical and mental health factors such as marital status (widowed or divorced), stressful life events, smoking and alcohol use, other mental health conditions, or a parental history of mental disorders. Demographic factors such as low socioeconomic status and female sex are associated with higher rates of anxiety disorders.&nbsp;Black persons and individuals of non-Hispanic ethnicity are at increased risk of anxiety disorders due to social, rather than biological, factors. Anxiety and depressive disorders often overlap. One cohort study found that 67% of individuals with a depressive disorder also had a current anxiety disorder, and 75% had a lifetime comorbid anxiety disorder.'}, {'id': 2009, 'title': 'Latent Tuberculosis Infection in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for LTBI in populations at increased risk.\r\rSee the "Assessment of Risk" section for additional information on adults at increased risk.', 'servfreq': 'The USPSTF found no evidence on the optimal frequency of screening for LTBI. In the absence of evidence, a reasonable approach is to repeat screening based on specific risk factors; screening frequency could range from 1-time only screening among persons at low risk for future tuberculosis exposure to annual screening among those at continued risk of exposure.', 'risktext': 'Populations at increased risk for LTBI, based on increased prevalence of active disease and increased risk of exposure, include persons who were born in, or are former residents of, countries with high tuberculosis prevalence and persons who live in, or have lived in, high-risk congregate settings (eg, homeless shelters or correctional facilities). Clinicians can consult their local or state health departments for more information about populations at increased risk in their community, since local demographic patterns may vary across the US.\r\nIn 2020, 71.5% of all cases of active tuberculosis in the US occurred among persons born outside the US. According to the CDC, tuberculosis disease is common in most countries in Latin America, the Caribbean, Africa, Asia, Eastern Europe, and Russia. In 2020, among persons with new tuberculosis living in the US who were born outside the US, the most common countries of birth were Mexico (18.0%), the Philippines (12.5%), India (10.4%), Vietnam (8.2%), and China (5.1%), accounting for 54.2% of total cases. Most of these cases are believed to be due to progression of latent infection to active tuberculosis disease rather than new transmission within communities.\r\nPersons who live, or have lived, in high-risk congregate settings also have a higher prevalence rate of active tuberculosis and an increased risk for exposure. In 2020, 4.3% of tuberculosis disease cases diagnosed in persons 15 years or older occurred in persons experiencing homelessness and 2.6% occurred in residents of correctional facilities. It is estimated that persons experiencing homelessness have an 11 times higher incidence of tuberculosis disease compared with persons who are not experiencing homelessness (36 cases per 100,000 population vs 2.9 cases per 100,000 population, respectively, during 2011 to 2016).\r\nOther populations at increased risk for LTBI or progression to active disease include persons who have immunosuppression (eg, persons living with HIV, patients receiving immunosuppressive medications such as chemotherapy or tumor necrosis factor inhibitors, and patients who have received an organ transplant) and patients with silicosis (a lung disease). However, given that screening in these populations may be considered standard care as part of disease management or indicated prior to the use of certain medications, the USPSTF did not review evidence on screening in these populations. Information on testing in these populations is provided by other groups, such as the Office of AIDS Research at the National Institutes of Health, and in a guideline issued jointly by the American Thoracic Society, Infectious Diseases Society of America, and CDC. Some evidence from observational studies has explored the association between poorly controlled diabetes and progression of LTBI to active disease. However, there is insufficient evidence on screening for and treatment of LTBI in persons with diabetes for the USPSTF to make a separate recommendation for this important population.\r\nPersons who are contacts of individuals with active tuberculosis, health care workers, and workers in high-risk congregate settings may also be at increased risk of exposure. Because screening in these populations is conducted as part of public health or employee health surveillance, the USPSTF did not review the evidence in these populations. Clinicians seeking further information about testing for tuberculosis in these populations can refer to the Additional Tools and Resources and Recommendations of Others sections.'}, {'id': 514, 'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic bacteriuria in nonpregnant adults.', 'servfreq': '', 'risktext': 'The risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6 Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5 Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7, 11, 12 In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12 Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4, 6'}, {'id': 1909, 'title': 'Asymptomatic Carotid Artery Stenosis: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic carotid artery stenosis in the general adult population.\r\rSee the Practice Considerations section for a description of adults at increased risk.', 'servfreq': '', 'risktext': ''}, {'id': 2017, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for suicide risk in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': '', 'risktext': ''}, {'id': 2016, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for depression in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding the optimal timing for screening for depression; more evidence is needed in both perinatal and general adult populations. In the absence of evidence, a pragmatic approach might include screening adults who have not been screened previously and using clinical judgment while considering risk factors, comorbid conditions, and life events to determine if additional screening of patients at increased risk is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nThe USPSTF recommends screening for depression in all adults regardless of risk factors. Risk factors for depression include a combination of genetic, biological, and environmental factors, such as a family history of depression, prior episode of depression or other mental health condition, a history of trauma or adverse life events, or a history of disease or illness (eg, cardiovascular disease).\r\nPrevalence rates vary by sex, age, race, ethnicity, education, marital status, geographic location, poverty level, and employment status. Women have twice the risk of depression compared with men. Young adults, multiracial individuals, and Native American/Alaska Native individuals have higher rates of depression.\r\nRisk factors for perinatal depression include life stress, low social support, history of depression, marital or partner dissatisfaction, and a history of abuse.'}, {'id': 1845, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends offering or referring adults with cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity.', 'servfreq': '', 'risktext': 'Adults 18 years or older at increased risk of CVD, defined as those with 1 or more of the following:\r\n1.Hypertension or elevated blood pressure2.Dyslipidemia3.Mixed or multiple risk factors such as the metabolic syndrome or an estimated 10-year CVD risk of &ge;7.5%\r\nThis recommendation does not apply to adults with other known modifiable cardiovascular risk factors such as abnormal blood glucose levels, obesity, and smoking; these populations are incorporated in other USPSTF recommendations.'}, {'id': 1885, 'title': 'Hepatitis B Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in adolescents and adults at increased risk for infection.\r\rSee the Practice Considerations section for a description of adolescents and adults at increased risk for infection.', 'servfreq': 'For patients with negative HBsAg results who have not received the HBV vaccine series, periodic screening may be useful for those who report continued risk for acquiring HBV transmission, such as persons who continue to inject drugs and men who have sex with men. Clinical judgment should be used to determine screening frequency. The USPSTF found no evidence to determine optimal screening intervals.', 'risktext': 'Persons from such risk groups include persons who have injected drugs in the past or currently; men who have sex with men; persons with HIV; and sex partners, needle-sharing contacts, and household contacts of persons known to be HBsAg positive. Some persons with combinations of risk factors who are not members of risk factor groups listed above may also be at increased risk for HBV infection.'}, {'id': 524, 'title': 'Hepatitis C Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis C virus (HCV) infection in adults aged 18 to 79 years.', 'servfreq': 'One-time screening for most adults.\r\nPeriodically screen persons with continued risk for HCV infection (eg, persons with past or current injection drug use). There is limited evidence to determine how often to screen persons at increased risk.&nbsp;', 'risktext': 'Asymptomatic adults aged 18 to 79 years (including pregnant persons) without known liver disease.&nbsp;\r\nThe USPSTF also suggests that clinicians consider screening persons younger than 18 years and older than 79 years who are at high risk for infection (eg, those with past or current injection drug use).&nbsp;'}, {'id': 1916, 'title': 'Lung Cancer: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery.', 'servfreq': ' \r\nThe USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. ', 'risktext': ' \r\nSmoking and older age are the 2 most important risk factors for lung cancer.&nbsp;The risk of lung cancer in persons who smoke increases with cumulative quantity and duration of smoking and with age but decreases with increasing time since quitting for persons who formerly smoked.3 The USPSTF considers adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years to be at high risk and recommends screening for lung cancer with annual LDCT in this population. \r\n \r\n&nbsp;\r\n \r\nAfrican American/Black (Black) men have a higher incidence of lung cancer than White men, and Black women have a lower incidence than White women.1 These differences are likely related to differences in smoking exposure (ie, prevalence of smoking) and related exposure to carcinogens in cigarettes.7,8 The differences may also be related to other social risk factors.\r\n \r\n&nbsp;\r\n \r\nOther risk factors for lung cancer include environmental exposures, prior radiation therapy, other (noncancer) lung diseases, and family history. Lower level of education is also associated with a higher risk of lung cancer.7 The task force recommends using age and smoking history to determine screening eligibility rather than more elaborate risk prediction models because there is insufficient evidence to assess whether risk prediction model&ndash;based screening would improve outcomes relative to using the risk factors of age and smoking history for broad implementation in primary care.\r\n '}, {'id': 1445, 'title': 'Sexually Transmitted Infections: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends behavioral counseling for all sexually active adolescents and for adults who are at increased risk for sexually transmitted infections (STIs).\r\rSee the Practice Considerations section for more information on populations at increased risk for acquiring STIs.', 'servfreq': '', 'risktext': 'All sexually active adolescents are at increased risk for STIs because of the high rates of STIs in this age group and should receive behavioral counseling interventions. Adults at increased risk for STIs include those who currently have an STI or were diagnosed with one within the past year, do not consistently use condoms, have multiple sex partners, or have sex partners within populations with a high prevalence of STIs. Populations with a high prevalence of STIs include persons who seek STI testing or attend STI clinics; sexual and gender minorities; persons who are living with HIV, inject drugs, have exchanged sex for money or drugs, or have entered correctional facilities; and some racial/ethnic minority groups.1-4'}, {'id': 402, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends counseling young adults, adolescents, children, and parents of young children about minimizing exposure to ultraviolet (UV) radiation for persons aged 6 months to 24 years with fair skin types to reduce their risk of skin cancer.', 'servfreq': '', 'risktext': 'Fair skin types'}, {'id': 438, 'title': 'Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for unhealthy alcohol use in primary care settings in adults 18 years or older, including pregnant women, and providing persons engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce unhealthy alcohol use.', 'servfreq': 'The USPSTF did not find adequate evidence to recommend an optimal screening interval for unhealthy alcohol use in adults.&nbsp;Brief behavioral counseling interventions were found to reduce unhealthy alcohol use in adults 18 years or older, including pregnant women. Effective behavioral counseling interventions vary in their specific components, administration, length, and number of interactions. The USPSTF was unable to identify specific intervention characteristics or components that were clearly associated with improved outcomes.', 'risktext': 'engaged in risky or hazardous drinking'}, {'id': 767, 'title': 'Unhealthy Drug Use: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening by asking questions about unhealthy drug use in adults age 18 years or older. Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. \r(Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'servfreq': 'Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. (Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'risktext': 'These include being aged 18 to 25 years; male sex; having a mental health condition, personality or mood disorder, or nicotine or alcohol dependence; a history of physical or sexual abuse, parental neglect, or other adversity in childhood; or drug or alcohol addiction in a first-degree relative.1,9&nbsp;Factors associated with misuse of prescription drugs include history of other drug use, mental illness, pain, and greater access to prescription drugs.10&nbsp;Factors associated with prenatal use of drugs include a mental health disorder, interpersonal violence, and family history of substance use.11'}, {'id': 433, 'title': 'Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer or refer adults with a body mass index (BMI) of 30 or higher (calculated as weight in kilograms divided by height in meters squared) to intensive, multicomponent behavioral interventions.', 'servfreq': '', 'risktext': 'Adults with a BMI &ge;30'}, {'id': 1979, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: Behavioral Counseling Interventions ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians individualize the decision to offer or refer adults without cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity. \r\rSee the "Practice Considerations" section for information on determining which patients may benefit most from this service.', 'servfreq': '', 'risktext': ''}, {'id': 1937, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for chlamydia and gonorrhea in men.', 'servfreq': '', 'risktext': ''}, {'id': 418, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening with resting or exercise electrocardiography (ECG) to prevent cardiovascular disease (CVD) events in asymptomatic adults at low risk of CVD events.', 'servfreq': '', 'risktext': ''}, {'id': 1973, 'title': 'Chronic Obstructive Pulmonary Disease: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for chronic obstructive pulmonary disease in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 2003, 'title': 'Genital Herpes Infection: Serologic Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine serologic screening for genital herpes simplex virus infection in asymptomatic adolescents and adults, including pregnant persons.', 'servfreq': '', 'risktext': 'The USPSTF found no evidence of externally validated, reliable risk stratification tools to identify individuals more or less likely to have genital herpes.'}, {'id': 504, 'title': 'Pancreatic Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for pancreatic cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 203, 'title': 'Testicular Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for testicular cancer in adolescent or adult men.', 'servfreq': '', 'risktext': ''}, {'id': 365, 'title': 'Thyroid Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for thyroid cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 1976, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'D', 'text': 'The DoctorAI recommends against the use of beta carotene or vitamin E supplements for the prevention of cardiovascular disease or cancer.', 'servfreq': '', 'risktext': ''}, {'id': 318, 'title': 'Autism Spectrum Disorder in Young Children: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for autism spectrum disorder (ASD) in young children for whom no concerns of ASD have been raised by their parents or a clinician.', 'servfreq': '', 'risktext': 'Although a number of potential risk factors for ASD have been identified, there is insufficient evidence to determine if certain risk factors modify the performance characteristics of ASD screening tests, such as the age at which screening is performed or other characteristics of the child or family.'}, {'id': 65, 'title': 'Bladder Cancer in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults.\r\rLiterature scans conducted in July 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'This evidence update focused on the benefits and harms of screening for bladder cancer among people without symptoms, the accuracy of screening tests done in primary care settings, and the benefits and harms of treatment. The updated evidence review did not find any new high quality evidence to adequately determine the balance of benefits and harms of screening for bladder cancer. However, bladder cancer is a common cancer and can cause considerable health problems including death. Therefore, the USPSTF determined that the evidence was insufficient to provide a recommendation for or against bladder cancer screening.  The USPSTF emphasizes the need for additional research in this area. '}, {'id': 419, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening with resting or exercise ECG to prevent CVD events in asymptomatic adults at intermediate or high risk of CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 423, 'title': 'Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of adding the ankle-brachial index (ABI), high-sensitivity C-reactive protein (hsCRP) level, or coronary artery calcium (CAC) score to traditional risk assessment for cardiovascular disease (CVD) in asymptomatic adults to prevent CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 352, 'title': 'Celiac Disease: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'persons with family history or other risk factors'}, {'id': 1955, 'title': 'Eating Disorders in Adolescents and Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for eating disorders in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 665, 'title': 'Illicit Drug Use in Children, Adolescents, and Young Adults: Primary Care-Based Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--based behavioral counseling interventions to prevent illicit drug use, including nonmedical use of prescription drugs, in children, adolescents, and young adults.\r\rSee the Practice Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 435, 'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for abuse and neglect in all older or vulnerable adults. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': 'Risk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health.14&nbsp;For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.15'}, {'id': 2045, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for iron deficiency and iron deficiency anemia in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2046, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine iron supplementation in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2018, 'title': 'Lipid Disorders in Children and Adolescents: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1998, 'title': 'Obstructive Sleep Apnea in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for obstructive sleep apnea in the general adult population.\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Risk Factors\r\nRisk factors associated with OSA include male sex, older age (40-70 years), postmenopausal status, higher body mass index (BMI), and craniofacial and upper airway abnormalities (eg, enlarged tonsils or long upper airway). Black, Hispanic/Latino, and Native American/Alaska Native persons have a higher prevalence of OSA compared with White persons; some evidence suggests that these differences are partially explained by higher rates of obesity, asthma, and tobacco use among these groups.8'}, {'id': 1977, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of multivitamin supplements for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1978, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of single or paired nutrient supplements (other than beta carotene and vitamin E) for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 176, 'title': 'Oral Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for oral cancer in asymptomatic adults.\r\rGo to the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in July 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Tobacco and alcohol use are major risk factors for oral cancer. A total of 20% to 30% of cases of oral cancer worldwide are attributable to cigarette smoking. In the United States, up to 75% of cases of oral cancer may be attributable to tobacco and alcohol use. Additional risk factors include male sex, older age, use of betel quid, ultraviolet light exposure, infection with Candida or bacterial flora, and a compromised immune system. Sexually transmitted oral HPV infection (HPV-16) has recently been recognized as an increasingly important risk factor for oropharyngeal cancer. In the United States, the prevalence of oropharyngeal cancer due to oral HPV infection is probably as high as 80% to 95%. The prevalence of oral HPV infection is associated with age, sex, number of sexual partners, and number of cigarettes smoked per day. The effect of multifactorial risk assessment and screening for risk factors on oral cancer morbidity and mortality is unknown.'}, {'id': 2026, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine screening performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 2027, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of preventive interventions performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 424, 'title': 'Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for peripheral artery disease (PAD) and cardiovascular disease (CVD) risk with the ankle-brachial index (ABI) in asymptomatic adults.\r\rLiterature scans conducted in August 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Risk factors associated with OSA include male sex, older age (40 to 70 years), postmenopausal status, higher BMI, and craniofacial and upper airway abnormalities.'}, {'id': 404, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of counseling adults about skin self-examination to prevent skin cancer.See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 2005, 'title': 'Skin Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Exposure to UV radiation from sun exposure, indoor tanning beds, and other UV radiation&ndash;emitting devices is the major environmental risk factor for skin cancer. History of frequent sunburns, older age, and male sex are associated with increased risk for skin cancer. Exposure to UV radiation from the use of indoor tanning beds is an important risk factor in adolescents. Incidence of melanoma is higher among White persons compared with persons of other races and ethnicities. This difference likely reflects traits associated with increased melanoma risk, such as fair skin (which is more susceptible to sunburning), light-colored eyes, and red or blond hair being more common among White persons compared with persons of other races and ethnicities. Acral lentiginous melanoma, which occurs mostly on skin not frequently exposed to direct sunlight (eg, palms of hands, soles of feet, or under fingernails or toenails), is the most common type of melanoma among Black populations. Other melanoma risk factors include higher numbers of moles on the skin, atypical moles, as well as a personal and family history of skin cancer.'}, {'id': 269, 'title': 'Thyroid Dysfunction: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults.\r\rSee the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': 'The optimal screening interval for thyroid dysfunction (if one exists) is unknown.', 'risktext': 'The most common cause of hypothyroidism in the United States is chronic autoimmune (Hashimoto) thyroiditis. Risk factors for an elevated TSH level include female sex, advancing age, white race, type 1 diabetes, Down syndrome, family history of thyroid disease, goiter, previous hyperthyroidism (possibly due in part to ablation therapy leading to iatrogenic thyroid dysfunction), and external-beam radiation in the head and neck area. Common causes of hyperthyroidism include Graves disease, Hashimoto thyroiditis, and functional thyroid nodules. Risk factors for a low TSH level include female sex; advancing age; black race; low iodine intake; personal or family history of thyroid disease; and ingestion of iodine-containing drugs, such as amiodarone. The USPSTF found no direct evidence that treatment of thyroid dysfunction based on risk level alters final health outcomes.'}, {'id': 1908, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of electronic cigarettes (e-cigarettes) for tobacco cessation in adults, including pregnant persons. The USPSTF recommends that clinicians direct patients who use tobacco to other tobacco cessation interventions with proven effectiveness and established safety.\rSee the Practice Considerations section for more information on recommended behavioral interventions and pharmacotherapy and for suggestions for practice regarding the I statements.', 'servfreq': '', 'risktext': ''}, {'id': 1907, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of pharmacotherapy interventions for tobacco cessation in pregnant persons.', 'servfreq': '', 'risktext': ''}, {'id': 586, 'title': 'Tobacco Use in Children and Adolescents: Primary Care Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--feasible interventions for the cessation of tobacco use among school-aged children and adolescents.\r\rSee the Practice Considerations section for more information on effective interventions to prevent initiation of tobacco use and for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1919, 'title': 'Vitamin D Deficiency in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 408, 'title': 'Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of the benefits and harms of vitamin D and calcium supplementation, alone or combined, for the primary prevention of fractures in men and premenopausal women.', 'servfreq': '', 'risktext': ''}], 'tools': [{'tool_id': 321, 'url': 'https://jamanetwork.com/journals/jama/fullarticle/2735342', 'title': 'JAMA Patient Page: Who Should Be Screened for HIV Infection? ', 'text': '', 'keywords': ''}, {'tool_id': 322, 'url': 'https://sites.jamanetwork.com/spanish-patient-pages/2019/hoja-para-el-paciente-de-jama-190618.pdf', 'title': 'ยฟQuiรฉnes deben someterse a una prueba de detecciรณn de infecciรณn por VIH?', 'text': '', 'keywords': 'HIV|Human immunodeficiency syndrome|AIDS'}, {'tool_id': 210, 'url': 'https://www.aafp.org/afp/2019/1115/p637.html', 'title': "Screening for HIV Infection and Preexposure Prophylaxis for the Prevention of HIV Infection: AFP's Putting Into Practice", 'text': 'The journal American Family Physician (AFP) provides a series of short case studies and quizzes based on recommendations issued by the U.S. Preventive Services Task Force.', 'keywords': ''}]}
2025-01-29 21:51:08 [INFO] Recommendations: [{'id': 485, 'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in adolescents and adults aged 15 to 65 years. Younger adolescents and older adults who are at increased risk of infection should also be screened.\rSee the Clinical Considerations section for more information about assessment of risk, screening intervals, and rescreening in pregnancy.', 'servfreq': 'The USPSTF found insufficient evidence to determine appropriate or optimal time intervals or strategies for repeat HIV screening. However, repeat screening is reasonable for persons known to be at increased risk of HIV infection, such as sexually active men who have sex with men; persons with a sex partner who is living with HIV; or persons who engage in behaviors that may convey an increased risk of HIV infection, such as injection drug use, transactional sex or commercial sex work, having 1 or more new sex partners whose HIV status is unknown, or having other factors that can place a person at increased risk of HIV infection (see &ldquo;Risk Assessment&rdquo;). Repeat screening is also reasonable for persons who live or receive medical care in a high-prevalence setting, such as a sexually transmitted disease clinic, tuberculosis clinic, correctional facility, or homeless shelter.', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'id': 1921, 'title': 'Hypertension in Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hypertension in adults 18 years or older with office blood pressure measurement (OBPM). The USPSTF recommends obtaining blood pressure measurements outside of the clinical setting for diagnostic confirmation before starting treatment.', 'servfreq': ' \r\nAlthough evidence on optimal screening intervals is limited, reasonable options include:\r\n \r\n \r\n\r\n\r\nScreening for hypertension every year in adults 40 years or older and in adults at increased risk for hypertension (such as Black persons, persons with high-normal blood pressure, or persons who are overweight or obese)\r\n\r\n\r\n \r\n \r\n\r\n\r\nScreening less frequently (ie, every 3 to 5 years) as appropriate for adults aged 18 to 39 years not at increased risk for hypertension and with a prior normal blood pressure reading.\r\n\r\n\r\n ', 'risktext': ' \r\nAlthough all adults should be screened for hypertension, risk factors that increase a person&rsquo;s risk for the condition include older age, Black race, family history, excess weight and obesity, lifestyle habits (lack of physical activity, stress, and tobacco use), and dietary factors (diet high in fat or sodium, diet low in potassium, or excessive alcohol intake)\r\n '}, {'id': 2021, 'title': 'Prevention of Acquisition of HIV: Preexposure Prophylaxis ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians prescribe preexposure prophylaxis using effective antiretroviral therapy to persons who are at increased risk of HIV acquisition to decrease the risk of acquiring HIV. \r\rSee the Practice Considerations section for more information about identification of persons at increased risk and about effective antiretroviral therapy.', 'servfreq': '', 'risktext': 'HIV is primarily acquired via sexual activity or injection drug use. It is important that clinicians routinely take a sexual and injection drug use history for all their patients in an open and nonjudgmental manner. All adolescents and adults who are sexually active or who inject drugs should be informed that acquisition of HIV can be prevented, to facilitate subsequent risk assessment and discussions about preexposure prophylaxis (PrEP) and other ways to prevent acquisition of HIV. Importantly, risk of HIV acquisition exists on a continuum, and currently available risk assessment tools all have limitations. However, certain risk factors or behaviors are known to place persons at increased risk of HIV.\r\nRisk of HIV acquisition depends on the likelihood that a specific act or activity will transmit HIV and the likelihood that a sex partner or drug injection partner has HIV. Likelihood of HIV transmission is highest with needle-sharing injection drug use and condomless receptive anal intercourse. Condomless receptive anal intercourse has an approximately 10- to 15-fold higher risk of transmission than condomless insertive anal sex and condomless receptive and insertive penile-vaginal sex. A 2018 study estimated the prevalence of HIV (ie, an estimate of the likelihood that a partner whose HIV status is unknown has HIV at a population level) as 12.4% among men who have sex with men and 1.9% among persons who inject drugs. The overall prevalence of HIV in the US is estimated at 0.3%.&nbsp;Of note, both the frequency of specific sexual activities and a person&rsquo;s number of sexual partners will also affect their risk of HIV.\r\n&nbsp;The USPSTF recommends that the following persons be considered for PrEP:\r\n1.&nbsp;&nbsp;&nbsp;&nbsp; Sexually active adults and adolescents weighing at least 35 kg (77 lb) who have engaged in anal or vaginal sex in the past 6 months and have any of the following:\r\n&nbsp;\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A sexual partner who has HIV (especially if the partner has an unknown or detectable viral load).\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A bacterial sexually transmitted infection (STI) (syphilis, gonorrhea, or chlamydia for men who have sex with men and transgender women; gonorrhea and syphilis for heterosexual women and men) in the past 6 months.\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A history of inconsistent or no condom use with sex partner(s) whose HIV status is not known; assessing risk in conversation with the patient and considering factors such as number of partners, the specific sexual activities a person engages in, and whether their sex partner or partners are in a group with a higher prevalence of HIV (eg, men who have sex with men or with men and women, transgender women, persons who inject drugs, and persons who engage in transactional sex).\r\n&nbsp;\r\n2. &nbsp; Persons who inject drugs and have a drug-injecting partner who has HIV or who shares injection equipment.\r\nPersons who engage in transactional sex, such as sex for money, drugs, or housing, including commercial sex workers or persons trafficked for sex work, constitute a group at increased risk of HIV acquisition and should be considered for PrEP based on the criteria outlined above. Persons who request PrEP may have undisclosed behaviors that put them at risk. Transgender women and men who are sexually active should be considered for PrEP based on the criteria outlined above. Transgender women are at especially high risk of HIV acquisition. A Centers for Disease Control and and Prevention (CDC) survey in 7 cities found an HIV prevalence of 42% among transgender women. Prevalence was highest among Black transgender women (62%) and Native American/Alaska Native transgender women (65%).\r\nIn addition, studies have found that transmission of HIV to a seronegative partner from a partner with HIV has not been observed when the partner with HIV was being treated with antiretroviral therapy and had a suppressed viral load.&nbsp;It is not known whether PrEP use further decreases the risk of HIV transmission when a partner with HIV has a documented undetectable viral load. Factors such as the consistency or inconsistency of a partner&rsquo;s viral load being suppressed, a partner&rsquo;s adherence to antiretroviral therapy, and the degree of certainty that a partner&rsquo;s viral load is suppressed (eg, self-report vs availability of laboratory test results) may help inform decisions about the use of PrEP in this situation.\r\nAll persons being considered for PrEP must have a recently documented negative HIV antigen-antibody test result, and if they have taken oral PrEP or postexposure prophylaxis in the past 3 months, or injectable cabotegravir in the past 12 months, the CDC recommends testing with both an HIV antigen-antibody assay and an HIV-1 RNA assay.'}, {'id': 1989, 'title': 'Syphilis Infection in Nonpregnant Adolescents and Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for syphilis infection in persons who are at increased risk for infection.', 'servfreq': 'Optimal screening frequency for persons who are at increased risk for syphilis infection is not well established. Men who have sex with men or persons with HIV infection may benefit from screening at least annually or more frequently (eg, every 3 to 6 months) if they continue to be at high risk.', 'risktext': 'The USPSTF recommends screening for syphilis in persons who are at increased risk for infection. When deciding which persons to screen for syphilis, clinicians should consider the prevalence of infection in the communities they serve, as well as other sociodemographic and behavioral factors that may be associated with increased risk of syphilis infection. For example, prevalence of syphilis is higher in men, men who have sex with men, persons with HIV infection, young adults, and persons with a history of incarceration, sex work, or military service. A substantial percentage of heterosexual syphilis transmission occurs among persons who use illicit drugs, particularly methamphetamine. Diagnosis of another STI may signal that a person is having condomless sex, which increases their risk of syphilis infection. Higher infection rates in persons of some racial and ethnic groups have been reported and are primarily a reflection of a combination of factors, including social determinants of health (eg, disparities of income, low educational achievement, and unstable housing), differential health insurance coverage or access to quality health care, and differences in sexual network characteristics (eg, individuals living in communities with a high prevalence of STIs have an increased chance of encountering an infected partner). Local prevalence rates may change over time, so clinicians should be aware of the latest data and trends for their specific population and geographic area, which are available through their state and local health departments and Centers for Disease Control and Prevention (CDC) surveillance.\r\n&nbsp;\r\nAlthough direct evidence on screening in nonpregnant persons who are not at increased risk for syphilis infection is lacking, based on the established test performance characteristics of current screening tests and the low prevalence rate of syphilis in this population, the yield of screening is likely low.9,10 Therefore, screening in this population may result in high false-positive rates and overtreatment.'}, {'id': 1905, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and US Food and Drug Administration (FDA)--approved pharmacotherapy for cessation to nonpregnant adults who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 1906, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all pregnant persons about tobacco use, advise them to stop using tobacco, and provide behavioral interventions for cessation to pregnant persons who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 2014, 'title': 'Anxiety Disorders in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for anxiety disorders in adults, including pregnant and postpartum persons.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding optimal timing for screening, or screening interval, for both the perinatal and general adult populations; more evidence on both timing and screening interval is needed for all adult populations. A pragmatic approach in the absence of evidence might include screening all adults who have not been screened previously and using clinical judgment in considering risk factors, comorbid conditions, and life events to determine if additional screening of high-risk patients is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nRisk factors for anxiety disorders include sociodemographic factors, psychosocial factors, and physical and mental health factors such as marital status (widowed or divorced), stressful life events, smoking and alcohol use, other mental health conditions, or a parental history of mental disorders. Demographic factors such as low socioeconomic status and female sex are associated with higher rates of anxiety disorders.&nbsp;Black persons and individuals of non-Hispanic ethnicity are at increased risk of anxiety disorders due to social, rather than biological, factors. Anxiety and depressive disorders often overlap. One cohort study found that 67% of individuals with a depressive disorder also had a current anxiety disorder, and 75% had a lifetime comorbid anxiety disorder.'}, {'id': 2009, 'title': 'Latent Tuberculosis Infection in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for LTBI in populations at increased risk.\r\rSee the "Assessment of Risk" section for additional information on adults at increased risk.', 'servfreq': 'The USPSTF found no evidence on the optimal frequency of screening for LTBI. In the absence of evidence, a reasonable approach is to repeat screening based on specific risk factors; screening frequency could range from 1-time only screening among persons at low risk for future tuberculosis exposure to annual screening among those at continued risk of exposure.', 'risktext': 'Populations at increased risk for LTBI, based on increased prevalence of active disease and increased risk of exposure, include persons who were born in, or are former residents of, countries with high tuberculosis prevalence and persons who live in, or have lived in, high-risk congregate settings (eg, homeless shelters or correctional facilities). Clinicians can consult their local or state health departments for more information about populations at increased risk in their community, since local demographic patterns may vary across the US.\r\nIn 2020, 71.5% of all cases of active tuberculosis in the US occurred among persons born outside the US. According to the CDC, tuberculosis disease is common in most countries in Latin America, the Caribbean, Africa, Asia, Eastern Europe, and Russia. In 2020, among persons with new tuberculosis living in the US who were born outside the US, the most common countries of birth were Mexico (18.0%), the Philippines (12.5%), India (10.4%), Vietnam (8.2%), and China (5.1%), accounting for 54.2% of total cases. Most of these cases are believed to be due to progression of latent infection to active tuberculosis disease rather than new transmission within communities.\r\nPersons who live, or have lived, in high-risk congregate settings also have a higher prevalence rate of active tuberculosis and an increased risk for exposure. In 2020, 4.3% of tuberculosis disease cases diagnosed in persons 15 years or older occurred in persons experiencing homelessness and 2.6% occurred in residents of correctional facilities. It is estimated that persons experiencing homelessness have an 11 times higher incidence of tuberculosis disease compared with persons who are not experiencing homelessness (36 cases per 100,000 population vs 2.9 cases per 100,000 population, respectively, during 2011 to 2016).\r\nOther populations at increased risk for LTBI or progression to active disease include persons who have immunosuppression (eg, persons living with HIV, patients receiving immunosuppressive medications such as chemotherapy or tumor necrosis factor inhibitors, and patients who have received an organ transplant) and patients with silicosis (a lung disease). However, given that screening in these populations may be considered standard care as part of disease management or indicated prior to the use of certain medications, the USPSTF did not review evidence on screening in these populations. Information on testing in these populations is provided by other groups, such as the Office of AIDS Research at the National Institutes of Health, and in a guideline issued jointly by the American Thoracic Society, Infectious Diseases Society of America, and CDC. Some evidence from observational studies has explored the association between poorly controlled diabetes and progression of LTBI to active disease. However, there is insufficient evidence on screening for and treatment of LTBI in persons with diabetes for the USPSTF to make a separate recommendation for this important population.\r\nPersons who are contacts of individuals with active tuberculosis, health care workers, and workers in high-risk congregate settings may also be at increased risk of exposure. Because screening in these populations is conducted as part of public health or employee health surveillance, the USPSTF did not review the evidence in these populations. Clinicians seeking further information about testing for tuberculosis in these populations can refer to the Additional Tools and Resources and Recommendations of Others sections.'}, {'id': 514, 'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic bacteriuria in nonpregnant adults.', 'servfreq': '', 'risktext': 'The risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6 Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5 Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7, 11, 12 In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12 Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4, 6'}, {'id': 1909, 'title': 'Asymptomatic Carotid Artery Stenosis: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic carotid artery stenosis in the general adult population.\r\rSee the Practice Considerations section for a description of adults at increased risk.', 'servfreq': '', 'risktext': ''}, {'id': 2017, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for suicide risk in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': '', 'risktext': ''}, {'id': 2016, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for depression in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding the optimal timing for screening for depression; more evidence is needed in both perinatal and general adult populations. In the absence of evidence, a pragmatic approach might include screening adults who have not been screened previously and using clinical judgment while considering risk factors, comorbid conditions, and life events to determine if additional screening of patients at increased risk is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nThe USPSTF recommends screening for depression in all adults regardless of risk factors. Risk factors for depression include a combination of genetic, biological, and environmental factors, such as a family history of depression, prior episode of depression or other mental health condition, a history of trauma or adverse life events, or a history of disease or illness (eg, cardiovascular disease).\r\nPrevalence rates vary by sex, age, race, ethnicity, education, marital status, geographic location, poverty level, and employment status. Women have twice the risk of depression compared with men. Young adults, multiracial individuals, and Native American/Alaska Native individuals have higher rates of depression.\r\nRisk factors for perinatal depression include life stress, low social support, history of depression, marital or partner dissatisfaction, and a history of abuse.'}, {'id': 1845, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends offering or referring adults with cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity.', 'servfreq': '', 'risktext': 'Adults 18 years or older at increased risk of CVD, defined as those with 1 or more of the following:\r\n1.Hypertension or elevated blood pressure2.Dyslipidemia3.Mixed or multiple risk factors such as the metabolic syndrome or an estimated 10-year CVD risk of &ge;7.5%\r\nThis recommendation does not apply to adults with other known modifiable cardiovascular risk factors such as abnormal blood glucose levels, obesity, and smoking; these populations are incorporated in other USPSTF recommendations.'}, {'id': 1885, 'title': 'Hepatitis B Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in adolescents and adults at increased risk for infection.\r\rSee the Practice Considerations section for a description of adolescents and adults at increased risk for infection.', 'servfreq': 'For patients with negative HBsAg results who have not received the HBV vaccine series, periodic screening may be useful for those who report continued risk for acquiring HBV transmission, such as persons who continue to inject drugs and men who have sex with men. Clinical judgment should be used to determine screening frequency. The USPSTF found no evidence to determine optimal screening intervals.', 'risktext': 'Persons from such risk groups include persons who have injected drugs in the past or currently; men who have sex with men; persons with HIV; and sex partners, needle-sharing contacts, and household contacts of persons known to be HBsAg positive. Some persons with combinations of risk factors who are not members of risk factor groups listed above may also be at increased risk for HBV infection.'}, {'id': 524, 'title': 'Hepatitis C Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis C virus (HCV) infection in adults aged 18 to 79 years.', 'servfreq': 'One-time screening for most adults.\r\nPeriodically screen persons with continued risk for HCV infection (eg, persons with past or current injection drug use). There is limited evidence to determine how often to screen persons at increased risk.&nbsp;', 'risktext': 'Asymptomatic adults aged 18 to 79 years (including pregnant persons) without known liver disease.&nbsp;\r\nThe USPSTF also suggests that clinicians consider screening persons younger than 18 years and older than 79 years who are at high risk for infection (eg, those with past or current injection drug use).&nbsp;'}, {'id': 1916, 'title': 'Lung Cancer: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery.', 'servfreq': ' \r\nThe USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. ', 'risktext': ' \r\nSmoking and older age are the 2 most important risk factors for lung cancer.&nbsp;The risk of lung cancer in persons who smoke increases with cumulative quantity and duration of smoking and with age but decreases with increasing time since quitting for persons who formerly smoked.3 The USPSTF considers adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years to be at high risk and recommends screening for lung cancer with annual LDCT in this population. \r\n \r\n&nbsp;\r\n \r\nAfrican American/Black (Black) men have a higher incidence of lung cancer than White men, and Black women have a lower incidence than White women.1 These differences are likely related to differences in smoking exposure (ie, prevalence of smoking) and related exposure to carcinogens in cigarettes.7,8 The differences may also be related to other social risk factors.\r\n \r\n&nbsp;\r\n \r\nOther risk factors for lung cancer include environmental exposures, prior radiation therapy, other (noncancer) lung diseases, and family history. Lower level of education is also associated with a higher risk of lung cancer.7 The task force recommends using age and smoking history to determine screening eligibility rather than more elaborate risk prediction models because there is insufficient evidence to assess whether risk prediction model&ndash;based screening would improve outcomes relative to using the risk factors of age and smoking history for broad implementation in primary care.\r\n '}, {'id': 1445, 'title': 'Sexually Transmitted Infections: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends behavioral counseling for all sexually active adolescents and for adults who are at increased risk for sexually transmitted infections (STIs).\r\rSee the Practice Considerations section for more information on populations at increased risk for acquiring STIs.', 'servfreq': '', 'risktext': 'All sexually active adolescents are at increased risk for STIs because of the high rates of STIs in this age group and should receive behavioral counseling interventions. Adults at increased risk for STIs include those who currently have an STI or were diagnosed with one within the past year, do not consistently use condoms, have multiple sex partners, or have sex partners within populations with a high prevalence of STIs. Populations with a high prevalence of STIs include persons who seek STI testing or attend STI clinics; sexual and gender minorities; persons who are living with HIV, inject drugs, have exchanged sex for money or drugs, or have entered correctional facilities; and some racial/ethnic minority groups.1-4'}, {'id': 402, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends counseling young adults, adolescents, children, and parents of young children about minimizing exposure to ultraviolet (UV) radiation for persons aged 6 months to 24 years with fair skin types to reduce their risk of skin cancer.', 'servfreq': '', 'risktext': 'Fair skin types'}, {'id': 438, 'title': 'Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for unhealthy alcohol use in primary care settings in adults 18 years or older, including pregnant women, and providing persons engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce unhealthy alcohol use.', 'servfreq': 'The USPSTF did not find adequate evidence to recommend an optimal screening interval for unhealthy alcohol use in adults.&nbsp;Brief behavioral counseling interventions were found to reduce unhealthy alcohol use in adults 18 years or older, including pregnant women. Effective behavioral counseling interventions vary in their specific components, administration, length, and number of interactions. The USPSTF was unable to identify specific intervention characteristics or components that were clearly associated with improved outcomes.', 'risktext': 'engaged in risky or hazardous drinking'}, {'id': 767, 'title': 'Unhealthy Drug Use: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening by asking questions about unhealthy drug use in adults age 18 years or older. Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. \r(Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'servfreq': 'Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. (Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'risktext': 'These include being aged 18 to 25 years; male sex; having a mental health condition, personality or mood disorder, or nicotine or alcohol dependence; a history of physical or sexual abuse, parental neglect, or other adversity in childhood; or drug or alcohol addiction in a first-degree relative.1,9&nbsp;Factors associated with misuse of prescription drugs include history of other drug use, mental illness, pain, and greater access to prescription drugs.10&nbsp;Factors associated with prenatal use of drugs include a mental health disorder, interpersonal violence, and family history of substance use.11'}, {'id': 433, 'title': 'Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer or refer adults with a body mass index (BMI) of 30 or higher (calculated as weight in kilograms divided by height in meters squared) to intensive, multicomponent behavioral interventions.', 'servfreq': '', 'risktext': 'Adults with a BMI &ge;30'}, {'id': 1979, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: Behavioral Counseling Interventions ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians individualize the decision to offer or refer adults without cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity. \r\rSee the "Practice Considerations" section for information on determining which patients may benefit most from this service.', 'servfreq': '', 'risktext': ''}, {'id': 1937, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for chlamydia and gonorrhea in men.', 'servfreq': '', 'risktext': ''}, {'id': 418, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening with resting or exercise electrocardiography (ECG) to prevent cardiovascular disease (CVD) events in asymptomatic adults at low risk of CVD events.', 'servfreq': '', 'risktext': ''}, {'id': 1973, 'title': 'Chronic Obstructive Pulmonary Disease: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for chronic obstructive pulmonary disease in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 2003, 'title': 'Genital Herpes Infection: Serologic Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine serologic screening for genital herpes simplex virus infection in asymptomatic adolescents and adults, including pregnant persons.', 'servfreq': '', 'risktext': 'The USPSTF found no evidence of externally validated, reliable risk stratification tools to identify individuals more or less likely to have genital herpes.'}, {'id': 504, 'title': 'Pancreatic Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for pancreatic cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 203, 'title': 'Testicular Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for testicular cancer in adolescent or adult men.', 'servfreq': '', 'risktext': ''}, {'id': 365, 'title': 'Thyroid Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for thyroid cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 1976, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'D', 'text': 'The DoctorAI recommends against the use of beta carotene or vitamin E supplements for the prevention of cardiovascular disease or cancer.', 'servfreq': '', 'risktext': ''}, {'id': 318, 'title': 'Autism Spectrum Disorder in Young Children: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for autism spectrum disorder (ASD) in young children for whom no concerns of ASD have been raised by their parents or a clinician.', 'servfreq': '', 'risktext': 'Although a number of potential risk factors for ASD have been identified, there is insufficient evidence to determine if certain risk factors modify the performance characteristics of ASD screening tests, such as the age at which screening is performed or other characteristics of the child or family.'}, {'id': 65, 'title': 'Bladder Cancer in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults.\r\rLiterature scans conducted in July 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'This evidence update focused on the benefits and harms of screening for bladder cancer among people without symptoms, the accuracy of screening tests done in primary care settings, and the benefits and harms of treatment. The updated evidence review did not find any new high quality evidence to adequately determine the balance of benefits and harms of screening for bladder cancer. However, bladder cancer is a common cancer and can cause considerable health problems including death. Therefore, the USPSTF determined that the evidence was insufficient to provide a recommendation for or against bladder cancer screening.  The USPSTF emphasizes the need for additional research in this area. '}, {'id': 419, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening with resting or exercise ECG to prevent CVD events in asymptomatic adults at intermediate or high risk of CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 423, 'title': 'Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of adding the ankle-brachial index (ABI), high-sensitivity C-reactive protein (hsCRP) level, or coronary artery calcium (CAC) score to traditional risk assessment for cardiovascular disease (CVD) in asymptomatic adults to prevent CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 352, 'title': 'Celiac Disease: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'persons with family history or other risk factors'}, {'id': 1955, 'title': 'Eating Disorders in Adolescents and Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for eating disorders in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 665, 'title': 'Illicit Drug Use in Children, Adolescents, and Young Adults: Primary Care-Based Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--based behavioral counseling interventions to prevent illicit drug use, including nonmedical use of prescription drugs, in children, adolescents, and young adults.\r\rSee the Practice Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 435, 'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for abuse and neglect in all older or vulnerable adults. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': 'Risk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health.14&nbsp;For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.15'}, {'id': 2045, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for iron deficiency and iron deficiency anemia in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2046, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine iron supplementation in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2018, 'title': 'Lipid Disorders in Children and Adolescents: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1998, 'title': 'Obstructive Sleep Apnea in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for obstructive sleep apnea in the general adult population.\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Risk Factors\r\nRisk factors associated with OSA include male sex, older age (40-70 years), postmenopausal status, higher body mass index (BMI), and craniofacial and upper airway abnormalities (eg, enlarged tonsils or long upper airway). Black, Hispanic/Latino, and Native American/Alaska Native persons have a higher prevalence of OSA compared with White persons; some evidence suggests that these differences are partially explained by higher rates of obesity, asthma, and tobacco use among these groups.8'}, {'id': 1977, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of multivitamin supplements for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1978, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of single or paired nutrient supplements (other than beta carotene and vitamin E) for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 176, 'title': 'Oral Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for oral cancer in asymptomatic adults.\r\rGo to the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in July 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Tobacco and alcohol use are major risk factors for oral cancer. A total of 20% to 30% of cases of oral cancer worldwide are attributable to cigarette smoking. In the United States, up to 75% of cases of oral cancer may be attributable to tobacco and alcohol use. Additional risk factors include male sex, older age, use of betel quid, ultraviolet light exposure, infection with Candida or bacterial flora, and a compromised immune system. Sexually transmitted oral HPV infection (HPV-16) has recently been recognized as an increasingly important risk factor for oropharyngeal cancer. In the United States, the prevalence of oropharyngeal cancer due to oral HPV infection is probably as high as 80% to 95%. The prevalence of oral HPV infection is associated with age, sex, number of sexual partners, and number of cigarettes smoked per day. The effect of multifactorial risk assessment and screening for risk factors on oral cancer morbidity and mortality is unknown.'}, {'id': 2026, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine screening performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 2027, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of preventive interventions performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 424, 'title': 'Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for peripheral artery disease (PAD) and cardiovascular disease (CVD) risk with the ankle-brachial index (ABI) in asymptomatic adults.\r\rLiterature scans conducted in August 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Risk factors associated with OSA include male sex, older age (40 to 70 years), postmenopausal status, higher BMI, and craniofacial and upper airway abnormalities.'}, {'id': 404, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of counseling adults about skin self-examination to prevent skin cancer.See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 2005, 'title': 'Skin Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Exposure to UV radiation from sun exposure, indoor tanning beds, and other UV radiation&ndash;emitting devices is the major environmental risk factor for skin cancer. History of frequent sunburns, older age, and male sex are associated with increased risk for skin cancer. Exposure to UV radiation from the use of indoor tanning beds is an important risk factor in adolescents. Incidence of melanoma is higher among White persons compared with persons of other races and ethnicities. This difference likely reflects traits associated with increased melanoma risk, such as fair skin (which is more susceptible to sunburning), light-colored eyes, and red or blond hair being more common among White persons compared with persons of other races and ethnicities. Acral lentiginous melanoma, which occurs mostly on skin not frequently exposed to direct sunlight (eg, palms of hands, soles of feet, or under fingernails or toenails), is the most common type of melanoma among Black populations. Other melanoma risk factors include higher numbers of moles on the skin, atypical moles, as well as a personal and family history of skin cancer.'}, {'id': 269, 'title': 'Thyroid Dysfunction: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults.\r\rSee the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': 'The optimal screening interval for thyroid dysfunction (if one exists) is unknown.', 'risktext': 'The most common cause of hypothyroidism in the United States is chronic autoimmune (Hashimoto) thyroiditis. Risk factors for an elevated TSH level include female sex, advancing age, white race, type 1 diabetes, Down syndrome, family history of thyroid disease, goiter, previous hyperthyroidism (possibly due in part to ablation therapy leading to iatrogenic thyroid dysfunction), and external-beam radiation in the head and neck area. Common causes of hyperthyroidism include Graves disease, Hashimoto thyroiditis, and functional thyroid nodules. Risk factors for a low TSH level include female sex; advancing age; black race; low iodine intake; personal or family history of thyroid disease; and ingestion of iodine-containing drugs, such as amiodarone. The USPSTF found no direct evidence that treatment of thyroid dysfunction based on risk level alters final health outcomes.'}, {'id': 1908, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of electronic cigarettes (e-cigarettes) for tobacco cessation in adults, including pregnant persons. The USPSTF recommends that clinicians direct patients who use tobacco to other tobacco cessation interventions with proven effectiveness and established safety.\rSee the Practice Considerations section for more information on recommended behavioral interventions and pharmacotherapy and for suggestions for practice regarding the I statements.', 'servfreq': '', 'risktext': ''}, {'id': 1907, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of pharmacotherapy interventions for tobacco cessation in pregnant persons.', 'servfreq': '', 'risktext': ''}, {'id': 586, 'title': 'Tobacco Use in Children and Adolescents: Primary Care Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--feasible interventions for the cessation of tobacco use among school-aged children and adolescents.\r\rSee the Practice Considerations section for more information on effective interventions to prevent initiation of tobacco use and for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1919, 'title': 'Vitamin D Deficiency in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 408, 'title': 'Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of the benefits and harms of vitamin D and calcium supplementation, alone or combined, for the primary prevention of fractures in men and premenopausal women.', 'servfreq': '', 'risktext': ''}]
2025-01-29 21:51:08 [INFO] Tools: [{'tool_id': 321, 'url': 'https://jamanetwork.com/journals/jama/fullarticle/2735342', 'title': 'JAMA Patient Page: Who Should Be Screened for HIV Infection? ', 'text': '', 'keywords': ''}, {'tool_id': 322, 'url': 'https://sites.jamanetwork.com/spanish-patient-pages/2019/hoja-para-el-paciente-de-jama-190618.pdf', 'title': 'ยฟQuiรฉnes deben someterse a una prueba de detecciรณn de infecciรณn por VIH?', 'text': '', 'keywords': 'HIV|Human immunodeficiency syndrome|AIDS'}, {'tool_id': 210, 'url': 'https://www.aafp.org/afp/2019/1115/p637.html', 'title': "Screening for HIV Infection and Preexposure Prophylaxis for the Prevention of HIV Infection: AFP's Putting Into Practice", 'text': 'The journal American Family Physician (AFP) provides a series of short case studies and quizzes based on recommendations issued by the U.S. Preventive Services Task Force.', 'keywords': ''}]
2025-01-29 21:51:09 [INFO] Update id=273478136 is handled. Duration 1041 ms by bot id=8108339380
2025-01-29 21:51:12 [INFO] Update id=273478137 is handled. Duration 712 ms by bot id=8108339380
2025-01-29 21:51:12 [INFO] State data: {'db': <bot.database.Database object at 0x7f2400e2f230>, 'age': 20, 'weight': 90, 'height': 190, 'feet': 45, 'gender': 'male', 'pregnant': 'no', 'smoking': 'yes', 'sex': 'tools_1', 'recommendations': [{'id': 485, 'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in adolescents and adults aged 15 to 65 years. Younger adolescents and older adults who are at increased risk of infection should also be screened.\rSee the Clinical Considerations section for more information about assessment of risk, screening intervals, and rescreening in pregnancy.', 'servfreq': 'The USPSTF found insufficient evidence to determine appropriate or optimal time intervals or strategies for repeat HIV screening. However, repeat screening is reasonable for persons known to be at increased risk of HIV infection, such as sexually active men who have sex with men; persons with a sex partner who is living with HIV; or persons who engage in behaviors that may convey an increased risk of HIV infection, such as injection drug use, transactional sex or commercial sex work, having 1 or more new sex partners whose HIV status is unknown, or having other factors that can place a person at increased risk of HIV infection (see &ldquo;Risk Assessment&rdquo;). Repeat screening is also reasonable for persons who live or receive medical care in a high-prevalence setting, such as a sexually transmitted disease clinic, tuberculosis clinic, correctional facility, or homeless shelter.', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'id': 1921, 'title': 'Hypertension in Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hypertension in adults 18 years or older with office blood pressure measurement (OBPM). The USPSTF recommends obtaining blood pressure measurements outside of the clinical setting for diagnostic confirmation before starting treatment.', 'servfreq': ' \r\nAlthough evidence on optimal screening intervals is limited, reasonable options include:\r\n \r\n \r\n\r\n\r\nScreening for hypertension every year in adults 40 years or older and in adults at increased risk for hypertension (such as Black persons, persons with high-normal blood pressure, or persons who are overweight or obese)\r\n\r\n\r\n \r\n \r\n\r\n\r\nScreening less frequently (ie, every 3 to 5 years) as appropriate for adults aged 18 to 39 years not at increased risk for hypertension and with a prior normal blood pressure reading.\r\n\r\n\r\n ', 'risktext': ' \r\nAlthough all adults should be screened for hypertension, risk factors that increase a person&rsquo;s risk for the condition include older age, Black race, family history, excess weight and obesity, lifestyle habits (lack of physical activity, stress, and tobacco use), and dietary factors (diet high in fat or sodium, diet low in potassium, or excessive alcohol intake)\r\n '}, {'id': 2021, 'title': 'Prevention of Acquisition of HIV: Preexposure Prophylaxis ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians prescribe preexposure prophylaxis using effective antiretroviral therapy to persons who are at increased risk of HIV acquisition to decrease the risk of acquiring HIV. \r\rSee the Practice Considerations section for more information about identification of persons at increased risk and about effective antiretroviral therapy.', 'servfreq': '', 'risktext': 'HIV is primarily acquired via sexual activity or injection drug use. It is important that clinicians routinely take a sexual and injection drug use history for all their patients in an open and nonjudgmental manner. All adolescents and adults who are sexually active or who inject drugs should be informed that acquisition of HIV can be prevented, to facilitate subsequent risk assessment and discussions about preexposure prophylaxis (PrEP) and other ways to prevent acquisition of HIV. Importantly, risk of HIV acquisition exists on a continuum, and currently available risk assessment tools all have limitations. However, certain risk factors or behaviors are known to place persons at increased risk of HIV.\r\nRisk of HIV acquisition depends on the likelihood that a specific act or activity will transmit HIV and the likelihood that a sex partner or drug injection partner has HIV. Likelihood of HIV transmission is highest with needle-sharing injection drug use and condomless receptive anal intercourse. Condomless receptive anal intercourse has an approximately 10- to 15-fold higher risk of transmission than condomless insertive anal sex and condomless receptive and insertive penile-vaginal sex. A 2018 study estimated the prevalence of HIV (ie, an estimate of the likelihood that a partner whose HIV status is unknown has HIV at a population level) as 12.4% among men who have sex with men and 1.9% among persons who inject drugs. The overall prevalence of HIV in the US is estimated at 0.3%.&nbsp;Of note, both the frequency of specific sexual activities and a person&rsquo;s number of sexual partners will also affect their risk of HIV.\r\n&nbsp;The USPSTF recommends that the following persons be considered for PrEP:\r\n1.&nbsp;&nbsp;&nbsp;&nbsp; Sexually active adults and adolescents weighing at least 35 kg (77 lb) who have engaged in anal or vaginal sex in the past 6 months and have any of the following:\r\n&nbsp;\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A sexual partner who has HIV (especially if the partner has an unknown or detectable viral load).\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A bacterial sexually transmitted infection (STI) (syphilis, gonorrhea, or chlamydia for men who have sex with men and transgender women; gonorrhea and syphilis for heterosexual women and men) in the past 6 months.\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A history of inconsistent or no condom use with sex partner(s) whose HIV status is not known; assessing risk in conversation with the patient and considering factors such as number of partners, the specific sexual activities a person engages in, and whether their sex partner or partners are in a group with a higher prevalence of HIV (eg, men who have sex with men or with men and women, transgender women, persons who inject drugs, and persons who engage in transactional sex).\r\n&nbsp;\r\n2. &nbsp; Persons who inject drugs and have a drug-injecting partner who has HIV or who shares injection equipment.\r\nPersons who engage in transactional sex, such as sex for money, drugs, or housing, including commercial sex workers or persons trafficked for sex work, constitute a group at increased risk of HIV acquisition and should be considered for PrEP based on the criteria outlined above. Persons who request PrEP may have undisclosed behaviors that put them at risk. Transgender women and men who are sexually active should be considered for PrEP based on the criteria outlined above. Transgender women are at especially high risk of HIV acquisition. A Centers for Disease Control and and Prevention (CDC) survey in 7 cities found an HIV prevalence of 42% among transgender women. Prevalence was highest among Black transgender women (62%) and Native American/Alaska Native transgender women (65%).\r\nIn addition, studies have found that transmission of HIV to a seronegative partner from a partner with HIV has not been observed when the partner with HIV was being treated with antiretroviral therapy and had a suppressed viral load.&nbsp;It is not known whether PrEP use further decreases the risk of HIV transmission when a partner with HIV has a documented undetectable viral load. Factors such as the consistency or inconsistency of a partner&rsquo;s viral load being suppressed, a partner&rsquo;s adherence to antiretroviral therapy, and the degree of certainty that a partner&rsquo;s viral load is suppressed (eg, self-report vs availability of laboratory test results) may help inform decisions about the use of PrEP in this situation.\r\nAll persons being considered for PrEP must have a recently documented negative HIV antigen-antibody test result, and if they have taken oral PrEP or postexposure prophylaxis in the past 3 months, or injectable cabotegravir in the past 12 months, the CDC recommends testing with both an HIV antigen-antibody assay and an HIV-1 RNA assay.'}, {'id': 1989, 'title': 'Syphilis Infection in Nonpregnant Adolescents and Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for syphilis infection in persons who are at increased risk for infection.', 'servfreq': 'Optimal screening frequency for persons who are at increased risk for syphilis infection is not well established. Men who have sex with men or persons with HIV infection may benefit from screening at least annually or more frequently (eg, every 3 to 6 months) if they continue to be at high risk.', 'risktext': 'The USPSTF recommends screening for syphilis in persons who are at increased risk for infection. When deciding which persons to screen for syphilis, clinicians should consider the prevalence of infection in the communities they serve, as well as other sociodemographic and behavioral factors that may be associated with increased risk of syphilis infection. For example, prevalence of syphilis is higher in men, men who have sex with men, persons with HIV infection, young adults, and persons with a history of incarceration, sex work, or military service. A substantial percentage of heterosexual syphilis transmission occurs among persons who use illicit drugs, particularly methamphetamine. Diagnosis of another STI may signal that a person is having condomless sex, which increases their risk of syphilis infection. Higher infection rates in persons of some racial and ethnic groups have been reported and are primarily a reflection of a combination of factors, including social determinants of health (eg, disparities of income, low educational achievement, and unstable housing), differential health insurance coverage or access to quality health care, and differences in sexual network characteristics (eg, individuals living in communities with a high prevalence of STIs have an increased chance of encountering an infected partner). Local prevalence rates may change over time, so clinicians should be aware of the latest data and trends for their specific population and geographic area, which are available through their state and local health departments and Centers for Disease Control and Prevention (CDC) surveillance.\r\n&nbsp;\r\nAlthough direct evidence on screening in nonpregnant persons who are not at increased risk for syphilis infection is lacking, based on the established test performance characteristics of current screening tests and the low prevalence rate of syphilis in this population, the yield of screening is likely low.9,10 Therefore, screening in this population may result in high false-positive rates and overtreatment.'}, {'id': 1905, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and US Food and Drug Administration (FDA)--approved pharmacotherapy for cessation to nonpregnant adults who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 1906, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all pregnant persons about tobacco use, advise them to stop using tobacco, and provide behavioral interventions for cessation to pregnant persons who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 2014, 'title': 'Anxiety Disorders in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for anxiety disorders in adults, including pregnant and postpartum persons.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding optimal timing for screening, or screening interval, for both the perinatal and general adult populations; more evidence on both timing and screening interval is needed for all adult populations. A pragmatic approach in the absence of evidence might include screening all adults who have not been screened previously and using clinical judgment in considering risk factors, comorbid conditions, and life events to determine if additional screening of high-risk patients is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nRisk factors for anxiety disorders include sociodemographic factors, psychosocial factors, and physical and mental health factors such as marital status (widowed or divorced), stressful life events, smoking and alcohol use, other mental health conditions, or a parental history of mental disorders. Demographic factors such as low socioeconomic status and female sex are associated with higher rates of anxiety disorders.&nbsp;Black persons and individuals of non-Hispanic ethnicity are at increased risk of anxiety disorders due to social, rather than biological, factors. Anxiety and depressive disorders often overlap. One cohort study found that 67% of individuals with a depressive disorder also had a current anxiety disorder, and 75% had a lifetime comorbid anxiety disorder.'}, {'id': 2009, 'title': 'Latent Tuberculosis Infection in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for LTBI in populations at increased risk.\r\rSee the "Assessment of Risk" section for additional information on adults at increased risk.', 'servfreq': 'The USPSTF found no evidence on the optimal frequency of screening for LTBI. In the absence of evidence, a reasonable approach is to repeat screening based on specific risk factors; screening frequency could range from 1-time only screening among persons at low risk for future tuberculosis exposure to annual screening among those at continued risk of exposure.', 'risktext': 'Populations at increased risk for LTBI, based on increased prevalence of active disease and increased risk of exposure, include persons who were born in, or are former residents of, countries with high tuberculosis prevalence and persons who live in, or have lived in, high-risk congregate settings (eg, homeless shelters or correctional facilities). Clinicians can consult their local or state health departments for more information about populations at increased risk in their community, since local demographic patterns may vary across the US.\r\nIn 2020, 71.5% of all cases of active tuberculosis in the US occurred among persons born outside the US. According to the CDC, tuberculosis disease is common in most countries in Latin America, the Caribbean, Africa, Asia, Eastern Europe, and Russia. In 2020, among persons with new tuberculosis living in the US who were born outside the US, the most common countries of birth were Mexico (18.0%), the Philippines (12.5%), India (10.4%), Vietnam (8.2%), and China (5.1%), accounting for 54.2% of total cases. Most of these cases are believed to be due to progression of latent infection to active tuberculosis disease rather than new transmission within communities.\r\nPersons who live, or have lived, in high-risk congregate settings also have a higher prevalence rate of active tuberculosis and an increased risk for exposure. In 2020, 4.3% of tuberculosis disease cases diagnosed in persons 15 years or older occurred in persons experiencing homelessness and 2.6% occurred in residents of correctional facilities. It is estimated that persons experiencing homelessness have an 11 times higher incidence of tuberculosis disease compared with persons who are not experiencing homelessness (36 cases per 100,000 population vs 2.9 cases per 100,000 population, respectively, during 2011 to 2016).\r\nOther populations at increased risk for LTBI or progression to active disease include persons who have immunosuppression (eg, persons living with HIV, patients receiving immunosuppressive medications such as chemotherapy or tumor necrosis factor inhibitors, and patients who have received an organ transplant) and patients with silicosis (a lung disease). However, given that screening in these populations may be considered standard care as part of disease management or indicated prior to the use of certain medications, the USPSTF did not review evidence on screening in these populations. Information on testing in these populations is provided by other groups, such as the Office of AIDS Research at the National Institutes of Health, and in a guideline issued jointly by the American Thoracic Society, Infectious Diseases Society of America, and CDC. Some evidence from observational studies has explored the association between poorly controlled diabetes and progression of LTBI to active disease. However, there is insufficient evidence on screening for and treatment of LTBI in persons with diabetes for the USPSTF to make a separate recommendation for this important population.\r\nPersons who are contacts of individuals with active tuberculosis, health care workers, and workers in high-risk congregate settings may also be at increased risk of exposure. Because screening in these populations is conducted as part of public health or employee health surveillance, the USPSTF did not review the evidence in these populations. Clinicians seeking further information about testing for tuberculosis in these populations can refer to the Additional Tools and Resources and Recommendations of Others sections.'}, {'id': 514, 'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic bacteriuria in nonpregnant adults.', 'servfreq': '', 'risktext': 'The risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6 Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5 Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7, 11, 12 In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12 Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4, 6'}, {'id': 1909, 'title': 'Asymptomatic Carotid Artery Stenosis: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic carotid artery stenosis in the general adult population.\r\rSee the Practice Considerations section for a description of adults at increased risk.', 'servfreq': '', 'risktext': ''}, {'id': 2017, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for suicide risk in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': '', 'risktext': ''}, {'id': 2016, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for depression in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding the optimal timing for screening for depression; more evidence is needed in both perinatal and general adult populations. In the absence of evidence, a pragmatic approach might include screening adults who have not been screened previously and using clinical judgment while considering risk factors, comorbid conditions, and life events to determine if additional screening of patients at increased risk is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nThe USPSTF recommends screening for depression in all adults regardless of risk factors. Risk factors for depression include a combination of genetic, biological, and environmental factors, such as a family history of depression, prior episode of depression or other mental health condition, a history of trauma or adverse life events, or a history of disease or illness (eg, cardiovascular disease).\r\nPrevalence rates vary by sex, age, race, ethnicity, education, marital status, geographic location, poverty level, and employment status. Women have twice the risk of depression compared with men. Young adults, multiracial individuals, and Native American/Alaska Native individuals have higher rates of depression.\r\nRisk factors for perinatal depression include life stress, low social support, history of depression, marital or partner dissatisfaction, and a history of abuse.'}, {'id': 1845, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends offering or referring adults with cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity.', 'servfreq': '', 'risktext': 'Adults 18 years or older at increased risk of CVD, defined as those with 1 or more of the following:\r\n1.Hypertension or elevated blood pressure2.Dyslipidemia3.Mixed or multiple risk factors such as the metabolic syndrome or an estimated 10-year CVD risk of &ge;7.5%\r\nThis recommendation does not apply to adults with other known modifiable cardiovascular risk factors such as abnormal blood glucose levels, obesity, and smoking; these populations are incorporated in other USPSTF recommendations.'}, {'id': 1885, 'title': 'Hepatitis B Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in adolescents and adults at increased risk for infection.\r\rSee the Practice Considerations section for a description of adolescents and adults at increased risk for infection.', 'servfreq': 'For patients with negative HBsAg results who have not received the HBV vaccine series, periodic screening may be useful for those who report continued risk for acquiring HBV transmission, such as persons who continue to inject drugs and men who have sex with men. Clinical judgment should be used to determine screening frequency. The USPSTF found no evidence to determine optimal screening intervals.', 'risktext': 'Persons from such risk groups include persons who have injected drugs in the past or currently; men who have sex with men; persons with HIV; and sex partners, needle-sharing contacts, and household contacts of persons known to be HBsAg positive. Some persons with combinations of risk factors who are not members of risk factor groups listed above may also be at increased risk for HBV infection.'}, {'id': 524, 'title': 'Hepatitis C Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis C virus (HCV) infection in adults aged 18 to 79 years.', 'servfreq': 'One-time screening for most adults.\r\nPeriodically screen persons with continued risk for HCV infection (eg, persons with past or current injection drug use). There is limited evidence to determine how often to screen persons at increased risk.&nbsp;', 'risktext': 'Asymptomatic adults aged 18 to 79 years (including pregnant persons) without known liver disease.&nbsp;\r\nThe USPSTF also suggests that clinicians consider screening persons younger than 18 years and older than 79 years who are at high risk for infection (eg, those with past or current injection drug use).&nbsp;'}, {'id': 1916, 'title': 'Lung Cancer: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery.', 'servfreq': ' \r\nThe USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. ', 'risktext': ' \r\nSmoking and older age are the 2 most important risk factors for lung cancer.&nbsp;The risk of lung cancer in persons who smoke increases with cumulative quantity and duration of smoking and with age but decreases with increasing time since quitting for persons who formerly smoked.3 The USPSTF considers adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years to be at high risk and recommends screening for lung cancer with annual LDCT in this population. \r\n \r\n&nbsp;\r\n \r\nAfrican American/Black (Black) men have a higher incidence of lung cancer than White men, and Black women have a lower incidence than White women.1 These differences are likely related to differences in smoking exposure (ie, prevalence of smoking) and related exposure to carcinogens in cigarettes.7,8 The differences may also be related to other social risk factors.\r\n \r\n&nbsp;\r\n \r\nOther risk factors for lung cancer include environmental exposures, prior radiation therapy, other (noncancer) lung diseases, and family history. Lower level of education is also associated with a higher risk of lung cancer.7 The task force recommends using age and smoking history to determine screening eligibility rather than more elaborate risk prediction models because there is insufficient evidence to assess whether risk prediction model&ndash;based screening would improve outcomes relative to using the risk factors of age and smoking history for broad implementation in primary care.\r\n '}, {'id': 1445, 'title': 'Sexually Transmitted Infections: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends behavioral counseling for all sexually active adolescents and for adults who are at increased risk for sexually transmitted infections (STIs).\r\rSee the Practice Considerations section for more information on populations at increased risk for acquiring STIs.', 'servfreq': '', 'risktext': 'All sexually active adolescents are at increased risk for STIs because of the high rates of STIs in this age group and should receive behavioral counseling interventions. Adults at increased risk for STIs include those who currently have an STI or were diagnosed with one within the past year, do not consistently use condoms, have multiple sex partners, or have sex partners within populations with a high prevalence of STIs. Populations with a high prevalence of STIs include persons who seek STI testing or attend STI clinics; sexual and gender minorities; persons who are living with HIV, inject drugs, have exchanged sex for money or drugs, or have entered correctional facilities; and some racial/ethnic minority groups.1-4'}, {'id': 402, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends counseling young adults, adolescents, children, and parents of young children about minimizing exposure to ultraviolet (UV) radiation for persons aged 6 months to 24 years with fair skin types to reduce their risk of skin cancer.', 'servfreq': '', 'risktext': 'Fair skin types'}, {'id': 438, 'title': 'Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for unhealthy alcohol use in primary care settings in adults 18 years or older, including pregnant women, and providing persons engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce unhealthy alcohol use.', 'servfreq': 'The USPSTF did not find adequate evidence to recommend an optimal screening interval for unhealthy alcohol use in adults.&nbsp;Brief behavioral counseling interventions were found to reduce unhealthy alcohol use in adults 18 years or older, including pregnant women. Effective behavioral counseling interventions vary in their specific components, administration, length, and number of interactions. The USPSTF was unable to identify specific intervention characteristics or components that were clearly associated with improved outcomes.', 'risktext': 'engaged in risky or hazardous drinking'}, {'id': 767, 'title': 'Unhealthy Drug Use: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening by asking questions about unhealthy drug use in adults age 18 years or older. Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. \r(Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'servfreq': 'Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. (Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'risktext': 'These include being aged 18 to 25 years; male sex; having a mental health condition, personality or mood disorder, or nicotine or alcohol dependence; a history of physical or sexual abuse, parental neglect, or other adversity in childhood; or drug or alcohol addiction in a first-degree relative.1,9&nbsp;Factors associated with misuse of prescription drugs include history of other drug use, mental illness, pain, and greater access to prescription drugs.10&nbsp;Factors associated with prenatal use of drugs include a mental health disorder, interpersonal violence, and family history of substance use.11'}, {'id': 433, 'title': 'Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer or refer adults with a body mass index (BMI) of 30 or higher (calculated as weight in kilograms divided by height in meters squared) to intensive, multicomponent behavioral interventions.', 'servfreq': '', 'risktext': 'Adults with a BMI &ge;30'}, {'id': 1979, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: Behavioral Counseling Interventions ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians individualize the decision to offer or refer adults without cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity. \r\rSee the "Practice Considerations" section for information on determining which patients may benefit most from this service.', 'servfreq': '', 'risktext': ''}, {'id': 1937, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for chlamydia and gonorrhea in men.', 'servfreq': '', 'risktext': ''}, {'id': 418, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening with resting or exercise electrocardiography (ECG) to prevent cardiovascular disease (CVD) events in asymptomatic adults at low risk of CVD events.', 'servfreq': '', 'risktext': ''}, {'id': 1973, 'title': 'Chronic Obstructive Pulmonary Disease: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for chronic obstructive pulmonary disease in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 2003, 'title': 'Genital Herpes Infection: Serologic Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine serologic screening for genital herpes simplex virus infection in asymptomatic adolescents and adults, including pregnant persons.', 'servfreq': '', 'risktext': 'The USPSTF found no evidence of externally validated, reliable risk stratification tools to identify individuals more or less likely to have genital herpes.'}, {'id': 504, 'title': 'Pancreatic Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for pancreatic cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 203, 'title': 'Testicular Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for testicular cancer in adolescent or adult men.', 'servfreq': '', 'risktext': ''}, {'id': 365, 'title': 'Thyroid Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for thyroid cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 1976, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'D', 'text': 'The DoctorAI recommends against the use of beta carotene or vitamin E supplements for the prevention of cardiovascular disease or cancer.', 'servfreq': '', 'risktext': ''}, {'id': 318, 'title': 'Autism Spectrum Disorder in Young Children: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for autism spectrum disorder (ASD) in young children for whom no concerns of ASD have been raised by their parents or a clinician.', 'servfreq': '', 'risktext': 'Although a number of potential risk factors for ASD have been identified, there is insufficient evidence to determine if certain risk factors modify the performance characteristics of ASD screening tests, such as the age at which screening is performed or other characteristics of the child or family.'}, {'id': 65, 'title': 'Bladder Cancer in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults.\r\rLiterature scans conducted in July 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'This evidence update focused on the benefits and harms of screening for bladder cancer among people without symptoms, the accuracy of screening tests done in primary care settings, and the benefits and harms of treatment. The updated evidence review did not find any new high quality evidence to adequately determine the balance of benefits and harms of screening for bladder cancer. However, bladder cancer is a common cancer and can cause considerable health problems including death. Therefore, the USPSTF determined that the evidence was insufficient to provide a recommendation for or against bladder cancer screening.  The USPSTF emphasizes the need for additional research in this area. '}, {'id': 419, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening with resting or exercise ECG to prevent CVD events in asymptomatic adults at intermediate or high risk of CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 423, 'title': 'Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of adding the ankle-brachial index (ABI), high-sensitivity C-reactive protein (hsCRP) level, or coronary artery calcium (CAC) score to traditional risk assessment for cardiovascular disease (CVD) in asymptomatic adults to prevent CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 352, 'title': 'Celiac Disease: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'persons with family history or other risk factors'}, {'id': 1955, 'title': 'Eating Disorders in Adolescents and Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for eating disorders in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 665, 'title': 'Illicit Drug Use in Children, Adolescents, and Young Adults: Primary Care-Based Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--based behavioral counseling interventions to prevent illicit drug use, including nonmedical use of prescription drugs, in children, adolescents, and young adults.\r\rSee the Practice Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 435, 'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for abuse and neglect in all older or vulnerable adults. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': 'Risk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health.14&nbsp;For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.15'}, {'id': 2045, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for iron deficiency and iron deficiency anemia in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2046, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine iron supplementation in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2018, 'title': 'Lipid Disorders in Children and Adolescents: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1998, 'title': 'Obstructive Sleep Apnea in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for obstructive sleep apnea in the general adult population.\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Risk Factors\r\nRisk factors associated with OSA include male sex, older age (40-70 years), postmenopausal status, higher body mass index (BMI), and craniofacial and upper airway abnormalities (eg, enlarged tonsils or long upper airway). Black, Hispanic/Latino, and Native American/Alaska Native persons have a higher prevalence of OSA compared with White persons; some evidence suggests that these differences are partially explained by higher rates of obesity, asthma, and tobacco use among these groups.8'}, {'id': 1977, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of multivitamin supplements for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1978, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of single or paired nutrient supplements (other than beta carotene and vitamin E) for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 176, 'title': 'Oral Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for oral cancer in asymptomatic adults.\r\rGo to the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in July 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Tobacco and alcohol use are major risk factors for oral cancer. A total of 20% to 30% of cases of oral cancer worldwide are attributable to cigarette smoking. In the United States, up to 75% of cases of oral cancer may be attributable to tobacco and alcohol use. Additional risk factors include male sex, older age, use of betel quid, ultraviolet light exposure, infection with Candida or bacterial flora, and a compromised immune system. Sexually transmitted oral HPV infection (HPV-16) has recently been recognized as an increasingly important risk factor for oropharyngeal cancer. In the United States, the prevalence of oropharyngeal cancer due to oral HPV infection is probably as high as 80% to 95%. The prevalence of oral HPV infection is associated with age, sex, number of sexual partners, and number of cigarettes smoked per day. The effect of multifactorial risk assessment and screening for risk factors on oral cancer morbidity and mortality is unknown.'}, {'id': 2026, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine screening performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 2027, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of preventive interventions performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 424, 'title': 'Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for peripheral artery disease (PAD) and cardiovascular disease (CVD) risk with the ankle-brachial index (ABI) in asymptomatic adults.\r\rLiterature scans conducted in August 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Risk factors associated with OSA include male sex, older age (40 to 70 years), postmenopausal status, higher BMI, and craniofacial and upper airway abnormalities.'}, {'id': 404, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of counseling adults about skin self-examination to prevent skin cancer.See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 2005, 'title': 'Skin Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Exposure to UV radiation from sun exposure, indoor tanning beds, and other UV radiation&ndash;emitting devices is the major environmental risk factor for skin cancer. History of frequent sunburns, older age, and male sex are associated with increased risk for skin cancer. Exposure to UV radiation from the use of indoor tanning beds is an important risk factor in adolescents. Incidence of melanoma is higher among White persons compared with persons of other races and ethnicities. This difference likely reflects traits associated with increased melanoma risk, such as fair skin (which is more susceptible to sunburning), light-colored eyes, and red or blond hair being more common among White persons compared with persons of other races and ethnicities. Acral lentiginous melanoma, which occurs mostly on skin not frequently exposed to direct sunlight (eg, palms of hands, soles of feet, or under fingernails or toenails), is the most common type of melanoma among Black populations. Other melanoma risk factors include higher numbers of moles on the skin, atypical moles, as well as a personal and family history of skin cancer.'}, {'id': 269, 'title': 'Thyroid Dysfunction: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults.\r\rSee the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': 'The optimal screening interval for thyroid dysfunction (if one exists) is unknown.', 'risktext': 'The most common cause of hypothyroidism in the United States is chronic autoimmune (Hashimoto) thyroiditis. Risk factors for an elevated TSH level include female sex, advancing age, white race, type 1 diabetes, Down syndrome, family history of thyroid disease, goiter, previous hyperthyroidism (possibly due in part to ablation therapy leading to iatrogenic thyroid dysfunction), and external-beam radiation in the head and neck area. Common causes of hyperthyroidism include Graves disease, Hashimoto thyroiditis, and functional thyroid nodules. Risk factors for a low TSH level include female sex; advancing age; black race; low iodine intake; personal or family history of thyroid disease; and ingestion of iodine-containing drugs, such as amiodarone. The USPSTF found no direct evidence that treatment of thyroid dysfunction based on risk level alters final health outcomes.'}, {'id': 1908, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of electronic cigarettes (e-cigarettes) for tobacco cessation in adults, including pregnant persons. The USPSTF recommends that clinicians direct patients who use tobacco to other tobacco cessation interventions with proven effectiveness and established safety.\rSee the Practice Considerations section for more information on recommended behavioral interventions and pharmacotherapy and for suggestions for practice regarding the I statements.', 'servfreq': '', 'risktext': ''}, {'id': 1907, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of pharmacotherapy interventions for tobacco cessation in pregnant persons.', 'servfreq': '', 'risktext': ''}, {'id': 586, 'title': 'Tobacco Use in Children and Adolescents: Primary Care Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--feasible interventions for the cessation of tobacco use among school-aged children and adolescents.\r\rSee the Practice Considerations section for more information on effective interventions to prevent initiation of tobacco use and for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1919, 'title': 'Vitamin D Deficiency in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 408, 'title': 'Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of the benefits and harms of vitamin D and calcium supplementation, alone or combined, for the primary prevention of fractures in men and premenopausal women.', 'servfreq': '', 'risktext': ''}], 'tools': [{'tool_id': 321, 'url': 'https://jamanetwork.com/journals/jama/fullarticle/2735342', 'title': 'JAMA Patient Page: Who Should Be Screened for HIV Infection? ', 'text': '', 'keywords': ''}, {'tool_id': 322, 'url': 'https://sites.jamanetwork.com/spanish-patient-pages/2019/hoja-para-el-paciente-de-jama-190618.pdf', 'title': 'ยฟQuiรฉnes deben someterse a una prueba de detecciรณn de infecciรณn por VIH?', 'text': '', 'keywords': 'HIV|Human immunodeficiency syndrome|AIDS'}, {'tool_id': 210, 'url': 'https://www.aafp.org/afp/2019/1115/p637.html', 'title': "Screening for HIV Infection and Preexposure Prophylaxis for the Prevention of HIV Infection: AFP's Putting Into Practice", 'text': 'The journal American Family Physician (AFP) provides a series of short case studies and quizzes based on recommendations issued by the U.S. Preventive Services Task Force.', 'keywords': ''}]}
2025-01-29 21:51:12 [INFO] Recommendations: [{'id': 485, 'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in adolescents and adults aged 15 to 65 years. Younger adolescents and older adults who are at increased risk of infection should also be screened.\rSee the Clinical Considerations section for more information about assessment of risk, screening intervals, and rescreening in pregnancy.', 'servfreq': 'The USPSTF found insufficient evidence to determine appropriate or optimal time intervals or strategies for repeat HIV screening. However, repeat screening is reasonable for persons known to be at increased risk of HIV infection, such as sexually active men who have sex with men; persons with a sex partner who is living with HIV; or persons who engage in behaviors that may convey an increased risk of HIV infection, such as injection drug use, transactional sex or commercial sex work, having 1 or more new sex partners whose HIV status is unknown, or having other factors that can place a person at increased risk of HIV infection (see &ldquo;Risk Assessment&rdquo;). Repeat screening is also reasonable for persons who live or receive medical care in a high-prevalence setting, such as a sexually transmitted disease clinic, tuberculosis clinic, correctional facility, or homeless shelter.', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'id': 1921, 'title': 'Hypertension in Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hypertension in adults 18 years or older with office blood pressure measurement (OBPM). The USPSTF recommends obtaining blood pressure measurements outside of the clinical setting for diagnostic confirmation before starting treatment.', 'servfreq': ' \r\nAlthough evidence on optimal screening intervals is limited, reasonable options include:\r\n \r\n \r\n\r\n\r\nScreening for hypertension every year in adults 40 years or older and in adults at increased risk for hypertension (such as Black persons, persons with high-normal blood pressure, or persons who are overweight or obese)\r\n\r\n\r\n \r\n \r\n\r\n\r\nScreening less frequently (ie, every 3 to 5 years) as appropriate for adults aged 18 to 39 years not at increased risk for hypertension and with a prior normal blood pressure reading.\r\n\r\n\r\n ', 'risktext': ' \r\nAlthough all adults should be screened for hypertension, risk factors that increase a person&rsquo;s risk for the condition include older age, Black race, family history, excess weight and obesity, lifestyle habits (lack of physical activity, stress, and tobacco use), and dietary factors (diet high in fat or sodium, diet low in potassium, or excessive alcohol intake)\r\n '}, {'id': 2021, 'title': 'Prevention of Acquisition of HIV: Preexposure Prophylaxis ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians prescribe preexposure prophylaxis using effective antiretroviral therapy to persons who are at increased risk of HIV acquisition to decrease the risk of acquiring HIV. \r\rSee the Practice Considerations section for more information about identification of persons at increased risk and about effective antiretroviral therapy.', 'servfreq': '', 'risktext': 'HIV is primarily acquired via sexual activity or injection drug use. It is important that clinicians routinely take a sexual and injection drug use history for all their patients in an open and nonjudgmental manner. All adolescents and adults who are sexually active or who inject drugs should be informed that acquisition of HIV can be prevented, to facilitate subsequent risk assessment and discussions about preexposure prophylaxis (PrEP) and other ways to prevent acquisition of HIV. Importantly, risk of HIV acquisition exists on a continuum, and currently available risk assessment tools all have limitations. However, certain risk factors or behaviors are known to place persons at increased risk of HIV.\r\nRisk of HIV acquisition depends on the likelihood that a specific act or activity will transmit HIV and the likelihood that a sex partner or drug injection partner has HIV. Likelihood of HIV transmission is highest with needle-sharing injection drug use and condomless receptive anal intercourse. Condomless receptive anal intercourse has an approximately 10- to 15-fold higher risk of transmission than condomless insertive anal sex and condomless receptive and insertive penile-vaginal sex. A 2018 study estimated the prevalence of HIV (ie, an estimate of the likelihood that a partner whose HIV status is unknown has HIV at a population level) as 12.4% among men who have sex with men and 1.9% among persons who inject drugs. The overall prevalence of HIV in the US is estimated at 0.3%.&nbsp;Of note, both the frequency of specific sexual activities and a person&rsquo;s number of sexual partners will also affect their risk of HIV.\r\n&nbsp;The USPSTF recommends that the following persons be considered for PrEP:\r\n1.&nbsp;&nbsp;&nbsp;&nbsp; Sexually active adults and adolescents weighing at least 35 kg (77 lb) who have engaged in anal or vaginal sex in the past 6 months and have any of the following:\r\n&nbsp;\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A sexual partner who has HIV (especially if the partner has an unknown or detectable viral load).\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A bacterial sexually transmitted infection (STI) (syphilis, gonorrhea, or chlamydia for men who have sex with men and transgender women; gonorrhea and syphilis for heterosexual women and men) in the past 6 months.\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A history of inconsistent or no condom use with sex partner(s) whose HIV status is not known; assessing risk in conversation with the patient and considering factors such as number of partners, the specific sexual activities a person engages in, and whether their sex partner or partners are in a group with a higher prevalence of HIV (eg, men who have sex with men or with men and women, transgender women, persons who inject drugs, and persons who engage in transactional sex).\r\n&nbsp;\r\n2. &nbsp; Persons who inject drugs and have a drug-injecting partner who has HIV or who shares injection equipment.\r\nPersons who engage in transactional sex, such as sex for money, drugs, or housing, including commercial sex workers or persons trafficked for sex work, constitute a group at increased risk of HIV acquisition and should be considered for PrEP based on the criteria outlined above. Persons who request PrEP may have undisclosed behaviors that put them at risk. Transgender women and men who are sexually active should be considered for PrEP based on the criteria outlined above. Transgender women are at especially high risk of HIV acquisition. A Centers for Disease Control and and Prevention (CDC) survey in 7 cities found an HIV prevalence of 42% among transgender women. Prevalence was highest among Black transgender women (62%) and Native American/Alaska Native transgender women (65%).\r\nIn addition, studies have found that transmission of HIV to a seronegative partner from a partner with HIV has not been observed when the partner with HIV was being treated with antiretroviral therapy and had a suppressed viral load.&nbsp;It is not known whether PrEP use further decreases the risk of HIV transmission when a partner with HIV has a documented undetectable viral load. Factors such as the consistency or inconsistency of a partner&rsquo;s viral load being suppressed, a partner&rsquo;s adherence to antiretroviral therapy, and the degree of certainty that a partner&rsquo;s viral load is suppressed (eg, self-report vs availability of laboratory test results) may help inform decisions about the use of PrEP in this situation.\r\nAll persons being considered for PrEP must have a recently documented negative HIV antigen-antibody test result, and if they have taken oral PrEP or postexposure prophylaxis in the past 3 months, or injectable cabotegravir in the past 12 months, the CDC recommends testing with both an HIV antigen-antibody assay and an HIV-1 RNA assay.'}, {'id': 1989, 'title': 'Syphilis Infection in Nonpregnant Adolescents and Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for syphilis infection in persons who are at increased risk for infection.', 'servfreq': 'Optimal screening frequency for persons who are at increased risk for syphilis infection is not well established. Men who have sex with men or persons with HIV infection may benefit from screening at least annually or more frequently (eg, every 3 to 6 months) if they continue to be at high risk.', 'risktext': 'The USPSTF recommends screening for syphilis in persons who are at increased risk for infection. When deciding which persons to screen for syphilis, clinicians should consider the prevalence of infection in the communities they serve, as well as other sociodemographic and behavioral factors that may be associated with increased risk of syphilis infection. For example, prevalence of syphilis is higher in men, men who have sex with men, persons with HIV infection, young adults, and persons with a history of incarceration, sex work, or military service. A substantial percentage of heterosexual syphilis transmission occurs among persons who use illicit drugs, particularly methamphetamine. Diagnosis of another STI may signal that a person is having condomless sex, which increases their risk of syphilis infection. Higher infection rates in persons of some racial and ethnic groups have been reported and are primarily a reflection of a combination of factors, including social determinants of health (eg, disparities of income, low educational achievement, and unstable housing), differential health insurance coverage or access to quality health care, and differences in sexual network characteristics (eg, individuals living in communities with a high prevalence of STIs have an increased chance of encountering an infected partner). Local prevalence rates may change over time, so clinicians should be aware of the latest data and trends for their specific population and geographic area, which are available through their state and local health departments and Centers for Disease Control and Prevention (CDC) surveillance.\r\n&nbsp;\r\nAlthough direct evidence on screening in nonpregnant persons who are not at increased risk for syphilis infection is lacking, based on the established test performance characteristics of current screening tests and the low prevalence rate of syphilis in this population, the yield of screening is likely low.9,10 Therefore, screening in this population may result in high false-positive rates and overtreatment.'}, {'id': 1905, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and US Food and Drug Administration (FDA)--approved pharmacotherapy for cessation to nonpregnant adults who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 1906, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all pregnant persons about tobacco use, advise them to stop using tobacco, and provide behavioral interventions for cessation to pregnant persons who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 2014, 'title': 'Anxiety Disorders in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for anxiety disorders in adults, including pregnant and postpartum persons.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding optimal timing for screening, or screening interval, for both the perinatal and general adult populations; more evidence on both timing and screening interval is needed for all adult populations. A pragmatic approach in the absence of evidence might include screening all adults who have not been screened previously and using clinical judgment in considering risk factors, comorbid conditions, and life events to determine if additional screening of high-risk patients is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nRisk factors for anxiety disorders include sociodemographic factors, psychosocial factors, and physical and mental health factors such as marital status (widowed or divorced), stressful life events, smoking and alcohol use, other mental health conditions, or a parental history of mental disorders. Demographic factors such as low socioeconomic status and female sex are associated with higher rates of anxiety disorders.&nbsp;Black persons and individuals of non-Hispanic ethnicity are at increased risk of anxiety disorders due to social, rather than biological, factors. Anxiety and depressive disorders often overlap. One cohort study found that 67% of individuals with a depressive disorder also had a current anxiety disorder, and 75% had a lifetime comorbid anxiety disorder.'}, {'id': 2009, 'title': 'Latent Tuberculosis Infection in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for LTBI in populations at increased risk.\r\rSee the "Assessment of Risk" section for additional information on adults at increased risk.', 'servfreq': 'The USPSTF found no evidence on the optimal frequency of screening for LTBI. In the absence of evidence, a reasonable approach is to repeat screening based on specific risk factors; screening frequency could range from 1-time only screening among persons at low risk for future tuberculosis exposure to annual screening among those at continued risk of exposure.', 'risktext': 'Populations at increased risk for LTBI, based on increased prevalence of active disease and increased risk of exposure, include persons who were born in, or are former residents of, countries with high tuberculosis prevalence and persons who live in, or have lived in, high-risk congregate settings (eg, homeless shelters or correctional facilities). Clinicians can consult their local or state health departments for more information about populations at increased risk in their community, since local demographic patterns may vary across the US.\r\nIn 2020, 71.5% of all cases of active tuberculosis in the US occurred among persons born outside the US. According to the CDC, tuberculosis disease is common in most countries in Latin America, the Caribbean, Africa, Asia, Eastern Europe, and Russia. In 2020, among persons with new tuberculosis living in the US who were born outside the US, the most common countries of birth were Mexico (18.0%), the Philippines (12.5%), India (10.4%), Vietnam (8.2%), and China (5.1%), accounting for 54.2% of total cases. Most of these cases are believed to be due to progression of latent infection to active tuberculosis disease rather than new transmission within communities.\r\nPersons who live, or have lived, in high-risk congregate settings also have a higher prevalence rate of active tuberculosis and an increased risk for exposure. In 2020, 4.3% of tuberculosis disease cases diagnosed in persons 15 years or older occurred in persons experiencing homelessness and 2.6% occurred in residents of correctional facilities. It is estimated that persons experiencing homelessness have an 11 times higher incidence of tuberculosis disease compared with persons who are not experiencing homelessness (36 cases per 100,000 population vs 2.9 cases per 100,000 population, respectively, during 2011 to 2016).\r\nOther populations at increased risk for LTBI or progression to active disease include persons who have immunosuppression (eg, persons living with HIV, patients receiving immunosuppressive medications such as chemotherapy or tumor necrosis factor inhibitors, and patients who have received an organ transplant) and patients with silicosis (a lung disease). However, given that screening in these populations may be considered standard care as part of disease management or indicated prior to the use of certain medications, the USPSTF did not review evidence on screening in these populations. Information on testing in these populations is provided by other groups, such as the Office of AIDS Research at the National Institutes of Health, and in a guideline issued jointly by the American Thoracic Society, Infectious Diseases Society of America, and CDC. Some evidence from observational studies has explored the association between poorly controlled diabetes and progression of LTBI to active disease. However, there is insufficient evidence on screening for and treatment of LTBI in persons with diabetes for the USPSTF to make a separate recommendation for this important population.\r\nPersons who are contacts of individuals with active tuberculosis, health care workers, and workers in high-risk congregate settings may also be at increased risk of exposure. Because screening in these populations is conducted as part of public health or employee health surveillance, the USPSTF did not review the evidence in these populations. Clinicians seeking further information about testing for tuberculosis in these populations can refer to the Additional Tools and Resources and Recommendations of Others sections.'}, {'id': 514, 'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic bacteriuria in nonpregnant adults.', 'servfreq': '', 'risktext': 'The risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6 Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5 Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7, 11, 12 In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12 Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4, 6'}, {'id': 1909, 'title': 'Asymptomatic Carotid Artery Stenosis: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic carotid artery stenosis in the general adult population.\r\rSee the Practice Considerations section for a description of adults at increased risk.', 'servfreq': '', 'risktext': ''}, {'id': 2017, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for suicide risk in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': '', 'risktext': ''}, {'id': 2016, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for depression in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding the optimal timing for screening for depression; more evidence is needed in both perinatal and general adult populations. In the absence of evidence, a pragmatic approach might include screening adults who have not been screened previously and using clinical judgment while considering risk factors, comorbid conditions, and life events to determine if additional screening of patients at increased risk is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nThe USPSTF recommends screening for depression in all adults regardless of risk factors. Risk factors for depression include a combination of genetic, biological, and environmental factors, such as a family history of depression, prior episode of depression or other mental health condition, a history of trauma or adverse life events, or a history of disease or illness (eg, cardiovascular disease).\r\nPrevalence rates vary by sex, age, race, ethnicity, education, marital status, geographic location, poverty level, and employment status. Women have twice the risk of depression compared with men. Young adults, multiracial individuals, and Native American/Alaska Native individuals have higher rates of depression.\r\nRisk factors for perinatal depression include life stress, low social support, history of depression, marital or partner dissatisfaction, and a history of abuse.'}, {'id': 1845, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends offering or referring adults with cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity.', 'servfreq': '', 'risktext': 'Adults 18 years or older at increased risk of CVD, defined as those with 1 or more of the following:\r\n1.Hypertension or elevated blood pressure2.Dyslipidemia3.Mixed or multiple risk factors such as the metabolic syndrome or an estimated 10-year CVD risk of &ge;7.5%\r\nThis recommendation does not apply to adults with other known modifiable cardiovascular risk factors such as abnormal blood glucose levels, obesity, and smoking; these populations are incorporated in other USPSTF recommendations.'}, {'id': 1885, 'title': 'Hepatitis B Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in adolescents and adults at increased risk for infection.\r\rSee the Practice Considerations section for a description of adolescents and adults at increased risk for infection.', 'servfreq': 'For patients with negative HBsAg results who have not received the HBV vaccine series, periodic screening may be useful for those who report continued risk for acquiring HBV transmission, such as persons who continue to inject drugs and men who have sex with men. Clinical judgment should be used to determine screening frequency. The USPSTF found no evidence to determine optimal screening intervals.', 'risktext': 'Persons from such risk groups include persons who have injected drugs in the past or currently; men who have sex with men; persons with HIV; and sex partners, needle-sharing contacts, and household contacts of persons known to be HBsAg positive. Some persons with combinations of risk factors who are not members of risk factor groups listed above may also be at increased risk for HBV infection.'}, {'id': 524, 'title': 'Hepatitis C Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis C virus (HCV) infection in adults aged 18 to 79 years.', 'servfreq': 'One-time screening for most adults.\r\nPeriodically screen persons with continued risk for HCV infection (eg, persons with past or current injection drug use). There is limited evidence to determine how often to screen persons at increased risk.&nbsp;', 'risktext': 'Asymptomatic adults aged 18 to 79 years (including pregnant persons) without known liver disease.&nbsp;\r\nThe USPSTF also suggests that clinicians consider screening persons younger than 18 years and older than 79 years who are at high risk for infection (eg, those with past or current injection drug use).&nbsp;'}, {'id': 1916, 'title': 'Lung Cancer: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery.', 'servfreq': ' \r\nThe USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. ', 'risktext': ' \r\nSmoking and older age are the 2 most important risk factors for lung cancer.&nbsp;The risk of lung cancer in persons who smoke increases with cumulative quantity and duration of smoking and with age but decreases with increasing time since quitting for persons who formerly smoked.3 The USPSTF considers adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years to be at high risk and recommends screening for lung cancer with annual LDCT in this population. \r\n \r\n&nbsp;\r\n \r\nAfrican American/Black (Black) men have a higher incidence of lung cancer than White men, and Black women have a lower incidence than White women.1 These differences are likely related to differences in smoking exposure (ie, prevalence of smoking) and related exposure to carcinogens in cigarettes.7,8 The differences may also be related to other social risk factors.\r\n \r\n&nbsp;\r\n \r\nOther risk factors for lung cancer include environmental exposures, prior radiation therapy, other (noncancer) lung diseases, and family history. Lower level of education is also associated with a higher risk of lung cancer.7 The task force recommends using age and smoking history to determine screening eligibility rather than more elaborate risk prediction models because there is insufficient evidence to assess whether risk prediction model&ndash;based screening would improve outcomes relative to using the risk factors of age and smoking history for broad implementation in primary care.\r\n '}, {'id': 1445, 'title': 'Sexually Transmitted Infections: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends behavioral counseling for all sexually active adolescents and for adults who are at increased risk for sexually transmitted infections (STIs).\r\rSee the Practice Considerations section for more information on populations at increased risk for acquiring STIs.', 'servfreq': '', 'risktext': 'All sexually active adolescents are at increased risk for STIs because of the high rates of STIs in this age group and should receive behavioral counseling interventions. Adults at increased risk for STIs include those who currently have an STI or were diagnosed with one within the past year, do not consistently use condoms, have multiple sex partners, or have sex partners within populations with a high prevalence of STIs. Populations with a high prevalence of STIs include persons who seek STI testing or attend STI clinics; sexual and gender minorities; persons who are living with HIV, inject drugs, have exchanged sex for money or drugs, or have entered correctional facilities; and some racial/ethnic minority groups.1-4'}, {'id': 402, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends counseling young adults, adolescents, children, and parents of young children about minimizing exposure to ultraviolet (UV) radiation for persons aged 6 months to 24 years with fair skin types to reduce their risk of skin cancer.', 'servfreq': '', 'risktext': 'Fair skin types'}, {'id': 438, 'title': 'Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for unhealthy alcohol use in primary care settings in adults 18 years or older, including pregnant women, and providing persons engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce unhealthy alcohol use.', 'servfreq': 'The USPSTF did not find adequate evidence to recommend an optimal screening interval for unhealthy alcohol use in adults.&nbsp;Brief behavioral counseling interventions were found to reduce unhealthy alcohol use in adults 18 years or older, including pregnant women. Effective behavioral counseling interventions vary in their specific components, administration, length, and number of interactions. The USPSTF was unable to identify specific intervention characteristics or components that were clearly associated with improved outcomes.', 'risktext': 'engaged in risky or hazardous drinking'}, {'id': 767, 'title': 'Unhealthy Drug Use: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening by asking questions about unhealthy drug use in adults age 18 years or older. Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. \r(Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'servfreq': 'Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. (Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'risktext': 'These include being aged 18 to 25 years; male sex; having a mental health condition, personality or mood disorder, or nicotine or alcohol dependence; a history of physical or sexual abuse, parental neglect, or other adversity in childhood; or drug or alcohol addiction in a first-degree relative.1,9&nbsp;Factors associated with misuse of prescription drugs include history of other drug use, mental illness, pain, and greater access to prescription drugs.10&nbsp;Factors associated with prenatal use of drugs include a mental health disorder, interpersonal violence, and family history of substance use.11'}, {'id': 433, 'title': 'Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer or refer adults with a body mass index (BMI) of 30 or higher (calculated as weight in kilograms divided by height in meters squared) to intensive, multicomponent behavioral interventions.', 'servfreq': '', 'risktext': 'Adults with a BMI &ge;30'}, {'id': 1979, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: Behavioral Counseling Interventions ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians individualize the decision to offer or refer adults without cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity. \r\rSee the "Practice Considerations" section for information on determining which patients may benefit most from this service.', 'servfreq': '', 'risktext': ''}, {'id': 1937, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for chlamydia and gonorrhea in men.', 'servfreq': '', 'risktext': ''}, {'id': 418, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening with resting or exercise electrocardiography (ECG) to prevent cardiovascular disease (CVD) events in asymptomatic adults at low risk of CVD events.', 'servfreq': '', 'risktext': ''}, {'id': 1973, 'title': 'Chronic Obstructive Pulmonary Disease: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for chronic obstructive pulmonary disease in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 2003, 'title': 'Genital Herpes Infection: Serologic Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine serologic screening for genital herpes simplex virus infection in asymptomatic adolescents and adults, including pregnant persons.', 'servfreq': '', 'risktext': 'The USPSTF found no evidence of externally validated, reliable risk stratification tools to identify individuals more or less likely to have genital herpes.'}, {'id': 504, 'title': 'Pancreatic Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for pancreatic cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 203, 'title': 'Testicular Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for testicular cancer in adolescent or adult men.', 'servfreq': '', 'risktext': ''}, {'id': 365, 'title': 'Thyroid Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for thyroid cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 1976, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'D', 'text': 'The DoctorAI recommends against the use of beta carotene or vitamin E supplements for the prevention of cardiovascular disease or cancer.', 'servfreq': '', 'risktext': ''}, {'id': 318, 'title': 'Autism Spectrum Disorder in Young Children: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for autism spectrum disorder (ASD) in young children for whom no concerns of ASD have been raised by their parents or a clinician.', 'servfreq': '', 'risktext': 'Although a number of potential risk factors for ASD have been identified, there is insufficient evidence to determine if certain risk factors modify the performance characteristics of ASD screening tests, such as the age at which screening is performed or other characteristics of the child or family.'}, {'id': 65, 'title': 'Bladder Cancer in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults.\r\rLiterature scans conducted in July 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'This evidence update focused on the benefits and harms of screening for bladder cancer among people without symptoms, the accuracy of screening tests done in primary care settings, and the benefits and harms of treatment. The updated evidence review did not find any new high quality evidence to adequately determine the balance of benefits and harms of screening for bladder cancer. However, bladder cancer is a common cancer and can cause considerable health problems including death. Therefore, the USPSTF determined that the evidence was insufficient to provide a recommendation for or against bladder cancer screening.  The USPSTF emphasizes the need for additional research in this area. '}, {'id': 419, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening with resting or exercise ECG to prevent CVD events in asymptomatic adults at intermediate or high risk of CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 423, 'title': 'Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of adding the ankle-brachial index (ABI), high-sensitivity C-reactive protein (hsCRP) level, or coronary artery calcium (CAC) score to traditional risk assessment for cardiovascular disease (CVD) in asymptomatic adults to prevent CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 352, 'title': 'Celiac Disease: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'persons with family history or other risk factors'}, {'id': 1955, 'title': 'Eating Disorders in Adolescents and Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for eating disorders in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 665, 'title': 'Illicit Drug Use in Children, Adolescents, and Young Adults: Primary Care-Based Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--based behavioral counseling interventions to prevent illicit drug use, including nonmedical use of prescription drugs, in children, adolescents, and young adults.\r\rSee the Practice Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 435, 'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for abuse and neglect in all older or vulnerable adults. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': 'Risk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health.14&nbsp;For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.15'}, {'id': 2045, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for iron deficiency and iron deficiency anemia in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2046, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine iron supplementation in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2018, 'title': 'Lipid Disorders in Children and Adolescents: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1998, 'title': 'Obstructive Sleep Apnea in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for obstructive sleep apnea in the general adult population.\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Risk Factors\r\nRisk factors associated with OSA include male sex, older age (40-70 years), postmenopausal status, higher body mass index (BMI), and craniofacial and upper airway abnormalities (eg, enlarged tonsils or long upper airway). Black, Hispanic/Latino, and Native American/Alaska Native persons have a higher prevalence of OSA compared with White persons; some evidence suggests that these differences are partially explained by higher rates of obesity, asthma, and tobacco use among these groups.8'}, {'id': 1977, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of multivitamin supplements for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1978, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of single or paired nutrient supplements (other than beta carotene and vitamin E) for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 176, 'title': 'Oral Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for oral cancer in asymptomatic adults.\r\rGo to the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in July 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Tobacco and alcohol use are major risk factors for oral cancer. A total of 20% to 30% of cases of oral cancer worldwide are attributable to cigarette smoking. In the United States, up to 75% of cases of oral cancer may be attributable to tobacco and alcohol use. Additional risk factors include male sex, older age, use of betel quid, ultraviolet light exposure, infection with Candida or bacterial flora, and a compromised immune system. Sexually transmitted oral HPV infection (HPV-16) has recently been recognized as an increasingly important risk factor for oropharyngeal cancer. In the United States, the prevalence of oropharyngeal cancer due to oral HPV infection is probably as high as 80% to 95%. The prevalence of oral HPV infection is associated with age, sex, number of sexual partners, and number of cigarettes smoked per day. The effect of multifactorial risk assessment and screening for risk factors on oral cancer morbidity and mortality is unknown.'}, {'id': 2026, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine screening performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 2027, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of preventive interventions performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 424, 'title': 'Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for peripheral artery disease (PAD) and cardiovascular disease (CVD) risk with the ankle-brachial index (ABI) in asymptomatic adults.\r\rLiterature scans conducted in August 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Risk factors associated with OSA include male sex, older age (40 to 70 years), postmenopausal status, higher BMI, and craniofacial and upper airway abnormalities.'}, {'id': 404, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of counseling adults about skin self-examination to prevent skin cancer.See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 2005, 'title': 'Skin Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Exposure to UV radiation from sun exposure, indoor tanning beds, and other UV radiation&ndash;emitting devices is the major environmental risk factor for skin cancer. History of frequent sunburns, older age, and male sex are associated with increased risk for skin cancer. Exposure to UV radiation from the use of indoor tanning beds is an important risk factor in adolescents. Incidence of melanoma is higher among White persons compared with persons of other races and ethnicities. This difference likely reflects traits associated with increased melanoma risk, such as fair skin (which is more susceptible to sunburning), light-colored eyes, and red or blond hair being more common among White persons compared with persons of other races and ethnicities. Acral lentiginous melanoma, which occurs mostly on skin not frequently exposed to direct sunlight (eg, palms of hands, soles of feet, or under fingernails or toenails), is the most common type of melanoma among Black populations. Other melanoma risk factors include higher numbers of moles on the skin, atypical moles, as well as a personal and family history of skin cancer.'}, {'id': 269, 'title': 'Thyroid Dysfunction: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults.\r\rSee the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': 'The optimal screening interval for thyroid dysfunction (if one exists) is unknown.', 'risktext': 'The most common cause of hypothyroidism in the United States is chronic autoimmune (Hashimoto) thyroiditis. Risk factors for an elevated TSH level include female sex, advancing age, white race, type 1 diabetes, Down syndrome, family history of thyroid disease, goiter, previous hyperthyroidism (possibly due in part to ablation therapy leading to iatrogenic thyroid dysfunction), and external-beam radiation in the head and neck area. Common causes of hyperthyroidism include Graves disease, Hashimoto thyroiditis, and functional thyroid nodules. Risk factors for a low TSH level include female sex; advancing age; black race; low iodine intake; personal or family history of thyroid disease; and ingestion of iodine-containing drugs, such as amiodarone. The USPSTF found no direct evidence that treatment of thyroid dysfunction based on risk level alters final health outcomes.'}, {'id': 1908, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of electronic cigarettes (e-cigarettes) for tobacco cessation in adults, including pregnant persons. The USPSTF recommends that clinicians direct patients who use tobacco to other tobacco cessation interventions with proven effectiveness and established safety.\rSee the Practice Considerations section for more information on recommended behavioral interventions and pharmacotherapy and for suggestions for practice regarding the I statements.', 'servfreq': '', 'risktext': ''}, {'id': 1907, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of pharmacotherapy interventions for tobacco cessation in pregnant persons.', 'servfreq': '', 'risktext': ''}, {'id': 586, 'title': 'Tobacco Use in Children and Adolescents: Primary Care Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--feasible interventions for the cessation of tobacco use among school-aged children and adolescents.\r\rSee the Practice Considerations section for more information on effective interventions to prevent initiation of tobacco use and for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1919, 'title': 'Vitamin D Deficiency in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 408, 'title': 'Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of the benefits and harms of vitamin D and calcium supplementation, alone or combined, for the primary prevention of fractures in men and premenopausal women.', 'servfreq': '', 'risktext': ''}]
2025-01-29 21:51:12 [INFO] Tools: [{'tool_id': 321, 'url': 'https://jamanetwork.com/journals/jama/fullarticle/2735342', 'title': 'JAMA Patient Page: Who Should Be Screened for HIV Infection? ', 'text': '', 'keywords': ''}, {'tool_id': 322, 'url': 'https://sites.jamanetwork.com/spanish-patient-pages/2019/hoja-para-el-paciente-de-jama-190618.pdf', 'title': 'ยฟQuiรฉnes deben someterse a una prueba de detecciรณn de infecciรณn por VIH?', 'text': '', 'keywords': 'HIV|Human immunodeficiency syndrome|AIDS'}, {'tool_id': 210, 'url': 'https://www.aafp.org/afp/2019/1115/p637.html', 'title': "Screening for HIV Infection and Preexposure Prophylaxis for the Prevention of HIV Infection: AFP's Putting Into Practice", 'text': 'The journal American Family Physician (AFP) provides a series of short case studies and quizzes based on recommendations issued by the U.S. Preventive Services Task Force.', 'keywords': ''}]
2025-01-29 21:51:13 [INFO] Update id=273478138 is handled. Duration 1135 ms by bot id=8108339380
2025-01-29 21:52:58 [WARNING] Received SIGTERM signal
2025-01-29 21:52:58 [INFO] Polling stopped for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-29 21:52:58 [INFO] Polling stopped
2025-01-29 21:52:58 [INFO] โ ะัะป ะฟะพะดะบะปััะตะฝะธะน ะบ ะะ ะทะฐะบััั.
2025-01-29 21:52:58 [INFO] โ ะะพะดะบะปััะตะฝะธะต ะบ ะะ ะทะฐะบัััะพ.
2025-01-29 21:53:06 [INFO] ๐ ะะพั ะทะฐะฟััะบะฐะตััั...
2025-01-29 21:53:06 [INFO] โ ะัะป ะฟะพะดะบะปััะตะฝะธะน ะบ ะะ ัะพะทะดะฐะฝ.
2025-01-29 21:53:06 [INFO] โ ะขะฐะฑะปะธัั ะฒ ะฑะฐะทะต ะดะฐะฝะฝัั ััะฟะตัะฝะพ ัะพะทะดะฐะฝั.
2025-01-29 21:53:06 [INFO] Start polling
2025-01-29 21:53:07 [INFO] Run polling for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-29 21:53:14 [INFO] The user 711983855 called the command /start.
2025-01-29 21:53:15 [INFO] Update id=273478139 is handled. Duration 1291 ms by bot id=8108339380
2025-01-29 21:53:16 [INFO] The user 711983855's state has been set to Survey.age.
2025-01-29 21:53:17 [INFO] Update id=273478140 is handled. Duration 387 ms by bot id=8108339380
2025-01-29 21:53:19 [INFO] The user 711983855's state has been set to Survey.weight.
2025-01-29 21:53:20 [INFO] Update id=273478141 is handled. Duration 340 ms by bot id=8108339380
2025-01-29 21:53:22 [INFO] The user 711983855's state has been set to Survey.height.
2025-01-29 21:53:22 [INFO] Update id=273478142 is handled. Duration 337 ms by bot id=8108339380
2025-01-29 21:53:23 [INFO] The user 711983855's state has been set to Survey.feet.
2025-01-29 21:53:24 [INFO] Update id=273478143 is handled. Duration 372 ms by bot id=8108339380
2025-01-29 21:53:26 [INFO] The user 711983855's state has been set to Survey.gender.
2025-01-29 21:53:26 [INFO] Update id=273478144 is handled. Duration 330 ms by bot id=8108339380
2025-01-29 21:53:28 [INFO] The user 711983855's state has been set to Survey.smoking.
2025-01-29 21:53:29 [INFO] Update id=273478145 is handled. Duration 330 ms by bot id=8108339380
2025-01-29 21:53:30 [INFO] The user 711983855's state has been set to Survey.sex.
2025-01-29 21:53:30 [INFO] Update id=273478146 is handled. Duration 325 ms by bot id=8108339380
2025-01-29 21:53:31 [INFO] State data: {'db': <bot.database.Database object at 0x7fb55054b2f0>, 'age': 40, 'weight': 90, 'height': 190, 'feet': 45, 'gender': 'male', 'pregnant': 'no', 'smoking': 'yes', 'sex': 'yes'}
2025-01-29 21:53:31 [INFO] Recommendations: [{'id': 485, 'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in adolescents and adults aged 15 to 65 years. Younger adolescents and older adults who are at increased risk of infection should also be screened.\rSee the Clinical Considerations section for more information about assessment of risk, screening intervals, and rescreening in pregnancy.', 'servfreq': 'The USPSTF found insufficient evidence to determine appropriate or optimal time intervals or strategies for repeat HIV screening. However, repeat screening is reasonable for persons known to be at increased risk of HIV infection, such as sexually active men who have sex with men; persons with a sex partner who is living with HIV; or persons who engage in behaviors that may convey an increased risk of HIV infection, such as injection drug use, transactional sex or commercial sex work, having 1 or more new sex partners whose HIV status is unknown, or having other factors that can place a person at increased risk of HIV infection (see &ldquo;Risk Assessment&rdquo;). Repeat screening is also reasonable for persons who live or receive medical care in a high-prevalence setting, such as a sexually transmitted disease clinic, tuberculosis clinic, correctional facility, or homeless shelter.', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'id': 1921, 'title': 'Hypertension in Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hypertension in adults 18 years or older with office blood pressure measurement (OBPM). The USPSTF recommends obtaining blood pressure measurements outside of the clinical setting for diagnostic confirmation before starting treatment.', 'servfreq': ' \r\nAlthough evidence on optimal screening intervals is limited, reasonable options include:\r\n \r\n \r\n\r\n\r\nScreening for hypertension every year in adults 40 years or older and in adults at increased risk for hypertension (such as Black persons, persons with high-normal blood pressure, or persons who are overweight or obese)\r\n\r\n\r\n \r\n \r\n\r\n\r\nScreening less frequently (ie, every 3 to 5 years) as appropriate for adults aged 18 to 39 years not at increased risk for hypertension and with a prior normal blood pressure reading.\r\n\r\n\r\n ', 'risktext': ' \r\nAlthough all adults should be screened for hypertension, risk factors that increase a person&rsquo;s risk for the condition include older age, Black race, family history, excess weight and obesity, lifestyle habits (lack of physical activity, stress, and tobacco use), and dietary factors (diet high in fat or sodium, diet low in potassium, or excessive alcohol intake)\r\n '}, {'id': 2021, 'title': 'Prevention of Acquisition of HIV: Preexposure Prophylaxis ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians prescribe preexposure prophylaxis using effective antiretroviral therapy to persons who are at increased risk of HIV acquisition to decrease the risk of acquiring HIV. \r\rSee the Practice Considerations section for more information about identification of persons at increased risk and about effective antiretroviral therapy.', 'servfreq': '', 'risktext': 'HIV is primarily acquired via sexual activity or injection drug use. It is important that clinicians routinely take a sexual and injection drug use history for all their patients in an open and nonjudgmental manner. All adolescents and adults who are sexually active or who inject drugs should be informed that acquisition of HIV can be prevented, to facilitate subsequent risk assessment and discussions about preexposure prophylaxis (PrEP) and other ways to prevent acquisition of HIV. Importantly, risk of HIV acquisition exists on a continuum, and currently available risk assessment tools all have limitations. However, certain risk factors or behaviors are known to place persons at increased risk of HIV.\r\nRisk of HIV acquisition depends on the likelihood that a specific act or activity will transmit HIV and the likelihood that a sex partner or drug injection partner has HIV. Likelihood of HIV transmission is highest with needle-sharing injection drug use and condomless receptive anal intercourse. Condomless receptive anal intercourse has an approximately 10- to 15-fold higher risk of transmission than condomless insertive anal sex and condomless receptive and insertive penile-vaginal sex. A 2018 study estimated the prevalence of HIV (ie, an estimate of the likelihood that a partner whose HIV status is unknown has HIV at a population level) as 12.4% among men who have sex with men and 1.9% among persons who inject drugs. The overall prevalence of HIV in the US is estimated at 0.3%.&nbsp;Of note, both the frequency of specific sexual activities and a person&rsquo;s number of sexual partners will also affect their risk of HIV.\r\n&nbsp;The USPSTF recommends that the following persons be considered for PrEP:\r\n1.&nbsp;&nbsp;&nbsp;&nbsp; Sexually active adults and adolescents weighing at least 35 kg (77 lb) who have engaged in anal or vaginal sex in the past 6 months and have any of the following:\r\n&nbsp;\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A sexual partner who has HIV (especially if the partner has an unknown or detectable viral load).\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A bacterial sexually transmitted infection (STI) (syphilis, gonorrhea, or chlamydia for men who have sex with men and transgender women; gonorrhea and syphilis for heterosexual women and men) in the past 6 months.\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A history of inconsistent or no condom use with sex partner(s) whose HIV status is not known; assessing risk in conversation with the patient and considering factors such as number of partners, the specific sexual activities a person engages in, and whether their sex partner or partners are in a group with a higher prevalence of HIV (eg, men who have sex with men or with men and women, transgender women, persons who inject drugs, and persons who engage in transactional sex).\r\n&nbsp;\r\n2. &nbsp; Persons who inject drugs and have a drug-injecting partner who has HIV or who shares injection equipment.\r\nPersons who engage in transactional sex, such as sex for money, drugs, or housing, including commercial sex workers or persons trafficked for sex work, constitute a group at increased risk of HIV acquisition and should be considered for PrEP based on the criteria outlined above. Persons who request PrEP may have undisclosed behaviors that put them at risk. Transgender women and men who are sexually active should be considered for PrEP based on the criteria outlined above. Transgender women are at especially high risk of HIV acquisition. A Centers for Disease Control and and Prevention (CDC) survey in 7 cities found an HIV prevalence of 42% among transgender women. Prevalence was highest among Black transgender women (62%) and Native American/Alaska Native transgender women (65%).\r\nIn addition, studies have found that transmission of HIV to a seronegative partner from a partner with HIV has not been observed when the partner with HIV was being treated with antiretroviral therapy and had a suppressed viral load.&nbsp;It is not known whether PrEP use further decreases the risk of HIV transmission when a partner with HIV has a documented undetectable viral load. Factors such as the consistency or inconsistency of a partner&rsquo;s viral load being suppressed, a partner&rsquo;s adherence to antiretroviral therapy, and the degree of certainty that a partner&rsquo;s viral load is suppressed (eg, self-report vs availability of laboratory test results) may help inform decisions about the use of PrEP in this situation.\r\nAll persons being considered for PrEP must have a recently documented negative HIV antigen-antibody test result, and if they have taken oral PrEP or postexposure prophylaxis in the past 3 months, or injectable cabotegravir in the past 12 months, the CDC recommends testing with both an HIV antigen-antibody assay and an HIV-1 RNA assay.'}, {'id': 1989, 'title': 'Syphilis Infection in Nonpregnant Adolescents and Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for syphilis infection in persons who are at increased risk for infection.', 'servfreq': 'Optimal screening frequency for persons who are at increased risk for syphilis infection is not well established. Men who have sex with men or persons with HIV infection may benefit from screening at least annually or more frequently (eg, every 3 to 6 months) if they continue to be at high risk.', 'risktext': 'The USPSTF recommends screening for syphilis in persons who are at increased risk for infection. When deciding which persons to screen for syphilis, clinicians should consider the prevalence of infection in the communities they serve, as well as other sociodemographic and behavioral factors that may be associated with increased risk of syphilis infection. For example, prevalence of syphilis is higher in men, men who have sex with men, persons with HIV infection, young adults, and persons with a history of incarceration, sex work, or military service. A substantial percentage of heterosexual syphilis transmission occurs among persons who use illicit drugs, particularly methamphetamine. Diagnosis of another STI may signal that a person is having condomless sex, which increases their risk of syphilis infection. Higher infection rates in persons of some racial and ethnic groups have been reported and are primarily a reflection of a combination of factors, including social determinants of health (eg, disparities of income, low educational achievement, and unstable housing), differential health insurance coverage or access to quality health care, and differences in sexual network characteristics (eg, individuals living in communities with a high prevalence of STIs have an increased chance of encountering an infected partner). Local prevalence rates may change over time, so clinicians should be aware of the latest data and trends for their specific population and geographic area, which are available through their state and local health departments and Centers for Disease Control and Prevention (CDC) surveillance.\r\n&nbsp;\r\nAlthough direct evidence on screening in nonpregnant persons who are not at increased risk for syphilis infection is lacking, based on the established test performance characteristics of current screening tests and the low prevalence rate of syphilis in this population, the yield of screening is likely low.9,10 Therefore, screening in this population may result in high false-positive rates and overtreatment.'}, {'id': 1905, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and US Food and Drug Administration (FDA)--approved pharmacotherapy for cessation to nonpregnant adults who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 1906, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all pregnant persons about tobacco use, advise them to stop using tobacco, and provide behavioral interventions for cessation to pregnant persons who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 2014, 'title': 'Anxiety Disorders in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for anxiety disorders in adults, including pregnant and postpartum persons.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding optimal timing for screening, or screening interval, for both the perinatal and general adult populations; more evidence on both timing and screening interval is needed for all adult populations. A pragmatic approach in the absence of evidence might include screening all adults who have not been screened previously and using clinical judgment in considering risk factors, comorbid conditions, and life events to determine if additional screening of high-risk patients is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nRisk factors for anxiety disorders include sociodemographic factors, psychosocial factors, and physical and mental health factors such as marital status (widowed or divorced), stressful life events, smoking and alcohol use, other mental health conditions, or a parental history of mental disorders. Demographic factors such as low socioeconomic status and female sex are associated with higher rates of anxiety disorders.&nbsp;Black persons and individuals of non-Hispanic ethnicity are at increased risk of anxiety disorders due to social, rather than biological, factors. Anxiety and depressive disorders often overlap. One cohort study found that 67% of individuals with a depressive disorder also had a current anxiety disorder, and 75% had a lifetime comorbid anxiety disorder.'}, {'id': 2009, 'title': 'Latent Tuberculosis Infection in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for LTBI in populations at increased risk.\r\rSee the "Assessment of Risk" section for additional information on adults at increased risk.', 'servfreq': 'The USPSTF found no evidence on the optimal frequency of screening for LTBI. In the absence of evidence, a reasonable approach is to repeat screening based on specific risk factors; screening frequency could range from 1-time only screening among persons at low risk for future tuberculosis exposure to annual screening among those at continued risk of exposure.', 'risktext': 'Populations at increased risk for LTBI, based on increased prevalence of active disease and increased risk of exposure, include persons who were born in, or are former residents of, countries with high tuberculosis prevalence and persons who live in, or have lived in, high-risk congregate settings (eg, homeless shelters or correctional facilities). Clinicians can consult their local or state health departments for more information about populations at increased risk in their community, since local demographic patterns may vary across the US.\r\nIn 2020, 71.5% of all cases of active tuberculosis in the US occurred among persons born outside the US. According to the CDC, tuberculosis disease is common in most countries in Latin America, the Caribbean, Africa, Asia, Eastern Europe, and Russia. In 2020, among persons with new tuberculosis living in the US who were born outside the US, the most common countries of birth were Mexico (18.0%), the Philippines (12.5%), India (10.4%), Vietnam (8.2%), and China (5.1%), accounting for 54.2% of total cases. Most of these cases are believed to be due to progression of latent infection to active tuberculosis disease rather than new transmission within communities.\r\nPersons who live, or have lived, in high-risk congregate settings also have a higher prevalence rate of active tuberculosis and an increased risk for exposure. In 2020, 4.3% of tuberculosis disease cases diagnosed in persons 15 years or older occurred in persons experiencing homelessness and 2.6% occurred in residents of correctional facilities. It is estimated that persons experiencing homelessness have an 11 times higher incidence of tuberculosis disease compared with persons who are not experiencing homelessness (36 cases per 100,000 population vs 2.9 cases per 100,000 population, respectively, during 2011 to 2016).\r\nOther populations at increased risk for LTBI or progression to active disease include persons who have immunosuppression (eg, persons living with HIV, patients receiving immunosuppressive medications such as chemotherapy or tumor necrosis factor inhibitors, and patients who have received an organ transplant) and patients with silicosis (a lung disease). However, given that screening in these populations may be considered standard care as part of disease management or indicated prior to the use of certain medications, the USPSTF did not review evidence on screening in these populations. Information on testing in these populations is provided by other groups, such as the Office of AIDS Research at the National Institutes of Health, and in a guideline issued jointly by the American Thoracic Society, Infectious Diseases Society of America, and CDC. Some evidence from observational studies has explored the association between poorly controlled diabetes and progression of LTBI to active disease. However, there is insufficient evidence on screening for and treatment of LTBI in persons with diabetes for the USPSTF to make a separate recommendation for this important population.\r\nPersons who are contacts of individuals with active tuberculosis, health care workers, and workers in high-risk congregate settings may also be at increased risk of exposure. Because screening in these populations is conducted as part of public health or employee health surveillance, the USPSTF did not review the evidence in these populations. Clinicians seeking further information about testing for tuberculosis in these populations can refer to the Additional Tools and Resources and Recommendations of Others sections.'}, {'id': 514, 'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic bacteriuria in nonpregnant adults.', 'servfreq': '', 'risktext': 'The risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6 Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5 Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7, 11, 12 In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12 Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4, 6'}, {'id': 1909, 'title': 'Asymptomatic Carotid Artery Stenosis: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic carotid artery stenosis in the general adult population.\r\rSee the Practice Considerations section for a description of adults at increased risk.', 'servfreq': '', 'risktext': ''}, {'id': 2017, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for suicide risk in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': '', 'risktext': ''}, {'id': 2016, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for depression in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding the optimal timing for screening for depression; more evidence is needed in both perinatal and general adult populations. In the absence of evidence, a pragmatic approach might include screening adults who have not been screened previously and using clinical judgment while considering risk factors, comorbid conditions, and life events to determine if additional screening of patients at increased risk is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nThe USPSTF recommends screening for depression in all adults regardless of risk factors. Risk factors for depression include a combination of genetic, biological, and environmental factors, such as a family history of depression, prior episode of depression or other mental health condition, a history of trauma or adverse life events, or a history of disease or illness (eg, cardiovascular disease).\r\nPrevalence rates vary by sex, age, race, ethnicity, education, marital status, geographic location, poverty level, and employment status. Women have twice the risk of depression compared with men. Young adults, multiracial individuals, and Native American/Alaska Native individuals have higher rates of depression.\r\nRisk factors for perinatal depression include life stress, low social support, history of depression, marital or partner dissatisfaction, and a history of abuse.'}, {'id': 1845, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends offering or referring adults with cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity.', 'servfreq': '', 'risktext': 'Adults 18 years or older at increased risk of CVD, defined as those with 1 or more of the following:\r\n1.Hypertension or elevated blood pressure2.Dyslipidemia3.Mixed or multiple risk factors such as the metabolic syndrome or an estimated 10-year CVD risk of &ge;7.5%\r\nThis recommendation does not apply to adults with other known modifiable cardiovascular risk factors such as abnormal blood glucose levels, obesity, and smoking; these populations are incorporated in other USPSTF recommendations.'}, {'id': 1885, 'title': 'Hepatitis B Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in adolescents and adults at increased risk for infection.\r\rSee the Practice Considerations section for a description of adolescents and adults at increased risk for infection.', 'servfreq': 'For patients with negative HBsAg results who have not received the HBV vaccine series, periodic screening may be useful for those who report continued risk for acquiring HBV transmission, such as persons who continue to inject drugs and men who have sex with men. Clinical judgment should be used to determine screening frequency. The USPSTF found no evidence to determine optimal screening intervals.', 'risktext': 'Persons from such risk groups include persons who have injected drugs in the past or currently; men who have sex with men; persons with HIV; and sex partners, needle-sharing contacts, and household contacts of persons known to be HBsAg positive. Some persons with combinations of risk factors who are not members of risk factor groups listed above may also be at increased risk for HBV infection.'}, {'id': 524, 'title': 'Hepatitis C Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis C virus (HCV) infection in adults aged 18 to 79 years.', 'servfreq': 'One-time screening for most adults.\r\nPeriodically screen persons with continued risk for HCV infection (eg, persons with past or current injection drug use). There is limited evidence to determine how often to screen persons at increased risk.&nbsp;', 'risktext': 'Asymptomatic adults aged 18 to 79 years (including pregnant persons) without known liver disease.&nbsp;\r\nThe USPSTF also suggests that clinicians consider screening persons younger than 18 years and older than 79 years who are at high risk for infection (eg, those with past or current injection drug use).&nbsp;'}, {'id': 1916, 'title': 'Lung Cancer: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery.', 'servfreq': ' \r\nThe USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. ', 'risktext': ' \r\nSmoking and older age are the 2 most important risk factors for lung cancer.&nbsp;The risk of lung cancer in persons who smoke increases with cumulative quantity and duration of smoking and with age but decreases with increasing time since quitting for persons who formerly smoked.3 The USPSTF considers adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years to be at high risk and recommends screening for lung cancer with annual LDCT in this population. \r\n \r\n&nbsp;\r\n \r\nAfrican American/Black (Black) men have a higher incidence of lung cancer than White men, and Black women have a lower incidence than White women.1 These differences are likely related to differences in smoking exposure (ie, prevalence of smoking) and related exposure to carcinogens in cigarettes.7,8 The differences may also be related to other social risk factors.\r\n \r\n&nbsp;\r\n \r\nOther risk factors for lung cancer include environmental exposures, prior radiation therapy, other (noncancer) lung diseases, and family history. Lower level of education is also associated with a higher risk of lung cancer.7 The task force recommends using age and smoking history to determine screening eligibility rather than more elaborate risk prediction models because there is insufficient evidence to assess whether risk prediction model&ndash;based screening would improve outcomes relative to using the risk factors of age and smoking history for broad implementation in primary care.\r\n '}, {'id': 1934, 'title': 'Prediabetes and Type 2 Diabetes: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for prediabetes and type 2 diabetes in adults aged 35 to 70 years who have overweight or obesity. Clinicians should offer or refer patients with prediabetes to effective preventive interventions.', 'servfreq': ' \r\nEvidence on the optimal screening interval for adults with an initial normal glucose test result is limited. Cohort and modeling studies suggest that screening every 3 years may be a reasonable approach for adults with normal blood glucose levels.\r\n ', 'risktext': 'Overweight and obesity are the strongest risk factors for developing prediabetes and type 2 diabetes in adults. Other risk factors include older age, family history, history of gestational diabetes, history of polycystic ovarian syndrome, and dietary and lifestyle factors. The prevalence of diabetes is higher among American Indian/Alaska Native (14.7%), Asian (9.2%), Hispanic/Latino (12.5%), and non-Hispanic Black (11.7%) persons than among non-Hispanic White (7.5%) persons. Disparities in diabetes prevalence are the result of a variety of factors. A large body of evidence demonstrates strong associations between prevalence of diabetes and social factors such as socioeconomic status, food environment, and physical environment. The higher prevalence of diabetes in Asian persons may be related to differences in body composition. A difference in body fat composition in Asian persons results in underestimation of risk based on BMI thresholds used to define overweight in the US.\r\n \r\n&nbsp;\r\n \r\nClinicians should consider screening at an earlier age in persons from groups with disproportionately high incidence and prevalence (American Indian/Alaska Native, Asian American, Black, Hispanic/Latino, or Native Hawaiian/Pacific Islander persons) or in persons who have a family history of diabetes, a history of gestational diabetes, or a history of polycystic ovarian syndrome, and at a lower BMI in Asian American persons.11,12 Data suggest that a BMI of 23 or greater may be an appropriate cut point in Asian American persons.13\r\n '}, {'id': 1445, 'title': 'Sexually Transmitted Infections: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends behavioral counseling for all sexually active adolescents and for adults who are at increased risk for sexually transmitted infections (STIs).\r\rSee the Practice Considerations section for more information on populations at increased risk for acquiring STIs.', 'servfreq': '', 'risktext': 'All sexually active adolescents are at increased risk for STIs because of the high rates of STIs in this age group and should receive behavioral counseling interventions. Adults at increased risk for STIs include those who currently have an STI or were diagnosed with one within the past year, do not consistently use condoms, have multiple sex partners, or have sex partners within populations with a high prevalence of STIs. Populations with a high prevalence of STIs include persons who seek STI testing or attend STI clinics; sexual and gender minorities; persons who are living with HIV, inject drugs, have exchanged sex for money or drugs, or have entered correctional facilities; and some racial/ethnic minority groups.1-4'}, {'id': 1981, 'title': 'Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians prescribe a statin for the primary prevention of CVD for adults aged 40 to 75 years who have 1 or more CVD risk factors (i.e. dyslipidemia, diabetes, hypertension, or smoking) and an estimated 10-year risk of a cardiovascular event of 10% or greater.', 'servfreq': '', 'risktext': ''}, {'id': 438, 'title': 'Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for unhealthy alcohol use in primary care settings in adults 18 years or older, including pregnant women, and providing persons engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce unhealthy alcohol use.', 'servfreq': 'The USPSTF did not find adequate evidence to recommend an optimal screening interval for unhealthy alcohol use in adults.&nbsp;Brief behavioral counseling interventions were found to reduce unhealthy alcohol use in adults 18 years or older, including pregnant women. Effective behavioral counseling interventions vary in their specific components, administration, length, and number of interactions. The USPSTF was unable to identify specific intervention characteristics or components that were clearly associated with improved outcomes.', 'risktext': 'engaged in risky or hazardous drinking'}, {'id': 767, 'title': 'Unhealthy Drug Use: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening by asking questions about unhealthy drug use in adults age 18 years or older. Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. \r(Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'servfreq': 'Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. (Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'risktext': 'These include being aged 18 to 25 years; male sex; having a mental health condition, personality or mood disorder, or nicotine or alcohol dependence; a history of physical or sexual abuse, parental neglect, or other adversity in childhood; or drug or alcohol addiction in a first-degree relative.1,9&nbsp;Factors associated with misuse of prescription drugs include history of other drug use, mental illness, pain, and greater access to prescription drugs.10&nbsp;Factors associated with prenatal use of drugs include a mental health disorder, interpersonal violence, and family history of substance use.11'}, {'id': 433, 'title': 'Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer or refer adults with a body mass index (BMI) of 30 or higher (calculated as weight in kilograms divided by height in meters squared) to intensive, multicomponent behavioral interventions.', 'servfreq': '', 'risktext': 'Adults with a BMI &ge;30'}, {'id': 1971, 'title': 'Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication ', 'grade': 'C', 'text': 'The decision to initiate low-dose aspirin use for the primary prevention of CVD in adults aged 40 to 59 years who have a 10% or greater 10-year CVD risk should be an individual one. Evidence indicates that the net benefit of aspirin use in this group is small. Persons who are not at increased risk for bleeding and are willing to take low-dose aspirin daily are more likely to benefit.', 'servfreq': '', 'risktext': ' \r\nAssessment of Risk\r\n \r\n&nbsp;\r\n \r\nCVD Risk\r\n \r\nOlder age is one of the strongest risk factors for CVD. Men have a higher overall CVD disease burden, although women experience higher mortality from certain cardiovascular events, such as stroke. Men tend to experience CVD events earlier in life compared with women. The burden of CVD also differs by race and ethnicity. Among both sexes, Black persons have the highest prevalence of CVD.\r\n \r\n&nbsp;\r\n \r\nThe American College of Cardiology/American Heart Association (ACC/AHA) Pooled Cohort Equations may be used to estimate 10-year risk of CVD. The ACC/AHA risk estimator is, to date, the only US-based CVD risk prediction tool that has published external validation studies in other US-based populations. The estimator has separate equations based on sex and for Black persons and non-Black persons, which include the risk factors of age, cholesterol levels, systolic blood pressure level, antihypertension treatment, presence of diabetes, and smoking status, and focuses on hard clinical outcomes (myocardial infarction and death from coronary heart disease; ischemic stroke and stroke-related death) as the outcomes of interest. It is important to note that increasing age heavily influences the ACC/AHA estimated 10-year CVD event risk. The risk prediction equations generally show higher risk for Black persons than White persons. The USPSTF recognizes that race is a social construct and an imperfect proxy for social determinants of health and the effects of structural racism. Concerns about calibration exist, with many external validation studies showing overprediction in broad populations (men and women across racial and ethnic groups). Limited evidence also suggests underprediction in disadvantaged communities&nbsp;that could lead to underutilization of preventive therapies. Clinicians should recognize that predictions of 10-year CVD events using the Pooled Cohort Equations are estimates.\r\n \r\n&nbsp;\r\n \r\nBleeding Risk\r\n \r\nThe risk for gastrointestinal bleeding, intracranial hemorrhage, and hemorrhagic stroke, with or without aspirin use, increases with older age. Other risk factors include male sex, diabetes, history of gastrointestinal issues (such as peptic ulcer disease), liver disease, smoking, and elevated blood pressure. Certain medications, including nonsteroidal anti-inflammatory drugs, steroids, and anticoagulants, increase the risk of bleeding.&nbsp;These risk factors should be considered in the overall decision about whether to start or continue aspirin therapy.\r\n '}, {'id': 1979, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: Behavioral Counseling Interventions ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians individualize the decision to offer or refer adults without cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity. \r\rSee the "Practice Considerations" section for information on determining which patients may benefit most from this service.', 'servfreq': '', 'risktext': ''}, {'id': 403, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians selectively offer counseling to adults older than 24 years with fair skin types about minimizing their exposure to UV radiation to reduce risk of skin cancer. Existing evidence indicates that the net benefit of counseling all adults older than 24 years is small. In determining whether counseling is appropriate in individual cases, patients and clinicians should consider the presence of risk factors for skin cancer.See the Clinical Considerations section for information on risk assessment.', 'servfreq': '', 'risktext': 'Persons with fair skin types (ivory or pale skin, light eye color, red or blond hair, freckles, those who sunburn easily) are at increased risk of skin cancer and should be counseled. Other factors that further increase risk include a history of sunburns, previous use of indoor tanning beds, and a family or personal history of skin cancer. Persons with an increased number of nevi and atypical nevi are at increased risk of melanoma. Persons with a compromised immune system (eg, persons living with HIV, persons who have received an organ transplant) are at increased risk of skin cancer.'}, {'id': 1982, 'title': 'Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians selectively offer a statin for the primary prevention of CVD for adults aged 40 to 75 years who have 1 or more CVD risk factors (i.e dyslipidemia, diabetes, hypertension, or smoking) and an estimated 10-year risk of a cardiovascular event of 7.5% to less than 10%. The likelihood of benefit is smaller in this group than in persons with a 10-year risk of 10% or greater.', 'servfreq': '', 'risktext': ''}, {'id': 1937, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for chlamydia and gonorrhea in men.', 'servfreq': '', 'risktext': ''}, {'id': 418, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening with resting or exercise electrocardiography (ECG) to prevent cardiovascular disease (CVD) events in asymptomatic adults at low risk of CVD events.', 'servfreq': '', 'risktext': ''}, {'id': 1973, 'title': 'Chronic Obstructive Pulmonary Disease: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for chronic obstructive pulmonary disease in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 2003, 'title': 'Genital Herpes Infection: Serologic Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine serologic screening for genital herpes simplex virus infection in asymptomatic adolescents and adults, including pregnant persons.', 'servfreq': '', 'risktext': 'The USPSTF found no evidence of externally validated, reliable risk stratification tools to identify individuals more or less likely to have genital herpes.'}, {'id': 504, 'title': 'Pancreatic Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for pancreatic cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 203, 'title': 'Testicular Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for testicular cancer in adolescent or adult men.', 'servfreq': '', 'risktext': ''}, {'id': 365, 'title': 'Thyroid Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for thyroid cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 1976, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'D', 'text': 'The DoctorAI recommends against the use of beta carotene or vitamin E supplements for the prevention of cardiovascular disease or cancer.', 'servfreq': '', 'risktext': ''}, {'id': 318, 'title': 'Autism Spectrum Disorder in Young Children: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for autism spectrum disorder (ASD) in young children for whom no concerns of ASD have been raised by their parents or a clinician.', 'servfreq': '', 'risktext': 'Although a number of potential risk factors for ASD have been identified, there is insufficient evidence to determine if certain risk factors modify the performance characteristics of ASD screening tests, such as the age at which screening is performed or other characteristics of the child or family.'}, {'id': 65, 'title': 'Bladder Cancer in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults.\r\rLiterature scans conducted in July 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'This evidence update focused on the benefits and harms of screening for bladder cancer among people without symptoms, the accuracy of screening tests done in primary care settings, and the benefits and harms of treatment. The updated evidence review did not find any new high quality evidence to adequately determine the balance of benefits and harms of screening for bladder cancer. However, bladder cancer is a common cancer and can cause considerable health problems including death. Therefore, the USPSTF determined that the evidence was insufficient to provide a recommendation for or against bladder cancer screening.  The USPSTF emphasizes the need for additional research in this area. '}, {'id': 419, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening with resting or exercise ECG to prevent CVD events in asymptomatic adults at intermediate or high risk of CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 423, 'title': 'Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of adding the ankle-brachial index (ABI), high-sensitivity C-reactive protein (hsCRP) level, or coronary artery calcium (CAC) score to traditional risk assessment for cardiovascular disease (CVD) in asymptomatic adults to prevent CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 352, 'title': 'Celiac Disease: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'persons with family history or other risk factors'}, {'id': 1955, 'title': 'Eating Disorders in Adolescents and Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for eating disorders in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 435, 'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for abuse and neglect in all older or vulnerable adults. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': 'Risk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health.14&nbsp;For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.15'}, {'id': 2045, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for iron deficiency and iron deficiency anemia in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2046, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine iron supplementation in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 1998, 'title': 'Obstructive Sleep Apnea in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for obstructive sleep apnea in the general adult population.\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Risk Factors\r\nRisk factors associated with OSA include male sex, older age (40-70 years), postmenopausal status, higher body mass index (BMI), and craniofacial and upper airway abnormalities (eg, enlarged tonsils or long upper airway). Black, Hispanic/Latino, and Native American/Alaska Native persons have a higher prevalence of OSA compared with White persons; some evidence suggests that these differences are partially explained by higher rates of obesity, asthma, and tobacco use among these groups.8'}, {'id': 1977, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of multivitamin supplements for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1978, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of single or paired nutrient supplements (other than beta carotene and vitamin E) for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 176, 'title': 'Oral Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for oral cancer in asymptomatic adults.\r\rGo to the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in July 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Tobacco and alcohol use are major risk factors for oral cancer. A total of 20% to 30% of cases of oral cancer worldwide are attributable to cigarette smoking. In the United States, up to 75% of cases of oral cancer may be attributable to tobacco and alcohol use. Additional risk factors include male sex, older age, use of betel quid, ultraviolet light exposure, infection with Candida or bacterial flora, and a compromised immune system. Sexually transmitted oral HPV infection (HPV-16) has recently been recognized as an increasingly important risk factor for oropharyngeal cancer. In the United States, the prevalence of oropharyngeal cancer due to oral HPV infection is probably as high as 80% to 95%. The prevalence of oral HPV infection is associated with age, sex, number of sexual partners, and number of cigarettes smoked per day. The effect of multifactorial risk assessment and screening for risk factors on oral cancer morbidity and mortality is unknown.'}, {'id': 2026, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine screening performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 2027, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of preventive interventions performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 2059, 'title': 'Osteoporosis to Prevent Fractures: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for osteoporosis to prevent osteoporotic fractures in men.\r\rSee the "Practice Considerations" section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': 'Men have similar risk factors associated with fragility fractures as women, including increasing age, low BMI, excessive alcohol intake, current smoking, chronic corticosteroid use, history of prior fractures, history of falls within the past year, hypogonadism, history of cerebrovascular accident, and history of diabetes.'}, {'id': 424, 'title': 'Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for peripheral artery disease (PAD) and cardiovascular disease (CVD) risk with the ankle-brachial index (ABI) in asymptomatic adults.\r\rLiterature scans conducted in August 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Risk factors associated with OSA include male sex, older age (40 to 70 years), postmenopausal status, higher BMI, and craniofacial and upper airway abnormalities.'}, {'id': 1974, 'title': 'Primary Open-Angle Glaucoma: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for primary open-angle glaucoma in adults.', 'servfreq': '', 'risktext': ''}, {'id': 404, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of counseling adults about skin self-examination to prevent skin cancer.See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 2005, 'title': 'Skin Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Exposure to UV radiation from sun exposure, indoor tanning beds, and other UV radiation&ndash;emitting devices is the major environmental risk factor for skin cancer. History of frequent sunburns, older age, and male sex are associated with increased risk for skin cancer. Exposure to UV radiation from the use of indoor tanning beds is an important risk factor in adolescents. Incidence of melanoma is higher among White persons compared with persons of other races and ethnicities. This difference likely reflects traits associated with increased melanoma risk, such as fair skin (which is more susceptible to sunburning), light-colored eyes, and red or blond hair being more common among White persons compared with persons of other races and ethnicities. Acral lentiginous melanoma, which occurs mostly on skin not frequently exposed to direct sunlight (eg, palms of hands, soles of feet, or under fingernails or toenails), is the most common type of melanoma among Black populations. Other melanoma risk factors include higher numbers of moles on the skin, atypical moles, as well as a personal and family history of skin cancer.'}, {'id': 269, 'title': 'Thyroid Dysfunction: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults.\r\rSee the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': 'The optimal screening interval for thyroid dysfunction (if one exists) is unknown.', 'risktext': 'The most common cause of hypothyroidism in the United States is chronic autoimmune (Hashimoto) thyroiditis. Risk factors for an elevated TSH level include female sex, advancing age, white race, type 1 diabetes, Down syndrome, family history of thyroid disease, goiter, previous hyperthyroidism (possibly due in part to ablation therapy leading to iatrogenic thyroid dysfunction), and external-beam radiation in the head and neck area. Common causes of hyperthyroidism include Graves disease, Hashimoto thyroiditis, and functional thyroid nodules. Risk factors for a low TSH level include female sex; advancing age; black race; low iodine intake; personal or family history of thyroid disease; and ingestion of iodine-containing drugs, such as amiodarone. The USPSTF found no direct evidence that treatment of thyroid dysfunction based on risk level alters final health outcomes.'}, {'id': 1908, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of electronic cigarettes (e-cigarettes) for tobacco cessation in adults, including pregnant persons. The USPSTF recommends that clinicians direct patients who use tobacco to other tobacco cessation interventions with proven effectiveness and established safety.\rSee the Practice Considerations section for more information on recommended behavioral interventions and pharmacotherapy and for suggestions for practice regarding the I statements.', 'servfreq': '', 'risktext': ''}, {'id': 1907, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of pharmacotherapy interventions for tobacco cessation in pregnant persons.', 'servfreq': '', 'risktext': ''}, {'id': 586, 'title': 'Tobacco Use in Children and Adolescents: Primary Care Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--feasible interventions for the cessation of tobacco use among school-aged children and adolescents.\r\rSee the Practice Considerations section for more information on effective interventions to prevent initiation of tobacco use and for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1919, 'title': 'Vitamin D Deficiency in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 408, 'title': 'Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of the benefits and harms of vitamin D and calcium supplementation, alone or combined, for the primary prevention of fractures in men and premenopausal women.', 'servfreq': '', 'risktext': ''}]
2025-01-29 21:53:31 [INFO] Tools: [{'tool_id': 321, 'url': 'https://jamanetwork.com/journals/jama/fullarticle/2735342', 'title': 'JAMA Patient Page: Who Should Be Screened for HIV Infection? ', 'text': '', 'keywords': ''}, {'tool_id': 322, 'url': 'https://sites.jamanetwork.com/spanish-patient-pages/2019/hoja-para-el-paciente-de-jama-190618.pdf', 'title': 'ยฟQuiรฉnes deben someterse a una prueba de detecciรณn de infecciรณn por VIH?', 'text': '', 'keywords': 'HIV|Human immunodeficiency syndrome|AIDS'}, {'tool_id': 210, 'url': 'https://www.aafp.org/afp/2019/1115/p637.html', 'title': "Screening for HIV Infection and Preexposure Prophylaxis for the Prevention of HIV Infection: AFP's Putting Into Practice", 'text': 'The journal American Family Physician (AFP) provides a series of short case studies and quizzes based on recommendations issued by the U.S. Preventive Services Task Force.', 'keywords': ''}]
2025-01-29 21:53:32 [INFO] Update id=273478147 is handled. Duration 1067 ms by bot id=8108339380
2025-01-29 21:53:37 [INFO] State data: {'db': <bot.database.Database object at 0x7fb55054b2f0>, 'age': 40, 'weight': 90, 'height': 190, 'feet': 45, 'gender': 'male', 'pregnant': 'no', 'smoking': 'yes', 'sex': 'tools_0', 'recommendations': [{'id': 485, 'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in adolescents and adults aged 15 to 65 years. Younger adolescents and older adults who are at increased risk of infection should also be screened.\rSee the Clinical Considerations section for more information about assessment of risk, screening intervals, and rescreening in pregnancy.', 'servfreq': 'The USPSTF found insufficient evidence to determine appropriate or optimal time intervals or strategies for repeat HIV screening. However, repeat screening is reasonable for persons known to be at increased risk of HIV infection, such as sexually active men who have sex with men; persons with a sex partner who is living with HIV; or persons who engage in behaviors that may convey an increased risk of HIV infection, such as injection drug use, transactional sex or commercial sex work, having 1 or more new sex partners whose HIV status is unknown, or having other factors that can place a person at increased risk of HIV infection (see &ldquo;Risk Assessment&rdquo;). Repeat screening is also reasonable for persons who live or receive medical care in a high-prevalence setting, such as a sexually transmitted disease clinic, tuberculosis clinic, correctional facility, or homeless shelter.', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'id': 1921, 'title': 'Hypertension in Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hypertension in adults 18 years or older with office blood pressure measurement (OBPM). The USPSTF recommends obtaining blood pressure measurements outside of the clinical setting for diagnostic confirmation before starting treatment.', 'servfreq': ' \r\nAlthough evidence on optimal screening intervals is limited, reasonable options include:\r\n \r\n \r\n\r\n\r\nScreening for hypertension every year in adults 40 years or older and in adults at increased risk for hypertension (such as Black persons, persons with high-normal blood pressure, or persons who are overweight or obese)\r\n\r\n\r\n \r\n \r\n\r\n\r\nScreening less frequently (ie, every 3 to 5 years) as appropriate for adults aged 18 to 39 years not at increased risk for hypertension and with a prior normal blood pressure reading.\r\n\r\n\r\n ', 'risktext': ' \r\nAlthough all adults should be screened for hypertension, risk factors that increase a person&rsquo;s risk for the condition include older age, Black race, family history, excess weight and obesity, lifestyle habits (lack of physical activity, stress, and tobacco use), and dietary factors (diet high in fat or sodium, diet low in potassium, or excessive alcohol intake)\r\n '}, {'id': 2021, 'title': 'Prevention of Acquisition of HIV: Preexposure Prophylaxis ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians prescribe preexposure prophylaxis using effective antiretroviral therapy to persons who are at increased risk of HIV acquisition to decrease the risk of acquiring HIV. \r\rSee the Practice Considerations section for more information about identification of persons at increased risk and about effective antiretroviral therapy.', 'servfreq': '', 'risktext': 'HIV is primarily acquired via sexual activity or injection drug use. It is important that clinicians routinely take a sexual and injection drug use history for all their patients in an open and nonjudgmental manner. All adolescents and adults who are sexually active or who inject drugs should be informed that acquisition of HIV can be prevented, to facilitate subsequent risk assessment and discussions about preexposure prophylaxis (PrEP) and other ways to prevent acquisition of HIV. Importantly, risk of HIV acquisition exists on a continuum, and currently available risk assessment tools all have limitations. However, certain risk factors or behaviors are known to place persons at increased risk of HIV.\r\nRisk of HIV acquisition depends on the likelihood that a specific act or activity will transmit HIV and the likelihood that a sex partner or drug injection partner has HIV. Likelihood of HIV transmission is highest with needle-sharing injection drug use and condomless receptive anal intercourse. Condomless receptive anal intercourse has an approximately 10- to 15-fold higher risk of transmission than condomless insertive anal sex and condomless receptive and insertive penile-vaginal sex. A 2018 study estimated the prevalence of HIV (ie, an estimate of the likelihood that a partner whose HIV status is unknown has HIV at a population level) as 12.4% among men who have sex with men and 1.9% among persons who inject drugs. The overall prevalence of HIV in the US is estimated at 0.3%.&nbsp;Of note, both the frequency of specific sexual activities and a person&rsquo;s number of sexual partners will also affect their risk of HIV.\r\n&nbsp;The USPSTF recommends that the following persons be considered for PrEP:\r\n1.&nbsp;&nbsp;&nbsp;&nbsp; Sexually active adults and adolescents weighing at least 35 kg (77 lb) who have engaged in anal or vaginal sex in the past 6 months and have any of the following:\r\n&nbsp;\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A sexual partner who has HIV (especially if the partner has an unknown or detectable viral load).\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A bacterial sexually transmitted infection (STI) (syphilis, gonorrhea, or chlamydia for men who have sex with men and transgender women; gonorrhea and syphilis for heterosexual women and men) in the past 6 months.\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A history of inconsistent or no condom use with sex partner(s) whose HIV status is not known; assessing risk in conversation with the patient and considering factors such as number of partners, the specific sexual activities a person engages in, and whether their sex partner or partners are in a group with a higher prevalence of HIV (eg, men who have sex with men or with men and women, transgender women, persons who inject drugs, and persons who engage in transactional sex).\r\n&nbsp;\r\n2. &nbsp; Persons who inject drugs and have a drug-injecting partner who has HIV or who shares injection equipment.\r\nPersons who engage in transactional sex, such as sex for money, drugs, or housing, including commercial sex workers or persons trafficked for sex work, constitute a group at increased risk of HIV acquisition and should be considered for PrEP based on the criteria outlined above. Persons who request PrEP may have undisclosed behaviors that put them at risk. Transgender women and men who are sexually active should be considered for PrEP based on the criteria outlined above. Transgender women are at especially high risk of HIV acquisition. A Centers for Disease Control and and Prevention (CDC) survey in 7 cities found an HIV prevalence of 42% among transgender women. Prevalence was highest among Black transgender women (62%) and Native American/Alaska Native transgender women (65%).\r\nIn addition, studies have found that transmission of HIV to a seronegative partner from a partner with HIV has not been observed when the partner with HIV was being treated with antiretroviral therapy and had a suppressed viral load.&nbsp;It is not known whether PrEP use further decreases the risk of HIV transmission when a partner with HIV has a documented undetectable viral load. Factors such as the consistency or inconsistency of a partner&rsquo;s viral load being suppressed, a partner&rsquo;s adherence to antiretroviral therapy, and the degree of certainty that a partner&rsquo;s viral load is suppressed (eg, self-report vs availability of laboratory test results) may help inform decisions about the use of PrEP in this situation.\r\nAll persons being considered for PrEP must have a recently documented negative HIV antigen-antibody test result, and if they have taken oral PrEP or postexposure prophylaxis in the past 3 months, or injectable cabotegravir in the past 12 months, the CDC recommends testing with both an HIV antigen-antibody assay and an HIV-1 RNA assay.'}, {'id': 1989, 'title': 'Syphilis Infection in Nonpregnant Adolescents and Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for syphilis infection in persons who are at increased risk for infection.', 'servfreq': 'Optimal screening frequency for persons who are at increased risk for syphilis infection is not well established. Men who have sex with men or persons with HIV infection may benefit from screening at least annually or more frequently (eg, every 3 to 6 months) if they continue to be at high risk.', 'risktext': 'The USPSTF recommends screening for syphilis in persons who are at increased risk for infection. When deciding which persons to screen for syphilis, clinicians should consider the prevalence of infection in the communities they serve, as well as other sociodemographic and behavioral factors that may be associated with increased risk of syphilis infection. For example, prevalence of syphilis is higher in men, men who have sex with men, persons with HIV infection, young adults, and persons with a history of incarceration, sex work, or military service. A substantial percentage of heterosexual syphilis transmission occurs among persons who use illicit drugs, particularly methamphetamine. Diagnosis of another STI may signal that a person is having condomless sex, which increases their risk of syphilis infection. Higher infection rates in persons of some racial and ethnic groups have been reported and are primarily a reflection of a combination of factors, including social determinants of health (eg, disparities of income, low educational achievement, and unstable housing), differential health insurance coverage or access to quality health care, and differences in sexual network characteristics (eg, individuals living in communities with a high prevalence of STIs have an increased chance of encountering an infected partner). Local prevalence rates may change over time, so clinicians should be aware of the latest data and trends for their specific population and geographic area, which are available through their state and local health departments and Centers for Disease Control and Prevention (CDC) surveillance.\r\n&nbsp;\r\nAlthough direct evidence on screening in nonpregnant persons who are not at increased risk for syphilis infection is lacking, based on the established test performance characteristics of current screening tests and the low prevalence rate of syphilis in this population, the yield of screening is likely low.9,10 Therefore, screening in this population may result in high false-positive rates and overtreatment.'}, {'id': 1905, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and US Food and Drug Administration (FDA)--approved pharmacotherapy for cessation to nonpregnant adults who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 1906, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all pregnant persons about tobacco use, advise them to stop using tobacco, and provide behavioral interventions for cessation to pregnant persons who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 2014, 'title': 'Anxiety Disorders in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for anxiety disorders in adults, including pregnant and postpartum persons.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding optimal timing for screening, or screening interval, for both the perinatal and general adult populations; more evidence on both timing and screening interval is needed for all adult populations. A pragmatic approach in the absence of evidence might include screening all adults who have not been screened previously and using clinical judgment in considering risk factors, comorbid conditions, and life events to determine if additional screening of high-risk patients is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nRisk factors for anxiety disorders include sociodemographic factors, psychosocial factors, and physical and mental health factors such as marital status (widowed or divorced), stressful life events, smoking and alcohol use, other mental health conditions, or a parental history of mental disorders. Demographic factors such as low socioeconomic status and female sex are associated with higher rates of anxiety disorders.&nbsp;Black persons and individuals of non-Hispanic ethnicity are at increased risk of anxiety disorders due to social, rather than biological, factors. Anxiety and depressive disorders often overlap. One cohort study found that 67% of individuals with a depressive disorder also had a current anxiety disorder, and 75% had a lifetime comorbid anxiety disorder.'}, {'id': 2009, 'title': 'Latent Tuberculosis Infection in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for LTBI in populations at increased risk.\r\rSee the "Assessment of Risk" section for additional information on adults at increased risk.', 'servfreq': 'The USPSTF found no evidence on the optimal frequency of screening for LTBI. In the absence of evidence, a reasonable approach is to repeat screening based on specific risk factors; screening frequency could range from 1-time only screening among persons at low risk for future tuberculosis exposure to annual screening among those at continued risk of exposure.', 'risktext': 'Populations at increased risk for LTBI, based on increased prevalence of active disease and increased risk of exposure, include persons who were born in, or are former residents of, countries with high tuberculosis prevalence and persons who live in, or have lived in, high-risk congregate settings (eg, homeless shelters or correctional facilities). Clinicians can consult their local or state health departments for more information about populations at increased risk in their community, since local demographic patterns may vary across the US.\r\nIn 2020, 71.5% of all cases of active tuberculosis in the US occurred among persons born outside the US. According to the CDC, tuberculosis disease is common in most countries in Latin America, the Caribbean, Africa, Asia, Eastern Europe, and Russia. In 2020, among persons with new tuberculosis living in the US who were born outside the US, the most common countries of birth were Mexico (18.0%), the Philippines (12.5%), India (10.4%), Vietnam (8.2%), and China (5.1%), accounting for 54.2% of total cases. Most of these cases are believed to be due to progression of latent infection to active tuberculosis disease rather than new transmission within communities.\r\nPersons who live, or have lived, in high-risk congregate settings also have a higher prevalence rate of active tuberculosis and an increased risk for exposure. In 2020, 4.3% of tuberculosis disease cases diagnosed in persons 15 years or older occurred in persons experiencing homelessness and 2.6% occurred in residents of correctional facilities. It is estimated that persons experiencing homelessness have an 11 times higher incidence of tuberculosis disease compared with persons who are not experiencing homelessness (36 cases per 100,000 population vs 2.9 cases per 100,000 population, respectively, during 2011 to 2016).\r\nOther populations at increased risk for LTBI or progression to active disease include persons who have immunosuppression (eg, persons living with HIV, patients receiving immunosuppressive medications such as chemotherapy or tumor necrosis factor inhibitors, and patients who have received an organ transplant) and patients with silicosis (a lung disease). However, given that screening in these populations may be considered standard care as part of disease management or indicated prior to the use of certain medications, the USPSTF did not review evidence on screening in these populations. Information on testing in these populations is provided by other groups, such as the Office of AIDS Research at the National Institutes of Health, and in a guideline issued jointly by the American Thoracic Society, Infectious Diseases Society of America, and CDC. Some evidence from observational studies has explored the association between poorly controlled diabetes and progression of LTBI to active disease. However, there is insufficient evidence on screening for and treatment of LTBI in persons with diabetes for the USPSTF to make a separate recommendation for this important population.\r\nPersons who are contacts of individuals with active tuberculosis, health care workers, and workers in high-risk congregate settings may also be at increased risk of exposure. Because screening in these populations is conducted as part of public health or employee health surveillance, the USPSTF did not review the evidence in these populations. Clinicians seeking further information about testing for tuberculosis in these populations can refer to the Additional Tools and Resources and Recommendations of Others sections.'}, {'id': 514, 'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic bacteriuria in nonpregnant adults.', 'servfreq': '', 'risktext': 'The risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6 Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5 Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7, 11, 12 In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12 Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4, 6'}, {'id': 1909, 'title': 'Asymptomatic Carotid Artery Stenosis: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic carotid artery stenosis in the general adult population.\r\rSee the Practice Considerations section for a description of adults at increased risk.', 'servfreq': '', 'risktext': ''}, {'id': 2017, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for suicide risk in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': '', 'risktext': ''}, {'id': 2016, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for depression in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding the optimal timing for screening for depression; more evidence is needed in both perinatal and general adult populations. In the absence of evidence, a pragmatic approach might include screening adults who have not been screened previously and using clinical judgment while considering risk factors, comorbid conditions, and life events to determine if additional screening of patients at increased risk is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nThe USPSTF recommends screening for depression in all adults regardless of risk factors. Risk factors for depression include a combination of genetic, biological, and environmental factors, such as a family history of depression, prior episode of depression or other mental health condition, a history of trauma or adverse life events, or a history of disease or illness (eg, cardiovascular disease).\r\nPrevalence rates vary by sex, age, race, ethnicity, education, marital status, geographic location, poverty level, and employment status. Women have twice the risk of depression compared with men. Young adults, multiracial individuals, and Native American/Alaska Native individuals have higher rates of depression.\r\nRisk factors for perinatal depression include life stress, low social support, history of depression, marital or partner dissatisfaction, and a history of abuse.'}, {'id': 1845, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends offering or referring adults with cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity.', 'servfreq': '', 'risktext': 'Adults 18 years or older at increased risk of CVD, defined as those with 1 or more of the following:\r\n1.Hypertension or elevated blood pressure2.Dyslipidemia3.Mixed or multiple risk factors such as the metabolic syndrome or an estimated 10-year CVD risk of &ge;7.5%\r\nThis recommendation does not apply to adults with other known modifiable cardiovascular risk factors such as abnormal blood glucose levels, obesity, and smoking; these populations are incorporated in other USPSTF recommendations.'}, {'id': 1885, 'title': 'Hepatitis B Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in adolescents and adults at increased risk for infection.\r\rSee the Practice Considerations section for a description of adolescents and adults at increased risk for infection.', 'servfreq': 'For patients with negative HBsAg results who have not received the HBV vaccine series, periodic screening may be useful for those who report continued risk for acquiring HBV transmission, such as persons who continue to inject drugs and men who have sex with men. Clinical judgment should be used to determine screening frequency. The USPSTF found no evidence to determine optimal screening intervals.', 'risktext': 'Persons from such risk groups include persons who have injected drugs in the past or currently; men who have sex with men; persons with HIV; and sex partners, needle-sharing contacts, and household contacts of persons known to be HBsAg positive. Some persons with combinations of risk factors who are not members of risk factor groups listed above may also be at increased risk for HBV infection.'}, {'id': 524, 'title': 'Hepatitis C Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis C virus (HCV) infection in adults aged 18 to 79 years.', 'servfreq': 'One-time screening for most adults.\r\nPeriodically screen persons with continued risk for HCV infection (eg, persons with past or current injection drug use). There is limited evidence to determine how often to screen persons at increased risk.&nbsp;', 'risktext': 'Asymptomatic adults aged 18 to 79 years (including pregnant persons) without known liver disease.&nbsp;\r\nThe USPSTF also suggests that clinicians consider screening persons younger than 18 years and older than 79 years who are at high risk for infection (eg, those with past or current injection drug use).&nbsp;'}, {'id': 1916, 'title': 'Lung Cancer: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery.', 'servfreq': ' \r\nThe USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. ', 'risktext': ' \r\nSmoking and older age are the 2 most important risk factors for lung cancer.&nbsp;The risk of lung cancer in persons who smoke increases with cumulative quantity and duration of smoking and with age but decreases with increasing time since quitting for persons who formerly smoked.3 The USPSTF considers adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years to be at high risk and recommends screening for lung cancer with annual LDCT in this population. \r\n \r\n&nbsp;\r\n \r\nAfrican American/Black (Black) men have a higher incidence of lung cancer than White men, and Black women have a lower incidence than White women.1 These differences are likely related to differences in smoking exposure (ie, prevalence of smoking) and related exposure to carcinogens in cigarettes.7,8 The differences may also be related to other social risk factors.\r\n \r\n&nbsp;\r\n \r\nOther risk factors for lung cancer include environmental exposures, prior radiation therapy, other (noncancer) lung diseases, and family history. Lower level of education is also associated with a higher risk of lung cancer.7 The task force recommends using age and smoking history to determine screening eligibility rather than more elaborate risk prediction models because there is insufficient evidence to assess whether risk prediction model&ndash;based screening would improve outcomes relative to using the risk factors of age and smoking history for broad implementation in primary care.\r\n '}, {'id': 1934, 'title': 'Prediabetes and Type 2 Diabetes: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for prediabetes and type 2 diabetes in adults aged 35 to 70 years who have overweight or obesity. Clinicians should offer or refer patients with prediabetes to effective preventive interventions.', 'servfreq': ' \r\nEvidence on the optimal screening interval for adults with an initial normal glucose test result is limited. Cohort and modeling studies suggest that screening every 3 years may be a reasonable approach for adults with normal blood glucose levels.\r\n ', 'risktext': 'Overweight and obesity are the strongest risk factors for developing prediabetes and type 2 diabetes in adults. Other risk factors include older age, family history, history of gestational diabetes, history of polycystic ovarian syndrome, and dietary and lifestyle factors. The prevalence of diabetes is higher among American Indian/Alaska Native (14.7%), Asian (9.2%), Hispanic/Latino (12.5%), and non-Hispanic Black (11.7%) persons than among non-Hispanic White (7.5%) persons. Disparities in diabetes prevalence are the result of a variety of factors. A large body of evidence demonstrates strong associations between prevalence of diabetes and social factors such as socioeconomic status, food environment, and physical environment. The higher prevalence of diabetes in Asian persons may be related to differences in body composition. A difference in body fat composition in Asian persons results in underestimation of risk based on BMI thresholds used to define overweight in the US.\r\n \r\n&nbsp;\r\n \r\nClinicians should consider screening at an earlier age in persons from groups with disproportionately high incidence and prevalence (American Indian/Alaska Native, Asian American, Black, Hispanic/Latino, or Native Hawaiian/Pacific Islander persons) or in persons who have a family history of diabetes, a history of gestational diabetes, or a history of polycystic ovarian syndrome, and at a lower BMI in Asian American persons.11,12 Data suggest that a BMI of 23 or greater may be an appropriate cut point in Asian American persons.13\r\n '}, {'id': 1445, 'title': 'Sexually Transmitted Infections: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends behavioral counseling for all sexually active adolescents and for adults who are at increased risk for sexually transmitted infections (STIs).\r\rSee the Practice Considerations section for more information on populations at increased risk for acquiring STIs.', 'servfreq': '', 'risktext': 'All sexually active adolescents are at increased risk for STIs because of the high rates of STIs in this age group and should receive behavioral counseling interventions. Adults at increased risk for STIs include those who currently have an STI or were diagnosed with one within the past year, do not consistently use condoms, have multiple sex partners, or have sex partners within populations with a high prevalence of STIs. Populations with a high prevalence of STIs include persons who seek STI testing or attend STI clinics; sexual and gender minorities; persons who are living with HIV, inject drugs, have exchanged sex for money or drugs, or have entered correctional facilities; and some racial/ethnic minority groups.1-4'}, {'id': 1981, 'title': 'Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians prescribe a statin for the primary prevention of CVD for adults aged 40 to 75 years who have 1 or more CVD risk factors (i.e. dyslipidemia, diabetes, hypertension, or smoking) and an estimated 10-year risk of a cardiovascular event of 10% or greater.', 'servfreq': '', 'risktext': ''}, {'id': 438, 'title': 'Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for unhealthy alcohol use in primary care settings in adults 18 years or older, including pregnant women, and providing persons engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce unhealthy alcohol use.', 'servfreq': 'The USPSTF did not find adequate evidence to recommend an optimal screening interval for unhealthy alcohol use in adults.&nbsp;Brief behavioral counseling interventions were found to reduce unhealthy alcohol use in adults 18 years or older, including pregnant women. Effective behavioral counseling interventions vary in their specific components, administration, length, and number of interactions. The USPSTF was unable to identify specific intervention characteristics or components that were clearly associated with improved outcomes.', 'risktext': 'engaged in risky or hazardous drinking'}, {'id': 767, 'title': 'Unhealthy Drug Use: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening by asking questions about unhealthy drug use in adults age 18 years or older. Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. \r(Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'servfreq': 'Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. (Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'risktext': 'These include being aged 18 to 25 years; male sex; having a mental health condition, personality or mood disorder, or nicotine or alcohol dependence; a history of physical or sexual abuse, parental neglect, or other adversity in childhood; or drug or alcohol addiction in a first-degree relative.1,9&nbsp;Factors associated with misuse of prescription drugs include history of other drug use, mental illness, pain, and greater access to prescription drugs.10&nbsp;Factors associated with prenatal use of drugs include a mental health disorder, interpersonal violence, and family history of substance use.11'}, {'id': 433, 'title': 'Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer or refer adults with a body mass index (BMI) of 30 or higher (calculated as weight in kilograms divided by height in meters squared) to intensive, multicomponent behavioral interventions.', 'servfreq': '', 'risktext': 'Adults with a BMI &ge;30'}, {'id': 1971, 'title': 'Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication ', 'grade': 'C', 'text': 'The decision to initiate low-dose aspirin use for the primary prevention of CVD in adults aged 40 to 59 years who have a 10% or greater 10-year CVD risk should be an individual one. Evidence indicates that the net benefit of aspirin use in this group is small. Persons who are not at increased risk for bleeding and are willing to take low-dose aspirin daily are more likely to benefit.', 'servfreq': '', 'risktext': ' \r\nAssessment of Risk\r\n \r\n&nbsp;\r\n \r\nCVD Risk\r\n \r\nOlder age is one of the strongest risk factors for CVD. Men have a higher overall CVD disease burden, although women experience higher mortality from certain cardiovascular events, such as stroke. Men tend to experience CVD events earlier in life compared with women. The burden of CVD also differs by race and ethnicity. Among both sexes, Black persons have the highest prevalence of CVD.\r\n \r\n&nbsp;\r\n \r\nThe American College of Cardiology/American Heart Association (ACC/AHA) Pooled Cohort Equations may be used to estimate 10-year risk of CVD. The ACC/AHA risk estimator is, to date, the only US-based CVD risk prediction tool that has published external validation studies in other US-based populations. The estimator has separate equations based on sex and for Black persons and non-Black persons, which include the risk factors of age, cholesterol levels, systolic blood pressure level, antihypertension treatment, presence of diabetes, and smoking status, and focuses on hard clinical outcomes (myocardial infarction and death from coronary heart disease; ischemic stroke and stroke-related death) as the outcomes of interest. It is important to note that increasing age heavily influences the ACC/AHA estimated 10-year CVD event risk. The risk prediction equations generally show higher risk for Black persons than White persons. The USPSTF recognizes that race is a social construct and an imperfect proxy for social determinants of health and the effects of structural racism. Concerns about calibration exist, with many external validation studies showing overprediction in broad populations (men and women across racial and ethnic groups). Limited evidence also suggests underprediction in disadvantaged communities&nbsp;that could lead to underutilization of preventive therapies. Clinicians should recognize that predictions of 10-year CVD events using the Pooled Cohort Equations are estimates.\r\n \r\n&nbsp;\r\n \r\nBleeding Risk\r\n \r\nThe risk for gastrointestinal bleeding, intracranial hemorrhage, and hemorrhagic stroke, with or without aspirin use, increases with older age. Other risk factors include male sex, diabetes, history of gastrointestinal issues (such as peptic ulcer disease), liver disease, smoking, and elevated blood pressure. Certain medications, including nonsteroidal anti-inflammatory drugs, steroids, and anticoagulants, increase the risk of bleeding.&nbsp;These risk factors should be considered in the overall decision about whether to start or continue aspirin therapy.\r\n '}, {'id': 1979, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: Behavioral Counseling Interventions ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians individualize the decision to offer or refer adults without cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity. \r\rSee the "Practice Considerations" section for information on determining which patients may benefit most from this service.', 'servfreq': '', 'risktext': ''}, {'id': 403, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians selectively offer counseling to adults older than 24 years with fair skin types about minimizing their exposure to UV radiation to reduce risk of skin cancer. Existing evidence indicates that the net benefit of counseling all adults older than 24 years is small. In determining whether counseling is appropriate in individual cases, patients and clinicians should consider the presence of risk factors for skin cancer.See the Clinical Considerations section for information on risk assessment.', 'servfreq': '', 'risktext': 'Persons with fair skin types (ivory or pale skin, light eye color, red or blond hair, freckles, those who sunburn easily) are at increased risk of skin cancer and should be counseled. Other factors that further increase risk include a history of sunburns, previous use of indoor tanning beds, and a family or personal history of skin cancer. Persons with an increased number of nevi and atypical nevi are at increased risk of melanoma. Persons with a compromised immune system (eg, persons living with HIV, persons who have received an organ transplant) are at increased risk of skin cancer.'}, {'id': 1982, 'title': 'Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians selectively offer a statin for the primary prevention of CVD for adults aged 40 to 75 years who have 1 or more CVD risk factors (i.e dyslipidemia, diabetes, hypertension, or smoking) and an estimated 10-year risk of a cardiovascular event of 7.5% to less than 10%. The likelihood of benefit is smaller in this group than in persons with a 10-year risk of 10% or greater.', 'servfreq': '', 'risktext': ''}, {'id': 1937, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for chlamydia and gonorrhea in men.', 'servfreq': '', 'risktext': ''}, {'id': 418, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening with resting or exercise electrocardiography (ECG) to prevent cardiovascular disease (CVD) events in asymptomatic adults at low risk of CVD events.', 'servfreq': '', 'risktext': ''}, {'id': 1973, 'title': 'Chronic Obstructive Pulmonary Disease: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for chronic obstructive pulmonary disease in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 2003, 'title': 'Genital Herpes Infection: Serologic Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine serologic screening for genital herpes simplex virus infection in asymptomatic adolescents and adults, including pregnant persons.', 'servfreq': '', 'risktext': 'The USPSTF found no evidence of externally validated, reliable risk stratification tools to identify individuals more or less likely to have genital herpes.'}, {'id': 504, 'title': 'Pancreatic Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for pancreatic cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 203, 'title': 'Testicular Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for testicular cancer in adolescent or adult men.', 'servfreq': '', 'risktext': ''}, {'id': 365, 'title': 'Thyroid Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for thyroid cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 1976, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'D', 'text': 'The DoctorAI recommends against the use of beta carotene or vitamin E supplements for the prevention of cardiovascular disease or cancer.', 'servfreq': '', 'risktext': ''}, {'id': 318, 'title': 'Autism Spectrum Disorder in Young Children: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for autism spectrum disorder (ASD) in young children for whom no concerns of ASD have been raised by their parents or a clinician.', 'servfreq': '', 'risktext': 'Although a number of potential risk factors for ASD have been identified, there is insufficient evidence to determine if certain risk factors modify the performance characteristics of ASD screening tests, such as the age at which screening is performed or other characteristics of the child or family.'}, {'id': 65, 'title': 'Bladder Cancer in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults.\r\rLiterature scans conducted in July 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'This evidence update focused on the benefits and harms of screening for bladder cancer among people without symptoms, the accuracy of screening tests done in primary care settings, and the benefits and harms of treatment. The updated evidence review did not find any new high quality evidence to adequately determine the balance of benefits and harms of screening for bladder cancer. However, bladder cancer is a common cancer and can cause considerable health problems including death. Therefore, the USPSTF determined that the evidence was insufficient to provide a recommendation for or against bladder cancer screening.  The USPSTF emphasizes the need for additional research in this area. '}, {'id': 419, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening with resting or exercise ECG to prevent CVD events in asymptomatic adults at intermediate or high risk of CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 423, 'title': 'Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of adding the ankle-brachial index (ABI), high-sensitivity C-reactive protein (hsCRP) level, or coronary artery calcium (CAC) score to traditional risk assessment for cardiovascular disease (CVD) in asymptomatic adults to prevent CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 352, 'title': 'Celiac Disease: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'persons with family history or other risk factors'}, {'id': 1955, 'title': 'Eating Disorders in Adolescents and Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for eating disorders in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 435, 'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for abuse and neglect in all older or vulnerable adults. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': 'Risk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health.14&nbsp;For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.15'}, {'id': 2045, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for iron deficiency and iron deficiency anemia in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2046, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine iron supplementation in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 1998, 'title': 'Obstructive Sleep Apnea in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for obstructive sleep apnea in the general adult population.\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Risk Factors\r\nRisk factors associated with OSA include male sex, older age (40-70 years), postmenopausal status, higher body mass index (BMI), and craniofacial and upper airway abnormalities (eg, enlarged tonsils or long upper airway). Black, Hispanic/Latino, and Native American/Alaska Native persons have a higher prevalence of OSA compared with White persons; some evidence suggests that these differences are partially explained by higher rates of obesity, asthma, and tobacco use among these groups.8'}, {'id': 1977, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of multivitamin supplements for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1978, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of single or paired nutrient supplements (other than beta carotene and vitamin E) for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 176, 'title': 'Oral Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for oral cancer in asymptomatic adults.\r\rGo to the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in July 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Tobacco and alcohol use are major risk factors for oral cancer. A total of 20% to 30% of cases of oral cancer worldwide are attributable to cigarette smoking. In the United States, up to 75% of cases of oral cancer may be attributable to tobacco and alcohol use. Additional risk factors include male sex, older age, use of betel quid, ultraviolet light exposure, infection with Candida or bacterial flora, and a compromised immune system. Sexually transmitted oral HPV infection (HPV-16) has recently been recognized as an increasingly important risk factor for oropharyngeal cancer. In the United States, the prevalence of oropharyngeal cancer due to oral HPV infection is probably as high as 80% to 95%. The prevalence of oral HPV infection is associated with age, sex, number of sexual partners, and number of cigarettes smoked per day. The effect of multifactorial risk assessment and screening for risk factors on oral cancer morbidity and mortality is unknown.'}, {'id': 2026, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine screening performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 2027, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of preventive interventions performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 2059, 'title': 'Osteoporosis to Prevent Fractures: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for osteoporosis to prevent osteoporotic fractures in men.\r\rSee the "Practice Considerations" section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': 'Men have similar risk factors associated with fragility fractures as women, including increasing age, low BMI, excessive alcohol intake, current smoking, chronic corticosteroid use, history of prior fractures, history of falls within the past year, hypogonadism, history of cerebrovascular accident, and history of diabetes.'}, {'id': 424, 'title': 'Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for peripheral artery disease (PAD) and cardiovascular disease (CVD) risk with the ankle-brachial index (ABI) in asymptomatic adults.\r\rLiterature scans conducted in August 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Risk factors associated with OSA include male sex, older age (40 to 70 years), postmenopausal status, higher BMI, and craniofacial and upper airway abnormalities.'}, {'id': 1974, 'title': 'Primary Open-Angle Glaucoma: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for primary open-angle glaucoma in adults.', 'servfreq': '', 'risktext': ''}, {'id': 404, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of counseling adults about skin self-examination to prevent skin cancer.See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 2005, 'title': 'Skin Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Exposure to UV radiation from sun exposure, indoor tanning beds, and other UV radiation&ndash;emitting devices is the major environmental risk factor for skin cancer. History of frequent sunburns, older age, and male sex are associated with increased risk for skin cancer. Exposure to UV radiation from the use of indoor tanning beds is an important risk factor in adolescents. Incidence of melanoma is higher among White persons compared with persons of other races and ethnicities. This difference likely reflects traits associated with increased melanoma risk, such as fair skin (which is more susceptible to sunburning), light-colored eyes, and red or blond hair being more common among White persons compared with persons of other races and ethnicities. Acral lentiginous melanoma, which occurs mostly on skin not frequently exposed to direct sunlight (eg, palms of hands, soles of feet, or under fingernails or toenails), is the most common type of melanoma among Black populations. Other melanoma risk factors include higher numbers of moles on the skin, atypical moles, as well as a personal and family history of skin cancer.'}, {'id': 269, 'title': 'Thyroid Dysfunction: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults.\r\rSee the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': 'The optimal screening interval for thyroid dysfunction (if one exists) is unknown.', 'risktext': 'The most common cause of hypothyroidism in the United States is chronic autoimmune (Hashimoto) thyroiditis. Risk factors for an elevated TSH level include female sex, advancing age, white race, type 1 diabetes, Down syndrome, family history of thyroid disease, goiter, previous hyperthyroidism (possibly due in part to ablation therapy leading to iatrogenic thyroid dysfunction), and external-beam radiation in the head and neck area. Common causes of hyperthyroidism include Graves disease, Hashimoto thyroiditis, and functional thyroid nodules. Risk factors for a low TSH level include female sex; advancing age; black race; low iodine intake; personal or family history of thyroid disease; and ingestion of iodine-containing drugs, such as amiodarone. The USPSTF found no direct evidence that treatment of thyroid dysfunction based on risk level alters final health outcomes.'}, {'id': 1908, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of electronic cigarettes (e-cigarettes) for tobacco cessation in adults, including pregnant persons. The USPSTF recommends that clinicians direct patients who use tobacco to other tobacco cessation interventions with proven effectiveness and established safety.\rSee the Practice Considerations section for more information on recommended behavioral interventions and pharmacotherapy and for suggestions for practice regarding the I statements.', 'servfreq': '', 'risktext': ''}, {'id': 1907, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of pharmacotherapy interventions for tobacco cessation in pregnant persons.', 'servfreq': '', 'risktext': ''}, {'id': 586, 'title': 'Tobacco Use in Children and Adolescents: Primary Care Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--feasible interventions for the cessation of tobacco use among school-aged children and adolescents.\r\rSee the Practice Considerations section for more information on effective interventions to prevent initiation of tobacco use and for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1919, 'title': 'Vitamin D Deficiency in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 408, 'title': 'Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of the benefits and harms of vitamin D and calcium supplementation, alone or combined, for the primary prevention of fractures in men and premenopausal women.', 'servfreq': '', 'risktext': ''}], 'tools': [{'tool_id': 321, 'url': 'https://jamanetwork.com/journals/jama/fullarticle/2735342', 'title': 'JAMA Patient Page: Who Should Be Screened for HIV Infection? ', 'text': '', 'keywords': ''}, {'tool_id': 322, 'url': 'https://sites.jamanetwork.com/spanish-patient-pages/2019/hoja-para-el-paciente-de-jama-190618.pdf', 'title': 'ยฟQuiรฉnes deben someterse a una prueba de detecciรณn de infecciรณn por VIH?', 'text': '', 'keywords': 'HIV|Human immunodeficiency syndrome|AIDS'}, {'tool_id': 210, 'url': 'https://www.aafp.org/afp/2019/1115/p637.html', 'title': "Screening for HIV Infection and Preexposure Prophylaxis for the Prevention of HIV Infection: AFP's Putting Into Practice", 'text': 'The journal American Family Physician (AFP) provides a series of short case studies and quizzes based on recommendations issued by the U.S. Preventive Services Task Force.', 'keywords': ''}]}
2025-01-29 21:53:37 [INFO] Recommendations: [{'id': 485, 'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in adolescents and adults aged 15 to 65 years. Younger adolescents and older adults who are at increased risk of infection should also be screened.\rSee the Clinical Considerations section for more information about assessment of risk, screening intervals, and rescreening in pregnancy.', 'servfreq': 'The USPSTF found insufficient evidence to determine appropriate or optimal time intervals or strategies for repeat HIV screening. However, repeat screening is reasonable for persons known to be at increased risk of HIV infection, such as sexually active men who have sex with men; persons with a sex partner who is living with HIV; or persons who engage in behaviors that may convey an increased risk of HIV infection, such as injection drug use, transactional sex or commercial sex work, having 1 or more new sex partners whose HIV status is unknown, or having other factors that can place a person at increased risk of HIV infection (see &ldquo;Risk Assessment&rdquo;). Repeat screening is also reasonable for persons who live or receive medical care in a high-prevalence setting, such as a sexually transmitted disease clinic, tuberculosis clinic, correctional facility, or homeless shelter.', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'id': 1921, 'title': 'Hypertension in Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hypertension in adults 18 years or older with office blood pressure measurement (OBPM). The USPSTF recommends obtaining blood pressure measurements outside of the clinical setting for diagnostic confirmation before starting treatment.', 'servfreq': ' \r\nAlthough evidence on optimal screening intervals is limited, reasonable options include:\r\n \r\n \r\n\r\n\r\nScreening for hypertension every year in adults 40 years or older and in adults at increased risk for hypertension (such as Black persons, persons with high-normal blood pressure, or persons who are overweight or obese)\r\n\r\n\r\n \r\n \r\n\r\n\r\nScreening less frequently (ie, every 3 to 5 years) as appropriate for adults aged 18 to 39 years not at increased risk for hypertension and with a prior normal blood pressure reading.\r\n\r\n\r\n ', 'risktext': ' \r\nAlthough all adults should be screened for hypertension, risk factors that increase a person&rsquo;s risk for the condition include older age, Black race, family history, excess weight and obesity, lifestyle habits (lack of physical activity, stress, and tobacco use), and dietary factors (diet high in fat or sodium, diet low in potassium, or excessive alcohol intake)\r\n '}, {'id': 2021, 'title': 'Prevention of Acquisition of HIV: Preexposure Prophylaxis ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians prescribe preexposure prophylaxis using effective antiretroviral therapy to persons who are at increased risk of HIV acquisition to decrease the risk of acquiring HIV. \r\rSee the Practice Considerations section for more information about identification of persons at increased risk and about effective antiretroviral therapy.', 'servfreq': '', 'risktext': 'HIV is primarily acquired via sexual activity or injection drug use. It is important that clinicians routinely take a sexual and injection drug use history for all their patients in an open and nonjudgmental manner. All adolescents and adults who are sexually active or who inject drugs should be informed that acquisition of HIV can be prevented, to facilitate subsequent risk assessment and discussions about preexposure prophylaxis (PrEP) and other ways to prevent acquisition of HIV. Importantly, risk of HIV acquisition exists on a continuum, and currently available risk assessment tools all have limitations. However, certain risk factors or behaviors are known to place persons at increased risk of HIV.\r\nRisk of HIV acquisition depends on the likelihood that a specific act or activity will transmit HIV and the likelihood that a sex partner or drug injection partner has HIV. Likelihood of HIV transmission is highest with needle-sharing injection drug use and condomless receptive anal intercourse. Condomless receptive anal intercourse has an approximately 10- to 15-fold higher risk of transmission than condomless insertive anal sex and condomless receptive and insertive penile-vaginal sex. A 2018 study estimated the prevalence of HIV (ie, an estimate of the likelihood that a partner whose HIV status is unknown has HIV at a population level) as 12.4% among men who have sex with men and 1.9% among persons who inject drugs. The overall prevalence of HIV in the US is estimated at 0.3%.&nbsp;Of note, both the frequency of specific sexual activities and a person&rsquo;s number of sexual partners will also affect their risk of HIV.\r\n&nbsp;The USPSTF recommends that the following persons be considered for PrEP:\r\n1.&nbsp;&nbsp;&nbsp;&nbsp; Sexually active adults and adolescents weighing at least 35 kg (77 lb) who have engaged in anal or vaginal sex in the past 6 months and have any of the following:\r\n&nbsp;\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A sexual partner who has HIV (especially if the partner has an unknown or detectable viral load).\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A bacterial sexually transmitted infection (STI) (syphilis, gonorrhea, or chlamydia for men who have sex with men and transgender women; gonorrhea and syphilis for heterosexual women and men) in the past 6 months.\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A history of inconsistent or no condom use with sex partner(s) whose HIV status is not known; assessing risk in conversation with the patient and considering factors such as number of partners, the specific sexual activities a person engages in, and whether their sex partner or partners are in a group with a higher prevalence of HIV (eg, men who have sex with men or with men and women, transgender women, persons who inject drugs, and persons who engage in transactional sex).\r\n&nbsp;\r\n2. &nbsp; Persons who inject drugs and have a drug-injecting partner who has HIV or who shares injection equipment.\r\nPersons who engage in transactional sex, such as sex for money, drugs, or housing, including commercial sex workers or persons trafficked for sex work, constitute a group at increased risk of HIV acquisition and should be considered for PrEP based on the criteria outlined above. Persons who request PrEP may have undisclosed behaviors that put them at risk. Transgender women and men who are sexually active should be considered for PrEP based on the criteria outlined above. Transgender women are at especially high risk of HIV acquisition. A Centers for Disease Control and and Prevention (CDC) survey in 7 cities found an HIV prevalence of 42% among transgender women. Prevalence was highest among Black transgender women (62%) and Native American/Alaska Native transgender women (65%).\r\nIn addition, studies have found that transmission of HIV to a seronegative partner from a partner with HIV has not been observed when the partner with HIV was being treated with antiretroviral therapy and had a suppressed viral load.&nbsp;It is not known whether PrEP use further decreases the risk of HIV transmission when a partner with HIV has a documented undetectable viral load. Factors such as the consistency or inconsistency of a partner&rsquo;s viral load being suppressed, a partner&rsquo;s adherence to antiretroviral therapy, and the degree of certainty that a partner&rsquo;s viral load is suppressed (eg, self-report vs availability of laboratory test results) may help inform decisions about the use of PrEP in this situation.\r\nAll persons being considered for PrEP must have a recently documented negative HIV antigen-antibody test result, and if they have taken oral PrEP or postexposure prophylaxis in the past 3 months, or injectable cabotegravir in the past 12 months, the CDC recommends testing with both an HIV antigen-antibody assay and an HIV-1 RNA assay.'}, {'id': 1989, 'title': 'Syphilis Infection in Nonpregnant Adolescents and Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for syphilis infection in persons who are at increased risk for infection.', 'servfreq': 'Optimal screening frequency for persons who are at increased risk for syphilis infection is not well established. Men who have sex with men or persons with HIV infection may benefit from screening at least annually or more frequently (eg, every 3 to 6 months) if they continue to be at high risk.', 'risktext': 'The USPSTF recommends screening for syphilis in persons who are at increased risk for infection. When deciding which persons to screen for syphilis, clinicians should consider the prevalence of infection in the communities they serve, as well as other sociodemographic and behavioral factors that may be associated with increased risk of syphilis infection. For example, prevalence of syphilis is higher in men, men who have sex with men, persons with HIV infection, young adults, and persons with a history of incarceration, sex work, or military service. A substantial percentage of heterosexual syphilis transmission occurs among persons who use illicit drugs, particularly methamphetamine. Diagnosis of another STI may signal that a person is having condomless sex, which increases their risk of syphilis infection. Higher infection rates in persons of some racial and ethnic groups have been reported and are primarily a reflection of a combination of factors, including social determinants of health (eg, disparities of income, low educational achievement, and unstable housing), differential health insurance coverage or access to quality health care, and differences in sexual network characteristics (eg, individuals living in communities with a high prevalence of STIs have an increased chance of encountering an infected partner). Local prevalence rates may change over time, so clinicians should be aware of the latest data and trends for their specific population and geographic area, which are available through their state and local health departments and Centers for Disease Control and Prevention (CDC) surveillance.\r\n&nbsp;\r\nAlthough direct evidence on screening in nonpregnant persons who are not at increased risk for syphilis infection is lacking, based on the established test performance characteristics of current screening tests and the low prevalence rate of syphilis in this population, the yield of screening is likely low.9,10 Therefore, screening in this population may result in high false-positive rates and overtreatment.'}, {'id': 1905, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and US Food and Drug Administration (FDA)--approved pharmacotherapy for cessation to nonpregnant adults who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 1906, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all pregnant persons about tobacco use, advise them to stop using tobacco, and provide behavioral interventions for cessation to pregnant persons who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 2014, 'title': 'Anxiety Disorders in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for anxiety disorders in adults, including pregnant and postpartum persons.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding optimal timing for screening, or screening interval, for both the perinatal and general adult populations; more evidence on both timing and screening interval is needed for all adult populations. A pragmatic approach in the absence of evidence might include screening all adults who have not been screened previously and using clinical judgment in considering risk factors, comorbid conditions, and life events to determine if additional screening of high-risk patients is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nRisk factors for anxiety disorders include sociodemographic factors, psychosocial factors, and physical and mental health factors such as marital status (widowed or divorced), stressful life events, smoking and alcohol use, other mental health conditions, or a parental history of mental disorders. Demographic factors such as low socioeconomic status and female sex are associated with higher rates of anxiety disorders.&nbsp;Black persons and individuals of non-Hispanic ethnicity are at increased risk of anxiety disorders due to social, rather than biological, factors. Anxiety and depressive disorders often overlap. One cohort study found that 67% of individuals with a depressive disorder also had a current anxiety disorder, and 75% had a lifetime comorbid anxiety disorder.'}, {'id': 2009, 'title': 'Latent Tuberculosis Infection in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for LTBI in populations at increased risk.\r\rSee the "Assessment of Risk" section for additional information on adults at increased risk.', 'servfreq': 'The USPSTF found no evidence on the optimal frequency of screening for LTBI. In the absence of evidence, a reasonable approach is to repeat screening based on specific risk factors; screening frequency could range from 1-time only screening among persons at low risk for future tuberculosis exposure to annual screening among those at continued risk of exposure.', 'risktext': 'Populations at increased risk for LTBI, based on increased prevalence of active disease and increased risk of exposure, include persons who were born in, or are former residents of, countries with high tuberculosis prevalence and persons who live in, or have lived in, high-risk congregate settings (eg, homeless shelters or correctional facilities). Clinicians can consult their local or state health departments for more information about populations at increased risk in their community, since local demographic patterns may vary across the US.\r\nIn 2020, 71.5% of all cases of active tuberculosis in the US occurred among persons born outside the US. According to the CDC, tuberculosis disease is common in most countries in Latin America, the Caribbean, Africa, Asia, Eastern Europe, and Russia. In 2020, among persons with new tuberculosis living in the US who were born outside the US, the most common countries of birth were Mexico (18.0%), the Philippines (12.5%), India (10.4%), Vietnam (8.2%), and China (5.1%), accounting for 54.2% of total cases. Most of these cases are believed to be due to progression of latent infection to active tuberculosis disease rather than new transmission within communities.\r\nPersons who live, or have lived, in high-risk congregate settings also have a higher prevalence rate of active tuberculosis and an increased risk for exposure. In 2020, 4.3% of tuberculosis disease cases diagnosed in persons 15 years or older occurred in persons experiencing homelessness and 2.6% occurred in residents of correctional facilities. It is estimated that persons experiencing homelessness have an 11 times higher incidence of tuberculosis disease compared with persons who are not experiencing homelessness (36 cases per 100,000 population vs 2.9 cases per 100,000 population, respectively, during 2011 to 2016).\r\nOther populations at increased risk for LTBI or progression to active disease include persons who have immunosuppression (eg, persons living with HIV, patients receiving immunosuppressive medications such as chemotherapy or tumor necrosis factor inhibitors, and patients who have received an organ transplant) and patients with silicosis (a lung disease). However, given that screening in these populations may be considered standard care as part of disease management or indicated prior to the use of certain medications, the USPSTF did not review evidence on screening in these populations. Information on testing in these populations is provided by other groups, such as the Office of AIDS Research at the National Institutes of Health, and in a guideline issued jointly by the American Thoracic Society, Infectious Diseases Society of America, and CDC. Some evidence from observational studies has explored the association between poorly controlled diabetes and progression of LTBI to active disease. However, there is insufficient evidence on screening for and treatment of LTBI in persons with diabetes for the USPSTF to make a separate recommendation for this important population.\r\nPersons who are contacts of individuals with active tuberculosis, health care workers, and workers in high-risk congregate settings may also be at increased risk of exposure. Because screening in these populations is conducted as part of public health or employee health surveillance, the USPSTF did not review the evidence in these populations. Clinicians seeking further information about testing for tuberculosis in these populations can refer to the Additional Tools and Resources and Recommendations of Others sections.'}, {'id': 514, 'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic bacteriuria in nonpregnant adults.', 'servfreq': '', 'risktext': 'The risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6 Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5 Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7, 11, 12 In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12 Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4, 6'}, {'id': 1909, 'title': 'Asymptomatic Carotid Artery Stenosis: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic carotid artery stenosis in the general adult population.\r\rSee the Practice Considerations section for a description of adults at increased risk.', 'servfreq': '', 'risktext': ''}, {'id': 2017, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for suicide risk in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': '', 'risktext': ''}, {'id': 2016, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for depression in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding the optimal timing for screening for depression; more evidence is needed in both perinatal and general adult populations. In the absence of evidence, a pragmatic approach might include screening adults who have not been screened previously and using clinical judgment while considering risk factors, comorbid conditions, and life events to determine if additional screening of patients at increased risk is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nThe USPSTF recommends screening for depression in all adults regardless of risk factors. Risk factors for depression include a combination of genetic, biological, and environmental factors, such as a family history of depression, prior episode of depression or other mental health condition, a history of trauma or adverse life events, or a history of disease or illness (eg, cardiovascular disease).\r\nPrevalence rates vary by sex, age, race, ethnicity, education, marital status, geographic location, poverty level, and employment status. Women have twice the risk of depression compared with men. Young adults, multiracial individuals, and Native American/Alaska Native individuals have higher rates of depression.\r\nRisk factors for perinatal depression include life stress, low social support, history of depression, marital or partner dissatisfaction, and a history of abuse.'}, {'id': 1845, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends offering or referring adults with cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity.', 'servfreq': '', 'risktext': 'Adults 18 years or older at increased risk of CVD, defined as those with 1 or more of the following:\r\n1.Hypertension or elevated blood pressure2.Dyslipidemia3.Mixed or multiple risk factors such as the metabolic syndrome or an estimated 10-year CVD risk of &ge;7.5%\r\nThis recommendation does not apply to adults with other known modifiable cardiovascular risk factors such as abnormal blood glucose levels, obesity, and smoking; these populations are incorporated in other USPSTF recommendations.'}, {'id': 1885, 'title': 'Hepatitis B Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in adolescents and adults at increased risk for infection.\r\rSee the Practice Considerations section for a description of adolescents and adults at increased risk for infection.', 'servfreq': 'For patients with negative HBsAg results who have not received the HBV vaccine series, periodic screening may be useful for those who report continued risk for acquiring HBV transmission, such as persons who continue to inject drugs and men who have sex with men. Clinical judgment should be used to determine screening frequency. The USPSTF found no evidence to determine optimal screening intervals.', 'risktext': 'Persons from such risk groups include persons who have injected drugs in the past or currently; men who have sex with men; persons with HIV; and sex partners, needle-sharing contacts, and household contacts of persons known to be HBsAg positive. Some persons with combinations of risk factors who are not members of risk factor groups listed above may also be at increased risk for HBV infection.'}, {'id': 524, 'title': 'Hepatitis C Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis C virus (HCV) infection in adults aged 18 to 79 years.', 'servfreq': 'One-time screening for most adults.\r\nPeriodically screen persons with continued risk for HCV infection (eg, persons with past or current injection drug use). There is limited evidence to determine how often to screen persons at increased risk.&nbsp;', 'risktext': 'Asymptomatic adults aged 18 to 79 years (including pregnant persons) without known liver disease.&nbsp;\r\nThe USPSTF also suggests that clinicians consider screening persons younger than 18 years and older than 79 years who are at high risk for infection (eg, those with past or current injection drug use).&nbsp;'}, {'id': 1916, 'title': 'Lung Cancer: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery.', 'servfreq': ' \r\nThe USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. ', 'risktext': ' \r\nSmoking and older age are the 2 most important risk factors for lung cancer.&nbsp;The risk of lung cancer in persons who smoke increases with cumulative quantity and duration of smoking and with age but decreases with increasing time since quitting for persons who formerly smoked.3 The USPSTF considers adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years to be at high risk and recommends screening for lung cancer with annual LDCT in this population. \r\n \r\n&nbsp;\r\n \r\nAfrican American/Black (Black) men have a higher incidence of lung cancer than White men, and Black women have a lower incidence than White women.1 These differences are likely related to differences in smoking exposure (ie, prevalence of smoking) and related exposure to carcinogens in cigarettes.7,8 The differences may also be related to other social risk factors.\r\n \r\n&nbsp;\r\n \r\nOther risk factors for lung cancer include environmental exposures, prior radiation therapy, other (noncancer) lung diseases, and family history. Lower level of education is also associated with a higher risk of lung cancer.7 The task force recommends using age and smoking history to determine screening eligibility rather than more elaborate risk prediction models because there is insufficient evidence to assess whether risk prediction model&ndash;based screening would improve outcomes relative to using the risk factors of age and smoking history for broad implementation in primary care.\r\n '}, {'id': 1934, 'title': 'Prediabetes and Type 2 Diabetes: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for prediabetes and type 2 diabetes in adults aged 35 to 70 years who have overweight or obesity. Clinicians should offer or refer patients with prediabetes to effective preventive interventions.', 'servfreq': ' \r\nEvidence on the optimal screening interval for adults with an initial normal glucose test result is limited. Cohort and modeling studies suggest that screening every 3 years may be a reasonable approach for adults with normal blood glucose levels.\r\n ', 'risktext': 'Overweight and obesity are the strongest risk factors for developing prediabetes and type 2 diabetes in adults. Other risk factors include older age, family history, history of gestational diabetes, history of polycystic ovarian syndrome, and dietary and lifestyle factors. The prevalence of diabetes is higher among American Indian/Alaska Native (14.7%), Asian (9.2%), Hispanic/Latino (12.5%), and non-Hispanic Black (11.7%) persons than among non-Hispanic White (7.5%) persons. Disparities in diabetes prevalence are the result of a variety of factors. A large body of evidence demonstrates strong associations between prevalence of diabetes and social factors such as socioeconomic status, food environment, and physical environment. The higher prevalence of diabetes in Asian persons may be related to differences in body composition. A difference in body fat composition in Asian persons results in underestimation of risk based on BMI thresholds used to define overweight in the US.\r\n \r\n&nbsp;\r\n \r\nClinicians should consider screening at an earlier age in persons from groups with disproportionately high incidence and prevalence (American Indian/Alaska Native, Asian American, Black, Hispanic/Latino, or Native Hawaiian/Pacific Islander persons) or in persons who have a family history of diabetes, a history of gestational diabetes, or a history of polycystic ovarian syndrome, and at a lower BMI in Asian American persons.11,12 Data suggest that a BMI of 23 or greater may be an appropriate cut point in Asian American persons.13\r\n '}, {'id': 1445, 'title': 'Sexually Transmitted Infections: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends behavioral counseling for all sexually active adolescents and for adults who are at increased risk for sexually transmitted infections (STIs).\r\rSee the Practice Considerations section for more information on populations at increased risk for acquiring STIs.', 'servfreq': '', 'risktext': 'All sexually active adolescents are at increased risk for STIs because of the high rates of STIs in this age group and should receive behavioral counseling interventions. Adults at increased risk for STIs include those who currently have an STI or were diagnosed with one within the past year, do not consistently use condoms, have multiple sex partners, or have sex partners within populations with a high prevalence of STIs. Populations with a high prevalence of STIs include persons who seek STI testing or attend STI clinics; sexual and gender minorities; persons who are living with HIV, inject drugs, have exchanged sex for money or drugs, or have entered correctional facilities; and some racial/ethnic minority groups.1-4'}, {'id': 1981, 'title': 'Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians prescribe a statin for the primary prevention of CVD for adults aged 40 to 75 years who have 1 or more CVD risk factors (i.e. dyslipidemia, diabetes, hypertension, or smoking) and an estimated 10-year risk of a cardiovascular event of 10% or greater.', 'servfreq': '', 'risktext': ''}, {'id': 438, 'title': 'Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for unhealthy alcohol use in primary care settings in adults 18 years or older, including pregnant women, and providing persons engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce unhealthy alcohol use.', 'servfreq': 'The USPSTF did not find adequate evidence to recommend an optimal screening interval for unhealthy alcohol use in adults.&nbsp;Brief behavioral counseling interventions were found to reduce unhealthy alcohol use in adults 18 years or older, including pregnant women. Effective behavioral counseling interventions vary in their specific components, administration, length, and number of interactions. The USPSTF was unable to identify specific intervention characteristics or components that were clearly associated with improved outcomes.', 'risktext': 'engaged in risky or hazardous drinking'}, {'id': 767, 'title': 'Unhealthy Drug Use: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening by asking questions about unhealthy drug use in adults age 18 years or older. Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. \r(Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'servfreq': 'Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. (Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'risktext': 'These include being aged 18 to 25 years; male sex; having a mental health condition, personality or mood disorder, or nicotine or alcohol dependence; a history of physical or sexual abuse, parental neglect, or other adversity in childhood; or drug or alcohol addiction in a first-degree relative.1,9&nbsp;Factors associated with misuse of prescription drugs include history of other drug use, mental illness, pain, and greater access to prescription drugs.10&nbsp;Factors associated with prenatal use of drugs include a mental health disorder, interpersonal violence, and family history of substance use.11'}, {'id': 433, 'title': 'Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer or refer adults with a body mass index (BMI) of 30 or higher (calculated as weight in kilograms divided by height in meters squared) to intensive, multicomponent behavioral interventions.', 'servfreq': '', 'risktext': 'Adults with a BMI &ge;30'}, {'id': 1971, 'title': 'Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication ', 'grade': 'C', 'text': 'The decision to initiate low-dose aspirin use for the primary prevention of CVD in adults aged 40 to 59 years who have a 10% or greater 10-year CVD risk should be an individual one. Evidence indicates that the net benefit of aspirin use in this group is small. Persons who are not at increased risk for bleeding and are willing to take low-dose aspirin daily are more likely to benefit.', 'servfreq': '', 'risktext': ' \r\nAssessment of Risk\r\n \r\n&nbsp;\r\n \r\nCVD Risk\r\n \r\nOlder age is one of the strongest risk factors for CVD. Men have a higher overall CVD disease burden, although women experience higher mortality from certain cardiovascular events, such as stroke. Men tend to experience CVD events earlier in life compared with women. The burden of CVD also differs by race and ethnicity. Among both sexes, Black persons have the highest prevalence of CVD.\r\n \r\n&nbsp;\r\n \r\nThe American College of Cardiology/American Heart Association (ACC/AHA) Pooled Cohort Equations may be used to estimate 10-year risk of CVD. The ACC/AHA risk estimator is, to date, the only US-based CVD risk prediction tool that has published external validation studies in other US-based populations. The estimator has separate equations based on sex and for Black persons and non-Black persons, which include the risk factors of age, cholesterol levels, systolic blood pressure level, antihypertension treatment, presence of diabetes, and smoking status, and focuses on hard clinical outcomes (myocardial infarction and death from coronary heart disease; ischemic stroke and stroke-related death) as the outcomes of interest. It is important to note that increasing age heavily influences the ACC/AHA estimated 10-year CVD event risk. The risk prediction equations generally show higher risk for Black persons than White persons. The USPSTF recognizes that race is a social construct and an imperfect proxy for social determinants of health and the effects of structural racism. Concerns about calibration exist, with many external validation studies showing overprediction in broad populations (men and women across racial and ethnic groups). Limited evidence also suggests underprediction in disadvantaged communities&nbsp;that could lead to underutilization of preventive therapies. Clinicians should recognize that predictions of 10-year CVD events using the Pooled Cohort Equations are estimates.\r\n \r\n&nbsp;\r\n \r\nBleeding Risk\r\n \r\nThe risk for gastrointestinal bleeding, intracranial hemorrhage, and hemorrhagic stroke, with or without aspirin use, increases with older age. Other risk factors include male sex, diabetes, history of gastrointestinal issues (such as peptic ulcer disease), liver disease, smoking, and elevated blood pressure. Certain medications, including nonsteroidal anti-inflammatory drugs, steroids, and anticoagulants, increase the risk of bleeding.&nbsp;These risk factors should be considered in the overall decision about whether to start or continue aspirin therapy.\r\n '}, {'id': 1979, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: Behavioral Counseling Interventions ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians individualize the decision to offer or refer adults without cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity. \r\rSee the "Practice Considerations" section for information on determining which patients may benefit most from this service.', 'servfreq': '', 'risktext': ''}, {'id': 403, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians selectively offer counseling to adults older than 24 years with fair skin types about minimizing their exposure to UV radiation to reduce risk of skin cancer. Existing evidence indicates that the net benefit of counseling all adults older than 24 years is small. In determining whether counseling is appropriate in individual cases, patients and clinicians should consider the presence of risk factors for skin cancer.See the Clinical Considerations section for information on risk assessment.', 'servfreq': '', 'risktext': 'Persons with fair skin types (ivory or pale skin, light eye color, red or blond hair, freckles, those who sunburn easily) are at increased risk of skin cancer and should be counseled. Other factors that further increase risk include a history of sunburns, previous use of indoor tanning beds, and a family or personal history of skin cancer. Persons with an increased number of nevi and atypical nevi are at increased risk of melanoma. Persons with a compromised immune system (eg, persons living with HIV, persons who have received an organ transplant) are at increased risk of skin cancer.'}, {'id': 1982, 'title': 'Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians selectively offer a statin for the primary prevention of CVD for adults aged 40 to 75 years who have 1 or more CVD risk factors (i.e dyslipidemia, diabetes, hypertension, or smoking) and an estimated 10-year risk of a cardiovascular event of 7.5% to less than 10%. The likelihood of benefit is smaller in this group than in persons with a 10-year risk of 10% or greater.', 'servfreq': '', 'risktext': ''}, {'id': 1937, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for chlamydia and gonorrhea in men.', 'servfreq': '', 'risktext': ''}, {'id': 418, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening with resting or exercise electrocardiography (ECG) to prevent cardiovascular disease (CVD) events in asymptomatic adults at low risk of CVD events.', 'servfreq': '', 'risktext': ''}, {'id': 1973, 'title': 'Chronic Obstructive Pulmonary Disease: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for chronic obstructive pulmonary disease in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 2003, 'title': 'Genital Herpes Infection: Serologic Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine serologic screening for genital herpes simplex virus infection in asymptomatic adolescents and adults, including pregnant persons.', 'servfreq': '', 'risktext': 'The USPSTF found no evidence of externally validated, reliable risk stratification tools to identify individuals more or less likely to have genital herpes.'}, {'id': 504, 'title': 'Pancreatic Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for pancreatic cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 203, 'title': 'Testicular Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for testicular cancer in adolescent or adult men.', 'servfreq': '', 'risktext': ''}, {'id': 365, 'title': 'Thyroid Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for thyroid cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 1976, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'D', 'text': 'The DoctorAI recommends against the use of beta carotene or vitamin E supplements for the prevention of cardiovascular disease or cancer.', 'servfreq': '', 'risktext': ''}, {'id': 318, 'title': 'Autism Spectrum Disorder in Young Children: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for autism spectrum disorder (ASD) in young children for whom no concerns of ASD have been raised by their parents or a clinician.', 'servfreq': '', 'risktext': 'Although a number of potential risk factors for ASD have been identified, there is insufficient evidence to determine if certain risk factors modify the performance characteristics of ASD screening tests, such as the age at which screening is performed or other characteristics of the child or family.'}, {'id': 65, 'title': 'Bladder Cancer in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults.\r\rLiterature scans conducted in July 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'This evidence update focused on the benefits and harms of screening for bladder cancer among people without symptoms, the accuracy of screening tests done in primary care settings, and the benefits and harms of treatment. The updated evidence review did not find any new high quality evidence to adequately determine the balance of benefits and harms of screening for bladder cancer. However, bladder cancer is a common cancer and can cause considerable health problems including death. Therefore, the USPSTF determined that the evidence was insufficient to provide a recommendation for or against bladder cancer screening.  The USPSTF emphasizes the need for additional research in this area. '}, {'id': 419, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening with resting or exercise ECG to prevent CVD events in asymptomatic adults at intermediate or high risk of CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 423, 'title': 'Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of adding the ankle-brachial index (ABI), high-sensitivity C-reactive protein (hsCRP) level, or coronary artery calcium (CAC) score to traditional risk assessment for cardiovascular disease (CVD) in asymptomatic adults to prevent CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 352, 'title': 'Celiac Disease: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'persons with family history or other risk factors'}, {'id': 1955, 'title': 'Eating Disorders in Adolescents and Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for eating disorders in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 435, 'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for abuse and neglect in all older or vulnerable adults. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': 'Risk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health.14&nbsp;For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.15'}, {'id': 2045, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for iron deficiency and iron deficiency anemia in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2046, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine iron supplementation in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 1998, 'title': 'Obstructive Sleep Apnea in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for obstructive sleep apnea in the general adult population.\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Risk Factors\r\nRisk factors associated with OSA include male sex, older age (40-70 years), postmenopausal status, higher body mass index (BMI), and craniofacial and upper airway abnormalities (eg, enlarged tonsils or long upper airway). Black, Hispanic/Latino, and Native American/Alaska Native persons have a higher prevalence of OSA compared with White persons; some evidence suggests that these differences are partially explained by higher rates of obesity, asthma, and tobacco use among these groups.8'}, {'id': 1977, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of multivitamin supplements for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1978, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of single or paired nutrient supplements (other than beta carotene and vitamin E) for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 176, 'title': 'Oral Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for oral cancer in asymptomatic adults.\r\rGo to the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in July 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Tobacco and alcohol use are major risk factors for oral cancer. A total of 20% to 30% of cases of oral cancer worldwide are attributable to cigarette smoking. In the United States, up to 75% of cases of oral cancer may be attributable to tobacco and alcohol use. Additional risk factors include male sex, older age, use of betel quid, ultraviolet light exposure, infection with Candida or bacterial flora, and a compromised immune system. Sexually transmitted oral HPV infection (HPV-16) has recently been recognized as an increasingly important risk factor for oropharyngeal cancer. In the United States, the prevalence of oropharyngeal cancer due to oral HPV infection is probably as high as 80% to 95%. The prevalence of oral HPV infection is associated with age, sex, number of sexual partners, and number of cigarettes smoked per day. The effect of multifactorial risk assessment and screening for risk factors on oral cancer morbidity and mortality is unknown.'}, {'id': 2026, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine screening performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 2027, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of preventive interventions performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 2059, 'title': 'Osteoporosis to Prevent Fractures: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for osteoporosis to prevent osteoporotic fractures in men.\r\rSee the "Practice Considerations" section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': 'Men have similar risk factors associated with fragility fractures as women, including increasing age, low BMI, excessive alcohol intake, current smoking, chronic corticosteroid use, history of prior fractures, history of falls within the past year, hypogonadism, history of cerebrovascular accident, and history of diabetes.'}, {'id': 424, 'title': 'Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for peripheral artery disease (PAD) and cardiovascular disease (CVD) risk with the ankle-brachial index (ABI) in asymptomatic adults.\r\rLiterature scans conducted in August 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Risk factors associated with OSA include male sex, older age (40 to 70 years), postmenopausal status, higher BMI, and craniofacial and upper airway abnormalities.'}, {'id': 1974, 'title': 'Primary Open-Angle Glaucoma: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for primary open-angle glaucoma in adults.', 'servfreq': '', 'risktext': ''}, {'id': 404, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of counseling adults about skin self-examination to prevent skin cancer.See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 2005, 'title': 'Skin Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Exposure to UV radiation from sun exposure, indoor tanning beds, and other UV radiation&ndash;emitting devices is the major environmental risk factor for skin cancer. History of frequent sunburns, older age, and male sex are associated with increased risk for skin cancer. Exposure to UV radiation from the use of indoor tanning beds is an important risk factor in adolescents. Incidence of melanoma is higher among White persons compared with persons of other races and ethnicities. This difference likely reflects traits associated with increased melanoma risk, such as fair skin (which is more susceptible to sunburning), light-colored eyes, and red or blond hair being more common among White persons compared with persons of other races and ethnicities. Acral lentiginous melanoma, which occurs mostly on skin not frequently exposed to direct sunlight (eg, palms of hands, soles of feet, or under fingernails or toenails), is the most common type of melanoma among Black populations. Other melanoma risk factors include higher numbers of moles on the skin, atypical moles, as well as a personal and family history of skin cancer.'}, {'id': 269, 'title': 'Thyroid Dysfunction: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults.\r\rSee the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': 'The optimal screening interval for thyroid dysfunction (if one exists) is unknown.', 'risktext': 'The most common cause of hypothyroidism in the United States is chronic autoimmune (Hashimoto) thyroiditis. Risk factors for an elevated TSH level include female sex, advancing age, white race, type 1 diabetes, Down syndrome, family history of thyroid disease, goiter, previous hyperthyroidism (possibly due in part to ablation therapy leading to iatrogenic thyroid dysfunction), and external-beam radiation in the head and neck area. Common causes of hyperthyroidism include Graves disease, Hashimoto thyroiditis, and functional thyroid nodules. Risk factors for a low TSH level include female sex; advancing age; black race; low iodine intake; personal or family history of thyroid disease; and ingestion of iodine-containing drugs, such as amiodarone. The USPSTF found no direct evidence that treatment of thyroid dysfunction based on risk level alters final health outcomes.'}, {'id': 1908, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of electronic cigarettes (e-cigarettes) for tobacco cessation in adults, including pregnant persons. The USPSTF recommends that clinicians direct patients who use tobacco to other tobacco cessation interventions with proven effectiveness and established safety.\rSee the Practice Considerations section for more information on recommended behavioral interventions and pharmacotherapy and for suggestions for practice regarding the I statements.', 'servfreq': '', 'risktext': ''}, {'id': 1907, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of pharmacotherapy interventions for tobacco cessation in pregnant persons.', 'servfreq': '', 'risktext': ''}, {'id': 586, 'title': 'Tobacco Use in Children and Adolescents: Primary Care Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--feasible interventions for the cessation of tobacco use among school-aged children and adolescents.\r\rSee the Practice Considerations section for more information on effective interventions to prevent initiation of tobacco use and for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1919, 'title': 'Vitamin D Deficiency in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 408, 'title': 'Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of the benefits and harms of vitamin D and calcium supplementation, alone or combined, for the primary prevention of fractures in men and premenopausal women.', 'servfreq': '', 'risktext': ''}]
2025-01-29 21:53:37 [INFO] Tools: [{'tool_id': 321, 'url': 'https://jamanetwork.com/journals/jama/fullarticle/2735342', 'title': 'JAMA Patient Page: Who Should Be Screened for HIV Infection? ', 'text': '', 'keywords': ''}, {'tool_id': 322, 'url': 'https://sites.jamanetwork.com/spanish-patient-pages/2019/hoja-para-el-paciente-de-jama-190618.pdf', 'title': 'ยฟQuiรฉnes deben someterse a una prueba de detecciรณn de infecciรณn por VIH?', 'text': '', 'keywords': 'HIV|Human immunodeficiency syndrome|AIDS'}, {'tool_id': 210, 'url': 'https://www.aafp.org/afp/2019/1115/p637.html', 'title': "Screening for HIV Infection and Preexposure Prophylaxis for the Prevention of HIV Infection: AFP's Putting Into Practice", 'text': 'The journal American Family Physician (AFP) provides a series of short case studies and quizzes based on recommendations issued by the U.S. Preventive Services Task Force.', 'keywords': ''}]
2025-01-29 21:53:38 [INFO] Update id=273478148 is handled. Duration 1154 ms by bot id=8108339380
2025-01-29 21:53:41 [INFO] Update id=273478149 is handled. Duration 676 ms by bot id=8108339380
2025-01-29 21:53:41 [INFO] State data: {'db': <bot.database.Database object at 0x7fb55054b2f0>, 'age': 40, 'weight': 90, 'height': 190, 'feet': 45, 'gender': 'male', 'pregnant': 'no', 'smoking': 'yes', 'sex': 'tools_1', 'recommendations': [{'id': 485, 'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in adolescents and adults aged 15 to 65 years. Younger adolescents and older adults who are at increased risk of infection should also be screened.\rSee the Clinical Considerations section for more information about assessment of risk, screening intervals, and rescreening in pregnancy.', 'servfreq': 'The USPSTF found insufficient evidence to determine appropriate or optimal time intervals or strategies for repeat HIV screening. However, repeat screening is reasonable for persons known to be at increased risk of HIV infection, such as sexually active men who have sex with men; persons with a sex partner who is living with HIV; or persons who engage in behaviors that may convey an increased risk of HIV infection, such as injection drug use, transactional sex or commercial sex work, having 1 or more new sex partners whose HIV status is unknown, or having other factors that can place a person at increased risk of HIV infection (see &ldquo;Risk Assessment&rdquo;). Repeat screening is also reasonable for persons who live or receive medical care in a high-prevalence setting, such as a sexually transmitted disease clinic, tuberculosis clinic, correctional facility, or homeless shelter.', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'id': 1921, 'title': 'Hypertension in Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hypertension in adults 18 years or older with office blood pressure measurement (OBPM). The USPSTF recommends obtaining blood pressure measurements outside of the clinical setting for diagnostic confirmation before starting treatment.', 'servfreq': ' \r\nAlthough evidence on optimal screening intervals is limited, reasonable options include:\r\n \r\n \r\n\r\n\r\nScreening for hypertension every year in adults 40 years or older and in adults at increased risk for hypertension (such as Black persons, persons with high-normal blood pressure, or persons who are overweight or obese)\r\n\r\n\r\n \r\n \r\n\r\n\r\nScreening less frequently (ie, every 3 to 5 years) as appropriate for adults aged 18 to 39 years not at increased risk for hypertension and with a prior normal blood pressure reading.\r\n\r\n\r\n ', 'risktext': ' \r\nAlthough all adults should be screened for hypertension, risk factors that increase a person&rsquo;s risk for the condition include older age, Black race, family history, excess weight and obesity, lifestyle habits (lack of physical activity, stress, and tobacco use), and dietary factors (diet high in fat or sodium, diet low in potassium, or excessive alcohol intake)\r\n '}, {'id': 2021, 'title': 'Prevention of Acquisition of HIV: Preexposure Prophylaxis ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians prescribe preexposure prophylaxis using effective antiretroviral therapy to persons who are at increased risk of HIV acquisition to decrease the risk of acquiring HIV. \r\rSee the Practice Considerations section for more information about identification of persons at increased risk and about effective antiretroviral therapy.', 'servfreq': '', 'risktext': 'HIV is primarily acquired via sexual activity or injection drug use. It is important that clinicians routinely take a sexual and injection drug use history for all their patients in an open and nonjudgmental manner. All adolescents and adults who are sexually active or who inject drugs should be informed that acquisition of HIV can be prevented, to facilitate subsequent risk assessment and discussions about preexposure prophylaxis (PrEP) and other ways to prevent acquisition of HIV. Importantly, risk of HIV acquisition exists on a continuum, and currently available risk assessment tools all have limitations. However, certain risk factors or behaviors are known to place persons at increased risk of HIV.\r\nRisk of HIV acquisition depends on the likelihood that a specific act or activity will transmit HIV and the likelihood that a sex partner or drug injection partner has HIV. Likelihood of HIV transmission is highest with needle-sharing injection drug use and condomless receptive anal intercourse. Condomless receptive anal intercourse has an approximately 10- to 15-fold higher risk of transmission than condomless insertive anal sex and condomless receptive and insertive penile-vaginal sex. A 2018 study estimated the prevalence of HIV (ie, an estimate of the likelihood that a partner whose HIV status is unknown has HIV at a population level) as 12.4% among men who have sex with men and 1.9% among persons who inject drugs. The overall prevalence of HIV in the US is estimated at 0.3%.&nbsp;Of note, both the frequency of specific sexual activities and a person&rsquo;s number of sexual partners will also affect their risk of HIV.\r\n&nbsp;The USPSTF recommends that the following persons be considered for PrEP:\r\n1.&nbsp;&nbsp;&nbsp;&nbsp; Sexually active adults and adolescents weighing at least 35 kg (77 lb) who have engaged in anal or vaginal sex in the past 6 months and have any of the following:\r\n&nbsp;\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A sexual partner who has HIV (especially if the partner has an unknown or detectable viral load).\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A bacterial sexually transmitted infection (STI) (syphilis, gonorrhea, or chlamydia for men who have sex with men and transgender women; gonorrhea and syphilis for heterosexual women and men) in the past 6 months.\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A history of inconsistent or no condom use with sex partner(s) whose HIV status is not known; assessing risk in conversation with the patient and considering factors such as number of partners, the specific sexual activities a person engages in, and whether their sex partner or partners are in a group with a higher prevalence of HIV (eg, men who have sex with men or with men and women, transgender women, persons who inject drugs, and persons who engage in transactional sex).\r\n&nbsp;\r\n2. &nbsp; Persons who inject drugs and have a drug-injecting partner who has HIV or who shares injection equipment.\r\nPersons who engage in transactional sex, such as sex for money, drugs, or housing, including commercial sex workers or persons trafficked for sex work, constitute a group at increased risk of HIV acquisition and should be considered for PrEP based on the criteria outlined above. Persons who request PrEP may have undisclosed behaviors that put them at risk. Transgender women and men who are sexually active should be considered for PrEP based on the criteria outlined above. Transgender women are at especially high risk of HIV acquisition. A Centers for Disease Control and and Prevention (CDC) survey in 7 cities found an HIV prevalence of 42% among transgender women. Prevalence was highest among Black transgender women (62%) and Native American/Alaska Native transgender women (65%).\r\nIn addition, studies have found that transmission of HIV to a seronegative partner from a partner with HIV has not been observed when the partner with HIV was being treated with antiretroviral therapy and had a suppressed viral load.&nbsp;It is not known whether PrEP use further decreases the risk of HIV transmission when a partner with HIV has a documented undetectable viral load. Factors such as the consistency or inconsistency of a partner&rsquo;s viral load being suppressed, a partner&rsquo;s adherence to antiretroviral therapy, and the degree of certainty that a partner&rsquo;s viral load is suppressed (eg, self-report vs availability of laboratory test results) may help inform decisions about the use of PrEP in this situation.\r\nAll persons being considered for PrEP must have a recently documented negative HIV antigen-antibody test result, and if they have taken oral PrEP or postexposure prophylaxis in the past 3 months, or injectable cabotegravir in the past 12 months, the CDC recommends testing with both an HIV antigen-antibody assay and an HIV-1 RNA assay.'}, {'id': 1989, 'title': 'Syphilis Infection in Nonpregnant Adolescents and Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for syphilis infection in persons who are at increased risk for infection.', 'servfreq': 'Optimal screening frequency for persons who are at increased risk for syphilis infection is not well established. Men who have sex with men or persons with HIV infection may benefit from screening at least annually or more frequently (eg, every 3 to 6 months) if they continue to be at high risk.', 'risktext': 'The USPSTF recommends screening for syphilis in persons who are at increased risk for infection. When deciding which persons to screen for syphilis, clinicians should consider the prevalence of infection in the communities they serve, as well as other sociodemographic and behavioral factors that may be associated with increased risk of syphilis infection. For example, prevalence of syphilis is higher in men, men who have sex with men, persons with HIV infection, young adults, and persons with a history of incarceration, sex work, or military service. A substantial percentage of heterosexual syphilis transmission occurs among persons who use illicit drugs, particularly methamphetamine. Diagnosis of another STI may signal that a person is having condomless sex, which increases their risk of syphilis infection. Higher infection rates in persons of some racial and ethnic groups have been reported and are primarily a reflection of a combination of factors, including social determinants of health (eg, disparities of income, low educational achievement, and unstable housing), differential health insurance coverage or access to quality health care, and differences in sexual network characteristics (eg, individuals living in communities with a high prevalence of STIs have an increased chance of encountering an infected partner). Local prevalence rates may change over time, so clinicians should be aware of the latest data and trends for their specific population and geographic area, which are available through their state and local health departments and Centers for Disease Control and Prevention (CDC) surveillance.\r\n&nbsp;\r\nAlthough direct evidence on screening in nonpregnant persons who are not at increased risk for syphilis infection is lacking, based on the established test performance characteristics of current screening tests and the low prevalence rate of syphilis in this population, the yield of screening is likely low.9,10 Therefore, screening in this population may result in high false-positive rates and overtreatment.'}, {'id': 1905, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and US Food and Drug Administration (FDA)--approved pharmacotherapy for cessation to nonpregnant adults who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 1906, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all pregnant persons about tobacco use, advise them to stop using tobacco, and provide behavioral interventions for cessation to pregnant persons who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 2014, 'title': 'Anxiety Disorders in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for anxiety disorders in adults, including pregnant and postpartum persons.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding optimal timing for screening, or screening interval, for both the perinatal and general adult populations; more evidence on both timing and screening interval is needed for all adult populations. A pragmatic approach in the absence of evidence might include screening all adults who have not been screened previously and using clinical judgment in considering risk factors, comorbid conditions, and life events to determine if additional screening of high-risk patients is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nRisk factors for anxiety disorders include sociodemographic factors, psychosocial factors, and physical and mental health factors such as marital status (widowed or divorced), stressful life events, smoking and alcohol use, other mental health conditions, or a parental history of mental disorders. Demographic factors such as low socioeconomic status and female sex are associated with higher rates of anxiety disorders.&nbsp;Black persons and individuals of non-Hispanic ethnicity are at increased risk of anxiety disorders due to social, rather than biological, factors. Anxiety and depressive disorders often overlap. One cohort study found that 67% of individuals with a depressive disorder also had a current anxiety disorder, and 75% had a lifetime comorbid anxiety disorder.'}, {'id': 2009, 'title': 'Latent Tuberculosis Infection in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for LTBI in populations at increased risk.\r\rSee the "Assessment of Risk" section for additional information on adults at increased risk.', 'servfreq': 'The USPSTF found no evidence on the optimal frequency of screening for LTBI. In the absence of evidence, a reasonable approach is to repeat screening based on specific risk factors; screening frequency could range from 1-time only screening among persons at low risk for future tuberculosis exposure to annual screening among those at continued risk of exposure.', 'risktext': 'Populations at increased risk for LTBI, based on increased prevalence of active disease and increased risk of exposure, include persons who were born in, or are former residents of, countries with high tuberculosis prevalence and persons who live in, or have lived in, high-risk congregate settings (eg, homeless shelters or correctional facilities). Clinicians can consult their local or state health departments for more information about populations at increased risk in their community, since local demographic patterns may vary across the US.\r\nIn 2020, 71.5% of all cases of active tuberculosis in the US occurred among persons born outside the US. According to the CDC, tuberculosis disease is common in most countries in Latin America, the Caribbean, Africa, Asia, Eastern Europe, and Russia. In 2020, among persons with new tuberculosis living in the US who were born outside the US, the most common countries of birth were Mexico (18.0%), the Philippines (12.5%), India (10.4%), Vietnam (8.2%), and China (5.1%), accounting for 54.2% of total cases. Most of these cases are believed to be due to progression of latent infection to active tuberculosis disease rather than new transmission within communities.\r\nPersons who live, or have lived, in high-risk congregate settings also have a higher prevalence rate of active tuberculosis and an increased risk for exposure. In 2020, 4.3% of tuberculosis disease cases diagnosed in persons 15 years or older occurred in persons experiencing homelessness and 2.6% occurred in residents of correctional facilities. It is estimated that persons experiencing homelessness have an 11 times higher incidence of tuberculosis disease compared with persons who are not experiencing homelessness (36 cases per 100,000 population vs 2.9 cases per 100,000 population, respectively, during 2011 to 2016).\r\nOther populations at increased risk for LTBI or progression to active disease include persons who have immunosuppression (eg, persons living with HIV, patients receiving immunosuppressive medications such as chemotherapy or tumor necrosis factor inhibitors, and patients who have received an organ transplant) and patients with silicosis (a lung disease). However, given that screening in these populations may be considered standard care as part of disease management or indicated prior to the use of certain medications, the USPSTF did not review evidence on screening in these populations. Information on testing in these populations is provided by other groups, such as the Office of AIDS Research at the National Institutes of Health, and in a guideline issued jointly by the American Thoracic Society, Infectious Diseases Society of America, and CDC. Some evidence from observational studies has explored the association between poorly controlled diabetes and progression of LTBI to active disease. However, there is insufficient evidence on screening for and treatment of LTBI in persons with diabetes for the USPSTF to make a separate recommendation for this important population.\r\nPersons who are contacts of individuals with active tuberculosis, health care workers, and workers in high-risk congregate settings may also be at increased risk of exposure. Because screening in these populations is conducted as part of public health or employee health surveillance, the USPSTF did not review the evidence in these populations. Clinicians seeking further information about testing for tuberculosis in these populations can refer to the Additional Tools and Resources and Recommendations of Others sections.'}, {'id': 514, 'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic bacteriuria in nonpregnant adults.', 'servfreq': '', 'risktext': 'The risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6 Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5 Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7, 11, 12 In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12 Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4, 6'}, {'id': 1909, 'title': 'Asymptomatic Carotid Artery Stenosis: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic carotid artery stenosis in the general adult population.\r\rSee the Practice Considerations section for a description of adults at increased risk.', 'servfreq': '', 'risktext': ''}, {'id': 2017, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for suicide risk in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': '', 'risktext': ''}, {'id': 2016, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for depression in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding the optimal timing for screening for depression; more evidence is needed in both perinatal and general adult populations. In the absence of evidence, a pragmatic approach might include screening adults who have not been screened previously and using clinical judgment while considering risk factors, comorbid conditions, and life events to determine if additional screening of patients at increased risk is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nThe USPSTF recommends screening for depression in all adults regardless of risk factors. Risk factors for depression include a combination of genetic, biological, and environmental factors, such as a family history of depression, prior episode of depression or other mental health condition, a history of trauma or adverse life events, or a history of disease or illness (eg, cardiovascular disease).\r\nPrevalence rates vary by sex, age, race, ethnicity, education, marital status, geographic location, poverty level, and employment status. Women have twice the risk of depression compared with men. Young adults, multiracial individuals, and Native American/Alaska Native individuals have higher rates of depression.\r\nRisk factors for perinatal depression include life stress, low social support, history of depression, marital or partner dissatisfaction, and a history of abuse.'}, {'id': 1845, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends offering or referring adults with cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity.', 'servfreq': '', 'risktext': 'Adults 18 years or older at increased risk of CVD, defined as those with 1 or more of the following:\r\n1.Hypertension or elevated blood pressure2.Dyslipidemia3.Mixed or multiple risk factors such as the metabolic syndrome or an estimated 10-year CVD risk of &ge;7.5%\r\nThis recommendation does not apply to adults with other known modifiable cardiovascular risk factors such as abnormal blood glucose levels, obesity, and smoking; these populations are incorporated in other USPSTF recommendations.'}, {'id': 1885, 'title': 'Hepatitis B Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in adolescents and adults at increased risk for infection.\r\rSee the Practice Considerations section for a description of adolescents and adults at increased risk for infection.', 'servfreq': 'For patients with negative HBsAg results who have not received the HBV vaccine series, periodic screening may be useful for those who report continued risk for acquiring HBV transmission, such as persons who continue to inject drugs and men who have sex with men. Clinical judgment should be used to determine screening frequency. The USPSTF found no evidence to determine optimal screening intervals.', 'risktext': 'Persons from such risk groups include persons who have injected drugs in the past or currently; men who have sex with men; persons with HIV; and sex partners, needle-sharing contacts, and household contacts of persons known to be HBsAg positive. Some persons with combinations of risk factors who are not members of risk factor groups listed above may also be at increased risk for HBV infection.'}, {'id': 524, 'title': 'Hepatitis C Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis C virus (HCV) infection in adults aged 18 to 79 years.', 'servfreq': 'One-time screening for most adults.\r\nPeriodically screen persons with continued risk for HCV infection (eg, persons with past or current injection drug use). There is limited evidence to determine how often to screen persons at increased risk.&nbsp;', 'risktext': 'Asymptomatic adults aged 18 to 79 years (including pregnant persons) without known liver disease.&nbsp;\r\nThe USPSTF also suggests that clinicians consider screening persons younger than 18 years and older than 79 years who are at high risk for infection (eg, those with past or current injection drug use).&nbsp;'}, {'id': 1916, 'title': 'Lung Cancer: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery.', 'servfreq': ' \r\nThe USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. ', 'risktext': ' \r\nSmoking and older age are the 2 most important risk factors for lung cancer.&nbsp;The risk of lung cancer in persons who smoke increases with cumulative quantity and duration of smoking and with age but decreases with increasing time since quitting for persons who formerly smoked.3 The USPSTF considers adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years to be at high risk and recommends screening for lung cancer with annual LDCT in this population. \r\n \r\n&nbsp;\r\n \r\nAfrican American/Black (Black) men have a higher incidence of lung cancer than White men, and Black women have a lower incidence than White women.1 These differences are likely related to differences in smoking exposure (ie, prevalence of smoking) and related exposure to carcinogens in cigarettes.7,8 The differences may also be related to other social risk factors.\r\n \r\n&nbsp;\r\n \r\nOther risk factors for lung cancer include environmental exposures, prior radiation therapy, other (noncancer) lung diseases, and family history. Lower level of education is also associated with a higher risk of lung cancer.7 The task force recommends using age and smoking history to determine screening eligibility rather than more elaborate risk prediction models because there is insufficient evidence to assess whether risk prediction model&ndash;based screening would improve outcomes relative to using the risk factors of age and smoking history for broad implementation in primary care.\r\n '}, {'id': 1934, 'title': 'Prediabetes and Type 2 Diabetes: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for prediabetes and type 2 diabetes in adults aged 35 to 70 years who have overweight or obesity. Clinicians should offer or refer patients with prediabetes to effective preventive interventions.', 'servfreq': ' \r\nEvidence on the optimal screening interval for adults with an initial normal glucose test result is limited. Cohort and modeling studies suggest that screening every 3 years may be a reasonable approach for adults with normal blood glucose levels.\r\n ', 'risktext': 'Overweight and obesity are the strongest risk factors for developing prediabetes and type 2 diabetes in adults. Other risk factors include older age, family history, history of gestational diabetes, history of polycystic ovarian syndrome, and dietary and lifestyle factors. The prevalence of diabetes is higher among American Indian/Alaska Native (14.7%), Asian (9.2%), Hispanic/Latino (12.5%), and non-Hispanic Black (11.7%) persons than among non-Hispanic White (7.5%) persons. Disparities in diabetes prevalence are the result of a variety of factors. A large body of evidence demonstrates strong associations between prevalence of diabetes and social factors such as socioeconomic status, food environment, and physical environment. The higher prevalence of diabetes in Asian persons may be related to differences in body composition. A difference in body fat composition in Asian persons results in underestimation of risk based on BMI thresholds used to define overweight in the US.\r\n \r\n&nbsp;\r\n \r\nClinicians should consider screening at an earlier age in persons from groups with disproportionately high incidence and prevalence (American Indian/Alaska Native, Asian American, Black, Hispanic/Latino, or Native Hawaiian/Pacific Islander persons) or in persons who have a family history of diabetes, a history of gestational diabetes, or a history of polycystic ovarian syndrome, and at a lower BMI in Asian American persons.11,12 Data suggest that a BMI of 23 or greater may be an appropriate cut point in Asian American persons.13\r\n '}, {'id': 1445, 'title': 'Sexually Transmitted Infections: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends behavioral counseling for all sexually active adolescents and for adults who are at increased risk for sexually transmitted infections (STIs).\r\rSee the Practice Considerations section for more information on populations at increased risk for acquiring STIs.', 'servfreq': '', 'risktext': 'All sexually active adolescents are at increased risk for STIs because of the high rates of STIs in this age group and should receive behavioral counseling interventions. Adults at increased risk for STIs include those who currently have an STI or were diagnosed with one within the past year, do not consistently use condoms, have multiple sex partners, or have sex partners within populations with a high prevalence of STIs. Populations with a high prevalence of STIs include persons who seek STI testing or attend STI clinics; sexual and gender minorities; persons who are living with HIV, inject drugs, have exchanged sex for money or drugs, or have entered correctional facilities; and some racial/ethnic minority groups.1-4'}, {'id': 1981, 'title': 'Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians prescribe a statin for the primary prevention of CVD for adults aged 40 to 75 years who have 1 or more CVD risk factors (i.e. dyslipidemia, diabetes, hypertension, or smoking) and an estimated 10-year risk of a cardiovascular event of 10% or greater.', 'servfreq': '', 'risktext': ''}, {'id': 438, 'title': 'Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for unhealthy alcohol use in primary care settings in adults 18 years or older, including pregnant women, and providing persons engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce unhealthy alcohol use.', 'servfreq': 'The USPSTF did not find adequate evidence to recommend an optimal screening interval for unhealthy alcohol use in adults.&nbsp;Brief behavioral counseling interventions were found to reduce unhealthy alcohol use in adults 18 years or older, including pregnant women. Effective behavioral counseling interventions vary in their specific components, administration, length, and number of interactions. The USPSTF was unable to identify specific intervention characteristics or components that were clearly associated with improved outcomes.', 'risktext': 'engaged in risky or hazardous drinking'}, {'id': 767, 'title': 'Unhealthy Drug Use: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening by asking questions about unhealthy drug use in adults age 18 years or older. Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. \r(Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'servfreq': 'Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. (Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'risktext': 'These include being aged 18 to 25 years; male sex; having a mental health condition, personality or mood disorder, or nicotine or alcohol dependence; a history of physical or sexual abuse, parental neglect, or other adversity in childhood; or drug or alcohol addiction in a first-degree relative.1,9&nbsp;Factors associated with misuse of prescription drugs include history of other drug use, mental illness, pain, and greater access to prescription drugs.10&nbsp;Factors associated with prenatal use of drugs include a mental health disorder, interpersonal violence, and family history of substance use.11'}, {'id': 433, 'title': 'Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer or refer adults with a body mass index (BMI) of 30 or higher (calculated as weight in kilograms divided by height in meters squared) to intensive, multicomponent behavioral interventions.', 'servfreq': '', 'risktext': 'Adults with a BMI &ge;30'}, {'id': 1971, 'title': 'Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication ', 'grade': 'C', 'text': 'The decision to initiate low-dose aspirin use for the primary prevention of CVD in adults aged 40 to 59 years who have a 10% or greater 10-year CVD risk should be an individual one. Evidence indicates that the net benefit of aspirin use in this group is small. Persons who are not at increased risk for bleeding and are willing to take low-dose aspirin daily are more likely to benefit.', 'servfreq': '', 'risktext': ' \r\nAssessment of Risk\r\n \r\n&nbsp;\r\n \r\nCVD Risk\r\n \r\nOlder age is one of the strongest risk factors for CVD. Men have a higher overall CVD disease burden, although women experience higher mortality from certain cardiovascular events, such as stroke. Men tend to experience CVD events earlier in life compared with women. The burden of CVD also differs by race and ethnicity. Among both sexes, Black persons have the highest prevalence of CVD.\r\n \r\n&nbsp;\r\n \r\nThe American College of Cardiology/American Heart Association (ACC/AHA) Pooled Cohort Equations may be used to estimate 10-year risk of CVD. The ACC/AHA risk estimator is, to date, the only US-based CVD risk prediction tool that has published external validation studies in other US-based populations. The estimator has separate equations based on sex and for Black persons and non-Black persons, which include the risk factors of age, cholesterol levels, systolic blood pressure level, antihypertension treatment, presence of diabetes, and smoking status, and focuses on hard clinical outcomes (myocardial infarction and death from coronary heart disease; ischemic stroke and stroke-related death) as the outcomes of interest. It is important to note that increasing age heavily influences the ACC/AHA estimated 10-year CVD event risk. The risk prediction equations generally show higher risk for Black persons than White persons. The USPSTF recognizes that race is a social construct and an imperfect proxy for social determinants of health and the effects of structural racism. Concerns about calibration exist, with many external validation studies showing overprediction in broad populations (men and women across racial and ethnic groups). Limited evidence also suggests underprediction in disadvantaged communities&nbsp;that could lead to underutilization of preventive therapies. Clinicians should recognize that predictions of 10-year CVD events using the Pooled Cohort Equations are estimates.\r\n \r\n&nbsp;\r\n \r\nBleeding Risk\r\n \r\nThe risk for gastrointestinal bleeding, intracranial hemorrhage, and hemorrhagic stroke, with or without aspirin use, increases with older age. Other risk factors include male sex, diabetes, history of gastrointestinal issues (such as peptic ulcer disease), liver disease, smoking, and elevated blood pressure. Certain medications, including nonsteroidal anti-inflammatory drugs, steroids, and anticoagulants, increase the risk of bleeding.&nbsp;These risk factors should be considered in the overall decision about whether to start or continue aspirin therapy.\r\n '}, {'id': 1979, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: Behavioral Counseling Interventions ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians individualize the decision to offer or refer adults without cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity. \r\rSee the "Practice Considerations" section for information on determining which patients may benefit most from this service.', 'servfreq': '', 'risktext': ''}, {'id': 403, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians selectively offer counseling to adults older than 24 years with fair skin types about minimizing their exposure to UV radiation to reduce risk of skin cancer. Existing evidence indicates that the net benefit of counseling all adults older than 24 years is small. In determining whether counseling is appropriate in individual cases, patients and clinicians should consider the presence of risk factors for skin cancer.See the Clinical Considerations section for information on risk assessment.', 'servfreq': '', 'risktext': 'Persons with fair skin types (ivory or pale skin, light eye color, red or blond hair, freckles, those who sunburn easily) are at increased risk of skin cancer and should be counseled. Other factors that further increase risk include a history of sunburns, previous use of indoor tanning beds, and a family or personal history of skin cancer. Persons with an increased number of nevi and atypical nevi are at increased risk of melanoma. Persons with a compromised immune system (eg, persons living with HIV, persons who have received an organ transplant) are at increased risk of skin cancer.'}, {'id': 1982, 'title': 'Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians selectively offer a statin for the primary prevention of CVD for adults aged 40 to 75 years who have 1 or more CVD risk factors (i.e dyslipidemia, diabetes, hypertension, or smoking) and an estimated 10-year risk of a cardiovascular event of 7.5% to less than 10%. The likelihood of benefit is smaller in this group than in persons with a 10-year risk of 10% or greater.', 'servfreq': '', 'risktext': ''}, {'id': 1937, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for chlamydia and gonorrhea in men.', 'servfreq': '', 'risktext': ''}, {'id': 418, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening with resting or exercise electrocardiography (ECG) to prevent cardiovascular disease (CVD) events in asymptomatic adults at low risk of CVD events.', 'servfreq': '', 'risktext': ''}, {'id': 1973, 'title': 'Chronic Obstructive Pulmonary Disease: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for chronic obstructive pulmonary disease in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 2003, 'title': 'Genital Herpes Infection: Serologic Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine serologic screening for genital herpes simplex virus infection in asymptomatic adolescents and adults, including pregnant persons.', 'servfreq': '', 'risktext': 'The USPSTF found no evidence of externally validated, reliable risk stratification tools to identify individuals more or less likely to have genital herpes.'}, {'id': 504, 'title': 'Pancreatic Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for pancreatic cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 203, 'title': 'Testicular Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for testicular cancer in adolescent or adult men.', 'servfreq': '', 'risktext': ''}, {'id': 365, 'title': 'Thyroid Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for thyroid cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 1976, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'D', 'text': 'The DoctorAI recommends against the use of beta carotene or vitamin E supplements for the prevention of cardiovascular disease or cancer.', 'servfreq': '', 'risktext': ''}, {'id': 318, 'title': 'Autism Spectrum Disorder in Young Children: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for autism spectrum disorder (ASD) in young children for whom no concerns of ASD have been raised by their parents or a clinician.', 'servfreq': '', 'risktext': 'Although a number of potential risk factors for ASD have been identified, there is insufficient evidence to determine if certain risk factors modify the performance characteristics of ASD screening tests, such as the age at which screening is performed or other characteristics of the child or family.'}, {'id': 65, 'title': 'Bladder Cancer in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults.\r\rLiterature scans conducted in July 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'This evidence update focused on the benefits and harms of screening for bladder cancer among people without symptoms, the accuracy of screening tests done in primary care settings, and the benefits and harms of treatment. The updated evidence review did not find any new high quality evidence to adequately determine the balance of benefits and harms of screening for bladder cancer. However, bladder cancer is a common cancer and can cause considerable health problems including death. Therefore, the USPSTF determined that the evidence was insufficient to provide a recommendation for or against bladder cancer screening.  The USPSTF emphasizes the need for additional research in this area. '}, {'id': 419, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening with resting or exercise ECG to prevent CVD events in asymptomatic adults at intermediate or high risk of CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 423, 'title': 'Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of adding the ankle-brachial index (ABI), high-sensitivity C-reactive protein (hsCRP) level, or coronary artery calcium (CAC) score to traditional risk assessment for cardiovascular disease (CVD) in asymptomatic adults to prevent CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 352, 'title': 'Celiac Disease: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'persons with family history or other risk factors'}, {'id': 1955, 'title': 'Eating Disorders in Adolescents and Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for eating disorders in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 435, 'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for abuse and neglect in all older or vulnerable adults. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': 'Risk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health.14&nbsp;For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.15'}, {'id': 2045, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for iron deficiency and iron deficiency anemia in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2046, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine iron supplementation in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 1998, 'title': 'Obstructive Sleep Apnea in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for obstructive sleep apnea in the general adult population.\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Risk Factors\r\nRisk factors associated with OSA include male sex, older age (40-70 years), postmenopausal status, higher body mass index (BMI), and craniofacial and upper airway abnormalities (eg, enlarged tonsils or long upper airway). Black, Hispanic/Latino, and Native American/Alaska Native persons have a higher prevalence of OSA compared with White persons; some evidence suggests that these differences are partially explained by higher rates of obesity, asthma, and tobacco use among these groups.8'}, {'id': 1977, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of multivitamin supplements for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1978, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of single or paired nutrient supplements (other than beta carotene and vitamin E) for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 176, 'title': 'Oral Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for oral cancer in asymptomatic adults.\r\rGo to the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in July 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Tobacco and alcohol use are major risk factors for oral cancer. A total of 20% to 30% of cases of oral cancer worldwide are attributable to cigarette smoking. In the United States, up to 75% of cases of oral cancer may be attributable to tobacco and alcohol use. Additional risk factors include male sex, older age, use of betel quid, ultraviolet light exposure, infection with Candida or bacterial flora, and a compromised immune system. Sexually transmitted oral HPV infection (HPV-16) has recently been recognized as an increasingly important risk factor for oropharyngeal cancer. In the United States, the prevalence of oropharyngeal cancer due to oral HPV infection is probably as high as 80% to 95%. The prevalence of oral HPV infection is associated with age, sex, number of sexual partners, and number of cigarettes smoked per day. The effect of multifactorial risk assessment and screening for risk factors on oral cancer morbidity and mortality is unknown.'}, {'id': 2026, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine screening performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 2027, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of preventive interventions performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 2059, 'title': 'Osteoporosis to Prevent Fractures: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for osteoporosis to prevent osteoporotic fractures in men.\r\rSee the "Practice Considerations" section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': 'Men have similar risk factors associated with fragility fractures as women, including increasing age, low BMI, excessive alcohol intake, current smoking, chronic corticosteroid use, history of prior fractures, history of falls within the past year, hypogonadism, history of cerebrovascular accident, and history of diabetes.'}, {'id': 424, 'title': 'Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for peripheral artery disease (PAD) and cardiovascular disease (CVD) risk with the ankle-brachial index (ABI) in asymptomatic adults.\r\rLiterature scans conducted in August 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Risk factors associated with OSA include male sex, older age (40 to 70 years), postmenopausal status, higher BMI, and craniofacial and upper airway abnormalities.'}, {'id': 1974, 'title': 'Primary Open-Angle Glaucoma: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for primary open-angle glaucoma in adults.', 'servfreq': '', 'risktext': ''}, {'id': 404, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of counseling adults about skin self-examination to prevent skin cancer.See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 2005, 'title': 'Skin Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Exposure to UV radiation from sun exposure, indoor tanning beds, and other UV radiation&ndash;emitting devices is the major environmental risk factor for skin cancer. History of frequent sunburns, older age, and male sex are associated with increased risk for skin cancer. Exposure to UV radiation from the use of indoor tanning beds is an important risk factor in adolescents. Incidence of melanoma is higher among White persons compared with persons of other races and ethnicities. This difference likely reflects traits associated with increased melanoma risk, such as fair skin (which is more susceptible to sunburning), light-colored eyes, and red or blond hair being more common among White persons compared with persons of other races and ethnicities. Acral lentiginous melanoma, which occurs mostly on skin not frequently exposed to direct sunlight (eg, palms of hands, soles of feet, or under fingernails or toenails), is the most common type of melanoma among Black populations. Other melanoma risk factors include higher numbers of moles on the skin, atypical moles, as well as a personal and family history of skin cancer.'}, {'id': 269, 'title': 'Thyroid Dysfunction: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults.\r\rSee the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': 'The optimal screening interval for thyroid dysfunction (if one exists) is unknown.', 'risktext': 'The most common cause of hypothyroidism in the United States is chronic autoimmune (Hashimoto) thyroiditis. Risk factors for an elevated TSH level include female sex, advancing age, white race, type 1 diabetes, Down syndrome, family history of thyroid disease, goiter, previous hyperthyroidism (possibly due in part to ablation therapy leading to iatrogenic thyroid dysfunction), and external-beam radiation in the head and neck area. Common causes of hyperthyroidism include Graves disease, Hashimoto thyroiditis, and functional thyroid nodules. Risk factors for a low TSH level include female sex; advancing age; black race; low iodine intake; personal or family history of thyroid disease; and ingestion of iodine-containing drugs, such as amiodarone. The USPSTF found no direct evidence that treatment of thyroid dysfunction based on risk level alters final health outcomes.'}, {'id': 1908, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of electronic cigarettes (e-cigarettes) for tobacco cessation in adults, including pregnant persons. The USPSTF recommends that clinicians direct patients who use tobacco to other tobacco cessation interventions with proven effectiveness and established safety.\rSee the Practice Considerations section for more information on recommended behavioral interventions and pharmacotherapy and for suggestions for practice regarding the I statements.', 'servfreq': '', 'risktext': ''}, {'id': 1907, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of pharmacotherapy interventions for tobacco cessation in pregnant persons.', 'servfreq': '', 'risktext': ''}, {'id': 586, 'title': 'Tobacco Use in Children and Adolescents: Primary Care Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--feasible interventions for the cessation of tobacco use among school-aged children and adolescents.\r\rSee the Practice Considerations section for more information on effective interventions to prevent initiation of tobacco use and for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1919, 'title': 'Vitamin D Deficiency in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 408, 'title': 'Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of the benefits and harms of vitamin D and calcium supplementation, alone or combined, for the primary prevention of fractures in men and premenopausal women.', 'servfreq': '', 'risktext': ''}], 'tools': [{'tool_id': 321, 'url': 'https://jamanetwork.com/journals/jama/fullarticle/2735342', 'title': 'JAMA Patient Page: Who Should Be Screened for HIV Infection? ', 'text': '', 'keywords': ''}, {'tool_id': 322, 'url': 'https://sites.jamanetwork.com/spanish-patient-pages/2019/hoja-para-el-paciente-de-jama-190618.pdf', 'title': 'ยฟQuiรฉnes deben someterse a una prueba de detecciรณn de infecciรณn por VIH?', 'text': '', 'keywords': 'HIV|Human immunodeficiency syndrome|AIDS'}, {'tool_id': 210, 'url': 'https://www.aafp.org/afp/2019/1115/p637.html', 'title': "Screening for HIV Infection and Preexposure Prophylaxis for the Prevention of HIV Infection: AFP's Putting Into Practice", 'text': 'The journal American Family Physician (AFP) provides a series of short case studies and quizzes based on recommendations issued by the U.S. Preventive Services Task Force.', 'keywords': ''}]}
2025-01-29 21:53:41 [INFO] Recommendations: [{'id': 485, 'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in adolescents and adults aged 15 to 65 years. Younger adolescents and older adults who are at increased risk of infection should also be screened.\rSee the Clinical Considerations section for more information about assessment of risk, screening intervals, and rescreening in pregnancy.', 'servfreq': 'The USPSTF found insufficient evidence to determine appropriate or optimal time intervals or strategies for repeat HIV screening. However, repeat screening is reasonable for persons known to be at increased risk of HIV infection, such as sexually active men who have sex with men; persons with a sex partner who is living with HIV; or persons who engage in behaviors that may convey an increased risk of HIV infection, such as injection drug use, transactional sex or commercial sex work, having 1 or more new sex partners whose HIV status is unknown, or having other factors that can place a person at increased risk of HIV infection (see &ldquo;Risk Assessment&rdquo;). Repeat screening is also reasonable for persons who live or receive medical care in a high-prevalence setting, such as a sexually transmitted disease clinic, tuberculosis clinic, correctional facility, or homeless shelter.', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'id': 1921, 'title': 'Hypertension in Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hypertension in adults 18 years or older with office blood pressure measurement (OBPM). The USPSTF recommends obtaining blood pressure measurements outside of the clinical setting for diagnostic confirmation before starting treatment.', 'servfreq': ' \r\nAlthough evidence on optimal screening intervals is limited, reasonable options include:\r\n \r\n \r\n\r\n\r\nScreening for hypertension every year in adults 40 years or older and in adults at increased risk for hypertension (such as Black persons, persons with high-normal blood pressure, or persons who are overweight or obese)\r\n\r\n\r\n \r\n \r\n\r\n\r\nScreening less frequently (ie, every 3 to 5 years) as appropriate for adults aged 18 to 39 years not at increased risk for hypertension and with a prior normal blood pressure reading.\r\n\r\n\r\n ', 'risktext': ' \r\nAlthough all adults should be screened for hypertension, risk factors that increase a person&rsquo;s risk for the condition include older age, Black race, family history, excess weight and obesity, lifestyle habits (lack of physical activity, stress, and tobacco use), and dietary factors (diet high in fat or sodium, diet low in potassium, or excessive alcohol intake)\r\n '}, {'id': 2021, 'title': 'Prevention of Acquisition of HIV: Preexposure Prophylaxis ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians prescribe preexposure prophylaxis using effective antiretroviral therapy to persons who are at increased risk of HIV acquisition to decrease the risk of acquiring HIV. \r\rSee the Practice Considerations section for more information about identification of persons at increased risk and about effective antiretroviral therapy.', 'servfreq': '', 'risktext': 'HIV is primarily acquired via sexual activity or injection drug use. It is important that clinicians routinely take a sexual and injection drug use history for all their patients in an open and nonjudgmental manner. All adolescents and adults who are sexually active or who inject drugs should be informed that acquisition of HIV can be prevented, to facilitate subsequent risk assessment and discussions about preexposure prophylaxis (PrEP) and other ways to prevent acquisition of HIV. Importantly, risk of HIV acquisition exists on a continuum, and currently available risk assessment tools all have limitations. However, certain risk factors or behaviors are known to place persons at increased risk of HIV.\r\nRisk of HIV acquisition depends on the likelihood that a specific act or activity will transmit HIV and the likelihood that a sex partner or drug injection partner has HIV. Likelihood of HIV transmission is highest with needle-sharing injection drug use and condomless receptive anal intercourse. Condomless receptive anal intercourse has an approximately 10- to 15-fold higher risk of transmission than condomless insertive anal sex and condomless receptive and insertive penile-vaginal sex. A 2018 study estimated the prevalence of HIV (ie, an estimate of the likelihood that a partner whose HIV status is unknown has HIV at a population level) as 12.4% among men who have sex with men and 1.9% among persons who inject drugs. The overall prevalence of HIV in the US is estimated at 0.3%.&nbsp;Of note, both the frequency of specific sexual activities and a person&rsquo;s number of sexual partners will also affect their risk of HIV.\r\n&nbsp;The USPSTF recommends that the following persons be considered for PrEP:\r\n1.&nbsp;&nbsp;&nbsp;&nbsp; Sexually active adults and adolescents weighing at least 35 kg (77 lb) who have engaged in anal or vaginal sex in the past 6 months and have any of the following:\r\n&nbsp;\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A sexual partner who has HIV (especially if the partner has an unknown or detectable viral load).\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A bacterial sexually transmitted infection (STI) (syphilis, gonorrhea, or chlamydia for men who have sex with men and transgender women; gonorrhea and syphilis for heterosexual women and men) in the past 6 months.\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A history of inconsistent or no condom use with sex partner(s) whose HIV status is not known; assessing risk in conversation with the patient and considering factors such as number of partners, the specific sexual activities a person engages in, and whether their sex partner or partners are in a group with a higher prevalence of HIV (eg, men who have sex with men or with men and women, transgender women, persons who inject drugs, and persons who engage in transactional sex).\r\n&nbsp;\r\n2. &nbsp; Persons who inject drugs and have a drug-injecting partner who has HIV or who shares injection equipment.\r\nPersons who engage in transactional sex, such as sex for money, drugs, or housing, including commercial sex workers or persons trafficked for sex work, constitute a group at increased risk of HIV acquisition and should be considered for PrEP based on the criteria outlined above. Persons who request PrEP may have undisclosed behaviors that put them at risk. Transgender women and men who are sexually active should be considered for PrEP based on the criteria outlined above. Transgender women are at especially high risk of HIV acquisition. A Centers for Disease Control and and Prevention (CDC) survey in 7 cities found an HIV prevalence of 42% among transgender women. Prevalence was highest among Black transgender women (62%) and Native American/Alaska Native transgender women (65%).\r\nIn addition, studies have found that transmission of HIV to a seronegative partner from a partner with HIV has not been observed when the partner with HIV was being treated with antiretroviral therapy and had a suppressed viral load.&nbsp;It is not known whether PrEP use further decreases the risk of HIV transmission when a partner with HIV has a documented undetectable viral load. Factors such as the consistency or inconsistency of a partner&rsquo;s viral load being suppressed, a partner&rsquo;s adherence to antiretroviral therapy, and the degree of certainty that a partner&rsquo;s viral load is suppressed (eg, self-report vs availability of laboratory test results) may help inform decisions about the use of PrEP in this situation.\r\nAll persons being considered for PrEP must have a recently documented negative HIV antigen-antibody test result, and if they have taken oral PrEP or postexposure prophylaxis in the past 3 months, or injectable cabotegravir in the past 12 months, the CDC recommends testing with both an HIV antigen-antibody assay and an HIV-1 RNA assay.'}, {'id': 1989, 'title': 'Syphilis Infection in Nonpregnant Adolescents and Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for syphilis infection in persons who are at increased risk for infection.', 'servfreq': 'Optimal screening frequency for persons who are at increased risk for syphilis infection is not well established. Men who have sex with men or persons with HIV infection may benefit from screening at least annually or more frequently (eg, every 3 to 6 months) if they continue to be at high risk.', 'risktext': 'The USPSTF recommends screening for syphilis in persons who are at increased risk for infection. When deciding which persons to screen for syphilis, clinicians should consider the prevalence of infection in the communities they serve, as well as other sociodemographic and behavioral factors that may be associated with increased risk of syphilis infection. For example, prevalence of syphilis is higher in men, men who have sex with men, persons with HIV infection, young adults, and persons with a history of incarceration, sex work, or military service. A substantial percentage of heterosexual syphilis transmission occurs among persons who use illicit drugs, particularly methamphetamine. Diagnosis of another STI may signal that a person is having condomless sex, which increases their risk of syphilis infection. Higher infection rates in persons of some racial and ethnic groups have been reported and are primarily a reflection of a combination of factors, including social determinants of health (eg, disparities of income, low educational achievement, and unstable housing), differential health insurance coverage or access to quality health care, and differences in sexual network characteristics (eg, individuals living in communities with a high prevalence of STIs have an increased chance of encountering an infected partner). Local prevalence rates may change over time, so clinicians should be aware of the latest data and trends for their specific population and geographic area, which are available through their state and local health departments and Centers for Disease Control and Prevention (CDC) surveillance.\r\n&nbsp;\r\nAlthough direct evidence on screening in nonpregnant persons who are not at increased risk for syphilis infection is lacking, based on the established test performance characteristics of current screening tests and the low prevalence rate of syphilis in this population, the yield of screening is likely low.9,10 Therefore, screening in this population may result in high false-positive rates and overtreatment.'}, {'id': 1905, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and US Food and Drug Administration (FDA)--approved pharmacotherapy for cessation to nonpregnant adults who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 1906, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all pregnant persons about tobacco use, advise them to stop using tobacco, and provide behavioral interventions for cessation to pregnant persons who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 2014, 'title': 'Anxiety Disorders in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for anxiety disorders in adults, including pregnant and postpartum persons.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding optimal timing for screening, or screening interval, for both the perinatal and general adult populations; more evidence on both timing and screening interval is needed for all adult populations. A pragmatic approach in the absence of evidence might include screening all adults who have not been screened previously and using clinical judgment in considering risk factors, comorbid conditions, and life events to determine if additional screening of high-risk patients is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nRisk factors for anxiety disorders include sociodemographic factors, psychosocial factors, and physical and mental health factors such as marital status (widowed or divorced), stressful life events, smoking and alcohol use, other mental health conditions, or a parental history of mental disorders. Demographic factors such as low socioeconomic status and female sex are associated with higher rates of anxiety disorders.&nbsp;Black persons and individuals of non-Hispanic ethnicity are at increased risk of anxiety disorders due to social, rather than biological, factors. Anxiety and depressive disorders often overlap. One cohort study found that 67% of individuals with a depressive disorder also had a current anxiety disorder, and 75% had a lifetime comorbid anxiety disorder.'}, {'id': 2009, 'title': 'Latent Tuberculosis Infection in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for LTBI in populations at increased risk.\r\rSee the "Assessment of Risk" section for additional information on adults at increased risk.', 'servfreq': 'The USPSTF found no evidence on the optimal frequency of screening for LTBI. In the absence of evidence, a reasonable approach is to repeat screening based on specific risk factors; screening frequency could range from 1-time only screening among persons at low risk for future tuberculosis exposure to annual screening among those at continued risk of exposure.', 'risktext': 'Populations at increased risk for LTBI, based on increased prevalence of active disease and increased risk of exposure, include persons who were born in, or are former residents of, countries with high tuberculosis prevalence and persons who live in, or have lived in, high-risk congregate settings (eg, homeless shelters or correctional facilities). Clinicians can consult their local or state health departments for more information about populations at increased risk in their community, since local demographic patterns may vary across the US.\r\nIn 2020, 71.5% of all cases of active tuberculosis in the US occurred among persons born outside the US. According to the CDC, tuberculosis disease is common in most countries in Latin America, the Caribbean, Africa, Asia, Eastern Europe, and Russia. In 2020, among persons with new tuberculosis living in the US who were born outside the US, the most common countries of birth were Mexico (18.0%), the Philippines (12.5%), India (10.4%), Vietnam (8.2%), and China (5.1%), accounting for 54.2% of total cases. Most of these cases are believed to be due to progression of latent infection to active tuberculosis disease rather than new transmission within communities.\r\nPersons who live, or have lived, in high-risk congregate settings also have a higher prevalence rate of active tuberculosis and an increased risk for exposure. In 2020, 4.3% of tuberculosis disease cases diagnosed in persons 15 years or older occurred in persons experiencing homelessness and 2.6% occurred in residents of correctional facilities. It is estimated that persons experiencing homelessness have an 11 times higher incidence of tuberculosis disease compared with persons who are not experiencing homelessness (36 cases per 100,000 population vs 2.9 cases per 100,000 population, respectively, during 2011 to 2016).\r\nOther populations at increased risk for LTBI or progression to active disease include persons who have immunosuppression (eg, persons living with HIV, patients receiving immunosuppressive medications such as chemotherapy or tumor necrosis factor inhibitors, and patients who have received an organ transplant) and patients with silicosis (a lung disease). However, given that screening in these populations may be considered standard care as part of disease management or indicated prior to the use of certain medications, the USPSTF did not review evidence on screening in these populations. Information on testing in these populations is provided by other groups, such as the Office of AIDS Research at the National Institutes of Health, and in a guideline issued jointly by the American Thoracic Society, Infectious Diseases Society of America, and CDC. Some evidence from observational studies has explored the association between poorly controlled diabetes and progression of LTBI to active disease. However, there is insufficient evidence on screening for and treatment of LTBI in persons with diabetes for the USPSTF to make a separate recommendation for this important population.\r\nPersons who are contacts of individuals with active tuberculosis, health care workers, and workers in high-risk congregate settings may also be at increased risk of exposure. Because screening in these populations is conducted as part of public health or employee health surveillance, the USPSTF did not review the evidence in these populations. Clinicians seeking further information about testing for tuberculosis in these populations can refer to the Additional Tools and Resources and Recommendations of Others sections.'}, {'id': 514, 'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic bacteriuria in nonpregnant adults.', 'servfreq': '', 'risktext': 'The risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6 Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5 Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7, 11, 12 In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12 Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4, 6'}, {'id': 1909, 'title': 'Asymptomatic Carotid Artery Stenosis: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic carotid artery stenosis in the general adult population.\r\rSee the Practice Considerations section for a description of adults at increased risk.', 'servfreq': '', 'risktext': ''}, {'id': 2017, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for suicide risk in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': '', 'risktext': ''}, {'id': 2016, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for depression in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding the optimal timing for screening for depression; more evidence is needed in both perinatal and general adult populations. In the absence of evidence, a pragmatic approach might include screening adults who have not been screened previously and using clinical judgment while considering risk factors, comorbid conditions, and life events to determine if additional screening of patients at increased risk is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nThe USPSTF recommends screening for depression in all adults regardless of risk factors. Risk factors for depression include a combination of genetic, biological, and environmental factors, such as a family history of depression, prior episode of depression or other mental health condition, a history of trauma or adverse life events, or a history of disease or illness (eg, cardiovascular disease).\r\nPrevalence rates vary by sex, age, race, ethnicity, education, marital status, geographic location, poverty level, and employment status. Women have twice the risk of depression compared with men. Young adults, multiracial individuals, and Native American/Alaska Native individuals have higher rates of depression.\r\nRisk factors for perinatal depression include life stress, low social support, history of depression, marital or partner dissatisfaction, and a history of abuse.'}, {'id': 1845, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends offering or referring adults with cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity.', 'servfreq': '', 'risktext': 'Adults 18 years or older at increased risk of CVD, defined as those with 1 or more of the following:\r\n1.Hypertension or elevated blood pressure2.Dyslipidemia3.Mixed or multiple risk factors such as the metabolic syndrome or an estimated 10-year CVD risk of &ge;7.5%\r\nThis recommendation does not apply to adults with other known modifiable cardiovascular risk factors such as abnormal blood glucose levels, obesity, and smoking; these populations are incorporated in other USPSTF recommendations.'}, {'id': 1885, 'title': 'Hepatitis B Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in adolescents and adults at increased risk for infection.\r\rSee the Practice Considerations section for a description of adolescents and adults at increased risk for infection.', 'servfreq': 'For patients with negative HBsAg results who have not received the HBV vaccine series, periodic screening may be useful for those who report continued risk for acquiring HBV transmission, such as persons who continue to inject drugs and men who have sex with men. Clinical judgment should be used to determine screening frequency. The USPSTF found no evidence to determine optimal screening intervals.', 'risktext': 'Persons from such risk groups include persons who have injected drugs in the past or currently; men who have sex with men; persons with HIV; and sex partners, needle-sharing contacts, and household contacts of persons known to be HBsAg positive. Some persons with combinations of risk factors who are not members of risk factor groups listed above may also be at increased risk for HBV infection.'}, {'id': 524, 'title': 'Hepatitis C Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis C virus (HCV) infection in adults aged 18 to 79 years.', 'servfreq': 'One-time screening for most adults.\r\nPeriodically screen persons with continued risk for HCV infection (eg, persons with past or current injection drug use). There is limited evidence to determine how often to screen persons at increased risk.&nbsp;', 'risktext': 'Asymptomatic adults aged 18 to 79 years (including pregnant persons) without known liver disease.&nbsp;\r\nThe USPSTF also suggests that clinicians consider screening persons younger than 18 years and older than 79 years who are at high risk for infection (eg, those with past or current injection drug use).&nbsp;'}, {'id': 1916, 'title': 'Lung Cancer: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery.', 'servfreq': ' \r\nThe USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. ', 'risktext': ' \r\nSmoking and older age are the 2 most important risk factors for lung cancer.&nbsp;The risk of lung cancer in persons who smoke increases with cumulative quantity and duration of smoking and with age but decreases with increasing time since quitting for persons who formerly smoked.3 The USPSTF considers adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years to be at high risk and recommends screening for lung cancer with annual LDCT in this population. \r\n \r\n&nbsp;\r\n \r\nAfrican American/Black (Black) men have a higher incidence of lung cancer than White men, and Black women have a lower incidence than White women.1 These differences are likely related to differences in smoking exposure (ie, prevalence of smoking) and related exposure to carcinogens in cigarettes.7,8 The differences may also be related to other social risk factors.\r\n \r\n&nbsp;\r\n \r\nOther risk factors for lung cancer include environmental exposures, prior radiation therapy, other (noncancer) lung diseases, and family history. Lower level of education is also associated with a higher risk of lung cancer.7 The task force recommends using age and smoking history to determine screening eligibility rather than more elaborate risk prediction models because there is insufficient evidence to assess whether risk prediction model&ndash;based screening would improve outcomes relative to using the risk factors of age and smoking history for broad implementation in primary care.\r\n '}, {'id': 1934, 'title': 'Prediabetes and Type 2 Diabetes: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for prediabetes and type 2 diabetes in adults aged 35 to 70 years who have overweight or obesity. Clinicians should offer or refer patients with prediabetes to effective preventive interventions.', 'servfreq': ' \r\nEvidence on the optimal screening interval for adults with an initial normal glucose test result is limited. Cohort and modeling studies suggest that screening every 3 years may be a reasonable approach for adults with normal blood glucose levels.\r\n ', 'risktext': 'Overweight and obesity are the strongest risk factors for developing prediabetes and type 2 diabetes in adults. Other risk factors include older age, family history, history of gestational diabetes, history of polycystic ovarian syndrome, and dietary and lifestyle factors. The prevalence of diabetes is higher among American Indian/Alaska Native (14.7%), Asian (9.2%), Hispanic/Latino (12.5%), and non-Hispanic Black (11.7%) persons than among non-Hispanic White (7.5%) persons. Disparities in diabetes prevalence are the result of a variety of factors. A large body of evidence demonstrates strong associations between prevalence of diabetes and social factors such as socioeconomic status, food environment, and physical environment. The higher prevalence of diabetes in Asian persons may be related to differences in body composition. A difference in body fat composition in Asian persons results in underestimation of risk based on BMI thresholds used to define overweight in the US.\r\n \r\n&nbsp;\r\n \r\nClinicians should consider screening at an earlier age in persons from groups with disproportionately high incidence and prevalence (American Indian/Alaska Native, Asian American, Black, Hispanic/Latino, or Native Hawaiian/Pacific Islander persons) or in persons who have a family history of diabetes, a history of gestational diabetes, or a history of polycystic ovarian syndrome, and at a lower BMI in Asian American persons.11,12 Data suggest that a BMI of 23 or greater may be an appropriate cut point in Asian American persons.13\r\n '}, {'id': 1445, 'title': 'Sexually Transmitted Infections: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends behavioral counseling for all sexually active adolescents and for adults who are at increased risk for sexually transmitted infections (STIs).\r\rSee the Practice Considerations section for more information on populations at increased risk for acquiring STIs.', 'servfreq': '', 'risktext': 'All sexually active adolescents are at increased risk for STIs because of the high rates of STIs in this age group and should receive behavioral counseling interventions. Adults at increased risk for STIs include those who currently have an STI or were diagnosed with one within the past year, do not consistently use condoms, have multiple sex partners, or have sex partners within populations with a high prevalence of STIs. Populations with a high prevalence of STIs include persons who seek STI testing or attend STI clinics; sexual and gender minorities; persons who are living with HIV, inject drugs, have exchanged sex for money or drugs, or have entered correctional facilities; and some racial/ethnic minority groups.1-4'}, {'id': 1981, 'title': 'Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians prescribe a statin for the primary prevention of CVD for adults aged 40 to 75 years who have 1 or more CVD risk factors (i.e. dyslipidemia, diabetes, hypertension, or smoking) and an estimated 10-year risk of a cardiovascular event of 10% or greater.', 'servfreq': '', 'risktext': ''}, {'id': 438, 'title': 'Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for unhealthy alcohol use in primary care settings in adults 18 years or older, including pregnant women, and providing persons engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce unhealthy alcohol use.', 'servfreq': 'The USPSTF did not find adequate evidence to recommend an optimal screening interval for unhealthy alcohol use in adults.&nbsp;Brief behavioral counseling interventions were found to reduce unhealthy alcohol use in adults 18 years or older, including pregnant women. Effective behavioral counseling interventions vary in their specific components, administration, length, and number of interactions. The USPSTF was unable to identify specific intervention characteristics or components that were clearly associated with improved outcomes.', 'risktext': 'engaged in risky or hazardous drinking'}, {'id': 767, 'title': 'Unhealthy Drug Use: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening by asking questions about unhealthy drug use in adults age 18 years or older. Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. \r(Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'servfreq': 'Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. (Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'risktext': 'These include being aged 18 to 25 years; male sex; having a mental health condition, personality or mood disorder, or nicotine or alcohol dependence; a history of physical or sexual abuse, parental neglect, or other adversity in childhood; or drug or alcohol addiction in a first-degree relative.1,9&nbsp;Factors associated with misuse of prescription drugs include history of other drug use, mental illness, pain, and greater access to prescription drugs.10&nbsp;Factors associated with prenatal use of drugs include a mental health disorder, interpersonal violence, and family history of substance use.11'}, {'id': 433, 'title': 'Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer or refer adults with a body mass index (BMI) of 30 or higher (calculated as weight in kilograms divided by height in meters squared) to intensive, multicomponent behavioral interventions.', 'servfreq': '', 'risktext': 'Adults with a BMI &ge;30'}, {'id': 1971, 'title': 'Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication ', 'grade': 'C', 'text': 'The decision to initiate low-dose aspirin use for the primary prevention of CVD in adults aged 40 to 59 years who have a 10% or greater 10-year CVD risk should be an individual one. Evidence indicates that the net benefit of aspirin use in this group is small. Persons who are not at increased risk for bleeding and are willing to take low-dose aspirin daily are more likely to benefit.', 'servfreq': '', 'risktext': ' \r\nAssessment of Risk\r\n \r\n&nbsp;\r\n \r\nCVD Risk\r\n \r\nOlder age is one of the strongest risk factors for CVD. Men have a higher overall CVD disease burden, although women experience higher mortality from certain cardiovascular events, such as stroke. Men tend to experience CVD events earlier in life compared with women. The burden of CVD also differs by race and ethnicity. Among both sexes, Black persons have the highest prevalence of CVD.\r\n \r\n&nbsp;\r\n \r\nThe American College of Cardiology/American Heart Association (ACC/AHA) Pooled Cohort Equations may be used to estimate 10-year risk of CVD. The ACC/AHA risk estimator is, to date, the only US-based CVD risk prediction tool that has published external validation studies in other US-based populations. The estimator has separate equations based on sex and for Black persons and non-Black persons, which include the risk factors of age, cholesterol levels, systolic blood pressure level, antihypertension treatment, presence of diabetes, and smoking status, and focuses on hard clinical outcomes (myocardial infarction and death from coronary heart disease; ischemic stroke and stroke-related death) as the outcomes of interest. It is important to note that increasing age heavily influences the ACC/AHA estimated 10-year CVD event risk. The risk prediction equations generally show higher risk for Black persons than White persons. The USPSTF recognizes that race is a social construct and an imperfect proxy for social determinants of health and the effects of structural racism. Concerns about calibration exist, with many external validation studies showing overprediction in broad populations (men and women across racial and ethnic groups). Limited evidence also suggests underprediction in disadvantaged communities&nbsp;that could lead to underutilization of preventive therapies. Clinicians should recognize that predictions of 10-year CVD events using the Pooled Cohort Equations are estimates.\r\n \r\n&nbsp;\r\n \r\nBleeding Risk\r\n \r\nThe risk for gastrointestinal bleeding, intracranial hemorrhage, and hemorrhagic stroke, with or without aspirin use, increases with older age. Other risk factors include male sex, diabetes, history of gastrointestinal issues (such as peptic ulcer disease), liver disease, smoking, and elevated blood pressure. Certain medications, including nonsteroidal anti-inflammatory drugs, steroids, and anticoagulants, increase the risk of bleeding.&nbsp;These risk factors should be considered in the overall decision about whether to start or continue aspirin therapy.\r\n '}, {'id': 1979, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: Behavioral Counseling Interventions ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians individualize the decision to offer or refer adults without cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity. \r\rSee the "Practice Considerations" section for information on determining which patients may benefit most from this service.', 'servfreq': '', 'risktext': ''}, {'id': 403, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians selectively offer counseling to adults older than 24 years with fair skin types about minimizing their exposure to UV radiation to reduce risk of skin cancer. Existing evidence indicates that the net benefit of counseling all adults older than 24 years is small. In determining whether counseling is appropriate in individual cases, patients and clinicians should consider the presence of risk factors for skin cancer.See the Clinical Considerations section for information on risk assessment.', 'servfreq': '', 'risktext': 'Persons with fair skin types (ivory or pale skin, light eye color, red or blond hair, freckles, those who sunburn easily) are at increased risk of skin cancer and should be counseled. Other factors that further increase risk include a history of sunburns, previous use of indoor tanning beds, and a family or personal history of skin cancer. Persons with an increased number of nevi and atypical nevi are at increased risk of melanoma. Persons with a compromised immune system (eg, persons living with HIV, persons who have received an organ transplant) are at increased risk of skin cancer.'}, {'id': 1982, 'title': 'Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians selectively offer a statin for the primary prevention of CVD for adults aged 40 to 75 years who have 1 or more CVD risk factors (i.e dyslipidemia, diabetes, hypertension, or smoking) and an estimated 10-year risk of a cardiovascular event of 7.5% to less than 10%. The likelihood of benefit is smaller in this group than in persons with a 10-year risk of 10% or greater.', 'servfreq': '', 'risktext': ''}, {'id': 1937, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for chlamydia and gonorrhea in men.', 'servfreq': '', 'risktext': ''}, {'id': 418, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening with resting or exercise electrocardiography (ECG) to prevent cardiovascular disease (CVD) events in asymptomatic adults at low risk of CVD events.', 'servfreq': '', 'risktext': ''}, {'id': 1973, 'title': 'Chronic Obstructive Pulmonary Disease: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for chronic obstructive pulmonary disease in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 2003, 'title': 'Genital Herpes Infection: Serologic Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine serologic screening for genital herpes simplex virus infection in asymptomatic adolescents and adults, including pregnant persons.', 'servfreq': '', 'risktext': 'The USPSTF found no evidence of externally validated, reliable risk stratification tools to identify individuals more or less likely to have genital herpes.'}, {'id': 504, 'title': 'Pancreatic Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for pancreatic cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 203, 'title': 'Testicular Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for testicular cancer in adolescent or adult men.', 'servfreq': '', 'risktext': ''}, {'id': 365, 'title': 'Thyroid Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for thyroid cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 1976, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'D', 'text': 'The DoctorAI recommends against the use of beta carotene or vitamin E supplements for the prevention of cardiovascular disease or cancer.', 'servfreq': '', 'risktext': ''}, {'id': 318, 'title': 'Autism Spectrum Disorder in Young Children: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for autism spectrum disorder (ASD) in young children for whom no concerns of ASD have been raised by their parents or a clinician.', 'servfreq': '', 'risktext': 'Although a number of potential risk factors for ASD have been identified, there is insufficient evidence to determine if certain risk factors modify the performance characteristics of ASD screening tests, such as the age at which screening is performed or other characteristics of the child or family.'}, {'id': 65, 'title': 'Bladder Cancer in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults.\r\rLiterature scans conducted in July 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'This evidence update focused on the benefits and harms of screening for bladder cancer among people without symptoms, the accuracy of screening tests done in primary care settings, and the benefits and harms of treatment. The updated evidence review did not find any new high quality evidence to adequately determine the balance of benefits and harms of screening for bladder cancer. However, bladder cancer is a common cancer and can cause considerable health problems including death. Therefore, the USPSTF determined that the evidence was insufficient to provide a recommendation for or against bladder cancer screening.  The USPSTF emphasizes the need for additional research in this area. '}, {'id': 419, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening with resting or exercise ECG to prevent CVD events in asymptomatic adults at intermediate or high risk of CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 423, 'title': 'Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of adding the ankle-brachial index (ABI), high-sensitivity C-reactive protein (hsCRP) level, or coronary artery calcium (CAC) score to traditional risk assessment for cardiovascular disease (CVD) in asymptomatic adults to prevent CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 352, 'title': 'Celiac Disease: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'persons with family history or other risk factors'}, {'id': 1955, 'title': 'Eating Disorders in Adolescents and Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for eating disorders in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 435, 'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for abuse and neglect in all older or vulnerable adults. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': 'Risk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health.14&nbsp;For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.15'}, {'id': 2045, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for iron deficiency and iron deficiency anemia in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2046, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine iron supplementation in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 1998, 'title': 'Obstructive Sleep Apnea in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for obstructive sleep apnea in the general adult population.\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Risk Factors\r\nRisk factors associated with OSA include male sex, older age (40-70 years), postmenopausal status, higher body mass index (BMI), and craniofacial and upper airway abnormalities (eg, enlarged tonsils or long upper airway). Black, Hispanic/Latino, and Native American/Alaska Native persons have a higher prevalence of OSA compared with White persons; some evidence suggests that these differences are partially explained by higher rates of obesity, asthma, and tobacco use among these groups.8'}, {'id': 1977, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of multivitamin supplements for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1978, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of single or paired nutrient supplements (other than beta carotene and vitamin E) for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 176, 'title': 'Oral Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for oral cancer in asymptomatic adults.\r\rGo to the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in July 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Tobacco and alcohol use are major risk factors for oral cancer. A total of 20% to 30% of cases of oral cancer worldwide are attributable to cigarette smoking. In the United States, up to 75% of cases of oral cancer may be attributable to tobacco and alcohol use. Additional risk factors include male sex, older age, use of betel quid, ultraviolet light exposure, infection with Candida or bacterial flora, and a compromised immune system. Sexually transmitted oral HPV infection (HPV-16) has recently been recognized as an increasingly important risk factor for oropharyngeal cancer. In the United States, the prevalence of oropharyngeal cancer due to oral HPV infection is probably as high as 80% to 95%. The prevalence of oral HPV infection is associated with age, sex, number of sexual partners, and number of cigarettes smoked per day. The effect of multifactorial risk assessment and screening for risk factors on oral cancer morbidity and mortality is unknown.'}, {'id': 2026, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine screening performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 2027, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of preventive interventions performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 2059, 'title': 'Osteoporosis to Prevent Fractures: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for osteoporosis to prevent osteoporotic fractures in men.\r\rSee the "Practice Considerations" section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': 'Men have similar risk factors associated with fragility fractures as women, including increasing age, low BMI, excessive alcohol intake, current smoking, chronic corticosteroid use, history of prior fractures, history of falls within the past year, hypogonadism, history of cerebrovascular accident, and history of diabetes.'}, {'id': 424, 'title': 'Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for peripheral artery disease (PAD) and cardiovascular disease (CVD) risk with the ankle-brachial index (ABI) in asymptomatic adults.\r\rLiterature scans conducted in August 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Risk factors associated with OSA include male sex, older age (40 to 70 years), postmenopausal status, higher BMI, and craniofacial and upper airway abnormalities.'}, {'id': 1974, 'title': 'Primary Open-Angle Glaucoma: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for primary open-angle glaucoma in adults.', 'servfreq': '', 'risktext': ''}, {'id': 404, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of counseling adults about skin self-examination to prevent skin cancer.See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 2005, 'title': 'Skin Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Exposure to UV radiation from sun exposure, indoor tanning beds, and other UV radiation&ndash;emitting devices is the major environmental risk factor for skin cancer. History of frequent sunburns, older age, and male sex are associated with increased risk for skin cancer. Exposure to UV radiation from the use of indoor tanning beds is an important risk factor in adolescents. Incidence of melanoma is higher among White persons compared with persons of other races and ethnicities. This difference likely reflects traits associated with increased melanoma risk, such as fair skin (which is more susceptible to sunburning), light-colored eyes, and red or blond hair being more common among White persons compared with persons of other races and ethnicities. Acral lentiginous melanoma, which occurs mostly on skin not frequently exposed to direct sunlight (eg, palms of hands, soles of feet, or under fingernails or toenails), is the most common type of melanoma among Black populations. Other melanoma risk factors include higher numbers of moles on the skin, atypical moles, as well as a personal and family history of skin cancer.'}, {'id': 269, 'title': 'Thyroid Dysfunction: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults.\r\rSee the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': 'The optimal screening interval for thyroid dysfunction (if one exists) is unknown.', 'risktext': 'The most common cause of hypothyroidism in the United States is chronic autoimmune (Hashimoto) thyroiditis. Risk factors for an elevated TSH level include female sex, advancing age, white race, type 1 diabetes, Down syndrome, family history of thyroid disease, goiter, previous hyperthyroidism (possibly due in part to ablation therapy leading to iatrogenic thyroid dysfunction), and external-beam radiation in the head and neck area. Common causes of hyperthyroidism include Graves disease, Hashimoto thyroiditis, and functional thyroid nodules. Risk factors for a low TSH level include female sex; advancing age; black race; low iodine intake; personal or family history of thyroid disease; and ingestion of iodine-containing drugs, such as amiodarone. The USPSTF found no direct evidence that treatment of thyroid dysfunction based on risk level alters final health outcomes.'}, {'id': 1908, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of electronic cigarettes (e-cigarettes) for tobacco cessation in adults, including pregnant persons. The USPSTF recommends that clinicians direct patients who use tobacco to other tobacco cessation interventions with proven effectiveness and established safety.\rSee the Practice Considerations section for more information on recommended behavioral interventions and pharmacotherapy and for suggestions for practice regarding the I statements.', 'servfreq': '', 'risktext': ''}, {'id': 1907, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of pharmacotherapy interventions for tobacco cessation in pregnant persons.', 'servfreq': '', 'risktext': ''}, {'id': 586, 'title': 'Tobacco Use in Children and Adolescents: Primary Care Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--feasible interventions for the cessation of tobacco use among school-aged children and adolescents.\r\rSee the Practice Considerations section for more information on effective interventions to prevent initiation of tobacco use and for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1919, 'title': 'Vitamin D Deficiency in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 408, 'title': 'Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of the benefits and harms of vitamin D and calcium supplementation, alone or combined, for the primary prevention of fractures in men and premenopausal women.', 'servfreq': '', 'risktext': ''}]
2025-01-29 21:53:41 [INFO] Tools: [{'tool_id': 321, 'url': 'https://jamanetwork.com/journals/jama/fullarticle/2735342', 'title': 'JAMA Patient Page: Who Should Be Screened for HIV Infection? ', 'text': '', 'keywords': ''}, {'tool_id': 322, 'url': 'https://sites.jamanetwork.com/spanish-patient-pages/2019/hoja-para-el-paciente-de-jama-190618.pdf', 'title': 'ยฟQuiรฉnes deben someterse a una prueba de detecciรณn de infecciรณn por VIH?', 'text': '', 'keywords': 'HIV|Human immunodeficiency syndrome|AIDS'}, {'tool_id': 210, 'url': 'https://www.aafp.org/afp/2019/1115/p637.html', 'title': "Screening for HIV Infection and Preexposure Prophylaxis for the Prevention of HIV Infection: AFP's Putting Into Practice", 'text': 'The journal American Family Physician (AFP) provides a series of short case studies and quizzes based on recommendations issued by the U.S. Preventive Services Task Force.', 'keywords': ''}]
2025-01-29 21:53:43 [INFO] Update id=273478150 is handled. Duration 1163 ms by bot id=8108339380
2025-01-29 21:58:02 [WARNING] Received SIGTERM signal
2025-01-29 21:58:02 [INFO] Polling stopped for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-29 21:58:02 [INFO] Polling stopped
2025-01-29 21:58:02 [INFO] โ ะัะป ะฟะพะดะบะปััะตะฝะธะน ะบ ะะ ะทะฐะบััั.
2025-01-29 21:58:02 [INFO] โ ะะพะดะบะปััะตะฝะธะต ะบ ะะ ะทะฐะบัััะพ.
2025-01-29 21:58:10 [INFO] ๐ ะะพั ะทะฐะฟััะบะฐะตััั...
2025-01-29 21:58:10 [INFO] โ ะัะป ะฟะพะดะบะปััะตะฝะธะน ะบ ะะ ัะพะทะดะฐะฝ.
2025-01-29 21:58:10 [INFO] โ ะขะฐะฑะปะธัั ะฒ ะฑะฐะทะต ะดะฐะฝะฝัั ััะฟะตัะฝะพ ัะพะทะดะฐะฝั.
2025-01-29 21:58:10 [INFO] Start polling
2025-01-29 21:58:12 [INFO] Run polling for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-29 21:58:16 [INFO] The user 711983855 called the command /start.
2025-01-29 21:58:17 [INFO] Update id=273478151 is handled. Duration 1293 ms by bot id=8108339380
2025-01-29 21:58:18 [INFO] The user 711983855's state has been set to Survey.age.
2025-01-29 21:58:19 [INFO] Update id=273478152 is handled. Duration 341 ms by bot id=8108339380
2025-01-29 21:58:24 [INFO] The user 711983855's state has been set to Survey.weight.
2025-01-29 21:58:25 [INFO] Update id=273478153 is handled. Duration 342 ms by bot id=8108339380
2025-01-29 21:58:29 [INFO] The user 711983855's state has been set to Survey.height.
2025-01-29 21:58:29 [INFO] Update id=273478154 is handled. Duration 440 ms by bot id=8108339380
2025-01-29 21:58:31 [INFO] The user 711983855's state has been set to Survey.feet.
2025-01-29 21:58:31 [INFO] Update id=273478155 is handled. Duration 340 ms by bot id=8108339380
2025-01-29 21:58:34 [INFO] The user 711983855's state has been set to Survey.gender.
2025-01-29 21:58:35 [INFO] Update id=273478156 is handled. Duration 387 ms by bot id=8108339380
2025-01-29 21:58:38 [INFO] The user 711983855's state has been set to Survey.pregnant.
2025-01-29 21:58:39 [INFO] Update id=273478157 is handled. Duration 454 ms by bot id=8108339380
2025-01-29 21:58:40 [INFO] The user 711983855's state has been set to Survey.smoking.
2025-01-29 21:58:40 [INFO] Update id=273478158 is handled. Duration 339 ms by bot id=8108339380
2025-01-29 21:58:41 [INFO] The user 711983855's state has been set to Survey.sex.
2025-01-29 21:58:41 [INFO] Update id=273478159 is handled. Duration 337 ms by bot id=8108339380
2025-01-29 21:58:42 [INFO] Update id=273478160 is not handled. Duration 1 ms by bot id=8108339380
2025-01-29 21:59:00 [INFO] Update id=273478161 is not handled. Duration 1 ms by bot id=8108339380
2025-01-29 22:00:15 [WARNING] Received SIGTERM signal
2025-01-29 22:00:15 [INFO] Polling stopped for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-29 22:00:15 [INFO] Polling stopped
2025-01-29 22:00:15 [INFO] โ ะัะป ะฟะพะดะบะปััะตะฝะธะน ะบ ะะ ะทะฐะบััั.
2025-01-29 22:00:15 [INFO] โ ะะพะดะบะปััะตะฝะธะต ะบ ะะ ะทะฐะบัััะพ.
2025-01-29 22:00:23 [INFO] ๐ ะะพั ะทะฐะฟััะบะฐะตััั...
2025-01-29 22:00:23 [INFO] โ ะัะป ะฟะพะดะบะปััะตะฝะธะน ะบ ะะ ัะพะทะดะฐะฝ.
2025-01-29 22:00:23 [INFO] โ ะขะฐะฑะปะธัั ะฒ ะฑะฐะทะต ะดะฐะฝะฝัั ััะฟะตัะฝะพ ัะพะทะดะฐะฝั.
2025-01-29 22:00:23 [INFO] Start polling
2025-01-29 22:00:25 [INFO] Run polling for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-29 22:00:25 [INFO] The user 711983855 called the command /start.
2025-01-29 22:00:26 [INFO] Update id=273478162 is handled. Duration 1281 ms by bot id=8108339380
2025-01-29 22:00:27 [INFO] The user 711983855's state has been set to Survey.age.
2025-01-29 22:00:28 [INFO] Update id=273478163 is handled. Duration 359 ms by bot id=8108339380
2025-01-29 22:00:30 [INFO] The user 711983855's state has been set to Survey.weight.
2025-01-29 22:00:31 [INFO] Update id=273478164 is handled. Duration 398 ms by bot id=8108339380
2025-01-29 22:00:32 [INFO] The user 711983855's state has been set to Survey.height.
2025-01-29 22:00:32 [INFO] Update id=273478165 is handled. Duration 328 ms by bot id=8108339380
2025-01-29 22:00:35 [INFO] Update id=273478166 is handled. Duration 353 ms by bot id=8108339380
2025-01-29 22:00:36 [INFO] The user 711983855's state has been set to Survey.feet.
2025-01-29 22:00:37 [INFO] Update id=273478167 is handled. Duration 340 ms by bot id=8108339380
2025-01-29 22:00:39 [INFO] The user 711983855's state has been set to Survey.gender.
2025-01-29 22:00:40 [INFO] Update id=273478168 is handled. Duration 433 ms by bot id=8108339380
2025-01-29 22:00:42 [INFO] The user 711983855's state has been set to Survey.pregnant.
2025-01-29 22:00:42 [INFO] Update id=273478169 is handled. Duration 326 ms by bot id=8108339380
2025-01-29 22:00:43 [INFO] The user 711983855's state has been set to Survey.smoking.
2025-01-29 22:00:43 [INFO] Update id=273478170 is handled. Duration 337 ms by bot id=8108339380
2025-01-29 22:00:44 [INFO] The user 711983855's state has been set to Survey.sex.
2025-01-29 22:00:44 [INFO] Update id=273478171 is handled. Duration 326 ms by bot id=8108339380
2025-01-29 22:00:45 [INFO] State data: {'db': <bot.database.Database object at 0x7f78842cb740>, 'age': 20, 'weight': 190, 'height': 190, 'feet': 45, 'gender': 'female', 'pregnant': 'yes', 'smoking': 'yes', 'sex': 'yes'}
2025-01-29 22:00:45 [INFO] Recommendations fetched: [{'id': 2020, 'title': 'Folic Acid Supplementation to Prevent Neural Tube Defects: Preventive Medication ', 'grade': 'A', 'text': 'The DoctorAI recommends that all persons planning to or who could become pregnant take a daily supplement containing 0.4 to 0.8 mg (400 to 800 mcg) of folic acid.', 'servfreq': 'The neural plate completes its formation and closure early in pregnancy (usually 26 to 28 days after fertilization). This means the critical period for folic acid supplementation starts at least 1 month before conception and continues through the first 2 to 3 months of pregnancy. Nearly half of all pregnancies in the US are unplanned; to gain the full benefits of supplementation, clinicians should advise all persons who plan to or who could become pregnant to take daily folic acid.', 'risktext': 'All pregnancies are at risk for neural tube defects, and persons who are planning to or could become pregnant should take folic acid supplements. Certain risk factors convey a higher risk, and individuals with these risk factors should talk to their health care professional. These factors include personal, partner, or family history of neural tube defects, malabsorption caused by bariatric procedures, the use of certain antiseizure medicines, and genetic mutations in folate-related enzymes. Pregestational diabetes and obesity have been associated with an increased risk of neural tube defects. Ethnic groups such as First Nation persons in Canada and Hispanic persons in California are thought to be at higher risk of neural tube defects. It is unclear, however, whether this is related to a higher risk of genetic variations among these groups or due to differential intake of folic acid&ndash;fortified foods.'}, {'id': 503, 'title': 'Hepatitis B Virus Infection in Pregnant Women: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in pregnant women at their first prenatal visit', 'servfreq': 'A test for HBsAg should be ordered at the first prenatal visit. Women with unknown HBsAg status or with new or continuing risk factors for HBV infection (eg, injection drug use or a sexually transmitted infection) should be screened at the time of admission to a hospital or other delivery setting.', 'risktext': 'In the United States, new cases of HBV among adults are largely transmitted through injection drug use or sexual intercourse, but most prevalent cases of HBV infection are chronic infections from exposure occurring in infancy or childhood. Another major risk factor for HBV infection is country of origin. In the United States, adults with HBV born in high-prevalence countries were commonly infected during childhood. In children, the primary source of infection is perinatal transmission at birth.'}, {'id': 485, 'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in adolescents and adults aged 15 to 65 years. Younger adolescents and older adults who are at increased risk of infection should also be screened.\rSee the Clinical Considerations section for more information about assessment of risk, screening intervals, and rescreening in pregnancy.', 'servfreq': 'The USPSTF found insufficient evidence to determine appropriate or optimal time intervals or strategies for repeat HIV screening. However, repeat screening is reasonable for persons known to be at increased risk of HIV infection, such as sexually active men who have sex with men; persons with a sex partner who is living with HIV; or persons who engage in behaviors that may convey an increased risk of HIV infection, such as injection drug use, transactional sex or commercial sex work, having 1 or more new sex partners whose HIV status is unknown, or having other factors that can place a person at increased risk of HIV infection (see &ldquo;Risk Assessment&rdquo;). Repeat screening is also reasonable for persons who live or receive medical care in a high-prevalence setting, such as a sexually transmitted disease clinic, tuberculosis clinic, correctional facility, or homeless shelter.', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'id': 486, 'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in all pregnant persons, including those who present in labor or at delivery whose HIV status is unknown.', 'servfreq': 'The CDC and ACOG recommend repeat prenatal screening for HIV during the third trimester of pregnancy in women with risk factors for HIV acquisition and in women living or receiving care in high-incidence settings, and the CDC notes that repeat screening for HIV during the third trimester may be considered in all women.&nbsp;', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'id': 1921, 'title': 'Hypertension in Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hypertension in adults 18 years or older with office blood pressure measurement (OBPM). The USPSTF recommends obtaining blood pressure measurements outside of the clinical setting for diagnostic confirmation before starting treatment.', 'servfreq': ' \r\nAlthough evidence on optimal screening intervals is limited, reasonable options include:\r\n \r\n \r\n\r\n\r\nScreening for hypertension every year in adults 40 years or older and in adults at increased risk for hypertension (such as Black persons, persons with high-normal blood pressure, or persons who are overweight or obese)\r\n\r\n\r\n \r\n \r\n\r\n\r\nScreening less frequently (ie, every 3 to 5 years) as appropriate for adults aged 18 to 39 years not at increased risk for hypertension and with a prior normal blood pressure reading.\r\n\r\n\r\n ', 'risktext': ' \r\nAlthough all adults should be screened for hypertension, risk factors that increase a person&rsquo;s risk for the condition include older age, Black race, family history, excess weight and obesity, lifestyle habits (lack of physical activity, stress, and tobacco use), and dietary factors (diet high in fat or sodium, diet low in potassium, or excessive alcohol intake)\r\n '}, {'id': 2021, 'title': 'Prevention of Acquisition of HIV: Preexposure Prophylaxis ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians prescribe preexposure prophylaxis using effective antiretroviral therapy to persons who are at increased risk of HIV acquisition to decrease the risk of acquiring HIV. \r\rSee the Practice Considerations section for more information about identification of persons at increased risk and about effective antiretroviral therapy.', 'servfreq': '', 'risktext': 'HIV is primarily acquired via sexual activity or injection drug use. It is important that clinicians routinely take a sexual and injection drug use history for all their patients in an open and nonjudgmental manner. All adolescents and adults who are sexually active or who inject drugs should be informed that acquisition of HIV can be prevented, to facilitate subsequent risk assessment and discussions about preexposure prophylaxis (PrEP) and other ways to prevent acquisition of HIV. Importantly, risk of HIV acquisition exists on a continuum, and currently available risk assessment tools all have limitations. However, certain risk factors or behaviors are known to place persons at increased risk of HIV.\r\nRisk of HIV acquisition depends on the likelihood that a specific act or activity will transmit HIV and the likelihood that a sex partner or drug injection partner has HIV. Likelihood of HIV transmission is highest with needle-sharing injection drug use and condomless receptive anal intercourse. Condomless receptive anal intercourse has an approximately 10- to 15-fold higher risk of transmission than condomless insertive anal sex and condomless receptive and insertive penile-vaginal sex. A 2018 study estimated the prevalence of HIV (ie, an estimate of the likelihood that a partner whose HIV status is unknown has HIV at a population level) as 12.4% among men who have sex with men and 1.9% among persons who inject drugs. The overall prevalence of HIV in the US is estimated at 0.3%.&nbsp;Of note, both the frequency of specific sexual activities and a person&rsquo;s number of sexual partners will also affect their risk of HIV.\r\n&nbsp;The USPSTF recommends that the following persons be considered for PrEP:\r\n1.&nbsp;&nbsp;&nbsp;&nbsp; Sexually active adults and adolescents weighing at least 35 kg (77 lb) who have engaged in anal or vaginal sex in the past 6 months and have any of the following:\r\n&nbsp;\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A sexual partner who has HIV (especially if the partner has an unknown or detectable viral load).\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A bacterial sexually transmitted infection (STI) (syphilis, gonorrhea, or chlamydia for men who have sex with men and transgender women; gonorrhea and syphilis for heterosexual women and men) in the past 6 months.\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A history of inconsistent or no condom use with sex partner(s) whose HIV status is not known; assessing risk in conversation with the patient and considering factors such as number of partners, the specific sexual activities a person engages in, and whether their sex partner or partners are in a group with a higher prevalence of HIV (eg, men who have sex with men or with men and women, transgender women, persons who inject drugs, and persons who engage in transactional sex).\r\n&nbsp;\r\n2. &nbsp; Persons who inject drugs and have a drug-injecting partner who has HIV or who shares injection equipment.\r\nPersons who engage in transactional sex, such as sex for money, drugs, or housing, including commercial sex workers or persons trafficked for sex work, constitute a group at increased risk of HIV acquisition and should be considered for PrEP based on the criteria outlined above. Persons who request PrEP may have undisclosed behaviors that put them at risk. Transgender women and men who are sexually active should be considered for PrEP based on the criteria outlined above. Transgender women are at especially high risk of HIV acquisition. A Centers for Disease Control and and Prevention (CDC) survey in 7 cities found an HIV prevalence of 42% among transgender women. Prevalence was highest among Black transgender women (62%) and Native American/Alaska Native transgender women (65%).\r\nIn addition, studies have found that transmission of HIV to a seronegative partner from a partner with HIV has not been observed when the partner with HIV was being treated with antiretroviral therapy and had a suppressed viral load.&nbsp;It is not known whether PrEP use further decreases the risk of HIV transmission when a partner with HIV has a documented undetectable viral load. Factors such as the consistency or inconsistency of a partner&rsquo;s viral load being suppressed, a partner&rsquo;s adherence to antiretroviral therapy, and the degree of certainty that a partner&rsquo;s viral load is suppressed (eg, self-report vs availability of laboratory test results) may help inform decisions about the use of PrEP in this situation.\r\nAll persons being considered for PrEP must have a recently documented negative HIV antigen-antibody test result, and if they have taken oral PrEP or postexposure prophylaxis in the past 3 months, or injectable cabotegravir in the past 12 months, the CDC recommends testing with both an HIV antigen-antibody assay and an HIV-1 RNA assay.'}, {'id': 186, 'title': 'Rh(D) Incompatibility: Screening ', 'grade': 'A', 'text': 'The DoctorAI strongly recommends Rh(D) blood typing and antibody testing for all pregnant women during their first visit for pregnancy-related care.', 'servfreq': 'First prenatal visit.', 'risktext': ''}, {'id': 1989, 'title': 'Syphilis Infection in Nonpregnant Adolescents and Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for syphilis infection in persons who are at increased risk for infection.', 'servfreq': 'Optimal screening frequency for persons who are at increased risk for syphilis infection is not well established. Men who have sex with men or persons with HIV infection may benefit from screening at least annually or more frequently (eg, every 3 to 6 months) if they continue to be at high risk.', 'risktext': 'The USPSTF recommends screening for syphilis in persons who are at increased risk for infection. When deciding which persons to screen for syphilis, clinicians should consider the prevalence of infection in the communities they serve, as well as other sociodemographic and behavioral factors that may be associated with increased risk of syphilis infection. For example, prevalence of syphilis is higher in men, men who have sex with men, persons with HIV infection, young adults, and persons with a history of incarceration, sex work, or military service. A substantial percentage of heterosexual syphilis transmission occurs among persons who use illicit drugs, particularly methamphetamine. Diagnosis of another STI may signal that a person is having condomless sex, which increases their risk of syphilis infection. Higher infection rates in persons of some racial and ethnic groups have been reported and are primarily a reflection of a combination of factors, including social determinants of health (eg, disparities of income, low educational achievement, and unstable housing), differential health insurance coverage or access to quality health care, and differences in sexual network characteristics (eg, individuals living in communities with a high prevalence of STIs have an increased chance of encountering an infected partner). Local prevalence rates may change over time, so clinicians should be aware of the latest data and trends for their specific population and geographic area, which are available through their state and local health departments and Centers for Disease Control and Prevention (CDC) surveillance.\r\n&nbsp;\r\nAlthough direct evidence on screening in nonpregnant persons who are not at increased risk for syphilis infection is lacking, based on the established test performance characteristics of current screening tests and the low prevalence rate of syphilis in this population, the yield of screening is likely low.9,10 Therefore, screening in this population may result in high false-positive rates and overtreatment.'}, {'id': 431, 'title': 'Syphilis Infection in Pregnant Women: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends early screening for syphilis infection in all pregnant women.', 'servfreq': 'All pregnant women should be tested for syphilis as early as possible when they first present to care. If a woman has not received prenatal care prior to delivery, she should be tested at the time she presents for delivery. In most cases of congenital syphilis, pregnant women received prenatal care but were not screened and treated for syphilis early enough during the pregnancy to prevent transmission to the fetus.', 'risktext': ''}, {'id': 1905, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and US Food and Drug Administration (FDA)--approved pharmacotherapy for cessation to nonpregnant adults who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 1906, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all pregnant persons about tobacco use, advise them to stop using tobacco, and provide behavioral interventions for cessation to pregnant persons who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 2014, 'title': 'Anxiety Disorders in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for anxiety disorders in adults, including pregnant and postpartum persons.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding optimal timing for screening, or screening interval, for both the perinatal and general adult populations; more evidence on both timing and screening interval is needed for all adult populations. A pragmatic approach in the absence of evidence might include screening all adults who have not been screened previously and using clinical judgment in considering risk factors, comorbid conditions, and life events to determine if additional screening of high-risk patients is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nRisk factors for anxiety disorders include sociodemographic factors, psychosocial factors, and physical and mental health factors such as marital status (widowed or divorced), stressful life events, smoking and alcohol use, other mental health conditions, or a parental history of mental disorders. Demographic factors such as low socioeconomic status and female sex are associated with higher rates of anxiety disorders.&nbsp;Black persons and individuals of non-Hispanic ethnicity are at increased risk of anxiety disorders due to social, rather than biological, factors. Anxiety and depressive disorders often overlap. One cohort study found that 67% of individuals with a depressive disorder also had a current anxiety disorder, and 75% had a lifetime comorbid anxiety disorder.'}, {'id': 1938, 'title': 'Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication ', 'grade': 'B', 'text': 'The DoctorAI recommends the use of low-dose aspirin (81 mg/day) as preventive medication after 12 weeks of gestation in persons who are at high risk for preeclampsia.\r\rSee the Practice Considerations section for information on high risk and aspirin dose.', 'servfreq': 'Once daily after 12 weeks of gestation', 'risktext': ' \r\nPersons with a history of preeclampsia in a previous pregnancy, type 1 or type 2 diabetes, and chronic hypertension are at highest risk for preeclampsia. Additional conditions that place a person at high risk for preeclampsia include multifetal gestation, conception using assisted reproductive technology, autoimmune disease, and kidney disease. Other factors associated with increased preeclampsia risk include nulliparity, high prepregnancy body mass index, family history of preeclampsia, and advanced maternal age (35 years or older). In addition, Black persons have higher rates of preeclampsia and are at increased risk for serious complications due to various societal and health inequities.\r\n '}, {'id': 513, 'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for asymptomatic bacteriuria using urine culture in pregnant persons.', 'servfreq': 'In general, screening is performed once at the first prenatal visit per clinical guidelines. However, there is little evidence on the optimal timing and frequency of screening for asymptomatic bacteriuria in pregnancy.2&nbsp; .&nbsp;Screen pregnant persons for asymptomatic bacteriuria using a midstream, clean-catch urine culture at the first prenatal visit or at 12 to 16 weeks of gestation, whichever is earlier. A urine culture showing &gt;100,000 CFU/mL of a single uropathogen or &gt;10,000 CFU/mL if the pathogen is group B streptococcus indicates treatment.', 'risktext': 'This recommendation applies to adults 18 years and older and pregnant persons of any age without signs and symptoms of a urinary tract infection. It does not apply to persons who have chronic medical or urinary tract conditions, such as end-stage renal disease; have indwelling urinary catheters, urinary stents, or spinal cord injuries; are hospitalized; reside in an institution (eg, a nursing home); or who are transplant recipients.\r\n&nbsp;\r\nThe risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6&nbsp;Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5&nbsp;Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7,&nbsp;11,&nbsp;12&nbsp;In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12&nbsp;Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4,&nbsp;6'}, {'id': 2009, 'title': 'Latent Tuberculosis Infection in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for LTBI in populations at increased risk.\r\rSee the "Assessment of Risk" section for additional information on adults at increased risk.', 'servfreq': 'The USPSTF found no evidence on the optimal frequency of screening for LTBI. In the absence of evidence, a reasonable approach is to repeat screening based on specific risk factors; screening frequency could range from 1-time only screening among persons at low risk for future tuberculosis exposure to annual screening among those at continued risk of exposure.', 'risktext': 'Populations at increased risk for LTBI, based on increased prevalence of active disease and increased risk of exposure, include persons who were born in, or are former residents of, countries with high tuberculosis prevalence and persons who live in, or have lived in, high-risk congregate settings (eg, homeless shelters or correctional facilities). Clinicians can consult their local or state health departments for more information about populations at increased risk in their community, since local demographic patterns may vary across the US.\r\nIn 2020, 71.5% of all cases of active tuberculosis in the US occurred among persons born outside the US. According to the CDC, tuberculosis disease is common in most countries in Latin America, the Caribbean, Africa, Asia, Eastern Europe, and Russia. In 2020, among persons with new tuberculosis living in the US who were born outside the US, the most common countries of birth were Mexico (18.0%), the Philippines (12.5%), India (10.4%), Vietnam (8.2%), and China (5.1%), accounting for 54.2% of total cases. Most of these cases are believed to be due to progression of latent infection to active tuberculosis disease rather than new transmission within communities.\r\nPersons who live, or have lived, in high-risk congregate settings also have a higher prevalence rate of active tuberculosis and an increased risk for exposure. In 2020, 4.3% of tuberculosis disease cases diagnosed in persons 15 years or older occurred in persons experiencing homelessness and 2.6% occurred in residents of correctional facilities. It is estimated that persons experiencing homelessness have an 11 times higher incidence of tuberculosis disease compared with persons who are not experiencing homelessness (36 cases per 100,000 population vs 2.9 cases per 100,000 population, respectively, during 2011 to 2016).\r\nOther populations at increased risk for LTBI or progression to active disease include persons who have immunosuppression (eg, persons living with HIV, patients receiving immunosuppressive medications such as chemotherapy or tumor necrosis factor inhibitors, and patients who have received an organ transplant) and patients with silicosis (a lung disease). However, given that screening in these populations may be considered standard care as part of disease management or indicated prior to the use of certain medications, the USPSTF did not review evidence on screening in these populations. Information on testing in these populations is provided by other groups, such as the Office of AIDS Research at the National Institutes of Health, and in a guideline issued jointly by the American Thoracic Society, Infectious Diseases Society of America, and CDC. Some evidence from observational studies has explored the association between poorly controlled diabetes and progression of LTBI to active disease. However, there is insufficient evidence on screening for and treatment of LTBI in persons with diabetes for the USPSTF to make a separate recommendation for this important population.\r\nPersons who are contacts of individuals with active tuberculosis, health care workers, and workers in high-risk congregate settings may also be at increased risk of exposure. Because screening in these populations is conducted as part of public health or employee health surveillance, the USPSTF did not review the evidence in these populations. Clinicians seeking further information about testing for tuberculosis in these populations can refer to the Additional Tools and Resources and Recommendations of Others sections.'}, {'id': 514, 'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic bacteriuria in nonpregnant adults.', 'servfreq': '', 'risktext': 'The risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6 Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5 Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7, 11, 12 In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12 Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4, 6'}, {'id': 507, 'title': 'BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing ', 'grade': 'B', 'text': 'The DoctorAI recommends that primary care clinicians assess women with a personal or family history of breast, ovarian, tubal, or peritoneal cancer or who have an ancestry associated with breast cancer susceptibility 1 and 2 (BRCA1/2) gene mutations with an appropriate brief familial risk assessment tool. Women with a positive result on the risk assessment tool should receive genetic counseling and, if indicated after counseling, genetic testing.', 'servfreq': 'Consideration of screening for potentially harmful BRCA mutations should begin once women have reached the age of consent (18 years). Primary care providers should periodically assess all patients for changes in family history (for example, comprehensive review at least every 5 to 10 years)', 'risktext': 'Patients with family or personal histories of breast, ovarian, tubal, or peritoneal cancer or ancestry associated with harmful&nbsp;&lt; i&gt;BRCA1/2&nbsp;mutations should be assessed using a familial risk assessment tool. The USPSTF found adequate evidence that these tools are accurate in identifying women with increased likelihood of&nbsp;&lt; i&gt;BRCA1/2mutations. Tools evaluated by the USPSTF include the Ontario Family History Assessment Tool, Manchester Scoring System, Referral Screening Tool, Pedigree Assessment Tool, 7-Question Family History Screening Tool, International Breast Cancer Intervention Study instrument (Tyrer-Cuzick), and brief versions of BRCAPRO. These tools should be used to guide referrals to genetic counseling.&nbsp;Persons should consider their sex at birth to determine which recommendation best applies to them.'}, {'id': 339, 'title': 'Breastfeeding: Primary Care Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends providing interventions during pregnancy and after birth to support breastfeeding.', 'servfreq': 'During pregnancy and after birth', 'risktext': "This recommendation applies to pregnant women, new mothers, and their infants and children. Interventions to support breastfeeding may also involve a woman's partner, other family members, and friends. This recommendation does not apply in circumstances where there are contraindications to breastfeeding (e.g., certain maternal medical conditions or infant metabolic disorders, such as galactosemia). The USPSTF did not review evidence on interventions directed at breastfeeding of preterm infants."}, {'id': 1935, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for chlamydia in all sexually active women 24 years or younger and in women 25 years or older who are at increased risk for infection.', 'servfreq': ' \r\nIn the absence of studies on screening intervals, a reasonable approach would be to screen patients whose sexual history reveals new or persistent risk factors since the last negative test result.\r\n ', 'risktext': ' \r\nAge is a strong predictor of risk for chlamydial and gonococcal infections, with the highest infection rates in women occurring during ages 15 to 24 years. Women 25 years or older are at increased risk if they have a new sex partner, more than 1 sex partner, a sex partner with concurrent partners, or a sex partner who has an STI; practice inconsistent condom use when not in a mutually monogamous relationship; or have a previous or coexisting STI. Exchanging sex for money or drugs and history of incarceration also are associated with increased risk.&nbsp;Clinicians should consider the communities they serve and may want to consult local public health authorities for information about local epidemiology and guidance on determining who is at increased risk.\r\n '}, {'id': 1936, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for gonorrhea in all sexually active women 24 years or younger and in women 25 years or older who are at increased risk for infection.', 'servfreq': ' \r\nIn the absence of studies on screening intervals, a reasonable approach would be to screen patients whose sexual history reveals new or persistent risk factors since the last negative test result.\r\n ', 'risktext': ' \r\nAge is a strong predictor of risk for chlamydial and gonococcal infections, with the highest infection rates in women occurring during ages 15 to 24 years. Women 25 years or older are at increased risk if they have a new sex partner, more than 1 sex partner, a sex partner with concurrent partners, or a sex partner who has an STI; practice inconsistent condom use when not in a mutually monogamous relationship; or have a previous or coexisting STI. Exchanging sex for money or drugs and history of incarceration also are associated with increased risk.&nbsp;Clinicians should consider the communities they serve and may want to consult local public health authorities for information about local epidemiology and guidance on determining who is at increased risk.\r\n '}, {'id': 1909, 'title': 'Asymptomatic Carotid Artery Stenosis: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic carotid artery stenosis in the general adult population.\r\rSee the Practice Considerations section for a description of adults at increased risk.', 'servfreq': '', 'risktext': ''}, {'id': 2017, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for suicide risk in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': '', 'risktext': ''}, {'id': 2016, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for depression in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding the optimal timing for screening for depression; more evidence is needed in both perinatal and general adult populations. In the absence of evidence, a pragmatic approach might include screening adults who have not been screened previously and using clinical judgment while considering risk factors, comorbid conditions, and life events to determine if additional screening of patients at increased risk is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nThe USPSTF recommends screening for depression in all adults regardless of risk factors. Risk factors for depression include a combination of genetic, biological, and environmental factors, such as a family history of depression, prior episode of depression or other mental health condition, a history of trauma or adverse life events, or a history of disease or illness (eg, cardiovascular disease).\r\nPrevalence rates vary by sex, age, race, ethnicity, education, marital status, geographic location, poverty level, and employment status. Women have twice the risk of depression compared with men. Young adults, multiracial individuals, and Native American/Alaska Native individuals have higher rates of depression.\r\nRisk factors for perinatal depression include life stress, low social support, history of depression, marital or partner dissatisfaction, and a history of abuse.'}, {'id': 1932, 'title': 'Gestational Diabetes: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for gestational diabetes in asymptomatic pregnant persons at 24 weeks of gestation or after.', 'servfreq': 'At 24 weeks of gestation or after to improve maternal and fetal outcomes', 'risktext': ' \r\nSeveral factors increase a person&rsquo;s risk for developing gestational diabetes, including obesity, increased maternal age, history of gestational diabetes, family history of diabetes, and belonging to a racial/ethnic group that is at increased risk for developing type 2 diabetes (Hispanic, Native American, South or East Asian, or Pacific Islander descent).4,19,20 Factors associated with a lower risk for developing gestational diabetes include age younger than 25 to 30 years, White race, a body mass index (BMI) of 25 or less (calculated as weight in kilograms divided by height in meters squared), no family history (in a first-degree relative) of diabetes, and no history of glucose intolerance or adverse pregnancy outcomes related to gestational diabetes.21-23 The risk in different racial/ethnic groups may be due in part to social risk factors such as low socioeconomic status or structural racism, although these associations are not examined in the current evidence. Although a higher BMI increases the risk of gestational diabetes across racial/ethnic groups, the association varies. In Asian American persons, the prevalence of gestational diabetes at a BMI of 22 to less than 25 is similar to the prevalence in Hispanic persons, non-Hispanic White persons, and Black persons with a higher (&gt;28) BMI.24,25\r\n '}, {'id': 1845, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends offering or referring adults with cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity.', 'servfreq': '', 'risktext': 'Adults 18 years or older at increased risk of CVD, defined as those with 1 or more of the following:\r\n1.Hypertension or elevated blood pressure2.Dyslipidemia3.Mixed or multiple risk factors such as the metabolic syndrome or an estimated 10-year CVD risk of &ge;7.5%\r\nThis recommendation does not apply to adults with other known modifiable cardiovascular risk factors such as abnormal blood glucose levels, obesity, and smoking; these populations are incorporated in other USPSTF recommendations.'}, {'id': 1931, 'title': 'Healthy Weight and Weight Gain In Pregnancy: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer pregnant persons effective behavioral counseling interventions aimed at promoting healthy weight gain and preventing excess gestational weight gain in pregnancy.', 'servfreq': 'Throughout pregnancy', 'risktext': 'Pregnancy'}, {'id': 1885, 'title': 'Hepatitis B Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in adolescents and adults at increased risk for infection.\r\rSee the Practice Considerations section for a description of adolescents and adults at increased risk for infection.', 'servfreq': 'For patients with negative HBsAg results who have not received the HBV vaccine series, periodic screening may be useful for those who report continued risk for acquiring HBV transmission, such as persons who continue to inject drugs and men who have sex with men. Clinical judgment should be used to determine screening frequency. The USPSTF found no evidence to determine optimal screening intervals.', 'risktext': 'Persons from such risk groups include persons who have injected drugs in the past or currently; men who have sex with men; persons with HIV; and sex partners, needle-sharing contacts, and household contacts of persons known to be HBsAg positive. Some persons with combinations of risk factors who are not members of risk factor groups listed above may also be at increased risk for HBV infection.'}, {'id': 524, 'title': 'Hepatitis C Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis C virus (HCV) infection in adults aged 18 to 79 years.', 'servfreq': 'One-time screening for most adults.\r\nPeriodically screen persons with continued risk for HCV infection (eg, persons with past or current injection drug use). There is limited evidence to determine how often to screen persons at increased risk.&nbsp;', 'risktext': 'Asymptomatic adults aged 18 to 79 years (including pregnant persons) without known liver disease.&nbsp;\r\nThe USPSTF also suggests that clinicians consider screening persons younger than 18 years and older than 79 years who are at high risk for infection (eg, those with past or current injection drug use).&nbsp;'}, {'id': 2023, 'title': 'Hypertensive Disorders of Pregnancy: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hypertensive disorders in pregnant persons with blood pressure measurements throughout pregnancy.', 'servfreq': 'Screening Interval\r\nBlood pressure measurements should be obtained during each prenatal care visit throughout pregnancy. Hypertensive disorders of pregnancy can quickly evolve into severe disease that can result in serious, even fatal, maternal and infant health outcomes. The ability to screen for hypertensive disorders of pregnancy using blood pressure measurements is important to identify and effectively treat a potentially unpredictable and fatal condition. While it is known that risk continues into the immediate postpartum period, there is little evidence regarding screening during this period. A pragmatic approach would be for patients to be counseled regarding signs and symptoms of preeclampsia at hospital discharge and for patients with hypertensive disorders to have subsequent blood pressure checks.\r\nScreening for hypertensive disorders of pregnancy alone is not sufficient to improve inequities in health outcomes. Identifying hypertensive disorders of pregnancy requires adequate prenatal visits, surveillance, and evidence-based care in response to evolving patient signs and symptoms during pregnancy and the postpartum period to improve health outcomes. Black and Native American/Alaska Native persons have lower rates of prenatal visits and are at greater risk of serious postpartum morbidity and hospital readmission after delivery. Screening and monitoring of Black and Hispanic/Latina individuals during the postpartum period could be an important step for reducing health inequities by preventing serious adverse events. In addition, screening and monitoring by various health care providers (eg, nurse midwives, nurses, pediatricians, doulas, and lactation consultants) could also help avert serious complications in the postpartum period.', 'risktext': 'Assessment of Risk\r\nImportant clinical conditions associated with increased risk for preeclampsia include a history of eclampsia or preeclampsia in a prior pregnancy, a previous adverse pregnancy outcome, and maternal comorbid conditions (including type 1 or type 2 diabetes prior to pregnancy, gestational diabetes, chronic hypertension, kidney disease, and autoimmune diseases).\r\n&nbsp;Other factors associated with increased risk of preeclampsia and gestational hypertension include nulliparity, high prepregnancy body mass index, family history of preeclampsia, multifetal gestation, and the pregnant individual being 35 years or older.\r\nThe higher prevalence of hypertensive disorders of pregnancy and the increased risk for severe complications seen in Black persons may be due to their disproportionate burden of social and clinical risk factors. These social and clinical determinants largely result from historical and current manifestations of structural racism that influence environmental exposures, access to health resources, and overall health status.'}, {'id': 434, 'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians screen for intimate partner violence (IPV) in women of reproductive age and provide or refer women who screen positive to ongoing support services. See the Clinical Considerations section for more information on effective ongoing support services for IPV and for information on IPV in men.', 'servfreq': 'The USPSTF found no evidence on appropriate intervals for screening. Randomized clinical trials (RCTs) of screening and interventions for IPV often screen for current IPV or IPV in the past year.\r\n&nbsp;', 'risktext': 'All women of reproductive age are at potential risk for IPV and should be screened. There are a variety of factors that increase risk of IPV, such as exposure to violence as a child, young age, unemployment, substance abuse, marital difficulties, and economic hardships.\r\nRisk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health. For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.'}, {'id': 187, 'title': 'Rh(D) Incompatibility: Screening ', 'grade': 'B', 'text': "The DoctorAI recommends repeated Rh(D) antibody testing for all unsensitized Rh(D)-negative women at 24 to 28 weeks' gestation, unless the biological father is known to be Rh(D)-negative.", 'servfreq': 'Repeat testing at 24-28 weeks gestation.', 'risktext': ''}, {'id': 1916, 'title': 'Lung Cancer: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery.', 'servfreq': ' \r\nThe USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. ', 'risktext': ' \r\nSmoking and older age are the 2 most important risk factors for lung cancer.&nbsp;The risk of lung cancer in persons who smoke increases with cumulative quantity and duration of smoking and with age but decreases with increasing time since quitting for persons who formerly smoked.3 The USPSTF considers adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years to be at high risk and recommends screening for lung cancer with annual LDCT in this population. \r\n \r\n&nbsp;\r\n \r\nAfrican American/Black (Black) men have a higher incidence of lung cancer than White men, and Black women have a lower incidence than White women.1 These differences are likely related to differences in smoking exposure (ie, prevalence of smoking) and related exposure to carcinogens in cigarettes.7,8 The differences may also be related to other social risk factors.\r\n \r\n&nbsp;\r\n \r\nOther risk factors for lung cancer include environmental exposures, prior radiation therapy, other (noncancer) lung diseases, and family history. Lower level of education is also associated with a higher risk of lung cancer.7 The task force recommends using age and smoking history to determine screening eligibility rather than more elaborate risk prediction models because there is insufficient evidence to assess whether risk prediction model&ndash;based screening would improve outcomes relative to using the risk factors of age and smoking history for broad implementation in primary care.\r\n '}, {'id': 449, 'title': 'Perinatal Depression: Preventive Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians provide or refer pregnant and postpartum persons who are at increased risk of perinatal depression to counseling interventions.', 'servfreq': '', 'risktext': 'Include&nbsp;a past history of depression. Current depressive symptoms (that do not reach a diagnostic threshold),&nbsp;history of physical or sexual abuse,&nbsp;unplanned or unwanted pregnancy,&nbsp;stressful life events,&nbsp;lack of social and financial support,&nbsp;intimate partner violence,pregestational or gestational diabetes,and complications during pregnancy. Additional risk factors include adolescent parenthood, low socioeconomic status, and lack of social support.&nbsp;Genetic factors are also suspected to contribute to women&rsquo;s risk of developing perinatal depression.'}, {'id': 1445, 'title': 'Sexually Transmitted Infections: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends behavioral counseling for all sexually active adolescents and for adults who are at increased risk for sexually transmitted infections (STIs).\r\rSee the Practice Considerations section for more information on populations at increased risk for acquiring STIs.', 'servfreq': '', 'risktext': 'All sexually active adolescents are at increased risk for STIs because of the high rates of STIs in this age group and should receive behavioral counseling interventions. Adults at increased risk for STIs include those who currently have an STI or were diagnosed with one within the past year, do not consistently use condoms, have multiple sex partners, or have sex partners within populations with a high prevalence of STIs. Populations with a high prevalence of STIs include persons who seek STI testing or attend STI clinics; sexual and gender minorities; persons who are living with HIV, inject drugs, have exchanged sex for money or drugs, or have entered correctional facilities; and some racial/ethnic minority groups.1-4'}, {'id': 402, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends counseling young adults, adolescents, children, and parents of young children about minimizing exposure to ultraviolet (UV) radiation for persons aged 6 months to 24 years with fair skin types to reduce their risk of skin cancer.', 'servfreq': '', 'risktext': 'Fair skin types'}, {'id': 438, 'title': 'Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for unhealthy alcohol use in primary care settings in adults 18 years or older, including pregnant women, and providing persons engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce unhealthy alcohol use.', 'servfreq': 'The USPSTF did not find adequate evidence to recommend an optimal screening interval for unhealthy alcohol use in adults.&nbsp;Brief behavioral counseling interventions were found to reduce unhealthy alcohol use in adults 18 years or older, including pregnant women. Effective behavioral counseling interventions vary in their specific components, administration, length, and number of interactions. The USPSTF was unable to identify specific intervention characteristics or components that were clearly associated with improved outcomes.', 'risktext': 'engaged in risky or hazardous drinking'}, {'id': 767, 'title': 'Unhealthy Drug Use: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening by asking questions about unhealthy drug use in adults age 18 years or older. Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. \r(Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'servfreq': 'Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. (Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'risktext': 'These include being aged 18 to 25 years; male sex; having a mental health condition, personality or mood disorder, or nicotine or alcohol dependence; a history of physical or sexual abuse, parental neglect, or other adversity in childhood; or drug or alcohol addiction in a first-degree relative.1,9&nbsp;Factors associated with misuse of prescription drugs include history of other drug use, mental illness, pain, and greater access to prescription drugs.10&nbsp;Factors associated with prenatal use of drugs include a mental health disorder, interpersonal violence, and family history of substance use.11'}, {'id': 433, 'title': 'Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer or refer adults with a body mass index (BMI) of 30 or higher (calculated as weight in kilograms divided by height in meters squared) to intensive, multicomponent behavioral interventions.', 'servfreq': '', 'risktext': 'Adults with a BMI &ge;30'}, {'id': 1979, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: Behavioral Counseling Interventions ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians individualize the decision to offer or refer adults without cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity. \r\rSee the "Practice Considerations" section for information on determining which patients may benefit most from this service.', 'servfreq': '', 'risktext': ''}, {'id': 1937, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for chlamydia and gonorrhea in men.', 'servfreq': '', 'risktext': ''}, {'id': 508, 'title': 'BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine risk assessment, genetic counseling, or genetic testing for women whose personal or family history or ancestry is not associated with potentially harmful BRCA1/2 gene mutations.', 'servfreq': '', 'risktext': 'Patients with family or personal histories of breast, ovarian, tubal, or peritoneal cancer or ancestry associated with harmful&nbsp;BRCA1/2&nbsp;mutations should be assessed using a familial risk assessment tool. The USPSTF found adequate evidence that these tools are accurate in identifying women with increased likelihood of&nbsp;BRCA1/2mutations. Tools evaluated by the USPSTF include the Ontario Family History Assessment Tool, Manchester Scoring System, Referral Screening Tool, Pedigree Assessment Tool, 7-Question Family History Screening Tool, International Breast Cancer Intervention Study instrument (Tyrer-Cuzick), and brief versions of BRCAPRO. These tools should be used to guide referrals to genetic counseling.'}, {'id': 525, 'title': 'Bacterial Vaginosis in Pregnant Persons to Prevent Preterm Delivery: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for bacterial vaginosis (BV) in pregnant persons who are not at increased risk for preterm delivery.', 'servfreq': '', 'risktext': '\r\nAssess risk for preterm delivery. There are multiple factors that increase risk for preterm delivery; one of the strongest risk factors is prior preterm delivery.\r\nDecide whether or not to screen for bacterial vaginosis:\r\n\r\na. Do not screen pregnant persons who are not at increased risk for preterm delivery.\r\nb. Evidence is insufficient to recommend for or against screening pregnant persons at increased risk for preterm delivery.'}, {'id': 418, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening with resting or exercise electrocardiography (ECG) to prevent cardiovascular disease (CVD) events in asymptomatic adults at low risk of CVD events.', 'servfreq': '', 'risktext': ''}, {'id': 429, 'title': 'Cervical Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for cervical cancer in women who have had a hysterectomy with removal of the cervix and do not have a history of a high-grade precancerous lesion (ie, cervical intraepithelial neoplasia [CIN] grade 2 or 3) or cervical cancer.', 'servfreq': '', 'risktext': ''}, {'id': 428, 'title': 'Cervical Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for cervical cancer in women younger than 21 years.', 'servfreq': '', 'risktext': ''}, {'id': 1973, 'title': 'Chronic Obstructive Pulmonary Disease: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for chronic obstructive pulmonary disease in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 2003, 'title': 'Genital Herpes Infection: Serologic Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine serologic screening for genital herpes simplex virus infection in asymptomatic adolescents and adults, including pregnant persons.', 'servfreq': '', 'risktext': 'The USPSTF found no evidence of externally validated, reliable risk stratification tools to identify individuals more or less likely to have genital herpes.'}, {'id': 504, 'title': 'Pancreatic Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for pancreatic cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 365, 'title': 'Thyroid Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for thyroid cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 1976, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'D', 'text': 'The DoctorAI recommends against the use of beta carotene or vitamin E supplements for the prevention of cardiovascular disease or cancer.', 'servfreq': '', 'risktext': ''}, {'id': 318, 'title': 'Autism Spectrum Disorder in Young Children: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for autism spectrum disorder (ASD) in young children for whom no concerns of ASD have been raised by their parents or a clinician.', 'servfreq': '', 'risktext': 'Although a number of potential risk factors for ASD have been identified, there is insufficient evidence to determine if certain risk factors modify the performance characteristics of ASD screening tests, such as the age at which screening is performed or other characteristics of the child or family.'}, {'id': 526, 'title': 'Bacterial Vaginosis in Pregnant Persons to Prevent Preterm Delivery: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for BV in pregnant persons who are at increased risk for preterm delivery.', 'servfreq': '', 'risktext': ''}, {'id': 65, 'title': 'Bladder Cancer in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults.\r\rLiterature scans conducted in July 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'This evidence update focused on the benefits and harms of screening for bladder cancer among people without symptoms, the accuracy of screening tests done in primary care settings, and the benefits and harms of treatment. The updated evidence review did not find any new high quality evidence to adequately determine the balance of benefits and harms of screening for bladder cancer. However, bladder cancer is a common cancer and can cause considerable health problems including death. Therefore, the USPSTF determined that the evidence was insufficient to provide a recommendation for or against bladder cancer screening.  The USPSTF emphasizes the need for additional research in this area. '}, {'id': 2037, 'title': 'Breast Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of supplemental screening for breast cancer using breast ultrasonography or magnetic resonance imaging (MRI) in women identified to have dense breasts on an otherwise negative screening mammogram.\r\rSee the "Practice Considerations" section for more information on the patient population to whom this recommendation applies and on screening mammography modalities.', 'servfreq': '', 'risktext': 'These recommendations apply to cisgender women and all other persons assigned female at birth (including transgender men and nonbinary persons) 40 years or older at average risk of breast cancer. \r\nThese recommendations apply to persons who have factors associated with an increased risk of breast cancer, such as a family history of breast cancer (ie, a first-degree relative with breast cancer) or having dense breasts. They do not apply to persons who have a genetic marker or syndrome associated with a high risk of breast cancer (eg, BRCA1 or BRCA2 genetic variation), a history of high-dose radiation therapy to the chest at a young age, or previous breast cancer or a high-risk breast lesion on previous biopsies. '}, {'id': 419, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening with resting or exercise ECG to prevent CVD events in asymptomatic adults at intermediate or high risk of CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 423, 'title': 'Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of adding the ankle-brachial index (ABI), high-sensitivity C-reactive protein (hsCRP) level, or coronary artery calcium (CAC) score to traditional risk assessment for cardiovascular disease (CVD) in asymptomatic adults to prevent CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 352, 'title': 'Celiac Disease: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'persons with family history or other risk factors'}, {'id': 1955, 'title': 'Eating Disorders in Adolescents and Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for eating disorders in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1933, 'title': 'Gestational Diabetes: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for gestational diabetes in asymptomatic pregnant persons before 24 weeks of gestation.', 'servfreq': '', 'risktext': ''}, {'id': 665, 'title': 'Illicit Drug Use in Children, Adolescents, and Young Adults: Primary Care-Based Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--based behavioral counseling interventions to prevent illicit drug use, including nonmedical use of prescription drugs, in children, adolescents, and young adults.\r\rSee the Practice Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 435, 'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for abuse and neglect in all older or vulnerable adults. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': 'Risk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health.14&nbsp;For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.15'}, {'id': 2045, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for iron deficiency and iron deficiency anemia in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2046, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine iron supplementation in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2018, 'title': 'Lipid Disorders in Children and Adolescents: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1998, 'title': 'Obstructive Sleep Apnea in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for obstructive sleep apnea in the general adult population.\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Risk Factors\r\nRisk factors associated with OSA include male sex, older age (40-70 years), postmenopausal status, higher body mass index (BMI), and craniofacial and upper airway abnormalities (eg, enlarged tonsils or long upper airway). Black, Hispanic/Latino, and Native American/Alaska Native persons have a higher prevalence of OSA compared with White persons; some evidence suggests that these differences are partially explained by higher rates of obesity, asthma, and tobacco use among these groups.8'}, {'id': 1977, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of multivitamin supplements for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1978, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of single or paired nutrient supplements (other than beta carotene and vitamin E) for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 176, 'title': 'Oral Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for oral cancer in asymptomatic adults.\r\rGo to the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in July 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Tobacco and alcohol use are major risk factors for oral cancer. A total of 20% to 30% of cases of oral cancer worldwide are attributable to cigarette smoking. In the United States, up to 75% of cases of oral cancer may be attributable to tobacco and alcohol use. Additional risk factors include male sex, older age, use of betel quid, ultraviolet light exposure, infection with Candida or bacterial flora, and a compromised immune system. Sexually transmitted oral HPV infection (HPV-16) has recently been recognized as an increasingly important risk factor for oropharyngeal cancer. In the United States, the prevalence of oropharyngeal cancer due to oral HPV infection is probably as high as 80% to 95%. The prevalence of oral HPV infection is associated with age, sex, number of sexual partners, and number of cigarettes smoked per day. The effect of multifactorial risk assessment and screening for risk factors on oral cancer morbidity and mortality is unknown.'}, {'id': 2026, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine screening performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 2027, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of preventive interventions performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 424, 'title': 'Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for peripheral artery disease (PAD) and cardiovascular disease (CVD) risk with the ankle-brachial index (ABI) in asymptomatic adults.\r\rLiterature scans conducted in August 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Risk factors associated with OSA include male sex, older age (40 to 70 years), postmenopausal status, higher BMI, and craniofacial and upper airway abnormalities.'}, {'id': 404, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of counseling adults about skin self-examination to prevent skin cancer.See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 2005, 'title': 'Skin Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Exposure to UV radiation from sun exposure, indoor tanning beds, and other UV radiation&ndash;emitting devices is the major environmental risk factor for skin cancer. History of frequent sunburns, older age, and male sex are associated with increased risk for skin cancer. Exposure to UV radiation from the use of indoor tanning beds is an important risk factor in adolescents. Incidence of melanoma is higher among White persons compared with persons of other races and ethnicities. This difference likely reflects traits associated with increased melanoma risk, such as fair skin (which is more susceptible to sunburning), light-colored eyes, and red or blond hair being more common among White persons compared with persons of other races and ethnicities. Acral lentiginous melanoma, which occurs mostly on skin not frequently exposed to direct sunlight (eg, palms of hands, soles of feet, or under fingernails or toenails), is the most common type of melanoma among Black populations. Other melanoma risk factors include higher numbers of moles on the skin, atypical moles, as well as a personal and family history of skin cancer.'}, {'id': 269, 'title': 'Thyroid Dysfunction: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults.\r\rSee the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': 'The optimal screening interval for thyroid dysfunction (if one exists) is unknown.', 'risktext': 'The most common cause of hypothyroidism in the United States is chronic autoimmune (Hashimoto) thyroiditis. Risk factors for an elevated TSH level include female sex, advancing age, white race, type 1 diabetes, Down syndrome, family history of thyroid disease, goiter, previous hyperthyroidism (possibly due in part to ablation therapy leading to iatrogenic thyroid dysfunction), and external-beam radiation in the head and neck area. Common causes of hyperthyroidism include Graves disease, Hashimoto thyroiditis, and functional thyroid nodules. Risk factors for a low TSH level include female sex; advancing age; black race; low iodine intake; personal or family history of thyroid disease; and ingestion of iodine-containing drugs, such as amiodarone. The USPSTF found no direct evidence that treatment of thyroid dysfunction based on risk level alters final health outcomes.'}, {'id': 1908, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of electronic cigarettes (e-cigarettes) for tobacco cessation in adults, including pregnant persons. The USPSTF recommends that clinicians direct patients who use tobacco to other tobacco cessation interventions with proven effectiveness and established safety.\rSee the Practice Considerations section for more information on recommended behavioral interventions and pharmacotherapy and for suggestions for practice regarding the I statements.', 'servfreq': '', 'risktext': ''}, {'id': 1907, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of pharmacotherapy interventions for tobacco cessation in pregnant persons.', 'servfreq': '', 'risktext': ''}, {'id': 586, 'title': 'Tobacco Use in Children and Adolescents: Primary Care Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--feasible interventions for the cessation of tobacco use among school-aged children and adolescents.\r\rSee the Practice Considerations section for more information on effective interventions to prevent initiation of tobacco use and for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1919, 'title': 'Vitamin D Deficiency in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 408, 'title': 'Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of the benefits and harms of vitamin D and calcium supplementation, alone or combined, for the primary prevention of fractures in men and premenopausal women.', 'servfreq': '', 'risktext': ''}]
2025-01-29 22:00:46 [INFO] Update id=273478172 is handled. Duration 696 ms by bot id=8108339380
2025-01-29 22:00:48 [INFO] State data: {'db': <bot.database.Database object at 0x7f78842cb740>, 'age': 20, 'weight': 190, 'height': 190, 'feet': 45, 'gender': 'female', 'pregnant': 'yes', 'smoking': 'yes', 'sex': 'tools_0', 'recommendations': [{'id': 2020, 'title': 'Folic Acid Supplementation to Prevent Neural Tube Defects: Preventive Medication ', 'grade': 'A', 'text': 'The DoctorAI recommends that all persons planning to or who could become pregnant take a daily supplement containing 0.4 to 0.8 mg (400 to 800 mcg) of folic acid.', 'servfreq': 'The neural plate completes its formation and closure early in pregnancy (usually 26 to 28 days after fertilization). This means the critical period for folic acid supplementation starts at least 1 month before conception and continues through the first 2 to 3 months of pregnancy. Nearly half of all pregnancies in the US are unplanned; to gain the full benefits of supplementation, clinicians should advise all persons who plan to or who could become pregnant to take daily folic acid.', 'risktext': 'All pregnancies are at risk for neural tube defects, and persons who are planning to or could become pregnant should take folic acid supplements. Certain risk factors convey a higher risk, and individuals with these risk factors should talk to their health care professional. These factors include personal, partner, or family history of neural tube defects, malabsorption caused by bariatric procedures, the use of certain antiseizure medicines, and genetic mutations in folate-related enzymes. Pregestational diabetes and obesity have been associated with an increased risk of neural tube defects. Ethnic groups such as First Nation persons in Canada and Hispanic persons in California are thought to be at higher risk of neural tube defects. It is unclear, however, whether this is related to a higher risk of genetic variations among these groups or due to differential intake of folic acid&ndash;fortified foods.'}, {'id': 503, 'title': 'Hepatitis B Virus Infection in Pregnant Women: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in pregnant women at their first prenatal visit', 'servfreq': 'A test for HBsAg should be ordered at the first prenatal visit. Women with unknown HBsAg status or with new or continuing risk factors for HBV infection (eg, injection drug use or a sexually transmitted infection) should be screened at the time of admission to a hospital or other delivery setting.', 'risktext': 'In the United States, new cases of HBV among adults are largely transmitted through injection drug use or sexual intercourse, but most prevalent cases of HBV infection are chronic infections from exposure occurring in infancy or childhood. Another major risk factor for HBV infection is country of origin. In the United States, adults with HBV born in high-prevalence countries were commonly infected during childhood. In children, the primary source of infection is perinatal transmission at birth.'}, {'id': 485, 'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in adolescents and adults aged 15 to 65 years. Younger adolescents and older adults who are at increased risk of infection should also be screened.\rSee the Clinical Considerations section for more information about assessment of risk, screening intervals, and rescreening in pregnancy.', 'servfreq': 'The USPSTF found insufficient evidence to determine appropriate or optimal time intervals or strategies for repeat HIV screening. However, repeat screening is reasonable for persons known to be at increased risk of HIV infection, such as sexually active men who have sex with men; persons with a sex partner who is living with HIV; or persons who engage in behaviors that may convey an increased risk of HIV infection, such as injection drug use, transactional sex or commercial sex work, having 1 or more new sex partners whose HIV status is unknown, or having other factors that can place a person at increased risk of HIV infection (see &ldquo;Risk Assessment&rdquo;). Repeat screening is also reasonable for persons who live or receive medical care in a high-prevalence setting, such as a sexually transmitted disease clinic, tuberculosis clinic, correctional facility, or homeless shelter.', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'id': 486, 'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in all pregnant persons, including those who present in labor or at delivery whose HIV status is unknown.', 'servfreq': 'The CDC and ACOG recommend repeat prenatal screening for HIV during the third trimester of pregnancy in women with risk factors for HIV acquisition and in women living or receiving care in high-incidence settings, and the CDC notes that repeat screening for HIV during the third trimester may be considered in all women.&nbsp;', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'id': 1921, 'title': 'Hypertension in Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hypertension in adults 18 years or older with office blood pressure measurement (OBPM). The USPSTF recommends obtaining blood pressure measurements outside of the clinical setting for diagnostic confirmation before starting treatment.', 'servfreq': ' \r\nAlthough evidence on optimal screening intervals is limited, reasonable options include:\r\n \r\n \r\n\r\n\r\nScreening for hypertension every year in adults 40 years or older and in adults at increased risk for hypertension (such as Black persons, persons with high-normal blood pressure, or persons who are overweight or obese)\r\n\r\n\r\n \r\n \r\n\r\n\r\nScreening less frequently (ie, every 3 to 5 years) as appropriate for adults aged 18 to 39 years not at increased risk for hypertension and with a prior normal blood pressure reading.\r\n\r\n\r\n ', 'risktext': ' \r\nAlthough all adults should be screened for hypertension, risk factors that increase a person&rsquo;s risk for the condition include older age, Black race, family history, excess weight and obesity, lifestyle habits (lack of physical activity, stress, and tobacco use), and dietary factors (diet high in fat or sodium, diet low in potassium, or excessive alcohol intake)\r\n '}, {'id': 2021, 'title': 'Prevention of Acquisition of HIV: Preexposure Prophylaxis ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians prescribe preexposure prophylaxis using effective antiretroviral therapy to persons who are at increased risk of HIV acquisition to decrease the risk of acquiring HIV. \r\rSee the Practice Considerations section for more information about identification of persons at increased risk and about effective antiretroviral therapy.', 'servfreq': '', 'risktext': 'HIV is primarily acquired via sexual activity or injection drug use. It is important that clinicians routinely take a sexual and injection drug use history for all their patients in an open and nonjudgmental manner. All adolescents and adults who are sexually active or who inject drugs should be informed that acquisition of HIV can be prevented, to facilitate subsequent risk assessment and discussions about preexposure prophylaxis (PrEP) and other ways to prevent acquisition of HIV. Importantly, risk of HIV acquisition exists on a continuum, and currently available risk assessment tools all have limitations. However, certain risk factors or behaviors are known to place persons at increased risk of HIV.\r\nRisk of HIV acquisition depends on the likelihood that a specific act or activity will transmit HIV and the likelihood that a sex partner or drug injection partner has HIV. Likelihood of HIV transmission is highest with needle-sharing injection drug use and condomless receptive anal intercourse. Condomless receptive anal intercourse has an approximately 10- to 15-fold higher risk of transmission than condomless insertive anal sex and condomless receptive and insertive penile-vaginal sex. A 2018 study estimated the prevalence of HIV (ie, an estimate of the likelihood that a partner whose HIV status is unknown has HIV at a population level) as 12.4% among men who have sex with men and 1.9% among persons who inject drugs. The overall prevalence of HIV in the US is estimated at 0.3%.&nbsp;Of note, both the frequency of specific sexual activities and a person&rsquo;s number of sexual partners will also affect their risk of HIV.\r\n&nbsp;The USPSTF recommends that the following persons be considered for PrEP:\r\n1.&nbsp;&nbsp;&nbsp;&nbsp; Sexually active adults and adolescents weighing at least 35 kg (77 lb) who have engaged in anal or vaginal sex in the past 6 months and have any of the following:\r\n&nbsp;\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A sexual partner who has HIV (especially if the partner has an unknown or detectable viral load).\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A bacterial sexually transmitted infection (STI) (syphilis, gonorrhea, or chlamydia for men who have sex with men and transgender women; gonorrhea and syphilis for heterosexual women and men) in the past 6 months.\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A history of inconsistent or no condom use with sex partner(s) whose HIV status is not known; assessing risk in conversation with the patient and considering factors such as number of partners, the specific sexual activities a person engages in, and whether their sex partner or partners are in a group with a higher prevalence of HIV (eg, men who have sex with men or with men and women, transgender women, persons who inject drugs, and persons who engage in transactional sex).\r\n&nbsp;\r\n2. &nbsp; Persons who inject drugs and have a drug-injecting partner who has HIV or who shares injection equipment.\r\nPersons who engage in transactional sex, such as sex for money, drugs, or housing, including commercial sex workers or persons trafficked for sex work, constitute a group at increased risk of HIV acquisition and should be considered for PrEP based on the criteria outlined above. Persons who request PrEP may have undisclosed behaviors that put them at risk. Transgender women and men who are sexually active should be considered for PrEP based on the criteria outlined above. Transgender women are at especially high risk of HIV acquisition. A Centers for Disease Control and and Prevention (CDC) survey in 7 cities found an HIV prevalence of 42% among transgender women. Prevalence was highest among Black transgender women (62%) and Native American/Alaska Native transgender women (65%).\r\nIn addition, studies have found that transmission of HIV to a seronegative partner from a partner with HIV has not been observed when the partner with HIV was being treated with antiretroviral therapy and had a suppressed viral load.&nbsp;It is not known whether PrEP use further decreases the risk of HIV transmission when a partner with HIV has a documented undetectable viral load. Factors such as the consistency or inconsistency of a partner&rsquo;s viral load being suppressed, a partner&rsquo;s adherence to antiretroviral therapy, and the degree of certainty that a partner&rsquo;s viral load is suppressed (eg, self-report vs availability of laboratory test results) may help inform decisions about the use of PrEP in this situation.\r\nAll persons being considered for PrEP must have a recently documented negative HIV antigen-antibody test result, and if they have taken oral PrEP or postexposure prophylaxis in the past 3 months, or injectable cabotegravir in the past 12 months, the CDC recommends testing with both an HIV antigen-antibody assay and an HIV-1 RNA assay.'}, {'id': 186, 'title': 'Rh(D) Incompatibility: Screening ', 'grade': 'A', 'text': 'The DoctorAI strongly recommends Rh(D) blood typing and antibody testing for all pregnant women during their first visit for pregnancy-related care.', 'servfreq': 'First prenatal visit.', 'risktext': ''}, {'id': 1989, 'title': 'Syphilis Infection in Nonpregnant Adolescents and Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for syphilis infection in persons who are at increased risk for infection.', 'servfreq': 'Optimal screening frequency for persons who are at increased risk for syphilis infection is not well established. Men who have sex with men or persons with HIV infection may benefit from screening at least annually or more frequently (eg, every 3 to 6 months) if they continue to be at high risk.', 'risktext': 'The USPSTF recommends screening for syphilis in persons who are at increased risk for infection. When deciding which persons to screen for syphilis, clinicians should consider the prevalence of infection in the communities they serve, as well as other sociodemographic and behavioral factors that may be associated with increased risk of syphilis infection. For example, prevalence of syphilis is higher in men, men who have sex with men, persons with HIV infection, young adults, and persons with a history of incarceration, sex work, or military service. A substantial percentage of heterosexual syphilis transmission occurs among persons who use illicit drugs, particularly methamphetamine. Diagnosis of another STI may signal that a person is having condomless sex, which increases their risk of syphilis infection. Higher infection rates in persons of some racial and ethnic groups have been reported and are primarily a reflection of a combination of factors, including social determinants of health (eg, disparities of income, low educational achievement, and unstable housing), differential health insurance coverage or access to quality health care, and differences in sexual network characteristics (eg, individuals living in communities with a high prevalence of STIs have an increased chance of encountering an infected partner). Local prevalence rates may change over time, so clinicians should be aware of the latest data and trends for their specific population and geographic area, which are available through their state and local health departments and Centers for Disease Control and Prevention (CDC) surveillance.\r\n&nbsp;\r\nAlthough direct evidence on screening in nonpregnant persons who are not at increased risk for syphilis infection is lacking, based on the established test performance characteristics of current screening tests and the low prevalence rate of syphilis in this population, the yield of screening is likely low.9,10 Therefore, screening in this population may result in high false-positive rates and overtreatment.'}, {'id': 431, 'title': 'Syphilis Infection in Pregnant Women: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends early screening for syphilis infection in all pregnant women.', 'servfreq': 'All pregnant women should be tested for syphilis as early as possible when they first present to care. If a woman has not received prenatal care prior to delivery, she should be tested at the time she presents for delivery. In most cases of congenital syphilis, pregnant women received prenatal care but were not screened and treated for syphilis early enough during the pregnancy to prevent transmission to the fetus.', 'risktext': ''}, {'id': 1905, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and US Food and Drug Administration (FDA)--approved pharmacotherapy for cessation to nonpregnant adults who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 1906, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all pregnant persons about tobacco use, advise them to stop using tobacco, and provide behavioral interventions for cessation to pregnant persons who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 2014, 'title': 'Anxiety Disorders in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for anxiety disorders in adults, including pregnant and postpartum persons.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding optimal timing for screening, or screening interval, for both the perinatal and general adult populations; more evidence on both timing and screening interval is needed for all adult populations. A pragmatic approach in the absence of evidence might include screening all adults who have not been screened previously and using clinical judgment in considering risk factors, comorbid conditions, and life events to determine if additional screening of high-risk patients is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nRisk factors for anxiety disorders include sociodemographic factors, psychosocial factors, and physical and mental health factors such as marital status (widowed or divorced), stressful life events, smoking and alcohol use, other mental health conditions, or a parental history of mental disorders. Demographic factors such as low socioeconomic status and female sex are associated with higher rates of anxiety disorders.&nbsp;Black persons and individuals of non-Hispanic ethnicity are at increased risk of anxiety disorders due to social, rather than biological, factors. Anxiety and depressive disorders often overlap. One cohort study found that 67% of individuals with a depressive disorder also had a current anxiety disorder, and 75% had a lifetime comorbid anxiety disorder.'}, {'id': 1938, 'title': 'Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication ', 'grade': 'B', 'text': 'The DoctorAI recommends the use of low-dose aspirin (81 mg/day) as preventive medication after 12 weeks of gestation in persons who are at high risk for preeclampsia.\r\rSee the Practice Considerations section for information on high risk and aspirin dose.', 'servfreq': 'Once daily after 12 weeks of gestation', 'risktext': ' \r\nPersons with a history of preeclampsia in a previous pregnancy, type 1 or type 2 diabetes, and chronic hypertension are at highest risk for preeclampsia. Additional conditions that place a person at high risk for preeclampsia include multifetal gestation, conception using assisted reproductive technology, autoimmune disease, and kidney disease. Other factors associated with increased preeclampsia risk include nulliparity, high prepregnancy body mass index, family history of preeclampsia, and advanced maternal age (35 years or older). In addition, Black persons have higher rates of preeclampsia and are at increased risk for serious complications due to various societal and health inequities.\r\n '}, {'id': 513, 'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for asymptomatic bacteriuria using urine culture in pregnant persons.', 'servfreq': 'In general, screening is performed once at the first prenatal visit per clinical guidelines. However, there is little evidence on the optimal timing and frequency of screening for asymptomatic bacteriuria in pregnancy.2&nbsp; .&nbsp;Screen pregnant persons for asymptomatic bacteriuria using a midstream, clean-catch urine culture at the first prenatal visit or at 12 to 16 weeks of gestation, whichever is earlier. A urine culture showing &gt;100,000 CFU/mL of a single uropathogen or &gt;10,000 CFU/mL if the pathogen is group B streptococcus indicates treatment.', 'risktext': 'This recommendation applies to adults 18 years and older and pregnant persons of any age without signs and symptoms of a urinary tract infection. It does not apply to persons who have chronic medical or urinary tract conditions, such as end-stage renal disease; have indwelling urinary catheters, urinary stents, or spinal cord injuries; are hospitalized; reside in an institution (eg, a nursing home); or who are transplant recipients.\r\n&nbsp;\r\nThe risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6&nbsp;Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5&nbsp;Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7,&nbsp;11,&nbsp;12&nbsp;In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12&nbsp;Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4,&nbsp;6'}, {'id': 2009, 'title': 'Latent Tuberculosis Infection in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for LTBI in populations at increased risk.\r\rSee the "Assessment of Risk" section for additional information on adults at increased risk.', 'servfreq': 'The USPSTF found no evidence on the optimal frequency of screening for LTBI. In the absence of evidence, a reasonable approach is to repeat screening based on specific risk factors; screening frequency could range from 1-time only screening among persons at low risk for future tuberculosis exposure to annual screening among those at continued risk of exposure.', 'risktext': 'Populations at increased risk for LTBI, based on increased prevalence of active disease and increased risk of exposure, include persons who were born in, or are former residents of, countries with high tuberculosis prevalence and persons who live in, or have lived in, high-risk congregate settings (eg, homeless shelters or correctional facilities). Clinicians can consult their local or state health departments for more information about populations at increased risk in their community, since local demographic patterns may vary across the US.\r\nIn 2020, 71.5% of all cases of active tuberculosis in the US occurred among persons born outside the US. According to the CDC, tuberculosis disease is common in most countries in Latin America, the Caribbean, Africa, Asia, Eastern Europe, and Russia. In 2020, among persons with new tuberculosis living in the US who were born outside the US, the most common countries of birth were Mexico (18.0%), the Philippines (12.5%), India (10.4%), Vietnam (8.2%), and China (5.1%), accounting for 54.2% of total cases. Most of these cases are believed to be due to progression of latent infection to active tuberculosis disease rather than new transmission within communities.\r\nPersons who live, or have lived, in high-risk congregate settings also have a higher prevalence rate of active tuberculosis and an increased risk for exposure. In 2020, 4.3% of tuberculosis disease cases diagnosed in persons 15 years or older occurred in persons experiencing homelessness and 2.6% occurred in residents of correctional facilities. It is estimated that persons experiencing homelessness have an 11 times higher incidence of tuberculosis disease compared with persons who are not experiencing homelessness (36 cases per 100,000 population vs 2.9 cases per 100,000 population, respectively, during 2011 to 2016).\r\nOther populations at increased risk for LTBI or progression to active disease include persons who have immunosuppression (eg, persons living with HIV, patients receiving immunosuppressive medications such as chemotherapy or tumor necrosis factor inhibitors, and patients who have received an organ transplant) and patients with silicosis (a lung disease). However, given that screening in these populations may be considered standard care as part of disease management or indicated prior to the use of certain medications, the USPSTF did not review evidence on screening in these populations. Information on testing in these populations is provided by other groups, such as the Office of AIDS Research at the National Institutes of Health, and in a guideline issued jointly by the American Thoracic Society, Infectious Diseases Society of America, and CDC. Some evidence from observational studies has explored the association between poorly controlled diabetes and progression of LTBI to active disease. However, there is insufficient evidence on screening for and treatment of LTBI in persons with diabetes for the USPSTF to make a separate recommendation for this important population.\r\nPersons who are contacts of individuals with active tuberculosis, health care workers, and workers in high-risk congregate settings may also be at increased risk of exposure. Because screening in these populations is conducted as part of public health or employee health surveillance, the USPSTF did not review the evidence in these populations. Clinicians seeking further information about testing for tuberculosis in these populations can refer to the Additional Tools and Resources and Recommendations of Others sections.'}, {'id': 514, 'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic bacteriuria in nonpregnant adults.', 'servfreq': '', 'risktext': 'The risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6 Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5 Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7, 11, 12 In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12 Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4, 6'}, {'id': 507, 'title': 'BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing ', 'grade': 'B', 'text': 'The DoctorAI recommends that primary care clinicians assess women with a personal or family history of breast, ovarian, tubal, or peritoneal cancer or who have an ancestry associated with breast cancer susceptibility 1 and 2 (BRCA1/2) gene mutations with an appropriate brief familial risk assessment tool. Women with a positive result on the risk assessment tool should receive genetic counseling and, if indicated after counseling, genetic testing.', 'servfreq': 'Consideration of screening for potentially harmful BRCA mutations should begin once women have reached the age of consent (18 years). Primary care providers should periodically assess all patients for changes in family history (for example, comprehensive review at least every 5 to 10 years)', 'risktext': 'Patients with family or personal histories of breast, ovarian, tubal, or peritoneal cancer or ancestry associated with harmful&nbsp;&lt; i&gt;BRCA1/2&nbsp;mutations should be assessed using a familial risk assessment tool. The USPSTF found adequate evidence that these tools are accurate in identifying women with increased likelihood of&nbsp;&lt; i&gt;BRCA1/2mutations. Tools evaluated by the USPSTF include the Ontario Family History Assessment Tool, Manchester Scoring System, Referral Screening Tool, Pedigree Assessment Tool, 7-Question Family History Screening Tool, International Breast Cancer Intervention Study instrument (Tyrer-Cuzick), and brief versions of BRCAPRO. These tools should be used to guide referrals to genetic counseling.&nbsp;Persons should consider their sex at birth to determine which recommendation best applies to them.'}, {'id': 339, 'title': 'Breastfeeding: Primary Care Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends providing interventions during pregnancy and after birth to support breastfeeding.', 'servfreq': 'During pregnancy and after birth', 'risktext': "This recommendation applies to pregnant women, new mothers, and their infants and children. Interventions to support breastfeeding may also involve a woman's partner, other family members, and friends. This recommendation does not apply in circumstances where there are contraindications to breastfeeding (e.g., certain maternal medical conditions or infant metabolic disorders, such as galactosemia). The USPSTF did not review evidence on interventions directed at breastfeeding of preterm infants."}, {'id': 1935, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for chlamydia in all sexually active women 24 years or younger and in women 25 years or older who are at increased risk for infection.', 'servfreq': ' \r\nIn the absence of studies on screening intervals, a reasonable approach would be to screen patients whose sexual history reveals new or persistent risk factors since the last negative test result.\r\n ', 'risktext': ' \r\nAge is a strong predictor of risk for chlamydial and gonococcal infections, with the highest infection rates in women occurring during ages 15 to 24 years. Women 25 years or older are at increased risk if they have a new sex partner, more than 1 sex partner, a sex partner with concurrent partners, or a sex partner who has an STI; practice inconsistent condom use when not in a mutually monogamous relationship; or have a previous or coexisting STI. Exchanging sex for money or drugs and history of incarceration also are associated with increased risk.&nbsp;Clinicians should consider the communities they serve and may want to consult local public health authorities for information about local epidemiology and guidance on determining who is at increased risk.\r\n '}, {'id': 1936, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for gonorrhea in all sexually active women 24 years or younger and in women 25 years or older who are at increased risk for infection.', 'servfreq': ' \r\nIn the absence of studies on screening intervals, a reasonable approach would be to screen patients whose sexual history reveals new or persistent risk factors since the last negative test result.\r\n ', 'risktext': ' \r\nAge is a strong predictor of risk for chlamydial and gonococcal infections, with the highest infection rates in women occurring during ages 15 to 24 years. Women 25 years or older are at increased risk if they have a new sex partner, more than 1 sex partner, a sex partner with concurrent partners, or a sex partner who has an STI; practice inconsistent condom use when not in a mutually monogamous relationship; or have a previous or coexisting STI. Exchanging sex for money or drugs and history of incarceration also are associated with increased risk.&nbsp;Clinicians should consider the communities they serve and may want to consult local public health authorities for information about local epidemiology and guidance on determining who is at increased risk.\r\n '}, {'id': 1909, 'title': 'Asymptomatic Carotid Artery Stenosis: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic carotid artery stenosis in the general adult population.\r\rSee the Practice Considerations section for a description of adults at increased risk.', 'servfreq': '', 'risktext': ''}, {'id': 2017, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for suicide risk in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': '', 'risktext': ''}, {'id': 2016, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for depression in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding the optimal timing for screening for depression; more evidence is needed in both perinatal and general adult populations. In the absence of evidence, a pragmatic approach might include screening adults who have not been screened previously and using clinical judgment while considering risk factors, comorbid conditions, and life events to determine if additional screening of patients at increased risk is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nThe USPSTF recommends screening for depression in all adults regardless of risk factors. Risk factors for depression include a combination of genetic, biological, and environmental factors, such as a family history of depression, prior episode of depression or other mental health condition, a history of trauma or adverse life events, or a history of disease or illness (eg, cardiovascular disease).\r\nPrevalence rates vary by sex, age, race, ethnicity, education, marital status, geographic location, poverty level, and employment status. Women have twice the risk of depression compared with men. Young adults, multiracial individuals, and Native American/Alaska Native individuals have higher rates of depression.\r\nRisk factors for perinatal depression include life stress, low social support, history of depression, marital or partner dissatisfaction, and a history of abuse.'}, {'id': 1932, 'title': 'Gestational Diabetes: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for gestational diabetes in asymptomatic pregnant persons at 24 weeks of gestation or after.', 'servfreq': 'At 24 weeks of gestation or after to improve maternal and fetal outcomes', 'risktext': ' \r\nSeveral factors increase a person&rsquo;s risk for developing gestational diabetes, including obesity, increased maternal age, history of gestational diabetes, family history of diabetes, and belonging to a racial/ethnic group that is at increased risk for developing type 2 diabetes (Hispanic, Native American, South or East Asian, or Pacific Islander descent).4,19,20 Factors associated with a lower risk for developing gestational diabetes include age younger than 25 to 30 years, White race, a body mass index (BMI) of 25 or less (calculated as weight in kilograms divided by height in meters squared), no family history (in a first-degree relative) of diabetes, and no history of glucose intolerance or adverse pregnancy outcomes related to gestational diabetes.21-23 The risk in different racial/ethnic groups may be due in part to social risk factors such as low socioeconomic status or structural racism, although these associations are not examined in the current evidence. Although a higher BMI increases the risk of gestational diabetes across racial/ethnic groups, the association varies. In Asian American persons, the prevalence of gestational diabetes at a BMI of 22 to less than 25 is similar to the prevalence in Hispanic persons, non-Hispanic White persons, and Black persons with a higher (&gt;28) BMI.24,25\r\n '}, {'id': 1845, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends offering or referring adults with cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity.', 'servfreq': '', 'risktext': 'Adults 18 years or older at increased risk of CVD, defined as those with 1 or more of the following:\r\n1.Hypertension or elevated blood pressure2.Dyslipidemia3.Mixed or multiple risk factors such as the metabolic syndrome or an estimated 10-year CVD risk of &ge;7.5%\r\nThis recommendation does not apply to adults with other known modifiable cardiovascular risk factors such as abnormal blood glucose levels, obesity, and smoking; these populations are incorporated in other USPSTF recommendations.'}, {'id': 1931, 'title': 'Healthy Weight and Weight Gain In Pregnancy: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer pregnant persons effective behavioral counseling interventions aimed at promoting healthy weight gain and preventing excess gestational weight gain in pregnancy.', 'servfreq': 'Throughout pregnancy', 'risktext': 'Pregnancy'}, {'id': 1885, 'title': 'Hepatitis B Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in adolescents and adults at increased risk for infection.\r\rSee the Practice Considerations section for a description of adolescents and adults at increased risk for infection.', 'servfreq': 'For patients with negative HBsAg results who have not received the HBV vaccine series, periodic screening may be useful for those who report continued risk for acquiring HBV transmission, such as persons who continue to inject drugs and men who have sex with men. Clinical judgment should be used to determine screening frequency. The USPSTF found no evidence to determine optimal screening intervals.', 'risktext': 'Persons from such risk groups include persons who have injected drugs in the past or currently; men who have sex with men; persons with HIV; and sex partners, needle-sharing contacts, and household contacts of persons known to be HBsAg positive. Some persons with combinations of risk factors who are not members of risk factor groups listed above may also be at increased risk for HBV infection.'}, {'id': 524, 'title': 'Hepatitis C Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis C virus (HCV) infection in adults aged 18 to 79 years.', 'servfreq': 'One-time screening for most adults.\r\nPeriodically screen persons with continued risk for HCV infection (eg, persons with past or current injection drug use). There is limited evidence to determine how often to screen persons at increased risk.&nbsp;', 'risktext': 'Asymptomatic adults aged 18 to 79 years (including pregnant persons) without known liver disease.&nbsp;\r\nThe USPSTF also suggests that clinicians consider screening persons younger than 18 years and older than 79 years who are at high risk for infection (eg, those with past or current injection drug use).&nbsp;'}, {'id': 2023, 'title': 'Hypertensive Disorders of Pregnancy: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hypertensive disorders in pregnant persons with blood pressure measurements throughout pregnancy.', 'servfreq': 'Screening Interval\r\nBlood pressure measurements should be obtained during each prenatal care visit throughout pregnancy. Hypertensive disorders of pregnancy can quickly evolve into severe disease that can result in serious, even fatal, maternal and infant health outcomes. The ability to screen for hypertensive disorders of pregnancy using blood pressure measurements is important to identify and effectively treat a potentially unpredictable and fatal condition. While it is known that risk continues into the immediate postpartum period, there is little evidence regarding screening during this period. A pragmatic approach would be for patients to be counseled regarding signs and symptoms of preeclampsia at hospital discharge and for patients with hypertensive disorders to have subsequent blood pressure checks.\r\nScreening for hypertensive disorders of pregnancy alone is not sufficient to improve inequities in health outcomes. Identifying hypertensive disorders of pregnancy requires adequate prenatal visits, surveillance, and evidence-based care in response to evolving patient signs and symptoms during pregnancy and the postpartum period to improve health outcomes. Black and Native American/Alaska Native persons have lower rates of prenatal visits and are at greater risk of serious postpartum morbidity and hospital readmission after delivery. Screening and monitoring of Black and Hispanic/Latina individuals during the postpartum period could be an important step for reducing health inequities by preventing serious adverse events. In addition, screening and monitoring by various health care providers (eg, nurse midwives, nurses, pediatricians, doulas, and lactation consultants) could also help avert serious complications in the postpartum period.', 'risktext': 'Assessment of Risk\r\nImportant clinical conditions associated with increased risk for preeclampsia include a history of eclampsia or preeclampsia in a prior pregnancy, a previous adverse pregnancy outcome, and maternal comorbid conditions (including type 1 or type 2 diabetes prior to pregnancy, gestational diabetes, chronic hypertension, kidney disease, and autoimmune diseases).\r\n&nbsp;Other factors associated with increased risk of preeclampsia and gestational hypertension include nulliparity, high prepregnancy body mass index, family history of preeclampsia, multifetal gestation, and the pregnant individual being 35 years or older.\r\nThe higher prevalence of hypertensive disorders of pregnancy and the increased risk for severe complications seen in Black persons may be due to their disproportionate burden of social and clinical risk factors. These social and clinical determinants largely result from historical and current manifestations of structural racism that influence environmental exposures, access to health resources, and overall health status.'}, {'id': 434, 'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians screen for intimate partner violence (IPV) in women of reproductive age and provide or refer women who screen positive to ongoing support services. See the Clinical Considerations section for more information on effective ongoing support services for IPV and for information on IPV in men.', 'servfreq': 'The USPSTF found no evidence on appropriate intervals for screening. Randomized clinical trials (RCTs) of screening and interventions for IPV often screen for current IPV or IPV in the past year.\r\n&nbsp;', 'risktext': 'All women of reproductive age are at potential risk for IPV and should be screened. There are a variety of factors that increase risk of IPV, such as exposure to violence as a child, young age, unemployment, substance abuse, marital difficulties, and economic hardships.\r\nRisk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health. For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.'}, {'id': 187, 'title': 'Rh(D) Incompatibility: Screening ', 'grade': 'B', 'text': "The DoctorAI recommends repeated Rh(D) antibody testing for all unsensitized Rh(D)-negative women at 24 to 28 weeks' gestation, unless the biological father is known to be Rh(D)-negative.", 'servfreq': 'Repeat testing at 24-28 weeks gestation.', 'risktext': ''}, {'id': 1916, 'title': 'Lung Cancer: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery.', 'servfreq': ' \r\nThe USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. ', 'risktext': ' \r\nSmoking and older age are the 2 most important risk factors for lung cancer.&nbsp;The risk of lung cancer in persons who smoke increases with cumulative quantity and duration of smoking and with age but decreases with increasing time since quitting for persons who formerly smoked.3 The USPSTF considers adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years to be at high risk and recommends screening for lung cancer with annual LDCT in this population. \r\n \r\n&nbsp;\r\n \r\nAfrican American/Black (Black) men have a higher incidence of lung cancer than White men, and Black women have a lower incidence than White women.1 These differences are likely related to differences in smoking exposure (ie, prevalence of smoking) and related exposure to carcinogens in cigarettes.7,8 The differences may also be related to other social risk factors.\r\n \r\n&nbsp;\r\n \r\nOther risk factors for lung cancer include environmental exposures, prior radiation therapy, other (noncancer) lung diseases, and family history. Lower level of education is also associated with a higher risk of lung cancer.7 The task force recommends using age and smoking history to determine screening eligibility rather than more elaborate risk prediction models because there is insufficient evidence to assess whether risk prediction model&ndash;based screening would improve outcomes relative to using the risk factors of age and smoking history for broad implementation in primary care.\r\n '}, {'id': 449, 'title': 'Perinatal Depression: Preventive Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians provide or refer pregnant and postpartum persons who are at increased risk of perinatal depression to counseling interventions.', 'servfreq': '', 'risktext': 'Include&nbsp;a past history of depression. Current depressive symptoms (that do not reach a diagnostic threshold),&nbsp;history of physical or sexual abuse,&nbsp;unplanned or unwanted pregnancy,&nbsp;stressful life events,&nbsp;lack of social and financial support,&nbsp;intimate partner violence,pregestational or gestational diabetes,and complications during pregnancy. Additional risk factors include adolescent parenthood, low socioeconomic status, and lack of social support.&nbsp;Genetic factors are also suspected to contribute to women&rsquo;s risk of developing perinatal depression.'}, {'id': 1445, 'title': 'Sexually Transmitted Infections: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends behavioral counseling for all sexually active adolescents and for adults who are at increased risk for sexually transmitted infections (STIs).\r\rSee the Practice Considerations section for more information on populations at increased risk for acquiring STIs.', 'servfreq': '', 'risktext': 'All sexually active adolescents are at increased risk for STIs because of the high rates of STIs in this age group and should receive behavioral counseling interventions. Adults at increased risk for STIs include those who currently have an STI or were diagnosed with one within the past year, do not consistently use condoms, have multiple sex partners, or have sex partners within populations with a high prevalence of STIs. Populations with a high prevalence of STIs include persons who seek STI testing or attend STI clinics; sexual and gender minorities; persons who are living with HIV, inject drugs, have exchanged sex for money or drugs, or have entered correctional facilities; and some racial/ethnic minority groups.1-4'}, {'id': 402, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends counseling young adults, adolescents, children, and parents of young children about minimizing exposure to ultraviolet (UV) radiation for persons aged 6 months to 24 years with fair skin types to reduce their risk of skin cancer.', 'servfreq': '', 'risktext': 'Fair skin types'}, {'id': 438, 'title': 'Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for unhealthy alcohol use in primary care settings in adults 18 years or older, including pregnant women, and providing persons engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce unhealthy alcohol use.', 'servfreq': 'The USPSTF did not find adequate evidence to recommend an optimal screening interval for unhealthy alcohol use in adults.&nbsp;Brief behavioral counseling interventions were found to reduce unhealthy alcohol use in adults 18 years or older, including pregnant women. Effective behavioral counseling interventions vary in their specific components, administration, length, and number of interactions. The USPSTF was unable to identify specific intervention characteristics or components that were clearly associated with improved outcomes.', 'risktext': 'engaged in risky or hazardous drinking'}, {'id': 767, 'title': 'Unhealthy Drug Use: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening by asking questions about unhealthy drug use in adults age 18 years or older. Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. \r(Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'servfreq': 'Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. (Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'risktext': 'These include being aged 18 to 25 years; male sex; having a mental health condition, personality or mood disorder, or nicotine or alcohol dependence; a history of physical or sexual abuse, parental neglect, or other adversity in childhood; or drug or alcohol addiction in a first-degree relative.1,9&nbsp;Factors associated with misuse of prescription drugs include history of other drug use, mental illness, pain, and greater access to prescription drugs.10&nbsp;Factors associated with prenatal use of drugs include a mental health disorder, interpersonal violence, and family history of substance use.11'}, {'id': 433, 'title': 'Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer or refer adults with a body mass index (BMI) of 30 or higher (calculated as weight in kilograms divided by height in meters squared) to intensive, multicomponent behavioral interventions.', 'servfreq': '', 'risktext': 'Adults with a BMI &ge;30'}, {'id': 1979, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: Behavioral Counseling Interventions ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians individualize the decision to offer or refer adults without cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity. \r\rSee the "Practice Considerations" section for information on determining which patients may benefit most from this service.', 'servfreq': '', 'risktext': ''}, {'id': 1937, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for chlamydia and gonorrhea in men.', 'servfreq': '', 'risktext': ''}, {'id': 508, 'title': 'BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine risk assessment, genetic counseling, or genetic testing for women whose personal or family history or ancestry is not associated with potentially harmful BRCA1/2 gene mutations.', 'servfreq': '', 'risktext': 'Patients with family or personal histories of breast, ovarian, tubal, or peritoneal cancer or ancestry associated with harmful&nbsp;BRCA1/2&nbsp;mutations should be assessed using a familial risk assessment tool. The USPSTF found adequate evidence that these tools are accurate in identifying women with increased likelihood of&nbsp;BRCA1/2mutations. Tools evaluated by the USPSTF include the Ontario Family History Assessment Tool, Manchester Scoring System, Referral Screening Tool, Pedigree Assessment Tool, 7-Question Family History Screening Tool, International Breast Cancer Intervention Study instrument (Tyrer-Cuzick), and brief versions of BRCAPRO. These tools should be used to guide referrals to genetic counseling.'}, {'id': 525, 'title': 'Bacterial Vaginosis in Pregnant Persons to Prevent Preterm Delivery: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for bacterial vaginosis (BV) in pregnant persons who are not at increased risk for preterm delivery.', 'servfreq': '', 'risktext': '\r\nAssess risk for preterm delivery. There are multiple factors that increase risk for preterm delivery; one of the strongest risk factors is prior preterm delivery.\r\nDecide whether or not to screen for bacterial vaginosis:\r\n\r\na. Do not screen pregnant persons who are not at increased risk for preterm delivery.\r\nb. Evidence is insufficient to recommend for or against screening pregnant persons at increased risk for preterm delivery.'}, {'id': 418, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening with resting or exercise electrocardiography (ECG) to prevent cardiovascular disease (CVD) events in asymptomatic adults at low risk of CVD events.', 'servfreq': '', 'risktext': ''}, {'id': 429, 'title': 'Cervical Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for cervical cancer in women who have had a hysterectomy with removal of the cervix and do not have a history of a high-grade precancerous lesion (ie, cervical intraepithelial neoplasia [CIN] grade 2 or 3) or cervical cancer.', 'servfreq': '', 'risktext': ''}, {'id': 428, 'title': 'Cervical Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for cervical cancer in women younger than 21 years.', 'servfreq': '', 'risktext': ''}, {'id': 1973, 'title': 'Chronic Obstructive Pulmonary Disease: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for chronic obstructive pulmonary disease in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 2003, 'title': 'Genital Herpes Infection: Serologic Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine serologic screening for genital herpes simplex virus infection in asymptomatic adolescents and adults, including pregnant persons.', 'servfreq': '', 'risktext': 'The USPSTF found no evidence of externally validated, reliable risk stratification tools to identify individuals more or less likely to have genital herpes.'}, {'id': 504, 'title': 'Pancreatic Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for pancreatic cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 365, 'title': 'Thyroid Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for thyroid cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 1976, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'D', 'text': 'The DoctorAI recommends against the use of beta carotene or vitamin E supplements for the prevention of cardiovascular disease or cancer.', 'servfreq': '', 'risktext': ''}, {'id': 318, 'title': 'Autism Spectrum Disorder in Young Children: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for autism spectrum disorder (ASD) in young children for whom no concerns of ASD have been raised by their parents or a clinician.', 'servfreq': '', 'risktext': 'Although a number of potential risk factors for ASD have been identified, there is insufficient evidence to determine if certain risk factors modify the performance characteristics of ASD screening tests, such as the age at which screening is performed or other characteristics of the child or family.'}, {'id': 526, 'title': 'Bacterial Vaginosis in Pregnant Persons to Prevent Preterm Delivery: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for BV in pregnant persons who are at increased risk for preterm delivery.', 'servfreq': '', 'risktext': ''}, {'id': 65, 'title': 'Bladder Cancer in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults.\r\rLiterature scans conducted in July 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'This evidence update focused on the benefits and harms of screening for bladder cancer among people without symptoms, the accuracy of screening tests done in primary care settings, and the benefits and harms of treatment. The updated evidence review did not find any new high quality evidence to adequately determine the balance of benefits and harms of screening for bladder cancer. However, bladder cancer is a common cancer and can cause considerable health problems including death. Therefore, the USPSTF determined that the evidence was insufficient to provide a recommendation for or against bladder cancer screening.  The USPSTF emphasizes the need for additional research in this area. '}, {'id': 2037, 'title': 'Breast Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of supplemental screening for breast cancer using breast ultrasonography or magnetic resonance imaging (MRI) in women identified to have dense breasts on an otherwise negative screening mammogram.\r\rSee the "Practice Considerations" section for more information on the patient population to whom this recommendation applies and on screening mammography modalities.', 'servfreq': '', 'risktext': 'These recommendations apply to cisgender women and all other persons assigned female at birth (including transgender men and nonbinary persons) 40 years or older at average risk of breast cancer. \r\nThese recommendations apply to persons who have factors associated with an increased risk of breast cancer, such as a family history of breast cancer (ie, a first-degree relative with breast cancer) or having dense breasts. They do not apply to persons who have a genetic marker or syndrome associated with a high risk of breast cancer (eg, BRCA1 or BRCA2 genetic variation), a history of high-dose radiation therapy to the chest at a young age, or previous breast cancer or a high-risk breast lesion on previous biopsies. '}, {'id': 419, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening with resting or exercise ECG to prevent CVD events in asymptomatic adults at intermediate or high risk of CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 423, 'title': 'Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of adding the ankle-brachial index (ABI), high-sensitivity C-reactive protein (hsCRP) level, or coronary artery calcium (CAC) score to traditional risk assessment for cardiovascular disease (CVD) in asymptomatic adults to prevent CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 352, 'title': 'Celiac Disease: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'persons with family history or other risk factors'}, {'id': 1955, 'title': 'Eating Disorders in Adolescents and Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for eating disorders in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1933, 'title': 'Gestational Diabetes: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for gestational diabetes in asymptomatic pregnant persons before 24 weeks of gestation.', 'servfreq': '', 'risktext': ''}, {'id': 665, 'title': 'Illicit Drug Use in Children, Adolescents, and Young Adults: Primary Care-Based Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--based behavioral counseling interventions to prevent illicit drug use, including nonmedical use of prescription drugs, in children, adolescents, and young adults.\r\rSee the Practice Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 435, 'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for abuse and neglect in all older or vulnerable adults. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': 'Risk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health.14&nbsp;For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.15'}, {'id': 2045, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for iron deficiency and iron deficiency anemia in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2046, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine iron supplementation in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2018, 'title': 'Lipid Disorders in Children and Adolescents: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1998, 'title': 'Obstructive Sleep Apnea in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for obstructive sleep apnea in the general adult population.\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Risk Factors\r\nRisk factors associated with OSA include male sex, older age (40-70 years), postmenopausal status, higher body mass index (BMI), and craniofacial and upper airway abnormalities (eg, enlarged tonsils or long upper airway). Black, Hispanic/Latino, and Native American/Alaska Native persons have a higher prevalence of OSA compared with White persons; some evidence suggests that these differences are partially explained by higher rates of obesity, asthma, and tobacco use among these groups.8'}, {'id': 1977, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of multivitamin supplements for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1978, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of single or paired nutrient supplements (other than beta carotene and vitamin E) for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 176, 'title': 'Oral Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for oral cancer in asymptomatic adults.\r\rGo to the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in July 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Tobacco and alcohol use are major risk factors for oral cancer. A total of 20% to 30% of cases of oral cancer worldwide are attributable to cigarette smoking. In the United States, up to 75% of cases of oral cancer may be attributable to tobacco and alcohol use. Additional risk factors include male sex, older age, use of betel quid, ultraviolet light exposure, infection with Candida or bacterial flora, and a compromised immune system. Sexually transmitted oral HPV infection (HPV-16) has recently been recognized as an increasingly important risk factor for oropharyngeal cancer. In the United States, the prevalence of oropharyngeal cancer due to oral HPV infection is probably as high as 80% to 95%. The prevalence of oral HPV infection is associated with age, sex, number of sexual partners, and number of cigarettes smoked per day. The effect of multifactorial risk assessment and screening for risk factors on oral cancer morbidity and mortality is unknown.'}, {'id': 2026, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine screening performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 2027, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of preventive interventions performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 424, 'title': 'Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for peripheral artery disease (PAD) and cardiovascular disease (CVD) risk with the ankle-brachial index (ABI) in asymptomatic adults.\r\rLiterature scans conducted in August 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Risk factors associated with OSA include male sex, older age (40 to 70 years), postmenopausal status, higher BMI, and craniofacial and upper airway abnormalities.'}, {'id': 404, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of counseling adults about skin self-examination to prevent skin cancer.See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 2005, 'title': 'Skin Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Exposure to UV radiation from sun exposure, indoor tanning beds, and other UV radiation&ndash;emitting devices is the major environmental risk factor for skin cancer. History of frequent sunburns, older age, and male sex are associated with increased risk for skin cancer. Exposure to UV radiation from the use of indoor tanning beds is an important risk factor in adolescents. Incidence of melanoma is higher among White persons compared with persons of other races and ethnicities. This difference likely reflects traits associated with increased melanoma risk, such as fair skin (which is more susceptible to sunburning), light-colored eyes, and red or blond hair being more common among White persons compared with persons of other races and ethnicities. Acral lentiginous melanoma, which occurs mostly on skin not frequently exposed to direct sunlight (eg, palms of hands, soles of feet, or under fingernails or toenails), is the most common type of melanoma among Black populations. Other melanoma risk factors include higher numbers of moles on the skin, atypical moles, as well as a personal and family history of skin cancer.'}, {'id': 269, 'title': 'Thyroid Dysfunction: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults.\r\rSee the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': 'The optimal screening interval for thyroid dysfunction (if one exists) is unknown.', 'risktext': 'The most common cause of hypothyroidism in the United States is chronic autoimmune (Hashimoto) thyroiditis. Risk factors for an elevated TSH level include female sex, advancing age, white race, type 1 diabetes, Down syndrome, family history of thyroid disease, goiter, previous hyperthyroidism (possibly due in part to ablation therapy leading to iatrogenic thyroid dysfunction), and external-beam radiation in the head and neck area. Common causes of hyperthyroidism include Graves disease, Hashimoto thyroiditis, and functional thyroid nodules. Risk factors for a low TSH level include female sex; advancing age; black race; low iodine intake; personal or family history of thyroid disease; and ingestion of iodine-containing drugs, such as amiodarone. The USPSTF found no direct evidence that treatment of thyroid dysfunction based on risk level alters final health outcomes.'}, {'id': 1908, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of electronic cigarettes (e-cigarettes) for tobacco cessation in adults, including pregnant persons. The USPSTF recommends that clinicians direct patients who use tobacco to other tobacco cessation interventions with proven effectiveness and established safety.\rSee the Practice Considerations section for more information on recommended behavioral interventions and pharmacotherapy and for suggestions for practice regarding the I statements.', 'servfreq': '', 'risktext': ''}, {'id': 1907, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of pharmacotherapy interventions for tobacco cessation in pregnant persons.', 'servfreq': '', 'risktext': ''}, {'id': 586, 'title': 'Tobacco Use in Children and Adolescents: Primary Care Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--feasible interventions for the cessation of tobacco use among school-aged children and adolescents.\r\rSee the Practice Considerations section for more information on effective interventions to prevent initiation of tobacco use and for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1919, 'title': 'Vitamin D Deficiency in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 408, 'title': 'Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of the benefits and harms of vitamin D and calcium supplementation, alone or combined, for the primary prevention of fractures in men and premenopausal women.', 'servfreq': '', 'risktext': ''}]}
2025-01-29 22:00:48 [INFO] Recommendations fetched: [{'id': 2020, 'title': 'Folic Acid Supplementation to Prevent Neural Tube Defects: Preventive Medication ', 'grade': 'A', 'text': 'The DoctorAI recommends that all persons planning to or who could become pregnant take a daily supplement containing 0.4 to 0.8 mg (400 to 800 mcg) of folic acid.', 'servfreq': 'The neural plate completes its formation and closure early in pregnancy (usually 26 to 28 days after fertilization). This means the critical period for folic acid supplementation starts at least 1 month before conception and continues through the first 2 to 3 months of pregnancy. Nearly half of all pregnancies in the US are unplanned; to gain the full benefits of supplementation, clinicians should advise all persons who plan to or who could become pregnant to take daily folic acid.', 'risktext': 'All pregnancies are at risk for neural tube defects, and persons who are planning to or could become pregnant should take folic acid supplements. Certain risk factors convey a higher risk, and individuals with these risk factors should talk to their health care professional. These factors include personal, partner, or family history of neural tube defects, malabsorption caused by bariatric procedures, the use of certain antiseizure medicines, and genetic mutations in folate-related enzymes. Pregestational diabetes and obesity have been associated with an increased risk of neural tube defects. Ethnic groups such as First Nation persons in Canada and Hispanic persons in California are thought to be at higher risk of neural tube defects. It is unclear, however, whether this is related to a higher risk of genetic variations among these groups or due to differential intake of folic acid&ndash;fortified foods.'}, {'id': 503, 'title': 'Hepatitis B Virus Infection in Pregnant Women: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in pregnant women at their first prenatal visit', 'servfreq': 'A test for HBsAg should be ordered at the first prenatal visit. Women with unknown HBsAg status or with new or continuing risk factors for HBV infection (eg, injection drug use or a sexually transmitted infection) should be screened at the time of admission to a hospital or other delivery setting.', 'risktext': 'In the United States, new cases of HBV among adults are largely transmitted through injection drug use or sexual intercourse, but most prevalent cases of HBV infection are chronic infections from exposure occurring in infancy or childhood. Another major risk factor for HBV infection is country of origin. In the United States, adults with HBV born in high-prevalence countries were commonly infected during childhood. In children, the primary source of infection is perinatal transmission at birth.'}, {'id': 485, 'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in adolescents and adults aged 15 to 65 years. Younger adolescents and older adults who are at increased risk of infection should also be screened.\rSee the Clinical Considerations section for more information about assessment of risk, screening intervals, and rescreening in pregnancy.', 'servfreq': 'The USPSTF found insufficient evidence to determine appropriate or optimal time intervals or strategies for repeat HIV screening. However, repeat screening is reasonable for persons known to be at increased risk of HIV infection, such as sexually active men who have sex with men; persons with a sex partner who is living with HIV; or persons who engage in behaviors that may convey an increased risk of HIV infection, such as injection drug use, transactional sex or commercial sex work, having 1 or more new sex partners whose HIV status is unknown, or having other factors that can place a person at increased risk of HIV infection (see &ldquo;Risk Assessment&rdquo;). Repeat screening is also reasonable for persons who live or receive medical care in a high-prevalence setting, such as a sexually transmitted disease clinic, tuberculosis clinic, correctional facility, or homeless shelter.', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'id': 486, 'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in all pregnant persons, including those who present in labor or at delivery whose HIV status is unknown.', 'servfreq': 'The CDC and ACOG recommend repeat prenatal screening for HIV during the third trimester of pregnancy in women with risk factors for HIV acquisition and in women living or receiving care in high-incidence settings, and the CDC notes that repeat screening for HIV during the third trimester may be considered in all women.&nbsp;', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'id': 1921, 'title': 'Hypertension in Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hypertension in adults 18 years or older with office blood pressure measurement (OBPM). The USPSTF recommends obtaining blood pressure measurements outside of the clinical setting for diagnostic confirmation before starting treatment.', 'servfreq': ' \r\nAlthough evidence on optimal screening intervals is limited, reasonable options include:\r\n \r\n \r\n\r\n\r\nScreening for hypertension every year in adults 40 years or older and in adults at increased risk for hypertension (such as Black persons, persons with high-normal blood pressure, or persons who are overweight or obese)\r\n\r\n\r\n \r\n \r\n\r\n\r\nScreening less frequently (ie, every 3 to 5 years) as appropriate for adults aged 18 to 39 years not at increased risk for hypertension and with a prior normal blood pressure reading.\r\n\r\n\r\n ', 'risktext': ' \r\nAlthough all adults should be screened for hypertension, risk factors that increase a person&rsquo;s risk for the condition include older age, Black race, family history, excess weight and obesity, lifestyle habits (lack of physical activity, stress, and tobacco use), and dietary factors (diet high in fat or sodium, diet low in potassium, or excessive alcohol intake)\r\n '}, {'id': 2021, 'title': 'Prevention of Acquisition of HIV: Preexposure Prophylaxis ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians prescribe preexposure prophylaxis using effective antiretroviral therapy to persons who are at increased risk of HIV acquisition to decrease the risk of acquiring HIV. \r\rSee the Practice Considerations section for more information about identification of persons at increased risk and about effective antiretroviral therapy.', 'servfreq': '', 'risktext': 'HIV is primarily acquired via sexual activity or injection drug use. It is important that clinicians routinely take a sexual and injection drug use history for all their patients in an open and nonjudgmental manner. All adolescents and adults who are sexually active or who inject drugs should be informed that acquisition of HIV can be prevented, to facilitate subsequent risk assessment and discussions about preexposure prophylaxis (PrEP) and other ways to prevent acquisition of HIV. Importantly, risk of HIV acquisition exists on a continuum, and currently available risk assessment tools all have limitations. However, certain risk factors or behaviors are known to place persons at increased risk of HIV.\r\nRisk of HIV acquisition depends on the likelihood that a specific act or activity will transmit HIV and the likelihood that a sex partner or drug injection partner has HIV. Likelihood of HIV transmission is highest with needle-sharing injection drug use and condomless receptive anal intercourse. Condomless receptive anal intercourse has an approximately 10- to 15-fold higher risk of transmission than condomless insertive anal sex and condomless receptive and insertive penile-vaginal sex. A 2018 study estimated the prevalence of HIV (ie, an estimate of the likelihood that a partner whose HIV status is unknown has HIV at a population level) as 12.4% among men who have sex with men and 1.9% among persons who inject drugs. The overall prevalence of HIV in the US is estimated at 0.3%.&nbsp;Of note, both the frequency of specific sexual activities and a person&rsquo;s number of sexual partners will also affect their risk of HIV.\r\n&nbsp;The USPSTF recommends that the following persons be considered for PrEP:\r\n1.&nbsp;&nbsp;&nbsp;&nbsp; Sexually active adults and adolescents weighing at least 35 kg (77 lb) who have engaged in anal or vaginal sex in the past 6 months and have any of the following:\r\n&nbsp;\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A sexual partner who has HIV (especially if the partner has an unknown or detectable viral load).\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A bacterial sexually transmitted infection (STI) (syphilis, gonorrhea, or chlamydia for men who have sex with men and transgender women; gonorrhea and syphilis for heterosexual women and men) in the past 6 months.\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A history of inconsistent or no condom use with sex partner(s) whose HIV status is not known; assessing risk in conversation with the patient and considering factors such as number of partners, the specific sexual activities a person engages in, and whether their sex partner or partners are in a group with a higher prevalence of HIV (eg, men who have sex with men or with men and women, transgender women, persons who inject drugs, and persons who engage in transactional sex).\r\n&nbsp;\r\n2. &nbsp; Persons who inject drugs and have a drug-injecting partner who has HIV or who shares injection equipment.\r\nPersons who engage in transactional sex, such as sex for money, drugs, or housing, including commercial sex workers or persons trafficked for sex work, constitute a group at increased risk of HIV acquisition and should be considered for PrEP based on the criteria outlined above. Persons who request PrEP may have undisclosed behaviors that put them at risk. Transgender women and men who are sexually active should be considered for PrEP based on the criteria outlined above. Transgender women are at especially high risk of HIV acquisition. A Centers for Disease Control and and Prevention (CDC) survey in 7 cities found an HIV prevalence of 42% among transgender women. Prevalence was highest among Black transgender women (62%) and Native American/Alaska Native transgender women (65%).\r\nIn addition, studies have found that transmission of HIV to a seronegative partner from a partner with HIV has not been observed when the partner with HIV was being treated with antiretroviral therapy and had a suppressed viral load.&nbsp;It is not known whether PrEP use further decreases the risk of HIV transmission when a partner with HIV has a documented undetectable viral load. Factors such as the consistency or inconsistency of a partner&rsquo;s viral load being suppressed, a partner&rsquo;s adherence to antiretroviral therapy, and the degree of certainty that a partner&rsquo;s viral load is suppressed (eg, self-report vs availability of laboratory test results) may help inform decisions about the use of PrEP in this situation.\r\nAll persons being considered for PrEP must have a recently documented negative HIV antigen-antibody test result, and if they have taken oral PrEP or postexposure prophylaxis in the past 3 months, or injectable cabotegravir in the past 12 months, the CDC recommends testing with both an HIV antigen-antibody assay and an HIV-1 RNA assay.'}, {'id': 186, 'title': 'Rh(D) Incompatibility: Screening ', 'grade': 'A', 'text': 'The DoctorAI strongly recommends Rh(D) blood typing and antibody testing for all pregnant women during their first visit for pregnancy-related care.', 'servfreq': 'First prenatal visit.', 'risktext': ''}, {'id': 1989, 'title': 'Syphilis Infection in Nonpregnant Adolescents and Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for syphilis infection in persons who are at increased risk for infection.', 'servfreq': 'Optimal screening frequency for persons who are at increased risk for syphilis infection is not well established. Men who have sex with men or persons with HIV infection may benefit from screening at least annually or more frequently (eg, every 3 to 6 months) if they continue to be at high risk.', 'risktext': 'The USPSTF recommends screening for syphilis in persons who are at increased risk for infection. When deciding which persons to screen for syphilis, clinicians should consider the prevalence of infection in the communities they serve, as well as other sociodemographic and behavioral factors that may be associated with increased risk of syphilis infection. For example, prevalence of syphilis is higher in men, men who have sex with men, persons with HIV infection, young adults, and persons with a history of incarceration, sex work, or military service. A substantial percentage of heterosexual syphilis transmission occurs among persons who use illicit drugs, particularly methamphetamine. Diagnosis of another STI may signal that a person is having condomless sex, which increases their risk of syphilis infection. Higher infection rates in persons of some racial and ethnic groups have been reported and are primarily a reflection of a combination of factors, including social determinants of health (eg, disparities of income, low educational achievement, and unstable housing), differential health insurance coverage or access to quality health care, and differences in sexual network characteristics (eg, individuals living in communities with a high prevalence of STIs have an increased chance of encountering an infected partner). Local prevalence rates may change over time, so clinicians should be aware of the latest data and trends for their specific population and geographic area, which are available through their state and local health departments and Centers for Disease Control and Prevention (CDC) surveillance.\r\n&nbsp;\r\nAlthough direct evidence on screening in nonpregnant persons who are not at increased risk for syphilis infection is lacking, based on the established test performance characteristics of current screening tests and the low prevalence rate of syphilis in this population, the yield of screening is likely low.9,10 Therefore, screening in this population may result in high false-positive rates and overtreatment.'}, {'id': 431, 'title': 'Syphilis Infection in Pregnant Women: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends early screening for syphilis infection in all pregnant women.', 'servfreq': 'All pregnant women should be tested for syphilis as early as possible when they first present to care. If a woman has not received prenatal care prior to delivery, she should be tested at the time she presents for delivery. In most cases of congenital syphilis, pregnant women received prenatal care but were not screened and treated for syphilis early enough during the pregnancy to prevent transmission to the fetus.', 'risktext': ''}, {'id': 1905, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and US Food and Drug Administration (FDA)--approved pharmacotherapy for cessation to nonpregnant adults who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 1906, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all pregnant persons about tobacco use, advise them to stop using tobacco, and provide behavioral interventions for cessation to pregnant persons who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 2014, 'title': 'Anxiety Disorders in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for anxiety disorders in adults, including pregnant and postpartum persons.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding optimal timing for screening, or screening interval, for both the perinatal and general adult populations; more evidence on both timing and screening interval is needed for all adult populations. A pragmatic approach in the absence of evidence might include screening all adults who have not been screened previously and using clinical judgment in considering risk factors, comorbid conditions, and life events to determine if additional screening of high-risk patients is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nRisk factors for anxiety disorders include sociodemographic factors, psychosocial factors, and physical and mental health factors such as marital status (widowed or divorced), stressful life events, smoking and alcohol use, other mental health conditions, or a parental history of mental disorders. Demographic factors such as low socioeconomic status and female sex are associated with higher rates of anxiety disorders.&nbsp;Black persons and individuals of non-Hispanic ethnicity are at increased risk of anxiety disorders due to social, rather than biological, factors. Anxiety and depressive disorders often overlap. One cohort study found that 67% of individuals with a depressive disorder also had a current anxiety disorder, and 75% had a lifetime comorbid anxiety disorder.'}, {'id': 1938, 'title': 'Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication ', 'grade': 'B', 'text': 'The DoctorAI recommends the use of low-dose aspirin (81 mg/day) as preventive medication after 12 weeks of gestation in persons who are at high risk for preeclampsia.\r\rSee the Practice Considerations section for information on high risk and aspirin dose.', 'servfreq': 'Once daily after 12 weeks of gestation', 'risktext': ' \r\nPersons with a history of preeclampsia in a previous pregnancy, type 1 or type 2 diabetes, and chronic hypertension are at highest risk for preeclampsia. Additional conditions that place a person at high risk for preeclampsia include multifetal gestation, conception using assisted reproductive technology, autoimmune disease, and kidney disease. Other factors associated with increased preeclampsia risk include nulliparity, high prepregnancy body mass index, family history of preeclampsia, and advanced maternal age (35 years or older). In addition, Black persons have higher rates of preeclampsia and are at increased risk for serious complications due to various societal and health inequities.\r\n '}, {'id': 513, 'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for asymptomatic bacteriuria using urine culture in pregnant persons.', 'servfreq': 'In general, screening is performed once at the first prenatal visit per clinical guidelines. However, there is little evidence on the optimal timing and frequency of screening for asymptomatic bacteriuria in pregnancy.2&nbsp; .&nbsp;Screen pregnant persons for asymptomatic bacteriuria using a midstream, clean-catch urine culture at the first prenatal visit or at 12 to 16 weeks of gestation, whichever is earlier. A urine culture showing &gt;100,000 CFU/mL of a single uropathogen or &gt;10,000 CFU/mL if the pathogen is group B streptococcus indicates treatment.', 'risktext': 'This recommendation applies to adults 18 years and older and pregnant persons of any age without signs and symptoms of a urinary tract infection. It does not apply to persons who have chronic medical or urinary tract conditions, such as end-stage renal disease; have indwelling urinary catheters, urinary stents, or spinal cord injuries; are hospitalized; reside in an institution (eg, a nursing home); or who are transplant recipients.\r\n&nbsp;\r\nThe risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6&nbsp;Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5&nbsp;Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7,&nbsp;11,&nbsp;12&nbsp;In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12&nbsp;Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4,&nbsp;6'}, {'id': 2009, 'title': 'Latent Tuberculosis Infection in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for LTBI in populations at increased risk.\r\rSee the "Assessment of Risk" section for additional information on adults at increased risk.', 'servfreq': 'The USPSTF found no evidence on the optimal frequency of screening for LTBI. In the absence of evidence, a reasonable approach is to repeat screening based on specific risk factors; screening frequency could range from 1-time only screening among persons at low risk for future tuberculosis exposure to annual screening among those at continued risk of exposure.', 'risktext': 'Populations at increased risk for LTBI, based on increased prevalence of active disease and increased risk of exposure, include persons who were born in, or are former residents of, countries with high tuberculosis prevalence and persons who live in, or have lived in, high-risk congregate settings (eg, homeless shelters or correctional facilities). Clinicians can consult their local or state health departments for more information about populations at increased risk in their community, since local demographic patterns may vary across the US.\r\nIn 2020, 71.5% of all cases of active tuberculosis in the US occurred among persons born outside the US. According to the CDC, tuberculosis disease is common in most countries in Latin America, the Caribbean, Africa, Asia, Eastern Europe, and Russia. In 2020, among persons with new tuberculosis living in the US who were born outside the US, the most common countries of birth were Mexico (18.0%), the Philippines (12.5%), India (10.4%), Vietnam (8.2%), and China (5.1%), accounting for 54.2% of total cases. Most of these cases are believed to be due to progression of latent infection to active tuberculosis disease rather than new transmission within communities.\r\nPersons who live, or have lived, in high-risk congregate settings also have a higher prevalence rate of active tuberculosis and an increased risk for exposure. In 2020, 4.3% of tuberculosis disease cases diagnosed in persons 15 years or older occurred in persons experiencing homelessness and 2.6% occurred in residents of correctional facilities. It is estimated that persons experiencing homelessness have an 11 times higher incidence of tuberculosis disease compared with persons who are not experiencing homelessness (36 cases per 100,000 population vs 2.9 cases per 100,000 population, respectively, during 2011 to 2016).\r\nOther populations at increased risk for LTBI or progression to active disease include persons who have immunosuppression (eg, persons living with HIV, patients receiving immunosuppressive medications such as chemotherapy or tumor necrosis factor inhibitors, and patients who have received an organ transplant) and patients with silicosis (a lung disease). However, given that screening in these populations may be considered standard care as part of disease management or indicated prior to the use of certain medications, the USPSTF did not review evidence on screening in these populations. Information on testing in these populations is provided by other groups, such as the Office of AIDS Research at the National Institutes of Health, and in a guideline issued jointly by the American Thoracic Society, Infectious Diseases Society of America, and CDC. Some evidence from observational studies has explored the association between poorly controlled diabetes and progression of LTBI to active disease. However, there is insufficient evidence on screening for and treatment of LTBI in persons with diabetes for the USPSTF to make a separate recommendation for this important population.\r\nPersons who are contacts of individuals with active tuberculosis, health care workers, and workers in high-risk congregate settings may also be at increased risk of exposure. Because screening in these populations is conducted as part of public health or employee health surveillance, the USPSTF did not review the evidence in these populations. Clinicians seeking further information about testing for tuberculosis in these populations can refer to the Additional Tools and Resources and Recommendations of Others sections.'}, {'id': 514, 'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic bacteriuria in nonpregnant adults.', 'servfreq': '', 'risktext': 'The risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6 Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5 Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7, 11, 12 In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12 Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4, 6'}, {'id': 507, 'title': 'BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing ', 'grade': 'B', 'text': 'The DoctorAI recommends that primary care clinicians assess women with a personal or family history of breast, ovarian, tubal, or peritoneal cancer or who have an ancestry associated with breast cancer susceptibility 1 and 2 (BRCA1/2) gene mutations with an appropriate brief familial risk assessment tool. Women with a positive result on the risk assessment tool should receive genetic counseling and, if indicated after counseling, genetic testing.', 'servfreq': 'Consideration of screening for potentially harmful BRCA mutations should begin once women have reached the age of consent (18 years). Primary care providers should periodically assess all patients for changes in family history (for example, comprehensive review at least every 5 to 10 years)', 'risktext': 'Patients with family or personal histories of breast, ovarian, tubal, or peritoneal cancer or ancestry associated with harmful&nbsp;&lt; i&gt;BRCA1/2&nbsp;mutations should be assessed using a familial risk assessment tool. The USPSTF found adequate evidence that these tools are accurate in identifying women with increased likelihood of&nbsp;&lt; i&gt;BRCA1/2mutations. Tools evaluated by the USPSTF include the Ontario Family History Assessment Tool, Manchester Scoring System, Referral Screening Tool, Pedigree Assessment Tool, 7-Question Family History Screening Tool, International Breast Cancer Intervention Study instrument (Tyrer-Cuzick), and brief versions of BRCAPRO. These tools should be used to guide referrals to genetic counseling.&nbsp;Persons should consider their sex at birth to determine which recommendation best applies to them.'}, {'id': 339, 'title': 'Breastfeeding: Primary Care Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends providing interventions during pregnancy and after birth to support breastfeeding.', 'servfreq': 'During pregnancy and after birth', 'risktext': "This recommendation applies to pregnant women, new mothers, and their infants and children. Interventions to support breastfeeding may also involve a woman's partner, other family members, and friends. This recommendation does not apply in circumstances where there are contraindications to breastfeeding (e.g., certain maternal medical conditions or infant metabolic disorders, such as galactosemia). The USPSTF did not review evidence on interventions directed at breastfeeding of preterm infants."}, {'id': 1935, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for chlamydia in all sexually active women 24 years or younger and in women 25 years or older who are at increased risk for infection.', 'servfreq': ' \r\nIn the absence of studies on screening intervals, a reasonable approach would be to screen patients whose sexual history reveals new or persistent risk factors since the last negative test result.\r\n ', 'risktext': ' \r\nAge is a strong predictor of risk for chlamydial and gonococcal infections, with the highest infection rates in women occurring during ages 15 to 24 years. Women 25 years or older are at increased risk if they have a new sex partner, more than 1 sex partner, a sex partner with concurrent partners, or a sex partner who has an STI; practice inconsistent condom use when not in a mutually monogamous relationship; or have a previous or coexisting STI. Exchanging sex for money or drugs and history of incarceration also are associated with increased risk.&nbsp;Clinicians should consider the communities they serve and may want to consult local public health authorities for information about local epidemiology and guidance on determining who is at increased risk.\r\n '}, {'id': 1936, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for gonorrhea in all sexually active women 24 years or younger and in women 25 years or older who are at increased risk for infection.', 'servfreq': ' \r\nIn the absence of studies on screening intervals, a reasonable approach would be to screen patients whose sexual history reveals new or persistent risk factors since the last negative test result.\r\n ', 'risktext': ' \r\nAge is a strong predictor of risk for chlamydial and gonococcal infections, with the highest infection rates in women occurring during ages 15 to 24 years. Women 25 years or older are at increased risk if they have a new sex partner, more than 1 sex partner, a sex partner with concurrent partners, or a sex partner who has an STI; practice inconsistent condom use when not in a mutually monogamous relationship; or have a previous or coexisting STI. Exchanging sex for money or drugs and history of incarceration also are associated with increased risk.&nbsp;Clinicians should consider the communities they serve and may want to consult local public health authorities for information about local epidemiology and guidance on determining who is at increased risk.\r\n '}, {'id': 1909, 'title': 'Asymptomatic Carotid Artery Stenosis: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic carotid artery stenosis in the general adult population.\r\rSee the Practice Considerations section for a description of adults at increased risk.', 'servfreq': '', 'risktext': ''}, {'id': 2017, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for suicide risk in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': '', 'risktext': ''}, {'id': 2016, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for depression in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding the optimal timing for screening for depression; more evidence is needed in both perinatal and general adult populations. In the absence of evidence, a pragmatic approach might include screening adults who have not been screened previously and using clinical judgment while considering risk factors, comorbid conditions, and life events to determine if additional screening of patients at increased risk is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nThe USPSTF recommends screening for depression in all adults regardless of risk factors. Risk factors for depression include a combination of genetic, biological, and environmental factors, such as a family history of depression, prior episode of depression or other mental health condition, a history of trauma or adverse life events, or a history of disease or illness (eg, cardiovascular disease).\r\nPrevalence rates vary by sex, age, race, ethnicity, education, marital status, geographic location, poverty level, and employment status. Women have twice the risk of depression compared with men. Young adults, multiracial individuals, and Native American/Alaska Native individuals have higher rates of depression.\r\nRisk factors for perinatal depression include life stress, low social support, history of depression, marital or partner dissatisfaction, and a history of abuse.'}, {'id': 1932, 'title': 'Gestational Diabetes: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for gestational diabetes in asymptomatic pregnant persons at 24 weeks of gestation or after.', 'servfreq': 'At 24 weeks of gestation or after to improve maternal and fetal outcomes', 'risktext': ' \r\nSeveral factors increase a person&rsquo;s risk for developing gestational diabetes, including obesity, increased maternal age, history of gestational diabetes, family history of diabetes, and belonging to a racial/ethnic group that is at increased risk for developing type 2 diabetes (Hispanic, Native American, South or East Asian, or Pacific Islander descent).4,19,20 Factors associated with a lower risk for developing gestational diabetes include age younger than 25 to 30 years, White race, a body mass index (BMI) of 25 or less (calculated as weight in kilograms divided by height in meters squared), no family history (in a first-degree relative) of diabetes, and no history of glucose intolerance or adverse pregnancy outcomes related to gestational diabetes.21-23 The risk in different racial/ethnic groups may be due in part to social risk factors such as low socioeconomic status or structural racism, although these associations are not examined in the current evidence. Although a higher BMI increases the risk of gestational diabetes across racial/ethnic groups, the association varies. In Asian American persons, the prevalence of gestational diabetes at a BMI of 22 to less than 25 is similar to the prevalence in Hispanic persons, non-Hispanic White persons, and Black persons with a higher (&gt;28) BMI.24,25\r\n '}, {'id': 1845, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends offering or referring adults with cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity.', 'servfreq': '', 'risktext': 'Adults 18 years or older at increased risk of CVD, defined as those with 1 or more of the following:\r\n1.Hypertension or elevated blood pressure2.Dyslipidemia3.Mixed or multiple risk factors such as the metabolic syndrome or an estimated 10-year CVD risk of &ge;7.5%\r\nThis recommendation does not apply to adults with other known modifiable cardiovascular risk factors such as abnormal blood glucose levels, obesity, and smoking; these populations are incorporated in other USPSTF recommendations.'}, {'id': 1931, 'title': 'Healthy Weight and Weight Gain In Pregnancy: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer pregnant persons effective behavioral counseling interventions aimed at promoting healthy weight gain and preventing excess gestational weight gain in pregnancy.', 'servfreq': 'Throughout pregnancy', 'risktext': 'Pregnancy'}, {'id': 1885, 'title': 'Hepatitis B Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in adolescents and adults at increased risk for infection.\r\rSee the Practice Considerations section for a description of adolescents and adults at increased risk for infection.', 'servfreq': 'For patients with negative HBsAg results who have not received the HBV vaccine series, periodic screening may be useful for those who report continued risk for acquiring HBV transmission, such as persons who continue to inject drugs and men who have sex with men. Clinical judgment should be used to determine screening frequency. The USPSTF found no evidence to determine optimal screening intervals.', 'risktext': 'Persons from such risk groups include persons who have injected drugs in the past or currently; men who have sex with men; persons with HIV; and sex partners, needle-sharing contacts, and household contacts of persons known to be HBsAg positive. Some persons with combinations of risk factors who are not members of risk factor groups listed above may also be at increased risk for HBV infection.'}, {'id': 524, 'title': 'Hepatitis C Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis C virus (HCV) infection in adults aged 18 to 79 years.', 'servfreq': 'One-time screening for most adults.\r\nPeriodically screen persons with continued risk for HCV infection (eg, persons with past or current injection drug use). There is limited evidence to determine how often to screen persons at increased risk.&nbsp;', 'risktext': 'Asymptomatic adults aged 18 to 79 years (including pregnant persons) without known liver disease.&nbsp;\r\nThe USPSTF also suggests that clinicians consider screening persons younger than 18 years and older than 79 years who are at high risk for infection (eg, those with past or current injection drug use).&nbsp;'}, {'id': 2023, 'title': 'Hypertensive Disorders of Pregnancy: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hypertensive disorders in pregnant persons with blood pressure measurements throughout pregnancy.', 'servfreq': 'Screening Interval\r\nBlood pressure measurements should be obtained during each prenatal care visit throughout pregnancy. Hypertensive disorders of pregnancy can quickly evolve into severe disease that can result in serious, even fatal, maternal and infant health outcomes. The ability to screen for hypertensive disorders of pregnancy using blood pressure measurements is important to identify and effectively treat a potentially unpredictable and fatal condition. While it is known that risk continues into the immediate postpartum period, there is little evidence regarding screening during this period. A pragmatic approach would be for patients to be counseled regarding signs and symptoms of preeclampsia at hospital discharge and for patients with hypertensive disorders to have subsequent blood pressure checks.\r\nScreening for hypertensive disorders of pregnancy alone is not sufficient to improve inequities in health outcomes. Identifying hypertensive disorders of pregnancy requires adequate prenatal visits, surveillance, and evidence-based care in response to evolving patient signs and symptoms during pregnancy and the postpartum period to improve health outcomes. Black and Native American/Alaska Native persons have lower rates of prenatal visits and are at greater risk of serious postpartum morbidity and hospital readmission after delivery. Screening and monitoring of Black and Hispanic/Latina individuals during the postpartum period could be an important step for reducing health inequities by preventing serious adverse events. In addition, screening and monitoring by various health care providers (eg, nurse midwives, nurses, pediatricians, doulas, and lactation consultants) could also help avert serious complications in the postpartum period.', 'risktext': 'Assessment of Risk\r\nImportant clinical conditions associated with increased risk for preeclampsia include a history of eclampsia or preeclampsia in a prior pregnancy, a previous adverse pregnancy outcome, and maternal comorbid conditions (including type 1 or type 2 diabetes prior to pregnancy, gestational diabetes, chronic hypertension, kidney disease, and autoimmune diseases).\r\n&nbsp;Other factors associated with increased risk of preeclampsia and gestational hypertension include nulliparity, high prepregnancy body mass index, family history of preeclampsia, multifetal gestation, and the pregnant individual being 35 years or older.\r\nThe higher prevalence of hypertensive disorders of pregnancy and the increased risk for severe complications seen in Black persons may be due to their disproportionate burden of social and clinical risk factors. These social and clinical determinants largely result from historical and current manifestations of structural racism that influence environmental exposures, access to health resources, and overall health status.'}, {'id': 434, 'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians screen for intimate partner violence (IPV) in women of reproductive age and provide or refer women who screen positive to ongoing support services. See the Clinical Considerations section for more information on effective ongoing support services for IPV and for information on IPV in men.', 'servfreq': 'The USPSTF found no evidence on appropriate intervals for screening. Randomized clinical trials (RCTs) of screening and interventions for IPV often screen for current IPV or IPV in the past year.\r\n&nbsp;', 'risktext': 'All women of reproductive age are at potential risk for IPV and should be screened. There are a variety of factors that increase risk of IPV, such as exposure to violence as a child, young age, unemployment, substance abuse, marital difficulties, and economic hardships.\r\nRisk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health. For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.'}, {'id': 187, 'title': 'Rh(D) Incompatibility: Screening ', 'grade': 'B', 'text': "The DoctorAI recommends repeated Rh(D) antibody testing for all unsensitized Rh(D)-negative women at 24 to 28 weeks' gestation, unless the biological father is known to be Rh(D)-negative.", 'servfreq': 'Repeat testing at 24-28 weeks gestation.', 'risktext': ''}, {'id': 1916, 'title': 'Lung Cancer: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery.', 'servfreq': ' \r\nThe USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. ', 'risktext': ' \r\nSmoking and older age are the 2 most important risk factors for lung cancer.&nbsp;The risk of lung cancer in persons who smoke increases with cumulative quantity and duration of smoking and with age but decreases with increasing time since quitting for persons who formerly smoked.3 The USPSTF considers adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years to be at high risk and recommends screening for lung cancer with annual LDCT in this population. \r\n \r\n&nbsp;\r\n \r\nAfrican American/Black (Black) men have a higher incidence of lung cancer than White men, and Black women have a lower incidence than White women.1 These differences are likely related to differences in smoking exposure (ie, prevalence of smoking) and related exposure to carcinogens in cigarettes.7,8 The differences may also be related to other social risk factors.\r\n \r\n&nbsp;\r\n \r\nOther risk factors for lung cancer include environmental exposures, prior radiation therapy, other (noncancer) lung diseases, and family history. Lower level of education is also associated with a higher risk of lung cancer.7 The task force recommends using age and smoking history to determine screening eligibility rather than more elaborate risk prediction models because there is insufficient evidence to assess whether risk prediction model&ndash;based screening would improve outcomes relative to using the risk factors of age and smoking history for broad implementation in primary care.\r\n '}, {'id': 449, 'title': 'Perinatal Depression: Preventive Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians provide or refer pregnant and postpartum persons who are at increased risk of perinatal depression to counseling interventions.', 'servfreq': '', 'risktext': 'Include&nbsp;a past history of depression. Current depressive symptoms (that do not reach a diagnostic threshold),&nbsp;history of physical or sexual abuse,&nbsp;unplanned or unwanted pregnancy,&nbsp;stressful life events,&nbsp;lack of social and financial support,&nbsp;intimate partner violence,pregestational or gestational diabetes,and complications during pregnancy. Additional risk factors include adolescent parenthood, low socioeconomic status, and lack of social support.&nbsp;Genetic factors are also suspected to contribute to women&rsquo;s risk of developing perinatal depression.'}, {'id': 1445, 'title': 'Sexually Transmitted Infections: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends behavioral counseling for all sexually active adolescents and for adults who are at increased risk for sexually transmitted infections (STIs).\r\rSee the Practice Considerations section for more information on populations at increased risk for acquiring STIs.', 'servfreq': '', 'risktext': 'All sexually active adolescents are at increased risk for STIs because of the high rates of STIs in this age group and should receive behavioral counseling interventions. Adults at increased risk for STIs include those who currently have an STI or were diagnosed with one within the past year, do not consistently use condoms, have multiple sex partners, or have sex partners within populations with a high prevalence of STIs. Populations with a high prevalence of STIs include persons who seek STI testing or attend STI clinics; sexual and gender minorities; persons who are living with HIV, inject drugs, have exchanged sex for money or drugs, or have entered correctional facilities; and some racial/ethnic minority groups.1-4'}, {'id': 402, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends counseling young adults, adolescents, children, and parents of young children about minimizing exposure to ultraviolet (UV) radiation for persons aged 6 months to 24 years with fair skin types to reduce their risk of skin cancer.', 'servfreq': '', 'risktext': 'Fair skin types'}, {'id': 438, 'title': 'Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for unhealthy alcohol use in primary care settings in adults 18 years or older, including pregnant women, and providing persons engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce unhealthy alcohol use.', 'servfreq': 'The USPSTF did not find adequate evidence to recommend an optimal screening interval for unhealthy alcohol use in adults.&nbsp;Brief behavioral counseling interventions were found to reduce unhealthy alcohol use in adults 18 years or older, including pregnant women. Effective behavioral counseling interventions vary in their specific components, administration, length, and number of interactions. The USPSTF was unable to identify specific intervention characteristics or components that were clearly associated with improved outcomes.', 'risktext': 'engaged in risky or hazardous drinking'}, {'id': 767, 'title': 'Unhealthy Drug Use: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening by asking questions about unhealthy drug use in adults age 18 years or older. Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. \r(Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'servfreq': 'Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. (Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'risktext': 'These include being aged 18 to 25 years; male sex; having a mental health condition, personality or mood disorder, or nicotine or alcohol dependence; a history of physical or sexual abuse, parental neglect, or other adversity in childhood; or drug or alcohol addiction in a first-degree relative.1,9&nbsp;Factors associated with misuse of prescription drugs include history of other drug use, mental illness, pain, and greater access to prescription drugs.10&nbsp;Factors associated with prenatal use of drugs include a mental health disorder, interpersonal violence, and family history of substance use.11'}, {'id': 433, 'title': 'Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer or refer adults with a body mass index (BMI) of 30 or higher (calculated as weight in kilograms divided by height in meters squared) to intensive, multicomponent behavioral interventions.', 'servfreq': '', 'risktext': 'Adults with a BMI &ge;30'}, {'id': 1979, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: Behavioral Counseling Interventions ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians individualize the decision to offer or refer adults without cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity. \r\rSee the "Practice Considerations" section for information on determining which patients may benefit most from this service.', 'servfreq': '', 'risktext': ''}, {'id': 508, 'title': 'BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine risk assessment, genetic counseling, or genetic testing for women whose personal or family history or ancestry is not associated with potentially harmful BRCA1/2 gene mutations.', 'servfreq': '', 'risktext': 'Patients with family or personal histories of breast, ovarian, tubal, or peritoneal cancer or ancestry associated with harmful&nbsp;BRCA1/2&nbsp;mutations should be assessed using a familial risk assessment tool. The USPSTF found adequate evidence that these tools are accurate in identifying women with increased likelihood of&nbsp;BRCA1/2mutations. Tools evaluated by the USPSTF include the Ontario Family History Assessment Tool, Manchester Scoring System, Referral Screening Tool, Pedigree Assessment Tool, 7-Question Family History Screening Tool, International Breast Cancer Intervention Study instrument (Tyrer-Cuzick), and brief versions of BRCAPRO. These tools should be used to guide referrals to genetic counseling.'}, {'id': 525, 'title': 'Bacterial Vaginosis in Pregnant Persons to Prevent Preterm Delivery: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for bacterial vaginosis (BV) in pregnant persons who are not at increased risk for preterm delivery.', 'servfreq': '', 'risktext': '\r\nAssess risk for preterm delivery. There are multiple factors that increase risk for preterm delivery; one of the strongest risk factors is prior preterm delivery.\r\nDecide whether or not to screen for bacterial vaginosis:\r\n\r\na. Do not screen pregnant persons who are not at increased risk for preterm delivery.\r\nb. Evidence is insufficient to recommend for or against screening pregnant persons at increased risk for preterm delivery.'}, {'id': 418, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening with resting or exercise electrocardiography (ECG) to prevent cardiovascular disease (CVD) events in asymptomatic adults at low risk of CVD events.', 'servfreq': '', 'risktext': ''}, {'id': 429, 'title': 'Cervical Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for cervical cancer in women who have had a hysterectomy with removal of the cervix and do not have a history of a high-grade precancerous lesion (ie, cervical intraepithelial neoplasia [CIN] grade 2 or 3) or cervical cancer.', 'servfreq': '', 'risktext': ''}, {'id': 428, 'title': 'Cervical Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for cervical cancer in women younger than 21 years.', 'servfreq': '', 'risktext': ''}, {'id': 1973, 'title': 'Chronic Obstructive Pulmonary Disease: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for chronic obstructive pulmonary disease in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 2003, 'title': 'Genital Herpes Infection: Serologic Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine serologic screening for genital herpes simplex virus infection in asymptomatic adolescents and adults, including pregnant persons.', 'servfreq': '', 'risktext': 'The USPSTF found no evidence of externally validated, reliable risk stratification tools to identify individuals more or less likely to have genital herpes.'}, {'id': 504, 'title': 'Pancreatic Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for pancreatic cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 365, 'title': 'Thyroid Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for thyroid cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 1976, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'D', 'text': 'The DoctorAI recommends against the use of beta carotene or vitamin E supplements for the prevention of cardiovascular disease or cancer.', 'servfreq': '', 'risktext': ''}, {'id': 318, 'title': 'Autism Spectrum Disorder in Young Children: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for autism spectrum disorder (ASD) in young children for whom no concerns of ASD have been raised by their parents or a clinician.', 'servfreq': '', 'risktext': 'Although a number of potential risk factors for ASD have been identified, there is insufficient evidence to determine if certain risk factors modify the performance characteristics of ASD screening tests, such as the age at which screening is performed or other characteristics of the child or family.'}, {'id': 526, 'title': 'Bacterial Vaginosis in Pregnant Persons to Prevent Preterm Delivery: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for BV in pregnant persons who are at increased risk for preterm delivery.', 'servfreq': '', 'risktext': ''}, {'id': 65, 'title': 'Bladder Cancer in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults.\r\rLiterature scans conducted in July 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'This evidence update focused on the benefits and harms of screening for bladder cancer among people without symptoms, the accuracy of screening tests done in primary care settings, and the benefits and harms of treatment. The updated evidence review did not find any new high quality evidence to adequately determine the balance of benefits and harms of screening for bladder cancer. However, bladder cancer is a common cancer and can cause considerable health problems including death. Therefore, the USPSTF determined that the evidence was insufficient to provide a recommendation for or against bladder cancer screening.  The USPSTF emphasizes the need for additional research in this area. '}, {'id': 2037, 'title': 'Breast Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of supplemental screening for breast cancer using breast ultrasonography or magnetic resonance imaging (MRI) in women identified to have dense breasts on an otherwise negative screening mammogram.\r\rSee the "Practice Considerations" section for more information on the patient population to whom this recommendation applies and on screening mammography modalities.', 'servfreq': '', 'risktext': 'These recommendations apply to cisgender women and all other persons assigned female at birth (including transgender men and nonbinary persons) 40 years or older at average risk of breast cancer. \r\nThese recommendations apply to persons who have factors associated with an increased risk of breast cancer, such as a family history of breast cancer (ie, a first-degree relative with breast cancer) or having dense breasts. They do not apply to persons who have a genetic marker or syndrome associated with a high risk of breast cancer (eg, BRCA1 or BRCA2 genetic variation), a history of high-dose radiation therapy to the chest at a young age, or previous breast cancer or a high-risk breast lesion on previous biopsies. '}, {'id': 419, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening with resting or exercise ECG to prevent CVD events in asymptomatic adults at intermediate or high risk of CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 423, 'title': 'Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of adding the ankle-brachial index (ABI), high-sensitivity C-reactive protein (hsCRP) level, or coronary artery calcium (CAC) score to traditional risk assessment for cardiovascular disease (CVD) in asymptomatic adults to prevent CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 352, 'title': 'Celiac Disease: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'persons with family history or other risk factors'}, {'id': 1955, 'title': 'Eating Disorders in Adolescents and Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for eating disorders in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1933, 'title': 'Gestational Diabetes: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for gestational diabetes in asymptomatic pregnant persons before 24 weeks of gestation.', 'servfreq': '', 'risktext': ''}, {'id': 665, 'title': 'Illicit Drug Use in Children, Adolescents, and Young Adults: Primary Care-Based Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--based behavioral counseling interventions to prevent illicit drug use, including nonmedical use of prescription drugs, in children, adolescents, and young adults.\r\rSee the Practice Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 435, 'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for abuse and neglect in all older or vulnerable adults. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': 'Risk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health.14&nbsp;For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.15'}, {'id': 2045, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for iron deficiency and iron deficiency anemia in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2046, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine iron supplementation in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2018, 'title': 'Lipid Disorders in Children and Adolescents: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1998, 'title': 'Obstructive Sleep Apnea in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for obstructive sleep apnea in the general adult population.\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Risk Factors\r\nRisk factors associated with OSA include male sex, older age (40-70 years), postmenopausal status, higher body mass index (BMI), and craniofacial and upper airway abnormalities (eg, enlarged tonsils or long upper airway). Black, Hispanic/Latino, and Native American/Alaska Native persons have a higher prevalence of OSA compared with White persons; some evidence suggests that these differences are partially explained by higher rates of obesity, asthma, and tobacco use among these groups.8'}, {'id': 1977, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of multivitamin supplements for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1978, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of single or paired nutrient supplements (other than beta carotene and vitamin E) for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 176, 'title': 'Oral Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for oral cancer in asymptomatic adults.\r\rGo to the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in July 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Tobacco and alcohol use are major risk factors for oral cancer. A total of 20% to 30% of cases of oral cancer worldwide are attributable to cigarette smoking. In the United States, up to 75% of cases of oral cancer may be attributable to tobacco and alcohol use. Additional risk factors include male sex, older age, use of betel quid, ultraviolet light exposure, infection with Candida or bacterial flora, and a compromised immune system. Sexually transmitted oral HPV infection (HPV-16) has recently been recognized as an increasingly important risk factor for oropharyngeal cancer. In the United States, the prevalence of oropharyngeal cancer due to oral HPV infection is probably as high as 80% to 95%. The prevalence of oral HPV infection is associated with age, sex, number of sexual partners, and number of cigarettes smoked per day. The effect of multifactorial risk assessment and screening for risk factors on oral cancer morbidity and mortality is unknown.'}, {'id': 2026, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine screening performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 2027, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of preventive interventions performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 424, 'title': 'Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for peripheral artery disease (PAD) and cardiovascular disease (CVD) risk with the ankle-brachial index (ABI) in asymptomatic adults.\r\rLiterature scans conducted in August 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Risk factors associated with OSA include male sex, older age (40 to 70 years), postmenopausal status, higher BMI, and craniofacial and upper airway abnormalities.'}, {'id': 404, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of counseling adults about skin self-examination to prevent skin cancer.See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 2005, 'title': 'Skin Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Exposure to UV radiation from sun exposure, indoor tanning beds, and other UV radiation&ndash;emitting devices is the major environmental risk factor for skin cancer. History of frequent sunburns, older age, and male sex are associated with increased risk for skin cancer. Exposure to UV radiation from the use of indoor tanning beds is an important risk factor in adolescents. Incidence of melanoma is higher among White persons compared with persons of other races and ethnicities. This difference likely reflects traits associated with increased melanoma risk, such as fair skin (which is more susceptible to sunburning), light-colored eyes, and red or blond hair being more common among White persons compared with persons of other races and ethnicities. Acral lentiginous melanoma, which occurs mostly on skin not frequently exposed to direct sunlight (eg, palms of hands, soles of feet, or under fingernails or toenails), is the most common type of melanoma among Black populations. Other melanoma risk factors include higher numbers of moles on the skin, atypical moles, as well as a personal and family history of skin cancer.'}, {'id': 269, 'title': 'Thyroid Dysfunction: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults.\r\rSee the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': 'The optimal screening interval for thyroid dysfunction (if one exists) is unknown.', 'risktext': 'The most common cause of hypothyroidism in the United States is chronic autoimmune (Hashimoto) thyroiditis. Risk factors for an elevated TSH level include female sex, advancing age, white race, type 1 diabetes, Down syndrome, family history of thyroid disease, goiter, previous hyperthyroidism (possibly due in part to ablation therapy leading to iatrogenic thyroid dysfunction), and external-beam radiation in the head and neck area. Common causes of hyperthyroidism include Graves disease, Hashimoto thyroiditis, and functional thyroid nodules. Risk factors for a low TSH level include female sex; advancing age; black race; low iodine intake; personal or family history of thyroid disease; and ingestion of iodine-containing drugs, such as amiodarone. The USPSTF found no direct evidence that treatment of thyroid dysfunction based on risk level alters final health outcomes.'}, {'id': 1908, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of electronic cigarettes (e-cigarettes) for tobacco cessation in adults, including pregnant persons. The USPSTF recommends that clinicians direct patients who use tobacco to other tobacco cessation interventions with proven effectiveness and established safety.\rSee the Practice Considerations section for more information on recommended behavioral interventions and pharmacotherapy and for suggestions for practice regarding the I statements.', 'servfreq': '', 'risktext': ''}, {'id': 1907, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of pharmacotherapy interventions for tobacco cessation in pregnant persons.', 'servfreq': '', 'risktext': ''}, {'id': 586, 'title': 'Tobacco Use in Children and Adolescents: Primary Care Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--feasible interventions for the cessation of tobacco use among school-aged children and adolescents.\r\rSee the Practice Considerations section for more information on effective interventions to prevent initiation of tobacco use and for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1919, 'title': 'Vitamin D Deficiency in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 408, 'title': 'Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of the benefits and harms of vitamin D and calcium supplementation, alone or combined, for the primary prevention of fractures in men and premenopausal women.', 'servfreq': '', 'risktext': ''}]
2025-01-29 22:00:48 [INFO] Update id=273478173 is handled. Duration 661 ms by bot id=8108339380
2025-01-29 22:00:54 [INFO] Update id=273478174 is handled. Duration 702 ms by bot id=8108339380
2025-01-29 22:00:57 [INFO] State data: {'db': <bot.database.Database object at 0x7f78842cb740>, 'age': 20, 'weight': 190, 'height': 190, 'feet': 45, 'gender': 'female', 'pregnant': 'yes', 'smoking': 'yes', 'sex': 'tools_1', 'recommendations': [{'id': 2020, 'title': 'Folic Acid Supplementation to Prevent Neural Tube Defects: Preventive Medication ', 'grade': 'A', 'text': 'The DoctorAI recommends that all persons planning to or who could become pregnant take a daily supplement containing 0.4 to 0.8 mg (400 to 800 mcg) of folic acid.', 'servfreq': 'The neural plate completes its formation and closure early in pregnancy (usually 26 to 28 days after fertilization). This means the critical period for folic acid supplementation starts at least 1 month before conception and continues through the first 2 to 3 months of pregnancy. Nearly half of all pregnancies in the US are unplanned; to gain the full benefits of supplementation, clinicians should advise all persons who plan to or who could become pregnant to take daily folic acid.', 'risktext': 'All pregnancies are at risk for neural tube defects, and persons who are planning to or could become pregnant should take folic acid supplements. Certain risk factors convey a higher risk, and individuals with these risk factors should talk to their health care professional. These factors include personal, partner, or family history of neural tube defects, malabsorption caused by bariatric procedures, the use of certain antiseizure medicines, and genetic mutations in folate-related enzymes. Pregestational diabetes and obesity have been associated with an increased risk of neural tube defects. Ethnic groups such as First Nation persons in Canada and Hispanic persons in California are thought to be at higher risk of neural tube defects. It is unclear, however, whether this is related to a higher risk of genetic variations among these groups or due to differential intake of folic acid&ndash;fortified foods.'}, {'id': 503, 'title': 'Hepatitis B Virus Infection in Pregnant Women: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in pregnant women at their first prenatal visit', 'servfreq': 'A test for HBsAg should be ordered at the first prenatal visit. Women with unknown HBsAg status or with new or continuing risk factors for HBV infection (eg, injection drug use or a sexually transmitted infection) should be screened at the time of admission to a hospital or other delivery setting.', 'risktext': 'In the United States, new cases of HBV among adults are largely transmitted through injection drug use or sexual intercourse, but most prevalent cases of HBV infection are chronic infections from exposure occurring in infancy or childhood. Another major risk factor for HBV infection is country of origin. In the United States, adults with HBV born in high-prevalence countries were commonly infected during childhood. In children, the primary source of infection is perinatal transmission at birth.'}, {'id': 485, 'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in adolescents and adults aged 15 to 65 years. Younger adolescents and older adults who are at increased risk of infection should also be screened.\rSee the Clinical Considerations section for more information about assessment of risk, screening intervals, and rescreening in pregnancy.', 'servfreq': 'The USPSTF found insufficient evidence to determine appropriate or optimal time intervals or strategies for repeat HIV screening. However, repeat screening is reasonable for persons known to be at increased risk of HIV infection, such as sexually active men who have sex with men; persons with a sex partner who is living with HIV; or persons who engage in behaviors that may convey an increased risk of HIV infection, such as injection drug use, transactional sex or commercial sex work, having 1 or more new sex partners whose HIV status is unknown, or having other factors that can place a person at increased risk of HIV infection (see &ldquo;Risk Assessment&rdquo;). Repeat screening is also reasonable for persons who live or receive medical care in a high-prevalence setting, such as a sexually transmitted disease clinic, tuberculosis clinic, correctional facility, or homeless shelter.', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'id': 486, 'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in all pregnant persons, including those who present in labor or at delivery whose HIV status is unknown.', 'servfreq': 'The CDC and ACOG recommend repeat prenatal screening for HIV during the third trimester of pregnancy in women with risk factors for HIV acquisition and in women living or receiving care in high-incidence settings, and the CDC notes that repeat screening for HIV during the third trimester may be considered in all women.&nbsp;', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'id': 1921, 'title': 'Hypertension in Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hypertension in adults 18 years or older with office blood pressure measurement (OBPM). The USPSTF recommends obtaining blood pressure measurements outside of the clinical setting for diagnostic confirmation before starting treatment.', 'servfreq': ' \r\nAlthough evidence on optimal screening intervals is limited, reasonable options include:\r\n \r\n \r\n\r\n\r\nScreening for hypertension every year in adults 40 years or older and in adults at increased risk for hypertension (such as Black persons, persons with high-normal blood pressure, or persons who are overweight or obese)\r\n\r\n\r\n \r\n \r\n\r\n\r\nScreening less frequently (ie, every 3 to 5 years) as appropriate for adults aged 18 to 39 years not at increased risk for hypertension and with a prior normal blood pressure reading.\r\n\r\n\r\n ', 'risktext': ' \r\nAlthough all adults should be screened for hypertension, risk factors that increase a person&rsquo;s risk for the condition include older age, Black race, family history, excess weight and obesity, lifestyle habits (lack of physical activity, stress, and tobacco use), and dietary factors (diet high in fat or sodium, diet low in potassium, or excessive alcohol intake)\r\n '}, {'id': 2021, 'title': 'Prevention of Acquisition of HIV: Preexposure Prophylaxis ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians prescribe preexposure prophylaxis using effective antiretroviral therapy to persons who are at increased risk of HIV acquisition to decrease the risk of acquiring HIV. \r\rSee the Practice Considerations section for more information about identification of persons at increased risk and about effective antiretroviral therapy.', 'servfreq': '', 'risktext': 'HIV is primarily acquired via sexual activity or injection drug use. It is important that clinicians routinely take a sexual and injection drug use history for all their patients in an open and nonjudgmental manner. All adolescents and adults who are sexually active or who inject drugs should be informed that acquisition of HIV can be prevented, to facilitate subsequent risk assessment and discussions about preexposure prophylaxis (PrEP) and other ways to prevent acquisition of HIV. Importantly, risk of HIV acquisition exists on a continuum, and currently available risk assessment tools all have limitations. However, certain risk factors or behaviors are known to place persons at increased risk of HIV.\r\nRisk of HIV acquisition depends on the likelihood that a specific act or activity will transmit HIV and the likelihood that a sex partner or drug injection partner has HIV. Likelihood of HIV transmission is highest with needle-sharing injection drug use and condomless receptive anal intercourse. Condomless receptive anal intercourse has an approximately 10- to 15-fold higher risk of transmission than condomless insertive anal sex and condomless receptive and insertive penile-vaginal sex. A 2018 study estimated the prevalence of HIV (ie, an estimate of the likelihood that a partner whose HIV status is unknown has HIV at a population level) as 12.4% among men who have sex with men and 1.9% among persons who inject drugs. The overall prevalence of HIV in the US is estimated at 0.3%.&nbsp;Of note, both the frequency of specific sexual activities and a person&rsquo;s number of sexual partners will also affect their risk of HIV.\r\n&nbsp;The USPSTF recommends that the following persons be considered for PrEP:\r\n1.&nbsp;&nbsp;&nbsp;&nbsp; Sexually active adults and adolescents weighing at least 35 kg (77 lb) who have engaged in anal or vaginal sex in the past 6 months and have any of the following:\r\n&nbsp;\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A sexual partner who has HIV (especially if the partner has an unknown or detectable viral load).\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A bacterial sexually transmitted infection (STI) (syphilis, gonorrhea, or chlamydia for men who have sex with men and transgender women; gonorrhea and syphilis for heterosexual women and men) in the past 6 months.\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A history of inconsistent or no condom use with sex partner(s) whose HIV status is not known; assessing risk in conversation with the patient and considering factors such as number of partners, the specific sexual activities a person engages in, and whether their sex partner or partners are in a group with a higher prevalence of HIV (eg, men who have sex with men or with men and women, transgender women, persons who inject drugs, and persons who engage in transactional sex).\r\n&nbsp;\r\n2. &nbsp; Persons who inject drugs and have a drug-injecting partner who has HIV or who shares injection equipment.\r\nPersons who engage in transactional sex, such as sex for money, drugs, or housing, including commercial sex workers or persons trafficked for sex work, constitute a group at increased risk of HIV acquisition and should be considered for PrEP based on the criteria outlined above. Persons who request PrEP may have undisclosed behaviors that put them at risk. Transgender women and men who are sexually active should be considered for PrEP based on the criteria outlined above. Transgender women are at especially high risk of HIV acquisition. A Centers for Disease Control and and Prevention (CDC) survey in 7 cities found an HIV prevalence of 42% among transgender women. Prevalence was highest among Black transgender women (62%) and Native American/Alaska Native transgender women (65%).\r\nIn addition, studies have found that transmission of HIV to a seronegative partner from a partner with HIV has not been observed when the partner with HIV was being treated with antiretroviral therapy and had a suppressed viral load.&nbsp;It is not known whether PrEP use further decreases the risk of HIV transmission when a partner with HIV has a documented undetectable viral load. Factors such as the consistency or inconsistency of a partner&rsquo;s viral load being suppressed, a partner&rsquo;s adherence to antiretroviral therapy, and the degree of certainty that a partner&rsquo;s viral load is suppressed (eg, self-report vs availability of laboratory test results) may help inform decisions about the use of PrEP in this situation.\r\nAll persons being considered for PrEP must have a recently documented negative HIV antigen-antibody test result, and if they have taken oral PrEP or postexposure prophylaxis in the past 3 months, or injectable cabotegravir in the past 12 months, the CDC recommends testing with both an HIV antigen-antibody assay and an HIV-1 RNA assay.'}, {'id': 186, 'title': 'Rh(D) Incompatibility: Screening ', 'grade': 'A', 'text': 'The DoctorAI strongly recommends Rh(D) blood typing and antibody testing for all pregnant women during their first visit for pregnancy-related care.', 'servfreq': 'First prenatal visit.', 'risktext': ''}, {'id': 1989, 'title': 'Syphilis Infection in Nonpregnant Adolescents and Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for syphilis infection in persons who are at increased risk for infection.', 'servfreq': 'Optimal screening frequency for persons who are at increased risk for syphilis infection is not well established. Men who have sex with men or persons with HIV infection may benefit from screening at least annually or more frequently (eg, every 3 to 6 months) if they continue to be at high risk.', 'risktext': 'The USPSTF recommends screening for syphilis in persons who are at increased risk for infection. When deciding which persons to screen for syphilis, clinicians should consider the prevalence of infection in the communities they serve, as well as other sociodemographic and behavioral factors that may be associated with increased risk of syphilis infection. For example, prevalence of syphilis is higher in men, men who have sex with men, persons with HIV infection, young adults, and persons with a history of incarceration, sex work, or military service. A substantial percentage of heterosexual syphilis transmission occurs among persons who use illicit drugs, particularly methamphetamine. Diagnosis of another STI may signal that a person is having condomless sex, which increases their risk of syphilis infection. Higher infection rates in persons of some racial and ethnic groups have been reported and are primarily a reflection of a combination of factors, including social determinants of health (eg, disparities of income, low educational achievement, and unstable housing), differential health insurance coverage or access to quality health care, and differences in sexual network characteristics (eg, individuals living in communities with a high prevalence of STIs have an increased chance of encountering an infected partner). Local prevalence rates may change over time, so clinicians should be aware of the latest data and trends for their specific population and geographic area, which are available through their state and local health departments and Centers for Disease Control and Prevention (CDC) surveillance.\r\n&nbsp;\r\nAlthough direct evidence on screening in nonpregnant persons who are not at increased risk for syphilis infection is lacking, based on the established test performance characteristics of current screening tests and the low prevalence rate of syphilis in this population, the yield of screening is likely low.9,10 Therefore, screening in this population may result in high false-positive rates and overtreatment.'}, {'id': 431, 'title': 'Syphilis Infection in Pregnant Women: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends early screening for syphilis infection in all pregnant women.', 'servfreq': 'All pregnant women should be tested for syphilis as early as possible when they first present to care. If a woman has not received prenatal care prior to delivery, she should be tested at the time she presents for delivery. In most cases of congenital syphilis, pregnant women received prenatal care but were not screened and treated for syphilis early enough during the pregnancy to prevent transmission to the fetus.', 'risktext': ''}, {'id': 1905, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and US Food and Drug Administration (FDA)--approved pharmacotherapy for cessation to nonpregnant adults who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 1906, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all pregnant persons about tobacco use, advise them to stop using tobacco, and provide behavioral interventions for cessation to pregnant persons who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 2014, 'title': 'Anxiety Disorders in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for anxiety disorders in adults, including pregnant and postpartum persons.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding optimal timing for screening, or screening interval, for both the perinatal and general adult populations; more evidence on both timing and screening interval is needed for all adult populations. A pragmatic approach in the absence of evidence might include screening all adults who have not been screened previously and using clinical judgment in considering risk factors, comorbid conditions, and life events to determine if additional screening of high-risk patients is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nRisk factors for anxiety disorders include sociodemographic factors, psychosocial factors, and physical and mental health factors such as marital status (widowed or divorced), stressful life events, smoking and alcohol use, other mental health conditions, or a parental history of mental disorders. Demographic factors such as low socioeconomic status and female sex are associated with higher rates of anxiety disorders.&nbsp;Black persons and individuals of non-Hispanic ethnicity are at increased risk of anxiety disorders due to social, rather than biological, factors. Anxiety and depressive disorders often overlap. One cohort study found that 67% of individuals with a depressive disorder also had a current anxiety disorder, and 75% had a lifetime comorbid anxiety disorder.'}, {'id': 1938, 'title': 'Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication ', 'grade': 'B', 'text': 'The DoctorAI recommends the use of low-dose aspirin (81 mg/day) as preventive medication after 12 weeks of gestation in persons who are at high risk for preeclampsia.\r\rSee the Practice Considerations section for information on high risk and aspirin dose.', 'servfreq': 'Once daily after 12 weeks of gestation', 'risktext': ' \r\nPersons with a history of preeclampsia in a previous pregnancy, type 1 or type 2 diabetes, and chronic hypertension are at highest risk for preeclampsia. Additional conditions that place a person at high risk for preeclampsia include multifetal gestation, conception using assisted reproductive technology, autoimmune disease, and kidney disease. Other factors associated with increased preeclampsia risk include nulliparity, high prepregnancy body mass index, family history of preeclampsia, and advanced maternal age (35 years or older). In addition, Black persons have higher rates of preeclampsia and are at increased risk for serious complications due to various societal and health inequities.\r\n '}, {'id': 513, 'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for asymptomatic bacteriuria using urine culture in pregnant persons.', 'servfreq': 'In general, screening is performed once at the first prenatal visit per clinical guidelines. However, there is little evidence on the optimal timing and frequency of screening for asymptomatic bacteriuria in pregnancy.2&nbsp; .&nbsp;Screen pregnant persons for asymptomatic bacteriuria using a midstream, clean-catch urine culture at the first prenatal visit or at 12 to 16 weeks of gestation, whichever is earlier. A urine culture showing &gt;100,000 CFU/mL of a single uropathogen or &gt;10,000 CFU/mL if the pathogen is group B streptococcus indicates treatment.', 'risktext': 'This recommendation applies to adults 18 years and older and pregnant persons of any age without signs and symptoms of a urinary tract infection. It does not apply to persons who have chronic medical or urinary tract conditions, such as end-stage renal disease; have indwelling urinary catheters, urinary stents, or spinal cord injuries; are hospitalized; reside in an institution (eg, a nursing home); or who are transplant recipients.\r\n&nbsp;\r\nThe risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6&nbsp;Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5&nbsp;Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7,&nbsp;11,&nbsp;12&nbsp;In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12&nbsp;Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4,&nbsp;6'}, {'id': 2009, 'title': 'Latent Tuberculosis Infection in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for LTBI in populations at increased risk.\r\rSee the "Assessment of Risk" section for additional information on adults at increased risk.', 'servfreq': 'The USPSTF found no evidence on the optimal frequency of screening for LTBI. In the absence of evidence, a reasonable approach is to repeat screening based on specific risk factors; screening frequency could range from 1-time only screening among persons at low risk for future tuberculosis exposure to annual screening among those at continued risk of exposure.', 'risktext': 'Populations at increased risk for LTBI, based on increased prevalence of active disease and increased risk of exposure, include persons who were born in, or are former residents of, countries with high tuberculosis prevalence and persons who live in, or have lived in, high-risk congregate settings (eg, homeless shelters or correctional facilities). Clinicians can consult their local or state health departments for more information about populations at increased risk in their community, since local demographic patterns may vary across the US.\r\nIn 2020, 71.5% of all cases of active tuberculosis in the US occurred among persons born outside the US. According to the CDC, tuberculosis disease is common in most countries in Latin America, the Caribbean, Africa, Asia, Eastern Europe, and Russia. In 2020, among persons with new tuberculosis living in the US who were born outside the US, the most common countries of birth were Mexico (18.0%), the Philippines (12.5%), India (10.4%), Vietnam (8.2%), and China (5.1%), accounting for 54.2% of total cases. Most of these cases are believed to be due to progression of latent infection to active tuberculosis disease rather than new transmission within communities.\r\nPersons who live, or have lived, in high-risk congregate settings also have a higher prevalence rate of active tuberculosis and an increased risk for exposure. In 2020, 4.3% of tuberculosis disease cases diagnosed in persons 15 years or older occurred in persons experiencing homelessness and 2.6% occurred in residents of correctional facilities. It is estimated that persons experiencing homelessness have an 11 times higher incidence of tuberculosis disease compared with persons who are not experiencing homelessness (36 cases per 100,000 population vs 2.9 cases per 100,000 population, respectively, during 2011 to 2016).\r\nOther populations at increased risk for LTBI or progression to active disease include persons who have immunosuppression (eg, persons living with HIV, patients receiving immunosuppressive medications such as chemotherapy or tumor necrosis factor inhibitors, and patients who have received an organ transplant) and patients with silicosis (a lung disease). However, given that screening in these populations may be considered standard care as part of disease management or indicated prior to the use of certain medications, the USPSTF did not review evidence on screening in these populations. Information on testing in these populations is provided by other groups, such as the Office of AIDS Research at the National Institutes of Health, and in a guideline issued jointly by the American Thoracic Society, Infectious Diseases Society of America, and CDC. Some evidence from observational studies has explored the association between poorly controlled diabetes and progression of LTBI to active disease. However, there is insufficient evidence on screening for and treatment of LTBI in persons with diabetes for the USPSTF to make a separate recommendation for this important population.\r\nPersons who are contacts of individuals with active tuberculosis, health care workers, and workers in high-risk congregate settings may also be at increased risk of exposure. Because screening in these populations is conducted as part of public health or employee health surveillance, the USPSTF did not review the evidence in these populations. Clinicians seeking further information about testing for tuberculosis in these populations can refer to the Additional Tools and Resources and Recommendations of Others sections.'}, {'id': 514, 'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic bacteriuria in nonpregnant adults.', 'servfreq': '', 'risktext': 'The risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6 Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5 Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7, 11, 12 In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12 Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4, 6'}, {'id': 507, 'title': 'BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing ', 'grade': 'B', 'text': 'The DoctorAI recommends that primary care clinicians assess women with a personal or family history of breast, ovarian, tubal, or peritoneal cancer or who have an ancestry associated with breast cancer susceptibility 1 and 2 (BRCA1/2) gene mutations with an appropriate brief familial risk assessment tool. Women with a positive result on the risk assessment tool should receive genetic counseling and, if indicated after counseling, genetic testing.', 'servfreq': 'Consideration of screening for potentially harmful BRCA mutations should begin once women have reached the age of consent (18 years). Primary care providers should periodically assess all patients for changes in family history (for example, comprehensive review at least every 5 to 10 years)', 'risktext': 'Patients with family or personal histories of breast, ovarian, tubal, or peritoneal cancer or ancestry associated with harmful&nbsp;&lt; i&gt;BRCA1/2&nbsp;mutations should be assessed using a familial risk assessment tool. The USPSTF found adequate evidence that these tools are accurate in identifying women with increased likelihood of&nbsp;&lt; i&gt;BRCA1/2mutations. Tools evaluated by the USPSTF include the Ontario Family History Assessment Tool, Manchester Scoring System, Referral Screening Tool, Pedigree Assessment Tool, 7-Question Family History Screening Tool, International Breast Cancer Intervention Study instrument (Tyrer-Cuzick), and brief versions of BRCAPRO. These tools should be used to guide referrals to genetic counseling.&nbsp;Persons should consider their sex at birth to determine which recommendation best applies to them.'}, {'id': 339, 'title': 'Breastfeeding: Primary Care Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends providing interventions during pregnancy and after birth to support breastfeeding.', 'servfreq': 'During pregnancy and after birth', 'risktext': "This recommendation applies to pregnant women, new mothers, and their infants and children. Interventions to support breastfeeding may also involve a woman's partner, other family members, and friends. This recommendation does not apply in circumstances where there are contraindications to breastfeeding (e.g., certain maternal medical conditions or infant metabolic disorders, such as galactosemia). The USPSTF did not review evidence on interventions directed at breastfeeding of preterm infants."}, {'id': 1935, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for chlamydia in all sexually active women 24 years or younger and in women 25 years or older who are at increased risk for infection.', 'servfreq': ' \r\nIn the absence of studies on screening intervals, a reasonable approach would be to screen patients whose sexual history reveals new or persistent risk factors since the last negative test result.\r\n ', 'risktext': ' \r\nAge is a strong predictor of risk for chlamydial and gonococcal infections, with the highest infection rates in women occurring during ages 15 to 24 years. Women 25 years or older are at increased risk if they have a new sex partner, more than 1 sex partner, a sex partner with concurrent partners, or a sex partner who has an STI; practice inconsistent condom use when not in a mutually monogamous relationship; or have a previous or coexisting STI. Exchanging sex for money or drugs and history of incarceration also are associated with increased risk.&nbsp;Clinicians should consider the communities they serve and may want to consult local public health authorities for information about local epidemiology and guidance on determining who is at increased risk.\r\n '}, {'id': 1936, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for gonorrhea in all sexually active women 24 years or younger and in women 25 years or older who are at increased risk for infection.', 'servfreq': ' \r\nIn the absence of studies on screening intervals, a reasonable approach would be to screen patients whose sexual history reveals new or persistent risk factors since the last negative test result.\r\n ', 'risktext': ' \r\nAge is a strong predictor of risk for chlamydial and gonococcal infections, with the highest infection rates in women occurring during ages 15 to 24 years. Women 25 years or older are at increased risk if they have a new sex partner, more than 1 sex partner, a sex partner with concurrent partners, or a sex partner who has an STI; practice inconsistent condom use when not in a mutually monogamous relationship; or have a previous or coexisting STI. Exchanging sex for money or drugs and history of incarceration also are associated with increased risk.&nbsp;Clinicians should consider the communities they serve and may want to consult local public health authorities for information about local epidemiology and guidance on determining who is at increased risk.\r\n '}, {'id': 1909, 'title': 'Asymptomatic Carotid Artery Stenosis: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic carotid artery stenosis in the general adult population.\r\rSee the Practice Considerations section for a description of adults at increased risk.', 'servfreq': '', 'risktext': ''}, {'id': 2017, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for suicide risk in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': '', 'risktext': ''}, {'id': 2016, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for depression in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding the optimal timing for screening for depression; more evidence is needed in both perinatal and general adult populations. In the absence of evidence, a pragmatic approach might include screening adults who have not been screened previously and using clinical judgment while considering risk factors, comorbid conditions, and life events to determine if additional screening of patients at increased risk is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nThe USPSTF recommends screening for depression in all adults regardless of risk factors. Risk factors for depression include a combination of genetic, biological, and environmental factors, such as a family history of depression, prior episode of depression or other mental health condition, a history of trauma or adverse life events, or a history of disease or illness (eg, cardiovascular disease).\r\nPrevalence rates vary by sex, age, race, ethnicity, education, marital status, geographic location, poverty level, and employment status. Women have twice the risk of depression compared with men. Young adults, multiracial individuals, and Native American/Alaska Native individuals have higher rates of depression.\r\nRisk factors for perinatal depression include life stress, low social support, history of depression, marital or partner dissatisfaction, and a history of abuse.'}, {'id': 1932, 'title': 'Gestational Diabetes: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for gestational diabetes in asymptomatic pregnant persons at 24 weeks of gestation or after.', 'servfreq': 'At 24 weeks of gestation or after to improve maternal and fetal outcomes', 'risktext': ' \r\nSeveral factors increase a person&rsquo;s risk for developing gestational diabetes, including obesity, increased maternal age, history of gestational diabetes, family history of diabetes, and belonging to a racial/ethnic group that is at increased risk for developing type 2 diabetes (Hispanic, Native American, South or East Asian, or Pacific Islander descent).4,19,20 Factors associated with a lower risk for developing gestational diabetes include age younger than 25 to 30 years, White race, a body mass index (BMI) of 25 or less (calculated as weight in kilograms divided by height in meters squared), no family history (in a first-degree relative) of diabetes, and no history of glucose intolerance or adverse pregnancy outcomes related to gestational diabetes.21-23 The risk in different racial/ethnic groups may be due in part to social risk factors such as low socioeconomic status or structural racism, although these associations are not examined in the current evidence. Although a higher BMI increases the risk of gestational diabetes across racial/ethnic groups, the association varies. In Asian American persons, the prevalence of gestational diabetes at a BMI of 22 to less than 25 is similar to the prevalence in Hispanic persons, non-Hispanic White persons, and Black persons with a higher (&gt;28) BMI.24,25\r\n '}, {'id': 1845, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends offering or referring adults with cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity.', 'servfreq': '', 'risktext': 'Adults 18 years or older at increased risk of CVD, defined as those with 1 or more of the following:\r\n1.Hypertension or elevated blood pressure2.Dyslipidemia3.Mixed or multiple risk factors such as the metabolic syndrome or an estimated 10-year CVD risk of &ge;7.5%\r\nThis recommendation does not apply to adults with other known modifiable cardiovascular risk factors such as abnormal blood glucose levels, obesity, and smoking; these populations are incorporated in other USPSTF recommendations.'}, {'id': 1931, 'title': 'Healthy Weight and Weight Gain In Pregnancy: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer pregnant persons effective behavioral counseling interventions aimed at promoting healthy weight gain and preventing excess gestational weight gain in pregnancy.', 'servfreq': 'Throughout pregnancy', 'risktext': 'Pregnancy'}, {'id': 1885, 'title': 'Hepatitis B Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in adolescents and adults at increased risk for infection.\r\rSee the Practice Considerations section for a description of adolescents and adults at increased risk for infection.', 'servfreq': 'For patients with negative HBsAg results who have not received the HBV vaccine series, periodic screening may be useful for those who report continued risk for acquiring HBV transmission, such as persons who continue to inject drugs and men who have sex with men. Clinical judgment should be used to determine screening frequency. The USPSTF found no evidence to determine optimal screening intervals.', 'risktext': 'Persons from such risk groups include persons who have injected drugs in the past or currently; men who have sex with men; persons with HIV; and sex partners, needle-sharing contacts, and household contacts of persons known to be HBsAg positive. Some persons with combinations of risk factors who are not members of risk factor groups listed above may also be at increased risk for HBV infection.'}, {'id': 524, 'title': 'Hepatitis C Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis C virus (HCV) infection in adults aged 18 to 79 years.', 'servfreq': 'One-time screening for most adults.\r\nPeriodically screen persons with continued risk for HCV infection (eg, persons with past or current injection drug use). There is limited evidence to determine how often to screen persons at increased risk.&nbsp;', 'risktext': 'Asymptomatic adults aged 18 to 79 years (including pregnant persons) without known liver disease.&nbsp;\r\nThe USPSTF also suggests that clinicians consider screening persons younger than 18 years and older than 79 years who are at high risk for infection (eg, those with past or current injection drug use).&nbsp;'}, {'id': 2023, 'title': 'Hypertensive Disorders of Pregnancy: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hypertensive disorders in pregnant persons with blood pressure measurements throughout pregnancy.', 'servfreq': 'Screening Interval\r\nBlood pressure measurements should be obtained during each prenatal care visit throughout pregnancy. Hypertensive disorders of pregnancy can quickly evolve into severe disease that can result in serious, even fatal, maternal and infant health outcomes. The ability to screen for hypertensive disorders of pregnancy using blood pressure measurements is important to identify and effectively treat a potentially unpredictable and fatal condition. While it is known that risk continues into the immediate postpartum period, there is little evidence regarding screening during this period. A pragmatic approach would be for patients to be counseled regarding signs and symptoms of preeclampsia at hospital discharge and for patients with hypertensive disorders to have subsequent blood pressure checks.\r\nScreening for hypertensive disorders of pregnancy alone is not sufficient to improve inequities in health outcomes. Identifying hypertensive disorders of pregnancy requires adequate prenatal visits, surveillance, and evidence-based care in response to evolving patient signs and symptoms during pregnancy and the postpartum period to improve health outcomes. Black and Native American/Alaska Native persons have lower rates of prenatal visits and are at greater risk of serious postpartum morbidity and hospital readmission after delivery. Screening and monitoring of Black and Hispanic/Latina individuals during the postpartum period could be an important step for reducing health inequities by preventing serious adverse events. In addition, screening and monitoring by various health care providers (eg, nurse midwives, nurses, pediatricians, doulas, and lactation consultants) could also help avert serious complications in the postpartum period.', 'risktext': 'Assessment of Risk\r\nImportant clinical conditions associated with increased risk for preeclampsia include a history of eclampsia or preeclampsia in a prior pregnancy, a previous adverse pregnancy outcome, and maternal comorbid conditions (including type 1 or type 2 diabetes prior to pregnancy, gestational diabetes, chronic hypertension, kidney disease, and autoimmune diseases).\r\n&nbsp;Other factors associated with increased risk of preeclampsia and gestational hypertension include nulliparity, high prepregnancy body mass index, family history of preeclampsia, multifetal gestation, and the pregnant individual being 35 years or older.\r\nThe higher prevalence of hypertensive disorders of pregnancy and the increased risk for severe complications seen in Black persons may be due to their disproportionate burden of social and clinical risk factors. These social and clinical determinants largely result from historical and current manifestations of structural racism that influence environmental exposures, access to health resources, and overall health status.'}, {'id': 434, 'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians screen for intimate partner violence (IPV) in women of reproductive age and provide or refer women who screen positive to ongoing support services. See the Clinical Considerations section for more information on effective ongoing support services for IPV and for information on IPV in men.', 'servfreq': 'The USPSTF found no evidence on appropriate intervals for screening. Randomized clinical trials (RCTs) of screening and interventions for IPV often screen for current IPV or IPV in the past year.\r\n&nbsp;', 'risktext': 'All women of reproductive age are at potential risk for IPV and should be screened. There are a variety of factors that increase risk of IPV, such as exposure to violence as a child, young age, unemployment, substance abuse, marital difficulties, and economic hardships.\r\nRisk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health. For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.'}, {'id': 187, 'title': 'Rh(D) Incompatibility: Screening ', 'grade': 'B', 'text': "The DoctorAI recommends repeated Rh(D) antibody testing for all unsensitized Rh(D)-negative women at 24 to 28 weeks' gestation, unless the biological father is known to be Rh(D)-negative.", 'servfreq': 'Repeat testing at 24-28 weeks gestation.', 'risktext': ''}, {'id': 1916, 'title': 'Lung Cancer: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery.', 'servfreq': ' \r\nThe USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. ', 'risktext': ' \r\nSmoking and older age are the 2 most important risk factors for lung cancer.&nbsp;The risk of lung cancer in persons who smoke increases with cumulative quantity and duration of smoking and with age but decreases with increasing time since quitting for persons who formerly smoked.3 The USPSTF considers adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years to be at high risk and recommends screening for lung cancer with annual LDCT in this population. \r\n \r\n&nbsp;\r\n \r\nAfrican American/Black (Black) men have a higher incidence of lung cancer than White men, and Black women have a lower incidence than White women.1 These differences are likely related to differences in smoking exposure (ie, prevalence of smoking) and related exposure to carcinogens in cigarettes.7,8 The differences may also be related to other social risk factors.\r\n \r\n&nbsp;\r\n \r\nOther risk factors for lung cancer include environmental exposures, prior radiation therapy, other (noncancer) lung diseases, and family history. Lower level of education is also associated with a higher risk of lung cancer.7 The task force recommends using age and smoking history to determine screening eligibility rather than more elaborate risk prediction models because there is insufficient evidence to assess whether risk prediction model&ndash;based screening would improve outcomes relative to using the risk factors of age and smoking history for broad implementation in primary care.\r\n '}, {'id': 449, 'title': 'Perinatal Depression: Preventive Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians provide or refer pregnant and postpartum persons who are at increased risk of perinatal depression to counseling interventions.', 'servfreq': '', 'risktext': 'Include&nbsp;a past history of depression. Current depressive symptoms (that do not reach a diagnostic threshold),&nbsp;history of physical or sexual abuse,&nbsp;unplanned or unwanted pregnancy,&nbsp;stressful life events,&nbsp;lack of social and financial support,&nbsp;intimate partner violence,pregestational or gestational diabetes,and complications during pregnancy. Additional risk factors include adolescent parenthood, low socioeconomic status, and lack of social support.&nbsp;Genetic factors are also suspected to contribute to women&rsquo;s risk of developing perinatal depression.'}, {'id': 1445, 'title': 'Sexually Transmitted Infections: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends behavioral counseling for all sexually active adolescents and for adults who are at increased risk for sexually transmitted infections (STIs).\r\rSee the Practice Considerations section for more information on populations at increased risk for acquiring STIs.', 'servfreq': '', 'risktext': 'All sexually active adolescents are at increased risk for STIs because of the high rates of STIs in this age group and should receive behavioral counseling interventions. Adults at increased risk for STIs include those who currently have an STI or were diagnosed with one within the past year, do not consistently use condoms, have multiple sex partners, or have sex partners within populations with a high prevalence of STIs. Populations with a high prevalence of STIs include persons who seek STI testing or attend STI clinics; sexual and gender minorities; persons who are living with HIV, inject drugs, have exchanged sex for money or drugs, or have entered correctional facilities; and some racial/ethnic minority groups.1-4'}, {'id': 402, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends counseling young adults, adolescents, children, and parents of young children about minimizing exposure to ultraviolet (UV) radiation for persons aged 6 months to 24 years with fair skin types to reduce their risk of skin cancer.', 'servfreq': '', 'risktext': 'Fair skin types'}, {'id': 438, 'title': 'Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for unhealthy alcohol use in primary care settings in adults 18 years or older, including pregnant women, and providing persons engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce unhealthy alcohol use.', 'servfreq': 'The USPSTF did not find adequate evidence to recommend an optimal screening interval for unhealthy alcohol use in adults.&nbsp;Brief behavioral counseling interventions were found to reduce unhealthy alcohol use in adults 18 years or older, including pregnant women. Effective behavioral counseling interventions vary in their specific components, administration, length, and number of interactions. The USPSTF was unable to identify specific intervention characteristics or components that were clearly associated with improved outcomes.', 'risktext': 'engaged in risky or hazardous drinking'}, {'id': 767, 'title': 'Unhealthy Drug Use: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening by asking questions about unhealthy drug use in adults age 18 years or older. Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. \r(Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'servfreq': 'Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. (Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'risktext': 'These include being aged 18 to 25 years; male sex; having a mental health condition, personality or mood disorder, or nicotine or alcohol dependence; a history of physical or sexual abuse, parental neglect, or other adversity in childhood; or drug or alcohol addiction in a first-degree relative.1,9&nbsp;Factors associated with misuse of prescription drugs include history of other drug use, mental illness, pain, and greater access to prescription drugs.10&nbsp;Factors associated with prenatal use of drugs include a mental health disorder, interpersonal violence, and family history of substance use.11'}, {'id': 433, 'title': 'Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer or refer adults with a body mass index (BMI) of 30 or higher (calculated as weight in kilograms divided by height in meters squared) to intensive, multicomponent behavioral interventions.', 'servfreq': '', 'risktext': 'Adults with a BMI &ge;30'}, {'id': 1979, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: Behavioral Counseling Interventions ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians individualize the decision to offer or refer adults without cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity. \r\rSee the "Practice Considerations" section for information on determining which patients may benefit most from this service.', 'servfreq': '', 'risktext': ''}, {'id': 508, 'title': 'BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine risk assessment, genetic counseling, or genetic testing for women whose personal or family history or ancestry is not associated with potentially harmful BRCA1/2 gene mutations.', 'servfreq': '', 'risktext': 'Patients with family or personal histories of breast, ovarian, tubal, or peritoneal cancer or ancestry associated with harmful&nbsp;BRCA1/2&nbsp;mutations should be assessed using a familial risk assessment tool. The USPSTF found adequate evidence that these tools are accurate in identifying women with increased likelihood of&nbsp;BRCA1/2mutations. Tools evaluated by the USPSTF include the Ontario Family History Assessment Tool, Manchester Scoring System, Referral Screening Tool, Pedigree Assessment Tool, 7-Question Family History Screening Tool, International Breast Cancer Intervention Study instrument (Tyrer-Cuzick), and brief versions of BRCAPRO. These tools should be used to guide referrals to genetic counseling.'}, {'id': 525, 'title': 'Bacterial Vaginosis in Pregnant Persons to Prevent Preterm Delivery: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for bacterial vaginosis (BV) in pregnant persons who are not at increased risk for preterm delivery.', 'servfreq': '', 'risktext': '\r\nAssess risk for preterm delivery. There are multiple factors that increase risk for preterm delivery; one of the strongest risk factors is prior preterm delivery.\r\nDecide whether or not to screen for bacterial vaginosis:\r\n\r\na. Do not screen pregnant persons who are not at increased risk for preterm delivery.\r\nb. Evidence is insufficient to recommend for or against screening pregnant persons at increased risk for preterm delivery.'}, {'id': 418, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening with resting or exercise electrocardiography (ECG) to prevent cardiovascular disease (CVD) events in asymptomatic adults at low risk of CVD events.', 'servfreq': '', 'risktext': ''}, {'id': 429, 'title': 'Cervical Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for cervical cancer in women who have had a hysterectomy with removal of the cervix and do not have a history of a high-grade precancerous lesion (ie, cervical intraepithelial neoplasia [CIN] grade 2 or 3) or cervical cancer.', 'servfreq': '', 'risktext': ''}, {'id': 428, 'title': 'Cervical Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for cervical cancer in women younger than 21 years.', 'servfreq': '', 'risktext': ''}, {'id': 1973, 'title': 'Chronic Obstructive Pulmonary Disease: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for chronic obstructive pulmonary disease in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 2003, 'title': 'Genital Herpes Infection: Serologic Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine serologic screening for genital herpes simplex virus infection in asymptomatic adolescents and adults, including pregnant persons.', 'servfreq': '', 'risktext': 'The USPSTF found no evidence of externally validated, reliable risk stratification tools to identify individuals more or less likely to have genital herpes.'}, {'id': 504, 'title': 'Pancreatic Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for pancreatic cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 365, 'title': 'Thyroid Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for thyroid cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 1976, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'D', 'text': 'The DoctorAI recommends against the use of beta carotene or vitamin E supplements for the prevention of cardiovascular disease or cancer.', 'servfreq': '', 'risktext': ''}, {'id': 318, 'title': 'Autism Spectrum Disorder in Young Children: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for autism spectrum disorder (ASD) in young children for whom no concerns of ASD have been raised by their parents or a clinician.', 'servfreq': '', 'risktext': 'Although a number of potential risk factors for ASD have been identified, there is insufficient evidence to determine if certain risk factors modify the performance characteristics of ASD screening tests, such as the age at which screening is performed or other characteristics of the child or family.'}, {'id': 526, 'title': 'Bacterial Vaginosis in Pregnant Persons to Prevent Preterm Delivery: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for BV in pregnant persons who are at increased risk for preterm delivery.', 'servfreq': '', 'risktext': ''}, {'id': 65, 'title': 'Bladder Cancer in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults.\r\rLiterature scans conducted in July 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'This evidence update focused on the benefits and harms of screening for bladder cancer among people without symptoms, the accuracy of screening tests done in primary care settings, and the benefits and harms of treatment. The updated evidence review did not find any new high quality evidence to adequately determine the balance of benefits and harms of screening for bladder cancer. However, bladder cancer is a common cancer and can cause considerable health problems including death. Therefore, the USPSTF determined that the evidence was insufficient to provide a recommendation for or against bladder cancer screening.  The USPSTF emphasizes the need for additional research in this area. '}, {'id': 2037, 'title': 'Breast Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of supplemental screening for breast cancer using breast ultrasonography or magnetic resonance imaging (MRI) in women identified to have dense breasts on an otherwise negative screening mammogram.\r\rSee the "Practice Considerations" section for more information on the patient population to whom this recommendation applies and on screening mammography modalities.', 'servfreq': '', 'risktext': 'These recommendations apply to cisgender women and all other persons assigned female at birth (including transgender men and nonbinary persons) 40 years or older at average risk of breast cancer. \r\nThese recommendations apply to persons who have factors associated with an increased risk of breast cancer, such as a family history of breast cancer (ie, a first-degree relative with breast cancer) or having dense breasts. They do not apply to persons who have a genetic marker or syndrome associated with a high risk of breast cancer (eg, BRCA1 or BRCA2 genetic variation), a history of high-dose radiation therapy to the chest at a young age, or previous breast cancer or a high-risk breast lesion on previous biopsies. '}, {'id': 419, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening with resting or exercise ECG to prevent CVD events in asymptomatic adults at intermediate or high risk of CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 423, 'title': 'Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of adding the ankle-brachial index (ABI), high-sensitivity C-reactive protein (hsCRP) level, or coronary artery calcium (CAC) score to traditional risk assessment for cardiovascular disease (CVD) in asymptomatic adults to prevent CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 352, 'title': 'Celiac Disease: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'persons with family history or other risk factors'}, {'id': 1955, 'title': 'Eating Disorders in Adolescents and Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for eating disorders in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1933, 'title': 'Gestational Diabetes: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for gestational diabetes in asymptomatic pregnant persons before 24 weeks of gestation.', 'servfreq': '', 'risktext': ''}, {'id': 665, 'title': 'Illicit Drug Use in Children, Adolescents, and Young Adults: Primary Care-Based Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--based behavioral counseling interventions to prevent illicit drug use, including nonmedical use of prescription drugs, in children, adolescents, and young adults.\r\rSee the Practice Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 435, 'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for abuse and neglect in all older or vulnerable adults. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': 'Risk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health.14&nbsp;For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.15'}, {'id': 2045, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for iron deficiency and iron deficiency anemia in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2046, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine iron supplementation in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2018, 'title': 'Lipid Disorders in Children and Adolescents: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1998, 'title': 'Obstructive Sleep Apnea in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for obstructive sleep apnea in the general adult population.\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Risk Factors\r\nRisk factors associated with OSA include male sex, older age (40-70 years), postmenopausal status, higher body mass index (BMI), and craniofacial and upper airway abnormalities (eg, enlarged tonsils or long upper airway). Black, Hispanic/Latino, and Native American/Alaska Native persons have a higher prevalence of OSA compared with White persons; some evidence suggests that these differences are partially explained by higher rates of obesity, asthma, and tobacco use among these groups.8'}, {'id': 1977, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of multivitamin supplements for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1978, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of single or paired nutrient supplements (other than beta carotene and vitamin E) for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 176, 'title': 'Oral Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for oral cancer in asymptomatic adults.\r\rGo to the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in July 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Tobacco and alcohol use are major risk factors for oral cancer. A total of 20% to 30% of cases of oral cancer worldwide are attributable to cigarette smoking. In the United States, up to 75% of cases of oral cancer may be attributable to tobacco and alcohol use. Additional risk factors include male sex, older age, use of betel quid, ultraviolet light exposure, infection with Candida or bacterial flora, and a compromised immune system. Sexually transmitted oral HPV infection (HPV-16) has recently been recognized as an increasingly important risk factor for oropharyngeal cancer. In the United States, the prevalence of oropharyngeal cancer due to oral HPV infection is probably as high as 80% to 95%. The prevalence of oral HPV infection is associated with age, sex, number of sexual partners, and number of cigarettes smoked per day. The effect of multifactorial risk assessment and screening for risk factors on oral cancer morbidity and mortality is unknown.'}, {'id': 2026, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine screening performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 2027, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of preventive interventions performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 424, 'title': 'Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for peripheral artery disease (PAD) and cardiovascular disease (CVD) risk with the ankle-brachial index (ABI) in asymptomatic adults.\r\rLiterature scans conducted in August 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Risk factors associated with OSA include male sex, older age (40 to 70 years), postmenopausal status, higher BMI, and craniofacial and upper airway abnormalities.'}, {'id': 404, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of counseling adults about skin self-examination to prevent skin cancer.See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 2005, 'title': 'Skin Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Exposure to UV radiation from sun exposure, indoor tanning beds, and other UV radiation&ndash;emitting devices is the major environmental risk factor for skin cancer. History of frequent sunburns, older age, and male sex are associated with increased risk for skin cancer. Exposure to UV radiation from the use of indoor tanning beds is an important risk factor in adolescents. Incidence of melanoma is higher among White persons compared with persons of other races and ethnicities. This difference likely reflects traits associated with increased melanoma risk, such as fair skin (which is more susceptible to sunburning), light-colored eyes, and red or blond hair being more common among White persons compared with persons of other races and ethnicities. Acral lentiginous melanoma, which occurs mostly on skin not frequently exposed to direct sunlight (eg, palms of hands, soles of feet, or under fingernails or toenails), is the most common type of melanoma among Black populations. Other melanoma risk factors include higher numbers of moles on the skin, atypical moles, as well as a personal and family history of skin cancer.'}, {'id': 269, 'title': 'Thyroid Dysfunction: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults.\r\rSee the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': 'The optimal screening interval for thyroid dysfunction (if one exists) is unknown.', 'risktext': 'The most common cause of hypothyroidism in the United States is chronic autoimmune (Hashimoto) thyroiditis. Risk factors for an elevated TSH level include female sex, advancing age, white race, type 1 diabetes, Down syndrome, family history of thyroid disease, goiter, previous hyperthyroidism (possibly due in part to ablation therapy leading to iatrogenic thyroid dysfunction), and external-beam radiation in the head and neck area. Common causes of hyperthyroidism include Graves disease, Hashimoto thyroiditis, and functional thyroid nodules. Risk factors for a low TSH level include female sex; advancing age; black race; low iodine intake; personal or family history of thyroid disease; and ingestion of iodine-containing drugs, such as amiodarone. The USPSTF found no direct evidence that treatment of thyroid dysfunction based on risk level alters final health outcomes.'}, {'id': 1908, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of electronic cigarettes (e-cigarettes) for tobacco cessation in adults, including pregnant persons. The USPSTF recommends that clinicians direct patients who use tobacco to other tobacco cessation interventions with proven effectiveness and established safety.\rSee the Practice Considerations section for more information on recommended behavioral interventions and pharmacotherapy and for suggestions for practice regarding the I statements.', 'servfreq': '', 'risktext': ''}, {'id': 1907, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of pharmacotherapy interventions for tobacco cessation in pregnant persons.', 'servfreq': '', 'risktext': ''}, {'id': 586, 'title': 'Tobacco Use in Children and Adolescents: Primary Care Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--feasible interventions for the cessation of tobacco use among school-aged children and adolescents.\r\rSee the Practice Considerations section for more information on effective interventions to prevent initiation of tobacco use and for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1919, 'title': 'Vitamin D Deficiency in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 408, 'title': 'Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of the benefits and harms of vitamin D and calcium supplementation, alone or combined, for the primary prevention of fractures in men and premenopausal women.', 'servfreq': '', 'risktext': ''}]}
2025-01-29 22:00:57 [INFO] Recommendations fetched: [{'id': 2020, 'title': 'Folic Acid Supplementation to Prevent Neural Tube Defects: Preventive Medication ', 'grade': 'A', 'text': 'The DoctorAI recommends that all persons planning to or who could become pregnant take a daily supplement containing 0.4 to 0.8 mg (400 to 800 mcg) of folic acid.', 'servfreq': 'The neural plate completes its formation and closure early in pregnancy (usually 26 to 28 days after fertilization). This means the critical period for folic acid supplementation starts at least 1 month before conception and continues through the first 2 to 3 months of pregnancy. Nearly half of all pregnancies in the US are unplanned; to gain the full benefits of supplementation, clinicians should advise all persons who plan to or who could become pregnant to take daily folic acid.', 'risktext': 'All pregnancies are at risk for neural tube defects, and persons who are planning to or could become pregnant should take folic acid supplements. Certain risk factors convey a higher risk, and individuals with these risk factors should talk to their health care professional. These factors include personal, partner, or family history of neural tube defects, malabsorption caused by bariatric procedures, the use of certain antiseizure medicines, and genetic mutations in folate-related enzymes. Pregestational diabetes and obesity have been associated with an increased risk of neural tube defects. Ethnic groups such as First Nation persons in Canada and Hispanic persons in California are thought to be at higher risk of neural tube defects. It is unclear, however, whether this is related to a higher risk of genetic variations among these groups or due to differential intake of folic acid&ndash;fortified foods.'}, {'id': 503, 'title': 'Hepatitis B Virus Infection in Pregnant Women: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in pregnant women at their first prenatal visit', 'servfreq': 'A test for HBsAg should be ordered at the first prenatal visit. Women with unknown HBsAg status or with new or continuing risk factors for HBV infection (eg, injection drug use or a sexually transmitted infection) should be screened at the time of admission to a hospital or other delivery setting.', 'risktext': 'In the United States, new cases of HBV among adults are largely transmitted through injection drug use or sexual intercourse, but most prevalent cases of HBV infection are chronic infections from exposure occurring in infancy or childhood. Another major risk factor for HBV infection is country of origin. In the United States, adults with HBV born in high-prevalence countries were commonly infected during childhood. In children, the primary source of infection is perinatal transmission at birth.'}, {'id': 485, 'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in adolescents and adults aged 15 to 65 years. Younger adolescents and older adults who are at increased risk of infection should also be screened.\rSee the Clinical Considerations section for more information about assessment of risk, screening intervals, and rescreening in pregnancy.', 'servfreq': 'The USPSTF found insufficient evidence to determine appropriate or optimal time intervals or strategies for repeat HIV screening. However, repeat screening is reasonable for persons known to be at increased risk of HIV infection, such as sexually active men who have sex with men; persons with a sex partner who is living with HIV; or persons who engage in behaviors that may convey an increased risk of HIV infection, such as injection drug use, transactional sex or commercial sex work, having 1 or more new sex partners whose HIV status is unknown, or having other factors that can place a person at increased risk of HIV infection (see &ldquo;Risk Assessment&rdquo;). Repeat screening is also reasonable for persons who live or receive medical care in a high-prevalence setting, such as a sexually transmitted disease clinic, tuberculosis clinic, correctional facility, or homeless shelter.', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'id': 486, 'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in all pregnant persons, including those who present in labor or at delivery whose HIV status is unknown.', 'servfreq': 'The CDC and ACOG recommend repeat prenatal screening for HIV during the third trimester of pregnancy in women with risk factors for HIV acquisition and in women living or receiving care in high-incidence settings, and the CDC notes that repeat screening for HIV during the third trimester may be considered in all women.&nbsp;', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'id': 1921, 'title': 'Hypertension in Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hypertension in adults 18 years or older with office blood pressure measurement (OBPM). The USPSTF recommends obtaining blood pressure measurements outside of the clinical setting for diagnostic confirmation before starting treatment.', 'servfreq': ' \r\nAlthough evidence on optimal screening intervals is limited, reasonable options include:\r\n \r\n \r\n\r\n\r\nScreening for hypertension every year in adults 40 years or older and in adults at increased risk for hypertension (such as Black persons, persons with high-normal blood pressure, or persons who are overweight or obese)\r\n\r\n\r\n \r\n \r\n\r\n\r\nScreening less frequently (ie, every 3 to 5 years) as appropriate for adults aged 18 to 39 years not at increased risk for hypertension and with a prior normal blood pressure reading.\r\n\r\n\r\n ', 'risktext': ' \r\nAlthough all adults should be screened for hypertension, risk factors that increase a person&rsquo;s risk for the condition include older age, Black race, family history, excess weight and obesity, lifestyle habits (lack of physical activity, stress, and tobacco use), and dietary factors (diet high in fat or sodium, diet low in potassium, or excessive alcohol intake)\r\n '}, {'id': 2021, 'title': 'Prevention of Acquisition of HIV: Preexposure Prophylaxis ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians prescribe preexposure prophylaxis using effective antiretroviral therapy to persons who are at increased risk of HIV acquisition to decrease the risk of acquiring HIV. \r\rSee the Practice Considerations section for more information about identification of persons at increased risk and about effective antiretroviral therapy.', 'servfreq': '', 'risktext': 'HIV is primarily acquired via sexual activity or injection drug use. It is important that clinicians routinely take a sexual and injection drug use history for all their patients in an open and nonjudgmental manner. All adolescents and adults who are sexually active or who inject drugs should be informed that acquisition of HIV can be prevented, to facilitate subsequent risk assessment and discussions about preexposure prophylaxis (PrEP) and other ways to prevent acquisition of HIV. Importantly, risk of HIV acquisition exists on a continuum, and currently available risk assessment tools all have limitations. However, certain risk factors or behaviors are known to place persons at increased risk of HIV.\r\nRisk of HIV acquisition depends on the likelihood that a specific act or activity will transmit HIV and the likelihood that a sex partner or drug injection partner has HIV. Likelihood of HIV transmission is highest with needle-sharing injection drug use and condomless receptive anal intercourse. Condomless receptive anal intercourse has an approximately 10- to 15-fold higher risk of transmission than condomless insertive anal sex and condomless receptive and insertive penile-vaginal sex. A 2018 study estimated the prevalence of HIV (ie, an estimate of the likelihood that a partner whose HIV status is unknown has HIV at a population level) as 12.4% among men who have sex with men and 1.9% among persons who inject drugs. The overall prevalence of HIV in the US is estimated at 0.3%.&nbsp;Of note, both the frequency of specific sexual activities and a person&rsquo;s number of sexual partners will also affect their risk of HIV.\r\n&nbsp;The USPSTF recommends that the following persons be considered for PrEP:\r\n1.&nbsp;&nbsp;&nbsp;&nbsp; Sexually active adults and adolescents weighing at least 35 kg (77 lb) who have engaged in anal or vaginal sex in the past 6 months and have any of the following:\r\n&nbsp;\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A sexual partner who has HIV (especially if the partner has an unknown or detectable viral load).\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A bacterial sexually transmitted infection (STI) (syphilis, gonorrhea, or chlamydia for men who have sex with men and transgender women; gonorrhea and syphilis for heterosexual women and men) in the past 6 months.\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A history of inconsistent or no condom use with sex partner(s) whose HIV status is not known; assessing risk in conversation with the patient and considering factors such as number of partners, the specific sexual activities a person engages in, and whether their sex partner or partners are in a group with a higher prevalence of HIV (eg, men who have sex with men or with men and women, transgender women, persons who inject drugs, and persons who engage in transactional sex).\r\n&nbsp;\r\n2. &nbsp; Persons who inject drugs and have a drug-injecting partner who has HIV or who shares injection equipment.\r\nPersons who engage in transactional sex, such as sex for money, drugs, or housing, including commercial sex workers or persons trafficked for sex work, constitute a group at increased risk of HIV acquisition and should be considered for PrEP based on the criteria outlined above. Persons who request PrEP may have undisclosed behaviors that put them at risk. Transgender women and men who are sexually active should be considered for PrEP based on the criteria outlined above. Transgender women are at especially high risk of HIV acquisition. A Centers for Disease Control and and Prevention (CDC) survey in 7 cities found an HIV prevalence of 42% among transgender women. Prevalence was highest among Black transgender women (62%) and Native American/Alaska Native transgender women (65%).\r\nIn addition, studies have found that transmission of HIV to a seronegative partner from a partner with HIV has not been observed when the partner with HIV was being treated with antiretroviral therapy and had a suppressed viral load.&nbsp;It is not known whether PrEP use further decreases the risk of HIV transmission when a partner with HIV has a documented undetectable viral load. Factors such as the consistency or inconsistency of a partner&rsquo;s viral load being suppressed, a partner&rsquo;s adherence to antiretroviral therapy, and the degree of certainty that a partner&rsquo;s viral load is suppressed (eg, self-report vs availability of laboratory test results) may help inform decisions about the use of PrEP in this situation.\r\nAll persons being considered for PrEP must have a recently documented negative HIV antigen-antibody test result, and if they have taken oral PrEP or postexposure prophylaxis in the past 3 months, or injectable cabotegravir in the past 12 months, the CDC recommends testing with both an HIV antigen-antibody assay and an HIV-1 RNA assay.'}, {'id': 186, 'title': 'Rh(D) Incompatibility: Screening ', 'grade': 'A', 'text': 'The DoctorAI strongly recommends Rh(D) blood typing and antibody testing for all pregnant women during their first visit for pregnancy-related care.', 'servfreq': 'First prenatal visit.', 'risktext': ''}, {'id': 1989, 'title': 'Syphilis Infection in Nonpregnant Adolescents and Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for syphilis infection in persons who are at increased risk for infection.', 'servfreq': 'Optimal screening frequency for persons who are at increased risk for syphilis infection is not well established. Men who have sex with men or persons with HIV infection may benefit from screening at least annually or more frequently (eg, every 3 to 6 months) if they continue to be at high risk.', 'risktext': 'The USPSTF recommends screening for syphilis in persons who are at increased risk for infection. When deciding which persons to screen for syphilis, clinicians should consider the prevalence of infection in the communities they serve, as well as other sociodemographic and behavioral factors that may be associated with increased risk of syphilis infection. For example, prevalence of syphilis is higher in men, men who have sex with men, persons with HIV infection, young adults, and persons with a history of incarceration, sex work, or military service. A substantial percentage of heterosexual syphilis transmission occurs among persons who use illicit drugs, particularly methamphetamine. Diagnosis of another STI may signal that a person is having condomless sex, which increases their risk of syphilis infection. Higher infection rates in persons of some racial and ethnic groups have been reported and are primarily a reflection of a combination of factors, including social determinants of health (eg, disparities of income, low educational achievement, and unstable housing), differential health insurance coverage or access to quality health care, and differences in sexual network characteristics (eg, individuals living in communities with a high prevalence of STIs have an increased chance of encountering an infected partner). Local prevalence rates may change over time, so clinicians should be aware of the latest data and trends for their specific population and geographic area, which are available through their state and local health departments and Centers for Disease Control and Prevention (CDC) surveillance.\r\n&nbsp;\r\nAlthough direct evidence on screening in nonpregnant persons who are not at increased risk for syphilis infection is lacking, based on the established test performance characteristics of current screening tests and the low prevalence rate of syphilis in this population, the yield of screening is likely low.9,10 Therefore, screening in this population may result in high false-positive rates and overtreatment.'}, {'id': 431, 'title': 'Syphilis Infection in Pregnant Women: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends early screening for syphilis infection in all pregnant women.', 'servfreq': 'All pregnant women should be tested for syphilis as early as possible when they first present to care. If a woman has not received prenatal care prior to delivery, she should be tested at the time she presents for delivery. In most cases of congenital syphilis, pregnant women received prenatal care but were not screened and treated for syphilis early enough during the pregnancy to prevent transmission to the fetus.', 'risktext': ''}, {'id': 1905, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and US Food and Drug Administration (FDA)--approved pharmacotherapy for cessation to nonpregnant adults who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 1906, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all pregnant persons about tobacco use, advise them to stop using tobacco, and provide behavioral interventions for cessation to pregnant persons who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 2014, 'title': 'Anxiety Disorders in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for anxiety disorders in adults, including pregnant and postpartum persons.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding optimal timing for screening, or screening interval, for both the perinatal and general adult populations; more evidence on both timing and screening interval is needed for all adult populations. A pragmatic approach in the absence of evidence might include screening all adults who have not been screened previously and using clinical judgment in considering risk factors, comorbid conditions, and life events to determine if additional screening of high-risk patients is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nRisk factors for anxiety disorders include sociodemographic factors, psychosocial factors, and physical and mental health factors such as marital status (widowed or divorced), stressful life events, smoking and alcohol use, other mental health conditions, or a parental history of mental disorders. Demographic factors such as low socioeconomic status and female sex are associated with higher rates of anxiety disorders.&nbsp;Black persons and individuals of non-Hispanic ethnicity are at increased risk of anxiety disorders due to social, rather than biological, factors. Anxiety and depressive disorders often overlap. One cohort study found that 67% of individuals with a depressive disorder also had a current anxiety disorder, and 75% had a lifetime comorbid anxiety disorder.'}, {'id': 1938, 'title': 'Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication ', 'grade': 'B', 'text': 'The DoctorAI recommends the use of low-dose aspirin (81 mg/day) as preventive medication after 12 weeks of gestation in persons who are at high risk for preeclampsia.\r\rSee the Practice Considerations section for information on high risk and aspirin dose.', 'servfreq': 'Once daily after 12 weeks of gestation', 'risktext': ' \r\nPersons with a history of preeclampsia in a previous pregnancy, type 1 or type 2 diabetes, and chronic hypertension are at highest risk for preeclampsia. Additional conditions that place a person at high risk for preeclampsia include multifetal gestation, conception using assisted reproductive technology, autoimmune disease, and kidney disease. Other factors associated with increased preeclampsia risk include nulliparity, high prepregnancy body mass index, family history of preeclampsia, and advanced maternal age (35 years or older). In addition, Black persons have higher rates of preeclampsia and are at increased risk for serious complications due to various societal and health inequities.\r\n '}, {'id': 513, 'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for asymptomatic bacteriuria using urine culture in pregnant persons.', 'servfreq': 'In general, screening is performed once at the first prenatal visit per clinical guidelines. However, there is little evidence on the optimal timing and frequency of screening for asymptomatic bacteriuria in pregnancy.2&nbsp; .&nbsp;Screen pregnant persons for asymptomatic bacteriuria using a midstream, clean-catch urine culture at the first prenatal visit or at 12 to 16 weeks of gestation, whichever is earlier. A urine culture showing &gt;100,000 CFU/mL of a single uropathogen or &gt;10,000 CFU/mL if the pathogen is group B streptococcus indicates treatment.', 'risktext': 'This recommendation applies to adults 18 years and older and pregnant persons of any age without signs and symptoms of a urinary tract infection. It does not apply to persons who have chronic medical or urinary tract conditions, such as end-stage renal disease; have indwelling urinary catheters, urinary stents, or spinal cord injuries; are hospitalized; reside in an institution (eg, a nursing home); or who are transplant recipients.\r\n&nbsp;\r\nThe risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6&nbsp;Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5&nbsp;Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7,&nbsp;11,&nbsp;12&nbsp;In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12&nbsp;Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4,&nbsp;6'}, {'id': 2009, 'title': 'Latent Tuberculosis Infection in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for LTBI in populations at increased risk.\r\rSee the "Assessment of Risk" section for additional information on adults at increased risk.', 'servfreq': 'The USPSTF found no evidence on the optimal frequency of screening for LTBI. In the absence of evidence, a reasonable approach is to repeat screening based on specific risk factors; screening frequency could range from 1-time only screening among persons at low risk for future tuberculosis exposure to annual screening among those at continued risk of exposure.', 'risktext': 'Populations at increased risk for LTBI, based on increased prevalence of active disease and increased risk of exposure, include persons who were born in, or are former residents of, countries with high tuberculosis prevalence and persons who live in, or have lived in, high-risk congregate settings (eg, homeless shelters or correctional facilities). Clinicians can consult their local or state health departments for more information about populations at increased risk in their community, since local demographic patterns may vary across the US.\r\nIn 2020, 71.5% of all cases of active tuberculosis in the US occurred among persons born outside the US. According to the CDC, tuberculosis disease is common in most countries in Latin America, the Caribbean, Africa, Asia, Eastern Europe, and Russia. In 2020, among persons with new tuberculosis living in the US who were born outside the US, the most common countries of birth were Mexico (18.0%), the Philippines (12.5%), India (10.4%), Vietnam (8.2%), and China (5.1%), accounting for 54.2% of total cases. Most of these cases are believed to be due to progression of latent infection to active tuberculosis disease rather than new transmission within communities.\r\nPersons who live, or have lived, in high-risk congregate settings also have a higher prevalence rate of active tuberculosis and an increased risk for exposure. In 2020, 4.3% of tuberculosis disease cases diagnosed in persons 15 years or older occurred in persons experiencing homelessness and 2.6% occurred in residents of correctional facilities. It is estimated that persons experiencing homelessness have an 11 times higher incidence of tuberculosis disease compared with persons who are not experiencing homelessness (36 cases per 100,000 population vs 2.9 cases per 100,000 population, respectively, during 2011 to 2016).\r\nOther populations at increased risk for LTBI or progression to active disease include persons who have immunosuppression (eg, persons living with HIV, patients receiving immunosuppressive medications such as chemotherapy or tumor necrosis factor inhibitors, and patients who have received an organ transplant) and patients with silicosis (a lung disease). However, given that screening in these populations may be considered standard care as part of disease management or indicated prior to the use of certain medications, the USPSTF did not review evidence on screening in these populations. Information on testing in these populations is provided by other groups, such as the Office of AIDS Research at the National Institutes of Health, and in a guideline issued jointly by the American Thoracic Society, Infectious Diseases Society of America, and CDC. Some evidence from observational studies has explored the association between poorly controlled diabetes and progression of LTBI to active disease. However, there is insufficient evidence on screening for and treatment of LTBI in persons with diabetes for the USPSTF to make a separate recommendation for this important population.\r\nPersons who are contacts of individuals with active tuberculosis, health care workers, and workers in high-risk congregate settings may also be at increased risk of exposure. Because screening in these populations is conducted as part of public health or employee health surveillance, the USPSTF did not review the evidence in these populations. Clinicians seeking further information about testing for tuberculosis in these populations can refer to the Additional Tools and Resources and Recommendations of Others sections.'}, {'id': 514, 'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic bacteriuria in nonpregnant adults.', 'servfreq': '', 'risktext': 'The risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6 Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5 Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7, 11, 12 In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12 Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4, 6'}, {'id': 507, 'title': 'BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing ', 'grade': 'B', 'text': 'The DoctorAI recommends that primary care clinicians assess women with a personal or family history of breast, ovarian, tubal, or peritoneal cancer or who have an ancestry associated with breast cancer susceptibility 1 and 2 (BRCA1/2) gene mutations with an appropriate brief familial risk assessment tool. Women with a positive result on the risk assessment tool should receive genetic counseling and, if indicated after counseling, genetic testing.', 'servfreq': 'Consideration of screening for potentially harmful BRCA mutations should begin once women have reached the age of consent (18 years). Primary care providers should periodically assess all patients for changes in family history (for example, comprehensive review at least every 5 to 10 years)', 'risktext': 'Patients with family or personal histories of breast, ovarian, tubal, or peritoneal cancer or ancestry associated with harmful&nbsp;&lt; i&gt;BRCA1/2&nbsp;mutations should be assessed using a familial risk assessment tool. The USPSTF found adequate evidence that these tools are accurate in identifying women with increased likelihood of&nbsp;&lt; i&gt;BRCA1/2mutations. Tools evaluated by the USPSTF include the Ontario Family History Assessment Tool, Manchester Scoring System, Referral Screening Tool, Pedigree Assessment Tool, 7-Question Family History Screening Tool, International Breast Cancer Intervention Study instrument (Tyrer-Cuzick), and brief versions of BRCAPRO. These tools should be used to guide referrals to genetic counseling.&nbsp;Persons should consider their sex at birth to determine which recommendation best applies to them.'}, {'id': 339, 'title': 'Breastfeeding: Primary Care Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends providing interventions during pregnancy and after birth to support breastfeeding.', 'servfreq': 'During pregnancy and after birth', 'risktext': "This recommendation applies to pregnant women, new mothers, and their infants and children. Interventions to support breastfeeding may also involve a woman's partner, other family members, and friends. This recommendation does not apply in circumstances where there are contraindications to breastfeeding (e.g., certain maternal medical conditions or infant metabolic disorders, such as galactosemia). The USPSTF did not review evidence on interventions directed at breastfeeding of preterm infants."}, {'id': 1935, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for chlamydia in all sexually active women 24 years or younger and in women 25 years or older who are at increased risk for infection.', 'servfreq': ' \r\nIn the absence of studies on screening intervals, a reasonable approach would be to screen patients whose sexual history reveals new or persistent risk factors since the last negative test result.\r\n ', 'risktext': ' \r\nAge is a strong predictor of risk for chlamydial and gonococcal infections, with the highest infection rates in women occurring during ages 15 to 24 years. Women 25 years or older are at increased risk if they have a new sex partner, more than 1 sex partner, a sex partner with concurrent partners, or a sex partner who has an STI; practice inconsistent condom use when not in a mutually monogamous relationship; or have a previous or coexisting STI. Exchanging sex for money or drugs and history of incarceration also are associated with increased risk.&nbsp;Clinicians should consider the communities they serve and may want to consult local public health authorities for information about local epidemiology and guidance on determining who is at increased risk.\r\n '}, {'id': 1936, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for gonorrhea in all sexually active women 24 years or younger and in women 25 years or older who are at increased risk for infection.', 'servfreq': ' \r\nIn the absence of studies on screening intervals, a reasonable approach would be to screen patients whose sexual history reveals new or persistent risk factors since the last negative test result.\r\n ', 'risktext': ' \r\nAge is a strong predictor of risk for chlamydial and gonococcal infections, with the highest infection rates in women occurring during ages 15 to 24 years. Women 25 years or older are at increased risk if they have a new sex partner, more than 1 sex partner, a sex partner with concurrent partners, or a sex partner who has an STI; practice inconsistent condom use when not in a mutually monogamous relationship; or have a previous or coexisting STI. Exchanging sex for money or drugs and history of incarceration also are associated with increased risk.&nbsp;Clinicians should consider the communities they serve and may want to consult local public health authorities for information about local epidemiology and guidance on determining who is at increased risk.\r\n '}, {'id': 1909, 'title': 'Asymptomatic Carotid Artery Stenosis: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic carotid artery stenosis in the general adult population.\r\rSee the Practice Considerations section for a description of adults at increased risk.', 'servfreq': '', 'risktext': ''}, {'id': 2017, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for suicide risk in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': '', 'risktext': ''}, {'id': 2016, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for depression in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding the optimal timing for screening for depression; more evidence is needed in both perinatal and general adult populations. In the absence of evidence, a pragmatic approach might include screening adults who have not been screened previously and using clinical judgment while considering risk factors, comorbid conditions, and life events to determine if additional screening of patients at increased risk is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nThe USPSTF recommends screening for depression in all adults regardless of risk factors. Risk factors for depression include a combination of genetic, biological, and environmental factors, such as a family history of depression, prior episode of depression or other mental health condition, a history of trauma or adverse life events, or a history of disease or illness (eg, cardiovascular disease).\r\nPrevalence rates vary by sex, age, race, ethnicity, education, marital status, geographic location, poverty level, and employment status. Women have twice the risk of depression compared with men. Young adults, multiracial individuals, and Native American/Alaska Native individuals have higher rates of depression.\r\nRisk factors for perinatal depression include life stress, low social support, history of depression, marital or partner dissatisfaction, and a history of abuse.'}, {'id': 1932, 'title': 'Gestational Diabetes: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for gestational diabetes in asymptomatic pregnant persons at 24 weeks of gestation or after.', 'servfreq': 'At 24 weeks of gestation or after to improve maternal and fetal outcomes', 'risktext': ' \r\nSeveral factors increase a person&rsquo;s risk for developing gestational diabetes, including obesity, increased maternal age, history of gestational diabetes, family history of diabetes, and belonging to a racial/ethnic group that is at increased risk for developing type 2 diabetes (Hispanic, Native American, South or East Asian, or Pacific Islander descent).4,19,20 Factors associated with a lower risk for developing gestational diabetes include age younger than 25 to 30 years, White race, a body mass index (BMI) of 25 or less (calculated as weight in kilograms divided by height in meters squared), no family history (in a first-degree relative) of diabetes, and no history of glucose intolerance or adverse pregnancy outcomes related to gestational diabetes.21-23 The risk in different racial/ethnic groups may be due in part to social risk factors such as low socioeconomic status or structural racism, although these associations are not examined in the current evidence. Although a higher BMI increases the risk of gestational diabetes across racial/ethnic groups, the association varies. In Asian American persons, the prevalence of gestational diabetes at a BMI of 22 to less than 25 is similar to the prevalence in Hispanic persons, non-Hispanic White persons, and Black persons with a higher (&gt;28) BMI.24,25\r\n '}, {'id': 1845, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends offering or referring adults with cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity.', 'servfreq': '', 'risktext': 'Adults 18 years or older at increased risk of CVD, defined as those with 1 or more of the following:\r\n1.Hypertension or elevated blood pressure2.Dyslipidemia3.Mixed or multiple risk factors such as the metabolic syndrome or an estimated 10-year CVD risk of &ge;7.5%\r\nThis recommendation does not apply to adults with other known modifiable cardiovascular risk factors such as abnormal blood glucose levels, obesity, and smoking; these populations are incorporated in other USPSTF recommendations.'}, {'id': 1931, 'title': 'Healthy Weight and Weight Gain In Pregnancy: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer pregnant persons effective behavioral counseling interventions aimed at promoting healthy weight gain and preventing excess gestational weight gain in pregnancy.', 'servfreq': 'Throughout pregnancy', 'risktext': 'Pregnancy'}, {'id': 1885, 'title': 'Hepatitis B Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in adolescents and adults at increased risk for infection.\r\rSee the Practice Considerations section for a description of adolescents and adults at increased risk for infection.', 'servfreq': 'For patients with negative HBsAg results who have not received the HBV vaccine series, periodic screening may be useful for those who report continued risk for acquiring HBV transmission, such as persons who continue to inject drugs and men who have sex with men. Clinical judgment should be used to determine screening frequency. The USPSTF found no evidence to determine optimal screening intervals.', 'risktext': 'Persons from such risk groups include persons who have injected drugs in the past or currently; men who have sex with men; persons with HIV; and sex partners, needle-sharing contacts, and household contacts of persons known to be HBsAg positive. Some persons with combinations of risk factors who are not members of risk factor groups listed above may also be at increased risk for HBV infection.'}, {'id': 524, 'title': 'Hepatitis C Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis C virus (HCV) infection in adults aged 18 to 79 years.', 'servfreq': 'One-time screening for most adults.\r\nPeriodically screen persons with continued risk for HCV infection (eg, persons with past or current injection drug use). There is limited evidence to determine how often to screen persons at increased risk.&nbsp;', 'risktext': 'Asymptomatic adults aged 18 to 79 years (including pregnant persons) without known liver disease.&nbsp;\r\nThe USPSTF also suggests that clinicians consider screening persons younger than 18 years and older than 79 years who are at high risk for infection (eg, those with past or current injection drug use).&nbsp;'}, {'id': 2023, 'title': 'Hypertensive Disorders of Pregnancy: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hypertensive disorders in pregnant persons with blood pressure measurements throughout pregnancy.', 'servfreq': 'Screening Interval\r\nBlood pressure measurements should be obtained during each prenatal care visit throughout pregnancy. Hypertensive disorders of pregnancy can quickly evolve into severe disease that can result in serious, even fatal, maternal and infant health outcomes. The ability to screen for hypertensive disorders of pregnancy using blood pressure measurements is important to identify and effectively treat a potentially unpredictable and fatal condition. While it is known that risk continues into the immediate postpartum period, there is little evidence regarding screening during this period. A pragmatic approach would be for patients to be counseled regarding signs and symptoms of preeclampsia at hospital discharge and for patients with hypertensive disorders to have subsequent blood pressure checks.\r\nScreening for hypertensive disorders of pregnancy alone is not sufficient to improve inequities in health outcomes. Identifying hypertensive disorders of pregnancy requires adequate prenatal visits, surveillance, and evidence-based care in response to evolving patient signs and symptoms during pregnancy and the postpartum period to improve health outcomes. Black and Native American/Alaska Native persons have lower rates of prenatal visits and are at greater risk of serious postpartum morbidity and hospital readmission after delivery. Screening and monitoring of Black and Hispanic/Latina individuals during the postpartum period could be an important step for reducing health inequities by preventing serious adverse events. In addition, screening and monitoring by various health care providers (eg, nurse midwives, nurses, pediatricians, doulas, and lactation consultants) could also help avert serious complications in the postpartum period.', 'risktext': 'Assessment of Risk\r\nImportant clinical conditions associated with increased risk for preeclampsia include a history of eclampsia or preeclampsia in a prior pregnancy, a previous adverse pregnancy outcome, and maternal comorbid conditions (including type 1 or type 2 diabetes prior to pregnancy, gestational diabetes, chronic hypertension, kidney disease, and autoimmune diseases).\r\n&nbsp;Other factors associated with increased risk of preeclampsia and gestational hypertension include nulliparity, high prepregnancy body mass index, family history of preeclampsia, multifetal gestation, and the pregnant individual being 35 years or older.\r\nThe higher prevalence of hypertensive disorders of pregnancy and the increased risk for severe complications seen in Black persons may be due to their disproportionate burden of social and clinical risk factors. These social and clinical determinants largely result from historical and current manifestations of structural racism that influence environmental exposures, access to health resources, and overall health status.'}, {'id': 434, 'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians screen for intimate partner violence (IPV) in women of reproductive age and provide or refer women who screen positive to ongoing support services. See the Clinical Considerations section for more information on effective ongoing support services for IPV and for information on IPV in men.', 'servfreq': 'The USPSTF found no evidence on appropriate intervals for screening. Randomized clinical trials (RCTs) of screening and interventions for IPV often screen for current IPV or IPV in the past year.\r\n&nbsp;', 'risktext': 'All women of reproductive age are at potential risk for IPV and should be screened. There are a variety of factors that increase risk of IPV, such as exposure to violence as a child, young age, unemployment, substance abuse, marital difficulties, and economic hardships.\r\nRisk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health. For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.'}, {'id': 187, 'title': 'Rh(D) Incompatibility: Screening ', 'grade': 'B', 'text': "The DoctorAI recommends repeated Rh(D) antibody testing for all unsensitized Rh(D)-negative women at 24 to 28 weeks' gestation, unless the biological father is known to be Rh(D)-negative.", 'servfreq': 'Repeat testing at 24-28 weeks gestation.', 'risktext': ''}, {'id': 1916, 'title': 'Lung Cancer: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery.', 'servfreq': ' \r\nThe USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. ', 'risktext': ' \r\nSmoking and older age are the 2 most important risk factors for lung cancer.&nbsp;The risk of lung cancer in persons who smoke increases with cumulative quantity and duration of smoking and with age but decreases with increasing time since quitting for persons who formerly smoked.3 The USPSTF considers adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years to be at high risk and recommends screening for lung cancer with annual LDCT in this population. \r\n \r\n&nbsp;\r\n \r\nAfrican American/Black (Black) men have a higher incidence of lung cancer than White men, and Black women have a lower incidence than White women.1 These differences are likely related to differences in smoking exposure (ie, prevalence of smoking) and related exposure to carcinogens in cigarettes.7,8 The differences may also be related to other social risk factors.\r\n \r\n&nbsp;\r\n \r\nOther risk factors for lung cancer include environmental exposures, prior radiation therapy, other (noncancer) lung diseases, and family history. Lower level of education is also associated with a higher risk of lung cancer.7 The task force recommends using age and smoking history to determine screening eligibility rather than more elaborate risk prediction models because there is insufficient evidence to assess whether risk prediction model&ndash;based screening would improve outcomes relative to using the risk factors of age and smoking history for broad implementation in primary care.\r\n '}, {'id': 449, 'title': 'Perinatal Depression: Preventive Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians provide or refer pregnant and postpartum persons who are at increased risk of perinatal depression to counseling interventions.', 'servfreq': '', 'risktext': 'Include&nbsp;a past history of depression. Current depressive symptoms (that do not reach a diagnostic threshold),&nbsp;history of physical or sexual abuse,&nbsp;unplanned or unwanted pregnancy,&nbsp;stressful life events,&nbsp;lack of social and financial support,&nbsp;intimate partner violence,pregestational or gestational diabetes,and complications during pregnancy. Additional risk factors include adolescent parenthood, low socioeconomic status, and lack of social support.&nbsp;Genetic factors are also suspected to contribute to women&rsquo;s risk of developing perinatal depression.'}, {'id': 1445, 'title': 'Sexually Transmitted Infections: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends behavioral counseling for all sexually active adolescents and for adults who are at increased risk for sexually transmitted infections (STIs).\r\rSee the Practice Considerations section for more information on populations at increased risk for acquiring STIs.', 'servfreq': '', 'risktext': 'All sexually active adolescents are at increased risk for STIs because of the high rates of STIs in this age group and should receive behavioral counseling interventions. Adults at increased risk for STIs include those who currently have an STI or were diagnosed with one within the past year, do not consistently use condoms, have multiple sex partners, or have sex partners within populations with a high prevalence of STIs. Populations with a high prevalence of STIs include persons who seek STI testing or attend STI clinics; sexual and gender minorities; persons who are living with HIV, inject drugs, have exchanged sex for money or drugs, or have entered correctional facilities; and some racial/ethnic minority groups.1-4'}, {'id': 402, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends counseling young adults, adolescents, children, and parents of young children about minimizing exposure to ultraviolet (UV) radiation for persons aged 6 months to 24 years with fair skin types to reduce their risk of skin cancer.', 'servfreq': '', 'risktext': 'Fair skin types'}, {'id': 438, 'title': 'Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for unhealthy alcohol use in primary care settings in adults 18 years or older, including pregnant women, and providing persons engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce unhealthy alcohol use.', 'servfreq': 'The USPSTF did not find adequate evidence to recommend an optimal screening interval for unhealthy alcohol use in adults.&nbsp;Brief behavioral counseling interventions were found to reduce unhealthy alcohol use in adults 18 years or older, including pregnant women. Effective behavioral counseling interventions vary in their specific components, administration, length, and number of interactions. The USPSTF was unable to identify specific intervention characteristics or components that were clearly associated with improved outcomes.', 'risktext': 'engaged in risky or hazardous drinking'}, {'id': 767, 'title': 'Unhealthy Drug Use: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening by asking questions about unhealthy drug use in adults age 18 years or older. Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. \r(Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'servfreq': 'Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. (Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'risktext': 'These include being aged 18 to 25 years; male sex; having a mental health condition, personality or mood disorder, or nicotine or alcohol dependence; a history of physical or sexual abuse, parental neglect, or other adversity in childhood; or drug or alcohol addiction in a first-degree relative.1,9&nbsp;Factors associated with misuse of prescription drugs include history of other drug use, mental illness, pain, and greater access to prescription drugs.10&nbsp;Factors associated with prenatal use of drugs include a mental health disorder, interpersonal violence, and family history of substance use.11'}, {'id': 433, 'title': 'Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer or refer adults with a body mass index (BMI) of 30 or higher (calculated as weight in kilograms divided by height in meters squared) to intensive, multicomponent behavioral interventions.', 'servfreq': '', 'risktext': 'Adults with a BMI &ge;30'}, {'id': 1979, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: Behavioral Counseling Interventions ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians individualize the decision to offer or refer adults without cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity. \r\rSee the "Practice Considerations" section for information on determining which patients may benefit most from this service.', 'servfreq': '', 'risktext': ''}, {'id': 508, 'title': 'BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine risk assessment, genetic counseling, or genetic testing for women whose personal or family history or ancestry is not associated with potentially harmful BRCA1/2 gene mutations.', 'servfreq': '', 'risktext': 'Patients with family or personal histories of breast, ovarian, tubal, or peritoneal cancer or ancestry associated with harmful&nbsp;BRCA1/2&nbsp;mutations should be assessed using a familial risk assessment tool. The USPSTF found adequate evidence that these tools are accurate in identifying women with increased likelihood of&nbsp;BRCA1/2mutations. Tools evaluated by the USPSTF include the Ontario Family History Assessment Tool, Manchester Scoring System, Referral Screening Tool, Pedigree Assessment Tool, 7-Question Family History Screening Tool, International Breast Cancer Intervention Study instrument (Tyrer-Cuzick), and brief versions of BRCAPRO. These tools should be used to guide referrals to genetic counseling.'}, {'id': 525, 'title': 'Bacterial Vaginosis in Pregnant Persons to Prevent Preterm Delivery: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for bacterial vaginosis (BV) in pregnant persons who are not at increased risk for preterm delivery.', 'servfreq': '', 'risktext': '\r\nAssess risk for preterm delivery. There are multiple factors that increase risk for preterm delivery; one of the strongest risk factors is prior preterm delivery.\r\nDecide whether or not to screen for bacterial vaginosis:\r\n\r\na. Do not screen pregnant persons who are not at increased risk for preterm delivery.\r\nb. Evidence is insufficient to recommend for or against screening pregnant persons at increased risk for preterm delivery.'}, {'id': 418, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening with resting or exercise electrocardiography (ECG) to prevent cardiovascular disease (CVD) events in asymptomatic adults at low risk of CVD events.', 'servfreq': '', 'risktext': ''}, {'id': 429, 'title': 'Cervical Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for cervical cancer in women who have had a hysterectomy with removal of the cervix and do not have a history of a high-grade precancerous lesion (ie, cervical intraepithelial neoplasia [CIN] grade 2 or 3) or cervical cancer.', 'servfreq': '', 'risktext': ''}, {'id': 428, 'title': 'Cervical Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for cervical cancer in women younger than 21 years.', 'servfreq': '', 'risktext': ''}, {'id': 1973, 'title': 'Chronic Obstructive Pulmonary Disease: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for chronic obstructive pulmonary disease in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 2003, 'title': 'Genital Herpes Infection: Serologic Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine serologic screening for genital herpes simplex virus infection in asymptomatic adolescents and adults, including pregnant persons.', 'servfreq': '', 'risktext': 'The USPSTF found no evidence of externally validated, reliable risk stratification tools to identify individuals more or less likely to have genital herpes.'}, {'id': 504, 'title': 'Pancreatic Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for pancreatic cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 365, 'title': 'Thyroid Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for thyroid cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 1976, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'D', 'text': 'The DoctorAI recommends against the use of beta carotene or vitamin E supplements for the prevention of cardiovascular disease or cancer.', 'servfreq': '', 'risktext': ''}, {'id': 318, 'title': 'Autism Spectrum Disorder in Young Children: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for autism spectrum disorder (ASD) in young children for whom no concerns of ASD have been raised by their parents or a clinician.', 'servfreq': '', 'risktext': 'Although a number of potential risk factors for ASD have been identified, there is insufficient evidence to determine if certain risk factors modify the performance characteristics of ASD screening tests, such as the age at which screening is performed or other characteristics of the child or family.'}, {'id': 526, 'title': 'Bacterial Vaginosis in Pregnant Persons to Prevent Preterm Delivery: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for BV in pregnant persons who are at increased risk for preterm delivery.', 'servfreq': '', 'risktext': ''}, {'id': 65, 'title': 'Bladder Cancer in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults.\r\rLiterature scans conducted in July 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'This evidence update focused on the benefits and harms of screening for bladder cancer among people without symptoms, the accuracy of screening tests done in primary care settings, and the benefits and harms of treatment. The updated evidence review did not find any new high quality evidence to adequately determine the balance of benefits and harms of screening for bladder cancer. However, bladder cancer is a common cancer and can cause considerable health problems including death. Therefore, the USPSTF determined that the evidence was insufficient to provide a recommendation for or against bladder cancer screening.  The USPSTF emphasizes the need for additional research in this area. '}, {'id': 2037, 'title': 'Breast Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of supplemental screening for breast cancer using breast ultrasonography or magnetic resonance imaging (MRI) in women identified to have dense breasts on an otherwise negative screening mammogram.\r\rSee the "Practice Considerations" section for more information on the patient population to whom this recommendation applies and on screening mammography modalities.', 'servfreq': '', 'risktext': 'These recommendations apply to cisgender women and all other persons assigned female at birth (including transgender men and nonbinary persons) 40 years or older at average risk of breast cancer. \r\nThese recommendations apply to persons who have factors associated with an increased risk of breast cancer, such as a family history of breast cancer (ie, a first-degree relative with breast cancer) or having dense breasts. They do not apply to persons who have a genetic marker or syndrome associated with a high risk of breast cancer (eg, BRCA1 or BRCA2 genetic variation), a history of high-dose radiation therapy to the chest at a young age, or previous breast cancer or a high-risk breast lesion on previous biopsies. '}, {'id': 419, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening with resting or exercise ECG to prevent CVD events in asymptomatic adults at intermediate or high risk of CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 423, 'title': 'Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of adding the ankle-brachial index (ABI), high-sensitivity C-reactive protein (hsCRP) level, or coronary artery calcium (CAC) score to traditional risk assessment for cardiovascular disease (CVD) in asymptomatic adults to prevent CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 352, 'title': 'Celiac Disease: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'persons with family history or other risk factors'}, {'id': 1955, 'title': 'Eating Disorders in Adolescents and Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for eating disorders in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1933, 'title': 'Gestational Diabetes: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for gestational diabetes in asymptomatic pregnant persons before 24 weeks of gestation.', 'servfreq': '', 'risktext': ''}, {'id': 665, 'title': 'Illicit Drug Use in Children, Adolescents, and Young Adults: Primary Care-Based Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--based behavioral counseling interventions to prevent illicit drug use, including nonmedical use of prescription drugs, in children, adolescents, and young adults.\r\rSee the Practice Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 435, 'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for abuse and neglect in all older or vulnerable adults. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': 'Risk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health.14&nbsp;For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.15'}, {'id': 2045, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for iron deficiency and iron deficiency anemia in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2046, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine iron supplementation in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2018, 'title': 'Lipid Disorders in Children and Adolescents: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1998, 'title': 'Obstructive Sleep Apnea in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for obstructive sleep apnea in the general adult population.\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Risk Factors\r\nRisk factors associated with OSA include male sex, older age (40-70 years), postmenopausal status, higher body mass index (BMI), and craniofacial and upper airway abnormalities (eg, enlarged tonsils or long upper airway). Black, Hispanic/Latino, and Native American/Alaska Native persons have a higher prevalence of OSA compared with White persons; some evidence suggests that these differences are partially explained by higher rates of obesity, asthma, and tobacco use among these groups.8'}, {'id': 1977, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of multivitamin supplements for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1978, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of single or paired nutrient supplements (other than beta carotene and vitamin E) for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 176, 'title': 'Oral Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for oral cancer in asymptomatic adults.\r\rGo to the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in July 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Tobacco and alcohol use are major risk factors for oral cancer. A total of 20% to 30% of cases of oral cancer worldwide are attributable to cigarette smoking. In the United States, up to 75% of cases of oral cancer may be attributable to tobacco and alcohol use. Additional risk factors include male sex, older age, use of betel quid, ultraviolet light exposure, infection with Candida or bacterial flora, and a compromised immune system. Sexually transmitted oral HPV infection (HPV-16) has recently been recognized as an increasingly important risk factor for oropharyngeal cancer. In the United States, the prevalence of oropharyngeal cancer due to oral HPV infection is probably as high as 80% to 95%. The prevalence of oral HPV infection is associated with age, sex, number of sexual partners, and number of cigarettes smoked per day. The effect of multifactorial risk assessment and screening for risk factors on oral cancer morbidity and mortality is unknown.'}, {'id': 2026, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine screening performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 2027, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of preventive interventions performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 424, 'title': 'Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for peripheral artery disease (PAD) and cardiovascular disease (CVD) risk with the ankle-brachial index (ABI) in asymptomatic adults.\r\rLiterature scans conducted in August 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Risk factors associated with OSA include male sex, older age (40 to 70 years), postmenopausal status, higher BMI, and craniofacial and upper airway abnormalities.'}, {'id': 404, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of counseling adults about skin self-examination to prevent skin cancer.See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 2005, 'title': 'Skin Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Exposure to UV radiation from sun exposure, indoor tanning beds, and other UV radiation&ndash;emitting devices is the major environmental risk factor for skin cancer. History of frequent sunburns, older age, and male sex are associated with increased risk for skin cancer. Exposure to UV radiation from the use of indoor tanning beds is an important risk factor in adolescents. Incidence of melanoma is higher among White persons compared with persons of other races and ethnicities. This difference likely reflects traits associated with increased melanoma risk, such as fair skin (which is more susceptible to sunburning), light-colored eyes, and red or blond hair being more common among White persons compared with persons of other races and ethnicities. Acral lentiginous melanoma, which occurs mostly on skin not frequently exposed to direct sunlight (eg, palms of hands, soles of feet, or under fingernails or toenails), is the most common type of melanoma among Black populations. Other melanoma risk factors include higher numbers of moles on the skin, atypical moles, as well as a personal and family history of skin cancer.'}, {'id': 269, 'title': 'Thyroid Dysfunction: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults.\r\rSee the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': 'The optimal screening interval for thyroid dysfunction (if one exists) is unknown.', 'risktext': 'The most common cause of hypothyroidism in the United States is chronic autoimmune (Hashimoto) thyroiditis. Risk factors for an elevated TSH level include female sex, advancing age, white race, type 1 diabetes, Down syndrome, family history of thyroid disease, goiter, previous hyperthyroidism (possibly due in part to ablation therapy leading to iatrogenic thyroid dysfunction), and external-beam radiation in the head and neck area. Common causes of hyperthyroidism include Graves disease, Hashimoto thyroiditis, and functional thyroid nodules. Risk factors for a low TSH level include female sex; advancing age; black race; low iodine intake; personal or family history of thyroid disease; and ingestion of iodine-containing drugs, such as amiodarone. The USPSTF found no direct evidence that treatment of thyroid dysfunction based on risk level alters final health outcomes.'}, {'id': 1908, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of electronic cigarettes (e-cigarettes) for tobacco cessation in adults, including pregnant persons. The USPSTF recommends that clinicians direct patients who use tobacco to other tobacco cessation interventions with proven effectiveness and established safety.\rSee the Practice Considerations section for more information on recommended behavioral interventions and pharmacotherapy and for suggestions for practice regarding the I statements.', 'servfreq': '', 'risktext': ''}, {'id': 1907, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of pharmacotherapy interventions for tobacco cessation in pregnant persons.', 'servfreq': '', 'risktext': ''}, {'id': 586, 'title': 'Tobacco Use in Children and Adolescents: Primary Care Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--feasible interventions for the cessation of tobacco use among school-aged children and adolescents.\r\rSee the Practice Considerations section for more information on effective interventions to prevent initiation of tobacco use and for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1919, 'title': 'Vitamin D Deficiency in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 408, 'title': 'Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of the benefits and harms of vitamin D and calcium supplementation, alone or combined, for the primary prevention of fractures in men and premenopausal women.', 'servfreq': '', 'risktext': ''}]
2025-01-29 22:00:57 [INFO] Update id=273478175 is handled. Duration 756 ms by bot id=8108339380
2025-01-29 22:01:01 [INFO] Update id=273478176 is handled. Duration 706 ms by bot id=8108339380
2025-01-29 22:01:08 [INFO] Update id=273478177 is handled. Duration 655 ms by bot id=8108339380
2025-01-29 22:01:13 [INFO] Update id=273478178 is handled. Duration 727 ms by bot id=8108339380
2025-01-29 22:01:16 [INFO] Update id=273478179 is handled. Duration 679 ms by bot id=8108339380
2025-01-29 22:01:18 [INFO] Update id=273478180 is handled. Duration 770 ms by bot id=8108339380
2025-01-29 22:01:21 [INFO] Update id=273478181 is handled. Duration 632 ms by bot id=8108339380
2025-01-29 22:01:23 [INFO] Update id=273478182 is handled. Duration 682 ms by bot id=8108339380
2025-01-29 22:01:24 [INFO] State data: {'db': <bot.database.Database object at 0x7f78842cb740>, 'age': 20, 'weight': 190, 'height': 190, 'feet': 45, 'gender': 'female', 'pregnant': 'yes', 'smoking': 'yes', 'sex': 'tools_3', 'recommendations': [{'id': 2020, 'title': 'Folic Acid Supplementation to Prevent Neural Tube Defects: Preventive Medication ', 'grade': 'A', 'text': 'The DoctorAI recommends that all persons planning to or who could become pregnant take a daily supplement containing 0.4 to 0.8 mg (400 to 800 mcg) of folic acid.', 'servfreq': 'The neural plate completes its formation and closure early in pregnancy (usually 26 to 28 days after fertilization). This means the critical period for folic acid supplementation starts at least 1 month before conception and continues through the first 2 to 3 months of pregnancy. Nearly half of all pregnancies in the US are unplanned; to gain the full benefits of supplementation, clinicians should advise all persons who plan to or who could become pregnant to take daily folic acid.', 'risktext': 'All pregnancies are at risk for neural tube defects, and persons who are planning to or could become pregnant should take folic acid supplements. Certain risk factors convey a higher risk, and individuals with these risk factors should talk to their health care professional. These factors include personal, partner, or family history of neural tube defects, malabsorption caused by bariatric procedures, the use of certain antiseizure medicines, and genetic mutations in folate-related enzymes. Pregestational diabetes and obesity have been associated with an increased risk of neural tube defects. Ethnic groups such as First Nation persons in Canada and Hispanic persons in California are thought to be at higher risk of neural tube defects. It is unclear, however, whether this is related to a higher risk of genetic variations among these groups or due to differential intake of folic acid&ndash;fortified foods.'}, {'id': 503, 'title': 'Hepatitis B Virus Infection in Pregnant Women: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in pregnant women at their first prenatal visit', 'servfreq': 'A test for HBsAg should be ordered at the first prenatal visit. Women with unknown HBsAg status or with new or continuing risk factors for HBV infection (eg, injection drug use or a sexually transmitted infection) should be screened at the time of admission to a hospital or other delivery setting.', 'risktext': 'In the United States, new cases of HBV among adults are largely transmitted through injection drug use or sexual intercourse, but most prevalent cases of HBV infection are chronic infections from exposure occurring in infancy or childhood. Another major risk factor for HBV infection is country of origin. In the United States, adults with HBV born in high-prevalence countries were commonly infected during childhood. In children, the primary source of infection is perinatal transmission at birth.'}, {'id': 485, 'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in adolescents and adults aged 15 to 65 years. Younger adolescents and older adults who are at increased risk of infection should also be screened.\rSee the Clinical Considerations section for more information about assessment of risk, screening intervals, and rescreening in pregnancy.', 'servfreq': 'The USPSTF found insufficient evidence to determine appropriate or optimal time intervals or strategies for repeat HIV screening. However, repeat screening is reasonable for persons known to be at increased risk of HIV infection, such as sexually active men who have sex with men; persons with a sex partner who is living with HIV; or persons who engage in behaviors that may convey an increased risk of HIV infection, such as injection drug use, transactional sex or commercial sex work, having 1 or more new sex partners whose HIV status is unknown, or having other factors that can place a person at increased risk of HIV infection (see &ldquo;Risk Assessment&rdquo;). Repeat screening is also reasonable for persons who live or receive medical care in a high-prevalence setting, such as a sexually transmitted disease clinic, tuberculosis clinic, correctional facility, or homeless shelter.', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'id': 486, 'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in all pregnant persons, including those who present in labor or at delivery whose HIV status is unknown.', 'servfreq': 'The CDC and ACOG recommend repeat prenatal screening for HIV during the third trimester of pregnancy in women with risk factors for HIV acquisition and in women living or receiving care in high-incidence settings, and the CDC notes that repeat screening for HIV during the third trimester may be considered in all women.&nbsp;', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'id': 1921, 'title': 'Hypertension in Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hypertension in adults 18 years or older with office blood pressure measurement (OBPM). The USPSTF recommends obtaining blood pressure measurements outside of the clinical setting for diagnostic confirmation before starting treatment.', 'servfreq': ' \r\nAlthough evidence on optimal screening intervals is limited, reasonable options include:\r\n \r\n \r\n\r\n\r\nScreening for hypertension every year in adults 40 years or older and in adults at increased risk for hypertension (such as Black persons, persons with high-normal blood pressure, or persons who are overweight or obese)\r\n\r\n\r\n \r\n \r\n\r\n\r\nScreening less frequently (ie, every 3 to 5 years) as appropriate for adults aged 18 to 39 years not at increased risk for hypertension and with a prior normal blood pressure reading.\r\n\r\n\r\n ', 'risktext': ' \r\nAlthough all adults should be screened for hypertension, risk factors that increase a person&rsquo;s risk for the condition include older age, Black race, family history, excess weight and obesity, lifestyle habits (lack of physical activity, stress, and tobacco use), and dietary factors (diet high in fat or sodium, diet low in potassium, or excessive alcohol intake)\r\n '}, {'id': 2021, 'title': 'Prevention of Acquisition of HIV: Preexposure Prophylaxis ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians prescribe preexposure prophylaxis using effective antiretroviral therapy to persons who are at increased risk of HIV acquisition to decrease the risk of acquiring HIV. \r\rSee the Practice Considerations section for more information about identification of persons at increased risk and about effective antiretroviral therapy.', 'servfreq': '', 'risktext': 'HIV is primarily acquired via sexual activity or injection drug use. It is important that clinicians routinely take a sexual and injection drug use history for all their patients in an open and nonjudgmental manner. All adolescents and adults who are sexually active or who inject drugs should be informed that acquisition of HIV can be prevented, to facilitate subsequent risk assessment and discussions about preexposure prophylaxis (PrEP) and other ways to prevent acquisition of HIV. Importantly, risk of HIV acquisition exists on a continuum, and currently available risk assessment tools all have limitations. However, certain risk factors or behaviors are known to place persons at increased risk of HIV.\r\nRisk of HIV acquisition depends on the likelihood that a specific act or activity will transmit HIV and the likelihood that a sex partner or drug injection partner has HIV. Likelihood of HIV transmission is highest with needle-sharing injection drug use and condomless receptive anal intercourse. Condomless receptive anal intercourse has an approximately 10- to 15-fold higher risk of transmission than condomless insertive anal sex and condomless receptive and insertive penile-vaginal sex. A 2018 study estimated the prevalence of HIV (ie, an estimate of the likelihood that a partner whose HIV status is unknown has HIV at a population level) as 12.4% among men who have sex with men and 1.9% among persons who inject drugs. The overall prevalence of HIV in the US is estimated at 0.3%.&nbsp;Of note, both the frequency of specific sexual activities and a person&rsquo;s number of sexual partners will also affect their risk of HIV.\r\n&nbsp;The USPSTF recommends that the following persons be considered for PrEP:\r\n1.&nbsp;&nbsp;&nbsp;&nbsp; Sexually active adults and adolescents weighing at least 35 kg (77 lb) who have engaged in anal or vaginal sex in the past 6 months and have any of the following:\r\n&nbsp;\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A sexual partner who has HIV (especially if the partner has an unknown or detectable viral load).\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A bacterial sexually transmitted infection (STI) (syphilis, gonorrhea, or chlamydia for men who have sex with men and transgender women; gonorrhea and syphilis for heterosexual women and men) in the past 6 months.\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A history of inconsistent or no condom use with sex partner(s) whose HIV status is not known; assessing risk in conversation with the patient and considering factors such as number of partners, the specific sexual activities a person engages in, and whether their sex partner or partners are in a group with a higher prevalence of HIV (eg, men who have sex with men or with men and women, transgender women, persons who inject drugs, and persons who engage in transactional sex).\r\n&nbsp;\r\n2. &nbsp; Persons who inject drugs and have a drug-injecting partner who has HIV or who shares injection equipment.\r\nPersons who engage in transactional sex, such as sex for money, drugs, or housing, including commercial sex workers or persons trafficked for sex work, constitute a group at increased risk of HIV acquisition and should be considered for PrEP based on the criteria outlined above. Persons who request PrEP may have undisclosed behaviors that put them at risk. Transgender women and men who are sexually active should be considered for PrEP based on the criteria outlined above. Transgender women are at especially high risk of HIV acquisition. A Centers for Disease Control and and Prevention (CDC) survey in 7 cities found an HIV prevalence of 42% among transgender women. Prevalence was highest among Black transgender women (62%) and Native American/Alaska Native transgender women (65%).\r\nIn addition, studies have found that transmission of HIV to a seronegative partner from a partner with HIV has not been observed when the partner with HIV was being treated with antiretroviral therapy and had a suppressed viral load.&nbsp;It is not known whether PrEP use further decreases the risk of HIV transmission when a partner with HIV has a documented undetectable viral load. Factors such as the consistency or inconsistency of a partner&rsquo;s viral load being suppressed, a partner&rsquo;s adherence to antiretroviral therapy, and the degree of certainty that a partner&rsquo;s viral load is suppressed (eg, self-report vs availability of laboratory test results) may help inform decisions about the use of PrEP in this situation.\r\nAll persons being considered for PrEP must have a recently documented negative HIV antigen-antibody test result, and if they have taken oral PrEP or postexposure prophylaxis in the past 3 months, or injectable cabotegravir in the past 12 months, the CDC recommends testing with both an HIV antigen-antibody assay and an HIV-1 RNA assay.'}, {'id': 186, 'title': 'Rh(D) Incompatibility: Screening ', 'grade': 'A', 'text': 'The DoctorAI strongly recommends Rh(D) blood typing and antibody testing for all pregnant women during their first visit for pregnancy-related care.', 'servfreq': 'First prenatal visit.', 'risktext': ''}, {'id': 1989, 'title': 'Syphilis Infection in Nonpregnant Adolescents and Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for syphilis infection in persons who are at increased risk for infection.', 'servfreq': 'Optimal screening frequency for persons who are at increased risk for syphilis infection is not well established. Men who have sex with men or persons with HIV infection may benefit from screening at least annually or more frequently (eg, every 3 to 6 months) if they continue to be at high risk.', 'risktext': 'The USPSTF recommends screening for syphilis in persons who are at increased risk for infection. When deciding which persons to screen for syphilis, clinicians should consider the prevalence of infection in the communities they serve, as well as other sociodemographic and behavioral factors that may be associated with increased risk of syphilis infection. For example, prevalence of syphilis is higher in men, men who have sex with men, persons with HIV infection, young adults, and persons with a history of incarceration, sex work, or military service. A substantial percentage of heterosexual syphilis transmission occurs among persons who use illicit drugs, particularly methamphetamine. Diagnosis of another STI may signal that a person is having condomless sex, which increases their risk of syphilis infection. Higher infection rates in persons of some racial and ethnic groups have been reported and are primarily a reflection of a combination of factors, including social determinants of health (eg, disparities of income, low educational achievement, and unstable housing), differential health insurance coverage or access to quality health care, and differences in sexual network characteristics (eg, individuals living in communities with a high prevalence of STIs have an increased chance of encountering an infected partner). Local prevalence rates may change over time, so clinicians should be aware of the latest data and trends for their specific population and geographic area, which are available through their state and local health departments and Centers for Disease Control and Prevention (CDC) surveillance.\r\n&nbsp;\r\nAlthough direct evidence on screening in nonpregnant persons who are not at increased risk for syphilis infection is lacking, based on the established test performance characteristics of current screening tests and the low prevalence rate of syphilis in this population, the yield of screening is likely low.9,10 Therefore, screening in this population may result in high false-positive rates and overtreatment.'}, {'id': 431, 'title': 'Syphilis Infection in Pregnant Women: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends early screening for syphilis infection in all pregnant women.', 'servfreq': 'All pregnant women should be tested for syphilis as early as possible when they first present to care. If a woman has not received prenatal care prior to delivery, she should be tested at the time she presents for delivery. In most cases of congenital syphilis, pregnant women received prenatal care but were not screened and treated for syphilis early enough during the pregnancy to prevent transmission to the fetus.', 'risktext': ''}, {'id': 1905, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and US Food and Drug Administration (FDA)--approved pharmacotherapy for cessation to nonpregnant adults who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 1906, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all pregnant persons about tobacco use, advise them to stop using tobacco, and provide behavioral interventions for cessation to pregnant persons who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 2014, 'title': 'Anxiety Disorders in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for anxiety disorders in adults, including pregnant and postpartum persons.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding optimal timing for screening, or screening interval, for both the perinatal and general adult populations; more evidence on both timing and screening interval is needed for all adult populations. A pragmatic approach in the absence of evidence might include screening all adults who have not been screened previously and using clinical judgment in considering risk factors, comorbid conditions, and life events to determine if additional screening of high-risk patients is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nRisk factors for anxiety disorders include sociodemographic factors, psychosocial factors, and physical and mental health factors such as marital status (widowed or divorced), stressful life events, smoking and alcohol use, other mental health conditions, or a parental history of mental disorders. Demographic factors such as low socioeconomic status and female sex are associated with higher rates of anxiety disorders.&nbsp;Black persons and individuals of non-Hispanic ethnicity are at increased risk of anxiety disorders due to social, rather than biological, factors. Anxiety and depressive disorders often overlap. One cohort study found that 67% of individuals with a depressive disorder also had a current anxiety disorder, and 75% had a lifetime comorbid anxiety disorder.'}, {'id': 1938, 'title': 'Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication ', 'grade': 'B', 'text': 'The DoctorAI recommends the use of low-dose aspirin (81 mg/day) as preventive medication after 12 weeks of gestation in persons who are at high risk for preeclampsia.\r\rSee the Practice Considerations section for information on high risk and aspirin dose.', 'servfreq': 'Once daily after 12 weeks of gestation', 'risktext': ' \r\nPersons with a history of preeclampsia in a previous pregnancy, type 1 or type 2 diabetes, and chronic hypertension are at highest risk for preeclampsia. Additional conditions that place a person at high risk for preeclampsia include multifetal gestation, conception using assisted reproductive technology, autoimmune disease, and kidney disease. Other factors associated with increased preeclampsia risk include nulliparity, high prepregnancy body mass index, family history of preeclampsia, and advanced maternal age (35 years or older). In addition, Black persons have higher rates of preeclampsia and are at increased risk for serious complications due to various societal and health inequities.\r\n '}, {'id': 513, 'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for asymptomatic bacteriuria using urine culture in pregnant persons.', 'servfreq': 'In general, screening is performed once at the first prenatal visit per clinical guidelines. However, there is little evidence on the optimal timing and frequency of screening for asymptomatic bacteriuria in pregnancy.2&nbsp; .&nbsp;Screen pregnant persons for asymptomatic bacteriuria using a midstream, clean-catch urine culture at the first prenatal visit or at 12 to 16 weeks of gestation, whichever is earlier. A urine culture showing &gt;100,000 CFU/mL of a single uropathogen or &gt;10,000 CFU/mL if the pathogen is group B streptococcus indicates treatment.', 'risktext': 'This recommendation applies to adults 18 years and older and pregnant persons of any age without signs and symptoms of a urinary tract infection. It does not apply to persons who have chronic medical or urinary tract conditions, such as end-stage renal disease; have indwelling urinary catheters, urinary stents, or spinal cord injuries; are hospitalized; reside in an institution (eg, a nursing home); or who are transplant recipients.\r\n&nbsp;\r\nThe risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6&nbsp;Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5&nbsp;Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7,&nbsp;11,&nbsp;12&nbsp;In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12&nbsp;Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4,&nbsp;6'}, {'id': 2009, 'title': 'Latent Tuberculosis Infection in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for LTBI in populations at increased risk.\r\rSee the "Assessment of Risk" section for additional information on adults at increased risk.', 'servfreq': 'The USPSTF found no evidence on the optimal frequency of screening for LTBI. In the absence of evidence, a reasonable approach is to repeat screening based on specific risk factors; screening frequency could range from 1-time only screening among persons at low risk for future tuberculosis exposure to annual screening among those at continued risk of exposure.', 'risktext': 'Populations at increased risk for LTBI, based on increased prevalence of active disease and increased risk of exposure, include persons who were born in, or are former residents of, countries with high tuberculosis prevalence and persons who live in, or have lived in, high-risk congregate settings (eg, homeless shelters or correctional facilities). Clinicians can consult their local or state health departments for more information about populations at increased risk in their community, since local demographic patterns may vary across the US.\r\nIn 2020, 71.5% of all cases of active tuberculosis in the US occurred among persons born outside the US. According to the CDC, tuberculosis disease is common in most countries in Latin America, the Caribbean, Africa, Asia, Eastern Europe, and Russia. In 2020, among persons with new tuberculosis living in the US who were born outside the US, the most common countries of birth were Mexico (18.0%), the Philippines (12.5%), India (10.4%), Vietnam (8.2%), and China (5.1%), accounting for 54.2% of total cases. Most of these cases are believed to be due to progression of latent infection to active tuberculosis disease rather than new transmission within communities.\r\nPersons who live, or have lived, in high-risk congregate settings also have a higher prevalence rate of active tuberculosis and an increased risk for exposure. In 2020, 4.3% of tuberculosis disease cases diagnosed in persons 15 years or older occurred in persons experiencing homelessness and 2.6% occurred in residents of correctional facilities. It is estimated that persons experiencing homelessness have an 11 times higher incidence of tuberculosis disease compared with persons who are not experiencing homelessness (36 cases per 100,000 population vs 2.9 cases per 100,000 population, respectively, during 2011 to 2016).\r\nOther populations at increased risk for LTBI or progression to active disease include persons who have immunosuppression (eg, persons living with HIV, patients receiving immunosuppressive medications such as chemotherapy or tumor necrosis factor inhibitors, and patients who have received an organ transplant) and patients with silicosis (a lung disease). However, given that screening in these populations may be considered standard care as part of disease management or indicated prior to the use of certain medications, the USPSTF did not review evidence on screening in these populations. Information on testing in these populations is provided by other groups, such as the Office of AIDS Research at the National Institutes of Health, and in a guideline issued jointly by the American Thoracic Society, Infectious Diseases Society of America, and CDC. Some evidence from observational studies has explored the association between poorly controlled diabetes and progression of LTBI to active disease. However, there is insufficient evidence on screening for and treatment of LTBI in persons with diabetes for the USPSTF to make a separate recommendation for this important population.\r\nPersons who are contacts of individuals with active tuberculosis, health care workers, and workers in high-risk congregate settings may also be at increased risk of exposure. Because screening in these populations is conducted as part of public health or employee health surveillance, the USPSTF did not review the evidence in these populations. Clinicians seeking further information about testing for tuberculosis in these populations can refer to the Additional Tools and Resources and Recommendations of Others sections.'}, {'id': 514, 'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic bacteriuria in nonpregnant adults.', 'servfreq': '', 'risktext': 'The risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6 Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5 Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7, 11, 12 In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12 Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4, 6'}, {'id': 507, 'title': 'BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing ', 'grade': 'B', 'text': 'The DoctorAI recommends that primary care clinicians assess women with a personal or family history of breast, ovarian, tubal, or peritoneal cancer or who have an ancestry associated with breast cancer susceptibility 1 and 2 (BRCA1/2) gene mutations with an appropriate brief familial risk assessment tool. Women with a positive result on the risk assessment tool should receive genetic counseling and, if indicated after counseling, genetic testing.', 'servfreq': 'Consideration of screening for potentially harmful BRCA mutations should begin once women have reached the age of consent (18 years). Primary care providers should periodically assess all patients for changes in family history (for example, comprehensive review at least every 5 to 10 years)', 'risktext': 'Patients with family or personal histories of breast, ovarian, tubal, or peritoneal cancer or ancestry associated with harmful&nbsp;&lt; i&gt;BRCA1/2&nbsp;mutations should be assessed using a familial risk assessment tool. The USPSTF found adequate evidence that these tools are accurate in identifying women with increased likelihood of&nbsp;&lt; i&gt;BRCA1/2mutations. Tools evaluated by the USPSTF include the Ontario Family History Assessment Tool, Manchester Scoring System, Referral Screening Tool, Pedigree Assessment Tool, 7-Question Family History Screening Tool, International Breast Cancer Intervention Study instrument (Tyrer-Cuzick), and brief versions of BRCAPRO. These tools should be used to guide referrals to genetic counseling.&nbsp;Persons should consider their sex at birth to determine which recommendation best applies to them.'}, {'id': 339, 'title': 'Breastfeeding: Primary Care Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends providing interventions during pregnancy and after birth to support breastfeeding.', 'servfreq': 'During pregnancy and after birth', 'risktext': "This recommendation applies to pregnant women, new mothers, and their infants and children. Interventions to support breastfeeding may also involve a woman's partner, other family members, and friends. This recommendation does not apply in circumstances where there are contraindications to breastfeeding (e.g., certain maternal medical conditions or infant metabolic disorders, such as galactosemia). The USPSTF did not review evidence on interventions directed at breastfeeding of preterm infants."}, {'id': 1935, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for chlamydia in all sexually active women 24 years or younger and in women 25 years or older who are at increased risk for infection.', 'servfreq': ' \r\nIn the absence of studies on screening intervals, a reasonable approach would be to screen patients whose sexual history reveals new or persistent risk factors since the last negative test result.\r\n ', 'risktext': ' \r\nAge is a strong predictor of risk for chlamydial and gonococcal infections, with the highest infection rates in women occurring during ages 15 to 24 years. Women 25 years or older are at increased risk if they have a new sex partner, more than 1 sex partner, a sex partner with concurrent partners, or a sex partner who has an STI; practice inconsistent condom use when not in a mutually monogamous relationship; or have a previous or coexisting STI. Exchanging sex for money or drugs and history of incarceration also are associated with increased risk.&nbsp;Clinicians should consider the communities they serve and may want to consult local public health authorities for information about local epidemiology and guidance on determining who is at increased risk.\r\n '}, {'id': 1936, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for gonorrhea in all sexually active women 24 years or younger and in women 25 years or older who are at increased risk for infection.', 'servfreq': ' \r\nIn the absence of studies on screening intervals, a reasonable approach would be to screen patients whose sexual history reveals new or persistent risk factors since the last negative test result.\r\n ', 'risktext': ' \r\nAge is a strong predictor of risk for chlamydial and gonococcal infections, with the highest infection rates in women occurring during ages 15 to 24 years. Women 25 years or older are at increased risk if they have a new sex partner, more than 1 sex partner, a sex partner with concurrent partners, or a sex partner who has an STI; practice inconsistent condom use when not in a mutually monogamous relationship; or have a previous or coexisting STI. Exchanging sex for money or drugs and history of incarceration also are associated with increased risk.&nbsp;Clinicians should consider the communities they serve and may want to consult local public health authorities for information about local epidemiology and guidance on determining who is at increased risk.\r\n '}, {'id': 1909, 'title': 'Asymptomatic Carotid Artery Stenosis: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic carotid artery stenosis in the general adult population.\r\rSee the Practice Considerations section for a description of adults at increased risk.', 'servfreq': '', 'risktext': ''}, {'id': 2017, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for suicide risk in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': '', 'risktext': ''}, {'id': 2016, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for depression in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding the optimal timing for screening for depression; more evidence is needed in both perinatal and general adult populations. In the absence of evidence, a pragmatic approach might include screening adults who have not been screened previously and using clinical judgment while considering risk factors, comorbid conditions, and life events to determine if additional screening of patients at increased risk is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nThe USPSTF recommends screening for depression in all adults regardless of risk factors. Risk factors for depression include a combination of genetic, biological, and environmental factors, such as a family history of depression, prior episode of depression or other mental health condition, a history of trauma or adverse life events, or a history of disease or illness (eg, cardiovascular disease).\r\nPrevalence rates vary by sex, age, race, ethnicity, education, marital status, geographic location, poverty level, and employment status. Women have twice the risk of depression compared with men. Young adults, multiracial individuals, and Native American/Alaska Native individuals have higher rates of depression.\r\nRisk factors for perinatal depression include life stress, low social support, history of depression, marital or partner dissatisfaction, and a history of abuse.'}, {'id': 1932, 'title': 'Gestational Diabetes: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for gestational diabetes in asymptomatic pregnant persons at 24 weeks of gestation or after.', 'servfreq': 'At 24 weeks of gestation or after to improve maternal and fetal outcomes', 'risktext': ' \r\nSeveral factors increase a person&rsquo;s risk for developing gestational diabetes, including obesity, increased maternal age, history of gestational diabetes, family history of diabetes, and belonging to a racial/ethnic group that is at increased risk for developing type 2 diabetes (Hispanic, Native American, South or East Asian, or Pacific Islander descent).4,19,20 Factors associated with a lower risk for developing gestational diabetes include age younger than 25 to 30 years, White race, a body mass index (BMI) of 25 or less (calculated as weight in kilograms divided by height in meters squared), no family history (in a first-degree relative) of diabetes, and no history of glucose intolerance or adverse pregnancy outcomes related to gestational diabetes.21-23 The risk in different racial/ethnic groups may be due in part to social risk factors such as low socioeconomic status or structural racism, although these associations are not examined in the current evidence. Although a higher BMI increases the risk of gestational diabetes across racial/ethnic groups, the association varies. In Asian American persons, the prevalence of gestational diabetes at a BMI of 22 to less than 25 is similar to the prevalence in Hispanic persons, non-Hispanic White persons, and Black persons with a higher (&gt;28) BMI.24,25\r\n '}, {'id': 1845, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends offering or referring adults with cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity.', 'servfreq': '', 'risktext': 'Adults 18 years or older at increased risk of CVD, defined as those with 1 or more of the following:\r\n1.Hypertension or elevated blood pressure2.Dyslipidemia3.Mixed or multiple risk factors such as the metabolic syndrome or an estimated 10-year CVD risk of &ge;7.5%\r\nThis recommendation does not apply to adults with other known modifiable cardiovascular risk factors such as abnormal blood glucose levels, obesity, and smoking; these populations are incorporated in other USPSTF recommendations.'}, {'id': 1931, 'title': 'Healthy Weight and Weight Gain In Pregnancy: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer pregnant persons effective behavioral counseling interventions aimed at promoting healthy weight gain and preventing excess gestational weight gain in pregnancy.', 'servfreq': 'Throughout pregnancy', 'risktext': 'Pregnancy'}, {'id': 1885, 'title': 'Hepatitis B Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in adolescents and adults at increased risk for infection.\r\rSee the Practice Considerations section for a description of adolescents and adults at increased risk for infection.', 'servfreq': 'For patients with negative HBsAg results who have not received the HBV vaccine series, periodic screening may be useful for those who report continued risk for acquiring HBV transmission, such as persons who continue to inject drugs and men who have sex with men. Clinical judgment should be used to determine screening frequency. The USPSTF found no evidence to determine optimal screening intervals.', 'risktext': 'Persons from such risk groups include persons who have injected drugs in the past or currently; men who have sex with men; persons with HIV; and sex partners, needle-sharing contacts, and household contacts of persons known to be HBsAg positive. Some persons with combinations of risk factors who are not members of risk factor groups listed above may also be at increased risk for HBV infection.'}, {'id': 524, 'title': 'Hepatitis C Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis C virus (HCV) infection in adults aged 18 to 79 years.', 'servfreq': 'One-time screening for most adults.\r\nPeriodically screen persons with continued risk for HCV infection (eg, persons with past or current injection drug use). There is limited evidence to determine how often to screen persons at increased risk.&nbsp;', 'risktext': 'Asymptomatic adults aged 18 to 79 years (including pregnant persons) without known liver disease.&nbsp;\r\nThe USPSTF also suggests that clinicians consider screening persons younger than 18 years and older than 79 years who are at high risk for infection (eg, those with past or current injection drug use).&nbsp;'}, {'id': 2023, 'title': 'Hypertensive Disorders of Pregnancy: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hypertensive disorders in pregnant persons with blood pressure measurements throughout pregnancy.', 'servfreq': 'Screening Interval\r\nBlood pressure measurements should be obtained during each prenatal care visit throughout pregnancy. Hypertensive disorders of pregnancy can quickly evolve into severe disease that can result in serious, even fatal, maternal and infant health outcomes. The ability to screen for hypertensive disorders of pregnancy using blood pressure measurements is important to identify and effectively treat a potentially unpredictable and fatal condition. While it is known that risk continues into the immediate postpartum period, there is little evidence regarding screening during this period. A pragmatic approach would be for patients to be counseled regarding signs and symptoms of preeclampsia at hospital discharge and for patients with hypertensive disorders to have subsequent blood pressure checks.\r\nScreening for hypertensive disorders of pregnancy alone is not sufficient to improve inequities in health outcomes. Identifying hypertensive disorders of pregnancy requires adequate prenatal visits, surveillance, and evidence-based care in response to evolving patient signs and symptoms during pregnancy and the postpartum period to improve health outcomes. Black and Native American/Alaska Native persons have lower rates of prenatal visits and are at greater risk of serious postpartum morbidity and hospital readmission after delivery. Screening and monitoring of Black and Hispanic/Latina individuals during the postpartum period could be an important step for reducing health inequities by preventing serious adverse events. In addition, screening and monitoring by various health care providers (eg, nurse midwives, nurses, pediatricians, doulas, and lactation consultants) could also help avert serious complications in the postpartum period.', 'risktext': 'Assessment of Risk\r\nImportant clinical conditions associated with increased risk for preeclampsia include a history of eclampsia or preeclampsia in a prior pregnancy, a previous adverse pregnancy outcome, and maternal comorbid conditions (including type 1 or type 2 diabetes prior to pregnancy, gestational diabetes, chronic hypertension, kidney disease, and autoimmune diseases).\r\n&nbsp;Other factors associated with increased risk of preeclampsia and gestational hypertension include nulliparity, high prepregnancy body mass index, family history of preeclampsia, multifetal gestation, and the pregnant individual being 35 years or older.\r\nThe higher prevalence of hypertensive disorders of pregnancy and the increased risk for severe complications seen in Black persons may be due to their disproportionate burden of social and clinical risk factors. These social and clinical determinants largely result from historical and current manifestations of structural racism that influence environmental exposures, access to health resources, and overall health status.'}, {'id': 434, 'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians screen for intimate partner violence (IPV) in women of reproductive age and provide or refer women who screen positive to ongoing support services. See the Clinical Considerations section for more information on effective ongoing support services for IPV and for information on IPV in men.', 'servfreq': 'The USPSTF found no evidence on appropriate intervals for screening. Randomized clinical trials (RCTs) of screening and interventions for IPV often screen for current IPV or IPV in the past year.\r\n&nbsp;', 'risktext': 'All women of reproductive age are at potential risk for IPV and should be screened. There are a variety of factors that increase risk of IPV, such as exposure to violence as a child, young age, unemployment, substance abuse, marital difficulties, and economic hardships.\r\nRisk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health. For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.'}, {'id': 187, 'title': 'Rh(D) Incompatibility: Screening ', 'grade': 'B', 'text': "The DoctorAI recommends repeated Rh(D) antibody testing for all unsensitized Rh(D)-negative women at 24 to 28 weeks' gestation, unless the biological father is known to be Rh(D)-negative.", 'servfreq': 'Repeat testing at 24-28 weeks gestation.', 'risktext': ''}, {'id': 1916, 'title': 'Lung Cancer: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery.', 'servfreq': ' \r\nThe USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. ', 'risktext': ' \r\nSmoking and older age are the 2 most important risk factors for lung cancer.&nbsp;The risk of lung cancer in persons who smoke increases with cumulative quantity and duration of smoking and with age but decreases with increasing time since quitting for persons who formerly smoked.3 The USPSTF considers adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years to be at high risk and recommends screening for lung cancer with annual LDCT in this population. \r\n \r\n&nbsp;\r\n \r\nAfrican American/Black (Black) men have a higher incidence of lung cancer than White men, and Black women have a lower incidence than White women.1 These differences are likely related to differences in smoking exposure (ie, prevalence of smoking) and related exposure to carcinogens in cigarettes.7,8 The differences may also be related to other social risk factors.\r\n \r\n&nbsp;\r\n \r\nOther risk factors for lung cancer include environmental exposures, prior radiation therapy, other (noncancer) lung diseases, and family history. Lower level of education is also associated with a higher risk of lung cancer.7 The task force recommends using age and smoking history to determine screening eligibility rather than more elaborate risk prediction models because there is insufficient evidence to assess whether risk prediction model&ndash;based screening would improve outcomes relative to using the risk factors of age and smoking history for broad implementation in primary care.\r\n '}, {'id': 449, 'title': 'Perinatal Depression: Preventive Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians provide or refer pregnant and postpartum persons who are at increased risk of perinatal depression to counseling interventions.', 'servfreq': '', 'risktext': 'Include&nbsp;a past history of depression. Current depressive symptoms (that do not reach a diagnostic threshold),&nbsp;history of physical or sexual abuse,&nbsp;unplanned or unwanted pregnancy,&nbsp;stressful life events,&nbsp;lack of social and financial support,&nbsp;intimate partner violence,pregestational or gestational diabetes,and complications during pregnancy. Additional risk factors include adolescent parenthood, low socioeconomic status, and lack of social support.&nbsp;Genetic factors are also suspected to contribute to women&rsquo;s risk of developing perinatal depression.'}, {'id': 1445, 'title': 'Sexually Transmitted Infections: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends behavioral counseling for all sexually active adolescents and for adults who are at increased risk for sexually transmitted infections (STIs).\r\rSee the Practice Considerations section for more information on populations at increased risk for acquiring STIs.', 'servfreq': '', 'risktext': 'All sexually active adolescents are at increased risk for STIs because of the high rates of STIs in this age group and should receive behavioral counseling interventions. Adults at increased risk for STIs include those who currently have an STI or were diagnosed with one within the past year, do not consistently use condoms, have multiple sex partners, or have sex partners within populations with a high prevalence of STIs. Populations with a high prevalence of STIs include persons who seek STI testing or attend STI clinics; sexual and gender minorities; persons who are living with HIV, inject drugs, have exchanged sex for money or drugs, or have entered correctional facilities; and some racial/ethnic minority groups.1-4'}, {'id': 402, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends counseling young adults, adolescents, children, and parents of young children about minimizing exposure to ultraviolet (UV) radiation for persons aged 6 months to 24 years with fair skin types to reduce their risk of skin cancer.', 'servfreq': '', 'risktext': 'Fair skin types'}, {'id': 438, 'title': 'Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for unhealthy alcohol use in primary care settings in adults 18 years or older, including pregnant women, and providing persons engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce unhealthy alcohol use.', 'servfreq': 'The USPSTF did not find adequate evidence to recommend an optimal screening interval for unhealthy alcohol use in adults.&nbsp;Brief behavioral counseling interventions were found to reduce unhealthy alcohol use in adults 18 years or older, including pregnant women. Effective behavioral counseling interventions vary in their specific components, administration, length, and number of interactions. The USPSTF was unable to identify specific intervention characteristics or components that were clearly associated with improved outcomes.', 'risktext': 'engaged in risky or hazardous drinking'}, {'id': 767, 'title': 'Unhealthy Drug Use: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening by asking questions about unhealthy drug use in adults age 18 years or older. Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. \r(Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'servfreq': 'Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. (Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'risktext': 'These include being aged 18 to 25 years; male sex; having a mental health condition, personality or mood disorder, or nicotine or alcohol dependence; a history of physical or sexual abuse, parental neglect, or other adversity in childhood; or drug or alcohol addiction in a first-degree relative.1,9&nbsp;Factors associated with misuse of prescription drugs include history of other drug use, mental illness, pain, and greater access to prescription drugs.10&nbsp;Factors associated with prenatal use of drugs include a mental health disorder, interpersonal violence, and family history of substance use.11'}, {'id': 433, 'title': 'Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer or refer adults with a body mass index (BMI) of 30 or higher (calculated as weight in kilograms divided by height in meters squared) to intensive, multicomponent behavioral interventions.', 'servfreq': '', 'risktext': 'Adults with a BMI &ge;30'}, {'id': 1979, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: Behavioral Counseling Interventions ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians individualize the decision to offer or refer adults without cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity. \r\rSee the "Practice Considerations" section for information on determining which patients may benefit most from this service.', 'servfreq': '', 'risktext': ''}, {'id': 508, 'title': 'BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine risk assessment, genetic counseling, or genetic testing for women whose personal or family history or ancestry is not associated with potentially harmful BRCA1/2 gene mutations.', 'servfreq': '', 'risktext': 'Patients with family or personal histories of breast, ovarian, tubal, or peritoneal cancer or ancestry associated with harmful&nbsp;BRCA1/2&nbsp;mutations should be assessed using a familial risk assessment tool. The USPSTF found adequate evidence that these tools are accurate in identifying women with increased likelihood of&nbsp;BRCA1/2mutations. Tools evaluated by the USPSTF include the Ontario Family History Assessment Tool, Manchester Scoring System, Referral Screening Tool, Pedigree Assessment Tool, 7-Question Family History Screening Tool, International Breast Cancer Intervention Study instrument (Tyrer-Cuzick), and brief versions of BRCAPRO. These tools should be used to guide referrals to genetic counseling.'}, {'id': 525, 'title': 'Bacterial Vaginosis in Pregnant Persons to Prevent Preterm Delivery: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for bacterial vaginosis (BV) in pregnant persons who are not at increased risk for preterm delivery.', 'servfreq': '', 'risktext': '\r\nAssess risk for preterm delivery. There are multiple factors that increase risk for preterm delivery; one of the strongest risk factors is prior preterm delivery.\r\nDecide whether or not to screen for bacterial vaginosis:\r\n\r\na. Do not screen pregnant persons who are not at increased risk for preterm delivery.\r\nb. Evidence is insufficient to recommend for or against screening pregnant persons at increased risk for preterm delivery.'}, {'id': 418, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening with resting or exercise electrocardiography (ECG) to prevent cardiovascular disease (CVD) events in asymptomatic adults at low risk of CVD events.', 'servfreq': '', 'risktext': ''}, {'id': 429, 'title': 'Cervical Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for cervical cancer in women who have had a hysterectomy with removal of the cervix and do not have a history of a high-grade precancerous lesion (ie, cervical intraepithelial neoplasia [CIN] grade 2 or 3) or cervical cancer.', 'servfreq': '', 'risktext': ''}, {'id': 428, 'title': 'Cervical Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for cervical cancer in women younger than 21 years.', 'servfreq': '', 'risktext': ''}, {'id': 1973, 'title': 'Chronic Obstructive Pulmonary Disease: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for chronic obstructive pulmonary disease in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 2003, 'title': 'Genital Herpes Infection: Serologic Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine serologic screening for genital herpes simplex virus infection in asymptomatic adolescents and adults, including pregnant persons.', 'servfreq': '', 'risktext': 'The USPSTF found no evidence of externally validated, reliable risk stratification tools to identify individuals more or less likely to have genital herpes.'}, {'id': 504, 'title': 'Pancreatic Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for pancreatic cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 365, 'title': 'Thyroid Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for thyroid cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 1976, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'D', 'text': 'The DoctorAI recommends against the use of beta carotene or vitamin E supplements for the prevention of cardiovascular disease or cancer.', 'servfreq': '', 'risktext': ''}, {'id': 318, 'title': 'Autism Spectrum Disorder in Young Children: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for autism spectrum disorder (ASD) in young children for whom no concerns of ASD have been raised by their parents or a clinician.', 'servfreq': '', 'risktext': 'Although a number of potential risk factors for ASD have been identified, there is insufficient evidence to determine if certain risk factors modify the performance characteristics of ASD screening tests, such as the age at which screening is performed or other characteristics of the child or family.'}, {'id': 526, 'title': 'Bacterial Vaginosis in Pregnant Persons to Prevent Preterm Delivery: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for BV in pregnant persons who are at increased risk for preterm delivery.', 'servfreq': '', 'risktext': ''}, {'id': 65, 'title': 'Bladder Cancer in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults.\r\rLiterature scans conducted in July 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'This evidence update focused on the benefits and harms of screening for bladder cancer among people without symptoms, the accuracy of screening tests done in primary care settings, and the benefits and harms of treatment. The updated evidence review did not find any new high quality evidence to adequately determine the balance of benefits and harms of screening for bladder cancer. However, bladder cancer is a common cancer and can cause considerable health problems including death. Therefore, the USPSTF determined that the evidence was insufficient to provide a recommendation for or against bladder cancer screening.  The USPSTF emphasizes the need for additional research in this area. '}, {'id': 2037, 'title': 'Breast Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of supplemental screening for breast cancer using breast ultrasonography or magnetic resonance imaging (MRI) in women identified to have dense breasts on an otherwise negative screening mammogram.\r\rSee the "Practice Considerations" section for more information on the patient population to whom this recommendation applies and on screening mammography modalities.', 'servfreq': '', 'risktext': 'These recommendations apply to cisgender women and all other persons assigned female at birth (including transgender men and nonbinary persons) 40 years or older at average risk of breast cancer. \r\nThese recommendations apply to persons who have factors associated with an increased risk of breast cancer, such as a family history of breast cancer (ie, a first-degree relative with breast cancer) or having dense breasts. They do not apply to persons who have a genetic marker or syndrome associated with a high risk of breast cancer (eg, BRCA1 or BRCA2 genetic variation), a history of high-dose radiation therapy to the chest at a young age, or previous breast cancer or a high-risk breast lesion on previous biopsies. '}, {'id': 419, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening with resting or exercise ECG to prevent CVD events in asymptomatic adults at intermediate or high risk of CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 423, 'title': 'Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of adding the ankle-brachial index (ABI), high-sensitivity C-reactive protein (hsCRP) level, or coronary artery calcium (CAC) score to traditional risk assessment for cardiovascular disease (CVD) in asymptomatic adults to prevent CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 352, 'title': 'Celiac Disease: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'persons with family history or other risk factors'}, {'id': 1955, 'title': 'Eating Disorders in Adolescents and Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for eating disorders in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1933, 'title': 'Gestational Diabetes: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for gestational diabetes in asymptomatic pregnant persons before 24 weeks of gestation.', 'servfreq': '', 'risktext': ''}, {'id': 665, 'title': 'Illicit Drug Use in Children, Adolescents, and Young Adults: Primary Care-Based Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--based behavioral counseling interventions to prevent illicit drug use, including nonmedical use of prescription drugs, in children, adolescents, and young adults.\r\rSee the Practice Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 435, 'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for abuse and neglect in all older or vulnerable adults. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': 'Risk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health.14&nbsp;For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.15'}, {'id': 2045, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for iron deficiency and iron deficiency anemia in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2046, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine iron supplementation in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2018, 'title': 'Lipid Disorders in Children and Adolescents: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1998, 'title': 'Obstructive Sleep Apnea in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for obstructive sleep apnea in the general adult population.\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Risk Factors\r\nRisk factors associated with OSA include male sex, older age (40-70 years), postmenopausal status, higher body mass index (BMI), and craniofacial and upper airway abnormalities (eg, enlarged tonsils or long upper airway). Black, Hispanic/Latino, and Native American/Alaska Native persons have a higher prevalence of OSA compared with White persons; some evidence suggests that these differences are partially explained by higher rates of obesity, asthma, and tobacco use among these groups.8'}, {'id': 1977, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of multivitamin supplements for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1978, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of single or paired nutrient supplements (other than beta carotene and vitamin E) for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 176, 'title': 'Oral Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for oral cancer in asymptomatic adults.\r\rGo to the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in July 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Tobacco and alcohol use are major risk factors for oral cancer. A total of 20% to 30% of cases of oral cancer worldwide are attributable to cigarette smoking. In the United States, up to 75% of cases of oral cancer may be attributable to tobacco and alcohol use. Additional risk factors include male sex, older age, use of betel quid, ultraviolet light exposure, infection with Candida or bacterial flora, and a compromised immune system. Sexually transmitted oral HPV infection (HPV-16) has recently been recognized as an increasingly important risk factor for oropharyngeal cancer. In the United States, the prevalence of oropharyngeal cancer due to oral HPV infection is probably as high as 80% to 95%. The prevalence of oral HPV infection is associated with age, sex, number of sexual partners, and number of cigarettes smoked per day. The effect of multifactorial risk assessment and screening for risk factors on oral cancer morbidity and mortality is unknown.'}, {'id': 2026, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine screening performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 2027, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of preventive interventions performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 424, 'title': 'Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for peripheral artery disease (PAD) and cardiovascular disease (CVD) risk with the ankle-brachial index (ABI) in asymptomatic adults.\r\rLiterature scans conducted in August 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Risk factors associated with OSA include male sex, older age (40 to 70 years), postmenopausal status, higher BMI, and craniofacial and upper airway abnormalities.'}, {'id': 404, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of counseling adults about skin self-examination to prevent skin cancer.See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 2005, 'title': 'Skin Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Exposure to UV radiation from sun exposure, indoor tanning beds, and other UV radiation&ndash;emitting devices is the major environmental risk factor for skin cancer. History of frequent sunburns, older age, and male sex are associated with increased risk for skin cancer. Exposure to UV radiation from the use of indoor tanning beds is an important risk factor in adolescents. Incidence of melanoma is higher among White persons compared with persons of other races and ethnicities. This difference likely reflects traits associated with increased melanoma risk, such as fair skin (which is more susceptible to sunburning), light-colored eyes, and red or blond hair being more common among White persons compared with persons of other races and ethnicities. Acral lentiginous melanoma, which occurs mostly on skin not frequently exposed to direct sunlight (eg, palms of hands, soles of feet, or under fingernails or toenails), is the most common type of melanoma among Black populations. Other melanoma risk factors include higher numbers of moles on the skin, atypical moles, as well as a personal and family history of skin cancer.'}, {'id': 269, 'title': 'Thyroid Dysfunction: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults.\r\rSee the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': 'The optimal screening interval for thyroid dysfunction (if one exists) is unknown.', 'risktext': 'The most common cause of hypothyroidism in the United States is chronic autoimmune (Hashimoto) thyroiditis. Risk factors for an elevated TSH level include female sex, advancing age, white race, type 1 diabetes, Down syndrome, family history of thyroid disease, goiter, previous hyperthyroidism (possibly due in part to ablation therapy leading to iatrogenic thyroid dysfunction), and external-beam radiation in the head and neck area. Common causes of hyperthyroidism include Graves disease, Hashimoto thyroiditis, and functional thyroid nodules. Risk factors for a low TSH level include female sex; advancing age; black race; low iodine intake; personal or family history of thyroid disease; and ingestion of iodine-containing drugs, such as amiodarone. The USPSTF found no direct evidence that treatment of thyroid dysfunction based on risk level alters final health outcomes.'}, {'id': 1908, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of electronic cigarettes (e-cigarettes) for tobacco cessation in adults, including pregnant persons. The USPSTF recommends that clinicians direct patients who use tobacco to other tobacco cessation interventions with proven effectiveness and established safety.\rSee the Practice Considerations section for more information on recommended behavioral interventions and pharmacotherapy and for suggestions for practice regarding the I statements.', 'servfreq': '', 'risktext': ''}, {'id': 1907, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of pharmacotherapy interventions for tobacco cessation in pregnant persons.', 'servfreq': '', 'risktext': ''}, {'id': 586, 'title': 'Tobacco Use in Children and Adolescents: Primary Care Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--feasible interventions for the cessation of tobacco use among school-aged children and adolescents.\r\rSee the Practice Considerations section for more information on effective interventions to prevent initiation of tobacco use and for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1919, 'title': 'Vitamin D Deficiency in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 408, 'title': 'Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of the benefits and harms of vitamin D and calcium supplementation, alone or combined, for the primary prevention of fractures in men and premenopausal women.', 'servfreq': '', 'risktext': ''}]}
2025-01-29 22:01:24 [INFO] Recommendations fetched: [{'id': 2020, 'title': 'Folic Acid Supplementation to Prevent Neural Tube Defects: Preventive Medication ', 'grade': 'A', 'text': 'The DoctorAI recommends that all persons planning to or who could become pregnant take a daily supplement containing 0.4 to 0.8 mg (400 to 800 mcg) of folic acid.', 'servfreq': 'The neural plate completes its formation and closure early in pregnancy (usually 26 to 28 days after fertilization). This means the critical period for folic acid supplementation starts at least 1 month before conception and continues through the first 2 to 3 months of pregnancy. Nearly half of all pregnancies in the US are unplanned; to gain the full benefits of supplementation, clinicians should advise all persons who plan to or who could become pregnant to take daily folic acid.', 'risktext': 'All pregnancies are at risk for neural tube defects, and persons who are planning to or could become pregnant should take folic acid supplements. Certain risk factors convey a higher risk, and individuals with these risk factors should talk to their health care professional. These factors include personal, partner, or family history of neural tube defects, malabsorption caused by bariatric procedures, the use of certain antiseizure medicines, and genetic mutations in folate-related enzymes. Pregestational diabetes and obesity have been associated with an increased risk of neural tube defects. Ethnic groups such as First Nation persons in Canada and Hispanic persons in California are thought to be at higher risk of neural tube defects. It is unclear, however, whether this is related to a higher risk of genetic variations among these groups or due to differential intake of folic acid&ndash;fortified foods.'}, {'id': 503, 'title': 'Hepatitis B Virus Infection in Pregnant Women: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in pregnant women at their first prenatal visit', 'servfreq': 'A test for HBsAg should be ordered at the first prenatal visit. Women with unknown HBsAg status or with new or continuing risk factors for HBV infection (eg, injection drug use or a sexually transmitted infection) should be screened at the time of admission to a hospital or other delivery setting.', 'risktext': 'In the United States, new cases of HBV among adults are largely transmitted through injection drug use or sexual intercourse, but most prevalent cases of HBV infection are chronic infections from exposure occurring in infancy or childhood. Another major risk factor for HBV infection is country of origin. In the United States, adults with HBV born in high-prevalence countries were commonly infected during childhood. In children, the primary source of infection is perinatal transmission at birth.'}, {'id': 485, 'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in adolescents and adults aged 15 to 65 years. Younger adolescents and older adults who are at increased risk of infection should also be screened.\rSee the Clinical Considerations section for more information about assessment of risk, screening intervals, and rescreening in pregnancy.', 'servfreq': 'The USPSTF found insufficient evidence to determine appropriate or optimal time intervals or strategies for repeat HIV screening. However, repeat screening is reasonable for persons known to be at increased risk of HIV infection, such as sexually active men who have sex with men; persons with a sex partner who is living with HIV; or persons who engage in behaviors that may convey an increased risk of HIV infection, such as injection drug use, transactional sex or commercial sex work, having 1 or more new sex partners whose HIV status is unknown, or having other factors that can place a person at increased risk of HIV infection (see &ldquo;Risk Assessment&rdquo;). Repeat screening is also reasonable for persons who live or receive medical care in a high-prevalence setting, such as a sexually transmitted disease clinic, tuberculosis clinic, correctional facility, or homeless shelter.', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'id': 486, 'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in all pregnant persons, including those who present in labor or at delivery whose HIV status is unknown.', 'servfreq': 'The CDC and ACOG recommend repeat prenatal screening for HIV during the third trimester of pregnancy in women with risk factors for HIV acquisition and in women living or receiving care in high-incidence settings, and the CDC notes that repeat screening for HIV during the third trimester may be considered in all women.&nbsp;', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'id': 1921, 'title': 'Hypertension in Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hypertension in adults 18 years or older with office blood pressure measurement (OBPM). The USPSTF recommends obtaining blood pressure measurements outside of the clinical setting for diagnostic confirmation before starting treatment.', 'servfreq': ' \r\nAlthough evidence on optimal screening intervals is limited, reasonable options include:\r\n \r\n \r\n\r\n\r\nScreening for hypertension every year in adults 40 years or older and in adults at increased risk for hypertension (such as Black persons, persons with high-normal blood pressure, or persons who are overweight or obese)\r\n\r\n\r\n \r\n \r\n\r\n\r\nScreening less frequently (ie, every 3 to 5 years) as appropriate for adults aged 18 to 39 years not at increased risk for hypertension and with a prior normal blood pressure reading.\r\n\r\n\r\n ', 'risktext': ' \r\nAlthough all adults should be screened for hypertension, risk factors that increase a person&rsquo;s risk for the condition include older age, Black race, family history, excess weight and obesity, lifestyle habits (lack of physical activity, stress, and tobacco use), and dietary factors (diet high in fat or sodium, diet low in potassium, or excessive alcohol intake)\r\n '}, {'id': 2021, 'title': 'Prevention of Acquisition of HIV: Preexposure Prophylaxis ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians prescribe preexposure prophylaxis using effective antiretroviral therapy to persons who are at increased risk of HIV acquisition to decrease the risk of acquiring HIV. \r\rSee the Practice Considerations section for more information about identification of persons at increased risk and about effective antiretroviral therapy.', 'servfreq': '', 'risktext': 'HIV is primarily acquired via sexual activity or injection drug use. It is important that clinicians routinely take a sexual and injection drug use history for all their patients in an open and nonjudgmental manner. All adolescents and adults who are sexually active or who inject drugs should be informed that acquisition of HIV can be prevented, to facilitate subsequent risk assessment and discussions about preexposure prophylaxis (PrEP) and other ways to prevent acquisition of HIV. Importantly, risk of HIV acquisition exists on a continuum, and currently available risk assessment tools all have limitations. However, certain risk factors or behaviors are known to place persons at increased risk of HIV.\r\nRisk of HIV acquisition depends on the likelihood that a specific act or activity will transmit HIV and the likelihood that a sex partner or drug injection partner has HIV. Likelihood of HIV transmission is highest with needle-sharing injection drug use and condomless receptive anal intercourse. Condomless receptive anal intercourse has an approximately 10- to 15-fold higher risk of transmission than condomless insertive anal sex and condomless receptive and insertive penile-vaginal sex. A 2018 study estimated the prevalence of HIV (ie, an estimate of the likelihood that a partner whose HIV status is unknown has HIV at a population level) as 12.4% among men who have sex with men and 1.9% among persons who inject drugs. The overall prevalence of HIV in the US is estimated at 0.3%.&nbsp;Of note, both the frequency of specific sexual activities and a person&rsquo;s number of sexual partners will also affect their risk of HIV.\r\n&nbsp;The USPSTF recommends that the following persons be considered for PrEP:\r\n1.&nbsp;&nbsp;&nbsp;&nbsp; Sexually active adults and adolescents weighing at least 35 kg (77 lb) who have engaged in anal or vaginal sex in the past 6 months and have any of the following:\r\n&nbsp;\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A sexual partner who has HIV (especially if the partner has an unknown or detectable viral load).\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A bacterial sexually transmitted infection (STI) (syphilis, gonorrhea, or chlamydia for men who have sex with men and transgender women; gonorrhea and syphilis for heterosexual women and men) in the past 6 months.\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A history of inconsistent or no condom use with sex partner(s) whose HIV status is not known; assessing risk in conversation with the patient and considering factors such as number of partners, the specific sexual activities a person engages in, and whether their sex partner or partners are in a group with a higher prevalence of HIV (eg, men who have sex with men or with men and women, transgender women, persons who inject drugs, and persons who engage in transactional sex).\r\n&nbsp;\r\n2. &nbsp; Persons who inject drugs and have a drug-injecting partner who has HIV or who shares injection equipment.\r\nPersons who engage in transactional sex, such as sex for money, drugs, or housing, including commercial sex workers or persons trafficked for sex work, constitute a group at increased risk of HIV acquisition and should be considered for PrEP based on the criteria outlined above. Persons who request PrEP may have undisclosed behaviors that put them at risk. Transgender women and men who are sexually active should be considered for PrEP based on the criteria outlined above. Transgender women are at especially high risk of HIV acquisition. A Centers for Disease Control and and Prevention (CDC) survey in 7 cities found an HIV prevalence of 42% among transgender women. Prevalence was highest among Black transgender women (62%) and Native American/Alaska Native transgender women (65%).\r\nIn addition, studies have found that transmission of HIV to a seronegative partner from a partner with HIV has not been observed when the partner with HIV was being treated with antiretroviral therapy and had a suppressed viral load.&nbsp;It is not known whether PrEP use further decreases the risk of HIV transmission when a partner with HIV has a documented undetectable viral load. Factors such as the consistency or inconsistency of a partner&rsquo;s viral load being suppressed, a partner&rsquo;s adherence to antiretroviral therapy, and the degree of certainty that a partner&rsquo;s viral load is suppressed (eg, self-report vs availability of laboratory test results) may help inform decisions about the use of PrEP in this situation.\r\nAll persons being considered for PrEP must have a recently documented negative HIV antigen-antibody test result, and if they have taken oral PrEP or postexposure prophylaxis in the past 3 months, or injectable cabotegravir in the past 12 months, the CDC recommends testing with both an HIV antigen-antibody assay and an HIV-1 RNA assay.'}, {'id': 186, 'title': 'Rh(D) Incompatibility: Screening ', 'grade': 'A', 'text': 'The DoctorAI strongly recommends Rh(D) blood typing and antibody testing for all pregnant women during their first visit for pregnancy-related care.', 'servfreq': 'First prenatal visit.', 'risktext': ''}, {'id': 1989, 'title': 'Syphilis Infection in Nonpregnant Adolescents and Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for syphilis infection in persons who are at increased risk for infection.', 'servfreq': 'Optimal screening frequency for persons who are at increased risk for syphilis infection is not well established. Men who have sex with men or persons with HIV infection may benefit from screening at least annually or more frequently (eg, every 3 to 6 months) if they continue to be at high risk.', 'risktext': 'The USPSTF recommends screening for syphilis in persons who are at increased risk for infection. When deciding which persons to screen for syphilis, clinicians should consider the prevalence of infection in the communities they serve, as well as other sociodemographic and behavioral factors that may be associated with increased risk of syphilis infection. For example, prevalence of syphilis is higher in men, men who have sex with men, persons with HIV infection, young adults, and persons with a history of incarceration, sex work, or military service. A substantial percentage of heterosexual syphilis transmission occurs among persons who use illicit drugs, particularly methamphetamine. Diagnosis of another STI may signal that a person is having condomless sex, which increases their risk of syphilis infection. Higher infection rates in persons of some racial and ethnic groups have been reported and are primarily a reflection of a combination of factors, including social determinants of health (eg, disparities of income, low educational achievement, and unstable housing), differential health insurance coverage or access to quality health care, and differences in sexual network characteristics (eg, individuals living in communities with a high prevalence of STIs have an increased chance of encountering an infected partner). Local prevalence rates may change over time, so clinicians should be aware of the latest data and trends for their specific population and geographic area, which are available through their state and local health departments and Centers for Disease Control and Prevention (CDC) surveillance.\r\n&nbsp;\r\nAlthough direct evidence on screening in nonpregnant persons who are not at increased risk for syphilis infection is lacking, based on the established test performance characteristics of current screening tests and the low prevalence rate of syphilis in this population, the yield of screening is likely low.9,10 Therefore, screening in this population may result in high false-positive rates and overtreatment.'}, {'id': 431, 'title': 'Syphilis Infection in Pregnant Women: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends early screening for syphilis infection in all pregnant women.', 'servfreq': 'All pregnant women should be tested for syphilis as early as possible when they first present to care. If a woman has not received prenatal care prior to delivery, she should be tested at the time she presents for delivery. In most cases of congenital syphilis, pregnant women received prenatal care but were not screened and treated for syphilis early enough during the pregnancy to prevent transmission to the fetus.', 'risktext': ''}, {'id': 1905, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and US Food and Drug Administration (FDA)--approved pharmacotherapy for cessation to nonpregnant adults who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 1906, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all pregnant persons about tobacco use, advise them to stop using tobacco, and provide behavioral interventions for cessation to pregnant persons who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 2014, 'title': 'Anxiety Disorders in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for anxiety disorders in adults, including pregnant and postpartum persons.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding optimal timing for screening, or screening interval, for both the perinatal and general adult populations; more evidence on both timing and screening interval is needed for all adult populations. A pragmatic approach in the absence of evidence might include screening all adults who have not been screened previously and using clinical judgment in considering risk factors, comorbid conditions, and life events to determine if additional screening of high-risk patients is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nRisk factors for anxiety disorders include sociodemographic factors, psychosocial factors, and physical and mental health factors such as marital status (widowed or divorced), stressful life events, smoking and alcohol use, other mental health conditions, or a parental history of mental disorders. Demographic factors such as low socioeconomic status and female sex are associated with higher rates of anxiety disorders.&nbsp;Black persons and individuals of non-Hispanic ethnicity are at increased risk of anxiety disorders due to social, rather than biological, factors. Anxiety and depressive disorders often overlap. One cohort study found that 67% of individuals with a depressive disorder also had a current anxiety disorder, and 75% had a lifetime comorbid anxiety disorder.'}, {'id': 1938, 'title': 'Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication ', 'grade': 'B', 'text': 'The DoctorAI recommends the use of low-dose aspirin (81 mg/day) as preventive medication after 12 weeks of gestation in persons who are at high risk for preeclampsia.\r\rSee the Practice Considerations section for information on high risk and aspirin dose.', 'servfreq': 'Once daily after 12 weeks of gestation', 'risktext': ' \r\nPersons with a history of preeclampsia in a previous pregnancy, type 1 or type 2 diabetes, and chronic hypertension are at highest risk for preeclampsia. Additional conditions that place a person at high risk for preeclampsia include multifetal gestation, conception using assisted reproductive technology, autoimmune disease, and kidney disease. Other factors associated with increased preeclampsia risk include nulliparity, high prepregnancy body mass index, family history of preeclampsia, and advanced maternal age (35 years or older). In addition, Black persons have higher rates of preeclampsia and are at increased risk for serious complications due to various societal and health inequities.\r\n '}, {'id': 513, 'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for asymptomatic bacteriuria using urine culture in pregnant persons.', 'servfreq': 'In general, screening is performed once at the first prenatal visit per clinical guidelines. However, there is little evidence on the optimal timing and frequency of screening for asymptomatic bacteriuria in pregnancy.2&nbsp; .&nbsp;Screen pregnant persons for asymptomatic bacteriuria using a midstream, clean-catch urine culture at the first prenatal visit or at 12 to 16 weeks of gestation, whichever is earlier. A urine culture showing &gt;100,000 CFU/mL of a single uropathogen or &gt;10,000 CFU/mL if the pathogen is group B streptococcus indicates treatment.', 'risktext': 'This recommendation applies to adults 18 years and older and pregnant persons of any age without signs and symptoms of a urinary tract infection. It does not apply to persons who have chronic medical or urinary tract conditions, such as end-stage renal disease; have indwelling urinary catheters, urinary stents, or spinal cord injuries; are hospitalized; reside in an institution (eg, a nursing home); or who are transplant recipients.\r\n&nbsp;\r\nThe risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6&nbsp;Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5&nbsp;Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7,&nbsp;11,&nbsp;12&nbsp;In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12&nbsp;Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4,&nbsp;6'}, {'id': 2009, 'title': 'Latent Tuberculosis Infection in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for LTBI in populations at increased risk.\r\rSee the "Assessment of Risk" section for additional information on adults at increased risk.', 'servfreq': 'The USPSTF found no evidence on the optimal frequency of screening for LTBI. In the absence of evidence, a reasonable approach is to repeat screening based on specific risk factors; screening frequency could range from 1-time only screening among persons at low risk for future tuberculosis exposure to annual screening among those at continued risk of exposure.', 'risktext': 'Populations at increased risk for LTBI, based on increased prevalence of active disease and increased risk of exposure, include persons who were born in, or are former residents of, countries with high tuberculosis prevalence and persons who live in, or have lived in, high-risk congregate settings (eg, homeless shelters or correctional facilities). Clinicians can consult their local or state health departments for more information about populations at increased risk in their community, since local demographic patterns may vary across the US.\r\nIn 2020, 71.5% of all cases of active tuberculosis in the US occurred among persons born outside the US. According to the CDC, tuberculosis disease is common in most countries in Latin America, the Caribbean, Africa, Asia, Eastern Europe, and Russia. In 2020, among persons with new tuberculosis living in the US who were born outside the US, the most common countries of birth were Mexico (18.0%), the Philippines (12.5%), India (10.4%), Vietnam (8.2%), and China (5.1%), accounting for 54.2% of total cases. Most of these cases are believed to be due to progression of latent infection to active tuberculosis disease rather than new transmission within communities.\r\nPersons who live, or have lived, in high-risk congregate settings also have a higher prevalence rate of active tuberculosis and an increased risk for exposure. In 2020, 4.3% of tuberculosis disease cases diagnosed in persons 15 years or older occurred in persons experiencing homelessness and 2.6% occurred in residents of correctional facilities. It is estimated that persons experiencing homelessness have an 11 times higher incidence of tuberculosis disease compared with persons who are not experiencing homelessness (36 cases per 100,000 population vs 2.9 cases per 100,000 population, respectively, during 2011 to 2016).\r\nOther populations at increased risk for LTBI or progression to active disease include persons who have immunosuppression (eg, persons living with HIV, patients receiving immunosuppressive medications such as chemotherapy or tumor necrosis factor inhibitors, and patients who have received an organ transplant) and patients with silicosis (a lung disease). However, given that screening in these populations may be considered standard care as part of disease management or indicated prior to the use of certain medications, the USPSTF did not review evidence on screening in these populations. Information on testing in these populations is provided by other groups, such as the Office of AIDS Research at the National Institutes of Health, and in a guideline issued jointly by the American Thoracic Society, Infectious Diseases Society of America, and CDC. Some evidence from observational studies has explored the association between poorly controlled diabetes and progression of LTBI to active disease. However, there is insufficient evidence on screening for and treatment of LTBI in persons with diabetes for the USPSTF to make a separate recommendation for this important population.\r\nPersons who are contacts of individuals with active tuberculosis, health care workers, and workers in high-risk congregate settings may also be at increased risk of exposure. Because screening in these populations is conducted as part of public health or employee health surveillance, the USPSTF did not review the evidence in these populations. Clinicians seeking further information about testing for tuberculosis in these populations can refer to the Additional Tools and Resources and Recommendations of Others sections.'}, {'id': 514, 'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic bacteriuria in nonpregnant adults.', 'servfreq': '', 'risktext': 'The risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6 Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5 Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7, 11, 12 In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12 Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4, 6'}, {'id': 507, 'title': 'BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing ', 'grade': 'B', 'text': 'The DoctorAI recommends that primary care clinicians assess women with a personal or family history of breast, ovarian, tubal, or peritoneal cancer or who have an ancestry associated with breast cancer susceptibility 1 and 2 (BRCA1/2) gene mutations with an appropriate brief familial risk assessment tool. Women with a positive result on the risk assessment tool should receive genetic counseling and, if indicated after counseling, genetic testing.', 'servfreq': 'Consideration of screening for potentially harmful BRCA mutations should begin once women have reached the age of consent (18 years). Primary care providers should periodically assess all patients for changes in family history (for example, comprehensive review at least every 5 to 10 years)', 'risktext': 'Patients with family or personal histories of breast, ovarian, tubal, or peritoneal cancer or ancestry associated with harmful&nbsp;&lt; i&gt;BRCA1/2&nbsp;mutations should be assessed using a familial risk assessment tool. The USPSTF found adequate evidence that these tools are accurate in identifying women with increased likelihood of&nbsp;&lt; i&gt;BRCA1/2mutations. Tools evaluated by the USPSTF include the Ontario Family History Assessment Tool, Manchester Scoring System, Referral Screening Tool, Pedigree Assessment Tool, 7-Question Family History Screening Tool, International Breast Cancer Intervention Study instrument (Tyrer-Cuzick), and brief versions of BRCAPRO. These tools should be used to guide referrals to genetic counseling.&nbsp;Persons should consider their sex at birth to determine which recommendation best applies to them.'}, {'id': 339, 'title': 'Breastfeeding: Primary Care Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends providing interventions during pregnancy and after birth to support breastfeeding.', 'servfreq': 'During pregnancy and after birth', 'risktext': "This recommendation applies to pregnant women, new mothers, and their infants and children. Interventions to support breastfeeding may also involve a woman's partner, other family members, and friends. This recommendation does not apply in circumstances where there are contraindications to breastfeeding (e.g., certain maternal medical conditions or infant metabolic disorders, such as galactosemia). The USPSTF did not review evidence on interventions directed at breastfeeding of preterm infants."}, {'id': 1935, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for chlamydia in all sexually active women 24 years or younger and in women 25 years or older who are at increased risk for infection.', 'servfreq': ' \r\nIn the absence of studies on screening intervals, a reasonable approach would be to screen patients whose sexual history reveals new or persistent risk factors since the last negative test result.\r\n ', 'risktext': ' \r\nAge is a strong predictor of risk for chlamydial and gonococcal infections, with the highest infection rates in women occurring during ages 15 to 24 years. Women 25 years or older are at increased risk if they have a new sex partner, more than 1 sex partner, a sex partner with concurrent partners, or a sex partner who has an STI; practice inconsistent condom use when not in a mutually monogamous relationship; or have a previous or coexisting STI. Exchanging sex for money or drugs and history of incarceration also are associated with increased risk.&nbsp;Clinicians should consider the communities they serve and may want to consult local public health authorities for information about local epidemiology and guidance on determining who is at increased risk.\r\n '}, {'id': 1936, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for gonorrhea in all sexually active women 24 years or younger and in women 25 years or older who are at increased risk for infection.', 'servfreq': ' \r\nIn the absence of studies on screening intervals, a reasonable approach would be to screen patients whose sexual history reveals new or persistent risk factors since the last negative test result.\r\n ', 'risktext': ' \r\nAge is a strong predictor of risk for chlamydial and gonococcal infections, with the highest infection rates in women occurring during ages 15 to 24 years. Women 25 years or older are at increased risk if they have a new sex partner, more than 1 sex partner, a sex partner with concurrent partners, or a sex partner who has an STI; practice inconsistent condom use when not in a mutually monogamous relationship; or have a previous or coexisting STI. Exchanging sex for money or drugs and history of incarceration also are associated with increased risk.&nbsp;Clinicians should consider the communities they serve and may want to consult local public health authorities for information about local epidemiology and guidance on determining who is at increased risk.\r\n '}, {'id': 1909, 'title': 'Asymptomatic Carotid Artery Stenosis: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic carotid artery stenosis in the general adult population.\r\rSee the Practice Considerations section for a description of adults at increased risk.', 'servfreq': '', 'risktext': ''}, {'id': 2017, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for suicide risk in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': '', 'risktext': ''}, {'id': 2016, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for depression in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding the optimal timing for screening for depression; more evidence is needed in both perinatal and general adult populations. In the absence of evidence, a pragmatic approach might include screening adults who have not been screened previously and using clinical judgment while considering risk factors, comorbid conditions, and life events to determine if additional screening of patients at increased risk is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nThe USPSTF recommends screening for depression in all adults regardless of risk factors. Risk factors for depression include a combination of genetic, biological, and environmental factors, such as a family history of depression, prior episode of depression or other mental health condition, a history of trauma or adverse life events, or a history of disease or illness (eg, cardiovascular disease).\r\nPrevalence rates vary by sex, age, race, ethnicity, education, marital status, geographic location, poverty level, and employment status. Women have twice the risk of depression compared with men. Young adults, multiracial individuals, and Native American/Alaska Native individuals have higher rates of depression.\r\nRisk factors for perinatal depression include life stress, low social support, history of depression, marital or partner dissatisfaction, and a history of abuse.'}, {'id': 1932, 'title': 'Gestational Diabetes: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for gestational diabetes in asymptomatic pregnant persons at 24 weeks of gestation or after.', 'servfreq': 'At 24 weeks of gestation or after to improve maternal and fetal outcomes', 'risktext': ' \r\nSeveral factors increase a person&rsquo;s risk for developing gestational diabetes, including obesity, increased maternal age, history of gestational diabetes, family history of diabetes, and belonging to a racial/ethnic group that is at increased risk for developing type 2 diabetes (Hispanic, Native American, South or East Asian, or Pacific Islander descent).4,19,20 Factors associated with a lower risk for developing gestational diabetes include age younger than 25 to 30 years, White race, a body mass index (BMI) of 25 or less (calculated as weight in kilograms divided by height in meters squared), no family history (in a first-degree relative) of diabetes, and no history of glucose intolerance or adverse pregnancy outcomes related to gestational diabetes.21-23 The risk in different racial/ethnic groups may be due in part to social risk factors such as low socioeconomic status or structural racism, although these associations are not examined in the current evidence. Although a higher BMI increases the risk of gestational diabetes across racial/ethnic groups, the association varies. In Asian American persons, the prevalence of gestational diabetes at a BMI of 22 to less than 25 is similar to the prevalence in Hispanic persons, non-Hispanic White persons, and Black persons with a higher (&gt;28) BMI.24,25\r\n '}, {'id': 1845, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends offering or referring adults with cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity.', 'servfreq': '', 'risktext': 'Adults 18 years or older at increased risk of CVD, defined as those with 1 or more of the following:\r\n1.Hypertension or elevated blood pressure2.Dyslipidemia3.Mixed or multiple risk factors such as the metabolic syndrome or an estimated 10-year CVD risk of &ge;7.5%\r\nThis recommendation does not apply to adults with other known modifiable cardiovascular risk factors such as abnormal blood glucose levels, obesity, and smoking; these populations are incorporated in other USPSTF recommendations.'}, {'id': 1931, 'title': 'Healthy Weight and Weight Gain In Pregnancy: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer pregnant persons effective behavioral counseling interventions aimed at promoting healthy weight gain and preventing excess gestational weight gain in pregnancy.', 'servfreq': 'Throughout pregnancy', 'risktext': 'Pregnancy'}, {'id': 1885, 'title': 'Hepatitis B Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in adolescents and adults at increased risk for infection.\r\rSee the Practice Considerations section for a description of adolescents and adults at increased risk for infection.', 'servfreq': 'For patients with negative HBsAg results who have not received the HBV vaccine series, periodic screening may be useful for those who report continued risk for acquiring HBV transmission, such as persons who continue to inject drugs and men who have sex with men. Clinical judgment should be used to determine screening frequency. The USPSTF found no evidence to determine optimal screening intervals.', 'risktext': 'Persons from such risk groups include persons who have injected drugs in the past or currently; men who have sex with men; persons with HIV; and sex partners, needle-sharing contacts, and household contacts of persons known to be HBsAg positive. Some persons with combinations of risk factors who are not members of risk factor groups listed above may also be at increased risk for HBV infection.'}, {'id': 524, 'title': 'Hepatitis C Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis C virus (HCV) infection in adults aged 18 to 79 years.', 'servfreq': 'One-time screening for most adults.\r\nPeriodically screen persons with continued risk for HCV infection (eg, persons with past or current injection drug use). There is limited evidence to determine how often to screen persons at increased risk.&nbsp;', 'risktext': 'Asymptomatic adults aged 18 to 79 years (including pregnant persons) without known liver disease.&nbsp;\r\nThe USPSTF also suggests that clinicians consider screening persons younger than 18 years and older than 79 years who are at high risk for infection (eg, those with past or current injection drug use).&nbsp;'}, {'id': 2023, 'title': 'Hypertensive Disorders of Pregnancy: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hypertensive disorders in pregnant persons with blood pressure measurements throughout pregnancy.', 'servfreq': 'Screening Interval\r\nBlood pressure measurements should be obtained during each prenatal care visit throughout pregnancy. Hypertensive disorders of pregnancy can quickly evolve into severe disease that can result in serious, even fatal, maternal and infant health outcomes. The ability to screen for hypertensive disorders of pregnancy using blood pressure measurements is important to identify and effectively treat a potentially unpredictable and fatal condition. While it is known that risk continues into the immediate postpartum period, there is little evidence regarding screening during this period. A pragmatic approach would be for patients to be counseled regarding signs and symptoms of preeclampsia at hospital discharge and for patients with hypertensive disorders to have subsequent blood pressure checks.\r\nScreening for hypertensive disorders of pregnancy alone is not sufficient to improve inequities in health outcomes. Identifying hypertensive disorders of pregnancy requires adequate prenatal visits, surveillance, and evidence-based care in response to evolving patient signs and symptoms during pregnancy and the postpartum period to improve health outcomes. Black and Native American/Alaska Native persons have lower rates of prenatal visits and are at greater risk of serious postpartum morbidity and hospital readmission after delivery. Screening and monitoring of Black and Hispanic/Latina individuals during the postpartum period could be an important step for reducing health inequities by preventing serious adverse events. In addition, screening and monitoring by various health care providers (eg, nurse midwives, nurses, pediatricians, doulas, and lactation consultants) could also help avert serious complications in the postpartum period.', 'risktext': 'Assessment of Risk\r\nImportant clinical conditions associated with increased risk for preeclampsia include a history of eclampsia or preeclampsia in a prior pregnancy, a previous adverse pregnancy outcome, and maternal comorbid conditions (including type 1 or type 2 diabetes prior to pregnancy, gestational diabetes, chronic hypertension, kidney disease, and autoimmune diseases).\r\n&nbsp;Other factors associated with increased risk of preeclampsia and gestational hypertension include nulliparity, high prepregnancy body mass index, family history of preeclampsia, multifetal gestation, and the pregnant individual being 35 years or older.\r\nThe higher prevalence of hypertensive disorders of pregnancy and the increased risk for severe complications seen in Black persons may be due to their disproportionate burden of social and clinical risk factors. These social and clinical determinants largely result from historical and current manifestations of structural racism that influence environmental exposures, access to health resources, and overall health status.'}, {'id': 434, 'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians screen for intimate partner violence (IPV) in women of reproductive age and provide or refer women who screen positive to ongoing support services. See the Clinical Considerations section for more information on effective ongoing support services for IPV and for information on IPV in men.', 'servfreq': 'The USPSTF found no evidence on appropriate intervals for screening. Randomized clinical trials (RCTs) of screening and interventions for IPV often screen for current IPV or IPV in the past year.\r\n&nbsp;', 'risktext': 'All women of reproductive age are at potential risk for IPV and should be screened. There are a variety of factors that increase risk of IPV, such as exposure to violence as a child, young age, unemployment, substance abuse, marital difficulties, and economic hardships.\r\nRisk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health. For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.'}, {'id': 187, 'title': 'Rh(D) Incompatibility: Screening ', 'grade': 'B', 'text': "The DoctorAI recommends repeated Rh(D) antibody testing for all unsensitized Rh(D)-negative women at 24 to 28 weeks' gestation, unless the biological father is known to be Rh(D)-negative.", 'servfreq': 'Repeat testing at 24-28 weeks gestation.', 'risktext': ''}, {'id': 1916, 'title': 'Lung Cancer: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery.', 'servfreq': ' \r\nThe USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. ', 'risktext': ' \r\nSmoking and older age are the 2 most important risk factors for lung cancer.&nbsp;The risk of lung cancer in persons who smoke increases with cumulative quantity and duration of smoking and with age but decreases with increasing time since quitting for persons who formerly smoked.3 The USPSTF considers adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years to be at high risk and recommends screening for lung cancer with annual LDCT in this population. \r\n \r\n&nbsp;\r\n \r\nAfrican American/Black (Black) men have a higher incidence of lung cancer than White men, and Black women have a lower incidence than White women.1 These differences are likely related to differences in smoking exposure (ie, prevalence of smoking) and related exposure to carcinogens in cigarettes.7,8 The differences may also be related to other social risk factors.\r\n \r\n&nbsp;\r\n \r\nOther risk factors for lung cancer include environmental exposures, prior radiation therapy, other (noncancer) lung diseases, and family history. Lower level of education is also associated with a higher risk of lung cancer.7 The task force recommends using age and smoking history to determine screening eligibility rather than more elaborate risk prediction models because there is insufficient evidence to assess whether risk prediction model&ndash;based screening would improve outcomes relative to using the risk factors of age and smoking history for broad implementation in primary care.\r\n '}, {'id': 449, 'title': 'Perinatal Depression: Preventive Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians provide or refer pregnant and postpartum persons who are at increased risk of perinatal depression to counseling interventions.', 'servfreq': '', 'risktext': 'Include&nbsp;a past history of depression. Current depressive symptoms (that do not reach a diagnostic threshold),&nbsp;history of physical or sexual abuse,&nbsp;unplanned or unwanted pregnancy,&nbsp;stressful life events,&nbsp;lack of social and financial support,&nbsp;intimate partner violence,pregestational or gestational diabetes,and complications during pregnancy. Additional risk factors include adolescent parenthood, low socioeconomic status, and lack of social support.&nbsp;Genetic factors are also suspected to contribute to women&rsquo;s risk of developing perinatal depression.'}, {'id': 1445, 'title': 'Sexually Transmitted Infections: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends behavioral counseling for all sexually active adolescents and for adults who are at increased risk for sexually transmitted infections (STIs).\r\rSee the Practice Considerations section for more information on populations at increased risk for acquiring STIs.', 'servfreq': '', 'risktext': 'All sexually active adolescents are at increased risk for STIs because of the high rates of STIs in this age group and should receive behavioral counseling interventions. Adults at increased risk for STIs include those who currently have an STI or were diagnosed with one within the past year, do not consistently use condoms, have multiple sex partners, or have sex partners within populations with a high prevalence of STIs. Populations with a high prevalence of STIs include persons who seek STI testing or attend STI clinics; sexual and gender minorities; persons who are living with HIV, inject drugs, have exchanged sex for money or drugs, or have entered correctional facilities; and some racial/ethnic minority groups.1-4'}, {'id': 402, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends counseling young adults, adolescents, children, and parents of young children about minimizing exposure to ultraviolet (UV) radiation for persons aged 6 months to 24 years with fair skin types to reduce their risk of skin cancer.', 'servfreq': '', 'risktext': 'Fair skin types'}, {'id': 438, 'title': 'Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for unhealthy alcohol use in primary care settings in adults 18 years or older, including pregnant women, and providing persons engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce unhealthy alcohol use.', 'servfreq': 'The USPSTF did not find adequate evidence to recommend an optimal screening interval for unhealthy alcohol use in adults.&nbsp;Brief behavioral counseling interventions were found to reduce unhealthy alcohol use in adults 18 years or older, including pregnant women. Effective behavioral counseling interventions vary in their specific components, administration, length, and number of interactions. The USPSTF was unable to identify specific intervention characteristics or components that were clearly associated with improved outcomes.', 'risktext': 'engaged in risky or hazardous drinking'}, {'id': 767, 'title': 'Unhealthy Drug Use: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening by asking questions about unhealthy drug use in adults age 18 years or older. Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. \r(Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'servfreq': 'Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. (Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'risktext': 'These include being aged 18 to 25 years; male sex; having a mental health condition, personality or mood disorder, or nicotine or alcohol dependence; a history of physical or sexual abuse, parental neglect, or other adversity in childhood; or drug or alcohol addiction in a first-degree relative.1,9&nbsp;Factors associated with misuse of prescription drugs include history of other drug use, mental illness, pain, and greater access to prescription drugs.10&nbsp;Factors associated with prenatal use of drugs include a mental health disorder, interpersonal violence, and family history of substance use.11'}, {'id': 433, 'title': 'Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer or refer adults with a body mass index (BMI) of 30 or higher (calculated as weight in kilograms divided by height in meters squared) to intensive, multicomponent behavioral interventions.', 'servfreq': '', 'risktext': 'Adults with a BMI &ge;30'}, {'id': 1979, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: Behavioral Counseling Interventions ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians individualize the decision to offer or refer adults without cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity. \r\rSee the "Practice Considerations" section for information on determining which patients may benefit most from this service.', 'servfreq': '', 'risktext': ''}, {'id': 508, 'title': 'BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine risk assessment, genetic counseling, or genetic testing for women whose personal or family history or ancestry is not associated with potentially harmful BRCA1/2 gene mutations.', 'servfreq': '', 'risktext': 'Patients with family or personal histories of breast, ovarian, tubal, or peritoneal cancer or ancestry associated with harmful&nbsp;BRCA1/2&nbsp;mutations should be assessed using a familial risk assessment tool. The USPSTF found adequate evidence that these tools are accurate in identifying women with increased likelihood of&nbsp;BRCA1/2mutations. Tools evaluated by the USPSTF include the Ontario Family History Assessment Tool, Manchester Scoring System, Referral Screening Tool, Pedigree Assessment Tool, 7-Question Family History Screening Tool, International Breast Cancer Intervention Study instrument (Tyrer-Cuzick), and brief versions of BRCAPRO. These tools should be used to guide referrals to genetic counseling.'}, {'id': 525, 'title': 'Bacterial Vaginosis in Pregnant Persons to Prevent Preterm Delivery: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for bacterial vaginosis (BV) in pregnant persons who are not at increased risk for preterm delivery.', 'servfreq': '', 'risktext': '\r\nAssess risk for preterm delivery. There are multiple factors that increase risk for preterm delivery; one of the strongest risk factors is prior preterm delivery.\r\nDecide whether or not to screen for bacterial vaginosis:\r\n\r\na. Do not screen pregnant persons who are not at increased risk for preterm delivery.\r\nb. Evidence is insufficient to recommend for or against screening pregnant persons at increased risk for preterm delivery.'}, {'id': 418, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening with resting or exercise electrocardiography (ECG) to prevent cardiovascular disease (CVD) events in asymptomatic adults at low risk of CVD events.', 'servfreq': '', 'risktext': ''}, {'id': 429, 'title': 'Cervical Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for cervical cancer in women who have had a hysterectomy with removal of the cervix and do not have a history of a high-grade precancerous lesion (ie, cervical intraepithelial neoplasia [CIN] grade 2 or 3) or cervical cancer.', 'servfreq': '', 'risktext': ''}, {'id': 428, 'title': 'Cervical Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for cervical cancer in women younger than 21 years.', 'servfreq': '', 'risktext': ''}, {'id': 1973, 'title': 'Chronic Obstructive Pulmonary Disease: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for chronic obstructive pulmonary disease in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 2003, 'title': 'Genital Herpes Infection: Serologic Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine serologic screening for genital herpes simplex virus infection in asymptomatic adolescents and adults, including pregnant persons.', 'servfreq': '', 'risktext': 'The USPSTF found no evidence of externally validated, reliable risk stratification tools to identify individuals more or less likely to have genital herpes.'}, {'id': 504, 'title': 'Pancreatic Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for pancreatic cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 365, 'title': 'Thyroid Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for thyroid cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 1976, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'D', 'text': 'The DoctorAI recommends against the use of beta carotene or vitamin E supplements for the prevention of cardiovascular disease or cancer.', 'servfreq': '', 'risktext': ''}, {'id': 318, 'title': 'Autism Spectrum Disorder in Young Children: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for autism spectrum disorder (ASD) in young children for whom no concerns of ASD have been raised by their parents or a clinician.', 'servfreq': '', 'risktext': 'Although a number of potential risk factors for ASD have been identified, there is insufficient evidence to determine if certain risk factors modify the performance characteristics of ASD screening tests, such as the age at which screening is performed or other characteristics of the child or family.'}, {'id': 526, 'title': 'Bacterial Vaginosis in Pregnant Persons to Prevent Preterm Delivery: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for BV in pregnant persons who are at increased risk for preterm delivery.', 'servfreq': '', 'risktext': ''}, {'id': 65, 'title': 'Bladder Cancer in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults.\r\rLiterature scans conducted in July 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'This evidence update focused on the benefits and harms of screening for bladder cancer among people without symptoms, the accuracy of screening tests done in primary care settings, and the benefits and harms of treatment. The updated evidence review did not find any new high quality evidence to adequately determine the balance of benefits and harms of screening for bladder cancer. However, bladder cancer is a common cancer and can cause considerable health problems including death. Therefore, the USPSTF determined that the evidence was insufficient to provide a recommendation for or against bladder cancer screening.  The USPSTF emphasizes the need for additional research in this area. '}, {'id': 2037, 'title': 'Breast Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of supplemental screening for breast cancer using breast ultrasonography or magnetic resonance imaging (MRI) in women identified to have dense breasts on an otherwise negative screening mammogram.\r\rSee the "Practice Considerations" section for more information on the patient population to whom this recommendation applies and on screening mammography modalities.', 'servfreq': '', 'risktext': 'These recommendations apply to cisgender women and all other persons assigned female at birth (including transgender men and nonbinary persons) 40 years or older at average risk of breast cancer. \r\nThese recommendations apply to persons who have factors associated with an increased risk of breast cancer, such as a family history of breast cancer (ie, a first-degree relative with breast cancer) or having dense breasts. They do not apply to persons who have a genetic marker or syndrome associated with a high risk of breast cancer (eg, BRCA1 or BRCA2 genetic variation), a history of high-dose radiation therapy to the chest at a young age, or previous breast cancer or a high-risk breast lesion on previous biopsies. '}, {'id': 419, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening with resting or exercise ECG to prevent CVD events in asymptomatic adults at intermediate or high risk of CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 423, 'title': 'Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of adding the ankle-brachial index (ABI), high-sensitivity C-reactive protein (hsCRP) level, or coronary artery calcium (CAC) score to traditional risk assessment for cardiovascular disease (CVD) in asymptomatic adults to prevent CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 352, 'title': 'Celiac Disease: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'persons with family history or other risk factors'}, {'id': 1955, 'title': 'Eating Disorders in Adolescents and Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for eating disorders in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1933, 'title': 'Gestational Diabetes: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for gestational diabetes in asymptomatic pregnant persons before 24 weeks of gestation.', 'servfreq': '', 'risktext': ''}, {'id': 665, 'title': 'Illicit Drug Use in Children, Adolescents, and Young Adults: Primary Care-Based Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--based behavioral counseling interventions to prevent illicit drug use, including nonmedical use of prescription drugs, in children, adolescents, and young adults.\r\rSee the Practice Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 435, 'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for abuse and neglect in all older or vulnerable adults. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': 'Risk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health.14&nbsp;For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.15'}, {'id': 2045, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for iron deficiency and iron deficiency anemia in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2046, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine iron supplementation in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2018, 'title': 'Lipid Disorders in Children and Adolescents: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1998, 'title': 'Obstructive Sleep Apnea in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for obstructive sleep apnea in the general adult population.\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Risk Factors\r\nRisk factors associated with OSA include male sex, older age (40-70 years), postmenopausal status, higher body mass index (BMI), and craniofacial and upper airway abnormalities (eg, enlarged tonsils or long upper airway). Black, Hispanic/Latino, and Native American/Alaska Native persons have a higher prevalence of OSA compared with White persons; some evidence suggests that these differences are partially explained by higher rates of obesity, asthma, and tobacco use among these groups.8'}, {'id': 1977, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of multivitamin supplements for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1978, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of single or paired nutrient supplements (other than beta carotene and vitamin E) for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 176, 'title': 'Oral Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for oral cancer in asymptomatic adults.\r\rGo to the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in July 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Tobacco and alcohol use are major risk factors for oral cancer. A total of 20% to 30% of cases of oral cancer worldwide are attributable to cigarette smoking. In the United States, up to 75% of cases of oral cancer may be attributable to tobacco and alcohol use. Additional risk factors include male sex, older age, use of betel quid, ultraviolet light exposure, infection with Candida or bacterial flora, and a compromised immune system. Sexually transmitted oral HPV infection (HPV-16) has recently been recognized as an increasingly important risk factor for oropharyngeal cancer. In the United States, the prevalence of oropharyngeal cancer due to oral HPV infection is probably as high as 80% to 95%. The prevalence of oral HPV infection is associated with age, sex, number of sexual partners, and number of cigarettes smoked per day. The effect of multifactorial risk assessment and screening for risk factors on oral cancer morbidity and mortality is unknown.'}, {'id': 2026, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine screening performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 2027, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of preventive interventions performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 424, 'title': 'Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for peripheral artery disease (PAD) and cardiovascular disease (CVD) risk with the ankle-brachial index (ABI) in asymptomatic adults.\r\rLiterature scans conducted in August 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Risk factors associated with OSA include male sex, older age (40 to 70 years), postmenopausal status, higher BMI, and craniofacial and upper airway abnormalities.'}, {'id': 404, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of counseling adults about skin self-examination to prevent skin cancer.See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 2005, 'title': 'Skin Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Exposure to UV radiation from sun exposure, indoor tanning beds, and other UV radiation&ndash;emitting devices is the major environmental risk factor for skin cancer. History of frequent sunburns, older age, and male sex are associated with increased risk for skin cancer. Exposure to UV radiation from the use of indoor tanning beds is an important risk factor in adolescents. Incidence of melanoma is higher among White persons compared with persons of other races and ethnicities. This difference likely reflects traits associated with increased melanoma risk, such as fair skin (which is more susceptible to sunburning), light-colored eyes, and red or blond hair being more common among White persons compared with persons of other races and ethnicities. Acral lentiginous melanoma, which occurs mostly on skin not frequently exposed to direct sunlight (eg, palms of hands, soles of feet, or under fingernails or toenails), is the most common type of melanoma among Black populations. Other melanoma risk factors include higher numbers of moles on the skin, atypical moles, as well as a personal and family history of skin cancer.'}, {'id': 269, 'title': 'Thyroid Dysfunction: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults.\r\rSee the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': 'The optimal screening interval for thyroid dysfunction (if one exists) is unknown.', 'risktext': 'The most common cause of hypothyroidism in the United States is chronic autoimmune (Hashimoto) thyroiditis. Risk factors for an elevated TSH level include female sex, advancing age, white race, type 1 diabetes, Down syndrome, family history of thyroid disease, goiter, previous hyperthyroidism (possibly due in part to ablation therapy leading to iatrogenic thyroid dysfunction), and external-beam radiation in the head and neck area. Common causes of hyperthyroidism include Graves disease, Hashimoto thyroiditis, and functional thyroid nodules. Risk factors for a low TSH level include female sex; advancing age; black race; low iodine intake; personal or family history of thyroid disease; and ingestion of iodine-containing drugs, such as amiodarone. The USPSTF found no direct evidence that treatment of thyroid dysfunction based on risk level alters final health outcomes.'}, {'id': 1908, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of electronic cigarettes (e-cigarettes) for tobacco cessation in adults, including pregnant persons. The USPSTF recommends that clinicians direct patients who use tobacco to other tobacco cessation interventions with proven effectiveness and established safety.\rSee the Practice Considerations section for more information on recommended behavioral interventions and pharmacotherapy and for suggestions for practice regarding the I statements.', 'servfreq': '', 'risktext': ''}, {'id': 1907, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of pharmacotherapy interventions for tobacco cessation in pregnant persons.', 'servfreq': '', 'risktext': ''}, {'id': 586, 'title': 'Tobacco Use in Children and Adolescents: Primary Care Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--feasible interventions for the cessation of tobacco use among school-aged children and adolescents.\r\rSee the Practice Considerations section for more information on effective interventions to prevent initiation of tobacco use and for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1919, 'title': 'Vitamin D Deficiency in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 408, 'title': 'Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of the benefits and harms of vitamin D and calcium supplementation, alone or combined, for the primary prevention of fractures in men and premenopausal women.', 'servfreq': '', 'risktext': ''}]
2025-01-29 22:01:25 [INFO] Update id=273478183 is handled. Duration 681 ms by bot id=8108339380
2025-01-29 22:02:26 [WARNING] Received SIGTERM signal
2025-01-29 22:02:26 [INFO] Polling stopped for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-29 22:02:26 [INFO] Polling stopped
2025-01-29 22:02:26 [INFO] โ ะัะป ะฟะพะดะบะปััะตะฝะธะน ะบ ะะ ะทะฐะบััั.
2025-01-29 22:02:26 [INFO] โ ะะพะดะบะปััะตะฝะธะต ะบ ะะ ะทะฐะบัััะพ.
2025-01-29 22:02:34 [INFO] ๐ ะะพั ะทะฐะฟััะบะฐะตััั...
2025-01-29 22:02:34 [INFO] โ ะัะป ะฟะพะดะบะปััะตะฝะธะน ะบ ะะ ัะพะทะดะฐะฝ.
2025-01-29 22:02:34 [INFO] โ ะขะฐะฑะปะธัั ะฒ ะฑะฐะทะต ะดะฐะฝะฝัั ััะฟะตัะฝะพ ัะพะทะดะฐะฝั.
2025-01-29 22:02:34 [INFO] Start polling
2025-01-29 22:02:36 [INFO] Run polling for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-29 22:02:39 [INFO] The user 711983855 called the command /start.
2025-01-29 22:02:40 [INFO] Update id=273478184 is handled. Duration 1292 ms by bot id=8108339380
2025-01-29 22:02:41 [INFO] The user 711983855's state has been set to Survey.age.
2025-01-29 22:02:42 [INFO] Update id=273478185 is handled. Duration 368 ms by bot id=8108339380
2025-01-29 22:02:45 [INFO] The user 711983855's state has been set to Survey.weight.
2025-01-29 22:02:45 [INFO] Update id=273478186 is handled. Duration 327 ms by bot id=8108339380
2025-01-29 22:02:47 [INFO] The user 711983855's state has been set to Survey.height.
2025-01-29 22:02:48 [INFO] Update id=273478187 is handled. Duration 335 ms by bot id=8108339380
2025-01-29 22:02:49 [INFO] The user 711983855's state has been set to Survey.feet.
2025-01-29 22:02:50 [INFO] Update id=273478188 is handled. Duration 337 ms by bot id=8108339380
2025-01-29 22:02:52 [INFO] The user 711983855's state has been set to Survey.gender.
2025-01-29 22:02:52 [INFO] Update id=273478189 is handled. Duration 336 ms by bot id=8108339380
2025-01-29 22:02:53 [INFO] The user 711983855's state has been set to Survey.pregnant.
2025-01-29 22:02:54 [INFO] Update id=273478190 is handled. Duration 333 ms by bot id=8108339380
2025-01-29 22:02:55 [INFO] The user 711983855's state has been set to Survey.smoking.
2025-01-29 22:02:55 [INFO] Update id=273478191 is handled. Duration 334 ms by bot id=8108339380
2025-01-29 22:02:56 [INFO] The user 711983855's state has been set to Survey.sex.
2025-01-29 22:02:56 [INFO] Update id=273478192 is handled. Duration 324 ms by bot id=8108339380
2025-01-29 22:02:57 [INFO] State data: {'db': <bot.database.Database object at 0x7f4d3139b5f0>, 'age': 20, 'weight': 90, 'height': 190, 'feet': 45, 'gender': 'female', 'pregnant': 'yes', 'smoking': 'yes', 'sex': 'yes'}
2025-01-29 22:02:57 [INFO] Recommendations fetched: [{'id': 2020, 'title': 'Folic Acid Supplementation to Prevent Neural Tube Defects: Preventive Medication ', 'grade': 'A', 'text': 'The DoctorAI recommends that all persons planning to or who could become pregnant take a daily supplement containing 0.4 to 0.8 mg (400 to 800 mcg) of folic acid.', 'servfreq': 'The neural plate completes its formation and closure early in pregnancy (usually 26 to 28 days after fertilization). This means the critical period for folic acid supplementation starts at least 1 month before conception and continues through the first 2 to 3 months of pregnancy. Nearly half of all pregnancies in the US are unplanned; to gain the full benefits of supplementation, clinicians should advise all persons who plan to or who could become pregnant to take daily folic acid.', 'risktext': 'All pregnancies are at risk for neural tube defects, and persons who are planning to or could become pregnant should take folic acid supplements. Certain risk factors convey a higher risk, and individuals with these risk factors should talk to their health care professional. These factors include personal, partner, or family history of neural tube defects, malabsorption caused by bariatric procedures, the use of certain antiseizure medicines, and genetic mutations in folate-related enzymes. Pregestational diabetes and obesity have been associated with an increased risk of neural tube defects. Ethnic groups such as First Nation persons in Canada and Hispanic persons in California are thought to be at higher risk of neural tube defects. It is unclear, however, whether this is related to a higher risk of genetic variations among these groups or due to differential intake of folic acid&ndash;fortified foods.'}, {'id': 503, 'title': 'Hepatitis B Virus Infection in Pregnant Women: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in pregnant women at their first prenatal visit', 'servfreq': 'A test for HBsAg should be ordered at the first prenatal visit. Women with unknown HBsAg status or with new or continuing risk factors for HBV infection (eg, injection drug use or a sexually transmitted infection) should be screened at the time of admission to a hospital or other delivery setting.', 'risktext': 'In the United States, new cases of HBV among adults are largely transmitted through injection drug use or sexual intercourse, but most prevalent cases of HBV infection are chronic infections from exposure occurring in infancy or childhood. Another major risk factor for HBV infection is country of origin. In the United States, adults with HBV born in high-prevalence countries were commonly infected during childhood. In children, the primary source of infection is perinatal transmission at birth.'}, {'id': 485, 'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in adolescents and adults aged 15 to 65 years. Younger adolescents and older adults who are at increased risk of infection should also be screened.\rSee the Clinical Considerations section for more information about assessment of risk, screening intervals, and rescreening in pregnancy.', 'servfreq': 'The USPSTF found insufficient evidence to determine appropriate or optimal time intervals or strategies for repeat HIV screening. However, repeat screening is reasonable for persons known to be at increased risk of HIV infection, such as sexually active men who have sex with men; persons with a sex partner who is living with HIV; or persons who engage in behaviors that may convey an increased risk of HIV infection, such as injection drug use, transactional sex or commercial sex work, having 1 or more new sex partners whose HIV status is unknown, or having other factors that can place a person at increased risk of HIV infection (see &ldquo;Risk Assessment&rdquo;). Repeat screening is also reasonable for persons who live or receive medical care in a high-prevalence setting, such as a sexually transmitted disease clinic, tuberculosis clinic, correctional facility, or homeless shelter.', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'id': 486, 'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in all pregnant persons, including those who present in labor or at delivery whose HIV status is unknown.', 'servfreq': 'The CDC and ACOG recommend repeat prenatal screening for HIV during the third trimester of pregnancy in women with risk factors for HIV acquisition and in women living or receiving care in high-incidence settings, and the CDC notes that repeat screening for HIV during the third trimester may be considered in all women.&nbsp;', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'id': 1921, 'title': 'Hypertension in Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hypertension in adults 18 years or older with office blood pressure measurement (OBPM). The USPSTF recommends obtaining blood pressure measurements outside of the clinical setting for diagnostic confirmation before starting treatment.', 'servfreq': ' \r\nAlthough evidence on optimal screening intervals is limited, reasonable options include:\r\n \r\n \r\n\r\n\r\nScreening for hypertension every year in adults 40 years or older and in adults at increased risk for hypertension (such as Black persons, persons with high-normal blood pressure, or persons who are overweight or obese)\r\n\r\n\r\n \r\n \r\n\r\n\r\nScreening less frequently (ie, every 3 to 5 years) as appropriate for adults aged 18 to 39 years not at increased risk for hypertension and with a prior normal blood pressure reading.\r\n\r\n\r\n ', 'risktext': ' \r\nAlthough all adults should be screened for hypertension, risk factors that increase a person&rsquo;s risk for the condition include older age, Black race, family history, excess weight and obesity, lifestyle habits (lack of physical activity, stress, and tobacco use), and dietary factors (diet high in fat or sodium, diet low in potassium, or excessive alcohol intake)\r\n '}, {'id': 2021, 'title': 'Prevention of Acquisition of HIV: Preexposure Prophylaxis ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians prescribe preexposure prophylaxis using effective antiretroviral therapy to persons who are at increased risk of HIV acquisition to decrease the risk of acquiring HIV. \r\rSee the Practice Considerations section for more information about identification of persons at increased risk and about effective antiretroviral therapy.', 'servfreq': '', 'risktext': 'HIV is primarily acquired via sexual activity or injection drug use. It is important that clinicians routinely take a sexual and injection drug use history for all their patients in an open and nonjudgmental manner. All adolescents and adults who are sexually active or who inject drugs should be informed that acquisition of HIV can be prevented, to facilitate subsequent risk assessment and discussions about preexposure prophylaxis (PrEP) and other ways to prevent acquisition of HIV. Importantly, risk of HIV acquisition exists on a continuum, and currently available risk assessment tools all have limitations. However, certain risk factors or behaviors are known to place persons at increased risk of HIV.\r\nRisk of HIV acquisition depends on the likelihood that a specific act or activity will transmit HIV and the likelihood that a sex partner or drug injection partner has HIV. Likelihood of HIV transmission is highest with needle-sharing injection drug use and condomless receptive anal intercourse. Condomless receptive anal intercourse has an approximately 10- to 15-fold higher risk of transmission than condomless insertive anal sex and condomless receptive and insertive penile-vaginal sex. A 2018 study estimated the prevalence of HIV (ie, an estimate of the likelihood that a partner whose HIV status is unknown has HIV at a population level) as 12.4% among men who have sex with men and 1.9% among persons who inject drugs. The overall prevalence of HIV in the US is estimated at 0.3%.&nbsp;Of note, both the frequency of specific sexual activities and a person&rsquo;s number of sexual partners will also affect their risk of HIV.\r\n&nbsp;The USPSTF recommends that the following persons be considered for PrEP:\r\n1.&nbsp;&nbsp;&nbsp;&nbsp; Sexually active adults and adolescents weighing at least 35 kg (77 lb) who have engaged in anal or vaginal sex in the past 6 months and have any of the following:\r\n&nbsp;\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A sexual partner who has HIV (especially if the partner has an unknown or detectable viral load).\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A bacterial sexually transmitted infection (STI) (syphilis, gonorrhea, or chlamydia for men who have sex with men and transgender women; gonorrhea and syphilis for heterosexual women and men) in the past 6 months.\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A history of inconsistent or no condom use with sex partner(s) whose HIV status is not known; assessing risk in conversation with the patient and considering factors such as number of partners, the specific sexual activities a person engages in, and whether their sex partner or partners are in a group with a higher prevalence of HIV (eg, men who have sex with men or with men and women, transgender women, persons who inject drugs, and persons who engage in transactional sex).\r\n&nbsp;\r\n2. &nbsp; Persons who inject drugs and have a drug-injecting partner who has HIV or who shares injection equipment.\r\nPersons who engage in transactional sex, such as sex for money, drugs, or housing, including commercial sex workers or persons trafficked for sex work, constitute a group at increased risk of HIV acquisition and should be considered for PrEP based on the criteria outlined above. Persons who request PrEP may have undisclosed behaviors that put them at risk. Transgender women and men who are sexually active should be considered for PrEP based on the criteria outlined above. Transgender women are at especially high risk of HIV acquisition. A Centers for Disease Control and and Prevention (CDC) survey in 7 cities found an HIV prevalence of 42% among transgender women. Prevalence was highest among Black transgender women (62%) and Native American/Alaska Native transgender women (65%).\r\nIn addition, studies have found that transmission of HIV to a seronegative partner from a partner with HIV has not been observed when the partner with HIV was being treated with antiretroviral therapy and had a suppressed viral load.&nbsp;It is not known whether PrEP use further decreases the risk of HIV transmission when a partner with HIV has a documented undetectable viral load. Factors such as the consistency or inconsistency of a partner&rsquo;s viral load being suppressed, a partner&rsquo;s adherence to antiretroviral therapy, and the degree of certainty that a partner&rsquo;s viral load is suppressed (eg, self-report vs availability of laboratory test results) may help inform decisions about the use of PrEP in this situation.\r\nAll persons being considered for PrEP must have a recently documented negative HIV antigen-antibody test result, and if they have taken oral PrEP or postexposure prophylaxis in the past 3 months, or injectable cabotegravir in the past 12 months, the CDC recommends testing with both an HIV antigen-antibody assay and an HIV-1 RNA assay.'}, {'id': 186, 'title': 'Rh(D) Incompatibility: Screening ', 'grade': 'A', 'text': 'The DoctorAI strongly recommends Rh(D) blood typing and antibody testing for all pregnant women during their first visit for pregnancy-related care.', 'servfreq': 'First prenatal visit.', 'risktext': ''}, {'id': 1989, 'title': 'Syphilis Infection in Nonpregnant Adolescents and Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for syphilis infection in persons who are at increased risk for infection.', 'servfreq': 'Optimal screening frequency for persons who are at increased risk for syphilis infection is not well established. Men who have sex with men or persons with HIV infection may benefit from screening at least annually or more frequently (eg, every 3 to 6 months) if they continue to be at high risk.', 'risktext': 'The USPSTF recommends screening for syphilis in persons who are at increased risk for infection. When deciding which persons to screen for syphilis, clinicians should consider the prevalence of infection in the communities they serve, as well as other sociodemographic and behavioral factors that may be associated with increased risk of syphilis infection. For example, prevalence of syphilis is higher in men, men who have sex with men, persons with HIV infection, young adults, and persons with a history of incarceration, sex work, or military service. A substantial percentage of heterosexual syphilis transmission occurs among persons who use illicit drugs, particularly methamphetamine. Diagnosis of another STI may signal that a person is having condomless sex, which increases their risk of syphilis infection. Higher infection rates in persons of some racial and ethnic groups have been reported and are primarily a reflection of a combination of factors, including social determinants of health (eg, disparities of income, low educational achievement, and unstable housing), differential health insurance coverage or access to quality health care, and differences in sexual network characteristics (eg, individuals living in communities with a high prevalence of STIs have an increased chance of encountering an infected partner). Local prevalence rates may change over time, so clinicians should be aware of the latest data and trends for their specific population and geographic area, which are available through their state and local health departments and Centers for Disease Control and Prevention (CDC) surveillance.\r\n&nbsp;\r\nAlthough direct evidence on screening in nonpregnant persons who are not at increased risk for syphilis infection is lacking, based on the established test performance characteristics of current screening tests and the low prevalence rate of syphilis in this population, the yield of screening is likely low.9,10 Therefore, screening in this population may result in high false-positive rates and overtreatment.'}, {'id': 431, 'title': 'Syphilis Infection in Pregnant Women: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends early screening for syphilis infection in all pregnant women.', 'servfreq': 'All pregnant women should be tested for syphilis as early as possible when they first present to care. If a woman has not received prenatal care prior to delivery, she should be tested at the time she presents for delivery. In most cases of congenital syphilis, pregnant women received prenatal care but were not screened and treated for syphilis early enough during the pregnancy to prevent transmission to the fetus.', 'risktext': ''}, {'id': 1905, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and US Food and Drug Administration (FDA)--approved pharmacotherapy for cessation to nonpregnant adults who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 1906, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all pregnant persons about tobacco use, advise them to stop using tobacco, and provide behavioral interventions for cessation to pregnant persons who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 2014, 'title': 'Anxiety Disorders in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for anxiety disorders in adults, including pregnant and postpartum persons.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding optimal timing for screening, or screening interval, for both the perinatal and general adult populations; more evidence on both timing and screening interval is needed for all adult populations. A pragmatic approach in the absence of evidence might include screening all adults who have not been screened previously and using clinical judgment in considering risk factors, comorbid conditions, and life events to determine if additional screening of high-risk patients is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nRisk factors for anxiety disorders include sociodemographic factors, psychosocial factors, and physical and mental health factors such as marital status (widowed or divorced), stressful life events, smoking and alcohol use, other mental health conditions, or a parental history of mental disorders. Demographic factors such as low socioeconomic status and female sex are associated with higher rates of anxiety disorders.&nbsp;Black persons and individuals of non-Hispanic ethnicity are at increased risk of anxiety disorders due to social, rather than biological, factors. Anxiety and depressive disorders often overlap. One cohort study found that 67% of individuals with a depressive disorder also had a current anxiety disorder, and 75% had a lifetime comorbid anxiety disorder.'}, {'id': 1938, 'title': 'Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication ', 'grade': 'B', 'text': 'The DoctorAI recommends the use of low-dose aspirin (81 mg/day) as preventive medication after 12 weeks of gestation in persons who are at high risk for preeclampsia.\r\rSee the Practice Considerations section for information on high risk and aspirin dose.', 'servfreq': 'Once daily after 12 weeks of gestation', 'risktext': ' \r\nPersons with a history of preeclampsia in a previous pregnancy, type 1 or type 2 diabetes, and chronic hypertension are at highest risk for preeclampsia. Additional conditions that place a person at high risk for preeclampsia include multifetal gestation, conception using assisted reproductive technology, autoimmune disease, and kidney disease. Other factors associated with increased preeclampsia risk include nulliparity, high prepregnancy body mass index, family history of preeclampsia, and advanced maternal age (35 years or older). In addition, Black persons have higher rates of preeclampsia and are at increased risk for serious complications due to various societal and health inequities.\r\n '}, {'id': 513, 'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for asymptomatic bacteriuria using urine culture in pregnant persons.', 'servfreq': 'In general, screening is performed once at the first prenatal visit per clinical guidelines. However, there is little evidence on the optimal timing and frequency of screening for asymptomatic bacteriuria in pregnancy.2&nbsp; .&nbsp;Screen pregnant persons for asymptomatic bacteriuria using a midstream, clean-catch urine culture at the first prenatal visit or at 12 to 16 weeks of gestation, whichever is earlier. A urine culture showing &gt;100,000 CFU/mL of a single uropathogen or &gt;10,000 CFU/mL if the pathogen is group B streptococcus indicates treatment.', 'risktext': 'This recommendation applies to adults 18 years and older and pregnant persons of any age without signs and symptoms of a urinary tract infection. It does not apply to persons who have chronic medical or urinary tract conditions, such as end-stage renal disease; have indwelling urinary catheters, urinary stents, or spinal cord injuries; are hospitalized; reside in an institution (eg, a nursing home); or who are transplant recipients.\r\n&nbsp;\r\nThe risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6&nbsp;Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5&nbsp;Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7,&nbsp;11,&nbsp;12&nbsp;In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12&nbsp;Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4,&nbsp;6'}, {'id': 2009, 'title': 'Latent Tuberculosis Infection in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for LTBI in populations at increased risk.\r\rSee the "Assessment of Risk" section for additional information on adults at increased risk.', 'servfreq': 'The USPSTF found no evidence on the optimal frequency of screening for LTBI. In the absence of evidence, a reasonable approach is to repeat screening based on specific risk factors; screening frequency could range from 1-time only screening among persons at low risk for future tuberculosis exposure to annual screening among those at continued risk of exposure.', 'risktext': 'Populations at increased risk for LTBI, based on increased prevalence of active disease and increased risk of exposure, include persons who were born in, or are former residents of, countries with high tuberculosis prevalence and persons who live in, or have lived in, high-risk congregate settings (eg, homeless shelters or correctional facilities). Clinicians can consult their local or state health departments for more information about populations at increased risk in their community, since local demographic patterns may vary across the US.\r\nIn 2020, 71.5% of all cases of active tuberculosis in the US occurred among persons born outside the US. According to the CDC, tuberculosis disease is common in most countries in Latin America, the Caribbean, Africa, Asia, Eastern Europe, and Russia. In 2020, among persons with new tuberculosis living in the US who were born outside the US, the most common countries of birth were Mexico (18.0%), the Philippines (12.5%), India (10.4%), Vietnam (8.2%), and China (5.1%), accounting for 54.2% of total cases. Most of these cases are believed to be due to progression of latent infection to active tuberculosis disease rather than new transmission within communities.\r\nPersons who live, or have lived, in high-risk congregate settings also have a higher prevalence rate of active tuberculosis and an increased risk for exposure. In 2020, 4.3% of tuberculosis disease cases diagnosed in persons 15 years or older occurred in persons experiencing homelessness and 2.6% occurred in residents of correctional facilities. It is estimated that persons experiencing homelessness have an 11 times higher incidence of tuberculosis disease compared with persons who are not experiencing homelessness (36 cases per 100,000 population vs 2.9 cases per 100,000 population, respectively, during 2011 to 2016).\r\nOther populations at increased risk for LTBI or progression to active disease include persons who have immunosuppression (eg, persons living with HIV, patients receiving immunosuppressive medications such as chemotherapy or tumor necrosis factor inhibitors, and patients who have received an organ transplant) and patients with silicosis (a lung disease). However, given that screening in these populations may be considered standard care as part of disease management or indicated prior to the use of certain medications, the USPSTF did not review evidence on screening in these populations. Information on testing in these populations is provided by other groups, such as the Office of AIDS Research at the National Institutes of Health, and in a guideline issued jointly by the American Thoracic Society, Infectious Diseases Society of America, and CDC. Some evidence from observational studies has explored the association between poorly controlled diabetes and progression of LTBI to active disease. However, there is insufficient evidence on screening for and treatment of LTBI in persons with diabetes for the USPSTF to make a separate recommendation for this important population.\r\nPersons who are contacts of individuals with active tuberculosis, health care workers, and workers in high-risk congregate settings may also be at increased risk of exposure. Because screening in these populations is conducted as part of public health or employee health surveillance, the USPSTF did not review the evidence in these populations. Clinicians seeking further information about testing for tuberculosis in these populations can refer to the Additional Tools and Resources and Recommendations of Others sections.'}, {'id': 514, 'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic bacteriuria in nonpregnant adults.', 'servfreq': '', 'risktext': 'The risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6 Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5 Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7, 11, 12 In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12 Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4, 6'}, {'id': 507, 'title': 'BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing ', 'grade': 'B', 'text': 'The DoctorAI recommends that primary care clinicians assess women with a personal or family history of breast, ovarian, tubal, or peritoneal cancer or who have an ancestry associated with breast cancer susceptibility 1 and 2 (BRCA1/2) gene mutations with an appropriate brief familial risk assessment tool. Women with a positive result on the risk assessment tool should receive genetic counseling and, if indicated after counseling, genetic testing.', 'servfreq': 'Consideration of screening for potentially harmful BRCA mutations should begin once women have reached the age of consent (18 years). Primary care providers should periodically assess all patients for changes in family history (for example, comprehensive review at least every 5 to 10 years)', 'risktext': 'Patients with family or personal histories of breast, ovarian, tubal, or peritoneal cancer or ancestry associated with harmful&nbsp;&lt; i&gt;BRCA1/2&nbsp;mutations should be assessed using a familial risk assessment tool. The USPSTF found adequate evidence that these tools are accurate in identifying women with increased likelihood of&nbsp;&lt; i&gt;BRCA1/2mutations. Tools evaluated by the USPSTF include the Ontario Family History Assessment Tool, Manchester Scoring System, Referral Screening Tool, Pedigree Assessment Tool, 7-Question Family History Screening Tool, International Breast Cancer Intervention Study instrument (Tyrer-Cuzick), and brief versions of BRCAPRO. These tools should be used to guide referrals to genetic counseling.&nbsp;Persons should consider their sex at birth to determine which recommendation best applies to them.'}, {'id': 339, 'title': 'Breastfeeding: Primary Care Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends providing interventions during pregnancy and after birth to support breastfeeding.', 'servfreq': 'During pregnancy and after birth', 'risktext': "This recommendation applies to pregnant women, new mothers, and their infants and children. Interventions to support breastfeeding may also involve a woman's partner, other family members, and friends. This recommendation does not apply in circumstances where there are contraindications to breastfeeding (e.g., certain maternal medical conditions or infant metabolic disorders, such as galactosemia). The USPSTF did not review evidence on interventions directed at breastfeeding of preterm infants."}, {'id': 1935, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for chlamydia in all sexually active women 24 years or younger and in women 25 years or older who are at increased risk for infection.', 'servfreq': ' \r\nIn the absence of studies on screening intervals, a reasonable approach would be to screen patients whose sexual history reveals new or persistent risk factors since the last negative test result.\r\n ', 'risktext': ' \r\nAge is a strong predictor of risk for chlamydial and gonococcal infections, with the highest infection rates in women occurring during ages 15 to 24 years. Women 25 years or older are at increased risk if they have a new sex partner, more than 1 sex partner, a sex partner with concurrent partners, or a sex partner who has an STI; practice inconsistent condom use when not in a mutually monogamous relationship; or have a previous or coexisting STI. Exchanging sex for money or drugs and history of incarceration also are associated with increased risk.&nbsp;Clinicians should consider the communities they serve and may want to consult local public health authorities for information about local epidemiology and guidance on determining who is at increased risk.\r\n '}, {'id': 1936, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for gonorrhea in all sexually active women 24 years or younger and in women 25 years or older who are at increased risk for infection.', 'servfreq': ' \r\nIn the absence of studies on screening intervals, a reasonable approach would be to screen patients whose sexual history reveals new or persistent risk factors since the last negative test result.\r\n ', 'risktext': ' \r\nAge is a strong predictor of risk for chlamydial and gonococcal infections, with the highest infection rates in women occurring during ages 15 to 24 years. Women 25 years or older are at increased risk if they have a new sex partner, more than 1 sex partner, a sex partner with concurrent partners, or a sex partner who has an STI; practice inconsistent condom use when not in a mutually monogamous relationship; or have a previous or coexisting STI. Exchanging sex for money or drugs and history of incarceration also are associated with increased risk.&nbsp;Clinicians should consider the communities they serve and may want to consult local public health authorities for information about local epidemiology and guidance on determining who is at increased risk.\r\n '}, {'id': 1909, 'title': 'Asymptomatic Carotid Artery Stenosis: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic carotid artery stenosis in the general adult population.\r\rSee the Practice Considerations section for a description of adults at increased risk.', 'servfreq': '', 'risktext': ''}, {'id': 2017, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for suicide risk in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': '', 'risktext': ''}, {'id': 2016, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for depression in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding the optimal timing for screening for depression; more evidence is needed in both perinatal and general adult populations. In the absence of evidence, a pragmatic approach might include screening adults who have not been screened previously and using clinical judgment while considering risk factors, comorbid conditions, and life events to determine if additional screening of patients at increased risk is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nThe USPSTF recommends screening for depression in all adults regardless of risk factors. Risk factors for depression include a combination of genetic, biological, and environmental factors, such as a family history of depression, prior episode of depression or other mental health condition, a history of trauma or adverse life events, or a history of disease or illness (eg, cardiovascular disease).\r\nPrevalence rates vary by sex, age, race, ethnicity, education, marital status, geographic location, poverty level, and employment status. Women have twice the risk of depression compared with men. Young adults, multiracial individuals, and Native American/Alaska Native individuals have higher rates of depression.\r\nRisk factors for perinatal depression include life stress, low social support, history of depression, marital or partner dissatisfaction, and a history of abuse.'}, {'id': 1932, 'title': 'Gestational Diabetes: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for gestational diabetes in asymptomatic pregnant persons at 24 weeks of gestation or after.', 'servfreq': 'At 24 weeks of gestation or after to improve maternal and fetal outcomes', 'risktext': ' \r\nSeveral factors increase a person&rsquo;s risk for developing gestational diabetes, including obesity, increased maternal age, history of gestational diabetes, family history of diabetes, and belonging to a racial/ethnic group that is at increased risk for developing type 2 diabetes (Hispanic, Native American, South or East Asian, or Pacific Islander descent).4,19,20 Factors associated with a lower risk for developing gestational diabetes include age younger than 25 to 30 years, White race, a body mass index (BMI) of 25 or less (calculated as weight in kilograms divided by height in meters squared), no family history (in a first-degree relative) of diabetes, and no history of glucose intolerance or adverse pregnancy outcomes related to gestational diabetes.21-23 The risk in different racial/ethnic groups may be due in part to social risk factors such as low socioeconomic status or structural racism, although these associations are not examined in the current evidence. Although a higher BMI increases the risk of gestational diabetes across racial/ethnic groups, the association varies. In Asian American persons, the prevalence of gestational diabetes at a BMI of 22 to less than 25 is similar to the prevalence in Hispanic persons, non-Hispanic White persons, and Black persons with a higher (&gt;28) BMI.24,25\r\n '}, {'id': 1845, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends offering or referring adults with cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity.', 'servfreq': '', 'risktext': 'Adults 18 years or older at increased risk of CVD, defined as those with 1 or more of the following:\r\n1.Hypertension or elevated blood pressure2.Dyslipidemia3.Mixed or multiple risk factors such as the metabolic syndrome or an estimated 10-year CVD risk of &ge;7.5%\r\nThis recommendation does not apply to adults with other known modifiable cardiovascular risk factors such as abnormal blood glucose levels, obesity, and smoking; these populations are incorporated in other USPSTF recommendations.'}, {'id': 1931, 'title': 'Healthy Weight and Weight Gain In Pregnancy: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer pregnant persons effective behavioral counseling interventions aimed at promoting healthy weight gain and preventing excess gestational weight gain in pregnancy.', 'servfreq': 'Throughout pregnancy', 'risktext': 'Pregnancy'}, {'id': 1885, 'title': 'Hepatitis B Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in adolescents and adults at increased risk for infection.\r\rSee the Practice Considerations section for a description of adolescents and adults at increased risk for infection.', 'servfreq': 'For patients with negative HBsAg results who have not received the HBV vaccine series, periodic screening may be useful for those who report continued risk for acquiring HBV transmission, such as persons who continue to inject drugs and men who have sex with men. Clinical judgment should be used to determine screening frequency. The USPSTF found no evidence to determine optimal screening intervals.', 'risktext': 'Persons from such risk groups include persons who have injected drugs in the past or currently; men who have sex with men; persons with HIV; and sex partners, needle-sharing contacts, and household contacts of persons known to be HBsAg positive. Some persons with combinations of risk factors who are not members of risk factor groups listed above may also be at increased risk for HBV infection.'}, {'id': 524, 'title': 'Hepatitis C Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis C virus (HCV) infection in adults aged 18 to 79 years.', 'servfreq': 'One-time screening for most adults.\r\nPeriodically screen persons with continued risk for HCV infection (eg, persons with past or current injection drug use). There is limited evidence to determine how often to screen persons at increased risk.&nbsp;', 'risktext': 'Asymptomatic adults aged 18 to 79 years (including pregnant persons) without known liver disease.&nbsp;\r\nThe USPSTF also suggests that clinicians consider screening persons younger than 18 years and older than 79 years who are at high risk for infection (eg, those with past or current injection drug use).&nbsp;'}, {'id': 2023, 'title': 'Hypertensive Disorders of Pregnancy: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hypertensive disorders in pregnant persons with blood pressure measurements throughout pregnancy.', 'servfreq': 'Screening Interval\r\nBlood pressure measurements should be obtained during each prenatal care visit throughout pregnancy. Hypertensive disorders of pregnancy can quickly evolve into severe disease that can result in serious, even fatal, maternal and infant health outcomes. The ability to screen for hypertensive disorders of pregnancy using blood pressure measurements is important to identify and effectively treat a potentially unpredictable and fatal condition. While it is known that risk continues into the immediate postpartum period, there is little evidence regarding screening during this period. A pragmatic approach would be for patients to be counseled regarding signs and symptoms of preeclampsia at hospital discharge and for patients with hypertensive disorders to have subsequent blood pressure checks.\r\nScreening for hypertensive disorders of pregnancy alone is not sufficient to improve inequities in health outcomes. Identifying hypertensive disorders of pregnancy requires adequate prenatal visits, surveillance, and evidence-based care in response to evolving patient signs and symptoms during pregnancy and the postpartum period to improve health outcomes. Black and Native American/Alaska Native persons have lower rates of prenatal visits and are at greater risk of serious postpartum morbidity and hospital readmission after delivery. Screening and monitoring of Black and Hispanic/Latina individuals during the postpartum period could be an important step for reducing health inequities by preventing serious adverse events. In addition, screening and monitoring by various health care providers (eg, nurse midwives, nurses, pediatricians, doulas, and lactation consultants) could also help avert serious complications in the postpartum period.', 'risktext': 'Assessment of Risk\r\nImportant clinical conditions associated with increased risk for preeclampsia include a history of eclampsia or preeclampsia in a prior pregnancy, a previous adverse pregnancy outcome, and maternal comorbid conditions (including type 1 or type 2 diabetes prior to pregnancy, gestational diabetes, chronic hypertension, kidney disease, and autoimmune diseases).\r\n&nbsp;Other factors associated with increased risk of preeclampsia and gestational hypertension include nulliparity, high prepregnancy body mass index, family history of preeclampsia, multifetal gestation, and the pregnant individual being 35 years or older.\r\nThe higher prevalence of hypertensive disorders of pregnancy and the increased risk for severe complications seen in Black persons may be due to their disproportionate burden of social and clinical risk factors. These social and clinical determinants largely result from historical and current manifestations of structural racism that influence environmental exposures, access to health resources, and overall health status.'}, {'id': 434, 'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians screen for intimate partner violence (IPV) in women of reproductive age and provide or refer women who screen positive to ongoing support services. See the Clinical Considerations section for more information on effective ongoing support services for IPV and for information on IPV in men.', 'servfreq': 'The USPSTF found no evidence on appropriate intervals for screening. Randomized clinical trials (RCTs) of screening and interventions for IPV often screen for current IPV or IPV in the past year.\r\n&nbsp;', 'risktext': 'All women of reproductive age are at potential risk for IPV and should be screened. There are a variety of factors that increase risk of IPV, such as exposure to violence as a child, young age, unemployment, substance abuse, marital difficulties, and economic hardships.\r\nRisk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health. For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.'}, {'id': 187, 'title': 'Rh(D) Incompatibility: Screening ', 'grade': 'B', 'text': "The DoctorAI recommends repeated Rh(D) antibody testing for all unsensitized Rh(D)-negative women at 24 to 28 weeks' gestation, unless the biological father is known to be Rh(D)-negative.", 'servfreq': 'Repeat testing at 24-28 weeks gestation.', 'risktext': ''}, {'id': 1916, 'title': 'Lung Cancer: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery.', 'servfreq': ' \r\nThe USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. ', 'risktext': ' \r\nSmoking and older age are the 2 most important risk factors for lung cancer.&nbsp;The risk of lung cancer in persons who smoke increases with cumulative quantity and duration of smoking and with age but decreases with increasing time since quitting for persons who formerly smoked.3 The USPSTF considers adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years to be at high risk and recommends screening for lung cancer with annual LDCT in this population. \r\n \r\n&nbsp;\r\n \r\nAfrican American/Black (Black) men have a higher incidence of lung cancer than White men, and Black women have a lower incidence than White women.1 These differences are likely related to differences in smoking exposure (ie, prevalence of smoking) and related exposure to carcinogens in cigarettes.7,8 The differences may also be related to other social risk factors.\r\n \r\n&nbsp;\r\n \r\nOther risk factors for lung cancer include environmental exposures, prior radiation therapy, other (noncancer) lung diseases, and family history. Lower level of education is also associated with a higher risk of lung cancer.7 The task force recommends using age and smoking history to determine screening eligibility rather than more elaborate risk prediction models because there is insufficient evidence to assess whether risk prediction model&ndash;based screening would improve outcomes relative to using the risk factors of age and smoking history for broad implementation in primary care.\r\n '}, {'id': 449, 'title': 'Perinatal Depression: Preventive Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians provide or refer pregnant and postpartum persons who are at increased risk of perinatal depression to counseling interventions.', 'servfreq': '', 'risktext': 'Include&nbsp;a past history of depression. Current depressive symptoms (that do not reach a diagnostic threshold),&nbsp;history of physical or sexual abuse,&nbsp;unplanned or unwanted pregnancy,&nbsp;stressful life events,&nbsp;lack of social and financial support,&nbsp;intimate partner violence,pregestational or gestational diabetes,and complications during pregnancy. Additional risk factors include adolescent parenthood, low socioeconomic status, and lack of social support.&nbsp;Genetic factors are also suspected to contribute to women&rsquo;s risk of developing perinatal depression.'}, {'id': 1445, 'title': 'Sexually Transmitted Infections: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends behavioral counseling for all sexually active adolescents and for adults who are at increased risk for sexually transmitted infections (STIs).\r\rSee the Practice Considerations section for more information on populations at increased risk for acquiring STIs.', 'servfreq': '', 'risktext': 'All sexually active adolescents are at increased risk for STIs because of the high rates of STIs in this age group and should receive behavioral counseling interventions. Adults at increased risk for STIs include those who currently have an STI or were diagnosed with one within the past year, do not consistently use condoms, have multiple sex partners, or have sex partners within populations with a high prevalence of STIs. Populations with a high prevalence of STIs include persons who seek STI testing or attend STI clinics; sexual and gender minorities; persons who are living with HIV, inject drugs, have exchanged sex for money or drugs, or have entered correctional facilities; and some racial/ethnic minority groups.1-4'}, {'id': 402, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends counseling young adults, adolescents, children, and parents of young children about minimizing exposure to ultraviolet (UV) radiation for persons aged 6 months to 24 years with fair skin types to reduce their risk of skin cancer.', 'servfreq': '', 'risktext': 'Fair skin types'}, {'id': 438, 'title': 'Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for unhealthy alcohol use in primary care settings in adults 18 years or older, including pregnant women, and providing persons engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce unhealthy alcohol use.', 'servfreq': 'The USPSTF did not find adequate evidence to recommend an optimal screening interval for unhealthy alcohol use in adults.&nbsp;Brief behavioral counseling interventions were found to reduce unhealthy alcohol use in adults 18 years or older, including pregnant women. Effective behavioral counseling interventions vary in their specific components, administration, length, and number of interactions. The USPSTF was unable to identify specific intervention characteristics or components that were clearly associated with improved outcomes.', 'risktext': 'engaged in risky or hazardous drinking'}, {'id': 767, 'title': 'Unhealthy Drug Use: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening by asking questions about unhealthy drug use in adults age 18 years or older. Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. \r(Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'servfreq': 'Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. (Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'risktext': 'These include being aged 18 to 25 years; male sex; having a mental health condition, personality or mood disorder, or nicotine or alcohol dependence; a history of physical or sexual abuse, parental neglect, or other adversity in childhood; or drug or alcohol addiction in a first-degree relative.1,9&nbsp;Factors associated with misuse of prescription drugs include history of other drug use, mental illness, pain, and greater access to prescription drugs.10&nbsp;Factors associated with prenatal use of drugs include a mental health disorder, interpersonal violence, and family history of substance use.11'}, {'id': 433, 'title': 'Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer or refer adults with a body mass index (BMI) of 30 or higher (calculated as weight in kilograms divided by height in meters squared) to intensive, multicomponent behavioral interventions.', 'servfreq': '', 'risktext': 'Adults with a BMI &ge;30'}, {'id': 1979, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: Behavioral Counseling Interventions ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians individualize the decision to offer or refer adults without cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity. \r\rSee the "Practice Considerations" section for information on determining which patients may benefit most from this service.', 'servfreq': '', 'risktext': ''}, {'id': 1937, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for chlamydia and gonorrhea in men.', 'servfreq': '', 'risktext': ''}, {'id': 508, 'title': 'BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine risk assessment, genetic counseling, or genetic testing for women whose personal or family history or ancestry is not associated with potentially harmful BRCA1/2 gene mutations.', 'servfreq': '', 'risktext': 'Patients with family or personal histories of breast, ovarian, tubal, or peritoneal cancer or ancestry associated with harmful&nbsp;BRCA1/2&nbsp;mutations should be assessed using a familial risk assessment tool. The USPSTF found adequate evidence that these tools are accurate in identifying women with increased likelihood of&nbsp;BRCA1/2mutations. Tools evaluated by the USPSTF include the Ontario Family History Assessment Tool, Manchester Scoring System, Referral Screening Tool, Pedigree Assessment Tool, 7-Question Family History Screening Tool, International Breast Cancer Intervention Study instrument (Tyrer-Cuzick), and brief versions of BRCAPRO. These tools should be used to guide referrals to genetic counseling.'}, {'id': 525, 'title': 'Bacterial Vaginosis in Pregnant Persons to Prevent Preterm Delivery: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for bacterial vaginosis (BV) in pregnant persons who are not at increased risk for preterm delivery.', 'servfreq': '', 'risktext': '\r\nAssess risk for preterm delivery. There are multiple factors that increase risk for preterm delivery; one of the strongest risk factors is prior preterm delivery.\r\nDecide whether or not to screen for bacterial vaginosis:\r\n\r\na. Do not screen pregnant persons who are not at increased risk for preterm delivery.\r\nb. Evidence is insufficient to recommend for or against screening pregnant persons at increased risk for preterm delivery.'}, {'id': 418, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening with resting or exercise electrocardiography (ECG) to prevent cardiovascular disease (CVD) events in asymptomatic adults at low risk of CVD events.', 'servfreq': '', 'risktext': ''}, {'id': 429, 'title': 'Cervical Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for cervical cancer in women who have had a hysterectomy with removal of the cervix and do not have a history of a high-grade precancerous lesion (ie, cervical intraepithelial neoplasia [CIN] grade 2 or 3) or cervical cancer.', 'servfreq': '', 'risktext': ''}, {'id': 428, 'title': 'Cervical Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for cervical cancer in women younger than 21 years.', 'servfreq': '', 'risktext': ''}, {'id': 1973, 'title': 'Chronic Obstructive Pulmonary Disease: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for chronic obstructive pulmonary disease in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 2003, 'title': 'Genital Herpes Infection: Serologic Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine serologic screening for genital herpes simplex virus infection in asymptomatic adolescents and adults, including pregnant persons.', 'servfreq': '', 'risktext': 'The USPSTF found no evidence of externally validated, reliable risk stratification tools to identify individuals more or less likely to have genital herpes.'}, {'id': 504, 'title': 'Pancreatic Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for pancreatic cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 365, 'title': 'Thyroid Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for thyroid cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 1976, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'D', 'text': 'The DoctorAI recommends against the use of beta carotene or vitamin E supplements for the prevention of cardiovascular disease or cancer.', 'servfreq': '', 'risktext': ''}, {'id': 318, 'title': 'Autism Spectrum Disorder in Young Children: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for autism spectrum disorder (ASD) in young children for whom no concerns of ASD have been raised by their parents or a clinician.', 'servfreq': '', 'risktext': 'Although a number of potential risk factors for ASD have been identified, there is insufficient evidence to determine if certain risk factors modify the performance characteristics of ASD screening tests, such as the age at which screening is performed or other characteristics of the child or family.'}, {'id': 526, 'title': 'Bacterial Vaginosis in Pregnant Persons to Prevent Preterm Delivery: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for BV in pregnant persons who are at increased risk for preterm delivery.', 'servfreq': '', 'risktext': ''}, {'id': 65, 'title': 'Bladder Cancer in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults.\r\rLiterature scans conducted in July 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'This evidence update focused on the benefits and harms of screening for bladder cancer among people without symptoms, the accuracy of screening tests done in primary care settings, and the benefits and harms of treatment. The updated evidence review did not find any new high quality evidence to adequately determine the balance of benefits and harms of screening for bladder cancer. However, bladder cancer is a common cancer and can cause considerable health problems including death. Therefore, the USPSTF determined that the evidence was insufficient to provide a recommendation for or against bladder cancer screening.  The USPSTF emphasizes the need for additional research in this area. '}, {'id': 2037, 'title': 'Breast Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of supplemental screening for breast cancer using breast ultrasonography or magnetic resonance imaging (MRI) in women identified to have dense breasts on an otherwise negative screening mammogram.\r\rSee the "Practice Considerations" section for more information on the patient population to whom this recommendation applies and on screening mammography modalities.', 'servfreq': '', 'risktext': 'These recommendations apply to cisgender women and all other persons assigned female at birth (including transgender men and nonbinary persons) 40 years or older at average risk of breast cancer. \r\nThese recommendations apply to persons who have factors associated with an increased risk of breast cancer, such as a family history of breast cancer (ie, a first-degree relative with breast cancer) or having dense breasts. They do not apply to persons who have a genetic marker or syndrome associated with a high risk of breast cancer (eg, BRCA1 or BRCA2 genetic variation), a history of high-dose radiation therapy to the chest at a young age, or previous breast cancer or a high-risk breast lesion on previous biopsies. '}, {'id': 419, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening with resting or exercise ECG to prevent CVD events in asymptomatic adults at intermediate or high risk of CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 423, 'title': 'Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of adding the ankle-brachial index (ABI), high-sensitivity C-reactive protein (hsCRP) level, or coronary artery calcium (CAC) score to traditional risk assessment for cardiovascular disease (CVD) in asymptomatic adults to prevent CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 352, 'title': 'Celiac Disease: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'persons with family history or other risk factors'}, {'id': 1955, 'title': 'Eating Disorders in Adolescents and Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for eating disorders in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1933, 'title': 'Gestational Diabetes: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for gestational diabetes in asymptomatic pregnant persons before 24 weeks of gestation.', 'servfreq': '', 'risktext': ''}, {'id': 665, 'title': 'Illicit Drug Use in Children, Adolescents, and Young Adults: Primary Care-Based Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--based behavioral counseling interventions to prevent illicit drug use, including nonmedical use of prescription drugs, in children, adolescents, and young adults.\r\rSee the Practice Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 435, 'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for abuse and neglect in all older or vulnerable adults. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': 'Risk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health.14&nbsp;For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.15'}, {'id': 2045, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for iron deficiency and iron deficiency anemia in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2046, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine iron supplementation in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2018, 'title': 'Lipid Disorders in Children and Adolescents: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1998, 'title': 'Obstructive Sleep Apnea in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for obstructive sleep apnea in the general adult population.\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Risk Factors\r\nRisk factors associated with OSA include male sex, older age (40-70 years), postmenopausal status, higher body mass index (BMI), and craniofacial and upper airway abnormalities (eg, enlarged tonsils or long upper airway). Black, Hispanic/Latino, and Native American/Alaska Native persons have a higher prevalence of OSA compared with White persons; some evidence suggests that these differences are partially explained by higher rates of obesity, asthma, and tobacco use among these groups.8'}, {'id': 1977, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of multivitamin supplements for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1978, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of single or paired nutrient supplements (other than beta carotene and vitamin E) for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 176, 'title': 'Oral Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for oral cancer in asymptomatic adults.\r\rGo to the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in July 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Tobacco and alcohol use are major risk factors for oral cancer. A total of 20% to 30% of cases of oral cancer worldwide are attributable to cigarette smoking. In the United States, up to 75% of cases of oral cancer may be attributable to tobacco and alcohol use. Additional risk factors include male sex, older age, use of betel quid, ultraviolet light exposure, infection with Candida or bacterial flora, and a compromised immune system. Sexually transmitted oral HPV infection (HPV-16) has recently been recognized as an increasingly important risk factor for oropharyngeal cancer. In the United States, the prevalence of oropharyngeal cancer due to oral HPV infection is probably as high as 80% to 95%. The prevalence of oral HPV infection is associated with age, sex, number of sexual partners, and number of cigarettes smoked per day. The effect of multifactorial risk assessment and screening for risk factors on oral cancer morbidity and mortality is unknown.'}, {'id': 2026, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine screening performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 2027, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of preventive interventions performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 424, 'title': 'Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for peripheral artery disease (PAD) and cardiovascular disease (CVD) risk with the ankle-brachial index (ABI) in asymptomatic adults.\r\rLiterature scans conducted in August 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Risk factors associated with OSA include male sex, older age (40 to 70 years), postmenopausal status, higher BMI, and craniofacial and upper airway abnormalities.'}, {'id': 404, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of counseling adults about skin self-examination to prevent skin cancer.See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 2005, 'title': 'Skin Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Exposure to UV radiation from sun exposure, indoor tanning beds, and other UV radiation&ndash;emitting devices is the major environmental risk factor for skin cancer. History of frequent sunburns, older age, and male sex are associated with increased risk for skin cancer. Exposure to UV radiation from the use of indoor tanning beds is an important risk factor in adolescents. Incidence of melanoma is higher among White persons compared with persons of other races and ethnicities. This difference likely reflects traits associated with increased melanoma risk, such as fair skin (which is more susceptible to sunburning), light-colored eyes, and red or blond hair being more common among White persons compared with persons of other races and ethnicities. Acral lentiginous melanoma, which occurs mostly on skin not frequently exposed to direct sunlight (eg, palms of hands, soles of feet, or under fingernails or toenails), is the most common type of melanoma among Black populations. Other melanoma risk factors include higher numbers of moles on the skin, atypical moles, as well as a personal and family history of skin cancer.'}, {'id': 269, 'title': 'Thyroid Dysfunction: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults.\r\rSee the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': 'The optimal screening interval for thyroid dysfunction (if one exists) is unknown.', 'risktext': 'The most common cause of hypothyroidism in the United States is chronic autoimmune (Hashimoto) thyroiditis. Risk factors for an elevated TSH level include female sex, advancing age, white race, type 1 diabetes, Down syndrome, family history of thyroid disease, goiter, previous hyperthyroidism (possibly due in part to ablation therapy leading to iatrogenic thyroid dysfunction), and external-beam radiation in the head and neck area. Common causes of hyperthyroidism include Graves disease, Hashimoto thyroiditis, and functional thyroid nodules. Risk factors for a low TSH level include female sex; advancing age; black race; low iodine intake; personal or family history of thyroid disease; and ingestion of iodine-containing drugs, such as amiodarone. The USPSTF found no direct evidence that treatment of thyroid dysfunction based on risk level alters final health outcomes.'}, {'id': 1908, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of electronic cigarettes (e-cigarettes) for tobacco cessation in adults, including pregnant persons. The USPSTF recommends that clinicians direct patients who use tobacco to other tobacco cessation interventions with proven effectiveness and established safety.\rSee the Practice Considerations section for more information on recommended behavioral interventions and pharmacotherapy and for suggestions for practice regarding the I statements.', 'servfreq': '', 'risktext': ''}, {'id': 1907, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of pharmacotherapy interventions for tobacco cessation in pregnant persons.', 'servfreq': '', 'risktext': ''}, {'id': 586, 'title': 'Tobacco Use in Children and Adolescents: Primary Care Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--feasible interventions for the cessation of tobacco use among school-aged children and adolescents.\r\rSee the Practice Considerations section for more information on effective interventions to prevent initiation of tobacco use and for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1919, 'title': 'Vitamin D Deficiency in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 408, 'title': 'Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of the benefits and harms of vitamin D and calcium supplementation, alone or combined, for the primary prevention of fractures in men and premenopausal women.', 'servfreq': '', 'risktext': ''}]
2025-01-29 22:02:58 [INFO] Update id=273478193 is handled. Duration 745 ms by bot id=8108339380
2025-01-29 22:02:59 [INFO] State data: {'db': <bot.database.Database object at 0x7f4d3139b5f0>, 'age': 20, 'weight': 90, 'height': 190, 'feet': 45, 'gender': 'female', 'pregnant': 'yes', 'smoking': 'yes', 'sex': 'tools_0', 'recommendations': [{'id': 2020, 'title': 'Folic Acid Supplementation to Prevent Neural Tube Defects: Preventive Medication ', 'grade': 'A', 'text': 'The DoctorAI recommends that all persons planning to or who could become pregnant take a daily supplement containing 0.4 to 0.8 mg (400 to 800 mcg) of folic acid.', 'servfreq': 'The neural plate completes its formation and closure early in pregnancy (usually 26 to 28 days after fertilization). This means the critical period for folic acid supplementation starts at least 1 month before conception and continues through the first 2 to 3 months of pregnancy. Nearly half of all pregnancies in the US are unplanned; to gain the full benefits of supplementation, clinicians should advise all persons who plan to or who could become pregnant to take daily folic acid.', 'risktext': 'All pregnancies are at risk for neural tube defects, and persons who are planning to or could become pregnant should take folic acid supplements. Certain risk factors convey a higher risk, and individuals with these risk factors should talk to their health care professional. These factors include personal, partner, or family history of neural tube defects, malabsorption caused by bariatric procedures, the use of certain antiseizure medicines, and genetic mutations in folate-related enzymes. Pregestational diabetes and obesity have been associated with an increased risk of neural tube defects. Ethnic groups such as First Nation persons in Canada and Hispanic persons in California are thought to be at higher risk of neural tube defects. It is unclear, however, whether this is related to a higher risk of genetic variations among these groups or due to differential intake of folic acid&ndash;fortified foods.'}, {'id': 503, 'title': 'Hepatitis B Virus Infection in Pregnant Women: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in pregnant women at their first prenatal visit', 'servfreq': 'A test for HBsAg should be ordered at the first prenatal visit. Women with unknown HBsAg status or with new or continuing risk factors for HBV infection (eg, injection drug use or a sexually transmitted infection) should be screened at the time of admission to a hospital or other delivery setting.', 'risktext': 'In the United States, new cases of HBV among adults are largely transmitted through injection drug use or sexual intercourse, but most prevalent cases of HBV infection are chronic infections from exposure occurring in infancy or childhood. Another major risk factor for HBV infection is country of origin. In the United States, adults with HBV born in high-prevalence countries were commonly infected during childhood. In children, the primary source of infection is perinatal transmission at birth.'}, {'id': 485, 'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in adolescents and adults aged 15 to 65 years. Younger adolescents and older adults who are at increased risk of infection should also be screened.\rSee the Clinical Considerations section for more information about assessment of risk, screening intervals, and rescreening in pregnancy.', 'servfreq': 'The USPSTF found insufficient evidence to determine appropriate or optimal time intervals or strategies for repeat HIV screening. However, repeat screening is reasonable for persons known to be at increased risk of HIV infection, such as sexually active men who have sex with men; persons with a sex partner who is living with HIV; or persons who engage in behaviors that may convey an increased risk of HIV infection, such as injection drug use, transactional sex or commercial sex work, having 1 or more new sex partners whose HIV status is unknown, or having other factors that can place a person at increased risk of HIV infection (see &ldquo;Risk Assessment&rdquo;). Repeat screening is also reasonable for persons who live or receive medical care in a high-prevalence setting, such as a sexually transmitted disease clinic, tuberculosis clinic, correctional facility, or homeless shelter.', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'id': 486, 'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in all pregnant persons, including those who present in labor or at delivery whose HIV status is unknown.', 'servfreq': 'The CDC and ACOG recommend repeat prenatal screening for HIV during the third trimester of pregnancy in women with risk factors for HIV acquisition and in women living or receiving care in high-incidence settings, and the CDC notes that repeat screening for HIV during the third trimester may be considered in all women.&nbsp;', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'id': 1921, 'title': 'Hypertension in Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hypertension in adults 18 years or older with office blood pressure measurement (OBPM). The USPSTF recommends obtaining blood pressure measurements outside of the clinical setting for diagnostic confirmation before starting treatment.', 'servfreq': ' \r\nAlthough evidence on optimal screening intervals is limited, reasonable options include:\r\n \r\n \r\n\r\n\r\nScreening for hypertension every year in adults 40 years or older and in adults at increased risk for hypertension (such as Black persons, persons with high-normal blood pressure, or persons who are overweight or obese)\r\n\r\n\r\n \r\n \r\n\r\n\r\nScreening less frequently (ie, every 3 to 5 years) as appropriate for adults aged 18 to 39 years not at increased risk for hypertension and with a prior normal blood pressure reading.\r\n\r\n\r\n ', 'risktext': ' \r\nAlthough all adults should be screened for hypertension, risk factors that increase a person&rsquo;s risk for the condition include older age, Black race, family history, excess weight and obesity, lifestyle habits (lack of physical activity, stress, and tobacco use), and dietary factors (diet high in fat or sodium, diet low in potassium, or excessive alcohol intake)\r\n '}, {'id': 2021, 'title': 'Prevention of Acquisition of HIV: Preexposure Prophylaxis ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians prescribe preexposure prophylaxis using effective antiretroviral therapy to persons who are at increased risk of HIV acquisition to decrease the risk of acquiring HIV. \r\rSee the Practice Considerations section for more information about identification of persons at increased risk and about effective antiretroviral therapy.', 'servfreq': '', 'risktext': 'HIV is primarily acquired via sexual activity or injection drug use. It is important that clinicians routinely take a sexual and injection drug use history for all their patients in an open and nonjudgmental manner. All adolescents and adults who are sexually active or who inject drugs should be informed that acquisition of HIV can be prevented, to facilitate subsequent risk assessment and discussions about preexposure prophylaxis (PrEP) and other ways to prevent acquisition of HIV. Importantly, risk of HIV acquisition exists on a continuum, and currently available risk assessment tools all have limitations. However, certain risk factors or behaviors are known to place persons at increased risk of HIV.\r\nRisk of HIV acquisition depends on the likelihood that a specific act or activity will transmit HIV and the likelihood that a sex partner or drug injection partner has HIV. Likelihood of HIV transmission is highest with needle-sharing injection drug use and condomless receptive anal intercourse. Condomless receptive anal intercourse has an approximately 10- to 15-fold higher risk of transmission than condomless insertive anal sex and condomless receptive and insertive penile-vaginal sex. A 2018 study estimated the prevalence of HIV (ie, an estimate of the likelihood that a partner whose HIV status is unknown has HIV at a population level) as 12.4% among men who have sex with men and 1.9% among persons who inject drugs. The overall prevalence of HIV in the US is estimated at 0.3%.&nbsp;Of note, both the frequency of specific sexual activities and a person&rsquo;s number of sexual partners will also affect their risk of HIV.\r\n&nbsp;The USPSTF recommends that the following persons be considered for PrEP:\r\n1.&nbsp;&nbsp;&nbsp;&nbsp; Sexually active adults and adolescents weighing at least 35 kg (77 lb) who have engaged in anal or vaginal sex in the past 6 months and have any of the following:\r\n&nbsp;\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A sexual partner who has HIV (especially if the partner has an unknown or detectable viral load).\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A bacterial sexually transmitted infection (STI) (syphilis, gonorrhea, or chlamydia for men who have sex with men and transgender women; gonorrhea and syphilis for heterosexual women and men) in the past 6 months.\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A history of inconsistent or no condom use with sex partner(s) whose HIV status is not known; assessing risk in conversation with the patient and considering factors such as number of partners, the specific sexual activities a person engages in, and whether their sex partner or partners are in a group with a higher prevalence of HIV (eg, men who have sex with men or with men and women, transgender women, persons who inject drugs, and persons who engage in transactional sex).\r\n&nbsp;\r\n2. &nbsp; Persons who inject drugs and have a drug-injecting partner who has HIV or who shares injection equipment.\r\nPersons who engage in transactional sex, such as sex for money, drugs, or housing, including commercial sex workers or persons trafficked for sex work, constitute a group at increased risk of HIV acquisition and should be considered for PrEP based on the criteria outlined above. Persons who request PrEP may have undisclosed behaviors that put them at risk. Transgender women and men who are sexually active should be considered for PrEP based on the criteria outlined above. Transgender women are at especially high risk of HIV acquisition. A Centers for Disease Control and and Prevention (CDC) survey in 7 cities found an HIV prevalence of 42% among transgender women. Prevalence was highest among Black transgender women (62%) and Native American/Alaska Native transgender women (65%).\r\nIn addition, studies have found that transmission of HIV to a seronegative partner from a partner with HIV has not been observed when the partner with HIV was being treated with antiretroviral therapy and had a suppressed viral load.&nbsp;It is not known whether PrEP use further decreases the risk of HIV transmission when a partner with HIV has a documented undetectable viral load. Factors such as the consistency or inconsistency of a partner&rsquo;s viral load being suppressed, a partner&rsquo;s adherence to antiretroviral therapy, and the degree of certainty that a partner&rsquo;s viral load is suppressed (eg, self-report vs availability of laboratory test results) may help inform decisions about the use of PrEP in this situation.\r\nAll persons being considered for PrEP must have a recently documented negative HIV antigen-antibody test result, and if they have taken oral PrEP or postexposure prophylaxis in the past 3 months, or injectable cabotegravir in the past 12 months, the CDC recommends testing with both an HIV antigen-antibody assay and an HIV-1 RNA assay.'}, {'id': 186, 'title': 'Rh(D) Incompatibility: Screening ', 'grade': 'A', 'text': 'The DoctorAI strongly recommends Rh(D) blood typing and antibody testing for all pregnant women during their first visit for pregnancy-related care.', 'servfreq': 'First prenatal visit.', 'risktext': ''}, {'id': 1989, 'title': 'Syphilis Infection in Nonpregnant Adolescents and Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for syphilis infection in persons who are at increased risk for infection.', 'servfreq': 'Optimal screening frequency for persons who are at increased risk for syphilis infection is not well established. Men who have sex with men or persons with HIV infection may benefit from screening at least annually or more frequently (eg, every 3 to 6 months) if they continue to be at high risk.', 'risktext': 'The USPSTF recommends screening for syphilis in persons who are at increased risk for infection. When deciding which persons to screen for syphilis, clinicians should consider the prevalence of infection in the communities they serve, as well as other sociodemographic and behavioral factors that may be associated with increased risk of syphilis infection. For example, prevalence of syphilis is higher in men, men who have sex with men, persons with HIV infection, young adults, and persons with a history of incarceration, sex work, or military service. A substantial percentage of heterosexual syphilis transmission occurs among persons who use illicit drugs, particularly methamphetamine. Diagnosis of another STI may signal that a person is having condomless sex, which increases their risk of syphilis infection. Higher infection rates in persons of some racial and ethnic groups have been reported and are primarily a reflection of a combination of factors, including social determinants of health (eg, disparities of income, low educational achievement, and unstable housing), differential health insurance coverage or access to quality health care, and differences in sexual network characteristics (eg, individuals living in communities with a high prevalence of STIs have an increased chance of encountering an infected partner). Local prevalence rates may change over time, so clinicians should be aware of the latest data and trends for their specific population and geographic area, which are available through their state and local health departments and Centers for Disease Control and Prevention (CDC) surveillance.\r\n&nbsp;\r\nAlthough direct evidence on screening in nonpregnant persons who are not at increased risk for syphilis infection is lacking, based on the established test performance characteristics of current screening tests and the low prevalence rate of syphilis in this population, the yield of screening is likely low.9,10 Therefore, screening in this population may result in high false-positive rates and overtreatment.'}, {'id': 431, 'title': 'Syphilis Infection in Pregnant Women: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends early screening for syphilis infection in all pregnant women.', 'servfreq': 'All pregnant women should be tested for syphilis as early as possible when they first present to care. If a woman has not received prenatal care prior to delivery, she should be tested at the time she presents for delivery. In most cases of congenital syphilis, pregnant women received prenatal care but were not screened and treated for syphilis early enough during the pregnancy to prevent transmission to the fetus.', 'risktext': ''}, {'id': 1905, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and US Food and Drug Administration (FDA)--approved pharmacotherapy for cessation to nonpregnant adults who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 1906, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all pregnant persons about tobacco use, advise them to stop using tobacco, and provide behavioral interventions for cessation to pregnant persons who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 2014, 'title': 'Anxiety Disorders in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for anxiety disorders in adults, including pregnant and postpartum persons.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding optimal timing for screening, or screening interval, for both the perinatal and general adult populations; more evidence on both timing and screening interval is needed for all adult populations. A pragmatic approach in the absence of evidence might include screening all adults who have not been screened previously and using clinical judgment in considering risk factors, comorbid conditions, and life events to determine if additional screening of high-risk patients is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nRisk factors for anxiety disorders include sociodemographic factors, psychosocial factors, and physical and mental health factors such as marital status (widowed or divorced), stressful life events, smoking and alcohol use, other mental health conditions, or a parental history of mental disorders. Demographic factors such as low socioeconomic status and female sex are associated with higher rates of anxiety disorders.&nbsp;Black persons and individuals of non-Hispanic ethnicity are at increased risk of anxiety disorders due to social, rather than biological, factors. Anxiety and depressive disorders often overlap. One cohort study found that 67% of individuals with a depressive disorder also had a current anxiety disorder, and 75% had a lifetime comorbid anxiety disorder.'}, {'id': 1938, 'title': 'Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication ', 'grade': 'B', 'text': 'The DoctorAI recommends the use of low-dose aspirin (81 mg/day) as preventive medication after 12 weeks of gestation in persons who are at high risk for preeclampsia.\r\rSee the Practice Considerations section for information on high risk and aspirin dose.', 'servfreq': 'Once daily after 12 weeks of gestation', 'risktext': ' \r\nPersons with a history of preeclampsia in a previous pregnancy, type 1 or type 2 diabetes, and chronic hypertension are at highest risk for preeclampsia. Additional conditions that place a person at high risk for preeclampsia include multifetal gestation, conception using assisted reproductive technology, autoimmune disease, and kidney disease. Other factors associated with increased preeclampsia risk include nulliparity, high prepregnancy body mass index, family history of preeclampsia, and advanced maternal age (35 years or older). In addition, Black persons have higher rates of preeclampsia and are at increased risk for serious complications due to various societal and health inequities.\r\n '}, {'id': 513, 'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for asymptomatic bacteriuria using urine culture in pregnant persons.', 'servfreq': 'In general, screening is performed once at the first prenatal visit per clinical guidelines. However, there is little evidence on the optimal timing and frequency of screening for asymptomatic bacteriuria in pregnancy.2&nbsp; .&nbsp;Screen pregnant persons for asymptomatic bacteriuria using a midstream, clean-catch urine culture at the first prenatal visit or at 12 to 16 weeks of gestation, whichever is earlier. A urine culture showing &gt;100,000 CFU/mL of a single uropathogen or &gt;10,000 CFU/mL if the pathogen is group B streptococcus indicates treatment.', 'risktext': 'This recommendation applies to adults 18 years and older and pregnant persons of any age without signs and symptoms of a urinary tract infection. It does not apply to persons who have chronic medical or urinary tract conditions, such as end-stage renal disease; have indwelling urinary catheters, urinary stents, or spinal cord injuries; are hospitalized; reside in an institution (eg, a nursing home); or who are transplant recipients.\r\n&nbsp;\r\nThe risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6&nbsp;Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5&nbsp;Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7,&nbsp;11,&nbsp;12&nbsp;In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12&nbsp;Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4,&nbsp;6'}, {'id': 2009, 'title': 'Latent Tuberculosis Infection in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for LTBI in populations at increased risk.\r\rSee the "Assessment of Risk" section for additional information on adults at increased risk.', 'servfreq': 'The USPSTF found no evidence on the optimal frequency of screening for LTBI. In the absence of evidence, a reasonable approach is to repeat screening based on specific risk factors; screening frequency could range from 1-time only screening among persons at low risk for future tuberculosis exposure to annual screening among those at continued risk of exposure.', 'risktext': 'Populations at increased risk for LTBI, based on increased prevalence of active disease and increased risk of exposure, include persons who were born in, or are former residents of, countries with high tuberculosis prevalence and persons who live in, or have lived in, high-risk congregate settings (eg, homeless shelters or correctional facilities). Clinicians can consult their local or state health departments for more information about populations at increased risk in their community, since local demographic patterns may vary across the US.\r\nIn 2020, 71.5% of all cases of active tuberculosis in the US occurred among persons born outside the US. According to the CDC, tuberculosis disease is common in most countries in Latin America, the Caribbean, Africa, Asia, Eastern Europe, and Russia. In 2020, among persons with new tuberculosis living in the US who were born outside the US, the most common countries of birth were Mexico (18.0%), the Philippines (12.5%), India (10.4%), Vietnam (8.2%), and China (5.1%), accounting for 54.2% of total cases. Most of these cases are believed to be due to progression of latent infection to active tuberculosis disease rather than new transmission within communities.\r\nPersons who live, or have lived, in high-risk congregate settings also have a higher prevalence rate of active tuberculosis and an increased risk for exposure. In 2020, 4.3% of tuberculosis disease cases diagnosed in persons 15 years or older occurred in persons experiencing homelessness and 2.6% occurred in residents of correctional facilities. It is estimated that persons experiencing homelessness have an 11 times higher incidence of tuberculosis disease compared with persons who are not experiencing homelessness (36 cases per 100,000 population vs 2.9 cases per 100,000 population, respectively, during 2011 to 2016).\r\nOther populations at increased risk for LTBI or progression to active disease include persons who have immunosuppression (eg, persons living with HIV, patients receiving immunosuppressive medications such as chemotherapy or tumor necrosis factor inhibitors, and patients who have received an organ transplant) and patients with silicosis (a lung disease). However, given that screening in these populations may be considered standard care as part of disease management or indicated prior to the use of certain medications, the USPSTF did not review evidence on screening in these populations. Information on testing in these populations is provided by other groups, such as the Office of AIDS Research at the National Institutes of Health, and in a guideline issued jointly by the American Thoracic Society, Infectious Diseases Society of America, and CDC. Some evidence from observational studies has explored the association between poorly controlled diabetes and progression of LTBI to active disease. However, there is insufficient evidence on screening for and treatment of LTBI in persons with diabetes for the USPSTF to make a separate recommendation for this important population.\r\nPersons who are contacts of individuals with active tuberculosis, health care workers, and workers in high-risk congregate settings may also be at increased risk of exposure. Because screening in these populations is conducted as part of public health or employee health surveillance, the USPSTF did not review the evidence in these populations. Clinicians seeking further information about testing for tuberculosis in these populations can refer to the Additional Tools and Resources and Recommendations of Others sections.'}, {'id': 514, 'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic bacteriuria in nonpregnant adults.', 'servfreq': '', 'risktext': 'The risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6 Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5 Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7, 11, 12 In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12 Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4, 6'}, {'id': 507, 'title': 'BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing ', 'grade': 'B', 'text': 'The DoctorAI recommends that primary care clinicians assess women with a personal or family history of breast, ovarian, tubal, or peritoneal cancer or who have an ancestry associated with breast cancer susceptibility 1 and 2 (BRCA1/2) gene mutations with an appropriate brief familial risk assessment tool. Women with a positive result on the risk assessment tool should receive genetic counseling and, if indicated after counseling, genetic testing.', 'servfreq': 'Consideration of screening for potentially harmful BRCA mutations should begin once women have reached the age of consent (18 years). Primary care providers should periodically assess all patients for changes in family history (for example, comprehensive review at least every 5 to 10 years)', 'risktext': 'Patients with family or personal histories of breast, ovarian, tubal, or peritoneal cancer or ancestry associated with harmful&nbsp;&lt; i&gt;BRCA1/2&nbsp;mutations should be assessed using a familial risk assessment tool. The USPSTF found adequate evidence that these tools are accurate in identifying women with increased likelihood of&nbsp;&lt; i&gt;BRCA1/2mutations. Tools evaluated by the USPSTF include the Ontario Family History Assessment Tool, Manchester Scoring System, Referral Screening Tool, Pedigree Assessment Tool, 7-Question Family History Screening Tool, International Breast Cancer Intervention Study instrument (Tyrer-Cuzick), and brief versions of BRCAPRO. These tools should be used to guide referrals to genetic counseling.&nbsp;Persons should consider their sex at birth to determine which recommendation best applies to them.'}, {'id': 339, 'title': 'Breastfeeding: Primary Care Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends providing interventions during pregnancy and after birth to support breastfeeding.', 'servfreq': 'During pregnancy and after birth', 'risktext': "This recommendation applies to pregnant women, new mothers, and their infants and children. Interventions to support breastfeeding may also involve a woman's partner, other family members, and friends. This recommendation does not apply in circumstances where there are contraindications to breastfeeding (e.g., certain maternal medical conditions or infant metabolic disorders, such as galactosemia). The USPSTF did not review evidence on interventions directed at breastfeeding of preterm infants."}, {'id': 1935, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for chlamydia in all sexually active women 24 years or younger and in women 25 years or older who are at increased risk for infection.', 'servfreq': ' \r\nIn the absence of studies on screening intervals, a reasonable approach would be to screen patients whose sexual history reveals new or persistent risk factors since the last negative test result.\r\n ', 'risktext': ' \r\nAge is a strong predictor of risk for chlamydial and gonococcal infections, with the highest infection rates in women occurring during ages 15 to 24 years. Women 25 years or older are at increased risk if they have a new sex partner, more than 1 sex partner, a sex partner with concurrent partners, or a sex partner who has an STI; practice inconsistent condom use when not in a mutually monogamous relationship; or have a previous or coexisting STI. Exchanging sex for money or drugs and history of incarceration also are associated with increased risk.&nbsp;Clinicians should consider the communities they serve and may want to consult local public health authorities for information about local epidemiology and guidance on determining who is at increased risk.\r\n '}, {'id': 1936, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for gonorrhea in all sexually active women 24 years or younger and in women 25 years or older who are at increased risk for infection.', 'servfreq': ' \r\nIn the absence of studies on screening intervals, a reasonable approach would be to screen patients whose sexual history reveals new or persistent risk factors since the last negative test result.\r\n ', 'risktext': ' \r\nAge is a strong predictor of risk for chlamydial and gonococcal infections, with the highest infection rates in women occurring during ages 15 to 24 years. Women 25 years or older are at increased risk if they have a new sex partner, more than 1 sex partner, a sex partner with concurrent partners, or a sex partner who has an STI; practice inconsistent condom use when not in a mutually monogamous relationship; or have a previous or coexisting STI. Exchanging sex for money or drugs and history of incarceration also are associated with increased risk.&nbsp;Clinicians should consider the communities they serve and may want to consult local public health authorities for information about local epidemiology and guidance on determining who is at increased risk.\r\n '}, {'id': 1909, 'title': 'Asymptomatic Carotid Artery Stenosis: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic carotid artery stenosis in the general adult population.\r\rSee the Practice Considerations section for a description of adults at increased risk.', 'servfreq': '', 'risktext': ''}, {'id': 2017, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for suicide risk in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': '', 'risktext': ''}, {'id': 2016, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for depression in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding the optimal timing for screening for depression; more evidence is needed in both perinatal and general adult populations. In the absence of evidence, a pragmatic approach might include screening adults who have not been screened previously and using clinical judgment while considering risk factors, comorbid conditions, and life events to determine if additional screening of patients at increased risk is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nThe USPSTF recommends screening for depression in all adults regardless of risk factors. Risk factors for depression include a combination of genetic, biological, and environmental factors, such as a family history of depression, prior episode of depression or other mental health condition, a history of trauma or adverse life events, or a history of disease or illness (eg, cardiovascular disease).\r\nPrevalence rates vary by sex, age, race, ethnicity, education, marital status, geographic location, poverty level, and employment status. Women have twice the risk of depression compared with men. Young adults, multiracial individuals, and Native American/Alaska Native individuals have higher rates of depression.\r\nRisk factors for perinatal depression include life stress, low social support, history of depression, marital or partner dissatisfaction, and a history of abuse.'}, {'id': 1932, 'title': 'Gestational Diabetes: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for gestational diabetes in asymptomatic pregnant persons at 24 weeks of gestation or after.', 'servfreq': 'At 24 weeks of gestation or after to improve maternal and fetal outcomes', 'risktext': ' \r\nSeveral factors increase a person&rsquo;s risk for developing gestational diabetes, including obesity, increased maternal age, history of gestational diabetes, family history of diabetes, and belonging to a racial/ethnic group that is at increased risk for developing type 2 diabetes (Hispanic, Native American, South or East Asian, or Pacific Islander descent).4,19,20 Factors associated with a lower risk for developing gestational diabetes include age younger than 25 to 30 years, White race, a body mass index (BMI) of 25 or less (calculated as weight in kilograms divided by height in meters squared), no family history (in a first-degree relative) of diabetes, and no history of glucose intolerance or adverse pregnancy outcomes related to gestational diabetes.21-23 The risk in different racial/ethnic groups may be due in part to social risk factors such as low socioeconomic status or structural racism, although these associations are not examined in the current evidence. Although a higher BMI increases the risk of gestational diabetes across racial/ethnic groups, the association varies. In Asian American persons, the prevalence of gestational diabetes at a BMI of 22 to less than 25 is similar to the prevalence in Hispanic persons, non-Hispanic White persons, and Black persons with a higher (&gt;28) BMI.24,25\r\n '}, {'id': 1845, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends offering or referring adults with cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity.', 'servfreq': '', 'risktext': 'Adults 18 years or older at increased risk of CVD, defined as those with 1 or more of the following:\r\n1.Hypertension or elevated blood pressure2.Dyslipidemia3.Mixed or multiple risk factors such as the metabolic syndrome or an estimated 10-year CVD risk of &ge;7.5%\r\nThis recommendation does not apply to adults with other known modifiable cardiovascular risk factors such as abnormal blood glucose levels, obesity, and smoking; these populations are incorporated in other USPSTF recommendations.'}, {'id': 1931, 'title': 'Healthy Weight and Weight Gain In Pregnancy: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer pregnant persons effective behavioral counseling interventions aimed at promoting healthy weight gain and preventing excess gestational weight gain in pregnancy.', 'servfreq': 'Throughout pregnancy', 'risktext': 'Pregnancy'}, {'id': 1885, 'title': 'Hepatitis B Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in adolescents and adults at increased risk for infection.\r\rSee the Practice Considerations section for a description of adolescents and adults at increased risk for infection.', 'servfreq': 'For patients with negative HBsAg results who have not received the HBV vaccine series, periodic screening may be useful for those who report continued risk for acquiring HBV transmission, such as persons who continue to inject drugs and men who have sex with men. Clinical judgment should be used to determine screening frequency. The USPSTF found no evidence to determine optimal screening intervals.', 'risktext': 'Persons from such risk groups include persons who have injected drugs in the past or currently; men who have sex with men; persons with HIV; and sex partners, needle-sharing contacts, and household contacts of persons known to be HBsAg positive. Some persons with combinations of risk factors who are not members of risk factor groups listed above may also be at increased risk for HBV infection.'}, {'id': 524, 'title': 'Hepatitis C Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis C virus (HCV) infection in adults aged 18 to 79 years.', 'servfreq': 'One-time screening for most adults.\r\nPeriodically screen persons with continued risk for HCV infection (eg, persons with past or current injection drug use). There is limited evidence to determine how often to screen persons at increased risk.&nbsp;', 'risktext': 'Asymptomatic adults aged 18 to 79 years (including pregnant persons) without known liver disease.&nbsp;\r\nThe USPSTF also suggests that clinicians consider screening persons younger than 18 years and older than 79 years who are at high risk for infection (eg, those with past or current injection drug use).&nbsp;'}, {'id': 2023, 'title': 'Hypertensive Disorders of Pregnancy: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hypertensive disorders in pregnant persons with blood pressure measurements throughout pregnancy.', 'servfreq': 'Screening Interval\r\nBlood pressure measurements should be obtained during each prenatal care visit throughout pregnancy. Hypertensive disorders of pregnancy can quickly evolve into severe disease that can result in serious, even fatal, maternal and infant health outcomes. The ability to screen for hypertensive disorders of pregnancy using blood pressure measurements is important to identify and effectively treat a potentially unpredictable and fatal condition. While it is known that risk continues into the immediate postpartum period, there is little evidence regarding screening during this period. A pragmatic approach would be for patients to be counseled regarding signs and symptoms of preeclampsia at hospital discharge and for patients with hypertensive disorders to have subsequent blood pressure checks.\r\nScreening for hypertensive disorders of pregnancy alone is not sufficient to improve inequities in health outcomes. Identifying hypertensive disorders of pregnancy requires adequate prenatal visits, surveillance, and evidence-based care in response to evolving patient signs and symptoms during pregnancy and the postpartum period to improve health outcomes. Black and Native American/Alaska Native persons have lower rates of prenatal visits and are at greater risk of serious postpartum morbidity and hospital readmission after delivery. Screening and monitoring of Black and Hispanic/Latina individuals during the postpartum period could be an important step for reducing health inequities by preventing serious adverse events. In addition, screening and monitoring by various health care providers (eg, nurse midwives, nurses, pediatricians, doulas, and lactation consultants) could also help avert serious complications in the postpartum period.', 'risktext': 'Assessment of Risk\r\nImportant clinical conditions associated with increased risk for preeclampsia include a history of eclampsia or preeclampsia in a prior pregnancy, a previous adverse pregnancy outcome, and maternal comorbid conditions (including type 1 or type 2 diabetes prior to pregnancy, gestational diabetes, chronic hypertension, kidney disease, and autoimmune diseases).\r\n&nbsp;Other factors associated with increased risk of preeclampsia and gestational hypertension include nulliparity, high prepregnancy body mass index, family history of preeclampsia, multifetal gestation, and the pregnant individual being 35 years or older.\r\nThe higher prevalence of hypertensive disorders of pregnancy and the increased risk for severe complications seen in Black persons may be due to their disproportionate burden of social and clinical risk factors. These social and clinical determinants largely result from historical and current manifestations of structural racism that influence environmental exposures, access to health resources, and overall health status.'}, {'id': 434, 'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians screen for intimate partner violence (IPV) in women of reproductive age and provide or refer women who screen positive to ongoing support services. See the Clinical Considerations section for more information on effective ongoing support services for IPV and for information on IPV in men.', 'servfreq': 'The USPSTF found no evidence on appropriate intervals for screening. Randomized clinical trials (RCTs) of screening and interventions for IPV often screen for current IPV or IPV in the past year.\r\n&nbsp;', 'risktext': 'All women of reproductive age are at potential risk for IPV and should be screened. There are a variety of factors that increase risk of IPV, such as exposure to violence as a child, young age, unemployment, substance abuse, marital difficulties, and economic hardships.\r\nRisk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health. For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.'}, {'id': 187, 'title': 'Rh(D) Incompatibility: Screening ', 'grade': 'B', 'text': "The DoctorAI recommends repeated Rh(D) antibody testing for all unsensitized Rh(D)-negative women at 24 to 28 weeks' gestation, unless the biological father is known to be Rh(D)-negative.", 'servfreq': 'Repeat testing at 24-28 weeks gestation.', 'risktext': ''}, {'id': 1916, 'title': 'Lung Cancer: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery.', 'servfreq': ' \r\nThe USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. ', 'risktext': ' \r\nSmoking and older age are the 2 most important risk factors for lung cancer.&nbsp;The risk of lung cancer in persons who smoke increases with cumulative quantity and duration of smoking and with age but decreases with increasing time since quitting for persons who formerly smoked.3 The USPSTF considers adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years to be at high risk and recommends screening for lung cancer with annual LDCT in this population. \r\n \r\n&nbsp;\r\n \r\nAfrican American/Black (Black) men have a higher incidence of lung cancer than White men, and Black women have a lower incidence than White women.1 These differences are likely related to differences in smoking exposure (ie, prevalence of smoking) and related exposure to carcinogens in cigarettes.7,8 The differences may also be related to other social risk factors.\r\n \r\n&nbsp;\r\n \r\nOther risk factors for lung cancer include environmental exposures, prior radiation therapy, other (noncancer) lung diseases, and family history. Lower level of education is also associated with a higher risk of lung cancer.7 The task force recommends using age and smoking history to determine screening eligibility rather than more elaborate risk prediction models because there is insufficient evidence to assess whether risk prediction model&ndash;based screening would improve outcomes relative to using the risk factors of age and smoking history for broad implementation in primary care.\r\n '}, {'id': 449, 'title': 'Perinatal Depression: Preventive Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians provide or refer pregnant and postpartum persons who are at increased risk of perinatal depression to counseling interventions.', 'servfreq': '', 'risktext': 'Include&nbsp;a past history of depression. Current depressive symptoms (that do not reach a diagnostic threshold),&nbsp;history of physical or sexual abuse,&nbsp;unplanned or unwanted pregnancy,&nbsp;stressful life events,&nbsp;lack of social and financial support,&nbsp;intimate partner violence,pregestational or gestational diabetes,and complications during pregnancy. Additional risk factors include adolescent parenthood, low socioeconomic status, and lack of social support.&nbsp;Genetic factors are also suspected to contribute to women&rsquo;s risk of developing perinatal depression.'}, {'id': 1445, 'title': 'Sexually Transmitted Infections: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends behavioral counseling for all sexually active adolescents and for adults who are at increased risk for sexually transmitted infections (STIs).\r\rSee the Practice Considerations section for more information on populations at increased risk for acquiring STIs.', 'servfreq': '', 'risktext': 'All sexually active adolescents are at increased risk for STIs because of the high rates of STIs in this age group and should receive behavioral counseling interventions. Adults at increased risk for STIs include those who currently have an STI or were diagnosed with one within the past year, do not consistently use condoms, have multiple sex partners, or have sex partners within populations with a high prevalence of STIs. Populations with a high prevalence of STIs include persons who seek STI testing or attend STI clinics; sexual and gender minorities; persons who are living with HIV, inject drugs, have exchanged sex for money or drugs, or have entered correctional facilities; and some racial/ethnic minority groups.1-4'}, {'id': 402, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends counseling young adults, adolescents, children, and parents of young children about minimizing exposure to ultraviolet (UV) radiation for persons aged 6 months to 24 years with fair skin types to reduce their risk of skin cancer.', 'servfreq': '', 'risktext': 'Fair skin types'}, {'id': 438, 'title': 'Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for unhealthy alcohol use in primary care settings in adults 18 years or older, including pregnant women, and providing persons engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce unhealthy alcohol use.', 'servfreq': 'The USPSTF did not find adequate evidence to recommend an optimal screening interval for unhealthy alcohol use in adults.&nbsp;Brief behavioral counseling interventions were found to reduce unhealthy alcohol use in adults 18 years or older, including pregnant women. Effective behavioral counseling interventions vary in their specific components, administration, length, and number of interactions. The USPSTF was unable to identify specific intervention characteristics or components that were clearly associated with improved outcomes.', 'risktext': 'engaged in risky or hazardous drinking'}, {'id': 767, 'title': 'Unhealthy Drug Use: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening by asking questions about unhealthy drug use in adults age 18 years or older. Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. \r(Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'servfreq': 'Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. (Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'risktext': 'These include being aged 18 to 25 years; male sex; having a mental health condition, personality or mood disorder, or nicotine or alcohol dependence; a history of physical or sexual abuse, parental neglect, or other adversity in childhood; or drug or alcohol addiction in a first-degree relative.1,9&nbsp;Factors associated with misuse of prescription drugs include history of other drug use, mental illness, pain, and greater access to prescription drugs.10&nbsp;Factors associated with prenatal use of drugs include a mental health disorder, interpersonal violence, and family history of substance use.11'}, {'id': 433, 'title': 'Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer or refer adults with a body mass index (BMI) of 30 or higher (calculated as weight in kilograms divided by height in meters squared) to intensive, multicomponent behavioral interventions.', 'servfreq': '', 'risktext': 'Adults with a BMI &ge;30'}, {'id': 1979, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: Behavioral Counseling Interventions ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians individualize the decision to offer or refer adults without cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity. \r\rSee the "Practice Considerations" section for information on determining which patients may benefit most from this service.', 'servfreq': '', 'risktext': ''}, {'id': 1937, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for chlamydia and gonorrhea in men.', 'servfreq': '', 'risktext': ''}, {'id': 508, 'title': 'BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine risk assessment, genetic counseling, or genetic testing for women whose personal or family history or ancestry is not associated with potentially harmful BRCA1/2 gene mutations.', 'servfreq': '', 'risktext': 'Patients with family or personal histories of breast, ovarian, tubal, or peritoneal cancer or ancestry associated with harmful&nbsp;BRCA1/2&nbsp;mutations should be assessed using a familial risk assessment tool. The USPSTF found adequate evidence that these tools are accurate in identifying women with increased likelihood of&nbsp;BRCA1/2mutations. Tools evaluated by the USPSTF include the Ontario Family History Assessment Tool, Manchester Scoring System, Referral Screening Tool, Pedigree Assessment Tool, 7-Question Family History Screening Tool, International Breast Cancer Intervention Study instrument (Tyrer-Cuzick), and brief versions of BRCAPRO. These tools should be used to guide referrals to genetic counseling.'}, {'id': 525, 'title': 'Bacterial Vaginosis in Pregnant Persons to Prevent Preterm Delivery: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for bacterial vaginosis (BV) in pregnant persons who are not at increased risk for preterm delivery.', 'servfreq': '', 'risktext': '\r\nAssess risk for preterm delivery. There are multiple factors that increase risk for preterm delivery; one of the strongest risk factors is prior preterm delivery.\r\nDecide whether or not to screen for bacterial vaginosis:\r\n\r\na. Do not screen pregnant persons who are not at increased risk for preterm delivery.\r\nb. Evidence is insufficient to recommend for or against screening pregnant persons at increased risk for preterm delivery.'}, {'id': 418, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening with resting or exercise electrocardiography (ECG) to prevent cardiovascular disease (CVD) events in asymptomatic adults at low risk of CVD events.', 'servfreq': '', 'risktext': ''}, {'id': 429, 'title': 'Cervical Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for cervical cancer in women who have had a hysterectomy with removal of the cervix and do not have a history of a high-grade precancerous lesion (ie, cervical intraepithelial neoplasia [CIN] grade 2 or 3) or cervical cancer.', 'servfreq': '', 'risktext': ''}, {'id': 428, 'title': 'Cervical Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for cervical cancer in women younger than 21 years.', 'servfreq': '', 'risktext': ''}, {'id': 1973, 'title': 'Chronic Obstructive Pulmonary Disease: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for chronic obstructive pulmonary disease in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 2003, 'title': 'Genital Herpes Infection: Serologic Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine serologic screening for genital herpes simplex virus infection in asymptomatic adolescents and adults, including pregnant persons.', 'servfreq': '', 'risktext': 'The USPSTF found no evidence of externally validated, reliable risk stratification tools to identify individuals more or less likely to have genital herpes.'}, {'id': 504, 'title': 'Pancreatic Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for pancreatic cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 365, 'title': 'Thyroid Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for thyroid cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 1976, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'D', 'text': 'The DoctorAI recommends against the use of beta carotene or vitamin E supplements for the prevention of cardiovascular disease or cancer.', 'servfreq': '', 'risktext': ''}, {'id': 318, 'title': 'Autism Spectrum Disorder in Young Children: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for autism spectrum disorder (ASD) in young children for whom no concerns of ASD have been raised by their parents or a clinician.', 'servfreq': '', 'risktext': 'Although a number of potential risk factors for ASD have been identified, there is insufficient evidence to determine if certain risk factors modify the performance characteristics of ASD screening tests, such as the age at which screening is performed or other characteristics of the child or family.'}, {'id': 526, 'title': 'Bacterial Vaginosis in Pregnant Persons to Prevent Preterm Delivery: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for BV in pregnant persons who are at increased risk for preterm delivery.', 'servfreq': '', 'risktext': ''}, {'id': 65, 'title': 'Bladder Cancer in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults.\r\rLiterature scans conducted in July 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'This evidence update focused on the benefits and harms of screening for bladder cancer among people without symptoms, the accuracy of screening tests done in primary care settings, and the benefits and harms of treatment. The updated evidence review did not find any new high quality evidence to adequately determine the balance of benefits and harms of screening for bladder cancer. However, bladder cancer is a common cancer and can cause considerable health problems including death. Therefore, the USPSTF determined that the evidence was insufficient to provide a recommendation for or against bladder cancer screening.  The USPSTF emphasizes the need for additional research in this area. '}, {'id': 2037, 'title': 'Breast Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of supplemental screening for breast cancer using breast ultrasonography or magnetic resonance imaging (MRI) in women identified to have dense breasts on an otherwise negative screening mammogram.\r\rSee the "Practice Considerations" section for more information on the patient population to whom this recommendation applies and on screening mammography modalities.', 'servfreq': '', 'risktext': 'These recommendations apply to cisgender women and all other persons assigned female at birth (including transgender men and nonbinary persons) 40 years or older at average risk of breast cancer. \r\nThese recommendations apply to persons who have factors associated with an increased risk of breast cancer, such as a family history of breast cancer (ie, a first-degree relative with breast cancer) or having dense breasts. They do not apply to persons who have a genetic marker or syndrome associated with a high risk of breast cancer (eg, BRCA1 or BRCA2 genetic variation), a history of high-dose radiation therapy to the chest at a young age, or previous breast cancer or a high-risk breast lesion on previous biopsies. '}, {'id': 419, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening with resting or exercise ECG to prevent CVD events in asymptomatic adults at intermediate or high risk of CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 423, 'title': 'Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of adding the ankle-brachial index (ABI), high-sensitivity C-reactive protein (hsCRP) level, or coronary artery calcium (CAC) score to traditional risk assessment for cardiovascular disease (CVD) in asymptomatic adults to prevent CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 352, 'title': 'Celiac Disease: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'persons with family history or other risk factors'}, {'id': 1955, 'title': 'Eating Disorders in Adolescents and Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for eating disorders in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1933, 'title': 'Gestational Diabetes: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for gestational diabetes in asymptomatic pregnant persons before 24 weeks of gestation.', 'servfreq': '', 'risktext': ''}, {'id': 665, 'title': 'Illicit Drug Use in Children, Adolescents, and Young Adults: Primary Care-Based Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--based behavioral counseling interventions to prevent illicit drug use, including nonmedical use of prescription drugs, in children, adolescents, and young adults.\r\rSee the Practice Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 435, 'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for abuse and neglect in all older or vulnerable adults. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': 'Risk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health.14&nbsp;For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.15'}, {'id': 2045, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for iron deficiency and iron deficiency anemia in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2046, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine iron supplementation in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2018, 'title': 'Lipid Disorders in Children and Adolescents: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1998, 'title': 'Obstructive Sleep Apnea in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for obstructive sleep apnea in the general adult population.\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Risk Factors\r\nRisk factors associated with OSA include male sex, older age (40-70 years), postmenopausal status, higher body mass index (BMI), and craniofacial and upper airway abnormalities (eg, enlarged tonsils or long upper airway). Black, Hispanic/Latino, and Native American/Alaska Native persons have a higher prevalence of OSA compared with White persons; some evidence suggests that these differences are partially explained by higher rates of obesity, asthma, and tobacco use among these groups.8'}, {'id': 1977, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of multivitamin supplements for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1978, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of single or paired nutrient supplements (other than beta carotene and vitamin E) for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 176, 'title': 'Oral Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for oral cancer in asymptomatic adults.\r\rGo to the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in July 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Tobacco and alcohol use are major risk factors for oral cancer. A total of 20% to 30% of cases of oral cancer worldwide are attributable to cigarette smoking. In the United States, up to 75% of cases of oral cancer may be attributable to tobacco and alcohol use. Additional risk factors include male sex, older age, use of betel quid, ultraviolet light exposure, infection with Candida or bacterial flora, and a compromised immune system. Sexually transmitted oral HPV infection (HPV-16) has recently been recognized as an increasingly important risk factor for oropharyngeal cancer. In the United States, the prevalence of oropharyngeal cancer due to oral HPV infection is probably as high as 80% to 95%. The prevalence of oral HPV infection is associated with age, sex, number of sexual partners, and number of cigarettes smoked per day. The effect of multifactorial risk assessment and screening for risk factors on oral cancer morbidity and mortality is unknown.'}, {'id': 2026, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine screening performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 2027, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of preventive interventions performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 424, 'title': 'Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for peripheral artery disease (PAD) and cardiovascular disease (CVD) risk with the ankle-brachial index (ABI) in asymptomatic adults.\r\rLiterature scans conducted in August 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Risk factors associated with OSA include male sex, older age (40 to 70 years), postmenopausal status, higher BMI, and craniofacial and upper airway abnormalities.'}, {'id': 404, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of counseling adults about skin self-examination to prevent skin cancer.See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 2005, 'title': 'Skin Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Exposure to UV radiation from sun exposure, indoor tanning beds, and other UV radiation&ndash;emitting devices is the major environmental risk factor for skin cancer. History of frequent sunburns, older age, and male sex are associated with increased risk for skin cancer. Exposure to UV radiation from the use of indoor tanning beds is an important risk factor in adolescents. Incidence of melanoma is higher among White persons compared with persons of other races and ethnicities. This difference likely reflects traits associated with increased melanoma risk, such as fair skin (which is more susceptible to sunburning), light-colored eyes, and red or blond hair being more common among White persons compared with persons of other races and ethnicities. Acral lentiginous melanoma, which occurs mostly on skin not frequently exposed to direct sunlight (eg, palms of hands, soles of feet, or under fingernails or toenails), is the most common type of melanoma among Black populations. Other melanoma risk factors include higher numbers of moles on the skin, atypical moles, as well as a personal and family history of skin cancer.'}, {'id': 269, 'title': 'Thyroid Dysfunction: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults.\r\rSee the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': 'The optimal screening interval for thyroid dysfunction (if one exists) is unknown.', 'risktext': 'The most common cause of hypothyroidism in the United States is chronic autoimmune (Hashimoto) thyroiditis. Risk factors for an elevated TSH level include female sex, advancing age, white race, type 1 diabetes, Down syndrome, family history of thyroid disease, goiter, previous hyperthyroidism (possibly due in part to ablation therapy leading to iatrogenic thyroid dysfunction), and external-beam radiation in the head and neck area. Common causes of hyperthyroidism include Graves disease, Hashimoto thyroiditis, and functional thyroid nodules. Risk factors for a low TSH level include female sex; advancing age; black race; low iodine intake; personal or family history of thyroid disease; and ingestion of iodine-containing drugs, such as amiodarone. The USPSTF found no direct evidence that treatment of thyroid dysfunction based on risk level alters final health outcomes.'}, {'id': 1908, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of electronic cigarettes (e-cigarettes) for tobacco cessation in adults, including pregnant persons. The USPSTF recommends that clinicians direct patients who use tobacco to other tobacco cessation interventions with proven effectiveness and established safety.\rSee the Practice Considerations section for more information on recommended behavioral interventions and pharmacotherapy and for suggestions for practice regarding the I statements.', 'servfreq': '', 'risktext': ''}, {'id': 1907, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of pharmacotherapy interventions for tobacco cessation in pregnant persons.', 'servfreq': '', 'risktext': ''}, {'id': 586, 'title': 'Tobacco Use in Children and Adolescents: Primary Care Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--feasible interventions for the cessation of tobacco use among school-aged children and adolescents.\r\rSee the Practice Considerations section for more information on effective interventions to prevent initiation of tobacco use and for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1919, 'title': 'Vitamin D Deficiency in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 408, 'title': 'Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of the benefits and harms of vitamin D and calcium supplementation, alone or combined, for the primary prevention of fractures in men and premenopausal women.', 'servfreq': '', 'risktext': ''}]}
2025-01-29 22:02:59 [INFO] Recommendations fetched: [{'id': 2020, 'title': 'Folic Acid Supplementation to Prevent Neural Tube Defects: Preventive Medication ', 'grade': 'A', 'text': 'The DoctorAI recommends that all persons planning to or who could become pregnant take a daily supplement containing 0.4 to 0.8 mg (400 to 800 mcg) of folic acid.', 'servfreq': 'The neural plate completes its formation and closure early in pregnancy (usually 26 to 28 days after fertilization). This means the critical period for folic acid supplementation starts at least 1 month before conception and continues through the first 2 to 3 months of pregnancy. Nearly half of all pregnancies in the US are unplanned; to gain the full benefits of supplementation, clinicians should advise all persons who plan to or who could become pregnant to take daily folic acid.', 'risktext': 'All pregnancies are at risk for neural tube defects, and persons who are planning to or could become pregnant should take folic acid supplements. Certain risk factors convey a higher risk, and individuals with these risk factors should talk to their health care professional. These factors include personal, partner, or family history of neural tube defects, malabsorption caused by bariatric procedures, the use of certain antiseizure medicines, and genetic mutations in folate-related enzymes. Pregestational diabetes and obesity have been associated with an increased risk of neural tube defects. Ethnic groups such as First Nation persons in Canada and Hispanic persons in California are thought to be at higher risk of neural tube defects. It is unclear, however, whether this is related to a higher risk of genetic variations among these groups or due to differential intake of folic acid&ndash;fortified foods.'}, {'id': 503, 'title': 'Hepatitis B Virus Infection in Pregnant Women: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in pregnant women at their first prenatal visit', 'servfreq': 'A test for HBsAg should be ordered at the first prenatal visit. Women with unknown HBsAg status or with new or continuing risk factors for HBV infection (eg, injection drug use or a sexually transmitted infection) should be screened at the time of admission to a hospital or other delivery setting.', 'risktext': 'In the United States, new cases of HBV among adults are largely transmitted through injection drug use or sexual intercourse, but most prevalent cases of HBV infection are chronic infections from exposure occurring in infancy or childhood. Another major risk factor for HBV infection is country of origin. In the United States, adults with HBV born in high-prevalence countries were commonly infected during childhood. In children, the primary source of infection is perinatal transmission at birth.'}, {'id': 485, 'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in adolescents and adults aged 15 to 65 years. Younger adolescents and older adults who are at increased risk of infection should also be screened.\rSee the Clinical Considerations section for more information about assessment of risk, screening intervals, and rescreening in pregnancy.', 'servfreq': 'The USPSTF found insufficient evidence to determine appropriate or optimal time intervals or strategies for repeat HIV screening. However, repeat screening is reasonable for persons known to be at increased risk of HIV infection, such as sexually active men who have sex with men; persons with a sex partner who is living with HIV; or persons who engage in behaviors that may convey an increased risk of HIV infection, such as injection drug use, transactional sex or commercial sex work, having 1 or more new sex partners whose HIV status is unknown, or having other factors that can place a person at increased risk of HIV infection (see &ldquo;Risk Assessment&rdquo;). Repeat screening is also reasonable for persons who live or receive medical care in a high-prevalence setting, such as a sexually transmitted disease clinic, tuberculosis clinic, correctional facility, or homeless shelter.', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'id': 486, 'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in all pregnant persons, including those who present in labor or at delivery whose HIV status is unknown.', 'servfreq': 'The CDC and ACOG recommend repeat prenatal screening for HIV during the third trimester of pregnancy in women with risk factors for HIV acquisition and in women living or receiving care in high-incidence settings, and the CDC notes that repeat screening for HIV during the third trimester may be considered in all women.&nbsp;', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'id': 1921, 'title': 'Hypertension in Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hypertension in adults 18 years or older with office blood pressure measurement (OBPM). The USPSTF recommends obtaining blood pressure measurements outside of the clinical setting for diagnostic confirmation before starting treatment.', 'servfreq': ' \r\nAlthough evidence on optimal screening intervals is limited, reasonable options include:\r\n \r\n \r\n\r\n\r\nScreening for hypertension every year in adults 40 years or older and in adults at increased risk for hypertension (such as Black persons, persons with high-normal blood pressure, or persons who are overweight or obese)\r\n\r\n\r\n \r\n \r\n\r\n\r\nScreening less frequently (ie, every 3 to 5 years) as appropriate for adults aged 18 to 39 years not at increased risk for hypertension and with a prior normal blood pressure reading.\r\n\r\n\r\n ', 'risktext': ' \r\nAlthough all adults should be screened for hypertension, risk factors that increase a person&rsquo;s risk for the condition include older age, Black race, family history, excess weight and obesity, lifestyle habits (lack of physical activity, stress, and tobacco use), and dietary factors (diet high in fat or sodium, diet low in potassium, or excessive alcohol intake)\r\n '}, {'id': 2021, 'title': 'Prevention of Acquisition of HIV: Preexposure Prophylaxis ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians prescribe preexposure prophylaxis using effective antiretroviral therapy to persons who are at increased risk of HIV acquisition to decrease the risk of acquiring HIV. \r\rSee the Practice Considerations section for more information about identification of persons at increased risk and about effective antiretroviral therapy.', 'servfreq': '', 'risktext': 'HIV is primarily acquired via sexual activity or injection drug use. It is important that clinicians routinely take a sexual and injection drug use history for all their patients in an open and nonjudgmental manner. All adolescents and adults who are sexually active or who inject drugs should be informed that acquisition of HIV can be prevented, to facilitate subsequent risk assessment and discussions about preexposure prophylaxis (PrEP) and other ways to prevent acquisition of HIV. Importantly, risk of HIV acquisition exists on a continuum, and currently available risk assessment tools all have limitations. However, certain risk factors or behaviors are known to place persons at increased risk of HIV.\r\nRisk of HIV acquisition depends on the likelihood that a specific act or activity will transmit HIV and the likelihood that a sex partner or drug injection partner has HIV. Likelihood of HIV transmission is highest with needle-sharing injection drug use and condomless receptive anal intercourse. Condomless receptive anal intercourse has an approximately 10- to 15-fold higher risk of transmission than condomless insertive anal sex and condomless receptive and insertive penile-vaginal sex. A 2018 study estimated the prevalence of HIV (ie, an estimate of the likelihood that a partner whose HIV status is unknown has HIV at a population level) as 12.4% among men who have sex with men and 1.9% among persons who inject drugs. The overall prevalence of HIV in the US is estimated at 0.3%.&nbsp;Of note, both the frequency of specific sexual activities and a person&rsquo;s number of sexual partners will also affect their risk of HIV.\r\n&nbsp;The USPSTF recommends that the following persons be considered for PrEP:\r\n1.&nbsp;&nbsp;&nbsp;&nbsp; Sexually active adults and adolescents weighing at least 35 kg (77 lb) who have engaged in anal or vaginal sex in the past 6 months and have any of the following:\r\n&nbsp;\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A sexual partner who has HIV (especially if the partner has an unknown or detectable viral load).\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A bacterial sexually transmitted infection (STI) (syphilis, gonorrhea, or chlamydia for men who have sex with men and transgender women; gonorrhea and syphilis for heterosexual women and men) in the past 6 months.\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A history of inconsistent or no condom use with sex partner(s) whose HIV status is not known; assessing risk in conversation with the patient and considering factors such as number of partners, the specific sexual activities a person engages in, and whether their sex partner or partners are in a group with a higher prevalence of HIV (eg, men who have sex with men or with men and women, transgender women, persons who inject drugs, and persons who engage in transactional sex).\r\n&nbsp;\r\n2. &nbsp; Persons who inject drugs and have a drug-injecting partner who has HIV or who shares injection equipment.\r\nPersons who engage in transactional sex, such as sex for money, drugs, or housing, including commercial sex workers or persons trafficked for sex work, constitute a group at increased risk of HIV acquisition and should be considered for PrEP based on the criteria outlined above. Persons who request PrEP may have undisclosed behaviors that put them at risk. Transgender women and men who are sexually active should be considered for PrEP based on the criteria outlined above. Transgender women are at especially high risk of HIV acquisition. A Centers for Disease Control and and Prevention (CDC) survey in 7 cities found an HIV prevalence of 42% among transgender women. Prevalence was highest among Black transgender women (62%) and Native American/Alaska Native transgender women (65%).\r\nIn addition, studies have found that transmission of HIV to a seronegative partner from a partner with HIV has not been observed when the partner with HIV was being treated with antiretroviral therapy and had a suppressed viral load.&nbsp;It is not known whether PrEP use further decreases the risk of HIV transmission when a partner with HIV has a documented undetectable viral load. Factors such as the consistency or inconsistency of a partner&rsquo;s viral load being suppressed, a partner&rsquo;s adherence to antiretroviral therapy, and the degree of certainty that a partner&rsquo;s viral load is suppressed (eg, self-report vs availability of laboratory test results) may help inform decisions about the use of PrEP in this situation.\r\nAll persons being considered for PrEP must have a recently documented negative HIV antigen-antibody test result, and if they have taken oral PrEP or postexposure prophylaxis in the past 3 months, or injectable cabotegravir in the past 12 months, the CDC recommends testing with both an HIV antigen-antibody assay and an HIV-1 RNA assay.'}, {'id': 186, 'title': 'Rh(D) Incompatibility: Screening ', 'grade': 'A', 'text': 'The DoctorAI strongly recommends Rh(D) blood typing and antibody testing for all pregnant women during their first visit for pregnancy-related care.', 'servfreq': 'First prenatal visit.', 'risktext': ''}, {'id': 1989, 'title': 'Syphilis Infection in Nonpregnant Adolescents and Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for syphilis infection in persons who are at increased risk for infection.', 'servfreq': 'Optimal screening frequency for persons who are at increased risk for syphilis infection is not well established. Men who have sex with men or persons with HIV infection may benefit from screening at least annually or more frequently (eg, every 3 to 6 months) if they continue to be at high risk.', 'risktext': 'The USPSTF recommends screening for syphilis in persons who are at increased risk for infection. When deciding which persons to screen for syphilis, clinicians should consider the prevalence of infection in the communities they serve, as well as other sociodemographic and behavioral factors that may be associated with increased risk of syphilis infection. For example, prevalence of syphilis is higher in men, men who have sex with men, persons with HIV infection, young adults, and persons with a history of incarceration, sex work, or military service. A substantial percentage of heterosexual syphilis transmission occurs among persons who use illicit drugs, particularly methamphetamine. Diagnosis of another STI may signal that a person is having condomless sex, which increases their risk of syphilis infection. Higher infection rates in persons of some racial and ethnic groups have been reported and are primarily a reflection of a combination of factors, including social determinants of health (eg, disparities of income, low educational achievement, and unstable housing), differential health insurance coverage or access to quality health care, and differences in sexual network characteristics (eg, individuals living in communities with a high prevalence of STIs have an increased chance of encountering an infected partner). Local prevalence rates may change over time, so clinicians should be aware of the latest data and trends for their specific population and geographic area, which are available through their state and local health departments and Centers for Disease Control and Prevention (CDC) surveillance.\r\n&nbsp;\r\nAlthough direct evidence on screening in nonpregnant persons who are not at increased risk for syphilis infection is lacking, based on the established test performance characteristics of current screening tests and the low prevalence rate of syphilis in this population, the yield of screening is likely low.9,10 Therefore, screening in this population may result in high false-positive rates and overtreatment.'}, {'id': 431, 'title': 'Syphilis Infection in Pregnant Women: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends early screening for syphilis infection in all pregnant women.', 'servfreq': 'All pregnant women should be tested for syphilis as early as possible when they first present to care. If a woman has not received prenatal care prior to delivery, she should be tested at the time she presents for delivery. In most cases of congenital syphilis, pregnant women received prenatal care but were not screened and treated for syphilis early enough during the pregnancy to prevent transmission to the fetus.', 'risktext': ''}, {'id': 1905, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and US Food and Drug Administration (FDA)--approved pharmacotherapy for cessation to nonpregnant adults who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 1906, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all pregnant persons about tobacco use, advise them to stop using tobacco, and provide behavioral interventions for cessation to pregnant persons who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 2014, 'title': 'Anxiety Disorders in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for anxiety disorders in adults, including pregnant and postpartum persons.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding optimal timing for screening, or screening interval, for both the perinatal and general adult populations; more evidence on both timing and screening interval is needed for all adult populations. A pragmatic approach in the absence of evidence might include screening all adults who have not been screened previously and using clinical judgment in considering risk factors, comorbid conditions, and life events to determine if additional screening of high-risk patients is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nRisk factors for anxiety disorders include sociodemographic factors, psychosocial factors, and physical and mental health factors such as marital status (widowed or divorced), stressful life events, smoking and alcohol use, other mental health conditions, or a parental history of mental disorders. Demographic factors such as low socioeconomic status and female sex are associated with higher rates of anxiety disorders.&nbsp;Black persons and individuals of non-Hispanic ethnicity are at increased risk of anxiety disorders due to social, rather than biological, factors. Anxiety and depressive disorders often overlap. One cohort study found that 67% of individuals with a depressive disorder also had a current anxiety disorder, and 75% had a lifetime comorbid anxiety disorder.'}, {'id': 1938, 'title': 'Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication ', 'grade': 'B', 'text': 'The DoctorAI recommends the use of low-dose aspirin (81 mg/day) as preventive medication after 12 weeks of gestation in persons who are at high risk for preeclampsia.\r\rSee the Practice Considerations section for information on high risk and aspirin dose.', 'servfreq': 'Once daily after 12 weeks of gestation', 'risktext': ' \r\nPersons with a history of preeclampsia in a previous pregnancy, type 1 or type 2 diabetes, and chronic hypertension are at highest risk for preeclampsia. Additional conditions that place a person at high risk for preeclampsia include multifetal gestation, conception using assisted reproductive technology, autoimmune disease, and kidney disease. Other factors associated with increased preeclampsia risk include nulliparity, high prepregnancy body mass index, family history of preeclampsia, and advanced maternal age (35 years or older). In addition, Black persons have higher rates of preeclampsia and are at increased risk for serious complications due to various societal and health inequities.\r\n '}, {'id': 513, 'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for asymptomatic bacteriuria using urine culture in pregnant persons.', 'servfreq': 'In general, screening is performed once at the first prenatal visit per clinical guidelines. However, there is little evidence on the optimal timing and frequency of screening for asymptomatic bacteriuria in pregnancy.2&nbsp; .&nbsp;Screen pregnant persons for asymptomatic bacteriuria using a midstream, clean-catch urine culture at the first prenatal visit or at 12 to 16 weeks of gestation, whichever is earlier. A urine culture showing &gt;100,000 CFU/mL of a single uropathogen or &gt;10,000 CFU/mL if the pathogen is group B streptococcus indicates treatment.', 'risktext': 'This recommendation applies to adults 18 years and older and pregnant persons of any age without signs and symptoms of a urinary tract infection. It does not apply to persons who have chronic medical or urinary tract conditions, such as end-stage renal disease; have indwelling urinary catheters, urinary stents, or spinal cord injuries; are hospitalized; reside in an institution (eg, a nursing home); or who are transplant recipients.\r\n&nbsp;\r\nThe risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6&nbsp;Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5&nbsp;Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7,&nbsp;11,&nbsp;12&nbsp;In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12&nbsp;Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4,&nbsp;6'}, {'id': 2009, 'title': 'Latent Tuberculosis Infection in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for LTBI in populations at increased risk.\r\rSee the "Assessment of Risk" section for additional information on adults at increased risk.', 'servfreq': 'The USPSTF found no evidence on the optimal frequency of screening for LTBI. In the absence of evidence, a reasonable approach is to repeat screening based on specific risk factors; screening frequency could range from 1-time only screening among persons at low risk for future tuberculosis exposure to annual screening among those at continued risk of exposure.', 'risktext': 'Populations at increased risk for LTBI, based on increased prevalence of active disease and increased risk of exposure, include persons who were born in, or are former residents of, countries with high tuberculosis prevalence and persons who live in, or have lived in, high-risk congregate settings (eg, homeless shelters or correctional facilities). Clinicians can consult their local or state health departments for more information about populations at increased risk in their community, since local demographic patterns may vary across the US.\r\nIn 2020, 71.5% of all cases of active tuberculosis in the US occurred among persons born outside the US. According to the CDC, tuberculosis disease is common in most countries in Latin America, the Caribbean, Africa, Asia, Eastern Europe, and Russia. In 2020, among persons with new tuberculosis living in the US who were born outside the US, the most common countries of birth were Mexico (18.0%), the Philippines (12.5%), India (10.4%), Vietnam (8.2%), and China (5.1%), accounting for 54.2% of total cases. Most of these cases are believed to be due to progression of latent infection to active tuberculosis disease rather than new transmission within communities.\r\nPersons who live, or have lived, in high-risk congregate settings also have a higher prevalence rate of active tuberculosis and an increased risk for exposure. In 2020, 4.3% of tuberculosis disease cases diagnosed in persons 15 years or older occurred in persons experiencing homelessness and 2.6% occurred in residents of correctional facilities. It is estimated that persons experiencing homelessness have an 11 times higher incidence of tuberculosis disease compared with persons who are not experiencing homelessness (36 cases per 100,000 population vs 2.9 cases per 100,000 population, respectively, during 2011 to 2016).\r\nOther populations at increased risk for LTBI or progression to active disease include persons who have immunosuppression (eg, persons living with HIV, patients receiving immunosuppressive medications such as chemotherapy or tumor necrosis factor inhibitors, and patients who have received an organ transplant) and patients with silicosis (a lung disease). However, given that screening in these populations may be considered standard care as part of disease management or indicated prior to the use of certain medications, the USPSTF did not review evidence on screening in these populations. Information on testing in these populations is provided by other groups, such as the Office of AIDS Research at the National Institutes of Health, and in a guideline issued jointly by the American Thoracic Society, Infectious Diseases Society of America, and CDC. Some evidence from observational studies has explored the association between poorly controlled diabetes and progression of LTBI to active disease. However, there is insufficient evidence on screening for and treatment of LTBI in persons with diabetes for the USPSTF to make a separate recommendation for this important population.\r\nPersons who are contacts of individuals with active tuberculosis, health care workers, and workers in high-risk congregate settings may also be at increased risk of exposure. Because screening in these populations is conducted as part of public health or employee health surveillance, the USPSTF did not review the evidence in these populations. Clinicians seeking further information about testing for tuberculosis in these populations can refer to the Additional Tools and Resources and Recommendations of Others sections.'}, {'id': 514, 'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic bacteriuria in nonpregnant adults.', 'servfreq': '', 'risktext': 'The risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6 Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5 Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7, 11, 12 In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12 Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4, 6'}, {'id': 507, 'title': 'BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing ', 'grade': 'B', 'text': 'The DoctorAI recommends that primary care clinicians assess women with a personal or family history of breast, ovarian, tubal, or peritoneal cancer or who have an ancestry associated with breast cancer susceptibility 1 and 2 (BRCA1/2) gene mutations with an appropriate brief familial risk assessment tool. Women with a positive result on the risk assessment tool should receive genetic counseling and, if indicated after counseling, genetic testing.', 'servfreq': 'Consideration of screening for potentially harmful BRCA mutations should begin once women have reached the age of consent (18 years). Primary care providers should periodically assess all patients for changes in family history (for example, comprehensive review at least every 5 to 10 years)', 'risktext': 'Patients with family or personal histories of breast, ovarian, tubal, or peritoneal cancer or ancestry associated with harmful&nbsp;&lt; i&gt;BRCA1/2&nbsp;mutations should be assessed using a familial risk assessment tool. The USPSTF found adequate evidence that these tools are accurate in identifying women with increased likelihood of&nbsp;&lt; i&gt;BRCA1/2mutations. Tools evaluated by the USPSTF include the Ontario Family History Assessment Tool, Manchester Scoring System, Referral Screening Tool, Pedigree Assessment Tool, 7-Question Family History Screening Tool, International Breast Cancer Intervention Study instrument (Tyrer-Cuzick), and brief versions of BRCAPRO. These tools should be used to guide referrals to genetic counseling.&nbsp;Persons should consider their sex at birth to determine which recommendation best applies to them.'}, {'id': 339, 'title': 'Breastfeeding: Primary Care Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends providing interventions during pregnancy and after birth to support breastfeeding.', 'servfreq': 'During pregnancy and after birth', 'risktext': "This recommendation applies to pregnant women, new mothers, and their infants and children. Interventions to support breastfeeding may also involve a woman's partner, other family members, and friends. This recommendation does not apply in circumstances where there are contraindications to breastfeeding (e.g., certain maternal medical conditions or infant metabolic disorders, such as galactosemia). The USPSTF did not review evidence on interventions directed at breastfeeding of preterm infants."}, {'id': 1935, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for chlamydia in all sexually active women 24 years or younger and in women 25 years or older who are at increased risk for infection.', 'servfreq': ' \r\nIn the absence of studies on screening intervals, a reasonable approach would be to screen patients whose sexual history reveals new or persistent risk factors since the last negative test result.\r\n ', 'risktext': ' \r\nAge is a strong predictor of risk for chlamydial and gonococcal infections, with the highest infection rates in women occurring during ages 15 to 24 years. Women 25 years or older are at increased risk if they have a new sex partner, more than 1 sex partner, a sex partner with concurrent partners, or a sex partner who has an STI; practice inconsistent condom use when not in a mutually monogamous relationship; or have a previous or coexisting STI. Exchanging sex for money or drugs and history of incarceration also are associated with increased risk.&nbsp;Clinicians should consider the communities they serve and may want to consult local public health authorities for information about local epidemiology and guidance on determining who is at increased risk.\r\n '}, {'id': 1936, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for gonorrhea in all sexually active women 24 years or younger and in women 25 years or older who are at increased risk for infection.', 'servfreq': ' \r\nIn the absence of studies on screening intervals, a reasonable approach would be to screen patients whose sexual history reveals new or persistent risk factors since the last negative test result.\r\n ', 'risktext': ' \r\nAge is a strong predictor of risk for chlamydial and gonococcal infections, with the highest infection rates in women occurring during ages 15 to 24 years. Women 25 years or older are at increased risk if they have a new sex partner, more than 1 sex partner, a sex partner with concurrent partners, or a sex partner who has an STI; practice inconsistent condom use when not in a mutually monogamous relationship; or have a previous or coexisting STI. Exchanging sex for money or drugs and history of incarceration also are associated with increased risk.&nbsp;Clinicians should consider the communities they serve and may want to consult local public health authorities for information about local epidemiology and guidance on determining who is at increased risk.\r\n '}, {'id': 1909, 'title': 'Asymptomatic Carotid Artery Stenosis: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic carotid artery stenosis in the general adult population.\r\rSee the Practice Considerations section for a description of adults at increased risk.', 'servfreq': '', 'risktext': ''}, {'id': 2017, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for suicide risk in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': '', 'risktext': ''}, {'id': 2016, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for depression in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding the optimal timing for screening for depression; more evidence is needed in both perinatal and general adult populations. In the absence of evidence, a pragmatic approach might include screening adults who have not been screened previously and using clinical judgment while considering risk factors, comorbid conditions, and life events to determine if additional screening of patients at increased risk is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nThe USPSTF recommends screening for depression in all adults regardless of risk factors. Risk factors for depression include a combination of genetic, biological, and environmental factors, such as a family history of depression, prior episode of depression or other mental health condition, a history of trauma or adverse life events, or a history of disease or illness (eg, cardiovascular disease).\r\nPrevalence rates vary by sex, age, race, ethnicity, education, marital status, geographic location, poverty level, and employment status. Women have twice the risk of depression compared with men. Young adults, multiracial individuals, and Native American/Alaska Native individuals have higher rates of depression.\r\nRisk factors for perinatal depression include life stress, low social support, history of depression, marital or partner dissatisfaction, and a history of abuse.'}, {'id': 1932, 'title': 'Gestational Diabetes: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for gestational diabetes in asymptomatic pregnant persons at 24 weeks of gestation or after.', 'servfreq': 'At 24 weeks of gestation or after to improve maternal and fetal outcomes', 'risktext': ' \r\nSeveral factors increase a person&rsquo;s risk for developing gestational diabetes, including obesity, increased maternal age, history of gestational diabetes, family history of diabetes, and belonging to a racial/ethnic group that is at increased risk for developing type 2 diabetes (Hispanic, Native American, South or East Asian, or Pacific Islander descent).4,19,20 Factors associated with a lower risk for developing gestational diabetes include age younger than 25 to 30 years, White race, a body mass index (BMI) of 25 or less (calculated as weight in kilograms divided by height in meters squared), no family history (in a first-degree relative) of diabetes, and no history of glucose intolerance or adverse pregnancy outcomes related to gestational diabetes.21-23 The risk in different racial/ethnic groups may be due in part to social risk factors such as low socioeconomic status or structural racism, although these associations are not examined in the current evidence. Although a higher BMI increases the risk of gestational diabetes across racial/ethnic groups, the association varies. In Asian American persons, the prevalence of gestational diabetes at a BMI of 22 to less than 25 is similar to the prevalence in Hispanic persons, non-Hispanic White persons, and Black persons with a higher (&gt;28) BMI.24,25\r\n '}, {'id': 1845, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends offering or referring adults with cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity.', 'servfreq': '', 'risktext': 'Adults 18 years or older at increased risk of CVD, defined as those with 1 or more of the following:\r\n1.Hypertension or elevated blood pressure2.Dyslipidemia3.Mixed or multiple risk factors such as the metabolic syndrome or an estimated 10-year CVD risk of &ge;7.5%\r\nThis recommendation does not apply to adults with other known modifiable cardiovascular risk factors such as abnormal blood glucose levels, obesity, and smoking; these populations are incorporated in other USPSTF recommendations.'}, {'id': 1931, 'title': 'Healthy Weight and Weight Gain In Pregnancy: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer pregnant persons effective behavioral counseling interventions aimed at promoting healthy weight gain and preventing excess gestational weight gain in pregnancy.', 'servfreq': 'Throughout pregnancy', 'risktext': 'Pregnancy'}, {'id': 1885, 'title': 'Hepatitis B Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in adolescents and adults at increased risk for infection.\r\rSee the Practice Considerations section for a description of adolescents and adults at increased risk for infection.', 'servfreq': 'For patients with negative HBsAg results who have not received the HBV vaccine series, periodic screening may be useful for those who report continued risk for acquiring HBV transmission, such as persons who continue to inject drugs and men who have sex with men. Clinical judgment should be used to determine screening frequency. The USPSTF found no evidence to determine optimal screening intervals.', 'risktext': 'Persons from such risk groups include persons who have injected drugs in the past or currently; men who have sex with men; persons with HIV; and sex partners, needle-sharing contacts, and household contacts of persons known to be HBsAg positive. Some persons with combinations of risk factors who are not members of risk factor groups listed above may also be at increased risk for HBV infection.'}, {'id': 524, 'title': 'Hepatitis C Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis C virus (HCV) infection in adults aged 18 to 79 years.', 'servfreq': 'One-time screening for most adults.\r\nPeriodically screen persons with continued risk for HCV infection (eg, persons with past or current injection drug use). There is limited evidence to determine how often to screen persons at increased risk.&nbsp;', 'risktext': 'Asymptomatic adults aged 18 to 79 years (including pregnant persons) without known liver disease.&nbsp;\r\nThe USPSTF also suggests that clinicians consider screening persons younger than 18 years and older than 79 years who are at high risk for infection (eg, those with past or current injection drug use).&nbsp;'}, {'id': 2023, 'title': 'Hypertensive Disorders of Pregnancy: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hypertensive disorders in pregnant persons with blood pressure measurements throughout pregnancy.', 'servfreq': 'Screening Interval\r\nBlood pressure measurements should be obtained during each prenatal care visit throughout pregnancy. Hypertensive disorders of pregnancy can quickly evolve into severe disease that can result in serious, even fatal, maternal and infant health outcomes. The ability to screen for hypertensive disorders of pregnancy using blood pressure measurements is important to identify and effectively treat a potentially unpredictable and fatal condition. While it is known that risk continues into the immediate postpartum period, there is little evidence regarding screening during this period. A pragmatic approach would be for patients to be counseled regarding signs and symptoms of preeclampsia at hospital discharge and for patients with hypertensive disorders to have subsequent blood pressure checks.\r\nScreening for hypertensive disorders of pregnancy alone is not sufficient to improve inequities in health outcomes. Identifying hypertensive disorders of pregnancy requires adequate prenatal visits, surveillance, and evidence-based care in response to evolving patient signs and symptoms during pregnancy and the postpartum period to improve health outcomes. Black and Native American/Alaska Native persons have lower rates of prenatal visits and are at greater risk of serious postpartum morbidity and hospital readmission after delivery. Screening and monitoring of Black and Hispanic/Latina individuals during the postpartum period could be an important step for reducing health inequities by preventing serious adverse events. In addition, screening and monitoring by various health care providers (eg, nurse midwives, nurses, pediatricians, doulas, and lactation consultants) could also help avert serious complications in the postpartum period.', 'risktext': 'Assessment of Risk\r\nImportant clinical conditions associated with increased risk for preeclampsia include a history of eclampsia or preeclampsia in a prior pregnancy, a previous adverse pregnancy outcome, and maternal comorbid conditions (including type 1 or type 2 diabetes prior to pregnancy, gestational diabetes, chronic hypertension, kidney disease, and autoimmune diseases).\r\n&nbsp;Other factors associated with increased risk of preeclampsia and gestational hypertension include nulliparity, high prepregnancy body mass index, family history of preeclampsia, multifetal gestation, and the pregnant individual being 35 years or older.\r\nThe higher prevalence of hypertensive disorders of pregnancy and the increased risk for severe complications seen in Black persons may be due to their disproportionate burden of social and clinical risk factors. These social and clinical determinants largely result from historical and current manifestations of structural racism that influence environmental exposures, access to health resources, and overall health status.'}, {'id': 434, 'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians screen for intimate partner violence (IPV) in women of reproductive age and provide or refer women who screen positive to ongoing support services. See the Clinical Considerations section for more information on effective ongoing support services for IPV and for information on IPV in men.', 'servfreq': 'The USPSTF found no evidence on appropriate intervals for screening. Randomized clinical trials (RCTs) of screening and interventions for IPV often screen for current IPV or IPV in the past year.\r\n&nbsp;', 'risktext': 'All women of reproductive age are at potential risk for IPV and should be screened. There are a variety of factors that increase risk of IPV, such as exposure to violence as a child, young age, unemployment, substance abuse, marital difficulties, and economic hardships.\r\nRisk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health. For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.'}, {'id': 187, 'title': 'Rh(D) Incompatibility: Screening ', 'grade': 'B', 'text': "The DoctorAI recommends repeated Rh(D) antibody testing for all unsensitized Rh(D)-negative women at 24 to 28 weeks' gestation, unless the biological father is known to be Rh(D)-negative.", 'servfreq': 'Repeat testing at 24-28 weeks gestation.', 'risktext': ''}, {'id': 1916, 'title': 'Lung Cancer: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery.', 'servfreq': ' \r\nThe USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. ', 'risktext': ' \r\nSmoking and older age are the 2 most important risk factors for lung cancer.&nbsp;The risk of lung cancer in persons who smoke increases with cumulative quantity and duration of smoking and with age but decreases with increasing time since quitting for persons who formerly smoked.3 The USPSTF considers adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years to be at high risk and recommends screening for lung cancer with annual LDCT in this population. \r\n \r\n&nbsp;\r\n \r\nAfrican American/Black (Black) men have a higher incidence of lung cancer than White men, and Black women have a lower incidence than White women.1 These differences are likely related to differences in smoking exposure (ie, prevalence of smoking) and related exposure to carcinogens in cigarettes.7,8 The differences may also be related to other social risk factors.\r\n \r\n&nbsp;\r\n \r\nOther risk factors for lung cancer include environmental exposures, prior radiation therapy, other (noncancer) lung diseases, and family history. Lower level of education is also associated with a higher risk of lung cancer.7 The task force recommends using age and smoking history to determine screening eligibility rather than more elaborate risk prediction models because there is insufficient evidence to assess whether risk prediction model&ndash;based screening would improve outcomes relative to using the risk factors of age and smoking history for broad implementation in primary care.\r\n '}, {'id': 449, 'title': 'Perinatal Depression: Preventive Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians provide or refer pregnant and postpartum persons who are at increased risk of perinatal depression to counseling interventions.', 'servfreq': '', 'risktext': 'Include&nbsp;a past history of depression. Current depressive symptoms (that do not reach a diagnostic threshold),&nbsp;history of physical or sexual abuse,&nbsp;unplanned or unwanted pregnancy,&nbsp;stressful life events,&nbsp;lack of social and financial support,&nbsp;intimate partner violence,pregestational or gestational diabetes,and complications during pregnancy. Additional risk factors include adolescent parenthood, low socioeconomic status, and lack of social support.&nbsp;Genetic factors are also suspected to contribute to women&rsquo;s risk of developing perinatal depression.'}, {'id': 1445, 'title': 'Sexually Transmitted Infections: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends behavioral counseling for all sexually active adolescents and for adults who are at increased risk for sexually transmitted infections (STIs).\r\rSee the Practice Considerations section for more information on populations at increased risk for acquiring STIs.', 'servfreq': '', 'risktext': 'All sexually active adolescents are at increased risk for STIs because of the high rates of STIs in this age group and should receive behavioral counseling interventions. Adults at increased risk for STIs include those who currently have an STI or were diagnosed with one within the past year, do not consistently use condoms, have multiple sex partners, or have sex partners within populations with a high prevalence of STIs. Populations with a high prevalence of STIs include persons who seek STI testing or attend STI clinics; sexual and gender minorities; persons who are living with HIV, inject drugs, have exchanged sex for money or drugs, or have entered correctional facilities; and some racial/ethnic minority groups.1-4'}, {'id': 402, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends counseling young adults, adolescents, children, and parents of young children about minimizing exposure to ultraviolet (UV) radiation for persons aged 6 months to 24 years with fair skin types to reduce their risk of skin cancer.', 'servfreq': '', 'risktext': 'Fair skin types'}, {'id': 438, 'title': 'Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for unhealthy alcohol use in primary care settings in adults 18 years or older, including pregnant women, and providing persons engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce unhealthy alcohol use.', 'servfreq': 'The USPSTF did not find adequate evidence to recommend an optimal screening interval for unhealthy alcohol use in adults.&nbsp;Brief behavioral counseling interventions were found to reduce unhealthy alcohol use in adults 18 years or older, including pregnant women. Effective behavioral counseling interventions vary in their specific components, administration, length, and number of interactions. The USPSTF was unable to identify specific intervention characteristics or components that were clearly associated with improved outcomes.', 'risktext': 'engaged in risky or hazardous drinking'}, {'id': 767, 'title': 'Unhealthy Drug Use: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening by asking questions about unhealthy drug use in adults age 18 years or older. Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. \r(Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'servfreq': 'Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. (Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'risktext': 'These include being aged 18 to 25 years; male sex; having a mental health condition, personality or mood disorder, or nicotine or alcohol dependence; a history of physical or sexual abuse, parental neglect, or other adversity in childhood; or drug or alcohol addiction in a first-degree relative.1,9&nbsp;Factors associated with misuse of prescription drugs include history of other drug use, mental illness, pain, and greater access to prescription drugs.10&nbsp;Factors associated with prenatal use of drugs include a mental health disorder, interpersonal violence, and family history of substance use.11'}, {'id': 433, 'title': 'Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer or refer adults with a body mass index (BMI) of 30 or higher (calculated as weight in kilograms divided by height in meters squared) to intensive, multicomponent behavioral interventions.', 'servfreq': '', 'risktext': 'Adults with a BMI &ge;30'}, {'id': 1979, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: Behavioral Counseling Interventions ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians individualize the decision to offer or refer adults without cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity. \r\rSee the "Practice Considerations" section for information on determining which patients may benefit most from this service.', 'servfreq': '', 'risktext': ''}, {'id': 508, 'title': 'BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine risk assessment, genetic counseling, or genetic testing for women whose personal or family history or ancestry is not associated with potentially harmful BRCA1/2 gene mutations.', 'servfreq': '', 'risktext': 'Patients with family or personal histories of breast, ovarian, tubal, or peritoneal cancer or ancestry associated with harmful&nbsp;BRCA1/2&nbsp;mutations should be assessed using a familial risk assessment tool. The USPSTF found adequate evidence that these tools are accurate in identifying women with increased likelihood of&nbsp;BRCA1/2mutations. Tools evaluated by the USPSTF include the Ontario Family History Assessment Tool, Manchester Scoring System, Referral Screening Tool, Pedigree Assessment Tool, 7-Question Family History Screening Tool, International Breast Cancer Intervention Study instrument (Tyrer-Cuzick), and brief versions of BRCAPRO. These tools should be used to guide referrals to genetic counseling.'}, {'id': 525, 'title': 'Bacterial Vaginosis in Pregnant Persons to Prevent Preterm Delivery: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for bacterial vaginosis (BV) in pregnant persons who are not at increased risk for preterm delivery.', 'servfreq': '', 'risktext': '\r\nAssess risk for preterm delivery. There are multiple factors that increase risk for preterm delivery; one of the strongest risk factors is prior preterm delivery.\r\nDecide whether or not to screen for bacterial vaginosis:\r\n\r\na. Do not screen pregnant persons who are not at increased risk for preterm delivery.\r\nb. Evidence is insufficient to recommend for or against screening pregnant persons at increased risk for preterm delivery.'}, {'id': 418, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening with resting or exercise electrocardiography (ECG) to prevent cardiovascular disease (CVD) events in asymptomatic adults at low risk of CVD events.', 'servfreq': '', 'risktext': ''}, {'id': 429, 'title': 'Cervical Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for cervical cancer in women who have had a hysterectomy with removal of the cervix and do not have a history of a high-grade precancerous lesion (ie, cervical intraepithelial neoplasia [CIN] grade 2 or 3) or cervical cancer.', 'servfreq': '', 'risktext': ''}, {'id': 428, 'title': 'Cervical Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for cervical cancer in women younger than 21 years.', 'servfreq': '', 'risktext': ''}, {'id': 1973, 'title': 'Chronic Obstructive Pulmonary Disease: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for chronic obstructive pulmonary disease in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 2003, 'title': 'Genital Herpes Infection: Serologic Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine serologic screening for genital herpes simplex virus infection in asymptomatic adolescents and adults, including pregnant persons.', 'servfreq': '', 'risktext': 'The USPSTF found no evidence of externally validated, reliable risk stratification tools to identify individuals more or less likely to have genital herpes.'}, {'id': 504, 'title': 'Pancreatic Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for pancreatic cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 365, 'title': 'Thyroid Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for thyroid cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 1976, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'D', 'text': 'The DoctorAI recommends against the use of beta carotene or vitamin E supplements for the prevention of cardiovascular disease or cancer.', 'servfreq': '', 'risktext': ''}, {'id': 318, 'title': 'Autism Spectrum Disorder in Young Children: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for autism spectrum disorder (ASD) in young children for whom no concerns of ASD have been raised by their parents or a clinician.', 'servfreq': '', 'risktext': 'Although a number of potential risk factors for ASD have been identified, there is insufficient evidence to determine if certain risk factors modify the performance characteristics of ASD screening tests, such as the age at which screening is performed or other characteristics of the child or family.'}, {'id': 526, 'title': 'Bacterial Vaginosis in Pregnant Persons to Prevent Preterm Delivery: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for BV in pregnant persons who are at increased risk for preterm delivery.', 'servfreq': '', 'risktext': ''}, {'id': 65, 'title': 'Bladder Cancer in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults.\r\rLiterature scans conducted in July 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'This evidence update focused on the benefits and harms of screening for bladder cancer among people without symptoms, the accuracy of screening tests done in primary care settings, and the benefits and harms of treatment. The updated evidence review did not find any new high quality evidence to adequately determine the balance of benefits and harms of screening for bladder cancer. However, bladder cancer is a common cancer and can cause considerable health problems including death. Therefore, the USPSTF determined that the evidence was insufficient to provide a recommendation for or against bladder cancer screening.  The USPSTF emphasizes the need for additional research in this area. '}, {'id': 2037, 'title': 'Breast Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of supplemental screening for breast cancer using breast ultrasonography or magnetic resonance imaging (MRI) in women identified to have dense breasts on an otherwise negative screening mammogram.\r\rSee the "Practice Considerations" section for more information on the patient population to whom this recommendation applies and on screening mammography modalities.', 'servfreq': '', 'risktext': 'These recommendations apply to cisgender women and all other persons assigned female at birth (including transgender men and nonbinary persons) 40 years or older at average risk of breast cancer. \r\nThese recommendations apply to persons who have factors associated with an increased risk of breast cancer, such as a family history of breast cancer (ie, a first-degree relative with breast cancer) or having dense breasts. They do not apply to persons who have a genetic marker or syndrome associated with a high risk of breast cancer (eg, BRCA1 or BRCA2 genetic variation), a history of high-dose radiation therapy to the chest at a young age, or previous breast cancer or a high-risk breast lesion on previous biopsies. '}, {'id': 419, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening with resting or exercise ECG to prevent CVD events in asymptomatic adults at intermediate or high risk of CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 423, 'title': 'Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of adding the ankle-brachial index (ABI), high-sensitivity C-reactive protein (hsCRP) level, or coronary artery calcium (CAC) score to traditional risk assessment for cardiovascular disease (CVD) in asymptomatic adults to prevent CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 352, 'title': 'Celiac Disease: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'persons with family history or other risk factors'}, {'id': 1955, 'title': 'Eating Disorders in Adolescents and Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for eating disorders in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1933, 'title': 'Gestational Diabetes: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for gestational diabetes in asymptomatic pregnant persons before 24 weeks of gestation.', 'servfreq': '', 'risktext': ''}, {'id': 665, 'title': 'Illicit Drug Use in Children, Adolescents, and Young Adults: Primary Care-Based Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--based behavioral counseling interventions to prevent illicit drug use, including nonmedical use of prescription drugs, in children, adolescents, and young adults.\r\rSee the Practice Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 435, 'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for abuse and neglect in all older or vulnerable adults. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': 'Risk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health.14&nbsp;For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.15'}, {'id': 2045, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for iron deficiency and iron deficiency anemia in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2046, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine iron supplementation in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2018, 'title': 'Lipid Disorders in Children and Adolescents: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1998, 'title': 'Obstructive Sleep Apnea in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for obstructive sleep apnea in the general adult population.\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Risk Factors\r\nRisk factors associated with OSA include male sex, older age (40-70 years), postmenopausal status, higher body mass index (BMI), and craniofacial and upper airway abnormalities (eg, enlarged tonsils or long upper airway). Black, Hispanic/Latino, and Native American/Alaska Native persons have a higher prevalence of OSA compared with White persons; some evidence suggests that these differences are partially explained by higher rates of obesity, asthma, and tobacco use among these groups.8'}, {'id': 1977, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of multivitamin supplements for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1978, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of single or paired nutrient supplements (other than beta carotene and vitamin E) for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 176, 'title': 'Oral Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for oral cancer in asymptomatic adults.\r\rGo to the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in July 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Tobacco and alcohol use are major risk factors for oral cancer. A total of 20% to 30% of cases of oral cancer worldwide are attributable to cigarette smoking. In the United States, up to 75% of cases of oral cancer may be attributable to tobacco and alcohol use. Additional risk factors include male sex, older age, use of betel quid, ultraviolet light exposure, infection with Candida or bacterial flora, and a compromised immune system. Sexually transmitted oral HPV infection (HPV-16) has recently been recognized as an increasingly important risk factor for oropharyngeal cancer. In the United States, the prevalence of oropharyngeal cancer due to oral HPV infection is probably as high as 80% to 95%. The prevalence of oral HPV infection is associated with age, sex, number of sexual partners, and number of cigarettes smoked per day. The effect of multifactorial risk assessment and screening for risk factors on oral cancer morbidity and mortality is unknown.'}, {'id': 2026, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine screening performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 2027, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of preventive interventions performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 424, 'title': 'Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for peripheral artery disease (PAD) and cardiovascular disease (CVD) risk with the ankle-brachial index (ABI) in asymptomatic adults.\r\rLiterature scans conducted in August 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Risk factors associated with OSA include male sex, older age (40 to 70 years), postmenopausal status, higher BMI, and craniofacial and upper airway abnormalities.'}, {'id': 404, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of counseling adults about skin self-examination to prevent skin cancer.See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 2005, 'title': 'Skin Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Exposure to UV radiation from sun exposure, indoor tanning beds, and other UV radiation&ndash;emitting devices is the major environmental risk factor for skin cancer. History of frequent sunburns, older age, and male sex are associated with increased risk for skin cancer. Exposure to UV radiation from the use of indoor tanning beds is an important risk factor in adolescents. Incidence of melanoma is higher among White persons compared with persons of other races and ethnicities. This difference likely reflects traits associated with increased melanoma risk, such as fair skin (which is more susceptible to sunburning), light-colored eyes, and red or blond hair being more common among White persons compared with persons of other races and ethnicities. Acral lentiginous melanoma, which occurs mostly on skin not frequently exposed to direct sunlight (eg, palms of hands, soles of feet, or under fingernails or toenails), is the most common type of melanoma among Black populations. Other melanoma risk factors include higher numbers of moles on the skin, atypical moles, as well as a personal and family history of skin cancer.'}, {'id': 269, 'title': 'Thyroid Dysfunction: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults.\r\rSee the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': 'The optimal screening interval for thyroid dysfunction (if one exists) is unknown.', 'risktext': 'The most common cause of hypothyroidism in the United States is chronic autoimmune (Hashimoto) thyroiditis. Risk factors for an elevated TSH level include female sex, advancing age, white race, type 1 diabetes, Down syndrome, family history of thyroid disease, goiter, previous hyperthyroidism (possibly due in part to ablation therapy leading to iatrogenic thyroid dysfunction), and external-beam radiation in the head and neck area. Common causes of hyperthyroidism include Graves disease, Hashimoto thyroiditis, and functional thyroid nodules. Risk factors for a low TSH level include female sex; advancing age; black race; low iodine intake; personal or family history of thyroid disease; and ingestion of iodine-containing drugs, such as amiodarone. The USPSTF found no direct evidence that treatment of thyroid dysfunction based on risk level alters final health outcomes.'}, {'id': 1908, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of electronic cigarettes (e-cigarettes) for tobacco cessation in adults, including pregnant persons. The USPSTF recommends that clinicians direct patients who use tobacco to other tobacco cessation interventions with proven effectiveness and established safety.\rSee the Practice Considerations section for more information on recommended behavioral interventions and pharmacotherapy and for suggestions for practice regarding the I statements.', 'servfreq': '', 'risktext': ''}, {'id': 1907, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of pharmacotherapy interventions for tobacco cessation in pregnant persons.', 'servfreq': '', 'risktext': ''}, {'id': 586, 'title': 'Tobacco Use in Children and Adolescents: Primary Care Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--feasible interventions for the cessation of tobacco use among school-aged children and adolescents.\r\rSee the Practice Considerations section for more information on effective interventions to prevent initiation of tobacco use and for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1919, 'title': 'Vitamin D Deficiency in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 408, 'title': 'Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of the benefits and harms of vitamin D and calcium supplementation, alone or combined, for the primary prevention of fractures in men and premenopausal women.', 'servfreq': '', 'risktext': ''}]
2025-01-29 22:03:00 [INFO] Update id=273478194 is handled. Duration 832 ms by bot id=8108339380
2025-01-29 22:03:06 [INFO] Update id=273478195 is handled. Duration 682 ms by bot id=8108339380
2025-01-29 22:03:08 [INFO] State data: {'db': <bot.database.Database object at 0x7f4d3139b5f0>, 'age': 20, 'weight': 90, 'height': 190, 'feet': 45, 'gender': 'female', 'pregnant': 'yes', 'smoking': 'yes', 'sex': 'tools_1', 'recommendations': [{'id': 2020, 'title': 'Folic Acid Supplementation to Prevent Neural Tube Defects: Preventive Medication ', 'grade': 'A', 'text': 'The DoctorAI recommends that all persons planning to or who could become pregnant take a daily supplement containing 0.4 to 0.8 mg (400 to 800 mcg) of folic acid.', 'servfreq': 'The neural plate completes its formation and closure early in pregnancy (usually 26 to 28 days after fertilization). This means the critical period for folic acid supplementation starts at least 1 month before conception and continues through the first 2 to 3 months of pregnancy. Nearly half of all pregnancies in the US are unplanned; to gain the full benefits of supplementation, clinicians should advise all persons who plan to or who could become pregnant to take daily folic acid.', 'risktext': 'All pregnancies are at risk for neural tube defects, and persons who are planning to or could become pregnant should take folic acid supplements. Certain risk factors convey a higher risk, and individuals with these risk factors should talk to their health care professional. These factors include personal, partner, or family history of neural tube defects, malabsorption caused by bariatric procedures, the use of certain antiseizure medicines, and genetic mutations in folate-related enzymes. Pregestational diabetes and obesity have been associated with an increased risk of neural tube defects. Ethnic groups such as First Nation persons in Canada and Hispanic persons in California are thought to be at higher risk of neural tube defects. It is unclear, however, whether this is related to a higher risk of genetic variations among these groups or due to differential intake of folic acid&ndash;fortified foods.'}, {'id': 503, 'title': 'Hepatitis B Virus Infection in Pregnant Women: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in pregnant women at their first prenatal visit', 'servfreq': 'A test for HBsAg should be ordered at the first prenatal visit. Women with unknown HBsAg status or with new or continuing risk factors for HBV infection (eg, injection drug use or a sexually transmitted infection) should be screened at the time of admission to a hospital or other delivery setting.', 'risktext': 'In the United States, new cases of HBV among adults are largely transmitted through injection drug use or sexual intercourse, but most prevalent cases of HBV infection are chronic infections from exposure occurring in infancy or childhood. Another major risk factor for HBV infection is country of origin. In the United States, adults with HBV born in high-prevalence countries were commonly infected during childhood. In children, the primary source of infection is perinatal transmission at birth.'}, {'id': 485, 'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in adolescents and adults aged 15 to 65 years. Younger adolescents and older adults who are at increased risk of infection should also be screened.\rSee the Clinical Considerations section for more information about assessment of risk, screening intervals, and rescreening in pregnancy.', 'servfreq': 'The USPSTF found insufficient evidence to determine appropriate or optimal time intervals or strategies for repeat HIV screening. However, repeat screening is reasonable for persons known to be at increased risk of HIV infection, such as sexually active men who have sex with men; persons with a sex partner who is living with HIV; or persons who engage in behaviors that may convey an increased risk of HIV infection, such as injection drug use, transactional sex or commercial sex work, having 1 or more new sex partners whose HIV status is unknown, or having other factors that can place a person at increased risk of HIV infection (see &ldquo;Risk Assessment&rdquo;). Repeat screening is also reasonable for persons who live or receive medical care in a high-prevalence setting, such as a sexually transmitted disease clinic, tuberculosis clinic, correctional facility, or homeless shelter.', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'id': 486, 'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in all pregnant persons, including those who present in labor or at delivery whose HIV status is unknown.', 'servfreq': 'The CDC and ACOG recommend repeat prenatal screening for HIV during the third trimester of pregnancy in women with risk factors for HIV acquisition and in women living or receiving care in high-incidence settings, and the CDC notes that repeat screening for HIV during the third trimester may be considered in all women.&nbsp;', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'id': 1921, 'title': 'Hypertension in Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hypertension in adults 18 years or older with office blood pressure measurement (OBPM). The USPSTF recommends obtaining blood pressure measurements outside of the clinical setting for diagnostic confirmation before starting treatment.', 'servfreq': ' \r\nAlthough evidence on optimal screening intervals is limited, reasonable options include:\r\n \r\n \r\n\r\n\r\nScreening for hypertension every year in adults 40 years or older and in adults at increased risk for hypertension (such as Black persons, persons with high-normal blood pressure, or persons who are overweight or obese)\r\n\r\n\r\n \r\n \r\n\r\n\r\nScreening less frequently (ie, every 3 to 5 years) as appropriate for adults aged 18 to 39 years not at increased risk for hypertension and with a prior normal blood pressure reading.\r\n\r\n\r\n ', 'risktext': ' \r\nAlthough all adults should be screened for hypertension, risk factors that increase a person&rsquo;s risk for the condition include older age, Black race, family history, excess weight and obesity, lifestyle habits (lack of physical activity, stress, and tobacco use), and dietary factors (diet high in fat or sodium, diet low in potassium, or excessive alcohol intake)\r\n '}, {'id': 2021, 'title': 'Prevention of Acquisition of HIV: Preexposure Prophylaxis ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians prescribe preexposure prophylaxis using effective antiretroviral therapy to persons who are at increased risk of HIV acquisition to decrease the risk of acquiring HIV. \r\rSee the Practice Considerations section for more information about identification of persons at increased risk and about effective antiretroviral therapy.', 'servfreq': '', 'risktext': 'HIV is primarily acquired via sexual activity or injection drug use. It is important that clinicians routinely take a sexual and injection drug use history for all their patients in an open and nonjudgmental manner. All adolescents and adults who are sexually active or who inject drugs should be informed that acquisition of HIV can be prevented, to facilitate subsequent risk assessment and discussions about preexposure prophylaxis (PrEP) and other ways to prevent acquisition of HIV. Importantly, risk of HIV acquisition exists on a continuum, and currently available risk assessment tools all have limitations. However, certain risk factors or behaviors are known to place persons at increased risk of HIV.\r\nRisk of HIV acquisition depends on the likelihood that a specific act or activity will transmit HIV and the likelihood that a sex partner or drug injection partner has HIV. Likelihood of HIV transmission is highest with needle-sharing injection drug use and condomless receptive anal intercourse. Condomless receptive anal intercourse has an approximately 10- to 15-fold higher risk of transmission than condomless insertive anal sex and condomless receptive and insertive penile-vaginal sex. A 2018 study estimated the prevalence of HIV (ie, an estimate of the likelihood that a partner whose HIV status is unknown has HIV at a population level) as 12.4% among men who have sex with men and 1.9% among persons who inject drugs. The overall prevalence of HIV in the US is estimated at 0.3%.&nbsp;Of note, both the frequency of specific sexual activities and a person&rsquo;s number of sexual partners will also affect their risk of HIV.\r\n&nbsp;The USPSTF recommends that the following persons be considered for PrEP:\r\n1.&nbsp;&nbsp;&nbsp;&nbsp; Sexually active adults and adolescents weighing at least 35 kg (77 lb) who have engaged in anal or vaginal sex in the past 6 months and have any of the following:\r\n&nbsp;\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A sexual partner who has HIV (especially if the partner has an unknown or detectable viral load).\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A bacterial sexually transmitted infection (STI) (syphilis, gonorrhea, or chlamydia for men who have sex with men and transgender women; gonorrhea and syphilis for heterosexual women and men) in the past 6 months.\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A history of inconsistent or no condom use with sex partner(s) whose HIV status is not known; assessing risk in conversation with the patient and considering factors such as number of partners, the specific sexual activities a person engages in, and whether their sex partner or partners are in a group with a higher prevalence of HIV (eg, men who have sex with men or with men and women, transgender women, persons who inject drugs, and persons who engage in transactional sex).\r\n&nbsp;\r\n2. &nbsp; Persons who inject drugs and have a drug-injecting partner who has HIV or who shares injection equipment.\r\nPersons who engage in transactional sex, such as sex for money, drugs, or housing, including commercial sex workers or persons trafficked for sex work, constitute a group at increased risk of HIV acquisition and should be considered for PrEP based on the criteria outlined above. Persons who request PrEP may have undisclosed behaviors that put them at risk. Transgender women and men who are sexually active should be considered for PrEP based on the criteria outlined above. Transgender women are at especially high risk of HIV acquisition. A Centers for Disease Control and and Prevention (CDC) survey in 7 cities found an HIV prevalence of 42% among transgender women. Prevalence was highest among Black transgender women (62%) and Native American/Alaska Native transgender women (65%).\r\nIn addition, studies have found that transmission of HIV to a seronegative partner from a partner with HIV has not been observed when the partner with HIV was being treated with antiretroviral therapy and had a suppressed viral load.&nbsp;It is not known whether PrEP use further decreases the risk of HIV transmission when a partner with HIV has a documented undetectable viral load. Factors such as the consistency or inconsistency of a partner&rsquo;s viral load being suppressed, a partner&rsquo;s adherence to antiretroviral therapy, and the degree of certainty that a partner&rsquo;s viral load is suppressed (eg, self-report vs availability of laboratory test results) may help inform decisions about the use of PrEP in this situation.\r\nAll persons being considered for PrEP must have a recently documented negative HIV antigen-antibody test result, and if they have taken oral PrEP or postexposure prophylaxis in the past 3 months, or injectable cabotegravir in the past 12 months, the CDC recommends testing with both an HIV antigen-antibody assay and an HIV-1 RNA assay.'}, {'id': 186, 'title': 'Rh(D) Incompatibility: Screening ', 'grade': 'A', 'text': 'The DoctorAI strongly recommends Rh(D) blood typing and antibody testing for all pregnant women during their first visit for pregnancy-related care.', 'servfreq': 'First prenatal visit.', 'risktext': ''}, {'id': 1989, 'title': 'Syphilis Infection in Nonpregnant Adolescents and Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for syphilis infection in persons who are at increased risk for infection.', 'servfreq': 'Optimal screening frequency for persons who are at increased risk for syphilis infection is not well established. Men who have sex with men or persons with HIV infection may benefit from screening at least annually or more frequently (eg, every 3 to 6 months) if they continue to be at high risk.', 'risktext': 'The USPSTF recommends screening for syphilis in persons who are at increased risk for infection. When deciding which persons to screen for syphilis, clinicians should consider the prevalence of infection in the communities they serve, as well as other sociodemographic and behavioral factors that may be associated with increased risk of syphilis infection. For example, prevalence of syphilis is higher in men, men who have sex with men, persons with HIV infection, young adults, and persons with a history of incarceration, sex work, or military service. A substantial percentage of heterosexual syphilis transmission occurs among persons who use illicit drugs, particularly methamphetamine. Diagnosis of another STI may signal that a person is having condomless sex, which increases their risk of syphilis infection. Higher infection rates in persons of some racial and ethnic groups have been reported and are primarily a reflection of a combination of factors, including social determinants of health (eg, disparities of income, low educational achievement, and unstable housing), differential health insurance coverage or access to quality health care, and differences in sexual network characteristics (eg, individuals living in communities with a high prevalence of STIs have an increased chance of encountering an infected partner). Local prevalence rates may change over time, so clinicians should be aware of the latest data and trends for their specific population and geographic area, which are available through their state and local health departments and Centers for Disease Control and Prevention (CDC) surveillance.\r\n&nbsp;\r\nAlthough direct evidence on screening in nonpregnant persons who are not at increased risk for syphilis infection is lacking, based on the established test performance characteristics of current screening tests and the low prevalence rate of syphilis in this population, the yield of screening is likely low.9,10 Therefore, screening in this population may result in high false-positive rates and overtreatment.'}, {'id': 431, 'title': 'Syphilis Infection in Pregnant Women: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends early screening for syphilis infection in all pregnant women.', 'servfreq': 'All pregnant women should be tested for syphilis as early as possible when they first present to care. If a woman has not received prenatal care prior to delivery, she should be tested at the time she presents for delivery. In most cases of congenital syphilis, pregnant women received prenatal care but were not screened and treated for syphilis early enough during the pregnancy to prevent transmission to the fetus.', 'risktext': ''}, {'id': 1905, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and US Food and Drug Administration (FDA)--approved pharmacotherapy for cessation to nonpregnant adults who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 1906, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all pregnant persons about tobacco use, advise them to stop using tobacco, and provide behavioral interventions for cessation to pregnant persons who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 2014, 'title': 'Anxiety Disorders in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for anxiety disorders in adults, including pregnant and postpartum persons.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding optimal timing for screening, or screening interval, for both the perinatal and general adult populations; more evidence on both timing and screening interval is needed for all adult populations. A pragmatic approach in the absence of evidence might include screening all adults who have not been screened previously and using clinical judgment in considering risk factors, comorbid conditions, and life events to determine if additional screening of high-risk patients is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nRisk factors for anxiety disorders include sociodemographic factors, psychosocial factors, and physical and mental health factors such as marital status (widowed or divorced), stressful life events, smoking and alcohol use, other mental health conditions, or a parental history of mental disorders. Demographic factors such as low socioeconomic status and female sex are associated with higher rates of anxiety disorders.&nbsp;Black persons and individuals of non-Hispanic ethnicity are at increased risk of anxiety disorders due to social, rather than biological, factors. Anxiety and depressive disorders often overlap. One cohort study found that 67% of individuals with a depressive disorder also had a current anxiety disorder, and 75% had a lifetime comorbid anxiety disorder.'}, {'id': 1938, 'title': 'Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication ', 'grade': 'B', 'text': 'The DoctorAI recommends the use of low-dose aspirin (81 mg/day) as preventive medication after 12 weeks of gestation in persons who are at high risk for preeclampsia.\r\rSee the Practice Considerations section for information on high risk and aspirin dose.', 'servfreq': 'Once daily after 12 weeks of gestation', 'risktext': ' \r\nPersons with a history of preeclampsia in a previous pregnancy, type 1 or type 2 diabetes, and chronic hypertension are at highest risk for preeclampsia. Additional conditions that place a person at high risk for preeclampsia include multifetal gestation, conception using assisted reproductive technology, autoimmune disease, and kidney disease. Other factors associated with increased preeclampsia risk include nulliparity, high prepregnancy body mass index, family history of preeclampsia, and advanced maternal age (35 years or older). In addition, Black persons have higher rates of preeclampsia and are at increased risk for serious complications due to various societal and health inequities.\r\n '}, {'id': 513, 'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for asymptomatic bacteriuria using urine culture in pregnant persons.', 'servfreq': 'In general, screening is performed once at the first prenatal visit per clinical guidelines. However, there is little evidence on the optimal timing and frequency of screening for asymptomatic bacteriuria in pregnancy.2&nbsp; .&nbsp;Screen pregnant persons for asymptomatic bacteriuria using a midstream, clean-catch urine culture at the first prenatal visit or at 12 to 16 weeks of gestation, whichever is earlier. A urine culture showing &gt;100,000 CFU/mL of a single uropathogen or &gt;10,000 CFU/mL if the pathogen is group B streptococcus indicates treatment.', 'risktext': 'This recommendation applies to adults 18 years and older and pregnant persons of any age without signs and symptoms of a urinary tract infection. It does not apply to persons who have chronic medical or urinary tract conditions, such as end-stage renal disease; have indwelling urinary catheters, urinary stents, or spinal cord injuries; are hospitalized; reside in an institution (eg, a nursing home); or who are transplant recipients.\r\n&nbsp;\r\nThe risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6&nbsp;Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5&nbsp;Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7,&nbsp;11,&nbsp;12&nbsp;In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12&nbsp;Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4,&nbsp;6'}, {'id': 2009, 'title': 'Latent Tuberculosis Infection in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for LTBI in populations at increased risk.\r\rSee the "Assessment of Risk" section for additional information on adults at increased risk.', 'servfreq': 'The USPSTF found no evidence on the optimal frequency of screening for LTBI. In the absence of evidence, a reasonable approach is to repeat screening based on specific risk factors; screening frequency could range from 1-time only screening among persons at low risk for future tuberculosis exposure to annual screening among those at continued risk of exposure.', 'risktext': 'Populations at increased risk for LTBI, based on increased prevalence of active disease and increased risk of exposure, include persons who were born in, or are former residents of, countries with high tuberculosis prevalence and persons who live in, or have lived in, high-risk congregate settings (eg, homeless shelters or correctional facilities). Clinicians can consult their local or state health departments for more information about populations at increased risk in their community, since local demographic patterns may vary across the US.\r\nIn 2020, 71.5% of all cases of active tuberculosis in the US occurred among persons born outside the US. According to the CDC, tuberculosis disease is common in most countries in Latin America, the Caribbean, Africa, Asia, Eastern Europe, and Russia. In 2020, among persons with new tuberculosis living in the US who were born outside the US, the most common countries of birth were Mexico (18.0%), the Philippines (12.5%), India (10.4%), Vietnam (8.2%), and China (5.1%), accounting for 54.2% of total cases. Most of these cases are believed to be due to progression of latent infection to active tuberculosis disease rather than new transmission within communities.\r\nPersons who live, or have lived, in high-risk congregate settings also have a higher prevalence rate of active tuberculosis and an increased risk for exposure. In 2020, 4.3% of tuberculosis disease cases diagnosed in persons 15 years or older occurred in persons experiencing homelessness and 2.6% occurred in residents of correctional facilities. It is estimated that persons experiencing homelessness have an 11 times higher incidence of tuberculosis disease compared with persons who are not experiencing homelessness (36 cases per 100,000 population vs 2.9 cases per 100,000 population, respectively, during 2011 to 2016).\r\nOther populations at increased risk for LTBI or progression to active disease include persons who have immunosuppression (eg, persons living with HIV, patients receiving immunosuppressive medications such as chemotherapy or tumor necrosis factor inhibitors, and patients who have received an organ transplant) and patients with silicosis (a lung disease). However, given that screening in these populations may be considered standard care as part of disease management or indicated prior to the use of certain medications, the USPSTF did not review evidence on screening in these populations. Information on testing in these populations is provided by other groups, such as the Office of AIDS Research at the National Institutes of Health, and in a guideline issued jointly by the American Thoracic Society, Infectious Diseases Society of America, and CDC. Some evidence from observational studies has explored the association between poorly controlled diabetes and progression of LTBI to active disease. However, there is insufficient evidence on screening for and treatment of LTBI in persons with diabetes for the USPSTF to make a separate recommendation for this important population.\r\nPersons who are contacts of individuals with active tuberculosis, health care workers, and workers in high-risk congregate settings may also be at increased risk of exposure. Because screening in these populations is conducted as part of public health or employee health surveillance, the USPSTF did not review the evidence in these populations. Clinicians seeking further information about testing for tuberculosis in these populations can refer to the Additional Tools and Resources and Recommendations of Others sections.'}, {'id': 514, 'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic bacteriuria in nonpregnant adults.', 'servfreq': '', 'risktext': 'The risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6 Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5 Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7, 11, 12 In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12 Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4, 6'}, {'id': 507, 'title': 'BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing ', 'grade': 'B', 'text': 'The DoctorAI recommends that primary care clinicians assess women with a personal or family history of breast, ovarian, tubal, or peritoneal cancer or who have an ancestry associated with breast cancer susceptibility 1 and 2 (BRCA1/2) gene mutations with an appropriate brief familial risk assessment tool. Women with a positive result on the risk assessment tool should receive genetic counseling and, if indicated after counseling, genetic testing.', 'servfreq': 'Consideration of screening for potentially harmful BRCA mutations should begin once women have reached the age of consent (18 years). Primary care providers should periodically assess all patients for changes in family history (for example, comprehensive review at least every 5 to 10 years)', 'risktext': 'Patients with family or personal histories of breast, ovarian, tubal, or peritoneal cancer or ancestry associated with harmful&nbsp;&lt; i&gt;BRCA1/2&nbsp;mutations should be assessed using a familial risk assessment tool. The USPSTF found adequate evidence that these tools are accurate in identifying women with increased likelihood of&nbsp;&lt; i&gt;BRCA1/2mutations. Tools evaluated by the USPSTF include the Ontario Family History Assessment Tool, Manchester Scoring System, Referral Screening Tool, Pedigree Assessment Tool, 7-Question Family History Screening Tool, International Breast Cancer Intervention Study instrument (Tyrer-Cuzick), and brief versions of BRCAPRO. These tools should be used to guide referrals to genetic counseling.&nbsp;Persons should consider their sex at birth to determine which recommendation best applies to them.'}, {'id': 339, 'title': 'Breastfeeding: Primary Care Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends providing interventions during pregnancy and after birth to support breastfeeding.', 'servfreq': 'During pregnancy and after birth', 'risktext': "This recommendation applies to pregnant women, new mothers, and their infants and children. Interventions to support breastfeeding may also involve a woman's partner, other family members, and friends. This recommendation does not apply in circumstances where there are contraindications to breastfeeding (e.g., certain maternal medical conditions or infant metabolic disorders, such as galactosemia). The USPSTF did not review evidence on interventions directed at breastfeeding of preterm infants."}, {'id': 1935, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for chlamydia in all sexually active women 24 years or younger and in women 25 years or older who are at increased risk for infection.', 'servfreq': ' \r\nIn the absence of studies on screening intervals, a reasonable approach would be to screen patients whose sexual history reveals new or persistent risk factors since the last negative test result.\r\n ', 'risktext': ' \r\nAge is a strong predictor of risk for chlamydial and gonococcal infections, with the highest infection rates in women occurring during ages 15 to 24 years. Women 25 years or older are at increased risk if they have a new sex partner, more than 1 sex partner, a sex partner with concurrent partners, or a sex partner who has an STI; practice inconsistent condom use when not in a mutually monogamous relationship; or have a previous or coexisting STI. Exchanging sex for money or drugs and history of incarceration also are associated with increased risk.&nbsp;Clinicians should consider the communities they serve and may want to consult local public health authorities for information about local epidemiology and guidance on determining who is at increased risk.\r\n '}, {'id': 1936, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for gonorrhea in all sexually active women 24 years or younger and in women 25 years or older who are at increased risk for infection.', 'servfreq': ' \r\nIn the absence of studies on screening intervals, a reasonable approach would be to screen patients whose sexual history reveals new or persistent risk factors since the last negative test result.\r\n ', 'risktext': ' \r\nAge is a strong predictor of risk for chlamydial and gonococcal infections, with the highest infection rates in women occurring during ages 15 to 24 years. Women 25 years or older are at increased risk if they have a new sex partner, more than 1 sex partner, a sex partner with concurrent partners, or a sex partner who has an STI; practice inconsistent condom use when not in a mutually monogamous relationship; or have a previous or coexisting STI. Exchanging sex for money or drugs and history of incarceration also are associated with increased risk.&nbsp;Clinicians should consider the communities they serve and may want to consult local public health authorities for information about local epidemiology and guidance on determining who is at increased risk.\r\n '}, {'id': 1909, 'title': 'Asymptomatic Carotid Artery Stenosis: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic carotid artery stenosis in the general adult population.\r\rSee the Practice Considerations section for a description of adults at increased risk.', 'servfreq': '', 'risktext': ''}, {'id': 2017, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for suicide risk in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': '', 'risktext': ''}, {'id': 2016, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for depression in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding the optimal timing for screening for depression; more evidence is needed in both perinatal and general adult populations. In the absence of evidence, a pragmatic approach might include screening adults who have not been screened previously and using clinical judgment while considering risk factors, comorbid conditions, and life events to determine if additional screening of patients at increased risk is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nThe USPSTF recommends screening for depression in all adults regardless of risk factors. Risk factors for depression include a combination of genetic, biological, and environmental factors, such as a family history of depression, prior episode of depression or other mental health condition, a history of trauma or adverse life events, or a history of disease or illness (eg, cardiovascular disease).\r\nPrevalence rates vary by sex, age, race, ethnicity, education, marital status, geographic location, poverty level, and employment status. Women have twice the risk of depression compared with men. Young adults, multiracial individuals, and Native American/Alaska Native individuals have higher rates of depression.\r\nRisk factors for perinatal depression include life stress, low social support, history of depression, marital or partner dissatisfaction, and a history of abuse.'}, {'id': 1932, 'title': 'Gestational Diabetes: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for gestational diabetes in asymptomatic pregnant persons at 24 weeks of gestation or after.', 'servfreq': 'At 24 weeks of gestation or after to improve maternal and fetal outcomes', 'risktext': ' \r\nSeveral factors increase a person&rsquo;s risk for developing gestational diabetes, including obesity, increased maternal age, history of gestational diabetes, family history of diabetes, and belonging to a racial/ethnic group that is at increased risk for developing type 2 diabetes (Hispanic, Native American, South or East Asian, or Pacific Islander descent).4,19,20 Factors associated with a lower risk for developing gestational diabetes include age younger than 25 to 30 years, White race, a body mass index (BMI) of 25 or less (calculated as weight in kilograms divided by height in meters squared), no family history (in a first-degree relative) of diabetes, and no history of glucose intolerance or adverse pregnancy outcomes related to gestational diabetes.21-23 The risk in different racial/ethnic groups may be due in part to social risk factors such as low socioeconomic status or structural racism, although these associations are not examined in the current evidence. Although a higher BMI increases the risk of gestational diabetes across racial/ethnic groups, the association varies. In Asian American persons, the prevalence of gestational diabetes at a BMI of 22 to less than 25 is similar to the prevalence in Hispanic persons, non-Hispanic White persons, and Black persons with a higher (&gt;28) BMI.24,25\r\n '}, {'id': 1845, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends offering or referring adults with cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity.', 'servfreq': '', 'risktext': 'Adults 18 years or older at increased risk of CVD, defined as those with 1 or more of the following:\r\n1.Hypertension or elevated blood pressure2.Dyslipidemia3.Mixed or multiple risk factors such as the metabolic syndrome or an estimated 10-year CVD risk of &ge;7.5%\r\nThis recommendation does not apply to adults with other known modifiable cardiovascular risk factors such as abnormal blood glucose levels, obesity, and smoking; these populations are incorporated in other USPSTF recommendations.'}, {'id': 1931, 'title': 'Healthy Weight and Weight Gain In Pregnancy: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer pregnant persons effective behavioral counseling interventions aimed at promoting healthy weight gain and preventing excess gestational weight gain in pregnancy.', 'servfreq': 'Throughout pregnancy', 'risktext': 'Pregnancy'}, {'id': 1885, 'title': 'Hepatitis B Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in adolescents and adults at increased risk for infection.\r\rSee the Practice Considerations section for a description of adolescents and adults at increased risk for infection.', 'servfreq': 'For patients with negative HBsAg results who have not received the HBV vaccine series, periodic screening may be useful for those who report continued risk for acquiring HBV transmission, such as persons who continue to inject drugs and men who have sex with men. Clinical judgment should be used to determine screening frequency. The USPSTF found no evidence to determine optimal screening intervals.', 'risktext': 'Persons from such risk groups include persons who have injected drugs in the past or currently; men who have sex with men; persons with HIV; and sex partners, needle-sharing contacts, and household contacts of persons known to be HBsAg positive. Some persons with combinations of risk factors who are not members of risk factor groups listed above may also be at increased risk for HBV infection.'}, {'id': 524, 'title': 'Hepatitis C Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis C virus (HCV) infection in adults aged 18 to 79 years.', 'servfreq': 'One-time screening for most adults.\r\nPeriodically screen persons with continued risk for HCV infection (eg, persons with past or current injection drug use). There is limited evidence to determine how often to screen persons at increased risk.&nbsp;', 'risktext': 'Asymptomatic adults aged 18 to 79 years (including pregnant persons) without known liver disease.&nbsp;\r\nThe USPSTF also suggests that clinicians consider screening persons younger than 18 years and older than 79 years who are at high risk for infection (eg, those with past or current injection drug use).&nbsp;'}, {'id': 2023, 'title': 'Hypertensive Disorders of Pregnancy: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hypertensive disorders in pregnant persons with blood pressure measurements throughout pregnancy.', 'servfreq': 'Screening Interval\r\nBlood pressure measurements should be obtained during each prenatal care visit throughout pregnancy. Hypertensive disorders of pregnancy can quickly evolve into severe disease that can result in serious, even fatal, maternal and infant health outcomes. The ability to screen for hypertensive disorders of pregnancy using blood pressure measurements is important to identify and effectively treat a potentially unpredictable and fatal condition. While it is known that risk continues into the immediate postpartum period, there is little evidence regarding screening during this period. A pragmatic approach would be for patients to be counseled regarding signs and symptoms of preeclampsia at hospital discharge and for patients with hypertensive disorders to have subsequent blood pressure checks.\r\nScreening for hypertensive disorders of pregnancy alone is not sufficient to improve inequities in health outcomes. Identifying hypertensive disorders of pregnancy requires adequate prenatal visits, surveillance, and evidence-based care in response to evolving patient signs and symptoms during pregnancy and the postpartum period to improve health outcomes. Black and Native American/Alaska Native persons have lower rates of prenatal visits and are at greater risk of serious postpartum morbidity and hospital readmission after delivery. Screening and monitoring of Black and Hispanic/Latina individuals during the postpartum period could be an important step for reducing health inequities by preventing serious adverse events. In addition, screening and monitoring by various health care providers (eg, nurse midwives, nurses, pediatricians, doulas, and lactation consultants) could also help avert serious complications in the postpartum period.', 'risktext': 'Assessment of Risk\r\nImportant clinical conditions associated with increased risk for preeclampsia include a history of eclampsia or preeclampsia in a prior pregnancy, a previous adverse pregnancy outcome, and maternal comorbid conditions (including type 1 or type 2 diabetes prior to pregnancy, gestational diabetes, chronic hypertension, kidney disease, and autoimmune diseases).\r\n&nbsp;Other factors associated with increased risk of preeclampsia and gestational hypertension include nulliparity, high prepregnancy body mass index, family history of preeclampsia, multifetal gestation, and the pregnant individual being 35 years or older.\r\nThe higher prevalence of hypertensive disorders of pregnancy and the increased risk for severe complications seen in Black persons may be due to their disproportionate burden of social and clinical risk factors. These social and clinical determinants largely result from historical and current manifestations of structural racism that influence environmental exposures, access to health resources, and overall health status.'}, {'id': 434, 'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians screen for intimate partner violence (IPV) in women of reproductive age and provide or refer women who screen positive to ongoing support services. See the Clinical Considerations section for more information on effective ongoing support services for IPV and for information on IPV in men.', 'servfreq': 'The USPSTF found no evidence on appropriate intervals for screening. Randomized clinical trials (RCTs) of screening and interventions for IPV often screen for current IPV or IPV in the past year.\r\n&nbsp;', 'risktext': 'All women of reproductive age are at potential risk for IPV and should be screened. There are a variety of factors that increase risk of IPV, such as exposure to violence as a child, young age, unemployment, substance abuse, marital difficulties, and economic hardships.\r\nRisk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health. For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.'}, {'id': 187, 'title': 'Rh(D) Incompatibility: Screening ', 'grade': 'B', 'text': "The DoctorAI recommends repeated Rh(D) antibody testing for all unsensitized Rh(D)-negative women at 24 to 28 weeks' gestation, unless the biological father is known to be Rh(D)-negative.", 'servfreq': 'Repeat testing at 24-28 weeks gestation.', 'risktext': ''}, {'id': 1916, 'title': 'Lung Cancer: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery.', 'servfreq': ' \r\nThe USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. ', 'risktext': ' \r\nSmoking and older age are the 2 most important risk factors for lung cancer.&nbsp;The risk of lung cancer in persons who smoke increases with cumulative quantity and duration of smoking and with age but decreases with increasing time since quitting for persons who formerly smoked.3 The USPSTF considers adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years to be at high risk and recommends screening for lung cancer with annual LDCT in this population. \r\n \r\n&nbsp;\r\n \r\nAfrican American/Black (Black) men have a higher incidence of lung cancer than White men, and Black women have a lower incidence than White women.1 These differences are likely related to differences in smoking exposure (ie, prevalence of smoking) and related exposure to carcinogens in cigarettes.7,8 The differences may also be related to other social risk factors.\r\n \r\n&nbsp;\r\n \r\nOther risk factors for lung cancer include environmental exposures, prior radiation therapy, other (noncancer) lung diseases, and family history. Lower level of education is also associated with a higher risk of lung cancer.7 The task force recommends using age and smoking history to determine screening eligibility rather than more elaborate risk prediction models because there is insufficient evidence to assess whether risk prediction model&ndash;based screening would improve outcomes relative to using the risk factors of age and smoking history for broad implementation in primary care.\r\n '}, {'id': 449, 'title': 'Perinatal Depression: Preventive Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians provide or refer pregnant and postpartum persons who are at increased risk of perinatal depression to counseling interventions.', 'servfreq': '', 'risktext': 'Include&nbsp;a past history of depression. Current depressive symptoms (that do not reach a diagnostic threshold),&nbsp;history of physical or sexual abuse,&nbsp;unplanned or unwanted pregnancy,&nbsp;stressful life events,&nbsp;lack of social and financial support,&nbsp;intimate partner violence,pregestational or gestational diabetes,and complications during pregnancy. Additional risk factors include adolescent parenthood, low socioeconomic status, and lack of social support.&nbsp;Genetic factors are also suspected to contribute to women&rsquo;s risk of developing perinatal depression.'}, {'id': 1445, 'title': 'Sexually Transmitted Infections: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends behavioral counseling for all sexually active adolescents and for adults who are at increased risk for sexually transmitted infections (STIs).\r\rSee the Practice Considerations section for more information on populations at increased risk for acquiring STIs.', 'servfreq': '', 'risktext': 'All sexually active adolescents are at increased risk for STIs because of the high rates of STIs in this age group and should receive behavioral counseling interventions. Adults at increased risk for STIs include those who currently have an STI or were diagnosed with one within the past year, do not consistently use condoms, have multiple sex partners, or have sex partners within populations with a high prevalence of STIs. Populations with a high prevalence of STIs include persons who seek STI testing or attend STI clinics; sexual and gender minorities; persons who are living with HIV, inject drugs, have exchanged sex for money or drugs, or have entered correctional facilities; and some racial/ethnic minority groups.1-4'}, {'id': 402, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends counseling young adults, adolescents, children, and parents of young children about minimizing exposure to ultraviolet (UV) radiation for persons aged 6 months to 24 years with fair skin types to reduce their risk of skin cancer.', 'servfreq': '', 'risktext': 'Fair skin types'}, {'id': 438, 'title': 'Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for unhealthy alcohol use in primary care settings in adults 18 years or older, including pregnant women, and providing persons engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce unhealthy alcohol use.', 'servfreq': 'The USPSTF did not find adequate evidence to recommend an optimal screening interval for unhealthy alcohol use in adults.&nbsp;Brief behavioral counseling interventions were found to reduce unhealthy alcohol use in adults 18 years or older, including pregnant women. Effective behavioral counseling interventions vary in their specific components, administration, length, and number of interactions. The USPSTF was unable to identify specific intervention characteristics or components that were clearly associated with improved outcomes.', 'risktext': 'engaged in risky or hazardous drinking'}, {'id': 767, 'title': 'Unhealthy Drug Use: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening by asking questions about unhealthy drug use in adults age 18 years or older. Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. \r(Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'servfreq': 'Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. (Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'risktext': 'These include being aged 18 to 25 years; male sex; having a mental health condition, personality or mood disorder, or nicotine or alcohol dependence; a history of physical or sexual abuse, parental neglect, or other adversity in childhood; or drug or alcohol addiction in a first-degree relative.1,9&nbsp;Factors associated with misuse of prescription drugs include history of other drug use, mental illness, pain, and greater access to prescription drugs.10&nbsp;Factors associated with prenatal use of drugs include a mental health disorder, interpersonal violence, and family history of substance use.11'}, {'id': 433, 'title': 'Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer or refer adults with a body mass index (BMI) of 30 or higher (calculated as weight in kilograms divided by height in meters squared) to intensive, multicomponent behavioral interventions.', 'servfreq': '', 'risktext': 'Adults with a BMI &ge;30'}, {'id': 1979, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: Behavioral Counseling Interventions ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians individualize the decision to offer or refer adults without cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity. \r\rSee the "Practice Considerations" section for information on determining which patients may benefit most from this service.', 'servfreq': '', 'risktext': ''}, {'id': 508, 'title': 'BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine risk assessment, genetic counseling, or genetic testing for women whose personal or family history or ancestry is not associated with potentially harmful BRCA1/2 gene mutations.', 'servfreq': '', 'risktext': 'Patients with family or personal histories of breast, ovarian, tubal, or peritoneal cancer or ancestry associated with harmful&nbsp;BRCA1/2&nbsp;mutations should be assessed using a familial risk assessment tool. The USPSTF found adequate evidence that these tools are accurate in identifying women with increased likelihood of&nbsp;BRCA1/2mutations. Tools evaluated by the USPSTF include the Ontario Family History Assessment Tool, Manchester Scoring System, Referral Screening Tool, Pedigree Assessment Tool, 7-Question Family History Screening Tool, International Breast Cancer Intervention Study instrument (Tyrer-Cuzick), and brief versions of BRCAPRO. These tools should be used to guide referrals to genetic counseling.'}, {'id': 525, 'title': 'Bacterial Vaginosis in Pregnant Persons to Prevent Preterm Delivery: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for bacterial vaginosis (BV) in pregnant persons who are not at increased risk for preterm delivery.', 'servfreq': '', 'risktext': '\r\nAssess risk for preterm delivery. There are multiple factors that increase risk for preterm delivery; one of the strongest risk factors is prior preterm delivery.\r\nDecide whether or not to screen for bacterial vaginosis:\r\n\r\na. Do not screen pregnant persons who are not at increased risk for preterm delivery.\r\nb. Evidence is insufficient to recommend for or against screening pregnant persons at increased risk for preterm delivery.'}, {'id': 418, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening with resting or exercise electrocardiography (ECG) to prevent cardiovascular disease (CVD) events in asymptomatic adults at low risk of CVD events.', 'servfreq': '', 'risktext': ''}, {'id': 429, 'title': 'Cervical Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for cervical cancer in women who have had a hysterectomy with removal of the cervix and do not have a history of a high-grade precancerous lesion (ie, cervical intraepithelial neoplasia [CIN] grade 2 or 3) or cervical cancer.', 'servfreq': '', 'risktext': ''}, {'id': 428, 'title': 'Cervical Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for cervical cancer in women younger than 21 years.', 'servfreq': '', 'risktext': ''}, {'id': 1973, 'title': 'Chronic Obstructive Pulmonary Disease: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for chronic obstructive pulmonary disease in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 2003, 'title': 'Genital Herpes Infection: Serologic Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine serologic screening for genital herpes simplex virus infection in asymptomatic adolescents and adults, including pregnant persons.', 'servfreq': '', 'risktext': 'The USPSTF found no evidence of externally validated, reliable risk stratification tools to identify individuals more or less likely to have genital herpes.'}, {'id': 504, 'title': 'Pancreatic Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for pancreatic cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 365, 'title': 'Thyroid Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for thyroid cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 1976, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'D', 'text': 'The DoctorAI recommends against the use of beta carotene or vitamin E supplements for the prevention of cardiovascular disease or cancer.', 'servfreq': '', 'risktext': ''}, {'id': 318, 'title': 'Autism Spectrum Disorder in Young Children: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for autism spectrum disorder (ASD) in young children for whom no concerns of ASD have been raised by their parents or a clinician.', 'servfreq': '', 'risktext': 'Although a number of potential risk factors for ASD have been identified, there is insufficient evidence to determine if certain risk factors modify the performance characteristics of ASD screening tests, such as the age at which screening is performed or other characteristics of the child or family.'}, {'id': 526, 'title': 'Bacterial Vaginosis in Pregnant Persons to Prevent Preterm Delivery: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for BV in pregnant persons who are at increased risk for preterm delivery.', 'servfreq': '', 'risktext': ''}, {'id': 65, 'title': 'Bladder Cancer in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults.\r\rLiterature scans conducted in July 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'This evidence update focused on the benefits and harms of screening for bladder cancer among people without symptoms, the accuracy of screening tests done in primary care settings, and the benefits and harms of treatment. The updated evidence review did not find any new high quality evidence to adequately determine the balance of benefits and harms of screening for bladder cancer. However, bladder cancer is a common cancer and can cause considerable health problems including death. Therefore, the USPSTF determined that the evidence was insufficient to provide a recommendation for or against bladder cancer screening.  The USPSTF emphasizes the need for additional research in this area. '}, {'id': 2037, 'title': 'Breast Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of supplemental screening for breast cancer using breast ultrasonography or magnetic resonance imaging (MRI) in women identified to have dense breasts on an otherwise negative screening mammogram.\r\rSee the "Practice Considerations" section for more information on the patient population to whom this recommendation applies and on screening mammography modalities.', 'servfreq': '', 'risktext': 'These recommendations apply to cisgender women and all other persons assigned female at birth (including transgender men and nonbinary persons) 40 years or older at average risk of breast cancer. \r\nThese recommendations apply to persons who have factors associated with an increased risk of breast cancer, such as a family history of breast cancer (ie, a first-degree relative with breast cancer) or having dense breasts. They do not apply to persons who have a genetic marker or syndrome associated with a high risk of breast cancer (eg, BRCA1 or BRCA2 genetic variation), a history of high-dose radiation therapy to the chest at a young age, or previous breast cancer or a high-risk breast lesion on previous biopsies. '}, {'id': 419, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening with resting or exercise ECG to prevent CVD events in asymptomatic adults at intermediate or high risk of CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 423, 'title': 'Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of adding the ankle-brachial index (ABI), high-sensitivity C-reactive protein (hsCRP) level, or coronary artery calcium (CAC) score to traditional risk assessment for cardiovascular disease (CVD) in asymptomatic adults to prevent CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 352, 'title': 'Celiac Disease: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'persons with family history or other risk factors'}, {'id': 1955, 'title': 'Eating Disorders in Adolescents and Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for eating disorders in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1933, 'title': 'Gestational Diabetes: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for gestational diabetes in asymptomatic pregnant persons before 24 weeks of gestation.', 'servfreq': '', 'risktext': ''}, {'id': 665, 'title': 'Illicit Drug Use in Children, Adolescents, and Young Adults: Primary Care-Based Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--based behavioral counseling interventions to prevent illicit drug use, including nonmedical use of prescription drugs, in children, adolescents, and young adults.\r\rSee the Practice Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 435, 'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for abuse and neglect in all older or vulnerable adults. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': 'Risk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health.14&nbsp;For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.15'}, {'id': 2045, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for iron deficiency and iron deficiency anemia in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2046, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine iron supplementation in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2018, 'title': 'Lipid Disorders in Children and Adolescents: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1998, 'title': 'Obstructive Sleep Apnea in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for obstructive sleep apnea in the general adult population.\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Risk Factors\r\nRisk factors associated with OSA include male sex, older age (40-70 years), postmenopausal status, higher body mass index (BMI), and craniofacial and upper airway abnormalities (eg, enlarged tonsils or long upper airway). Black, Hispanic/Latino, and Native American/Alaska Native persons have a higher prevalence of OSA compared with White persons; some evidence suggests that these differences are partially explained by higher rates of obesity, asthma, and tobacco use among these groups.8'}, {'id': 1977, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of multivitamin supplements for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1978, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of single or paired nutrient supplements (other than beta carotene and vitamin E) for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 176, 'title': 'Oral Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for oral cancer in asymptomatic adults.\r\rGo to the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in July 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Tobacco and alcohol use are major risk factors for oral cancer. A total of 20% to 30% of cases of oral cancer worldwide are attributable to cigarette smoking. In the United States, up to 75% of cases of oral cancer may be attributable to tobacco and alcohol use. Additional risk factors include male sex, older age, use of betel quid, ultraviolet light exposure, infection with Candida or bacterial flora, and a compromised immune system. Sexually transmitted oral HPV infection (HPV-16) has recently been recognized as an increasingly important risk factor for oropharyngeal cancer. In the United States, the prevalence of oropharyngeal cancer due to oral HPV infection is probably as high as 80% to 95%. The prevalence of oral HPV infection is associated with age, sex, number of sexual partners, and number of cigarettes smoked per day. The effect of multifactorial risk assessment and screening for risk factors on oral cancer morbidity and mortality is unknown.'}, {'id': 2026, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine screening performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 2027, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of preventive interventions performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 424, 'title': 'Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for peripheral artery disease (PAD) and cardiovascular disease (CVD) risk with the ankle-brachial index (ABI) in asymptomatic adults.\r\rLiterature scans conducted in August 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Risk factors associated with OSA include male sex, older age (40 to 70 years), postmenopausal status, higher BMI, and craniofacial and upper airway abnormalities.'}, {'id': 404, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of counseling adults about skin self-examination to prevent skin cancer.See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 2005, 'title': 'Skin Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Exposure to UV radiation from sun exposure, indoor tanning beds, and other UV radiation&ndash;emitting devices is the major environmental risk factor for skin cancer. History of frequent sunburns, older age, and male sex are associated with increased risk for skin cancer. Exposure to UV radiation from the use of indoor tanning beds is an important risk factor in adolescents. Incidence of melanoma is higher among White persons compared with persons of other races and ethnicities. This difference likely reflects traits associated with increased melanoma risk, such as fair skin (which is more susceptible to sunburning), light-colored eyes, and red or blond hair being more common among White persons compared with persons of other races and ethnicities. Acral lentiginous melanoma, which occurs mostly on skin not frequently exposed to direct sunlight (eg, palms of hands, soles of feet, or under fingernails or toenails), is the most common type of melanoma among Black populations. Other melanoma risk factors include higher numbers of moles on the skin, atypical moles, as well as a personal and family history of skin cancer.'}, {'id': 269, 'title': 'Thyroid Dysfunction: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults.\r\rSee the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': 'The optimal screening interval for thyroid dysfunction (if one exists) is unknown.', 'risktext': 'The most common cause of hypothyroidism in the United States is chronic autoimmune (Hashimoto) thyroiditis. Risk factors for an elevated TSH level include female sex, advancing age, white race, type 1 diabetes, Down syndrome, family history of thyroid disease, goiter, previous hyperthyroidism (possibly due in part to ablation therapy leading to iatrogenic thyroid dysfunction), and external-beam radiation in the head and neck area. Common causes of hyperthyroidism include Graves disease, Hashimoto thyroiditis, and functional thyroid nodules. Risk factors for a low TSH level include female sex; advancing age; black race; low iodine intake; personal or family history of thyroid disease; and ingestion of iodine-containing drugs, such as amiodarone. The USPSTF found no direct evidence that treatment of thyroid dysfunction based on risk level alters final health outcomes.'}, {'id': 1908, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of electronic cigarettes (e-cigarettes) for tobacco cessation in adults, including pregnant persons. The USPSTF recommends that clinicians direct patients who use tobacco to other tobacco cessation interventions with proven effectiveness and established safety.\rSee the Practice Considerations section for more information on recommended behavioral interventions and pharmacotherapy and for suggestions for practice regarding the I statements.', 'servfreq': '', 'risktext': ''}, {'id': 1907, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of pharmacotherapy interventions for tobacco cessation in pregnant persons.', 'servfreq': '', 'risktext': ''}, {'id': 586, 'title': 'Tobacco Use in Children and Adolescents: Primary Care Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--feasible interventions for the cessation of tobacco use among school-aged children and adolescents.\r\rSee the Practice Considerations section for more information on effective interventions to prevent initiation of tobacco use and for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1919, 'title': 'Vitamin D Deficiency in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 408, 'title': 'Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of the benefits and harms of vitamin D and calcium supplementation, alone or combined, for the primary prevention of fractures in men and premenopausal women.', 'servfreq': '', 'risktext': ''}]}
2025-01-29 22:03:08 [INFO] Recommendations fetched: [{'id': 2020, 'title': 'Folic Acid Supplementation to Prevent Neural Tube Defects: Preventive Medication ', 'grade': 'A', 'text': 'The DoctorAI recommends that all persons planning to or who could become pregnant take a daily supplement containing 0.4 to 0.8 mg (400 to 800 mcg) of folic acid.', 'servfreq': 'The neural plate completes its formation and closure early in pregnancy (usually 26 to 28 days after fertilization). This means the critical period for folic acid supplementation starts at least 1 month before conception and continues through the first 2 to 3 months of pregnancy. Nearly half of all pregnancies in the US are unplanned; to gain the full benefits of supplementation, clinicians should advise all persons who plan to or who could become pregnant to take daily folic acid.', 'risktext': 'All pregnancies are at risk for neural tube defects, and persons who are planning to or could become pregnant should take folic acid supplements. Certain risk factors convey a higher risk, and individuals with these risk factors should talk to their health care professional. These factors include personal, partner, or family history of neural tube defects, malabsorption caused by bariatric procedures, the use of certain antiseizure medicines, and genetic mutations in folate-related enzymes. Pregestational diabetes and obesity have been associated with an increased risk of neural tube defects. Ethnic groups such as First Nation persons in Canada and Hispanic persons in California are thought to be at higher risk of neural tube defects. It is unclear, however, whether this is related to a higher risk of genetic variations among these groups or due to differential intake of folic acid&ndash;fortified foods.'}, {'id': 503, 'title': 'Hepatitis B Virus Infection in Pregnant Women: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in pregnant women at their first prenatal visit', 'servfreq': 'A test for HBsAg should be ordered at the first prenatal visit. Women with unknown HBsAg status or with new or continuing risk factors for HBV infection (eg, injection drug use or a sexually transmitted infection) should be screened at the time of admission to a hospital or other delivery setting.', 'risktext': 'In the United States, new cases of HBV among adults are largely transmitted through injection drug use or sexual intercourse, but most prevalent cases of HBV infection are chronic infections from exposure occurring in infancy or childhood. Another major risk factor for HBV infection is country of origin. In the United States, adults with HBV born in high-prevalence countries were commonly infected during childhood. In children, the primary source of infection is perinatal transmission at birth.'}, {'id': 485, 'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in adolescents and adults aged 15 to 65 years. Younger adolescents and older adults who are at increased risk of infection should also be screened.\rSee the Clinical Considerations section for more information about assessment of risk, screening intervals, and rescreening in pregnancy.', 'servfreq': 'The USPSTF found insufficient evidence to determine appropriate or optimal time intervals or strategies for repeat HIV screening. However, repeat screening is reasonable for persons known to be at increased risk of HIV infection, such as sexually active men who have sex with men; persons with a sex partner who is living with HIV; or persons who engage in behaviors that may convey an increased risk of HIV infection, such as injection drug use, transactional sex or commercial sex work, having 1 or more new sex partners whose HIV status is unknown, or having other factors that can place a person at increased risk of HIV infection (see &ldquo;Risk Assessment&rdquo;). Repeat screening is also reasonable for persons who live or receive medical care in a high-prevalence setting, such as a sexually transmitted disease clinic, tuberculosis clinic, correctional facility, or homeless shelter.', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'id': 486, 'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in all pregnant persons, including those who present in labor or at delivery whose HIV status is unknown.', 'servfreq': 'The CDC and ACOG recommend repeat prenatal screening for HIV during the third trimester of pregnancy in women with risk factors for HIV acquisition and in women living or receiving care in high-incidence settings, and the CDC notes that repeat screening for HIV during the third trimester may be considered in all women.&nbsp;', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'id': 1921, 'title': 'Hypertension in Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hypertension in adults 18 years or older with office blood pressure measurement (OBPM). The USPSTF recommends obtaining blood pressure measurements outside of the clinical setting for diagnostic confirmation before starting treatment.', 'servfreq': ' \r\nAlthough evidence on optimal screening intervals is limited, reasonable options include:\r\n \r\n \r\n\r\n\r\nScreening for hypertension every year in adults 40 years or older and in adults at increased risk for hypertension (such as Black persons, persons with high-normal blood pressure, or persons who are overweight or obese)\r\n\r\n\r\n \r\n \r\n\r\n\r\nScreening less frequently (ie, every 3 to 5 years) as appropriate for adults aged 18 to 39 years not at increased risk for hypertension and with a prior normal blood pressure reading.\r\n\r\n\r\n ', 'risktext': ' \r\nAlthough all adults should be screened for hypertension, risk factors that increase a person&rsquo;s risk for the condition include older age, Black race, family history, excess weight and obesity, lifestyle habits (lack of physical activity, stress, and tobacco use), and dietary factors (diet high in fat or sodium, diet low in potassium, or excessive alcohol intake)\r\n '}, {'id': 2021, 'title': 'Prevention of Acquisition of HIV: Preexposure Prophylaxis ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians prescribe preexposure prophylaxis using effective antiretroviral therapy to persons who are at increased risk of HIV acquisition to decrease the risk of acquiring HIV. \r\rSee the Practice Considerations section for more information about identification of persons at increased risk and about effective antiretroviral therapy.', 'servfreq': '', 'risktext': 'HIV is primarily acquired via sexual activity or injection drug use. It is important that clinicians routinely take a sexual and injection drug use history for all their patients in an open and nonjudgmental manner. All adolescents and adults who are sexually active or who inject drugs should be informed that acquisition of HIV can be prevented, to facilitate subsequent risk assessment and discussions about preexposure prophylaxis (PrEP) and other ways to prevent acquisition of HIV. Importantly, risk of HIV acquisition exists on a continuum, and currently available risk assessment tools all have limitations. However, certain risk factors or behaviors are known to place persons at increased risk of HIV.\r\nRisk of HIV acquisition depends on the likelihood that a specific act or activity will transmit HIV and the likelihood that a sex partner or drug injection partner has HIV. Likelihood of HIV transmission is highest with needle-sharing injection drug use and condomless receptive anal intercourse. Condomless receptive anal intercourse has an approximately 10- to 15-fold higher risk of transmission than condomless insertive anal sex and condomless receptive and insertive penile-vaginal sex. A 2018 study estimated the prevalence of HIV (ie, an estimate of the likelihood that a partner whose HIV status is unknown has HIV at a population level) as 12.4% among men who have sex with men and 1.9% among persons who inject drugs. The overall prevalence of HIV in the US is estimated at 0.3%.&nbsp;Of note, both the frequency of specific sexual activities and a person&rsquo;s number of sexual partners will also affect their risk of HIV.\r\n&nbsp;The USPSTF recommends that the following persons be considered for PrEP:\r\n1.&nbsp;&nbsp;&nbsp;&nbsp; Sexually active adults and adolescents weighing at least 35 kg (77 lb) who have engaged in anal or vaginal sex in the past 6 months and have any of the following:\r\n&nbsp;\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A sexual partner who has HIV (especially if the partner has an unknown or detectable viral load).\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A bacterial sexually transmitted infection (STI) (syphilis, gonorrhea, or chlamydia for men who have sex with men and transgender women; gonorrhea and syphilis for heterosexual women and men) in the past 6 months.\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A history of inconsistent or no condom use with sex partner(s) whose HIV status is not known; assessing risk in conversation with the patient and considering factors such as number of partners, the specific sexual activities a person engages in, and whether their sex partner or partners are in a group with a higher prevalence of HIV (eg, men who have sex with men or with men and women, transgender women, persons who inject drugs, and persons who engage in transactional sex).\r\n&nbsp;\r\n2. &nbsp; Persons who inject drugs and have a drug-injecting partner who has HIV or who shares injection equipment.\r\nPersons who engage in transactional sex, such as sex for money, drugs, or housing, including commercial sex workers or persons trafficked for sex work, constitute a group at increased risk of HIV acquisition and should be considered for PrEP based on the criteria outlined above. Persons who request PrEP may have undisclosed behaviors that put them at risk. Transgender women and men who are sexually active should be considered for PrEP based on the criteria outlined above. Transgender women are at especially high risk of HIV acquisition. A Centers for Disease Control and and Prevention (CDC) survey in 7 cities found an HIV prevalence of 42% among transgender women. Prevalence was highest among Black transgender women (62%) and Native American/Alaska Native transgender women (65%).\r\nIn addition, studies have found that transmission of HIV to a seronegative partner from a partner with HIV has not been observed when the partner with HIV was being treated with antiretroviral therapy and had a suppressed viral load.&nbsp;It is not known whether PrEP use further decreases the risk of HIV transmission when a partner with HIV has a documented undetectable viral load. Factors such as the consistency or inconsistency of a partner&rsquo;s viral load being suppressed, a partner&rsquo;s adherence to antiretroviral therapy, and the degree of certainty that a partner&rsquo;s viral load is suppressed (eg, self-report vs availability of laboratory test results) may help inform decisions about the use of PrEP in this situation.\r\nAll persons being considered for PrEP must have a recently documented negative HIV antigen-antibody test result, and if they have taken oral PrEP or postexposure prophylaxis in the past 3 months, or injectable cabotegravir in the past 12 months, the CDC recommends testing with both an HIV antigen-antibody assay and an HIV-1 RNA assay.'}, {'id': 186, 'title': 'Rh(D) Incompatibility: Screening ', 'grade': 'A', 'text': 'The DoctorAI strongly recommends Rh(D) blood typing and antibody testing for all pregnant women during their first visit for pregnancy-related care.', 'servfreq': 'First prenatal visit.', 'risktext': ''}, {'id': 1989, 'title': 'Syphilis Infection in Nonpregnant Adolescents and Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for syphilis infection in persons who are at increased risk for infection.', 'servfreq': 'Optimal screening frequency for persons who are at increased risk for syphilis infection is not well established. Men who have sex with men or persons with HIV infection may benefit from screening at least annually or more frequently (eg, every 3 to 6 months) if they continue to be at high risk.', 'risktext': 'The USPSTF recommends screening for syphilis in persons who are at increased risk for infection. When deciding which persons to screen for syphilis, clinicians should consider the prevalence of infection in the communities they serve, as well as other sociodemographic and behavioral factors that may be associated with increased risk of syphilis infection. For example, prevalence of syphilis is higher in men, men who have sex with men, persons with HIV infection, young adults, and persons with a history of incarceration, sex work, or military service. A substantial percentage of heterosexual syphilis transmission occurs among persons who use illicit drugs, particularly methamphetamine. Diagnosis of another STI may signal that a person is having condomless sex, which increases their risk of syphilis infection. Higher infection rates in persons of some racial and ethnic groups have been reported and are primarily a reflection of a combination of factors, including social determinants of health (eg, disparities of income, low educational achievement, and unstable housing), differential health insurance coverage or access to quality health care, and differences in sexual network characteristics (eg, individuals living in communities with a high prevalence of STIs have an increased chance of encountering an infected partner). Local prevalence rates may change over time, so clinicians should be aware of the latest data and trends for their specific population and geographic area, which are available through their state and local health departments and Centers for Disease Control and Prevention (CDC) surveillance.\r\n&nbsp;\r\nAlthough direct evidence on screening in nonpregnant persons who are not at increased risk for syphilis infection is lacking, based on the established test performance characteristics of current screening tests and the low prevalence rate of syphilis in this population, the yield of screening is likely low.9,10 Therefore, screening in this population may result in high false-positive rates and overtreatment.'}, {'id': 431, 'title': 'Syphilis Infection in Pregnant Women: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends early screening for syphilis infection in all pregnant women.', 'servfreq': 'All pregnant women should be tested for syphilis as early as possible when they first present to care. If a woman has not received prenatal care prior to delivery, she should be tested at the time she presents for delivery. In most cases of congenital syphilis, pregnant women received prenatal care but were not screened and treated for syphilis early enough during the pregnancy to prevent transmission to the fetus.', 'risktext': ''}, {'id': 1905, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and US Food and Drug Administration (FDA)--approved pharmacotherapy for cessation to nonpregnant adults who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 1906, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all pregnant persons about tobacco use, advise them to stop using tobacco, and provide behavioral interventions for cessation to pregnant persons who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 2014, 'title': 'Anxiety Disorders in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for anxiety disorders in adults, including pregnant and postpartum persons.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding optimal timing for screening, or screening interval, for both the perinatal and general adult populations; more evidence on both timing and screening interval is needed for all adult populations. A pragmatic approach in the absence of evidence might include screening all adults who have not been screened previously and using clinical judgment in considering risk factors, comorbid conditions, and life events to determine if additional screening of high-risk patients is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nRisk factors for anxiety disorders include sociodemographic factors, psychosocial factors, and physical and mental health factors such as marital status (widowed or divorced), stressful life events, smoking and alcohol use, other mental health conditions, or a parental history of mental disorders. Demographic factors such as low socioeconomic status and female sex are associated with higher rates of anxiety disorders.&nbsp;Black persons and individuals of non-Hispanic ethnicity are at increased risk of anxiety disorders due to social, rather than biological, factors. Anxiety and depressive disorders often overlap. One cohort study found that 67% of individuals with a depressive disorder also had a current anxiety disorder, and 75% had a lifetime comorbid anxiety disorder.'}, {'id': 1938, 'title': 'Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication ', 'grade': 'B', 'text': 'The DoctorAI recommends the use of low-dose aspirin (81 mg/day) as preventive medication after 12 weeks of gestation in persons who are at high risk for preeclampsia.\r\rSee the Practice Considerations section for information on high risk and aspirin dose.', 'servfreq': 'Once daily after 12 weeks of gestation', 'risktext': ' \r\nPersons with a history of preeclampsia in a previous pregnancy, type 1 or type 2 diabetes, and chronic hypertension are at highest risk for preeclampsia. Additional conditions that place a person at high risk for preeclampsia include multifetal gestation, conception using assisted reproductive technology, autoimmune disease, and kidney disease. Other factors associated with increased preeclampsia risk include nulliparity, high prepregnancy body mass index, family history of preeclampsia, and advanced maternal age (35 years or older). In addition, Black persons have higher rates of preeclampsia and are at increased risk for serious complications due to various societal and health inequities.\r\n '}, {'id': 513, 'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for asymptomatic bacteriuria using urine culture in pregnant persons.', 'servfreq': 'In general, screening is performed once at the first prenatal visit per clinical guidelines. However, there is little evidence on the optimal timing and frequency of screening for asymptomatic bacteriuria in pregnancy.2&nbsp; .&nbsp;Screen pregnant persons for asymptomatic bacteriuria using a midstream, clean-catch urine culture at the first prenatal visit or at 12 to 16 weeks of gestation, whichever is earlier. A urine culture showing &gt;100,000 CFU/mL of a single uropathogen or &gt;10,000 CFU/mL if the pathogen is group B streptococcus indicates treatment.', 'risktext': 'This recommendation applies to adults 18 years and older and pregnant persons of any age without signs and symptoms of a urinary tract infection. It does not apply to persons who have chronic medical or urinary tract conditions, such as end-stage renal disease; have indwelling urinary catheters, urinary stents, or spinal cord injuries; are hospitalized; reside in an institution (eg, a nursing home); or who are transplant recipients.\r\n&nbsp;\r\nThe risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6&nbsp;Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5&nbsp;Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7,&nbsp;11,&nbsp;12&nbsp;In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12&nbsp;Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4,&nbsp;6'}, {'id': 2009, 'title': 'Latent Tuberculosis Infection in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for LTBI in populations at increased risk.\r\rSee the "Assessment of Risk" section for additional information on adults at increased risk.', 'servfreq': 'The USPSTF found no evidence on the optimal frequency of screening for LTBI. In the absence of evidence, a reasonable approach is to repeat screening based on specific risk factors; screening frequency could range from 1-time only screening among persons at low risk for future tuberculosis exposure to annual screening among those at continued risk of exposure.', 'risktext': 'Populations at increased risk for LTBI, based on increased prevalence of active disease and increased risk of exposure, include persons who were born in, or are former residents of, countries with high tuberculosis prevalence and persons who live in, or have lived in, high-risk congregate settings (eg, homeless shelters or correctional facilities). Clinicians can consult their local or state health departments for more information about populations at increased risk in their community, since local demographic patterns may vary across the US.\r\nIn 2020, 71.5% of all cases of active tuberculosis in the US occurred among persons born outside the US. According to the CDC, tuberculosis disease is common in most countries in Latin America, the Caribbean, Africa, Asia, Eastern Europe, and Russia. In 2020, among persons with new tuberculosis living in the US who were born outside the US, the most common countries of birth were Mexico (18.0%), the Philippines (12.5%), India (10.4%), Vietnam (8.2%), and China (5.1%), accounting for 54.2% of total cases. Most of these cases are believed to be due to progression of latent infection to active tuberculosis disease rather than new transmission within communities.\r\nPersons who live, or have lived, in high-risk congregate settings also have a higher prevalence rate of active tuberculosis and an increased risk for exposure. In 2020, 4.3% of tuberculosis disease cases diagnosed in persons 15 years or older occurred in persons experiencing homelessness and 2.6% occurred in residents of correctional facilities. It is estimated that persons experiencing homelessness have an 11 times higher incidence of tuberculosis disease compared with persons who are not experiencing homelessness (36 cases per 100,000 population vs 2.9 cases per 100,000 population, respectively, during 2011 to 2016).\r\nOther populations at increased risk for LTBI or progression to active disease include persons who have immunosuppression (eg, persons living with HIV, patients receiving immunosuppressive medications such as chemotherapy or tumor necrosis factor inhibitors, and patients who have received an organ transplant) and patients with silicosis (a lung disease). However, given that screening in these populations may be considered standard care as part of disease management or indicated prior to the use of certain medications, the USPSTF did not review evidence on screening in these populations. Information on testing in these populations is provided by other groups, such as the Office of AIDS Research at the National Institutes of Health, and in a guideline issued jointly by the American Thoracic Society, Infectious Diseases Society of America, and CDC. Some evidence from observational studies has explored the association between poorly controlled diabetes and progression of LTBI to active disease. However, there is insufficient evidence on screening for and treatment of LTBI in persons with diabetes for the USPSTF to make a separate recommendation for this important population.\r\nPersons who are contacts of individuals with active tuberculosis, health care workers, and workers in high-risk congregate settings may also be at increased risk of exposure. Because screening in these populations is conducted as part of public health or employee health surveillance, the USPSTF did not review the evidence in these populations. Clinicians seeking further information about testing for tuberculosis in these populations can refer to the Additional Tools and Resources and Recommendations of Others sections.'}, {'id': 514, 'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic bacteriuria in nonpregnant adults.', 'servfreq': '', 'risktext': 'The risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6 Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5 Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7, 11, 12 In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12 Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4, 6'}, {'id': 507, 'title': 'BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing ', 'grade': 'B', 'text': 'The DoctorAI recommends that primary care clinicians assess women with a personal or family history of breast, ovarian, tubal, or peritoneal cancer or who have an ancestry associated with breast cancer susceptibility 1 and 2 (BRCA1/2) gene mutations with an appropriate brief familial risk assessment tool. Women with a positive result on the risk assessment tool should receive genetic counseling and, if indicated after counseling, genetic testing.', 'servfreq': 'Consideration of screening for potentially harmful BRCA mutations should begin once women have reached the age of consent (18 years). Primary care providers should periodically assess all patients for changes in family history (for example, comprehensive review at least every 5 to 10 years)', 'risktext': 'Patients with family or personal histories of breast, ovarian, tubal, or peritoneal cancer or ancestry associated with harmful&nbsp;&lt; i&gt;BRCA1/2&nbsp;mutations should be assessed using a familial risk assessment tool. The USPSTF found adequate evidence that these tools are accurate in identifying women with increased likelihood of&nbsp;&lt; i&gt;BRCA1/2mutations. Tools evaluated by the USPSTF include the Ontario Family History Assessment Tool, Manchester Scoring System, Referral Screening Tool, Pedigree Assessment Tool, 7-Question Family History Screening Tool, International Breast Cancer Intervention Study instrument (Tyrer-Cuzick), and brief versions of BRCAPRO. These tools should be used to guide referrals to genetic counseling.&nbsp;Persons should consider their sex at birth to determine which recommendation best applies to them.'}, {'id': 339, 'title': 'Breastfeeding: Primary Care Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends providing interventions during pregnancy and after birth to support breastfeeding.', 'servfreq': 'During pregnancy and after birth', 'risktext': "This recommendation applies to pregnant women, new mothers, and their infants and children. Interventions to support breastfeeding may also involve a woman's partner, other family members, and friends. This recommendation does not apply in circumstances where there are contraindications to breastfeeding (e.g., certain maternal medical conditions or infant metabolic disorders, such as galactosemia). The USPSTF did not review evidence on interventions directed at breastfeeding of preterm infants."}, {'id': 1935, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for chlamydia in all sexually active women 24 years or younger and in women 25 years or older who are at increased risk for infection.', 'servfreq': ' \r\nIn the absence of studies on screening intervals, a reasonable approach would be to screen patients whose sexual history reveals new or persistent risk factors since the last negative test result.\r\n ', 'risktext': ' \r\nAge is a strong predictor of risk for chlamydial and gonococcal infections, with the highest infection rates in women occurring during ages 15 to 24 years. Women 25 years or older are at increased risk if they have a new sex partner, more than 1 sex partner, a sex partner with concurrent partners, or a sex partner who has an STI; practice inconsistent condom use when not in a mutually monogamous relationship; or have a previous or coexisting STI. Exchanging sex for money or drugs and history of incarceration also are associated with increased risk.&nbsp;Clinicians should consider the communities they serve and may want to consult local public health authorities for information about local epidemiology and guidance on determining who is at increased risk.\r\n '}, {'id': 1936, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for gonorrhea in all sexually active women 24 years or younger and in women 25 years or older who are at increased risk for infection.', 'servfreq': ' \r\nIn the absence of studies on screening intervals, a reasonable approach would be to screen patients whose sexual history reveals new or persistent risk factors since the last negative test result.\r\n ', 'risktext': ' \r\nAge is a strong predictor of risk for chlamydial and gonococcal infections, with the highest infection rates in women occurring during ages 15 to 24 years. Women 25 years or older are at increased risk if they have a new sex partner, more than 1 sex partner, a sex partner with concurrent partners, or a sex partner who has an STI; practice inconsistent condom use when not in a mutually monogamous relationship; or have a previous or coexisting STI. Exchanging sex for money or drugs and history of incarceration also are associated with increased risk.&nbsp;Clinicians should consider the communities they serve and may want to consult local public health authorities for information about local epidemiology and guidance on determining who is at increased risk.\r\n '}, {'id': 1909, 'title': 'Asymptomatic Carotid Artery Stenosis: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic carotid artery stenosis in the general adult population.\r\rSee the Practice Considerations section for a description of adults at increased risk.', 'servfreq': '', 'risktext': ''}, {'id': 2017, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for suicide risk in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': '', 'risktext': ''}, {'id': 2016, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for depression in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding the optimal timing for screening for depression; more evidence is needed in both perinatal and general adult populations. In the absence of evidence, a pragmatic approach might include screening adults who have not been screened previously and using clinical judgment while considering risk factors, comorbid conditions, and life events to determine if additional screening of patients at increased risk is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nThe USPSTF recommends screening for depression in all adults regardless of risk factors. Risk factors for depression include a combination of genetic, biological, and environmental factors, such as a family history of depression, prior episode of depression or other mental health condition, a history of trauma or adverse life events, or a history of disease or illness (eg, cardiovascular disease).\r\nPrevalence rates vary by sex, age, race, ethnicity, education, marital status, geographic location, poverty level, and employment status. Women have twice the risk of depression compared with men. Young adults, multiracial individuals, and Native American/Alaska Native individuals have higher rates of depression.\r\nRisk factors for perinatal depression include life stress, low social support, history of depression, marital or partner dissatisfaction, and a history of abuse.'}, {'id': 1932, 'title': 'Gestational Diabetes: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for gestational diabetes in asymptomatic pregnant persons at 24 weeks of gestation or after.', 'servfreq': 'At 24 weeks of gestation or after to improve maternal and fetal outcomes', 'risktext': ' \r\nSeveral factors increase a person&rsquo;s risk for developing gestational diabetes, including obesity, increased maternal age, history of gestational diabetes, family history of diabetes, and belonging to a racial/ethnic group that is at increased risk for developing type 2 diabetes (Hispanic, Native American, South or East Asian, or Pacific Islander descent).4,19,20 Factors associated with a lower risk for developing gestational diabetes include age younger than 25 to 30 years, White race, a body mass index (BMI) of 25 or less (calculated as weight in kilograms divided by height in meters squared), no family history (in a first-degree relative) of diabetes, and no history of glucose intolerance or adverse pregnancy outcomes related to gestational diabetes.21-23 The risk in different racial/ethnic groups may be due in part to social risk factors such as low socioeconomic status or structural racism, although these associations are not examined in the current evidence. Although a higher BMI increases the risk of gestational diabetes across racial/ethnic groups, the association varies. In Asian American persons, the prevalence of gestational diabetes at a BMI of 22 to less than 25 is similar to the prevalence in Hispanic persons, non-Hispanic White persons, and Black persons with a higher (&gt;28) BMI.24,25\r\n '}, {'id': 1845, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends offering or referring adults with cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity.', 'servfreq': '', 'risktext': 'Adults 18 years or older at increased risk of CVD, defined as those with 1 or more of the following:\r\n1.Hypertension or elevated blood pressure2.Dyslipidemia3.Mixed or multiple risk factors such as the metabolic syndrome or an estimated 10-year CVD risk of &ge;7.5%\r\nThis recommendation does not apply to adults with other known modifiable cardiovascular risk factors such as abnormal blood glucose levels, obesity, and smoking; these populations are incorporated in other USPSTF recommendations.'}, {'id': 1931, 'title': 'Healthy Weight and Weight Gain In Pregnancy: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer pregnant persons effective behavioral counseling interventions aimed at promoting healthy weight gain and preventing excess gestational weight gain in pregnancy.', 'servfreq': 'Throughout pregnancy', 'risktext': 'Pregnancy'}, {'id': 1885, 'title': 'Hepatitis B Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in adolescents and adults at increased risk for infection.\r\rSee the Practice Considerations section for a description of adolescents and adults at increased risk for infection.', 'servfreq': 'For patients with negative HBsAg results who have not received the HBV vaccine series, periodic screening may be useful for those who report continued risk for acquiring HBV transmission, such as persons who continue to inject drugs and men who have sex with men. Clinical judgment should be used to determine screening frequency. The USPSTF found no evidence to determine optimal screening intervals.', 'risktext': 'Persons from such risk groups include persons who have injected drugs in the past or currently; men who have sex with men; persons with HIV; and sex partners, needle-sharing contacts, and household contacts of persons known to be HBsAg positive. Some persons with combinations of risk factors who are not members of risk factor groups listed above may also be at increased risk for HBV infection.'}, {'id': 524, 'title': 'Hepatitis C Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis C virus (HCV) infection in adults aged 18 to 79 years.', 'servfreq': 'One-time screening for most adults.\r\nPeriodically screen persons with continued risk for HCV infection (eg, persons with past or current injection drug use). There is limited evidence to determine how often to screen persons at increased risk.&nbsp;', 'risktext': 'Asymptomatic adults aged 18 to 79 years (including pregnant persons) without known liver disease.&nbsp;\r\nThe USPSTF also suggests that clinicians consider screening persons younger than 18 years and older than 79 years who are at high risk for infection (eg, those with past or current injection drug use).&nbsp;'}, {'id': 2023, 'title': 'Hypertensive Disorders of Pregnancy: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hypertensive disorders in pregnant persons with blood pressure measurements throughout pregnancy.', 'servfreq': 'Screening Interval\r\nBlood pressure measurements should be obtained during each prenatal care visit throughout pregnancy. Hypertensive disorders of pregnancy can quickly evolve into severe disease that can result in serious, even fatal, maternal and infant health outcomes. The ability to screen for hypertensive disorders of pregnancy using blood pressure measurements is important to identify and effectively treat a potentially unpredictable and fatal condition. While it is known that risk continues into the immediate postpartum period, there is little evidence regarding screening during this period. A pragmatic approach would be for patients to be counseled regarding signs and symptoms of preeclampsia at hospital discharge and for patients with hypertensive disorders to have subsequent blood pressure checks.\r\nScreening for hypertensive disorders of pregnancy alone is not sufficient to improve inequities in health outcomes. Identifying hypertensive disorders of pregnancy requires adequate prenatal visits, surveillance, and evidence-based care in response to evolving patient signs and symptoms during pregnancy and the postpartum period to improve health outcomes. Black and Native American/Alaska Native persons have lower rates of prenatal visits and are at greater risk of serious postpartum morbidity and hospital readmission after delivery. Screening and monitoring of Black and Hispanic/Latina individuals during the postpartum period could be an important step for reducing health inequities by preventing serious adverse events. In addition, screening and monitoring by various health care providers (eg, nurse midwives, nurses, pediatricians, doulas, and lactation consultants) could also help avert serious complications in the postpartum period.', 'risktext': 'Assessment of Risk\r\nImportant clinical conditions associated with increased risk for preeclampsia include a history of eclampsia or preeclampsia in a prior pregnancy, a previous adverse pregnancy outcome, and maternal comorbid conditions (including type 1 or type 2 diabetes prior to pregnancy, gestational diabetes, chronic hypertension, kidney disease, and autoimmune diseases).\r\n&nbsp;Other factors associated with increased risk of preeclampsia and gestational hypertension include nulliparity, high prepregnancy body mass index, family history of preeclampsia, multifetal gestation, and the pregnant individual being 35 years or older.\r\nThe higher prevalence of hypertensive disorders of pregnancy and the increased risk for severe complications seen in Black persons may be due to their disproportionate burden of social and clinical risk factors. These social and clinical determinants largely result from historical and current manifestations of structural racism that influence environmental exposures, access to health resources, and overall health status.'}, {'id': 434, 'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians screen for intimate partner violence (IPV) in women of reproductive age and provide or refer women who screen positive to ongoing support services. See the Clinical Considerations section for more information on effective ongoing support services for IPV and for information on IPV in men.', 'servfreq': 'The USPSTF found no evidence on appropriate intervals for screening. Randomized clinical trials (RCTs) of screening and interventions for IPV often screen for current IPV or IPV in the past year.\r\n&nbsp;', 'risktext': 'All women of reproductive age are at potential risk for IPV and should be screened. There are a variety of factors that increase risk of IPV, such as exposure to violence as a child, young age, unemployment, substance abuse, marital difficulties, and economic hardships.\r\nRisk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health. For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.'}, {'id': 187, 'title': 'Rh(D) Incompatibility: Screening ', 'grade': 'B', 'text': "The DoctorAI recommends repeated Rh(D) antibody testing for all unsensitized Rh(D)-negative women at 24 to 28 weeks' gestation, unless the biological father is known to be Rh(D)-negative.", 'servfreq': 'Repeat testing at 24-28 weeks gestation.', 'risktext': ''}, {'id': 1916, 'title': 'Lung Cancer: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery.', 'servfreq': ' \r\nThe USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. ', 'risktext': ' \r\nSmoking and older age are the 2 most important risk factors for lung cancer.&nbsp;The risk of lung cancer in persons who smoke increases with cumulative quantity and duration of smoking and with age but decreases with increasing time since quitting for persons who formerly smoked.3 The USPSTF considers adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years to be at high risk and recommends screening for lung cancer with annual LDCT in this population. \r\n \r\n&nbsp;\r\n \r\nAfrican American/Black (Black) men have a higher incidence of lung cancer than White men, and Black women have a lower incidence than White women.1 These differences are likely related to differences in smoking exposure (ie, prevalence of smoking) and related exposure to carcinogens in cigarettes.7,8 The differences may also be related to other social risk factors.\r\n \r\n&nbsp;\r\n \r\nOther risk factors for lung cancer include environmental exposures, prior radiation therapy, other (noncancer) lung diseases, and family history. Lower level of education is also associated with a higher risk of lung cancer.7 The task force recommends using age and smoking history to determine screening eligibility rather than more elaborate risk prediction models because there is insufficient evidence to assess whether risk prediction model&ndash;based screening would improve outcomes relative to using the risk factors of age and smoking history for broad implementation in primary care.\r\n '}, {'id': 449, 'title': 'Perinatal Depression: Preventive Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians provide or refer pregnant and postpartum persons who are at increased risk of perinatal depression to counseling interventions.', 'servfreq': '', 'risktext': 'Include&nbsp;a past history of depression. Current depressive symptoms (that do not reach a diagnostic threshold),&nbsp;history of physical or sexual abuse,&nbsp;unplanned or unwanted pregnancy,&nbsp;stressful life events,&nbsp;lack of social and financial support,&nbsp;intimate partner violence,pregestational or gestational diabetes,and complications during pregnancy. Additional risk factors include adolescent parenthood, low socioeconomic status, and lack of social support.&nbsp;Genetic factors are also suspected to contribute to women&rsquo;s risk of developing perinatal depression.'}, {'id': 1445, 'title': 'Sexually Transmitted Infections: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends behavioral counseling for all sexually active adolescents and for adults who are at increased risk for sexually transmitted infections (STIs).\r\rSee the Practice Considerations section for more information on populations at increased risk for acquiring STIs.', 'servfreq': '', 'risktext': 'All sexually active adolescents are at increased risk for STIs because of the high rates of STIs in this age group and should receive behavioral counseling interventions. Adults at increased risk for STIs include those who currently have an STI or were diagnosed with one within the past year, do not consistently use condoms, have multiple sex partners, or have sex partners within populations with a high prevalence of STIs. Populations with a high prevalence of STIs include persons who seek STI testing or attend STI clinics; sexual and gender minorities; persons who are living with HIV, inject drugs, have exchanged sex for money or drugs, or have entered correctional facilities; and some racial/ethnic minority groups.1-4'}, {'id': 402, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends counseling young adults, adolescents, children, and parents of young children about minimizing exposure to ultraviolet (UV) radiation for persons aged 6 months to 24 years with fair skin types to reduce their risk of skin cancer.', 'servfreq': '', 'risktext': 'Fair skin types'}, {'id': 438, 'title': 'Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for unhealthy alcohol use in primary care settings in adults 18 years or older, including pregnant women, and providing persons engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce unhealthy alcohol use.', 'servfreq': 'The USPSTF did not find adequate evidence to recommend an optimal screening interval for unhealthy alcohol use in adults.&nbsp;Brief behavioral counseling interventions were found to reduce unhealthy alcohol use in adults 18 years or older, including pregnant women. Effective behavioral counseling interventions vary in their specific components, administration, length, and number of interactions. The USPSTF was unable to identify specific intervention characteristics or components that were clearly associated with improved outcomes.', 'risktext': 'engaged in risky or hazardous drinking'}, {'id': 767, 'title': 'Unhealthy Drug Use: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening by asking questions about unhealthy drug use in adults age 18 years or older. Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. \r(Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'servfreq': 'Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. (Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'risktext': 'These include being aged 18 to 25 years; male sex; having a mental health condition, personality or mood disorder, or nicotine or alcohol dependence; a history of physical or sexual abuse, parental neglect, or other adversity in childhood; or drug or alcohol addiction in a first-degree relative.1,9&nbsp;Factors associated with misuse of prescription drugs include history of other drug use, mental illness, pain, and greater access to prescription drugs.10&nbsp;Factors associated with prenatal use of drugs include a mental health disorder, interpersonal violence, and family history of substance use.11'}, {'id': 433, 'title': 'Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer or refer adults with a body mass index (BMI) of 30 or higher (calculated as weight in kilograms divided by height in meters squared) to intensive, multicomponent behavioral interventions.', 'servfreq': '', 'risktext': 'Adults with a BMI &ge;30'}, {'id': 1979, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: Behavioral Counseling Interventions ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians individualize the decision to offer or refer adults without cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity. \r\rSee the "Practice Considerations" section for information on determining which patients may benefit most from this service.', 'servfreq': '', 'risktext': ''}, {'id': 508, 'title': 'BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine risk assessment, genetic counseling, or genetic testing for women whose personal or family history or ancestry is not associated with potentially harmful BRCA1/2 gene mutations.', 'servfreq': '', 'risktext': 'Patients with family or personal histories of breast, ovarian, tubal, or peritoneal cancer or ancestry associated with harmful&nbsp;BRCA1/2&nbsp;mutations should be assessed using a familial risk assessment tool. The USPSTF found adequate evidence that these tools are accurate in identifying women with increased likelihood of&nbsp;BRCA1/2mutations. Tools evaluated by the USPSTF include the Ontario Family History Assessment Tool, Manchester Scoring System, Referral Screening Tool, Pedigree Assessment Tool, 7-Question Family History Screening Tool, International Breast Cancer Intervention Study instrument (Tyrer-Cuzick), and brief versions of BRCAPRO. These tools should be used to guide referrals to genetic counseling.'}, {'id': 525, 'title': 'Bacterial Vaginosis in Pregnant Persons to Prevent Preterm Delivery: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for bacterial vaginosis (BV) in pregnant persons who are not at increased risk for preterm delivery.', 'servfreq': '', 'risktext': '\r\nAssess risk for preterm delivery. There are multiple factors that increase risk for preterm delivery; one of the strongest risk factors is prior preterm delivery.\r\nDecide whether or not to screen for bacterial vaginosis:\r\n\r\na. Do not screen pregnant persons who are not at increased risk for preterm delivery.\r\nb. Evidence is insufficient to recommend for or against screening pregnant persons at increased risk for preterm delivery.'}, {'id': 418, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening with resting or exercise electrocardiography (ECG) to prevent cardiovascular disease (CVD) events in asymptomatic adults at low risk of CVD events.', 'servfreq': '', 'risktext': ''}, {'id': 429, 'title': 'Cervical Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for cervical cancer in women who have had a hysterectomy with removal of the cervix and do not have a history of a high-grade precancerous lesion (ie, cervical intraepithelial neoplasia [CIN] grade 2 or 3) or cervical cancer.', 'servfreq': '', 'risktext': ''}, {'id': 428, 'title': 'Cervical Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for cervical cancer in women younger than 21 years.', 'servfreq': '', 'risktext': ''}, {'id': 1973, 'title': 'Chronic Obstructive Pulmonary Disease: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for chronic obstructive pulmonary disease in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 2003, 'title': 'Genital Herpes Infection: Serologic Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine serologic screening for genital herpes simplex virus infection in asymptomatic adolescents and adults, including pregnant persons.', 'servfreq': '', 'risktext': 'The USPSTF found no evidence of externally validated, reliable risk stratification tools to identify individuals more or less likely to have genital herpes.'}, {'id': 504, 'title': 'Pancreatic Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for pancreatic cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 365, 'title': 'Thyroid Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for thyroid cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 1976, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'D', 'text': 'The DoctorAI recommends against the use of beta carotene or vitamin E supplements for the prevention of cardiovascular disease or cancer.', 'servfreq': '', 'risktext': ''}, {'id': 318, 'title': 'Autism Spectrum Disorder in Young Children: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for autism spectrum disorder (ASD) in young children for whom no concerns of ASD have been raised by their parents or a clinician.', 'servfreq': '', 'risktext': 'Although a number of potential risk factors for ASD have been identified, there is insufficient evidence to determine if certain risk factors modify the performance characteristics of ASD screening tests, such as the age at which screening is performed or other characteristics of the child or family.'}, {'id': 526, 'title': 'Bacterial Vaginosis in Pregnant Persons to Prevent Preterm Delivery: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for BV in pregnant persons who are at increased risk for preterm delivery.', 'servfreq': '', 'risktext': ''}, {'id': 65, 'title': 'Bladder Cancer in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults.\r\rLiterature scans conducted in July 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'This evidence update focused on the benefits and harms of screening for bladder cancer among people without symptoms, the accuracy of screening tests done in primary care settings, and the benefits and harms of treatment. The updated evidence review did not find any new high quality evidence to adequately determine the balance of benefits and harms of screening for bladder cancer. However, bladder cancer is a common cancer and can cause considerable health problems including death. Therefore, the USPSTF determined that the evidence was insufficient to provide a recommendation for or against bladder cancer screening.  The USPSTF emphasizes the need for additional research in this area. '}, {'id': 2037, 'title': 'Breast Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of supplemental screening for breast cancer using breast ultrasonography or magnetic resonance imaging (MRI) in women identified to have dense breasts on an otherwise negative screening mammogram.\r\rSee the "Practice Considerations" section for more information on the patient population to whom this recommendation applies and on screening mammography modalities.', 'servfreq': '', 'risktext': 'These recommendations apply to cisgender women and all other persons assigned female at birth (including transgender men and nonbinary persons) 40 years or older at average risk of breast cancer. \r\nThese recommendations apply to persons who have factors associated with an increased risk of breast cancer, such as a family history of breast cancer (ie, a first-degree relative with breast cancer) or having dense breasts. They do not apply to persons who have a genetic marker or syndrome associated with a high risk of breast cancer (eg, BRCA1 or BRCA2 genetic variation), a history of high-dose radiation therapy to the chest at a young age, or previous breast cancer or a high-risk breast lesion on previous biopsies. '}, {'id': 419, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening with resting or exercise ECG to prevent CVD events in asymptomatic adults at intermediate or high risk of CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 423, 'title': 'Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of adding the ankle-brachial index (ABI), high-sensitivity C-reactive protein (hsCRP) level, or coronary artery calcium (CAC) score to traditional risk assessment for cardiovascular disease (CVD) in asymptomatic adults to prevent CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 352, 'title': 'Celiac Disease: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'persons with family history or other risk factors'}, {'id': 1955, 'title': 'Eating Disorders in Adolescents and Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for eating disorders in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1933, 'title': 'Gestational Diabetes: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for gestational diabetes in asymptomatic pregnant persons before 24 weeks of gestation.', 'servfreq': '', 'risktext': ''}, {'id': 665, 'title': 'Illicit Drug Use in Children, Adolescents, and Young Adults: Primary Care-Based Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--based behavioral counseling interventions to prevent illicit drug use, including nonmedical use of prescription drugs, in children, adolescents, and young adults.\r\rSee the Practice Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 435, 'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for abuse and neglect in all older or vulnerable adults. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': 'Risk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health.14&nbsp;For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.15'}, {'id': 2045, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for iron deficiency and iron deficiency anemia in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2046, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine iron supplementation in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2018, 'title': 'Lipid Disorders in Children and Adolescents: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1998, 'title': 'Obstructive Sleep Apnea in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for obstructive sleep apnea in the general adult population.\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Risk Factors\r\nRisk factors associated with OSA include male sex, older age (40-70 years), postmenopausal status, higher body mass index (BMI), and craniofacial and upper airway abnormalities (eg, enlarged tonsils or long upper airway). Black, Hispanic/Latino, and Native American/Alaska Native persons have a higher prevalence of OSA compared with White persons; some evidence suggests that these differences are partially explained by higher rates of obesity, asthma, and tobacco use among these groups.8'}, {'id': 1977, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of multivitamin supplements for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1978, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of single or paired nutrient supplements (other than beta carotene and vitamin E) for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 176, 'title': 'Oral Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for oral cancer in asymptomatic adults.\r\rGo to the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in July 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Tobacco and alcohol use are major risk factors for oral cancer. A total of 20% to 30% of cases of oral cancer worldwide are attributable to cigarette smoking. In the United States, up to 75% of cases of oral cancer may be attributable to tobacco and alcohol use. Additional risk factors include male sex, older age, use of betel quid, ultraviolet light exposure, infection with Candida or bacterial flora, and a compromised immune system. Sexually transmitted oral HPV infection (HPV-16) has recently been recognized as an increasingly important risk factor for oropharyngeal cancer. In the United States, the prevalence of oropharyngeal cancer due to oral HPV infection is probably as high as 80% to 95%. The prevalence of oral HPV infection is associated with age, sex, number of sexual partners, and number of cigarettes smoked per day. The effect of multifactorial risk assessment and screening for risk factors on oral cancer morbidity and mortality is unknown.'}, {'id': 2026, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine screening performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 2027, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of preventive interventions performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 424, 'title': 'Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for peripheral artery disease (PAD) and cardiovascular disease (CVD) risk with the ankle-brachial index (ABI) in asymptomatic adults.\r\rLiterature scans conducted in August 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Risk factors associated with OSA include male sex, older age (40 to 70 years), postmenopausal status, higher BMI, and craniofacial and upper airway abnormalities.'}, {'id': 404, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of counseling adults about skin self-examination to prevent skin cancer.See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 2005, 'title': 'Skin Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Exposure to UV radiation from sun exposure, indoor tanning beds, and other UV radiation&ndash;emitting devices is the major environmental risk factor for skin cancer. History of frequent sunburns, older age, and male sex are associated with increased risk for skin cancer. Exposure to UV radiation from the use of indoor tanning beds is an important risk factor in adolescents. Incidence of melanoma is higher among White persons compared with persons of other races and ethnicities. This difference likely reflects traits associated with increased melanoma risk, such as fair skin (which is more susceptible to sunburning), light-colored eyes, and red or blond hair being more common among White persons compared with persons of other races and ethnicities. Acral lentiginous melanoma, which occurs mostly on skin not frequently exposed to direct sunlight (eg, palms of hands, soles of feet, or under fingernails or toenails), is the most common type of melanoma among Black populations. Other melanoma risk factors include higher numbers of moles on the skin, atypical moles, as well as a personal and family history of skin cancer.'}, {'id': 269, 'title': 'Thyroid Dysfunction: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults.\r\rSee the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': 'The optimal screening interval for thyroid dysfunction (if one exists) is unknown.', 'risktext': 'The most common cause of hypothyroidism in the United States is chronic autoimmune (Hashimoto) thyroiditis. Risk factors for an elevated TSH level include female sex, advancing age, white race, type 1 diabetes, Down syndrome, family history of thyroid disease, goiter, previous hyperthyroidism (possibly due in part to ablation therapy leading to iatrogenic thyroid dysfunction), and external-beam radiation in the head and neck area. Common causes of hyperthyroidism include Graves disease, Hashimoto thyroiditis, and functional thyroid nodules. Risk factors for a low TSH level include female sex; advancing age; black race; low iodine intake; personal or family history of thyroid disease; and ingestion of iodine-containing drugs, such as amiodarone. The USPSTF found no direct evidence that treatment of thyroid dysfunction based on risk level alters final health outcomes.'}, {'id': 1908, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of electronic cigarettes (e-cigarettes) for tobacco cessation in adults, including pregnant persons. The USPSTF recommends that clinicians direct patients who use tobacco to other tobacco cessation interventions with proven effectiveness and established safety.\rSee the Practice Considerations section for more information on recommended behavioral interventions and pharmacotherapy and for suggestions for practice regarding the I statements.', 'servfreq': '', 'risktext': ''}, {'id': 1907, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of pharmacotherapy interventions for tobacco cessation in pregnant persons.', 'servfreq': '', 'risktext': ''}, {'id': 586, 'title': 'Tobacco Use in Children and Adolescents: Primary Care Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--feasible interventions for the cessation of tobacco use among school-aged children and adolescents.\r\rSee the Practice Considerations section for more information on effective interventions to prevent initiation of tobacco use and for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1919, 'title': 'Vitamin D Deficiency in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 408, 'title': 'Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of the benefits and harms of vitamin D and calcium supplementation, alone or combined, for the primary prevention of fractures in men and premenopausal women.', 'servfreq': '', 'risktext': ''}]
2025-01-29 22:03:09 [INFO] Update id=273478196 is handled. Duration 720 ms by bot id=8108339380
2025-01-29 22:06:09 [WARNING] Received SIGTERM signal
2025-01-29 22:06:09 [INFO] Polling stopped for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-29 22:06:09 [INFO] Polling stopped
2025-01-29 22:06:10 [INFO] โ ะัะป ะฟะพะดะบะปััะตะฝะธะน ะบ ะะ ะทะฐะบััั.
2025-01-29 22:06:10 [INFO] โ ะะพะดะบะปััะตะฝะธะต ะบ ะะ ะทะฐะบัััะพ.
2025-01-29 22:06:22 [INFO] ๐ ะะพั ะทะฐะฟััะบะฐะตััั...
2025-01-29 22:06:22 [INFO] โ ะัะป ะฟะพะดะบะปััะตะฝะธะน ะบ ะะ ัะพะทะดะฐะฝ.
2025-01-29 22:06:22 [INFO] โ ะขะฐะฑะปะธัั ะฒ ะฑะฐะทะต ะดะฐะฝะฝัั ััะฟะตัะฝะพ ัะพะทะดะฐะฝั.
2025-01-29 22:06:22 [INFO] Start polling
2025-01-29 22:06:23 [INFO] Run polling for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-29 22:06:24 [INFO] The user 711983855 called the command /start.
2025-01-29 22:06:25 [INFO] Update id=273478197 is handled. Duration 1260 ms by bot id=8108339380
2025-01-29 22:06:26 [INFO] The user 711983855's state has been set to Survey.age.
2025-01-29 22:06:26 [INFO] Update id=273478198 is handled. Duration 375 ms by bot id=8108339380
2025-01-29 22:06:29 [INFO] The user 711983855's state has been set to Survey.weight.
2025-01-29 22:06:29 [INFO] Update id=273478199 is handled. Duration 329 ms by bot id=8108339380
2025-01-29 22:06:31 [INFO] The user 711983855's state has been set to Survey.height.
2025-01-29 22:06:31 [INFO] Update id=273478200 is handled. Duration 399 ms by bot id=8108339380
2025-01-29 22:06:32 [INFO] The user 711983855's state has been set to Survey.feet.
2025-01-29 22:06:33 [INFO] Update id=273478201 is handled. Duration 355 ms by bot id=8108339380
2025-01-29 22:06:35 [INFO] The user 711983855's state has been set to Survey.gender.
2025-01-29 22:06:35 [INFO] Update id=273478202 is handled. Duration 337 ms by bot id=8108339380
2025-01-29 22:06:38 [INFO] The user 711983855's state has been set to Survey.smoking.
2025-01-29 22:06:38 [INFO] Update id=273478203 is handled. Duration 342 ms by bot id=8108339380
2025-01-29 22:06:39 [INFO] The user 711983855's state has been set to Survey.sex.
2025-01-29 22:06:40 [INFO] Update id=273478204 is handled. Duration 379 ms by bot id=8108339380
2025-01-29 22:06:41 [INFO] State data: {'db': <bot.database.Database object at 0x7f8939ee3590>, 'age': 20, 'weight': 90, 'height': 190, 'feet': 45, 'gender': 'male', 'pregnant': 'no', 'smoking': 'no', 'sex': 'yes'}
2025-01-29 22:06:41 [INFO] Recommendations fetched: [{'id': 485, 'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in adolescents and adults aged 15 to 65 years. Younger adolescents and older adults who are at increased risk of infection should also be screened.\rSee the Clinical Considerations section for more information about assessment of risk, screening intervals, and rescreening in pregnancy.', 'servfreq': 'The USPSTF found insufficient evidence to determine appropriate or optimal time intervals or strategies for repeat HIV screening. However, repeat screening is reasonable for persons known to be at increased risk of HIV infection, such as sexually active men who have sex with men; persons with a sex partner who is living with HIV; or persons who engage in behaviors that may convey an increased risk of HIV infection, such as injection drug use, transactional sex or commercial sex work, having 1 or more new sex partners whose HIV status is unknown, or having other factors that can place a person at increased risk of HIV infection (see &ldquo;Risk Assessment&rdquo;). Repeat screening is also reasonable for persons who live or receive medical care in a high-prevalence setting, such as a sexually transmitted disease clinic, tuberculosis clinic, correctional facility, or homeless shelter.', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'id': 1921, 'title': 'Hypertension in Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hypertension in adults 18 years or older with office blood pressure measurement (OBPM). The USPSTF recommends obtaining blood pressure measurements outside of the clinical setting for diagnostic confirmation before starting treatment.', 'servfreq': ' \r\nAlthough evidence on optimal screening intervals is limited, reasonable options include:\r\n \r\n \r\n\r\n\r\nScreening for hypertension every year in adults 40 years or older and in adults at increased risk for hypertension (such as Black persons, persons with high-normal blood pressure, or persons who are overweight or obese)\r\n\r\n\r\n \r\n \r\n\r\n\r\nScreening less frequently (ie, every 3 to 5 years) as appropriate for adults aged 18 to 39 years not at increased risk for hypertension and with a prior normal blood pressure reading.\r\n\r\n\r\n ', 'risktext': ' \r\nAlthough all adults should be screened for hypertension, risk factors that increase a person&rsquo;s risk for the condition include older age, Black race, family history, excess weight and obesity, lifestyle habits (lack of physical activity, stress, and tobacco use), and dietary factors (diet high in fat or sodium, diet low in potassium, or excessive alcohol intake)\r\n '}, {'id': 2021, 'title': 'Prevention of Acquisition of HIV: Preexposure Prophylaxis ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians prescribe preexposure prophylaxis using effective antiretroviral therapy to persons who are at increased risk of HIV acquisition to decrease the risk of acquiring HIV. \r\rSee the Practice Considerations section for more information about identification of persons at increased risk and about effective antiretroviral therapy.', 'servfreq': '', 'risktext': 'HIV is primarily acquired via sexual activity or injection drug use. It is important that clinicians routinely take a sexual and injection drug use history for all their patients in an open and nonjudgmental manner. All adolescents and adults who are sexually active or who inject drugs should be informed that acquisition of HIV can be prevented, to facilitate subsequent risk assessment and discussions about preexposure prophylaxis (PrEP) and other ways to prevent acquisition of HIV. Importantly, risk of HIV acquisition exists on a continuum, and currently available risk assessment tools all have limitations. However, certain risk factors or behaviors are known to place persons at increased risk of HIV.\r\nRisk of HIV acquisition depends on the likelihood that a specific act or activity will transmit HIV and the likelihood that a sex partner or drug injection partner has HIV. Likelihood of HIV transmission is highest with needle-sharing injection drug use and condomless receptive anal intercourse. Condomless receptive anal intercourse has an approximately 10- to 15-fold higher risk of transmission than condomless insertive anal sex and condomless receptive and insertive penile-vaginal sex. A 2018 study estimated the prevalence of HIV (ie, an estimate of the likelihood that a partner whose HIV status is unknown has HIV at a population level) as 12.4% among men who have sex with men and 1.9% among persons who inject drugs. The overall prevalence of HIV in the US is estimated at 0.3%.&nbsp;Of note, both the frequency of specific sexual activities and a person&rsquo;s number of sexual partners will also affect their risk of HIV.\r\n&nbsp;The USPSTF recommends that the following persons be considered for PrEP:\r\n1.&nbsp;&nbsp;&nbsp;&nbsp; Sexually active adults and adolescents weighing at least 35 kg (77 lb) who have engaged in anal or vaginal sex in the past 6 months and have any of the following:\r\n&nbsp;\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A sexual partner who has HIV (especially if the partner has an unknown or detectable viral load).\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A bacterial sexually transmitted infection (STI) (syphilis, gonorrhea, or chlamydia for men who have sex with men and transgender women; gonorrhea and syphilis for heterosexual women and men) in the past 6 months.\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A history of inconsistent or no condom use with sex partner(s) whose HIV status is not known; assessing risk in conversation with the patient and considering factors such as number of partners, the specific sexual activities a person engages in, and whether their sex partner or partners are in a group with a higher prevalence of HIV (eg, men who have sex with men or with men and women, transgender women, persons who inject drugs, and persons who engage in transactional sex).\r\n&nbsp;\r\n2. &nbsp; Persons who inject drugs and have a drug-injecting partner who has HIV or who shares injection equipment.\r\nPersons who engage in transactional sex, such as sex for money, drugs, or housing, including commercial sex workers or persons trafficked for sex work, constitute a group at increased risk of HIV acquisition and should be considered for PrEP based on the criteria outlined above. Persons who request PrEP may have undisclosed behaviors that put them at risk. Transgender women and men who are sexually active should be considered for PrEP based on the criteria outlined above. Transgender women are at especially high risk of HIV acquisition. A Centers for Disease Control and and Prevention (CDC) survey in 7 cities found an HIV prevalence of 42% among transgender women. Prevalence was highest among Black transgender women (62%) and Native American/Alaska Native transgender women (65%).\r\nIn addition, studies have found that transmission of HIV to a seronegative partner from a partner with HIV has not been observed when the partner with HIV was being treated with antiretroviral therapy and had a suppressed viral load.&nbsp;It is not known whether PrEP use further decreases the risk of HIV transmission when a partner with HIV has a documented undetectable viral load. Factors such as the consistency or inconsistency of a partner&rsquo;s viral load being suppressed, a partner&rsquo;s adherence to antiretroviral therapy, and the degree of certainty that a partner&rsquo;s viral load is suppressed (eg, self-report vs availability of laboratory test results) may help inform decisions about the use of PrEP in this situation.\r\nAll persons being considered for PrEP must have a recently documented negative HIV antigen-antibody test result, and if they have taken oral PrEP or postexposure prophylaxis in the past 3 months, or injectable cabotegravir in the past 12 months, the CDC recommends testing with both an HIV antigen-antibody assay and an HIV-1 RNA assay.'}, {'id': 1989, 'title': 'Syphilis Infection in Nonpregnant Adolescents and Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for syphilis infection in persons who are at increased risk for infection.', 'servfreq': 'Optimal screening frequency for persons who are at increased risk for syphilis infection is not well established. Men who have sex with men or persons with HIV infection may benefit from screening at least annually or more frequently (eg, every 3 to 6 months) if they continue to be at high risk.', 'risktext': 'The USPSTF recommends screening for syphilis in persons who are at increased risk for infection. When deciding which persons to screen for syphilis, clinicians should consider the prevalence of infection in the communities they serve, as well as other sociodemographic and behavioral factors that may be associated with increased risk of syphilis infection. For example, prevalence of syphilis is higher in men, men who have sex with men, persons with HIV infection, young adults, and persons with a history of incarceration, sex work, or military service. A substantial percentage of heterosexual syphilis transmission occurs among persons who use illicit drugs, particularly methamphetamine. Diagnosis of another STI may signal that a person is having condomless sex, which increases their risk of syphilis infection. Higher infection rates in persons of some racial and ethnic groups have been reported and are primarily a reflection of a combination of factors, including social determinants of health (eg, disparities of income, low educational achievement, and unstable housing), differential health insurance coverage or access to quality health care, and differences in sexual network characteristics (eg, individuals living in communities with a high prevalence of STIs have an increased chance of encountering an infected partner). Local prevalence rates may change over time, so clinicians should be aware of the latest data and trends for their specific population and geographic area, which are available through their state and local health departments and Centers for Disease Control and Prevention (CDC) surveillance.\r\n&nbsp;\r\nAlthough direct evidence on screening in nonpregnant persons who are not at increased risk for syphilis infection is lacking, based on the established test performance characteristics of current screening tests and the low prevalence rate of syphilis in this population, the yield of screening is likely low.9,10 Therefore, screening in this population may result in high false-positive rates and overtreatment.'}, {'id': 1905, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and US Food and Drug Administration (FDA)--approved pharmacotherapy for cessation to nonpregnant adults who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 2014, 'title': 'Anxiety Disorders in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for anxiety disorders in adults, including pregnant and postpartum persons.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding optimal timing for screening, or screening interval, for both the perinatal and general adult populations; more evidence on both timing and screening interval is needed for all adult populations. A pragmatic approach in the absence of evidence might include screening all adults who have not been screened previously and using clinical judgment in considering risk factors, comorbid conditions, and life events to determine if additional screening of high-risk patients is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nRisk factors for anxiety disorders include sociodemographic factors, psychosocial factors, and physical and mental health factors such as marital status (widowed or divorced), stressful life events, smoking and alcohol use, other mental health conditions, or a parental history of mental disorders. Demographic factors such as low socioeconomic status and female sex are associated with higher rates of anxiety disorders.&nbsp;Black persons and individuals of non-Hispanic ethnicity are at increased risk of anxiety disorders due to social, rather than biological, factors. Anxiety and depressive disorders often overlap. One cohort study found that 67% of individuals with a depressive disorder also had a current anxiety disorder, and 75% had a lifetime comorbid anxiety disorder.'}, {'id': 2009, 'title': 'Latent Tuberculosis Infection in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for LTBI in populations at increased risk.\r\rSee the "Assessment of Risk" section for additional information on adults at increased risk.', 'servfreq': 'The USPSTF found no evidence on the optimal frequency of screening for LTBI. In the absence of evidence, a reasonable approach is to repeat screening based on specific risk factors; screening frequency could range from 1-time only screening among persons at low risk for future tuberculosis exposure to annual screening among those at continued risk of exposure.', 'risktext': 'Populations at increased risk for LTBI, based on increased prevalence of active disease and increased risk of exposure, include persons who were born in, or are former residents of, countries with high tuberculosis prevalence and persons who live in, or have lived in, high-risk congregate settings (eg, homeless shelters or correctional facilities). Clinicians can consult their local or state health departments for more information about populations at increased risk in their community, since local demographic patterns may vary across the US.\r\nIn 2020, 71.5% of all cases of active tuberculosis in the US occurred among persons born outside the US. According to the CDC, tuberculosis disease is common in most countries in Latin America, the Caribbean, Africa, Asia, Eastern Europe, and Russia. In 2020, among persons with new tuberculosis living in the US who were born outside the US, the most common countries of birth were Mexico (18.0%), the Philippines (12.5%), India (10.4%), Vietnam (8.2%), and China (5.1%), accounting for 54.2% of total cases. Most of these cases are believed to be due to progression of latent infection to active tuberculosis disease rather than new transmission within communities.\r\nPersons who live, or have lived, in high-risk congregate settings also have a higher prevalence rate of active tuberculosis and an increased risk for exposure. In 2020, 4.3% of tuberculosis disease cases diagnosed in persons 15 years or older occurred in persons experiencing homelessness and 2.6% occurred in residents of correctional facilities. It is estimated that persons experiencing homelessness have an 11 times higher incidence of tuberculosis disease compared with persons who are not experiencing homelessness (36 cases per 100,000 population vs 2.9 cases per 100,000 population, respectively, during 2011 to 2016).\r\nOther populations at increased risk for LTBI or progression to active disease include persons who have immunosuppression (eg, persons living with HIV, patients receiving immunosuppressive medications such as chemotherapy or tumor necrosis factor inhibitors, and patients who have received an organ transplant) and patients with silicosis (a lung disease). However, given that screening in these populations may be considered standard care as part of disease management or indicated prior to the use of certain medications, the USPSTF did not review evidence on screening in these populations. Information on testing in these populations is provided by other groups, such as the Office of AIDS Research at the National Institutes of Health, and in a guideline issued jointly by the American Thoracic Society, Infectious Diseases Society of America, and CDC. Some evidence from observational studies has explored the association between poorly controlled diabetes and progression of LTBI to active disease. However, there is insufficient evidence on screening for and treatment of LTBI in persons with diabetes for the USPSTF to make a separate recommendation for this important population.\r\nPersons who are contacts of individuals with active tuberculosis, health care workers, and workers in high-risk congregate settings may also be at increased risk of exposure. Because screening in these populations is conducted as part of public health or employee health surveillance, the USPSTF did not review the evidence in these populations. Clinicians seeking further information about testing for tuberculosis in these populations can refer to the Additional Tools and Resources and Recommendations of Others sections.'}, {'id': 514, 'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic bacteriuria in nonpregnant adults.', 'servfreq': '', 'risktext': 'The risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6 Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5 Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7, 11, 12 In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12 Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4, 6'}, {'id': 1909, 'title': 'Asymptomatic Carotid Artery Stenosis: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic carotid artery stenosis in the general adult population.\r\rSee the Practice Considerations section for a description of adults at increased risk.', 'servfreq': '', 'risktext': ''}, {'id': 2017, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for suicide risk in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': '', 'risktext': ''}, {'id': 2016, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for depression in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding the optimal timing for screening for depression; more evidence is needed in both perinatal and general adult populations. In the absence of evidence, a pragmatic approach might include screening adults who have not been screened previously and using clinical judgment while considering risk factors, comorbid conditions, and life events to determine if additional screening of patients at increased risk is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nThe USPSTF recommends screening for depression in all adults regardless of risk factors. Risk factors for depression include a combination of genetic, biological, and environmental factors, such as a family history of depression, prior episode of depression or other mental health condition, a history of trauma or adverse life events, or a history of disease or illness (eg, cardiovascular disease).\r\nPrevalence rates vary by sex, age, race, ethnicity, education, marital status, geographic location, poverty level, and employment status. Women have twice the risk of depression compared with men. Young adults, multiracial individuals, and Native American/Alaska Native individuals have higher rates of depression.\r\nRisk factors for perinatal depression include life stress, low social support, history of depression, marital or partner dissatisfaction, and a history of abuse.'}, {'id': 1845, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends offering or referring adults with cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity.', 'servfreq': '', 'risktext': 'Adults 18 years or older at increased risk of CVD, defined as those with 1 or more of the following:\r\n1.Hypertension or elevated blood pressure2.Dyslipidemia3.Mixed or multiple risk factors such as the metabolic syndrome or an estimated 10-year CVD risk of &ge;7.5%\r\nThis recommendation does not apply to adults with other known modifiable cardiovascular risk factors such as abnormal blood glucose levels, obesity, and smoking; these populations are incorporated in other USPSTF recommendations.'}, {'id': 1885, 'title': 'Hepatitis B Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in adolescents and adults at increased risk for infection.\r\rSee the Practice Considerations section for a description of adolescents and adults at increased risk for infection.', 'servfreq': 'For patients with negative HBsAg results who have not received the HBV vaccine series, periodic screening may be useful for those who report continued risk for acquiring HBV transmission, such as persons who continue to inject drugs and men who have sex with men. Clinical judgment should be used to determine screening frequency. The USPSTF found no evidence to determine optimal screening intervals.', 'risktext': 'Persons from such risk groups include persons who have injected drugs in the past or currently; men who have sex with men; persons with HIV; and sex partners, needle-sharing contacts, and household contacts of persons known to be HBsAg positive. Some persons with combinations of risk factors who are not members of risk factor groups listed above may also be at increased risk for HBV infection.'}, {'id': 524, 'title': 'Hepatitis C Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis C virus (HCV) infection in adults aged 18 to 79 years.', 'servfreq': 'One-time screening for most adults.\r\nPeriodically screen persons with continued risk for HCV infection (eg, persons with past or current injection drug use). There is limited evidence to determine how often to screen persons at increased risk.&nbsp;', 'risktext': 'Asymptomatic adults aged 18 to 79 years (including pregnant persons) without known liver disease.&nbsp;\r\nThe USPSTF also suggests that clinicians consider screening persons younger than 18 years and older than 79 years who are at high risk for infection (eg, those with past or current injection drug use).&nbsp;'}, {'id': 1445, 'title': 'Sexually Transmitted Infections: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends behavioral counseling for all sexually active adolescents and for adults who are at increased risk for sexually transmitted infections (STIs).\r\rSee the Practice Considerations section for more information on populations at increased risk for acquiring STIs.', 'servfreq': '', 'risktext': 'All sexually active adolescents are at increased risk for STIs because of the high rates of STIs in this age group and should receive behavioral counseling interventions. Adults at increased risk for STIs include those who currently have an STI or were diagnosed with one within the past year, do not consistently use condoms, have multiple sex partners, or have sex partners within populations with a high prevalence of STIs. Populations with a high prevalence of STIs include persons who seek STI testing or attend STI clinics; sexual and gender minorities; persons who are living with HIV, inject drugs, have exchanged sex for money or drugs, or have entered correctional facilities; and some racial/ethnic minority groups.1-4'}, {'id': 402, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends counseling young adults, adolescents, children, and parents of young children about minimizing exposure to ultraviolet (UV) radiation for persons aged 6 months to 24 years with fair skin types to reduce their risk of skin cancer.', 'servfreq': '', 'risktext': 'Fair skin types'}, {'id': 438, 'title': 'Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for unhealthy alcohol use in primary care settings in adults 18 years or older, including pregnant women, and providing persons engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce unhealthy alcohol use.', 'servfreq': 'The USPSTF did not find adequate evidence to recommend an optimal screening interval for unhealthy alcohol use in adults.&nbsp;Brief behavioral counseling interventions were found to reduce unhealthy alcohol use in adults 18 years or older, including pregnant women. Effective behavioral counseling interventions vary in their specific components, administration, length, and number of interactions. The USPSTF was unable to identify specific intervention characteristics or components that were clearly associated with improved outcomes.', 'risktext': 'engaged in risky or hazardous drinking'}, {'id': 767, 'title': 'Unhealthy Drug Use: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening by asking questions about unhealthy drug use in adults age 18 years or older. Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. \r(Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'servfreq': 'Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. (Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'risktext': 'These include being aged 18 to 25 years; male sex; having a mental health condition, personality or mood disorder, or nicotine or alcohol dependence; a history of physical or sexual abuse, parental neglect, or other adversity in childhood; or drug or alcohol addiction in a first-degree relative.1,9&nbsp;Factors associated with misuse of prescription drugs include history of other drug use, mental illness, pain, and greater access to prescription drugs.10&nbsp;Factors associated with prenatal use of drugs include a mental health disorder, interpersonal violence, and family history of substance use.11'}, {'id': 433, 'title': 'Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer or refer adults with a body mass index (BMI) of 30 or higher (calculated as weight in kilograms divided by height in meters squared) to intensive, multicomponent behavioral interventions.', 'servfreq': '', 'risktext': 'Adults with a BMI &ge;30'}, {'id': 1979, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: Behavioral Counseling Interventions ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians individualize the decision to offer or refer adults without cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity. \r\rSee the "Practice Considerations" section for information on determining which patients may benefit most from this service.', 'servfreq': '', 'risktext': ''}, {'id': 1937, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for chlamydia and gonorrhea in men.', 'servfreq': '', 'risktext': ''}, {'id': 418, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening with resting or exercise electrocardiography (ECG) to prevent cardiovascular disease (CVD) events in asymptomatic adults at low risk of CVD events.', 'servfreq': '', 'risktext': ''}, {'id': 1973, 'title': 'Chronic Obstructive Pulmonary Disease: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for chronic obstructive pulmonary disease in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 2003, 'title': 'Genital Herpes Infection: Serologic Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine serologic screening for genital herpes simplex virus infection in asymptomatic adolescents and adults, including pregnant persons.', 'servfreq': '', 'risktext': 'The USPSTF found no evidence of externally validated, reliable risk stratification tools to identify individuals more or less likely to have genital herpes.'}, {'id': 504, 'title': 'Pancreatic Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for pancreatic cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 203, 'title': 'Testicular Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for testicular cancer in adolescent or adult men.', 'servfreq': '', 'risktext': ''}, {'id': 365, 'title': 'Thyroid Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for thyroid cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 1976, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'D', 'text': 'The DoctorAI recommends against the use of beta carotene or vitamin E supplements for the prevention of cardiovascular disease or cancer.', 'servfreq': '', 'risktext': ''}, {'id': 318, 'title': 'Autism Spectrum Disorder in Young Children: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for autism spectrum disorder (ASD) in young children for whom no concerns of ASD have been raised by their parents or a clinician.', 'servfreq': '', 'risktext': 'Although a number of potential risk factors for ASD have been identified, there is insufficient evidence to determine if certain risk factors modify the performance characteristics of ASD screening tests, such as the age at which screening is performed or other characteristics of the child or family.'}, {'id': 65, 'title': 'Bladder Cancer in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults.\r\rLiterature scans conducted in July 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'This evidence update focused on the benefits and harms of screening for bladder cancer among people without symptoms, the accuracy of screening tests done in primary care settings, and the benefits and harms of treatment. The updated evidence review did not find any new high quality evidence to adequately determine the balance of benefits and harms of screening for bladder cancer. However, bladder cancer is a common cancer and can cause considerable health problems including death. Therefore, the USPSTF determined that the evidence was insufficient to provide a recommendation for or against bladder cancer screening.  The USPSTF emphasizes the need for additional research in this area. '}, {'id': 419, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening with resting or exercise ECG to prevent CVD events in asymptomatic adults at intermediate or high risk of CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 423, 'title': 'Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of adding the ankle-brachial index (ABI), high-sensitivity C-reactive protein (hsCRP) level, or coronary artery calcium (CAC) score to traditional risk assessment for cardiovascular disease (CVD) in asymptomatic adults to prevent CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 352, 'title': 'Celiac Disease: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'persons with family history or other risk factors'}, {'id': 1955, 'title': 'Eating Disorders in Adolescents and Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for eating disorders in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 665, 'title': 'Illicit Drug Use in Children, Adolescents, and Young Adults: Primary Care-Based Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--based behavioral counseling interventions to prevent illicit drug use, including nonmedical use of prescription drugs, in children, adolescents, and young adults.\r\rSee the Practice Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 435, 'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for abuse and neglect in all older or vulnerable adults. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': 'Risk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health.14&nbsp;For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.15'}, {'id': 2045, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for iron deficiency and iron deficiency anemia in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2046, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine iron supplementation in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2018, 'title': 'Lipid Disorders in Children and Adolescents: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1998, 'title': 'Obstructive Sleep Apnea in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for obstructive sleep apnea in the general adult population.\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Risk Factors\r\nRisk factors associated with OSA include male sex, older age (40-70 years), postmenopausal status, higher body mass index (BMI), and craniofacial and upper airway abnormalities (eg, enlarged tonsils or long upper airway). Black, Hispanic/Latino, and Native American/Alaska Native persons have a higher prevalence of OSA compared with White persons; some evidence suggests that these differences are partially explained by higher rates of obesity, asthma, and tobacco use among these groups.8'}, {'id': 1977, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of multivitamin supplements for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1978, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of single or paired nutrient supplements (other than beta carotene and vitamin E) for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 176, 'title': 'Oral Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for oral cancer in asymptomatic adults.\r\rGo to the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in July 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Tobacco and alcohol use are major risk factors for oral cancer. A total of 20% to 30% of cases of oral cancer worldwide are attributable to cigarette smoking. In the United States, up to 75% of cases of oral cancer may be attributable to tobacco and alcohol use. Additional risk factors include male sex, older age, use of betel quid, ultraviolet light exposure, infection with Candida or bacterial flora, and a compromised immune system. Sexually transmitted oral HPV infection (HPV-16) has recently been recognized as an increasingly important risk factor for oropharyngeal cancer. In the United States, the prevalence of oropharyngeal cancer due to oral HPV infection is probably as high as 80% to 95%. The prevalence of oral HPV infection is associated with age, sex, number of sexual partners, and number of cigarettes smoked per day. The effect of multifactorial risk assessment and screening for risk factors on oral cancer morbidity and mortality is unknown.'}, {'id': 2026, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine screening performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 2027, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of preventive interventions performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 424, 'title': 'Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for peripheral artery disease (PAD) and cardiovascular disease (CVD) risk with the ankle-brachial index (ABI) in asymptomatic adults.\r\rLiterature scans conducted in August 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Risk factors associated with OSA include male sex, older age (40 to 70 years), postmenopausal status, higher BMI, and craniofacial and upper airway abnormalities.'}, {'id': 404, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of counseling adults about skin self-examination to prevent skin cancer.See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 2005, 'title': 'Skin Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Exposure to UV radiation from sun exposure, indoor tanning beds, and other UV radiation&ndash;emitting devices is the major environmental risk factor for skin cancer. History of frequent sunburns, older age, and male sex are associated with increased risk for skin cancer. Exposure to UV radiation from the use of indoor tanning beds is an important risk factor in adolescents. Incidence of melanoma is higher among White persons compared with persons of other races and ethnicities. This difference likely reflects traits associated with increased melanoma risk, such as fair skin (which is more susceptible to sunburning), light-colored eyes, and red or blond hair being more common among White persons compared with persons of other races and ethnicities. Acral lentiginous melanoma, which occurs mostly on skin not frequently exposed to direct sunlight (eg, palms of hands, soles of feet, or under fingernails or toenails), is the most common type of melanoma among Black populations. Other melanoma risk factors include higher numbers of moles on the skin, atypical moles, as well as a personal and family history of skin cancer.'}, {'id': 269, 'title': 'Thyroid Dysfunction: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults.\r\rSee the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': 'The optimal screening interval for thyroid dysfunction (if one exists) is unknown.', 'risktext': 'The most common cause of hypothyroidism in the United States is chronic autoimmune (Hashimoto) thyroiditis. Risk factors for an elevated TSH level include female sex, advancing age, white race, type 1 diabetes, Down syndrome, family history of thyroid disease, goiter, previous hyperthyroidism (possibly due in part to ablation therapy leading to iatrogenic thyroid dysfunction), and external-beam radiation in the head and neck area. Common causes of hyperthyroidism include Graves disease, Hashimoto thyroiditis, and functional thyroid nodules. Risk factors for a low TSH level include female sex; advancing age; black race; low iodine intake; personal or family history of thyroid disease; and ingestion of iodine-containing drugs, such as amiodarone. The USPSTF found no direct evidence that treatment of thyroid dysfunction based on risk level alters final health outcomes.'}, {'id': 1908, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of electronic cigarettes (e-cigarettes) for tobacco cessation in adults, including pregnant persons. The USPSTF recommends that clinicians direct patients who use tobacco to other tobacco cessation interventions with proven effectiveness and established safety.\rSee the Practice Considerations section for more information on recommended behavioral interventions and pharmacotherapy and for suggestions for practice regarding the I statements.', 'servfreq': '', 'risktext': ''}, {'id': 1919, 'title': 'Vitamin D Deficiency in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 408, 'title': 'Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of the benefits and harms of vitamin D and calcium supplementation, alone or combined, for the primary prevention of fractures in men and premenopausal women.', 'servfreq': '', 'risktext': ''}]
2025-01-29 22:06:42 [INFO] Update id=273478205 is handled. Duration 740 ms by bot id=8108339380
2025-01-29 22:06:44 [INFO] State data: {'db': <bot.database.Database object at 0x7f8939ee3590>, 'age': 20, 'weight': 90, 'height': 190, 'feet': 45, 'gender': 'male', 'pregnant': 'no', 'smoking': 'no', 'sex': 'Tools_0', 'recommendations': [{'id': 485, 'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in adolescents and adults aged 15 to 65 years. Younger adolescents and older adults who are at increased risk of infection should also be screened.\rSee the Clinical Considerations section for more information about assessment of risk, screening intervals, and rescreening in pregnancy.', 'servfreq': 'The USPSTF found insufficient evidence to determine appropriate or optimal time intervals or strategies for repeat HIV screening. However, repeat screening is reasonable for persons known to be at increased risk of HIV infection, such as sexually active men who have sex with men; persons with a sex partner who is living with HIV; or persons who engage in behaviors that may convey an increased risk of HIV infection, such as injection drug use, transactional sex or commercial sex work, having 1 or more new sex partners whose HIV status is unknown, or having other factors that can place a person at increased risk of HIV infection (see &ldquo;Risk Assessment&rdquo;). Repeat screening is also reasonable for persons who live or receive medical care in a high-prevalence setting, such as a sexually transmitted disease clinic, tuberculosis clinic, correctional facility, or homeless shelter.', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'id': 1921, 'title': 'Hypertension in Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hypertension in adults 18 years or older with office blood pressure measurement (OBPM). The USPSTF recommends obtaining blood pressure measurements outside of the clinical setting for diagnostic confirmation before starting treatment.', 'servfreq': ' \r\nAlthough evidence on optimal screening intervals is limited, reasonable options include:\r\n \r\n \r\n\r\n\r\nScreening for hypertension every year in adults 40 years or older and in adults at increased risk for hypertension (such as Black persons, persons with high-normal blood pressure, or persons who are overweight or obese)\r\n\r\n\r\n \r\n \r\n\r\n\r\nScreening less frequently (ie, every 3 to 5 years) as appropriate for adults aged 18 to 39 years not at increased risk for hypertension and with a prior normal blood pressure reading.\r\n\r\n\r\n ', 'risktext': ' \r\nAlthough all adults should be screened for hypertension, risk factors that increase a person&rsquo;s risk for the condition include older age, Black race, family history, excess weight and obesity, lifestyle habits (lack of physical activity, stress, and tobacco use), and dietary factors (diet high in fat or sodium, diet low in potassium, or excessive alcohol intake)\r\n '}, {'id': 2021, 'title': 'Prevention of Acquisition of HIV: Preexposure Prophylaxis ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians prescribe preexposure prophylaxis using effective antiretroviral therapy to persons who are at increased risk of HIV acquisition to decrease the risk of acquiring HIV. \r\rSee the Practice Considerations section for more information about identification of persons at increased risk and about effective antiretroviral therapy.', 'servfreq': '', 'risktext': 'HIV is primarily acquired via sexual activity or injection drug use. It is important that clinicians routinely take a sexual and injection drug use history for all their patients in an open and nonjudgmental manner. All adolescents and adults who are sexually active or who inject drugs should be informed that acquisition of HIV can be prevented, to facilitate subsequent risk assessment and discussions about preexposure prophylaxis (PrEP) and other ways to prevent acquisition of HIV. Importantly, risk of HIV acquisition exists on a continuum, and currently available risk assessment tools all have limitations. However, certain risk factors or behaviors are known to place persons at increased risk of HIV.\r\nRisk of HIV acquisition depends on the likelihood that a specific act or activity will transmit HIV and the likelihood that a sex partner or drug injection partner has HIV. Likelihood of HIV transmission is highest with needle-sharing injection drug use and condomless receptive anal intercourse. Condomless receptive anal intercourse has an approximately 10- to 15-fold higher risk of transmission than condomless insertive anal sex and condomless receptive and insertive penile-vaginal sex. A 2018 study estimated the prevalence of HIV (ie, an estimate of the likelihood that a partner whose HIV status is unknown has HIV at a population level) as 12.4% among men who have sex with men and 1.9% among persons who inject drugs. The overall prevalence of HIV in the US is estimated at 0.3%.&nbsp;Of note, both the frequency of specific sexual activities and a person&rsquo;s number of sexual partners will also affect their risk of HIV.\r\n&nbsp;The USPSTF recommends that the following persons be considered for PrEP:\r\n1.&nbsp;&nbsp;&nbsp;&nbsp; Sexually active adults and adolescents weighing at least 35 kg (77 lb) who have engaged in anal or vaginal sex in the past 6 months and have any of the following:\r\n&nbsp;\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A sexual partner who has HIV (especially if the partner has an unknown or detectable viral load).\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A bacterial sexually transmitted infection (STI) (syphilis, gonorrhea, or chlamydia for men who have sex with men and transgender women; gonorrhea and syphilis for heterosexual women and men) in the past 6 months.\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A history of inconsistent or no condom use with sex partner(s) whose HIV status is not known; assessing risk in conversation with the patient and considering factors such as number of partners, the specific sexual activities a person engages in, and whether their sex partner or partners are in a group with a higher prevalence of HIV (eg, men who have sex with men or with men and women, transgender women, persons who inject drugs, and persons who engage in transactional sex).\r\n&nbsp;\r\n2. &nbsp; Persons who inject drugs and have a drug-injecting partner who has HIV or who shares injection equipment.\r\nPersons who engage in transactional sex, such as sex for money, drugs, or housing, including commercial sex workers or persons trafficked for sex work, constitute a group at increased risk of HIV acquisition and should be considered for PrEP based on the criteria outlined above. Persons who request PrEP may have undisclosed behaviors that put them at risk. Transgender women and men who are sexually active should be considered for PrEP based on the criteria outlined above. Transgender women are at especially high risk of HIV acquisition. A Centers for Disease Control and and Prevention (CDC) survey in 7 cities found an HIV prevalence of 42% among transgender women. Prevalence was highest among Black transgender women (62%) and Native American/Alaska Native transgender women (65%).\r\nIn addition, studies have found that transmission of HIV to a seronegative partner from a partner with HIV has not been observed when the partner with HIV was being treated with antiretroviral therapy and had a suppressed viral load.&nbsp;It is not known whether PrEP use further decreases the risk of HIV transmission when a partner with HIV has a documented undetectable viral load. Factors such as the consistency or inconsistency of a partner&rsquo;s viral load being suppressed, a partner&rsquo;s adherence to antiretroviral therapy, and the degree of certainty that a partner&rsquo;s viral load is suppressed (eg, self-report vs availability of laboratory test results) may help inform decisions about the use of PrEP in this situation.\r\nAll persons being considered for PrEP must have a recently documented negative HIV antigen-antibody test result, and if they have taken oral PrEP or postexposure prophylaxis in the past 3 months, or injectable cabotegravir in the past 12 months, the CDC recommends testing with both an HIV antigen-antibody assay and an HIV-1 RNA assay.'}, {'id': 1989, 'title': 'Syphilis Infection in Nonpregnant Adolescents and Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for syphilis infection in persons who are at increased risk for infection.', 'servfreq': 'Optimal screening frequency for persons who are at increased risk for syphilis infection is not well established. Men who have sex with men or persons with HIV infection may benefit from screening at least annually or more frequently (eg, every 3 to 6 months) if they continue to be at high risk.', 'risktext': 'The USPSTF recommends screening for syphilis in persons who are at increased risk for infection. When deciding which persons to screen for syphilis, clinicians should consider the prevalence of infection in the communities they serve, as well as other sociodemographic and behavioral factors that may be associated with increased risk of syphilis infection. For example, prevalence of syphilis is higher in men, men who have sex with men, persons with HIV infection, young adults, and persons with a history of incarceration, sex work, or military service. A substantial percentage of heterosexual syphilis transmission occurs among persons who use illicit drugs, particularly methamphetamine. Diagnosis of another STI may signal that a person is having condomless sex, which increases their risk of syphilis infection. Higher infection rates in persons of some racial and ethnic groups have been reported and are primarily a reflection of a combination of factors, including social determinants of health (eg, disparities of income, low educational achievement, and unstable housing), differential health insurance coverage or access to quality health care, and differences in sexual network characteristics (eg, individuals living in communities with a high prevalence of STIs have an increased chance of encountering an infected partner). Local prevalence rates may change over time, so clinicians should be aware of the latest data and trends for their specific population and geographic area, which are available through their state and local health departments and Centers for Disease Control and Prevention (CDC) surveillance.\r\n&nbsp;\r\nAlthough direct evidence on screening in nonpregnant persons who are not at increased risk for syphilis infection is lacking, based on the established test performance characteristics of current screening tests and the low prevalence rate of syphilis in this population, the yield of screening is likely low.9,10 Therefore, screening in this population may result in high false-positive rates and overtreatment.'}, {'id': 1905, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and US Food and Drug Administration (FDA)--approved pharmacotherapy for cessation to nonpregnant adults who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 2014, 'title': 'Anxiety Disorders in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for anxiety disorders in adults, including pregnant and postpartum persons.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding optimal timing for screening, or screening interval, for both the perinatal and general adult populations; more evidence on both timing and screening interval is needed for all adult populations. A pragmatic approach in the absence of evidence might include screening all adults who have not been screened previously and using clinical judgment in considering risk factors, comorbid conditions, and life events to determine if additional screening of high-risk patients is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nRisk factors for anxiety disorders include sociodemographic factors, psychosocial factors, and physical and mental health factors such as marital status (widowed or divorced), stressful life events, smoking and alcohol use, other mental health conditions, or a parental history of mental disorders. Demographic factors such as low socioeconomic status and female sex are associated with higher rates of anxiety disorders.&nbsp;Black persons and individuals of non-Hispanic ethnicity are at increased risk of anxiety disorders due to social, rather than biological, factors. Anxiety and depressive disorders often overlap. One cohort study found that 67% of individuals with a depressive disorder also had a current anxiety disorder, and 75% had a lifetime comorbid anxiety disorder.'}, {'id': 2009, 'title': 'Latent Tuberculosis Infection in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for LTBI in populations at increased risk.\r\rSee the "Assessment of Risk" section for additional information on adults at increased risk.', 'servfreq': 'The USPSTF found no evidence on the optimal frequency of screening for LTBI. In the absence of evidence, a reasonable approach is to repeat screening based on specific risk factors; screening frequency could range from 1-time only screening among persons at low risk for future tuberculosis exposure to annual screening among those at continued risk of exposure.', 'risktext': 'Populations at increased risk for LTBI, based on increased prevalence of active disease and increased risk of exposure, include persons who were born in, or are former residents of, countries with high tuberculosis prevalence and persons who live in, or have lived in, high-risk congregate settings (eg, homeless shelters or correctional facilities). Clinicians can consult their local or state health departments for more information about populations at increased risk in their community, since local demographic patterns may vary across the US.\r\nIn 2020, 71.5% of all cases of active tuberculosis in the US occurred among persons born outside the US. According to the CDC, tuberculosis disease is common in most countries in Latin America, the Caribbean, Africa, Asia, Eastern Europe, and Russia. In 2020, among persons with new tuberculosis living in the US who were born outside the US, the most common countries of birth were Mexico (18.0%), the Philippines (12.5%), India (10.4%), Vietnam (8.2%), and China (5.1%), accounting for 54.2% of total cases. Most of these cases are believed to be due to progression of latent infection to active tuberculosis disease rather than new transmission within communities.\r\nPersons who live, or have lived, in high-risk congregate settings also have a higher prevalence rate of active tuberculosis and an increased risk for exposure. In 2020, 4.3% of tuberculosis disease cases diagnosed in persons 15 years or older occurred in persons experiencing homelessness and 2.6% occurred in residents of correctional facilities. It is estimated that persons experiencing homelessness have an 11 times higher incidence of tuberculosis disease compared with persons who are not experiencing homelessness (36 cases per 100,000 population vs 2.9 cases per 100,000 population, respectively, during 2011 to 2016).\r\nOther populations at increased risk for LTBI or progression to active disease include persons who have immunosuppression (eg, persons living with HIV, patients receiving immunosuppressive medications such as chemotherapy or tumor necrosis factor inhibitors, and patients who have received an organ transplant) and patients with silicosis (a lung disease). However, given that screening in these populations may be considered standard care as part of disease management or indicated prior to the use of certain medications, the USPSTF did not review evidence on screening in these populations. Information on testing in these populations is provided by other groups, such as the Office of AIDS Research at the National Institutes of Health, and in a guideline issued jointly by the American Thoracic Society, Infectious Diseases Society of America, and CDC. Some evidence from observational studies has explored the association between poorly controlled diabetes and progression of LTBI to active disease. However, there is insufficient evidence on screening for and treatment of LTBI in persons with diabetes for the USPSTF to make a separate recommendation for this important population.\r\nPersons who are contacts of individuals with active tuberculosis, health care workers, and workers in high-risk congregate settings may also be at increased risk of exposure. Because screening in these populations is conducted as part of public health or employee health surveillance, the USPSTF did not review the evidence in these populations. Clinicians seeking further information about testing for tuberculosis in these populations can refer to the Additional Tools and Resources and Recommendations of Others sections.'}, {'id': 514, 'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic bacteriuria in nonpregnant adults.', 'servfreq': '', 'risktext': 'The risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6 Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5 Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7, 11, 12 In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12 Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4, 6'}, {'id': 1909, 'title': 'Asymptomatic Carotid Artery Stenosis: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic carotid artery stenosis in the general adult population.\r\rSee the Practice Considerations section for a description of adults at increased risk.', 'servfreq': '', 'risktext': ''}, {'id': 2017, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for suicide risk in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': '', 'risktext': ''}, {'id': 2016, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for depression in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding the optimal timing for screening for depression; more evidence is needed in both perinatal and general adult populations. In the absence of evidence, a pragmatic approach might include screening adults who have not been screened previously and using clinical judgment while considering risk factors, comorbid conditions, and life events to determine if additional screening of patients at increased risk is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nThe USPSTF recommends screening for depression in all adults regardless of risk factors. Risk factors for depression include a combination of genetic, biological, and environmental factors, such as a family history of depression, prior episode of depression or other mental health condition, a history of trauma or adverse life events, or a history of disease or illness (eg, cardiovascular disease).\r\nPrevalence rates vary by sex, age, race, ethnicity, education, marital status, geographic location, poverty level, and employment status. Women have twice the risk of depression compared with men. Young adults, multiracial individuals, and Native American/Alaska Native individuals have higher rates of depression.\r\nRisk factors for perinatal depression include life stress, low social support, history of depression, marital or partner dissatisfaction, and a history of abuse.'}, {'id': 1845, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends offering or referring adults with cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity.', 'servfreq': '', 'risktext': 'Adults 18 years or older at increased risk of CVD, defined as those with 1 or more of the following:\r\n1.Hypertension or elevated blood pressure2.Dyslipidemia3.Mixed or multiple risk factors such as the metabolic syndrome or an estimated 10-year CVD risk of &ge;7.5%\r\nThis recommendation does not apply to adults with other known modifiable cardiovascular risk factors such as abnormal blood glucose levels, obesity, and smoking; these populations are incorporated in other USPSTF recommendations.'}, {'id': 1885, 'title': 'Hepatitis B Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in adolescents and adults at increased risk for infection.\r\rSee the Practice Considerations section for a description of adolescents and adults at increased risk for infection.', 'servfreq': 'For patients with negative HBsAg results who have not received the HBV vaccine series, periodic screening may be useful for those who report continued risk for acquiring HBV transmission, such as persons who continue to inject drugs and men who have sex with men. Clinical judgment should be used to determine screening frequency. The USPSTF found no evidence to determine optimal screening intervals.', 'risktext': 'Persons from such risk groups include persons who have injected drugs in the past or currently; men who have sex with men; persons with HIV; and sex partners, needle-sharing contacts, and household contacts of persons known to be HBsAg positive. Some persons with combinations of risk factors who are not members of risk factor groups listed above may also be at increased risk for HBV infection.'}, {'id': 524, 'title': 'Hepatitis C Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis C virus (HCV) infection in adults aged 18 to 79 years.', 'servfreq': 'One-time screening for most adults.\r\nPeriodically screen persons with continued risk for HCV infection (eg, persons with past or current injection drug use). There is limited evidence to determine how often to screen persons at increased risk.&nbsp;', 'risktext': 'Asymptomatic adults aged 18 to 79 years (including pregnant persons) without known liver disease.&nbsp;\r\nThe USPSTF also suggests that clinicians consider screening persons younger than 18 years and older than 79 years who are at high risk for infection (eg, those with past or current injection drug use).&nbsp;'}, {'id': 1445, 'title': 'Sexually Transmitted Infections: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends behavioral counseling for all sexually active adolescents and for adults who are at increased risk for sexually transmitted infections (STIs).\r\rSee the Practice Considerations section for more information on populations at increased risk for acquiring STIs.', 'servfreq': '', 'risktext': 'All sexually active adolescents are at increased risk for STIs because of the high rates of STIs in this age group and should receive behavioral counseling interventions. Adults at increased risk for STIs include those who currently have an STI or were diagnosed with one within the past year, do not consistently use condoms, have multiple sex partners, or have sex partners within populations with a high prevalence of STIs. Populations with a high prevalence of STIs include persons who seek STI testing or attend STI clinics; sexual and gender minorities; persons who are living with HIV, inject drugs, have exchanged sex for money or drugs, or have entered correctional facilities; and some racial/ethnic minority groups.1-4'}, {'id': 402, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends counseling young adults, adolescents, children, and parents of young children about minimizing exposure to ultraviolet (UV) radiation for persons aged 6 months to 24 years with fair skin types to reduce their risk of skin cancer.', 'servfreq': '', 'risktext': 'Fair skin types'}, {'id': 438, 'title': 'Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for unhealthy alcohol use in primary care settings in adults 18 years or older, including pregnant women, and providing persons engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce unhealthy alcohol use.', 'servfreq': 'The USPSTF did not find adequate evidence to recommend an optimal screening interval for unhealthy alcohol use in adults.&nbsp;Brief behavioral counseling interventions were found to reduce unhealthy alcohol use in adults 18 years or older, including pregnant women. Effective behavioral counseling interventions vary in their specific components, administration, length, and number of interactions. The USPSTF was unable to identify specific intervention characteristics or components that were clearly associated with improved outcomes.', 'risktext': 'engaged in risky or hazardous drinking'}, {'id': 767, 'title': 'Unhealthy Drug Use: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening by asking questions about unhealthy drug use in adults age 18 years or older. Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. \r(Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'servfreq': 'Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. (Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'risktext': 'These include being aged 18 to 25 years; male sex; having a mental health condition, personality or mood disorder, or nicotine or alcohol dependence; a history of physical or sexual abuse, parental neglect, or other adversity in childhood; or drug or alcohol addiction in a first-degree relative.1,9&nbsp;Factors associated with misuse of prescription drugs include history of other drug use, mental illness, pain, and greater access to prescription drugs.10&nbsp;Factors associated with prenatal use of drugs include a mental health disorder, interpersonal violence, and family history of substance use.11'}, {'id': 433, 'title': 'Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer or refer adults with a body mass index (BMI) of 30 or higher (calculated as weight in kilograms divided by height in meters squared) to intensive, multicomponent behavioral interventions.', 'servfreq': '', 'risktext': 'Adults with a BMI &ge;30'}, {'id': 1979, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: Behavioral Counseling Interventions ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians individualize the decision to offer or refer adults without cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity. \r\rSee the "Practice Considerations" section for information on determining which patients may benefit most from this service.', 'servfreq': '', 'risktext': ''}, {'id': 1937, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for chlamydia and gonorrhea in men.', 'servfreq': '', 'risktext': ''}, {'id': 418, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening with resting or exercise electrocardiography (ECG) to prevent cardiovascular disease (CVD) events in asymptomatic adults at low risk of CVD events.', 'servfreq': '', 'risktext': ''}, {'id': 1973, 'title': 'Chronic Obstructive Pulmonary Disease: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for chronic obstructive pulmonary disease in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 2003, 'title': 'Genital Herpes Infection: Serologic Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine serologic screening for genital herpes simplex virus infection in asymptomatic adolescents and adults, including pregnant persons.', 'servfreq': '', 'risktext': 'The USPSTF found no evidence of externally validated, reliable risk stratification tools to identify individuals more or less likely to have genital herpes.'}, {'id': 504, 'title': 'Pancreatic Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for pancreatic cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 203, 'title': 'Testicular Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for testicular cancer in adolescent or adult men.', 'servfreq': '', 'risktext': ''}, {'id': 365, 'title': 'Thyroid Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for thyroid cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 1976, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'D', 'text': 'The DoctorAI recommends against the use of beta carotene or vitamin E supplements for the prevention of cardiovascular disease or cancer.', 'servfreq': '', 'risktext': ''}, {'id': 318, 'title': 'Autism Spectrum Disorder in Young Children: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for autism spectrum disorder (ASD) in young children for whom no concerns of ASD have been raised by their parents or a clinician.', 'servfreq': '', 'risktext': 'Although a number of potential risk factors for ASD have been identified, there is insufficient evidence to determine if certain risk factors modify the performance characteristics of ASD screening tests, such as the age at which screening is performed or other characteristics of the child or family.'}, {'id': 65, 'title': 'Bladder Cancer in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults.\r\rLiterature scans conducted in July 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'This evidence update focused on the benefits and harms of screening for bladder cancer among people without symptoms, the accuracy of screening tests done in primary care settings, and the benefits and harms of treatment. The updated evidence review did not find any new high quality evidence to adequately determine the balance of benefits and harms of screening for bladder cancer. However, bladder cancer is a common cancer and can cause considerable health problems including death. Therefore, the USPSTF determined that the evidence was insufficient to provide a recommendation for or against bladder cancer screening.  The USPSTF emphasizes the need for additional research in this area. '}, {'id': 419, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening with resting or exercise ECG to prevent CVD events in asymptomatic adults at intermediate or high risk of CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 423, 'title': 'Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of adding the ankle-brachial index (ABI), high-sensitivity C-reactive protein (hsCRP) level, or coronary artery calcium (CAC) score to traditional risk assessment for cardiovascular disease (CVD) in asymptomatic adults to prevent CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 352, 'title': 'Celiac Disease: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'persons with family history or other risk factors'}, {'id': 1955, 'title': 'Eating Disorders in Adolescents and Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for eating disorders in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 665, 'title': 'Illicit Drug Use in Children, Adolescents, and Young Adults: Primary Care-Based Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--based behavioral counseling interventions to prevent illicit drug use, including nonmedical use of prescription drugs, in children, adolescents, and young adults.\r\rSee the Practice Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 435, 'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for abuse and neglect in all older or vulnerable adults. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': 'Risk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health.14&nbsp;For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.15'}, {'id': 2045, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for iron deficiency and iron deficiency anemia in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2046, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine iron supplementation in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2018, 'title': 'Lipid Disorders in Children and Adolescents: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1998, 'title': 'Obstructive Sleep Apnea in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for obstructive sleep apnea in the general adult population.\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Risk Factors\r\nRisk factors associated with OSA include male sex, older age (40-70 years), postmenopausal status, higher body mass index (BMI), and craniofacial and upper airway abnormalities (eg, enlarged tonsils or long upper airway). Black, Hispanic/Latino, and Native American/Alaska Native persons have a higher prevalence of OSA compared with White persons; some evidence suggests that these differences are partially explained by higher rates of obesity, asthma, and tobacco use among these groups.8'}, {'id': 1977, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of multivitamin supplements for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1978, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of single or paired nutrient supplements (other than beta carotene and vitamin E) for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 176, 'title': 'Oral Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for oral cancer in asymptomatic adults.\r\rGo to the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in July 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Tobacco and alcohol use are major risk factors for oral cancer. A total of 20% to 30% of cases of oral cancer worldwide are attributable to cigarette smoking. In the United States, up to 75% of cases of oral cancer may be attributable to tobacco and alcohol use. Additional risk factors include male sex, older age, use of betel quid, ultraviolet light exposure, infection with Candida or bacterial flora, and a compromised immune system. Sexually transmitted oral HPV infection (HPV-16) has recently been recognized as an increasingly important risk factor for oropharyngeal cancer. In the United States, the prevalence of oropharyngeal cancer due to oral HPV infection is probably as high as 80% to 95%. The prevalence of oral HPV infection is associated with age, sex, number of sexual partners, and number of cigarettes smoked per day. The effect of multifactorial risk assessment and screening for risk factors on oral cancer morbidity and mortality is unknown.'}, {'id': 2026, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine screening performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 2027, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of preventive interventions performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 424, 'title': 'Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for peripheral artery disease (PAD) and cardiovascular disease (CVD) risk with the ankle-brachial index (ABI) in asymptomatic adults.\r\rLiterature scans conducted in August 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Risk factors associated with OSA include male sex, older age (40 to 70 years), postmenopausal status, higher BMI, and craniofacial and upper airway abnormalities.'}, {'id': 404, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of counseling adults about skin self-examination to prevent skin cancer.See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 2005, 'title': 'Skin Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Exposure to UV radiation from sun exposure, indoor tanning beds, and other UV radiation&ndash;emitting devices is the major environmental risk factor for skin cancer. History of frequent sunburns, older age, and male sex are associated with increased risk for skin cancer. Exposure to UV radiation from the use of indoor tanning beds is an important risk factor in adolescents. Incidence of melanoma is higher among White persons compared with persons of other races and ethnicities. This difference likely reflects traits associated with increased melanoma risk, such as fair skin (which is more susceptible to sunburning), light-colored eyes, and red or blond hair being more common among White persons compared with persons of other races and ethnicities. Acral lentiginous melanoma, which occurs mostly on skin not frequently exposed to direct sunlight (eg, palms of hands, soles of feet, or under fingernails or toenails), is the most common type of melanoma among Black populations. Other melanoma risk factors include higher numbers of moles on the skin, atypical moles, as well as a personal and family history of skin cancer.'}, {'id': 269, 'title': 'Thyroid Dysfunction: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults.\r\rSee the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': 'The optimal screening interval for thyroid dysfunction (if one exists) is unknown.', 'risktext': 'The most common cause of hypothyroidism in the United States is chronic autoimmune (Hashimoto) thyroiditis. Risk factors for an elevated TSH level include female sex, advancing age, white race, type 1 diabetes, Down syndrome, family history of thyroid disease, goiter, previous hyperthyroidism (possibly due in part to ablation therapy leading to iatrogenic thyroid dysfunction), and external-beam radiation in the head and neck area. Common causes of hyperthyroidism include Graves disease, Hashimoto thyroiditis, and functional thyroid nodules. Risk factors for a low TSH level include female sex; advancing age; black race; low iodine intake; personal or family history of thyroid disease; and ingestion of iodine-containing drugs, such as amiodarone. The USPSTF found no direct evidence that treatment of thyroid dysfunction based on risk level alters final health outcomes.'}, {'id': 1908, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of electronic cigarettes (e-cigarettes) for tobacco cessation in adults, including pregnant persons. The USPSTF recommends that clinicians direct patients who use tobacco to other tobacco cessation interventions with proven effectiveness and established safety.\rSee the Practice Considerations section for more information on recommended behavioral interventions and pharmacotherapy and for suggestions for practice regarding the I statements.', 'servfreq': '', 'risktext': ''}, {'id': 1919, 'title': 'Vitamin D Deficiency in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 408, 'title': 'Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of the benefits and harms of vitamin D and calcium supplementation, alone or combined, for the primary prevention of fractures in men and premenopausal women.', 'servfreq': '', 'risktext': ''}]}
2025-01-29 22:06:44 [INFO] Recommendations fetched: [{'id': 485, 'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in adolescents and adults aged 15 to 65 years. Younger adolescents and older adults who are at increased risk of infection should also be screened.\rSee the Clinical Considerations section for more information about assessment of risk, screening intervals, and rescreening in pregnancy.', 'servfreq': 'The USPSTF found insufficient evidence to determine appropriate or optimal time intervals or strategies for repeat HIV screening. However, repeat screening is reasonable for persons known to be at increased risk of HIV infection, such as sexually active men who have sex with men; persons with a sex partner who is living with HIV; or persons who engage in behaviors that may convey an increased risk of HIV infection, such as injection drug use, transactional sex or commercial sex work, having 1 or more new sex partners whose HIV status is unknown, or having other factors that can place a person at increased risk of HIV infection (see &ldquo;Risk Assessment&rdquo;). Repeat screening is also reasonable for persons who live or receive medical care in a high-prevalence setting, such as a sexually transmitted disease clinic, tuberculosis clinic, correctional facility, or homeless shelter.', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'id': 1921, 'title': 'Hypertension in Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hypertension in adults 18 years or older with office blood pressure measurement (OBPM). The USPSTF recommends obtaining blood pressure measurements outside of the clinical setting for diagnostic confirmation before starting treatment.', 'servfreq': ' \r\nAlthough evidence on optimal screening intervals is limited, reasonable options include:\r\n \r\n \r\n\r\n\r\nScreening for hypertension every year in adults 40 years or older and in adults at increased risk for hypertension (such as Black persons, persons with high-normal blood pressure, or persons who are overweight or obese)\r\n\r\n\r\n \r\n \r\n\r\n\r\nScreening less frequently (ie, every 3 to 5 years) as appropriate for adults aged 18 to 39 years not at increased risk for hypertension and with a prior normal blood pressure reading.\r\n\r\n\r\n ', 'risktext': ' \r\nAlthough all adults should be screened for hypertension, risk factors that increase a person&rsquo;s risk for the condition include older age, Black race, family history, excess weight and obesity, lifestyle habits (lack of physical activity, stress, and tobacco use), and dietary factors (diet high in fat or sodium, diet low in potassium, or excessive alcohol intake)\r\n '}, {'id': 2021, 'title': 'Prevention of Acquisition of HIV: Preexposure Prophylaxis ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians prescribe preexposure prophylaxis using effective antiretroviral therapy to persons who are at increased risk of HIV acquisition to decrease the risk of acquiring HIV. \r\rSee the Practice Considerations section for more information about identification of persons at increased risk and about effective antiretroviral therapy.', 'servfreq': '', 'risktext': 'HIV is primarily acquired via sexual activity or injection drug use. It is important that clinicians routinely take a sexual and injection drug use history for all their patients in an open and nonjudgmental manner. All adolescents and adults who are sexually active or who inject drugs should be informed that acquisition of HIV can be prevented, to facilitate subsequent risk assessment and discussions about preexposure prophylaxis (PrEP) and other ways to prevent acquisition of HIV. Importantly, risk of HIV acquisition exists on a continuum, and currently available risk assessment tools all have limitations. However, certain risk factors or behaviors are known to place persons at increased risk of HIV.\r\nRisk of HIV acquisition depends on the likelihood that a specific act or activity will transmit HIV and the likelihood that a sex partner or drug injection partner has HIV. Likelihood of HIV transmission is highest with needle-sharing injection drug use and condomless receptive anal intercourse. Condomless receptive anal intercourse has an approximately 10- to 15-fold higher risk of transmission than condomless insertive anal sex and condomless receptive and insertive penile-vaginal sex. A 2018 study estimated the prevalence of HIV (ie, an estimate of the likelihood that a partner whose HIV status is unknown has HIV at a population level) as 12.4% among men who have sex with men and 1.9% among persons who inject drugs. The overall prevalence of HIV in the US is estimated at 0.3%.&nbsp;Of note, both the frequency of specific sexual activities and a person&rsquo;s number of sexual partners will also affect their risk of HIV.\r\n&nbsp;The USPSTF recommends that the following persons be considered for PrEP:\r\n1.&nbsp;&nbsp;&nbsp;&nbsp; Sexually active adults and adolescents weighing at least 35 kg (77 lb) who have engaged in anal or vaginal sex in the past 6 months and have any of the following:\r\n&nbsp;\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A sexual partner who has HIV (especially if the partner has an unknown or detectable viral load).\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A bacterial sexually transmitted infection (STI) (syphilis, gonorrhea, or chlamydia for men who have sex with men and transgender women; gonorrhea and syphilis for heterosexual women and men) in the past 6 months.\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A history of inconsistent or no condom use with sex partner(s) whose HIV status is not known; assessing risk in conversation with the patient and considering factors such as number of partners, the specific sexual activities a person engages in, and whether their sex partner or partners are in a group with a higher prevalence of HIV (eg, men who have sex with men or with men and women, transgender women, persons who inject drugs, and persons who engage in transactional sex).\r\n&nbsp;\r\n2. &nbsp; Persons who inject drugs and have a drug-injecting partner who has HIV or who shares injection equipment.\r\nPersons who engage in transactional sex, such as sex for money, drugs, or housing, including commercial sex workers or persons trafficked for sex work, constitute a group at increased risk of HIV acquisition and should be considered for PrEP based on the criteria outlined above. Persons who request PrEP may have undisclosed behaviors that put them at risk. Transgender women and men who are sexually active should be considered for PrEP based on the criteria outlined above. Transgender women are at especially high risk of HIV acquisition. A Centers for Disease Control and and Prevention (CDC) survey in 7 cities found an HIV prevalence of 42% among transgender women. Prevalence was highest among Black transgender women (62%) and Native American/Alaska Native transgender women (65%).\r\nIn addition, studies have found that transmission of HIV to a seronegative partner from a partner with HIV has not been observed when the partner with HIV was being treated with antiretroviral therapy and had a suppressed viral load.&nbsp;It is not known whether PrEP use further decreases the risk of HIV transmission when a partner with HIV has a documented undetectable viral load. Factors such as the consistency or inconsistency of a partner&rsquo;s viral load being suppressed, a partner&rsquo;s adherence to antiretroviral therapy, and the degree of certainty that a partner&rsquo;s viral load is suppressed (eg, self-report vs availability of laboratory test results) may help inform decisions about the use of PrEP in this situation.\r\nAll persons being considered for PrEP must have a recently documented negative HIV antigen-antibody test result, and if they have taken oral PrEP or postexposure prophylaxis in the past 3 months, or injectable cabotegravir in the past 12 months, the CDC recommends testing with both an HIV antigen-antibody assay and an HIV-1 RNA assay.'}, {'id': 1989, 'title': 'Syphilis Infection in Nonpregnant Adolescents and Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for syphilis infection in persons who are at increased risk for infection.', 'servfreq': 'Optimal screening frequency for persons who are at increased risk for syphilis infection is not well established. Men who have sex with men or persons with HIV infection may benefit from screening at least annually or more frequently (eg, every 3 to 6 months) if they continue to be at high risk.', 'risktext': 'The USPSTF recommends screening for syphilis in persons who are at increased risk for infection. When deciding which persons to screen for syphilis, clinicians should consider the prevalence of infection in the communities they serve, as well as other sociodemographic and behavioral factors that may be associated with increased risk of syphilis infection. For example, prevalence of syphilis is higher in men, men who have sex with men, persons with HIV infection, young adults, and persons with a history of incarceration, sex work, or military service. A substantial percentage of heterosexual syphilis transmission occurs among persons who use illicit drugs, particularly methamphetamine. Diagnosis of another STI may signal that a person is having condomless sex, which increases their risk of syphilis infection. Higher infection rates in persons of some racial and ethnic groups have been reported and are primarily a reflection of a combination of factors, including social determinants of health (eg, disparities of income, low educational achievement, and unstable housing), differential health insurance coverage or access to quality health care, and differences in sexual network characteristics (eg, individuals living in communities with a high prevalence of STIs have an increased chance of encountering an infected partner). Local prevalence rates may change over time, so clinicians should be aware of the latest data and trends for their specific population and geographic area, which are available through their state and local health departments and Centers for Disease Control and Prevention (CDC) surveillance.\r\n&nbsp;\r\nAlthough direct evidence on screening in nonpregnant persons who are not at increased risk for syphilis infection is lacking, based on the established test performance characteristics of current screening tests and the low prevalence rate of syphilis in this population, the yield of screening is likely low.9,10 Therefore, screening in this population may result in high false-positive rates and overtreatment.'}, {'id': 1905, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and US Food and Drug Administration (FDA)--approved pharmacotherapy for cessation to nonpregnant adults who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 2014, 'title': 'Anxiety Disorders in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for anxiety disorders in adults, including pregnant and postpartum persons.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding optimal timing for screening, or screening interval, for both the perinatal and general adult populations; more evidence on both timing and screening interval is needed for all adult populations. A pragmatic approach in the absence of evidence might include screening all adults who have not been screened previously and using clinical judgment in considering risk factors, comorbid conditions, and life events to determine if additional screening of high-risk patients is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nRisk factors for anxiety disorders include sociodemographic factors, psychosocial factors, and physical and mental health factors such as marital status (widowed or divorced), stressful life events, smoking and alcohol use, other mental health conditions, or a parental history of mental disorders. Demographic factors such as low socioeconomic status and female sex are associated with higher rates of anxiety disorders.&nbsp;Black persons and individuals of non-Hispanic ethnicity are at increased risk of anxiety disorders due to social, rather than biological, factors. Anxiety and depressive disorders often overlap. One cohort study found that 67% of individuals with a depressive disorder also had a current anxiety disorder, and 75% had a lifetime comorbid anxiety disorder.'}, {'id': 2009, 'title': 'Latent Tuberculosis Infection in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for LTBI in populations at increased risk.\r\rSee the "Assessment of Risk" section for additional information on adults at increased risk.', 'servfreq': 'The USPSTF found no evidence on the optimal frequency of screening for LTBI. In the absence of evidence, a reasonable approach is to repeat screening based on specific risk factors; screening frequency could range from 1-time only screening among persons at low risk for future tuberculosis exposure to annual screening among those at continued risk of exposure.', 'risktext': 'Populations at increased risk for LTBI, based on increased prevalence of active disease and increased risk of exposure, include persons who were born in, or are former residents of, countries with high tuberculosis prevalence and persons who live in, or have lived in, high-risk congregate settings (eg, homeless shelters or correctional facilities). Clinicians can consult their local or state health departments for more information about populations at increased risk in their community, since local demographic patterns may vary across the US.\r\nIn 2020, 71.5% of all cases of active tuberculosis in the US occurred among persons born outside the US. According to the CDC, tuberculosis disease is common in most countries in Latin America, the Caribbean, Africa, Asia, Eastern Europe, and Russia. In 2020, among persons with new tuberculosis living in the US who were born outside the US, the most common countries of birth were Mexico (18.0%), the Philippines (12.5%), India (10.4%), Vietnam (8.2%), and China (5.1%), accounting for 54.2% of total cases. Most of these cases are believed to be due to progression of latent infection to active tuberculosis disease rather than new transmission within communities.\r\nPersons who live, or have lived, in high-risk congregate settings also have a higher prevalence rate of active tuberculosis and an increased risk for exposure. In 2020, 4.3% of tuberculosis disease cases diagnosed in persons 15 years or older occurred in persons experiencing homelessness and 2.6% occurred in residents of correctional facilities. It is estimated that persons experiencing homelessness have an 11 times higher incidence of tuberculosis disease compared with persons who are not experiencing homelessness (36 cases per 100,000 population vs 2.9 cases per 100,000 population, respectively, during 2011 to 2016).\r\nOther populations at increased risk for LTBI or progression to active disease include persons who have immunosuppression (eg, persons living with HIV, patients receiving immunosuppressive medications such as chemotherapy or tumor necrosis factor inhibitors, and patients who have received an organ transplant) and patients with silicosis (a lung disease). However, given that screening in these populations may be considered standard care as part of disease management or indicated prior to the use of certain medications, the USPSTF did not review evidence on screening in these populations. Information on testing in these populations is provided by other groups, such as the Office of AIDS Research at the National Institutes of Health, and in a guideline issued jointly by the American Thoracic Society, Infectious Diseases Society of America, and CDC. Some evidence from observational studies has explored the association between poorly controlled diabetes and progression of LTBI to active disease. However, there is insufficient evidence on screening for and treatment of LTBI in persons with diabetes for the USPSTF to make a separate recommendation for this important population.\r\nPersons who are contacts of individuals with active tuberculosis, health care workers, and workers in high-risk congregate settings may also be at increased risk of exposure. Because screening in these populations is conducted as part of public health or employee health surveillance, the USPSTF did not review the evidence in these populations. Clinicians seeking further information about testing for tuberculosis in these populations can refer to the Additional Tools and Resources and Recommendations of Others sections.'}, {'id': 514, 'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic bacteriuria in nonpregnant adults.', 'servfreq': '', 'risktext': 'The risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6 Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5 Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7, 11, 12 In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12 Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4, 6'}, {'id': 1909, 'title': 'Asymptomatic Carotid Artery Stenosis: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic carotid artery stenosis in the general adult population.\r\rSee the Practice Considerations section for a description of adults at increased risk.', 'servfreq': '', 'risktext': ''}, {'id': 2017, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for suicide risk in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': '', 'risktext': ''}, {'id': 2016, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for depression in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding the optimal timing for screening for depression; more evidence is needed in both perinatal and general adult populations. In the absence of evidence, a pragmatic approach might include screening adults who have not been screened previously and using clinical judgment while considering risk factors, comorbid conditions, and life events to determine if additional screening of patients at increased risk is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nThe USPSTF recommends screening for depression in all adults regardless of risk factors. Risk factors for depression include a combination of genetic, biological, and environmental factors, such as a family history of depression, prior episode of depression or other mental health condition, a history of trauma or adverse life events, or a history of disease or illness (eg, cardiovascular disease).\r\nPrevalence rates vary by sex, age, race, ethnicity, education, marital status, geographic location, poverty level, and employment status. Women have twice the risk of depression compared with men. Young adults, multiracial individuals, and Native American/Alaska Native individuals have higher rates of depression.\r\nRisk factors for perinatal depression include life stress, low social support, history of depression, marital or partner dissatisfaction, and a history of abuse.'}, {'id': 1845, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends offering or referring adults with cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity.', 'servfreq': '', 'risktext': 'Adults 18 years or older at increased risk of CVD, defined as those with 1 or more of the following:\r\n1.Hypertension or elevated blood pressure2.Dyslipidemia3.Mixed or multiple risk factors such as the metabolic syndrome or an estimated 10-year CVD risk of &ge;7.5%\r\nThis recommendation does not apply to adults with other known modifiable cardiovascular risk factors such as abnormal blood glucose levels, obesity, and smoking; these populations are incorporated in other USPSTF recommendations.'}, {'id': 1885, 'title': 'Hepatitis B Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in adolescents and adults at increased risk for infection.\r\rSee the Practice Considerations section for a description of adolescents and adults at increased risk for infection.', 'servfreq': 'For patients with negative HBsAg results who have not received the HBV vaccine series, periodic screening may be useful for those who report continued risk for acquiring HBV transmission, such as persons who continue to inject drugs and men who have sex with men. Clinical judgment should be used to determine screening frequency. The USPSTF found no evidence to determine optimal screening intervals.', 'risktext': 'Persons from such risk groups include persons who have injected drugs in the past or currently; men who have sex with men; persons with HIV; and sex partners, needle-sharing contacts, and household contacts of persons known to be HBsAg positive. Some persons with combinations of risk factors who are not members of risk factor groups listed above may also be at increased risk for HBV infection.'}, {'id': 524, 'title': 'Hepatitis C Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis C virus (HCV) infection in adults aged 18 to 79 years.', 'servfreq': 'One-time screening for most adults.\r\nPeriodically screen persons with continued risk for HCV infection (eg, persons with past or current injection drug use). There is limited evidence to determine how often to screen persons at increased risk.&nbsp;', 'risktext': 'Asymptomatic adults aged 18 to 79 years (including pregnant persons) without known liver disease.&nbsp;\r\nThe USPSTF also suggests that clinicians consider screening persons younger than 18 years and older than 79 years who are at high risk for infection (eg, those with past or current injection drug use).&nbsp;'}, {'id': 1445, 'title': 'Sexually Transmitted Infections: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends behavioral counseling for all sexually active adolescents and for adults who are at increased risk for sexually transmitted infections (STIs).\r\rSee the Practice Considerations section for more information on populations at increased risk for acquiring STIs.', 'servfreq': '', 'risktext': 'All sexually active adolescents are at increased risk for STIs because of the high rates of STIs in this age group and should receive behavioral counseling interventions. Adults at increased risk for STIs include those who currently have an STI or were diagnosed with one within the past year, do not consistently use condoms, have multiple sex partners, or have sex partners within populations with a high prevalence of STIs. Populations with a high prevalence of STIs include persons who seek STI testing or attend STI clinics; sexual and gender minorities; persons who are living with HIV, inject drugs, have exchanged sex for money or drugs, or have entered correctional facilities; and some racial/ethnic minority groups.1-4'}, {'id': 402, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends counseling young adults, adolescents, children, and parents of young children about minimizing exposure to ultraviolet (UV) radiation for persons aged 6 months to 24 years with fair skin types to reduce their risk of skin cancer.', 'servfreq': '', 'risktext': 'Fair skin types'}, {'id': 438, 'title': 'Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for unhealthy alcohol use in primary care settings in adults 18 years or older, including pregnant women, and providing persons engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce unhealthy alcohol use.', 'servfreq': 'The USPSTF did not find adequate evidence to recommend an optimal screening interval for unhealthy alcohol use in adults.&nbsp;Brief behavioral counseling interventions were found to reduce unhealthy alcohol use in adults 18 years or older, including pregnant women. Effective behavioral counseling interventions vary in their specific components, administration, length, and number of interactions. The USPSTF was unable to identify specific intervention characteristics or components that were clearly associated with improved outcomes.', 'risktext': 'engaged in risky or hazardous drinking'}, {'id': 767, 'title': 'Unhealthy Drug Use: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening by asking questions about unhealthy drug use in adults age 18 years or older. Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. \r(Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'servfreq': 'Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. (Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'risktext': 'These include being aged 18 to 25 years; male sex; having a mental health condition, personality or mood disorder, or nicotine or alcohol dependence; a history of physical or sexual abuse, parental neglect, or other adversity in childhood; or drug or alcohol addiction in a first-degree relative.1,9&nbsp;Factors associated with misuse of prescription drugs include history of other drug use, mental illness, pain, and greater access to prescription drugs.10&nbsp;Factors associated with prenatal use of drugs include a mental health disorder, interpersonal violence, and family history of substance use.11'}, {'id': 433, 'title': 'Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer or refer adults with a body mass index (BMI) of 30 or higher (calculated as weight in kilograms divided by height in meters squared) to intensive, multicomponent behavioral interventions.', 'servfreq': '', 'risktext': 'Adults with a BMI &ge;30'}, {'id': 1979, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: Behavioral Counseling Interventions ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians individualize the decision to offer or refer adults without cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity. \r\rSee the "Practice Considerations" section for information on determining which patients may benefit most from this service.', 'servfreq': '', 'risktext': ''}, {'id': 1937, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for chlamydia and gonorrhea in men.', 'servfreq': '', 'risktext': ''}, {'id': 418, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening with resting or exercise electrocardiography (ECG) to prevent cardiovascular disease (CVD) events in asymptomatic adults at low risk of CVD events.', 'servfreq': '', 'risktext': ''}, {'id': 1973, 'title': 'Chronic Obstructive Pulmonary Disease: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for chronic obstructive pulmonary disease in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 2003, 'title': 'Genital Herpes Infection: Serologic Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine serologic screening for genital herpes simplex virus infection in asymptomatic adolescents and adults, including pregnant persons.', 'servfreq': '', 'risktext': 'The USPSTF found no evidence of externally validated, reliable risk stratification tools to identify individuals more or less likely to have genital herpes.'}, {'id': 504, 'title': 'Pancreatic Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for pancreatic cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 203, 'title': 'Testicular Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for testicular cancer in adolescent or adult men.', 'servfreq': '', 'risktext': ''}, {'id': 365, 'title': 'Thyroid Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for thyroid cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 1976, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'D', 'text': 'The DoctorAI recommends against the use of beta carotene or vitamin E supplements for the prevention of cardiovascular disease or cancer.', 'servfreq': '', 'risktext': ''}, {'id': 318, 'title': 'Autism Spectrum Disorder in Young Children: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for autism spectrum disorder (ASD) in young children for whom no concerns of ASD have been raised by their parents or a clinician.', 'servfreq': '', 'risktext': 'Although a number of potential risk factors for ASD have been identified, there is insufficient evidence to determine if certain risk factors modify the performance characteristics of ASD screening tests, such as the age at which screening is performed or other characteristics of the child or family.'}, {'id': 65, 'title': 'Bladder Cancer in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults.\r\rLiterature scans conducted in July 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'This evidence update focused on the benefits and harms of screening for bladder cancer among people without symptoms, the accuracy of screening tests done in primary care settings, and the benefits and harms of treatment. The updated evidence review did not find any new high quality evidence to adequately determine the balance of benefits and harms of screening for bladder cancer. However, bladder cancer is a common cancer and can cause considerable health problems including death. Therefore, the USPSTF determined that the evidence was insufficient to provide a recommendation for or against bladder cancer screening.  The USPSTF emphasizes the need for additional research in this area. '}, {'id': 419, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening with resting or exercise ECG to prevent CVD events in asymptomatic adults at intermediate or high risk of CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 423, 'title': 'Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of adding the ankle-brachial index (ABI), high-sensitivity C-reactive protein (hsCRP) level, or coronary artery calcium (CAC) score to traditional risk assessment for cardiovascular disease (CVD) in asymptomatic adults to prevent CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 352, 'title': 'Celiac Disease: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'persons with family history or other risk factors'}, {'id': 1955, 'title': 'Eating Disorders in Adolescents and Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for eating disorders in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 665, 'title': 'Illicit Drug Use in Children, Adolescents, and Young Adults: Primary Care-Based Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--based behavioral counseling interventions to prevent illicit drug use, including nonmedical use of prescription drugs, in children, adolescents, and young adults.\r\rSee the Practice Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 435, 'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for abuse and neglect in all older or vulnerable adults. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': 'Risk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health.14&nbsp;For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.15'}, {'id': 2045, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for iron deficiency and iron deficiency anemia in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2046, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine iron supplementation in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2018, 'title': 'Lipid Disorders in Children and Adolescents: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1998, 'title': 'Obstructive Sleep Apnea in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for obstructive sleep apnea in the general adult population.\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Risk Factors\r\nRisk factors associated with OSA include male sex, older age (40-70 years), postmenopausal status, higher body mass index (BMI), and craniofacial and upper airway abnormalities (eg, enlarged tonsils or long upper airway). Black, Hispanic/Latino, and Native American/Alaska Native persons have a higher prevalence of OSA compared with White persons; some evidence suggests that these differences are partially explained by higher rates of obesity, asthma, and tobacco use among these groups.8'}, {'id': 1977, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of multivitamin supplements for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1978, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of single or paired nutrient supplements (other than beta carotene and vitamin E) for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 176, 'title': 'Oral Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for oral cancer in asymptomatic adults.\r\rGo to the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in July 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Tobacco and alcohol use are major risk factors for oral cancer. A total of 20% to 30% of cases of oral cancer worldwide are attributable to cigarette smoking. In the United States, up to 75% of cases of oral cancer may be attributable to tobacco and alcohol use. Additional risk factors include male sex, older age, use of betel quid, ultraviolet light exposure, infection with Candida or bacterial flora, and a compromised immune system. Sexually transmitted oral HPV infection (HPV-16) has recently been recognized as an increasingly important risk factor for oropharyngeal cancer. In the United States, the prevalence of oropharyngeal cancer due to oral HPV infection is probably as high as 80% to 95%. The prevalence of oral HPV infection is associated with age, sex, number of sexual partners, and number of cigarettes smoked per day. The effect of multifactorial risk assessment and screening for risk factors on oral cancer morbidity and mortality is unknown.'}, {'id': 2026, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine screening performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 2027, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of preventive interventions performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 424, 'title': 'Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for peripheral artery disease (PAD) and cardiovascular disease (CVD) risk with the ankle-brachial index (ABI) in asymptomatic adults.\r\rLiterature scans conducted in August 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Risk factors associated with OSA include male sex, older age (40 to 70 years), postmenopausal status, higher BMI, and craniofacial and upper airway abnormalities.'}, {'id': 404, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of counseling adults about skin self-examination to prevent skin cancer.See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 2005, 'title': 'Skin Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Exposure to UV radiation from sun exposure, indoor tanning beds, and other UV radiation&ndash;emitting devices is the major environmental risk factor for skin cancer. History of frequent sunburns, older age, and male sex are associated with increased risk for skin cancer. Exposure to UV radiation from the use of indoor tanning beds is an important risk factor in adolescents. Incidence of melanoma is higher among White persons compared with persons of other races and ethnicities. This difference likely reflects traits associated with increased melanoma risk, such as fair skin (which is more susceptible to sunburning), light-colored eyes, and red or blond hair being more common among White persons compared with persons of other races and ethnicities. Acral lentiginous melanoma, which occurs mostly on skin not frequently exposed to direct sunlight (eg, palms of hands, soles of feet, or under fingernails or toenails), is the most common type of melanoma among Black populations. Other melanoma risk factors include higher numbers of moles on the skin, atypical moles, as well as a personal and family history of skin cancer.'}, {'id': 269, 'title': 'Thyroid Dysfunction: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults.\r\rSee the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': 'The optimal screening interval for thyroid dysfunction (if one exists) is unknown.', 'risktext': 'The most common cause of hypothyroidism in the United States is chronic autoimmune (Hashimoto) thyroiditis. Risk factors for an elevated TSH level include female sex, advancing age, white race, type 1 diabetes, Down syndrome, family history of thyroid disease, goiter, previous hyperthyroidism (possibly due in part to ablation therapy leading to iatrogenic thyroid dysfunction), and external-beam radiation in the head and neck area. Common causes of hyperthyroidism include Graves disease, Hashimoto thyroiditis, and functional thyroid nodules. Risk factors for a low TSH level include female sex; advancing age; black race; low iodine intake; personal or family history of thyroid disease; and ingestion of iodine-containing drugs, such as amiodarone. The USPSTF found no direct evidence that treatment of thyroid dysfunction based on risk level alters final health outcomes.'}, {'id': 1908, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of electronic cigarettes (e-cigarettes) for tobacco cessation in adults, including pregnant persons. The USPSTF recommends that clinicians direct patients who use tobacco to other tobacco cessation interventions with proven effectiveness and established safety.\rSee the Practice Considerations section for more information on recommended behavioral interventions and pharmacotherapy and for suggestions for practice regarding the I statements.', 'servfreq': '', 'risktext': ''}, {'id': 1919, 'title': 'Vitamin D Deficiency in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 408, 'title': 'Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of the benefits and harms of vitamin D and calcium supplementation, alone or combined, for the primary prevention of fractures in men and premenopausal women.', 'servfreq': '', 'risktext': ''}]
2025-01-29 22:06:44 [INFO] Update id=273478206 is handled. Duration 785 ms by bot id=8108339380
2025-01-29 22:07:02 [INFO] Update id=273478207 is handled. Duration 710 ms by bot id=8108339380
2025-01-29 22:07:05 [INFO] Update id=273478208 is handled. Duration 667 ms by bot id=8108339380
2025-01-29 22:07:08 [INFO] Update id=273478209 is handled. Duration 854 ms by bot id=8108339380
2025-01-29 22:07:11 [INFO] Update id=273478210 is handled. Duration 668 ms by bot id=8108339380
2025-01-29 22:07:14 [INFO] Update id=273478211 is handled. Duration 754 ms by bot id=8108339380
2025-01-29 22:07:15 [INFO] Update id=273478212 is handled. Duration 802 ms by bot id=8108339380
2025-01-29 22:07:16 [INFO] State data: {'db': <bot.database.Database object at 0x7f8939ee3590>, 'age': 20, 'weight': 90, 'height': 190, 'feet': 45, 'gender': 'male', 'pregnant': 'no', 'smoking': 'no', 'sex': 'Tools_0', 'recommendations': [{'id': 485, 'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in adolescents and adults aged 15 to 65 years. Younger adolescents and older adults who are at increased risk of infection should also be screened.\rSee the Clinical Considerations section for more information about assessment of risk, screening intervals, and rescreening in pregnancy.', 'servfreq': 'The USPSTF found insufficient evidence to determine appropriate or optimal time intervals or strategies for repeat HIV screening. However, repeat screening is reasonable for persons known to be at increased risk of HIV infection, such as sexually active men who have sex with men; persons with a sex partner who is living with HIV; or persons who engage in behaviors that may convey an increased risk of HIV infection, such as injection drug use, transactional sex or commercial sex work, having 1 or more new sex partners whose HIV status is unknown, or having other factors that can place a person at increased risk of HIV infection (see &ldquo;Risk Assessment&rdquo;). Repeat screening is also reasonable for persons who live or receive medical care in a high-prevalence setting, such as a sexually transmitted disease clinic, tuberculosis clinic, correctional facility, or homeless shelter.', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'id': 1921, 'title': 'Hypertension in Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hypertension in adults 18 years or older with office blood pressure measurement (OBPM). The USPSTF recommends obtaining blood pressure measurements outside of the clinical setting for diagnostic confirmation before starting treatment.', 'servfreq': ' \r\nAlthough evidence on optimal screening intervals is limited, reasonable options include:\r\n \r\n \r\n\r\n\r\nScreening for hypertension every year in adults 40 years or older and in adults at increased risk for hypertension (such as Black persons, persons with high-normal blood pressure, or persons who are overweight or obese)\r\n\r\n\r\n \r\n \r\n\r\n\r\nScreening less frequently (ie, every 3 to 5 years) as appropriate for adults aged 18 to 39 years not at increased risk for hypertension and with a prior normal blood pressure reading.\r\n\r\n\r\n ', 'risktext': ' \r\nAlthough all adults should be screened for hypertension, risk factors that increase a person&rsquo;s risk for the condition include older age, Black race, family history, excess weight and obesity, lifestyle habits (lack of physical activity, stress, and tobacco use), and dietary factors (diet high in fat or sodium, diet low in potassium, or excessive alcohol intake)\r\n '}, {'id': 2021, 'title': 'Prevention of Acquisition of HIV: Preexposure Prophylaxis ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians prescribe preexposure prophylaxis using effective antiretroviral therapy to persons who are at increased risk of HIV acquisition to decrease the risk of acquiring HIV. \r\rSee the Practice Considerations section for more information about identification of persons at increased risk and about effective antiretroviral therapy.', 'servfreq': '', 'risktext': 'HIV is primarily acquired via sexual activity or injection drug use. It is important that clinicians routinely take a sexual and injection drug use history for all their patients in an open and nonjudgmental manner. All adolescents and adults who are sexually active or who inject drugs should be informed that acquisition of HIV can be prevented, to facilitate subsequent risk assessment and discussions about preexposure prophylaxis (PrEP) and other ways to prevent acquisition of HIV. Importantly, risk of HIV acquisition exists on a continuum, and currently available risk assessment tools all have limitations. However, certain risk factors or behaviors are known to place persons at increased risk of HIV.\r\nRisk of HIV acquisition depends on the likelihood that a specific act or activity will transmit HIV and the likelihood that a sex partner or drug injection partner has HIV. Likelihood of HIV transmission is highest with needle-sharing injection drug use and condomless receptive anal intercourse. Condomless receptive anal intercourse has an approximately 10- to 15-fold higher risk of transmission than condomless insertive anal sex and condomless receptive and insertive penile-vaginal sex. A 2018 study estimated the prevalence of HIV (ie, an estimate of the likelihood that a partner whose HIV status is unknown has HIV at a population level) as 12.4% among men who have sex with men and 1.9% among persons who inject drugs. The overall prevalence of HIV in the US is estimated at 0.3%.&nbsp;Of note, both the frequency of specific sexual activities and a person&rsquo;s number of sexual partners will also affect their risk of HIV.\r\n&nbsp;The USPSTF recommends that the following persons be considered for PrEP:\r\n1.&nbsp;&nbsp;&nbsp;&nbsp; Sexually active adults and adolescents weighing at least 35 kg (77 lb) who have engaged in anal or vaginal sex in the past 6 months and have any of the following:\r\n&nbsp;\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A sexual partner who has HIV (especially if the partner has an unknown or detectable viral load).\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A bacterial sexually transmitted infection (STI) (syphilis, gonorrhea, or chlamydia for men who have sex with men and transgender women; gonorrhea and syphilis for heterosexual women and men) in the past 6 months.\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A history of inconsistent or no condom use with sex partner(s) whose HIV status is not known; assessing risk in conversation with the patient and considering factors such as number of partners, the specific sexual activities a person engages in, and whether their sex partner or partners are in a group with a higher prevalence of HIV (eg, men who have sex with men or with men and women, transgender women, persons who inject drugs, and persons who engage in transactional sex).\r\n&nbsp;\r\n2. &nbsp; Persons who inject drugs and have a drug-injecting partner who has HIV or who shares injection equipment.\r\nPersons who engage in transactional sex, such as sex for money, drugs, or housing, including commercial sex workers or persons trafficked for sex work, constitute a group at increased risk of HIV acquisition and should be considered for PrEP based on the criteria outlined above. Persons who request PrEP may have undisclosed behaviors that put them at risk. Transgender women and men who are sexually active should be considered for PrEP based on the criteria outlined above. Transgender women are at especially high risk of HIV acquisition. A Centers for Disease Control and and Prevention (CDC) survey in 7 cities found an HIV prevalence of 42% among transgender women. Prevalence was highest among Black transgender women (62%) and Native American/Alaska Native transgender women (65%).\r\nIn addition, studies have found that transmission of HIV to a seronegative partner from a partner with HIV has not been observed when the partner with HIV was being treated with antiretroviral therapy and had a suppressed viral load.&nbsp;It is not known whether PrEP use further decreases the risk of HIV transmission when a partner with HIV has a documented undetectable viral load. Factors such as the consistency or inconsistency of a partner&rsquo;s viral load being suppressed, a partner&rsquo;s adherence to antiretroviral therapy, and the degree of certainty that a partner&rsquo;s viral load is suppressed (eg, self-report vs availability of laboratory test results) may help inform decisions about the use of PrEP in this situation.\r\nAll persons being considered for PrEP must have a recently documented negative HIV antigen-antibody test result, and if they have taken oral PrEP or postexposure prophylaxis in the past 3 months, or injectable cabotegravir in the past 12 months, the CDC recommends testing with both an HIV antigen-antibody assay and an HIV-1 RNA assay.'}, {'id': 1989, 'title': 'Syphilis Infection in Nonpregnant Adolescents and Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for syphilis infection in persons who are at increased risk for infection.', 'servfreq': 'Optimal screening frequency for persons who are at increased risk for syphilis infection is not well established. Men who have sex with men or persons with HIV infection may benefit from screening at least annually or more frequently (eg, every 3 to 6 months) if they continue to be at high risk.', 'risktext': 'The USPSTF recommends screening for syphilis in persons who are at increased risk for infection. When deciding which persons to screen for syphilis, clinicians should consider the prevalence of infection in the communities they serve, as well as other sociodemographic and behavioral factors that may be associated with increased risk of syphilis infection. For example, prevalence of syphilis is higher in men, men who have sex with men, persons with HIV infection, young adults, and persons with a history of incarceration, sex work, or military service. A substantial percentage of heterosexual syphilis transmission occurs among persons who use illicit drugs, particularly methamphetamine. Diagnosis of another STI may signal that a person is having condomless sex, which increases their risk of syphilis infection. Higher infection rates in persons of some racial and ethnic groups have been reported and are primarily a reflection of a combination of factors, including social determinants of health (eg, disparities of income, low educational achievement, and unstable housing), differential health insurance coverage or access to quality health care, and differences in sexual network characteristics (eg, individuals living in communities with a high prevalence of STIs have an increased chance of encountering an infected partner). Local prevalence rates may change over time, so clinicians should be aware of the latest data and trends for their specific population and geographic area, which are available through their state and local health departments and Centers for Disease Control and Prevention (CDC) surveillance.\r\n&nbsp;\r\nAlthough direct evidence on screening in nonpregnant persons who are not at increased risk for syphilis infection is lacking, based on the established test performance characteristics of current screening tests and the low prevalence rate of syphilis in this population, the yield of screening is likely low.9,10 Therefore, screening in this population may result in high false-positive rates and overtreatment.'}, {'id': 1905, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and US Food and Drug Administration (FDA)--approved pharmacotherapy for cessation to nonpregnant adults who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 2014, 'title': 'Anxiety Disorders in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for anxiety disorders in adults, including pregnant and postpartum persons.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding optimal timing for screening, or screening interval, for both the perinatal and general adult populations; more evidence on both timing and screening interval is needed for all adult populations. A pragmatic approach in the absence of evidence might include screening all adults who have not been screened previously and using clinical judgment in considering risk factors, comorbid conditions, and life events to determine if additional screening of high-risk patients is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nRisk factors for anxiety disorders include sociodemographic factors, psychosocial factors, and physical and mental health factors such as marital status (widowed or divorced), stressful life events, smoking and alcohol use, other mental health conditions, or a parental history of mental disorders. Demographic factors such as low socioeconomic status and female sex are associated with higher rates of anxiety disorders.&nbsp;Black persons and individuals of non-Hispanic ethnicity are at increased risk of anxiety disorders due to social, rather than biological, factors. Anxiety and depressive disorders often overlap. One cohort study found that 67% of individuals with a depressive disorder also had a current anxiety disorder, and 75% had a lifetime comorbid anxiety disorder.'}, {'id': 2009, 'title': 'Latent Tuberculosis Infection in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for LTBI in populations at increased risk.\r\rSee the "Assessment of Risk" section for additional information on adults at increased risk.', 'servfreq': 'The USPSTF found no evidence on the optimal frequency of screening for LTBI. In the absence of evidence, a reasonable approach is to repeat screening based on specific risk factors; screening frequency could range from 1-time only screening among persons at low risk for future tuberculosis exposure to annual screening among those at continued risk of exposure.', 'risktext': 'Populations at increased risk for LTBI, based on increased prevalence of active disease and increased risk of exposure, include persons who were born in, or are former residents of, countries with high tuberculosis prevalence and persons who live in, or have lived in, high-risk congregate settings (eg, homeless shelters or correctional facilities). Clinicians can consult their local or state health departments for more information about populations at increased risk in their community, since local demographic patterns may vary across the US.\r\nIn 2020, 71.5% of all cases of active tuberculosis in the US occurred among persons born outside the US. According to the CDC, tuberculosis disease is common in most countries in Latin America, the Caribbean, Africa, Asia, Eastern Europe, and Russia. In 2020, among persons with new tuberculosis living in the US who were born outside the US, the most common countries of birth were Mexico (18.0%), the Philippines (12.5%), India (10.4%), Vietnam (8.2%), and China (5.1%), accounting for 54.2% of total cases. Most of these cases are believed to be due to progression of latent infection to active tuberculosis disease rather than new transmission within communities.\r\nPersons who live, or have lived, in high-risk congregate settings also have a higher prevalence rate of active tuberculosis and an increased risk for exposure. In 2020, 4.3% of tuberculosis disease cases diagnosed in persons 15 years or older occurred in persons experiencing homelessness and 2.6% occurred in residents of correctional facilities. It is estimated that persons experiencing homelessness have an 11 times higher incidence of tuberculosis disease compared with persons who are not experiencing homelessness (36 cases per 100,000 population vs 2.9 cases per 100,000 population, respectively, during 2011 to 2016).\r\nOther populations at increased risk for LTBI or progression to active disease include persons who have immunosuppression (eg, persons living with HIV, patients receiving immunosuppressive medications such as chemotherapy or tumor necrosis factor inhibitors, and patients who have received an organ transplant) and patients with silicosis (a lung disease). However, given that screening in these populations may be considered standard care as part of disease management or indicated prior to the use of certain medications, the USPSTF did not review evidence on screening in these populations. Information on testing in these populations is provided by other groups, such as the Office of AIDS Research at the National Institutes of Health, and in a guideline issued jointly by the American Thoracic Society, Infectious Diseases Society of America, and CDC. Some evidence from observational studies has explored the association between poorly controlled diabetes and progression of LTBI to active disease. However, there is insufficient evidence on screening for and treatment of LTBI in persons with diabetes for the USPSTF to make a separate recommendation for this important population.\r\nPersons who are contacts of individuals with active tuberculosis, health care workers, and workers in high-risk congregate settings may also be at increased risk of exposure. Because screening in these populations is conducted as part of public health or employee health surveillance, the USPSTF did not review the evidence in these populations. Clinicians seeking further information about testing for tuberculosis in these populations can refer to the Additional Tools and Resources and Recommendations of Others sections.'}, {'id': 514, 'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic bacteriuria in nonpregnant adults.', 'servfreq': '', 'risktext': 'The risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6 Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5 Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7, 11, 12 In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12 Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4, 6'}, {'id': 1909, 'title': 'Asymptomatic Carotid Artery Stenosis: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic carotid artery stenosis in the general adult population.\r\rSee the Practice Considerations section for a description of adults at increased risk.', 'servfreq': '', 'risktext': ''}, {'id': 2017, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for suicide risk in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': '', 'risktext': ''}, {'id': 2016, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for depression in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding the optimal timing for screening for depression; more evidence is needed in both perinatal and general adult populations. In the absence of evidence, a pragmatic approach might include screening adults who have not been screened previously and using clinical judgment while considering risk factors, comorbid conditions, and life events to determine if additional screening of patients at increased risk is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nThe USPSTF recommends screening for depression in all adults regardless of risk factors. Risk factors for depression include a combination of genetic, biological, and environmental factors, such as a family history of depression, prior episode of depression or other mental health condition, a history of trauma or adverse life events, or a history of disease or illness (eg, cardiovascular disease).\r\nPrevalence rates vary by sex, age, race, ethnicity, education, marital status, geographic location, poverty level, and employment status. Women have twice the risk of depression compared with men. Young adults, multiracial individuals, and Native American/Alaska Native individuals have higher rates of depression.\r\nRisk factors for perinatal depression include life stress, low social support, history of depression, marital or partner dissatisfaction, and a history of abuse.'}, {'id': 1845, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends offering or referring adults with cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity.', 'servfreq': '', 'risktext': 'Adults 18 years or older at increased risk of CVD, defined as those with 1 or more of the following:\r\n1.Hypertension or elevated blood pressure2.Dyslipidemia3.Mixed or multiple risk factors such as the metabolic syndrome or an estimated 10-year CVD risk of &ge;7.5%\r\nThis recommendation does not apply to adults with other known modifiable cardiovascular risk factors such as abnormal blood glucose levels, obesity, and smoking; these populations are incorporated in other USPSTF recommendations.'}, {'id': 1885, 'title': 'Hepatitis B Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in adolescents and adults at increased risk for infection.\r\rSee the Practice Considerations section for a description of adolescents and adults at increased risk for infection.', 'servfreq': 'For patients with negative HBsAg results who have not received the HBV vaccine series, periodic screening may be useful for those who report continued risk for acquiring HBV transmission, such as persons who continue to inject drugs and men who have sex with men. Clinical judgment should be used to determine screening frequency. The USPSTF found no evidence to determine optimal screening intervals.', 'risktext': 'Persons from such risk groups include persons who have injected drugs in the past or currently; men who have sex with men; persons with HIV; and sex partners, needle-sharing contacts, and household contacts of persons known to be HBsAg positive. Some persons with combinations of risk factors who are not members of risk factor groups listed above may also be at increased risk for HBV infection.'}, {'id': 524, 'title': 'Hepatitis C Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis C virus (HCV) infection in adults aged 18 to 79 years.', 'servfreq': 'One-time screening for most adults.\r\nPeriodically screen persons with continued risk for HCV infection (eg, persons with past or current injection drug use). There is limited evidence to determine how often to screen persons at increased risk.&nbsp;', 'risktext': 'Asymptomatic adults aged 18 to 79 years (including pregnant persons) without known liver disease.&nbsp;\r\nThe USPSTF also suggests that clinicians consider screening persons younger than 18 years and older than 79 years who are at high risk for infection (eg, those with past or current injection drug use).&nbsp;'}, {'id': 1445, 'title': 'Sexually Transmitted Infections: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends behavioral counseling for all sexually active adolescents and for adults who are at increased risk for sexually transmitted infections (STIs).\r\rSee the Practice Considerations section for more information on populations at increased risk for acquiring STIs.', 'servfreq': '', 'risktext': 'All sexually active adolescents are at increased risk for STIs because of the high rates of STIs in this age group and should receive behavioral counseling interventions. Adults at increased risk for STIs include those who currently have an STI or were diagnosed with one within the past year, do not consistently use condoms, have multiple sex partners, or have sex partners within populations with a high prevalence of STIs. Populations with a high prevalence of STIs include persons who seek STI testing or attend STI clinics; sexual and gender minorities; persons who are living with HIV, inject drugs, have exchanged sex for money or drugs, or have entered correctional facilities; and some racial/ethnic minority groups.1-4'}, {'id': 402, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends counseling young adults, adolescents, children, and parents of young children about minimizing exposure to ultraviolet (UV) radiation for persons aged 6 months to 24 years with fair skin types to reduce their risk of skin cancer.', 'servfreq': '', 'risktext': 'Fair skin types'}, {'id': 438, 'title': 'Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for unhealthy alcohol use in primary care settings in adults 18 years or older, including pregnant women, and providing persons engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce unhealthy alcohol use.', 'servfreq': 'The USPSTF did not find adequate evidence to recommend an optimal screening interval for unhealthy alcohol use in adults.&nbsp;Brief behavioral counseling interventions were found to reduce unhealthy alcohol use in adults 18 years or older, including pregnant women. Effective behavioral counseling interventions vary in their specific components, administration, length, and number of interactions. The USPSTF was unable to identify specific intervention characteristics or components that were clearly associated with improved outcomes.', 'risktext': 'engaged in risky or hazardous drinking'}, {'id': 767, 'title': 'Unhealthy Drug Use: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening by asking questions about unhealthy drug use in adults age 18 years or older. Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. \r(Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'servfreq': 'Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. (Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'risktext': 'These include being aged 18 to 25 years; male sex; having a mental health condition, personality or mood disorder, or nicotine or alcohol dependence; a history of physical or sexual abuse, parental neglect, or other adversity in childhood; or drug or alcohol addiction in a first-degree relative.1,9&nbsp;Factors associated with misuse of prescription drugs include history of other drug use, mental illness, pain, and greater access to prescription drugs.10&nbsp;Factors associated with prenatal use of drugs include a mental health disorder, interpersonal violence, and family history of substance use.11'}, {'id': 433, 'title': 'Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer or refer adults with a body mass index (BMI) of 30 or higher (calculated as weight in kilograms divided by height in meters squared) to intensive, multicomponent behavioral interventions.', 'servfreq': '', 'risktext': 'Adults with a BMI &ge;30'}, {'id': 1979, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: Behavioral Counseling Interventions ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians individualize the decision to offer or refer adults without cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity. \r\rSee the "Practice Considerations" section for information on determining which patients may benefit most from this service.', 'servfreq': '', 'risktext': ''}, {'id': 1937, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for chlamydia and gonorrhea in men.', 'servfreq': '', 'risktext': ''}, {'id': 418, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening with resting or exercise electrocardiography (ECG) to prevent cardiovascular disease (CVD) events in asymptomatic adults at low risk of CVD events.', 'servfreq': '', 'risktext': ''}, {'id': 1973, 'title': 'Chronic Obstructive Pulmonary Disease: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for chronic obstructive pulmonary disease in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 2003, 'title': 'Genital Herpes Infection: Serologic Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine serologic screening for genital herpes simplex virus infection in asymptomatic adolescents and adults, including pregnant persons.', 'servfreq': '', 'risktext': 'The USPSTF found no evidence of externally validated, reliable risk stratification tools to identify individuals more or less likely to have genital herpes.'}, {'id': 504, 'title': 'Pancreatic Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for pancreatic cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 203, 'title': 'Testicular Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for testicular cancer in adolescent or adult men.', 'servfreq': '', 'risktext': ''}, {'id': 365, 'title': 'Thyroid Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for thyroid cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 1976, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'D', 'text': 'The DoctorAI recommends against the use of beta carotene or vitamin E supplements for the prevention of cardiovascular disease or cancer.', 'servfreq': '', 'risktext': ''}, {'id': 318, 'title': 'Autism Spectrum Disorder in Young Children: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for autism spectrum disorder (ASD) in young children for whom no concerns of ASD have been raised by their parents or a clinician.', 'servfreq': '', 'risktext': 'Although a number of potential risk factors for ASD have been identified, there is insufficient evidence to determine if certain risk factors modify the performance characteristics of ASD screening tests, such as the age at which screening is performed or other characteristics of the child or family.'}, {'id': 65, 'title': 'Bladder Cancer in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults.\r\rLiterature scans conducted in July 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'This evidence update focused on the benefits and harms of screening for bladder cancer among people without symptoms, the accuracy of screening tests done in primary care settings, and the benefits and harms of treatment. The updated evidence review did not find any new high quality evidence to adequately determine the balance of benefits and harms of screening for bladder cancer. However, bladder cancer is a common cancer and can cause considerable health problems including death. Therefore, the USPSTF determined that the evidence was insufficient to provide a recommendation for or against bladder cancer screening.  The USPSTF emphasizes the need for additional research in this area. '}, {'id': 419, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening with resting or exercise ECG to prevent CVD events in asymptomatic adults at intermediate or high risk of CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 423, 'title': 'Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of adding the ankle-brachial index (ABI), high-sensitivity C-reactive protein (hsCRP) level, or coronary artery calcium (CAC) score to traditional risk assessment for cardiovascular disease (CVD) in asymptomatic adults to prevent CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 352, 'title': 'Celiac Disease: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'persons with family history or other risk factors'}, {'id': 1955, 'title': 'Eating Disorders in Adolescents and Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for eating disorders in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 665, 'title': 'Illicit Drug Use in Children, Adolescents, and Young Adults: Primary Care-Based Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--based behavioral counseling interventions to prevent illicit drug use, including nonmedical use of prescription drugs, in children, adolescents, and young adults.\r\rSee the Practice Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 435, 'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for abuse and neglect in all older or vulnerable adults. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': 'Risk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health.14&nbsp;For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.15'}, {'id': 2045, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for iron deficiency and iron deficiency anemia in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2046, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine iron supplementation in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2018, 'title': 'Lipid Disorders in Children and Adolescents: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1998, 'title': 'Obstructive Sleep Apnea in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for obstructive sleep apnea in the general adult population.\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Risk Factors\r\nRisk factors associated with OSA include male sex, older age (40-70 years), postmenopausal status, higher body mass index (BMI), and craniofacial and upper airway abnormalities (eg, enlarged tonsils or long upper airway). Black, Hispanic/Latino, and Native American/Alaska Native persons have a higher prevalence of OSA compared with White persons; some evidence suggests that these differences are partially explained by higher rates of obesity, asthma, and tobacco use among these groups.8'}, {'id': 1977, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of multivitamin supplements for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1978, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of single or paired nutrient supplements (other than beta carotene and vitamin E) for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 176, 'title': 'Oral Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for oral cancer in asymptomatic adults.\r\rGo to the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in July 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Tobacco and alcohol use are major risk factors for oral cancer. A total of 20% to 30% of cases of oral cancer worldwide are attributable to cigarette smoking. In the United States, up to 75% of cases of oral cancer may be attributable to tobacco and alcohol use. Additional risk factors include male sex, older age, use of betel quid, ultraviolet light exposure, infection with Candida or bacterial flora, and a compromised immune system. Sexually transmitted oral HPV infection (HPV-16) has recently been recognized as an increasingly important risk factor for oropharyngeal cancer. In the United States, the prevalence of oropharyngeal cancer due to oral HPV infection is probably as high as 80% to 95%. The prevalence of oral HPV infection is associated with age, sex, number of sexual partners, and number of cigarettes smoked per day. The effect of multifactorial risk assessment and screening for risk factors on oral cancer morbidity and mortality is unknown.'}, {'id': 2026, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine screening performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 2027, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of preventive interventions performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 424, 'title': 'Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for peripheral artery disease (PAD) and cardiovascular disease (CVD) risk with the ankle-brachial index (ABI) in asymptomatic adults.\r\rLiterature scans conducted in August 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Risk factors associated with OSA include male sex, older age (40 to 70 years), postmenopausal status, higher BMI, and craniofacial and upper airway abnormalities.'}, {'id': 404, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of counseling adults about skin self-examination to prevent skin cancer.See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 2005, 'title': 'Skin Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Exposure to UV radiation from sun exposure, indoor tanning beds, and other UV radiation&ndash;emitting devices is the major environmental risk factor for skin cancer. History of frequent sunburns, older age, and male sex are associated with increased risk for skin cancer. Exposure to UV radiation from the use of indoor tanning beds is an important risk factor in adolescents. Incidence of melanoma is higher among White persons compared with persons of other races and ethnicities. This difference likely reflects traits associated with increased melanoma risk, such as fair skin (which is more susceptible to sunburning), light-colored eyes, and red or blond hair being more common among White persons compared with persons of other races and ethnicities. Acral lentiginous melanoma, which occurs mostly on skin not frequently exposed to direct sunlight (eg, palms of hands, soles of feet, or under fingernails or toenails), is the most common type of melanoma among Black populations. Other melanoma risk factors include higher numbers of moles on the skin, atypical moles, as well as a personal and family history of skin cancer.'}, {'id': 269, 'title': 'Thyroid Dysfunction: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults.\r\rSee the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': 'The optimal screening interval for thyroid dysfunction (if one exists) is unknown.', 'risktext': 'The most common cause of hypothyroidism in the United States is chronic autoimmune (Hashimoto) thyroiditis. Risk factors for an elevated TSH level include female sex, advancing age, white race, type 1 diabetes, Down syndrome, family history of thyroid disease, goiter, previous hyperthyroidism (possibly due in part to ablation therapy leading to iatrogenic thyroid dysfunction), and external-beam radiation in the head and neck area. Common causes of hyperthyroidism include Graves disease, Hashimoto thyroiditis, and functional thyroid nodules. Risk factors for a low TSH level include female sex; advancing age; black race; low iodine intake; personal or family history of thyroid disease; and ingestion of iodine-containing drugs, such as amiodarone. The USPSTF found no direct evidence that treatment of thyroid dysfunction based on risk level alters final health outcomes.'}, {'id': 1908, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of electronic cigarettes (e-cigarettes) for tobacco cessation in adults, including pregnant persons. The USPSTF recommends that clinicians direct patients who use tobacco to other tobacco cessation interventions with proven effectiveness and established safety.\rSee the Practice Considerations section for more information on recommended behavioral interventions and pharmacotherapy and for suggestions for practice regarding the I statements.', 'servfreq': '', 'risktext': ''}, {'id': 1919, 'title': 'Vitamin D Deficiency in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 408, 'title': 'Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of the benefits and harms of vitamin D and calcium supplementation, alone or combined, for the primary prevention of fractures in men and premenopausal women.', 'servfreq': '', 'risktext': ''}]}
2025-01-29 22:07:16 [INFO] Recommendations fetched: [{'id': 485, 'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in adolescents and adults aged 15 to 65 years. Younger adolescents and older adults who are at increased risk of infection should also be screened.\rSee the Clinical Considerations section for more information about assessment of risk, screening intervals, and rescreening in pregnancy.', 'servfreq': 'The USPSTF found insufficient evidence to determine appropriate or optimal time intervals or strategies for repeat HIV screening. However, repeat screening is reasonable for persons known to be at increased risk of HIV infection, such as sexually active men who have sex with men; persons with a sex partner who is living with HIV; or persons who engage in behaviors that may convey an increased risk of HIV infection, such as injection drug use, transactional sex or commercial sex work, having 1 or more new sex partners whose HIV status is unknown, or having other factors that can place a person at increased risk of HIV infection (see &ldquo;Risk Assessment&rdquo;). Repeat screening is also reasonable for persons who live or receive medical care in a high-prevalence setting, such as a sexually transmitted disease clinic, tuberculosis clinic, correctional facility, or homeless shelter.', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'id': 1921, 'title': 'Hypertension in Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hypertension in adults 18 years or older with office blood pressure measurement (OBPM). The USPSTF recommends obtaining blood pressure measurements outside of the clinical setting for diagnostic confirmation before starting treatment.', 'servfreq': ' \r\nAlthough evidence on optimal screening intervals is limited, reasonable options include:\r\n \r\n \r\n\r\n\r\nScreening for hypertension every year in adults 40 years or older and in adults at increased risk for hypertension (such as Black persons, persons with high-normal blood pressure, or persons who are overweight or obese)\r\n\r\n\r\n \r\n \r\n\r\n\r\nScreening less frequently (ie, every 3 to 5 years) as appropriate for adults aged 18 to 39 years not at increased risk for hypertension and with a prior normal blood pressure reading.\r\n\r\n\r\n ', 'risktext': ' \r\nAlthough all adults should be screened for hypertension, risk factors that increase a person&rsquo;s risk for the condition include older age, Black race, family history, excess weight and obesity, lifestyle habits (lack of physical activity, stress, and tobacco use), and dietary factors (diet high in fat or sodium, diet low in potassium, or excessive alcohol intake)\r\n '}, {'id': 2021, 'title': 'Prevention of Acquisition of HIV: Preexposure Prophylaxis ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians prescribe preexposure prophylaxis using effective antiretroviral therapy to persons who are at increased risk of HIV acquisition to decrease the risk of acquiring HIV. \r\rSee the Practice Considerations section for more information about identification of persons at increased risk and about effective antiretroviral therapy.', 'servfreq': '', 'risktext': 'HIV is primarily acquired via sexual activity or injection drug use. It is important that clinicians routinely take a sexual and injection drug use history for all their patients in an open and nonjudgmental manner. All adolescents and adults who are sexually active or who inject drugs should be informed that acquisition of HIV can be prevented, to facilitate subsequent risk assessment and discussions about preexposure prophylaxis (PrEP) and other ways to prevent acquisition of HIV. Importantly, risk of HIV acquisition exists on a continuum, and currently available risk assessment tools all have limitations. However, certain risk factors or behaviors are known to place persons at increased risk of HIV.\r\nRisk of HIV acquisition depends on the likelihood that a specific act or activity will transmit HIV and the likelihood that a sex partner or drug injection partner has HIV. Likelihood of HIV transmission is highest with needle-sharing injection drug use and condomless receptive anal intercourse. Condomless receptive anal intercourse has an approximately 10- to 15-fold higher risk of transmission than condomless insertive anal sex and condomless receptive and insertive penile-vaginal sex. A 2018 study estimated the prevalence of HIV (ie, an estimate of the likelihood that a partner whose HIV status is unknown has HIV at a population level) as 12.4% among men who have sex with men and 1.9% among persons who inject drugs. The overall prevalence of HIV in the US is estimated at 0.3%.&nbsp;Of note, both the frequency of specific sexual activities and a person&rsquo;s number of sexual partners will also affect their risk of HIV.\r\n&nbsp;The USPSTF recommends that the following persons be considered for PrEP:\r\n1.&nbsp;&nbsp;&nbsp;&nbsp; Sexually active adults and adolescents weighing at least 35 kg (77 lb) who have engaged in anal or vaginal sex in the past 6 months and have any of the following:\r\n&nbsp;\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A sexual partner who has HIV (especially if the partner has an unknown or detectable viral load).\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A bacterial sexually transmitted infection (STI) (syphilis, gonorrhea, or chlamydia for men who have sex with men and transgender women; gonorrhea and syphilis for heterosexual women and men) in the past 6 months.\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A history of inconsistent or no condom use with sex partner(s) whose HIV status is not known; assessing risk in conversation with the patient and considering factors such as number of partners, the specific sexual activities a person engages in, and whether their sex partner or partners are in a group with a higher prevalence of HIV (eg, men who have sex with men or with men and women, transgender women, persons who inject drugs, and persons who engage in transactional sex).\r\n&nbsp;\r\n2. &nbsp; Persons who inject drugs and have a drug-injecting partner who has HIV or who shares injection equipment.\r\nPersons who engage in transactional sex, such as sex for money, drugs, or housing, including commercial sex workers or persons trafficked for sex work, constitute a group at increased risk of HIV acquisition and should be considered for PrEP based on the criteria outlined above. Persons who request PrEP may have undisclosed behaviors that put them at risk. Transgender women and men who are sexually active should be considered for PrEP based on the criteria outlined above. Transgender women are at especially high risk of HIV acquisition. A Centers for Disease Control and and Prevention (CDC) survey in 7 cities found an HIV prevalence of 42% among transgender women. Prevalence was highest among Black transgender women (62%) and Native American/Alaska Native transgender women (65%).\r\nIn addition, studies have found that transmission of HIV to a seronegative partner from a partner with HIV has not been observed when the partner with HIV was being treated with antiretroviral therapy and had a suppressed viral load.&nbsp;It is not known whether PrEP use further decreases the risk of HIV transmission when a partner with HIV has a documented undetectable viral load. Factors such as the consistency or inconsistency of a partner&rsquo;s viral load being suppressed, a partner&rsquo;s adherence to antiretroviral therapy, and the degree of certainty that a partner&rsquo;s viral load is suppressed (eg, self-report vs availability of laboratory test results) may help inform decisions about the use of PrEP in this situation.\r\nAll persons being considered for PrEP must have a recently documented negative HIV antigen-antibody test result, and if they have taken oral PrEP or postexposure prophylaxis in the past 3 months, or injectable cabotegravir in the past 12 months, the CDC recommends testing with both an HIV antigen-antibody assay and an HIV-1 RNA assay.'}, {'id': 1989, 'title': 'Syphilis Infection in Nonpregnant Adolescents and Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for syphilis infection in persons who are at increased risk for infection.', 'servfreq': 'Optimal screening frequency for persons who are at increased risk for syphilis infection is not well established. Men who have sex with men or persons with HIV infection may benefit from screening at least annually or more frequently (eg, every 3 to 6 months) if they continue to be at high risk.', 'risktext': 'The USPSTF recommends screening for syphilis in persons who are at increased risk for infection. When deciding which persons to screen for syphilis, clinicians should consider the prevalence of infection in the communities they serve, as well as other sociodemographic and behavioral factors that may be associated with increased risk of syphilis infection. For example, prevalence of syphilis is higher in men, men who have sex with men, persons with HIV infection, young adults, and persons with a history of incarceration, sex work, or military service. A substantial percentage of heterosexual syphilis transmission occurs among persons who use illicit drugs, particularly methamphetamine. Diagnosis of another STI may signal that a person is having condomless sex, which increases their risk of syphilis infection. Higher infection rates in persons of some racial and ethnic groups have been reported and are primarily a reflection of a combination of factors, including social determinants of health (eg, disparities of income, low educational achievement, and unstable housing), differential health insurance coverage or access to quality health care, and differences in sexual network characteristics (eg, individuals living in communities with a high prevalence of STIs have an increased chance of encountering an infected partner). Local prevalence rates may change over time, so clinicians should be aware of the latest data and trends for their specific population and geographic area, which are available through their state and local health departments and Centers for Disease Control and Prevention (CDC) surveillance.\r\n&nbsp;\r\nAlthough direct evidence on screening in nonpregnant persons who are not at increased risk for syphilis infection is lacking, based on the established test performance characteristics of current screening tests and the low prevalence rate of syphilis in this population, the yield of screening is likely low.9,10 Therefore, screening in this population may result in high false-positive rates and overtreatment.'}, {'id': 1905, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and US Food and Drug Administration (FDA)--approved pharmacotherapy for cessation to nonpregnant adults who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 2014, 'title': 'Anxiety Disorders in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for anxiety disorders in adults, including pregnant and postpartum persons.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding optimal timing for screening, or screening interval, for both the perinatal and general adult populations; more evidence on both timing and screening interval is needed for all adult populations. A pragmatic approach in the absence of evidence might include screening all adults who have not been screened previously and using clinical judgment in considering risk factors, comorbid conditions, and life events to determine if additional screening of high-risk patients is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nRisk factors for anxiety disorders include sociodemographic factors, psychosocial factors, and physical and mental health factors such as marital status (widowed or divorced), stressful life events, smoking and alcohol use, other mental health conditions, or a parental history of mental disorders. Demographic factors such as low socioeconomic status and female sex are associated with higher rates of anxiety disorders.&nbsp;Black persons and individuals of non-Hispanic ethnicity are at increased risk of anxiety disorders due to social, rather than biological, factors. Anxiety and depressive disorders often overlap. One cohort study found that 67% of individuals with a depressive disorder also had a current anxiety disorder, and 75% had a lifetime comorbid anxiety disorder.'}, {'id': 2009, 'title': 'Latent Tuberculosis Infection in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for LTBI in populations at increased risk.\r\rSee the "Assessment of Risk" section for additional information on adults at increased risk.', 'servfreq': 'The USPSTF found no evidence on the optimal frequency of screening for LTBI. In the absence of evidence, a reasonable approach is to repeat screening based on specific risk factors; screening frequency could range from 1-time only screening among persons at low risk for future tuberculosis exposure to annual screening among those at continued risk of exposure.', 'risktext': 'Populations at increased risk for LTBI, based on increased prevalence of active disease and increased risk of exposure, include persons who were born in, or are former residents of, countries with high tuberculosis prevalence and persons who live in, or have lived in, high-risk congregate settings (eg, homeless shelters or correctional facilities). Clinicians can consult their local or state health departments for more information about populations at increased risk in their community, since local demographic patterns may vary across the US.\r\nIn 2020, 71.5% of all cases of active tuberculosis in the US occurred among persons born outside the US. According to the CDC, tuberculosis disease is common in most countries in Latin America, the Caribbean, Africa, Asia, Eastern Europe, and Russia. In 2020, among persons with new tuberculosis living in the US who were born outside the US, the most common countries of birth were Mexico (18.0%), the Philippines (12.5%), India (10.4%), Vietnam (8.2%), and China (5.1%), accounting for 54.2% of total cases. Most of these cases are believed to be due to progression of latent infection to active tuberculosis disease rather than new transmission within communities.\r\nPersons who live, or have lived, in high-risk congregate settings also have a higher prevalence rate of active tuberculosis and an increased risk for exposure. In 2020, 4.3% of tuberculosis disease cases diagnosed in persons 15 years or older occurred in persons experiencing homelessness and 2.6% occurred in residents of correctional facilities. It is estimated that persons experiencing homelessness have an 11 times higher incidence of tuberculosis disease compared with persons who are not experiencing homelessness (36 cases per 100,000 population vs 2.9 cases per 100,000 population, respectively, during 2011 to 2016).\r\nOther populations at increased risk for LTBI or progression to active disease include persons who have immunosuppression (eg, persons living with HIV, patients receiving immunosuppressive medications such as chemotherapy or tumor necrosis factor inhibitors, and patients who have received an organ transplant) and patients with silicosis (a lung disease). However, given that screening in these populations may be considered standard care as part of disease management or indicated prior to the use of certain medications, the USPSTF did not review evidence on screening in these populations. Information on testing in these populations is provided by other groups, such as the Office of AIDS Research at the National Institutes of Health, and in a guideline issued jointly by the American Thoracic Society, Infectious Diseases Society of America, and CDC. Some evidence from observational studies has explored the association between poorly controlled diabetes and progression of LTBI to active disease. However, there is insufficient evidence on screening for and treatment of LTBI in persons with diabetes for the USPSTF to make a separate recommendation for this important population.\r\nPersons who are contacts of individuals with active tuberculosis, health care workers, and workers in high-risk congregate settings may also be at increased risk of exposure. Because screening in these populations is conducted as part of public health or employee health surveillance, the USPSTF did not review the evidence in these populations. Clinicians seeking further information about testing for tuberculosis in these populations can refer to the Additional Tools and Resources and Recommendations of Others sections.'}, {'id': 514, 'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic bacteriuria in nonpregnant adults.', 'servfreq': '', 'risktext': 'The risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6 Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5 Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7, 11, 12 In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12 Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4, 6'}, {'id': 1909, 'title': 'Asymptomatic Carotid Artery Stenosis: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic carotid artery stenosis in the general adult population.\r\rSee the Practice Considerations section for a description of adults at increased risk.', 'servfreq': '', 'risktext': ''}, {'id': 2017, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for suicide risk in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': '', 'risktext': ''}, {'id': 2016, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for depression in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding the optimal timing for screening for depression; more evidence is needed in both perinatal and general adult populations. In the absence of evidence, a pragmatic approach might include screening adults who have not been screened previously and using clinical judgment while considering risk factors, comorbid conditions, and life events to determine if additional screening of patients at increased risk is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nThe USPSTF recommends screening for depression in all adults regardless of risk factors. Risk factors for depression include a combination of genetic, biological, and environmental factors, such as a family history of depression, prior episode of depression or other mental health condition, a history of trauma or adverse life events, or a history of disease or illness (eg, cardiovascular disease).\r\nPrevalence rates vary by sex, age, race, ethnicity, education, marital status, geographic location, poverty level, and employment status. Women have twice the risk of depression compared with men. Young adults, multiracial individuals, and Native American/Alaska Native individuals have higher rates of depression.\r\nRisk factors for perinatal depression include life stress, low social support, history of depression, marital or partner dissatisfaction, and a history of abuse.'}, {'id': 1845, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends offering or referring adults with cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity.', 'servfreq': '', 'risktext': 'Adults 18 years or older at increased risk of CVD, defined as those with 1 or more of the following:\r\n1.Hypertension or elevated blood pressure2.Dyslipidemia3.Mixed or multiple risk factors such as the metabolic syndrome or an estimated 10-year CVD risk of &ge;7.5%\r\nThis recommendation does not apply to adults with other known modifiable cardiovascular risk factors such as abnormal blood glucose levels, obesity, and smoking; these populations are incorporated in other USPSTF recommendations.'}, {'id': 1885, 'title': 'Hepatitis B Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in adolescents and adults at increased risk for infection.\r\rSee the Practice Considerations section for a description of adolescents and adults at increased risk for infection.', 'servfreq': 'For patients with negative HBsAg results who have not received the HBV vaccine series, periodic screening may be useful for those who report continued risk for acquiring HBV transmission, such as persons who continue to inject drugs and men who have sex with men. Clinical judgment should be used to determine screening frequency. The USPSTF found no evidence to determine optimal screening intervals.', 'risktext': 'Persons from such risk groups include persons who have injected drugs in the past or currently; men who have sex with men; persons with HIV; and sex partners, needle-sharing contacts, and household contacts of persons known to be HBsAg positive. Some persons with combinations of risk factors who are not members of risk factor groups listed above may also be at increased risk for HBV infection.'}, {'id': 524, 'title': 'Hepatitis C Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis C virus (HCV) infection in adults aged 18 to 79 years.', 'servfreq': 'One-time screening for most adults.\r\nPeriodically screen persons with continued risk for HCV infection (eg, persons with past or current injection drug use). There is limited evidence to determine how often to screen persons at increased risk.&nbsp;', 'risktext': 'Asymptomatic adults aged 18 to 79 years (including pregnant persons) without known liver disease.&nbsp;\r\nThe USPSTF also suggests that clinicians consider screening persons younger than 18 years and older than 79 years who are at high risk for infection (eg, those with past or current injection drug use).&nbsp;'}, {'id': 1445, 'title': 'Sexually Transmitted Infections: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends behavioral counseling for all sexually active adolescents and for adults who are at increased risk for sexually transmitted infections (STIs).\r\rSee the Practice Considerations section for more information on populations at increased risk for acquiring STIs.', 'servfreq': '', 'risktext': 'All sexually active adolescents are at increased risk for STIs because of the high rates of STIs in this age group and should receive behavioral counseling interventions. Adults at increased risk for STIs include those who currently have an STI or were diagnosed with one within the past year, do not consistently use condoms, have multiple sex partners, or have sex partners within populations with a high prevalence of STIs. Populations with a high prevalence of STIs include persons who seek STI testing or attend STI clinics; sexual and gender minorities; persons who are living with HIV, inject drugs, have exchanged sex for money or drugs, or have entered correctional facilities; and some racial/ethnic minority groups.1-4'}, {'id': 402, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends counseling young adults, adolescents, children, and parents of young children about minimizing exposure to ultraviolet (UV) radiation for persons aged 6 months to 24 years with fair skin types to reduce their risk of skin cancer.', 'servfreq': '', 'risktext': 'Fair skin types'}, {'id': 438, 'title': 'Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for unhealthy alcohol use in primary care settings in adults 18 years or older, including pregnant women, and providing persons engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce unhealthy alcohol use.', 'servfreq': 'The USPSTF did not find adequate evidence to recommend an optimal screening interval for unhealthy alcohol use in adults.&nbsp;Brief behavioral counseling interventions were found to reduce unhealthy alcohol use in adults 18 years or older, including pregnant women. Effective behavioral counseling interventions vary in their specific components, administration, length, and number of interactions. The USPSTF was unable to identify specific intervention characteristics or components that were clearly associated with improved outcomes.', 'risktext': 'engaged in risky or hazardous drinking'}, {'id': 767, 'title': 'Unhealthy Drug Use: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening by asking questions about unhealthy drug use in adults age 18 years or older. Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. \r(Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'servfreq': 'Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. (Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'risktext': 'These include being aged 18 to 25 years; male sex; having a mental health condition, personality or mood disorder, or nicotine or alcohol dependence; a history of physical or sexual abuse, parental neglect, or other adversity in childhood; or drug or alcohol addiction in a first-degree relative.1,9&nbsp;Factors associated with misuse of prescription drugs include history of other drug use, mental illness, pain, and greater access to prescription drugs.10&nbsp;Factors associated with prenatal use of drugs include a mental health disorder, interpersonal violence, and family history of substance use.11'}, {'id': 433, 'title': 'Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer or refer adults with a body mass index (BMI) of 30 or higher (calculated as weight in kilograms divided by height in meters squared) to intensive, multicomponent behavioral interventions.', 'servfreq': '', 'risktext': 'Adults with a BMI &ge;30'}, {'id': 1979, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: Behavioral Counseling Interventions ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians individualize the decision to offer or refer adults without cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity. \r\rSee the "Practice Considerations" section for information on determining which patients may benefit most from this service.', 'servfreq': '', 'risktext': ''}, {'id': 1937, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for chlamydia and gonorrhea in men.', 'servfreq': '', 'risktext': ''}, {'id': 418, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening with resting or exercise electrocardiography (ECG) to prevent cardiovascular disease (CVD) events in asymptomatic adults at low risk of CVD events.', 'servfreq': '', 'risktext': ''}, {'id': 1973, 'title': 'Chronic Obstructive Pulmonary Disease: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for chronic obstructive pulmonary disease in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 2003, 'title': 'Genital Herpes Infection: Serologic Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine serologic screening for genital herpes simplex virus infection in asymptomatic adolescents and adults, including pregnant persons.', 'servfreq': '', 'risktext': 'The USPSTF found no evidence of externally validated, reliable risk stratification tools to identify individuals more or less likely to have genital herpes.'}, {'id': 504, 'title': 'Pancreatic Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for pancreatic cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 203, 'title': 'Testicular Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for testicular cancer in adolescent or adult men.', 'servfreq': '', 'risktext': ''}, {'id': 365, 'title': 'Thyroid Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for thyroid cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 1976, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'D', 'text': 'The DoctorAI recommends against the use of beta carotene or vitamin E supplements for the prevention of cardiovascular disease or cancer.', 'servfreq': '', 'risktext': ''}, {'id': 318, 'title': 'Autism Spectrum Disorder in Young Children: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for autism spectrum disorder (ASD) in young children for whom no concerns of ASD have been raised by their parents or a clinician.', 'servfreq': '', 'risktext': 'Although a number of potential risk factors for ASD have been identified, there is insufficient evidence to determine if certain risk factors modify the performance characteristics of ASD screening tests, such as the age at which screening is performed or other characteristics of the child or family.'}, {'id': 65, 'title': 'Bladder Cancer in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults.\r\rLiterature scans conducted in July 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'This evidence update focused on the benefits and harms of screening for bladder cancer among people without symptoms, the accuracy of screening tests done in primary care settings, and the benefits and harms of treatment. The updated evidence review did not find any new high quality evidence to adequately determine the balance of benefits and harms of screening for bladder cancer. However, bladder cancer is a common cancer and can cause considerable health problems including death. Therefore, the USPSTF determined that the evidence was insufficient to provide a recommendation for or against bladder cancer screening.  The USPSTF emphasizes the need for additional research in this area. '}, {'id': 419, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening with resting or exercise ECG to prevent CVD events in asymptomatic adults at intermediate or high risk of CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 423, 'title': 'Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of adding the ankle-brachial index (ABI), high-sensitivity C-reactive protein (hsCRP) level, or coronary artery calcium (CAC) score to traditional risk assessment for cardiovascular disease (CVD) in asymptomatic adults to prevent CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 352, 'title': 'Celiac Disease: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'persons with family history or other risk factors'}, {'id': 1955, 'title': 'Eating Disorders in Adolescents and Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for eating disorders in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 665, 'title': 'Illicit Drug Use in Children, Adolescents, and Young Adults: Primary Care-Based Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--based behavioral counseling interventions to prevent illicit drug use, including nonmedical use of prescription drugs, in children, adolescents, and young adults.\r\rSee the Practice Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 435, 'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for abuse and neglect in all older or vulnerable adults. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': 'Risk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health.14&nbsp;For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.15'}, {'id': 2045, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for iron deficiency and iron deficiency anemia in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2046, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine iron supplementation in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2018, 'title': 'Lipid Disorders in Children and Adolescents: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1998, 'title': 'Obstructive Sleep Apnea in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for obstructive sleep apnea in the general adult population.\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Risk Factors\r\nRisk factors associated with OSA include male sex, older age (40-70 years), postmenopausal status, higher body mass index (BMI), and craniofacial and upper airway abnormalities (eg, enlarged tonsils or long upper airway). Black, Hispanic/Latino, and Native American/Alaska Native persons have a higher prevalence of OSA compared with White persons; some evidence suggests that these differences are partially explained by higher rates of obesity, asthma, and tobacco use among these groups.8'}, {'id': 1977, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of multivitamin supplements for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1978, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of single or paired nutrient supplements (other than beta carotene and vitamin E) for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 176, 'title': 'Oral Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for oral cancer in asymptomatic adults.\r\rGo to the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in July 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Tobacco and alcohol use are major risk factors for oral cancer. A total of 20% to 30% of cases of oral cancer worldwide are attributable to cigarette smoking. In the United States, up to 75% of cases of oral cancer may be attributable to tobacco and alcohol use. Additional risk factors include male sex, older age, use of betel quid, ultraviolet light exposure, infection with Candida or bacterial flora, and a compromised immune system. Sexually transmitted oral HPV infection (HPV-16) has recently been recognized as an increasingly important risk factor for oropharyngeal cancer. In the United States, the prevalence of oropharyngeal cancer due to oral HPV infection is probably as high as 80% to 95%. The prevalence of oral HPV infection is associated with age, sex, number of sexual partners, and number of cigarettes smoked per day. The effect of multifactorial risk assessment and screening for risk factors on oral cancer morbidity and mortality is unknown.'}, {'id': 2026, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine screening performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 2027, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of preventive interventions performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 424, 'title': 'Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for peripheral artery disease (PAD) and cardiovascular disease (CVD) risk with the ankle-brachial index (ABI) in asymptomatic adults.\r\rLiterature scans conducted in August 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Risk factors associated with OSA include male sex, older age (40 to 70 years), postmenopausal status, higher BMI, and craniofacial and upper airway abnormalities.'}, {'id': 404, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of counseling adults about skin self-examination to prevent skin cancer.See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 2005, 'title': 'Skin Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Exposure to UV radiation from sun exposure, indoor tanning beds, and other UV radiation&ndash;emitting devices is the major environmental risk factor for skin cancer. History of frequent sunburns, older age, and male sex are associated with increased risk for skin cancer. Exposure to UV radiation from the use of indoor tanning beds is an important risk factor in adolescents. Incidence of melanoma is higher among White persons compared with persons of other races and ethnicities. This difference likely reflects traits associated with increased melanoma risk, such as fair skin (which is more susceptible to sunburning), light-colored eyes, and red or blond hair being more common among White persons compared with persons of other races and ethnicities. Acral lentiginous melanoma, which occurs mostly on skin not frequently exposed to direct sunlight (eg, palms of hands, soles of feet, or under fingernails or toenails), is the most common type of melanoma among Black populations. Other melanoma risk factors include higher numbers of moles on the skin, atypical moles, as well as a personal and family history of skin cancer.'}, {'id': 269, 'title': 'Thyroid Dysfunction: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults.\r\rSee the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': 'The optimal screening interval for thyroid dysfunction (if one exists) is unknown.', 'risktext': 'The most common cause of hypothyroidism in the United States is chronic autoimmune (Hashimoto) thyroiditis. Risk factors for an elevated TSH level include female sex, advancing age, white race, type 1 diabetes, Down syndrome, family history of thyroid disease, goiter, previous hyperthyroidism (possibly due in part to ablation therapy leading to iatrogenic thyroid dysfunction), and external-beam radiation in the head and neck area. Common causes of hyperthyroidism include Graves disease, Hashimoto thyroiditis, and functional thyroid nodules. Risk factors for a low TSH level include female sex; advancing age; black race; low iodine intake; personal or family history of thyroid disease; and ingestion of iodine-containing drugs, such as amiodarone. The USPSTF found no direct evidence that treatment of thyroid dysfunction based on risk level alters final health outcomes.'}, {'id': 1908, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of electronic cigarettes (e-cigarettes) for tobacco cessation in adults, including pregnant persons. The USPSTF recommends that clinicians direct patients who use tobacco to other tobacco cessation interventions with proven effectiveness and established safety.\rSee the Practice Considerations section for more information on recommended behavioral interventions and pharmacotherapy and for suggestions for practice regarding the I statements.', 'servfreq': '', 'risktext': ''}, {'id': 1919, 'title': 'Vitamin D Deficiency in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 408, 'title': 'Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of the benefits and harms of vitamin D and calcium supplementation, alone or combined, for the primary prevention of fractures in men and premenopausal women.', 'servfreq': '', 'risktext': ''}]
2025-01-29 22:07:17 [INFO] Update id=273478213 is handled. Duration 705 ms by bot id=8108339380
2025-01-29 22:07:19 [INFO] Update id=273478214 is handled. Duration 652 ms by bot id=8108339380
2025-01-29 22:07:20 [INFO] State data: {'db': <bot.database.Database object at 0x7f8939ee3590>, 'age': 20, 'weight': 90, 'height': 190, 'feet': 45, 'gender': 'male', 'pregnant': 'no', 'smoking': 'no', 'sex': 'Tools_1', 'recommendations': [{'id': 485, 'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in adolescents and adults aged 15 to 65 years. Younger adolescents and older adults who are at increased risk of infection should also be screened.\rSee the Clinical Considerations section for more information about assessment of risk, screening intervals, and rescreening in pregnancy.', 'servfreq': 'The USPSTF found insufficient evidence to determine appropriate or optimal time intervals or strategies for repeat HIV screening. However, repeat screening is reasonable for persons known to be at increased risk of HIV infection, such as sexually active men who have sex with men; persons with a sex partner who is living with HIV; or persons who engage in behaviors that may convey an increased risk of HIV infection, such as injection drug use, transactional sex or commercial sex work, having 1 or more new sex partners whose HIV status is unknown, or having other factors that can place a person at increased risk of HIV infection (see &ldquo;Risk Assessment&rdquo;). Repeat screening is also reasonable for persons who live or receive medical care in a high-prevalence setting, such as a sexually transmitted disease clinic, tuberculosis clinic, correctional facility, or homeless shelter.', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'id': 1921, 'title': 'Hypertension in Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hypertension in adults 18 years or older with office blood pressure measurement (OBPM). The USPSTF recommends obtaining blood pressure measurements outside of the clinical setting for diagnostic confirmation before starting treatment.', 'servfreq': ' \r\nAlthough evidence on optimal screening intervals is limited, reasonable options include:\r\n \r\n \r\n\r\n\r\nScreening for hypertension every year in adults 40 years or older and in adults at increased risk for hypertension (such as Black persons, persons with high-normal blood pressure, or persons who are overweight or obese)\r\n\r\n\r\n \r\n \r\n\r\n\r\nScreening less frequently (ie, every 3 to 5 years) as appropriate for adults aged 18 to 39 years not at increased risk for hypertension and with a prior normal blood pressure reading.\r\n\r\n\r\n ', 'risktext': ' \r\nAlthough all adults should be screened for hypertension, risk factors that increase a person&rsquo;s risk for the condition include older age, Black race, family history, excess weight and obesity, lifestyle habits (lack of physical activity, stress, and tobacco use), and dietary factors (diet high in fat or sodium, diet low in potassium, or excessive alcohol intake)\r\n '}, {'id': 2021, 'title': 'Prevention of Acquisition of HIV: Preexposure Prophylaxis ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians prescribe preexposure prophylaxis using effective antiretroviral therapy to persons who are at increased risk of HIV acquisition to decrease the risk of acquiring HIV. \r\rSee the Practice Considerations section for more information about identification of persons at increased risk and about effective antiretroviral therapy.', 'servfreq': '', 'risktext': 'HIV is primarily acquired via sexual activity or injection drug use. It is important that clinicians routinely take a sexual and injection drug use history for all their patients in an open and nonjudgmental manner. All adolescents and adults who are sexually active or who inject drugs should be informed that acquisition of HIV can be prevented, to facilitate subsequent risk assessment and discussions about preexposure prophylaxis (PrEP) and other ways to prevent acquisition of HIV. Importantly, risk of HIV acquisition exists on a continuum, and currently available risk assessment tools all have limitations. However, certain risk factors or behaviors are known to place persons at increased risk of HIV.\r\nRisk of HIV acquisition depends on the likelihood that a specific act or activity will transmit HIV and the likelihood that a sex partner or drug injection partner has HIV. Likelihood of HIV transmission is highest with needle-sharing injection drug use and condomless receptive anal intercourse. Condomless receptive anal intercourse has an approximately 10- to 15-fold higher risk of transmission than condomless insertive anal sex and condomless receptive and insertive penile-vaginal sex. A 2018 study estimated the prevalence of HIV (ie, an estimate of the likelihood that a partner whose HIV status is unknown has HIV at a population level) as 12.4% among men who have sex with men and 1.9% among persons who inject drugs. The overall prevalence of HIV in the US is estimated at 0.3%.&nbsp;Of note, both the frequency of specific sexual activities and a person&rsquo;s number of sexual partners will also affect their risk of HIV.\r\n&nbsp;The USPSTF recommends that the following persons be considered for PrEP:\r\n1.&nbsp;&nbsp;&nbsp;&nbsp; Sexually active adults and adolescents weighing at least 35 kg (77 lb) who have engaged in anal or vaginal sex in the past 6 months and have any of the following:\r\n&nbsp;\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A sexual partner who has HIV (especially if the partner has an unknown or detectable viral load).\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A bacterial sexually transmitted infection (STI) (syphilis, gonorrhea, or chlamydia for men who have sex with men and transgender women; gonorrhea and syphilis for heterosexual women and men) in the past 6 months.\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A history of inconsistent or no condom use with sex partner(s) whose HIV status is not known; assessing risk in conversation with the patient and considering factors such as number of partners, the specific sexual activities a person engages in, and whether their sex partner or partners are in a group with a higher prevalence of HIV (eg, men who have sex with men or with men and women, transgender women, persons who inject drugs, and persons who engage in transactional sex).\r\n&nbsp;\r\n2. &nbsp; Persons who inject drugs and have a drug-injecting partner who has HIV or who shares injection equipment.\r\nPersons who engage in transactional sex, such as sex for money, drugs, or housing, including commercial sex workers or persons trafficked for sex work, constitute a group at increased risk of HIV acquisition and should be considered for PrEP based on the criteria outlined above. Persons who request PrEP may have undisclosed behaviors that put them at risk. Transgender women and men who are sexually active should be considered for PrEP based on the criteria outlined above. Transgender women are at especially high risk of HIV acquisition. A Centers for Disease Control and and Prevention (CDC) survey in 7 cities found an HIV prevalence of 42% among transgender women. Prevalence was highest among Black transgender women (62%) and Native American/Alaska Native transgender women (65%).\r\nIn addition, studies have found that transmission of HIV to a seronegative partner from a partner with HIV has not been observed when the partner with HIV was being treated with antiretroviral therapy and had a suppressed viral load.&nbsp;It is not known whether PrEP use further decreases the risk of HIV transmission when a partner with HIV has a documented undetectable viral load. Factors such as the consistency or inconsistency of a partner&rsquo;s viral load being suppressed, a partner&rsquo;s adherence to antiretroviral therapy, and the degree of certainty that a partner&rsquo;s viral load is suppressed (eg, self-report vs availability of laboratory test results) may help inform decisions about the use of PrEP in this situation.\r\nAll persons being considered for PrEP must have a recently documented negative HIV antigen-antibody test result, and if they have taken oral PrEP or postexposure prophylaxis in the past 3 months, or injectable cabotegravir in the past 12 months, the CDC recommends testing with both an HIV antigen-antibody assay and an HIV-1 RNA assay.'}, {'id': 1989, 'title': 'Syphilis Infection in Nonpregnant Adolescents and Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for syphilis infection in persons who are at increased risk for infection.', 'servfreq': 'Optimal screening frequency for persons who are at increased risk for syphilis infection is not well established. Men who have sex with men or persons with HIV infection may benefit from screening at least annually or more frequently (eg, every 3 to 6 months) if they continue to be at high risk.', 'risktext': 'The USPSTF recommends screening for syphilis in persons who are at increased risk for infection. When deciding which persons to screen for syphilis, clinicians should consider the prevalence of infection in the communities they serve, as well as other sociodemographic and behavioral factors that may be associated with increased risk of syphilis infection. For example, prevalence of syphilis is higher in men, men who have sex with men, persons with HIV infection, young adults, and persons with a history of incarceration, sex work, or military service. A substantial percentage of heterosexual syphilis transmission occurs among persons who use illicit drugs, particularly methamphetamine. Diagnosis of another STI may signal that a person is having condomless sex, which increases their risk of syphilis infection. Higher infection rates in persons of some racial and ethnic groups have been reported and are primarily a reflection of a combination of factors, including social determinants of health (eg, disparities of income, low educational achievement, and unstable housing), differential health insurance coverage or access to quality health care, and differences in sexual network characteristics (eg, individuals living in communities with a high prevalence of STIs have an increased chance of encountering an infected partner). Local prevalence rates may change over time, so clinicians should be aware of the latest data and trends for their specific population and geographic area, which are available through their state and local health departments and Centers for Disease Control and Prevention (CDC) surveillance.\r\n&nbsp;\r\nAlthough direct evidence on screening in nonpregnant persons who are not at increased risk for syphilis infection is lacking, based on the established test performance characteristics of current screening tests and the low prevalence rate of syphilis in this population, the yield of screening is likely low.9,10 Therefore, screening in this population may result in high false-positive rates and overtreatment.'}, {'id': 1905, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and US Food and Drug Administration (FDA)--approved pharmacotherapy for cessation to nonpregnant adults who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 2014, 'title': 'Anxiety Disorders in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for anxiety disorders in adults, including pregnant and postpartum persons.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding optimal timing for screening, or screening interval, for both the perinatal and general adult populations; more evidence on both timing and screening interval is needed for all adult populations. A pragmatic approach in the absence of evidence might include screening all adults who have not been screened previously and using clinical judgment in considering risk factors, comorbid conditions, and life events to determine if additional screening of high-risk patients is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nRisk factors for anxiety disorders include sociodemographic factors, psychosocial factors, and physical and mental health factors such as marital status (widowed or divorced), stressful life events, smoking and alcohol use, other mental health conditions, or a parental history of mental disorders. Demographic factors such as low socioeconomic status and female sex are associated with higher rates of anxiety disorders.&nbsp;Black persons and individuals of non-Hispanic ethnicity are at increased risk of anxiety disorders due to social, rather than biological, factors. Anxiety and depressive disorders often overlap. One cohort study found that 67% of individuals with a depressive disorder also had a current anxiety disorder, and 75% had a lifetime comorbid anxiety disorder.'}, {'id': 2009, 'title': 'Latent Tuberculosis Infection in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for LTBI in populations at increased risk.\r\rSee the "Assessment of Risk" section for additional information on adults at increased risk.', 'servfreq': 'The USPSTF found no evidence on the optimal frequency of screening for LTBI. In the absence of evidence, a reasonable approach is to repeat screening based on specific risk factors; screening frequency could range from 1-time only screening among persons at low risk for future tuberculosis exposure to annual screening among those at continued risk of exposure.', 'risktext': 'Populations at increased risk for LTBI, based on increased prevalence of active disease and increased risk of exposure, include persons who were born in, or are former residents of, countries with high tuberculosis prevalence and persons who live in, or have lived in, high-risk congregate settings (eg, homeless shelters or correctional facilities). Clinicians can consult their local or state health departments for more information about populations at increased risk in their community, since local demographic patterns may vary across the US.\r\nIn 2020, 71.5% of all cases of active tuberculosis in the US occurred among persons born outside the US. According to the CDC, tuberculosis disease is common in most countries in Latin America, the Caribbean, Africa, Asia, Eastern Europe, and Russia. In 2020, among persons with new tuberculosis living in the US who were born outside the US, the most common countries of birth were Mexico (18.0%), the Philippines (12.5%), India (10.4%), Vietnam (8.2%), and China (5.1%), accounting for 54.2% of total cases. Most of these cases are believed to be due to progression of latent infection to active tuberculosis disease rather than new transmission within communities.\r\nPersons who live, or have lived, in high-risk congregate settings also have a higher prevalence rate of active tuberculosis and an increased risk for exposure. In 2020, 4.3% of tuberculosis disease cases diagnosed in persons 15 years or older occurred in persons experiencing homelessness and 2.6% occurred in residents of correctional facilities. It is estimated that persons experiencing homelessness have an 11 times higher incidence of tuberculosis disease compared with persons who are not experiencing homelessness (36 cases per 100,000 population vs 2.9 cases per 100,000 population, respectively, during 2011 to 2016).\r\nOther populations at increased risk for LTBI or progression to active disease include persons who have immunosuppression (eg, persons living with HIV, patients receiving immunosuppressive medications such as chemotherapy or tumor necrosis factor inhibitors, and patients who have received an organ transplant) and patients with silicosis (a lung disease). However, given that screening in these populations may be considered standard care as part of disease management or indicated prior to the use of certain medications, the USPSTF did not review evidence on screening in these populations. Information on testing in these populations is provided by other groups, such as the Office of AIDS Research at the National Institutes of Health, and in a guideline issued jointly by the American Thoracic Society, Infectious Diseases Society of America, and CDC. Some evidence from observational studies has explored the association between poorly controlled diabetes and progression of LTBI to active disease. However, there is insufficient evidence on screening for and treatment of LTBI in persons with diabetes for the USPSTF to make a separate recommendation for this important population.\r\nPersons who are contacts of individuals with active tuberculosis, health care workers, and workers in high-risk congregate settings may also be at increased risk of exposure. Because screening in these populations is conducted as part of public health or employee health surveillance, the USPSTF did not review the evidence in these populations. Clinicians seeking further information about testing for tuberculosis in these populations can refer to the Additional Tools and Resources and Recommendations of Others sections.'}, {'id': 514, 'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic bacteriuria in nonpregnant adults.', 'servfreq': '', 'risktext': 'The risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6 Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5 Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7, 11, 12 In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12 Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4, 6'}, {'id': 1909, 'title': 'Asymptomatic Carotid Artery Stenosis: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic carotid artery stenosis in the general adult population.\r\rSee the Practice Considerations section for a description of adults at increased risk.', 'servfreq': '', 'risktext': ''}, {'id': 2017, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for suicide risk in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': '', 'risktext': ''}, {'id': 2016, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for depression in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding the optimal timing for screening for depression; more evidence is needed in both perinatal and general adult populations. In the absence of evidence, a pragmatic approach might include screening adults who have not been screened previously and using clinical judgment while considering risk factors, comorbid conditions, and life events to determine if additional screening of patients at increased risk is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nThe USPSTF recommends screening for depression in all adults regardless of risk factors. Risk factors for depression include a combination of genetic, biological, and environmental factors, such as a family history of depression, prior episode of depression or other mental health condition, a history of trauma or adverse life events, or a history of disease or illness (eg, cardiovascular disease).\r\nPrevalence rates vary by sex, age, race, ethnicity, education, marital status, geographic location, poverty level, and employment status. Women have twice the risk of depression compared with men. Young adults, multiracial individuals, and Native American/Alaska Native individuals have higher rates of depression.\r\nRisk factors for perinatal depression include life stress, low social support, history of depression, marital or partner dissatisfaction, and a history of abuse.'}, {'id': 1845, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends offering or referring adults with cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity.', 'servfreq': '', 'risktext': 'Adults 18 years or older at increased risk of CVD, defined as those with 1 or more of the following:\r\n1.Hypertension or elevated blood pressure2.Dyslipidemia3.Mixed or multiple risk factors such as the metabolic syndrome or an estimated 10-year CVD risk of &ge;7.5%\r\nThis recommendation does not apply to adults with other known modifiable cardiovascular risk factors such as abnormal blood glucose levels, obesity, and smoking; these populations are incorporated in other USPSTF recommendations.'}, {'id': 1885, 'title': 'Hepatitis B Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in adolescents and adults at increased risk for infection.\r\rSee the Practice Considerations section for a description of adolescents and adults at increased risk for infection.', 'servfreq': 'For patients with negative HBsAg results who have not received the HBV vaccine series, periodic screening may be useful for those who report continued risk for acquiring HBV transmission, such as persons who continue to inject drugs and men who have sex with men. Clinical judgment should be used to determine screening frequency. The USPSTF found no evidence to determine optimal screening intervals.', 'risktext': 'Persons from such risk groups include persons who have injected drugs in the past or currently; men who have sex with men; persons with HIV; and sex partners, needle-sharing contacts, and household contacts of persons known to be HBsAg positive. Some persons with combinations of risk factors who are not members of risk factor groups listed above may also be at increased risk for HBV infection.'}, {'id': 524, 'title': 'Hepatitis C Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis C virus (HCV) infection in adults aged 18 to 79 years.', 'servfreq': 'One-time screening for most adults.\r\nPeriodically screen persons with continued risk for HCV infection (eg, persons with past or current injection drug use). There is limited evidence to determine how often to screen persons at increased risk.&nbsp;', 'risktext': 'Asymptomatic adults aged 18 to 79 years (including pregnant persons) without known liver disease.&nbsp;\r\nThe USPSTF also suggests that clinicians consider screening persons younger than 18 years and older than 79 years who are at high risk for infection (eg, those with past or current injection drug use).&nbsp;'}, {'id': 1445, 'title': 'Sexually Transmitted Infections: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends behavioral counseling for all sexually active adolescents and for adults who are at increased risk for sexually transmitted infections (STIs).\r\rSee the Practice Considerations section for more information on populations at increased risk for acquiring STIs.', 'servfreq': '', 'risktext': 'All sexually active adolescents are at increased risk for STIs because of the high rates of STIs in this age group and should receive behavioral counseling interventions. Adults at increased risk for STIs include those who currently have an STI or were diagnosed with one within the past year, do not consistently use condoms, have multiple sex partners, or have sex partners within populations with a high prevalence of STIs. Populations with a high prevalence of STIs include persons who seek STI testing or attend STI clinics; sexual and gender minorities; persons who are living with HIV, inject drugs, have exchanged sex for money or drugs, or have entered correctional facilities; and some racial/ethnic minority groups.1-4'}, {'id': 402, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends counseling young adults, adolescents, children, and parents of young children about minimizing exposure to ultraviolet (UV) radiation for persons aged 6 months to 24 years with fair skin types to reduce their risk of skin cancer.', 'servfreq': '', 'risktext': 'Fair skin types'}, {'id': 438, 'title': 'Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for unhealthy alcohol use in primary care settings in adults 18 years or older, including pregnant women, and providing persons engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce unhealthy alcohol use.', 'servfreq': 'The USPSTF did not find adequate evidence to recommend an optimal screening interval for unhealthy alcohol use in adults.&nbsp;Brief behavioral counseling interventions were found to reduce unhealthy alcohol use in adults 18 years or older, including pregnant women. Effective behavioral counseling interventions vary in their specific components, administration, length, and number of interactions. The USPSTF was unable to identify specific intervention characteristics or components that were clearly associated with improved outcomes.', 'risktext': 'engaged in risky or hazardous drinking'}, {'id': 767, 'title': 'Unhealthy Drug Use: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening by asking questions about unhealthy drug use in adults age 18 years or older. Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. \r(Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'servfreq': 'Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. (Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'risktext': 'These include being aged 18 to 25 years; male sex; having a mental health condition, personality or mood disorder, or nicotine or alcohol dependence; a history of physical or sexual abuse, parental neglect, or other adversity in childhood; or drug or alcohol addiction in a first-degree relative.1,9&nbsp;Factors associated with misuse of prescription drugs include history of other drug use, mental illness, pain, and greater access to prescription drugs.10&nbsp;Factors associated with prenatal use of drugs include a mental health disorder, interpersonal violence, and family history of substance use.11'}, {'id': 433, 'title': 'Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer or refer adults with a body mass index (BMI) of 30 or higher (calculated as weight in kilograms divided by height in meters squared) to intensive, multicomponent behavioral interventions.', 'servfreq': '', 'risktext': 'Adults with a BMI &ge;30'}, {'id': 1979, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: Behavioral Counseling Interventions ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians individualize the decision to offer or refer adults without cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity. \r\rSee the "Practice Considerations" section for information on determining which patients may benefit most from this service.', 'servfreq': '', 'risktext': ''}, {'id': 1937, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for chlamydia and gonorrhea in men.', 'servfreq': '', 'risktext': ''}, {'id': 418, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening with resting or exercise electrocardiography (ECG) to prevent cardiovascular disease (CVD) events in asymptomatic adults at low risk of CVD events.', 'servfreq': '', 'risktext': ''}, {'id': 1973, 'title': 'Chronic Obstructive Pulmonary Disease: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for chronic obstructive pulmonary disease in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 2003, 'title': 'Genital Herpes Infection: Serologic Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine serologic screening for genital herpes simplex virus infection in asymptomatic adolescents and adults, including pregnant persons.', 'servfreq': '', 'risktext': 'The USPSTF found no evidence of externally validated, reliable risk stratification tools to identify individuals more or less likely to have genital herpes.'}, {'id': 504, 'title': 'Pancreatic Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for pancreatic cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 203, 'title': 'Testicular Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for testicular cancer in adolescent or adult men.', 'servfreq': '', 'risktext': ''}, {'id': 365, 'title': 'Thyroid Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for thyroid cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 1976, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'D', 'text': 'The DoctorAI recommends against the use of beta carotene or vitamin E supplements for the prevention of cardiovascular disease or cancer.', 'servfreq': '', 'risktext': ''}, {'id': 318, 'title': 'Autism Spectrum Disorder in Young Children: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for autism spectrum disorder (ASD) in young children for whom no concerns of ASD have been raised by their parents or a clinician.', 'servfreq': '', 'risktext': 'Although a number of potential risk factors for ASD have been identified, there is insufficient evidence to determine if certain risk factors modify the performance characteristics of ASD screening tests, such as the age at which screening is performed or other characteristics of the child or family.'}, {'id': 65, 'title': 'Bladder Cancer in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults.\r\rLiterature scans conducted in July 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'This evidence update focused on the benefits and harms of screening for bladder cancer among people without symptoms, the accuracy of screening tests done in primary care settings, and the benefits and harms of treatment. The updated evidence review did not find any new high quality evidence to adequately determine the balance of benefits and harms of screening for bladder cancer. However, bladder cancer is a common cancer and can cause considerable health problems including death. Therefore, the USPSTF determined that the evidence was insufficient to provide a recommendation for or against bladder cancer screening.  The USPSTF emphasizes the need for additional research in this area. '}, {'id': 419, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening with resting or exercise ECG to prevent CVD events in asymptomatic adults at intermediate or high risk of CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 423, 'title': 'Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of adding the ankle-brachial index (ABI), high-sensitivity C-reactive protein (hsCRP) level, or coronary artery calcium (CAC) score to traditional risk assessment for cardiovascular disease (CVD) in asymptomatic adults to prevent CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 352, 'title': 'Celiac Disease: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'persons with family history or other risk factors'}, {'id': 1955, 'title': 'Eating Disorders in Adolescents and Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for eating disorders in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 665, 'title': 'Illicit Drug Use in Children, Adolescents, and Young Adults: Primary Care-Based Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--based behavioral counseling interventions to prevent illicit drug use, including nonmedical use of prescription drugs, in children, adolescents, and young adults.\r\rSee the Practice Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 435, 'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for abuse and neglect in all older or vulnerable adults. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': 'Risk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health.14&nbsp;For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.15'}, {'id': 2045, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for iron deficiency and iron deficiency anemia in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2046, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine iron supplementation in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2018, 'title': 'Lipid Disorders in Children and Adolescents: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1998, 'title': 'Obstructive Sleep Apnea in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for obstructive sleep apnea in the general adult population.\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Risk Factors\r\nRisk factors associated with OSA include male sex, older age (40-70 years), postmenopausal status, higher body mass index (BMI), and craniofacial and upper airway abnormalities (eg, enlarged tonsils or long upper airway). Black, Hispanic/Latino, and Native American/Alaska Native persons have a higher prevalence of OSA compared with White persons; some evidence suggests that these differences are partially explained by higher rates of obesity, asthma, and tobacco use among these groups.8'}, {'id': 1977, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of multivitamin supplements for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1978, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of single or paired nutrient supplements (other than beta carotene and vitamin E) for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 176, 'title': 'Oral Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for oral cancer in asymptomatic adults.\r\rGo to the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in July 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Tobacco and alcohol use are major risk factors for oral cancer. A total of 20% to 30% of cases of oral cancer worldwide are attributable to cigarette smoking. In the United States, up to 75% of cases of oral cancer may be attributable to tobacco and alcohol use. Additional risk factors include male sex, older age, use of betel quid, ultraviolet light exposure, infection with Candida or bacterial flora, and a compromised immune system. Sexually transmitted oral HPV infection (HPV-16) has recently been recognized as an increasingly important risk factor for oropharyngeal cancer. In the United States, the prevalence of oropharyngeal cancer due to oral HPV infection is probably as high as 80% to 95%. The prevalence of oral HPV infection is associated with age, sex, number of sexual partners, and number of cigarettes smoked per day. The effect of multifactorial risk assessment and screening for risk factors on oral cancer morbidity and mortality is unknown.'}, {'id': 2026, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine screening performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 2027, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of preventive interventions performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 424, 'title': 'Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for peripheral artery disease (PAD) and cardiovascular disease (CVD) risk with the ankle-brachial index (ABI) in asymptomatic adults.\r\rLiterature scans conducted in August 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Risk factors associated with OSA include male sex, older age (40 to 70 years), postmenopausal status, higher BMI, and craniofacial and upper airway abnormalities.'}, {'id': 404, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of counseling adults about skin self-examination to prevent skin cancer.See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 2005, 'title': 'Skin Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Exposure to UV radiation from sun exposure, indoor tanning beds, and other UV radiation&ndash;emitting devices is the major environmental risk factor for skin cancer. History of frequent sunburns, older age, and male sex are associated with increased risk for skin cancer. Exposure to UV radiation from the use of indoor tanning beds is an important risk factor in adolescents. Incidence of melanoma is higher among White persons compared with persons of other races and ethnicities. This difference likely reflects traits associated with increased melanoma risk, such as fair skin (which is more susceptible to sunburning), light-colored eyes, and red or blond hair being more common among White persons compared with persons of other races and ethnicities. Acral lentiginous melanoma, which occurs mostly on skin not frequently exposed to direct sunlight (eg, palms of hands, soles of feet, or under fingernails or toenails), is the most common type of melanoma among Black populations. Other melanoma risk factors include higher numbers of moles on the skin, atypical moles, as well as a personal and family history of skin cancer.'}, {'id': 269, 'title': 'Thyroid Dysfunction: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults.\r\rSee the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': 'The optimal screening interval for thyroid dysfunction (if one exists) is unknown.', 'risktext': 'The most common cause of hypothyroidism in the United States is chronic autoimmune (Hashimoto) thyroiditis. Risk factors for an elevated TSH level include female sex, advancing age, white race, type 1 diabetes, Down syndrome, family history of thyroid disease, goiter, previous hyperthyroidism (possibly due in part to ablation therapy leading to iatrogenic thyroid dysfunction), and external-beam radiation in the head and neck area. Common causes of hyperthyroidism include Graves disease, Hashimoto thyroiditis, and functional thyroid nodules. Risk factors for a low TSH level include female sex; advancing age; black race; low iodine intake; personal or family history of thyroid disease; and ingestion of iodine-containing drugs, such as amiodarone. The USPSTF found no direct evidence that treatment of thyroid dysfunction based on risk level alters final health outcomes.'}, {'id': 1908, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of electronic cigarettes (e-cigarettes) for tobacco cessation in adults, including pregnant persons. The USPSTF recommends that clinicians direct patients who use tobacco to other tobacco cessation interventions with proven effectiveness and established safety.\rSee the Practice Considerations section for more information on recommended behavioral interventions and pharmacotherapy and for suggestions for practice regarding the I statements.', 'servfreq': '', 'risktext': ''}, {'id': 1919, 'title': 'Vitamin D Deficiency in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 408, 'title': 'Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of the benefits and harms of vitamin D and calcium supplementation, alone or combined, for the primary prevention of fractures in men and premenopausal women.', 'servfreq': '', 'risktext': ''}]}
2025-01-29 22:07:20 [INFO] Recommendations fetched: [{'id': 485, 'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in adolescents and adults aged 15 to 65 years. Younger adolescents and older adults who are at increased risk of infection should also be screened.\rSee the Clinical Considerations section for more information about assessment of risk, screening intervals, and rescreening in pregnancy.', 'servfreq': 'The USPSTF found insufficient evidence to determine appropriate or optimal time intervals or strategies for repeat HIV screening. However, repeat screening is reasonable for persons known to be at increased risk of HIV infection, such as sexually active men who have sex with men; persons with a sex partner who is living with HIV; or persons who engage in behaviors that may convey an increased risk of HIV infection, such as injection drug use, transactional sex or commercial sex work, having 1 or more new sex partners whose HIV status is unknown, or having other factors that can place a person at increased risk of HIV infection (see &ldquo;Risk Assessment&rdquo;). Repeat screening is also reasonable for persons who live or receive medical care in a high-prevalence setting, such as a sexually transmitted disease clinic, tuberculosis clinic, correctional facility, or homeless shelter.', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'id': 1921, 'title': 'Hypertension in Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hypertension in adults 18 years or older with office blood pressure measurement (OBPM). The USPSTF recommends obtaining blood pressure measurements outside of the clinical setting for diagnostic confirmation before starting treatment.', 'servfreq': ' \r\nAlthough evidence on optimal screening intervals is limited, reasonable options include:\r\n \r\n \r\n\r\n\r\nScreening for hypertension every year in adults 40 years or older and in adults at increased risk for hypertension (such as Black persons, persons with high-normal blood pressure, or persons who are overweight or obese)\r\n\r\n\r\n \r\n \r\n\r\n\r\nScreening less frequently (ie, every 3 to 5 years) as appropriate for adults aged 18 to 39 years not at increased risk for hypertension and with a prior normal blood pressure reading.\r\n\r\n\r\n ', 'risktext': ' \r\nAlthough all adults should be screened for hypertension, risk factors that increase a person&rsquo;s risk for the condition include older age, Black race, family history, excess weight and obesity, lifestyle habits (lack of physical activity, stress, and tobacco use), and dietary factors (diet high in fat or sodium, diet low in potassium, or excessive alcohol intake)\r\n '}, {'id': 2021, 'title': 'Prevention of Acquisition of HIV: Preexposure Prophylaxis ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians prescribe preexposure prophylaxis using effective antiretroviral therapy to persons who are at increased risk of HIV acquisition to decrease the risk of acquiring HIV. \r\rSee the Practice Considerations section for more information about identification of persons at increased risk and about effective antiretroviral therapy.', 'servfreq': '', 'risktext': 'HIV is primarily acquired via sexual activity or injection drug use. It is important that clinicians routinely take a sexual and injection drug use history for all their patients in an open and nonjudgmental manner. All adolescents and adults who are sexually active or who inject drugs should be informed that acquisition of HIV can be prevented, to facilitate subsequent risk assessment and discussions about preexposure prophylaxis (PrEP) and other ways to prevent acquisition of HIV. Importantly, risk of HIV acquisition exists on a continuum, and currently available risk assessment tools all have limitations. However, certain risk factors or behaviors are known to place persons at increased risk of HIV.\r\nRisk of HIV acquisition depends on the likelihood that a specific act or activity will transmit HIV and the likelihood that a sex partner or drug injection partner has HIV. Likelihood of HIV transmission is highest with needle-sharing injection drug use and condomless receptive anal intercourse. Condomless receptive anal intercourse has an approximately 10- to 15-fold higher risk of transmission than condomless insertive anal sex and condomless receptive and insertive penile-vaginal sex. A 2018 study estimated the prevalence of HIV (ie, an estimate of the likelihood that a partner whose HIV status is unknown has HIV at a population level) as 12.4% among men who have sex with men and 1.9% among persons who inject drugs. The overall prevalence of HIV in the US is estimated at 0.3%.&nbsp;Of note, both the frequency of specific sexual activities and a person&rsquo;s number of sexual partners will also affect their risk of HIV.\r\n&nbsp;The USPSTF recommends that the following persons be considered for PrEP:\r\n1.&nbsp;&nbsp;&nbsp;&nbsp; Sexually active adults and adolescents weighing at least 35 kg (77 lb) who have engaged in anal or vaginal sex in the past 6 months and have any of the following:\r\n&nbsp;\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A sexual partner who has HIV (especially if the partner has an unknown or detectable viral load).\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A bacterial sexually transmitted infection (STI) (syphilis, gonorrhea, or chlamydia for men who have sex with men and transgender women; gonorrhea and syphilis for heterosexual women and men) in the past 6 months.\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A history of inconsistent or no condom use with sex partner(s) whose HIV status is not known; assessing risk in conversation with the patient and considering factors such as number of partners, the specific sexual activities a person engages in, and whether their sex partner or partners are in a group with a higher prevalence of HIV (eg, men who have sex with men or with men and women, transgender women, persons who inject drugs, and persons who engage in transactional sex).\r\n&nbsp;\r\n2. &nbsp; Persons who inject drugs and have a drug-injecting partner who has HIV or who shares injection equipment.\r\nPersons who engage in transactional sex, such as sex for money, drugs, or housing, including commercial sex workers or persons trafficked for sex work, constitute a group at increased risk of HIV acquisition and should be considered for PrEP based on the criteria outlined above. Persons who request PrEP may have undisclosed behaviors that put them at risk. Transgender women and men who are sexually active should be considered for PrEP based on the criteria outlined above. Transgender women are at especially high risk of HIV acquisition. A Centers for Disease Control and and Prevention (CDC) survey in 7 cities found an HIV prevalence of 42% among transgender women. Prevalence was highest among Black transgender women (62%) and Native American/Alaska Native transgender women (65%).\r\nIn addition, studies have found that transmission of HIV to a seronegative partner from a partner with HIV has not been observed when the partner with HIV was being treated with antiretroviral therapy and had a suppressed viral load.&nbsp;It is not known whether PrEP use further decreases the risk of HIV transmission when a partner with HIV has a documented undetectable viral load. Factors such as the consistency or inconsistency of a partner&rsquo;s viral load being suppressed, a partner&rsquo;s adherence to antiretroviral therapy, and the degree of certainty that a partner&rsquo;s viral load is suppressed (eg, self-report vs availability of laboratory test results) may help inform decisions about the use of PrEP in this situation.\r\nAll persons being considered for PrEP must have a recently documented negative HIV antigen-antibody test result, and if they have taken oral PrEP or postexposure prophylaxis in the past 3 months, or injectable cabotegravir in the past 12 months, the CDC recommends testing with both an HIV antigen-antibody assay and an HIV-1 RNA assay.'}, {'id': 1989, 'title': 'Syphilis Infection in Nonpregnant Adolescents and Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for syphilis infection in persons who are at increased risk for infection.', 'servfreq': 'Optimal screening frequency for persons who are at increased risk for syphilis infection is not well established. Men who have sex with men or persons with HIV infection may benefit from screening at least annually or more frequently (eg, every 3 to 6 months) if they continue to be at high risk.', 'risktext': 'The USPSTF recommends screening for syphilis in persons who are at increased risk for infection. When deciding which persons to screen for syphilis, clinicians should consider the prevalence of infection in the communities they serve, as well as other sociodemographic and behavioral factors that may be associated with increased risk of syphilis infection. For example, prevalence of syphilis is higher in men, men who have sex with men, persons with HIV infection, young adults, and persons with a history of incarceration, sex work, or military service. A substantial percentage of heterosexual syphilis transmission occurs among persons who use illicit drugs, particularly methamphetamine. Diagnosis of another STI may signal that a person is having condomless sex, which increases their risk of syphilis infection. Higher infection rates in persons of some racial and ethnic groups have been reported and are primarily a reflection of a combination of factors, including social determinants of health (eg, disparities of income, low educational achievement, and unstable housing), differential health insurance coverage or access to quality health care, and differences in sexual network characteristics (eg, individuals living in communities with a high prevalence of STIs have an increased chance of encountering an infected partner). Local prevalence rates may change over time, so clinicians should be aware of the latest data and trends for their specific population and geographic area, which are available through their state and local health departments and Centers for Disease Control and Prevention (CDC) surveillance.\r\n&nbsp;\r\nAlthough direct evidence on screening in nonpregnant persons who are not at increased risk for syphilis infection is lacking, based on the established test performance characteristics of current screening tests and the low prevalence rate of syphilis in this population, the yield of screening is likely low.9,10 Therefore, screening in this population may result in high false-positive rates and overtreatment.'}, {'id': 1905, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and US Food and Drug Administration (FDA)--approved pharmacotherapy for cessation to nonpregnant adults who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 2014, 'title': 'Anxiety Disorders in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for anxiety disorders in adults, including pregnant and postpartum persons.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding optimal timing for screening, or screening interval, for both the perinatal and general adult populations; more evidence on both timing and screening interval is needed for all adult populations. A pragmatic approach in the absence of evidence might include screening all adults who have not been screened previously and using clinical judgment in considering risk factors, comorbid conditions, and life events to determine if additional screening of high-risk patients is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nRisk factors for anxiety disorders include sociodemographic factors, psychosocial factors, and physical and mental health factors such as marital status (widowed or divorced), stressful life events, smoking and alcohol use, other mental health conditions, or a parental history of mental disorders. Demographic factors such as low socioeconomic status and female sex are associated with higher rates of anxiety disorders.&nbsp;Black persons and individuals of non-Hispanic ethnicity are at increased risk of anxiety disorders due to social, rather than biological, factors. Anxiety and depressive disorders often overlap. One cohort study found that 67% of individuals with a depressive disorder also had a current anxiety disorder, and 75% had a lifetime comorbid anxiety disorder.'}, {'id': 2009, 'title': 'Latent Tuberculosis Infection in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for LTBI in populations at increased risk.\r\rSee the "Assessment of Risk" section for additional information on adults at increased risk.', 'servfreq': 'The USPSTF found no evidence on the optimal frequency of screening for LTBI. In the absence of evidence, a reasonable approach is to repeat screening based on specific risk factors; screening frequency could range from 1-time only screening among persons at low risk for future tuberculosis exposure to annual screening among those at continued risk of exposure.', 'risktext': 'Populations at increased risk for LTBI, based on increased prevalence of active disease and increased risk of exposure, include persons who were born in, or are former residents of, countries with high tuberculosis prevalence and persons who live in, or have lived in, high-risk congregate settings (eg, homeless shelters or correctional facilities). Clinicians can consult their local or state health departments for more information about populations at increased risk in their community, since local demographic patterns may vary across the US.\r\nIn 2020, 71.5% of all cases of active tuberculosis in the US occurred among persons born outside the US. According to the CDC, tuberculosis disease is common in most countries in Latin America, the Caribbean, Africa, Asia, Eastern Europe, and Russia. In 2020, among persons with new tuberculosis living in the US who were born outside the US, the most common countries of birth were Mexico (18.0%), the Philippines (12.5%), India (10.4%), Vietnam (8.2%), and China (5.1%), accounting for 54.2% of total cases. Most of these cases are believed to be due to progression of latent infection to active tuberculosis disease rather than new transmission within communities.\r\nPersons who live, or have lived, in high-risk congregate settings also have a higher prevalence rate of active tuberculosis and an increased risk for exposure. In 2020, 4.3% of tuberculosis disease cases diagnosed in persons 15 years or older occurred in persons experiencing homelessness and 2.6% occurred in residents of correctional facilities. It is estimated that persons experiencing homelessness have an 11 times higher incidence of tuberculosis disease compared with persons who are not experiencing homelessness (36 cases per 100,000 population vs 2.9 cases per 100,000 population, respectively, during 2011 to 2016).\r\nOther populations at increased risk for LTBI or progression to active disease include persons who have immunosuppression (eg, persons living with HIV, patients receiving immunosuppressive medications such as chemotherapy or tumor necrosis factor inhibitors, and patients who have received an organ transplant) and patients with silicosis (a lung disease). However, given that screening in these populations may be considered standard care as part of disease management or indicated prior to the use of certain medications, the USPSTF did not review evidence on screening in these populations. Information on testing in these populations is provided by other groups, such as the Office of AIDS Research at the National Institutes of Health, and in a guideline issued jointly by the American Thoracic Society, Infectious Diseases Society of America, and CDC. Some evidence from observational studies has explored the association between poorly controlled diabetes and progression of LTBI to active disease. However, there is insufficient evidence on screening for and treatment of LTBI in persons with diabetes for the USPSTF to make a separate recommendation for this important population.\r\nPersons who are contacts of individuals with active tuberculosis, health care workers, and workers in high-risk congregate settings may also be at increased risk of exposure. Because screening in these populations is conducted as part of public health or employee health surveillance, the USPSTF did not review the evidence in these populations. Clinicians seeking further information about testing for tuberculosis in these populations can refer to the Additional Tools and Resources and Recommendations of Others sections.'}, {'id': 514, 'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic bacteriuria in nonpregnant adults.', 'servfreq': '', 'risktext': 'The risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6 Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5 Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7, 11, 12 In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12 Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4, 6'}, {'id': 1909, 'title': 'Asymptomatic Carotid Artery Stenosis: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic carotid artery stenosis in the general adult population.\r\rSee the Practice Considerations section for a description of adults at increased risk.', 'servfreq': '', 'risktext': ''}, {'id': 2017, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for suicide risk in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': '', 'risktext': ''}, {'id': 2016, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for depression in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding the optimal timing for screening for depression; more evidence is needed in both perinatal and general adult populations. In the absence of evidence, a pragmatic approach might include screening adults who have not been screened previously and using clinical judgment while considering risk factors, comorbid conditions, and life events to determine if additional screening of patients at increased risk is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nThe USPSTF recommends screening for depression in all adults regardless of risk factors. Risk factors for depression include a combination of genetic, biological, and environmental factors, such as a family history of depression, prior episode of depression or other mental health condition, a history of trauma or adverse life events, or a history of disease or illness (eg, cardiovascular disease).\r\nPrevalence rates vary by sex, age, race, ethnicity, education, marital status, geographic location, poverty level, and employment status. Women have twice the risk of depression compared with men. Young adults, multiracial individuals, and Native American/Alaska Native individuals have higher rates of depression.\r\nRisk factors for perinatal depression include life stress, low social support, history of depression, marital or partner dissatisfaction, and a history of abuse.'}, {'id': 1845, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends offering or referring adults with cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity.', 'servfreq': '', 'risktext': 'Adults 18 years or older at increased risk of CVD, defined as those with 1 or more of the following:\r\n1.Hypertension or elevated blood pressure2.Dyslipidemia3.Mixed or multiple risk factors such as the metabolic syndrome or an estimated 10-year CVD risk of &ge;7.5%\r\nThis recommendation does not apply to adults with other known modifiable cardiovascular risk factors such as abnormal blood glucose levels, obesity, and smoking; these populations are incorporated in other USPSTF recommendations.'}, {'id': 1885, 'title': 'Hepatitis B Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in adolescents and adults at increased risk for infection.\r\rSee the Practice Considerations section for a description of adolescents and adults at increased risk for infection.', 'servfreq': 'For patients with negative HBsAg results who have not received the HBV vaccine series, periodic screening may be useful for those who report continued risk for acquiring HBV transmission, such as persons who continue to inject drugs and men who have sex with men. Clinical judgment should be used to determine screening frequency. The USPSTF found no evidence to determine optimal screening intervals.', 'risktext': 'Persons from such risk groups include persons who have injected drugs in the past or currently; men who have sex with men; persons with HIV; and sex partners, needle-sharing contacts, and household contacts of persons known to be HBsAg positive. Some persons with combinations of risk factors who are not members of risk factor groups listed above may also be at increased risk for HBV infection.'}, {'id': 524, 'title': 'Hepatitis C Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis C virus (HCV) infection in adults aged 18 to 79 years.', 'servfreq': 'One-time screening for most adults.\r\nPeriodically screen persons with continued risk for HCV infection (eg, persons with past or current injection drug use). There is limited evidence to determine how often to screen persons at increased risk.&nbsp;', 'risktext': 'Asymptomatic adults aged 18 to 79 years (including pregnant persons) without known liver disease.&nbsp;\r\nThe USPSTF also suggests that clinicians consider screening persons younger than 18 years and older than 79 years who are at high risk for infection (eg, those with past or current injection drug use).&nbsp;'}, {'id': 1445, 'title': 'Sexually Transmitted Infections: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends behavioral counseling for all sexually active adolescents and for adults who are at increased risk for sexually transmitted infections (STIs).\r\rSee the Practice Considerations section for more information on populations at increased risk for acquiring STIs.', 'servfreq': '', 'risktext': 'All sexually active adolescents are at increased risk for STIs because of the high rates of STIs in this age group and should receive behavioral counseling interventions. Adults at increased risk for STIs include those who currently have an STI or were diagnosed with one within the past year, do not consistently use condoms, have multiple sex partners, or have sex partners within populations with a high prevalence of STIs. Populations with a high prevalence of STIs include persons who seek STI testing or attend STI clinics; sexual and gender minorities; persons who are living with HIV, inject drugs, have exchanged sex for money or drugs, or have entered correctional facilities; and some racial/ethnic minority groups.1-4'}, {'id': 402, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends counseling young adults, adolescents, children, and parents of young children about minimizing exposure to ultraviolet (UV) radiation for persons aged 6 months to 24 years with fair skin types to reduce their risk of skin cancer.', 'servfreq': '', 'risktext': 'Fair skin types'}, {'id': 438, 'title': 'Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for unhealthy alcohol use in primary care settings in adults 18 years or older, including pregnant women, and providing persons engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce unhealthy alcohol use.', 'servfreq': 'The USPSTF did not find adequate evidence to recommend an optimal screening interval for unhealthy alcohol use in adults.&nbsp;Brief behavioral counseling interventions were found to reduce unhealthy alcohol use in adults 18 years or older, including pregnant women. Effective behavioral counseling interventions vary in their specific components, administration, length, and number of interactions. The USPSTF was unable to identify specific intervention characteristics or components that were clearly associated with improved outcomes.', 'risktext': 'engaged in risky or hazardous drinking'}, {'id': 767, 'title': 'Unhealthy Drug Use: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening by asking questions about unhealthy drug use in adults age 18 years or older. Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. \r(Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'servfreq': 'Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. (Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'risktext': 'These include being aged 18 to 25 years; male sex; having a mental health condition, personality or mood disorder, or nicotine or alcohol dependence; a history of physical or sexual abuse, parental neglect, or other adversity in childhood; or drug or alcohol addiction in a first-degree relative.1,9&nbsp;Factors associated with misuse of prescription drugs include history of other drug use, mental illness, pain, and greater access to prescription drugs.10&nbsp;Factors associated with prenatal use of drugs include a mental health disorder, interpersonal violence, and family history of substance use.11'}, {'id': 433, 'title': 'Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer or refer adults with a body mass index (BMI) of 30 or higher (calculated as weight in kilograms divided by height in meters squared) to intensive, multicomponent behavioral interventions.', 'servfreq': '', 'risktext': 'Adults with a BMI &ge;30'}, {'id': 1979, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: Behavioral Counseling Interventions ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians individualize the decision to offer or refer adults without cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity. \r\rSee the "Practice Considerations" section for information on determining which patients may benefit most from this service.', 'servfreq': '', 'risktext': ''}, {'id': 1937, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for chlamydia and gonorrhea in men.', 'servfreq': '', 'risktext': ''}, {'id': 418, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening with resting or exercise electrocardiography (ECG) to prevent cardiovascular disease (CVD) events in asymptomatic adults at low risk of CVD events.', 'servfreq': '', 'risktext': ''}, {'id': 1973, 'title': 'Chronic Obstructive Pulmonary Disease: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for chronic obstructive pulmonary disease in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 2003, 'title': 'Genital Herpes Infection: Serologic Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine serologic screening for genital herpes simplex virus infection in asymptomatic adolescents and adults, including pregnant persons.', 'servfreq': '', 'risktext': 'The USPSTF found no evidence of externally validated, reliable risk stratification tools to identify individuals more or less likely to have genital herpes.'}, {'id': 504, 'title': 'Pancreatic Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for pancreatic cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 203, 'title': 'Testicular Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for testicular cancer in adolescent or adult men.', 'servfreq': '', 'risktext': ''}, {'id': 365, 'title': 'Thyroid Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for thyroid cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 1976, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'D', 'text': 'The DoctorAI recommends against the use of beta carotene or vitamin E supplements for the prevention of cardiovascular disease or cancer.', 'servfreq': '', 'risktext': ''}, {'id': 318, 'title': 'Autism Spectrum Disorder in Young Children: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for autism spectrum disorder (ASD) in young children for whom no concerns of ASD have been raised by their parents or a clinician.', 'servfreq': '', 'risktext': 'Although a number of potential risk factors for ASD have been identified, there is insufficient evidence to determine if certain risk factors modify the performance characteristics of ASD screening tests, such as the age at which screening is performed or other characteristics of the child or family.'}, {'id': 65, 'title': 'Bladder Cancer in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults.\r\rLiterature scans conducted in July 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'This evidence update focused on the benefits and harms of screening for bladder cancer among people without symptoms, the accuracy of screening tests done in primary care settings, and the benefits and harms of treatment. The updated evidence review did not find any new high quality evidence to adequately determine the balance of benefits and harms of screening for bladder cancer. However, bladder cancer is a common cancer and can cause considerable health problems including death. Therefore, the USPSTF determined that the evidence was insufficient to provide a recommendation for or against bladder cancer screening.  The USPSTF emphasizes the need for additional research in this area. '}, {'id': 419, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening with resting or exercise ECG to prevent CVD events in asymptomatic adults at intermediate or high risk of CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 423, 'title': 'Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of adding the ankle-brachial index (ABI), high-sensitivity C-reactive protein (hsCRP) level, or coronary artery calcium (CAC) score to traditional risk assessment for cardiovascular disease (CVD) in asymptomatic adults to prevent CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 352, 'title': 'Celiac Disease: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'persons with family history or other risk factors'}, {'id': 1955, 'title': 'Eating Disorders in Adolescents and Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for eating disorders in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 665, 'title': 'Illicit Drug Use in Children, Adolescents, and Young Adults: Primary Care-Based Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--based behavioral counseling interventions to prevent illicit drug use, including nonmedical use of prescription drugs, in children, adolescents, and young adults.\r\rSee the Practice Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 435, 'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for abuse and neglect in all older or vulnerable adults. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': 'Risk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health.14&nbsp;For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.15'}, {'id': 2045, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for iron deficiency and iron deficiency anemia in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2046, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine iron supplementation in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2018, 'title': 'Lipid Disorders in Children and Adolescents: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1998, 'title': 'Obstructive Sleep Apnea in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for obstructive sleep apnea in the general adult population.\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Risk Factors\r\nRisk factors associated with OSA include male sex, older age (40-70 years), postmenopausal status, higher body mass index (BMI), and craniofacial and upper airway abnormalities (eg, enlarged tonsils or long upper airway). Black, Hispanic/Latino, and Native American/Alaska Native persons have a higher prevalence of OSA compared with White persons; some evidence suggests that these differences are partially explained by higher rates of obesity, asthma, and tobacco use among these groups.8'}, {'id': 1977, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of multivitamin supplements for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1978, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of single or paired nutrient supplements (other than beta carotene and vitamin E) for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 176, 'title': 'Oral Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for oral cancer in asymptomatic adults.\r\rGo to the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in July 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Tobacco and alcohol use are major risk factors for oral cancer. A total of 20% to 30% of cases of oral cancer worldwide are attributable to cigarette smoking. In the United States, up to 75% of cases of oral cancer may be attributable to tobacco and alcohol use. Additional risk factors include male sex, older age, use of betel quid, ultraviolet light exposure, infection with Candida or bacterial flora, and a compromised immune system. Sexually transmitted oral HPV infection (HPV-16) has recently been recognized as an increasingly important risk factor for oropharyngeal cancer. In the United States, the prevalence of oropharyngeal cancer due to oral HPV infection is probably as high as 80% to 95%. The prevalence of oral HPV infection is associated with age, sex, number of sexual partners, and number of cigarettes smoked per day. The effect of multifactorial risk assessment and screening for risk factors on oral cancer morbidity and mortality is unknown.'}, {'id': 2026, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine screening performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 2027, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of preventive interventions performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 424, 'title': 'Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for peripheral artery disease (PAD) and cardiovascular disease (CVD) risk with the ankle-brachial index (ABI) in asymptomatic adults.\r\rLiterature scans conducted in August 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Risk factors associated with OSA include male sex, older age (40 to 70 years), postmenopausal status, higher BMI, and craniofacial and upper airway abnormalities.'}, {'id': 404, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of counseling adults about skin self-examination to prevent skin cancer.See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 2005, 'title': 'Skin Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Exposure to UV radiation from sun exposure, indoor tanning beds, and other UV radiation&ndash;emitting devices is the major environmental risk factor for skin cancer. History of frequent sunburns, older age, and male sex are associated with increased risk for skin cancer. Exposure to UV radiation from the use of indoor tanning beds is an important risk factor in adolescents. Incidence of melanoma is higher among White persons compared with persons of other races and ethnicities. This difference likely reflects traits associated with increased melanoma risk, such as fair skin (which is more susceptible to sunburning), light-colored eyes, and red or blond hair being more common among White persons compared with persons of other races and ethnicities. Acral lentiginous melanoma, which occurs mostly on skin not frequently exposed to direct sunlight (eg, palms of hands, soles of feet, or under fingernails or toenails), is the most common type of melanoma among Black populations. Other melanoma risk factors include higher numbers of moles on the skin, atypical moles, as well as a personal and family history of skin cancer.'}, {'id': 269, 'title': 'Thyroid Dysfunction: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults.\r\rSee the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': 'The optimal screening interval for thyroid dysfunction (if one exists) is unknown.', 'risktext': 'The most common cause of hypothyroidism in the United States is chronic autoimmune (Hashimoto) thyroiditis. Risk factors for an elevated TSH level include female sex, advancing age, white race, type 1 diabetes, Down syndrome, family history of thyroid disease, goiter, previous hyperthyroidism (possibly due in part to ablation therapy leading to iatrogenic thyroid dysfunction), and external-beam radiation in the head and neck area. Common causes of hyperthyroidism include Graves disease, Hashimoto thyroiditis, and functional thyroid nodules. Risk factors for a low TSH level include female sex; advancing age; black race; low iodine intake; personal or family history of thyroid disease; and ingestion of iodine-containing drugs, such as amiodarone. The USPSTF found no direct evidence that treatment of thyroid dysfunction based on risk level alters final health outcomes.'}, {'id': 1908, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of electronic cigarettes (e-cigarettes) for tobacco cessation in adults, including pregnant persons. The USPSTF recommends that clinicians direct patients who use tobacco to other tobacco cessation interventions with proven effectiveness and established safety.\rSee the Practice Considerations section for more information on recommended behavioral interventions and pharmacotherapy and for suggestions for practice regarding the I statements.', 'servfreq': '', 'risktext': ''}, {'id': 1919, 'title': 'Vitamin D Deficiency in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 408, 'title': 'Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of the benefits and harms of vitamin D and calcium supplementation, alone or combined, for the primary prevention of fractures in men and premenopausal women.', 'servfreq': '', 'risktext': ''}]
2025-01-29 22:07:21 [INFO] Update id=273478215 is handled. Duration 848 ms by bot id=8108339380
2025-01-29 22:08:36 [WARNING] Received SIGTERM signal
2025-01-29 22:08:36 [INFO] Polling stopped for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-29 22:08:36 [INFO] Polling stopped
2025-01-29 22:08:36 [INFO] โ ะัะป ะฟะพะดะบะปััะตะฝะธะน ะบ ะะ ะทะฐะบััั.
2025-01-29 22:08:36 [INFO] โ ะะพะดะบะปััะตะฝะธะต ะบ ะะ ะทะฐะบัััะพ.
2025-01-29 22:08:44 [INFO] ๐ ะะพั ะทะฐะฟััะบะฐะตััั...
2025-01-29 22:08:44 [INFO] โ ะัะป ะฟะพะดะบะปััะตะฝะธะน ะบ ะะ ัะพะทะดะฐะฝ.
2025-01-29 22:08:44 [INFO] โ ะขะฐะฑะปะธัั ะฒ ะฑะฐะทะต ะดะฐะฝะฝัั ััะฟะตัะฝะพ ัะพะทะดะฐะฝั.
2025-01-29 22:08:44 [INFO] Start polling
2025-01-29 22:08:46 [INFO] Run polling for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-29 22:08:46 [INFO] The user 711983855 called the command /start.
2025-01-29 22:08:47 [INFO] Update id=273478216 is handled. Duration 1247 ms by bot id=8108339380
2025-01-29 22:08:49 [INFO] The user 711983855's state has been set to Survey.age.
2025-01-29 22:08:49 [INFO] Update id=273478217 is handled. Duration 344 ms by bot id=8108339380
2025-01-29 22:08:53 [INFO] The user 711983855's state has been set to Survey.weight.
2025-01-29 22:08:54 [INFO] Update id=273478218 is handled. Duration 422 ms by bot id=8108339380
2025-01-29 22:08:55 [INFO] The user 711983855's state has been set to Survey.height.
2025-01-29 22:08:56 [INFO] Update id=273478219 is handled. Duration 339 ms by bot id=8108339380
2025-01-29 22:08:58 [INFO] The user 711983855's state has been set to Survey.feet.
2025-01-29 22:08:58 [INFO] Update id=273478220 is handled. Duration 333 ms by bot id=8108339380
2025-01-29 22:09:00 [INFO] The user 711983855's state has been set to Survey.gender.
2025-01-29 22:09:01 [INFO] Update id=273478221 is handled. Duration 339 ms by bot id=8108339380
2025-01-29 22:09:03 [INFO] The user 711983855's state has been set to Survey.smoking.
2025-01-29 22:09:04 [INFO] Update id=273478222 is handled. Duration 402 ms by bot id=8108339380
2025-01-29 22:09:05 [INFO] The user 711983855's state has been set to Survey.sex.
2025-01-29 22:09:05 [INFO] Update id=273478223 is handled. Duration 352 ms by bot id=8108339380
2025-01-29 22:09:06 [INFO] State data: {'db': <bot.database.Database object at 0x7f20a250f530>, 'age': 20, 'weight': 90, 'height': 190, 'feet': 45, 'gender': 'male', 'pregnant': 'no', 'smoking': 'no', 'sex': 'no'}
2025-01-29 22:09:07 [INFO] Update id=273478224 is handled. Duration 707 ms by bot id=8108339380
2025-01-29 22:09:09 [INFO] State data: {'db': <bot.database.Database object at 0x7f20a250f530>, 'age': 20, 'weight': 90, 'height': 190, 'feet': 45, 'gender': 'male', 'pregnant': 'no', 'smoking': 'no', 'sex': 'Tools_0', 'recommendations': [{'id': 485, 'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in adolescents and adults aged 15 to 65 years. Younger adolescents and older adults who are at increased risk of infection should also be screened.\rSee the Clinical Considerations section for more information about assessment of risk, screening intervals, and rescreening in pregnancy.', 'servfreq': 'The USPSTF found insufficient evidence to determine appropriate or optimal time intervals or strategies for repeat HIV screening. However, repeat screening is reasonable for persons known to be at increased risk of HIV infection, such as sexually active men who have sex with men; persons with a sex partner who is living with HIV; or persons who engage in behaviors that may convey an increased risk of HIV infection, such as injection drug use, transactional sex or commercial sex work, having 1 or more new sex partners whose HIV status is unknown, or having other factors that can place a person at increased risk of HIV infection (see &ldquo;Risk Assessment&rdquo;). Repeat screening is also reasonable for persons who live or receive medical care in a high-prevalence setting, such as a sexually transmitted disease clinic, tuberculosis clinic, correctional facility, or homeless shelter.', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'id': 1921, 'title': 'Hypertension in Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hypertension in adults 18 years or older with office blood pressure measurement (OBPM). The USPSTF recommends obtaining blood pressure measurements outside of the clinical setting for diagnostic confirmation before starting treatment.', 'servfreq': ' \r\nAlthough evidence on optimal screening intervals is limited, reasonable options include:\r\n \r\n \r\n\r\n\r\nScreening for hypertension every year in adults 40 years or older and in adults at increased risk for hypertension (such as Black persons, persons with high-normal blood pressure, or persons who are overweight or obese)\r\n\r\n\r\n \r\n \r\n\r\n\r\nScreening less frequently (ie, every 3 to 5 years) as appropriate for adults aged 18 to 39 years not at increased risk for hypertension and with a prior normal blood pressure reading.\r\n\r\n\r\n ', 'risktext': ' \r\nAlthough all adults should be screened for hypertension, risk factors that increase a person&rsquo;s risk for the condition include older age, Black race, family history, excess weight and obesity, lifestyle habits (lack of physical activity, stress, and tobacco use), and dietary factors (diet high in fat or sodium, diet low in potassium, or excessive alcohol intake)\r\n '}, {'id': 2021, 'title': 'Prevention of Acquisition of HIV: Preexposure Prophylaxis ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians prescribe preexposure prophylaxis using effective antiretroviral therapy to persons who are at increased risk of HIV acquisition to decrease the risk of acquiring HIV. \r\rSee the Practice Considerations section for more information about identification of persons at increased risk and about effective antiretroviral therapy.', 'servfreq': '', 'risktext': 'HIV is primarily acquired via sexual activity or injection drug use. It is important that clinicians routinely take a sexual and injection drug use history for all their patients in an open and nonjudgmental manner. All adolescents and adults who are sexually active or who inject drugs should be informed that acquisition of HIV can be prevented, to facilitate subsequent risk assessment and discussions about preexposure prophylaxis (PrEP) and other ways to prevent acquisition of HIV. Importantly, risk of HIV acquisition exists on a continuum, and currently available risk assessment tools all have limitations. However, certain risk factors or behaviors are known to place persons at increased risk of HIV.\r\nRisk of HIV acquisition depends on the likelihood that a specific act or activity will transmit HIV and the likelihood that a sex partner or drug injection partner has HIV. Likelihood of HIV transmission is highest with needle-sharing injection drug use and condomless receptive anal intercourse. Condomless receptive anal intercourse has an approximately 10- to 15-fold higher risk of transmission than condomless insertive anal sex and condomless receptive and insertive penile-vaginal sex. A 2018 study estimated the prevalence of HIV (ie, an estimate of the likelihood that a partner whose HIV status is unknown has HIV at a population level) as 12.4% among men who have sex with men and 1.9% among persons who inject drugs. The overall prevalence of HIV in the US is estimated at 0.3%.&nbsp;Of note, both the frequency of specific sexual activities and a person&rsquo;s number of sexual partners will also affect their risk of HIV.\r\n&nbsp;The USPSTF recommends that the following persons be considered for PrEP:\r\n1.&nbsp;&nbsp;&nbsp;&nbsp; Sexually active adults and adolescents weighing at least 35 kg (77 lb) who have engaged in anal or vaginal sex in the past 6 months and have any of the following:\r\n&nbsp;\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A sexual partner who has HIV (especially if the partner has an unknown or detectable viral load).\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A bacterial sexually transmitted infection (STI) (syphilis, gonorrhea, or chlamydia for men who have sex with men and transgender women; gonorrhea and syphilis for heterosexual women and men) in the past 6 months.\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A history of inconsistent or no condom use with sex partner(s) whose HIV status is not known; assessing risk in conversation with the patient and considering factors such as number of partners, the specific sexual activities a person engages in, and whether their sex partner or partners are in a group with a higher prevalence of HIV (eg, men who have sex with men or with men and women, transgender women, persons who inject drugs, and persons who engage in transactional sex).\r\n&nbsp;\r\n2. &nbsp; Persons who inject drugs and have a drug-injecting partner who has HIV or who shares injection equipment.\r\nPersons who engage in transactional sex, such as sex for money, drugs, or housing, including commercial sex workers or persons trafficked for sex work, constitute a group at increased risk of HIV acquisition and should be considered for PrEP based on the criteria outlined above. Persons who request PrEP may have undisclosed behaviors that put them at risk. Transgender women and men who are sexually active should be considered for PrEP based on the criteria outlined above. Transgender women are at especially high risk of HIV acquisition. A Centers for Disease Control and and Prevention (CDC) survey in 7 cities found an HIV prevalence of 42% among transgender women. Prevalence was highest among Black transgender women (62%) and Native American/Alaska Native transgender women (65%).\r\nIn addition, studies have found that transmission of HIV to a seronegative partner from a partner with HIV has not been observed when the partner with HIV was being treated with antiretroviral therapy and had a suppressed viral load.&nbsp;It is not known whether PrEP use further decreases the risk of HIV transmission when a partner with HIV has a documented undetectable viral load. Factors such as the consistency or inconsistency of a partner&rsquo;s viral load being suppressed, a partner&rsquo;s adherence to antiretroviral therapy, and the degree of certainty that a partner&rsquo;s viral load is suppressed (eg, self-report vs availability of laboratory test results) may help inform decisions about the use of PrEP in this situation.\r\nAll persons being considered for PrEP must have a recently documented negative HIV antigen-antibody test result, and if they have taken oral PrEP or postexposure prophylaxis in the past 3 months, or injectable cabotegravir in the past 12 months, the CDC recommends testing with both an HIV antigen-antibody assay and an HIV-1 RNA assay.'}, {'id': 1989, 'title': 'Syphilis Infection in Nonpregnant Adolescents and Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for syphilis infection in persons who are at increased risk for infection.', 'servfreq': 'Optimal screening frequency for persons who are at increased risk for syphilis infection is not well established. Men who have sex with men or persons with HIV infection may benefit from screening at least annually or more frequently (eg, every 3 to 6 months) if they continue to be at high risk.', 'risktext': 'The USPSTF recommends screening for syphilis in persons who are at increased risk for infection. When deciding which persons to screen for syphilis, clinicians should consider the prevalence of infection in the communities they serve, as well as other sociodemographic and behavioral factors that may be associated with increased risk of syphilis infection. For example, prevalence of syphilis is higher in men, men who have sex with men, persons with HIV infection, young adults, and persons with a history of incarceration, sex work, or military service. A substantial percentage of heterosexual syphilis transmission occurs among persons who use illicit drugs, particularly methamphetamine. Diagnosis of another STI may signal that a person is having condomless sex, which increases their risk of syphilis infection. Higher infection rates in persons of some racial and ethnic groups have been reported and are primarily a reflection of a combination of factors, including social determinants of health (eg, disparities of income, low educational achievement, and unstable housing), differential health insurance coverage or access to quality health care, and differences in sexual network characteristics (eg, individuals living in communities with a high prevalence of STIs have an increased chance of encountering an infected partner). Local prevalence rates may change over time, so clinicians should be aware of the latest data and trends for their specific population and geographic area, which are available through their state and local health departments and Centers for Disease Control and Prevention (CDC) surveillance.\r\n&nbsp;\r\nAlthough direct evidence on screening in nonpregnant persons who are not at increased risk for syphilis infection is lacking, based on the established test performance characteristics of current screening tests and the low prevalence rate of syphilis in this population, the yield of screening is likely low.9,10 Therefore, screening in this population may result in high false-positive rates and overtreatment.'}, {'id': 1905, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and US Food and Drug Administration (FDA)--approved pharmacotherapy for cessation to nonpregnant adults who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 2014, 'title': 'Anxiety Disorders in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for anxiety disorders in adults, including pregnant and postpartum persons.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding optimal timing for screening, or screening interval, for both the perinatal and general adult populations; more evidence on both timing and screening interval is needed for all adult populations. A pragmatic approach in the absence of evidence might include screening all adults who have not been screened previously and using clinical judgment in considering risk factors, comorbid conditions, and life events to determine if additional screening of high-risk patients is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nRisk factors for anxiety disorders include sociodemographic factors, psychosocial factors, and physical and mental health factors such as marital status (widowed or divorced), stressful life events, smoking and alcohol use, other mental health conditions, or a parental history of mental disorders. Demographic factors such as low socioeconomic status and female sex are associated with higher rates of anxiety disorders.&nbsp;Black persons and individuals of non-Hispanic ethnicity are at increased risk of anxiety disorders due to social, rather than biological, factors. Anxiety and depressive disorders often overlap. One cohort study found that 67% of individuals with a depressive disorder also had a current anxiety disorder, and 75% had a lifetime comorbid anxiety disorder.'}, {'id': 2009, 'title': 'Latent Tuberculosis Infection in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for LTBI in populations at increased risk.\r\rSee the "Assessment of Risk" section for additional information on adults at increased risk.', 'servfreq': 'The USPSTF found no evidence on the optimal frequency of screening for LTBI. In the absence of evidence, a reasonable approach is to repeat screening based on specific risk factors; screening frequency could range from 1-time only screening among persons at low risk for future tuberculosis exposure to annual screening among those at continued risk of exposure.', 'risktext': 'Populations at increased risk for LTBI, based on increased prevalence of active disease and increased risk of exposure, include persons who were born in, or are former residents of, countries with high tuberculosis prevalence and persons who live in, or have lived in, high-risk congregate settings (eg, homeless shelters or correctional facilities). Clinicians can consult their local or state health departments for more information about populations at increased risk in their community, since local demographic patterns may vary across the US.\r\nIn 2020, 71.5% of all cases of active tuberculosis in the US occurred among persons born outside the US. According to the CDC, tuberculosis disease is common in most countries in Latin America, the Caribbean, Africa, Asia, Eastern Europe, and Russia. In 2020, among persons with new tuberculosis living in the US who were born outside the US, the most common countries of birth were Mexico (18.0%), the Philippines (12.5%), India (10.4%), Vietnam (8.2%), and China (5.1%), accounting for 54.2% of total cases. Most of these cases are believed to be due to progression of latent infection to active tuberculosis disease rather than new transmission within communities.\r\nPersons who live, or have lived, in high-risk congregate settings also have a higher prevalence rate of active tuberculosis and an increased risk for exposure. In 2020, 4.3% of tuberculosis disease cases diagnosed in persons 15 years or older occurred in persons experiencing homelessness and 2.6% occurred in residents of correctional facilities. It is estimated that persons experiencing homelessness have an 11 times higher incidence of tuberculosis disease compared with persons who are not experiencing homelessness (36 cases per 100,000 population vs 2.9 cases per 100,000 population, respectively, during 2011 to 2016).\r\nOther populations at increased risk for LTBI or progression to active disease include persons who have immunosuppression (eg, persons living with HIV, patients receiving immunosuppressive medications such as chemotherapy or tumor necrosis factor inhibitors, and patients who have received an organ transplant) and patients with silicosis (a lung disease). However, given that screening in these populations may be considered standard care as part of disease management or indicated prior to the use of certain medications, the USPSTF did not review evidence on screening in these populations. Information on testing in these populations is provided by other groups, such as the Office of AIDS Research at the National Institutes of Health, and in a guideline issued jointly by the American Thoracic Society, Infectious Diseases Society of America, and CDC. Some evidence from observational studies has explored the association between poorly controlled diabetes and progression of LTBI to active disease. However, there is insufficient evidence on screening for and treatment of LTBI in persons with diabetes for the USPSTF to make a separate recommendation for this important population.\r\nPersons who are contacts of individuals with active tuberculosis, health care workers, and workers in high-risk congregate settings may also be at increased risk of exposure. Because screening in these populations is conducted as part of public health or employee health surveillance, the USPSTF did not review the evidence in these populations. Clinicians seeking further information about testing for tuberculosis in these populations can refer to the Additional Tools and Resources and Recommendations of Others sections.'}, {'id': 514, 'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic bacteriuria in nonpregnant adults.', 'servfreq': '', 'risktext': 'The risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6 Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5 Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7, 11, 12 In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12 Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4, 6'}, {'id': 1909, 'title': 'Asymptomatic Carotid Artery Stenosis: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic carotid artery stenosis in the general adult population.\r\rSee the Practice Considerations section for a description of adults at increased risk.', 'servfreq': '', 'risktext': ''}, {'id': 2017, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for suicide risk in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': '', 'risktext': ''}, {'id': 2016, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for depression in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding the optimal timing for screening for depression; more evidence is needed in both perinatal and general adult populations. In the absence of evidence, a pragmatic approach might include screening adults who have not been screened previously and using clinical judgment while considering risk factors, comorbid conditions, and life events to determine if additional screening of patients at increased risk is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nThe USPSTF recommends screening for depression in all adults regardless of risk factors. Risk factors for depression include a combination of genetic, biological, and environmental factors, such as a family history of depression, prior episode of depression or other mental health condition, a history of trauma or adverse life events, or a history of disease or illness (eg, cardiovascular disease).\r\nPrevalence rates vary by sex, age, race, ethnicity, education, marital status, geographic location, poverty level, and employment status. Women have twice the risk of depression compared with men. Young adults, multiracial individuals, and Native American/Alaska Native individuals have higher rates of depression.\r\nRisk factors for perinatal depression include life stress, low social support, history of depression, marital or partner dissatisfaction, and a history of abuse.'}, {'id': 1845, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends offering or referring adults with cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity.', 'servfreq': '', 'risktext': 'Adults 18 years or older at increased risk of CVD, defined as those with 1 or more of the following:\r\n1.Hypertension or elevated blood pressure2.Dyslipidemia3.Mixed or multiple risk factors such as the metabolic syndrome or an estimated 10-year CVD risk of &ge;7.5%\r\nThis recommendation does not apply to adults with other known modifiable cardiovascular risk factors such as abnormal blood glucose levels, obesity, and smoking; these populations are incorporated in other USPSTF recommendations.'}, {'id': 1885, 'title': 'Hepatitis B Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in adolescents and adults at increased risk for infection.\r\rSee the Practice Considerations section for a description of adolescents and adults at increased risk for infection.', 'servfreq': 'For patients with negative HBsAg results who have not received the HBV vaccine series, periodic screening may be useful for those who report continued risk for acquiring HBV transmission, such as persons who continue to inject drugs and men who have sex with men. Clinical judgment should be used to determine screening frequency. The USPSTF found no evidence to determine optimal screening intervals.', 'risktext': 'Persons from such risk groups include persons who have injected drugs in the past or currently; men who have sex with men; persons with HIV; and sex partners, needle-sharing contacts, and household contacts of persons known to be HBsAg positive. Some persons with combinations of risk factors who are not members of risk factor groups listed above may also be at increased risk for HBV infection.'}, {'id': 524, 'title': 'Hepatitis C Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis C virus (HCV) infection in adults aged 18 to 79 years.', 'servfreq': 'One-time screening for most adults.\r\nPeriodically screen persons with continued risk for HCV infection (eg, persons with past or current injection drug use). There is limited evidence to determine how often to screen persons at increased risk.&nbsp;', 'risktext': 'Asymptomatic adults aged 18 to 79 years (including pregnant persons) without known liver disease.&nbsp;\r\nThe USPSTF also suggests that clinicians consider screening persons younger than 18 years and older than 79 years who are at high risk for infection (eg, those with past or current injection drug use).&nbsp;'}, {'id': 1445, 'title': 'Sexually Transmitted Infections: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends behavioral counseling for all sexually active adolescents and for adults who are at increased risk for sexually transmitted infections (STIs).\r\rSee the Practice Considerations section for more information on populations at increased risk for acquiring STIs.', 'servfreq': '', 'risktext': 'All sexually active adolescents are at increased risk for STIs because of the high rates of STIs in this age group and should receive behavioral counseling interventions. Adults at increased risk for STIs include those who currently have an STI or were diagnosed with one within the past year, do not consistently use condoms, have multiple sex partners, or have sex partners within populations with a high prevalence of STIs. Populations with a high prevalence of STIs include persons who seek STI testing or attend STI clinics; sexual and gender minorities; persons who are living with HIV, inject drugs, have exchanged sex for money or drugs, or have entered correctional facilities; and some racial/ethnic minority groups.1-4'}, {'id': 402, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends counseling young adults, adolescents, children, and parents of young children about minimizing exposure to ultraviolet (UV) radiation for persons aged 6 months to 24 years with fair skin types to reduce their risk of skin cancer.', 'servfreq': '', 'risktext': 'Fair skin types'}, {'id': 438, 'title': 'Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for unhealthy alcohol use in primary care settings in adults 18 years or older, including pregnant women, and providing persons engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce unhealthy alcohol use.', 'servfreq': 'The USPSTF did not find adequate evidence to recommend an optimal screening interval for unhealthy alcohol use in adults.&nbsp;Brief behavioral counseling interventions were found to reduce unhealthy alcohol use in adults 18 years or older, including pregnant women. Effective behavioral counseling interventions vary in their specific components, administration, length, and number of interactions. The USPSTF was unable to identify specific intervention characteristics or components that were clearly associated with improved outcomes.', 'risktext': 'engaged in risky or hazardous drinking'}, {'id': 767, 'title': 'Unhealthy Drug Use: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening by asking questions about unhealthy drug use in adults age 18 years or older. Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. \r(Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'servfreq': 'Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. (Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'risktext': 'These include being aged 18 to 25 years; male sex; having a mental health condition, personality or mood disorder, or nicotine or alcohol dependence; a history of physical or sexual abuse, parental neglect, or other adversity in childhood; or drug or alcohol addiction in a first-degree relative.1,9&nbsp;Factors associated with misuse of prescription drugs include history of other drug use, mental illness, pain, and greater access to prescription drugs.10&nbsp;Factors associated with prenatal use of drugs include a mental health disorder, interpersonal violence, and family history of substance use.11'}, {'id': 433, 'title': 'Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer or refer adults with a body mass index (BMI) of 30 or higher (calculated as weight in kilograms divided by height in meters squared) to intensive, multicomponent behavioral interventions.', 'servfreq': '', 'risktext': 'Adults with a BMI &ge;30'}, {'id': 1979, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: Behavioral Counseling Interventions ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians individualize the decision to offer or refer adults without cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity. \r\rSee the "Practice Considerations" section for information on determining which patients may benefit most from this service.', 'servfreq': '', 'risktext': ''}, {'id': 1937, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for chlamydia and gonorrhea in men.', 'servfreq': '', 'risktext': ''}, {'id': 418, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening with resting or exercise electrocardiography (ECG) to prevent cardiovascular disease (CVD) events in asymptomatic adults at low risk of CVD events.', 'servfreq': '', 'risktext': ''}, {'id': 1973, 'title': 'Chronic Obstructive Pulmonary Disease: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for chronic obstructive pulmonary disease in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 2003, 'title': 'Genital Herpes Infection: Serologic Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine serologic screening for genital herpes simplex virus infection in asymptomatic adolescents and adults, including pregnant persons.', 'servfreq': '', 'risktext': 'The USPSTF found no evidence of externally validated, reliable risk stratification tools to identify individuals more or less likely to have genital herpes.'}, {'id': 504, 'title': 'Pancreatic Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for pancreatic cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 203, 'title': 'Testicular Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for testicular cancer in adolescent or adult men.', 'servfreq': '', 'risktext': ''}, {'id': 365, 'title': 'Thyroid Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for thyroid cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 1976, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'D', 'text': 'The DoctorAI recommends against the use of beta carotene or vitamin E supplements for the prevention of cardiovascular disease or cancer.', 'servfreq': '', 'risktext': ''}, {'id': 318, 'title': 'Autism Spectrum Disorder in Young Children: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for autism spectrum disorder (ASD) in young children for whom no concerns of ASD have been raised by their parents or a clinician.', 'servfreq': '', 'risktext': 'Although a number of potential risk factors for ASD have been identified, there is insufficient evidence to determine if certain risk factors modify the performance characteristics of ASD screening tests, such as the age at which screening is performed or other characteristics of the child or family.'}, {'id': 65, 'title': 'Bladder Cancer in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults.\r\rLiterature scans conducted in July 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'This evidence update focused on the benefits and harms of screening for bladder cancer among people without symptoms, the accuracy of screening tests done in primary care settings, and the benefits and harms of treatment. The updated evidence review did not find any new high quality evidence to adequately determine the balance of benefits and harms of screening for bladder cancer. However, bladder cancer is a common cancer and can cause considerable health problems including death. Therefore, the USPSTF determined that the evidence was insufficient to provide a recommendation for or against bladder cancer screening.  The USPSTF emphasizes the need for additional research in this area. '}, {'id': 419, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening with resting or exercise ECG to prevent CVD events in asymptomatic adults at intermediate or high risk of CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 423, 'title': 'Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of adding the ankle-brachial index (ABI), high-sensitivity C-reactive protein (hsCRP) level, or coronary artery calcium (CAC) score to traditional risk assessment for cardiovascular disease (CVD) in asymptomatic adults to prevent CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 352, 'title': 'Celiac Disease: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'persons with family history or other risk factors'}, {'id': 1955, 'title': 'Eating Disorders in Adolescents and Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for eating disorders in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 665, 'title': 'Illicit Drug Use in Children, Adolescents, and Young Adults: Primary Care-Based Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--based behavioral counseling interventions to prevent illicit drug use, including nonmedical use of prescription drugs, in children, adolescents, and young adults.\r\rSee the Practice Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 435, 'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for abuse and neglect in all older or vulnerable adults. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': 'Risk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health.14&nbsp;For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.15'}, {'id': 2045, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for iron deficiency and iron deficiency anemia in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2046, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine iron supplementation in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2018, 'title': 'Lipid Disorders in Children and Adolescents: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1998, 'title': 'Obstructive Sleep Apnea in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for obstructive sleep apnea in the general adult population.\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Risk Factors\r\nRisk factors associated with OSA include male sex, older age (40-70 years), postmenopausal status, higher body mass index (BMI), and craniofacial and upper airway abnormalities (eg, enlarged tonsils or long upper airway). Black, Hispanic/Latino, and Native American/Alaska Native persons have a higher prevalence of OSA compared with White persons; some evidence suggests that these differences are partially explained by higher rates of obesity, asthma, and tobacco use among these groups.8'}, {'id': 1977, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of multivitamin supplements for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1978, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of single or paired nutrient supplements (other than beta carotene and vitamin E) for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 176, 'title': 'Oral Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for oral cancer in asymptomatic adults.\r\rGo to the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in July 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Tobacco and alcohol use are major risk factors for oral cancer. A total of 20% to 30% of cases of oral cancer worldwide are attributable to cigarette smoking. In the United States, up to 75% of cases of oral cancer may be attributable to tobacco and alcohol use. Additional risk factors include male sex, older age, use of betel quid, ultraviolet light exposure, infection with Candida or bacterial flora, and a compromised immune system. Sexually transmitted oral HPV infection (HPV-16) has recently been recognized as an increasingly important risk factor for oropharyngeal cancer. In the United States, the prevalence of oropharyngeal cancer due to oral HPV infection is probably as high as 80% to 95%. The prevalence of oral HPV infection is associated with age, sex, number of sexual partners, and number of cigarettes smoked per day. The effect of multifactorial risk assessment and screening for risk factors on oral cancer morbidity and mortality is unknown.'}, {'id': 2026, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine screening performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 2027, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of preventive interventions performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 424, 'title': 'Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for peripheral artery disease (PAD) and cardiovascular disease (CVD) risk with the ankle-brachial index (ABI) in asymptomatic adults.\r\rLiterature scans conducted in August 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Risk factors associated with OSA include male sex, older age (40 to 70 years), postmenopausal status, higher BMI, and craniofacial and upper airway abnormalities.'}, {'id': 404, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of counseling adults about skin self-examination to prevent skin cancer.See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 2005, 'title': 'Skin Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Exposure to UV radiation from sun exposure, indoor tanning beds, and other UV radiation&ndash;emitting devices is the major environmental risk factor for skin cancer. History of frequent sunburns, older age, and male sex are associated with increased risk for skin cancer. Exposure to UV radiation from the use of indoor tanning beds is an important risk factor in adolescents. Incidence of melanoma is higher among White persons compared with persons of other races and ethnicities. This difference likely reflects traits associated with increased melanoma risk, such as fair skin (which is more susceptible to sunburning), light-colored eyes, and red or blond hair being more common among White persons compared with persons of other races and ethnicities. Acral lentiginous melanoma, which occurs mostly on skin not frequently exposed to direct sunlight (eg, palms of hands, soles of feet, or under fingernails or toenails), is the most common type of melanoma among Black populations. Other melanoma risk factors include higher numbers of moles on the skin, atypical moles, as well as a personal and family history of skin cancer.'}, {'id': 269, 'title': 'Thyroid Dysfunction: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults.\r\rSee the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': 'The optimal screening interval for thyroid dysfunction (if one exists) is unknown.', 'risktext': 'The most common cause of hypothyroidism in the United States is chronic autoimmune (Hashimoto) thyroiditis. Risk factors for an elevated TSH level include female sex, advancing age, white race, type 1 diabetes, Down syndrome, family history of thyroid disease, goiter, previous hyperthyroidism (possibly due in part to ablation therapy leading to iatrogenic thyroid dysfunction), and external-beam radiation in the head and neck area. Common causes of hyperthyroidism include Graves disease, Hashimoto thyroiditis, and functional thyroid nodules. Risk factors for a low TSH level include female sex; advancing age; black race; low iodine intake; personal or family history of thyroid disease; and ingestion of iodine-containing drugs, such as amiodarone. The USPSTF found no direct evidence that treatment of thyroid dysfunction based on risk level alters final health outcomes.'}, {'id': 1908, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of electronic cigarettes (e-cigarettes) for tobacco cessation in adults, including pregnant persons. The USPSTF recommends that clinicians direct patients who use tobacco to other tobacco cessation interventions with proven effectiveness and established safety.\rSee the Practice Considerations section for more information on recommended behavioral interventions and pharmacotherapy and for suggestions for practice regarding the I statements.', 'servfreq': '', 'risktext': ''}, {'id': 1919, 'title': 'Vitamin D Deficiency in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 408, 'title': 'Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of the benefits and harms of vitamin D and calcium supplementation, alone or combined, for the primary prevention of fractures in men and premenopausal women.', 'servfreq': '', 'risktext': ''}]}
2025-01-29 22:09:10 [INFO] Update id=273478225 is handled. Duration 684 ms by bot id=8108339380
2025-01-29 22:09:12 [INFO] Update id=273478226 is handled. Duration 676 ms by bot id=8108339380
2025-01-29 22:09:14 [INFO] Update id=273478227 is handled. Duration 713 ms by bot id=8108339380
2025-01-29 22:09:16 [INFO] Update id=273478228 is handled. Duration 681 ms by bot id=8108339380
2025-01-29 22:09:17 [INFO] State data: {'db': <bot.database.Database object at 0x7f20a250f530>, 'age': 20, 'weight': 90, 'height': 190, 'feet': 45, 'gender': 'male', 'pregnant': 'no', 'smoking': 'no', 'sex': 'Tools_1', 'recommendations': [{'id': 485, 'title': 'Human Immunodeficiency Virus (HIV) Infection: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians screen for HIV infection in adolescents and adults aged 15 to 65 years. Younger adolescents and older adults who are at increased risk of infection should also be screened.\rSee the Clinical Considerations section for more information about assessment of risk, screening intervals, and rescreening in pregnancy.', 'servfreq': 'The USPSTF found insufficient evidence to determine appropriate or optimal time intervals or strategies for repeat HIV screening. However, repeat screening is reasonable for persons known to be at increased risk of HIV infection, such as sexually active men who have sex with men; persons with a sex partner who is living with HIV; or persons who engage in behaviors that may convey an increased risk of HIV infection, such as injection drug use, transactional sex or commercial sex work, having 1 or more new sex partners whose HIV status is unknown, or having other factors that can place a person at increased risk of HIV infection (see &ldquo;Risk Assessment&rdquo;). Repeat screening is also reasonable for persons who live or receive medical care in a high-prevalence setting, such as a sexually transmitted disease clinic, tuberculosis clinic, correctional facility, or homeless shelter.', 'risktext': 'Although all adolescents and adults aged 15 to 65 years should be screened, there are a number of risk factors that increase risk. Among adolescents younger than 15 years and adults older than 65 years, clinicians should offer testing to patients at increased risk. Most new diagnoses of HIV infection are attributed to male-to-male sexual contact; injection drug use is another important risk factor. Additional risk factors include having anal intercourse without a condom, having vaginal intercourse without a condom and with more than 1 partner whose HIV status is unknown, exchanging sex for drugs or money (transactional sex), having other STIs or a sex partner with an STI, and having a sex partner who is living with HIV or is in a high-risk category. Persons who request testing for STIs, including HIV, are also considered to be at increased risk.'}, {'id': 1921, 'title': 'Hypertension in Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for hypertension in adults 18 years or older with office blood pressure measurement (OBPM). The USPSTF recommends obtaining blood pressure measurements outside of the clinical setting for diagnostic confirmation before starting treatment.', 'servfreq': ' \r\nAlthough evidence on optimal screening intervals is limited, reasonable options include:\r\n \r\n \r\n\r\n\r\nScreening for hypertension every year in adults 40 years or older and in adults at increased risk for hypertension (such as Black persons, persons with high-normal blood pressure, or persons who are overweight or obese)\r\n\r\n\r\n \r\n \r\n\r\n\r\nScreening less frequently (ie, every 3 to 5 years) as appropriate for adults aged 18 to 39 years not at increased risk for hypertension and with a prior normal blood pressure reading.\r\n\r\n\r\n ', 'risktext': ' \r\nAlthough all adults should be screened for hypertension, risk factors that increase a person&rsquo;s risk for the condition include older age, Black race, family history, excess weight and obesity, lifestyle habits (lack of physical activity, stress, and tobacco use), and dietary factors (diet high in fat or sodium, diet low in potassium, or excessive alcohol intake)\r\n '}, {'id': 2021, 'title': 'Prevention of Acquisition of HIV: Preexposure Prophylaxis ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians prescribe preexposure prophylaxis using effective antiretroviral therapy to persons who are at increased risk of HIV acquisition to decrease the risk of acquiring HIV. \r\rSee the Practice Considerations section for more information about identification of persons at increased risk and about effective antiretroviral therapy.', 'servfreq': '', 'risktext': 'HIV is primarily acquired via sexual activity or injection drug use. It is important that clinicians routinely take a sexual and injection drug use history for all their patients in an open and nonjudgmental manner. All adolescents and adults who are sexually active or who inject drugs should be informed that acquisition of HIV can be prevented, to facilitate subsequent risk assessment and discussions about preexposure prophylaxis (PrEP) and other ways to prevent acquisition of HIV. Importantly, risk of HIV acquisition exists on a continuum, and currently available risk assessment tools all have limitations. However, certain risk factors or behaviors are known to place persons at increased risk of HIV.\r\nRisk of HIV acquisition depends on the likelihood that a specific act or activity will transmit HIV and the likelihood that a sex partner or drug injection partner has HIV. Likelihood of HIV transmission is highest with needle-sharing injection drug use and condomless receptive anal intercourse. Condomless receptive anal intercourse has an approximately 10- to 15-fold higher risk of transmission than condomless insertive anal sex and condomless receptive and insertive penile-vaginal sex. A 2018 study estimated the prevalence of HIV (ie, an estimate of the likelihood that a partner whose HIV status is unknown has HIV at a population level) as 12.4% among men who have sex with men and 1.9% among persons who inject drugs. The overall prevalence of HIV in the US is estimated at 0.3%.&nbsp;Of note, both the frequency of specific sexual activities and a person&rsquo;s number of sexual partners will also affect their risk of HIV.\r\n&nbsp;The USPSTF recommends that the following persons be considered for PrEP:\r\n1.&nbsp;&nbsp;&nbsp;&nbsp; Sexually active adults and adolescents weighing at least 35 kg (77 lb) who have engaged in anal or vaginal sex in the past 6 months and have any of the following:\r\n&nbsp;\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A sexual partner who has HIV (especially if the partner has an unknown or detectable viral load).\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A bacterial sexually transmitted infection (STI) (syphilis, gonorrhea, or chlamydia for men who have sex with men and transgender women; gonorrhea and syphilis for heterosexual women and men) in the past 6 months.\r\n&middot;&nbsp;&nbsp;&nbsp;&nbsp; A history of inconsistent or no condom use with sex partner(s) whose HIV status is not known; assessing risk in conversation with the patient and considering factors such as number of partners, the specific sexual activities a person engages in, and whether their sex partner or partners are in a group with a higher prevalence of HIV (eg, men who have sex with men or with men and women, transgender women, persons who inject drugs, and persons who engage in transactional sex).\r\n&nbsp;\r\n2. &nbsp; Persons who inject drugs and have a drug-injecting partner who has HIV or who shares injection equipment.\r\nPersons who engage in transactional sex, such as sex for money, drugs, or housing, including commercial sex workers or persons trafficked for sex work, constitute a group at increased risk of HIV acquisition and should be considered for PrEP based on the criteria outlined above. Persons who request PrEP may have undisclosed behaviors that put them at risk. Transgender women and men who are sexually active should be considered for PrEP based on the criteria outlined above. Transgender women are at especially high risk of HIV acquisition. A Centers for Disease Control and and Prevention (CDC) survey in 7 cities found an HIV prevalence of 42% among transgender women. Prevalence was highest among Black transgender women (62%) and Native American/Alaska Native transgender women (65%).\r\nIn addition, studies have found that transmission of HIV to a seronegative partner from a partner with HIV has not been observed when the partner with HIV was being treated with antiretroviral therapy and had a suppressed viral load.&nbsp;It is not known whether PrEP use further decreases the risk of HIV transmission when a partner with HIV has a documented undetectable viral load. Factors such as the consistency or inconsistency of a partner&rsquo;s viral load being suppressed, a partner&rsquo;s adherence to antiretroviral therapy, and the degree of certainty that a partner&rsquo;s viral load is suppressed (eg, self-report vs availability of laboratory test results) may help inform decisions about the use of PrEP in this situation.\r\nAll persons being considered for PrEP must have a recently documented negative HIV antigen-antibody test result, and if they have taken oral PrEP or postexposure prophylaxis in the past 3 months, or injectable cabotegravir in the past 12 months, the CDC recommends testing with both an HIV antigen-antibody assay and an HIV-1 RNA assay.'}, {'id': 1989, 'title': 'Syphilis Infection in Nonpregnant Adolescents and Adults: Screening ', 'grade': 'A', 'text': 'The DoctorAI recommends screening for syphilis infection in persons who are at increased risk for infection.', 'servfreq': 'Optimal screening frequency for persons who are at increased risk for syphilis infection is not well established. Men who have sex with men or persons with HIV infection may benefit from screening at least annually or more frequently (eg, every 3 to 6 months) if they continue to be at high risk.', 'risktext': 'The USPSTF recommends screening for syphilis in persons who are at increased risk for infection. When deciding which persons to screen for syphilis, clinicians should consider the prevalence of infection in the communities they serve, as well as other sociodemographic and behavioral factors that may be associated with increased risk of syphilis infection. For example, prevalence of syphilis is higher in men, men who have sex with men, persons with HIV infection, young adults, and persons with a history of incarceration, sex work, or military service. A substantial percentage of heterosexual syphilis transmission occurs among persons who use illicit drugs, particularly methamphetamine. Diagnosis of another STI may signal that a person is having condomless sex, which increases their risk of syphilis infection. Higher infection rates in persons of some racial and ethnic groups have been reported and are primarily a reflection of a combination of factors, including social determinants of health (eg, disparities of income, low educational achievement, and unstable housing), differential health insurance coverage or access to quality health care, and differences in sexual network characteristics (eg, individuals living in communities with a high prevalence of STIs have an increased chance of encountering an infected partner). Local prevalence rates may change over time, so clinicians should be aware of the latest data and trends for their specific population and geographic area, which are available through their state and local health departments and Centers for Disease Control and Prevention (CDC) surveillance.\r\n&nbsp;\r\nAlthough direct evidence on screening in nonpregnant persons who are not at increased risk for syphilis infection is lacking, based on the established test performance characteristics of current screening tests and the low prevalence rate of syphilis in this population, the yield of screening is likely low.9,10 Therefore, screening in this population may result in high false-positive rates and overtreatment.'}, {'id': 1905, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'A', 'text': 'The DoctorAI recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and US Food and Drug Administration (FDA)--approved pharmacotherapy for cessation to nonpregnant adults who use tobacco.', 'servfreq': '', 'risktext': ''}, {'id': 2014, 'title': 'Anxiety Disorders in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for anxiety disorders in adults, including pregnant and postpartum persons.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding optimal timing for screening, or screening interval, for both the perinatal and general adult populations; more evidence on both timing and screening interval is needed for all adult populations. A pragmatic approach in the absence of evidence might include screening all adults who have not been screened previously and using clinical judgment in considering risk factors, comorbid conditions, and life events to determine if additional screening of high-risk patients is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nRisk factors for anxiety disorders include sociodemographic factors, psychosocial factors, and physical and mental health factors such as marital status (widowed or divorced), stressful life events, smoking and alcohol use, other mental health conditions, or a parental history of mental disorders. Demographic factors such as low socioeconomic status and female sex are associated with higher rates of anxiety disorders.&nbsp;Black persons and individuals of non-Hispanic ethnicity are at increased risk of anxiety disorders due to social, rather than biological, factors. Anxiety and depressive disorders often overlap. One cohort study found that 67% of individuals with a depressive disorder also had a current anxiety disorder, and 75% had a lifetime comorbid anxiety disorder.'}, {'id': 2009, 'title': 'Latent Tuberculosis Infection in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for LTBI in populations at increased risk.\r\rSee the "Assessment of Risk" section for additional information on adults at increased risk.', 'servfreq': 'The USPSTF found no evidence on the optimal frequency of screening for LTBI. In the absence of evidence, a reasonable approach is to repeat screening based on specific risk factors; screening frequency could range from 1-time only screening among persons at low risk for future tuberculosis exposure to annual screening among those at continued risk of exposure.', 'risktext': 'Populations at increased risk for LTBI, based on increased prevalence of active disease and increased risk of exposure, include persons who were born in, or are former residents of, countries with high tuberculosis prevalence and persons who live in, or have lived in, high-risk congregate settings (eg, homeless shelters or correctional facilities). Clinicians can consult their local or state health departments for more information about populations at increased risk in their community, since local demographic patterns may vary across the US.\r\nIn 2020, 71.5% of all cases of active tuberculosis in the US occurred among persons born outside the US. According to the CDC, tuberculosis disease is common in most countries in Latin America, the Caribbean, Africa, Asia, Eastern Europe, and Russia. In 2020, among persons with new tuberculosis living in the US who were born outside the US, the most common countries of birth were Mexico (18.0%), the Philippines (12.5%), India (10.4%), Vietnam (8.2%), and China (5.1%), accounting for 54.2% of total cases. Most of these cases are believed to be due to progression of latent infection to active tuberculosis disease rather than new transmission within communities.\r\nPersons who live, or have lived, in high-risk congregate settings also have a higher prevalence rate of active tuberculosis and an increased risk for exposure. In 2020, 4.3% of tuberculosis disease cases diagnosed in persons 15 years or older occurred in persons experiencing homelessness and 2.6% occurred in residents of correctional facilities. It is estimated that persons experiencing homelessness have an 11 times higher incidence of tuberculosis disease compared with persons who are not experiencing homelessness (36 cases per 100,000 population vs 2.9 cases per 100,000 population, respectively, during 2011 to 2016).\r\nOther populations at increased risk for LTBI or progression to active disease include persons who have immunosuppression (eg, persons living with HIV, patients receiving immunosuppressive medications such as chemotherapy or tumor necrosis factor inhibitors, and patients who have received an organ transplant) and patients with silicosis (a lung disease). However, given that screening in these populations may be considered standard care as part of disease management or indicated prior to the use of certain medications, the USPSTF did not review evidence on screening in these populations. Information on testing in these populations is provided by other groups, such as the Office of AIDS Research at the National Institutes of Health, and in a guideline issued jointly by the American Thoracic Society, Infectious Diseases Society of America, and CDC. Some evidence from observational studies has explored the association between poorly controlled diabetes and progression of LTBI to active disease. However, there is insufficient evidence on screening for and treatment of LTBI in persons with diabetes for the USPSTF to make a separate recommendation for this important population.\r\nPersons who are contacts of individuals with active tuberculosis, health care workers, and workers in high-risk congregate settings may also be at increased risk of exposure. Because screening in these populations is conducted as part of public health or employee health surveillance, the USPSTF did not review the evidence in these populations. Clinicians seeking further information about testing for tuberculosis in these populations can refer to the Additional Tools and Resources and Recommendations of Others sections.'}, {'id': 514, 'title': 'Asymptomatic Bacteriuria in Adults: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic bacteriuria in nonpregnant adults.', 'servfreq': '', 'risktext': 'The risk of developing asymptomatic bacteriuria varies by age, sex, and pregnancy status.6 Because of the location and length of the female urethra, women are predisposed to infections of the urinary tract, including asymptomatic bacteriuria.5 Physiologic changes in both pregnant and older women increase the risk of asymptomatic bacteriuria and a urinary tract infection.7, 11, 12 In general, men are at low risk of developing asymptomatic bacteriuria, although rates increase with older age.12 Persons with diabetes are also at increased risk of developing asymptomatic bacteriuria.4, 6'}, {'id': 1909, 'title': 'Asymptomatic Carotid Artery Stenosis: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for asymptomatic carotid artery stenosis in the general adult population.\r\rSee the Practice Considerations section for a description of adults at increased risk.', 'servfreq': '', 'risktext': ''}, {'id': 2017, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for suicide risk in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': '', 'risktext': ''}, {'id': 2016, 'title': 'Depression and Suicide Risk in Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for depression in the adult population, including pregnant and postpartum persons, as well as older adults.', 'servfreq': 'Screening Intervals\r\nThere is little evidence regarding the optimal timing for screening for depression; more evidence is needed in both perinatal and general adult populations. In the absence of evidence, a pragmatic approach might include screening adults who have not been screened previously and using clinical judgment while considering risk factors, comorbid conditions, and life events to determine if additional screening of patients at increased risk is warranted. Ongoing assessment of risks that may develop during pregnancy and the postpartum period is also a reasonable approach.', 'risktext': 'Assessment of Risk\r\nThe USPSTF recommends screening for depression in all adults regardless of risk factors. Risk factors for depression include a combination of genetic, biological, and environmental factors, such as a family history of depression, prior episode of depression or other mental health condition, a history of trauma or adverse life events, or a history of disease or illness (eg, cardiovascular disease).\r\nPrevalence rates vary by sex, age, race, ethnicity, education, marital status, geographic location, poverty level, and employment status. Women have twice the risk of depression compared with men. Young adults, multiracial individuals, and Native American/Alaska Native individuals have higher rates of depression.\r\nRisk factors for perinatal depression include life stress, low social support, history of depression, marital or partner dissatisfaction, and a history of abuse.'}, {'id': 1845, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends offering or referring adults with cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity.', 'servfreq': '', 'risktext': 'Adults 18 years or older at increased risk of CVD, defined as those with 1 or more of the following:\r\n1.Hypertension or elevated blood pressure2.Dyslipidemia3.Mixed or multiple risk factors such as the metabolic syndrome or an estimated 10-year CVD risk of &ge;7.5%\r\nThis recommendation does not apply to adults with other known modifiable cardiovascular risk factors such as abnormal blood glucose levels, obesity, and smoking; these populations are incorporated in other USPSTF recommendations.'}, {'id': 1885, 'title': 'Hepatitis B Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis B virus (HBV) infection in adolescents and adults at increased risk for infection.\r\rSee the Practice Considerations section for a description of adolescents and adults at increased risk for infection.', 'servfreq': 'For patients with negative HBsAg results who have not received the HBV vaccine series, periodic screening may be useful for those who report continued risk for acquiring HBV transmission, such as persons who continue to inject drugs and men who have sex with men. Clinical judgment should be used to determine screening frequency. The USPSTF found no evidence to determine optimal screening intervals.', 'risktext': 'Persons from such risk groups include persons who have injected drugs in the past or currently; men who have sex with men; persons with HIV; and sex partners, needle-sharing contacts, and household contacts of persons known to be HBsAg positive. Some persons with combinations of risk factors who are not members of risk factor groups listed above may also be at increased risk for HBV infection.'}, {'id': 524, 'title': 'Hepatitis C Virus Infection in Adolescents and Adults: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for hepatitis C virus (HCV) infection in adults aged 18 to 79 years.', 'servfreq': 'One-time screening for most adults.\r\nPeriodically screen persons with continued risk for HCV infection (eg, persons with past or current injection drug use). There is limited evidence to determine how often to screen persons at increased risk.&nbsp;', 'risktext': 'Asymptomatic adults aged 18 to 79 years (including pregnant persons) without known liver disease.&nbsp;\r\nThe USPSTF also suggests that clinicians consider screening persons younger than 18 years and older than 79 years who are at high risk for infection (eg, those with past or current injection drug use).&nbsp;'}, {'id': 1445, 'title': 'Sexually Transmitted Infections: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends behavioral counseling for all sexually active adolescents and for adults who are at increased risk for sexually transmitted infections (STIs).\r\rSee the Practice Considerations section for more information on populations at increased risk for acquiring STIs.', 'servfreq': '', 'risktext': 'All sexually active adolescents are at increased risk for STIs because of the high rates of STIs in this age group and should receive behavioral counseling interventions. Adults at increased risk for STIs include those who currently have an STI or were diagnosed with one within the past year, do not consistently use condoms, have multiple sex partners, or have sex partners within populations with a high prevalence of STIs. Populations with a high prevalence of STIs include persons who seek STI testing or attend STI clinics; sexual and gender minorities; persons who are living with HIV, inject drugs, have exchanged sex for money or drugs, or have entered correctional facilities; and some racial/ethnic minority groups.1-4'}, {'id': 402, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'B', 'text': 'The DoctorAI recommends counseling young adults, adolescents, children, and parents of young children about minimizing exposure to ultraviolet (UV) radiation for persons aged 6 months to 24 years with fair skin types to reduce their risk of skin cancer.', 'servfreq': '', 'risktext': 'Fair skin types'}, {'id': 438, 'title': 'Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends screening for unhealthy alcohol use in primary care settings in adults 18 years or older, including pregnant women, and providing persons engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce unhealthy alcohol use.', 'servfreq': 'The USPSTF did not find adequate evidence to recommend an optimal screening interval for unhealthy alcohol use in adults.&nbsp;Brief behavioral counseling interventions were found to reduce unhealthy alcohol use in adults 18 years or older, including pregnant women. Effective behavioral counseling interventions vary in their specific components, administration, length, and number of interactions. The USPSTF was unable to identify specific intervention characteristics or components that were clearly associated with improved outcomes.', 'risktext': 'engaged in risky or hazardous drinking'}, {'id': 767, 'title': 'Unhealthy Drug Use: Screening ', 'grade': 'B', 'text': 'The DoctorAI recommends screening by asking questions about unhealthy drug use in adults age 18 years or older. Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. \r(Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'servfreq': 'Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. (Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)', 'risktext': 'These include being aged 18 to 25 years; male sex; having a mental health condition, personality or mood disorder, or nicotine or alcohol dependence; a history of physical or sexual abuse, parental neglect, or other adversity in childhood; or drug or alcohol addiction in a first-degree relative.1,9&nbsp;Factors associated with misuse of prescription drugs include history of other drug use, mental illness, pain, and greater access to prescription drugs.10&nbsp;Factors associated with prenatal use of drugs include a mental health disorder, interpersonal violence, and family history of substance use.11'}, {'id': 433, 'title': 'Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions ', 'grade': 'B', 'text': 'The DoctorAI recommends that clinicians offer or refer adults with a body mass index (BMI) of 30 or higher (calculated as weight in kilograms divided by height in meters squared) to intensive, multicomponent behavioral interventions.', 'servfreq': '', 'risktext': 'Adults with a BMI &ge;30'}, {'id': 1979, 'title': 'Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Disease Risk Factors: Behavioral Counseling Interventions ', 'grade': 'C', 'text': 'The DoctorAI recommends that clinicians individualize the decision to offer or refer adults without cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity. \r\rSee the "Practice Considerations" section for information on determining which patients may benefit most from this service.', 'servfreq': '', 'risktext': ''}, {'id': 1937, 'title': 'Chlamydia and Gonorrhea: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for chlamydia and gonorrhea in men.', 'servfreq': '', 'risktext': ''}, {'id': 418, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening with resting or exercise electrocardiography (ECG) to prevent cardiovascular disease (CVD) events in asymptomatic adults at low risk of CVD events.', 'servfreq': '', 'risktext': ''}, {'id': 1973, 'title': 'Chronic Obstructive Pulmonary Disease: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for chronic obstructive pulmonary disease in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 2003, 'title': 'Genital Herpes Infection: Serologic Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against routine serologic screening for genital herpes simplex virus infection in asymptomatic adolescents and adults, including pregnant persons.', 'servfreq': '', 'risktext': 'The USPSTF found no evidence of externally validated, reliable risk stratification tools to identify individuals more or less likely to have genital herpes.'}, {'id': 504, 'title': 'Pancreatic Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for pancreatic cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 203, 'title': 'Testicular Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for testicular cancer in adolescent or adult men.', 'servfreq': '', 'risktext': ''}, {'id': 365, 'title': 'Thyroid Cancer: Screening ', 'grade': 'D', 'text': 'The DoctorAI recommends against screening for thyroid cancer in asymptomatic adults.', 'servfreq': '', 'risktext': ''}, {'id': 1976, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'D', 'text': 'The DoctorAI recommends against the use of beta carotene or vitamin E supplements for the prevention of cardiovascular disease or cancer.', 'servfreq': '', 'risktext': ''}, {'id': 318, 'title': 'Autism Spectrum Disorder in Young Children: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for autism spectrum disorder (ASD) in young children for whom no concerns of ASD have been raised by their parents or a clinician.', 'servfreq': '', 'risktext': 'Although a number of potential risk factors for ASD have been identified, there is insufficient evidence to determine if certain risk factors modify the performance characteristics of ASD screening tests, such as the age at which screening is performed or other characteristics of the child or family.'}, {'id': 65, 'title': 'Bladder Cancer in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults.\r\rLiterature scans conducted in July 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'This evidence update focused on the benefits and harms of screening for bladder cancer among people without symptoms, the accuracy of screening tests done in primary care settings, and the benefits and harms of treatment. The updated evidence review did not find any new high quality evidence to adequately determine the balance of benefits and harms of screening for bladder cancer. However, bladder cancer is a common cancer and can cause considerable health problems including death. Therefore, the USPSTF determined that the evidence was insufficient to provide a recommendation for or against bladder cancer screening.  The USPSTF emphasizes the need for additional research in this area. '}, {'id': 419, 'title': 'Cardiovascular Disease Risk: Screening With Electrocardiography ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening with resting or exercise ECG to prevent CVD events in asymptomatic adults at intermediate or high risk of CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 423, 'title': 'Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of adding the ankle-brachial index (ABI), high-sensitivity C-reactive protein (hsCRP) level, or coronary artery calcium (CAC) score to traditional risk assessment for cardiovascular disease (CVD) in asymptomatic adults to prevent CVD events. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 352, 'title': 'Celiac Disease: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'persons with family history or other risk factors'}, {'id': 1955, 'title': 'Eating Disorders in Adolescents and Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for eating disorders in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 665, 'title': 'Illicit Drug Use in Children, Adolescents, and Young Adults: Primary Care-Based Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care--based behavioral counseling interventions to prevent illicit drug use, including nonmedical use of prescription drugs, in children, adolescents, and young adults.\r\rSee the Practice Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 435, 'title': 'Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for abuse and neglect in all older or vulnerable adults. See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': 'Risk factors for elder abuse include isolation and lack of social support, functional impairment, and poor physical health.14&nbsp;For older adults, lower income and living in a shared living environment with a large number of household members (other than a spouse) are associated with an increased risk of financial and physical abuse.15'}, {'id': 2045, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for iron deficiency and iron deficiency anemia in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2046, 'title': 'Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine iron supplementation in pregnant persons to prevent adverse maternal and infant health outcomes.', 'servfreq': '', 'risktext': ''}, {'id': 2018, 'title': 'Lipid Disorders in Children and Adolescents: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1998, 'title': 'Obstructive Sleep Apnea in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for obstructive sleep apnea in the general adult population.\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Risk Factors\r\nRisk factors associated with OSA include male sex, older age (40-70 years), postmenopausal status, higher body mass index (BMI), and craniofacial and upper airway abnormalities (eg, enlarged tonsils or long upper airway). Black, Hispanic/Latino, and Native American/Alaska Native persons have a higher prevalence of OSA compared with White persons; some evidence suggests that these differences are partially explained by higher rates of obesity, asthma, and tobacco use among these groups.8'}, {'id': 1977, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of multivitamin supplements for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 1978, 'title': 'Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of single or paired nutrient supplements (other than beta carotene and vitamin E) for the prevention of cardiovascular disease or cancer.\r\rSee the "Practice Considerations" section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 176, 'title': 'Oral Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for oral cancer in asymptomatic adults.\r\rGo to the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in July 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Tobacco and alcohol use are major risk factors for oral cancer. A total of 20% to 30% of cases of oral cancer worldwide are attributable to cigarette smoking. In the United States, up to 75% of cases of oral cancer may be attributable to tobacco and alcohol use. Additional risk factors include male sex, older age, use of betel quid, ultraviolet light exposure, infection with Candida or bacterial flora, and a compromised immune system. Sexually transmitted oral HPV infection (HPV-16) has recently been recognized as an increasingly important risk factor for oropharyngeal cancer. In the United States, the prevalence of oropharyngeal cancer due to oral HPV infection is probably as high as 80% to 95%. The prevalence of oral HPV infection is associated with age, sex, number of sexual partners, and number of cigarettes smoked per day. The effect of multifactorial risk assessment and screening for risk factors on oral cancer morbidity and mortality is unknown.'}, {'id': 2026, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine screening performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 2027, 'title': 'Oral Health in Adults: Screening and Preventive Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of preventive interventions performed by primary care clinicians for oral health conditions, including dental caries or periodontal-related disease, in adults.', 'servfreq': '', 'risktext': ''}, {'id': 424, 'title': 'Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for peripheral artery disease (PAD) and cardiovascular disease (CVD) risk with the ankle-brachial index (ABI) in asymptomatic adults.\r\rLiterature scans conducted in August 2023 in the MEDLINE database and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': '', 'risktext': 'Risk factors associated with OSA include male sex, older age (40 to 70 years), postmenopausal status, higher BMI, and craniofacial and upper airway abnormalities.'}, {'id': 404, 'title': 'Skin Cancer Prevention: Behavioral Counseling ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of counseling adults about skin self-examination to prevent skin cancer.See the Clinical Considerations section for suggestions for practice regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 2005, 'title': 'Skin Cancer: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of visual skin examination by a clinician to screen for skin cancer in adolescents and adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': 'Exposure to UV radiation from sun exposure, indoor tanning beds, and other UV radiation&ndash;emitting devices is the major environmental risk factor for skin cancer. History of frequent sunburns, older age, and male sex are associated with increased risk for skin cancer. Exposure to UV radiation from the use of indoor tanning beds is an important risk factor in adolescents. Incidence of melanoma is higher among White persons compared with persons of other races and ethnicities. This difference likely reflects traits associated with increased melanoma risk, such as fair skin (which is more susceptible to sunburning), light-colored eyes, and red or blond hair being more common among White persons compared with persons of other races and ethnicities. Acral lentiginous melanoma, which occurs mostly on skin not frequently exposed to direct sunlight (eg, palms of hands, soles of feet, or under fingernails or toenails), is the most common type of melanoma among Black populations. Other melanoma risk factors include higher numbers of moles on the skin, atypical moles, as well as a personal and family history of skin cancer.'}, {'id': 269, 'title': 'Thyroid Dysfunction: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults.\r\rSee the Clinical Considerations section for suggestions for practice regarding the I statement.\r\rLiterature scans conducted in May 2024 in the MEDLINE and PubMed databases and the Cochrane Library showed a lack of new evidence to support an updated systematic review on the topic at this time. See the Literature Surveillance Report under the Supporting Evidence section of this webpage.', 'servfreq': 'The optimal screening interval for thyroid dysfunction (if one exists) is unknown.', 'risktext': 'The most common cause of hypothyroidism in the United States is chronic autoimmune (Hashimoto) thyroiditis. Risk factors for an elevated TSH level include female sex, advancing age, white race, type 1 diabetes, Down syndrome, family history of thyroid disease, goiter, previous hyperthyroidism (possibly due in part to ablation therapy leading to iatrogenic thyroid dysfunction), and external-beam radiation in the head and neck area. Common causes of hyperthyroidism include Graves disease, Hashimoto thyroiditis, and functional thyroid nodules. Risk factors for a low TSH level include female sex; advancing age; black race; low iodine intake; personal or family history of thyroid disease; and ingestion of iodine-containing drugs, such as amiodarone. The USPSTF found no direct evidence that treatment of thyroid dysfunction based on risk level alters final health outcomes.'}, {'id': 1908, 'title': 'Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of electronic cigarettes (e-cigarettes) for tobacco cessation in adults, including pregnant persons. The USPSTF recommends that clinicians direct patients who use tobacco to other tobacco cessation interventions with proven effectiveness and established safety.\rSee the Practice Considerations section for more information on recommended behavioral interventions and pharmacotherapy and for suggestions for practice regarding the I statements.', 'servfreq': '', 'risktext': ''}, {'id': 1919, 'title': 'Vitamin D Deficiency in Adults: Screening ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults.\r\rSee the Practice Considerations section for additional information regarding the I statement.', 'servfreq': '', 'risktext': ''}, {'id': 408, 'title': 'Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication ', 'grade': 'I', 'text': 'The DoctorAI concludes that the current evidence is insufficient to assess the balance of the benefits and harms of vitamin D and calcium supplementation, alone or combined, for the primary prevention of fractures in men and premenopausal women.', 'servfreq': '', 'risktext': ''}]}
2025-01-29 22:09:18 [INFO] Update id=273478229 is handled. Duration 851 ms by bot id=8108339380
2025-01-29 22:11:42 [WARNING] Received SIGTERM signal
2025-01-29 22:11:42 [INFO] Polling stopped for bot @phenkka_test_bot id=8108339380 - 'Test'
2025-01-29 22:11:42 [INFO] Polling stopped
2025-01-29 22:11:42 [INFO] โ ะัะป ะฟะพะดะบะปััะตะฝะธะน ะบ ะะ ะทะฐะบััั.
2025-01-29 22:11:42 [INFO] โ ะะพะดะบะปััะตะฝะธะต ะบ ะะ ะทะฐะบัััะพ.
